EC,reaction
1.1.1.1," a primary alcohol + NAD+ = an aldehyde + NADH + H+ (#4,43# ordered  bi-bi mechanism <31,43>; #4,78# rapid equilibrium random mechanism  <63>; #9# ordered bi bi mechanism with cofactor adding first to form a  binary enzyme complex <23>; #43# isoenzyme EE and SS: ordered bi bi  mechanism <35>; #11,35# mechanism is predominantly ordered with  ethanol, but partially random with butanol <91>; #43# kinetic mechanism  is random for ethanol oxidation and compulsory ordered for acetaldehyde  reduction <41>; #40# oxidizes ethanol in an ordered bi-bi mechanism  with NAD+ as the first substrate fixed <85>; #11# compulsory-order  mechanism with the rate-limiting step being the dissociation of the  product enzyme-NAD+ complex <90>; #30,70,81# Theorell-Chance mechanism  <38,69,74>; #46# sequential reaction mechanism <114>; #90# active site  structure <127>; #81# catalytic mechanism involves a proton relay  modulated by the coupled ionization of the active site Lys155/Tyr151  pair, and a NAD+ ribose 2-OH switch, other active site residues are  Ser138 and Trp144, ionization properties, substrate binding, overview  <130>; #9# class IV alcohol dehydrogenase also functions as retinol  dehydrogenase, reaction and kinetic mechanism: asymmetric rapid  equilibrium random mechanism with 2 dead-end ternary complexes fro  retinol oxidation and a rapid equilibrium ordered mechanism with one  dead-end ternary complex for retinal reduction, a unique mechanistic  form fro zinc-containing ADH in the medium chain  dehydrogenase/reductase superfamily of enzymes <124>; #11# detailed  determination of the reaction and kinetic mechanisms, active site  structure and determination of amino acid residues involved in  catalysis, 3 isozymes <120>; #119# ordered bibi mechanism, structural  and functional implications of amino acid residue 47 <110>; #43#  ordered sequential bibi reaction mechanism, modeling of oxidation  kinetic mechanism <117>; #121# reaction mechanism, His51 is involved,  but not essential, in catalysis facilitating the deprotonation of the  hydroxyl group of water or alcohol ligated to the catalytic zinc <111>;  #9# Ser48 is involved in catalysis, isozyme gamma(2)gamma(2) <109>;  #29# the catalytic triad consists of Cys44, His67, and Cys154, active  site structure <129>) "
1.1.1.1, a secondary alcohol + NAD+ = a ketone + NADH + H+  
1.1.1.10," xylitol + NADP+ = L-xylulose + NADPH + H+ (#16# probably identical with  EC 1.1.1.5 diacetyl reductase <10>; #3# active site structure <12>;  #18# active site residues are Cys138, Val143, His146, Trp191, and  Met200, the catalytic tetrad is formed by Asn107, Ser136, Tyr149, and  Lys153, substrate binding site structure, enzyme with dual function  showing L-xylulose reductase activity and dicarbonyl reductase  activity, EC 1.1.1.5 <17>; #20,21,22,23# enzyme with dual function  showing L-xylulose reductase and dicarbonyl reductase activities <14>;  #2,3,18# enzyme with dual function showing L-xylulose reductase and  dicarbonyl reductase activities, it is probably identical with sperm 34  kDa protein P34H and diacetyl reductase, EC 1.1.1.5 <11,14>; #4# enzyme  with dual function showing L-xylulose reductase and dicarbonyl  reductase activities, it is probably identical with sperm 34 kDa  protein P34H and diacetyl reductase, EC 1.1.1.5, the amino acid  residues Ser136, Tyr149, and Lys153 form the catalytic triad <13>; #9#  immunological analysis revealed that the dicarbonyl/L-xylulose  reductase is not identical with the sperm protein P26h <16>)  "
1.1.1.100," a (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ = a  3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#16# belongs to family  of short-chain alcohol dehydrogenases (SDR) with catalytic triad  Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #24# chemical and  kinetic mechanism <25>; #26# cofactor and substrate binding kinetics,  allosteric regulation mechanism, overview <26>; #43# ordered bi bi  kinetic mechanism, [acyl-carrier protein] recognition mechanism <23>;  #20# reaction mechanism, random bi bi kinetic mechanism <24>; #24#  positive cooperativity in binding of NADPH to enzyme, no cooperativity  in binding of acetoacyl-CoA. Pre-existing equilibrium of two forms of  free MabA in solution followed by a bimolecular association process  <31>)  "
1.1.1.101, 1-palmitoylglycerol 3-phosphate + NADP+ = palmitoylglycerone phosphate  + NADPH + H+  
1.1.1.102, sphinganine + NADP+ = 3-dehydrosphinganine + NADPH + H+  
1.1.1.103," L-threonine + NAD+ = L-2-amino-3-oxobutanoate + NADH + H+ (#7# it is  suggested that the unstable L-2-amino-3-oxobutanoate spontaneousely  decarboxylates to the stable aminoacetone, there is also some evidence  that L-threonine is oxidatively decarboxylated by threonine  dehydrogenase to produce aminoacetone <13>; #21# ordered bi-bi  mechanism, NAD+ binds prior to L-threonine <25>; #10# His94 is an  active site residue, substrate binding involved residues Gly66, Gly71,  Gly77, and Val80 <29>; #16# reaction mechanism, random bi bi kinetic  mechanism <28>; #22# catalytic mechanism, the carboxyl group of Glu152  is important for expressing the catalytic activity, the proton relay  system works as a catalytic mechanism of TDH <31>; #18# reaction  mechanism involving catalytic residues T112, Y137, and K141, overview  <40>)  "
1.1.1.104, 4-hydroxy-L-proline + NAD+ = 4-oxoproline + NADH + H+  
1.1.1.105, all-trans-retinol-[cellular-retinol-binding-protein] + NAD+ =  all-trans-retinal-[cellular-retinol-binding-protein] + NADH + H+  
1.1.1.106, (R)-pantoate + NAD+ = (R)-4-dehydropantoate + NADH + H+  
1.1.1.107, pyridoxal + NAD+ = 4-pyridoxolactone + NADH + H+  
1.1.1.108, carnitine + NAD+ = 3-dehydrocarnitine + NADH + H+  
1.1.1.11, D-arabinitol + NAD+ = D-xylulose + NADH + H+  
1.1.1.110, (R)-(indol-3-yl)lactate + NAD+ = (indol-3-yl)pyruvate + NADH + H+ 
1.1.1.110, (R)-3-(4-hydroxyphenyl)lactate + NAD+ = 3-(4-hydroxyphenyl)pyruvate +  NADH + H+  
1.1.1.111, (S)-3-(imidazol-5-yl)lactate + NAD(P)+ = 3-(imidazol-5-yl)pyruvate +  NAD(P)H + H+  
1.1.1.112," indan-1-ol + NAD(P)+ = indanone + NAD(P)H + H+ (#4# A-stereospecific  enzyme, ping-pong mechanism <1>)  "
1.1.1.113," L-xylose + NADP+ = L-xylono-1,4-lactone + NADPH + H+  "
1.1.1.114, D-apiitol + NAD+ = D-apiose + NADH + H+  
1.1.1.115, D-ribose + NADP+ + H2O = D-ribonate + NADPH + H+  
1.1.1.116," D-arabinose + NAD+ = D-arabinono-1,4-lactone + NADH + H+  "
1.1.1.117," D-arabinose + NAD(P)+ = D-arabinono-1,4-lactone + NAD(P)H + H+  "
1.1.1.118," D-glucose + NAD+ = D-glucono-1,5-lactone + NADH + H+  "
1.1.1.119," D-glucose + NADP+ = D-glucono-1,5-lactone + NADPH + H+  "
1.1.1.12, L-arabinitol + NAD+ = L-xylulose + NADH + H+  
1.1.1.120," D-galactose + NADP+ = D-galactono-1,5-lactone + NADPH + H+  "
1.1.1.121," D-aldose + NAD+ = D-aldonolactone + NADH + H+ (#2# catalytic mechanism  involving a conserved catalytic triad Ser-Tyr-Lys at the catalytic  site, the C-terminal tail shuts the substrate-binding pocket, overview  <6>)  "
1.1.1.122," a D-threo-aldose + NAD+ = a D-threo-aldono-1,5-lactone + NADH + H+  "
1.1.1.123, L-sorbose + NADP+ = 5-dehydro-D-fructose + NADPH + H+  
1.1.1.124, D-fructose + NADP+ = 5-dehydro-D-fructose + NADPH + H+  
1.1.1.125, 2-deoxy-D-gluconate + NAD+ = 3-dehydro-2-deoxy-D-gluconate + NADH + H+  
1.1.1.126," 2-dehydro-3-deoxy-D-gluconate + NADP+ =  (4S,5S)-4,5-dihydroxy-2,6-dioxohexanoate + NADPH + H+  "
1.1.1.127," 2-dehydro-3-deoxy-D-gluconate + NAD+ =  (4S)-4,6-dihydroxy-2,5-dioxohexanoate + NADH + H+  "
1.1.1.129, L-threonate + NAD+ = 3-dehydro-L-erythronate + NADH + H+  
1.1.1.13, L-arabinitol + NAD+ = L-ribulose + NADH + H+  
1.1.1.130," 3-dehydro-L-gulonate + NAD(P)+ =  (4R,5S)-4,5,6-trihydroxy-2,3-dioxohexanoate + NAD(P)H + H+  "
1.1.1.131, D-mannonate + NAD(P)+ = D-mannuronate + NAD(P)H + H+  
1.1.1.132, GDP-D-mannose + 2 NAD+ + H2O = GDP-D-mannuronate + 2 NADH + 2 H+ (#1#  class of 4-electron transfer dehydrogenases <12>)  
1.1.1.133, dTDP-beta-L-rhamnose + NADP+ = dTDP-4-dehydro-beta-L-rhamnose + NADPH +  H+  
1.1.1.134, dTDP-6-deoxy-beta-L-talose + NADP+ = dTDP-4-dehydro-beta-L-rhamnose +  NADPH + H+  
1.1.1.135, GDP-6-deoxy-alpha-D-talose + NAD(P)+ = GDP-4-dehydro-alpha-D-rhamnose +  NAD(P)H + H+  
1.1.1.136, UDP-N-acetyl-alpha-D-glucosamine + 2 NAD+ + H2O =  UDP-2-acetamido-2-deoxy-alpha-D-glucuronate + 2 NADH + 2 H+  
1.1.1.137, D-ribitol 5-phosphate + NAD(P)+ = D-ribulose 5-phosphate + NAD(P)H + H+  
1.1.1.138, D-mannitol + NADP+ = D-fructose + NADPH + H+ (#25# sequential ordered  bi-bi mechanism <19>; #29# sequential ordered bi bi mechanism <31>)  
1.1.1.14," L-iditol + NAD+ = L-sorbose + NADH + H+ (#3,6,7# ordered catalytic  mechanism and substrate binding <35>; #10# ordered catalytic mechanism  and substrate binding, active site structure <35>)  "
1.1.1.140, D-sorbitol 6-phosphate + NAD+ = D-fructose 6-phosphate + NADH + H+  
1.1.1.141," (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate + NAD+ =  (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NADH + H+ (#6#  NAD+ is added first, followed by prostaglandin E2, 15-ketoprostaglandin  is released followed by NADH <13>; #4# single displacement mechanism  <5,12>; #4,6# ordered bi-bi-mechanism <9,13>; #4# displacement reaction  mechanism, at pH 7.0 a kinetically significant ternary complex is  formed, while at pH 9.0 the ternary complex is not kinetically  significant, Theorell-Chance mechanism <5>; #4# residues and domains  involved in catalysis and substrate binding, overview <44>; #4#  substrate binidng and catalytic mechanism of the enzyme, homology  modeling, docking and molecular dynamics simulation, residues Gln148,  Ser138, Tyr151, and Lys155 are important, overview <39>)  "
1.1.1.142," 1D-3-O-methyl-chiro-inositol + NADP+ =  2D-5-O-methyl-2,3,5/4,6-pentahydroxycyclohexanone + NADPH + H+  "
1.1.1.143," 5-O-methyl-myo-inositol + NAD+ =  2D-5-O-methyl-2,3,5/4,6-pentahydroxycyclohexanone + NADH + H+  "
1.1.1.144, perillyl alcohol + NAD+ = perillyl aldehyde + NADH + H+  
1.1.1.145," a 3beta-hydroxy-DELTA5-steroid + NAD+ = a 3-oxo-DELTA5-steroid + NADH +  H+ (#4# structure-function relationship <41>; #25# catalytic residues  are Lys159 and Tyr154, structure/function analysis of isozyme 1 <36>;  #26# catalytic residues are Lys159 and Tyr154, structure/function  analysis of isozyme 2 <36>; #25# substrate binding and active site  residues, overview <50>; #11# enzyme forms a ternary complex with NAD+  binding before sterol binding <56>)  "
1.1.1.146," an 11beta-hydroxysteroid + NADP+ = an 11-oxosteroid + NADPH + H+  (#2,4,6,28# active site variability of isozyme 11beta-HSD1,  structure-activity analysis, catalytic mechanism <63>; #5# substrate  binding and active site structure, isozyme 11beta-HSD1 contains the  conserved catalytic motif YSASK, Tyr177 is not a hydrogen bond donor in  substrate binding but is involved via hydrophobic interaction, Tyr177  is not involved in determination of substrate specificity <41>; #29#  substrate binding site structure, reaction mechanism involving Lys187  and Tyr183, active site structure involving a S-Y-K catalytic triad  <40>)  "
1.1.1.147, a 16alpha-hydroxysteroid + NAD(P)+ = a 16-oxosteroid + NAD(P)H + H+  
1.1.1.148, estradiol-17alpha + NAD(P)+ = estrone + NAD(P)H + H+  
1.1.1.149," 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ =  17alpha-hydroxyprogesterone + NAD(P)H + H+ (#3,8,10# aldoketo reductase  superfamily <21,22,23>; #4,8,10# bibi mechanism <4,7,23,25,27>)  "
1.1.1.15, D-iditol + NAD+ = D-sorbose + NADH + H+  
1.1.1.150, pregnan-21-ol + NAD+ = pregnan-21-al + NADH + H+  
1.1.1.151, pregnan-21-ol + NADP+ = pregnan-21-al + NADPH + H+  
1.1.1.152," 3alpha-hydroxy-5beta-androstane-17-one + NAD+ =  5beta-androstane-3,17-dione + NADH + H+  "
1.1.1.153," L-erythro-7,8-dihydrobiopterin + NADP+ = sepiapterin + NADPH + H+ (#6#  ordered bi-bi mechanism, NADPH binds first and NADP+ releases last <6>;  #3,6,15# enzyme also reduces carbonyl compounds of non-pteridine  derivatives <11,12,17,22>; #15# active site structure <29>; #15# active  site structure, substrate binding mode for stereospecific production of  L-threo-tetrahydrobiopterin, stereospecific hydride transfer,  mechanism, structure-function relationship, overview <34>) "
1.1.1.153," L-erythro-tetrahydrobiopterin + 2 NADP+ =  6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH + 2 H+  "
1.1.1.154, (S)-ureidoglycolate + NAD(P)+ = oxalureate + NAD(P)H + H+  
1.1.1.156, glycerol + NADP+ = glycerone + NADPH + H+  
1.1.1.157, (S)-3-hydroxybutanoyl-CoA + NADP+ = 3-acetoacetyl-CoA + NADPH + H+  
1.1.1.159," cholate + NAD+ = 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholan-24-oate +  NADH + H+ (#1# Tyr159 acts as basic catalyst, Lys163 binds to NAD(H)  and lowers the pKa value of Tyr159, Ser146 stabilizes the substrate,  reaction intermediate and product in catalysis <12>; #16# belongs to  the short-chain dehydrogenase/reductase 1 familiy (SDR), mechanism  <10>; #7# short-chain dehydrogenase group <13>)  "
1.1.1.16, galactitol + NAD+ = D-tagatose + NADH + H+  
1.1.1.160," (+/-)-5-[(tert-butylamino)-2'-hydroxypropoxy]-1,2,3  4-tetrahydro-1-naphthol + NADP+ =  (+/-)-5-[(tert-butylamino)-2'-hydroxypropoxy]-3  4-dihydro-1(2H)-naphthalenone + NADPH + H+  "
1.1.1.162," D-threitol + NADP+ = D-erythrulose + NADPH + H+ (#2# in an early  reference the enzymatic reaction product of D-erythrulose was  incorrectly identified as erythritol, gas-liquid and thin-layer  chromatographic data have since confirmed the product to be D-threitol,  not erythritol, for this reason the systematic name D-threitol:NADP+  oxidoreductase is now used instead of erythritol:NADP+ oxidoreductase  <1>)  "
1.1.1.163, cyclopentanol + NAD+ = cyclopentanone + NADH + H+  
1.1.1.164, hexadecanol + NAD+ = hexadecanal + NADH + H+  
1.1.1.165," 2-butyne-1,4-diol + NAD+ = 4-hydroxy-2-butynal + NADH + H+  "
1.1.1.166," (1S,3R,4S)-3,4-dihydroxycyclohexane-1-carboxylate + NAD+ =  (1S,4S)-4-hydroxy-3-oxocyclohexane-1-carboxylate + NADH + H+  "
1.1.1.167, hydroxymalonate + NAD+ = oxomalonate + NADH + H+  
1.1.1.168, (R)-pantolactone + NADP+ = 2-dehydropantolactone + NADPH + H+  
1.1.1.169," (R)-pantoate + NADP+ = 2-dehydropantoate + NADPH + H+ (#11# molecular  catalytic mechanism, substrate and cofactor binding, Asn98, Glu256, and  Lys176 are essential, overview <13>; #2# protein-ligand interactions,  overview <14>; #14# the enzyme follows a random addition mechanism in  which the initial binding of NADPH is the kinetically preferred path,  with a small degree of cooperativity between subunits. The mechanism of  Staphylococcus aureus KPR is distinct from those of previously  described members of the family of 2-hydroxyacid dehydrogenases <22>)  "
1.1.1.17," D-mannitol 1-phosphate + NAD+ = D-fructose 6-phosphate + NADH + H+  (#27# the hydride transfer is strongly rate-determining for the overall  enzymatic reaction <24>; #15# the phosphate moiety in Man-ol1P and  Fru6P is essential for substrate recognition and/or catalysis by  Aspergillus fumigatus M1PDH. Binding of D-mannitol 1-phosphate and NAD+  is random, whereas D-fructose 6-phosphate binds only after NADH has  bound to the enzyme. Hydride transfer is rate-determining for  D-mannitol 1-phosphate oxidation by AfM1PDH. The enzyme behaves  kinetically as a fructose 6-phosphate reductase <31>)  "
1.1.1.170, a 3beta-hydroxysteroid-4alpha-carboxylate + NAD(P)+ = a 3-oxosteroid +  CO2 + NAD(P)H  
1.1.1.172, 2-hydroxyadipate + NAD+ = 2-oxoadipate + NADH + H+  
1.1.1.173," L-rhamnofuranose + NAD+ = L-rhamno-1,4-lactone + NADH + H+ (#2# the  catalytic triad is formed by conserved Ser-Tyr-Lys residues <7>; #3#  the catalytic triad is formed by conserved Ser148-Tyr161-Lys165  residues <7>)  "
1.1.1.174," trans-cyclohexane-1,2-diol + NAD+ = 2-hydroxycyclohexan-1-one + NADH +  H+  "
1.1.1.175, D-xylose + NAD+ = D-xylonolactone + NADH + H+  
1.1.1.176," cholate + NADP+ = 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholan-24-oate +  NADPH + H+  "
1.1.1.177, sn-glycerol 3-phosphate + NADP+ = D-glyceraldehyde 3-phosphate + NADPH  + H+  
1.1.1.178," (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD+ = 2-methylacetoacetyl-CoA  + NADH + H+ (#4# inducible by tiglate <1>)  "
1.1.1.179," D-xylose + NADP+ = D-xylono-1,5-lactone + NADPH + H+ (#2# mechanism  <3>; #2# ordered bi-bi mechanism <5>)  "
1.1.1.18," myo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+  (#1# His176 and Asp172 are proposed to act as the catalytic dyad, in  which His176 is proposed to be the acid/base catalyst <16>; #12#  ordered sequential Bi-Bi mechanism in the absence of products, residues  Y233, Y235, H176, and D172 are important for activity <18>; #1# Lys97,  Asp172, and His176 are the catalytic triad involved in the catalytic  mechanism, overview <19>)  "
1.1.1.181," cholest-5-ene-3beta,7alpha-diol + NAD+ =  7alpha-hydroxycholest-4-en-3-one + NADH + H+  "
1.1.1.183, geraniol + NADP+ = geranial + NADPH + H+ (#4# specifically acts on  geraniol <3>)  
1.1.1.184," R-CHOH-R' + NADP+ = R-CO-R' + NADPH + H+ (#3,7# mechanism <6,7>; #11#  ordered bi bi mechanism, in which NADPH binds first and NADP+ leaves  last <40>; #4# stereospecifc reaction mechanism <41>; #34# molecular  modeling and enzyme-substrate docking studies, reaction mechanism with  anthracyclin substrates <48>; #17# stereoselective enzyme, reaction  mechanism and substrate binding model, formation of a hydrophobic  channel induced by NADPH binding <51>; #17# substrate specificity,  enantioselectivity, and enzyme-substrate docking studies, Ser133 and  Tyr177 are important <53,55>)  "
1.1.1.185," an L-glycol + NAD(P)+ = a 2-hydroxycarbonyl compound + NAD(P)H + H+  (#1# glyoxal reduction by enzyme form pI 7.2 follows ordered bi-bi  mechanism in which the coenzyme is the first substrate to bind to the  enzyme <2,3>; #2# ordered bi-bi-mechanism, coenzyme binds as first  substrate to the enzyme <4>)  "
1.1.1.186, dTDP-D-galactose + 2 NADP+ + H2O = dTDP-D-galacturonate + 2 NADPH + 2 H+  
1.1.1.187, GDP-alpha-D-rhamnose + NAD(P)+ = GDP-4-dehydro-alpha-D-rhamnose +  NAD(P)H + H+  
1.1.1.188," (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+  = (5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADPH  + H+ (#16# active site structure, enzyme also shows  3alpha-hydroxysteroid dehydrogenase type II activity, i.e. 3alpha-HSD  <27>; #16# substrate binding and catalytic mechanism, catalytic site  residues are Y55 and H117, enzyme also shows 3alpha-hydroxysteroid  dehydrogenase type II activity, i.e. 3alpha-HSD <24>; #3# Tyr55 is  critical for the reaction, the reactions with different substrates  might follow different mechanisms <29>; #2# catalytic mechanisms, the  catalytic sites for PGD2 11-ketoreductase and PGH2 9,11-endoperoxide  reductase activities are located differently in the active site cavity,  residue Y55 is important for the PGD2 11-ketoreductase activity, but  not for the PGH2 9,11-endoperoxide reductase activity, involved  structural features, overview <34>)  "
1.1.1.189," (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate + NADP+  = (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH  + H+ (#5# enzyme is identical to carbonyl reductase <16>; #3# human  carbonyl reductase and 20alpha-hydroxysteroid dehydrogenase are  identical with the PGE2 9-ketoreductase <16>)  "
1.1.1.19, L-gulonate + NADP+ = D-glucuronate + NADPH + H+  
1.1.1.190, (indol-3-yl)ethanol + NAD+ = (indol-3-yl)acetaldehyde + NADH + H+  
1.1.1.191, (indol-3-yl)ethanol + NADP+ = (indol-3-yl)acetaldehyde + NADPH + H+  
1.1.1.192, a long-chain alcohol + 2 NAD+ + H2O = a long-chain carboxylate + 2 NADH  + 2 H+  
1.1.1.193, 5-amino-6-(5-phospho-D-ribitylamino)uracil + NADP+ =  5-amino-6-(5-phospho-D-ribosylamino)uracil + NADPH + H+  
1.1.1.194, coniferyl alcohol + NADP+ = coniferyl aldehyde + NADPH + H+  
1.1.1.195," cinnamyl alcohol + NADP+ = cinnamaldehyde + NADPH + H+ (#11# ordered  bi-bi mechanism <12>; #110# random mechanism <58>; #11,13# A-specific  enzyme <11,12>; #13# acts stereospecifically on the pro-R-hydrogen atom  of coniferyl alcohol <13>; #2# active site structure <25>; #99,100#  catalytic reaction mechanism, substrate and cofactor binding structure  <30>)  "
1.1.1.196," (5Z,13E)-(15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADP+ =  (5Z,13E)-9alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate + NADPH + H+  "
1.1.1.197," (13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate + NADP+ =  (13E)-11alpha-hydroxy-9,15-dioxoprost-13-enoate + NADPH + H+  "
1.1.1.198, (+)-borneol + NAD+ = (+)-camphor + NADH + H+  
1.1.1.199," (6R)-2-acetyl-6-(3-acetyl-2,4  6-trihydroxy-5-methylphenyl)-3-hydroxy-6-methyl-2,4-cyclohexadien-1-one  + NAD+ = (S)-usnate + NADH + H+  "
1.1.1.2," a primary alcohol + NADP+ = an aldehyde + NADPH + H+ (#11# a zinc  protein. Some members of this group oxidize only primary alcohols,  others act also on secondary alcohols. May be identical with EC  1.1.1.19 (L-glucuronate reductase), EC 1.1.1.33 [mevaldate reductase  (NADPH2)] and EC 1.1.1.55 [lactaldehyde reductase (NADPH2)]. A-specific  with respect to NADH2 <3>; #62# thermodynamics, standard electromotive  force for reduction of NADP+ is -0.140 V <61>)  "
1.1.1.20," L-gulono-1,4-lactone + NADP+ = D-glucurono-3,6-lactone + NADPH + H+  "
1.1.1.200, D-sorbitol 6-phosphate + NADP+ = D-glucose 6-phosphate + NADPH + H+  
1.1.1.201, a 7beta-hydroxysteroid + NADP+ = a 7-oxosteroid + NADPH + H+  
1.1.1.202," propane-1,3-diol + NAD+ = 3-hydroxypropanal + NADH + H+  "
1.1.1.203," beta-D-galacturonate + NAD+ = D-galactaro-1,5-lactone + NADH + H+ "
1.1.1.203," beta-D-glucuronate + NAD+ = D-glucaro-1,5-lactone + NADH + H+  "
1.1.1.205," IMP + NAD+ + H2O = XMP + NADH + H+ (#66# reaction mechanism <80>;  #6,8,9# ordered sequential mechanism <28,37,42>; #9,16# enzyme acts on  the hydroxyl group of the hydrated derivative of the substrate, ordered  bi-bi mechanism <12,25>; #6# sequential addition of IMP, NAD+ and K+  <42>; #16# IMP and K+ can bind randomly to the free enzyme, while NAD+  does not react unless K+ or both K+ and IMP are present on the enzyme  <21>; #9# IMP binds first, followed by NAD+, NADH dissociates from the  ternary complex first, then XMP is released <12>; #16# mechanism is  partially random <21,22>; #8# IMP binds first, XMP is released last  <28>; #38# Arg418 is involved in the reaction mechanism as catalytic  base <69>; #38# covalent enzyme reaction intermediate, hydrolysis of  enzyme-XMP is rate-limiting and requires the adoption of the closed  conformation, Arg418 is involved in the reaction mechanism as catalytic  base, Thr321 is involved in both hydride transfer and hydrolysis <68>;  #8# reaction and kinetic mechanism, an Arg residue is involved in  catalysis as general base <79>; #38# reaction and kinetic mechanism, an  Arg residue is involved in catalysis as general base, Cys319-linked  covalent enzyme intermediate E-XMP <79>; #38# substrate binding and  catalytic reaction mechanism, Cys319 is the catalytic residue, NAD+  promotes the nucleophilic attack of Cys319 on IMP <67>; #78# a  steady-state ordered Bi Bi kinetic mechanism in which IMP binds first  followed by NAD+, and product release is ordered. Hydride transfer  appears not to be rate-limiting. The pH-rate profile indicates one  deprotonated group essential for catalysis <153>; #81# reaction in two  steps via covalent interemediate state, the catalytic residue is Cys334  <142>; #78# the enzymatic mechanism of IMPDH consists two steps, a  dehydrogenase and a hydrolase reaction. Upon binding of IMP and NAD+  cofactor, a thioimidate enzyme-substrate adduct, E-XMP*, is formed via  a covalent bond to the catalytic C341 with concurrent production of  NADH. Hydride transfer occurs to the pro-S position with the cofactor  in the anti-conformation. The cofactor is released and an active site  mobile flap moves into the NAD+ site and facilitates E-XMP* hydrolysis  with a conserved R443 acting as a general base. The enzyme has two  distinct conformations, an open form for the dehydrogenase reaction and  a closed form for E-XMP* hydrolysis <152>; #30,36,42,45# the IMPDH  reaction involves two chemical transformations. First, the catalytic  Cys attacks IMP, and hydride is transferred to NAD to form the  covalent intermediate E-XMP*. In the second step, E-XMP* is hydrolyzed  to produce XMP <146>)  "
1.1.1.206, tropine + NADP+ = tropinone + NADPH + H+  
1.1.1.207, (-)-menthol + NADP+ = (-)-menthone + NADPH + H+  
1.1.1.208, (+)-neomenthol + NADP+ = (-)-menthone + NADPH + H+  
1.1.1.209," androsterone + NAD(P)+ = 5alpha-androstane-3,17-dione + NAD(P)H + H+  "
1.1.1.21," alditol + NAD(P)+ = aldose + NAD(P)H + H+ (#4,23# reaction mechanism  <19,22,24,28>; #29# mechanism, proton is donated by Tyr48 hydroxyl to  the substrate <30>; #29# reaction mechanism, catalytic residues are  Tyr48, Lys77, and His110, C-terminal loop residues Ala299, Leu300,  Leu301, Ser302, Cys303 are involved in substrate and inhibitor binding  <78>; #4# the ordered bi-bi kinetic mechanism is controlled by hinges  and latches of enzyme structure, residues R268, G213, and S226 are  involved <59>; #29# after the catalytic event, a rearrangement of a  bound ligand can trigger the opening of the safety-belt loop of  G213-S226, initiating the release of the oxidized cofactor <83>; #29#  after the hydride donation step, the positive charge in the  nicotinamide head stabilizes the neutral bridge between residues D43  and L77, allowing the relaxation of the tyrosine geometry toward the  substrate head and the subsequent proton donation. After this last  step, Y48 recoils to a locked geometry where the D43-L77 salt bridge is  formed again and completes a tight four-charge sandwich involving the  D(-), L(+), Y(-), and nicotinamide(+) head <101>)  "
1.1.1.210," 5alpha-androstan-3beta,17beta-diol + NADP+ =  17beta-hydroxy-5alpha-androstan-3-one + NADPH + H+ (#2,3# 3beta and  20alpha substrates share the same active site <1,2,3,4>)  "
1.1.1.211, a long-chain (S)-3-hydroxyacyl-CoA + NAD+ = a long-chain 3-oxoacyl-CoA  + NADH + H+  
1.1.1.212, a (3R)-3-hydroxyacyl-[acyl-carrier protein] + NAD+ = a  3-oxoacyl-[acyl-carrier protein] + NADH + H+  
1.1.1.213," a 3alpha-hydroxysteroid + NAD(P)+ = a 3-oxosteroid + NAD(P)H + H+ (#3#  binding and release or pyridine is rate-limiting <3>; #3,9#  aldoketoreductase superfamily <11,12,13>; #6# bi bi mechanism, NADP+  binds to the free enzyme before the hydroxysteroid substrate, the  ketosteroid product leaves first, followed by NADPH <2>; #3,9# bi bi  mechanism, pyridine nucleotide binds first and leaves last <3,12,13>;  #3# bi bi mechanism, pyridine nucleotide binds before substrate <5,11>;  #3,9# ordered and sequential mechanism, nucleotide binds first and  leaves last <8,13>; #5# short-chain alcohol/polyol dehydrogenase family  <9>; #3# ordered bi bi reaction mechanism <15>; #7# catalytic triad  residues Ser114, Tyr155, and Lys159 have mechanistic roles in the  catalytic reaction <17>; #8# the enzyme reveals an induced-fit  mechanism involving a bound citrate ion and a conserved basic motif  involved in the binding of androgen, the enzyme also binds many  structurally different molecules such as 4-hydroxynonenal, polycyclic  aromatic hydrocarbons, and indanone, modeling of substrate binding  <29>; #3# the reduction reaction is slightly preferred by the wild-type  enzyme, which is determined by residue Arg276 <20>; #3# bi bi ordered  mechanism, kinetic analysis, overview <32>; #3# the enzyme shows a  sequential ordered reaction mechanism, where NAD+ binds to the enzyme  first and NADH leaves last <30>; #7# The overall oxidoreductive  reaction comprises the deprotonation of tyrosine, proton abstraction by  the tyrosinate anion, and hydride transfer from the hydroxysteroid to  NAD+, followed by the release of a proton from the hydroxy group of  tyrosine to the solution., The proton transfer to the external base,  from Tyr155 to Lys159 via 2-OH of ribose, with a late transition state  is the rate-limiting step, mechanism, overview <34>)  "
1.1.1.214, (R)-pantolactone + NADP+ = 2-dehydropantolactone + NADPH + H+  
1.1.1.215, D-gluconate + NADP+ = 2-dehydro-D-gluconate + NADPH + H+  
1.1.1.216," (2E,6E)-farnesol + NADP+ = (2E,6E)-farnesal + NADPH + H+  "
1.1.1.217," benzyl (2R,3S)-2-methyl-3-hydroxybutanoate + NADP+ = benzyl  2-methyl-3-oxobutanoate + NADPH + H+  "
1.1.1.218," morphine + NAD(P)+ = morphinone + NAD(P)H + H+ (#1# dehydrogenation of  the 6-hydroxy group of morphine derivatives having a 7,8-unsaturated  bond <1>)  "
1.1.1.219," a (2R,3S,4S)-leucoanthocyanidin + NADP+ = a (2R,3R)-dihydroflavonol +  NADPH + H+  "
1.1.1.22," UDP-alpha-D-glucose + 2 NAD+ + H2O = UDP-alpha-D-glucuronate + 2 NADH +  2 H+ (#8# reaction mechanism, C275 provides SH-group in the catalytic  centre <17>; #12# two-step reaction, reaction mechanism <18>; #14#  ping-pong reaction mechanism <12>; #8# also shows aldehyde  dehydrogenase activity <17>; #2,8# also shows alcohol dehydrogenase  activity <13,17>; #20# bi-uni-uni-bi mechanism <19>; #14# mechanism,  ordered water molecule H-bonded to T118 serves as catalytic base in  hydride transfer <22>; #38# the enzyme is also binds RNA and acts as a  ribonuclease <67>)  "
1.1.1.220," 6-lactoyl-5,6,7,8-tetrahydropterin + NADP+ = 6-pyruvoyltetrahydropterin  + NADPH + H+  "
1.1.1.221," (6S,9R)-6-hydroxy-3-oxo-alpha-ionol + NAD+ =  (6S)-6-hydroxy-3-oxo-alpha-ionone + NADH + H+  "
1.1.1.223, (-)-trans-isopiperitenol + NAD+ = (-)-isopiperitenone + NADH + H+  
1.1.1.224, D-mannitol 1-phosphate + NADP+ = D-mannose 6-phosphate + NADPH + H+  
1.1.1.225, chlordecone alcohol + NADP+ = chlordecone + NADPH + H+  
1.1.1.226, trans-4-hydroxycyclohexanecarboxylate + NAD+ =  4-oxocyclohexanecarboxylate + NADH + H+  
1.1.1.227, (-)-borneol + NAD+ = (-)-camphor + NADH + H+  
1.1.1.228, (+)-cis-sabinol + NAD+ = (+)-sabinone + NADH + H+  
1.1.1.229," diethyl (2R,3R)-2-methyl-3-hydroxysuccinate + NADP+ = diethyl  2-methyl-3-oxosuccinate + NADPH + H+  "
1.1.1.23," L-histidinol + 2 NAD+ + H2O = L-histidine + 2 NADH + 3 H+ (#11# bi uni  uni bi ping pong mechanism, recombinant histidinol dehydrogenase <3>;  #1# fast reversible oxidation of L-histidanol, followed by slow  irreversible hydride transfer from the intermediate L-histidinal <1>;  #5# also oxidizes L-histidinal <20>; #21# reaction mechanism, amino  acid residues Glu326 and His327 are involved in catalysis <21>; #24# bi  uni uni bi ping-pong enzyme mechanism for MtHisD-catalyzed chemical  reaction, involves abstraction of the hydroxyl group proton of  L-histidinol by His336 and concomitant hydride transfer from the  reactive carbon (carbon bound to the hydroxyl group that upon hydride  transfer adopts the sp2 configuration) to NAD+, forming  L-histidinaldehyde and transiently protonated His336 <26>; #24# enzyme  HisD from Mycobacterium tuberculosis follows a bi uni uni bi ping-pong  mechanism in which L-histidinol is the first substrate to bind and  L-histidine the last product to dissociate, the amino acid side chains  of His336 and Glu335 are likely involved in catalysis and/or substrate  binding <31>; #13,21,23,24,25,26,27,28# the enzyme catalyzes the  sequential NAD-dependent oxidations of L-histidinol to  L-histidinaldehyde and then to L-histidine using a bi-uni-uni-bi ping  pong kinetic mechanism <32>)  "
1.1.1.230, 3alpha-hydroxyglycyrrhetinate + NADP+ = 3-oxoglycyrrhetinate + NADPH +  H+  
1.1.1.231," (5Z,13E)-(15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate  + NADP+ =  (5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate +  NADPH + H+ (#3# random mechanism or ordered mechanism with NADP+  binding first <3>)  "
1.1.1.232," (15S)-15-hydroxy-5,8,11-cis-13-trans-icosatetraenoate + NAD(P)+ =  15-oxo-5,8,11-cis-13-trans-icosatetraenoate + NAD(P)H + H+  "
1.1.1.233, N-acyl-D-mannosamine + NAD+ = N-acyl-D-mannosaminolactone + NADH + H+  
1.1.1.234," (2S)-flavan-4-ol + NADP+ = (2S)-flavanone + NADPH + H+ (#1,2,5# enzyme  acts as flavone 4-reductase as well as dihydroflavonol 4-reductase  <3,4>)  "
1.1.1.235, coformycin + NADP+ = 8-oxocoformycin + NADPH + H+ (#1# possible  mechanism <1>)  
1.1.1.236, pseudotropine + NADP+ = tropinone + NADPH + H+  
1.1.1.237, (R)-3-(4-hydroxyphenyl)lactate + NAD(P)+ = 3-(4-hydroxyphenyl)pyruvate  + NAD(P)H + H+ 
1.1.1.237," (R)-3-(3,4-dihydroxyphenyl)lactate + NAD(P)+ =  3-(3,4-dihydroxyphenyl)pyruvate + NAD(P)H + H+  "
1.1.1.238," 3alpha,7alpha,12beta-trihydroxy-5beta-cholan-24-oate + NADP+ =  3alpha,7alpha-dihydroxy-12-oxo-5beta-cholan-24-oate + NADPH + H+  "
1.1.1.239, testosterone + NAD+ = androstenedione + NADH + H+ (#5# random mechanism  <2>)  
1.1.1.24, L-quinate + NAD+ = 3-dehydroquinate + NADH + H+  
1.1.1.240, N-acetyl-alpha-D-glucosamine + NAD+ = N-acetyl-D-glucosaminate + NADH +  H+  
1.1.1.241, 6-endo-hydroxycineole + NAD+ = 6-oxocineole + NADH + H+  
1.1.1.243," (-)-trans-carveol + NADP+ = (-)-carvone + NADPH + H+ (#1#  steroselective conversion of (6S)-carveol stereomers from a  diastereomeric mixture of (4R)- or (4S)-carveol <2,3>)  "
1.1.1.244, methanol + NAD+ = formaldehyde + NADH + H+ (#3# ping-pong mechanism  <6>; #3# ping-pong mechanism in the absence of ACT protein <7>)  
1.1.1.245, cyclohexanol + NAD+ = cyclohexanone + NADH + H+  
1.1.1.247, codeine + NADP+ = codeinone + NADPH + H+  
1.1.1.248," salutaridinol + NADP+ = salutaridine + NADPH + H+ (#1# highly substrate  specific transfer of the pro-S hydride, B-type, of NADPH to C-7 of  salutaridine <1>)  "
1.1.1.25," shikimate + NADP+ = 3-dehydroshikimate + NADPH + H+ (#9# active site  structure, reaction and kinetic mechanisms <19>; #2# conserved residues  Asp103 and Lys67 are important for catalysis in all three paralogues,  kinetic mechanism of paralogue HI0607 and substrate binding site <23>;  #50# active-site base is K92. After the binding of quinate and NAD+,  the oxygen of the C3-OH of quinate forms a hydrogen bond to the side  chain of the conserved T88 and K92 functions as the active-site base to  remove the proton on the C3-OH. Simultaneously,a hydride is transferred  from C3 of quinate to NAD+ <27>; #64# steady-state ordered bi-bi  kinetic mechanism. The hydride transferred from NADPH and protons  transferred from the solvent in the catalytic cycle are not  significantly rate limiting in the overall reaction. Both hydride and  proton transfers are concerted, and acid/base chemistry takes place in  catalysis and substrate binding <28>; #39# the active enzyme for  dehydrogenation of shikimate contains a deprotonated K70 residue, a  deprotonated D106, and a protonated Y216. The hydride transfer and the  deprotonation of the 3-hydroxyl group of shikimate proceed in a  concerted manner. K70 functions as a general base and becomes  protonated in the dehydrogenation reaction. The proton is then  transferred to the bulk solvent via the short proton-conducting wire.  D106 plays a critical role in the transfer of the proton to the bulk  solvent <29>; #9# the pro-R hydrogen of the nicotinamide C4 is 3.35 A  from the C3 of shikimate. The catalytic K385 and D423 residues are  proximal to the C3-hydroxyl of shikimate, which is deprotonated in the  oxidation reaction. The enzyme adopts a concave architecture that  places the active sites in a face-to-face arrangement <30>; #49#  catalytic mechanism, residue Lys69 plays a catalytic role and is not  involved in substrate binding, overview <38>; #1# the enzyme catalysis  follows a sequential random mechanism, enzyme catalysis depends on  acid-basic amino acids <49>)  "
1.1.1.250, D-arabinitol + NAD+ = D-ribulose + NADH + H+ (#2# in the reverse  reaction the enzyme catalyzes transfer of 4(S) hydrogen of NADH <2>)  
1.1.1.251, galactitol 1-phosphate + NAD+ = D-tagatose 6-phosphate + NADH + H+  
1.1.1.252," scytalone + NADP+ = 1,3,6,8-tetrahydroxynaphthalene + NADPH + H+ (#6#  the catalytic triad is formed by residues S149, Y163, and K167 <12>)  "
1.1.1.254, (S)-carnitine + NAD+ = 3-dehydrocarnitine + NADH + H+ (#1# specific for  the (S)-enantiomer of carnitine <6>)  
1.1.1.255, D-mannitol + NAD+ = D-mannose + NADH + H+  
1.1.1.256, fluoren-9-ol + NAD(P)+ = fluoren-9-one + NAD(P)H + H+  
1.1.1.257, 4-(hydroxymethyl)benzenesulfonate + NAD+ = 4-formylbenzenesulfonate +  NADH + H+  
1.1.1.258, 6-hydroxyhexanoate + NAD+ = 6-oxohexanoate + NADH + H+  
1.1.1.259," 3-hydroxypimeloyl-CoA + NAD+ = 3-oxopimeloyl-CoA + NADH + H+ (#1,2#  Involved in the anaerobic pathway of benzoate degradation in bacteria  <1,2,3>)  "
1.1.1.26, glycolate + NAD+ = glyoxylate + NADH + H+ (#7# can convert L-lactate  <12>)  
1.1.1.260, sulcatol + NAD+ = sulcatone + NADH + H+  
1.1.1.261," sn-glycerol 1-phosphate + NAD(P)+ = glycerone phosphate + NAD(P)H + H+  (#8# ordered bi-bi mechanism <8>; #1,2,3,4,5,6,8,9# reaction mechanism  with transfer of pro-R hydrogen of NAD(P)H and a chiral product <12>)  "
1.1.1.262," 4-phosphooxy-L-threonine + NAD+ = 3-amino-2-oxopropyl phosphate + CO2 +  NADH + H+ (#1# 3-amino-1-hydroxyacetone 1-phosphate,i.e. AHAB, is the  primary product of the reaction, no formation of  2-amino-3-oxo-4-phosphonooxybutyrate as intermediate is detected,  identification by electrospray ionization mass spectrometry <4>; #2#  Asp247 and Asp267 are involved in formation and maintaining of the  integrity of the active site <5>)  "
1.1.1.263," 1,5-anhydro-D-glucitol + NADP+ = 1,5-anhydro-D-fructose + NADPH + H+  "
1.1.1.264, L-idonate + NAD(P)+ = 5-dehydro-D-gluconate + NAD(P)H + H+  
1.1.1.265, 3-methylbutanol + NAD(P)+ = 3-methylbutanal + NAD(P)H + H+  
1.1.1.266, dTDP-alpha-D-fucopyranose + NAD(P)+ =  dTDP-4-dehydro-6-deoxy-alpha-D-glucose + NAD(P)H + H+  
1.1.1.267," 2-C-methyl-D-erythritol 4-phosphate + NADP+ = 1-deoxy-D-xylulose  5-phosphate + NADPH + H+ (#2# mechanism <8>; #2# stereochemistry <2>;  #2# reaction mechanism <30>; #7# active site structure <21>; #7#  steady-state random mechanism <11>; #25# highly conserved active site  structure, active site residues Asp157, Glu159, and Glu241, residue  His219 is essential for placing the substrate in the active site for  optimal catalysis <29>; #13# reaction mechanism via 2-C-methylerythrose  4-phosphate intermediate <25>; #13# the conserved active site residue  Trp204 is important in catalysis <22>; #2# the reaction does not  exhibit burst kinetics for either substrate, indicating that product  release is not rate-limiting, the rearrangement step, which precedes  hydride transfer, is rate-limiting for 1-deoxy-D-xylulose 5-phosphate  but becomes partially ratelimiting for 1-fluoro-1-deoxy-D-xylulose  5-phosphate, thus, rearrangement appears to be enhanced by substitution  of a hydrogen atom in the methyl group of 1-deoxy-D-xylulose  5-phosphate by fluorine, consistent with a retro-aldol/aldol mechanism  for the rearrangement during conversion of 1-deoxy-D-xylulose  5-phosphate to 2-C-methyl-D-erythritol 4-phosphate <23>; #2#  retro-aldol/aldol mechanism <37>; #7# random ordered mechanism, though  binding of NADPH first is preferential at 0.2 mM due to its low Km.  Conformational equilibrium between a predominant, inactive open form  and a minor, active closed form of the unliganded enzyme, overview  <70>; #7# random substrate binding and ordered release of NADP+  followed by partially rate-limiting release of 2-C-methyl-D-erythritol  4-phosphate, transient generation of MtDXR-NADPH-MEP ternary complex,  kinetic analysis and modeling, overview <69>)  "
1.1.1.268," 2-(R)-hydroxypropyl-CoM + NAD+ = 2-oxopropyl-CoM + NADH + H+ (#3#  active site structure modeling and stereochemistry of reaction  mechanism, overview <9>)  "
1.1.1.269," (2S)-2-hydroxypropyl-CoM + NAD+ = 2-oxopropyl-CoM + NADH + H+ (#3#  active site structure modeling and stereochemistry of reaction  mechanism, overview <5>)  "
1.1.1.27," (S)-lactate + NAD+ = pyruvate + NADH + H+ (#24# mechanism <42>; #54#  reduction of pyruvate follows an Theorell-Chance mechanism <4>; #12#  the NAD (H)-dependent L-LDH catalyzes the reduction of pyruvate by an  ordered catalytic mechanism, catalytic cycle, overview <73>; #7# the  enzyme-NADH-pyruvate ternery complex undergoes a rate-limiting  conformational change, in which the substrate loop closes to form a  desolvated ternary complex in order to bring the catalytic residue  Arg109 into the active site, the catalytic residues Arg109, Asp168, and  His195 are highly conserved, catalyic mechanism, detailed overview  <109>; #54# the enzyme LDHA shows an ordered biÂ–bi kinetic mechanism of  nLDH with the coenzyme binding first <128>)  "
1.1.1.270," a 3beta-hydroxysteroid + NADP+ = a 3-oxosteroid + NADPH + H+ (#2,7#  stereoselectivity : #1,4,5# catalyzes reduction of the 3-keto group to  a 3beta-hydroxyl group <5,6,7> <3,6>; #12# residues Leu/Val54, Tyr55,  His117, Val128, Ile129, His222, and Trp227 are involved in substrate  binding, Tyr55, Asp50, Lys84, and His117 form the catalytic tetrad,  Tyr55 and His117 together with NADP+ form an oxyanion hole through  hydrogen bond networks, molecular docking simulations, detailed  overview <13>)  "
1.1.1.271, GDP-beta-L-fucose + NADP+ = GDP-4-dehydro-alpha-D-rhamnose + NADPH + H+  
1.1.1.272," an (R)-2-hydroxycarboxylate + NADP+ = a 2-oxocarboxylate + NADPH + H+  (#1# the catalytic triad is probably formed by Arg226, Glu255, and  His274 <1>)  "
1.1.1.273, 10-deoxysarpagine + NADP+ = vellosimine + NADPH + H+  
1.1.1.274," 2-dehydro-D-gluconate + NADP+ = 2,5-didehydro-D-gluconate + NADPH + H+  (#2# reaction mechanism <5>; #2# catalytic mechanism <3>; #1# enzyme  also possesses beta-keto ester reductase activity <10>; #5# reaction  mechanism of wild-type and F22Y/K232G/R238H/A272G mutant enzyme <12>)  "
1.1.1.275, (+)-trans-carveol + NAD+ = (+)-(S)-carvone + NADH + H+  
1.1.1.276, L-serine + NADP+ = 2-aminoacetaldehyde + CO2 + NADPH + H+ (#3#  sequential mechanism <1>) 
1.1.1.276, L-serine + NADP+ = 2-aminomalonate semialdehyde + NADPH + H+ 
1.1.1.276, 2-aminomalonate semialdehyde = 2-aminoacetaldehyde + CO2  
1.1.1.277," 3beta-hydroxy-5beta-pregnane-20-one + NADP+ = 5beta-pregnan-3,20-dione  + NADPH + H+  "
1.1.1.278," 3beta-hydroxy-5alpha-pregnane-20-one + NADP+ =  5alpha-pregnan-3,20-dione + NADPH + H+  "
1.1.1.279, ethyl (R)-3-hydroxyhexanoate + NADP+ = ethyl 3-oxohexanoate + NADPH + H+  
1.1.1.28," (R)-lactate + NAD+ = pyruvate + NADH + H+ (#72# catalytic mechanism  <56>; #47,48,49# binary-binary mechanism with either NAD+ or NADH as  the first substrate <3>; #64# substrate binding model <27>; #69,73,74#  allosteric mechanism <49>)  "
1.1.1.280, ethyl (S)-3-hydroxyhexanoate + NADP+ = ethyl 3-oxohexanoate + NADPH + H+  
1.1.1.281, GDP-alpha-D-rhamnose + NAD(P)+ = GDP-4-dehydro-alpha-D-rhamnose +  NAD(P)H + H+  
1.1.1.282," L-quinate + NAD(P)+ = 3-dehydroquinate + NAD(P)H + H+ (#25# reaction  mechanism <2>; #25# reaction mechanism, in which an aspartate acts as  the general acid/base catalyst during the hydride transfer <3>; #8#  stereospecificity <4>; #23,26# catalytic reaction mechanism <13>) "
1.1.1.282," shikimate + NAD(P)+ = 3-dehydroshikimate + NAD(P)H + H+ (#25# reaction  mechanism <2>; #25# reaction mechanism, in which an aspartate acts as  the general acid/base catalyst during the hydride transfer <3>; #8#  stereospecificity <4>; #23,26# catalytic reaction mechanism <13>)  "
1.1.1.283," (S)-lactaldehyde + NADP+ = 2-oxopropanal + NADPH + H+ (#1,2# similar  enzyme with NADPH-requirement for methylglyoxal reduction, that is  inactive with NAD+, NADH and NADP+ <2,3,4>; #18# catalytic mechanism  involving Ser127, Tyr165, and Lys169, overview. In the first step, the  hydroxyl groups of the Ser127 and Tyr165 residues form hydrogen bonds  with the carbonyl oxygen of isovaleraldehyde, stabilizing its position.  Subsequently, the hydroxyl group of Tyr165 donates a hydrogen to the  carbonyl through deprotonation. Concomitantly, NADPH releases a  hydrogen from the B-face of the nicotinamide ring onto the susceptible  position of the carbonyl group. Thus, the carbonyl group is reduced to  an alcohol group, and the isoamyl alcohol and NADP+ are produced. Upon  reduction of the carbonyl group, the hydrogen bond between the side  chain of Tyr165 and isoamyl alcohol is broken. With the redox state  change, the conformation of NADP+ also may change, accompanied by the  opening of the interdomain cleft for the release of the product <15>)  "
1.1.1.284," S-(hydroxymethyl)glutathione + NAD(P)+ = S-formylglutathione + NAD(P)H  + H+ (#9# random sequential mechanism <16>; #26# ordered bi-bi  mechanism <17>; #9# random bi-bi mechanism for oxidation of  S-hydroxymethylglutathione and 12-hydroxydodecanoic acid <34>; #26# bi  bi mechanism <7>; #61# structure-function analysis, active site and  ligand binding structures,reaction mechanism, overview <73>)  "
1.1.1.285, 2'-deoxymugineic acid + NAD(P)+ = 3''-deamino-3''-oxonicotianamine +  NAD(P)H + H+  
1.1.1.286," isocitrate + NAD+ = 2-oxoglutarate + CO2 + NADH (#1# chemical mechanism  on the basis of the pH dependence of kinetic parameters, dissociation  constants for competitive inhibitors, and multiple-substrate  deuterium/13C isotope effects suggesting a stepwise mechanism with  hydride transfer preceding decarboxylation, the decarboxylation step  contributes only slightly to rate limitation, overview <4>) "
1.1.1.286," (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate + NAD+ = 2-oxoadipate +  CO2 + NADH + H+ (#1# chemical mechanism on the basis of the pH  dependence of kinetic parameters, dissociation constants for  competitive inhibitors, and multiple-substrate deuterium/13C isotope  effects suggesting a stepwise mechanism with hydride transfer preceding  decarboxylation, the decarboxylation step contributes only slightly to  rate limitation, overview <4>)  "
1.1.1.287, D-arabinitol + NADP+ = D-xylulose + NADPH + H+ 
1.1.1.287, D-arabinitol + NADP+ = D-ribulose + NADPH + H+  
1.1.1.288, xanthoxin + NAD+ = abscisic aldehyde + NADH + H+  
1.1.1.289, D-glucitol + NADP+ = L-sorbose + NADPH + H+  
1.1.1.29, D-glycerate + NAD+ = hydroxypyruvate + NADH + H+  
1.1.1.290," 4-phospho-D-erythronate + NAD+ =  (3R)-3-hydroxy-2-oxo-4-phosphooxybutanoate + NADH + H+ (#4# substrate  recognition and catalytic mechanism, PdxB contains the conserved  His254/Glu237/Arg208 triad <6>)  "
1.1.1.291, (S)-2-hydroxymethylglutarate + NAD+ = 2-formylglutarate + NADH + H+  
1.1.1.292," 1,5-anhydro-D-mannitol + NADP+ = 1,5-anhydro-D-fructose + NADPH + H+  "
1.1.1.294, 71-hydroxychlorophyllide a + NAD(P)+ = chlorophyllide b + NAD(P)H + H+  
1.1.1.295," 3beta-hydroxy-9beta-pimara-7,15-diene-19,6beta-olide + NAD(P)+ =  momilactone A + NAD(P)H + H+  "
1.1.1.296, menth-8-en-2-ol + NAD+ = menth-8-en-2-one + NADH + H+  
1.1.1.297," menth-8-ene-1,2-diol + NAD+ = 1-hydroxymenth-8-en-2-one + NADH + H+ "
1.1.1.297," (1S,2S,4R)-menth-8-ene-1,2-diol + NAD+ =  (1S,4R)-1-hydroxymenth-8-en-2-one + NADH + H+ "
1.1.1.297," (1R,2R,4S)-menth-8-ene-1,2-diol + NAD+ =  (1R,4S)-1-hydroxymenth-8-en-2-one + NADH + H+  "
1.1.1.298, 3-hydroxypropanoate + NADP+ = malonate semialdehyde + NADPH + H+  
1.1.1.299, (S)-malate + NAD(P)+ = oxaloacetate + NAD(P)H + H+ (#2# ordered bi-bi  mechanism <1>)  
1.1.1.3," L-homoserine + NAD(P)+ = L-aspartate 4-semialdehyde + NAD(P)H + H+  (#10# bifunctional enzyme showing aspartate kinase, 2.7.2.4, and  homoserine dehydrogenase activities <27>; #3,10,16# bifunctional enzyme  showing aspartate kinase, EC 2.7.2.4, and homoserine dehydrogenase  activities <23,24,25>; #19# ordered bi bi kinetic mechanism in which  nicotinamide cofactor binds first and leaves last in the reaction  sequence <34>; #28# role of conserved water molecules and a lysine  residue in hydride transfer between the substrate and the cofactor.  Lys105, which is located at the interface of the catalytic and  cofactor-binding sites, mediates the hydride transfer step of the  reaction mechanism of the enzyme. Potential reaction mechanisms for  homoserine dehydrogenase, overview <37>; #30# L-homoserine oxidation by  StHSD proceeds through a sequentially ordered mechanism in which NAD+  binds to the free form of the enzyme, after which L-homoserine binds to  the enzyme-NAD+ complex <52>; #32# proposed reaction mechanisms of  hydride transfer from L-homoserine in the active site of  Paracoccidioides brasiliensis homoserine dehydrogenase (HSD), Glu218  accepts a proton from the hydroxyl group of L-homoserine, which donates  a hydride to the nC-4 carbon of NAD+. Lys233, Lys122, and the water  molecule at position 374 (Wat374) serve to bind the substrate <44>;  #37# two possible catalytic mechanisms of homoserine oxidation. (a)  Lys99 is the acidx02base catalytic residue. The hydroxy group of L-Hse  is activated by protonated Lys195, and a proton from the Od of L-Hse is  captured by the deprotonated Lys99. Lys99 exists in the simple proton  pathway, in which a proton can go in and out of an active site easily.  (b) Lys195 is drown as an acidx02base catalytic residue. L-Hse and  Asp191 exist deep inside of the active site and have no interaction to  the surface. Thus, the direct proton pathway from Lys195 to the bulk  water region cannot be realized. Lys99 and Lys195 of TtHSD are  essential for catalysis <47>)  "
1.1.1.30," (R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH + H+ (#6# enzyme is  completely dependent on the presence of phospholipid for activity <31>;  #24# the enzyme shows a dynamical reaction mechanism. In the catalytic  site, a water molecule is trapped by the catalytic Tyr155 and Ser142  residues in the vicinity of the bound NAD+ and acetate, substrate  binding structure, overview <44>)  "
1.1.1.300, retinol + NADP+ = retinal + NADPH + H+  
1.1.1.301, D-arabinitol 1-phosphate + NAD+ = D-xylulose 5-phosphate + NADH + H+  
1.1.1.302," 2,5-diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one + NAD(P)+ =  2,5-diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one + NAD(P)H +  H+ (#1# the reaction proceeds in the opposite direction <3>)  "
1.1.1.303, (R)-acetoin + NAD+ = diacetyl + NADH + H+  
1.1.1.304, (S)-acetoin + NAD+ = diacetyl + NADH + H+ (#6# Theorell-Chance  mechanism with NADH as the leading substrate <3>)  
1.1.1.305, UDP-alpha-D-glucuronate + NAD+ = UDP-beta-L-threo-pentapyranos-4-ulose  + CO2 + NADH + H+  
1.1.1.306, S-(hydroxymethyl)mycothiol + NAD+ = S-formylmycothiol + NADH + H+  
1.1.1.307, xylitol + NAD+ = D-xylose + NADH + H+ (#17# chemical mechanism of  carbonyl reduction by xylose reductase in which transfer of hydride ion  is a partially rate-limiting step and precedes the proton-transfer step  <11>) 
1.1.1.307," xylitol + NAD(P)+ = D-xylose + NAD(P)H + H+ (#23# enzymic mechanism in  which a catalytic proton bridge from the protonated side chain of Lys80  to the carbonyl group adjacent to the hydride acceptor carbonyl  facilitates the chemical reaction step. His113 contributes to  positioning of the 9,10-phenanthrenequinone substrate for catalysis.  Tyr51 controls release of the hydroquinone product. The proposed  chemistry involves delivery of both hydrogens required for reduction of  the alpha-dicarbonyl substrate to the carbonyl group undergoing  stereoselective transformation. Hydride transfer from NADH probably  precedes the transfer of a proton from Tyr51 <30>; #1# ordered  bi-substrate mechanism in which the coenzyme binds first <36>; #35#  structure-function analysis, overview <67>) "
1.1.1.307, xylitol + NADP+ = D-xylose + NADPH + H+ (#2# kinetic mechanism of  xylose reductase is iso-ordered bi bi <12>)  
1.1.1.308," (R)-2,3-dihydroxypropane-1-sulfonate + 2 NAD+ + H2O =  (R)-3-sulfolactate + 2 NADH + 2 H+  "
1.1.1.309, 2-hydroxyethylphosphonate + NAD+ = phosphonoacetaldehyde + NADH + H+  
1.1.1.31, 3-hydroxy-2-methylpropanoate + NAD+ = 2-methyl-3-oxopropanoate + NADH +  H+  
1.1.1.310, (2S)-3-sulfolactate + NAD+ = 3-sulfopyruvate + NADH + H+  
1.1.1.311, (S)-1-phenylethanol + NAD+ = acetophenone + NADH + H+  
1.1.1.312," 4-carboxy-2-hydroxymuconate semialdehyde hemiacetal + NADP+ =  2-oxo-2H-pyran-4,6-dicarboxylate + NADPH + H+ (#2# ordered bi-bi  mechanism <1>)  "
1.1.1.313, isethionate + NADP+ = 2-sulfoacetaldehyde + NADPH + H+  
1.1.1.315, 11-cis-retinol-[retinal-binding-protein] + NAD+ =  11-cis-retinal-[retinol-binding-protein] + NADH + H+  
1.1.1.316," L-galactose + NAD+ = L-galactono-1,4-lactone + NADH + H+  "
1.1.1.317, raucaffrinoline + NADP+ = perakine + NADPH + H+  
1.1.1.318," eugenol + a carboxylate + NADP+ = a coniferyl ester + NADPH + H+ (#6#  reaction mechanism, overview <6>; #5# reaction mechanism, detailed  overview <1>; #6# eugenol synthase catalyzes the reductive displacement  of acetate from the propenyl side chain of the substrate coniferyl  acetate to produce the allyl-phenylpropene eugenol, two-step reaction  mechanism involving the formation of a quinone-methide prior to  reduction, overview. The formation of this intermediate is promoted by  a hydrogen-bonding network that favors deprotonation of the substrates  4-hydroxyl group and disfavors binding of the acetate moiety, akin to a  push-pull catalytic mechanism, involvement of a quinone-methide, a  conjugated enone, intermediate in the bond cleavage <5>)  "
1.1.1.319," isoeugenol + acetate + NADP+ = coniferyl acetate + NADPH + H+ (#4#  reaction mechanism, overview <6>)  "
1.1.1.32," (R)-mevalonate + NAD+ = mevaldate + NADH + H+ (#2# stereospecific  insertion of hydride into C-5, hydride is added from the re-face of  carbonyl group in 3R and 3S-isomers <1>; #2# formation of mevalonic  acid is strongly favoured <2,3>)  "
1.1.1.320, (S)-benzoin + NADP+ = benzil + NADPH + H+  
1.1.1.321, (R)-benzoin + NADP+ = benzil + NADPH + H+  
1.1.1.322, (-)-endo-fenchol + NAD(P)+ = (+)-fenchone + NAD(P)H + H+  
1.1.1.323, (+)-thujan-3-ol + NAD(P)+ = (+)-thujan-3-one + NAD(P)H + H+  
1.1.1.324, (6E)-8-hydroxygeraniol + 2 NADP+ = (6E)-8-oxogeranial + 2 NADPH + 2 H+ 
1.1.1.324, (6E)-8-hydroxygeraniol + NADP+ = (6E)-8-hydroxygeranial + NADPH + H+ 
1.1.1.324, (6E)-8-hydroxygeraniol + NADP+ = (6E)-8-oxogeraniol + NADPH + H+ 
1.1.1.324, (6E)-8-hydroxygeranial + NADP+ = (6E)-8-oxogeranial + NADPH + H+ 
1.1.1.324, (6E)-8-oxogeraniol + NADP+ = (6E)-8-oxogeranial + NADPH + H+  
1.1.1.325," L-threo-7,8-dihydrobiopterin + NADP+ = sepiapterin + NADPH + H+ "
1.1.1.325," L-threo-tetrahydrobiopterin + 2 NADP+ =  6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH + 2 H+  "
1.1.1.326, 10-hydroxy-alpha-humulene + NAD+ = zerumbone + NADH + H+  
1.1.1.327," 5-exo-hydroxycamphor + NAD+ = bornane-2,5-dione + NADH + H+  "
1.1.1.328," 3,3'-bipyridine-2,2',5,5',6,6'-hexol + NAD(P)+ =  (E)-2,2',5,5'-tetrahydroxy-6H,6'H-[3,3'-bipyridinylidene]-6,6'-dione +  NAD(P)H + H+  "
1.1.1.329," 2-deoxy-scyllo-inosamine + NAD(P)+ = 3-amino-2,3-dideoxy-scyllo-inosose  + NAD(P)H + H+  "
1.1.1.33, (R)-mevalonate + NADP+ = mevaldate + NADPH + H+  
1.1.1.330, a very-long-chain (3R)-3-hydroxyacyl-CoA + NADP+ = a very-long-chain  3-oxoacyl-CoA + NADPH + H+  
1.1.1.331, (-)-secoisolariciresinol + 2 NAD+ = (-)-matairesinol + 2 NADH + 2 H+  
1.1.1.332, chanoclavine-I + NAD+ = chanoclavine-I aldehyde + NADH + H+  
1.1.1.333," trans,octacis-decaprenylphospho-beta-D-arabinofuranose + NAD+ =  trans,octacis-decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose +  NADH + H+  "
1.1.1.334, ecgonine methyl ester + NADP+ = ecgonone methyl ester + NADPH + H+  
1.1.1.335, UDP-N-acetyl-2-amino-2-deoxy-alpha-D-glucuronate + NAD+ =  UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate + NADH + H+  
1.1.1.336, UDP-N-acetyl-alpha-D-mannosamine + 2 NAD+ + H2O =  UDP-N-acetyl-alpha-D-mannosaminuronate + 2 NADH + 2 H+  
1.1.1.337, a (2S)-2-hydroxycarboxylate + NAD+ = a 2-oxocarboxylate + NADH + H+  
1.1.1.338, (2R)-3-sulfolactate + NADP+ = 3-sulfopyruvate + NADPH + H+  
1.1.1.339, dTDP-6-deoxy-beta-L-talose + NAD+ = dTDP-4-dehydro-beta-L-rhamnose +  NADH + H+  
1.1.1.34," (R)-mevalonate + CoA + 2 NADP+ = (S)-3-hydroxy-3-methylglutaryl-CoA + 2  NADPH + 2 H+ (#4# Glu559 and His866 are involved in catalysis <35>;  #21# via mevaldehyde as an intermediate product <32>; #38# via  mevaldehyde as an intermediate product, enzyme contains a catalytic  His381, Lys267 is also involved in catalysis, active site structure  <40>; #77# reaction mechanism, modelling of three different systems,  detailed overview. Formation of a mevaldyl-CoA intermediate protonated  by a conserved active site lysine, Lys691. The conserved active site  glutamate and aspartate residues, Glu559 and Asp767, along with the  ribose moiety of NADPH, form a hydrogen bond network crucial to the  increase of the stabilizing effect of Lys691 over the transition state.  A charged His752 forms an oxyanion hole with Lys691 to stabilize the  negative charge developed in the thioester oxygen <88>)  "
1.1.1.340, 1-deoxy-11beta-hydroxypentalenate + NAD+ = 1-deoxy-11-oxopentalenate +  NADH + H+  
1.1.1.341," CDP-alpha-D-abequose + NADP+ =  CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose + NADPH + H+  "
1.1.1.342," CDP-alpha-D-paratose + NADP+ =  CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose + NADPH + H+  "
1.1.1.343, 6-phospho-D-gluconate + NAD+ = D-ribulose 5-phosphate + CO2 + NADH + H+  
1.1.1.344, dTDP-6-deoxy-beta-L-talose + NAD(P)+ = dTDP-4-dehydro-beta-L-rhamnose +  NAD(P)H + H+  
1.1.1.345, an (R)-2-hydroxycarboxylate + NAD+ = a 2-oxocarboxylate + NADH + H+  
1.1.1.346," 2-dehydro-L-gulonate + NADP+ = 2,5-didehydro-D-gluconate + NADPH + H+  "
1.1.1.347, geraniol + NAD+ = geranial + NADH + H+  
1.1.1.348," a (4R)-4,2'-dihydroxyisoflavan + NADP+ = a (3R)-2'-hydroxyisoflavanone  + NADPH + H+  "
1.1.1.349, (1'S)-averantin + NADP+ = norsolorinic acid + NADPH + H+  
1.1.1.35," (S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H+ (#4# highly  conserved residue Ser137 is essential for activity <29>; #5# molecular  reaction mechanism, a His-Glu pair is essential for actalysis in the  active site <33>; #4# reaction mechanism via enolate intermediate <37>;  #22# structure-function analysis and catalytic mechanism, overview  <59>; #28# structure-function analysis using the crystal structure, PDB  ID 4j0f, and catalytic mechanism, overview <59>)  "
1.1.1.350, (S)-ureidoglycolate + NAD+ = N-carbamoyl-2-oxoglycine + NADH + H+  
1.1.1.351, 6-phospho-D-gluconate + NAD(P)+ = D-ribulose 5-phosphate + CO2 +  NAD(P)H + H+  
1.1.1.352," (1'S,5'S)-hydroxyaverantin + NAD+ = 5'-oxoaverantin + NADH + H+ "
1.1.1.352," (1'S,5'R)-hydroxyaverantin + NAD+ = 5'-oxoaverantin + NADH + H+  "
1.1.1.353, versicolorone + NADP+ = 1'-hydroxyversicolorone + NADPH + H+ 
1.1.1.353, versiconol acetate + NADP+ = versiconal hemiacetal acetate + NADPH + H+ 
1.1.1.353, versiconol + NADP+ = versiconal + NADPH + H+  
1.1.1.354," (2E,6E)-farnesol + NAD+ = (2E,6E)-farnesal + NADH + H+  "
1.1.1.355, kanamycin A + NADP+ = 2'-dehydrokanamycin A + NADPH + H+  
1.1.1.356," GDP-beta-L-colitose + NAD(P)+ =  GDP-4-dehydro-3,6-dideoxy-alpha-D-mannose + NAD(P)H + H+  "
1.1.1.357," a 3alpha-hydroxysteroid + NAD(P)+ = a 3-oxosteroid + NAD(P)H + H+ (#6#  rate-limiting step in the reaction is the release of NADH and proton.  P185, T188 and the flexible substrate-binding loop are involved in  binding with the nucleotide cofactor and with androsterone and are also  involved in catalysis, catalytic mechanism, overview <19>; #6# the  reaction catalyzed by the enzyme shows an ordered bi bi kinetic  mechanism with NAD+ being the first substrate to be bound and NADH the  last product to be released. The rate-limiting steps along the reaction  pathway is the release of NADH for reaction with andosterone or  androsterol, while the hydride transfer for 2-decalol is rate limiting  for the overall reaction. Structure of the transition state by  measuring the rate constant of a reaction upon substitution of a heavy  atom for a light one at or adjacent to the bond cleavage during the  reaction <16>; #6# rapid equilibrium ordered bi bi kinetic mechanism  <22>)  "
1.1.1.358," (R)-pantolactone + NADP+ = 2-dehydropantolactone + NADPH + H+ (#4#  catalytic mechanism of (R)-pantolactone synthesis, overview. The  conserved catalytic triad is formed by residues Thr30, Tyr66 and  His128. Tyr66 functions as a proton donor following hydrogen transfer  from NADPH. Thr30 and His128 are critical residues to bind and orient  2-dehydropantolactone (KPL). The phenolic hydroxyl group of Tyr66 forms  the hydrogen bond with the C5 carbonyl oxygen of 2-dehydropantolactone.  The HR of NADPH could just attack the si-face of the carbonyl group,  which results in the formation of (R)-pantolactone. The alpha-amino  group and the hydroxyl group of Thr30 form hydrogen bonds with the C4  carbonyl oxygen of KPL, and the epsilon-amino group of Lys33 formes the  hydrogen bond with the O2 of KPL. In addition, the hydrophobic  interaction of His128, Val165 and Phe302 with two methyl groups of KPL  might facilitate the substrate binding <6>; #5# enzyme CorCPR has a  catalytic tetrad D-Y-K-H, and the detailed catalytic mechanism is  clarified by molecular docking, overview <7>)  "
1.1.1.359," an aldopyranose + NAD(P)+ = an aldono-1,5-lactone + NAD(P)H + H+  "
1.1.1.36," (R)-3-hydroxyacyl-CoA + NADP+ = 3-oxoacyl-CoA + NADPH + H+ (#3#  catalytic site structure and catalytic triad Ser151, Tyr164, and Lys168  <19>)  "
1.1.1.360," D-glucopyranose + NADP+ = D-glucono-1,5-lactone + NADPH + H+ (#1# (1)  <1>) "
1.1.1.360," D-galactopyranose + NADP+ = D-galactono-1,5-lactone + NADPH + H+ (#1#  (2) <1>)  "
1.1.1.361," D-glucose 6-phosphate + NAD+ = 3-dehydro-D-glucose 6-phosphate + NADH +  H+ (#2# NtdC follows a random sequential mechanism, consistent with our  product inhibition. The equilibrium position of the NtdC-catalyzed  reaction greatly favors G6P, and the rate of 3-dehydro-D-glucose  6-phosphate formation at neutral pH is very low, under more favorable  basic conditions, the product of the reaction is unstable <3>)  "
1.1.1.362, aklavinone + NADP+ = aklaviketone + NADPH + H+  
1.1.1.363," D-glucose 6-phosphate + NAD(P)+ = 6-phospho-D-glucono-1,5-lactone +  NAD(P)H + H+ (#3# mechanism in which His240 acts as the general base  that abstracts the proton from the C1-hydroxyl group of glucose  6-phosphate, and the carboxylate group of D177 stabilizes the positive  charge that forms on H240 in the transition state. The results also  confirm the postulated role of His178 in binding the phosphate moiety  of glucose 6-phosphate <12>; #7# enzyme PputG6PDH-1 from Pseudomonas  putida KT2440 catalyzes the oxidation of D-glucose 6-phosphate using a  rapidequilibrium random mechanism <33>)  "
1.1.1.364, dTDP-6-deoxy-alpha-D-allose + NAD(P)+ =  dTDP-4-dehydro-6-deoxy-alpha-D-gulose + NAD(P)H + H+  
1.1.1.365, L-galactonate + NADP+ = D-galacturonate + NADPH + H+  
1.1.1.366, L-idonate + NAD+ = 5-dehydro-D-gluconate + NADH + H+  
1.1.1.367," UDP-2-acetamido-2,6-dideoxy-beta-L-talose + NAD(P)+ =  UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose + NAD(P)H + H+  "
1.1.1.368, 6-hydroxycyclohex-1-ene-1-carbonyl-CoA + NAD+ =  6-oxocyclohex-1-ene-1-carbonyl-CoA + NADH + H+  
1.1.1.369," 1D-chiro-inositol + NAD+ = 2D-2,3,5/4,6-pentahydroxycyclohexanone +  NADH + H+  "
1.1.1.37," (S)-malate + NAD+ = oxaloacetate + NADH + H+ (#198# an ordered bi-bi  mechanism with coenzyme binding first followed by the binding of  substrate is able to explain the kinetic data. The proposed mechanism  is similar to, but not identical to, the mechanism determined for the  cytoplasmic isoform, cMDH <135>; #197# an ordered bi-bi mechanism with  coenzyme binding first followed by the binding of substrate is able to  explain the kinetic data. The proposed mechanism is similar to, but not  identical to, the mechanism determined for the mitochondrial isoform,  mMDH <136>)  "
1.1.1.370," scyllo-inositol + NAD+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADH + H+  "
1.1.1.371," scyllo-inositol + NADP+ = 2,4,6/3,5-pentahydroxycyclohexanone + NADPH +  H+  "
1.1.1.372, glycerol + NADP+ = D-glyceraldehyde + NADPH + H+ 
1.1.1.372, glycerol + NADP+ = L-glyceraldehyde + NADPH + H+  
1.1.1.373," 2,3-dihydroxypropane-1-sulfonate + NAD+ =  2-hydroxy-3-oxopropane-1-sulfonate + NADH + H+ (#1# rapid equilibrium  sequential Bi-Bi mechanism, dynamic domain movements occurs during  catalysis. A conserved sulfonate pocket in SLA reductase recognizes the  sulfonate oxygens through hydrogen bonding to Asn174, Ser178, and the  backbone amide of Arg123, along with an ordered water molecule <2>)  "
1.1.1.374, UDP-N-acetyl-alpha-D-glucosamine + NAD+ =  UDP-2-acetamido-3-dehydro-2-deoxy-alpha-D-glucopyranose + NADH + H+  
1.1.1.375, a (2S)-2-hydroxycarboxylate + NAD(P)+ = a 2-oxocarboxylate + NAD(P)H +  H+  
1.1.1.376," L-arabinose + NAD(P)+ = L-arabinono-1,4-lactone + NAD(P)H + H+  "
1.1.1.377," L-rhamnose + NADP+ = L-rhamnono-1,4-lactone + NADPH + H+  "
1.1.1.378," L-rhamnose + NAD(P)+ = L-rhamnono-1,4-lactone + NAD(P)H + H+ (#1# in  putative catalytic mechanism, the C1-OH group of L-rhamnose is  deprotonated by Tyr159 as a general basic catalyst, with concurrent  transfer of the hydride ion to NAD(P)+, and the pKa value of its  hydroxyl group is lowered by Lysl63, leading to the stabilization of  the tyrosinate anion at physiological pH <3>)  "
1.1.1.379, (R)-mandelate + NAD+ = phenylglyoxylate + NADH + H+  
1.1.1.38, (S)-malate + NAD+ = pyruvate + CO2 + NADH (#9# stepwise reaction  mechanism in which hydride transfer preceeds decarboxylation <5>)  
1.1.1.380, L-gulonate + NAD+ = D-fructuronate + NADH + H+  
1.1.1.381, L-allo-threonine + NADP+ = aminoacetone + CO2 + NADPH + H+ 
1.1.1.381, L-allo-threonine + NADP+ = L-2-amino-3-oxobutanoate + NADPH + H+ 
1.1.1.381, L-2-amino-3-oxobutanoate = aminoacetone + CO2  
1.1.1.382," (2R)-2,3-dihydroxy-3-methylbutanoate + NAD+ =  (2S)-2-hydroxy-2-methyl-3-oxobutanoate + NADH + H+  "
1.1.1.383," (2R)-2,3-dihydroxy-3-methylbutanoate + NAD(P)+ =  (2S)-2-hydroxy-2-methyl-3-oxobutanoate + NAD(P)H + H+  "
1.1.1.384," dTDP-4-dehydro-2,6-dideoxy-alpha-D-glucose + NADP+ =  dTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose + NADPH + H+  "
1.1.1.385, L-dihydroanticapsin + NAD+ = L-anticapsin + NADH + H+  
1.1.1.386, (R)-ipsdienol + NAD(P)+ = ipsdienone + NAD(P)H + H+  
1.1.1.387," 2-aminomalonate semialdehyde = 2-aminoacetaldehyde + CO2 (#2# (1b),  spontaneous <1>) "
1.1.1.387, L-serine + NAD+ = 2-aminoacetaldehyde + CO2 + NADH + H+ (#2# overall  reaction <1>) 
1.1.1.387, L-serine + NAD+ = 2-aminomalonate semialdehyde + NADH + H+ (#2# (1a)  <1>)  
1.1.1.388," D-glucose 6-phosphate + NAD+ = 6-phospho-D-glucono-1,5-lactone + NADH +  H+  "
1.1.1.389," 2-dehydro-3-deoxy-L-galactonate + NAD+ =  3-deoxy-D-glycero-2,5-hexodiulosonate + NADH + H+  "
1.1.1.39," (S)-malate + NAD+ = pyruvate + CO2 + NADH (#19# sequential mechanism  <8>; #19# slow reaction transient in the form of a lag before reaching  a steady-state rate in assay <10>; #16# rapid equilibrium reaction of  the intersecting type <12>; #16# sequential mechanism, each of the  substrate pairs binds randomly to the enzyme <6>; #18# sequential  mechanism with each substrate bound randomly <20>; #12# active site  structure, catalytic residues are Y126, R181, K199, D295, N343, and  N479 <23>; #2# catalytic mechanism, malate is bound deeply in the  active site, Mn2+ catalyzes the entire reaction, Lys183 is the general  base for oxidation, Tyr112-Lys183 functions as the general acid-base  pair to catalyze the tautomerization of the enolpyruvate product from  decarboxylation to pyruvate, substrate and cofacor binding modes <28>;  #12# reaction mechanism of oxidative decarboxylation <22>; #12#  reaction mechanism, active site structure, enzyme-cofactor  interactions, overview <25>; #12# acid-base chemical mechanism for  Ascaris suum malic enzyme <31>; #46# isozyme NAD-ME2 and chimeric  mutant NAD-ME1q follow a sequential ordered Bi-Ter mechanism, NAD+  being the leading substrate followed by (S)-malate. Hetereodimer  NAD-MEH can bind both substrates randomly. Interaction between NAD-ME1  and -ME2 generates a heteromeric isozyme NAD-MEH with a particular  kinetic behaviour <37>; #45# isozyme NAD-ME2 and chimeric mutant  NAD-ME1q follow a sequential ordered Bi-Ter mechanism, NAD+ being the  leading substrate followed by (S)-malate. Isozyme NAD-ME1 and  hetereodimer NAD-MEH can bind both substrates randomly. However,  NAD-ME1 shows a preferred route that involves the addition of NAD+  first. interaction between NAD-ME1 and -ME2 generates a heteromeric  isozyme NAD-MEH with a particular kinetic behaviour <37>)  "
1.1.1.390," sulfoquinovose + NAD+ = 6-deoxy-6-sulfo-D-glucono-1,5-lactone + NADH +  H+  "
1.1.1.391, isolithocholate + NAD+ = 3-oxo-5beta-cholan-24-oate + NADH + H+  
1.1.1.392, lithocholate + NADP+ = 3-oxo-5beta-cholan-24-oate + NADPH + H+  
1.1.1.393, isolithocholate + NADP+ = 3-oxo-5beta-cholan-24-oate + NADPH + H+  
1.1.1.394," aurachin B + NAD+ + H2O =  4-[(2E,6E)-farnesyl]-4-hydroxy-2-methyl-3-oxo-3,4-dihydroquinoline  1-oxide + NADH + H+ (#1# reaction mechanism, overview <1>) "
1.1.1.394," 4-[(2E,6E)-farnesyl]-3,4-dihydroxy-2-methyl-3,4-dihydroquinoline  1-oxide + NAD+ =  4-[(2E,6E)-farnesyl]-4-hydroxy-2-methyl-3-oxo-3,4-dihydroquinoline  1-oxide + NADH + H+ "
1.1.1.394," aurachin B + H2O =  4-[(2E,6E)-farnesyl]-3,4-dihydroxy-2-methyl-3,4-dihydroquinoline 1-oxide  "
1.1.1.395, a 3alpha-hydroxy bile acid CoA ester + NAD+ = a 3-oxo bile acid CoA  ester + NADH + H+  
1.1.1.396, 3-deacetyl-3-(1-hydroxyethyl)bacteriochlorophyllide a + NAD+ =  bacteriochlorophyllide a + NADH + H+ 
1.1.1.396, 3-devinyl-3-(1-hydroxyethyl)chlorophyllide a + NAD+ =  3-acetyl-3-devinylchlorophyllide a + NADH + H+  
1.1.1.397," (2S,3R)-2-hydroxy-3-(indol-3-yl)butanoate + NAD+ =  (R)-3-(indol-3-yl)-2-oxobutanoate + NADH + H+  "
1.1.1.398, 2-(glutathion-S-yl)-2-methylbut-3-en-1-ol + 2 NAD+ + H2O =  2-(glutathion-S-yl)-2-methylbut-3-enoate + 2 NADH + 2 H+ 
1.1.1.398, 2-(glutathion-S-yl)-2-methylbut-3-en-1-ol + NAD+ =  2-(glutathion-S-yl)-2-methylbut-3-enal + NADH + H+ 
1.1.1.398, 2-(glutathion-S-yl)-2-methylbut-3-enal + NAD+ + H2O =  2-(glutathion-S-yl)-2-methylbut-3-enoate + NADH + H+  
1.1.1.399, (R)-2-hydroxyglutarate + NAD+ = 2-oxoglutarate + NADH + H+  
1.1.1.4," (R,R)-butane-2,3-diol + NAD+ = (R)-acetoin + NADH + H+  "
1.1.1.40," (S)-malate + NADP+ = pyruvate + CO2 + NADPH (#50# catalytic mechanism  <49>; #7# sequential ordered bi-ter kinetic mechanism with NADP+ as the  leading substrate followed by L-malate. The products are released in  the order of CO2, pyruvate and NADPH <24>; #14# the conserved residues  Arg237 and Lys225 are involved in catalysis and substrate binding as  proton acceptors <30>)  "
1.1.1.400," 2-methylpropane-1,2-diol + NAD+ = 2-hydroxy-2-methylpropanal + NADH + H+  "
1.1.1.401," 2-dehydro-3-deoxy-L-rhamnonate + NAD+ =  2,4-didehydro-3-deoxy-L-rhamnonate + NADH + H+  "
1.1.1.402, D-erythritol 1-phosphate + NADP+ = D-erythrulose 1-phosphate + NADPH +  H+  
1.1.1.403, D-threitol + NAD+ = D-erythrulose + NADH + H+  
1.1.1.404," 2,3,5,6-tetrachlorohydroquinone + NAD+ =  2,3,5,6-tetrachloro-1,4-benzoquinone + NADH + H+  "
1.1.1.405, D-ribitol 5-phosphate + NADP+ = D-ribulose 5-phosphate + NADPH + H+  
1.1.1.406," galactitol + NAD+ = D-tagatose + NADH + H+ (#3# reaction mechanism,  overview <3>) "
1.1.1.406, galactitol + NAD+ = L-tagatose + NADH + H+  
1.1.1.407, D-altritol + NAD+ = D-tagatose + NADH + H+  
1.1.1.408, 4-phospho-D-threonate + NAD+ = glycerone phosphate + CO2 + NADH + H+ 
1.1.1.408, 4-phospho-D-threonate + NAD+ = 3-dehydro-4-phospho-D-erythronate + NADH  + H+ 
1.1.1.408, 3-dehydro-4-phospho-D-erythronate = glycerone phosphate + CO2  
1.1.1.409, 4-phospho-D-erythronate + NAD+ = glycerone phosphate + CO2 + NADH + H+ 
1.1.1.409, 4-phospho-D-erythronate + NAD+ = 3-dehydro-4-phospho-L-threonate + NADH  + H+ 
1.1.1.409, 3-dehydro-4-phospho-L-threonate = glycerone phosphate + CO2  
1.1.1.41," isocitrate + NAD+ = 2-oxoglutarate + CO2 + NADH (#4# Arg97, and Arg99  contribute to activity, Arg88 is essential for catalysis <37>)  "
1.1.1.410, D-erythronate + NAD+ = 2-dehydro-D-erythronate + NADH + H+  
1.1.1.411, L-threonate + NAD+ = 2-dehydro-L-erythronate + NADH + H+  
1.1.1.412," a (2R,3S)-2-alkyl-3-hydroxyalkanoate + NADP+ = an  (R)-2-alkyl-3-oxoalkanoate + NADPH + H+  "
1.1.1.413," a (3R,4R)-3-[(1S)-1-hydroxyalkyl]-4-(hydroxymethyl)oxolan-2-one + NADP+  = a (3R,4R)-3-alkanoyl-4-(hydroxymethyl)oxolan-2-one + NADPH + H+  "
1.1.1.414, L-galactonate + NAD+ = D-tagaturonate + NADH + H+  
1.1.1.415, narcotine hemiacetal + NAD+ = noscapine + NADH + H+  
1.1.1.416, isopyridoxal + NAD+ = 5-pyridoxolactone + NADH + H+  
1.1.1.417, a 3beta-hydroxy-4alpha-methylsteroid-4beta-carboxylate + NAD(P)+ = a  4alpha-methyl-3-oxosteroid + NAD(P)H + CO2 + H+  
1.1.1.418, a 3beta-hydroxysteroid-4alpha-carboxylate + NAD+ = a 3-oxosteroid + CO2  + NADH  
1.1.1.419," (+)-cis,cis-nepetalactol + NAD+ = (+)-cis,cis-nepetalactone + NADH + H+ "
1.1.1.419," (+)-cis,trans-nepetalactol + NAD+ = (+)-cis,trans-nepetalactone + NADH  + H+  "
1.1.1.42," isocitrate + NADP+ = 2-oxoglutarate + CO2 + NADPH + H+ (#8# active site  structure and reaction mechanism, conformational changes at the active  site resulting in closed and open forms, regulatory residues are  isocitrate-binding Asp279and Ser94 <53>; #83# active site structure  contains a well-ordered Mn2+-isocitrate complex, reaction mechanism  <51>; #10# Ser95, Asn97, and Thr78 are important for the catalysis  having distinguishable functions, overview <59>; #83# Tyr140 and Lys212  are required for catalytic activity, Tyr140 is the general acid that  protonates the substrate after decarboxylation, Lys212 lowers as a  positively charged residue the pK of the nearby ionizable group in the  enzyme-substrate complex and stabilizes the carbanion formed initially  on substrate decarboxylation <52>; #87# protonation of the enolate to  form product 2-oxoglutarate is the rate-limiting step <117>; #8#  overall reaction, catalytic mechanism, overview. The catalysis proceeds  in three steps: (1) NADP+ reduction by the isocitrate substrate with  the help of the Lys212B base, (2) beta-decarboxylation of the resulting  oxalosuccinate, generating an enolate, and (3) protonation of this  intermediate by Tyr139A, giving rise to the 2-oxooglutarate product.  The beta-decarboxylation of oxalosuccinate is the most likely  rate-limiting step. Role of Mg2+ and Asp275A, whose acid/base  properties throughout the catalytic cycle lower the barrier to  physiologically competent values. The catalysis takes place in a  closed-conformation quaternary complex and involves significant  conformational changes as the divalent metal (Mg2+ or Mn2+), the NADP+  cofactor, and the trianionic form of the isocitrate substrate (ICT)  sequentially bind <134>) "
1.1.1.42, oxalosuccinate = 2-oxoglutarate + CO2 
1.1.1.42, isocitrate + NADP+ = oxalosuccinate + NADPH + H+  
1.1.1.420, D-apiofuranose + NAD+ = D-apionolactone + NADH + H+  
1.1.1.421, D-apionate + NAD+ = 3-oxo-D-isoapionate + NADH + H+  
1.1.1.422," (+)-(1S,2S)-pseudoephedrine + NAD+ =  (S)-2-methylamino-1-phenylpropan-1-one + NADH + H+  "
1.1.1.423," (-)-(1R,2S)-ephedrine + NAD+ = (S)-2-(methylamino)-1-phenylpropan-1-one  + NADH + H+  "
1.1.1.424," D-xylose + NADP+ = D-xylono-1,4-lactone + NADPH + H+  "
1.1.1.425, levoglucosan + NAD+ = 3-dehydrolevoglucosan + NADH + H+  
1.1.1.426," UDP-N-acetyl-alpha-D-quinovosamine + NAD(P)+ =  UDP-2-acetamido-2,6-dideoxy-alpha-D-xylohex-4-ulose + NAD(P)H + H+  "
1.1.1.43, 6-phospho-D-gluconate + NAD(P)+ = 6-phospho-2-dehydro-D-gluconate +  NAD(P)H + H+  
1.1.1.44," 6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH +  H+ (#7# reductive carboxylation of ribulose-5-phosphate by 6PGDH is  investigated using kinetic isotope effects. In the absence of  6-phosphogluconate, a slow step, which precedes the chemical process,  is rate-limiting for the reaction, whereas in the presence of  6-phosphogluconate, the rate-limiting step follows the  isotope-sensitive step. Full activity of 6PGDH is achieved when one  subunit carries out the catalysis and the other subunit carries an  unreacted 6-phosphogluconate (allosteric activator) <124>)  "
1.1.1.45," L-gulonate + NAD+ = 3-dehydro-L-gulonate + NADH + H+ (#9# Cys125,  Glu97, and Ser124 are putative coenzyme/substrate-binding residues,  catalytic mechanism with induced-fit mechanism upon coenzyme binding  and involving a network-based substrate recognition, overview <11>)  "
1.1.1.46," L-arabinose + NAD+ = L-arabinono-1,4-lactone + NADH + H+  "
1.1.1.47," D-glucose + NAD(P)+ = D-glucono-1,5-lactone + NAD(P)H + H+ (#6# ordered  bi bi mechanism <26>; #24# sequential ordered bi-bi mechanism <40>;  #11# ordered bi bi mechanism, formation of ternary complexes, NADP+  adds first, NADPH formed dissociates last, for reverse reaction, NADPH  adds first, NADP+ leaves last <4>; #18# sequential type ordered bibi  mechnanism <37>)  "
1.1.1.48," D-galactose + NAD+ = D-galactono-1,4-lactone + NADH + H+ (#2,5# B-type  enzyme with regard to stereochemistry, transfers hydrogen from carbon-1  of D-galactose to si face of NAD, in the reverse reaction the pro-S  hydrogen atom from carbon-4 of NAD(P)H is transferred to the re face of  carbon-1 of D-galactono-1,5-lactone <13,14>; #2,5# depending on the pH,  the immediately formed D-galactono-1,5-lactone rearranges  intramolecularly to the corresponding 1,4-lactone or hydrolyzes to  D-galctonate or both <11,14,17>)  "
1.1.1.49," D-glucose 6-phosphate + NADP+ = 6-phospho-D-glucono-1,5-lactone + NADPH  + H+ (#38# sequential mechanism <114>; #7# reaction mechanism is  important for regulation <37>; #9# rapid equilibrium ordered bi bi  kinetic <38>; #13# physiological regulating function is discussed <33>;  #9# rapid-equilibrium random-order mechanism <63>; #32# rapid  equilibrium random bi bi kinetic mechanism <46>; #59# ternary-complex  mechanism <64>; #17# the adult kidney cortex enzyme shows a ping pong  bi bi kinetic mechanism, while the lamb kidney enzyme obeys an ordered  bi bi mechanism, thus the kinetic mechanism alters due to aging <61>)  "
1.1.1.50," a 3alpha-hydroxysteroid + NAD(P)+ = a 3-oxosteroid + NAD(P)H + H+ (#3#  reaction mechanism <43>; #3# enzyme isoforms bind substrate in  different ways <25>; #3# isozymes AKR1C1 and AKR1C2 are bifunctional  enzymes also showing minor 20alpha-hydroxysteroid dehydrogenase  activity, EC 1.1.1.149 <44>; #3# isozymes also performs 17- and  20-ketosteroid reductase and 3alpha-, 17beta- and  20alpha-hydroxysteroid oxidase activities at varying rates <53>; #4#  ordered bi bi kinetic mechanism, catalytic residues are Y55 and H117  <46>; #6# ordered bi bi kinetic reaction mechanism with nucleotide  cofactor binding first <42>; #3# steroid binding pocket structure of  isozyme AKR1C2 <45>; #4# steroid binding pocket structure of isozyme  AKR1C9 <45>; #3# steroid substrate recognition mechanism by isozymes  AKR1C1-AKR1C4, Tyr55 is involved in catalysis, ordered bi bi mechanism  <54>; #10# the catalytic triad is composed of Ser-114, Tyr-155, and  Lys-159, structural analysis and sequence alignment of the short chain  dehydrogenase/reductase family <56>; #4# the reduction reaction is  slightly preferred by the wild-type enzyme, which is determined by  residue Arg276 <59>; #4# bi bi ordered mechanism, kinetic analysis,  overview <66>; #4# the enzyme shows a sequential ordered reaction  mechanism, where NAD+ binds to the enzyme first and NADH leaves last  <64>; #20# The overall oxidoreductive reaction comprises the  deprotonation of tyrosine, proton abstraction by the tyrosinate anion,  and hydride transfer from the hydroxysteroid to NAD+, followed by the  release of a proton from the hydroxy group of tyrosine to the solution.  The proton transfer to the external base, from Tyr155 to Lys159 via  2-OH of ribose, with a late transition state is the rate-limiting step,  mechanism, overview <67>; #20# rate-limiting step in the reaction is  the release of NADH and proton. P185, T188 and the flexible  substrate-binding loop are involved in binding with the nucleotide  cofactor and with androsterone and are also involved in catalysis,  catalytic mechanism, overview <84>)  "
1.1.1.51, testosterone + NAD(P)+ = androstenedione + NAD(P)H + H+  
1.1.1.52, lithocholate + NAD+ = 3-oxo-5beta-cholan-24-oate + NADH + H+  
1.1.1.53," androstan-3alpha,17beta-diol + NAD+ = 17beta-hydroxyandrostan-3-one +  NADH + H+ (#7# exhibits carbonyl reductase-like activity <24>; #5#  exhibits carbonyl reductase-like activity, 85% amino acid sequence  homology with human carbonyl reductase <23>; #4# exhibits in male rat  liver microsomes also a carbonyl reductase-like activity with  acetohexamide as substrate <19,20>; #9# deduced reaction mechanism from  crystal structure model <27>; #6# catalytic residues are Ser114,  Tyr127, and Lys131 <35>)  "
1.1.1.54, allyl alcohol + NADP+ = acrolein + NADPH + H+ (#4#  3-methyl-2-buten-1-ol-dependent inducible activity <3>)  
1.1.1.55," propane-1,2-diol + NADP+ = L-lactaldehyde + NADPH + H+  "
1.1.1.56, ribitol + NAD+ = D-ribulose + NADH + H+  
1.1.1.57, D-mannonate + NAD+ = D-fructuronate + NADH + H+  
1.1.1.58, D-altronate + NAD+ = D-tagaturonate + NADH + H+  
1.1.1.59, 3-hydroxypropanoate + NAD+ = 3-oxopropanoate + NADH + H+  
1.1.1.6, glycerol + NAD+ = glycerone + NADH + H+ (#12# catalytic bi-bi mechanism  <57>; #32# the enzyme follows an ordered Bi-Bi mechanism kinetic model  and shows product inhibition <57>)  
1.1.1.60, D-glycerate + NAD(P)+ = 2-hydroxy-3-oxopropanoate + NAD(P)H + H+  
1.1.1.61, 4-hydroxybutanoate + NAD+ = succinate semialdehyde + NADH + H+  
1.1.1.62," 17beta-estradiol + NAD(P)+ = estrone + NAD(P)H + H+ (#2# ordered bi bi  mechanism <22>; #3# 17beta-HSD2 and 5 catalyzes the reaction of  estradiol-17beta to estrone and testosterone to androstenedione,  17beta-HSD2 also has 20alpha-HSD activity <45>; #3# 5 isoforms with  different substrate specificities and tissue distribution, 17beta-HSD1  predominantly catalyzes the reaction of estrone to estradiol-17beta,  17beta-HSD2 catalyzes the reaction of estradiol-17beta to estrone and  testosterone to androstenedione, 17beta-HSD3 and 5 catalyzes the  reaction of androstenedione to testosterone, 17beta-HSD4 catalyzes the  reaction of estradiol-17beta to estrone with low substrate affinty  <44>; #3# isoforms differs in substrate specificity and tissue  distribution, some enzyme forms displays also other activities such as  type 4 that acts also as a short chain alcohol dehydrogenase and  hydratase and type 10, that is identical to endoplasmic  amyloid-beta-binding protein and mitochondrial short chain  L-3-hydroxyacyl-CoA dehydrogenase <46>; #3# active site structure of  isozymes 17beta-HSD1 and 17beta-HSD14 <79>; #11# cofactor binding  residues are Tyr49, Thr202, Ala50, and Asn51, Theorell-Chance reaction  mechanism <76>; #11# structure-function analysis, dimerization is  crucial for catalytic activity <74>; #20# a structural analysis of  available crystal structures is performed and representative  conformations are assigned to each step of the putative kinetic  mechanism. An essential role played by the backbone and side chain  motions, especially of the betaFalphaGÂ’-loop, in cofactor and substrate  binding is disclosed. A selected-fit mechanism is suggested for  17beta-HSD1, where ligand-binding induces concerted motions of the  FG-segment and the C-terminal part guide the enzyme along its preferred  catalytic pathway <113>)  "
1.1.1.64, testosterone + NADP+ = androstenedione + NADPH + H+ (#5#  4-pro-S-hydrogen atom of NADPH is transferred to the alpha-face of the  steroid molecule <6>; #2# 4-pro-R-hydrogen atom of NADPH is transferred  to the alpha-face of the steroid molecule <1>)  
1.1.1.65, pyridoxine + NADP+ = pyridoxal + NADPH + H+  
1.1.1.66, 10-hydroxydecanoate + NAD+ = 10-oxodecanoate + NADH + H+  
1.1.1.67," D-mannitol + NAD+ = D-fructose + NADH + H+ (#37# the oxyanion hole of  mannitol 2-dehydrogenase drives a precatalytic conformational  equilibrium at the ternary complex level in which the reactive group of  the substrate is activated for chemical conversion through its precise  alignment with the unprotonated side chain of Lys295 in mannitol  oxidation and C=O bond polarization by the carboxamide moieties of  Asn191 and Asn300 in fructose reduction. In the subsequent hydride  transfer step, the two asparagine residues provide about 40 kJ/mol of  electrostatic stabilization <48>; #35# binding of substrate and NAD(H)  is random for both D-mannitol oxidation and D-fructose reduction.  Hydride transfer is rate-determining for D-fructose reduction. Product  release steps control the maximum rates in the other direction of the  enzymatic reaction <50>)  "
1.1.1.69, D-gluconate + NAD(P)+ = 5-dehydro-D-gluconate + NAD(P)H + H+  
1.1.1.7," propane-1,2-diol 1-phosphate + NAD+ = hydroxyacetone phosphate + NADH +  H+  "
1.1.1.71," a primary alcohol + NAD(P)+ = an aldehyde + NAD(P)H + H+ (#6,10# enzyme  is stereospecific for the pro-R hydride of NADPH <3>; #27# the  defence-related alcohol dehydrogenase DRD-1 is an alcohol:NADP+  oxidoreductase with preference for various aromatic and aliphatic  aldehydes <10>; #1# the enzyme is an aldo-keto reductase <1>; #26# the  human pancreas protein 2 has a retinal reductase activity <9>)  "
1.1.1.72, glycerol + NADP+ = D-glyceraldehyde + NADPH + H+  
1.1.1.73, octan-1-ol + NAD+ = octanal + NADH + H+  
1.1.1.75, (R)-1-aminopropan-2-ol + NAD+ = aminoacetone + NADH + H+  
1.1.1.76," (2S,3S)-butane-2,3-diol + NAD+ = (S)-acetoin + NADH + H+  "
1.1.1.77," (R)[or (S)]-propane-1,2-diol + NAD+ = (R)[or (S)]-lactaldehyde + NADH +  H+  "
1.1.1.78, (R)-lactaldehyde + NAD+ = 2-oxopropanal + NADH + H+  
1.1.1.79," glycolate + NADP+ = glyoxylate + NADPH + H+ (#19# ordered Bi Bi  mechanism, complexation of NADPH to the enzyme before glyoxylate or  succinic semialdehyde, and release of NADP+ before glycolate or  4-hydroxybutyrate <18>; #19# the enzyme performs an acid/base catalytic  mechanism involving Lys170 as the general acid and a conserved  active-site water molecule <24>) "
1.1.1.79, D-glycerate + NAD(P)+ = glyoxylate + NADPH + H+  
1.1.1.8," sn-glycerol 3-phosphate + NAD+ = glycerone phosphate + NADH + H+ (#33#  ordered bi-bi mechanism <37>; #8,9,13# one active site per enzyme  molecule <3>; #24# ordered ternary-complex mechanism, NADH binds first  <25>; #4,11# equilibrium random-bi-bi reaction mechanism <24,31>) "
1.1.1.8, sn-glycerol 3-phosphate + acceptor = glycerone phosphate + reduced  acceptor (#33# ordered bi-bi mechanism <37>)  
1.1.1.80, propan-2-ol + NADP+ = acetone + NADPH + H+  
1.1.1.81, D-glycerate + NAD(P)+ = hydroxypyruvate + NAD(P)H + H+  
1.1.1.82," (S)-malate + NADP+ = oxaloacetate + NADPH + H+ (#30# The enzyme is  highly conserved with plant counterparts, but bearing differences at  regulatory determinants with a critical role for redox control of  protein activity <46>)  "
1.1.1.83, (R)-malate + NAD+ = pyruvate + CO2 + NADH  
1.1.1.84," (R)-3,3-dimethylmalate + NAD+ = 3-methyl-2-oxobutanoate + CO2 + NADH  "
1.1.1.85," (2R,3S)-3-isopropylmalate + NAD+ = (2S)-2-isopropyl-3-oxosuccinate +  NADH + H+ (#5# the oxidative decarboxylation of 2-hydroxy acid  substrates by the enzyme occurs via a random kinetic mechanism with the  formation of two abortive complexes: enzyme-NADH-substrate and  enzyme-NADH-inhibitor <26>)  "
1.1.1.86," (2R)-2,3-dihydroxy-3-methylbutanoate + NADP+ =  (2S)-2-hydroxy-2-methyl-3-oxobutanoate + NADPH + H+ (#3# active site  structure <30>; #3# bifunctional enzyme that catalyses two different  reactions at a common active site, an isomerization consisting of an  alkyl migration, followed by an NADPH-dependent reduction of a-ketoacid  <22>; #15# catalytic mechanism, overview <37>; #27# active site  structure and catalytic mechanism, mechanism of induced fit, overview  <38>)  "
1.1.1.87," (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate + NAD+ = 2-oxoadipate +  CO2 + NADH + H+ (#3# two enzyme groups act as acid-base catalysts in  the reaction. A group with a pKa of 6.5-7 acts as a general base  accepting a proton as the beta-hydroxy acid is oxidized to the  beta-keto acid, and this residue participates in all three of the  chemical steps, acting to shuttle a proton between the C2 hydroxyl and  itself. The second group acts as a general acid with a pKa of 9.5 and  likely catalyzes the tautomerization step by donating a proton to the  enol to give the final product <12>; #13# there are 2 groups acting as  acid-base catalysts in the reaction. One residue with a pKa of 6.5-7.0  serves as the general base to accept a proton as the beta-hydroxy acid  is oxidized to the beta-keto acid, and this residue participates in all  three of the chemical steps, acting to shuttle a proton between the C2  hydroxyl and itself. The metal ion then acts as a Lewis acid to  catalyze the decarboxylation of the beta-ketoacid, with the general  base donating a proton to the keto oxygen as the enol of  alpha-ketoadipate is formed. A second residue with a pKa of 9.5 likely  catalyzes the tautomerization step by donating a proton to the enol to  give the final product. Catalytic rapid equilibrium random kinetic  mechanism, overview <20>)  "
1.1.1.88," (R)-mevalonate + CoA + 2 NAD+ = 3-hydroxy-3-methylglutaryl-CoA + 2 NADH  + 2 H+ (#8# reaction mechanism purposal <12>; #8# There are two classes  of enzyme, the third enzyme of the mevalonate pathway of isopentenyl  diphosphate biosynthesis: the class I enzymes of eukaryotes and the  class II enzymes of certain eubacteria <17>)  "
1.1.1.9," xylitol + NAD+ = D-xylulose + NADH + H+ (#26# it is concluded that the  enzyme reaction follows the mechanism where coenzyme binds first and  leaves last. Therefore, dissociation of D-xylulose-NADH complex is  suggested to be the rate-limiting step <38>)  "
1.1.1.90, an aromatic alcohol + NAD+ = an aromatic aldehyde + NADH + H+ (#3#  ordered bi-bi kinetic mechanism <14>)  
1.1.1.91, an aromatic alcohol + NADP+ = an aromatic aldehyde + NADPH + H+  
1.1.1.92, D-glycerate + NAD(P)+ + CO2 = 2-hydroxy-3-oxosuccinate + NAD(P)H + 2 H+  (#1# A-specific enzyme <1>)  
1.1.1.93," tartrate + NAD+ = oxaloglycolate + NADH + H+ (#3# primarily ordered  mechanism <11>; #3# A-side dehydrogenase, i.e. the hydride is  transferred from the substrate to the pro-R position of C4 of NADH <7>;  #3# kinetic mechanism, equilibrium-ordered addition of Mn2+ prior to  D-malate or meso-tartrate, overview <14>; #3# lysyl amino group, Lys192  is the base responsible for the water-mediated proton abstraction from  the C2 hydroxyl group of the substrate that begins the catalytic  reaction, followed by hydride transfer to NAD. The hydroxyl group of  Tyr141 functions as a general acid to protonate the enolate  intermediate. Each substrate undergoes the initial hydride transfer  <15>)  "
1.1.1.94, sn-glycerol 3-phosphate + NAD(P)+ = glycerone phosphate + NAD(P)H + H+  (#1# bimolecular kinetic mechanism <5>)  
1.1.1.95," 3-phospho-D-glycerate + NAD+ = 3-phosphooxypyruvate + NADH + H+ (#6#  member of the 2-hydroxyacid dehydrogenases family, whereof only the  enzymes from E. coli and Pisum sativum utilize phosphorylated  substrates and transfer the hydride ion to the A-site of NAD+, uses  also alpha-ketoglutarate as substrate <22>; #6# regulation model with  effector L-serine, member of the D-2-hydroxyacid dehydrogenases,  D-isomer substrate specific, overview of related enzymes from other  species <23>; #6# model for catalytic mechanism <21,26>)  "
1.1.1.96," 3-(3,5-diiodo-4-hydroxyphenyl)lactate + NAD+ =  3-(3,5-diiodo-4-hydroxyphenyl)pyruvate + NADH + H+  "
1.1.1.97, 3-hydroxybenzyl alcohol + NADP+ = 3-hydroxybenzaldehyde + NADPH + H+  
1.1.1.98, (R)-2-hydroxystearate + NAD+ = 2-oxostearate + NADH + H+  
1.1.1.99, (S)-2-hydroxystearate + NAD+ = 2-oxostearate + NADH + H+  
1.1.2.10, methanol + 2 oxidized cytochrome cL = formaldehyde + 2 reduced  cytochrome cL  
1.1.2.2, D-mannitol + a ferricytochrome c = D-fructose + a ferrocytochrome c + 2  H+  
1.1.2.3," (S)-lactate + 2 ferricytochrome c = pyruvate + 2 ferrocytochrome c + 2  H+ (#1,8# hydride transfer mechanism <27,28>; #1# catalytic cycle,  overview <49>; #8# the hydride transfer mechanism involves the transfer  of the lactate hydroxyl proton to H373 while the substrate aH atom is  transferred as a hydride to the flavin mononucleotide (FMN) prosthetic  group anchored in the active site <50>)  "
1.1.2.4, (R)-lactate + 2 ferricytochrome c = pyruvate + 2 ferrocytochrome c + 2  H+  
1.1.2.5, (R)-lactate + 2 ferricytochrome c-553 = pyruvate + 2 ferrocytochrome  c-553 + 2 H+  
1.1.2.6, polyvinyl alcohol + ferricytochrome c = oxidized polyvinyl alcohol +  ferrocytochrome c + H+  
1.1.2.7," a primary alcohol + 2 ferricytochrome cL = an aldehyde + 2  ferrocytochrome cL + 2 H+ (#4# active site structure with bound  cofactor, the reduced pyrroloquinoline quinone (PQQ) transfers two  electrons in single electron-transfer steps to cytochrome cL, creating  a semiquinone form of the prosthetic group after the first electron  transfer, electron transfer via enzyme residues Cys104, Asp105, and  Asn52 <3>; #3# additionÂ–elimination mechanism and hydride transfer  mechanism, the catalytic mechanism, with a tetrahedral intermediate,  involves the quinone containing prosthetic group, substrate binding and  active site structures, overview, the oxygen atoms of the PQQ are  involved in several hydrogen bonds with the residues Glu55, Arg109,  Thr153, Ser168, Arg324 and Asn387 <4>; #17# detailed mechanism of  methanol oxidation involving residues Asp297 and Glu171,  structure-activity analysis by quantum mechanics and molecular  mechanics, QM/MM, selfconsistent-charge density-functional  tight-binding, SCC-DFTB, and molecular dynamics, the transition state  involves Glu171-CO2- as general base <6>; #10# the amino-acid residues  related to the active site of MDH, E55, C103, C104, R109, T159, S174,  E177, T243, W243, N261, D303, R331, N394, and W476, are completely  conserved <5>; #16# catalytic mechanism, ping-pong kinetic schemes, and  transition state structures, analysis by ab initio quantum mechanical  methods, hydride transfer from the Calpha-position of the substrate  alcohol or aldehyde directly to the C-5 carbon of PQQ is energetically  feasible, detailed overview <17>; #16# detailed reaction mechanism with  direct hydride transfe, Glu177 plays the role of general base catalyst  <7>; #9# detailed reaction mechanism with direct hydride transfer <7>;  #22# chemical structure of pyrroloquinoline quinone and hydride  transfer mechanism of the enzymatic reaction catalyzed by MEDH,  overview <27>; #1,2,3,4,6,7,21# mechanism of methanol oxidation by  QMDH, overview <28>)  "
1.1.2.8, a primary alcohol + 2 ferricytochrome c = an aldehyde + 2  ferrocytochrome c + 2 H+  
1.1.2.9, butan-1-ol + 2 ferricytochrome c = butanal + 2 ferrocytochrome c + 2 H+  
1.1.3.10," D-glucose + O2 = 2-dehydro-D-glucose + H2O2 (#23# investigation of the  reaction mechanism by determining the rate constants <29>; #28# highly  regioselective mechanism, overview. The different conformations of the  454FSY456 gating segment in the semiopen and closed states induce  backbone and side-chain movements of Thr169 and Asp452 that add further  differential stabilization to the individual states <52>; #23# ping  pong bi bi reaction mechanism, sugar oxidation and flavin reduction  activation and mechanism, regiospecificity and selectivity of sugar  oxidation, overview. The 2-oxo-sugar product is released prior to the  oxygen reaction, overview. The enzyme shows a hydride transfer  mechanism in which there is stepwise formation of D-glucose alkoxide  prior to the hydride transfer, and a C4a-hydroperoxyflavin as an  intermediate during the oxidative half-reaction, the  C4a-hydroperoxyflavin merely eliminates H2O2 to generate oxidized FAD.  The breakage of the flavin N (5)-H bond controls the overall process of  H2O2 elimination from C4a-hydroperoxyflavin <50>; #23# ping pong bi bi  reaction mechanism, the catalytic reaction of P2O can be divided into a  reductive half-reaction in which two electrons are transferred as a  hydride equivalent from a sugar substrate to a flavin to generate  reduced FAD and a 2-oxo-sugar, and an oxidative half-reaction in which  two electrons are transferred from the reduced flavin to oxygen to form  hydrogen peroxide, formation of C(4a)-hydroperoxyflavin was observed  during enzyme turnovers, overview <49>; #23# ping-pong reaction  mechanism, but change in the enzyme kinetic mechanism from a ping-pong  type mechanism at pH values below 7.0 to a ternary complex type  mechanism at pH values above 7.0. The switching of reaction mechanism  from the ping-pong to the ternary complex type may be resulting from  the change of structural dynamics of the substrate loop in the T169A  mutant or at higher pH values, overview <48>; #28# the enzyme shows a  ping pong bi bi mechanism, a specialised bi bi mechanism in which  substrate binding and release of products are ordered and the enzyme  shuttles between a free and a substrate-modified intermediate  conformation <51>)  "
1.1.3.11, L-sorbose + O2 = 5-dehydro-D-fructose + H2O2  
1.1.3.12, pyridoxine + O2 = pyridoxal + H2O2  
1.1.3.13, a primary alcohol + O2 = an aldehyde + H2O2 (#5# ping-pong mechanism  operates via a two-electron transfer from substrate to oxygen <10>)  
1.1.3.14," 4 catechol + 3 O2 = 2 dibenzo[1,4]dioxin-2,3-dione + 6 H2O  "
1.1.3.15," an (S)-2-hydroxy carboxylate + O2 = a 2-oxo carboxylate + H2O2 (#42#  the catalytic residue is Phe23, reaction mechanism <49>; #37# the pH  affects the kinetic steps of the catalytic mechanism of human glycolate  oxidase, the enzyme shows a ping-pong bi-bi kinetic mechanism between  pH 6.0 and 10.0, overview. Formation of the enzyme-substrate complex  suggests the presence of a protonated group participating in substrate  binding <68>; #42# reaction mechanism, quantum mechanics/molecular  mechanics calculations and molecular dynamics simulations, overview.  LCHAO-catalyzed dehydrogenation of L-lactate is a stepwise catalytic  reaction in a hydride transfer mechanism but not a carbanion mechanism.  In contrast to the wild-type enzyme, the mutant Y129F LCHAO catalyzes  the oxidation of L-lactate in one step <85>)  "
1.1.3.16, ecdysone + O2 = 3-dehydroecdysone + H2O2  
1.1.3.17," choline + O2 = betaine aldehyde + H2O2 (#4# choline hydroxyl proton is  not in flight in the transition state for CH bond cleavage, steps of  flavin reduction by choline and betaine aldehyde is rate rate limiting  for the overall turnover <20>; #4# mechanism, carbon-hydrogen bond  cleavage of choline is nearly irreversible and fully rate-limiting at  low pH <19>; #4# sequential mechanism with oxygen reacting with the  reduced enzyme before release of the betaine-aldede or glycine-betaine,  kinetic step in the oxidation of choline to the ladehyde is partially  rate-limiting <18>; #4# His466 is a catalytic residue involved in the  oxidation but not the reduction, reaction mechanism <17>; #4# reaction  mechanism via FAD, the enzyme catalyzes the four-electron-oxidation of  choline to glycine betaine via the intermediate betaine aldehyde in two  sequential FAD-dependent reaction steps, hydride transfer and oxygen  radical mechanisms, overview <20>; #4# reaction mechanism via FAD, the  enzyme catalyzes the four-electron-oxidation of choline to glycine  betaine via the intermediate betaine aldehyde in two sequential  FAD-dependent reaction steps, the enzyme correlates reversible hydride  transfer with environmentally enhanced tunneling, oxygen- and  temperature-dependent kinetic isotope effects, overview <25>; #4#  reaction mechanism, the enzyme catalyzes the four-electron-oxidation of  choline to glycine betaine via the intermediate betaine aldehyde in two  sequential FAD-dependent reaction steps <22,28>; #4# reaction  mechanism, the enzyme catalyzes the four-electron-oxidation of choline  to glycine betaine via the intermediate betaine aldehyde in two  sequential FAD-dependent reaction steps, His466 is a catalytic residue  involved in flavin-binding <23>; #4# steady state kinetic mechanism,  the enzyme catalyzes the four-electron-oxidation of choline to glycine  betaine via the intermediate betaine aldehyde in two sequential  FAD-dependent reaction steps, detailed reaction mechanism <21>; #5# the  catalytic reaction involves an active site His residue and a Ser  residue in proximity to the active site <27>; #6# the enzyme catalyzes  the oxidation of choline to glycine betaine via the intermediate  betaine aldehyde <26>) "
1.1.3.17," choline + 2 O2 + H2O = betaine + 2 H2O2 (#11# two-step, four-electron  oxidation (alcohol oxidation, aldehyd hydration, aldehyde oxidation)  <41>; #4# reaction mechanism of reductive and oxidative half-reactions,  determination of a mechanism of flavin oxidation that directly results  in the formation of oxidized flavin and hydrogen peroxide without  stabilization of reaction intermediates, overview <53>) "
1.1.3.17," betaine aldehyde + O2 + H2O = betaine + H2O2 (#4# His466 is a catalytic  residue involved in the oxidation but not the reduction, reaction  mechanism <17>; #4# reaction mechanism, the enzyme catalyzes the  four-electron-oxidation of choline to glycine betaine via the  intermediate betaine aldehyde in two sequential FAD-dependent reaction  steps <22>)  "
1.1.3.18, a secondary alcohol + O2 = a ketone + H2O2  
1.1.3.19, (S)-4-hydroxymandelate + O2 = 4-hydroxybenzaldehyde + CO2 + H2O2  
1.1.3.2, (S)-lactate + O2 = pyruvate + H2O2  
1.1.3.20," a long-chain alcohol + O2 = a long-chain aldehyde + H2O2 (#5# ping-pong  mechanism <8>; #2,5,8,11,12# 2 long-chain alcohol + O2 = 2 long-chain  aldehyde + 2 H2O2 <2,3,4,5,6,7,8>)  "
1.1.3.21, sn-glycerol 3-phosphate + O2 = glycerone phosphate + H2O2 (#5#  mechanism <3>)  
1.1.3.23, thiamine + 2 O2 + H2O = thiamine acetic acid + 2 H2O2  
1.1.3.27, L-2-hydroxyphytanate + O2 = 2-oxophytanate + H2O2  
1.1.3.28, inosine + O2 = 9-riburonosylhypoxanthine + H2O  
1.1.3.29, N-acetyl-D-glucosamine + O2 = N-acetyl-D-glucosaminate + H2O2  
1.1.3.30, polyvinyl alcohol + O2 = oxidized polyvinyl alcohol + H2O2  
1.1.3.37," D-arabinono-1,4-lactone + O2 = dehydro-D-arabinono-1,4-lactone + H2O2  "
1.1.3.38, Vanillyl alcohol + O2 = vanillin + H2O2 (#1# the shape of the  active-site cavity controls substrate specificity by providing a size  exclusion mechanism. Inside the cavity the substrate aromatic ring is  positioned at an angle of 18Â° to the flavin ring <9>; #1# hydride  transfer mechanism involving a p-quinone methide intermediate is  proposed for the reaction with 4-allylphenols <2>)  
1.1.3.39, adenosine + 2 O2 + H2O = 9-riburonosyladenine + 2 H2O2 
1.1.3.39, adenosine + O2 = 5'-dehydroadenosine + H2O2  
1.1.3.4," beta-D-glucose + O2 = D-glucono-1,5-lactone + H2O2 (#3# mechanism  <38,39>; #20# stereochemistry <23>; #6# catalytic mechanism and  stereoselectivity, substrate binding occurs through a lock-and-key  mechanism and does not induce conformational changes with respect to  the ligand-free protein, overview <90>; #6# proposed mechanism for the  oxidation of 1,2-diols to the alpha-hydroxy acids, overview <82>)  "
1.1.3.40," D-mannitol + O2 = D-mannose + H2O2 (#1# utilization of the sugar  alcohols generally proceeds by an initial oxidation, producing a hexose  <1>; #1# stoichiometry, mannose/H2O2 = 0.86 <1>)  "
1.1.3.41, xylitol + O2 = xylose + H2O2 
1.1.3.41," an alditol + O2 = an aldose + H2O2 (#3# catalytic mechanism and  stereoselectivity, substrate binding occurs through a lock-and-key  mechanism and does not induce conformational changes with respect to  the ligand-free protein, overview <6>; #1# proposed mechanism for the  oxidation of 1,2-diols to the alpha-hydroxy acids, overview <4>)  "
1.1.3.42, prosolanapyrone II + O2 = prosolanapyrone III + H2O2  
1.1.3.43, paromamine + O2 = 6'-dehydroparomamine + H2O2  
1.1.3.44, 6'''-deamino-6'''-hydroxyneomycin C + O2 =  6'''-deamino-6'''-oxoneomycin C + H2O2  
1.1.3.45, aclacinomycin N + O2 = aclacinomycin A + H2O2  
1.1.3.46, (S)-4-hydroxymandelate + O2 = 2-(4-hydroxyphenyl)-2-oxoacetate + H2O2  
1.1.3.47," 5-(hydroxymethyl)furfural + 3 O2 + 2 H2O = furan-2,5-dicarboxylate + 3  H2O2 "
1.1.3.47," 5-(hydroxymethyl)furfural + O2 = furan-2,5-dicarbaldehyde + H2O2 "
1.1.3.47," furan-2,5-dicarbaldehyde + H2O = 5-(dihydroxymethyl)furan-2-carbaldehyde "
1.1.3.47, 5-(dihydroxymethyl)furan-2-carbaldehyde + O2 =  5-formylfuran-2-carboxylate + H2O2 
1.1.3.47, 5-formylfuran-2-carboxylate + H2O =  5-(dihydroxymethyl)furan-2-carboxylate 
1.1.3.47," 5-(dihydroxymethyl)furan-2-carboxylate + O2 = furan-2,5-dicarboxylate +  H2O2  "
1.1.3.48," 3-deoxy-alpha-D-manno-octulopyranosonate + O2 =  3,8-dideoxy-8-oxo-alpha-D-manno-octulosonate + H2O2  "
1.1.3.49, (R)-mandelonitrile + O2 = benzoyl cyanide + H2O2  
1.1.3.5," D-glucose + O2 = D-glucono-1,5-lactone + H2O2  "
1.1.3.6," cholesterol + O2 = cholest-5-en-3-one + H2O2  (#5,6,12,15,16,17,18,21,22,24,26,27,30,31,34,35,36,37,43# bifunctional  enzyme, catalyzes both the oxidation of DELTA5-ene-3beta  hydroxysteroids with a trans A-B ring junction to the corresponding  DELTA5-3-ketosteroid with the reduction of oxygen to hydrogen peroxide,  and the isomerization to the DELTA4-3-ketosteroid  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26  27,28,29,30,31,32,33,34,38>; #30,36# isomerization is not the rate  limiting step <28>)  "
1.1.3.7," an aromatic primary alcohol + O2 = an aromatic aldehyde + H2O2 (#14#  the enzyme catalyzes two half-reactions: oxidation of benzyl alcohol  with FAD cofactor, and reduction of O2 with reduced cofactor FADH2,  active site structure, Tyr92, Phe501, His502 and His546 are strictly  required for activity, Tyr78 is not involved in catalysis, while Leu315  might be important <21>; #14# the enzyme catalyzes two half-reactions:  oxidation of benzyl alcohol with FAD cofactor, and reduction of O2 with  reduced cofactor FADH2, the enzyme does not thermodynamically stabilize  a flavin semiquinone radical and forms no sulphite adduct <17>; #23,24#  belongs to the GMC oxidoreductase family (GMC:  glucose-methanol-choline) <25>; #20# a sequential mechanism in which O2  reacts with reduced enzyme before release of the aldehyde product, the  AAO reductive half-reaction is essentially irreversible and rate  limiting during catalysis, a synchronous mechanism in which hydride  transfer from substrate alpha-carbon to FAD and proton abstraction from  hydroxyl occur simultaneously, reaction mechanism, overview. The AAO  catalytic mechanism proceeds via electrophilic attack and direct  transfer of a hydride to the flavin <26>; #20# catalytic mechanism with  catalytic cycle including two half-reactions, overview. Proton transfer  to His502 acting as a base, His546 plays a role in alcohol binding.  Phe501 forces O2 to approach the flavin C4a, and His502 yielding  hydrogen peroxide and the reoxidized flavin <32>; #20# modeling  protein-ligand recognition mechanisms, substrate diffusion into the AAO  active site, two conserved histidine residues, His502 and His546, are  involved in catalysis, structure-function analysis, overview <33>; #20#  oxidation mechanism by AAO, overview <36>; #20# two conserved histidine  residues, His502 and His546, are involved in catalysis and play roles  in the two half-reactions, with a stronger histidine involvement in the  reductive than in the oxidative half-reaction. His502 is the catalytic  base in the AAO reductive half-reaction. The His502 proton transfer  does not limit the oxidative half-reaction, stereoselective hydride  transfer. Quantum mechanical/molecular mechanical study, mutational  analysis, and computational simulations, detailed overview <34>; #20#  kinetic and reaction mechanisms involving residue Tyr92, hydride  transfer reaction and aromatic stacking interactions on catalysis.  Sequential reaction mechanism involving a ternary complex between AAO  and its reducing/oxidizing substrates versus a ping-pong mechanism,  overview <43>)  "
1.1.3.8," L-gulono-1,4-lactone + O2 = L-xylo-hex-2-ulono-1,4-lactone + H2O2  (#1,2,3,4,5,9,11,12,14,16,24,25,26,27,28,29# product isomerizes  spontaneously to L-ascorbate  <2,3,4,5,6,7,8,9,10,11,12,14,15,16,17,18,19,20,21,22,23,24>)  "
1.1.3.9," D-galactose + O2 = D-galacto-hexodialdose + H2O2 (#4# mechanism <37>;  #2# detailed mechanism, selective for pro-S hydrogen abstraction <34>;  #1# detailed reaction mechanism, the active site of galactose oxidase  bears a Cu2+ with an inner coordination sphere involving Tyr272,  Tyr495, His496, His581, and a coordinated solvent molecule, and Trp290  in the outer sphere of the complex, overview <39>; #5# reaction  mechanism, structure-function analysis, two-electron redox reaction  involving a Cu(I)/Cu(II) couple and the reversible oxidation of a  ligating phenolate, tyrosine residue of the Tyr272-Cys228 conjugate, to  a phenoxyl radical, overview <42>; #2# the active site consists of two  one-electron redox units involving residues Y495, H496, H581, Y272, and  W290, a Cu2+ ion, and a crosslinked Y272Â•-C228 radical cofactor, which  together are responsible for the catalytic activity, structure  modelling <41>; #9,11,12,13,14,18,19,20# oxidative and reductive  half-reactions in the enzymatic cycle of galactose oxidase during  oxidation of the C-6 hydroxyl group of D-galactose to the corresponding  aldehyde <63>; #4# the catalytic mechanism of enzyme GOase can be  described by the ping-pong bi bi mechanism, where the alcohol substrate  is oxidized in one catalytic halfreaction followed by reoxidation of  the enzyme by reduction of oxygen to hydrogen peroxide in a second  half-reaction <65>; #11# the first half-reaction involves proton  transfer from O-6 of galactose to the axial tyrosine anion, hydrogen  atom transfer (HAT) from C-6 of galactose to the tyrosine-cysteine  radical cofactor and electron transfer from the carbohydrate to  generate the aldehyde and Cu(I). To complete the catalytic cycle, the  second half-reaction is proposed to involve inner-sphere electron  transfer from Cu(I) to oxygen to yield superoxide, HAT from the  phenolic hydroxyl group of the Tyr-Cys cofactor to the superoxide to  produce metal-bound hydroperoxide and proton transfer from the axial  tyrosine to hydroperoxide to produce hydrogen peroxide and the  re-oxidized, active Cu(II)-radical state of the enzyme <64>)  "
1.1.5.10, (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol  
1.1.5.11, butan-1-ol + a quinone = butanal + a quinol  
1.1.5.12, (R)-lactate + a quinone = pyruvate + a quinol  
1.1.5.13, (S)-2-hydroxyglutarate + a quinone = 2-oxoglutarate + a quinol  
1.1.5.14, D-fructose + acceptor = 5-dehydro-D-fructose + reduced acceptor (#3#  ping-pong mechanism <4>) 
1.1.5.14, D-fructose + an ubiquinone = 5-dehydro-D-fructose + an ubiquinol  
1.1.5.2," D-glucose + ubiquinone = D-glucono-1,5-lactone + ubiquinol (#9#  ping-pong mechanism <4>; #19# catalytic mechanism <36>; #23,24# active  site structure <38,39>; #9# hexa uni ping-pong mechanism <3>; #2#  active site structure contains a loop 6BC region which does not  directly interact with the substrates <34>; #9# active site structure  from crystal structure, and detailed catalytic mechanism <37>; #2#  active site structure, putative catalytic mechanism and cycle involving  Asp466 and Lys493 <38>; #9# catalytic mechanism, His144, Arg228, and  Asn229 are involved <47>; #9# ping pong reaction mechanism <69>)  "
1.1.5.3, sn-glycerol 3-phosphate + a quinone = glycerone phosphate + a quinol  (#13# ping-pong mechanism <4>)  
1.1.5.4, (S)-malate + a quinone = oxaloacetate + reduced quinone  
1.1.5.5, ethanol + ubiquinone = acetaldehyde + ubiquinol  
1.1.5.7, a cyclic alcohol + a quinone = a cyclic ketone + a quinol  
1.1.5.8, quinate + quinone = 3-dehydroquinate + quinol  
1.1.5.9," D-glucose + a quinone = D-glucono-1,5-lactone + a quinol  "
1.1.7.1, benzoyl-CoA + oxidized ferredoxin + H2O = 4-hydroxybenzoyl-CoA +  reduced ferredoxin (#2# mechanism <6>; #3# Birch-like mechanism <10>;  #3# catalytic cycle with separated two-electron and one-electron  transfer steps <9>)  
1.1.9.1, a primary alcohol + azurin = an aldehyde + reduced azurin  
1.1.98.2," D-glucose 6-phosphate + oxidized coenzyme F420 =  6-phospho-D-glucono-1,5-lactone + reduced coenzyme F420  "
1.1.98.3," trans,octacis-decaprenylphospho-beta-D-ribofuranose + FAD =  trans,octacis-decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose +  FADH2  "
1.1.98.4, a quinol + oxidized coenzyme F420 = a quinone + reduced coenzyme F420  
1.1.98.5, R-CHOH-R' + oxidized coenzyme F420 = R-CO-R' + reduced coenzyme F420  
1.1.98.6, ribonucleoside 5'-triphosphate + formate = 2'-deoxyribonucleoside  5'-triphosphate + CO2 + H2O  
1.1.98.7, S-adenosyl-L-methionine + a [sulfatase]-L-serine = a  [sulfatase]-3-oxo-L-alanine + 5'-deoxyadenosine + L-methionine  
1.1.99.1, choline + acceptor = betaine aldehyde + reduced acceptor (#4# mechanism  <3>; #9# pingÂ–pong BiÂ–Bi steady state kinetic mechanism of partially  purified rat CHD <21>)  
1.1.99.12, L-sorbose + acceptor = 5-dehydro-D-fructose + reduced acceptor  
1.1.99.13, sucrose + acceptor = 3-dehydro-alpha-D-glucosyl-beta-D-fructofuranoside  + reduced acceptor  
1.1.99.14, glycolate + acceptor = glyoxylate + reduced acceptor  
1.1.99.18," cellobiose + acceptor = cellobiono-1,5-lactone + reduced acceptor (#11#  mechanism <19>; #11# mechanism of electron transfer <22>; #11#  mechanism: cellobiose rapidly reduces the flavin group, which in turn  slowly reduces the cytochrome b moiety, cytochrome b may donate  electrons very rapidly to either mammalian cytochrome c or bacterial  cytochrome c-551. Reactions are second-order <39>)  "
1.1.99.2, (S)-2-hydroxyglutarate + acceptor = 2-oxoglutarate + reduced acceptor  
1.1.99.20, primary alcohol + acceptor = aldehyde + reduced acceptor  
1.1.99.21, D-sorbitol + acceptor = L-sorbose + reduced acceptor  
1.1.99.22, glycerol + acceptor = glycerone + reduced acceptor  
1.1.99.24, (S)-3-hydroxybutanoate + 2-oxoglutarate = acetoacetate +  (R)-2-hydroxyglutarate  
1.1.99.26," 3-hydroxycyclohexanone + acceptor = cyclohexane-1,3-dione + reduced  acceptor  "
1.1.99.27, (R)-Pantolactone + acceptor = 2-dehydropantolactone + reduced acceptor  
1.1.99.28," D-glucose + D-fructose = D-gluconolactone + D-glucitol (#3# mechanism  <5>; #3# ping-pong mechanism with a single site for all substrates, two  half-reactions with alternate reduction of NADP+ and oxidation of NADPH  <3>)  "
1.1.99.29," a pyranose + acceptor = a pyranos-2-ulose (or a pyranos-3-ulose or a  pyranos-2,3-diulose) + reduced acceptor "
1.1.99.29," a pyranoside + acceptor = a pyranosid-3-ulose (or a  pyranosid-3,4-diulose) + reduced acceptor (#1# requires FAD, a number  of aldoses and ketoses in pyranose form, as well as glycosides,  gluco-oligosaccharides, sucrose and lactose can act as donor,  1,4-benzoquinone or ferricenium ion (ferrocene oxidized by removal of  one electron) can serve as acceptor, unlike EC 1.1.3.10, pyranose  oxidase, this fungal enzyme does not interact with O2 and exhibits  extremely broad substrate tolerance with variable regioselectivity  (C-3, C-2 or C3 + C-2 or C-3 + C-4) for (di)oxidation of different  sugars, D-glucose is exclusively or preferentially oxidized at C-3  (depending on the enzyme source), but can also be oxidized at C-2 +  C-3, the enzyme also acts on 1-4-alpha- and  1-4-beta-gluco-oligosaccharides, non-reducing gluco-oligosaccharides  and L-arabinose, which are not substrates of EC 1.1.3.10, sugars are  oxidized in their pyranose but not in their furanose form <1>)  "
1.1.99.3, D-gluconate + acceptor = 2-dehydro-D-gluconate + reduced acceptor  
1.1.99.30, a (2R)-hydroxy-carboxylate + acceptor = a 2-oxo-carboxylate + reduced  acceptor (#2# mechanism <7>; #1# aldonates and aldarates with an  (R)-configured alpha-carbon atom are converted to the corresponding  2-oxocarboxylates <4>)  
1.1.99.31, (S)-mandelate + acceptor = phenylglyoxylate + reduced acceptor  
1.1.99.32, L-sorbose + acceptor = 1-dehydro-L-sorbose + reduced acceptor  
1.1.99.35," D-glucose + acceptor = D-glucono-1,5-lactone + reduced acceptor (#2#  ping-pong behaviour and double-substrate inhibition <15>)  "
1.1.99.36, ethanol + acceptor = acetaldehyde + reduced acceptor  
1.1.99.37," methanol + acceptor = formaldehyde + reduced acceptor (#2# Ping-Pong  type of reaction mechanism <3>; #2# the low coenzyme NAD-dependent  activity of MDH with C1-C4 primary alcohols is strongly stimulated by  Bacillus methanolicus protein ACT, in presence of NAD(H) cofactor and  Mg2+-ions. MDH activation by ACT involves hydrolytic removal of the  nicotinamide mononucleotide NMN(H) moiety of the NAD(H) cofactor of  MDH, changing its Ping-Pong type of reaction mechanism into a ternary  complex reaction mechanism <2>)  "
1.1.99.38," 2-deoxy-scyllo-inosamine + S-adenosyl-L-methionine =  3-amino-2,3-dideoxy-scyllo-inosose + 5'-deoxyadenosine + L-methionine  "
1.1.99.39, (R)-2-hydroxyglutarate + acceptor = 2-oxoglutarate + reduced acceptor  
1.1.99.4," 2-dehydro-D-gluconate + acceptor = 2,5-didehydro-D-gluconate + reduced  acceptor  "
1.1.99.40, (R)-2-hydroxyglutarate + pyruvate = 2-oxoglutarate + (R)-lactate  
1.1.99.41," (3R)-3-hydroxy-16-methoxy-2,3-dihydrotabersonine + acceptor =  (3R)-3-hydroxy-16-methoxy-1,2-didehydro-2,3-dihydrotabersonine +  reduced acceptor "
1.1.99.41," (3R)-3-hydroxy-2,3-dihydrotabersonine + acceptor =  (3R)-3-hydroxy-1,2-didehydro-2,3-dihydrotabersonine + reduced acceptor  "
1.1.99.42, 4-pyridoxate + acceptor =  5-formyl-3-hydroxy-2-methylpyridine-4-carboxylate + reduced acceptor  
1.1.99.6, (R)-lactate + acceptor = pyruvate + reduced acceptor  
1.1.99.7," (S)-lactate + oxaloacetate = pyruvate + malate (#1# mechanism <3,5>)  "
1.1.99.9, pyridoxine + acceptor = isopyridoxal + reduced acceptor  
1.10.1.1," (+/-)-trans-acenaphthene-1,2-diol + 2 NADP+ = acenaphthenequinone + 2  NADPH + 2 H+  "
1.10.3.1," 2 catechol + O2 = 2 1,2-benzoquinone + 2 H2O (#28# catalytic reaction  mechanism of the enzyme in a copper(II) complex with a macrocyclic  ligand <38>; #41# the enzymes possesses a core carboxylate essential to  activity, this enhanced catalytic efficiency of PPO <32>)  "
1.10.3.11, 2 ubiquinol + O2 = 2 ubiquinone + 2 H2O (#8# modified ping-pong bi-bi  mechanism <23>)  
1.10.3.15, 2 3-amino-4-hydroxybenzoate + N-acetyl-L-cysteine + 2 O2 = grixazone B  + 4 H2O + CO2  
1.10.3.16," (1R,6R)-1,4,5,5a,6,9-hexahydrophenazine-1,6-dicarboxylate + O2 =  (1R,10aS)-1,4,10,10a-tetrahydrophenazine-1,6-dicarboxylate + H2O2 "
1.10.3.16," (1R,10aS)-1,4,10,10a-tetrahydrophenazine-1,6-dicarboxylate + O2 =  (5aS)-5,5a-dihydrophenazine-1,6-dicarboxylate + H2O2 "
1.10.3.16," (1R,10aS)-1,4,10,10a-tetrahydrophenazine-1-carboxylate + O2 =  (10aS)-10,10a-dihydrophenazine-1-carboxylate + H2O2 "
1.10.3.16," (1R)-1,4,5,10-tetrahydrophenazine-1-carboxylate + O2 =  (10aS)-5,10-dihydrophenazine-1-carboxylate + H2O2  "
1.10.3.17, 2 O2 + ubiquinol = 2 superoxide + ubiquinone + 2 H+  
1.10.3.2," 4 benzenediol + O2 = 4 benzosemiquinone + 2 H2O (#13,34,68# discussion  of mechanism <1,2,5>; #13# nonenzymatic disproportionation of 2  semiquinones to quinone and quinol <2>; #26# two site ping-pong bi-bi  mechanism <89>; #76# reaction mechanism of the reduction of dioxygen to  water, second-order rate constant for the reaction with dioxygen,  ping-pong mechanism, kinetic model <116>; #14# catalytic reaction  mechanism, modelling, overview <168>)  "
1.10.3.3," 4 L-ascorbate + O2 = 4 monodehydroascorbate + 2 H2O (#29# rate  determining step in the catalytic mechanism may involve protonation of  an intermediate <36>; #29# intramolecular electron transfer from type I  copper to type III copper is probably the rate-limiting step in enzyme  catalysis <14>; #28# multiple displacement mechanism, enzyme exhibits  enzymic memory <30>; #28# mechanism: Cu2+ is reduced to Cu+, which is  then reoxidized by oxygen <3>; #15# binding mode of phenolic inhibitors  and substrate to active site, binding site in a pocket near type I  copper center <54>; #29# mechanism and rate constants <57>; #40# the  transition from native dimer to the dimeric intermediate is  characterized by the release of copper ions forming the tri-nuclear  copper center located at the interface between domain 2 and 3 of each  subunit <65>)  "
1.10.3.4," 4 2-aminophenol + 3 O2 = 2 2-aminophenoxazin-3-one + 6 H2O (#5#  discussion of mechanism, isophenoxazine may be formed by a secondary  condensation from the initial oxidation product <3>)  "
1.10.3.5," 3-hydroxyanthranilate + O2 =  6-imino-5-oxocyclohexa-1,3-dienecarboxylate + H2O2  "
1.10.3.6," rifamycin B + O2 = rifamycin O + H2O2 (#2# acting on diphenols and  related substances as electron donors and on oxygen as an electron  acceptor <1>; #3# acts on various kinds of diphenol compounds,  converting them into quinonic forms and H2O2 <3>; #1,3# immobilized  enzyme <4,5>)  "
1.10.3.9, 2 H2O + 2 plastoquinone + 4 hnu = O2 + 2 plastoquinol  
1.10.5.1," 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone =  1-(beta-D-ribofuranosyl)nicotinamide + a quinol  "
1.11.1.1, NADH + H+ + H2O2 = NAD+ + 2 H2O (#27# catalyzes the two-electron  reduction of hydrogen peroxide to water using a cysteine-sulfenic acid  as a secondary redox center <27>)  
1.11.1.10, RH + chloride + H2O2 = RCl + 2 H2O (#3# mechanism <13>)  
1.11.1.11," 2 L-ascorbate + H2O2 + 2 H+ = 2 monodehydroascorbate + 2 H2O (#9,66#  mechanism <31,36>; #66# mechanism for electron transfer <36>; #9#  mechanism involves accumulation of a transient enzyme intermediate  <30>; #12# mechanism, structural hints to instability during catalysis  <32>) "
1.11.1.11, 2 monodehydroascorbate = L-ascorbate + L-dehydroascorbate 
1.11.1.11, 2 L-ascorbate + H2O2 + 2 H+ = L-ascorbate + L-dehydroascorbate + 2 H2O  
1.11.1.12," 2 glutathione + a hydroperoxy-fatty-acyl-[lipid] = glutathione  disulfide + a hydroxy-fatty-acyl-[lipid] + H2O (#5# ping-pong mechanism  <2>; #5# ping-pong mechanism with formation of ternary complexes <4>;  #3,5# tert-uni ping-pong mechanism <1,10>)  "
1.11.1.13," 2 Mn(II) + 2 H+ + H2O2 = 2 Mn(III) + 2 H2O (#6,23# mechanism  <1,3,4,6,7,13,15,17,39>; #6# ping-pong mechanism <12,17>; #6# kinetic  mechanism <8>; #6# shows properties of a peroxidase and an oxidase <1>)  "
1.11.1.14," 2 (3,4-dimethoxyphenyl)methanol + H2O2 = 2  (3,4-dimethoxyphenyl)methanol radical + 2 H2O (#6# mechanism  <1,3,4,8,11>) "
1.11.1.14," 1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol + H2O2 =  3,4-dimethoxybenzaldehyde + 2-methoxyphenol + glycolaldehyde + H2O  "
1.11.1.16," 1-(4-hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol +  H2O2 = 4-hydroxy-3-methoxybenzaldehyde + 2-methoxyphenol +  glycolaldehyde + H2O (#5# NMR study of enzyme both in resting state and  cyanide-inhibited form. Analysis of interaction with Mn2+ <15>; #4#  study of reaction of H2O2 with the enzyme in the absence of substrate  suggests an amino acid radical in moderate distance from ferryl heme. A  tryptophan radical is formed during the catalytic mechanism <8>; #7#  the radical intermediate in the reaction of enzyme with H2O2 is a  tryptophan neutral radical at W164 <14>) "
1.11.1.16, 2 manganese(II) + 2 H+ + H2O2 = 2 manganese(III) + 2 H2O  
1.11.1.17, 2 glutathione amide + H2O2 = glutathione amide disulfide + 2 H2O  
1.11.1.18, RH + HBr + H2O2 = RBr + 2 H2O  
1.11.1.19," Reactive Blue 5 + 2 H2O2 = phthalate + 2,2'-disulfonyl azobenzene +  3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]benzenesulfonate + 2 H2O  "
1.11.1.2, NADPH + H+ + H2O2 = NADP+ + 2 H2O  
1.11.1.20," thioredoxin +  (5Z,9alpha,11alpha,13E,15S)-9,11-epidioxy-15-hydroxy-prosta-5  13-dienoate = thioredoxin disulfide +  (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dienoate  "
1.11.1.21, donor + H2O2 = oxidized donor + 2 H2O 
1.11.1.21," 2 H2O2 = O2 + 2 H2O (#11# catalytic mechanism <10>; #19# distal site  Asp152 is essential for the catalase activity of catalase-peroxidase,  mechanism for hydrogen peroxide oxidation in volving residues Trp122  and Asp152 <8>; #25# the catalytically relevant active site residues  Trp111, Tyr238, and Met264 are linked by a covalent structure <12>)  "
1.11.1.22, a hydroperoxy fatty acid + NADPH + H+ = a hydroxy fatty acid + NADP+ +  H2O  
1.11.1.23," (S)-2-hydroxypropylphosphonate + H2O2 =  (1R,2S)-1,2-epoxypropylphosphonate + 2 H2O (#5# a straightforward  epoxidase mechanism is proposed that depends on the Lewis acid  properties of divalent cations and the redox properties of FMN <15>;  #5# an iron-redox mechanism is proposed in which the active site bound  Fe2+ serves as a Lewis acid to activate the 2-OH group of  (S)-2-hydroxypropylphosphonic acid, and the epoxide ring is formed by  the attack of the 2-OH group at C-1 coupled with the transfer of the  C-1 hydrogen as a hydride ion to the bound FMN <6>; #3# electron  transfer is presumed to be the predominant rate-limiting step. Proposed  mechanism: the reaction likely begins with hydrogen atom abstraction  from the C-1 position by an activated oxygen species. The C-1 centered  radical intermediate can then cyclize to form fosfomycin and the  reduced iron center <8>; #5# Tyr105 is a key residue, which plays a  role in the activation of dioxygen required for the enzymatic activity  of HppE <12>)  "
1.11.1.24," 2 R'-SH + ROOH = R'-S-S-R' + H2O + ROH (#68# the enzyme exhibits a  saturable, single-displacement-like reaction mechanism rather than  non-saturable double displacement (ping-pong) enzyme substitution  mechanism <22>) "
1.11.1.24, thioredoxin + ROOH = thioredoxin disulfide + H2O + ROH  
1.11.1.25, glutaredoxin + ROOH = glutaredoxin disulfide + H2O + ROH  
1.11.1.26," NADH + ROOH + H+ = NAD+ + H2O + ROH (#4# proposed mechanism of H2O2  reduction for the AhpC-AhpF complex. binding mechanism in which the C  terminus of AhpC wraps around the N-terminal domain, slowing the  dissociation rate for an efficient electron transfer process, and a  release mechanism mediated by the conformational change of the C  terminus of AhpC upon reduction <3>)  "
1.11.1.27, 2 glutathione + ROOH = glutathione disulfide + H2O + ROH  
1.11.1.28, a [lipoyl-carrier protein]-N6-[(R)-dihydrolipoyl]-L-lysine + ROOH = a  [lipoyl-carrier protein]-N6-lipoyl-L-lysine + H2O + ROH  
1.11.1.29, mycoredoxin + ROOH = mycoredoxin disulfide + H2O + ROH  
1.11.1.3, palmitate + 2 H2O2 = pentadecanal + CO2 + 3 H2O  
1.11.1.5," 2 ferrocytochrome c + H2O2 = 2 ferricytochrome c + 2 H2O (#1# kinetics  <27>; #4# kinetics, energy, catalysis information <23,24>; #6# reaction  scheme <2>; #7# pseudo-first-order kinetics <42>; #4# the enzyme uses  hydrogen peroxide as an electron acceptor to oxidize cytochrome c. The  enzyme is not essential for both cell viability and respiration. Its  biological function is to reduce H2O2 generated during aerobic  respiratory process. The enzyme may also act as a peroxynitrite  scavenger <38>; #4# only ferrocytochrome c bound at the Pelletier-Kraut  site of enzyme is oxidized during turnover <55>; #16# the intermediate  Compound I forms once H2O2 is heterolytically cleaved, releasing a  water molecule. The remaining O atom oxidizes the heme iron to Fe(IV)  and an organic moiety to a cation radical. For most heme peroxidases,  this moiety is the porphyrin ring. Upon two electron transfer events  from two substrate molecules, the enzyme returns to the resting state  with water occupying the active site <91>)  "
1.11.1.6," 2 H2O2 = O2 + 2 H2O (#69# reaction mechanism, overview <161>)  "
1.11.1.7, 2 phenolic donor + H2O2 = 2 phenoxyl radical of the donor + 2 H2O (#80#  Ping Pong Bi Bi mechanismÂ´ <167>; #106# ping-pong Bi-Bi reaction  mechanism <160>)  
1.11.1.8, 2 iodide + H2O2 + 2 H+ = diiodine + 2 H2O 
1.11.1.8, [thyroglobulin]-L-tyrosine + iodide + H2O2 =  [thyroglobulin]-3-iodo-L-tyrosine + 2 H2O 
1.11.1.8," [thyroglobulin]-3-iodo-L-tyrosine + iodide + H2O2 =  [thyroglobulin]-3,5-diiodo-L-tyrosine + 2 H2O "
1.11.1.8," 2 [thyroglobulin]-3,5-diiodo-L-tyrosine + H2O2 =  [thyroglobulin]-L-thyroxine + [thyroglobulin]-aminoacrylate + 2 H2O "
1.11.1.8," [thyroglobulin]-3-iodo-L-tyrosine +  [thyroglobulin]-3,5-diiodo-L-tyrosine + H2O2 =  [thyroglobulin]-3,5,3'-triiodo-L-thyronine +  [thyroglobulin]-aminoacrylate + 2 H2O  "
1.11.1.9, 2 glutathione + H2O2 = glutathione disulfide + 2 H2O (#3# mechanism  <25>; #3# 2 GSH + ROOH = ROH + H2O + GSSG <2>)  
1.11.2.1," RH + H2O2 = ROH + H2O (#7# kinetic mechanism, overview <38>)  "
1.11.2.2, Cl- + H2O2 + H+ = HClO + H2O  
1.11.2.3, R1H + R2OOH = R1OH + R2OH  
1.11.2.4, fatty acid + H2O2 = 3- or 2-hydroxy fatty acid + H2O  
1.11.2.5, 3-methyl-L-tyrosine + H2O2 = 3-hydroxy-5-methyl-L-tyrosine + H2O  
1.11.2.6, L-tyrosine + H2O2 = L-dopa + H2O  
1.12.1.2, H2 + NAD+ = H+ + NADH (#2# ping pong mechanism <8>; #2# catalytic  activity may be regulated by the reduction of a regulatory center  followed by a series of structural changes <15>; #2# molecular  mechanism of hydrogen activation <1>)  
1.12.1.3, H2 + NADP+ = H+ + NADPH  
1.12.1.4, 2 H2 + NAD+ + 2 oxidized ferredoxin = 5 H+ + NADH + 2 reduced ferredoxin  
1.12.1.5, H2 + NAD(P)+ = H+ + NAD(P)H  
1.12.2.1, H2 + 2 ferricytochrome c3 = 2 H+ + 2 ferrocytochrome c3  
1.12.5.1, H2 + menaquinone = menaquinol  
1.12.7.2, H2 + 2 oxidized ferredoxin = 2 reduced ferredoxin + 2 H+  
1.12.98.1, H2 + oxidized coenzyme F420 = reduced coenzyme F420  
1.12.98.2," H2 + 5,10-methenyltetrahydromethanopterin = H+ +  5,10-methylenetetrahydromethanopterin (#1# mechanism <3>; #1#  stereoselective hydride transfer <4>)  "
1.12.98.3," H2 + 2-(2,3-dihydropentaprenyloxy)phenazine =  2-dihydropentaprenyloxyphenazine  "
1.12.98.4," H2 + (sulfide)n = hydrogen sulfide + (sulfide)n-1 (#6# mechanism <4,6>;  #6,9# sulfur can be reduced with hydrogen as donor in the presence of  hydrogenase <1,5>; #14# two enzymes are involved in the production of  H2S: the sulfur reductase and the thiosulfate reductase <10>; #4# two  enzymes: hydrogenase with sulfur reductase activity and an  NADPH-utilizing polysulfide dehydrogenase are detected <8>; #6#  polysulfide appears to be the soluble intermediate in the sulfur  reduction <5>; #10,13# a sulfur-reducing complex including hydrogenase,  a sulfur reductase and electron-transferring components described  <9,11,12>; #6# two proteins occur: polysulfide reductase and sulfide  dehydrogenase or Sud or flavo-cytochrome-C-sulfide dehydrogenase or  polysulfide-sulfur transferase, CAS "
1.12.98.4,"G. NO.: 128826-29-9, EC Number:  1.8._._, the second enzyme has been proposed to transfer  polysulfide-sulfur to the active site of polysulfide reductase <4>)  "
1.12.99.6," H2 + acceptor = reduced acceptor (#8,20,24,31# reaction mechanism  <11,12,18,19>)  "
1.13.11.1," catechol + O2 = cis,cis-muconate  "
1.13.11.10," 7,8-dihydroxykynurenate + O2 =  5-(3-carboxy-3-oxopropenyl)-4,6-dihydroxypyridine-2-carboxylate  "
1.13.11.11," L-tryptophan + O2 = N-formyl-L-kynurenine (#5# catalytic mechanism,  modeling. hTDO exists as two discrete species with markedly different  ligand binding properties. The active site environment of the slowly  rebinding species is structurally very heterogeneous and ligand access  to greatly hindered. Binding of the L-Trp substrate stabilizes the  faster-binding species, which features a well-structured active site  and offers facile access of the ligand to the heme iron. This mechanism  ensures that the ternary complex forms mainly by first binding the  L-Trp substrate, which primes the active site for the subsequent  binding of O2, which ensures efficient enzyme action <6>; #5# the  dioxygenation reaction is initiated by a direct attack of O2 on the C2  atom of the L-Trp indole ring, catalytic mechanism, overview. Exo  binding site for L-Trp, located about 42 A from the active site and  formed by residues conserved among tryptophan-auxotrophic TDOs. Trp  binding at this exo site does not affect enzyme catalysis but instead  it retards the degradation of hTDO through the ubiquitin-dependent  proteasomal pathway <9>)  "
1.13.11.12," linoleate + O2 = (9Z,11E,13S)-13-hydroperoxyoctadeca-9,11-dienoate "
1.13.11.12," alpha-linolenate + O2 =  (9Z,11E,13S,15Z)-13-hydroperoxyoctadeca-9,11,15-trienoate  "
1.13.11.14," 2,3-dihydroxybenzoate + O2 = 3-carboxy-2-hydroxymuconate semialdehyde  "
1.13.11.15," 3,4-dihydroxyphenylacetate + O2 = 2-hydroxy-5-carboxymethylmuconate  semialdehyde (#12,18# mechanism, substrate chelates the metal ion  asymmetrically at sites trans to two imidazole ligands <29>; #18#  substrate binding occurs in a four-step process, transient  intermediates and mechanism <27>)  "
1.13.11.16," 3-(2,3-dihydroxyphenyl)propanoate + O2 =  (2Z,4E)-2-hydroxy-6-oxonona-2,4-diene-1,9-dioate "
1.13.11.16," (2E)-3-(2,3-dihydroxyphenyl)prop-2-enoate + O2 =  (2Z,4E,7E)-2-hydroxy-6-oxonona-2,4,7-triene-1,9-dioate  "
1.13.11.17, indole + O2 = 2-formylaminobenzaldehyde  
1.13.11.18, S-sulfanylglutathione + O2 + H2O = glutathione + sulfite + 2 H+ 
1.13.11.18, S-sulfanylglutathione + O2 = S-sulfinatoglutathione + H+ 
1.13.11.18, S-sulfinatoglutathione + H2O = glutathione + sulfite + H+  
1.13.11.19, 2-aminoethanethiol + O2 = hypotaurine  
1.13.11.2," catechol + O2 = 2-hydroxymuconate-6-semialdehyde (#8,32# mechanism  <31,33>; #8# ordered bi uni mechanism <10>)  "
1.13.11.20," L-cysteine + O2 = 3-sulfinoalanine (#4# mechanism <4>; #22# reaction  mechanism <58>; #4# Upon binding substrate, the structure of the iron  site is pertubed but is still consistent with six O/N donor, indicating  that cysteine may bind to the iron center, but is not bound via the  sulfur atom. <25>; #2# reaction mechanism with internal electron  transfer involving the ferric/ferrous enzyme forms, formation of a  transient substrate-bound FeIII-superoxo species, overview <43>; #22#  catalytic mechanism of cysteine dioxygenase compared to the mechanism  of sulfoxide synthase EgtB, EC 1.14.99.50, and its function of the  active-site Tyr377 residue. In the sulfoxide syntase reaction, the  conserved tyrosine residue reacts via proton-coupled electron transfer  with the iron(III)-superoxo species and creates an  iron(III)-hydroperoxo intermediate, thereby preventing the possible  thiolate dioxygenation side reaction, detailed overview <57>; #22#  proposed catalytic cycle of CDO enzymes: the pentacoordinated resting  state structure can convert to a hexacoordinated structure by binding  of water. Upon binding of molecular oxygen the water molecule is  displaced and an iron(III)-superoxo structure is formed. The terminal  oxygen atom of the iron(III)-superoxo group attacks the sulfur of the  cysteinate group to form a ring-structure, which can homogeneously  split into a sulfoxide and iron(IV)-oxo species. The sulfoxide-bound  complex rotates from sulfur-bound to oxygen-bound to the iron center.  The latter transfers the oxygen atom from the iron(IV)-oxo group to  substrate in a final step to form cysteine sulfinic acid product  complex <55>; #14# reaction mechanism and structure-function analysis  <59>; #20# reaction mechanism of cysteine oxygenation by CDO enzymes  and reactivity of [TpMe,PhFe(CysOEt)] towards O2, detailed quantum  mechanics/molecular mechanics calculations, overview <56>)  "
1.13.11.22," 3,4-dihydroxy-trans-cinnamate + O2 =  3-(2-carboxyethenyl)-cis,cis-muconate  "
1.13.11.23," 2,3-dihydroxyindole + O2 = anthranilate + CO2  "
1.13.11.24," quercetin + O2 = 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate + CO  + H+ (#11# EPR study, mechanism, N of His112 is the axial ligand of  type II copper site <12>; #6# hybrid density functional theory study on  mechanism, dioxygen attack on copper is energetically preferred <13>;  #10# structure-function analysis of the active site <11>; #11# study on  mobility and flexibility of substrate cavity, molecular dynamics  simulations <14>; #6# possible reaction mechanisms and pathways,  kinetics, detailed overview <36>; #6# reaction mechanism, overview.  Quantum mechanics/molecular mechanics (QM/MM) and QM-only study on the  oxidative ring-cleaving reaction of quercetin catalyzed by quercetin  2,4-dioxygenase, i.e. 2,4-QD, which has a mononuclear type 2 copper  center and incorporates two oxygen atoms at C2 and C4 positions of the  substrate. Dioxygen is more likely to bind to a Cu2+ ion than to a  substrate radical, involving the dissociation of the substrate from the  copper ion. Then a Cu2+-alkylperoxo complex can be generated. Steric  effects of the protein environment contribute to maintain the  orientation of the substrate dissociated from the copper center. A  prior rearrangement of the Cu2+-alkylperoxo complex and a subsequent  hydrogen bond switching assisted by the movement of Glu73 can  facilitate formation of an endoperoxide intermediate selectively.  Reaction mechanism for endoperoxide formation, overview <35>; #1# the  enzyme incorporates both atoms of dioxygen into the substrate by  cleaving the central heterocycle ring and releasing CO. The enzyme  activates quercetin through deprotonation and the proton acceptor-Glu69  needs to reorient for the reaction to proceed. Energy profiles and  reaction schemes for nonenzymatic nitroxygenation of quercetin  monoanion. Transient and intermediate structures, catalytic mechaanism,  detailed overview <34>)  "
1.13.11.25," 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione + O2 =  3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate  (#2# proximal extradiol cleavage <1>)  "
1.13.11.26, [protein]-L-tryptophan + O2 = [protein]-N-formyl-L-kynurenine  
1.13.11.27," 4-hydroxyphenylpyruvate + O2 = homogentisate + CO2 (#8# evidence  against participation of a quinol as a free intermediate <18>; #5#  enzyme form 3: ordered bi bi mechanism where 4-hydroxyphenylpyruvate is  added prior to oxygen and CO2 released before homogentisate <16>; #17#  in plants this enzyme activity is involved in two distinct metabolic  processes, the biosynthesis of prenylquinones and the catabolism of  tyrosine <31>; #7# rate-determining step in catalysis is a protein  conformation change <1>; #15# mono-iso-ordered bi-bi mechanism with  binding of 4-hydroxyphenylpyruvate before O2 and release of CO2 before  homogentisate. A Theorell-Chance mechanism can not be excluded <7>;  #25# addition of substrate and oxygen to the holoenzyme is formally  random, holo-enzym in complex with substrate has a 3600-fold increase  in oxygen reactivity <33>; #25# mechanism of oxygen binding and  activation, structural relationship to other dioxygenases <40>; #14#  ternary enzyme-substrate complex is firstly decarboxylated to the  iron(II)-peracid intermediate followed by heterolytic cleavage of the  O-O bond yielding an iron(IV)-oxospecies. This attacks the aromatic  ring in C1 position. The arene oxide has no catalytic relevance <35>;  #12# the C-terminal helix forms a gate for substrate access to the  active site around a nonheme ferrous iron center <41>; #11# the  C-terminal helix forms a gate for substrate access to the active site  around a nonheme ferrous iron center, completely sequestering the  active site from solvent <41>; #25# reaction mechanism, overview  <60,61>; #25# The data of the rapid acid quench followd by HPLC product  analysis, indicate that the homogenisate product is formed during one  turnover, as the amount of product is equivalent to the  enzyme-substrate complex at 191 ms. <42>; #12,14,20,25# direct  involvement of the arene oxide intermediate to the reaction mechanism  <62>; #27,30,38,39# dioxygen reactivity and the common decarboxylation  half reaction, and the hydroxylation half reaction, mechanisms,  detailed overview <67>; #14# dioxygen reactivity and the common  decarboxylation half reaction, and the hydroxylation half reaction,  mechanisms, inhibitor-bound crystal structure, PDB ID 1CJX, analysis,  detailed overview <67>; #28,30# reaction mechanism, quantum and  molecular mechanics (QM/MM) combined with coupling techniques and  molecular dynamics, overview <76>; #14# reaction mechanism, quantum  mechanics/molecular mechanics calculations and simulations, detailed  overview <75>)  "
1.13.11.28," 2,3-dihydroxybenzoate + O2 = 2-carboxy-cis,cis-muconate  "
1.13.11.29," L-dopa + O2 = 4-(L-alanin-3-yl)-2-hydroxy-cis,cis-muconate  6-semialdehyde  "
1.13.11.3," 3,4-dihydroxybenzoate + O2 = 3-carboxy-cis,cis-muconate (#5# proposed  reaction mechanism <27>; #5# proposed mechanism based on MÃ¶ssbauer, EPR  and inhibition kinetic data <7>; #5# examining a distorted  trigonal-bipyramidal geometry observed for the non-heme iron center in  protocatechuate 3,4-dioxygenase by utilizing a sterically hindered iron  salen complex gives following results: the extent of a structural  change of the iron center from a preferred square-pyramidal to a  distorted trigonal-bipyramidal geometry varies with the external ligand  that is bound in the order Cl <<EtO <H2O. The distortion in the model  system is not due to steric repulsions but electronic interactions  between the external ligand and the iron center. The distorted  trigonal-bipyramidal iron site might not be preorganized by a 3,4-PCD  protein but could be electronically induced upon the binding of an  external hydrocide ligand to the iron(3)center. The distorted  trigonal-bipyramidal distortion geometry in 3,4-PCD may serve to open  the binding site for the catechol substrate. <42>; #5# the  computational (hybrid density functional method B3LYP) results of the  catalytic cycle of the intradiol dioxygenases suggest: (1)binging of  the substrate as a dianion (2) binding of dioxygen to the metal aided  by an electron transfer from the substrate to O2 (3) formation of a  bridging peroxo intermediate and its conformational change, which opens  the coordination site trans to His462, (4) binding of a neutral XOH  ligand (H2O or Tyr447) at the open site, (5) proton transfer from XOH  to the neighboring peroxo ligand yielding the hydroperoxo intermediate,  (6) a Criegee rearrangment leading to the anhydride intermediate (the  criegee mechanism requires an in-plane oriantation of the involved two  oxygen and two carbon atoms. Under some conditions homolytic O-O bond  cleavage might compete with the Criegee rearangment.) and (7)  hydrolysis of the anhydride to the final acyclic product. <43>)  "
1.13.11.30," L-dopa + O2 = 5-(L-alanin-3-yl)-2-hydroxy-cis,cis-muconate  6-semialdehyde  "
1.13.11.31," arachidonate + O2 =  (5Z,8Z,10E,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoate  "
1.13.11.33," arachidonate + O2 =  (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate (#24#  important role of Leu597 in the mechanism of lipoxygenases <136>;  #16,18,22,24# the reaction proceeds via hydrogen abstraction, peroxide  cleavage, radical rearrangement, and epoxide formation. To initiate the  reaction the ferrous LOX is first activated by peroxide-dependent  oxidation to a ferric form. The lipohydroperoxidase activity is  initiatedwhen a lipid hydroperoxide (ROOH) is bound at the active site  of the enzyme. The enzyme then catalyzes a homolytic cleavage of the  hydroperoxy bond, which leads to the formation of an oxygen-centered  alkoxy radical, a hydroxyl and oxidizes the ferrous iron to a ferric  form. Then the enzyme binds a linoleic acid molecule (or an alterative  reductant such as guaiacol) and releases a carbon-centered linoleic  radical. This reaction reduces the ferric LOX back to its ferrous form  to start the next catalytic cycle. The released radical intermediates  may then initiate free radical secondary reactions leading to the  formation of mixed oxygenated and non-oxygenated linoleic acid dimer  <139>)  "
1.13.11.34," arachidonate + O2 =  (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate (#16# a  non-classical reaction mechanism <126>; #16# kinetic mechainsm,  overview <120>) "
1.13.11.34," (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate =  leukotriene A4 + H2O "
1.13.11.34, arachidonate + O2 = leukotriene A4 + H2O  
1.13.11.35," 1,2,3-trihydroxybenzene + O2 = (2Z,4E)-2-hydroxyhexa-2,4-dienedioate  "
1.13.11.36," 5-amino-4-chloro-2-(2,3-dihydroxyphenyl)-3(2H)-pyridazinone + O2 =  5-amino-4-chloro-2-(2-hydroxymuconoyl)-3(2H)-pyridazinone  "
1.13.11.37, hydroxyquinol + O2 = maleylacetate  
1.13.11.38, 1-hydroxy-2-naphthoate + O2 = (3Z)-4-(2-carboxyphenyl)-2-oxobut-3-enoate  
1.13.11.39," biphenyl-2,3-diol + O2 = 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate  "
1.13.11.4," 2,5-dihydroxybenzoate + O2 = maleylpyruvate (#7,9# mechanism <6>)  "
1.13.11.40," arachidonate + O2 =  (5Z,9E,11Z,14Z)-(8R)-8-hydroperoxyicosa-5,9,11,14-tetraenoate  "
1.13.11.41," 2,4'-dihydroxyacetophenone + O2 = 4-hydroxybenzoate + formate (#1# the  cleavage mechanism of the aliphatic C-C bond catalyzed by  2,4-dihydroxyacetophenone dioxygenase, quantum mechanics/molecular  mechanics calculations. The reactant complex may firstly undergo a  triplet-quintet crossing to initiate the reaction and then the  subsequent chemistry mainly occurs on the quintet state surface,  modeling of the enzyme-substrate complex, overview <7>)  "
1.13.11.43," 1,2-bis(4-hydroxy-3-methoxyphenyl)ethylene + O2 = 2 vanillin  "
1.13.11.45," linoleate + O2 = (9Z,12Z)-(11S)-11-hydroperoxyoctadeca-9,12-dienoate  (#5# mechanism via suprafacial migration of O2 <6>; #5# reaction  mechanism, tail-first model with rearrangement at C13 at the end of  lipoxygenation, influenced by double bond configuration and the chain  length of fatty acids, overview <8,9>; #8# the LOX reaction is always  catalyzed at a 1Z,4Z-pentadiene system of a polyunsaturated fatty acid.  In the initial step, a hydrogen atom is abstracted from the central  bis-allylic methylene group by the non-heme iron or in few cases  manganese in the active site. During this rate-limiting step, Fe(III)  is reduced to Fe(II) in the former case and a substrate radical is  formed which rapidly delocalizes over the five carbon unit. Addition of  dioxygen yields a peroxyl radical, which is finally reduced to the  hydroperoxide product <15>)  "
1.13.11.46," 4-hydroxyphenylpyruvate + O2 = (S)-4-hydroxymandelate + CO2 (#2# one  oxygen from molecular oxygen is incorporated into the carboxyl group  and one into the benzylic hydroxyl group <1>; #2# reaction mechanism,  overview <4,6>; #2# HMS uses Fe(IV)=O to perform hydroxylation of the  benzylic carbon, reaction mechanism with electrophilic attack on the  aromatic ring, and HMS catalytic cycle, overview <5>)  "
1.13.11.47, 3-hydroxy-1H-quinolin-4-one + O2 = N-formylanthranilate + CO  
1.13.11.48," 3-hydroxy-2-methyl-1H-quinolin-4-one + O2 = N-acetylanthranilate + CO  (#3# catalytic mechanism, overview. H251 acts as a general base to  abstract a proton from the organic substrate. Residue S101, which  corresponds to the nucleophile of the catalytic triad of  alpha/beta-hydrolases, presumably participates in binding the  heteroaromatic substrate. H102 and residues located in the topological  region of the triads acidic residue appear to influence O2 binding and  reactivity. Role of Y196 of Hod as hydrogen-bondforming residue to  oxygen atoms or even proton donor to negative charges of catalytic  intermediates <5>)  "
1.13.11.49," chloride + O2 = chlorite (#16# reaction mechanism and active site  structure, Arg173 plays a key role in (i) controlling of ligand and  substrate access and binding and (ii) in chlorite dismutation reaction,  overview <19>)  "
1.13.11.5, homogentisate + O2 = 4-maleylacetoacetate (#38# reaction mechanism  <34>; #4# catalytic mechanism <13>)  
1.13.11.50," pentane-2,4-dione + O2 = acetate + 2-oxopropanal (#1# reaction  mechanism <4>)  "
1.13.11.51," a 9-cis-epoxycarotenoid + O2 = 2-cis,4-trans-xanthoxin + a  12'-apo-carotenal "
1.13.11.51," 9-cis-violaxanthin + O2 = 2-cis,4-trans-xanthoxin +  (3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al "
1.13.11.51," 9'-cis-neoxanthin + O2 = 2-cis,4-trans-xanthoxin +  (3S,5R,6R)-5,6-dihydroxy-6,7-didehydro-5  6-dihydro-12'-apo-beta-caroten-12'-al  "
1.13.11.52," L-tryptophan + O2 = N-formyl-L-kynurenine (#7# density functional  theory calculations have been performed to elucidate the new reaction  mechanism of oxidative cleavage of Trp <125>; #7# density functional  theory calculations have been performed to elucidate the reaction  mechanism of oxidative cleavage of Trp <125>; #41# Criegee type  rearrangement for ring opening <132>; #39# substrate recognition and  catalytic mechanism, overview <208>; #41# electrophilic or radical  addition reaction mechanism via formation of a transient ferryl  intermediate, assigned as a Compound II (ferryl) species, during  oxidation of L-Trp, 1-methyl-L-Trp, and a number of other substrate  analogues, overview. A common reaction mechanism for indoleamine  2,3-dioxygenase-catalyzed oxidation of tryptophan and other tryptophan  analogues is determined <221>; #41# steady-state kinetic catalytic  mechanism of hIDO1 <213>) "
1.13.11.52, D-tryptophan + O2 = N-formyl-D-kynurenine  
1.13.11.53," 1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one + O2 =  3-(methylsulfanyl)propanoate + formate + CO  "
1.13.11.54," 1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one + O2 =  4-(methylsulfanyl)-2-oxobutanoate + formate  "
1.13.11.55, 4 sulfur + 4 H2O + O2 = 2 hydrogen sulfide + 2 sulfite  
1.13.11.56," naphthalene-1,2-diol + O2 = 2-hydroxy-2H-chromene-2-carboxylate  "
1.13.11.57," 3,4,5-trihydroxybenzoate + O2 = (1E)-4-oxobut-1-ene-1,2,4-tricarboxylate  "
1.13.11.58," linoleate + O2 = (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate  "
1.13.11.59," torulene + O2 = 4'-apo-beta,psi-caroten-4'-al + 3-methylbut-2-enal  "
1.13.11.6," 3-hydroxyanthranilate + O2 = 2-amino-3-carboxymuconate semialdehyde  (#4# mechanism <14>; #9# reaction mechanism, overview <26>; #15# the  3HAO reaction is initiated by substrate binding, which induces closure  of the active site. Oxygen then binds to the active-site iron. Transfer  of an electron from the active-site iron to oxygen creates an oxygen  radical, thereby facilitating the addition of both O atoms to 3-HANA  and forming 2-amino-3-carboxymuconic 6-semialdehyde (ACMS), an active  intermediate. ACMS then spontaneously cyclizes to form quinolinic acid  <27>)  "
1.13.11.60," linoleate + O2 = (8R,9Z,12Z)-8-hydroperoxyoctadeca-9,12-dienoate  "
1.13.11.61," alpha-linolenate + O2 =  (9R,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate (#3# the LOX  reaction is always catalyzed at a 1Z,4Z-pentadiene system of a  polyunsaturated fatty acid. In the initial step, a hydrogen atom is  abstracted from the central bis-allylic methylene group by the non-heme  iron or in few cases manganese in the active site. During this  rate-limiting step, Fe(III) is reduced to Fe(II) in the former case and  a substrate radical is formed which rapidly delocalizes over the five  carbon unit. Addition of dioxygen yields a peroxyl radical, which is  finally reduced to the hydroperoxide product <5>)  "
1.13.11.62," linoleate + O2 = (8E,10R,12Z)-10-hydroperoxy-8,12-octadecadienoate  "
1.13.11.63, beta-carotene + O2 = 2 all-trans retinal (#2# mechanism <10>) 
1.13.11.63, beta-carotene + O2 = 2 all-trans-retinal  
1.13.11.64, 5-nitrosalicylate + O2 = 2-oxo-3-(5-oxofuran-2-ylidene)propanoate +  nitrite 
1.13.11.64," 5-nitrosalicylate + O2 = 4-nitro-6-oxohepta-2,4-dienedioate "
1.13.11.64," 4-nitro-6-oxohepta-2,4-dienedioate =  2-oxo-3-(5-oxofuran-2-ylidene)propanoate + nitrite  "
1.13.11.65, zeaxanthin + O2 = (3R)-11-cis-3-hydroxyretinal +  (3R)-all-trans-3-hydroxyretinal  
1.13.11.66," benzene-1,4-diol + O2 = (2Z,4E)-4-hydroxy-6-oxohexa-2,4-dienoate (#12#  catalytic mechanism, overview <11>)  "
1.13.11.67, 8'-apo-beta-carotenol + O2 = 14'-apo-beta-carotenal + an  uncharacterized product  
1.13.11.68, 9-cis-beta-carotene + O2 = 9-cis-10'-apo-beta-carotenal + beta-ionone  
1.13.11.69," 9-cis-10'-apo-beta-carotenal + 2 O2 = carlactone +  (2E,4E,6E)-7-hydroxy-4-methylhepta-2,4,6-trienal (#4# acid-base  catalysis in the CCD8 catalytic cycle and existence of an essential  cysteine residue in the CCD8 active site, two-step kinetic mechanism  <10>; #1# proposed mechanism of 9-cis-beta-apo-10-carotenal conversion  into carlactone, overview <11>)  "
1.13.11.70," all-trans-10'-apo-beta-carotenal + O2 = 13-apo-beta-carotenone +  (2E,4E,6E)-4-methylocta-2,4,6-trienedial (#6# acid-base catalysis in  the CCD8 catalytic cycle and existence of an essential cysteine residue  in the CCD8 active site, two-step kinetic mechanism <12>)  "
1.13.11.71, all-trans-beta-carotene + O2 = all-trans-10'-apo-beta-carotenal +  beta-ionone  
1.13.11.72," 2-hydroxyethylphosphonate + O2 = hydroxymethylphosphonate + formate  (#1# catalytic mechanism <7>; #1# initial substrate oxidation by a  ferric-superoxo-intermediate and a second oxidation by a ferryl  species, catalytic mechanism, detailed overview <9>; #1# the reaction  proceeds via a transient iron(IV)-oxo (ferryl) complex, a mechanism  that involves activation of an O-H bond by the ferryl complex is  proposed. The isotope-sensitive C-H-cleavage step is not primarily  rate-limiting for the overall catalytic cycle. The reaction does  exhibit a significant 2H-kinetic isotope effect on kcat/Km for O2,  which implies reversible formation of the C-H-cleaving intermediate <8>)  "
1.13.11.73," 2-hydroxyethylphosphonate + O2 = methylphosphonate + HCO3- (#1#  catalytic mechanism <3>; #2# initial substrate oxidation by a  ferric-superoxo-intermediate and a second oxidation by a ferryl  species, catalytic mechanism, detailed overview <4>)  "
1.13.11.74, 2-aminophenol + O2 = 2-aminomuconate 6-semialdehyde  
1.13.11.75," all-trans-8'-apo-beta-carotenal + O2 = all-trans-retinal +  (2E,4E,6E)-2,6-dimethylocta-2,4,6-trienedial (#2# on binding, three  consecutive double bonds of the carotenoid change from a straight  all-trans to a cranked cis-trans-cis conformation. The remaining trans  bond is located at the dioxygen-ligated Fe2+ and cleaved by oxygen <3>;  #2# the enzyme utilizes a non-heme iron center to oxidatively cleave a  carbon-carbon double bond of a carotenoid substrate <7>)  "
1.13.11.76, 2-amino-5-chlorophenol + O2 = 2-amino-5-chloromuconate 6-semialdehyde  
1.13.11.77," oleate + O2 = (8E,10S)-10-hydroperoxyoctadeca-8-enoate "
1.13.11.77," linoleate + O2 = (8E,10S,12Z)-10-hydroperoxyoctadeca-8,12-dienoate "
1.13.11.77," alpha-linolenate + O2 =  (8E,10S,12Z,15Z)-10-hydroperoxyoctadeca-8,12,15-trienoate  "
1.13.11.78," (2-amino-1-hydroxyethyl)phosphonate + O2 = glycine + phosphate (#3#  PhnZ oxidatively cleaves the highly stable C-P bond in Pn to produce  phosphate. Quantum mechanics/molecular mechanics (QM/MM) calculations  reveal that the mechanism of PhnZ consists of four consecutive steps:  (1) rate-limiting alpha-H abstraction of Pn by FeIII-superoxo, (2)  formation of FeIIIOOCalpha peroxide, (3) concerted O insertion into  Calpha-P bond of organophosphonate initiated by inverse heterolytic O-O  cleavage, and (4) phosphonate hydrolysis to glycine and phosphate.  Inverse heterolytic O-O cleavage of FeIIIOOCalpha intermediate renders  the distal O atom more oxidative to oxygenate organophosphonate than  the homolytic O-O cleavage. The unusual inverse heterolytic O-O  cleavage mode constitutes a third iron-mediated O-O activation scenario  in nature, which is expected to have its broad occurrence in oxidative  transformation involving heteroatoms of sulfur and phosphorus, possible  enzymatic O-O cleavage mechanisms from FeIII/IIOOR(H) intermediates,  and electronic structure of resting state and superoxo intermediates,  overview <4>; #3# the enzyme uses a diiron oxygenase mechanism for  catabolism of organophosphonates. The fifth histidine that is conserved  in the PhnZ subclade, H62, specifically interacts with the substrate  1-hydroxy, residue Y24 forms a transient ligand interaction at the  dioxygen binding site of Fe2+. Residues Y24 and E27 mediate a unique  induced-fit mechanism whereby E27 specifically recognizes the 2-amino  group of the bound substrate and toggles the release of Y24 from the  active site, thereby creating space for molecular oxygen to bind to the  second Fe2+. The 2-amino group of (R)-2 triggers an induced-fit  mechanism <3>)  "
1.13.11.79," FMNH2 + O2 = 5,6-dimethylbenzimidazole + D-erythrose 4-phosphate +  other product(s) (#1# intermediate-assisted reaction mechanism in  multifunctional catalysis, conversion of FMNH2 to  5,6-dimethylbenzimidazole proceeds via more than 14 steps in two  distinct stages, modeling, analysis of crystal structure and geometry  optimization, detailed overview <4>)  "
1.13.11.8," 3,4-dihydroxybenzoate + O2 = 4-carboxy-2-hydroxymuconate semialdehyde  (#2# involvement of sulfhydryl groups at the active site, 2 free  sulfhydryl groups per enzyme molecule <3>)  "
1.13.11.80," (3,5-dihydroxyphenyl)acetyl-CoA + O2 =  2-(3,5-dihydroxyphenyl)-2-oxoacetate + CoA (#1# Arg254 and Glu189 join  to form a specific contact with one of the phenolic hydroxyls of the  substrate, and this interaction plays a key role in both substrate  recognition and catalysis <1>; #1# proposed catalytic mechanism <3>)  "
1.13.11.81," 7,8-dihydroneopterin + O2 = 7,8-dihydroxanthopterin + formate +  glycolaldehyde  "
1.13.11.82," 8'-apo-beta-carotenal + O2 = 13-apo-beta-carotenone +  2,6-dimethyldeca-2,4,6,8-tetraenedial  "
1.13.11.83, 3-dimethylallyl-4-hydroxyphenylpyruvate + O2 =  3-dimethylallyl-4-hydroxymandelate + CO2  
1.13.11.84, zeaxanthin + 2 O2 = crocetin dialdehyde + 2  3beta-hydroxy-beta-cyclocitral 
1.13.11.84, 3beta-hydroxy-8'-apo-beta-carotenal + O2 = crocetin dialdehyde +  3beta-hydroxy-beta-cyclocitral 
1.13.11.84, zeaxanthin + O2 = 3beta-hydroxy-8'-apo-beta-carotenal +  3beta-hydroxy-beta-cyclocitral  
1.13.11.85," cis-1,4-polyisoprene + n O2 = n  (4Z,8Z)-4,8-dimethyl-12-oxotrideca-4,8-dienal  "
1.13.11.86," 5-aminosalicylate + O2 = (2Z,4E)-4-amino-6-oxohepta-2,4-dienedioate  "
1.13.11.87," Cleavage of cis-1,4-polyisoprene polymers into a mixture of compounds,  including a C20 compound  ((4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8  12,16,20,24-hexaenal), a C25 compound  ((4Z,8Z,12Z,16Z,20Z)-4,8,12,16,20-pentamethyl-24-oxopentacosa-4,8,12,16  20-pentaenal), a C30 compound  ((4Z,8Z,12Z,16Z)-4,8,12,16-tetramethyl-20-oxohenicosa-4,8,12  16-tetraenal), and larger isoprenologes such as C35, C40, C45, and  higher analogues  "
1.13.11.88, isoeugenol + O2 = vanillin + acetaldehyde  
1.13.11.89, (hydroxymethyl)phosphonate + O2 = formate + phosphate  
1.13.11.9," 2,5-dihydroxypyridine + O2 = N-formylmaleamic acid  "
1.13.11.90, [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate + O2 = glycine  betaine + phosphate  
1.13.11.91, 3-sulfanylpropanoate + O2 = 3-sulfinopropanoate  
1.13.11.92, a fatty acid + O2 = a (2R)-2-hydroperoxyfatty acid  
1.13.12.1, L-arginine + O2 = 4-guanidinobutanamide + CO2 + H2O  
1.13.12.13, Oplophorus luciferin + O2 = oxidized Oplophorus luciferin + CO2 + hnu  
1.13.12.15," 2 L-dopa + O2 = 2 3,4-dihydroxyphenylpyruvate + 2 NH3  "
1.13.12.16," ethylnitronate + O2 = acetaldehyde + nitrite + other products (#5#  superoxide as reactive intermediate <3,6>; #5# ordered bi bi mechanism  in which 2-nitropropane first combines with the enzyme and the enzyme  2-nitropropane complex reacts with oxygen to form a ternary complex  <3>; #1# catalytic and kinetic reaction mechanism, comparison to the  nitroalkane oxigenase, EC 1.7.3.1, and other flavin-dependent enzymes,  ionization of nitroethane and ethylnitronate in aqueous solution,  overview. Enzymatic turnover begins with the rapid equilibrium  association of ethylnitronate and the enzyme. In the oxidative pathway,  the transfer of a single electron oxidizes the organic substrate and  reduces the enzyme-bound flavin to an anionic semiquinone species, the  electron transfer occurs while the substrate radical is still bound in  the active site of the enzyme. After formation of the flavosemiquinone  species in the active site of NMO, the subsequent oxidation of the one  electron reduced flavin occurs when molecular oxygen reacts with the  anionic flavosemiquinone to yield an enzyme-associated superoxide  species, with second-order rate constants <15>; #4,7# catalytic and  kinetic reaction mechanism, comparison to the nitroalkane oxygenase, EC  1.7.3.1, and other flavin-dependent enzymes, ionization of nitroethane  and ethylnitronate in aqueous solution, overview <15>; #10# catalyze  the oxidation of propionate-3-nitronate or other nitronate analogues  through a radical mechanism involving a catalytic flavosemiquinone  without formation of a canonical C4a-(hydro)peroxyflavin <25>)  "
1.13.12.17, dichlorochromopyrrolate + 4 O2 + 4 NADH + 4 H+ = dichloroarcyriaflavin  A + 2 CO2 + 6 H2O + 4 NAD+  
1.13.12.18, dinoflagellate luciferin + O2 = oxidized dinoflagellate luciferin + H2O  + hnu  
1.13.12.19," 2-oxoglutarate + O2 = ethene + 3 CO2 + H2O (#2,4,6,7# reaction  mechanism, overview <8>; #4# mechanism of ethylene formation, and  two-pathway reaction mechanism of EFE, structure-function relationship  <9>; #4# Pseudomonas syringae ethylene-forming enzyme reveal a branched  mechanism. In one branch, an apparently typical 2-oxoglutarate  oxygenase reaction to give succinate, carbon dioxide, and sometimes  pyrroline-5-carboxylate occurs, reaction of EC 1.13.11.34.  Alternatively, Grob-type oxidative fragmentation of a  2-oxoglutarate-derived intermediate occurs to give ethylene and carbon  dioxide, EC 1.13.12.19. Fragmentation to give ethylene is promoted by  binding of L-arginine in a nonoxidized conformation and of  2-oxoglutarate in an unprecedented high-energy conformation that favors  ethylene, relative to succinate formation. Induced fit reaction  mechanism, detailed overview <11>)  "
1.13.12.2," L-lysine + O2 = 5-aminopentanamide + CO2 + H2O (#1# mechanism <14>; #3#  a slight difference of the binding position of a substrate dictates the  activity of this type of enzyme as oxidase or monooxygenase, residue  C254 is involved <20>)  "
1.13.12.20, norsolorinic acid anthrone + O2 = norsolorinic acid + H2O  
1.13.12.21, tetracenomycin F1 + O2 = tetracenomycin D3 + H2O  
1.13.12.22, deoxynogalonate + O2 = nogalonate + H2O (#1# carbanion mechanism where  the deprotonated substrate reacts with molecular oxygen via one  electron transfer and formation of a caged radical <2>)  
1.13.12.23, 3-dimethylallyl-4-hydroxymandelate + O2 =  3-dimethylallyl-4-hydroxybenzoate + CO2 + H2O  
1.13.12.24, [apoaequorin] + coelenterazine + O2 + 3 Ca2+ = [excited state blue  fluorescent protein] + CO2 
1.13.12.24, [apoaequorin] + coelenterazine = [apoaequorin containing coelenterazine] 
1.13.12.24, [apoaequorin containing coelenterazine] + O2 = [aequorin] 
1.13.12.24," [aequorin] + 3 Ca2+ = [aequorin] 1,2-dioxetan-3-one "
1.13.12.24," [aequorin] 1,2-dioxetan-3-one = [excited state blue fluorescent  protein] + CO2  "
1.13.12.3, L-tryptophan + O2 = (indol-3-yl)acetamide + CO2 + H2O  
1.13.12.4, (S)-lactate + O2 = acetate + CO2 + H2O  
1.13.12.5," coelenterazine h + O2 = excited coelenteramide h monoanion + CO2  (#1,2,3# mechanism <1,4>) "
1.13.12.5, coelenterazine h + O2 = coelenterazine h dioxetanone 
1.13.12.5, coelenterazine h dioxetanone = excited coelenteramide h monoanion + CO2  
1.13.12.6," Cypridina luciferin + O2 = oxidized Cypridina luciferin + CO2 + hnu  (#1# light, mechanism <5>)  "
1.13.12.7, D-firefly luciferin + O2 + ATP = firefly oxyluciferin + CO2 + AMP +  diphosphate + hnu  
1.13.12.8," Watasenia luciferin + O2 = oxidized Watasenia luciferin + CO2 + hnu  (#4# the luciferase catalyzes the oxidation of luciferin to produce the  light emitter after thermolysis of the peroxide intermediate. The light  is produced via an ATP-dependent luciferin-luciferase reaction  involving oxygen molecule and Mg2+. The oxygenation reaction occurs  with a single electron-transfer (SET) mechanism. The luciferin of  Watasenia scintillans is a disulfonate derivative of coelenterazine,  i.e. coelenterazine disulfonate. Bioluminescence and luciferin  oxygenation reaction mechanism, analysis by density functional theory  (DFT) and time-dependent DFT (TDDFT), calculation, modeling, and  dynamics simulation, detailed overview <9>)  "
1.13.12.9, L-phenylalanine + O2 = 2-phenylacetamide + CO2 + H2O (#1# mechanism <5>)  
1.13.99.1," myo-Inositol + O2 = D-glucuronate + H2O (#5# mechanism <2>; #3# the  N-terminus is important, through coordination of a set of loops  covering the active site, in shielding the active site during  catalysis. Role of residue K127 in governing the access o the diiron  cluster <25>)  "
1.13.99.3," L-tryptophan + O2 = (indol-3-yl)glycolaldehyde + CO2 + NH3 (#3# primary  reaction is hydroxylation of the side chain carbon adjacent to the  indole ring, decarboxylation (of tryptophan only) is secondary <6>; #3#  model of mechanism <3>)  "
1.14.11.1," 4-trimethylammoniobutanoate + 2-oxoglutarate + O2 =  3-hydroxy-4-trimethylammoniobutanoate + succinate + CO2 (#6,7#  srereochemistry of reaction, pro-R hydrogen atom abstraction <13>)  "
1.14.11.10, 2'-deoxyuridine + 2-oxoglutarate + O2 = uracil + 2-deoxyribonolactone +  succinate + CO2  
1.14.11.11," L-hyoscyamine + 2-oxoglutarate + O2 = (6S)-hydroxyhyoscyamine +  succinate + CO2 (#1# proposed mechanism of epoxidation catalyzed by the  enzyme, overview <19>)  "
1.14.11.12, gibberellin 44 + 2-oxoglutarate + O2 = gibberellin 19 + succinate + CO2  
1.14.11.13, gibberellin 1 + 2-oxoglutarate + O2 = 2beta-hydroxygibberellin 1 +  succinate + CO2  
1.14.11.15, gibberellin 20 + 2-oxoglutarate + O2 = gibberellin 1 + succinate + CO2  
1.14.11.16, peptide-L-aspartate + 2-oxoglutarate + O2 =  peptide-3-hydroxy-L-aspartate + succinate + CO2  
1.14.11.17," taurine + 2-oxoglutarate + O2 = sulfite + aminoacetaldehyde + succinate  + CO2 (#2# mechanism <4,6>; #2# the TauD mechanism begins with the  bidentate coordination of 2-oxoglutarate to Fe(II) displacing two water  ligands. Taurine then binds to the active site resulting in the  displacement of the apical H2O and formation of a 5-coordinate Fe(II)  center. O2 binds to the open coordination site on Fe(II), yielding an  Fe(III)-superoxo species. Subsequent oxidative decarboxylation of  2-oxoglutarate leads to formation of a Fe(IV)=O intermediate that  triggers hydroxylation of the C1 carbon of taurine via hydrogen atom  abstraction and radical rebound chemistry The hydroxylated taurine  spontaneously decomposes to sulfite and aminoacetaldehyde <27>; #5# the  key step in the catalytic cycle of the alpha-ketoglutarate-dependent  dioxygenases is the hydrogen transfer process. A concerted mechanism  takes place, where the H atom transfer happens simultaneously with the  electron transfer from taurine to the Fe=O cofactor <30>)  "
1.14.11.18, phytanoyl-CoA + 2-oxoglutarate + O2 = 2-hydroxyphytanoyl-CoA +  succinate + CO2  
1.14.11.2," procollagen L-proline + 2-oxoglutarate + O2 = procollagen  trans-4-hydroxy-L-proline + succinate + CO2 (#1,8# mechanism <2,22>;  #1# mechanism, kinetic analysis of the reaction sequence <30>; #1#  mechanism, role of cosubstrates <29>; #6# active site and reaction  mechanism, overview <116>; #8# active site structure and action mode,  overview <119>; #7# reaction mechanism involving ascorbate, which are  not required for the hydroxylation reaction part, but for the uncoupled  cedarboxylation, overview <114>; #5,6,8,9,15# reaction mechanism  involving ascorbate, which not required for the hydroxylation reaction  part, but for the uncoupled cedarboxylation, overview <114>; #8#  reaction mechanism with Fe2+ bound in the active site by a 2-His-1-Asp  motif, overview <118>)  "
1.14.11.20," deacetoxyvindoline + 2-oxoglutarate + O2 = deacetylvindoline +  succinate + CO2 (#1# ordered Ter Ter mechanism is suggested,  deacetylvindoline is the first product released, followed by CO2 and  succinate <3>)  "
1.14.11.21," deoxyamidinoproclavaminate + 2-oxoglutarate + O2 =  amidinoproclavaminate + succinate + CO2 (#1,2,3# reaction mechanism  <3,6,17>; #2# this reaction is due to a proclavaminate amidinohydrolase  PAH, gene cla <1,8,9,10,12>; #3# once the oxoferryl species is formed,  the oxidative cyclization most likely involves either a mechanism  involving C4(S)-H bond cleavage of the monocyclic beta-lactam ring, or  a biosynthetically unprecedented mechanism comprising oxidation of the  hydroxyl group of procavaminate to an O-radical, retro-aldol-like  decomposition of the O-radical to an aldehyde and a C-centered radical,  which is stabilized by the captodative effect, abstraction of a  hydrogen atom from the C4(S) position of the C-centered radical by the  Fe(III)-OH species yielding an azomethine ylide, and 1,3-dipolar  cycloaddition to the ylide with aldehyde acting as a dipolarophile <18>) "
1.14.11.21," proclavaminate + 2-oxoglutarate + O2 = dihydroclavaminate + succinate +  CO2 + H2O (#1,2,3# reaction mechanism  <3,4,5,6,7,8,9,10,11,12,13,15,16,17>; #2# kinetic mechanism <2>; #2,3#  substrate-binding mechanism <11,13>) "
1.14.11.21," dihydroclavaminate + 2-oxoglutarate + O2 = clavaminate + succinate +  CO2 + H2O (#1,2,3# reaction mechanism  <3,4,5,6,7,8,9,10,11,12,13,15,16,17>; #2# kinetic mechanism <2>; #2,3#  substrate-binding mechanism <11,13>)  "
1.14.11.24, 2'-deoxymugineic acid + 2-oxoglutarate + O2 = mugineic acid + succinate  + CO2  
1.14.11.25, mugineic acid + 2-oxoglutarate + O2 = 3-epihydroxymugineic acid +  succinate + CO2 
1.14.11.25, 2'-deoxymugineic acid + 2-oxoglutarate + O2 =  3-epihydroxy-2'-deoxymugineic acid + succinate + CO2  
1.14.11.26, deacetoxycephalosporin C + 2-oxoglutarate + O2 = deacetylcephalosporin  C + succinate + CO2  
1.14.11.27," a [histone H3]-N6,N6-dimethyl-L-lysine36 + 2 2-oxoglutarate + 2 O2 = a  [histone H3]-L-lysine36 + 2 succinate + 2 formaldehyde + 2 CO2 "
1.14.11.27," a [histone H3]-N6,N6-dimethyl-L-lysine36 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine36 + succinate + formaldehyde + CO2 "
1.14.11.27, a [histone H3]-N6-methyl-L-lysine36 + 2-oxoglutarate + O2 = a [histone  H3]-L-lysine36 + succinate + formaldehyde + CO2  
1.14.11.28, L-proline + 2-oxoglutarate + O2 = cis-3-hydroxy-L-proline + succinate +  CO2  
1.14.11.29, hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 =  hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO2  
1.14.11.3, 2'-deoxyuridine + 2-oxoglutarate + O2 = uridine + succinate + CO2  
1.14.11.30, hypoxia-inducible factor-L-asparagine + 2-oxoglutarate + O2 =  hypoxia-inducible factor-(3S)-3-hydroxy-L-asparagine + succinate + CO2  
1.14.11.31, thebaine + 2-oxoglutarate + O2 = neopinone + formaldehyde + succinate +  CO2 (#1# spontaneous conversion of neopinione to codeinone <1>)  
1.14.11.32, codeine + 2-oxoglutarate + O2 = morphine + formaldehyde + succinate +  CO2  
1.14.11.33, DNA-base-CH3 + 2-oxoglutarate + O2 = DNA-base + formaldehyde +  succinate + CO2  
1.14.11.35, 1-deoxypentalenate + 2-oxoglutarate + O2 =  1-deoxy-11beta-hydroxypentalenate + succinate + CO2  
1.14.11.36, pentalenolactone D + 2 2-oxoglutarate + 2 O2 = pentalenolactone F + 2  succinate + 2 CO2 + H2O 
1.14.11.36, pentalenolactone D + 2-oxoglutarate + O2 = pentalenolactone E +  succinate + CO2 + H2O 
1.14.11.36, pentalenolactone E + 2-oxoglutarate + O2 = pentalenolactone F +  succinate + CO2  
1.14.11.37, kanamycin B + 2-oxoglutarate + O2 = 2'-dehydrokanamycin A + succinate +  NH3 + CO2  
1.14.11.38, fumitremorgin B + 2-oxoglutarate + 2 O2 + reduced acceptor =  verruculogen + succinate + CO2 + H2O + acceptor  
1.14.11.39," L-asparagine + 2-oxoglutarate + O2 = (2S,3S)-3-hydroxyasparagine +  succinate + CO2  "
1.14.11.4," [procollagen]-L-lysine + 2-oxoglutarate + O2 =  [procollagen]-(2S,5R)-5-hydroxy-L-lysine + succinate + CO2 (#1#  mechanism <2,7>)  "
1.14.11.40, L-enduracididine + 2-oxoglutarate + O2 =  (3S)-3-hydroxy-L-enduracididine + succinate + CO2  
1.14.11.41, L-arginine + 2-oxoglutarate + O2 = (3S)-3-hydroxy-L-arginine +  succinate + CO2  
1.14.11.42, 7-(3-amino-3-carboxypropyl)wyosine37 in tRNAPhe + 2-oxoglutarate + O2 =  7-(2-hydroxy-3-amino-3-carboxypropyl)wyosine37 in tRNAPhe + succinate +  CO2  
1.14.11.43, (S)-2-(4-chloro-2-methylphenoxy)propanoate + 2-oxoglutarate + O2 =  4-chloro-2-methylphenol + pyruvate + succinate + CO2 
1.14.11.43," (S)-(2,4-dichlorophenoxy)propanoate + 2-oxoglutarate + O2 =  2,4-dichlorophenol + pyruvate + succinate + CO2  "
1.14.11.44, (R)-2-(4-chloro-2-methylphenoxy)propanoate + 2-oxoglutarate + O2 =  4-chloro-2-methylphenol + pyruvate + succinate + CO2 
1.14.11.44," (R)-(2,4-dichlorophenoxy)propanoate + 2-oxoglutarate + O2 =  2,4-dichlorophenol + pyruvate + succinate + CO2  "
1.14.11.45, L-isoleucine + 2-oxoglutarate + O2 = (4S)-4-hydroxy-L-isoleucine +  succinate + CO2  
1.14.11.46, (2-aminoethyl)phosphonate + 2-oxoglutarate + O2 =  (2-amino-1-hydroxyethyl)phosphonate + succinate + CO2  
1.14.11.47, [50S ribosomal protein L16]-L-Arg81 + 2-oxoglutarate + O2 = [50S  ribosomal protein L16]-(3R)-3-hydroxy-L-Arg81 + succinate + CO2  
1.14.11.48, xanthine + 2-oxoglutarate + O2 = urate + succinate + CO2  
1.14.11.49, UMP + 2-oxoglutarate + O2 = 5'-dehydrouridine + succinate + CO2 +  phosphate  
1.14.11.51, N6-methyladenine in DNA + 2-oxoglutarate + O2 = adenine in DNA +  formaldehyde + succinate + CO2  
1.14.11.52, validamycin A + 2-oxoglutarate + O2 = validamycin B + succinate + CO2  
1.14.11.53, N6-methyladenine in mRNA + 2-oxoglutarate + O2 = adenine in mRNA +  formaldehyde + succinate + CO2  
1.14.11.54, N1-methyladenine in mRNA + 2-oxoglutarate + O2 = adenine in mRNA +  formaldehyde + succinate + CO2  
1.14.11.55, ectoine + 2-oxoglutarate + O2 = 5-hydroxyectoine + succinate + CO2  
1.14.11.56," L-proline + 2-oxoglutarate + O2 = cis-4-hydroxy-L-proline + succinate +  CO2 (#2,3# proposed catalytic mechanism of cis-P4H with L-proline and  L-pipecolate as substrates with 2-oxoglutarate and O2, overview <4>)  "
1.14.11.57, L-proline + 2-oxoglutarate + O2 = trans-4-hydroxy-L-proline + succinate  + CO2  
1.14.11.58, an ornithine lipid + 2-oxoglutarate + O2 = a 2-hydroxyornithine lipid +  succinate + CO2  
1.14.11.59," (2R)-4-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside + 2-oxoglutarate + O2 =  (2R)-4,7-dihydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside + succinate + CO2 + H2O  "
1.14.11.6, thymine + 2-oxoglutarate + O2 = 5-hydroxymethyluracil + succinate + CO2  
1.14.11.60, scopoletin + 2-oxoglutarate + O2 = fraxetin + succinate + CO2  
1.14.11.61, trans-feruloyl-CoA + 2-oxoglutarate + O2 = trans-6-hydroxyferuloyl-CoA  + succinate + CO2  
1.14.11.62," trans-4-coumaroyl-CoA + 2-oxoglutarate + O2 =  2,4-dihydroxycinnamoyl-CoA + succinate + CO2  "
1.14.11.63, a [protein]-L-lysine + 2-oxoglutarate + O2 = a  [protein]-(3S)-3-hydroxy-L-lysine + succinate + CO2  
1.14.11.64, glutarate + 2-oxoglutarate + O2 = (S)-2-hydroxyglutarate + succinate +  CO2  
1.14.11.65," a [histone H3]-N6,N6-dimethyl-L-lysine9 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine9 + succinate + formaldehyde + CO2 "
1.14.11.65," a [histone H3]-N6,N6-dimethyl-L-lysine9 + 2 2-oxoglutarate + 2 O2 = a  [histone H3]-L-lysine9 + 2 succinate + 2 formaldehyde + 2 CO2 "
1.14.11.65, a [histone H3]-N6-methyl-L-lysine9 + 2-oxoglutarate + O2 = a [histone  H3]-L-lysine9 + succinate + formaldehyde + CO2  
1.14.11.66," a [histone H3]-N6,N6,N6-trimethyl-L-lysine9 + 2 2-oxoglutarate + 2 O2 =  a [histone H3]-N6-methyl-L-lysine9 + 2 succinate + 2 formaldehyde + 2  CO2 "
1.14.11.66," a [histone H3]-N6,N6,N6-trimethyl-L-lysine9 + 2-oxoglutarate + O2 = a  [histone H3]-N6,N6-dimethyl-L-lysine9 + succinate + formaldehyde + CO2 "
1.14.11.66," a [histone H3]-N6,N6-dimethyl-L-lysine9 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine9 + succinate + formaldehyde + CO2  "
1.14.11.67," a [histone H3]-N6,N6,N6-trimethyl-L-lysine4 + 3 2-oxoglutarate + 3 O2 =  a [histone H3]-L-lysine4 + 3 succinate + 3 formaldehyde + 3 CO2 "
1.14.11.67," a [histone H3]-N6,N6-dimethyl-L-lysine4 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine4 + succinate + formaldehyde + CO2 "
1.14.11.67, a [histone H3]-N6-methyl-L-lysine4 + 2-oxoglutarate + O2 = a [histone  H3]-L-lysine4 + succinate + formaldehyde + CO2  
1.14.11.68," a [histone H3]-N6,N6,N6-trimethyl-L-lysine27 + 2 2-oxoglutarate + 2 O2  = a [histone H3]-N6-methyl-L-lysine27 + 2 succinate + 2 formaldehyde +  2 CO2 "
1.14.11.68," a [histone H3]-N6,N6,N6-trimethyl-L-lysine27 + 2-oxoglutarate + O2 = a  [histone H3]-N6,N6-dimethyl-L-lysine27 + succinate + formaldehyde + CO2 "
1.14.11.68," a [histone H3]-N6,N6-dimethyl-L-lysine27 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine27 + succinate + formaldehyde + CO2  "
1.14.11.69," a [histone H3]-N6,N6-dimethyl-L-lysine36 + 2-oxoglutarate + O2 = a  [histone H3]-N6-methyl-L-lysine36 + succinate + formaldehyde + CO2 "
1.14.11.69," a [histone H3]-N6,N6,N6-trimethyl-L-lysine36 + 2 2-oxoglutarate + 2 O2  = a [histone H3]-N6-methyl-L-lysine36 + 2 succinate + 2 formaldehyde +  2 CO2 "
1.14.11.69," a [histone H3]-N6,N6,N6-trimethyl-L-lysine36 + 2-oxoglutarate + O2 = a  [histone H3]-N6,N6-dimethyl-L-lysine36 + succinate + formaldehyde + CO2  "
1.14.11.7, [procollagen]-L-proline + 2-oxoglutarate + O2 =  [procollagen]-trans-3-hydroxy-L-proline + succinate + CO2  
1.14.11.70, 7-deoxycylindrospermopsin + 2-oxoglutarate + O2 = cylindrospermopsin +  succinate + CO2 
1.14.11.70, 7-deoxycylindrospermopsin + 2-oxoglutarate + O2 =  7-epi-cylindrospermopsin + succinate + CO2  
1.14.11.71, methylphosphonate + 2-oxoglutarate + O2 = hydroxymethylphosphonate +  succinate + CO2  
1.14.11.72, [2-(trimethylamino)ethyl]phosphonate + 2-oxoglutarate + O2 =  [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate + succinate + CO2  
1.14.11.73, [protein]-L-arginine + 2-oxoglutarate + O2 =  [protein]-(3R)-3-hydroxy-L-arginine + succinate + CO2  
1.14.11.74, L-isoleucine + 2-oxoglutarate + O2 = 31-hydroxy-L-isoleucine +  succinate + CO2  
1.14.11.75," 31-hydroxy-L-isoleucine + 2-oxoglutarate + O2 =  (4S)-31,4-dihydroxy-L-isoleucine + succinate + CO2  "
1.14.11.76, L-glutamate + 2-oxoglutarate + O2 = (3R)-3-hydroxy-L-glutamate +  succinate + CO2  
1.14.11.77, a primary alkyl sulfate ester + 2-oxoglutarate + O2 = an aldehyde +  succinate + CO2 + sulfate  
1.14.11.8," N6,N6,N6-trimethyl-L-lysine + 2-oxoglutarate + O2 =  (3S)-3-hydroxy-N6,N6,N6-trimethyl-L-lysine + succinate + CO2  "
1.14.11.9," a (2S)-flavan-4-one + 2-oxoglutarate + O2 = a (2R,3R)-dihydroflavonol +  succinate + CO2 (#4# enzyme catalyzes double-bond formation by direct  abstraction of vicinal hydrogen atoms at C-2 and C-3 of the substrate  <4>)  "
1.14.12.1, anthranilate + NAD(P)H + 2 H+ + O2 = catechol + CO2 + NAD(P)+ + NH3  
1.14.12.10," benzoate + NADH + H+ + O2 =  (1R,6S)-1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate + NAD+ (#2#  proposed catalytic cycle <5>; #2# the enzyme consists of two proteins,  a NADH-cytochrome c reductase and an oxygenase <1>)  "
1.14.12.11," toluene + NADH + H+ + O2 = (1S,2R)-3-methylcyclohexa-3,5-diene-1,2-diol  + NAD+ (#4# reaction mechanism, structure-function reklationship of the  enzyme organized in a multicomponent Rieske non-heme iron toluene  2,3-dioxygenase enzyme system, overview <42>; #4# formation of a stable  charge transfer complex between the reduced reductase and NAD+ at the  end of the reductive half-reaction, which is substantially less  reactive toward dioxygen than the reduced reductase in the absence of  NAD+. The nicotinamide ring and the protein matrix shield the reactive  C4a position of the isoalloxazine ring and force the tricycle into an  atypical planar conformation, both factors disfavoring the reaction of  the reduced flavin with dioxygen. A rapid electron transfer from the  charge transfer complex to electron acceptors further reduces the risk  of unwanted side reactions, there is a short distance between the  electron-donating and -accepting cofactors. Attraction between the two  proteins is likely mediated by opposite charges at one large patch of  the complex interface <51>)  "
1.14.12.12," naphthalene + NADH + H+ + O2 = (1R,2S)-1,2-dihydronaphthalene-1,2-diol  + NAD+ (#4# proposed mechanism <3>; #3# proposed electron transport  chain: NADH, ferredoxixinNAP reductase, ferredoxinNAP, terminal  oxygenase ISPNAP <2>)  "
1.14.12.13," a 2-halobenzoate + NADH + H+ + O2 = catechol + a halide anion + NAD+ +  CO2 (#4# broad substrate specificity, ability to transform all 3  monochlorobenzoates almost equally well. Enzyme appears to lack  absolute regioselectivity <7>; #3# two-component nonheme iron  dioxygenase system of oxygenase system class IB dioxygenase:  NADH:acceptor reductase containing both FAD and cloroplast-type 2Fe-2S  and Rieske-type 2Fe-2S-containing oxygenase component <3>; #3#  inducible two-component enzyme system: component B is an iron-sulfur  flavoprotein (reductase) and red-brown component A (oxygenase) is an  iron-sulfur protein <2>; #3# multi-component dioxygenase system  proposed: 1,2-hydroxylating, dehalogenating, decarboxylating <1,2>; #3#  EPR, electron spin echo envelope modulation, electron nuclear double  resonance studies and the electrochemical potential are performed.  Enzyme contains one ferredoxin-type (reductase) and one Rieske-type  (oxygenase) 2Fe2S center <4>)  "
1.14.12.14," 2-aminobenzenesulfonate + NADH + H+ + O2 =  2,3-dihydroxybenzenesulfonate + NH3 + NAD+  "
1.14.12.15," terephthalate + NADH + H+ + O2 =  (1R,6S)-dihydroxycyclohexa-2,4-diene-1,4-dicarboxylate + NAD+  "
1.14.12.16," quinolin-2-ol + NADH + H+ + O2 = 2,5,6-trihydroxy-5,6-dihydroquinoline  + NAD+  "
1.14.12.17, 2 nitric oxide + 2 O2 + NAD(P)H = 2 nitrate + NAD(P)+ + H+  
1.14.12.18," biphenyl + NADH + H+ + O2 =  (1S,2R)-3-phenylcyclohexa-3,5-diene-1,2-diol + NAD+ (#3# with  chlorinated biphenyls the product is 2,3-dihydroxybiphenyl and HCl <4>)  "
1.14.12.19," 3-phenylpropanoate + NADH + H+ + O2 =  3-(cis-5,6-dihydroxycyclohexa-1,3-dien-1-yl)propanoate + NAD+ "
1.14.12.19," (2E)-3-phenylprop-2-enoate + NADH + H+ + O2 =  (2E)-3-(2,3-dihydroxyphenyl)prop-2-enoate + NAD+  "
1.14.12.22," 9H-carbazole + NAD(P)H + H+ + O2 = 2'-aminobiphenyl-2,3-diol + NAD(P)+  (#17# catalytic mechanism is as follows: When the Rieske cluster is  reduced, substrate binding induces several conformational changes that  create room for oxygen binding. Dioxygen bound in a side-on fashion  onto nonheme iron is activated by reduction to the peroxo state  [Fe(III)-(hydro)peroxo]. This state may react directly with the bound  substrate, or O-O bond cleavage may occur to generate Fe(V)-oxo-hydroxo  species prior to the reaction. After producing a cisdihydrodiol, the  product is released by reducing the nonheme iron <18>)  "
1.14.12.23, nitrobenzene + NADH + O2 = catechol + nitrite + NAD+  
1.14.12.24," 2,4-dinitrotoluene + NADH + O2 = 4-methyl-5-nitrocatechol + nitrite +  NAD+  "
1.14.12.25," p-cumate + NADH + H+ + O2 = (2R,3S)-2,3-dihydroxy-2,3-dihydro-p-cumate  + NAD+  "
1.14.12.26," chlorobenzene + NADH + H+ + O2 =  (1R,2R)-3-chlorocyclohexa-3,5-diene-1,2-diol + NAD+  "
1.14.12.3," benzene + NADH + H+ + O2 = cis-cyclohexa-3,5-diene-1,2-diol + NAD+ (#2#  the catalytic iron-sulfur proteins of the enzyme consist of two  dissimilar alpha and beta subunits, the alpha subunit contains a  [2Fe-2S] cluster involved in electron transfer, the catalytic nonheme  iron center, and is also responsible for substrate specificity <11>)  "
1.14.12.7," phthalate + NADH + H+ + O2 =  cis-4,5-dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate + NAD+ (#1#  reduced phthalate dioxygenase reductase first interacts with phthylate  dioxygenase and reduces the Rieske [2Fe-2S]center. Phthalate and O2  then bind reversibly and reduced phthalate dioxygenase transfers one  more electron to the enzyme <3>; #1# mechanism, product formation is  tightly coupled to electron delivery, comparison of mechanisms of  different dioxygenases <10>; #1# mechanism, synergistic effect of  substrate and phthalate dioxygenase reductase rendering the enzyme  fully catalytically active <9>)  "
1.14.12.8," 4-sulfobenzoate + NADH + H+ + O2 = 3,4-dihydroxybenzoate + sulfite +  NAD+  "
1.14.12.9," 4-chlorophenylacetate + NADH + H+ + O2 = 3,4-dihydroxyphenylacetate +  chloride + NAD+  "
1.14.13.1, salicylate + NADH + 2 H+ + O2 = catechol + NAD+ + H2O + CO2  
1.14.13.10," 2,6-dihydroxypyridine + NADH + H+ + O2 = 2,3,6-trihydroxypyridine +  NAD+ + H2O  "
1.14.13.101, senecionine + NADPH + H+ + O2 = senecionine N-oxide + NADP+ + H2O  
1.14.13.105," (-)-menthone + NADPH + H+ + O2 =  (4R,7S)-7-isopropyl-4-methyloxepan-2-one + NADP+ + H2O "
1.14.13.105, dihydrocarvone + NADPH + H+ + O2 = 4-isopropenyl-7-methyloxepan-2-one +  NADP+ + H2O 
1.14.13.105, (iso)-dihydrocarvone + NADPH + H+ + O2 =  6-isopropenyl-3-methyloxepan-2-one + NADP+ + H2O 
1.14.13.105, 1-hydroxymenth-8-en-2-one + NADPH + H+ + O2 =  7-hydroxy-4-isopropenyl-7-methyloxepan-2-one + NADP+ + H2O  
1.14.13.107," (S)-limonene + NAD(P)H + H+ + O2 = 1,2-epoxymenth-8-ene + NAD(P)+ + H2O "
1.14.13.107," (R)-limonene + NAD(P)H + H+ + O2 = 1,2-epoxymenth-8-ene + NAD(P)+ + H2O  "
1.14.13.111, methanesulfonate + NADH + H+ + O2 = formaldehyde + NAD+ + sulfite + H2O  
1.14.13.113, urate + NADH + H+ + O2 = 5-hydroxyisourate + NAD+ + H2O  
1.14.13.114," 6-hydroxynicotinate + NADH + H+ + O2 = 2,5-dihydroxypyridine + NAD+ +  H2O + CO2 (#4,5# proposal of two catalytic mechanisms, overview <3>)  "
1.14.13.122," chlorophyllide a + O2 + NADPH + H+ = 71-hydroxychlorophyllide a + H2O +  NADP+ (#2,9# reaction mechanism <4,15>; #1# reaction mechanism, the  catalytic site harbors a stable radical formed by Tyr422 which is  involved in the catalytic reaction <2>; #4# reaction mechanism, the  catalytic site harbors a stable radical formed by Tyr518 which is  involved in the catalytic reaction <2>; #8# reaction mechanism, the  enzyme C-terminal C domain is sufficient for catalytic activity <13>) "
1.14.13.122," chlorophyllide a + 2 O2 + 2 NADPH + 2 H+ = chlorophyllide b + 3 H2O + 2  NADP+ (#9# reaction mechanism <15>; #2# reaction mechanism, mechanism  of 7-formyl group formation <4>; #1# reaction mechanism, the catalytic  site harbors a stable radical formed by Tyr422 which is involved in the  catalytic reaction <2>; #4# reaction mechanism, the catalytic site  harbors a stable radical formed by Tyr518 which is involved in the  catalytic reaction <2>; #8# reaction mechanism, the enzyme C-terminal C  domain is sufficient for catalytic activity <13>) "
1.14.13.122, 71-hydroxychlorophyllide a + O2 + NADPH + H+ = chlorophyllide b + 2 H2O  + NADP+  
1.14.13.127," 3-(3-hydroxyphenyl)propanoate + NADH + H+ + O2 =  3-(2,3-dihydroxyphenyl)propanoate + H2O + NAD+ "
1.14.13.127," (2E)-3-(3-hydroxyphenyl)prop-2-enoate + NADH + H+ + O2 =  (2E)-3-(2,3-dihydroxyphenyl)prop-2-enoate + H2O + NAD+  "
1.14.13.128, 7-methylxanthine + O2 + NAD(P)H + H+ = xanthine + NAD(P)+ + H2O +  formaldehyde  
1.14.13.130, pyrrole-2-carboxylate + NADH + H+ + O2 = 5-hydroxypyrrole-2-carboxylate  + NAD+ + H2O  
1.14.13.131, dimethyl sulfide + O2 + NADH + H+ = methanethiol + formaldehyde + NAD+  + H2O  
1.14.13.135," 1-hydroxy-2-naphthoate + NAD(P)H + H+ + O2 = 1,2-dihydroxynaphthalene +  NAD(P)+ + H2O + CO2  "
1.14.13.14, trans-cinnamate + NADPH + H+ + O2 = 2-hydroxycinnamate + NADP+ + H2O  
1.14.13.146," 10beta-hydroxytaxa-4(20),11-dien-5alpha-yl acetate + O2 + NADPH + H+ =  10beta,14beta-dihydroxytaxa-4(20),11-dien-5alpha-yl acetate + NADP+ +  H2O  "
1.14.13.147, taxusin + O2 + NADPH + H+ = 7beta-hydroxytaxusin + NADP+ + H2O  
1.14.13.148," N,N,N-trimethylamine + NADPH + H+ + O2 = N,N,N-trimethylamine N-oxide +  NADP+ + H2O  "
1.14.13.149," phenylacetyl-CoA + NADPH + H+ + O2 =  2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA + NADP+ + H2O  "
1.14.13.153, (+)-sabinene + NADPH + H+ + O2 = (+)-cis-sabinol + NADP+ + H2O  
1.14.13.154, erythromycin D + NADPH + H+ + O2 = erythromycin C + NADP+ + H2O  
1.14.13.155, (-)-alpha-pinene + NADH + H+ + O2 = alpha-pinene oxide + NAD+ + H2O  
1.14.13.16," cyclopentanone + NADPH + H+ + O2 = 5-valerolactone + NADP+ + H2O (#2#  reaction mechanism via key intermediate flavin C4a-peroxide, involving  the four-electron reduction of O2 at the expense of a two-electron  oxidation of NADPH and a two-electron oxidation of cyclohexanone to  epsilon-caprolactone, overview <9>; #2# residues Phe450 and Phe156 are  important for reaction stereospecificity <10>)  "
1.14.13.160," [(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA + O2 + NADPH +  H+ = [(2R)-3,3,4-trimethyl-6-oxo-3,6-dihydro-1H-pyran-2-yl]acetyl-CoA +  NADP+ + H2O  "
1.14.13.161, (+)-camphor + NADPH + H+ + O2 = (+)-6-exo-hydroxycamphor + NADP+ + H2O  
1.14.13.163," 4-(6-hydroxypyridin-3-yl)-4-oxobutanoate + 2 NADH + 2 H+ + O2 =  2,5-dihydroxypyridine + succinate semialdehyde + 2 NAD+ + H2O (#1#  catalytic mechanism, overview. In contrast to conclusions reported  previously, the second product of the HspB reaction is shown to be  succinate, with isotope labeling experiments providing direct evidence  that the newly introduced oxygen atom of succinate is derived from H2O.  Reduced HspB reacts with oxygen to form a C(4a)-(hydro)peroxyflavin  intermediate before it is converted to the oxidized flavoenzyme  species. The formed C(4a)-hydroperoxyflavin intermediate reacts with  HSP to form an intermediate that is hydrolyzed to the products  2,5-dihydroxypyridine and succinate <7>)  "
1.14.13.166," 4-nitrocatechol + NAD(P)H + H+ + O2 = 2-hydroxy-1,4-benzoquinone +  nitrite + NAD(P)+ + H2O  "
1.14.13.167," 4-nitrophenol + NADPH + H+ + O2 = 1,4-benzoquinone + nitrite + NADP+ +  H2O  "
1.14.13.168, (indol-3-yl)pyruvate + NADPH + H+ + O2 = (indol-3-yl)acetate + NADP+ +  H2O + CO2  
1.14.13.170, 1-deoxy-11-oxopentalenate + NADPH + H+ + O2 = pentalenolactone D +  NADP+ + H2O  
1.14.13.171, 1-deoxy-11-oxopentalenate + NADPH + H+ + O2 = neopentalenolactone D +  NADP+ + H2O  
1.14.13.172," salicylate + NADH + H+ + O2 = 2,5-dihydroxybenzoate + NAD+ + H2O  "
1.14.13.178, caffeine + O2 + NAD(P)H + H+ = theobromine + NAD(P)+ + H2O +  formaldehyde (#2# (1) <1>) 
1.14.13.178, theophylline + O2 + NAD(P)H + H+ = 3-methylxanthine + NAD(P)+ + H2O +  formaldehyde (#2# (2) <1>) 
1.14.13.178, paraxanthine + O2 + NAD(P)H + H+ = 7-methylxanthine + NAD(P)+ + H2O +  formaldehyde (#2# (3) <1>)  
1.14.13.179, theobromine + O2 + NAD(P)H + H+ = 7-methylxanthine + NAD(P)+ + H2O +  formaldehyde (#1# (1) <1>) 
1.14.13.179, 3-methylxanthine + O2 + NAD(P)H + H+ = xanthine + NAD(P)+ + H2O +  formaldehyde (#1# (2) <1>)  
1.14.13.18, 4-hydroxyphenylacetate + NAD(P)H + H+ + O2 = homogentisate + NAD(P)+ +  H2O  
1.14.13.180, aklavinone + NADPH + H+ + O2 = epsilon-rhodomycinone + NADP+ + H2O  
1.14.13.181, 13-deoxydaunorubicin + NADPH + H+ + O2 = 13-dihydrodaunorubicin + NADP+  + H2O 
1.14.13.181, 13-dihydrodaunorubicin + NADPH + H+ + O2 = daunorubicin + NADP+ + 2 H2O  
1.14.13.182, 2-heptyl-4(1H)-quinolone + NADH + H+ + O2 =  2-heptyl-3-hydroxy-4(1H)-quinolone + NAD+ + H2O  
1.14.13.187," dTDP-beta-L-evernosamine + 2 NADPH + 2 H+ + 2 O2 =  dTDP-2,3  6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose  + 2 NADP+ + 3 H2O (#1# (overall reaction) <1>; #5# reaction mechanism,  overview. Once formed, the product undergoes retro oxime-aldol cleavage  at the C3-C40bond before incorporation into baumycin <5>) "
1.14.13.187, dTDP-beta-L-evernosamine + NADPH + H+ + O2 =  dTDP-N-hydroxy-beta-L-evernosamine + NADP+ + H2O (#1# (1a) <1>) 
1.14.13.187," dTDP-N-hydroxy-beta-L-evernosamine + NADPH + H+ + O2 =  dTDP-2,3  6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose  + NADP+ + 2 H2O (#1# (1b) <1>)  "
1.14.13.189, 5-methyl-1-naphthoate + NADPH + H+ + O2 =  3-hydroxy-5-methyl-1-naphthoate + NADP+ + H2O  
1.14.13.19," taxifolin + NAD(P)H + H+ + O2 = 2,3-dihydrogossypetin + NAD(P)+ + H2O  "
1.14.13.195," L-ornithine + NADPH + H+ + O2 = N5-hydroxy-L-ornithine + NADP+ + H2O  (#2# binding of the hydroxylation target is not required to trigger  reduction of flavin by NADPH, the reductive half-reaction proceeds in  presence and absence of ornithine, reaction of O2 with FADH2 is  accelerated 80fold by ornithine, ensuring coupling of NADPH and  ornithine, C(4a)-hydroperoxyflavin intermediate, overview <3>; #13#  sequential kinetic mechanism for SidA. The reaction is initiated by  binding of NADPH to SidA with the flavin in its oxidized form (FADox).  The rate-limiting step in the reaction is the stereospecific transfer  of the pro-R-hydride equivalent from NADPH to yield reduced flavin  (FADred) and NADP+. The FADred-NADP+ complex reacts with molecular  oxygen forming the C4a-hydroperoxyflavin (FADOOH). In this complex,  NADP+ is essential for stabilization of the FADOOH. After ornithine  (Orn) binding, hydroxylation occurs very quickly. The last step in the  reaction is the release of products <15>)  "
1.14.13.196, L-ornithine + NAD(P)H + H+ + O2 = N5-hydroxy-L-ornithine + NAD(P)+ +  H2O (#1# the enzyme forms a ternary complex with NADP and L-ornithine  during catalysis. The enzyme likely proceeds by a sequential kinetic  mechanism <1>)  
1.14.13.2," 4-hydroxybenzoate + NADPH + H+ + O2 = 3,4-dihydroxybenzoate + NADP+ +  H2O (#1# bi uni uni uni ping-pong mechanism <7>; #27# kinetic scheme of  reductive half-reaction, flavin movement can occur in the presence or  absence of NADPH, but NADPH stimulates movement to the reactive  conformation required for hydride transfer <45>; #3# rate of formation  of the flavin hydroperoxide is not influenced by pH-change. Rate of  hydroxylation reaction increases with pH. The H-bond network abstracts  the phenolic proton from p-hydroxybenzoate in the transition state of  oxygen transfer. Product deprotonation enhances the rate of a specific  conformational change required for both product relase and the  elimination of water <42>)  "
1.14.13.20," 2,4-dichlorophenol + NADPH + H+ + O2 = 3,5-dichlorocatechol + NADP+ +  H2O  "
1.14.13.200," tetracenomycin A2 + 2 O2 + 2 NAD(P)H + 2 H+ = tetracenomycin C + 2  NAD(P)+ + H2O (#1,4# reaction proceeds via a monooxygenase-dioxygenase  mechanism, deriving the 4- and 12a-OH groups of tetracenomycin C from  two molecules of O2 and the 4a-OH group of etracenomycin C from a  molecule of H2O <5>)  "
1.14.13.208," benzoyl-CoA + NADPH + H+ + O2 = 2,3-epoxy-2,3-dihydrobenzoyl-CoA +  NADP+ + H2O (#3# epoxidation starts with the binding of the O2 molecule  to the diferrous center to generate a diferric peroxide complex,  followed by concerted O-O bond cleavage and epoxide formation. Two  different pathways have been located, leading to (2S,3R)-epoxy and  (2R,3S)-epoxy products. The barrier difference is 2.8 kcal/mol,  corresponding to a diastereomeric excess of about 99:1. Further  isomerization from epoxide to phenol has quite a high barrier, which  cannot compete with the product release step. After product release  into solution, fast epoxide-oxepin isomerization and racemization can  take place easily, leading to a racemic mixture of (2S,3R) and (2R,3S)  products. The deoxygenation of epoxide to regenerate benzoyl-CoA by a  diferrous form of the enzyme proceeds via a stepwise mechanism. The  C2-O bond cleavage happens first, coupled with one electron transfer  from one iron center to the substrate, to form a radical intermediate,  which is followed by the second C3-O bond cleavage. The first step is  rate-limiting. Reaction mechanism, modeling and simulations, detailed  overview <7>; #1# molecular reaction mechanism analysis, different  pathways are possible, detailed overview <8>)  "
1.14.13.209, 2-hydroxybenzoyl-CoA + NADH + H+ + O2 = gentisyl-CoA + NAD+ + H2O  
1.14.13.210," 4-methyl-5-nitrocatechol + NAD(P)H + H+ + O2 =  2-hydroxy-5-methylquinone + nitrite + NAD(P)+ + H2O (#1# mechanism of  removal of the nitro group from 4-methyl-5-nitrocatechol and subsequent  reactions leading to ring fission, overview <2>)  "
1.14.13.211, rifampicin + NAD(P)H + O2 = 2'-N-hydroxyrifampicin + NAD(P)+ + H2O  
1.14.13.212," 1,3,7-trimethylurate + NADH + H+ + O2 =  1,3,7-trimethyl-5-hydroxyisourate + NAD+ + H2O  "
1.14.13.215, protoasukamycin + NADH + H+ + O2 = 4-hydroxyprotoasukamycin + NAD+ + H2O  
1.14.13.216, asperlicin C + NAD(P)H + H+ + O2 = asperlicin E + NAD(P)+ + H2O (#1#  reaction mechanism <1>)  
1.14.13.217, protodeoxyviolaceinate + NAD(P)H + O2 = protoviolaceinate + NAD(P)+ +  H2O  
1.14.13.218, 5-methylphenazine-1-carboxylate + NADH + O2 = pyocyanin + NAD+ + CO2 +  H2O  
1.14.13.219, resorcinol + NADPH + H+ + O2 = hydroxyquinol + NADP+ + H2O  
1.14.13.22," cyclohexanone + NADPH + H+ + O2 = hexano-6-lactone + NADP+ + H2O (#8#  stereochemistry <12>; #8# reaction mechanism <14,22>; #2,7,8#  mechanistic study <12,14,18>; #8# re-side specificity of cofactor  binding, stereochemistry <5>; #8# kinetic studies <22>; #8# ter-ter  mechanism <2>; #8# a stable 4a-hydroperoxy-flavin carries out a  nucleophilic attack on the ketone <2>; #8# general mechanistic scheme  <3,11>; #8# stereochemistry and enantioselectivity of the oxidation  reaction depends strongly on the structure and stereochemistry of the  substrates <26,27>; #4,8# enantioselectivity <12,20,21>; #8#  regioselectivity <3,12>)  "
1.14.13.220, resorcinol + NADH + H+ + O2 = hydroxyquinol + NAD+ + H2O  
1.14.13.222," aurachin C + NAD(P)H + H+ + O2 =  4-hydroxy-2-methyl-3-oxo-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline  1-oxide + NAD(P)+ + H2O "
1.14.13.222," aurachin C + NAD(P)H + H+ + O2 =  2-hydroxy-1a-methyl-7a-[(2E,6E)-farnesyl]-1a,2-dihydrooxireno[2  3-b]quinolin-7(7aH)-one + NAD(P)+ + H2O "
1.14.13.222," 2-hydroxy-1a-methyl-7a-[(2E,6E)-farnesyl]-1a,2-dihydrooxireno[2  3-b]quinolin-7(7aH)-one =  4-hydroxy-2-methyl-3-oxo-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline  1-oxide  "
1.14.13.223," 3-hydroxy-4-methylanthranilyl-[aryl-carrier protein] + NADH + H+ + O2 =  3,5-dihydroxy-4-methylanthranilyl-[aryl-carrier protein] + NAD+ + H2O  "
1.14.13.224, protoviolaceinate + NAD(P)H + O2 = violaceinate + NAD(P)+ + H2O 
1.14.13.224, protodeoxyviolaceinate + NAD(P)H + O2 = deoxyviolaceinate + NAD(P)+ +  H2O  
1.14.13.225, [F-actin]-L-methionine + NADPH + O2 + H+ =  [F-actin]-L-methionine-(R)-S-oxide + NADP+ + H2O  
1.14.13.226, acetone + NADPH + H+ + O2 = methyl acetate + NADP+ + H2O  
1.14.13.227, propane + NADH + H+ + O2 = propan-2-ol + NAD+ + H2O  
1.14.13.228, (-)-jasmonate + NADPH + H+ + O2 = trans-12-hydroxyjasmonate + NADP+ +  H2O  
1.14.13.229," tert-butyl alcohol + NADPH + H+ + O2 = 2-methylpropane-1,2-diol + NADP+  + H2O  "
1.14.13.23," 3-hydroxybenzoate + NADPH + H+ + O2 = 3,4-dihydroxybenzoate + NADP+ +  H2O (#4# structural variations in the catalytic action, reaction  mechanism <7>)  "
1.14.13.230, butane + NADH + H+ + O2 = butan-1-ol + NAD+ + H2O  
1.14.13.231," RH + [reduced NADPH-hemoprotein reductase] + O2 = ROH + [oxidized  NADPH-hemoprotein reductase] + H2O (#1# tetracycline substrates,  initial monohydroxylation at position 11a followed by intramolecular  cyclization and non-enzymatic breakdown to undefined products <1>) "
1.14.13.231, tetracycline + NADPH + H+ + O2 = 11a-hydroxytetracycline + NADP+ + H2O  
1.14.13.232, 6-methylpretetramide + NADPH + H+ + O2 = 4-hydroxy-6-methylpretetramide  + NADP+ + H2O  
1.14.13.233, 4-hydroxy-6-methylpretetramide + NADPH + H+ + O2 =  4-de(dimethylamino)-4-oxoanhydrotetracycline + NADP+ + H2O  
1.14.13.234," 5a,11a-dehydrotetracycline + NADPH + H+ + O2 =  5a,11a-dehydrooxytetracycline + NADP+ + H2O  "
1.14.13.235, (indol-3-yl)acetate + NADH + H+ + O2 = (2-hydroxy-1H-indol-3-yl)acetate  + NAD+ + H2O  
1.14.13.236, toluene + NADH + H+ + O2 = 4-methylphenol + NAD+ + H2O  
1.14.13.237, an omega-(methylsulfanyl)alkyl-glucosinolate + NADPH + H+ + O2 = an  omega-(methylsulfinyl)alkyl-glucosinolate + NADP+ + H2O  
1.14.13.238, dimethylamine + NADPH + H+ + O2 = methylamine + formaldehyde + NADP+ +  H2O  
1.14.13.239, L-carnitine + NAD(P)H + H+ + O2 = (3R)-3-hydroxy-4-oxobutanoate +  trimethylamine + NAD(P)+ + H2O  
1.14.13.24," 3-hydroxybenzoate + NADH + H+ + O2 = 2,5-dihydroxybenzoate + NAD+ + H2O  (#4# mechanism <4>; #1# A-stereospecificity <1>; #7# Arg169 is  essential for catalytic activity <11>; #12# catalytic mechanism  involving FAD, overview <15>)  "
1.14.13.240," 2-(all-trans-polyprenyl)phenol + NADPH + H+ + O2 =  3-(all-trans-polyprenyl)benzene-1,2-diol + NADP+ + H2O  "
1.14.13.241, 3-hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate + NADPH + H+ +  O2 = 2-(acetamidomethylene)-3-(hydroxymethyl)succinate + NADP+  
1.14.13.242," 3-hydroxy-2-methylpyridine-5-carboxylate + NAD(P)H + H+ + O2 =  2-(acetamidomethylidene)succinate + NAD(P)+ (#1# reaction proceeds in a  concerted fashion via a ternary complex of oxygenase, NADH and  3-hydroxy-2-methylpyridine-5-carboxylate <1>; #1# ordered mechanism in  which 3-hydroxy-2-methylpyridine-5-carboxylate binds first, followed by  NADH. The first product NAD+ is then released, followed by oxygen  binding and finally release of the oxygenated and reduced cleavage  product 2-(acetamidomethylene)succinate <3>; #1# the enzyme catalyzes  both a classical hydroxylation and a subsequent unique hydrolysis of  the hydroxylated substrate to yield the acyclic product <6>; #1# the  binding proceeds in two steps: an enzyme-substrate complex initially  formed is followed by a ligand-induced isomerization <7>; #1#  oxygenation reaction occurs via an electrophilic aromatic substitution  mechanism <9>)  "
1.14.13.243, toluene + NADH + H+ + O2 = 2-methylphenol + NAD+ + H2O 
1.14.13.243, 2-methylphenol + NADH + H+ + O2 = 3-methylcatechol + NAD+ + H2O  
1.14.13.244, phenol + NADH + H+ + O2 = catechol + NAD+ + H2O  
1.14.13.245, dimethyl sulfide + NADH + H+ + O2 = dimethyl sulfoxide + NAD+ + H2O 
1.14.13.245, dimethyl sulfoxide + NADH + H+ + O2 = dimethyl sulfone + NAD+ + H2O  
1.14.13.246," a 3beta-hydroxy-4,4-dimethylsteroid + 3 NADH + 3 H+ + 3 O2 = a  3beta-hydroxy-4alpha-methylsteroid-4beta-carboxylate + 3 NAD+ + 4 H2O "
1.14.13.246," a 3beta-hydroxy-4,4-dimethylsteroid + NADH + H+ + O2 = a  3beta-hydroxy-4beta-hydroxymethyl-4alpha-methylsteroid + NAD+ + H2O "
1.14.13.246, a 3beta-hydroxy-4beta-hydroxymethyl-4alpha-methylsteroid + NADH + H+ +  O2 = a 3beta-hydroxy-4beta-formyl-4alpha-methylsteroid + NAD+ + 2 H2O 
1.14.13.246, a 3beta-hydroxy-4beta-formyl-4alpha-methylsteroid + NADH + H+ + O2 = a  3beta-hydroxy-4alpha-methylsteroid-4beta-carboxylate + NAD+ + H2O  
1.14.13.247, L-proline betaine + NAD(P)H + H+ + O2 = N-methyl-L-proline +  formaldehyde + NAD(P)+ + H2O  
1.14.13.248, L-aspartate + 3 NADPH + 3 H+ + 3 O2 = (2S)-2-nitrobutanedioate + 3  NADP+ + 4 H2O 
1.14.13.248, L-aspartate + NADPH + H+ + O2 = N-hydroxy-L-aspartate + NADP+ + H2O 
1.14.13.248," N-hydroxy-L-aspartate + NADPH + H+ + O2 = N,N-dihydroxy-L-aspartate +  NADP+ + H2O "
1.14.13.248," N,N-dihydroxy-L-aspartate = (2S)-2-nitrosobutanedioate + H2O "
1.14.13.248, (2S)-2-nitrosobutanedioate + NADPH + H+ + O2 = (2S)-2-nitrobutanedioate  + NADP+ + H2O  
1.14.13.249," 3-amino-4-hydroxybenzoate + NADPH + H+ + O2 =  3-amino-2,4-dihydroxybenzoate + NADP+ + H2O  "
1.14.13.25," methane + NAD(P)H + H+ + O2 = methanol + NAD(P)+ + H2O (#2,3,7#  mechanism <4,12,14,17>; #2# structural model for component protein B of  sMMO <27>; #3# kinetic model of protein component interaction <13>; #2#  modeling of interaction between the different protein components of  sMMO <22>; #2# distribution of electrons in intermolecular  electron-transfer intermediates, isomerization of the initial ternary  complex is required for maximal electron-transfer rates <41>; #3#  reaction cycle, via formation of the hydroperoxo intermediate compound  P and the key reaction cycle intermediate compound Q, overview <36>;  #12# reaction mechanism and regulation, catalytic cycle of sMMO, the  enzyme complex causes quantum tunneling to dominate in CÂ–H bond  cleavage reaction for methane, selectively increasing the rate for this  substrate, mechanism of C-H bond cleavage, overview <44>; #2# reaction  mechanism via carboxylate-bridged diiron center and dioxygen, a  di(my-oxo)diiron(IV) intermediate termed Q is responsible for the  catalytic activity with hydrocarbons, the peroxodiiron(III)  intermediate precedes Q formation in the catalytic cycle, which  consists of four principal steps, overview <40>; #6# reaction  mechanism, spin states analysis of polynuclear metal clusters, a  dinuclear oxygen-bridged iron(IV) model for the intermediate Q of the  hydroxylase component of methane monooxygenase by means of  spin-unrestricted KohnÂ–Sham density functional theory, overview <43>;  #3# reaction mechanism, substrate radical intermediates in the reaction  of soluble methane monooxygenase, the reaction involves the conversion  of the enzyme hydroxylase component, MMOH, diiron cluster to a strongly  oxidizing bis-l-oxo-Fe(IV)2 species termed compound Q, that is capable  of the fissure of stable CÂ–H bonds in methane and many other  hydrocarbons <33>; #2# the soluble enzyme utilizes a  carboxylate-bridged diiron center and dioxygen, a di(my-oxo)diiron(IV)  intermediate termed Q is responsible for the catalytic activity with  hydrocarbons, the peroxodiiron(III) intermediate precedes Q formation  in the catalytic cycle <42>; #2# via diiron(IV) reaction intermediate  Q, reaction mechanism of the soluble enzyme with different substrates,  overview <34>; #3# catalyzes the oxidation of methane through the  activation of O2 at a nonheme biferrous center in the hydroxylase  component MMOH <48>; #2# reaction mechanism and reaction cycle of  enzyme sMMO, via O2 activation intermediates, detailed overview <72>;  #2# reaction mechanism of enzyme sMMO. During methane oxidation, first,  the regulatory protein docks at the alpha2beta2 interface of  alpha2beta2gamma2 of hydroxylase and therefore triggering a  conformational change in the alpha-subunit. Subsequently, the  hydroxylase acts as a proton carrier allowing oxygen and methane  interface with the di-iron center, overview <77>)  "
1.14.13.250, Nomega-methyl-L-arginine + 2 NADH + 2 H+ + 3 O2 =  Ndelta-hydroxy-Nomega-methyl-Nomega-nitroso-L-citrulline + 2 NAD+ + 3  H2O 
1.14.13.250, Nomega-methyl-L-arginine + NADH + H+ + O2 =  Ndelta-hydroxy-Nomega-methyl-L-arginine + NAD+ + H2O 
1.14.13.250," Ndelta-hydroxy-Nomega-methyl-L-arginine + NADH + H+ + O2 =  Ndelta,Nomega'-dihydroxy-Nomega-methyl-L-arginine + NAD+ + H2O "
1.14.13.250," Ndelta,Nomega'-dihydroxy-Nomega-methyl-L-arginine + O2 =  Ndelta-hydroxy-Nomega-methyl-Nomega-nitroso-L-citrulline + H2O  "
1.14.13.27, 4-aminobenzoate + NAD(P)H + 2 H+ + O2 = 4-hydroxyaniline + NAD(P)+ +  H2O + CO2 (#1# A-stereospecificity <2>)  
1.14.13.29, 4-nitrophenol + NADH + H+ + O2 = 4-nitrocatechol + NAD+ + H2O  
1.14.13.31, 2-nitrophenol + 2 NADPH + 2 H+ + O2 = catechol + nitrite + 2 NADP+ + H2O  
1.14.13.32, albendazole + NADPH + H+ + O2 = albendazole S-oxide + NADP+ + H2O  
1.14.13.33," 4-hydroxybenzoate + NAD(P)H + H+ + O2 = 3,4-dihydroxybenzoate + NAD(P)+  + H2O  "
1.14.13.34," (7E,9E,11Z,14Z)-(5S,6R)-6-(cystein-S-yl)-5-hydroxyicosa-7,9,11  14-tetraenoate + NADPH + H+ + O2 = 20-hydroxyleukotriene E4 + NADP+ +  H2O  "
1.14.13.35," anthranilate + NADPH + H+ + O2 = 2,3-dihydroxybenzoate + NADP+ + NH3  (#2# mechanism <7>; #2# mechanism proposed involving imine formation  and hydrolysis during the reaction with the flavin peroxide formed from  reduced enzyme flavin and molecular oxygen <4,6>; #1# possible  involvement of superoxide anion (O2-) in the reaction <9>)  "
1.14.13.38, anhydrotetracycline + NADPH + H+ + O2 = 12-dehydrotetracycline + NADP+  + H2O  
1.14.13.39, 2 Nomega-hydroxy-L-arginine + NADPH + H+ + 2 O2 = 2 L-citrulline + 2  nitric oxide + NADP+ + 2 H2O 
1.14.13.39," 2 L-arginine + 3 NADPH + 3 H+ + 4 O2 = 2 L-citrulline + 2 nitric oxide  + 3 NADP+ + 4 H2O (#7,9# possible mechanism <9>; #7,9# cytochrome P-450  enzyme <3,9>; #7# alignment of heme-binding domain amino acid sequences  of NOS <28>; #7# dimerization is required, activation of NO-synthesis  by enabling electron transfer between the reductase and the oxygenase  domains, isolated monomers are inactive <32>; #7# relation between  structure, function and binding of prosthetic groups during  dissociation, unfolding and renaturation <49>; #7,8,9,10,11# isoform I  and II are regulated by Ca2+/calmodulin, isoform II is  Ca2+-independent, but requires calmodulin, inducible by cytokines <37>;  #7# structure-function study of macrophage enzyme <34>; #7# subunits  align in head-to-head manner with oxygenase domains interacting to form  a dimer and reductase domains existing as independent extensions <36>;  #5,6# reaction and kinetic mechanism <100>; #30# analysis of catalytic  site by Fourier transform infrared spectroscopy, extent of modulation  of vibrational modes upon photolysis of CO compound <54>; #6,31#  analysis of transition states via stopped-flow spectroscopy <62>;  #7,32,34# interaction and electrontransfer between enzyme domains and  bound cofactors calmodulin, FMN, FAD, tetrahydrobiopterin, heme, and  NADPH, overview <84>; #8# reaction mechanism, NO release and transport,  overview, NO formation through sequential electron transfer and the  oxidation of L-arginine, in the catalytic process, FMN, FAD, and  tetrahydrobiopterin are required as coenzymes, and the presence of  Ca2+/calmodulin can aid the electron transfer, isozymes NOS1 and NOS3  perform a similar reaction mechanism <81>; #8,9# reaction mechanism,  the reaction of the enzyme with oxygen is fast and takes place within  several steps, separated by ephemeral intermediates, two short-lived  oxy-compounds OxyI and OxyII <73>; #24# the key structural features  that are involved in the substrate and active site interaction are  highly conserved, e.g. residues Pro214, Glu235, Trp234, Tyr237, Asn246,  and Gln129, substrate binding structure and mechanism, overview <72>) "
1.14.13.39, 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 = 2 Nomega-hydroxy-L-arginine + 2  NADP+ + 2 H2O  
1.14.13.4," 3-(2-hydroxyphenyl)propanoate + NADH + H+ + O2 =  3-(2,3-dihydroxyphenyl)propanoate + NAD+ + H2O (#1,2# mechanism  <1,5,6,7>)  "
1.14.13.40, anthraniloyl-CoA + 2 NAD(P)H + 2 H+ + O2 =  2-amino-5-oxocyclohex-1-enecarboxyl-CoA + H2O + 2 NAD(P)+ (#1# reaction  mechanism <2>)  
1.14.13.43, questin + NADPH + H+ + O2 = demethylsulochrin + NADP+  
1.14.13.44," 2-hydroxybiphenyl + NADH + H+ + O2 = 2,3-dihydroxybiphenyl + NAD+ + H2O  (#2# ternary complex mechanism <3>)  "
1.14.13.46," (-)-menthol + NADPH + H+ + O2 = p-menthane-3,8-diol + NADP+ + H2O  "
1.14.13.5, 4-imidazoleacetate + NADH + H+ + O2 = 5-hydroxy-4-imidazoleacetate +  NAD+ + H2O  
1.14.13.50," pentachlorophenol + NADPH + H+ + O2 =  2,3,5,6-tetrachloro-1,4-benzoquinone + NADP+ + chloride + H2O (#3#  mechanism <2>; #8# benzene rings of Phe85, Phe87, Tyr397, as well as  Tyr216 and the positive charge of Arg235 are important for activity and  stabilization of the active site, reaction mechanism <13>; #8# direct  reduction by NADPH of the flavin at the active site without requirement  of intermediate formation <15>; #8# tetrachlorobenzoquinone reductase  PcpD reaction mechanism <15>) "
1.14.13.50," 2,3,5,6-tetrachlorophenol + NADPH + H+ + O2 =  2,3,5,6-tetrachlorohydroquinone + NADP+ + H2O  "
1.14.13.51," 6-oxocineole + NADPH + H+ + O2 =  1,6,6-trimethyl-2,7-dioxabicyclo[3.2.2]nonan-3-one + NADP+ + H2O  "
1.14.13.54, a ketosteroid + NADPH + H+ + O2 = a steroid ester/lactone + NADP+ + H2O 
1.14.13.54, progesterone + NADPH + H+ + O2 = testosterone acetate + NADP+ + H2O 
1.14.13.54, androstenedione + NADPH + H+ + O2 = testololactone + NADP+ + H2O 
1.14.13.54, 17alpha-hydroxyprogesterone + NADPH + H+ + O2 = androstenedione +  acetate + NADP+ + H2O  
1.14.13.58, benzoyl-CoA + NADPH + H+ + O2 = 3-hydroxybenzoyl-CoA + NADP+ + H2O  
1.14.13.59," L-lysine + NADPH + H+ + O2 = N6-hydroxy-L-lysine + NADP+ + H2O (#1#  reaction mechanism, Cys51 is involved, while Cys31, Cys146, Cys158, and  Cys166 are not <7>; #2# unique mechanism where a rate-limiting and  pH-sensitive conformational change occurs in the reductive  half-reaction, which affects the efficiency of lysine hydroxylation  <11>; #3# via C4a-hydroperoxyflavin intermediate <13>)  "
1.14.13.6," orcinol + NADH + H+ + O2 = 2,3,5-trihydroxytoluene + NAD+ + H2O  "
1.14.13.61," quinolin-2-ol + NADH + H+ + O2 = quinolin-2,8-diol + NAD+ + H2O (#1#  active site modulation by Rieske-[2Fe-2S] center oxidation/reduction  <4>)  "
1.14.13.62," quinolin-4-ol + NADH + H+ + O2 = quinolin-3,4-diol + NAD+ + H2O  "
1.14.13.63," 3-hydroxyphenylacetate + NAD(P)H + H+ + O2 = 2,5-dihydroxyphenylacetate  + NAD(P)+ + H2O  "
1.14.13.64, 4-hydroxybenzoate + NAD(P)H + 2 H+ + O2 = hydroquinone + NAD(P)+ + H2O  + CO2  
1.14.13.66, 2-hydroxycyclohexan-1-one + NADPH + H+ + O2 = 6-hydroxyhexan-6-olide +  NADP+ + H2O  
1.14.13.69," propene + NADH + H+ + O2 = 1,2-epoxypropane + NAD+ + H2O  "
1.14.13.7," phenol + NADPH + H+ + O2 = catechol + NADP+ + H2O (#3# catalytic  mechanism, conformational changes upon binding of the regulatory  protein comonent and effects on catalytic activity <38>)  "
1.14.13.8," N,N-dimethylaniline + NADPH + H+ + O2 = N,N-dimethylaniline N-oxide +  NADP+ + H2O (#5# ordered ter-bi mechanism with an irreversible step  between the second and third substrate, NADPH is added first, followed  by O2 and the oxidizable organic substrate last <4>; #5,15# reaction  mechanism of S-oxygenation of N-substituted thioureas <14>; #2,3,5,8#  catalytic cycle and catalytic reaction mechanism, structure-function  relationship, FMO oxygenates drugs and xenobiotics containing a soft  nucleophile, usually nitrogen or sulfur, utilizing the reducing  equivalents of NADPH to reduce 1 atom of molecular oxygen to water,  while the other atom is used to oxidize the substrate, FMO does not  require a reductase to transfer electrons from NADPH, substrate binding  has no effect on velocity, formation of a peroxyflavin intermediate  <58>; #46# catalytic reaction mechanism via 4alpha-hydroperoxyflavin  transient intermediate <62>; #3# catalytic reaction mechanism,  structure-function relationship, FMO oxygenates soft nucleophiles, and  converts lipophilic compounds into more hydrophilic metabolites, the  first step for FMO is reduction of the FAD by NADPH, the next step is  formation of a C4a-hydroperoxy flavin by addition of molecular oxygen  to the reduced FAD, when the substrate is accepted by FMO the enzyme is  already in an active form, the protein environment of FMO apparently  protects the hydroperoxy flavin from decomposing, conserving NADPH, and  affording an effcient two-electron oxygenating agent for nucleophiles  with the appropriate size and shape <43>; #27,29,30# catalytic cycle,  reaction mechanism and structure-function relationship, overview <74>;  #26# catalytic cycle, reaction mechanism via C4a-hydroperoxyflavin  intermediate and structure-function relationship, overview <73>)  "
1.14.13.81," magnesium-protoporphyrin IX 13-monomethyl ester + 3 NADPH + 3 H+ + 3 O2  = 3,8-divinyl protochlorophyllide a + 3 NADP+ + 5 H2O "
1.14.13.81, magnesium-protoporphyrin IX 13-monomethyl ester + NADPH + H+ + O2 =  131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester + NADP+ +  H2O 
1.14.13.81, 131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester + NADPH +  H+ + O2 = 131-oxo-magnesium-protoporphyrin IX 13-monomethyl ester +  NADP+ + 2 H2O 
1.14.13.81," 131-oxo-magnesium-protoporphyrin IX 13-monomethyl ester + NADPH + H+ +  O2 = 3,8-divinyl protochlorophyllide a + NADP+ + 2 H2O  "
1.14.13.82," vanillate + O2 + NADH + H+ = 3,4-dihydroxybenzoate + NAD+ + H2O +  formaldehyde  "
1.14.13.83, precorrin-3A + NADH + H+ + O2 = precorrin-3B + NAD+ + H2O (#1# reaction  mechanism of CobZ <5>)  
1.14.13.84," (4-hydroxyphenyl)ethan-1-one + NADPH + H+ + O2 = 4-hydroxyphenyl  acetate + NADP+ + H2O (#1# reaction mechanism <6>; #1#  enantioselectivity <2>; #2# contains FAD, the enzyme from Pseudomonas  fluorescens ACB catalyses the conversion of a wide range of  acetophenone derivatives, highest activity occurs with compounds  bearing an electron-donating substituent at the para position of the  aromatic ring, in the absence of substrate, the enzyme can act as an  NADPH oxidase (EC 1.6.3.1) <4>)  "
1.14.13.9, L-kynurenine + NADPH + H+ + O2 = 3-hydroxy-L-kynurenine + NADP+ + H2O  
1.14.13.92," phenylacetone + NADPH + H+ + O2 = benzyl acetate + NADP+ + H2O (#4#  reaction mechanism <4>; #4,5# reaction mechanism and catalytic cycle,  rapid binding of NADPH is followed by a transfer of the (4R)-hydride  from NADPH to the FAD cofactor. The reduced PAMO is rapidly oxygenated  by molecular oxygen, yielding a C4a-peroxyflavin. The peroxyflavin  enzyme intermediate, possibly a Criegee intermediate or a  C4a-hydroxyflavin form, reacts with phenylacetone to form  benzylacetate, residue R337 is important in catalysis, overview  <9,10,11>; #5# catalytic mechanism, via C4a-peroxyflavin and Criegee  intermediates, of phenylacetone monooxygenases for the native substrate  phenylacetone as well as for a linear non-native substrate 2-octanone,  using molecular dynamics simulations, quantum mechanics and quantum  mechanics/molecular mechanics calculations, and theoretical basis for  the preference of the enzyme for the native aromatic substrate over  non-native linear substrates, overview <21>)  "
1.14.14.1," RH + [reduced NADPH-hemoprotein reductase] + O2 = ROH + [oxidized  NADPH-hemoprotein reductase] + H2O (#6,8,9,10,25,34,35# reaction  mechanism <22>; #38# formation of a resonant network stabilizing the  P450Â’s catalytic site and allowing for interaction with substrates  <13>; #4# active site structures and function-structure relationships  of CYPS <18>; #4# catalytic reaction mechanism, structure-function  relationship, CYP can oxidize non-nucleophilic substrates, CYP  possesses genetic variability that may contribute to inter-individual  variability observed for drug metabolism, the first step of CYP is the  addition of substrate to the enzyme followed by electron transfer from  the flavoprotein NADPH-CYP reductase to the substrate-bound CYP, then  electrons flow to the FMN prosthetic group and then sequentially to the  CYP to ultimately afford a reactive iron-oxo species, although other  peroxy forms of the hemoprotein are proposed also to be oxidants  involved in CYP-dependent metabolism <19>)  "
1.14.14.10, nitrilotriacetate + FMNH2 + H+ + O2 = iminodiacetate + glyoxylate + FMN  + H2O  
1.14.14.100, dihydrosanguinarine + [reduced NADPH-hemoprotein reductase] + O2 =  10-hydroxydihydrosanguinarine + [oxidized NADPH-hemoprotein reductase]  + H2O  
1.14.14.101, dihydrochelirubine + [reduced NADPH-hemoprotein reductase] + O2 =  12-hydroxydihydrochelirubine + [oxidized NADPH-hemoprotein reductase] +  H2O  
1.14.14.102, (S)-N-methylcoclaurine + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-3'-hydroxy-N-methylcoclaurine + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.103, tabersonine + [reduced NADPH-hemoprotein reductase] + O2 =  16-hydroxytabersonine + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.104, vinorine + [reduced NADPH-hemoprotein reductase] + O2 = vomilenine +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.105," taxa-4(20),11-dien-5alpha-yl acetate + [reduced NADPH-hemoprotein  reductase] + O2 = 10beta-hydroxytaxa-4(20),11-dien-5alpha-yl acetate +  [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.106," taxa-4(20),11-dien-5alpha-ol + [reduced NADPH-hemoprotein reductase] +  O2 = taxa-4(20),11-dien-5alpha,13alpha-diol + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.107, ent-kaur-16-en-19-oate + [reduced NADPH-hemoprotein reductase] + O2 =  ent-7alpha-hydroxykaur-16-en-19-oate + [oxidized NADPH-hemoprotein  reductase] + H2O 
1.14.14.107, ent-7alpha-hydroxykaur-16-en-19-oate + [reduced NADPH-hemoprotein  reductase] + O2 = gibberellin A12 aldehyde + [oxidized  NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.107, gibberellin A12 aldehyde + [reduced NADPH-hemoprotein reductase] + O2 =  gibberellin A12 + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.107, ent-kaur-16-en-19-oate + 3 [reduced NADPH-hemoprotein reductase] + 3 O2  = gibberellin A12 + 3 [oxidized NADPH-hemoprotein reductase] + 4 H2O  
1.14.14.108," (+)-bornane-2,5-dione + FMNH2 + O2 = (+)-5-oxo-1,2-campholide + FMN +  H2O (#1# mechanism <1,2,6,7,9>; #1# catalysis of 2 mechanistically  different types of biochemical reactions within the confines of the  same active site <7>; #1# higher activity in lactonization of ketones  than in oxidation of sulfides to the corresponding sulfoxides <7>; #1#  belongs to group of Bayer-Villiger monooxygenases of the NADH plus  FMN-dependent type 2 enzymes <7,9>; #1# cubic space active site model,  topography <7>)  "
1.14.14.109," 3-hydroxyindolin-2-one + [reduced NADPH-hemoprotein reductase] + O2 =  2-hydroxy-2H-1,4-benzoxazin-3(4H)-one + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.11, styrene + FADH2 + O2 = (S)-2-phenyloxirane + FAD + H2O  
1.14.14.110," 3-hydroxyindolin-2-one + [reduced NADPH-hemoprotein reductase] + O2 =  2,4-dihydroxy-2H-1,4-benzoxazin-3(4H)-one + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.111," 9beta-pimara-7,15-diene + 3 O2 + 3 [reduced NADPH-hemoprotein  reductase] = 9beta-pimara-7,15-dien-19-oate + 3 [oxidized  NADPH-hemoprotein reductase] + 4 H2O "
1.14.14.111," 9beta-pimara-7,15-diene + O2 + [reduced NADPH-hemoprotein reductase] =  9beta-pimara-7,15-dien-19-ol + [oxidized NADPH-hemoprotein reductase] +  H2O "
1.14.14.111," 9beta-pimara-7,15-dien-19-ol + O2 + [reduced NADPH-hemoprotein  reductase] = 9beta-pimara-7,15-dien-19-al + [oxidized NADPH-hemoprotein  reductase] + 2 H2O "
1.14.14.111," 9beta-pimara-7,15-dien-19-al + O2 + [reduced NADPH-hemoprotein  reductase] = 9beta-pimara-7,15-dien-19-oate + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.112," ent-cassa-12,15-diene + O2 + [reduced NADPH-hemoprotein reductase] =  ent-11beta-hydroxycassa-12,15-diene + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.113, alpha-humulene + O2 + [reduced NADPH-hemoprotein reductase] =  10-hydroxy-alpha-humulene + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.114," amorpha-4,11-diene + 3 O2 + 3 [reduced NADPH-hemoprotein reductase] =  artemisinate + 3 [oxidized NADPH-hemoprotein reductase] + 4 H2O "
1.14.14.114, artemisinic alcohol + O2 + [reduced NADPH-hemoprotein reductase] =  artemisinic aldehyde + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.114, artemisinic aldehyde + O2 + [reduced NADPH-hemoprotein reductase] =  artemisinate + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.114," amorpha-4,11-diene + O2 + [reduced NADPH-hemoprotein reductase] =  artemisinic alcohol + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.115, 11-oxo-beta-amyrin + 3 O2 + 3 [reduced NADPH-hemoprotein reductase] =  glycyrrhetinate + 3 [oxidized NADPH-hemoprotein reductase] + 4 H2O 
1.14.14.115, 11-oxo-beta-amyrin + O2 + [reduced NADPH-hemoprotein reductase] =  30-hydroxy-11-oxo-beta-amyrin + [oxidized NADPH-hemoprotein reductase]  + H2O 
1.14.14.115, 30-hydroxy-11-oxo-beta-amyrin + O2 + [reduced NADPH-hemoprotein  reductase] = glycyrrhetaldehyde + [oxidized NADPH-hemoprotein  reductase] + 2 H2O 
1.14.14.115, glycyrrhetaldehyde + O2 + [reduced NADPH-hemoprotein reductase] =  glycyrrhetinate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.116," (1'S)-averantin + [reduced NADPH-hemoprotein reductase] + O2 =  (1'S,5'S)-5'-hydroxyaverantin + [oxidized NADPH-hemoprotein reductase]  + H2O "
1.14.14.116," (1'S)-averantin + [reduced NADPH-hemoprotein reductase] + O2 =  (1'S,5'R)-5'-hydroxyaverantin + [oxidized NADPH-hemoprotein reductase]  + H2O  "
1.14.14.117, 8-O-methylsterigmatocystin + 2 [reduced NADPH-hemoprotein reductase] +  2 O2 = aflatoxin B1 + 2 [oxidized NADPH-hemoprotein reductase] + H2O +  methanol + CO2 
1.14.14.117, 8-O-methyldihydrosterigmatocystin + 2 [reduced NADPH-hemoprotein  reductase] + 2 O2 = aflatoxin B2 + 2 [oxidized NADPH-hemoprotein  reductase] + H2O + methanol + CO2  
1.14.14.118, tryprostatin B + [reduced NADPH-hemoprotein reductase] + O2 =  6-hydroxytryprostatin B + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.119," fumitremorgin C + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  12alpha,13alpha-dihydroxyfumitremorgin C + 2 [oxidized  NADPH-hemoprotein reductase] + 2 H2O  "
1.14.14.12," 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione + FMNH2 + O2 =  3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione + FMN + H2O  "
1.14.14.120, dammarenediol-II + [reduced NADPH-hemoprotein reductase] + O2 =  protopanaxadiol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.121, protopanaxadiol + [reduced NADPH-hemoprotein reductase] + O2 =  protopanaxatriol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.122, ent-sandaracopimaradien-3beta-ol + [reduced NADPH-hemoprotein  reductase] + O2 = oryzalexin E + [oxidized NADPH-hemoprotein reductase]  + H2O  
1.14.14.123, ent-sandaracopimaradien-3beta-ol + [reduced NADPH-hemoprotein  reductase] + O2 = oryzalexin D + [oxidized NADPH-hemoprotein reductase]  + H2O  
1.14.14.124, dihydromonacolin L acid + O2 + [reduced NADPH-hemoprotein reductase] =  monacolin L acid + [oxidized NADPH-hemoprotein reductase] + 2 H2O (#2#  (overall reaction) <2>) 
1.14.14.124," dihydromonacolin L acid + O2 + [reduced NADPH-hemoprotein reductase] =  3alpha-hydroxy-3,5-dihydromonacolin L acid + [oxidized  NADPH-hemoprotein reductase] + H2O (#2# (1a) <2>) "
1.14.14.124," 3alpha-hydroxy-3,5-dihydromonacolin L acid = monacolin L acid + H2O  (#2# (1b), spontaneous <2>)  "
1.14.14.125, monacolin L acid + O2 + [reduced NADPH-hemoprotein reductase] =  monacolin J acid + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.126, beta-amyrin + O2 + [reduced NADPH-hemoprotein reductase] = erythrodiol  + [oxidized NADPH-hemoprotein reductase] + H2O (#3# (1a) <1>) 
1.14.14.126, erythrodiol + O2 + [reduced NADPH-hemoprotein reductase] = oleanolic  aldehyde + [oxidized NADPH-hemoprotein reductase] + 2 H2O (#3# (1b) <1>) 
1.14.14.126, oleanolic aldehyde + O2 + [reduced NADPH-hemoprotein reductase] =  oleanolate + [oxidized NADPH-hemoprotein reductase] + H2O (#3# (1c) <1>) 
1.14.14.126, beta-amyrin + 3 O2 + 3 [reduced NADPH-hemoprotein reductase] =  oleanolate + 3 [oxidized NADPH-hemoprotein reductase] + 4 H2O (#3#  overall reaction <1>)  
1.14.14.127," methyl (2E,6E)-farnesoate + [reduced NADPH-hemoprotein reductase] + O2  = juvenile hormone III + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.128," (2E,6E)-farnesoate + [reduced NADPH-hemoprotein reductase] + O2 =  juvenile-hormone-III carboxylate + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.129, oleoyl-CoA + [reduced NADPH-hemoprotein reductase] + O2 =  18-hydroxyoleoyl-CoA + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.129, linoleoyl-CoA + [reduced NADPH-hemoprotein reductase] + O2 =  18-hydroxylinoleoyl-CoA + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.13, 4-(gamma-L-glutamylamino)butanoyl-[BtrI acyl-carrier protein] + FMNH2 +  O2 = 4-(gamma-L-glutamylamino)-(2S)-2-hydroxybutanoyl-[BtrI  acyl-carrier protein] + FMN + H2O  
1.14.14.130, dodecanoate + [reduced NADPH-hemoprotein reductase] + O2 =  7-hydroxydodecanoate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.131, (-)-bursehernin + [reduced NADPH-hemoprotein reductase] + O2 =  (-)-5'-demethylyatein + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.132, (-)-4'-demethyldeoxypodophyllotoxin + [reduced NADPH-hemoprotein  reductase] + O2 = (-)-4'-demethylepipodophyllotoxin + [oxidized  NADPH-hemoprotein reductase] + H2O  
1.14.14.133," 1,8-cineole + [reduced flavodoxin] + O2 = 2-endo-hydroxy-1,8-cineole +  [oxidized flavodoxin] + H2O  "
1.14.14.134, beta-amyrin + [reduced NADPH-hemoprotein reductase] + O2 =  24-hydroxy-beta-amyrin + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.134, sophoradiol + [reduced NADPH-hemoprotein reductase] + O2 =  24-hydroxysophoradiol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.135," 2-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan + [reduced  NADPH-hemoprotein reductase] + O2 = glyceollin II + [oxidized  NADPH-hemoprotein reductase] + 2 H2O (#1# a heme-thiolate protein,  P-450, glyceollins II and III are formed from  2-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan whereas  glyceollin I is formed from the 4-isomer <1>) "
1.14.14.135," 2-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan + [reduced  NADPH-hemoprotein reductase] + O2 = glyceollin III + [oxidized  NADPH-hemoprotein reductase] + 2 H2O "
1.14.14.135," 4-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan + [reduced  NADPH-hemoprotein reductase] + O2 = glyceollin I + [oxidized  NADPH-hemoprotein reductase] + 2 H2O  "
1.14.14.136, 10-deoxysarpagine + [reduced NADPH-hemoprotein reductase] + O2 =  sarpagine + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.137, (+)-abscisate + [reduced NADPH-hemoprotein reductase] + O2 =  8'-hydroxyabscisate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.138, lithocholate + [reduced NADPH-hemoprotein reductase] + O2 =  6beta-hydroxylithocholate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.139," 5beta-cholestane-3alpha,7alpha-diol + [reduced NADPH-hemoprotein  reductase] + O2 = 5beta-cholestane-3alpha,7alpha,12alpha-triol +  [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.139," 7alpha-hydroxycholest-4-en-3-one + [reduced NADPH-hemoprotein  reductase] + O2 = 7alpha,12alpha-dihydroxycholest-4-en-3-one +  [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.139, chenodeoxycholate + [reduced NADPH-hemoprotein reductase] + O2 =  cholate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.14, testosterone + 3 O2 + 3 [reduced NADPH-hemoprotein reductase] =  17beta-estradiol + formate + 4 H2O + 3 [oxidized NADPH-hemoprotein  reductase] 
1.14.14.14, testosterone + O2 + [reduced NADPH-hemoprotein reductase] =  19-hydroxytestosterone + H2O + [oxidized NADPH-hemoprotein reductase] 
1.14.14.14, 19-hydroxytestosterone + O2 + [reduced NADPH-hemoprotein reductase] =  19-oxotestosterone + 2 H2O + [oxidized NADPH-hemoprotein reductase] 
1.14.14.14, 19-oxotestosterone + O2 + [reduced NADPH-hemoprotein reductase] =  17beta-estradiol + formate + H2O + [oxidized NADPH-hemoprotein  reductase] 
1.14.14.14," androst-4-ene-3,17-dione + 3 O2 + 3 [reduced NADPH-hemoprotein  reductase] = estrone + formate + 4 H2O + 3 [oxidized NADPH-hemoprotein  reductase] "
1.14.14.14," androst-4-ene-3,17-dione + O2 + [reduced NADPH-hemoprotein reductase] =  19-hydroxyandrost-4-ene-3,17-dione + H2O + [oxidized NADPH-hemoprotein  reductase] "
1.14.14.14," 19-hydroxyandrost-4-ene-3,17-dione + O2 + [reduced NADPH-hemoprotein  reductase] = 19-oxo-androst-4-ene-3,17-dione + 2 H2O + [oxidized  NADPH-hemoprotein reductase] "
1.14.14.14," 19-oxoandrost-4-ene-3,17-dione + O2 + [reduced NADPH-hemoprotein  reductase] = estrone + formate + H2O + [oxidized NADPH-hemoprotein  reductase]  "
1.14.14.141," (+)-marmesin + [reduced NADPH-hemoprotein reductase] + O2 = psoralen +  [oxidized NADPH-hemoprotein reductase] + acetone + 2 H2O (#1# reaction  mechanism <1>; #3# reaction mechanism, analogy modeling and docking  analysis of substrate binding, alignmant of recognition sites, modeling  of the catalytic site, overview <3>)  "
1.14.14.142, sophoraflavanone B + [reduced NADPH-hemoprotein reductase] + O2 =  leachianone G + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.143, (+)-pulegone + [reduced NADPH-hemoprotein reductase] + O2 =  (+)-menthofuran + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.144," abieta-7,13-diene + [reduced NADPH-hemoprotein reductase] + O2 =  abieta-7,13-dien-18-ol + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.145," abieta-7,13-dien-18-ol + 2 [reduced NADPH-hemoprotein reductase] + 2 O2  = abieta-7,13-dien-18-oate + 2 [oxidized NADPH-hemoprotein reductase] +  3 H2O "
1.14.14.145," abieta-7,13-dien-18-ol + [reduced NADPH-hemoprotein reductase] + O2 =  abieta-7,13-dien-18,18-diol + [oxidized NADPH-hemoprotein reductase] +  H2O "
1.14.14.145," abieta-7,13-dien-18,18-diol = abieta-7,13-dien-18-al + H2O "
1.14.14.145," abieta-7,13-dien-18-al + [reduced NADPH-hemoprotein reductase] + O2 =  abieta-7,13-dien-18-oate + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.146, geranylgeraniol + [reduced NADPH-hemoprotein reductase] + O2 =  18-hydroxygeranylgeraniol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.147, 3-epi-6-deoxocathasterone + [reduced NADPH-hemoprotein reductase] + O2  = 6-deoxotyphasterol + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.147," (22S,24R)-22-hydroxy-5alpha-ergostan-3-one + [reduced NADPH-hemoprotein  reductase] + O2 = 3-dehydro-6-deoxoteasterone + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.148, (+)-columbianetin + [reduced NADPH-hemoprotein reductase] + O2 =  angelicin + [oxidized NADPH-hemoprotein reductase] + acetone + 2 H2O  
1.14.14.149, 5-epiaristolochene + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  capsidiol + 2 [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.14.15, (3S)-3-amino-3-(3-chloro-4-hydroxyphenyl)propanoyl-[peptidyl-carrier  protein SgcC2] + FADH2 + O2 =  (3S)-3-amino-3-(3-chloro-4  5-dihydroxyphenyl)propanoyl-[peptidyl-carrier protein SgcC2] + FAD + H2O  
1.14.14.150," germacra-1(10),4,11(13)-trien-12-oate + [reduced NADPH-hemoprotein  reductase] + O2 = (+)-costunolide + [oxidized NADPH-hemoprotein  reductase] + 2 H2O "
1.14.14.150," germacra-1(10),4,11(13)-trien-12-oate + [reduced NADPH-hemoprotein  reductase] + O2 = 6alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate +  [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.150," 6alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate = (+)-costunolide +  H2O  "
1.14.14.151, (-)-vetispiradiene + [reduced NADPH-hemoprotein reductase] + O2 =  solavetivol + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.151, solavetivol + [reduced NADPH-hemoprotein reductase] + O2 = solavetivone  + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.151, (-)-vetispiradiene + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  solavetivone + 2 [oxidized NADPH-hemoprotein reductase] + 3 H2O  
1.14.14.152, beta-amyrin + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  11-oxo-beta-amyrin + 2 [oxidized NADPH-hemoprotein reductase] + 3 H2O 
1.14.14.152, beta-amyrin + [reduced NADPH-hemoprotein reductase] + O2 =  11alpha-hydroxy-beta-amyrin + [oxidized NADPH-hemoprotein reductase] +  H2O 
1.14.14.152, 11alpha-hydroxy-beta-amyrin + [reduced NADPH-hemoprotein reductase] +  O2 = 11-oxo-beta-amyrin + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.14.153, indole + [reduced NADPH-hemoprotein reductase] + O2 = indolin-2-one +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.154," a 14alpha-methylsteroid + 3 [reduced NADPH-hemoprotein reductase] + 3  O2 = a DELTA14-steroid + formate + 3 [oxidized NADPH-hemoprotein  reductase] + 4 H2O (#4,8# mechanism <4,8,12>; #4# stoichiometry <8>;  #64# regulation <10>; #17,25,29,31,38,47# active site structure,  structure-function relationship <30>; #13# heme iron reduction as a  rate-limiting step <27>; #49# reaction mechanism, phyla-specific  residues in CYP51 <34>) "
1.14.14.154, a 14alpha-methylsteroid + [reduced NADPH-hemoprotein reductase] + O2 =  a 14alpha-hydroxymethylsteroid + [oxidized NADPH-hemoprotein reductase]  + H2O 
1.14.14.154, a 14alpha-hydroxymethylsteroid + [reduced NADPH-hemoprotein reductase]  + O2 = a 14alpha-formylsteroid + [oxidized NADPH-hemoprotein reductase]  + 2 H2O 
1.14.14.154, a 14alpha-formylsteroid + [reduced NADPH-hemoprotein reductase] + O2 =  a DELTA14-steroid + formate + [oxidized NADPH-hemoprotein reductase] +  H2O  
1.14.14.155," (-)-bornane-2,5-dione + reduced rubredoxin + O2 + FMNH2 =  (-)-5-oxo-1,2-campholide + FMN + H2O (#1# mechanism <1,3>; #1#  catalysis of 2 mechanistically different types of biochemical reactions  within the confines of the same active site <1>; #1# belongs to group  of Bayer-Villiger monooxygenases of the NADH plus FMN-dependent type 2  enzymes <1,3>; #1# cubic space active site model, topography <1>; #1#  isozyme, enantiocomplementary and isofunctional isozymes 2,5-DKCMO EC  1.14.15.2 and 3,6-DKCMO EC 1.14.15.x <1>; #1# higher activity in  oxidation of sulfides to the corresponding sulfoxides than in  lactonization of ketones <1>) "
1.14.14.155," (-)-bornane-2,5-dione + O2 + FMNH2 = (-)-5-oxo-1,2-campholide + FMN +  H2O  "
1.14.14.156, L-tryptophan + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  (E)-indol-3-ylacetaldoxime + 2 [oxidized NADPH-hemoprotein reductase] +  CO2 + 3 H2O 
1.14.14.156, L-tryptophan + [reduced NADPH-hemoprotein reductase] + O2 =  N-hydroxy-L-tryptophan + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.156," N-hydroxy-L-tryptophan + [reduced NADPH-hemoprotein reductase] + O2 =  N,N-dihydroxy-L-tryptophan + [oxidized NADPH-hemoprotein reductase] +  H2O "
1.14.14.156," N,N-dihydroxy-L-tryptophan = (E)-indol-3-ylacetaldoxime + CO2 + H2O  "
1.14.14.157, indolin-2-one + [reduced NADPH-hemoprotein reductase] + O2 =  3-hydroxyindolin-2-one + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.158, alpha-carotene + [reduced NADPH-hemoprotein reductase] + O2 =  alpha-cryptoxanthin + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.158, zeinoxanthin + [reduced NADPH-hemoprotein reductase] + O2 = lutein +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.159," dolabradiene + O2 + [reduced NADPH-hemoprotein reductase] =  15,16-epoxydolabrene + H2O + [oxidized NADPH-hemoprotein reductase] "
1.14.14.159," 15,16-epoxydolabrene + O2 + [reduced NADPH-hemoprotein reductase] =  3beta-hydroxy-15,16-epoxydolabrene + H2O + [oxidized NADPH-hemoprotein  reductase]  "
1.14.14.16, a C21 steroid + [reduced NADPH-hemoprotein reductase] + O2 = a  21-hydroxy-C21-steroid + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.160, (S)-beta-macrocarpene + 3 O2 + 3 [reduced NADPH-hemoprotein reductase]  = zealexin A1 + 4 H2O + 3 [oxidized NADPH-hemoprotein reductase] 
1.14.14.160," (S)-beta-macrocarpene + O2 + [reduced NADPH-hemoprotein reductase] =  [(4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)-cyclohex-1-en-1-yl]methanol +  H2O + [oxidized NADPH-hemoprotein reductase] "
1.14.14.160," [(4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)-cyclohex-1-en-1-yl] methanol +  O2 + [reduced NADPH-hemoprotein reductase] =  (4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carbaldehyde +  2 H2O + [oxidized NADPH-hemoprotein reductase] "
1.14.14.160," (4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carbaldehyde +  O2 + [reduced NADPH-hemoprotein reductase] = zealexin A1 + H2O +  [oxidized NADPH-hemoprotein reductase]  "
1.14.14.161," (+)-cis,trans-nepetalactol + 3 [reduced NADPH-hemoprotein reductase] +  3 O2 = 7-deoxyloganetate + 3 [oxidized NADPH-hemoprotein reductase] + 4  H2O "
1.14.14.161," (+)-cis,trans-nepetalactol + [reduced NADPH-hemoprotein reductase] + O2  = 7-deoxyloganetic alcohol + [oxidized NADPH-hemoprotein reductase] +  H2O "
1.14.14.161, 7-deoxyloganetic alcohol + [reduced NADPH-hemoprotein reductase] + O2 =  iridotrial + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.161, iridotrial + [reduced NADPH-hemoprotein reductase] + O2 =  7-deoxyloganetate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.162," a flavanone + [reduced NADPH-hemoprotein reductase] + O2 = a  2-hydroxyflavanone + [oxidized NADPH-hemoprotein reductase] + H2O (#1#  a heme-thiolate protein, P-450, it probably forms  2-hydroxyliquiritigenin which spontaneously forms licodione, NADH can  act instead of NADPH, but more slowly, reaction mechanism <2>; #2#  mechanism, stereoselectivity <1>)  "
1.14.14.163," (S)-1-hydroxy-N-methylcanadine + [reduced NADPH-hemoprotein reductase]  + O2 = (13S,14R)-1,13-dihydroxy-N-methylcanadine + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.164, fraxetin + [reduced NADPH-hemoprotein reductase] + O2 = sideretin  (reduced form) + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.165, indole-3-carbonyl nitrile + [reduced NADPH-hemoprotein reductase] + O2  = 4-hydroxyindole-3-carbonyl nitrile + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.166, (S)-N-methylcanadine + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-1-hydroxy-N-methylcanadine + [oxidized NADPH-hemoprotein reductase]  + H2O  
1.14.14.167," (13S,14R)-13-O-acetyl-1-hydroxy-N-methylcanadine + [reduced  NADPH-hemoprotein reductase] + O2 =  (13S,14R)-13-O-acetyl-1,8-dihydroxy-N-methylcanadine + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.168," germacra-1(10),4,11(13)-trien-12-oate + [reduced NADPH-hemoprotein  reductase] + O2 = 8beta-hydroxygermacra-1(10),4,11(13)-trien-12-oate +  [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.169," 8beta-hydroxygermacra-1(10),4,11(13)-trien-12-oate + [reduced  NADPH-hemoprotein reductase] + O2 = eupatolide + [oxidized  NADPH-hemoprotein reductase] + 2 H2O "
1.14.14.169," 8beta-hydroxygermacra-1(10),4,11(13)-trien-12-oate + [reduced  NADPH-hemoprotein reductase] + O2 =  6alpha,8beta-dihydroxygermacra-1(10),4,11(13)-trien-12-oate + [oxidized  NADPH-hemoprotein reductase] + H2O "
1.14.14.169," 6alpha,8beta-dihydroxygermacra-1(10),4,11(13)-trien-12-oate =  eupatolide + H2O  "
1.14.14.17," squalene + [reduced NADPH-hemoprotein reductase] + O2 =  (3S)-2,3-epoxy-2,3-dihydrosqualene + [oxidized NADPH-hemoprotein  reductase] + H2O (#3# proposed mechanism <19>; #3# active site involves  the key residues K399, R400, and D407 <26>; #1# cytochrome P450 17alpha  hydroxylase/17,20 lyase CYP17 also catalyzes the reaction of squalene  epoxidase <28>; #3# aromatic amino acid residues located at the  substrate-binding domain of the active-site, e.g. Ph223 and Tyr473,  control the stereochemical course of the enzyme reaction, mechanism of  regio- and stereo-specific epoxidation of squalene to  (3S)2,3-oxidosqualene, overview <34>)  "
1.14.14.170," germacra-1(10),4,11(13)-trien-12-oate + [reduced NADPH-hemoprotein  reductase] + O2 = 8-epi-inunolide + [oxidized NADPH-hemoprotein  reductase] + 2 H2O "
1.14.14.170," germacra-1(10),4,11(13)-trien-12-oate + [reduced NADPH-hemoprotein  reductase] + O2 = 8alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate +  [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.170," 8alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate = 8-epi-inunolide +  H2O  "
1.14.14.171, beta-amyrin + [reduced NADPH-hemoprotein reductase] + O2 =  16alpha-hydroxy-beta-amyrin + [oxidized NADPH-hemoprotein reductase] +  H2O  
1.14.14.172," 3,5,6-trichloropyridin-2-ol + FADH2 + O2 =  3,6-dichloropyridine-2,5-dione + Cl- + FAD + H2O "
1.14.14.172," 3,6-dichloropyridine-2,5-diol + FADH2 + O2 =  6-chloro-3-hydroxypyridine-2,5-dione + Cl- + FAD + H2O "
1.14.14.172," 6-chloropyridine-2,3,5-triol + FADH2 + O2 =  3,6-dihydroxypyridine-2,5-dione + Cl- + FAD + H2O  "
1.14.14.173," 2,4,6-trichlorophenol + FADH2 + O2 = 2,6-dichloro-1,4-benzoquinone +  Cl- + FAD + H2O "
1.14.14.173," 2,6-dichlorohydroquinone + FADH2 + O2 =  2-chloro-6-hydroxy-1,4-benzoquinone + Cl- + FAD + H2O  "
1.14.14.174, geranylhydroquinone + [reduced NADPH-hemoprotein reductase] + O2 =  3''-hydroxygeranylhydroquinone + [oxidized NADPH-hemoprotein reductase]  + H2O  
1.14.14.175," abieta-8,11,13-triene + [reduced NADPH-hemoprotein reductase] + O2 =  ferruginol + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.176," taxa-4,11-diene + [reduced NADPH-hemoprotein reductase] + O2 =  taxa-4(20),11-dien-5alpha-ol + [oxidized NADPH-hemoprotein reductase] +  H2O (#4# reaction mechanism <5>; #2,3# requires P450, reaction includes  rearrangement of the 4(5)-double bound to a 4(20)-double bond, possibly  through allylic oxidation, proposed mechanism <2>; #4# mechanism  involving promiscuous radical abstraction with selective oxygen  insertion <4>)  "
1.14.14.177, an ultra-long-chain fatty acid + [reduced NADPH---hemoprotein  reductase] + O2 = an ultra-long-chain omega-hydroxy fatty acid +  [oxidized NADPH---hemoprotein reductase] + H2O  
1.14.14.18," protoheme + 3 [reduced NADPH-hemoprotein reductase] + 3 O2 = biliverdin  + Fe2+ + CO + 3 [oxidized NADPH-hemoprotein reductase] + 3 H2O (#9#  mechanism <8>; #22# a ferric hydroperoxide species must be an active  intermediate in the first oxygenation step <26>; #8# determination of  single turnover rate constants and reaction intermediates for heme  oxygenase-1 <30>; #9# hydroperoxoferri-heme oxygenase-1 is the reactive  species directly forming the alpha-meso-hydroxyheme product by attack  of the distal OH of the hydroperoxo moiety at the heme alpha-carbon  <36>; #8# binding of heme stabilizes the solvent H-bonded network in  the active site required for proper catalysis <48>; #21# docking model  of heme and ferredoxin, indirect electron transfer from an iron-sulfur  cluster in ferredoxin to the heme iron <45>; #25# electrophilic  oxidation mechanism, stereochemical control of the reaction  regiospecificity <52>; #35# model of activation mechanism of Fe-OOH  <54>; #35# model of active site <50>; #27# opened conformation of the  heme pocket facilitates sequential product release, first iron, then  biliverdin, iron triggers slow dissociation of biliverdin <46>; #8#  rate-limiting step of reaction is biliverdin release <42>; #35#  selective oxygenation at the alpha-meso carbon, model of active site  <49>; #32# a three-step mechanism, mechanism of the the third step,  heme oxygenase enzymatic ring-opening mechanism of verdoheme, a process  which maintains iron homeostasis, overview. Reaction mechanism for the  FeOOH pathway and the FeHOOH pathway, and complete triplet-state  mechanism, overview <159>; #15# heme degradation by heme oxygenase  proceeds through three successive steps of O2 activation. The first  step is formation of alpha-meso-hydroxyheme from from heme, second  formation of verdoheme from alpha-meso-hydroxyheme, the third step is  the ring opening of alpha-verdoheme to alpha-biliverdin, overview  <167>; #25,27,32# heme degradation by heme oxygenase proceeds through  three successive steps of O2 activation. The first step is formation of  alpha-meso-hydroxyheme from heme, second formation of verdoheme from  alpha-meso-hydroxyheme, the third step is the ring opening of  verdoheme. Only alpha-verdoheme with the O atom in its alpha position,  and not beta-, gamma-, or delta-verdoheme, is converted to biliverdin.  The third step, like the first, shows regiospecificity, the distal Asp  plays an important role in this step, similar to the first. The  substrate heme is sandwiched between two helices, termed the proximal  and distal helices. Reaction mechanism, overview <171>)  "
1.14.14.19, a C21-steroid + [reduced NADPH-hemoprotein reductase] + O2 = a  17alpha-hydroxy-C21-steroid + [oxidized NADPH-hemoprotein reductase] +  H2O (#16# the hydroxylation reaction is believed to proceed through a  conventional Compound I rebound mechanism. Thr306 is a member of the  conserved acid/alcohol pair essential for the efficient delivery of  protons required for hydroperoxoanion heterolysis and formation of  Compound I in the cytochromes P450. Involvement of a nucleophilic  peroxo-anion rather than the traditional Compound I in catalysis. The  peroxoanion is required to initiate O-O bond scission and formation of  the Cpd I reactive intermediate <79>)  
1.14.14.20, phenol + FADH2 + O2 = catechol + FAD + H2O (#3# smaller flavin  reductase PheA2 component catalyzes the NADH-dependent reduction of  free FAD according to a ping pong bisubstrate-biproduct mechanism <9>)  
1.14.14.21," dibenzothiophene + 2 FMNH2 + 2 O2 = dibenzothiophene-5,5-dioxide + 2  FMN + 2 H2O "
1.14.14.21, dibenzothiophene + FMNH2 + O2 = dibenzothiophene-5-oxide + FMN + H2O 
1.14.14.21," dibenzothiophene-5-oxide + FMNH2 + O2 = dibenzothiophene-5,5-dioxide +  FMN + H2O  "
1.14.14.22," dibenzothiophene-5,5-dioxide + FMNH2 + NADH + O2 =  2'-hydroxybiphenyl-2-sulfinate + H2O + FMN + NAD+ + H+ "
1.14.14.22," dibenzothiophene-5,5-dioxide + FMNH2 + O2 =  2'-hydroxybiphenyl-2-sulfinate + FMN-N5-oxide "
1.14.14.22, FMN-N5-oxide + NADH = FMN + H2O + NAD+ + H+  
1.14.14.23, cholesterol + [reduced NADPH-hemoprotein reductase] + O2 =  7alpha-hydroxycholesterol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.24, calciol + O2 + [reduced NADPH-hemoprotein reductase] = calcidiol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.25," cholesterol + [reduced NADPH-hemoprotein reductase] + O2 =  (24S)-cholest-5-ene-3beta,24-diol + [oxidized NADPH-hemoprotein  reductase] + H2O (#4# structure-function relationship <11>)  "
1.14.14.26," (24S)-cholest-5-ene-3beta,24-diol + [reduced NADPH-hemoprotein  reductase] + O2 = (24S)-cholest-5-ene-3beta,7alpha,24-triol + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.27, resorcinol + FADH2 + O2 = hydroxyquinol + FAD + H2O  
1.14.14.28, a long-chain alkane + FMNH2 + O2 = a long-chain primary alcohol + FMN +  H2O  
1.14.14.29," cholest-5-ene-3beta,25-diol + [reduced NADPH-hemoprotein reductase] +  O2 = cholest-5-ene-3beta,7alpha,25-triol + [oxidized NADPH-hemoprotein  reductase] + H2O "
1.14.14.29," (25R)-cholest-5-ene-3beta,26-diol + [reduced NADPH-hemoprotein  reductase] + O2 = (25R)-cholest-5-ene-3betA,7alpha,26-triol + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.3," a long-chain aldehyde + FMNH2 + O2 = a long-chain fatty acid + FMN +  H2O + hnu (#5# reaction mechanism and scheme, cofactor binding <74>;  #5# reaction mechanism, Cys106 is essential for stabilization of the  reaction intermediate, for consumption of aldehyde substrate, and for  activity <72>; #5# residue Val173 of the alpha-subunit is essential for  flavin binding and located in the active site, formation of a  C4a-hydroperoxyflavin intermediate <75>; #5# reaction mechanism via  4a-hydroperoxyflavin intermediates II-IV and H2O2 release, alphaE238,  alphaA75, and alphaA74 are catalytically important active site residues  of the alpha-subunit, structure-function relationship <84>; #5#  reaction mechanism via 4a-hydroperoxyflavin intermediates II-IV and  H2O2 release, overview, catalytically important active site residues of  the alpha-subunit are alphaF46, alphaF49, alphaF114, and alphaF117,  alphaF46 and alphaF117 also appear to be involved in the binding of  reduced flavin substrate <83>)  "
1.14.14.30, 2-methylpropan-1-amine + FADH2 + O2 = N-(2-methylpropyl)hydroxylamine +  FAD + H2O 
1.14.14.30, 2-methylpropan-1-amine + FMNH2 + O2 = N-(2-methylpropyl)hydroxylamine +  FMN + H2O  
1.14.14.31, myrcene + [reduced NADPH-hemoprotein reductase] + O2 = (R)-ipsdienol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.32, 17alpha-hydroxyprogesterone + [reduced NADPH-hemoprotein reductase] +  O2 = androstenedione + acetate + [oxidized NADPH-hemoprotein reductase]  + H2O (#7# bioconversion in vitro <1>) 
1.14.14.32, 17alpha-hydroxypregnenolone + [reduced NADPH-hemoprotein reductase] +  O2 = 3beta-hydroxyandrost-5-en-17-one + acetate + [oxidized  NADPH-hemoprotein reductase] + H2O  
1.14.14.33," ethylenediaminetetraacetate + 2 FMNH2 + 2 O2 =  ethylenediamine-N,N'-diacetate + 2 glyoxylate + 2 FMN + 2 H2O "
1.14.14.33, ethylenediaminetetraacetate + FMNH2 + O2 = ethylenediaminetriacetate +  glyoxylate + FMN + H2O 
1.14.14.33," ethylenediaminetriacetate + FMNH2 + O2 = ethylenediamine-N,N'-diacetate  + glyoxylate + FMN + H2O  "
1.14.14.34, methanesulfonate + FMNH2 + O2 = formaldehyde + FMN + sulfite + H2O  
1.14.14.35, dimethyl sulfone + FMNH2 + O2 = methanesulfinate + formaldehyde + FMN +  H2O  
1.14.14.36, L-tyrosine + O2 + [reduced NADPH-hemoprotein reductase] =  N-hydroxy-L-tyrosine + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.36," N-hydroxy-L-tyrosine + O2 + [reduced NADPH-hemoprotein reductase] =  N,N-dihydroxy-L-tyrosine + [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.36," N,N-dihydroxy-L-tyrosine = (E)-[4-hydroxyphenylacetaldehyde oxime] +  CO2 + H2O "
1.14.14.36, L-tyrosine + 2 O2 + 2 [reduced NADPH-hemoprotein reductase] =  (E)-[4-hydroxyphenylacetaldehyde oxime] + 2 [oxidized NADPH-hemoprotein  reductase] + CO2 + 3 H2O  
1.14.14.37, (E)-4-hydroxyphenylacetaldehyde oxime + [reduced NADPH-hemoprotein  reductase] + O2 = (S)-4-hydroxymandelonitrile + [oxidized  NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.37, (E)-4-hydroxyphenylacetaldehyde oxime = (Z)-4-hydroxyphenylacetaldehyde  oxime 
1.14.14.37, (Z)-4-hydroxyphenylacetaldehyde oxime = 4-hydroxyphenylacetonitrile +  H2O 
1.14.14.37, 4-hydroxyphenylacetonitrile + [reduced NADPH-hemoprotein reductase] +  O2 = (S)-4-hydroxymandelonitrile + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.38, L-valine + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  (E)-2-methylpropanal oxime + 2 [oxidized NADPH-hemoprotein reductase] +  CO2 + 3 H2O 
1.14.14.38, L-valine + [reduced NADPH-hemoprotein reductase] + O2 =  N-hydroxy-L-valine + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.38," N-hydroxy-L-valine + [reduced NADPH-hemoprotein reductase] + O2 =  N,N-dihydroxy-L-valine + [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.38," N,N-dihydroxy-L-valine = (E)-2-methylpropanal oxime + CO2 + H2O  "
1.14.14.39," L-isoleucine + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  (1E,2S)-2-methylbutanal oxime + 2 [oxidized NADPH-hemoprotein  reductase] + CO2 + 3 H2O "
1.14.14.39, L-isoleucine + [reduced NADPH-hemoprotein reductase] + O2 =  N-hydroxy-L-isoleucine + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.39," N-hydroxy-L-isoleucine + [reduced NADPH-hemoprotein reductase] + O2 =  N,N-dihydroxy-L-isoleucine + [oxidized NADPH-hemoprotein reductase] +  H2O "
1.14.14.39," N,N-dihydroxy-L-isoleucine = (1E,2S)-2-methylbutanal oxime + CO2 + H2O  "
1.14.14.40, L-phenylalanine + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  (E)-phenylacetaldoxime + 2 [oxidized NADPH-hemoprotein reductase] + CO2  + 3 H2O 
1.14.14.40, L-phenylalanine + [reduced NADPH-hemoprotein reductase] + O2 =  N-hydroxy-L-phenylalanine + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.40," N-hydroxy-L-phenylalanine + [reduced NADPH-hemoprotein reductase] + O2  = N,N-dihydroxy-L-phenylalanine + [oxidized NADPH-hemoprotein  reductase] + H2O "
1.14.14.40," N,N-dihydroxy-L-phenylalanine = (E)-phenylacetaldoxime + CO2 + H2O  "
1.14.14.41, (E)-2-methylbutanal oxime + [reduced NADPH-hemoprotein reductase] + O2  = 2-hydroxy-2-methylbutanenitrile + [oxidized NADPH-hemoprotein  reductase] + 2 H2O 
1.14.14.41, (E)-2-methylbutanal oxime = (Z)-2-methylbutanal oxime 
1.14.14.41, (Z)-2-methylbutanal oxime = 2-methylbutanenitrile + H2O 
1.14.14.41, 2-methylbutanenitrile + [reduced NADPH-hemoprotein reductase] + O2 =  2-hydroxy-2-methylbutanenitrile + [oxidized NADPH-hemoprotein  reductase] + H2O 
1.14.14.41, (E)-2-methylpropanal oxime + [reduced NADPH-hemoprotein reductase] + O2  = 2-hydroxy-2-methylpropanenitrile + [oxidized NADPH-hemoprotein  reductase] + 2 H2O 
1.14.14.41, (E)-2-methylpropanal oxime = (Z)-2-methylpropanal oxime 
1.14.14.41, (Z)-2-methylpropanal oxime = 2-methylpropanenitrile + H2O 
1.14.14.41, 2-methylpropanenitrile + [reduced NADPH-hemoprotein reductase] + O2 =  2-hydroxy-2-methylpropanenitrile + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.42, an L-polyhomomethionine + 2 [reduced NADPH-hemoprotein reductase] + 2  O2 = an (E)-omega-(methylsulfanyl)alkanal oxime + 2 [oxidized  NADPH-hemoprotein reductase] + CO2 + 3 H2O 
1.14.14.42, an L-polyhomomethionine + [reduced NADPH-hemoprotein reductase] + O2 =  an L-N-hydroxypolyhomomethionine + [oxidized NADPH-hemoprotein  reductase] + H2O 
1.14.14.42," an L-N-hydroxypolyhomomethionine + [reduced NADPH-hemoprotein  reductase] + O2 = an L-N,N-dihydroxypolyhomomethionine + [oxidized  NADPH-hemoprotein reductase] + H2O "
1.14.14.42," an L-N,N-dihydroxypolyhomomethionine = an  (E)-omega-(methylsulfanyl)alkanal oxime + CO2 + H2O  "
1.14.14.43, an (E)-omega-(methylsulfanyl)alkanal oxime + [reduced NADPH-hemoprotein  reductase] + glutathione + O2 = an  S-[(1E)-1-(hydroxyimino)-omega-(methylsulfanyl)alkyl]-L-glutathione +  [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.43, an (E)-omega-(methylsulfanyl)alkanal oxime + [reduced NADPH-hemoprotein  reductase] + O2 = a 1-(methylsulfanyl)-4-aci-nitroalkane + [oxidized  NADPH-hemoprotein reductase] + H2O 
1.14.14.43, a 1-(methylsulfanyl)-4-aci-nitroalkane + glutathione = an  S-[(1E)-1-(hydroxyimino)-omega-(methylsulfanyl)alkyl]-L-glutathione +  H2O  
1.14.14.44, (Z)-phenylacetaldehyde oxime = phenylacetonitrile + H2O 
1.14.14.44, (E)-phenylacetaldehyde oxime + [reduced NADPH-hemoprotein reductase] +  O2 = (R)-mandelonitrile + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.44, (E)-phenylacetaldehyde oxime = (Z)-phenylacetaldehyde oxime 
1.14.14.44, phenylacetonitrile + [reduced NADPH-hemoprotein reductase] + O2 =  (R)-mandelonitrile + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.45, (E)-indol-3-ylacetaldehyde oxime + [reduced NADPH-hemoprotein  reductase] + glutathione + O2 =  S-[(E)-N-hydroxy(indol-3-yl)acetimidoyl]-L-glutathione + [oxidized  NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.45, (E)-indol-3-ylacetaldehyde oxime + [reduced NADPH-hemoprotein  reductase] + O2 = 1-(1H-indol-3-yl)-2-aci-nitroethane + [oxidized  NADPH-hemoprotein reductase] + H2O 
1.14.14.45, 1-(1H-indol-3-yl)-2-aci-nitroethane + glutathione =  S-[(E)-N-hydroxy(indol-3-yl)acetimidoyl]-L-glutathione + H2O 
1.14.14.45, (E)-phenylacetaldehyde oxime + [reduced NADPH-hemoprotein reductase] +  glutathione + O2 = S-[(Z)-N-hydroxy(phenyl)acetimidoyl]-L-glutathione +  [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.45, (E)-phenylacetaldehyde oxime + [reduced NADPH-hemoprotein reductase] +  O2 = 1-aci-nitro-2-phenylethane + [oxidized NADPH-hemoprotein  reductase] + H2O 
1.14.14.45, 1-aci-nitro-2-phenylethane + glutathione =  S-[(Z)-N-hydroxy(phenyl)acetimidoyl]-L-glutathione + H2O  
1.14.14.46, a long-chain acyl-[acyl-carrier protein] + 2 reduced flavodoxin + 3 O2  = pimeloyl-[acyl-carrier protein] + an n-alkanal + 2 oxidized  flavodoxin + 3 H2O (#1# overall reaction <1>) 
1.14.14.46, a long-chain acyl-[acyl-carrier protein] + reduced flavodoxin + O2 = a  (7S)-7-hydroxy-long-chain-acyl-[acyl-carrier protein] + oxidized  flavodoxin + H2O (#1# 1a <1>) 
1.14.14.46," a (7S)-7-hydroxy-long-chain-acyl-[acyl-carrier protein] + reduced  flavodoxin + O2 = a (7R,8R)-7,8-dihydroxy-long-chain-acyl-[acyl-carrier  protein] + oxidized flavodoxin + H2O (#1# 1b <1>) "
1.14.14.46," a (7R,8R)-7,8-dihydroxy-long-chain-acyl-[acyl-carrier protein] +  reduced flavodoxin + O2 = a 7-oxoheptanoyl-[acyl-carrier protein] + an  n-alkanal + oxidized flavodoxin + 2 H2O (#1# 1c <1>) "
1.14.14.46, a 7-oxoheptanoyl-[acyl-carrier protein] + oxidized flavodoxin + H2O = a  pimeloyl-[acyl-carrier protein] + reduced flavodoxin + H+ (#1# 1d <1>)  
1.14.14.47, 2 L-arginine + 3 reduced flavodoxin + 4 O2 = 2 L-citrulline + 2 nitric  oxide + 3 oxidized flavodoxin + 4 H2O 
1.14.14.47, 2 Nomega-hydroxy-L-arginine + reduced flavodoxin + 2 O2 = 2  L-citrulline + 2 nitric oxide + oxidized flavodoxin + 2 H2O 
1.14.14.47, 2 L-arginine + 2 reduced flavodoxin + 2 O2 = 2  Nomega-hydroxy-L-arginine + 2 oxidized flavodoxin + 2 H2O  
1.14.14.48, a jasmonoyl-L-amino acid + [reduced NADPH-hemoprotein reductase] + O2 =  a 12-hydroxyjasmonoyl-L-amino acid + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.49, a 12-hydroxyjasmonoyl-L-amino acid + 2 [reduced NADPH-hemoprotein  reductase] + 2 O2 = a 12-hydroxy-12-oxojasmonoyl-L-amino acid + 2  [oxidized NADPH-hemoprotein reductase] + 3 H2O 
1.14.14.49, a 12-hydroxyjasmonoyl-L-amino acid + [reduced NADPH-hemoprotein  reductase] + O2 = a 12-oxojasmonoyl-L-amino acid + [oxidized  NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.49, a 12-oxojasmonoyl-L-amino acid + [reduced NADPH-hemoprotein reductase]  + O2 = a 12-hydroxy-12-oxojasmonoyl-L-amino acid + [oxidized  NADPH-hemoprotein reductase] + H2O  
1.14.14.5," an alkanesulfonate + FMNH2 + O2 = an aldehyde + FMN + sulfite + H2O  (#1# absolutely dependent on oxygen <2>; #1# catalysis by SsuD probably  results in an unstable 1-hydroxysulfonate that spontaneously decomposes  to the corresponding aldehyde and sulfite <3>; #1# kinetic reaction  mechanism, charge transfer complex formation with flavin mononucleotide  reductase in the alkanesulfonate monooxygenase system <6>; #1#  mechanism of flavin reduction in the alkanesulfonate monooxygenase  system, overview <6,8>)  "
1.14.14.50," 16-methoxytabersonine + [reduced NADPH-hemoprotein reductase] + O2 =  (3R)-3-hydroxy-16-methoxy-1,2-didehydro-2,3-dihydrotabersonine +  [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.50," tabersonine + [reduced NADPH-hemoprotein reductase] + O2 =  (3R)-3-hydroxy-1,2-didehydro-2,3-dihydrotabersonine + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.51, (S)-limonene + [reduced NADPH-hemoprotein reductase] + O2 =  (-)-trans-carveol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.52," (S)-limonene + [reduced NADPH-hemoprotein reductase] + O2 =  (-)-perillyl alcohol + [oxidized NADPH-hemoprotein reductase] + H2O  (#2# side-chain hydroxylation, mixed-function oxygenase <1>)  "
1.14.14.53, (R)-limonene + [reduced NADPH-hemoprotein reductase] + O2 =  (+)-trans-carveol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.54, phenylacetate + [reduced NADPH-hemoprotein reductase] + O2 =  (2-hydroxyphenyl)acetate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.55, quinine + [reduced NADPH-hemoprotein reductase] + O2 = 3-hydroxyquinine  + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.56," 1,8-cineole + [reduced NADPH-hemoprotein reductase] + O2 =  2-exo-hydroxy-1,8-cineole + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.57, taurochenodeoxycholate + [reduced NADPH-hemoprotein reductase] + O2 =  taurohyocholate + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.57, lithocholate + [reduced NADPH-hemoprotein reductase] + O2 =  hyodeoxycholate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.58," (6E,10E)-geranyllinalool + [reduced NADPH-hemoprotein reductase] + O2 =  (3E,7E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene + [oxidized  NADPH-hemoprotein reductase] + but-3-en-2-one + 2 H2O (#3# the exact  mechanism of enzyme is not yet determined. It is possible that CYP82G1  may promote the direct transformation of (E,E)-geranyllinalool and  (3R,6E)-nerolidol to (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene  and (3E)-4,8-dimethylnona-1,3,7-triene, respectively, with the  concomitant release of but-1-en-3-one. But it is also possible that a  two-step conversion occurs that includes the formation of intermediate  compounds C18 (E,E)-farnesylacetone (from  (E,E)-4,8,12-trimethyltrideca-1,3,7,11-tetraene) and C13  (E)-geranylacetone (from (3E)-4,8-dimethylnona-1,3,7-triene). A  C4-cleavage product (but-1-en-3-one) resulting from the breakdown of  (E,E)-geranyllinalool or (E)-nerolidol is not observed, neither in  vitro nor in vivo, and none of the previously proposed ketone  intermediates, C18-farnesylacetone and C13-geranylacetone, are detected  <1>)  "
1.14.14.59," (3S,6E)-nerolidol + [reduced NADPH-hemoprotein reductase] + O2 =  (3E)-4,8-dimethylnona-1,3,7-triene + [oxidized NADPH-hemoprotein  reductase] + but-3-en-2-one + 2 H2O  "
1.14.14.60, ferruginol + [reduced NADPH-hemoprotein reductase] + O2 =  11-hydroxyferruginol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.61, 11-hydroxyferruginol + 3 [reduced NADPH-hemoprotein reductase] + 3 O2 =  carnosic acid + 3 [oxidized NADPH-hemoprotein reductase] + 4 H2O  
1.14.14.62, ferruginol + [reduced NADPH-hemoprotein reductase] + O2 = salviol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.63, beta-amyrin + [reduced NADPH-hemoprotein reductase] + O2 = maniladiol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.64, beta-amyrin + [reduced NADPH-hemoprotein reductase] + O2 = daturadiol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.65, ferruginol + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 = sugiol +  2 [oxidized NADPH-hemoprotein reductase] + 3 H2O  
1.14.14.66, demethylsuberosin + [reduced NADPH-hemoprotein reductase] + O2 =  (+)-marmesin + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.67," 11-hydroxysugiol + [reduced NADPH-hemoprotein reductase] + O2 =  11,20-dihydroxysugiol + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.68," 9beta-pimara-7,15-diene + [reduced NADPH-hemoprotein reductase] + O2 =  9beta-pimara-7,15-diene-3beta-ol + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.69," ent-cassa-12,15-diene + 3 [reduced NADPH-hemoprotein reductase] + 3 O2  = ent-3beta-hydroxycassa-12,15-dien-2-one + 3 [oxidized  NADPH-hemoprotein reductase] + 4 H2O "
1.14.14.69," ent-cassa-12,15-diene + [reduced NADPH-hemoprotein reductase] + O2 =  ent-cassa-12,15-dien-2beta-ol + [oxidized NADPH-hemoprotein reductase]  + H2O "
1.14.14.69," ent-cassa-12,15-dien-2beta-ol + [reduced NADPH-hemoprotein reductase] +  O2 = ent-cassa-12,15-dien-2-one + [oxidized NADPH-hemoprotein  reductase] + 2 H2O "
1.14.14.69," ent-cassa-12,15-dien-2beta-ol + [reduced NADPH-hemoprotein reductase] +  O2 = ent-cassa-12,15-diene-2beta,3beta-diol + [oxidized  NADPH-hemoprotein reductase] + H2O "
1.14.14.69," ent-cassa-12,15-dien-2-one + [reduced NADPH-hemoprotein reductase] + O2  = ent-3beta-hydroxycassa-12,15-dien-2-one + [oxidized NADPH-hemoprotein  reductase] + H2O "
1.14.14.69," ent-cassa-12,15-diene-2beta,3beta-diol + [reduced NADPH-hemoprotein  reductase] + O2 = ent-3beta-hydroxycassa-12,15-dien-2-one + [oxidized  NADPH-hemoprotein reductase] + 2 H2O  "
1.14.14.70, ent-sandaracopimaradiene + [reduced NADPH-hemoprotein reductase] + O2 =  ent-sandaracopimaradien-3beta-ol + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.71, cucurbitadienol + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  11-oxocucurbitadienol + 2 [oxidized NADPH-hemoprotein reductase] + 3 H2O 
1.14.14.71, cucurbitadienol + [reduced NADPH-hemoprotein reductase] + O2 =  11-hydroxycucurbitadienol + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.71, 11-hydroxycucurbitadienol + [reduced NADPH-hemoprotein reductase] + O2  = 11-oxocucurbitadienol + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.14.72, drimenol + [reduced NADPH-hemoprotein reductase] + O2 = drimendiol +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.73, albendazole + [reduced NADPH-hemoprotein reductase] + O2 = albendazole  S-oxide + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.73, fenbendazole + [reduced NADPH-hemoprotein reductase] + O2 =  fenbendazole S-oxide + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.74, albendazole + [reduced NADPH-hemoprotein reductase] + O2 =  hydroxyalbendazole + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.75, fenbendazole + [reduced NADPH-hemoprotein reductase] + O2 =  4'-hydroxyfenbendazole + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.76," ent-isokaurene + 2 O2 + 2 [reduced NADPH-hemoprotein reductase] =  ent-isokaurene-2beta,3beta-diol + [oxidized NADPH-hemoprotein  reductase] + 2 H2O "
1.14.14.76, ent-isokaurene + O2 + [reduced NADPH-hemoprotein reductase] =  ent-isokauren-2beta-ol + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.76," ent-isokauren-2beta-ol + O2 + [reduced NADPH-hemoprotein reductase] =  ent-isokaurene-2beta,3beta-diol + [oxidized NADPH-hemoprotein  reductase] + H2O  "
1.14.14.77, phenylacetonitrile + [reduced NADPH-hemoprotein reductase] + O2 =  (R)-mandelonitrile + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.78, phylloquinone + [reduced NADPH-hemoprotein reductase] + O2 =  omega-hydroxyphylloquinone + [oxidized NADPH-hemoprotein reductase] +  H2O  
1.14.14.79, docosahexaenoate + [reduced NADPH-hemoprotein reductase] + O2 =  22-hydroxydocosahexaenoate + [oxidized NADPH-hemoprotein reductase] +  H2O  
1.14.14.8, anthranilate + FADH2 + O2 = 3-hydroxyanthranilate + FAD + H2O  
1.14.14.80, a long-chain fatty acid + [reduced NADPH-hemoprotein reductase] + O2 =  an omega-hydroxy-long-chain fatty acid + [oxidized NADPH-hemoprotein  reductase] + H2O  
1.14.14.81, a flavanone + [reduced NADPH-hemoprotein reductase] + O2 = a  3'-hydroxyflavanone + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.81," a 3'-hydroxyflavanone + [reduced NADPH-hemoprotein reductase] + O2 = a  3',5'-dihydroxyflavanone + [oxidized NADPH-hemoprotein reductase] + H2O "
1.14.14.81," a flavanone + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 = a  3',5'-dihydroxyflavanone + 2 [oxidized NADPH-hemoprotein reductase] + 2  H2O  "
1.14.14.82, a flavonoid + [reduced NADPH-hemoprotein reductase] + O2 = a  3'-hydroxyflavonoid + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.83, geraniol + [reduced NADPH-hemoprotein reductase] + O2 =  (6E)-8-hydroxygeraniol + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.84," linalool + 2 [reduced NADPH-hemoprotein reductase] + 2 O2 =  (6E)-8-oxolinalool + 2 [oxidized NADPH-hemoprotein reductase] + 3 H2O  (#1# mixed function monooxygenase consisting of LIN-reductase,  Fe2S2-redoxin and cytochrome LIN P-450 <2>) "
1.14.14.84, linalool + [reduced NADPH-hemoprotein reductase] + O2 =  (6E)-8-hydroxylinalool + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.84, (6E)-8-hydroxylinalool + [reduced NADPH-hemoprotein reductase] + O2 =  (6E)-8-oxolinalool + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.14.85, 7-deoxyloganate + [reduced NADPH-hemoprotein reductase] + O2 = loganate  + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.86, ent-kaur-16-ene + [reduced NADPH-hemoprotein reductase] + O2 =  ent-kaur-16-en-19-ol + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.86, ent-kaur-16-en-19-ol + [reduced NADPH-hemoprotein reductase] + O2 =  ent-kaur-16-en-19-al + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.14.86, ent-kaur-16-en-19-al + [reduced NADPH-hemoprotein reductase] + O2 =  ent-kaur-16-en-19-oate + [oxidized NADPH-hemoprotein reductase] + H2O 
1.14.14.86," ent-kaur-16-ene + 3 [reduced NADPH-hemoprotein reductase] + 3 O2 =  ent-kaur-16-en-19-oate + 3 [oxidized NADPH-hemoprotein reductase] + 4  H2O (#25# overall reaction, reaction mechanism of multifunctional  kaurene oxidase, overview <29>)  "
1.14.14.87," liquiritigenin + O2 + [reduced NADPH-hemoprotein reductase] =  2,4',7-trihydroxyisoflavanone + H2O + [oxidized NADPH-hemoprotein  reductase] "
1.14.14.87," (2S)-naringenin + O2 + [reduced NADPH-hemoprotein reductase] =  2,4',5,7-tetrahydroxyisoflavanone + H2O + [oxidized NADPH-hemoprotein  reductase]  "
1.14.14.88, formononetin + [reduced NADPH-hemoprotein reductase] + O2 = calycosin +  [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.89, formononetin + [reduced NADPH-hemoprotein reductase] + O2 =  2'-hydroxyformononetin + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.9," 4-hydroxyphenylacetate + FADH2 + O2 = 3,4-dihydroxyphenylacetate + FAD  + H2O (#4# two-protein enzyme: the flavoprotein catalyzes the  non-productive oxidation of NADH without substrate hydroxylation and  the coupling protein is an absolute requirement for productive  hydroxylation. Reaction mechanism and formation of 3 flavin-oxygen  intermediates are studied <12>; #2# member of novel two-component  flavin-diffusible monooxygenase family, both components required for  hydroxylation. The genes are located on the same operon. Physical  interaction between HpaB and HpaC is not required, enhancement of  activity by direct interaction is not excluded. Contains reductase  component <14>; #8# different from other hydroxylases. Two-protein  component enzyme: component C1 is a flavoprotein and C2 the hydroxylase  component. Mechanism: 4-hydroxyphenylacetate binds to C1, then the  enzyme-bound flavin is reduced by NADH, this reduced flavin is  transferred to C2 and the reoxidation of the flavin occurs concurrently  with the hydroxylation of the substrate <15>; #4# genes encoding the  first four enzymes of the 4-hydroxyphenylacetic acid meta-pathway exist  as two operons, one containing the hydroxylase gene while the other  contains the other three <7>; #4# family of external flavoprotein  monooxygenases. The activity is induced by the substrates <10>; #4#  dehydration of the C4a-hydroxyflavin is the rate-determining step in  catalysis <16>; #2# new type of FADH-utilizing monooxygenase <11>; #5#  two protein component enzyme: flavin-containing hydroxylase and  coupling protein that appears to be an effector protein, both needed  for productive hydroxylation. Enzyme synthesis is induced by 3- or  4-hydroxyphenylacetate <13>; #2# two enzymes suggested to be required  for hydroxylase activity, member of new family of two-component  aromatic hydroxylases. The hydroxylase, a flavoprotein, is encoded by  hpaB and the coupling protein by hpaC gene <8>; #4,7# enzymes of  4-hydroxyphenylacetic acid meta-cleavage pathway are sythesized  following at least two sequential inductive events <6,7>; #8# kinetic  reaction mechanisms of the smaller FMN reductase enzyme component C1  and the larger oxygenase enzyme component C2, C2 shows a random order  kinetic mechanism, detailed overview <20>; #8# kinetics and reaction  mechanism <19>; #12# catalytic mechanism and structure-function  relationship, overview <24>; #8# kinetic mechanism of enzyme components  C1 and C2 <21>; #1# structural basis of the catalytic mechanism of HpaB  <23>; #8# kinetic reaction mechanism, overview <29>)  "
1.14.14.90, an isoflavone + [reduced NADPH-hemoprotein reductase] + O2 = a  2'-hydroxyisoflavone + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.91, trans-cinnamate + [reduced NADPH-hemoprotein reductase] + O2 =  4-hydroxycinnamate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.92, benzoate + [reduced NADPH-hemoprotein reductase] + O2 =  4-hydroxybenzoate + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.93," (6aR,11aR)-3,9-dihydroxypterocarpan + [reduced NADPH-hemoprotein  reductase] + O2 = (6aS,11aS)-3,6a,9-trihydroxypterocarpan + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.94," (6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate +  [reduced NADPH-hemoprotein reductase] + O2 =  (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoate  + [oxidized NADPH-hemoprotein reductase] + H2O  "
1.14.14.95," (+)-germacrene A + 3 [reduced NADPH-hemoprotein reductase] + 3 O2 =  germacra-1(10),4,11(13)-trien-12-oate + 3 [oxidized NADPH-hemoprotein  reductase] + 4 H2O "
1.14.14.95," (+)-germacrene A + O2 + [reduced NADPH-hemoprotein reductase] =  germacra-1(10),4,11(13)-trien-12-ol + [oxidized NADPH-hemoprotein  reductase] + H2O "
1.14.14.95," germacra-1(10),4,11(13)-trien-12-ol + O2 + [reduced NADPH-hemoprotein  reductase] = germacra-1(10),4,11(13)-trien-12-al + [oxidized  NADPH-hemoprotein reductase] + 2 H2O "
1.14.14.95," germacra-1(10),4,11(13)-trien-12-al + O2 + [reduced NADPH-hemoprotein  reductase] = germacra-1(10),4,11(13)-trien-12-oate + [oxidized  NADPH-hemoprotein reductase] + H2O  "
1.14.14.96, trans-5-O-(4-coumaroyl)-D-quinate + [reduced NADPH-hemoprotein  reductase] + O2 = trans-5-O-caffeoyl-D-quinate + [oxidized  NADPH-hemoprotein reductase] + H2O  
1.14.14.97, (S)-N-methylcanadine + [reduced NADPH-hemoprotein reductase] + O2 =  allocryptopine + [oxidized NADPH-hemoprotein reductase] + H2O (#1#  stereo- and regiospecificity <1>)  
1.14.14.98, protopine + [reduced NADPH-hemoprotein reductase] + O2 =  6-hydroxyprotopine + [oxidized NADPH-hemoprotein reductase] + H2O  
1.14.14.99," (S)-limonene + [reduced NADPH-hemoprotein reductase] + O2 =  (-)-trans-isopiperitenol + [oxidized NADPH-hemoprotein reductase] + H2O  (#1# mixed-function oxygenase, ring-hydroxylation <1>)  "
1.14.15.1," (+)-camphor + reduced putidaredoxin + O2 = (+)-exo-5-hydroxycamphor +  oxidized putidaredoxin + H2O (#2# reaction mechanism <51>; #2#  multi-component mixed function oxidase, consisting of putidaredoxin  reductase, putidaredoxin and cytochrome P450cam, heme-thiolate protein  <2>; #4# binding of putidaredoxin forces selection of the active  conformation of enzyme <31>; #2# model for putidaredoxin activity,  primary role of putidaredoxin is to prevent uncoupling by enforcing  conformations of enzyme that prevent loss of substrate and to enforce  conformations that permit efficient proton transfer <27>; #2#  oxygen-transfer reaction via a monooxygenation mechanism <35>; #2#  putidaredoxin acts as a shuttle for transport of electrons from  putidaredoxin reductase to enzyme <28>; #2# the acvtive conformation of  enzyme is stabilized by binding of the substrate at the active site  <33>; #4# active binding of substrate camphor, analysis by density  functional theory calculations, residue Tyr96 is important forming a  strong hydrogen bond, catalytic cycle of cytochrome P450, the strong  hydrogen bonding is not affected by the enzymes environment, reaction  mechanism, overview <47>; #2# K+ plays an important role in substrate  binding and structural and conformational stability of the enzyme <40>;  #2# mechanism of O2 activation: binding of O2 to ferrous P450cam to  yield the ferric-superoxo form, oxyP450cam, followed by an  irreversible, long-range electron transfer from putidaredoxin to reduce  the oxyP450cam, camphor is bound to all enzyme forms, overview <41>;  #2# reaction mechanism and cycle of the enzyme including postulated  intermediates, detailed overview <53>; #2# reaction mechanism involving  a heme ring and residue Asp297, modelling of the hydroxylation of  camphor and the hydrogen abstraction from heme using combined quantum  mechanical/molecular mechanical method <57>; #2# reaction mechanism,  and second reductive step of the mechanism of interaction and electron  transfer, overview <38>; #4# rebound mechanism of C-H hydroxylation by  P450, molecular dynamics <50>; #4# the active site structure changes  due to putidaredoxin-enzyme interaction involving salt bridge and  hydrogen bonding network between Arg112, His355, Leu356, and the heme  ligand Cys357 <43>; #2# via H2O2 and a nucleophilic intermediate, the  substrate can modulate the properties of both the monoxygenase  active-oxygen intermediates and the proton-delivery network that  encompasses them, the catalytic cycle, overview <49>; #4# proposed  catalytic cycle for cytochrome P450, a ferryl-oxo Pi-cation porphyrin  radical, is the putative oxidant that reacts directly with substrate,  overview. The axial ligand to the heme iron, a cysteine thiolate, is  generally believed to control P450 reactivity <91>; #4# proposed  catalytic cycle for cytochrome P450, overview <80>)  "
1.14.15.10, (+)-camphor + reduced putidaredoxin + O2 = (+)-6-endo-hydroxycamphor +  oxidized putidaredoxin + H2O  
1.14.15.11, 1-deoxypentalenate + reduced ferredoxin + O2 = pentalenate + oxidized  ferredoxin + H2O  
1.14.15.13, cyclo(L-leucyl-L-leucyl) + 6 reduced ferredoxin + 3 O2 = pulcherriminic  acid + 6 oxidized ferredoxin + 4 H2O  
1.14.15.14, a methyl-branched lipid + O2 + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ = an omega-hydroxy-methyl-branched lipid + H2O + 2  oxidized ferredoxin [iron-sulfur] cluster  
1.14.15.15," 5beta-cholestane-3alpha,7alpha,12alpha-triol + 6 reduced adrenodoxin +  6 H+ + 3 O2 =  (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate + 6  oxidized adrenodoxin + 4 H2O (#5# reaction mechanism <21>) "
1.14.15.15," 5beta-cholestane-3alpha,7alpha,12alpha-triol + 2 reduced adrenodoxin +  2 H+ + O2 = (25R)-5beta-cholestane-3alpha,7alpha,12alpha,26-tetraol + 2  oxidized adrenodoxin + H2O "
1.14.15.15," (25R)-5beta-cholestane-3alpha,7alpha,12alpha,26-tetraol + 2 reduced  adrenodoxin + 2 H+ + O2 =  (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-al + 2  oxidized adrenodoxin + 2 H2O "
1.14.15.15," (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-al + 2  reduced adrenodoxin + 2 H+ + O2 =  (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate + 2  oxidized adrenodoxin + H2O  "
1.14.15.16, calcitriol + 2 reduced adrenodoxin + 2 H+ + O2 = calcitetrol + 2  oxidized adrenodoxin + H2O 
1.14.15.16, calcidiol + 2 reduced adrenodoxin + 2 H+ + O2 = secalciferol + 2  oxidized adrenodoxin + H2O  
1.14.15.17, pheophorbide a + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2  = red chlorophyll catabolite + 2 oxidized ferredoxin [iron-sulfur]  cluster 
1.14.15.17, pheophorbide a + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2  = epoxypheophorbide a + 2 oxidized ferredoxin [iron-sulfur] cluster +  H2O 
1.14.15.17, epoxypheophorbide a + H2O = red chlorophyll catabolite  
1.14.15.18," calcidiol + 2 reduced adrenodoxin + 2 H+ + O2 = calcitriol + 2 oxidized  adrenodoxin + H2O (#4,5# reconstitution of the enzyme system in E. coli  cells, consisting of NADH-adrenodoxin reductase, adrenodoxin and  CYP27B1 <31>; #1,2,3,10# 25-hydroxyvitamin D3 1alpha-hydroxylase is a  cytochrome P-450-dependent mixed-function oxidase <17,19,23,25>; #1#  amino acid composition and terminal sequence determination <21>;  #4,5,11# cytochrome P-450 enzyme <27,28,30,31,32>; #10# amino acid  sequence determination <25>; #1# kidney mitochondrial 25-hydroxyvitamin  D3-1alpha-hydroxylation system consists of a renal ferredoxin reductase  (flavoprotein), renal ferredoxin and cytochrome P-450 <14>;  #1,4,5,6,7,10# reconstituted with cytochrome P-450, adrenal ferredoxin,  i.e. adrenodoxin, and adrenodoxin reductase <13,14,24,25,26,27,31>; #7#  cytochrome P-450 type is specific for hydroxylation site of  25-hydroxyvitamin D3 <15>; #8# enzyme can be reconstituted with the 3  components: cytochrome P-450D1alpha, NADPH-renodoxin reductase and  renodoxin <16>; #1,3,7# ferredoxin, ferredoxin reductase and cytochrome  P-450 <1,12,14,15,19>)  "
1.14.15.19, testosterone + 2 reduced ferredoxin [iron-sulfur] cluster + O2 + 2 H+ =  1alpha-hydroxytestosterone + H2O + 2 oxidized ferredoxin [iron-sulfur]  cluster  
1.14.15.20, protoheme + 6 reduced ferredoxin [iron-sulfur] cluster + 3 O2 + 6 H+ =  biliverdin + Fe2+ + CO + 6 oxidized ferredoxin [iron-sulfur] cluster +  3 H2O  
1.14.15.21, zeaxanthin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  antheraxanthin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  (#11# creation of an unstable carotenoid carbocation in the molecular  mechanism of epoxidation <12>) 
1.14.15.21, antheraxanthin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2  = violaxanthin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  (#11# creation of an unstable carotenoid carbocation in the molecular  mechanism of epoxidation <12>) 
1.14.15.21, zeaxanthin + 4 reduced ferredoxin [iron-sulfur] cluster + 4 H+ + 2 O2 =  violaxanthin + 4 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.15.22, calciol + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  calcidiol + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O 
1.14.15.22, calcidiol + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  calcitriol + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  
1.14.15.23," butachlor + 2 reduced ferredoxin [iron-sulfur] cluster + O2 =  2-chloro-N-(2,6-diethylphenyl)acetamide + butyl formate + 2 oxidized  ferredoxin [iron-sulfur] cluster + H2O  "
1.14.15.24, beta-carotene + 4 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + 2  O2 = zeaxanthin + 4 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O 
1.14.15.24, beta-carotene + 2 reduced ferredoxin [iron-sulfur] cluster + H+ + O2 =  beta-cryptoxanthin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O 
1.14.15.24, beta-cryptoxanthin + 2 reduced ferredoxin [iron-sulfur] cluster + H+ +  O2 = zeaxanthin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  
1.14.15.25, p-cymene + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  4-isopropylbenzyl alcohol + 2 oxidized ferredoxin [iron-sulfur] cluster  + H2O  
1.14.15.26, toluene + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  benzyl alcohol + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O 
1.14.15.26, p-xylene + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  4-methylbenzyl alcohol + 2 oxidized ferredoxin [iron-sulfur] cluster +  H2O 
1.14.15.26, m-xylene + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  3-methylbenzyl alcohol + 2 oxidized ferredoxin [iron-sulfur] cluster +  H2O  
1.14.15.27, beta-dihydromenaquinone-9 + 2 reduced ferredoxin [iron-sulfur] cluster  + O2 = omega-hydroxy-beta-dihydromenaquinone-9 + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O  
1.14.15.28, cholest-4-en-3-one + 6 reduced [2Fe-2S] ferredoxin + 3 O2 =  (25R)-3-oxocholest-4-en-26-oate + 6 oxidized [2Fe-2S] ferredoxin + 4  H2O (#3# overall reaction <3>) 
1.14.15.28, cholest-4-en-3-one + 2 reduced [2Fe-2S] ferredoxin + O2 =  (25R)-26-hydroxycholest-4-en-3-one + 2 oxidized [2Fe-2S] ferredoxin +  H2O (#3# (1a) <3>) 
1.14.15.28, (25R)-26-hydroxycholest-4-en-3-one + 2 reduced [2Fe-2S] ferredoxin + O2  = (25R)-26-oxocholest-4-en-3-one + 2 oxidized [2Fe-2S] ferredoxin + 2  H2O (#3# (1b) <3>) 
1.14.15.28, (25R)-26-oxocholest-4-en-3-one + 2 reduced [2Fe-2S] ferredoxin + O2 =  (25R)-3-oxocholest-4-en-26-oate + 2 oxidized [2Fe-2S] ferredoxin + H2O  (#3# (1c) <3>)  
1.14.15.29, cholest-4-en-3-one + 3 NADH + 3 H+ + 3 O2 =  (25S)-3-oxocholest-4-en-26-oate + 3 NAD+ + 4 H2O 
1.14.15.29, cholest-4-en-3-one + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+  + O2 = (25S)-26-hydroxycholest-4-en-3-one + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O 
1.14.15.29, (25S)-26-hydroxycholest-4-en-3-one + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ + O2 = (25S)-26-oxocholest-4-en-3-one + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O 
1.14.15.29, cholest-4-en-3-one + 6 reduced ferredoxin [iron-sulfur] cluster + 6 H+  + 3 O2 = (25S)-3-oxocholest-4-en-26-oate + 6 oxidized ferredoxin  [iron-sulfur] cluster + 4 H2O  
1.14.15.3, octane + 2 reduced rubredoxin + O2 + 2 H+ = 1-octanol + 2 oxidized  rubredoxin + H2O  
1.14.15.30," androsta-1,4-diene-3,17-dione + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ + O2 = 9alpha-hydroxyandrosta-1,4-diene-3,17-dione + 2  oxidized ferredoxin [iron-sulfur] cluster + H2O (#2,7,10,24# KSH  enzymes employ an electron transport chain that starts with the  oxidation of NADH. The electrons are transferred to the flavin cofactor  (FAD) of the ferredoxin reductase component KshB and then transported  to the plant type iron-sulfur cluster of KshB. The Rieske iron-sulfur  cluster of the KshA oxygenase component subsequently accepts the  electrons from KshB. The electrons end up at the nonheme iron situated  in the active site of KshA. The mononuclear iron is the site where O2  is bound and activated and the substrate is hydroxylated <12>;  #1,5,7,25# KSH enzymes employ an electron transport chain that starts  with the oxidation of NADH. The electrons are transferred to the flavin  cofactor (FAD) of the ferredoxin reductase component KshB and then  transported to the plant type iron-sulfur cluster of KshB. The Rieske  ironÂ–sulfur cluster of the KshA oxygenase component subsequently  accepts the electrons from KshB. The electrons end up at the nonheme  iron situated in the active site of KshA. The mononuclear iron is the  site where O2 is bound and activated and the substrate is hydroxylated  <12>; #9,10,16# KshAB-catalyzed 9alpha-hydroxylation of 3-ketosteroids.  1,4-Diene ketosteroids undergo subsequent nonenzymatic cleavage of ring  B and aromatization of ring A <13>)  "
1.14.15.31," 2-hydroxy-5-methyl-1-naphthoate + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ + O2 = 2,7-dihydroxy-5-methyl-1-naphthoate + 2 oxidized  ferredoxin [iron-sulfur] cluster + H2O  "
1.14.15.32, pentalenene + 4 reduced ferredoxin [iron-sulfur] cluster + 4 H+ + 2 O2  = pentalen-13-al + 4 oxidized ferredoxin [iron-sulfur] cluster + 3 H2O 
1.14.15.32, pentalenene + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  pentalen-13-ol + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O 
1.14.15.32, pentalen-13-ol + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2  = pentalen-13-al + 2 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.15.33, narbomycin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  pikromycin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O (#2# (1)  <2>) 
1.14.15.33, narbomycin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  neopikromycin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O (#2#  (2) <2>) 
1.14.15.33, narbomycin + 4 reduced ferredoxin [iron-sulfur] cluster + 4 H+ + 2 O2 =  novapikromyin + 4 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  (#2# (3) <2>) 
1.14.15.33, 10-deoxymethymycin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+  + O2 = methymycin + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  (#2# (4) <2>) 
1.14.15.33, 10-deoxymethymycin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+  + O2 = neomethymycin + 2 oxidized ferredoxin [iron-sulfur] cluster +  H2O (#2# (5) <2>) 
1.14.15.33, 10-deoxymethymycin + 4 reduced ferredoxin [iron-sulfur] cluster + 4 H+  + 2 O2 = novamethymycin + 4 oxidized ferredoxin [iron-sulfur] cluster +  2 H2O (#2# (6) <2>)  
1.14.15.34, 20-oxo-5-O-beta-mycaminosyltylactone + 2 reduced ferredoxin  [iron-sulfur] cluster + 2 H+ + O2 = 5-O-beta-mycaminosyltylonolide + 2  oxidized ferredoxin [iron-sulfur] cluster + H2O  
1.14.15.35, 6-deoxyerythronolide B + 2 reduced ferredoxin [iron-sulfur] cluster + 2  H+ + O2 = erythronolide B + 2 oxidized ferredoxin [iron-sulfur] cluster  + H2O  
1.14.15.36, a 14alpha-methylsteroid + 6 reduced ferredoxin [iron-sulfur] cluster +  6 H+ + 3 O2 = a DELTA14-steroid + formate + 6 oxidized ferredoxin  [iron-sulfur] cluster + 4 H2O 
1.14.15.36, a 14alpha-methylsteroid + 2 reduced ferredoxin [iron-sulfur] cluster +  2 H+ + O2 = a 14alpha-hydroxymethylsteroid + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O 
1.14.15.36, a 14alpha-hydroxymethylsteroid + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ + O2 = a 14alpha-formylsteroid + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O 
1.14.15.36, a 14alpha-formylsteroid + 2 reduced ferredoxin [iron-sulfur] cluster +  2 H+ + O2 = a DELTA14-steroid + formate + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O  
1.14.15.37, luteothin + 2 O2 + 4 reduced ferredoxin [iron-sulfur] cluster + 4 H+ =  aureothin + 3 H2O + 4 oxidized ferredoxin [iron-sulfur] cluster 
1.14.15.37, luteothin + O2 + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ =  (7R)-7-hydroxyluteothin + H2O + 2 oxidized ferredoxin [iron-sulfur]  cluster 
1.14.15.37, (7R)-7-hydroxyluteothin + O2 + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ = aureothin + 2 H2O + 2 oxidized ferredoxin  [iron-sulfur] cluster  
1.14.15.38," an N,N-dimethyl-N'-phenylurea compound + 2 reduced ferredoxin  [iron-sulfur] cluster + 2 H+ + O2 = an N-methyl-N'-phenylurea compound  + formaldehyde + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O  "
1.14.15.39, (+)-epi-isozizaene + 2 reduced [2Fe-2S] ferredoxin + 2 H+ + O2 =  (5S)-albaflavenol + 2 oxidized [2Fe-2S] ferredoxin + H2O 
1.14.15.39, (5S)-albaflavenol + 2 reduced [2Fe-2S] ferredoxin + 2 H+ + O2 =  albaflavenone + 2 oxidized [2Fe-2S] ferredoxin + 2 H2O 
1.14.15.39, (+)-epi-isozizaene + 2 reduced [2Fe-2S] ferredoxin + 2 H+ + O2 =  (5R)-albaflavenol + 2 oxidized [2Fe-2S] ferredoxin + H2O 
1.14.15.39, (5R)-albaflavenol + 2 reduced [2Fe-2S] ferredoxin + 2 H+ + O2 =  albaflavenone + 2 oxidized [2Fe-2S] ferredoxin + 2 H2O 
1.14.15.39, (+)-epi-isozizaene + 4 reduced [2Fe-2S] ferredoxin + 4 H+ + 2 O2 =  albaflavenone + 4 oxidized [2Fe-2S] ferredoxin + 3 H2O  
1.14.15.4," a steroid + 2 reduced adrenodoxin + O2 + 2 H+ = an  11beta-hydroxysteroid + 2 oxidized adrenodoxin + H2O (#5# superfamily  of heme-containing enzyme, 11-/18-/19-hydroxylations of  11-deoxycorticosterone, 11-deoxycortisol and androstenedione <20>; #10#  one bifunctional cytochrome P-450, 11beta-/14alpha-hydroxylation <24>;  #5# cytochrome P45011beta is implicated in mineralocorticoid,  synthesized and secreted from zona glomerulosa, as well as  glucocorticoid, secreted primarily in zonae fasciculate and  reticularis, biosynthesis with multiple catalytic activities,  11beta-/18-/19-hydroxylase and 18-/19-hydroxysteroid oxidase activities  <13>; #5# for synthesis of aldosterone 3 molecules P450 must be reduced  or one molecule must be reduced 3 times <15>; #5# P-45011beta  responsible for two hydroxylase reactions <6>; #8# single enzyme,  11beta-/18-hydroxylation and aldosterone synthetic activities <23>;  #3,5# 11beta-/18-hydroxylation and aldosterone synthesis are catalyzed  by 2 distinct forms of cytochrome P-45011beta <11,12>; #5# 2 step  reduction: reduction of P-450 with non-specific donor and reduction  which is specifically dependent on reduced iron-sulfur protein <8>; #5#  ferric cytochrome P-45011beta-deoxycorticosterone complex classified as  a pentacoordinated species, H2O molecule binds ferric heme iron <14>;  #5,10# both hydroxylation activities seem to occur in a single enzyme  <3,4,5>; #5# heme protein of so-called P-450 family <5>)  "
1.14.15.5, corticosterone + 2 reduced adrenodoxin + O2 + 2 H+ =  18-hydroxycorticosterone + 2 oxidized adrenodoxin + H2O  
1.14.15.6, cholesterol + 6 reduced adrenodoxin + 3 O2 + 6 H+ = pregnenolone +  4-methylpentanal + 6 oxidized adrenodoxin + 4 H2O 
1.14.15.6, cholesterol + 2 reduced adrenodoxin + O2 + 2 H+ =  (22R)-22-hydroxycholesterol + 2 oxidized adrenodoxin + H2O 
1.14.15.6," (22R)-22-hydroxycholesterol + 2 reduced adrenodoxin + O2 + 2 H+ =  (20R,22R)-20,22-dihydroxycholesterol + 2 oxidized adrenodoxin + H2O "
1.14.15.6," (20R,22R)-20,22-dihydroxy-cholesterol + 2 reduced adrenodoxin + O2 + 2  H+ = pregnenolone + 4-methylpentanal + 2 oxidized adrenodoxin + 2 H2O  "
1.14.15.7, choline + O2 + 2 reduced ferredoxin + 2 H+ = betaine aldehyde hydrate +  H2O + 2 oxidized ferredoxin  
1.14.15.8, progesterone + 2 reduced [2Fe-2S] ferredoxin + O2 =  15beta-hydroxyprogesterone + 2 oxidized [2Fe-2S] ferredoxin + H2O  
1.14.15.9, spheroidene + 4 reduced ferredoxin [iron-sulfur] cluster + 2 O2 =  spheroiden-2-one + 4 oxidized ferredoxin [iron-sulfur] cluster + 3 H2O  (#1# (1) <1>) 
1.14.15.9, spirilloxanthin + 4 reduced ferredoxin [iron-sulfur] cluster + 2 O2 =  2-oxospirilloxanthin + 4 oxidized ferredoxin [iron-sulfur] cluster + 3  H2O 
1.14.15.9," 2-oxospirilloxanthin + 4 reduced ferredoxin [iron-sulfur] cluster + 2  O2 = 2,2'-dioxospirilloxanthin + 4 oxidized ferredoxin [iron-sulfur]  cluster + 3 H2O "
1.14.15.9, spheroidene + 2 reduced ferredoxin [iron-sulfur] cluster + O2 + 2 H+ =  2-hydroxyspheroidene + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O 
1.14.15.9," 2-hydroxyspheroidene + 2 reduced ferredoxin [iron-sulfur] cluster + O2  + 2 H+ = 2,2-dihydroxyspheroidene + 2 oxidized ferredoxin [iron-sulfur]  cluster + H2O "
1.14.15.9," 2,2-dihydroxyspheroidene = spheroiden-2-one + H2O "
1.14.15.9, spirilloxanthin + 2 reduced ferredoxin [iron-sulfur] cluster + O2 + 2  H+ = 2-hydroxyspirilloxanthin + 2 oxidized ferredoxin [iron-sulfur]  cluster + H2O 
1.14.15.9," 2-hydroxyspirilloxanthin + 2 reduced ferredoxin [iron-sulfur] cluster +  O2 + 2 H+ = 2,2-dihydroxyspirilloxanthin + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O "
1.14.15.9," 2,2-dihydroxyspirilloxanthin = 2-oxospirilloxanthin + H2O "
1.14.15.9, 2-oxospirilloxanthin + 2 reduced ferredoxin [iron-sulfur] cluster + O2  + 2 H+ = 2'-hydroxy-2-oxospirilloxanthin + 2 oxidized ferredoxin  [iron-sulfur] cluster + H2O 
1.14.15.9," 2',2'-dihydroxy-2-oxospirilloxanthin = 2,2'-dioxospirilloxanthin + H2O "
1.14.15.9," 2'-hydroxy-2-oxospirilloxanthin + reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = 2',2'-dihydroxy-2-oxospirilloxanthin + oxidized  ferredoxin [iron-sulfur] cluster + H2O  "
1.14.16.1," L-phenylalanine + a 5,6,7,8-tetrahydropteridine + O2 = L-tyrosine + a  4a-hydroxy-5,6,7,8-tetrahydropteridine (#4# catalytic mechanism <59>;  #19# proposed catalytic cycle <43>; #10# enzyme requires an initial  reduction of Cu2+ to Cu+ for activation <19>; #3# analysis of  conformational changes upon substrate binding <48>; #3# mechansim,  conformational transition and hysteresis <47>; #25# sequential ter-bi  mechansim, L-phenylalanine is the middle substrate in order of binding  <53>; #19# substrate binding triggers structural changes throughout the  entire tetrameric enzyme <57>; #19# kinetics, molecular dynamics  simulations, structure-energetics calculations, and molecular  interaction fields, structure-function analysis <63>; #3# residues S391  and G332 are important for activity <61>; #3,4,10# substrate and oxygen  binding site, reaction mechanism, structure-function analysis <67>;  #26# molecular mechanism <73>; #4# 1H-15N HSQC NMR spectra are obtained  of the 15N-labeled protein alone and in the presence of phenylalanine.  Regulatory domain of phenylalanine hydroxylase can bind phenylalanine,  consistent with the presence of an allosteric site for the amino acid  <105>; #28# hydrogen/deuterium exchange monitored by mass spectrometry  is used to gain insight into local conformational changes accompanying  activation of rat phenylalanine hydroxylase by phenylalanine. Peptides  in the regulatory and catalytic domains that lie in the interface  between these two domains show large increases in the extent of  deuterium incorporation from solvent in the presence of phenylalanine  <106>; #12# structural analysis reveal an additional L-Phe binding site  at the regulatory domain of full-length cePAH. This site involves the  GA(S)L/ISRP motifs, which are also found in ACT domains of other L-Phe  binding proteins <104>)  "
1.14.16.2," L-tyrosine + a 5,6,7,8-tetrahydropteridine + O2 = L-dopa + a  4a-hydroxy-5,6,7,8-tetrahydropteridine (#2,6,7,10,44# mechanism  <6,21,31>; #6# stereochemical analysis of ligand binding <20>; #5#  ligand binding model, hTH1 <30>; #5# H-NMR analysis of conformation of  the complex between phenylalanine, 6-methyltetrahydropterin and isoform  hTH1 <23>; #6# active binding site <20>; #5# secondary structure and  conformation analysis of phosphorylated and unphosphorylated isoform  hTH1 <28>; #5# phosphorylation site of hTH1 is Ser-40 <28>)  "
1.14.16.4," L-tryptophan + a 5,6,7,8-tetrahydropteridine + O2 =  5-hydroxy-L-tryptophan + a 4a-hydroxy-5,6,7,8-tetrahydropteridine (#8#  hydroxylation regiospecificity <21>; #7# phenylalanine hydroxylase, EC  1.14.16.1 also catalyzes this reaction <7>)  "
1.14.16.5," 1-O-alkyl-sn-glycerol + a 5,6,7,8-tetrahydropteridine + O2 =  1-O-(1-hydroxyalkyl)-sn-glycerol + a  4a-hydroxy-5,6,7,8-tetrahydropteridine (#4# mechanism <10>; #4# The  glyceryl ether substrate is first hydroxylated in a pteridine-dependent  monooxygenase reaction to yield the unstable semiacetal product. The  enzyme accepts a range of chain lengths from n = 11 to n = 20. The  tetrahydrobiopterin cofactor is first converted to a 4alpha-hydroxy  derivative and leaves the reaction after dehydration as  6,7[8H]-dihydrobiopterin, which is recycled to tetrahydrobiopterin by  dihydropteridine reductase with NADH or NADPH. The semiacetal  rearranges to the corresponding aldehyde and glycerol. In the presence  of oxygen, the aldehyde is readily oxidized to the corresponding acid  <16>)  "
1.14.16.6," (S)-2-hydroxy-2-phenylacetate + a 5,6,7,8-tetrahydropteridine + O2 =  (S)-4-hydroxymandelate + a 4a-hydroxy-5,6,7,8-tetrahydropteridine  "
1.14.16.7," L-phenylalanine + a 5,6,7,8-tetrahydropteridine + O2 =  3-hydroxy-L-phenylalanine + a 4a-hydroxy-5,6,7,8-tetrahydropteridine  "
1.14.17.1," dopamine + 2 ascorbate + O2 = noradrenaline + 2 monodehydroascorbate +  H2O (#6# mechanism <12,16,17,21,24,30>; #6# stoichiometry <11,24>; #6#  ping pong mechanism <9>; #1# uni-uni bi-uni ping pong mechanism <8>;  #6# new mechanism of enzyme <4>; #12# during the reaction, an O atom  from molecular O2 is inserted at the beta-carbon in dopamine with  retention of configuration, and the second O atom goes to water. The  reaction also requires two electrons provided by two ascorbate  molecules that are oxidized to semihydroascorbate <81>)  "
1.14.17.3," [peptide]-glycine + 2 ascorbate + O2 = [peptide]-(2S)-2-hydroxyglycine  + 2 monodehydroascorbate + H2O (#5,6,9# mechanism <2,3,8,17,29>; #4#  sequential activity of 2 enzymes contained within a bifunctional  protein <26,33>; #4# equilibrium ordered mechanism <33>; #4# kinetic  model for slow-binding inhibition <28>; #4# structural analysis of  mutant H172A, binding of ligands CO, Cu2+ <34>; #4# structural analysis  <32>; #9# ping-pong-mechanism <24,29>; #10# structure analysis <19>;  #4# kinetic analysis <33>; #2,4,12# bifunctional enzyme showing  peptidylglycine alpha-hydroxylating monooxygenase, EC 1.14.17.3, and  peptidylamidoglycolate lyase, PAL, EC 4.3.2.5, activities, the enzyme  possesses 2 catalytic domains <36,38,41>; #4# bifunctional enzyme  showing peptidylglycine alpha-hydroxylating monooxygenase, PHM, EC  1.14.17.3, and peptidylamidoglycolate lyase, PAL, EC 4.3.2.5,  activities <44>; #4# cleavage of CN bond in N-acetylated glycines,  R-CO-NH-CH2-COOH, e.g. found in neuropeptide prohormones <37>; #4#  detailed analysis of the reaction mechanism, reaction scheme, strictly  ordered ping-pong kinetic mechanism in which ascorbate first reduces  Cu(II) to Cu(I), semidehydroascorbate being released, after which the  peptide binds and finally oxygen, active site structure <46>; #4#  detailed analysis of the reaction mechanism, role of noncoupled nature  of the active site <45>; #4# equilibrium-ordered and  steady-state-random or -ordered reaction mechanism for the wild-type  and the mutant Y318F enzyme, respectively, active site Y318 is  involved, C-H bond activation is dominated by quantum mechanical  tunneling, peptide substrate binding structure at the active site <39>;  #4# inter-copper electron transfer, interdomain structure <43>; #4#  mechanism, substrate binding structure <40>; #14# equilibrium ordered  mechanism in which substrate binds prior to oxygen <82>; #14# reaction  mechanism simulation using quantum mechanics/molecular mechanics  calculations, molecular dynamics simulations, and the enzyme crystal  structure, PDB 1SDW, detailed overview. The overall reaction of PHM  consists of a stereospecific hydroxylation of the pro-S hydrogen using  molecular O2 as oxygen source. Two electrons and two protons are  consumed during the reaction. Ascorbate is the best (but not the only  possible) reductant. In the protein resting state, both copper atoms  are in the +2 oxidation state and are reduced by ascorbate to +1.  Molecular oxygen then binds to CuM as the substrate binds to the  protein. first and rate-limiting step is hydrogen abstraction, second  step is OH rebinding via double protonated intermediate and transition  state (TS2) <86>; #14# stopped-flow studies of the reduction of the  copper centers suggest a bifurcated electron transfer pathway in  peptidylglycine monooxygenase <81>)  "
1.14.17.4," 1-aminocyclopropane-1-carboxylate + ascorbate + O2 = ethene + cyanide +  dehydroascorbate + CO2 + 2 H2O (#5# reaction mechanism <41>;  #4,5,14,19# catalytic mechanism <14,15,16>; #10# active site contains a  single Fe(II) ligated by residues His177, Asp179, His234, mechanism  <19>; #3# ENDOR studies, structural model of active site both in  presence and in absence of substrate <20>; #11# mechanism, reaction  begins with binding of 1-aminocyclopropane-1-carboxylate and O2, and  proceeds via iron oxidation and one-electron reduction to form a peroxy  intermediate. Breakdown of the intermediate yields a high-valent iron  species which is the true oxidizing reagent for bound  1-aminocyclopropane-1-carboxylate <21>; #19# modelling studies,  catalytic mechanism <18>; #41# the reaction pathway incorporates  cyanide as an ACCO/Fe(II) ligand after reaction turnover. The cyanide  ligand is likely displaced upon binding of ACC and ascorbate to provide  a binding site for oxygen <59>)  "
1.14.18.1," L-tyrosine + O2 = dopaquinone + H2O (#5# 2 o-diphenol + O2 = 2  o-quinone + 2 H2O i.e. catecholase activity, proposed mechanism for  sequence of hydroxylase and catecholase <90>; #5# monophenol + O2 =  o-diphenol + H2O, i.e. cresolase activity, proposed mechanism for  sequence of hydroxylase and catecholase <90>; #25# proposed structural  reaction mechanism for the monophenolase and diphenolase activity  <104>; #10# proposed mechanism of hydroxylation and oxidation of  phenols <44>; #10# proposed interaction of the oxy site effective  structure with monophenolic and diphenolic substrates <59>; #25#  reaction mechanism of monophenolase and diphenolase activity <101>;  #5,7,10,25,33# catalytic cycle, reaction mechanism, active site  structure <126>; #74# the active site of the enzyme contains a pair of  antiferromagnetically coupled Cu2+ ions in the met form, and during  turnover both the reduced and the oxy forms are cyclically produced,  the rate-limiting step is associated with cleavage of the peroxide O-O  bond, reaction and kinetic mechanism <127>; #108# catalyzes the  hydroxylation of monophenols to o-diphenols (cresolase activity) and  the oxidation of o-diphenols to o-quinones (catecholase activity)  <177>; #136# EC 1.14.18.1, catalyze hydroxylation of monophenols to  o-diphenols and their subsequent oxidation to o-quinones <209>; #109#  PPO catalyzes the hydroxylation of monophenols to o-diphenols (EC  1.14.18.1) throughout a cresolase/monophenolase activity and a  subsequent oxidation of these o-diphenols to the corresponding  o-quinones (EC 1.10.3.1) by a catecholase/diphenolase activity <180>;  #25# mechanism of tyrosinase on monophenols and o-diphenol, overview  <307>; #18# molecular reaction mechanism and substrate binding mode,  L-tyrosine in the active site forms hydrogen bonds with R209 via its  carboxyl side chain <343>; #25# reaction mechanism with mono- and  diphenols, overview <327>) "
1.14.18.1, L-tyrosine + 1/2 O2 = L-dopa 
1.14.18.1, L-dopa + 1/2 O2 = dopaquinone + H2O 
1.14.18.1," 2 L-dopa + O2 = 2 dopaquinone + 2 H2O (#25# mechanism of tyrosinase on  monophenols and o-diphenol, overview <307>; #122# structure-function  relationship analysis and reaction mechanism, overview. The crystal  structure reveals that the distinction between mono- and diphenolase  activity does not depend on the degree of restriction of the active  site, and thus a more important role for amino acid residues located at  the entrance to and in the second shell of the active site is proposed  <303>)  "
1.14.18.10," 24-methylidenecycloartanol + 6 ferrocytochrome b5 + 3 O2 + 6 H+ =  3beta-hydroxy-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-4alpha-carboxylate + 6  ferricytochrome b5 + 4 H2O "
1.14.18.10," 24-methylidenecycloartanol + 2 ferrocytochrome b5 + O2 + 2 H+ =  4alpha-(hydroxymethyl)-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + 2 ferricytochrome b5 + H2O "
1.14.18.10," 4alpha-(hydroxymethyl)-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + 2 ferrocytochrome b5 + O2  + 2 H+ =  4alpha-formyl-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + 2 ferricytochrome b5 + 2  H2O "
1.14.18.10," 4alpha-formyl-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + 2 ferrocytochrome b5 + O2  + 2 H+ =  3beta-hydroxy-4beta,14alpha-dimethyl-9beta  19-cyclo-5alpha-ergost-24(241)-en-4alpha-carboxylate + 2  ferricytochrome b5 + H2O  "
1.14.18.11," 24-methylidenelophenol + 6 ferrocytochrome b5 + 3 O2 + 6 H+ =  3beta-hydroxyergosta-7,24(241)-dien-4alpha-carboxylate + 6  ferricytochrome b5 + 4 H2O "
1.14.18.11," 24-methylidenelophenol + 2 ferrocytochrome b5 + O2 + 2 H+ =  4alpha-(hydroxymethyl)ergosta-7,24(241)-dien-3beta-ol + 2  ferricytochrome b5 + H2O "
1.14.18.11," 4alpha-(hydroxymethyl)ergosta-7,24(241)-dien-3beta-ol + 2  ferrocytochrome b5 + O2 + 2 H+ =  4alpha-formylergosta-7,24(241)-dien-3beta-ol + 2 ferricytochrome b5 + 2  H2O "
1.14.18.11," 4alpha-formylergosta-7,24(241)-dien-3beta-ol + 2 ferrocytochrome b5 +  O2 + 2 H+ = 3beta-hydroxyergosta-7,24(241)-dien-4alpha-carboxylate + 2  ferricytochrome b5 + H2O  "
1.14.18.12, a (2R)-2-hydroxy Cn-fatty acid + O2 = a Cn-1-fatty acid + H2O + CO2  
1.14.18.2, CMP-N-acetylneuraminate + 2 ferrocytochrome b5 + O2 + 2 H+ =  CMP-N-glycoloylneuraminate + 2 ferricytochrome b5 + H2O  
1.14.18.3," methane + quinol + O2 = methanol + quinone + H2O (#3# mechanism <2>;  #2# mechanism of pMMO <4>; #40# putative mechanism for the reaction of  the mononuclear site with methane, structure modeling, overview <45>;  #40,44# reaction mechanism of enzyme pMMO, via O2 activation  intermediates, detailed overview <54>)  "
1.14.18.4, a 1-acyl-2-oleoyl-sn-glycero-3-phosphocholine + 2 ferrocytochrome b5 +  O2 + 2 H+ = a  1-acyl-2-[(12R)-12-hydroxyoleoyl]-sn-glycero-3-phosphocholine + 2  ferricytochrome b5 + H2O  
1.14.18.5, a dihydroceramide + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (4R)-4-hydroxysphinganine ceramide + 2 ferricytochrome b5 + H2O  
1.14.18.6, a phytoceramide + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (2'R)-2'-hydroxyphytoceramide + 2 ferricytochrome b5 + H2O  
1.14.18.7, a dihydroceramide + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (2'R)-2'-hydroxydihydroceramide + 2 ferricytochrome b5 + H2O  
1.14.18.9," 4,4-dimethyl-5alpha-cholest-7-en-3beta-ol + 2 ferrocytochrome b5 + O2 +  2 H+ = 4beta-hydroxymethyl-4alpha-methyl-5alpha-cholest-7-en-3beta-ol +  2 ferricytochrome b5 + H2O "
1.14.18.9, 4beta-hydroxymethyl-4alpha-methyl-5alpha-cholest-7-en-3beta-ol + 2  ferrocytochrome b5 + O2 + 2 H+ =  3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carbaldehyde + 2  ferricytochrome b5 + 2 H2O 
1.14.18.9," 4,4-dimethyl-5alpha-cholest-7-en-3beta-ol + 6 ferrocytochrome b5 + 3 O2  + 6 H+ =  3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate + 6  ferricytochrome b5 + 4 H2O (#2# aerobic hydroxylation <1>) "
1.14.18.9, 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carbaldehyde + 2  ferrocytochrome b5 + O2 + 2 H+ =  3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate + 2  ferricytochrome b5 + H2O  
1.14.19.1," stearoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = oleoyl-CoA + 2  ferricytochrome b5 + 2 H2O (#8# the possible mechanism would be that  dioxygen has to bind to both irons for effective two-electron transfer  to the half-occupied antibonding pi orbitals of dioxygen to give a  peroxide level intermediate <28>; #17# cold exposure leads to an  induced activity, in vivo cooling causes an activity induction of up to  15 to 30fold. Increase of desaturase synthesis by means of activated  gene transcription. Transfer of cells to 10Â°C causes a smaller increase  in activity compared to cells maintained at 30Â°C <27>; #24#  regioselectivity, substrate specificity, probably extra-plastidal <25>;  #4# the reducing equivalents required for the desaturation site seem to  be supplied from NADPH via cytochrome b5 as electron carrier <2>; #2#  existence of three highly homologous isoforms: SCD1, SCD2 and SCD3  which show different substrate specificities, here SCD1 is mainly  analysed <29>; #17# presence of two desaturase genes, isomers CDS1 and  CDS2. Cooling treatment of carp causes significant changes to the  activity of the DELTA9-desaturase. Modest cooling of carp shows an  increase in acticity without any increase in the amount of desaturase  protein, suggesting the activation of the pre-existing inactive latent  enzyme, possibly by a post-translational mechanism <20>; #17# increase  of activity induced by cold is preceded by the activation of latent  desaturase, probably by a posttranslational mechanism. Amounts of  desaturase transcript are increased as a result of cold-induced gene  transcription <26>; #12# SSI2 gene encodes a member of a family of  soluble fatty acid desaturases <30>; #4# introduction of double bonds  at fixed positions from the carboxyl group of the fatty acid.  D-hydrogen atoms are removed during desaturation. Mixed-function  oxidase, acting via hydroxy acid intermediates. Acetyl-CoA desaturase,  carboxylase and fatty acid synthetase are all controlled together as a  unit and influenced by dietary components <15>; #4# cytochrome b5,  cytochrome b5 reductase and lipid and/or detergent are needed for all  assays. A cis-hydrogen abstraction mechanism is involved in  desaturation <6>; #4,20# the synthesis is transcriptionally regulated  by fat-free diet and sterols. Cholesterol-supplemented media as well as  the transient transfection induces the expression of stearoyl-CoA  desaturase RNA <22>; #3# it is suggested that in HepG2 cells the  trans-10,cis-12 conjugated linoleic acid isomer regulates human  desaturase activity mainly by a posttranslational mechanism <23>; #23#  isolation of a third fatty acid DELTA9-desaturase. Higher activity with  longer chain fatty acid substrates. Desaturase expression is induced  significantly by increasing the ratio of carbon to nitrogen <24>; #4#  multienzyme, insertion of a double bond in 9,10 position <5>; #19#  incorporation of fatty acid into phospholipid. Enzyme may contain an  essential thiol group. Endogenous saturated phospholipid is desaturated  rapidly in all experiments in contrast with exogenous saturated  phospholipid, which generally is not desaturated <8>; #18# presence of  an unusual microsomal electron transport system associated with the  desaturase <9>; #19# significant amounts of DELTA8-isomers are present  <14>; #4# electron flow from NADH to cytochrome b5, via cytochrome b5  reductase. Different types of acyl-CoA desaturation show immunological  differences <7>; #1# introduction of double bond at position 9 <16>;  #47# the DELTA9-desaturase SCD-1 introduces a cis-double bond into  saturated fatty acids between carbons 9 and 10. Preferred substrates of  SCD-1 are long-chain acyl-CoAs with 13 to 19 carbons, among them  stearoyl-CoA and palmitoyl-CoA, the most abundant saturated fatty  acid-CoA ester in mammalians. Dehydrogenation of the pro-R hydrogens at  C9 and C10 requires molecular oxygen which is activated at the di-iron  center and reduced to water. Two of the electrons transferred to  molecular oxygen derive from the acyl-CoA substrate and two others from  the di-iron center. The ferrous catalytic center is regenerated by  electron transfer from cytochrome b5, which has been suggested to bind  to a groove at the cytoplasmic domain and to transmit electrons via two  histidine residues (H157 and H298) bridging the distance.  Ferrocytochrome b5 is provided by cytochrome b5 reductase using NAD(P)H  as co-substrate <134>; #33# the DELTA9-desaturase SCD-1 introduces a  cis-double bond into saturated fatty acids between carbons 9 and 10.  Preferred substrates of SCD-1 are long-chain acyl-CoAs with 13 to 19  carbons, among them stearoyl-CoA and palmitoyl-CoA, the most abundant  saturated fatty acid-CoA ester in mammalians. Dehydrogenation of the  pro-R hydrogens at C9 and C10 requires molecular oxygen which is  activated at the di-iron center and reduced to water. Two of the  electrons transferred to molecular oxygen derive from the acyl-CoA  substrate and two others from the di-iron center. The ferrous catalytic  center is regenerated by electron transfer from cytochrome b5, which  has been suggested to bind to a groove at the cytoplasmic domain and to  transmit electrons via two histidine residues bridging the distance.  Ferrocytochrome b5 is provided by cytochrome b5 reductase using NAD(P)H  as co-substrate <134>)  "
1.14.19.10, icosanoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = (Z)-icos-5-enoyl-CoA  + 2 ferricytochrome b5 + 2 H2O  
1.14.19.11, palmitoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = (4Z)-hexadec-4-enoyl-[acyl-carrier protein] + 2  oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.12, linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  pinolenoyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O 
1.14.19.12, alpha-linolenoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  coniferonoyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O  
1.14.19.13," (9Z,12Z)-hexadeca-9,12-dienoyl-CoA + reduced acceptor + O2 =  (9Z,12Z,15Z)-hexadeca-9,12,15-trienoyl-CoA + acceptor + 2 H2O  "
1.14.19.14," a linoleoyl-[glycerolipid] + reduced acceptor + O2 = an  (8E,10E,12Z)-octadeca-8,10,12-trienoyl-[glycerolipid] + acceptor + 2 H2O  "
1.14.19.15," (11Z)-hexadec-11-enoyl-CoA + reduced acceptor + O2 =  (10E,12Z)-hexadeca-10,12-dienoyl-CoA + acceptor + 2 H2O  "
1.14.19.16," a linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (9Z,11E,13Z)-octadeca-9,11,13-trienoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O  "
1.14.19.17," a dihydroceramide + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (4E)-sphing-4-enine ceramide + 2 ferricytochrome b5 + 2 H2O (#1# FAD  takes electrons from NADH and delivers them to ferrocytochrome b5 with  bound Fe3+, which is converted to ferricytochrome b5 with Fe2+.  Cytochrome b5-Fe2+ passes the electrons to another enzyme-bound Fe3+ to  reduce O2 and form ceramide from dihydroceramide <15>; #10,11,12,14#  the desaturation reaction catalyzed by Des1 is presumably initiated by  an enzyme-bound iron-oxo species that abstracts specifically the C-4  pro (R)-hydrogen atom from the substrate. FAD takes electrons from NADH  and delivers them to ferrocytochrome b5 with bound Fe3+, which is  converted to ferricytochrome b5 with Fe2+. Cytochrome b5-Fe2+ passes  the electrons to another enzyme-bound Fe3+ to reduce O2 and form  ceramide from dihydroceramide <15>)  "
1.14.19.18," a (4E)-sphing-4-enine ceramide + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (4E,8E)-sphing-4,8-dienine ceramide + 2 ferricytochrome b5 + 2 H2O  "
1.14.19.19," a (4E,8E)-sphinga-4,8-dienine ceramide + 2 ferrocytochrome b5 + O2 + 2  H+ = a (4E,8E,10E)-sphinga-4,8,10-trienine ceramide + 2 ferricytochrome  b5 + 2 H2O  "
1.14.19.2," stearoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = oleoyl-[acyl-carrier protein] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O (#1# enzyme acts on  derivatives of a number of long-chain fatty acids, requires ferredoxin,  formerly EC 1.14.99.6 <2>; #14# specific for stearoyl-CoA <1>; #15#  peroxodiferric intermediate is suggested <16>; #6# EPR and ENDOR  studies, both major conformers of the diferric cluster have a mu-oxo  bridge, structural alterations upon binding of substrate <24>)  "
1.14.19.20," a DELTA7-sterol + 2 ferrocytochrome b5 + O2 + 2 H+ = a DELTA5,7-sterol  + 2 ferricytochrome b5 + 2 H2O (#5,7# enzyme initiates oxidation by  cleavage of the chemically activated C6alpha-H bond, proposed mechanism  <12>)  "
1.14.19.21," cholesterol + O2 + NAD(P)H + H+ = cholesta-5,7-dien-3beta-ol + NAD(P)+  + 2 H2O  "
1.14.19.22, an oleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  linoleoyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O  
1.14.19.23, an oleoyl-[glycerolipid] + 2 reduced ferredoxin [iron-sulfur] cluster +  O2 + 2 H+ = a linoleoyl-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O  
1.14.19.24," an acyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = an (11E)-enoyl-CoA + 2  ferricytochrome b5 + 2 H2O (#1# reaction involves a first slow,  isotope-sensitive C11-H cleavage, with probable formation of an  unstable intermediate, followed by a second fast C12-H bond removal  <2>; #1# a single enzyme may be responsible for the formation of both  (Z)- and (E)-11-tetradecanoic acids. It is also possible that two  mechanistically identical discrete enzymes are involved in each  desaturation <2>)  "
1.14.19.25, a linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = an  alpha-linolenoyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O  
1.14.19.26, palmitoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = (6Z)-hexadec-6-enoyl-[acyl-carrier protein] + 2  oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.27, a 1-acyl-2-palmitoyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-acyl-2-palmitoleoyl-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O  
1.14.19.28, a 1-stearoyl-2-acyl-[glycerolipid] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = a 1-oleoyl-2-acyl-[glycerolipid] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.29," a (4R)-4-hydroxysphinganine ceramide + 2 ferrocytochrome b5 + O2 + 2 H+  = a (4R,8E)-4-hydroxysphing-8-enine ceramide + 2 ferricytochrome b5 + 2  H2O (#7# (1) <1>) "
1.14.19.29," a (4R)-4-hydroxysphinganine ceramide + 2 ferrocytochrome b5 + O2 + 2 H+  = a (4R,8Z)-4-hydroxysphing-8-enine ceramide + 2 ferricytochrome b5 + 2  H2O (#7# (2) <1>)  "
1.14.19.3," linoleoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = gamma-linolenoyl-CoA  + 2 ferricytochrome b5 + 2 H2O (#52,53# molecular mechanisms underlying  catalytic activity of delta 6 desaturase <66>) "
1.14.19.3, alpha-linolenoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ =  stearidonoyl-CoA + 2 ferricytochrome b5 + 2 H2O (#53# molecular  mechanisms underlying catalytic activity of delta 6 desaturase <66>)  
1.14.19.30," an (8Z,11Z,14Z)-icosa-8,11,14-trienoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-tetraenoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O "
1.14.19.30," an (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O "
1.14.19.30," an (8Z,11Z,14Z)-icosa-8,11,14-trienoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-tetraenoyl-[glycerolipid] +  ferricytochrome b5 + 2 H2O (#14# (1) <2>) "
1.14.19.30," an (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl-[glycerolipid] +  ferricytochrome b5 + 2 H2O (#14# (2) <2>)  "
1.14.19.31," a (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl-[glycerolipid] +  2 ferrocytochrome b5 + O2 + 2 H+ = a  (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-[glycerolipid]  + 2 ferricytochrome b5 + 2 H2O "
1.14.19.31," a (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O "
1.14.19.31," a (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl-[glycerolipid] +  2 ferrocytochrome b5 + O2 + 2 H+ = a  (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-[glycerolipid]  + ferricytochrome b5 + 2 H2O (#4# (1) <4>) "
1.14.19.31," a (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = a  (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl-[glycerolipid] +  ferricytochrome b5 + 2 H2O (#4# (1) <4>)  "
1.14.19.32, palmitoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ =  (14E)-hexadec-14-enoyl-CoA + 2 ferricytochrome b5 + 2 H2O (#3# (2) <3>) 
1.14.19.32, palmitoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ =  (14Z)-hexadec-14-enoyl-CoA + 2 ferricytochrome b5 + 2 H2O (#3# (1) <3>)  
1.14.19.33, a linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = an  alpha-eleostearoyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O (#1#  (1) <2>) 
1.14.19.33, a gamma-linolenoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  an alpha-parinaroyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O (#1#  (2) <2>)  
1.14.19.34," an oleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (9Z,12E)-octadeca-9,12-dienoyl-[glycerolipid] + 2 ferricytochrome b5 +  2 H2O (#2# proposed mechanism of DsFAD2-2: removal of a C-11 hydrogen  atom from trans-DELTA12-linoleic acid by the diiron-oxo center of  DsFAD2-2 results in the shift of the cis-DELTA9 double bond to the  trans-DELTA10 position. The radical remaining at the C-9 position is  then able to remove an oxygen atom from the diiron-oxo center because  of close proximity to the catalytic core of DsFAD2-2 as dictated by the  substrate binding properties of this enzyme <2>) "
1.14.19.34," a palmitoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (9Z,12E)-hexadeca-9,12-dienoyl-[glycerolipid] + 2 ferricytochrome b5 +  2 H2O  "
1.14.19.35," a (7Z,10Z)-hexadeca-7,10-dienoyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  (7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl-[glycerolipid] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O "
1.14.19.35, a linoleoyl-[glycerolipid] + 2 reduced ferredoxin [iron-sulfur] cluster  + O2 + 2 H+ = an alpha-linolenoyl-[glycerolipid] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O 
1.14.19.35," a (7Z,10Z)-hexadeca-7,10-dienoyl-[glycerolipid] + 2 reduced ferredoxin  + O2 + 2 H+ = a (7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl-[glycerolipid] +  2 oxidized ferredoxin + 2 H2O (#5# (1) <1>) "
1.14.19.35, a linoleoyl-[glycerolipid] + 2 reduced ferredoxin + O2 + 2 H+ = an  alpha-linolenoyl-[glycerolipid] + 2 oxidized ferredoxin + 2 H2O (#5#  (2) <1>)  
1.14.19.36, a 1-gamma-linolenoyl-2-acyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-stearidonoyl-2-acyl-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O 
1.14.19.36, a 1-linoleoyl-2-acyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-alpha-linolenoyl-2-acyl-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O 
1.14.19.36, a 1-gamma-linolenoyl 2-acyl-sn-glycerol 3-phosphate + 2 reduced  ferredoxin + O2 + 2 H+ = a 1-stearidonoyl 2-acyl-sn-glycerol  3-phosphate + 2 oxidized ferredoxin + 2 H2O (#3# (1) <1>) 
1.14.19.36, a 1-linoleoyl 2-acyl-sn-glycerol 3-phosphate + 2 reduced ferredoxin +  O2 + 2 H+ = a 1-alpha-linolenoyl 2-acyl-sn-glycerol 3-phosphate + 2  oxidized ferredoxin + 2 H2O (#3# (2) <1>)  
1.14.19.37," (11Z,14Z)-icosa-11,14-dienoyl-CoA + reduced acceptor + O2 =  (5Z,11Z,14Z)-icosa-5,11,14-trienoyl-CoA + acceptor + 2 H2O "
1.14.19.37," (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-CoA + reduced acceptor + O2 =  (5Z,11Z,14Z,17Z)-icosa-5,11,14,17-tetraenoyl-CoA + acceptor + 2 H2O  "
1.14.19.38," a gamma-linolenoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  a (9Z,12Z)-octadeca-9,12-dien-6-ynoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O "
1.14.19.38," a stearidonoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  (9Z,12Z,15Z)-octadeca-9,12,15-trien-6-ynoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O  "
1.14.19.39, linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  crepenynyl-[glycerolipid] + 2 ferricytochrome b5 + 2 H2O (#4#  stereochemical mechanism in reaction with oleate <3>)  
1.14.19.4," an (11Z,14Z)-icosa-11,14-dienoyl-[glycerolipid] + 2 ferrocytochrome b5  + O2 + 2 H+ = an (8Z,11Z,14Z)-icosa-8,11,14-trienoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O "
1.14.19.4," an (11Z,14Z,17Z)-icosa-11,14,17-trienoyl-[glycerolipid] + 2  ferrocytochrome b5 + O2 + 2 H+ = an  (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl-[glycerolipid] + 2  ferricytochrome b5 + 2 H2O  "
1.14.19.40, hex-5-enoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = hex-5-ynoyl-[acyl-carrier protein] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.41," ergosta-5,7,24(28)-trien-3beta-ol + NADPH + H+ + O2 =  ergosta-5,7,22,24(28)-tetraen-3beta-ol + NADP+ + 2 H2O  "
1.14.19.42, a 1-acyl-2-palmitoyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-acyl-2-[(7Z)-hexadec-7-enoyl]-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O  
1.14.19.43, a 1-acyl-2-palmitoyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-acyl-2-[(3E)-hexadec-3-enoyl]-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O  
1.14.19.44," (8Z,11Z,14Z)-icosa-8,11,14-trienoyl-CoA + 2 ferrocytochrome b5 + O2 + 2  H+ = arachidonoyl-CoA + 2 ferricytochrome b5 + 2 H2O "
1.14.19.44," (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl-CoA + 2 ferrocytochrome b5  + O2 + 2 H+ = (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl-CoA + 2  ferricytochrome b5 + 2 H2O  "
1.14.19.45, a 1-oleoyl-2-acyl-[glycerolipid] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = a 1-linoleoyl-2-acyl-[glycerolipid] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.46, a 1-linoleoyl-2-acyl-[glycerolipid] + 2 reduced ferredoxin  [iron-sulfur] cluster + O2 + 2 H+ = a  1-gamma-linolenoyl-2-acyl-[glycerolipid] + 2 oxidized ferredoxin  [iron-sulfur] cluster + 2 H2O  
1.14.19.47, an alpha-linolenoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ =  a stearidonoyl-[glycerolipid] + ferricytochrome b5 + 2 H2O 
1.14.19.47, a linoleoyl-[glycerolipid] + 2 ferrocytochrome b5 + O2 + 2 H+ = a  gamma-linolenoyl-[glycerolipid] + ferricytochrome b5 + 2 H2O  
1.14.19.48, tert-amyl alcohol + NADPH + H+ + O2 = isoprenyl alcohol + NADP+ + 2 H2O  
1.14.19.49, tetracycline + FADH2 + chloride + O2 + H+ = 7-chlorotetracycline + FAD  + 2 H2O  
1.14.19.5," an acyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = an (11Z)-enoyl-CoA + 2  ferricytochrome b5 + 2 H2O (#4# reaction involves a first slow,  isotope-sensitive C11-H cleavage, with probable formation of an  unstable intermediate, followed by a second fast C12-H bond removal  <2>; #4# a single enzyme may be responsible for the formation of both  (Z)- and (E)-11-tetradecanoic acids. It is also possible that two  mechanistically identical discrete enzymes are involved in each  desaturation <2>) "
1.14.19.5, acyl-CoA + reduced acceptor + O2 = Delta11-acyl-CoA + acceptor + 2 H2O  (#4# active site modeling <13>)  
1.14.19.50," 4'-O-methylnorbelladine + [reduced NADPH-hemoprotein reductase] + O2 =  (4aR,10bS)-noroxomaritidine + [oxidized NADPH-hemoprotein reductase] +  2 H2O "
1.14.19.50," 4'-O-methylnorbelladine + [reduced NADPH-hemoprotein reductase] + O2 =  (4aS,10bR)-noroxomaritidine + [oxidized NADPH-hemoprotein reductase] +  2 H2O  "
1.14.19.51, (S)-reticuline + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-corytuberine + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.52, 2-(L-cystein-S-yl)-2-(1H-indol-3-yl)acetonitrile + 2 [reduced  NADPH-hemoprotein reductase] + 2 O2 = camalexin + hydrogen cyanide +  CO2 + 2 [oxidized NADPH-hemoprotein reductase] + 4 H2O 
1.14.19.52, 2-(L-cystein-S-yl)-2-(1H-indol-3-yl)acetonitrile + [reduced  NADPH-hemoprotein reductase] + O2 = (R)-dihydrocamalexate + hydrogen  cyanide + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.19.52, (R)-dihydrocamalexate + [reduced NADPH-hemoprotein reductase] + O2 =  camalexin + CO2 + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.53," all-trans-retinol + 2 reduced adrenodoxin + 2 H+ + O2 =  all-trans-3,4-didehydroretinol + 2 oxidized adrenodoxin + 2 H2O  "
1.14.19.54," (S)-reticuline + [reduced NADPH-hemoprotein reductase] + O2 =  1,2-dehydroreticuline + [oxidized NADPH-hemoprotein reductase] + 2 H2O  "
1.14.19.55," 4-hydroxybenzoate + 2 NADPH + 2 bromide + 2 O2 + 2 H+ =  2,4-dibromophenol + 2 NADP+ + CO2 + 4 H2O "
1.14.19.55, 4-hydroxybenzoate + NADPH + bromide + O2 + H+ =  3-bromo-4-hydroxybenzoate + NADP+ + 2 H2O 
1.14.19.55," 3-bromo-4-hydroxybenzoate + NADPH + bromide + O2 + H+ =  2,4-dibromophenol + NADP+ + CO2 + 2 H2O "
1.14.19.55," 3,4-dihydroxybenzoate + 2 NADPH + 2 bromide + 2 O2 + 2 H+ =  3,5-dibromobenzene-1,2-diol + 2 NADP+ + CO2 + 4 H2O "
1.14.19.55," 3,4-dihydroxybenzoate + NADPH + bromide + O2 + H+ =  3-bromo-4,5-dihydroxybenzoate + NADP+ + 2 H2O "
1.14.19.55," 3-bromo-4,5-dihydroxybenzoate + NADPH + bromide + O2 + H+ =  3,5-dibromobenzene-1,2-diol + NADP+ + CO2 + 2 H2O  "
1.14.19.56," 1H-pyrrole-2-carbonyl-[PltL peptidyl-carrier protein] + 2 FADH2 + 2  chloride + 2 O2 = 4,5-dichloro-1H-pyrrole-2-carbonyl-[PltL  peptidyl-carrier protein] + 2 FAD + 4 H2O "
1.14.19.56, 1H-pyrrole-2-carbonyl-[PltL peptidyl-carrier protein] + FADH2 +  chloride + O2 = 5-chloro-1H-pyrrole-2-carbonyl-[PltL peptidyl-carrier  protein] + FAD + 2 H2O 
1.14.19.56," 5-chloro-1H-pyrrole-2-carbonyl-[PltL peptidyl-carrier protein] + FADH2  + chloride + O2 = 4,5-dichloro-1H-pyrrole-2-carbonyl-[PltL  peptidyl-carrier protein] + FAD + H2O  "
1.14.19.57," 1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier protein] + 3 FADH2 + 3  bromide + 3 O2 = 3,4,5-tribromo-1H-pyrrole-2-carbonyl-[Bmp1  peptidyl-carrier protein] + 3 FAD + 6 H2O "
1.14.19.57, 1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier protein] + FADH2 + bromide  + O2 = 5-bromo-1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier protein] +  FAD + 2 H2O 
1.14.19.57," 5-bromo-1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier protein] + FADH2 +  bromide + O2 = 4,5-dibromo-1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier  protein] + FAD + 2 H2O "
1.14.19.57," 4,5-dibromo-1H-pyrrole-2-carbonyl-[Bmp1 peptidyl-carrier protein] +  FADH2 + bromide + O2 = 3,4,5-tribromo-1H-pyrrole-2-carbonyl-[Bmp1  peptidyl-carrier protein] + FAD + 2 H2O  "
1.14.19.58, L-tryptophan + FADH2 + chloride + O2 + H+ = 5-chloro-L-tryptophan + FAD  + 2 H2O  
1.14.19.59, L-tryptophan + FADH2 + chloride + O2 + H+ = 6-chloro-L-tryptophan + FAD  + 2 H2O (#1# (1) <1>) 
1.14.19.59, D-tryptophan + FADH2 + chloride + O2 + H+ = 6-chloro-D-tryptophan + FAD  + 2 H2O (#1# (1) <1>)  
1.14.19.6, oleoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ = linoleoyl-CoA + 2  ferricytochrome b5 + 2 H2O 
1.14.19.6," palmitoleoyl-CoA + 2 ferrocytochrome b5 + O2 + 2 H+ =  (9Z,12Z)-hexadeca-9,12-dienoyl-CoA + 2 ferricytochrome b5 + 2 H2O  "
1.14.19.60," 7-chloro-L-tryptophan + FADH2 + chloride + O2 + H+ =  6,7-dichloro-L-tryptophan + FAD + 2 H2O  "
1.14.19.61, dihydrorhizobitoxine + 2 reduced ferredoxin [iron-sulfur] cluster + O2  + 2 H+ = rhizobitoxine + 2 oxidized ferredoxin [iron-sulfur] cluster +  2 H2O  
1.14.19.62, loganin + [reduced NADPH-hemoprotein reductase] + O2 = secologanin +  [oxidized NADPH-hemoprotein reductase] + 2 H2O (#2# constitutive enzyme  <1>; #2# enzyme belongs to the group of cytochrome P450 monooxygenases  <2>; #3# epidermis-specific expression in immature leaves <3>)  
1.14.19.63, calycosin + [reduced NADPH-hemoprotein reductase] + O2 =  pseudobaptigenin + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.19.63, pratensein + [reduced NADPH-hemoprotein reductase] + O2 =  5-hydroxypseudobaptigenin + [oxidized NADPH-hemoprotein reductase] + 2  H2O  
1.14.19.64, (S)-cheilanthifoline + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-stylopine + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.65, (S)-scoulerine + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-cheilanthifoline + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.66, (S)-N-methylcoclaurine + (R)-N-methylcoclaurine + [reduced  NADPH-hemoprotein reductase] + O2 = berbamunine + [oxidized  NADPH-hemoprotein reductase] + 2 H2O (#1# regioselective and  stereoselective formation of a C-O phenol couple in  bisbenzylisoquinoline alkaloid biosynthesis without concomitant  incorporation of activated oxygen into the product <1>)  
1.14.19.67, (R)-reticuline + [reduced NADPH-hemoprotein reductase] + O2 =  salutaridine + [oxidized NADPH-hemoprotein reductase] + 2 H2O (#7#  regioselective and stereoselective para-ortho oxidative coupling <1>)  
1.14.19.68, (S)-tetrahydrocolumbamine + [reduced NADPH-hemoprotein reductase] + O2  = (S)-canadine + [oxidized NADPH-hemoprotein reductase] + 2 H2O (#7#  formation of a methylenedioxy bridge in ring A <1>)  
1.14.19.69," 2 flaviolin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  3,3'-biflaviolin + 2 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O "
1.14.19.69," 2 flaviolin + 2 reduced ferredoxin [iron-sulfur] cluster + 2 H+ + O2 =  3,8'-biflaviolin + 2 oxidized ferredoxin [iron-sulfur] cluster + 2 H2O  "
1.14.19.70, cyclo(L-tyrosyl-L-tyrosyl) + 2 reduced ferredoxin [iron-sulfur] cluster  + 2 H+ + O2 = mycocyclosin + 2 oxidized ferredoxin [iron-sulfur]  cluster + 2 H2O  
1.14.19.71, tryprostatin A + [reduced NADPH-hemoprotein reductase] + O2 =  fumitremorgin C + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.72, (-)-matairesinol + [reduced NADPH-hemoprotein reductase] + O2 =  (-)-pluviatolide + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.73, (S)-scoulerine + [reduced NADPH-hemoprotein reductase] + O2 =  (S)-nandinine + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.74, (+)-pinoresinol + [reduced NADPH-hemoprotein reductase] + O2 =  (+)-piperitol + [oxidized NADPH-hemoprotein reductase] + 2 H2O 
1.14.19.74, (+)-piperitol + [reduced NADPH-hemoprotein reductase] + O2 =  (+)-sesamin + [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.75, 1-hexacosanoyl-2-acyl-[phosphoglycerolipid] + 2 ferrocytochrome b5 + O2  + 2 H+ = 1-[(17Z)-hexacos-17-enoyl]-2-acyl-[phosphoglycerolipid] + 2  ferricytochrome b5 + 2 H2O 
1.14.19.75, 1-tetracosanoyl-2-acyl-[phosphoglycerolipid] + 2 ferrocytochrome b5 +  O2 + 2 H+ = 1-[(15Z)-tetracos-15-enoyl]-2-acyl-[phosphoglycerolipid] +  2 ferricytochrome b5 + 2 H2O  
1.14.19.76, a flavanone + [reduced NADPH-hemoprotein reductase] + O2 = a flavone +  [oxidized NADPH-hemoprotein reductase] + 2 H2O  
1.14.19.77," a plasmanylethanolamine + 2 ferrocytochrome b5 + O2 + 2 H+ = a  plasmenylethanolamine + 2 ferricytochrome b5 + 2 H2O (#3,5# mixed  function oxidase <1,2>)  "
1.14.19.78, decanoyl-[acyl-carrier protein] + 4 reduced ferredoxin [iron-sulfur]  cluster + 2 O2 + 4 H+ = dec-9-ynoyl-[acyl-carrier protein] + 4 oxidized  ferredoxin [iron-sulfur] cluster + 4 H2O 
1.14.19.78, decanoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = dec-9-enoyl-[acyl-carrier protein] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O 
1.14.19.78, dec-9-enoyl-[acyl-carrier protein] + 2 reduced ferredoxin [iron-sulfur]  cluster + O2 + 2 H+ = dec-9-ynoyl-[acyl-carrier protein] + 2 oxidized  ferredoxin [iron-sulfur] cluster + 2 H2O  
1.14.19.8," pentalenolactone F + O2 + 2 reduced ferredoxin + 2 H+ =  pentalenolactone + 2 oxidized ferredoxin + 2 H2O (#4# molecular  reaction mechanism, overview <4>)  "
1.14.19.9," tryptophan + FADH2 + chloride + O2 + H+ = 7-chloro-L-tryptophan + FAD +  2 H2O (#2# reaction mechanism <6>; #2# FADH2 and O2 form an  4alpha-FAD-OOH intermediate that decays to 4alpha-FAD-OH. Tryptophan  likely does not react directly with any flavin intermediate. Substrate  chlorination occurs after completion of the flavin redox reactions <3>;  #1# FADH2 reacts with O2 to make peroxyflavin, which is decomposed by  Cl-. the resulting HOCl is guided through the tunnel to tryptophan,  where it is activated to participate in electrophilic aromatic  substitution <5>; #1# monooxygenase-like mechanism proposed. First,  FADH2 is produced by a flavin reductase using NADH. FADH2 binds to  flavin-free enzyme and reacts to enzyme-bound 4alpha-flavin  hydroperoxide which attacks L-tryptophan. Activated tryptophan is  attacked by chloride as a nucleophile, the resulting halohydrin is  dehydrated to the end product 7-chlorotryptophan <2>; #3# proposed  mechanism: after formation of a FAD-OOH intermediate, the reactive  chlorine is generated as a FAD-O-Cl intermediate. Chlorination of  L-tryptophan proceeds by attack of the aromatic pi electrons on the  intermediate in a two-electron mechanism and abstraction of a proton  generates the final product <4>; #6# reaction mechanism, combined  quantum mechanical/molecular mechanical (QM/MM) calculations of  potential energy and free energy surfaces, using the structure, PDB ID  2AR8, and employing density functional theory. First reaction step is  the formation of an arenium ion (Wheland intermediate), the second  reaction step is the deprotonation of the Wheland intermediate by  residue E346 oxygen, at the final stage of the mechanism residues K79  and E346 are regenerated <20>)  "
1.14.20.1," penicillin N + 2-oxoglutarate + O2 = deacetoxycephalosporin C +  succinate + CO2 + H2O (#9# reaction mechanism <21>; #10# bifunctional  enzyme, residues W82, N305 and M306 are involved in catalysis, overview  <20>; #9# presence of a stable iron-peroxo intermediate in equilibrium  with a more reactive ferryl species. Formation of CO2 as a leaving  group by decarboxylation of 2-oxoglutarate. Substitution of CO2 by the  penicillin substrate triggers the oxidation reaction in a  booby-trap-like mechanism <31>; #9# ping pong reaction mechanism,  analysis, overview <40>)  "
1.14.20.10, (2S)-3-(4-hydroxyphenyl)-2-isocyanopropanoate + 2-oxoglutarate + O2 =  4-[(E)-2-isocyanoethenyl]phenol + succinate + 2 CO2 + H2O  
1.14.20.11, (2S)-3-(1H-indol-3-yl)-2-isocyanopropanoate + 2-oxoglutarate + O2 =  3-[(Z)-2-isocyanoethenyl]-1H-indole + succinate + 2 CO2 + H2O  
1.14.20.12, (2S)-3-(1H-indol-3-yl)-2-isocyanopropanoate + 2-oxoglutarate + O2 =  3-[(E)-2-isocyanoethenyl]-1H-indole + succinate + 2 CO2 + H2O  
1.14.20.13," (6S)-6beta-hydroxyhyoscyamine + 2-oxoglutarate + O2 = scopolamine +  succinate + CO2 + H2O (#1# proposed mechanism of epoxidation catalyzed  by the enzyme, overview <2>)  "
1.14.20.14, hapalindole U + 2-oxoglutarate + O2 + chloride = hapalindole G +  succinate + CO2 + H2O 
1.14.20.14, 12-epi-fischerindole U + 2-oxoglutarate + O2 + chloride =  12-epi-fischerindole G + succinate + CO2 + H2O  
1.14.20.15, an L-threonyl-[L-threonyl-carrier protein] + 2-oxoglutarate + O2 + Cl-  = a 4-chloro-L-threonyl-[L-threonyl-carrier protein] + succinate + CO2  + H2O  
1.14.20.3," (3S,5S)-carbapenam-3-carboxylate + 2-oxoglutarate + O2 =  (5R)-carbapen-2-em-3-carboxylate + succinate + CO2 + H2O (#1# mechanism  <4>; #1# a mechanism for CarC-catalyzed coupled epimerization and  desaturation reactions is proposed <6>; #1# the contrathermodynamic  epimerization of (3S,5S)-carbapenam-3-carboxylate to  (3S,5R)-carbapenam-3-carboxylate is coupled at least to the binding of  2-oxoglutarate and it is probably coupled to the reduction of molecular  oxygen and proceeds by way of radical abstraction at C-5. The presumed  Fe(IV)=O species formed in these processes is required to drive the  subsequent desaturation process <2>)  "
1.14.20.4," a (2R,3S,4S)-leucoanthocyanidin + 2-oxoglutarate + O2 = an  anthocyanidin + succinate + CO2 + 2 H2O (#2,10# mechanism <1,2>) "
1.14.20.4," a (2R,3S,4S)-leucoanthocyanidin + 2-oxoglutarate + O2 = a (4S)-  2,3-dehydroflavan-3,4-diol + succinate + CO2 + H2O "
1.14.20.4," a (4S)- 2,3-dehydroflavan-3,4-diol = an anthocyanidin + H2O  "
1.14.20.5, a flavanone + 2-oxoglutarate + O2 = a flavone + succinate + CO2 + H2O  
1.14.20.6, a dihydroflavonol + 2-oxoglutarate + O2 = a flavonol + succinate + CO2  + H2O  
1.14.20.7," L-arginine + 2-oxoglutarate + O2 = succinate + CO2 + guanidine +  (S)-1-pyrroline-5-carboxylate + H2O (#7# reaction mechanism <7>; #7#  two-pathway reaction mechanism of EFE, structure-function relationship  <13>) "
1.14.20.7, L-arginine + 2-oxoglutarate + O2 = succinate + CO2 +  5-hydroxy-L-arginine 
1.14.20.7, 5-hydroxy-L-arginine = guanidine + (S)-1-pyrroline-5-carboxylate + H2O  
1.14.20.8, (-)-yatein + 2-oxoglutarate + O2 = (-)-deoxypodophyllotoxin + succinate  + CO2 + H2O  
1.14.20.9, (2S)-3-(4-hydroxyphenyl)-2-isocyanopropanoate + 2-oxoglutarate + O2 =  (2E)-3-(4-hydroxyphenyl)-2-isocyanoprop-2-enoate + succinate + CO2 + H2O  
1.14.99.1," arachidonate + reduced acceptor + 2 O2 = prostaglandin H2 + acceptor +  H2O (#8# mechanism, enzyme acts both as dioxygenase and as peroxidase  <8,19>)  "
1.14.99.11, estradiol-17beta + reduced acceptor + O2 =  6beta-hydroxyestradiol-17beta + acceptor + H2O  
1.14.99.12, androstenedione + reduced acceptor + O2 = testololactone + acceptor +  H2O  
1.14.99.14, progesterone + reduced acceptor + O2 = 11alpha-hydroxyprogesterone +  acceptor + H2O  
1.14.99.15," 4-methoxybenzoate + reduced acceptor + O2 = 4-hydroxybenzoate +  formaldehyde + acceptor + H2O (#2# a terminal oxygenase <3>; #2# the  bacterial enzyme is a two-component enzyme, consisting of an  iron-sulfur flavoprotein (FMN), NADH-putidamonooxin-reductase and a  ferredoxin-type, oxygen-activating protein, putidamonooxin <1,2>)  "
1.14.99.2," kynurenate + reduced acceptor + O2 =  7,8-dihydro-7,8-dihydroxykynurenate + acceptor  "
1.14.99.20," phylloquinone + reduced acceptor + O2 = 2,3-epoxyphylloquinone +  acceptor + H2O (#3# enzyme has two distinct functions: vitamin K  epoxidation and gamma-glutamyl carboxylation <9,10>; #3# propeptide and  glutamate-containing substrates bound to the vitamin K-dependent  carboxylase convert its vitamin K epoxidase function from an inactive  to an active state <11>; #2,3# enzyme linked to the vitamin K dependent  carboxylation system <2,3>; #3# vitamin K-dependent carboxylase  activity and vitamin K epoxidase activity are properties of the same  protein <8>; #4# K218 is the essential base that deprotonates AH2 to  initiate he reaction <13>)  "
1.14.99.21," Latia luciferin + reduced acceptor + 2 O2 = oxidized Latia luciferin +  CO2 + formate + acceptor + H2O + hnu (#1# possibly two enzyme  components are involved in the reaction, an oxygenase followed by a  monooxygenase for the actual light emitting step <1,2>)  "
1.14.99.22," ecdysone + reduced acceptor + O2 = 20-hydroxyecdysone + acceptor + H2O  (#7,12# 2 different isozymes of mitochondria and microsomes may have  different inducers, electron donors, endogenous inhibitors, and  physiological optima <9>; #1,2,3,4,6,10# NADPH-dependent monooxygenase  containing cytochrome P-450, a heme-thiolate protein <1,2,3,4,5,6,11>;  #3# ecdysteroid biosynthesis regulation <6>; #6# microsomal enzyme  system contains NADPH-dependent cytochrome P-450 reductase without a  second electron carrier type <8>; #6,11# a cytochrome P-450-dependent  steroid hydroxylase as part of the mitochondrial enzyme system with  both ferredoxin and cytochrome P-450 components <7,8>)  "
1.14.99.23," 3-hydroxybenzoate + reduced acceptor + O2 = 2,3-dihydroxybenzoate +  acceptor + H2O  "
1.14.99.24," pregna-4,9(11)-diene-3,20-dione + reduced acceptor + O2 =  9,11alpha-epoxypregn-4-ene-3,20-dione + acceptor + H2O  "
1.14.99.26," 2-hydroxypyridine + reduced acceptor + O2 = 2,5-dihydroxypyridine +  acceptor + H2O  "
1.14.99.29, [eIF5A]-deoxyhypusine + reduced acceptor + O2 = [eIF5A]-hypusine +  acceptor + H2O (#3# binuclear iron mediated reaction mechanism <11>)  
1.14.99.34, 7-O-methylluteone + NADPH + H+ + O2 = dihydrofurano derivatives + NADP+  + H2O  
1.14.99.35, thiophene-2-carbonyl-CoA + reduced acceptor + O2 =  5-hydroxythiophene-2-carbonyl-CoA + acceptor + H2O  
1.14.99.38, cholesterol + reduced acceptor + O2 = 25-hydroxycholesterol + acceptor  + H2O  
1.14.99.39," NH3 + a reduced acceptor + O2 = NH2OH + an acceptor + H2O (#2#  mechanism, active-site model for ammonia monooxygenase consisting of an  NH3-binding site and a second site that binds noncompetitive  inhibitors, with oxidation occurring at either site <3>)  "
1.14.99.4, progesterone + reduced acceptor + O2 = testosterone acetate + acceptor  + H2O  
1.14.99.44," 4,4'-diapolycopene + 4 reduced acceptor + 4 O2 = 4,4'-diapolycopenedial  + 4 acceptor + 6 H2O  "
1.14.99.46, uracil + FMNH2 + O2 + NADH = (Z)-3-ureidoacrylate + H2O + FMN + NAD+ +  H+ 
1.14.99.46, uracil + FMNH2 + O2 = (Z)-3-ureidoacrylate + FMN-N5-oxide 
1.14.99.46, FMN-N5-oxide + NADH = FMN + H2O + NAD+ + H+ 
1.14.99.46, thymine + FMNH2 + O2 + NADH = (Z)-2-methylureidoacrylate + H2O + FMN +  NAD+ + H+ 
1.14.99.46, thymine + FMNH2 + O2 = (Z)-2-methylureidoacrylate + FMN-N5-oxide  
1.14.99.47, (+)-larreatricin + reduced acceptor + O2 = (+)-3'-hydroxylarreatricin +  acceptor + H2O  
1.14.99.48, protoheme + 5 reduced acceptor + 4 O2 = delta-staphylobilin + Fe2+ +  formaldehyde + 5 acceptor + 4 H2O 
1.14.99.48, protoheme + 5 reduced acceptor + 4 O2 = beta-staphylobilin + Fe2+ +  formaldehyde + 5 acceptor + 4 H2O  
1.14.99.50," hercynine + gamma-L-glutamyl-L-cysteine + O2 =  gamma-L-glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide + H2O (#5#  catalytic mechanism in which C-S bond formation is initiated by an  iron(III)-complexed thiyl radical attacking the imidazole ring of  N-alpha-trimethyl histidine, proposed mechanism for EgtB-catalyzed C-S  bond formation and sulfoxidation, overview <3>; #5# EgtB contains a  conserved tyrosine residue that reacts via proton-coupled electron  transfer with the iron(III)-superoxo species and creates an  iron(III)-hydroperoxo intermediate, thereby preventing the possible  thiolate dioxygenation side reaction. The nucleophilic C-S  bond-formation step happens subsequently concomitant to relay of the  proton of the iron(II)-hydroperoxo back to Tyr377. This is the  rate-determining step in the reaction cycle and is followed by  hydrogen-atom transfer from the CE1-H group of trimethyl histidine  substrate to iron(II)-superoxo. In the final step, a quick and almost  barrierless sulfoxidation leads to the sulfoxide product complexes.  Quantum mechanics/molecular mechanics study of the mechanism of  sulfoxide synthase enzymes as compared to cysteine dioxygenase enzymes  and present pathways for both reaction channels in EgtB, reaction  mechanism, overview. The active site contains the unusual Tyr157-Cys93  cross-link with a covalent bond between the two amino acid residues. It  is believed this cross-link has a steric effect on the overall reaction  mechanism. The fast CDO-type side reaction is prevented through a  proton-coupled electron transfer from Tyr377 to iron(III)-superoxo,  which enables the slower C-S bond formation to take place and blocks  the sulfur dioxygenation side reaction <5>; #5# two different  mechanisms are analyzed, depending on whether the sulfoxidation or the  S-C bond formation takes place first. The calculations suggest that the  S-O bond formation occurs first between the thiolate and the ferric  superoxide, followed by homolytic O-O bond cleavage. Subsequently,  proton transfer from a second-shell residue Tyr377 to the newly  generated iron-oxo moiety takes place, which is followed by proton  transfer from the N-alpha-trimethyl histidine imidazole to Tyr377,  facilitated by two crystallographically observed water molecules. Next,  the S-C bond is formed between gamma-glutamyl cysteine and  N-alpha-trimethyl histidine, followed by proton transfer from the  imidazole CH moiety to Tyr377, which is calculated to be the  rate-limiting step for the whole reaction, with a barrier of 17.9  kcal/mol in the quintet state. Optimized structures for the second,  third, and fourth steps. Detailed overview <10>)  "
1.14.99.51, hercynine + L-cysteine + O2 = S-(hercyn-2-yl)-L-cysteine S-oxide + H2O  
1.14.99.52," L-histidine + L-cysteine + O2 = S-(L-histidin-5-yl)-L-cysteine S-oxide  + H2O (#3# catalytic mechanism: C-S bond formation is initiated by  formation of a histidyl sp2 radical, formation of a histidyl  PI-radical, and electrophilic attack of the iron-coordinated cysteine  sulfoxide on histidine. The enzyme OvoA oxidizes cysteine to access an  iron(IV)-oxo state (a in Figure 2) which then mediates oxidative  sulfurization of histidine <3>; #1# catalytic mechanism: C-S bond  formation is initiated by formation of a histidyl sp2 radical,  formation of a histidyl PI-radical, and electrophilic attack of the  iron-coordinated cysteine sulfoxide on histidine. The enzyme OvoA  oxidizes cysteine to access an iron(IV)-oxo state which then mediates  oxidative sulfurization of histidine <3>; #3# the catalytic mechanism  proceeds via radical intermediate, oxidation of histidine is  thermodynamically most favorable for the formation of a HisNdelta(-H).  radical via a proton-coupled electron transfer process, only the  ferrous peroxysulfur complexes are sufficiently powerful enough  oxidants to generate a histidyl-derived radical, not the  superoxo-complexes <2>; #3# the enzyme catalysis follows an thiol-ene  type mechanism, it catalyzes C-S bond formation through an OvoA  generated L-cysteine thiyl radical that attacks the unsaturated  imidazole ring of L-histidine, overview <1>)  "
1.14.99.53," [(1->4)-N-acetyl-beta-D-glucosaminyl](m+n) + reduced acceptor + O2 =  [(1->4)-N-acetyl-beta-D-glucosaminyl](m-1)-(1->4)-2-(acetylamino)-2  deoxy-D-glucono-1,5-lactone + [(1->4)-N-acetyl-beta-D-glucosaminyl]n +  acceptor + H2O (#5# (1) the initially formed D-glucono-1,5-lactone at  the reducing end of the chitin chain quickly hydrolyzes spontaneously  to the aldonic acid <5>)  "
1.14.99.54," [(1->4)-beta-D-glucosyl]n+m + reduced acceptor + O2 =  [(1->4)-beta-D-glucosyl]m-1-(1->4)-D-glucono-1,5-lactone +  [(1->4)-beta-D-glucosyl]n + acceptor + H2O (#12# (1) the  D-glucono-1,5-lactone at the reducing end of the cellulose chain  quickly hydrolyzes spontaneuosly to the aldonic acid <2>)  "
1.14.99.55," starch + reduced acceptor + O2 = D-glucono-1,5-lactone-terminated  malto-oligosaccharides + short-chain malto-oligosaccharides + acceptor  + H2O  "
1.14.99.56, [(1->4)-beta-D-glucosyl]n+m + reduced acceptor + O2 =  4-dehydro-beta-D-glucosyl-[(1->4)-beta-D-glucosyl]n-1 +  [(1->4)-beta-D-glucosyl]m + acceptor + H2O  
1.14.99.57, protoheme + 3 reduced acceptor + 3 O2 = mycobilin a + Fe2+ + 3 acceptor  + 3 H2O 
1.14.99.57, protoheme + 3 reduced acceptor + 3 O2 = mycobilin b + Fe2+ + 3 acceptor  + 3 H2O  
1.14.99.58," protoheme + 3 [reduced NADPH-hemoprotein reductase] + 3 O2 = biliverdin  + Fe2+ + CO + 3 [oxidized NADPH-hemoprotein reductase] + 3 H2O (#1#  rate-limiting step of reaction is release of product, involvement of  phytochrome BphP in product release <1>) "
1.14.99.58, protoheme + 3 reduced acceptor + 3 O2 = biliverdin-IX-delta + CO + Fe2+  + 3 acceptor + 3 H2O 
1.14.99.58, protoheme + 3 reduced acceptor + 3 O2 = biliverdin-IX-beta + CO + Fe2+  + 3 acceptor + 3 H2O  
1.14.99.59, tryptamine + reduced acceptor + O2 = 4-hydroxytryptamine + acceptor +  H2O  
1.14.99.60," 6-methoxy-3-methyl-2-(all-trans-polyprenyl)-1,4-benzoquinol + a reduced  acceptor + O2 = 3-demethylubiquinol + acceptor + H2O  "
1.14.99.61," cyclooctat-9-en-7-ol + reduced acceptor + O2 =  cyclooctat-9-ene-5,7-diol + acceptor + H2O  "
1.14.99.62," cyclooctat-9-ene-5,7-diol + reduced acceptor + O2 = cyclooctatin +  acceptor + H2O  "
1.14.99.63, beta-carotene + 2 reduced acceptor + 2 O2 = echinenone + 2 acceptor + 3  H2O 
1.14.99.63, echinenone + 2 reduced acceptor + 2 O2 = canthaxanthin + 2 acceptor + 3  H2O  
1.14.99.64, zeaxanthin + 2 reduced acceptor + 2 O2 = adonixanthin + 2 acceptor + 3  H2O 
1.14.99.64," adonixanthin + 2 reduced acceptor + 2 O2 = (3S,3'S)-astaxanthin + 2  acceptor + 3 H2O  "
1.14.99.65, 4-amino-L-phenylalanyl-[CmlP-peptidyl-carrier-protein] + reduced  acceptor + O2 =  2-(4-aminophenyl)-L-seryl-[CmlP-peptidyl-carrier-protein] + acceptor +  H2O  
1.14.99.66," a [histone H3]-N6,N6-dimethyl-L-lysine4 + 2 acceptor + 2 H2O = a  [histone H3]-L-lysine4 + 2 formaldehyde + 2 reduced acceptor "
1.14.99.66," a [histone H3]-N6,N6-dimethyl-L-lysine4 + acceptor + H2O = a [histone  H3]-N6-methyl-L-lysine4 + formaldehyde + reduced acceptor "
1.14.99.66, a [histone H3]-N6-methyl-L-lysine4 + acceptor + H2O = a [histone  H3]-L-lysine4 + formaldehyde + reduced acceptor  
1.14.99.67, alpha-N-dichloroacetyl-p-aminophenylserinol + reduced acceptor + 2 O2 =  chloramphenicol + acceptor + 2 H2O  
1.14.99.68, 4-aminobenzoate + reduced acceptor + 2 O2 = 4-nitrobenzoate + acceptor  + 2 H2O  
1.14.99.69, N6-(3-methylbut-2-en-1-yl)-2-(methylsulfanyl)adenosine37 in tRNA +  reduced acceptor + O2 =  N6-[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]-2-(methylsulfanyl)adenosine37  in tRNA + acceptor + H2O  
1.15.1.1," 2 superoxide + 2 H+ = O2 + H2O2  (#4,10,14,15,19,32,36,38,42,59,72,87,107,117# mechanism <8,9,34,37,38>;  #15# three-dimensional structure <9>; #15# Cu2+-binding <35>;  #11,14,20,22,24,25,26,34,43,49,57,60,61,62,64,74,107# amino acid  composition, comparison  <25,28,40,41,46,54,57,59,65,69,74,78,79,89,94,96>;  #2,6,8,9,10,11,12,14,19,27,32,34,36,75,126,127,216,218# amino acid  sequence alignment and comparison <8,53,83,85,91,99,100,101,102>;  #11,14,218# A metalloprotein. Enzymes from most eukaryotes contain both  copper and zinc, those from mitochondria and most prokaryotes contain  manganese or iron.  ligand binding site and structure <98,101,102>;  #9,10,19# active site, manganese-binding site and contact site between  monomers <8>; #36# active site is not conserved, differing from others  of Mn-SOD and Fe-SOD <8>; #15# presence of a general acid and a general  base in catalysis. Catalytic model requires histidine residues,  metal-bound water molecules and two hydrated metal ions to operate in  concert <163>; #24# the amino acid residues His46, His48, His63, His71,  His80, and His120, and Asp83 in the active site are conserved as in  other Cu/ZnSODs <219>; #209# electrostatic guidance of anionic  substrate to the active site, detailed overview. Generation of a model  for electrostatic-mediated diffusion, and efficient binding of  superoxide for catalysis <317>)  "
1.15.1.2," superoxide + reduced rubredoxin + 2 H+ = H2O2 + oxidized rubredoxin  (#10# very fast bimolecular reaction of iron center II with superoxide,  followed by the formation of two successive intermediate species <6>;  #10# reduction of superoxide may proceed through Fe3+-peroxo  intermediates <10>; #10# FITR study, presence of E47 is important for  the structural reorganization accompanying iron oxidation, catalytic  role of K48 is purely electrostatic, guiding superoxide toward the  reduced iron <16>; #10# in absence of O2.-, reduction potential and  absorption spectrum of the iron center II exhibit a pH transition.  First reaction intermediate is an iron(III)-peroxo species, second  intermediate is an iron(III)-hydroperoxo species <17>; #5# presence of  Fe(NHis)4(SCys) site is sufficient to catalyze reduction of the  intracellular superoxide to nonlethal levels <18>; #5# steady state  kinetics, diffusion-controlled reaction of reduced enzyme with  superoxide is the slowest process during turnover, neither ligation nor  deligation of the active site carboxylate limits turnover rate <18>;  #6# stopped-flow kinetics of electron transfer, second-order rate  constant of 10 million M-1 s-1 at 10Â°C and pH 7.2 <15>; #17# the iron  in the actice site is coordinated through a bent cyano bridge,  photo-reduction from FeIII to FeII induces an expansion of the enzyme  active site <19>; #6# the initial reaction between O2- and  Archaeoglobus fulgidus neelaredoxin leads to a short-lived transient  that immediately disappears to yield a solvent-bound ferric species in  acid-base equilibrium. The final step corresponds to the slow binding  of the glutamate sixth ligand to the oxidized iron, a process that may  be bypassed during in vivo catalytic turnover of the enzyme <21>; #6#  the initial reaction involves the formation of a short-lived transient  that decays by a proton-dependent step. This process generates an  Fe3+Â–OH species, which is converted to a glutamate-bound one. The  function of center I of Dfx remains to be elucidated. The completion of  the catalytic cycle of SOR, which involves the re-reduction of the  active site, can be attained by reduced rubredoxin <27>;  #1,4,7,9,15,16,17,18,19# enzyme active site structure and mechanism  <31>; #4,13,15,17# enzyme active site structure and mechanism,  catalytic cycle involving iron complexes, overview <32>; #17# enzyme  active site structure and mechanism, proposed mechanism for  SOR-catalyzed reduction of superoxide via hydroperoxo and solvent-bound  intermediates, catalytic cycle involving iron complexes, overview <29>;  #12# reaction mechanism involves the diffusion-limited encounter of  superoxide with the reduced iron site and concomitant formation of an  Fe3+-(hydro)peroxo adduct that, upon protonation, leads to the  formation of hydrogen peroxide. By the end of this process, a glutamate  residue coordinates the ferric ion, acting as a sixth ligand <36>; #15#  reaction mechanism of SOR involving transfer of an electron and two  protons to superoxide to form hydrogen peroxide, kinetic mechanism,  detailed overview <34>; #16# reaction mechanism, the active center of  SORs consists of a ferrous ion coordinated by four histidines and one  cysteine in a square-pyramidal geometry, formation of a hydroxo-iron  ligated species upon the decay of the first transient species followed  by conversion to the final species upon binding of the glutamate sixth  ligand, phosphate can serve as an exogenous sixth ligand, overview  <27>; #10# reaction mechanism of the SOR with superoxide, overview  <41>; #15,23# reaction mechanism, geometry of the catalytic center,  oxidative cycle/reductive pathway, overview <40>; #5,6,7,9,10,12,19,22#  reaction mechanism, oxidative cycle/reductive pathway, overview <40>;  #15# catalytic mechanism with the first step involving oxidative  addition of superoxide to form a ferric-peroxo intermediate. The Fe  spin state and the trans cysteinate ligand play an important role in  effecting superoxide reduction and peroxide release <46>)  "
1.16.1.1," Hg + NADP+ + H+ = Hg2+ + NADPH (#9# FAD mediates the transfer of  electrons between NADPH and Hg2+ bound to an adjacent pair of cysteine  thiols (C136 and C141) in the buried active site, while a second pair  of cysteines (C558 and C559) on the C-terminal tail mediates transfer  of Hg2+ from other protein and small molecule thiols in solution to the  active site cysteines through a ligand exchange mechanism,  structure-function study, overview <45>; #48# catalytic mechanisms of  the flavoprotein MerA, overview <55>; #9# MerA possesses  metallochaperone-like N-terminal domains (NmerA) tethered to its  catalytic core domain by linkers. The NmerA domains interacts  principally through electrostatic interactions with the core, leashed  by the linkers so as to subdiffuse on the surface over an area close to  the core C-terminal Hg(II)-binding cysteines <54>; #9# molecular  mechanism of the Hg transfer is analyzed by quantum  mechanical/molecular mechanical (QM/MM) calculations, and simulation.  The transfer is nearly thermoneutral and passes through a stable  tricoordinated intermediate that is marginally less stable than the two  end states. For the overall process, Hg2+ is always paired with at  least two thiolates and thus is present at both the C-terminal and  catalytic binding sites as a neutral complex. Prior to Hg2+ transfer,  C141 is negatively charged. As Hg2+ is transferred into the catalytic  site, a proton is transferred from C136 to C559 while C558 becomes  negatively charged, resulting in the net transfer of a negative charge  over a distance of about 7.5 A. Thus, the transport of this soft  divalent cation is made energetically feasible by pairing a competition  between multiple Cys thiols and/or thiolates for Hg2+ with a  competition between the Hg2+ and protons for the thiolates. Reaction  mechansim, detailed overview <52>)  "
1.16.1.10, 2 Fe(II)-siderophore + NAD(P)+ + H+ = 2 Fe(III)-siderophore + NAD(P)H  
1.16.1.2, transferrin[Fe(II)]2 + NAD+ + H+ = transferrin[Fe(III)]2 + NADH (#4#  amino acid composition <4>)  
1.16.1.6, 2 cob(II)alamin-[cyanocobalamin reductase] + 2 hydrogen cyanide + NADP+  = 2 cyanocob(III)alamin + 2 [cyanocobalamin reductase] + NADPH + H+  
1.16.1.7, 2 Fe(II)-siderophore + NAD+ + H+ = 2 Fe(III)-siderophore + NADH  
1.16.1.8," 2 [methionine synthase]-methylcob(III)alamin + 2  S-adenosyl-L-homocysteine + NADP+ = 2 [methionine  synthase]-cob(II)alamin + NADPH + H+ + 2 S-adenosyl-L-methionine (#2#  under anaerobic growth conditions, oxidized ferredoxin  (flavodoxin):NADP+ oxidoreductase accepts a hydride from NADPH and  transfers the electron to flavodoxin, generating primarily flavodoxin  semiquinone. Under anaerobic conditions the decarboxylation of pyruvate  is coupled to reduction of flavodoxin, forming the flavodoxin  hydroquinone. These reduced forms of flavodoxin bind to inactive  cob(II)alamin enzyme, causing a conformational change that is coupled  with dissociation of His759 and protonation of the His759-Asp757-Ser810  triad. Although NADPH oxidation ultimately produces 2 equivalent of  flavodoxin semiquinone, only one electron is transferred to methionine  synthase during reductive methylation <2>; #4# mechanism for the  NADPH-catalyzed reduction of diflavin oxidoreductases, overview <16>;  #4# hydride transfer and interflavin electron transfer are two  catalytic steps represented by two distinct kinetic phases leading to  transient formation of the FAD hydroquinone <17>)  "
1.16.1.9, 2 Fe(II)-siderophore + NADP+ + H+ = 2 Fe(III)-siderophore + NADPH  
1.16.3.1," 4 Fe(II) + 4 H+ + O2 = 4 Fe(III) + 2 H2O (#7# iron binding site plays a  major role in tuning the reduction potenzial of iron to provide a large  driving force for the reaction, E185 residue provides the dominant  electron transfer pathway to the T1 Cu site <38>; #7# residues D283,  E185, D409 provide a Fe(II) binding site that favors ferric ion thus  reducing the reduction potential of the bound Fe(II). Residues E185 and  D409 form part of the electron-transfer pathway from the bound Fe(II)  to the proteinÂ’s type I Cu(II) <45>; #37# reaction mechanism, overview.  Two reaction steps: 1. 2 Fe2+ O2 + 2 H+ = 2 Fe3+ + H2O2 and 2. H2O2 + 2  Fe2+ + 2 H+ = 2 Fe3+ + 2 H2O. The second step is rate-limiting <73>)  "
1.16.3.2, 4 Fe(II) + O2 + 6 H2O = 4 [FeO(OH)] + 8 H+ 
1.16.3.2, 2 Fe(II) + O2 + 4 H2O = 2 [FeO(OH)] + 4 H+ + H2O2 
1.16.3.2, 2 Fe(II) + H2O2 + 2 H2O = 2 [FeO(OH)] + 4 H+  
1.16.3.3, 4 Mn2+ + 2 O2 + 4 H2O = 4 MnIVO2 + 8 H+ 
1.16.3.3, 4 Mn2+ + O2 + 4 H+ = 4 Mn3+ + 2 H2O 
1.16.3.3, 4 Mn3+ + O2 + 6 H2O = 4 MnIVO2 + 12 H+  
1.16.3.4, 4 Cu+ + 4 H+ + O2 = 4 Cu2+ + 2 H2O  
1.16.9.1, Fe(II) + rusticyanin = Fe(III) + reduced rusticyanin  
1.16.99.1, ATP + a [Co(II) methylamine-specific corrinoid protein] + reduced  acceptor + H2O = ADP + phosphate + a [Co(I) methylamine-specific  corrinoid protein] + acceptor 
1.16.99.1, ATP + a [Co(II) dimethylamine-specific corrinoid protein] + reduced  acceptor + H2O = ADP + phosphate + a [Co(I) dimethylamine-specific  corrinoid protein] + acceptor 
1.16.99.1, ATP + a [Co(II) trimethylamine-specific corrinoid protein] + reduced  acceptor + H2O = ADP + phosphate + a [Co(I) trimethylamine-specific  corrinoid protein] + acceptor  
1.17.1.1," CDP-4-dehydro-3,6-dideoxy-D-glucose + NAD(P)+ + H2O =  CDP-4-dehydro-6-deoxy-D-glucose + NAD(P)H + H+ (#1,2# mechanism  <1,2,3>; #2# E1 binds the substrate pyridoxamine 5-phosphate essential  for binding, E3 possesses NADH oxidase activity, may be the reductase  <3>; #1,2# 2 proteins, E1 and E3, are involved but no partial reaction  is observed in the presence of either alone <1,2>; #2# role of the  enzymes E1 and E3, as well as role of the cofactor. Multicomponent  system consisting of substrate, NADH or NADPH, enzyme E1: recognition  unit of the system by binding to the substrate through the amino group  of the coenzyme, enzyme E3: acts as the dehydrogenase of the system,  and cofactor: pyridoxamine 5-phosphate <1,3>)  "
1.17.1.10, formate + NADP+ = CO2 + NADPH  
1.17.1.11, 2 formate + NAD+ + 2 oxidized ferredoxin [iron-sulfur] cluster = 2 CO2  + NADH + H+ + 2 reduced ferredoxin [iron-sulfur] cluster  
1.17.1.3," (2R,3S)-catechin + NADP+ + H2O = 2,3-trans-3,4-cis-leucocyanidin +  NADPH + H+ (#21# two-step catalytic mechanism involving the formation  of an enzyme-bound quinone methide intermediate prior to reduction,  overview. A concerted dehydration precedes an NADPH-mediated hydride  transfer at C4. The dehydration step involves a Lys-catalyzed  deprotonation of the phenolic OH7 through a bridging water molecule and  a His-catalyzed protonation of the benzylic hydroxyl at C4. The  resulting quinone methide serves as an electrophilic target for hydride  transfer at C4. The role of the lysine is to promote the formation of  this intermediate by catalyzing the deprotonation of a phenolic  hydroxyl <13>)  "
1.17.1.4," xanthine + NAD+ + H2O = urate + NADH + H+ (#68# catalytically labile  Mo-OH oxygen forms a bond with a carbon atom of substrate, the Mo=S  group of the oxidized enzyme becomes protonated to afford Mo-SH on  reduction of the molybdenum center <79>; #10# mechanism of conversion  of dehydrogenase form to oxidase form <75>; #9# reaction mechanism with  substrate all-trans-retinol, overview <114>; #66# the catalytic  sequence of Rhodobacter capsulatus XDH is initiated by abstraction of a  proton from the Mo-OH group by the highly conserved active site subunit  B residue Glu730, followed by nucleophilic attack of the resulting  Mo-O on the carbon center of the substrate (C-2 in hypoxanthine and  C-8 in xanthine) and concomitant hydride transfer to the Mo-S of the  molybdenum center, reaction and substrate binding mechanisms, overview  <111>; #12,67# reaction mechanism of XOR and binding modes of the  substrate xanthine, overview. The oxidative hydroxylation of purine  substrates takes place at the molybdenum center. Reducing equivalents  introduced there are then transferred via two [2Fe-2S] centers to the  FAD cofactor where reduction of the physiological electron acceptors  occurs, NAD+ in the case of the dehydrogenase form, XDH, or O2 in the  oxidase form, XO, of the enzyme occur <120>; #26# reaction mechanism,  The reaction is initiated by proton abstraction from the Mo-OH group by  Glu730, the active-site base, followed by nucleophilic attack on the  carbon to be hydroxylated, and hydride transfer to the Mo-S double  bond. Suitable substrate orientation, overview. Arg310 is involved in  stablizing the transition state in the course of nucleophilic attack,  overview <119>; #26# a reaction mechanism for XDH is suggested in which  an initial oxo rather than a hydroxo group and the sulfido ligand are  essential for xanthine oxidation <133>)  "
1.17.1.5, nicotinate + H2O + NADP+ = 6-hydroxynicotinate + NADPH + H+  
1.17.1.8," (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ + H2O =  (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate + NAD(P)H + H+ (#5,17#  mechanism <9,18>; #6# stereospecific transfer of the 4R hydrogen atom  of the reduced nucleotide, as a hydrid ion, to the 4 position of  dihydrodipicolinate <17>; #14# binding mechanism of diverse inhibitors  <16>; #17# structure of substrate-cofactor-complex <14>; #6# kinetic  and chemical mechanism <17>; #10# partly repressed by lysine <1>; #18#  substrate binding site structure <20>; #22# the domain movement for  active site constitution occurs when both cofactor and substrate bind  to the enzyme <36>)  "
1.17.1.9," formate + NAD+ = CO2 + NADH (#23# sequential mechanism <9>; #38#  ordered mechanism <31>; #36# sequential ordered bi-bi mechanism <20>;  #4# ordered kinetic mechanism with NAD+ adding before formate <6>; #12#  ordered bi-bi mechanism, NAD+ is the first substrate and NADH is the  last product <2>; #43# hydride-transfer step is rate-limiting <54>;  #40# ordered BiBi mechanism with NAD+ and NADH being the first  substrate and the second product, resp. <64>; #61# reaction mechanism:  step I, formate binds directly to Mo, displacing Se-Cys140. Step II,  the alpha-proton from formate may be transferred to the nearby His141  that acts as general base. Alternatively, step II may involve a  selenium-carboxylated intermediate. Step III, electrons from MoIV are  transferred via the 4Fe-4S center to an external electron acceptor and  the catalytic cycle is completed <66>)  "
1.17.2.1, nicotinate + a ferricytochrome + H2O = 6-hydroxynicotinate + a  ferrocytochrome + 2 H+  
1.17.2.2, lupanine + 2 ferricytochrome c + H2O = 17-hydroxylupanine + 2  ferrocytochrome c + 2 H+  
1.17.2.3, formate + 2 ferricytochrome c-553 = CO2 + 2 ferrocytochrome c-553 + H+  
1.17.3.1," 2-amino-4-hydroxypteridine + O2 = 2-amino-4,7-dihydroxypteridine + ?  "
1.17.3.2," xanthine + H2O + O2 = urate + H2O2 (#7# mechanism <4,30>; #5#  hydrogen-bonding arrangement of the substrate-bound complex at the  active site, and proposed mechanism of the purine oxidation reaction by  XOR <63>; #7# catalytic mechanism of xanthine oxidoreductase, overview  <126>; #7# favored mechanism for the reaction with xanthine, overview  <144>; #31# reaction mechanism for xanthine oxidase, overview.  Catalysis is initiated by base-assisted nucleophilic attack of the  equatorial Mo-OH on the C-8 carbon of xanthine with concomitant hydride  transfer from C-8 to Mo=S, which simultaneously results in reduction of  Mo(VI) to Mo(IV). Reoxidation of the molybdenum center occurs by  electron transfer to the other redox-active centers of the enzyme,  accompanied by deprotonation of the Mo-SH bond and displacement of  bound product by hydroxide from solvent to regenerate the Mo-OH group  <141>; #7,30# reaction mechanism of XOR and binding modes of the  substrate xanthine, overview. The oxidative hydroxylation of purine  substrates takes place at the molybdenum center. Reducing equivalents  introduced there are then transferred via two [2Fe-2S] centers to the  FAD cofactor where reduction of the physiological electron acceptors  occurs, NAD+ in the case of the dehydrogenase form, XDH, or O2 in the  oxidase form, XO, of the enzyme occur <140>; #7# reaction mechanism,  detailed overview. The reaction is initiated by proton abstraction from  the Mo-OH group by Glu1261, the active-site base, followed by  nucleophilic attack on the carbon to be hydroxylated, and hydride  transfer to the Mo-S double bond. Suitable substrate orientation,  overview. Arg880 is involved in stablizing the transition state in the  course of nucleophilic attack, overview <138>; #28# mechanism of the  reductive half-reaction of xanthine oxidase <162>; #18# the catalytic  reaction of xanthine oxidase is initiated by abstraction of a proton  from the Mo-OH group by a conserved active site glutamate residue. The  oxidative hydroxylation of xanthine to uric acid takes place at the  molybdenum center and results in the two-electron reduction of the  metal from Mo(VI) to Mo(IV). The enzyme is subsequently re-oxidized by  NAD+ or molecular oxygen in a reaction that occurs at the FAD cofactor  <158>)  "
1.17.3.3," 6-hydroxynicotinate + H2O + O2 = 2,6-dihydroxynicotinate + H2O2 (#2#  contains [2Fe-2S] iron-sulfur centres, FAD and molybdenum, it also has  a catalytically essential, labile selenium that can be removed by  reaction with cyanide, in Bacillus niacini, this enzyme is required for  growth on nicotinic acid <3>)  "
1.17.3.4," 2 juglone + O2 = 2 3,5-dihydroxy-1,4-naphthoquinone "
1.17.3.4," 2 juglone + 2 H2O = 2 naphthalene-1,2,4,8-tetrol "
1.17.3.4," 2 naphthalene-1,2,4,8-tetrol + O2 = 2 3,5-dihydroxy-1,4-naphthoquinone  + 2 H2O  "
1.17.4.1," 2'-deoxyribonucleoside 5'-diphosphate + thioredoxin disulfide + H2O =  ribonucleoside 5'-diphosphate + thioredoxin (#3# catalytic mechanism  <117>; #5,6,7,8,9,10,11,12,22# proposed mechanism <12,30,32,47>; #6,7#  postulated mechanism, radical cation intermediates <30>; #6# allosteric  regulation of the catalytic activity of subunit R1 <78>; #6# kinetics  and mechanism of formation of the tyrosyl radical and micro-oxo-diiron  cluster in the R2 subunit <80>; #7# NDP reduction requires cleavage of  the 3-C-H bond of the substrate, hypothesis of enzyme mechanism <49>;  #45# binding of specificity effector rearranges loop 2 and moves  residue P294 out of the catalytic site, accomodating substrate binding.  substrate binding further rearranges loop2. Cross-talk occurs largely  through R293 and Q288 of loop 2. Substrate ribose binds with its 3Â’  hydroxyl closer than its 2Â’ hydroxyl to residue C218 of the catalytic  redox pair <106>; #7# presence of divalent cations mediates a rapid  radical-transfer equilibrium between W48 and Y356. Cation-mediated  propagation of the radical from W48 to Y356 gives rise to a fast phase  of Y radical production that is essentially coincident with W48 cation  radical formation and creates an efficient pathway for decay of W48  cation radical <96>; #7# reaction involves formation of a  keto-deoxyribonucleotide intermediate. In case of furanone inhibitors,  the intermediate dissociates from the active site, depending on the  solvation free energy of the 2Â’-substituents, its influence inside the  active site, and the charge transfer mechanism from a protein side  chain to solution as thermodynamic driving forces. Substrates do not  dissociate from the active site but complete the catalytic cycle <111>;  #7# role of enzyme in second step of catalytic mechanism which  corresponds to the protonation/elimination of the substrateÂ’s C2  hydroxyl group is mainly entropic by placing the substrate and the two  reactive residues in a position that allows for the highly favorable  concerted trimolecular reaction, and to protect the enzyme radical from  the solvent <98>; #7# reaction mechanism via formation of a tyrosyl  radical at Tyr356 od subunit R1, model for radical transport in which  there is a unidirectional transport of the electron and proton  transport among residues of R1 <119>; #46# reaction mechanism, two  possible pathways, overview <133>)  "
1.17.4.2, 2'-deoxyribonucleoside 5'-triphosphate + thioredoxin disulfide + H2O =  ribonucleoside 5'-triphosphate + thioredoxin  
1.17.4.4," phylloquinone + a protein with a disulfide bond + H2O =  2,3-epoxyphylloquinone + a protein with reduced L-cysteine residues  (#6# ping-pong mechanism <5>; #3# analysis of the reaction mechanism by  quantum mechanical methods, modeling, the geometries of proposed model  intermediates in the mechanisms are energy optimized <30>; #2,3,4#  protein structure and catalytic mechanism, the enzyme activity is  rate-limiting for the following gamma-carboxylation step <24>; #3#  quantum chemical study on mechanism and transition states. Once a key  dissulfide is broken, the reaction proceeds largely downhill. The  initial protonation of the epoxide oxygen is an important step, with  the proton originating from a free mercapto group rather than a water  molecule <43>; #3# bi bi ping-pong mechanism for VKORC1, kinetic  modeling <61>) "
1.17.4.4, phylloquinol + a protein with a disulfide bond = phylloquinone + a  protein with reduced L-cysteine residues  
1.17.4.5," 3-hydroxy-2-methyl-3-phytyl-2,3-dihydro-1,4-naphthoquinone + oxidized  dithiothreitol =  2,3-epoxy-2-methyl-3-phytyl-2,3-dihydro-1,4-naphthoquinone +  1,4-dithiothreitol  "
1.17.5.1," phenylacetyl-CoA + H2O + 2 quinone = phenylglyoxylyl-CoA + 2 quinol  (#1# the enzyme from Thauera aromatica is a membrane-bound  molybdenum-iron-sulfur protein, the enzyme is specific for  phenylacetyl-CoA as substrate, phenylacetate, acetyl-CoA, benzoyl-CoA,  propionyl-CoA, crotonyl-CoA, succinyl-CoA and 3-hydroxybenzoyl-CoA  cannot act as substrates, the oxygen atom introduced into the product,  phenylglyoxylyl-CoA, is derived from water and not molecular oxygen,  duroquinone, menaquinone and 2,6-dichlorophenolindophenol(DCPIP) can  act as acceptor, but the likely physiological acceptor is ubiquinone, a  second enzyme, EC 3.1.2.25, phenylglyoxylyl-CoA hydrolase, converts the  phenylglyoxylyl-CoA formed into phenylglyoxylate <2>)  "
1.17.5.2," caffeine + ubiquinone + H2O = 1,3,7-trimethylurate + ubiquinol  "
1.17.5.3, formate + a quinone = CO2 + a quinol  
1.17.7.1," (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + H2O + 2 oxidized  ferredoxin = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + 2 reduced  ferredoxin  "
1.17.7.2, chlorophyll a + H2O + 2 oxidized ferredoxin = 71-hydroxychlorophyll a +  2 reduced ferredoxin + 2 H+  
1.17.7.3," (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + H2O + oxidized  flavodoxin = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate + reduced  flavodoxin  "
1.17.7.4," isopentenyl diphosphate + 2 oxidized ferredoxin [iron-sulfur] cluster +  H2O = (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + 2 reduced  ferredoxin [iron-sulfur] cluster + 2 H+ (#14# reaction mechanism <4>;  #1# reaction mechanism, detailed overview <13>; #9# reaction mechanism,  role of protein residues in the IspH mechanism, detailed overview <14>) "
1.17.7.4," dimethylallyl diphosphate + 2 oxidized ferredoxin [iron-sulfur] cluster  + H2O = (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + 2 reduced  ferredoxin [iron-sulfur] cluster + 2 H+ (#1# reaction mechanism,  detailed overview <13>; #9# reaction mechanism, role of protein  residues in the IspH mechanism, detailed overview <14>; #1# results  show a bioorganometallic mechanism of IspH catalysis. There are two  paramagnetic reaction intermediates proposed in this mechanism. The  intermediate trapped with IspH E126Q mutants represents the  3-CH2OH-rotated weak pi-complex, intermediate II. Following a formally  two-electron reduction and dehydration of the substrate, intermediate  II is converted into an eta3-allyl complex with an oxidized HiPIP-like  cluster [4Fe-4S]3+, intermediate III, which is observed with wild type  IspH <17>)  "
1.17.8.1, squalene + FAD + H2O = hydroxysqualene + FADH2  
1.17.9.1, 4-methylphenol + 4 oxidized azurin + H2O = 4-hydroxybenzaldehyde + 4  reduced azurin + 4 H+ (#1# mechanism <17>) 
1.17.9.1, 4-methylphenol + 2 oxidized azurin + H2O = 4-hydroxybenzyl alcohol + 2  reduced azurin + 2 H+ 
1.17.9.1, 4-hydroxybenzyl alcohol + 2 oxidized azurin = 4-hydroxybenzaldehyde + 2  reduced azurin + 2 H+  
1.17.9.2, (+)-pinoresinol + 2 oxidized azurin + H2O = (+)-6-hydroxypinoresinol +  2 reduced azurin + 2 H+  
1.17.98.2, 2 S-adenosyl-L-methionine + a bacteriochlorophyllide c + H2O = a  bacteriochlorophyllide e + 2 5'-deoxyadenosine + 2 L-methionine 
1.17.98.2, S-adenosyl-L-methionine + a bacteriochlorophyllide c + H2O = a  7-(hydroxymethyl)bacteriochlorophyllide c + 5'-deoxyadenosine +  L-methionine 
1.17.98.2, S-adenosyl-L-methionine + a 7-(hydroxymethyl)bacteriochlorophyllide c +  H2O = a 7-(dihydroxymethyl)bacteriochlorophyllide c + 5'-deoxyadenosine  + L-methionine 
1.17.98.2, a 7-(dihydroxymethyl)bacteriochlorophyllide c = a  bacteriochlorophyllide e + H2O  
1.17.98.3," formate + oxidized coenzyme F420 = CO2 + reduced coenzyme F420 (#1# the  enzyme is specific for the si face hydride transfer to C5 of coenzyme  F420. While catalysis probably occurs by hydride transfer from formate  to the enzyme to generate an enzyme-H2 species and then by hydride  transfer back out to F420, the formate-derived hydrogen exchanges with  solvent protons before transfer back out to coenzyme F420. The kinetics  of hydride transfer from formate reveals that this step is not rate  determining <2>)  "
1.17.98.4, formate + an [oxidized hydrogenase] = CO2 + a [reduced hydrogenase]  
1.17.99.10, cholest-4-en-3-one + acceptor + H2O = 25-hydroxycholest-4-en-3-one +  reduced acceptor  
1.17.99.11," a 3-oxo-DELTA1-steroid + H2O + acceptor = a steroid 1,3-dione + reduced  acceptor "
1.17.99.11, a 3-oxo-DELTA1-steroid + H2O = a 1-hydroxy-3-oxo-steroid 
1.17.99.11," a 1-hydroxy-3-oxo-steroid + acceptor = a steroid 1,3-dione + reduced  acceptor  "
1.17.99.2," ethylbenzene + H2O + acceptor = (S)-1-phenylethanol + reduced acceptor  (#2# kinetics and mechanism of oxygen-independent hydrocarbon  hydroxylation, quantitative structure-activity relationship modeling  <6>; #2# kinetics and mechanism of oxygen-independent hydrocarbon  hydroxylation, quantum chemical modelling and quantitative  structure-activity relationship modelling <7>; #3# ethylbenzene  oxidation mechanism involving active site residue His192, and two  one-electron transfers and a radical-type intermediate have lower  energy barriers than the corresponding two-electron transfer  mechanisms, modeling, overview <8>)  "
1.17.99.3," (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA + H2O  + acceptor =  (24R,25R)-3alpha,7alpha,12alpha  24-tetrahydroxy-5beta-cholestan-26-oyl-CoA + reduced acceptor  "
1.17.99.4, uracil + H2O + acceptor = barbiturate + reduced acceptor 
1.17.99.4, thymine + H2O + acceptor = 5-methylbarbiturate + reduced acceptor  
1.17.99.6, queuosine34 in tRNA + acceptor + H2O = epoxyqueuosine34 in tRNA +  reduced acceptor  
1.17.99.8, (S)-limonene + H2O + acceptor = (-)-perillyl alcohol + reduced acceptor 
1.17.99.8, (R)-limonene + H2O + acceptor = (+)-perillyl alcohol + reduced acceptor  
1.17.99.9, ferroheme o + H2O + 2 acceptor = ferroheme a + 2 reduced acceptor 
1.17.99.9, ferroheme o + H2O + acceptor = ferroheme i + reduced acceptor 
1.17.99.9, ferroheme i + H2O + acceptor = hydroxyferroheme i + reduced acceptor 
1.17.99.9, hydroxyferroheme i = ferroheme a + H2O  
1.18.1.1, 2 reduced rubredoxin + NAD+ + H+ = 2 oxidized rubredoxin + NADH (#7#  the electron transfer from NAD(P)H to rubredoxin involves a reductive  and an oxidative step with respect to the enzyme <12>)  
1.18.1.2," 2 reduced ferredoxin + NADP+ + H+ = 2 oxidized ferredoxin + NADPH  (#6,21,23# reaction mechanism <77,85>; #13# catalytic mechanism <35>;  #13# interaction between ferredoxin and ferredoxin-NADP+ reductase  <29>; #13# ping pong bi bi mechanism <81>; #14,15,25# active site  structure, reaction mechanism <85>; #47# active site structure of the  plant-type enzyme, reaction mechanism <85>; #13# active site structure,  ping pong reaction mechanism <85>; #3,4,6,13,21,23,33,46# catalytic  mechanism of forward and reverse reactions <82>; #14,64# catalytic  mechanism, initiated by reduction of FAD cofactor by obligatory  one-electron carriers ferredoxin or flavodoxin in presence of NADP+,  the enzymes C-terminal tyrosine residue is involved modulating the  enzyme affinity for NADP+/NADPH <80>; #64# coenzyme recognition and  reaction mechanism <89>; #33# Glu139 is essential for interaction with  the substrate steering ferredoxin, flavodoxin and NADP+/NADPH in  appropriate position for docking, Glu139 is not involved in binding  <84>; #33# mechanism of coenzyme recognition and binding <92>; #4#  positively charged residues K83 and K89 are required for catalytic  activity, methylation of K83, K89, and K135 is required for optimal  enzyme activity <98>; #13,14,15,25,32# reaction and substrate binding  mechanism, in vivo catalytic cycle <94>; #6,23# reaction mechanism via  semiquinone intermediate and radical formation <93>; #13,33# reaction  mechanism via semiquinone intermediate and radical formation,  enzyme-substrate interactions, overview <93>; #33# reaction mechanism,  interaction and electron transfer <85>; #6# reaction mechanism,  substrate recognition mechanism <85>; #21# hydride exchange occurs at  30-150 per s being not limiting for enzyme activity. Electron transfer  to flavodoxin proceeds at 2.7 per s, in the range of steady-state  catalysis, supporting that flavodoxin oscillates between the  semiquinone and fully reduced states when enzyme operates in vivo  <103>; #33# hydride transfer between Anabaena FNR and NADP+/H occurs  through formation of two charge transfer complexes. FNR and NADP+/H  conformations and orientation during the enzyme:coenzyme interaction is  critical during formation of charge transfer complexes, which are  necessary for an efficient hydride transfer <101>; #15# FNR is able to  transfer electrons between one-electron carriers, ferredoxin or  flavodoxin, and two-electron carriers, NADP+ and NADPH, involving its  redox cofactor FAD, involvement of Glu312 in the FNR catalytic  mechanism not only as a proton donor but also as a key residue for  stabilizing and destabilizing reaction intermediates, reaction  mechanism and catalytic cycle, overview <141>; #57# a hydride transfer  reaction with NAD(P)H and two separate one-electron transfer reactions  with ferredoxin are generally involved in te reaction process <174>;  #37# mechanism of FAD-based electron bifurcation, overview <171>; #50#  the overall reaction can be separated into a hydride-transfer step  between NADP(H) and FAD, and an electron-exchange reaction between FAD  and the electron-carrier protein partner <170>)  "
1.18.1.3, 2 reduced [2Fe-2S] ferredoxin + NAD+ + H+ = 2 oxidized [2Fe-2S]  ferredoxin + NADH 
1.18.1.3, reduced 2[4Fe-4S] ferredoxin + NAD+ + H+ = oxidized 2[4Fe-4S]  ferredoxin + NADH  
1.18.1.4, 2 reduced rubredoxin + NAD(P)+ + H+ = 2 oxidized rubredoxin + NAD(P)H  
1.18.1.5, reduced putidaredoxin + NAD+ = oxidized putidaredoxin + NADH + H+  
1.18.1.6, 2 reduced adrenodoxin + NADP+ + H+ = 2 oxidized adrenodoxin + NADPH  
1.18.1.7, 2 reduced [2Fe-2S] ferredoxin + NAD(P)+ + H+ = 2 oxidized [2Fe-2S]  ferredoxin + NAD(P)H  
1.18.6.1," 8 reduced ferredoxin + 8 H+ + N2 + 16 ATP + 16 H2O = 8 oxidized  ferredoxin + H2 + 2 NH3 + 16 ADP + 16 phosphate  (#4,6,7,8,9,11,13,14,15,19,23,28,34,42# catalytic mechanism  <4,6,8,9,11,34>; #9# mechanism, Fe protein cycle <2>; #9# enzyme  complex dissociation and association kinetics <2>; #9# C2H2 inhibition  mechanism, structure model <43>; #9# MgATP/MgADP-dependent electron and  proton transfer kinetics <35>; #9# structure of V-containing enzyme  form <12,47>;  #2,3,4,6,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,25,28,29,32,34,35,36  37,39,40,41,42,43,44,45,46,47# enzyme is composed of 2 metalloproteins:  component I MoFe protein and component II Fe protein  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26  27,28,29,30,31,32,33,34,35,37,38,39,40,41,42,43,44,45,46,48>; #9# Fe  protein and MoFe protein are assumed to associate and dissociate to  transfer a single electron to the substrates <2>; #9# schematic  electron flow from Fe protein to substrate via MoFe protein and MoFe  protein-cofactor <39>; #6# iron-only enzyme is composed of 2  components: FeFe protein and Fe protein <36,37>;  #7,8,9,12,14,15,20,25,32,34,36,41,47# schematic mechanism <12,28,34>;  #9# active site is located on the MoFe cofactor involving residues  alphaR96, alphaG69, alphaV70, and alphaH195 <50>; #9# active site  location <57>; #52# overall catalytic mechanism, overview, structures  of active site metal clusters, interactions of substrate and active  site, active site relevant residues are Arg96, Val70, Gly69, and  His195, substrate binding mechanism of complex components, mechanism of  MgATP hydrolysis and electron transfer, overview <53>; #7# the active  site is located on the MoFe protein, active site structure and  substrate binding mechanism <55>; #9# theoretical mechanisms of  substrate binding to molybdenum or iron in the FeMo cofactor, modeling  <51>; #9# first introduction of H at the NFe7MoS9(homocitrate) active  site is via a water chain terminating at water 679 to S3B of the my3-S  atoms of the active site. Discussion of subsequent movement of the H  atoms around the NFe7MoS9(homocitrate) preparatory to the binding and  hydrogenation of N2 and other substrates. S2B has a modulatory function  and is not an H-entry site <64>; #31# reaction mechanism, overview  <70>; #9# SEPR1 intermediate formed during turnover of the nitrogenase  alpha-195Gln MoFe protein with C2H2 in H2O buffers, is a product  complex with C2H4 bound as a ferracycle to a single Fe of the  FeMo-cofactor active site. CO bridges two Fe of lo-Co, while the C2H4  of SEPR1 binds to one of these. Correlation with Lowe-Thorneley En  kinetic state <65>; #9# theoretical investigation of the binding of N2  to the Fe7MoS9N(homocitrate)(cysteine)(histidine) active site,  calculation of reaction profiles and activation energies for the  association and dissociation of N2. An endo-ny1-N2 coordination at Fe6  is most probable <66>; #9# reaction mechanism, determination of  reaction intermediates, two-step relaxation of the nitrogenase H+/H+  intermediate during step-annealing,both steps show large solvent  kinetic isotope effects, step A is the catalytically central state that  is activated for N2 binding by the accumulation of 4 electrons, and  step B accumulates 2 electrons, overview <74>; #52# NO2- reduction by  nitrogenase begins with the generation of NO2H bound to a state in  which the active-site FeMo-cofactor (M) has accumulated two [e-/H+]  (E2), stored as a (bridging) hydride and proton. Proton transfer to  NO2H and H2O loss leaves M-[NO+], transfer of the E2 hydride to the  [NO+] directly to form HNO bound to FeMo-cofactor is one of two  alternative means for avoiding formation of a terminal M-[NO]  thermodynamic sink. Mechanism for N2 reduction, detailed overview. NO2-  reduction by nitrogenase begins with the generation of NO2H bound to  E2, E2 has accumulated two [e-/H+], stored in the form of a hydride  bridging between two Fe atoms and a proton bound to sulfur. Transfer of  the E2 proton to the -OH of NO2H followed by loss of H2O formally  leaves M-[NO+]. Nitrogenase is able to transfer the E2 hydride to  [NO+], directly forming HNO bound to FeMo-cofactor at its resting-state  redox level and totally avoiding formation of an M-[NO] sink <99>)  "
1.18.6.2, 12 reduced ferredoxin + 12 H+ + N2 + 40 ATP + 40 H2O = 12 oxidized  ferredoxin + 3 H2 + 2 NH3 + 40 ADP + 40 phosphate  
1.19.1.1, reduced flavodoxin + NADP+ = oxidized flavodoxin + NADPH + H+  
1.19.6.1," 4 reduced flavodoxin + N2 + 16 ATP + 16 H2O = 4 oxidized flavodoxin +  H2 + 2 NH3 + 16 ADP + 16 phosphate (#4# enzyme is composed of 2  metalloproteins: Fe protein and MoFe protein which are assumed to  associate and dissociate to transfer a single electron to the  substrates <5>; #4# mechanism, Fe protein cycle <5>; #4# enzyme complex  dissociation and association kinetics <5>; #7# residues Asn11, Ser68,  and Asn72 of the flavodoxin are involved in complex formation between  the flavodoxin and the Fe protein of the enzyme, influenced by MgADP-  <6>; #6# reaction mechanism, overview <10>)  "
1.2.1.10," acetaldehyde + CoA + NAD+ = acetyl-CoA + NADH + H+ (#1,6,8#  bi-uni-uni-uni-ping-pong mechanism <5,12,14>; #3# part of a  bifunctional enzyme complex that also displays 4-hydroxy-2-ketovalerate  aldolase activity <18>)  "
1.2.1.100," 5-formyl-3-hydroxy-2-methylpyridine-4-carboxylate + NAD+ + H2O =  3-hydroxy-2-methylpyridine-4,5-dicarboxylate + NADH + H+  "
1.2.1.101, L-tyrosinal + NADP+ + AMP + diphosphate = L-tyrosine + NADPH + H+ + ATP  
1.2.1.102, isopyridoxal + NAD+ + H2O = 5-pyridoxate + NADH + H+  
1.2.1.103, an [amino group carrier  protein]-C-terminal-N-(1-carboxy-5-oxopentan-1-yl)-L-glutamine +  phosphate + NADP+ = an [amino group carrier  protein]-C-terminal-N-(1-carboxy-5-phosphooxy-5-oxopentan-1-yl)-L  glutamine + NADPH + H+  
1.2.1.104," pyruvate + [dihydrolipoyllysine-residue acetyltransferase] lipoyllysine  = [dihydrolipoyllysine-residue acetyltransferase]  S-acetyldihydrolipoyllysine + CO2 (#7# overall reaction of pyruvate  dehydrogenase complex: CH3-CO-CO2H + CoA-SH + NAD+ = CH3-CO-S-CoA + CO2  + NADH + H+, proposed mechanism <23>) "
1.2.1.104, pyruvate + CoA + NAD+ = acetyl-CoA + CO2 + NADH  
1.2.1.105," 2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase]  lipoyllysine = [dihydrolipoyllysine-residue succinyltransferase]  S-succinyldihydrolipoyllysine + CO2 (#2,5,7,9,17,19,24# 2-oxoglutarate  dehydrogenase complex consists of 3 enzymes: E1 (alpha-ketoglutarate  dehydrogenase, EC 1.2.4.2), E2 (dihydrolipoyl transsuccinylase, EC  2.3.1.61), E3 (dihydrolipoyl dehydrogenase, EC 1.8.1.4)  <1,2,3,4,5,6,13,14,15,25>;  #2,3,4,5,6,7,9,10,11,12,13,17,18,19,22,23,24,26# the enzyme complex  catalyzes the reaction : 2-oxoglutarate + CoA + NAD+--> succinyl-CoA +  CO2 + NADH, the following partial reactions are catalyzed: 1.  HOOC(CH2)2COCOOH + (thiamine diphosphate)-E1--> (HOOC(CH2)2  CHOH-thiamine-diphosphate)-E1 + CO2, 2. (HOOC(CH2)2CH  OH-thiamine-diphosphate)-E1 + (LipS2)-E2--> (HOOC(CH)2 CO-(SLipSH))-E2  + (thiamine-diphosphate)-E1, 3. (HOOC(CH2)2CO-(SLipSH))-E2 + HSCoA-->  (Lip(SH)2)-E2 + HOOC(CH2)2CO-SCoA, 4. (Lip(SH)2)-E2 + E3-FAD-->  (LipS2)-E2 + reduced E3-FAD, 5. reduced E3-FAD + NAD+--> E3-FAD + NADH  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26  27,28,29,30,31,32,33,34,35,36,37,38>; #2# kinetics of succinylation and  desuccinylation <18>; #5# mechanism of the reaction catalyzed by the  2-oxoglutarate dehydrogenase complex <19>; #19# mechanism of the enzyme  complex is bi bi uni uni ping pong <14>; #2,8,15,22# substrate  channeling and catalytic mechanism, active site coupling <39>) "
1.2.1.105, 2-oxoglutarate + CoA + NAD+ = succinyl-CoA + CO2 + NADH  
1.2.1.106, an [amino-group carrier protein]-C-terminal-gamma-(L-glutamate  5-semialdehyde-2-yl)-L-glutamate + phosphate + NADP+ = an [amino-group  carrier protein]-C-terminal-gamma-(5-phospho-L-glutamyl)-L-glutamate +  NADPH + H+  
1.2.1.107, D-glyceraldehyde 3-phosphate + arsenate + NAD+ =  1-arsono-3-phospho-D-glycerate + NADH + H+  
1.2.1.11," L-aspartate 4-semialdehyde + phosphate + NADP+ = L-4-aspartyl phosphate  + NADPH + H+ (#5# catalytic Cys135 is essential for activity <28>; #25#  catalytic mechanism, active site structure, catalytic nucleophile is  Cys134 <32>; #23# catalytic mechanism, function of the catalytic  nucleophile Cys136 and the acid-base catalytic His277, the latter is  also stabilizing the hemithioacetal intermediate <26>; #23# catalytic  mechanism, identification and structural characterization of the  tetrahedral reaction intermediate, substrate binding structure <31>;  #4# catalytic mechanism, role of substrate binding groups, residues  Arg270, Glu243, Arg103, and Lys246 are involved <25>; #23# catalytic  mechanism, substrate recognition <27>)  "
1.2.1.12," D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl  phosphate + NADH + H+ (#14# ordered ter bi mechanism characterized by  the sequential addition of NAD+, glyceraldehyde 3-phosphate and  phosphate to the enzyme and the sequential release of  3-phospho-D-glyceroyl phosphate and NADH from the enzyme <47>; #103#  B-specific oxidoreductase <32>; #27# bi-uni-uni-uni-ping-pong mechanism  in which NAD+ and phosphate interact sequentially with the enzyme,  followed in turn by the release of 3-phospho-D-glyceroyl phosphate, the  addition of D-glyceraldehyde-3-phosphate, and the release of NADH. At  pH 7.2, NAD+ binds to the enzyme in a rapid-equilibrium fashion,  whereas at pH 8.8 there is rapid-equilibrium addition of both NAD+ and  phosphate to the enzyme <26>; #147# GAPDH-catalyzed phosphorylation of  D-G3H takes place in two steps. In the first exergonic reaction the  aldehyde group of D-glyceraldehyde 3-phosphate is converted into a  carboxylic acid with concomitant reduction of NAD+ to NADH. The energy  released by this reaction drives the endergonic second reaction in  which a molecule of inorganic phosphate is transferred to the  intermediate acid to form the product 3-phospho-D-glyceroyl phosphate.  The reaction mechanism involves formation of a covalent bond between  the thiol group of a conserved cysteine residue of GAPDH and the  carbonyl C-atom of D-glyceraldehyde 3-phosphate resulting in the  formation of the hemithioacetal intermediate. A hydride ion is  transferred from D-glyceraldehyde 3-phosphate to the cofactor NAD+ to  form NADH while oxidation of D-glyceraldehyde 3-phosphate by a water  molecule generates a thioester intermediate. In the second step, the  thioester is phosphorylated in a nucleophilic attack by an inorganic  phosphate ion resulting in the formation of the product  3-phospho-D-glyceroyl phosphate and the release of the thiol-group of  the active site cysteine <254>; #134# the conserved residue C158 is  responsible for nucleophilic catalysis and the conserved residue H185  acts as a catalytic base. The enzyme exhibits a kinetic mechanism in  which first NAD+, then D-glyceraldehyde 3-phosphate bind to the active  site resulting in the formation of a covalently bound thiohemiacetal  intermediate. After oxidation of the thiohemiacetal and subsequent  nucleotide exchange (NADH off, NAD+ on), the binding of inorganic  phosphate and phosphorolysis yields the product 3-phospho-D-glyceroyl  phosphate. Solvent and multiple kinetic isotope effects revealed that  the first halfreaction is rate limiting and utilizes a step-wise  mechanism for thiohemiacetal oxidation via a transient alkoxide to  promote hydride transfer and thioester formation <230>)  "
1.2.1.13," D-glyceraldehyde 3-phosphate + phosphate + NADP+ =  3-phospho-D-glyceroyl phosphate + NADPH + H+ (#33# uni uni ping pong  mechanism with an apparent Theorell Chance displacement between  1,3-diphosphoglycerate and phosphate, NAD(P)H on, glyceraldehyde  3-phosphate off, 1,3-diphosphoglycerate on, phosphate off, NAD(P)+ off  <38>)  "
1.2.1.15, 3-oxopropanoate + NAD(P)+ + H2O = malonate + NAD(P)H + 2 H+  
1.2.1.16," succinate semialdehyde + NAD(P)+ + H2O = succinate + NAD(P)H + 2 H+  (#10# mechanism is sequential, consistent with rapid-equilibrium  ordered bi-bi system and a steady-state ordered bi-bi system <24>; #24#  proposed enzymatic mechanism of cce4228 protein, overview <36>)  "
1.2.1.17, glyoxylate + CoA + NADP+ = oxalyl-CoA + NADPH + H+  
1.2.1.18, 3-oxopropanoate + CoA + NAD(P)+ = acetyl-CoA + CO2 + NAD(P)H  
1.2.1.19, 4-aminobutanal + NAD+ + H2O = 4-aminobutanoate + NADH + 2 H+ (#11#  A-stereospecific with respect to NAD+ <13>)  
1.2.1.20, 5-oxopentanoate + NADP+ + H2O = glutarate + NADPH + H+  
1.2.1.21, glycolaldehyde + NAD+ + H2O = glycolate + NADH + 2 H+  
1.2.1.22, (S)-lactaldehyde + NAD+ + H2O = (S)-lactate + NADH + 2 H+  
1.2.1.23, a 2-oxoaldehyde + NAD+ + H2O = a 2-oxo carboxylate + NADH + H+  
1.2.1.24," succinate semialdehyde + NAD+ + H2O = succinate + NADH + 2 H+ (#4#  compulsory ordered mechanism where NAD+ binds first followed by  succinate semialdehyde <19>; #4# compulsory-order mechanism, NAD+ is  the first substrate to bind to the enzyme and NADH is the last product  to dissociate from it <12>; #36# sequential ordered Bi-Bi reaction  mechanism <61>)  "
1.2.1.25, 3-methyl-2-oxobutanoate + CoA + NAD+ = 2-methylpropanoyl-CoA + CO2 +  NADH  
1.2.1.26," 2,5-dioxopentanoate + NADP+ + H2O = 2-oxoglutarate + NADPH + 2 H+  "
1.2.1.27, 2-methyl-3-oxopropanoate + CoA + H2O + NAD+ = propanoyl-CoA + HCO3- +  NADH  
1.2.1.28, benzaldehyde + NAD+ + H2O = benzoate + NADH + 2 H+  
1.2.1.29, an aromatic aldehyde + NAD+ + H2O = an aromatic acid + NADH + H+ (#3#  ALDH catalysis involves acylation and deacylation <3>)  
1.2.1.3," an aldehyde + NAD+ + H2O = a carboxylate + NADH + H+ (#7# mechanism  <25>; #5# mechanism proceeds mainly through an enzyme*NAD+ binary  complex, but at high concentrations of acetaldehyde a small degree of  randomness is observed, the rate-limiting step of the dehydrogenase  reaction occurs after ternary complex interconversion <41>; #9#  compulsory ordered ternary-complex mechanism with NAD+ binding before  acetaldehyde <30>; #5# sequential addition of both substrates prior to  release of products <43>; #7# compulsory ordered mechanism <26>; #12#  at low aldehyde concentrations the mechanism is ordered with NAD+ as  the first substrate to bind, at high aldehyde concentrations the  mechanism is complex <33>)  "
1.2.1.30," an aromatic aldehyde + NADP+ + AMP + diphosphate = an aromatic acid +  NADPH + H+ + ATP (#3# carboxylic acid and ATP are first bound in the  A-domain, wherein the alpha-phosphate of ATP is attacked by the acid,  releasing diphosphate and forming an acyl-adenylate complex. The CAR  enzyme then undergoes a domain shift into a thiolation state where the  adenylate is then attacked by the thiol group on the phosphopantetheine  arm at the carbonyl carbon, forming a thioester and releasing AMP. The  CAR enzyme then undergoes another domain shift where the  phosphopantetheine arm is exposed in the R-domain. Finally, the  thioester is reduced by NADPH, producing the aldehyde product while  returning the phosphopantetheine arm to its thiol form <15>;  #2,6,7,9,16,19,20# carboxylic acid and ATP are first bound in the  A-domain, wherein the alpha-phosphate of ATP is attacked by the acid,  releasing pyrophosphate and forming an acyl-adenylate complex. The CAR  enzyme then undergoes a domain shift into a thiolation state where the  adenylate is then attacked by the thiol group on the phosphopantetheine  arm at the carbonyl carbon, forming a thioester and releasing AMP. The  CAR enzyme then undergoes another domain shift where the  phosphopantetheine arm is exposed in the R-domain. Finally, the  thioester is reduced by NADPH, producing the aldehyde product while  returning the phosphopantetheine arm to its thiol form <15>;  #1,2,7,9,11,12,13,16,18,20# product inhibition by NADP+, adenosine  monophosphate, and diphosphate indicates that the binding of substrates  at the adenylation domain is ordered with ATP binding first, proposed  catalytic mechanism in 4 steps, overview. The first two steps, the  relatively unreactive carboxylic acid is activated to form a thioester  with the phosphopantetheine arm at the N-terminal adenylation domain  (1) ATP and a carboxylic acid enter the active site of the adenylation  domain in which the alpha-phosphate of ATP is attacked by an O atom  from the carboxylic acid to form an AMP-acyl phosphoester with the  release of diphosphate.(2) The thiol group of the phosphopantetheine  arm can then attack the carbonyl carbon atom of the AMP-acyl  phosphoester intermediate nucleophilically to release AMP and to form  an acyl thioester with the phosphopantetheine arm. (3) The  phosphopantetheine arm transfers to the C-terminal reductase domain in  which (4) the thioester is reduced by NADPH, the aldehyde and NADP+ are  released, and the thiol of the phosphopantetheine arm is regenerated in  the process <11>; #4# product inhibition by NADP+, adenosine  monophosphate, and diphosphate indicates that the binding of substrates  at the adenylation domain is ordered with ATP binding first, proposed  catalytic mechanism in 4 steps, overview. The first two steps, the  relatively unreactive carboxylic acid is activated to form a thioester  with the phosphopantetheine arm at the N-terminal adenylation domain  (1) ATP and a carboxylic acid enter the active site of the adenylation  domain in which the alpha-phosphate of ATP is attacked by an O-atom  from the carboxylic acid to form an AMP-acyl phosphoester with the  release of diphosphate.(2) The thiol group of the phosphopantetheine  arm can then attack the carbonyl carbon atom of the AMP-acyl  phosphoester intermediate nucleophilically to release AMP and to form  an acyl thioester with the phosphopantetheine arm. (3) The  phosphopantetheine arm transfers to the C-terminal reductase domain in  which (4) the thioester is reduced by NADPH, the aldehyde and NADP+ are  released, and the thiol of the phosphopantetheine arm is regenerated in  the process <11>; #2,16,20,22,23# the catalytic cycle starts with the  activation of the carboxylate substrate with ATP in the A-domain,  yielding an AMP-ester intermediate under release of pyrophosphate as  the co-product. The active thiol tether of the phosphopantetheinyl  moiety then binds the carboxylate, releasing AMP as a leaving group.  The resulting thioester is subsequently transferred to the R domain,  where it is reduced to the corresponding aldehyde product. The aldehyde  is not amenable to enter a second catalytic cycle. The enzyme does not  catalyze the overreduction of the aldehyde product to the respective  alcohol <13>)  "
1.2.1.31, (S)-2-amino-6-oxohexanoate + NAD(P)+ + H2O = L-2-aminoadipate + NAD(P)H  + H+  
1.2.1.32," 2-aminomuconate 6-semialdehyde + NAD+ + H2O = 2-aminomuconate + NADH +  2 H+ (#15# the catalytic cycle, overview <24>)  "
1.2.1.33," (R)-4-dehydropantoate + NAD+ + H2O = (R)-3,3-dimethylmalate + NADH + 2  H+  "
1.2.1.36," retinal + NAD+ + H2O = retinoate + NADH + 2 H+ (#4# participates in  vitamin A metabolism <9>; #4# does not catalyze 13-cis-retinal  oxidation <4>; #4# acts on both the all-trans- and 13-cis-form of  retinal <1>; #4# catalytic active nucleophil Cys302, not responsible  for substrate specificity <23>; #2# sulfhydryl group involved in  activity <6>)  "
1.2.1.38, N-acetyl-L-glutamate 5-semialdehyde + NADP+ + phosphate =  N-acetyl-L-glutamyl 5-phosphate + NADPH + H+  
1.2.1.39," phenylacetaldehyde + NAD+ + H2O = phenylacetate + NADH + 2 H+ (#14#  sequential reaction mechanism in which NAD+ serves as both the leading  substrate and homotropic allosteric activator, catalytic mechanism  involving E169, E267, and C301, overview. The catalytic Glu has two  conformations: a passive conformer that tucks away to allow hydride  transfer to the nicotinamide ring, and an active conformer that  abstracts a proton from the thioester-deacylating water <16>)  "
1.2.1.4, an aldehyde + NADP+ + H2O = a carboxylate + NADPH + H+ (#13# random  kinetic mechanism <3>)  
1.2.1.41, L-glutamyl 5-phosphate + NADPH + H+ = L-glutamate 5-semialdehyde +  phosphate + NADP+  
1.2.1.42," hexadecanal + CoA + NAD+ = hexadecanoyl-CoA + NADH + H+ (#2# also acts,  more slowly, on octadecanoyl-CoA <1>)  "
1.2.1.44," cinnamaldehyde + CoA + NADP+ = cinnamoyl-CoA + NADPH + H+ (#46#  although SbCCR1 displays higher affinity for caffeoyl-CoA or  4-coumaroyl-CoA than for feruloyl-CoA, the enzyme shows significantly  higher activity for the latter substrate. In the first catalytic step,  pro-R hydride transfer occurs from the C4 atom of NADPH to the reactive  thioester carbonyl. The resulting oxyanion is temporarily stabilized by  the oxyanion hole established from the side chain hydroxyl groups of  Ser149 and Tyr183. Collapse of the tetrahedral intermediate is then  followed by C-S bond cleavage and protonation of the CoA thiolate, in  the presence of NADP+, there is very low affinity for the CoA ester  compounds, which precludes the formation of a nonproductive complex,  catalytic mechanism and substrate specificity, overview <51>)  "
1.2.1.46, formaldehyde + NAD+ + H2O = formate + NADH + 2 H+ (#21# Pseudomonas  aeruginosa FDH has a conserved glutathione-independent ping pong  mechanism of formaldehyde oxidization <21>; #5# the catalytic reaction  proceeds by a Ping Pong mechanism as designated by the Michaelis-Menten  model of bi-substrate enzymatic kinetics <24>)  
1.2.1.47, 4-trimethylammoniobutanal + NAD+ + H2O = 4-trimethylammoniobutanoate +  NADH + 2 H+  
1.2.1.48," a long-chain aldehyde + NAD+ + H2O = a long-chain carboxylate + NADH +  2 H+ (#16# the human enzyme FALDH shows a unique reaction mechanism  that differs from other ALDHs, modelling giving an alternative model  for the reaction mechanism of FALDH, overview. The first step involves  the activation of the catalytic Cys241 by deprotonation and subsequent  substrate binding. Once Cys241 is deprotonated, it performs a  nucleophilic attack on the carbonyl carbon of the fatty aldehyde, which  forms a thiohemiacetal. Asn112 supports the orientation of the polar  head group by coordinating to the substrate oxygen and subsequently  stabilizes a tetrahedral reaction intermediate. In a second step, the  collapse of the primarily formed oxyanion then initiates a hydride  transfer to the NAD cofactor in a pro-R manner. Subsequently, a water  molecule is deprotonated by Glu207 or Glu331 and triggers a  nucleophilic attack of the hydroxide anion on the carbonyl carbon. In a  final step, a repeated collapse of the oxyanion forms the fatty acid  product and releases the covalent bond to Cys241, which remains  activated or can be potentially reactivated <22>)  "
1.2.1.49, a 2-oxoaldehyde + NADP+ + H2O = a 2-oxo carboxylate + NADPH + H+  
1.2.1.5, an aldehyde + NAD(P)+ + H2O = a carboxylate + NAD(P)H + H+ (#4# ordered  bi bi mechanism with NAD+ as the leading substrate <15>)  
1.2.1.50, a long-chain aldehyde + [protein]-L-cysteine + NADP+ = a  [protein]-S-(long-chain fatty acyl)-L-cysteine + NADPH + H+  
1.2.1.51, pyruvate + CoA + NADP+ = acetyl-CoA + CO2 + NADPH  
1.2.1.52, 2-oxoglutarate + CoA + NADP+ = succinyl-CoA + CO2 + NADPH  
1.2.1.53, 4-hydroxyphenylacetaldehyde + NAD+ + H2O = 4-hydroxyphenylacetate +  NADH + 2 H+  
1.2.1.54, 4-guanidinobutanal + NAD+ + H2O = 4-guanidinobutanoate + NADH + 2 H+  
1.2.1.57, butanal + CoA + NAD(P)+ = butanoyl-CoA + NAD(P)H + H+  
1.2.1.58, phenylglyoxylate + NAD+ + CoA = benzoyl-S-CoA + CO2 + NADH  
1.2.1.59," D-glyceraldehyde 3-phosphate + phosphate + NAD(P)+ =  3-phospho-D-glyceroyl phosphate + NAD(P)H + H+ (#23# GAPDH catalyzes  the oxidative phosphorylation of D-glyceraldehyde 3-phosphate (D-G3H)  to give 1,3-diphosphoglyceric acid and uses NAD+ or NADP+ as a  cofactor. In the first step of this two-step reaction the active-site  cysteine residue of GAPDH attaches covalently to D-G3H and forms a  thiohemiacetal intermediate, which transfers a hydride ion to NAD+,  resulting in the formation of the thioacyl enzyme. In the second step  the resulting thioester is phosphorylated through the nucleophilic  attack of an inorganic phosphate ion on the carbonyl C atom of the  thioacyl group, which leads to the formation of 1,3-diphosphoglycerate  <12>)  "
1.2.1.60, 5-carboxymethyl-2-hydroxymuconate semialdehyde + H2O + NAD+ =  5-carboxymethyl-2-hydroxymuconate + NADH + 2 H+  
1.2.1.61, 4-hydroxymuconic semialdehyde + NAD+ + H2O = maleylacetate + NADH + 2  H+ (#5# catalytic mechanism involving residues Glu247 and Cys281 <5>)  
1.2.1.62, 4-formylbenzenesulfonate + NAD+ + H2O = 4-sulfobenzoate + NADH + 2 H+  
1.2.1.63, 6-oxohexanoate + NADP+ + H2O = adipate + NADPH + 2 H+  
1.2.1.64, 4-hydroxybenzaldehyde + NAD+ + H2O = 4-hydroxybenzoate + NADH + 2 H+  
1.2.1.65," salicylaldehyde + NAD+ + H2O = salicylate + NADH + 2 H+ (#6# catalytic  mechanism, overview <14>)  "
1.2.1.67, vanillin + NAD+ + H2O = vanillate + NADH + 2 H+  
1.2.1.68, coniferyl aldehyde + H2O + NAD(P)+ = ferulate + NAD(P)H + 2 H+  
1.2.1.69, fluoroacetaldehyde + NAD+ + H2O = fluoroacetate + NADH + 2 H+  
1.2.1.7," benzaldehyde + NADP+ + H2O = benzoate + NADPH + 2 H+ (#4# inducible by  mandelic acid <8>; #1,5# inducible by xenobiotics, like DDT and TCDD  <10>)  "
1.2.1.70, L-glutamate 1-semialdehyde + NADP+ + tRNAGlu = L-glutamyl-tRNAGlu +  NADPH + H+  
1.2.1.71, N-succinyl-L-glutamate 5-semialdehyde + NAD+ + H2O =  N-succinyl-L-glutamate + NADH + 2 H+  
1.2.1.72, D-erythrose 4-phosphate + NAD+ + H2O = 4-phosphoerythronate + NADH + 2  H+  
1.2.1.73, 2-sulfoacetaldehyde + H2O + NAD+ = sulfoacetate + NADH + 2 H+  
1.2.1.74," abieta-7,13-dien-18-al + H2O + NAD+ = abieta-7,13-dien-18-oate + NADH +  H+  "
1.2.1.75," malonate semialdehyde + CoA + NADP+ = malonyl-CoA + NADPH + H+ (#3# the  protein acts as rigid template to press CoA and NADP into similar  S-shaped, superimposable forms <4>)  "
1.2.1.76, succinate semialdehyde + CoA + NADP+ = succinyl-CoA + NADPH + H+ (#1#  ping-pong mechanism <1>)  
1.2.1.77," 3,4-didehydroadipyl-CoA semialdehyde + NADP+ + H2O =  3,4-didehydroadipyl-CoA + NADPH + H+  "
1.2.1.78, 2-formylbenzoate + NAD+ + H2O = o-phthalic acid + NADH + H+  
1.2.1.79," succinate semialdehyde + NADP+ + H2O = succinate + NADPH + 2 H+ (#16#  proposed reaction mechanism of AbSSADH via thiohemiacetal intermediate  and thioester intermediate. Formation of Cys289 thiolate is necessary  for the activity of AbSSADH. Based on two independent methods of pKa  measurement, the pKa of Cys289 is 7.4-7.9. The rate-limiting step of  the overall reaction of AbSSADH are the thioester intermediate  hydrolysis and product liberation steps <21>; #17# the thiol-group of  Cys residue in aldehyde dehydrogenase will attack NADP+ to form the  adduct is the first step in the catalytic mechanism. The key step is  the formation of thiohemiacetal tetrahedral intermediate, which then is  converted to thioester intermediate by transferring the hydride to  NAD(P)+, catalytic reaction kinetic analysis <22>; #18# two arginine  residues at positions 121 and 457 are both essential for the catalytic  activity of ALDH21 and for the binding of SSAL <23>)  "
1.2.1.8," betaine aldehyde + NAD+ + H2O = betaine + NADH + 2 H+ (#28# ping-pong  mechanism <14>; #22# steady-state ordered bi bi or rapid equilibrium  mechanism <34>; #7,22# iso-ordered bi-bi steady state mechanism  <28,31>; #22# iso random steady state mechanism <33>; #22# NAD+ is the  first substrate to bind to the enzyme and NADH is the last product to  dissociate from it <31>; #14# steady-state ordered mechanism, in which  NAD+ binds first and NADH leaves last <48>; #7# catalyzes the last  irreversible step in the synthesis of the osmoprotector glycine betaine  <54>; #65# catalyzes the last step of the two-step oxidation <55>; #51#  the enzyme catalyzes the second step of the two-step conversion of  choline into glycine betaine <60>; #7# porcine kidney BADH follows an  iso bi-bi ordered mechanism in which NAD+ is the first substrate to  bind to pkBADH and NADH is the last product released <101>)  "
1.2.1.80, a long-chain aldehyde + an [acyl-carrier protein] + NAD(P)+ = a  long-chain acyl-[acyl-carrier protein] + NAD(P)H + H+  
1.2.1.81, 2-sulfoacetaldehyde + CoA + NADP+ = sulfoacetyl-CoA + NADPH + H+  
1.2.1.82," 4'-apo-beta,psi-caroten-4'-al + NAD+ + H2O = neurosporaxanthin + NADH +  2 H+  "
1.2.1.83, 4-oxo-4-(pyridin-3-yl)butanal + NADP+ + H2O =  4-oxo-4-(pyridin-3-yl)butanoate + NADPH + H+  
1.2.1.84, a long-chain acyl-CoA + 2 NADPH + 2 H+ = a long-chain alcohol + 2 NADP+  + CoA  
1.2.1.85," 2-hydroxymuconate-6-semialdehyde + NAD+ + H2O =  (2Z,4E)-2-hydroxyhexa-2,4-dienedioate + NADH + 2 H+  "
1.2.1.86, geranial + H2O + NAD+ = geranate + NADH + H+  
1.2.1.87, propanal + CoA + NAD+ = propanoyl-CoA + NADH + H+  
1.2.1.88," L-glutamate 5-semialdehyde + NAD+ + H2O = L-glutamate + NADH + H+ (#16#  no induction by ammonia <20>; #20# induction by proline, activation on  gene transcription level <21>; #1# ordered reaction mechanism <6>; #16#  enzyme is a gamma-glutamyl semialdehyde dehydrogenase <20>; #1,12#  induction by proline <13,23>)  "
1.2.1.89, D-glyceraldehyde + NADP+ + H2O = D-glycerate + NADPH + H+  
1.2.1.9," D-glyceraldehyde 3-phosphate + NADP+ + H2O = 3-phospho-D-glycerate +  NADPH + 2 H+ (#22# two-step mechanism and kinetics <10>; #5# proposed  mechanism <2>; #16# probably identical with EC 1.2.1.13 <9,12>)  "
1.2.1.90, D-glyceraldehyde 3-phosphate + NAD(P)+ + H2O = 3-phospho-D-glycerate +  NAD(P)H + 2 H+  
1.2.1.91," 3-oxo-5,6-dehydrosuberyl-CoA semialdehyde + NADP+ + H2O =  3-oxo-5,6-dehydrosuberyl-CoA + NADPH + H+  "
1.2.1.92," 3,6-anhydro-alpha-L-galactopyranose + NAD(P)+ + H2O =  3,6-anhydro-L-galactonate + NAD(P)H + H+ (#2# catalytic mechanism,  detailed overview. The catalytic process of VvAHGD involves both the  two catalytic residues, Cys282 and Glu248, which not only undergo  conformational changes but also function as gatekeepers between the  cofactor channel and the substrate channel. The conformational changes  of Cys282 and Glu248 lead to the connection and interruption of the  cofactor channel and the substrate channel, which promotes the  productive binding of NADPÃ¾/L-AHG and the efficient release of NADPH  and L-AHGA during the catalysis and therefore leads to the high  catalytic activity of VvAHGD <4>)  "
1.2.1.94," (2E,6E)-farnesal + NAD+ + H2O = (2E,6E)-farnesoate + NADH + 2 H+  "
1.2.1.95, (S)-2-amino-6-oxohexanoate + NADP+ + AMP + diphosphate =  L-2-aminoadipate + NADPH + H+ + ATP 
1.2.1.95, L-2-aminoadipyl-[LYS2 peptidyl-carrier-protein] + AMP + diphosphate =  L-2-aminoadipate + holo-[LYS2 peptidyl-carrier-protein] + ATP 
1.2.1.95, (S)-2-amino-6-oxohexanoate + holo-[LYS2 peptidyl-carrier-protein] +  NADP+ = L-2-aminoadipyl-[LYS2 peptidyl-carrier-protein] + NADPH + H+  
1.2.1.96, 4-hydroxybenzaldehyde + NADP+ + H2O = 4-hydroxybenzoate + NADPH + 2 H+  
1.2.1.97, (2S)-3-sulfolactaldehyde + NAD(P)+ + H2O = (2S)-3-sulfolactate +  NAD(P)H + H+  
1.2.1.98, 2-hydroxy-2-methylpropanal + NAD+ + H2O = 2-hydroxy-2-methylpropanoate  + NADH + H+  
1.2.1.99, 4-(gamma-L-glutamylamino)butanal + NAD(P)+ + H2O =  4-(gamma-L-glutamylamino)butanoate + NAD(P)H + H+  
1.2.2.1, formate + 2 ferricytochrome b1 = CO2 + 2 ferrocytochrome b1 + 2 H+  
1.2.3.1," an aldehyde + H2O + O2 = a carboxylate + H2O2 (#37# concerted mechanism  <109>; #50# base catalyzed mechanism. Residue E1265 acts as an active  site base that abstracts a proton from the Mo-OH group, which in turn  undertakes a nucleophilic attack on the substrate benzaldehyde. After  hydride transfer to the Mo= S group, the initial intermediate breaks  down, with the transient formation of a paramagnetic MoV species,  followed by displacement of product by a water molecule to return to  the starting LMoVIOS(OH) state. The roles of residues Met884 and Val806  are stabilization of substrate binding <111>)  "
1.2.3.13, 2 4-hydroxyphenylpyruvate + O2 = 2 4-hydroxyphenylacetate + 2 CO2  
1.2.3.14, abscisic aldehyde + H2O + O2 = abscisate + H2O2  
1.2.3.15, glyoxal + H2O + O2 = glyoxylate + H2O2 
1.2.3.15, 2-oxopropanal + H2O + O2 = pyruvate + H2O2  
1.2.3.3, pyruvate + phosphate + O2 = acetyl phosphate + CO2 + H2O2  
1.2.3.4," oxalate + O2 + 2 H+ = 2 CO2 + H2O2 (#6# The computer model supports the  following reaction mechanism: The Oxo-Mn(2)-oxalate complex exists as a  mixture of five-and six-coordinate species. The form with  coordinatively unsaturated Mn(2) site reacts with dioxygen on the  quartet potential energy surface. In this step, the proton from oxalate  monoanion is transferred to dioxygen through the first-shell glutamate.  The proton-transfer triggers the C-C bond cleavage, and the electron  follows the proton. Simultaneously, the second electron, necessary to  produce the peroxo species, is provided by manganese. This step, which  is also rate-limiting, yields the first CO2 molecule and the reactive  intermediate in which the formyl radical anion coordinates the  high-spin Mn(3). The quartet to sextet spin transition, which involves  a small apparent barrier, allows for the formyl radical -> Mn(3)  electron transfer. This step leads to the product-active site complex,  which upon protonation decays to H2O2, CO2, and the active site is then  ready to begin the next catalytic cycle <29>)  "
1.2.3.5, glyoxylate + H2O + O2 = oxalate + H2O2  
1.2.3.6, pyruvate + CoA + O2 = acetyl-CoA + CO2 + H2O2 (#1# enzyme catalyzes  transacetylation from pyruvate to CoA by an oxidase reaction in which  H2O2 is produced <1>)  
1.2.3.7, (indol-3-yl)acetaldehyde + H2O + O2 = (indol-3-yl)acetate + H2O2  
1.2.3.8, pyridoxal + H2O + O2 = 4-pyridoxate + (?)  
1.2.3.9, an aromatic aldehyde + O2 + H2O = an aromatic carboxylate + H2O2  
1.2.4.1," pyruvate + [dihydrolipoyllysine-residue acetyltransferase] lipoyllysine  = [dihydrolipoyllysine-residue acetyltransferase]  S-acetyldihydrolipoyllysine + CO2 (#4,8# two-step reaction: thiamine  diphosphate dependent decarboxylation of pyruvate to  2-hydroxyethylidene-thiamine diphosphate and subsequent reductive  acetylation of lipoic acid residues bound to the dihydrolipoamide  acetyltransferase, EC 2.3.1.12 <17>; #24# active site interactions,  reaction mechanism <24>; #9# catalytic site is formed by the conserved  residues Tyr281 and Arg282 <27>; #24# reaction mechanism, role of water  molecules <26>; #4# active center communication between the cofactors  in the enzyme complex. Only one of the thiamine molecules bound to the  two active sites is in a chemically activated state whereas the thiamin  in the inactive states ionizes with a rate that is at least three  orders of magnitude smaller. Model of an active site synchronization  via a proton wire that keeps the two active sites in an alternating  activation state <32>; #24# reaction with phosphonolactylthiamine  diphosphate gives a covalently bound, pre-decarboxylation reaction  intermediate analogue tightly held in the active site through hydrogen  bonds with H407, Y599, and H640 <35>; #9# substrate channelling in the  multienzyme complex rests on the recognition of the lipoyl domain by  enzyme. Cofactor thiamine diphosphate and substrate pyruvate have  distinct effects on enzyme/lipoyl domain interaction. conformational  freedom is allowed by the linker in the movement of the lipoyl domain  between active sites <36>)  "
1.2.4.2," 2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase]  lipoyllysine = [dihydrolipoyllysine-residue succinyltransferase]  S-succinyldihydrolipoyllysine + CO2 (#2,4,8,9,13,16# 2-oxoglutarate  dehydrogenase complex consists of 3 enzymes: E1 (alpha-ketoglutarate  dehydrogenase, EC 1.2.4.2), E2 (dihydrolipoyl transsuccinylase, EC  2.3.1.61), E3 (dihydrolipoyl dehydrogenase, EC 1.8.1.4)  <1,2,3,4,5,8,9>; #2,3,4,6,8,9,10,13,14,16,17# the enzyme complex  catalyzes the reaction : 2-oxoglutarate + CoA + NAD+--> succinyl-CoA +  CO2 + NADH, the following partial reactions are catalyzed: 1.  HOOC(CH2)2COCOOH + (thiamine diphosphate)-E1--> (HOOC(CH2)2  CHOH-thiamine-diphosphate)-E1 + CO2, 2. (HOOC(CH2)2CH  OH-thiamine-diphosphate)-E1 + (LipS2)-E2--> (HOOC(CH)2 CO-(SLipSH))-E2  + (thiamine-diphosphate)-E1, 3. (HOOC(CH2)2CO-(SLipSH))-E2 + HSCoA-->  (Lip(SH)2)-E2 + HOOC(CH2)2CO-SCoA, 4. (Lip(SH)2)-E2 + E3-FAD-->  (LipS2)-E2 + reduced E3-FAD, 5. reduced E3-FAD + NAD+--> E3-FAD + NADH  <1,2,3,4,5,6,7,8,9,10,11>)  "
1.2.4.4," 3-methyl-2-oxobutanoate + [dihydrolipoyllysine-residue  (2-methylpropanoyl)transferase] lipoyllysine =  [dihydrolipoyllysine-residue (2-methylpropanoyl)transferase]  S-(2-methylpropanoyl)dihydrolipoyllysine + CO2 (#6,8,9# the multienzyme  complex catalyzes a thiamine diphosphate- and Mg2+-dependent oxidative  decarboxylation of branched-chain keto acids with the formation of  branched-chain acyl-CoA and reduction of NAD+ to NADH: R1R2CHCOCOOH +  NAD+ + CoASH = R1R2CHCO-S-CoA + NADH + CO2, component E1 (EC 1.2.4.4,  branched-chain keto acid dehydrogenase), component E2 (no EC number,  branched-chain acyltransferase), component E3 (EC 1.8.1.4,  dihydrolipoamide dehydrogenase), partial reactions catalyzed by the  multienzyme complex: 1. R1R2CHCOCOOH + E1-(thiamine diphosphate) =  E1-(thiamine diphosphate)-COHCHR1R2 + CO2, 2. E1-(thiamine  diphosphate)-COHCHR1R2 + lipoyl-E2 = R1R2CHCO-SCoA + dihydrolipoyl-E2,  4. dihydrolipoyl-E2 + NAD+ = lipoyl-E2 + NADH, the multienzyme complex  also contains small amounts of a specific kinase and a specific  phosphatase which modulate the activity of E1 by phosphorylation and  dephosphorylation <3>; #5# residues His146beta and His291alpha of E1b  component are essential for catalysis <51>; #5# substrate recognition  and reaction mechanism <52>; #3# substrate recognition and reaction  mechanism, involving residues Gly131beta-Gln131beta, Phe66alpha,  Tyr86beta, Tyr95alpha, Met128alpha, His131alpha of component E1 <53>)  "
1.2.5.1, pyruvate + ubiquinone + H2O = acetate + CO2 + ubiquinol (#1# enzyme  also catalyzes the formation of acetoin from pyruvate and acetaldehyde  <6>)  
1.2.5.2, an aldehyde + a quinone + H2O = a carboxylate + a quinol  
1.2.5.3," CO + a quinone + H2O = CO2 + a quinol (#2# CO initially binds rapidly  to the enzyme, possibly at the Cu(I) of the active site, prior to  undergoing oxidation. A Mo(V) species exhibits strong coupling to the  copper of the active center, the rate-limiting step of overall turnover  is likely in the reductive half-reaction <8>; #4# hypothetical reaction  mechanism, overview <2>; #4# proposed reaction mechanisms for CO  dehydrogenase, the rate-limiting step for overall turnover resides in  the reductive half-reaction, reoxidation of reduced enzyme by quinones  occurs at the FAD site <16>; #5# reaction mechanism that initially  involves nucleophilic attack of a Mo=O oxo on the carbon center of  Cu(I)-CO, resulting in a 5-membered cyclic m2-e(2) CO2-bridged  Mo(VI)-Cu(I)-Cys complex I that can bind HO-/H2O to yield 1-OH. This is  followed by a second nucleophilic attack on the activated mu2-nu2 CO2  carbon centre of 1-OH to yield a Mo(IV)-bicarbonate product complex,  1-P. This second nucleophilic attack is suggested based on electronic  structure description of cyclic m2-e(2) CO2-bridged Mo(VI)-Cu(I)-Cys  complex I, which possesses a bent and activated CO2 bound to the Mo and  Cu ions. Proposed catalytic cycle for CODH that avoids formation of a  stable C-S bonded cyclic m2-e(2) CO2-bridged Mo(VI)-Cu(I)-Cys complex  II <10>; #8# reaction mechanism that initially involves nucleophilic  attack of a Mo=O oxo on the carbon center of Cu(I)-CO, resulting in a  5-membered cyclic m2-e(2) CO2-bridged Mo(VI)-Cu(I)-Cys complex I that  can bind HO-/H2O to yield 1-OH. This is followed by a second  nucleophilic attack on the activated mu2-nu2 CO2 carbon centre of 1-OH  to yield a Mo(IV)-bicarbonate product complex, 1-P. This second  nucleophilic attack is suggested based on our electronic structure  description of cyclic m2-e(2) CO2-bridged Mo(VI)-Cu(I)-Cys complex I,  which possesses a bent and activated CO2 bound to the Mo and Cu ions.  Proposed catalytic cycle for CODH that avoids formation of a stable C-S  bonded cyclic m2-e(2) CO2-bridged Mo(VI)-Cu(I)-Cys complex II <10>)  "
1.2.7.1, pyruvate + CoA + 2 oxidized ferredoxin = acetyl-CoA + CO2 + 2 reduced  ferredoxin + 2 H+  
1.2.7.10, oxalate + oxidized ferredoxin = 2 CO2 + reduced ferredoxin  
1.2.7.11, a 2-oxocarboxylate + CoA + 2 oxidized ferredoxin = an acyl-CoA + CO2 +  2 reduced ferredoxin + 2 H+  
1.2.7.12," a formylmethanofuran + H2O + 2 oxidized ferredoxin [iron-sulfur]  cluster = CO2 + a methanofuran + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+ (#1# the enzyme catalyzes a methanofuran-dependent  exchange between CO2 and the formyl group of formylmethanofuran,  N-carboxymethanofuran is an intermediate in CO2 reduction to  formylmethanofuran <15>; #2# bioenergetics, reaction is driven by the  import of two to four sodium ions <17>; #1# reaction step catalyzed by  enzyme is not energy-driven <18>)  "
1.2.7.3, 2-oxoglutarate + CoA + 2 oxidized ferredoxin = succinyl-CoA + CO2 + 2  reduced ferredoxin + 2 H+  
1.2.7.4," CO + H2O + 2 oxidized ferredoxin = CO2 + 2 reduced ferredoxin + 2 H+  (#6,9# ping-pong mechanism <14,19>; #7# CO may react with OH- rather  than with H2O <4>; #6# enzyme also catalyzes acetyl-CoA/CoA and  acetyl-CoA/CO exchange reaction, enzyme has both CO-dehydrogenase and  acetyl-CoA synthase activity <22>; #6# CO2/CO tunnel gating mechanism  <46>; #9# kinetics, oxidation state of Fe-S cluster during catalysis  <39>; #6,9# mechanism, CO binding labilizes the hydroxyl bridging Ni  and Fe and increases the nucleophilic tendency toward attacking  Ni-bound carbonyl <43>; #9# mechanism, enzyme is capable of producing  formate <45>; #12# mechnaism via thiocarbonate-like intermediate state  <47>; #6# CO and CO2 enter and exit the enzyme at the water channel  along the betabeta subunit interface. CO either enters the enzyme and  migrates through the tunnel before binding at the A-cluster, or it  binds the A-cluster directly from solvent <54>; #42# anaerobic CO  dehydrogenases catalyze the reversible oxidation of CO to CO2 at a  complex Ni-, Fe-, and S-containing metal center called cluster C <64>)  "
1.2.7.5," an aldehyde + H2O + 2 oxidized ferredoxin = a carboxylate + 2 H+ + 2  reduced ferredoxin (#1,5# active site structure <5,8>; #1#  intermolecular interaction analysis <8>; #1# substrate binding,  catalytic site and reaction mechanism including cofactor action <4,8>)  "
1.2.7.6," D-glyceraldehyde-3-phosphate + H2O + 2 oxidized ferredoxin =  3-phospho-D-glycerate + 2 H+ + 2 reduced ferredoxin (#1,5# this enzyme  is thought to function in place of glyceraldehyde-3-phosphate  dehydrogenase and possibly phosphoglycerate kinase in the novel  Embden-Meyerhoff-type glycolytic pathway found in Pyrococcus furiosus.  It is specific for glyceraldehyde-3-phosphate <2,4>; #1# electron  transfer, mechanism and reduction potential <3>)  "
1.2.7.7," 3-methyl-2-oxobutanoate + CoA + 2 oxidized ferredoxin =  S-(2-methylpropanoyl)-CoA + CO2 + 2 reduced ferredoxin + H+ (#3,5#  pathway <2>; #1,2,3,4,5# this enzyme is one of four 2-oxoacid  oxidoreductases: indolepyruvate oxidoreductase, EC 1.2.7.8, pyruvate  oxidoreductase, EC 1.2.7.1., 2-oxogluterate oxidoreductase, EC 1.2.7.3  <1,2,3,4>)  "
1.2.7.8, (indol-3-yl)pyruvate + CoA + 2 oxidized ferredoxin =  S-2-(indol-3-yl)acetyl-CoA + CO2 + 2 reduced ferredoxin + H+  
1.2.98.1, 2 formaldehyde + H2O = formate + methanol  
1.2.99.10," 4,4'-diapolycopen-4-al + H2O + acceptor = 4,4'-diapolycopen-4-oate +  reduced acceptor "
1.2.99.10," 4,4'-diapolycopene-4,4'-dial + 2 H2O + 2 acceptor =  4,4'-diapolycopene-4,4'-dioate + 2 reduced acceptor  "
1.2.99.6, An aldehyde + acceptor + H2O = a carboxylate + reduced acceptor (#8# bi  uni uni bi mechanism <6>)  
1.2.99.7, an aldehyde + H2O + acceptor = a carboxylate + reduced acceptor  
1.2.99.8, D-glyceraldehyde + H2O + acceptor = D-glycerate + reduced acceptor  
1.20.1.1, phosphonate + NAD+ + H2O = phosphate + NADH + H+ (#2# different  reaction mechanism discussed <6>)  
1.20.2.1, arsenite + H2O + 2 oxidized cytochrome c = arsenate + 2 reduced  cytochrome c + 2 H+  
1.20.4.1," arsenate + glutathione + glutaredoxin = arsenite + a  glutaredoxin-glutathione disulfide + H2O (#11# reaction mechanism <7>;  #2# arsenate reduction by glyceraldehyde-3-phosphate dehydrogenase may  take place during or as a consequence of, the arsenolytic cleavage of  the thioester bond formed between the enzymeÂ’s C149 and the  3-phosphoglycerol moiety of the substrate <11>; #13# first reaction  step is a nucleophilic displacement reaction by C10 on dianionic  arsenate. Second step is a preferential nucleophilic attack of C82 on  the monoanionic C10-arsenate intermediate stabilized by S17. Thiolate  form of C82 is stabilized by an eight-residue alpha helix flanked by  C82 and C89 and a hydrogen bond with T11. during the final step, C89 is  activated as a nucleophile by structural alterations of the redox helix  <8>)  "
1.20.4.2, methylarsonate + 2 glutathione = methylarsonite + glutathione disulfide  + H2O  
1.20.4.3, arseno-mycothiol + mycoredoxin = arsenite + mycothiol-mycoredoxin  disulfide  
1.20.4.4, arsenate + thioredoxin = arsenite + thioredoxin disulfide + H2O  
1.20.9.1, arsenite + H2O + 2 oxidized azurin = arsenate + 2 reduced azurin + 2 H+  
1.20.99.1," arsenite + acceptor = arsenate + reduced acceptor (#1# active site  structure <7>; #2# catalytic mechanism involves the essential residues  C10, C82, C89, R16, and D105, triple cysteine redox relay reduction  mechanism, active site structure <8>; #26,27# electron transport chain,  overview <6>; #3# reaction mechanism, the catalytic Cys12, located at  the active site, forms a covalent adduct with arsenate, the complex  shows tetrahedral geometry, arsenite binds to Cys12 in a thiarsahydroxy  adduct <10>; #3# the catalytic Cys12 of the wild-type enzyme, located  at the active site and surrounded by the Arg triad with Arg60, Arg94,  and Arg107, forms a unique monohydroxyl Cys12-thiol-arsenite adduct  with a positive charge on the arsenic, which is an unstable  intermediate <9>)  "
1.21.1.1, L-tyrosine + NADP+ + iodide = 3-iodo-L-tyrosine + NADPH + H+ 
1.21.1.1," 3-iodo-L-tyrosine + NADP+ + iodide = 3,5-diiodo-L-tyrosine + NADPH + H+ "
1.21.1.1," L-tyrosine + 2 NADP+ + 2 iodide = 3,5-diiodo-L-tyrosine + 2 NADPH + 2 H+  "
1.21.1.2," 4-chlorobenzoyl-CoA + NADP+ + chloride = 2,4-dichlorobenzoyl-CoA +  NADPH + H+  "
1.21.3.1," N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine + O2 =  isopenicillin N + 2 H2O (#1,8,10,11# structure and mechanism  <7,9,10,12>; #10# ligation of substrate to the iron centre <9>; #10#  active site with conserved jelly-roll motif, cysteine residues are not  directly involved in the coordination of the metal ion <7>; #8# Cys106  is involved in substrate binding, Cys255 is involved in maintaining the  protein structure <4>; #2,6,8# removal of 4 hydrogen atoms to form the  4-membered beta-lactam and the 5-membered thiazolidine ring <1>; #1#  catalytic reaction is under steric regulation <12>; #10# radical  pathway, analogous to the first step of a radicalbased hydroxylation  reaction <20>; #2# isopenicillin-N synthase is the main rate-limiting  enzyme for penicillin-G biosynthesis <29>; #1# the  hydroperoxide-ferrous intermediate, formed by O2-activated H atom  abstraction from the substrate, can exploit different reaction pathways  and interactions with the substrate govern the final pathway <28>)  "
1.21.3.2, 2 columbamine + O2 = 2 berberine + 2 H2O  
1.21.3.3, (S)-reticuline + O2 = (S)-scoulerine + H2O2  
1.21.3.4, 2 sulochrin + O2 = 2 (+)-bisdechlorogeodin + 2 H2O  
1.21.3.5, 2 sulochrin + O2 = 2 (-)-bisdechlorogeodin + 2 H2O  
1.21.3.6," 2',4,4',6'-tetrahydroxychalcone 4'-O-beta-D-glucoside + O2 = aureusidin  6-O-beta-D-glucoside + H2O (#2# mechanism <2,3>) "
1.21.3.6," 2',3,4,4',6'-pentahydroxychalcone 4'-O-beta-D-glucoside + 1/2 O2 =  aureusidin 6-O-beta-D-glucoside + H2O (#2# mechanism <2,3>) "
1.21.3.6," 2',3,4,4',6'-pentahydroxychalcone 4'-O-beta-D-glucoside + O2 =  bracteatin 6-O-beta-D-glucoside + H2O  "
1.21.3.7, cannabigerolate + O2 = DELTA9-tetrahydrocannabinolate + H2O2  
1.21.3.8, cannabigerolate + O2 = cannabidiolate + H2O2  
1.21.4.1, 5-aminopentanoate + a [PrdC protein with a selenide-sulfide bridge] =  D-proline + a [PrdC protein with thiol/selenol residues]  
1.21.4.2," acetyl phosphate + NH3 + thioredoxin disulfide + H2O = glycine +  phosphate + thioredoxin (#1,7,9# mechanism <1,2,3>; #7,9# cleavage  mechanism for the pyruvoyl group dependent reductase starting from  cysteine <1,2>; #1,4# the protein C component catalyses the  arsenate-dependent decomposition of acetyl phosphate <6,8,11>; #1# the  protein component C serves as the acetyl group acceptor in the overall  reaction <6>; #1,8# a selenium-containing protein, selenoprotein, is  essential component of the enzyme <4,5>; #4# GrdD of protein component  C catalyses the arsenate-dependent decomposition of acetyl phosphate,  whereas GrdC completely inactive <12>; #4# Cys 359 of GrdD is the thiol  responsible for the formation of the acetyl thioester during catalysis  of arsenate-dependent hydrolysis of acetyl phosphate <12>; #4# the  48000 Da subunit of protein component C catalyses the  arsenate-dependent decomposition of actetyl phosphate, a possible role  of the 57000 Da subunit of protein component C could be the involvement  in the reductive dehydration which leads to the cleavage of the protein  A-bound carboxymethyl-selenoether to ketene and oxidized protein A  <11>; #1# mechanism, thiols are present in protein C that is acetylated  during reaction <15>; #4# the thioredoxin system is involved in the  electron transport from reduced pyridine nucleotides to protein A, i.e.  in the electron flow between protein of glycine decarboxylase and  glycine reductase complex <10>; #4# glycine pathway is used for acetate  synthesis <14>; #1,4,5,7,8,9# The reaction is observed only in the  direction of glycine reduction. The enzyme consists of three protein  components A, B and C. Protein B contains selenocysteine and a pyruvoyl  group, and is responsible for glycine binding and ammonia release.  Protein A, which also contains selenocysteine, is reduced by  thioredoxin, and is needed to convert the carboxymethyl group into a  ketene equivalent, in turn used by protein C to produce acetyl  phosphate. Only protein B distinguishes this enzyme from EC 1.21.4.3  (sarcosine reductase) and EC 1.21.4.4 (betaine reductase)  <1,2,3,7,8,10,11,12,15>)  "
1.21.4.3, acetyl phosphate + methylamine + thioredoxin disulfide + H2O =  N-methylglycine + phosphate + thioredoxin  
1.21.4.4, acetyl phosphate + trimethylamine + thioredoxin disulfide + H2O =  betaine + phosphate + thioredoxin  
1.21.4.5," 2,6-dichlorohydroquinone + Cl- + glutathione disulfide =  2,3,6-trichlorohydroquinone + 2 glutathione "
1.21.4.5," 2,3,6-trichlorohydroquinone + Cl- + glutathione disulfide =  2,3,5,6-tetrachlorohydroquinone + 2 glutathione  "
1.21.98.1, dehypoxanthine futalosine + S-adenosyl-L-methionine = cyclic  dehypoxanthinyl futalosine + 5'-deoxyadenosine + L-methionine  
1.21.98.2," 2 3-(7-chloroindol-3-yl)-2-iminopropanoate + H2O2 =  dichlorochromopyrrolate + NH3 + 2 H2O (#1# peroxidative reaction  mechanism for oxidative coupling catalyzed by RebD to form  chromopyrrolic acid in the biosynthesis of rebeccamycin, and analysis  of the intermediates in the enzyme RebD reaction, overview <4>)  "
1.21.98.3," magnesium-protoporphyrin IX 13-monomethyl ester + 3  S-adenosyl-L-methionine + H2O = 3,8-divinyl protochlorophyllide a + 3  5'-deoxyadenosine + 3 L-methionine "
1.21.98.3, magnesium-protoporphyrin IX 13-monomethyl ester +  S-adenosyl-L-methionine + H2O = 131-hydroxy-magnesium-protoporphyrin IX  13-monomethyl ester + 5'-deoxyadenosine + L-methionine 
1.21.98.3, 131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester +  S-adenosyl-L-methionine = 131-oxo-magnesium-protoporphyrin IX  13-monomethyl ester + 5'-deoxyadenosine + L-methionine 
1.21.98.3," 131-oxo-magnesium-protoporphyrin IX 13-monomethyl ester +  S-adenosyl-L-methionine = 3,8-divinyl protochlorophyllide a +  5'-deoxyadenosine + L-methionine  "
1.21.98.4, a PqqA peptide + S-adenosyl-L-methionine = a PqqA peptide with linked  Glu-Tyr residues + 5'-deoxyadenosine + L-methionine  
1.21.99.1, beta-cyclopiazonate + acceptor = alpha-cyclopiazonate + reduced  acceptor (#1# ping-pong bi-bi mechanism <10>)  
1.21.99.3," 3,3',5'-triiodo-L-thyronine + iodide + acceptor + H+ = L-thyroxine +  reduced acceptor (#19# all 3 isozyme types contain a selenocysteine  residue at the active site <21>; #4# enzyme has both thyroxine  5-deiodinase and thyroxine 5-deiodinase activities <2,4,5>; #19# inner  ring deiodination <21>; #9# both 5-deiodinase isoforms and 5-deiodinase  contain a selenocysteine residue at the active site <19>)  "
1.21.99.4," 3,3',5-triiodo-L-thyronine + iodide + acceptor + H+ = L-thyroxine +  reduced acceptor (#14# reaction mechanism of thyronine 5-deiodinase  <6>; #14# type III, inner (tyrosyl) ring deiodination <6,10>; #14# type  II, outer ring (phenolic) deiodination <6,9,10,12>; #14# type I, outer  ring (phenolic) deiodination <6,10,12>; #3,5,7,12# isozyme type I,  reaction mechanism, both 5Â’-deiodinase isoforms and 5-deiodinase  contain a selenocysteine residue at the active site <26>)  "
1.21.99.5," trichloroethene + chloride + acceptor = tetrachloroethene + reduced  acceptor (#3,4,5# mechanism <1,2,3,4,8>; #3,4# chemiosmotic mechanism  <2,9>; #3,4# thermodynamics <1,2,3>; #8# an electron transfer mechanism  is not consistent with experimental data of rate constants. The actual  mechanism involves more intimate interactions between the electron  donor and the substrate in which the latter enters the cobalt  coordination sphere <16>; #3# standard potential of the electron  acceptor center in -0.57 V <17>)  "
1.23.1.1, (+)-lariciresinol + NADP+ = (+)-pinoresinol + NADPH + H+  
1.23.1.2, (-)-secoisolariciresinol + NADP+ = (+)-lariciresinol + NADPH + H+  
1.23.1.3, (-)-lariciresinol + NADP+ = (-)-pinoresinol + NADPH + H+  
1.23.1.4, (+)-secoisolariciresinol + NADP+ = (-)-lariciresinol + NADPH + H+  
1.23.5.1, violaxanthin + L-ascorbate = antheraxanthin + L-dehydroascorbate + H2O  (#14# (1a) <17>) 
1.23.5.1, antheraxanthin + L-ascorbate = zeaxanthin + L-dehydroascorbate + H2O 
1.23.5.1, violaxanthin + 2 L-ascorbate = zeaxanthin + 2 L-dehydroascorbate + 2 H2O  
1.3.1.1," 5,6-dihydrouracil + NAD+ = uracil + NADH + H+ "
1.3.1.1," 5,6-dihydrothymine + NAD+ = thymine + NADH + H+  "
1.3.1.10," an acyl-[acyl-carrier protein] + NADP+ = a  trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH + H+ (#5# anti  addition via 2Si,3Si attack on double bond <3>; #4# syn addition via  2Re,3Si attack on double bond <2>)  "
1.3.1.100, dihydrochanoclavine-I aldehyde + NADP+ = chanoclavine-I aldehyde +  NADPH + H+  
1.3.1.101," 2,3-bis-(O-phytanyl)-sn-glycerol 1-phosphate + 8 NAD(P)+ =  2,3-bis-(O-geranylgeranyl)-sn-glycerol 1-phosphate + 8 NAD(P)H + 8 H+  "
1.3.1.102, an n-alkanal + NADP+ = an alk-2-enal + NADPH + H+  
1.3.1.103, (S)-2-chloropropanoate + NADP+ = 2-chloroacrylate + NADPH + H+  
1.3.1.104," an acyl-[acyl-carrier protein] + NADP+ = a  trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH + H+  "
1.3.1.105," 4-hydroxy-2,5-dimethylfuran-3(2H)-one + NADP+ =  4-hydroxy-5-methyl-2-methylenefuran-3(2H)-one + NADPH + H+  "
1.3.1.106, cobalt-precorrin-6B + NAD+ = cobalt-precorrin-6A + NADH + H+  
1.3.1.107, dihydrosanguinarine + NAD(P)+ = sanguinarine + NAD(P)H + H+ (#1# (1)  <1>) 
1.3.1.107, dihydrochelirubine + NAD(P)+ = chelirubine + NAD(P)H + H+ (#1# (2) <1>)  
1.3.1.108," 3-(3,4-dihydroxyphenyl)propanoyl-CoA + 2 NAD+ + 2 reduced ferredoxin  [iron-sulfur] cluster = (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl-CoA +  2 NADH + 2 oxidized ferredoxin [iron-sulfur] cluster  "
1.3.1.109, butanoyl-CoA + 2 NAD+ + 2 reduced ferredoxin [iron-sulfur] cluster =  (E)-but-2-enoyl-CoA + 2 NADH + 2 oxidized ferredoxin [iron-sulfur]  cluster  
1.3.1.11, 3-(2-hydroxyphenyl)propanoate + NAD+ = 2-coumarate + NADH + H+  
1.3.1.110, lactate + 2 NAD+ + 2 reduced ferredoxin [iron-sulfur] cluster =  pyruvate + 2 NADH + 2 oxidized ferredoxin [iron-sulfur] cluster  
1.3.1.111, bacteriochlorophyll a + 3 NADP+ = geranylgeranyl bacteriochlorophyllide  a + 3 NADPH + 3 H+  
1.3.1.112," a (2S,3R)-flavan-3-ol + 2 NADP+ = an anthocyanidin with a 3-hydroxy  group + 2 NADPH + H+ "
1.3.1.112," a (2S,3S)-flavan-3-ol + 2 NADP+ = an anthocyanidin with a 3-hydroxy  group + 2 NADPH + H+  "
1.3.1.113," a [(3S)-4-alkanoyl-5-oxooxolan-3-yl]methyl phosphate + NADP+ = a  (4-alkanoyl-5-oxo-2,5-dihydrofuran-3-yl)methyl phosphate + NADPH + H+  "
1.3.1.114, 3-oxocholan-24-oyl-CoA + NAD+ = 3-oxochol-4-en-24-oyl-CoA + NADH + H+ 
1.3.1.114," 3-oxochol-4-en-24-oyl-CoA + NAD+ = 3-oxochol-4,6-dien-24-oyl-CoA + NADH  + H+ "
1.3.1.114, 12alpha-hydroxy-3-oxocholan-24-oyl-CoA + NAD+ =  12alpha-hydroxy-3-oxochol-4-en-24-oyl-CoA + NADH + H+ 
1.3.1.114," 12alpha-hydroxy-3-oxochol-4-en-24-oyl-CoA + NAD+ =  12alpha-hydroxy-3-oxochol-4,6-dien-24-oyl-CoA + NADH + H+  "
1.3.1.115, 7alpha-hydroxy-3-oxochol-24-oyl-CoA + NAD+ =  7alpha-hydroxy-3-oxochol-4-en-24-oyl-CoA + NADH + H+ 
1.3.1.115," 7alpha,12alpha-dihydroxy-3-oxochol-24-oyl-CoA + NAD+ =  7alpha,12alpha-dihydroxy-3-oxochol-4-en-24-oyl-CoA + NADH + H+  "
1.3.1.116, 7beta-hydroxy-3-oxochol-24-oyl-CoA + NAD+ =  7beta-hydroxy-3-oxochol-4-en-24-oyl-CoA + NADH + H+  
1.3.1.117, dihydro-4-coumaroyl-CoA + NADP+ = trans-4-coumaroyl-CoA + NADPH + H+ 
1.3.1.117, dihydroferuloyl-CoA + NADP+ = trans-feruloyl-CoA + NADPH + H+  
1.3.1.118, a meromycolyl-[acyl-carrier protein] + NAD+ = a  trans-DELTA2-meromycolyl-[acyl-carrier protein] + NADH + H+  
1.3.1.119," (1R,2R)-3-chlorocyclohexa-3,5-diene-1,2-diol + NAD+ = 3-chlorocatechol  + NADH + H+  "
1.3.1.12," prephenate + NAD+ = 4-hydroxyphenylpyruvate + CO2 + NADH (#3# the  T-protein is a bifunctional enzyme showing chorismate mutase, EC  5.4.99.5, and prephenate dehydrogenase activities at two separate  active sites <46,47>)  "
1.3.1.120, cyclohexane-1-carbonyl-CoA + NADP+ = cyclohex-1-ene-1-carbonyl-CoA +  NADPH + H+  
1.3.1.121, 4-amino-4-deoxyprephenate + NAD+ = 3-(4-aminophenyl)pyruvate + CO2 +  NADH + H+  
1.3.1.122, (S)-8-oxocitronellyl enol + NAD(P)+ = (6E)-8-oxogeranial + NAD(P)H + H+  
1.3.1.123, (R)-8-oxocitronellyl enol + NADP+ = (6E)-8-oxogeranial + NADPH + H+  
1.3.1.124," a (2E)-2-enoyl-CoA + NADP+ = a (2E,4E)-2,4-dienoyl-CoA + NADPH + H+  (#2# reaction mechanism, E276 is the proton donor in catalysis <14>;  #2# reaction mechanism, enzyme-ligand interactions in a distinctive  short-chain reductase active site, catalytic site structure,  stabilization of the dienolate reaction intermediate by Tyr199 and  Asn148, and NADP+, overview <15>) "
1.3.1.124," a (3E)-3-enoyl-CoA + NADP+ = a (2E,4E)-2,4-dienoyl-CoA + NADPH + H+ "
1.3.1.124," a (3E)-3-enoyl-CoA + NADP+ = a (2E,4Z)-2,4-dienoyl-CoA + NADPH + H+  "
1.3.1.13, prephenate + NADP+ = 4-hydroxyphenylpyruvate + CO2 + NADPH  
1.3.1.14," (S)-dihydroorotate + NAD+ = orotate + NADH + H+ (#4# ping-pong  mechanism <12>; #3# electron transfer mechanism <8,9>; #5#  trans-dehydrogenation mechanism <3>; #4,5# ping-pong steady-state  kinetic mechanism <8>; #1# PyrDI contains the dihydroorotate-binding  site, but PyrDII is required for full activity in vivo. Holoenzyme  joins a NAD+-reductase activity <11>; #3# detailed thermodynamic  analysis, midpoint reduction potential of 2Fe-2S center -212 mV,  midpoint reduction potential of FMN -298 mV <13>)  "
1.3.1.15, (S)-dihydroorotate + NADP+ = orotate + NADPH + H+  
1.3.1.16, 3-nitropropanoate + NADP+ = 3-nitroacrylate + NADPH + H+  
1.3.1.17," 3-methyl-1,3-dihydroindol-2-one + NADP+ =  3-methylene-1,3-dihydro-2H-indol-2-one + NADPH + H+  "
1.3.1.18," 7,8-dihydro-7,8-dihydroxykynurenate + NAD+ = 7,8-dihydroxykynurenate +  NADH + H+  "
1.3.1.19," cis-1,2-dihydrobenzene-1,2-diol + NAD+ = catechol + NADH + H+  "
1.3.1.2," 5,6-dihydrouracil + NADP+ = uracil + NADPH + H+ (#4,8# abstraction of  pro-S hydrogen of NADPH and thus B-side stereospecific class  dehydrogenase <13,16>; #5# random rapid-equilibrium mechanism <25>; #4#  mechanism, rate-determining half-reaction for reduction of flavin by  NADPH has minor rate limitation, while the following protonation of  flavin at N-1 is slow <26>; #4# nonclassical ping-pong mechanism <12>;  #4# comparison of substrate and cofactor binding to wild-type and  mutant enzyme <19>)  "
1.3.1.20," trans-1,2-dihydrobenzene-1,2-diol + NADP+ = catechol + NADPH + H+ (#4#  overview about the regio- and stereospecificity for utilization of  dihydrodiol derivatives as substrates <10>; #2# isoform DD3 probably  identical with 3(17)alpha-hydroxysteroid dehydrogenase EC 1.1.1.59 and  D-xylose dehydrogenase EC 1.1.1.179 <5>; #4,6# structure analysis  reveals that the enzyme belongs to the aldo-keto reductase superfamily,  like 3alpha-hydroxysteroid dehydrogenase, 17beta-hydroxysteroid  dehydrogenase, 20alpha-hydroxysteroid dehydrogenase, aldose reductase,  and aldehyde reductase <14,27>; #4# enzyme termed  3alpha-hydroxysteroid/dihydrodiol dehydrogenase, structure-based  catalytic mechanism analysis, ordered bi-bi mechanism <27>; #4#  cofactor binding and catalytic triad, alpha/beta-barrel structure  <21,27>; #4# enzyme is multifunctional: 3alpha-hydroxysteroid  dehydrogenase activity, EC 1.1.1.50, dihydrodiol dehydrogenase  activity, EC 1.3.1.20, and 9-, 11-, and15-hydroxyprostaglandin  dehydrogenase activity, belongs to aldo-keto reductase superfamily  <21>; #5# D-xylose dehydrogenase EC 1.1.1.179 and dihydrodiol  dehydrogenase EC 1.3.1.20 both follow an ordered bi-bi mechanism and  are thus considered the same enzyme <2>; #10# identical with D-xylose  dehydrogenase EC 1.1.1.179 <1,22>; #5# probably identical with aldehyde  reductase EC 1.1.1.2 <6>; #1# probably identical with D-xylose  dehydrogenase EC 1.1.1.179 <9>; #22# isoforms belong to aldo-keto  reductase superfamily <24>; #4# termed AKR1C as member of the  aldo-keto-superfamily, overview <27>; #4# the cytosolic, but not the  microsomal, enzyme is identical with 3alpha-hydroxysteroid  dehydrogenase EC 1.1.1.50 <11>; #3# DD4 is identical with human  chlordecone reductase and 3alpha-hydroxysteroid dehydrogenase type 1,  EC 1.1.1.213, catalyzes the oxidoreduction of various  3alpha-hydroxysteroids including bile acids and belong to the aldo-keto  reductase superfamily, in this concern termed AKR1C4 <16>; #6# isoform  DD1 is identical with 3alpha-hydroxysteroid dehydrogenase EC 1.1.1.50,  while isoform DD3 is a unique benzene dihydrodiol-specific enzyme <15>)  "
1.3.1.21," cholesterol + NADP+ = cholesta-5,7-dien-3beta-ol + NADPH + H+ (#3#  mechanism <15>; #4# carbocationic intermediate, mechanism <12>)  "
1.3.1.22," a 3-oxo-5alpha-steroid + NADP+ = a 3-oxo-DELTA4-steroid + NADPH + H+  (#3,4# mechanism <14>; #4# sequential mechanism <16>; #3# reaction  mechanism <64>; #4# kinetic mechanism <16>; #3,4# structure-activity  relationship <13>)  "
1.3.1.24," bilirubin + NAD(P)+ = biliverdin + NAD(P)H + H+ (#20# catalysis via  hydride transfer from NADH <44>; #5# induced fit docking is emplyed to  study the substrate binding modes to hBVR-A of biliverdin-IXalpha and  four analogues. Substrate binding modes are examined further by  performing molecular dynamics (MD) simulations followed by molecular  mechanics Poisson-Boltzmann surface area (MM-PBSA) calculations. On the  basis of our calculations, the energetically preferred pathway consists  of an initial protonation of the pyrrolic nitrogen on the biliverdin  substrate followed by hydride transfer to yield the reduction product  <82>)  "
1.3.1.25," (1R,6S)-1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate + NAD+ =  catechol + CO2 + NADH + H+ (#1,4# mechanism <6,11>; #1# by growth on  3-chloro-, 4-chloro-, and 3,5-dichlorobenzoate enzyme is induced when  combinated with recombinant toluate-1,2-dioxygenase <8>)  "
1.3.1.27, hexadecanal + NADP+ = 2-trans-hexadecenal + NADPH + H+  
1.3.1.28," (2S,3S)-2,3-dihydro-2,3-dihydroxybenzoate + NAD+ =  2,3-dihydroxybenzoate + NADH + H+ (#1# enzyme functions as an alcohol  dehydrogenase which oxidizes the C3-hydroxylgroup of the substrate, the  transient intermediate 2-hydroxy-3-oxo-4,6-cyclohexadiene-1-carboxylate  undergoes rapid aromatization to give 2,3-dihydroxybenzoate <3>)  "
1.3.1.29," (1R,2S)-1,2-dihydronaphthalene-1,2-diol + NAD+ = naphthalene-1,2-diol +  NADH + H+  "
1.3.1.3," 5beta-cholestan-3-one + NADP+ = cholest-4-en-3-one + NADPH + H+ (#4#  mechanism, Schiff-base intermediate not involved <3>; #15# reaction  mechanism, overview <24>) "
1.3.1.3," 17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+ = cortisone +  NADPH + H+ (#15# reaction mechanism, overview <24>; #15# catalyzes the  reduction of the DELTA4 double bond of DELTA4-3-ketosteroids,  converting those steroids into 5beta-dihydro-3-ketosteroids <18>)  "
1.3.1.31," butanoate + NAD+ = but-2-enoate + NADH + H+ (#13,14# bi bi ping pong  mechanism <11>; #14# ping-pong mechanism in aqueous solution <3>; #14#  enzyme kinetics in reversed micelles <3>)  "
1.3.1.32, 3-oxoadipate + NAD(P)+ = 2-maleylacetate + NAD(P)H + H+  
1.3.1.33," chlorophyllide a + NADP+ = protochlorophyllide + NADPH + H+ (#26#  catalytic mechanism suggested: protochlorophillide absorbs a photon,  creating a transient charge separtaion across the C17-C18 double bond,  which promotes ultrafast hydride transfer from the pro-S face of NADPH  to the C17 of protochlorophillide. The resulting A696 charge transfer  intermediate facilitates transfer of a proton to the C18 of  protochlorophillide during the subsequent first dark reaction <55>)  "
1.3.1.34," a (2E)-2-enoyl-CoA + NADP+ = a (2E,4E)-2,4-dienoyl-CoA + NADPH + H+  (#1# reaction mechanism, active site structure, substrate binding site,  His252 is the catalytic residue <8>) "
1.3.1.34," a (2E)-2-enoyl-CoA + NADP+ = a (2E,4Z)-2,4-dienoyl-CoA + NADPH + H+  "
1.3.1.36," geissoschizine + NADP+ = 4,21-didehydrogeissoschizine + NADPH (#1#  removal of 21alpha-hydrogen takes place from the less hindered site <1>)  "
1.3.1.37," acyl-CoA + NADP+ = cis-2,3-dehydroacyl-CoA + NADPH + H+ (#1# mechanism:  anti addition via 2Si, 2Re attack on cis double bond <1>)  "
1.3.1.38," acyl-CoA + NADP+ = trans-2,3-dehydroacyl-CoA + NADPH + H+ (#5#  stereospecificity of NADPH: pro-4S <14>; #1# mechanism: anti addition  of hydrogen via a 2Re, 3Re attack on trans double bond <3>; #1#  inducible by growth on oleic acid <2>)  "
1.3.1.39," an acyl-[acyl-carrier protein] + NADP+ = a  trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH + H+  "
1.3.1.40," 2,6-dioxo-6-phenylhexanoate + NADP+ =  2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate + NADPH + H+  "
1.3.1.41," 5,12-dihydroxanthommatin + NAD+ = xanthommatin + NADH + H+  "
1.3.1.42," 8-[(1R,2R)-3-oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate + NADP+ =  (15Z)-12-oxophyto-10,15-dienoate + NADPH + H+ (#16# catalyzes the  reduction of natural (+)-cis-12-oxophytodienoate for the jasmonic acid  biosynthesis <21>)  "
1.3.1.43, L-arogenate + NAD+ = L-tyrosine + NADH + CO2 (#3# TyrA dehydrogenase  superfamily <11>; #8# substrate binding motif <13>; #3# substrate  binding and inhibitory mechanism <11>)  
1.3.1.44, acyl-CoA + NAD+ = trans-didehydroacyl-CoA + NADH + H+ (#3# short  chain-length specific <4>)  
1.3.1.45, vestitone + NADP+ = 2'-hydroxyformononetin + NADPH + H+  
1.3.1.46, dihydrobiochanin A + NADP+ = biochanin A + NADPH + H+  
1.3.1.47," 1,2-dihydrosantonin + NAD(P)+ = alpha-santonin + NAD(P)H + H+ (#1#  proposed mechanism <1>)  "
1.3.1.48," 11alpha-hydroxy-9,15-dioxoprostanoate + NAD(P)+ =  (13E)-11alpha-hydroxy-9,15-dioxoprost-13-enoate + NAD(P)H + H+  "
1.3.1.49," (+)-cis-3,4-dihydrophenanthrene-3,4-diol + NAD+ = phenanthrene-3,4-diol  + NADH + H+  "
1.3.1.5," 23,24-dihydrocucurbitacin B + NAD(P)+ = cucurbitacin B + NAD(P)H + H+  (#1# plant terpenoid <1,2,3,4>)  "
1.3.1.51," 2'-hydroxy-2,3-dihydrodaidzein + NADP+ = 2'-hydroxydaidzein + NADPH + H+  "
1.3.1.53," (3S,4R)-3,4-dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate + NAD+ =  3,4-dihydroxybenzoate + CO2 + NADH + H+ "
1.3.1.53," (3S,4R)-3,4-dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate + NAD+ =  3,4-dihydroxybenzoate + CO2 + NADH  "
1.3.1.54, precorrin-6B + NADP+ = precorrin-6A + NADPH + H+ (#1# reaction  mechanism <4>)  
1.3.1.56," cis-3-phenylcyclohexa-3,5-diene-1,2-diol + NAD+ = biphenyl-2,3-diol +  NADH + H+ (#2# catalytic triad is formed by the conserved residues  SEr142, Tyr153, and Lys159 <6>; #8# a two-step reaction mechanism is  proposed <10>)  "
1.3.1.57, dihydrophloroglucinol + NADP+ = phloroglucinol + NADPH + H+  
1.3.1.58," cis-5,6-dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate + NAD+ =  2,3-dihydroxy-p-cumate + NADH + H+ (#2# involved in the p-cymene  degradation pathway in Pseudomonas putida <1>)  "
1.3.1.6, succinate + NAD+ = fumarate + NADH + H+ (#25# His505 influences the  active site <11>)  
1.3.1.60," cis-1,2-dihydroxy-1,2-dihydrodibenzothiophene + NAD+ =  1,2-dihydroxydibenzothiophene + NADH + H+  "
1.3.1.62, pimeloyl-CoA + NAD+ = 6-carboxyhex-2-enoyl-CoA + NADH + H+  
1.3.1.64," cis-4,5-dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate + NAD+ =  4,5-dihydroxyphthalate + NADH + H+  "
1.3.1.65," 5,6-dihydroxy-3-methyl-2-oxo-1,2,5,6-tetrahydroquinoline + NAD+ =  5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline + NADH + H+  "
1.3.1.66," cis-1,2-dihydro-3-ethylcatechol + NAD+ = 3-ethylcatechol + NADH + H+  "
1.3.1.67," cis-1,2-dihydroxy-4-methylcyclohexa-3,5-diene-1-carboxylate + NAD(P)+ =  4-methylcatechol + NAD(P)H + CO2 (#1# enzyme utilizes NAD+ but not  NAD(P) <1>)  "
1.3.1.68," 1,2-dihydroxy-6-methylcyclohexa-3,5-dienecarboxylate + NAD+ =  3-methylcatechol + NADH + CO2  "
1.3.1.69, dihydrozeatin + NADP+ = zeatin + NADPH + H+  
1.3.1.7, meso-tartrate + NAD+ = dihydroxyfumarate + NADH + H+ (#1# enzyme  catalyzes 3 different chemical reactions from a single active site <3>)  
1.3.1.70," 4,4-dimethyl-5alpha-cholesta-8,24-dien-3beta-ol + NADP+ =  4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + NADPH + H+  (#4,8,10# mechanism <5,7>; #2# regulation, regulatory mechanism, enzyme  induction and suppression, dietary induction <3>; #2# reduction of  14-double bond of conjugated DELTA8,14-sterols and DELTA7,14-sterols  <2,3>; #7# determination of residues critical for activity, overview  <12>; #7# residues G225, Y317, and E475 are not essential for activity  <11>)  "
1.3.1.71," ergosterol + NADP+ = ergosta-5,7,22,24(241)-tetraen-3beta-ol + NADPH +  H+ (#2# acts on a range of steroids with a 24(241)-double bond <1>)  "
1.3.1.72," 5alpha-cholest-7-en-3beta-ol + NADP+ =  5alpha-cholesta-7,24-dien-3beta-ol + NADPH + H+ (#8# mechanism <3>;  #5,8# stereochemistry <3>; #4# anaerobic reduction of 24(25)-enes of  lanosterol and other obligatory intermediates of cholesterol  biosynthesis from lanosterol <1>; #4# regulation, enzyme induction,  dietary induction <1>; #13# ArDWF1 directly reduces  24-methylenecholesterol to produce campesterol with retention of the  C-25 hydrogen and without passing through a DELTA24(25) intermediate,  mechansim <23>; #7# two-step mechanism involving the isomerization of  DELTA24(28) to DELTA24(25), which requires elimination of H-25,  mechanism <23>)  "
1.3.1.73," 17-O-acetylnorajmaline + NADP+ = 1,2-dihydrovomilenine + NADPH + H+  "
1.3.1.74, a n-alkanal + NAD(P)+ = an alk-2-enal + NAD(P)H + H+ (#2# catalytic and  kinetic mechanism <5>)  
1.3.1.75," protochlorophyllide a + NADP+ = 3,8-divinyl protochlorophyllide a +  NADPH + H+ (#6# [4-vinyl]chlorophyllide a reductase and  [4-vinyl]protochlorophyllide a reductase are 2 different enzymes in  Cucumis sativus <2>)  "
1.3.1.76, precorrin-2 + NAD+ = sirohydrochlorin + NADH + H+  
1.3.1.77," a (2R,3R)-flavan-3-ol + 2 NAD(P)+ = an anthocyanidin with a 3-hydroxy  group + 2 NAD(P)H + H+  "
1.3.1.78, L-arogenate + NADP+ = L-tyrosine + NADPH + CO2 (#23# mechanism is  probably steady-state random order <11>)  
1.3.1.79, L-arogenate + NAD(P)+ = L-tyrosine + NAD(P)H + CO2  
1.3.1.8," acyl-CoA + NADP+ = 2,3-dehydroacyl-CoA + NADPH + H+ (#11# enzyme might  also belong to EC 1.3.99.3, acyl-CoA dehydrogenase <26>)  "
1.3.1.81, (-)-menthone + NADP+ = (+)-pulegone + NADPH + H+ 
1.3.1.81, (+)-isomenthone + NADP+ = (+)-pulegone + NADPH + H+  
1.3.1.82, (+)-cis-isopulegone + NADP+ = (-)-isopiperitenone + NADPH + H+  
1.3.1.83, phytyl diphosphate + 3 NADP+ = geranylgeranyl diphosphate + 3 NADPH + 3  H+  
1.3.1.84, propanoyl-CoA + NADP+ = acryloyl-CoA + NADPH + H+ (#7# the enzyme  followes an ordered Bi-Bi reaction mechanism <5>)  
1.3.1.85, (2S)-ethylmalonyl-CoA + NADP+ = (E)-but-2-enoyl-CoA + CO2 + NADPH + H+  
1.3.1.86, butanoyl-CoA + NADP+ = (E)-but-2-enoyl-CoA + NADPH + H+  
1.3.1.87," 3-(cis-5,6-dihydroxycyclohexa-1,3-dien-1-yl)propanoate + NAD+ =  3-(2,3-dihydroxyphenyl)propanoate + NADH + H+ "
1.3.1.87," (2E)-3-(cis-5,6-dihydroxycyclohexa-1,3-dien-1-yl)prop-2-enoate + NAD+ =  (2E)-3-(2,3-dihydroxyphenyl)prop-2-enoate + NADH + H+  "
1.3.1.88," 5,6-dihydrouracil16 in tRNA + NAD(P)+ = uracil16 in tRNA + NAD(P)H + H+  (#1# (1) <1>) "
1.3.1.88," 5,6-dihydrouracil17 in tRNA + NAD(P)+ = uracil17 in tRNA + NAD(P)H + H+  (#1# (2) <1>)  "
1.3.1.89," 5,6-dihydrouracil47 in tRNA + NAD(P)+ = uracil47 in tRNA + NAD(P)H + H+  "
1.3.1.9," an acyl-[acyl-carrier protein] + NAD+ = a  trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ (#31# detailed  kinetic analysis of the sequential bi-bi mechanism with NADH binding  first and NAD+ dissociating last. The catalytic tyrosine (Y235) and  lysine (K244) residues are organized in the consensus Tyr-(Xaa)8-Lys  motif. Both Y235 and K244 are involved in acid-base chemistry during  substrate reduction <82>; #14# double displacement mechanism. In this  mechanism, a catalytic event occurs after the binding of NADH to free  enzyme, generating and releasing NAD+ into solution prior to the  binding of crotonoyl-CoA to a modified form of the enzyme, followed by  formation of butyryl-CoA and regeneration of free enzyme <95>; #31#  sequential Bi Bi mechanism with NADH binding first and NAD+  dissociating last <82>)  "
1.3.1.90," 5,6-dihydrouracil20a in tRNA + NAD(P)+ = uracil20a in tRNA + NAD(P)H +  H+ (#1# (1) <1>) "
1.3.1.90," 5,6-dihydrouracil20b in tRNA + NAD(P)+ = uracil20b in tRNA + NAD(P)H +  H+ (#1# (2) <1>)  "
1.3.1.91," 5,6-dihydrouracil20 in tRNA + NAD(P)+ = uracil20 in tRNA + NAD(P)H + H+  (#2# dsRNA binding mode, modeling <7>; #3# Dus proteins adopt a common  substrate recognition mechanism using an adapter molecule, whereas the  manner of tRNA binding is diverse <6>)  "
1.3.1.92, (11R)-dihydroartemisinic aldehyde + NADP+ = artemisinic aldehyde +  NADPH + H+  
1.3.1.93," a very-long-chain acyl-CoA + NADP+ = a very-long-chain  trans-2,3-dehydroacyl-CoA + NADPH + H+  "
1.3.1.94," ditrans,polycis-dolichol + NADP+ = ditrans,polycis-polyprenol + NADPH +  H+  "
1.3.1.95, propanoyl-CoA + NAD+ = acryloyl-CoA + NADH + H+  
1.3.1.96, squalene + diphosphate + NADP+ = presqualene diphosphate + NADPH + H+  
1.3.1.97, C30 botryococcene + NADP+ + diphosphate = presqualene diphosphate +  NADPH + H+  
1.3.1.98," UDP-N-acetyl-alpha-D-muramate + NADP+ =  UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine + NADPH + H+ (#5#  ping pong mechanism, contains FAD <10>; #12# reaction mechanism,  detailed scheme of the second half <15>; #15# the nicotinamide ring of  NADP+ stacks against the si face of the isoalloxazine ring of FAD,  suggesting an unusual mode of hydride transfer to flavin. Both  substrates share the binding site located between two lobes of the  substrate-binding domain III, consistent with a ping pong mechanism  with sequential substrate binding, structural analysis of the first  half-reaction, overview <24>)  "
1.3.2.3," L-galactono-1,4-lactone + 2 ferricytochrome c = L-ascorbate + 2  ferrocytochrome c + 2 H+  "
1.3.3.10," L-tryptophan + O2 = alpha,beta-didehydrotryptophan + H2O2  "
1.3.3.11," 6-(2-amino-2-carboxyethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2  4-dicarboxylate + 3 O2 =  4,5-dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylate +  2 H2O2 + 2 H2O (#9# PqqC is part of a complex of six enzymes that act  together in pyrroloquinoline-quinone synthesis: PqqA serves as a  complex precursor for for pyrroloquinoline-quinone synthesis, PqqB is  not directly required for pyrroloquinoline-quinone biosynthesis, but a  carrier and responsible for its transport across the plasma-membrane  into the periplasm, PqqC does not contain a redox-active metal or other  cofactor and is responsible for the last cyclization and oxidation  steps in pyrroloquinoline-quinone synthesis, PqqD has three possible  functions: first, it could play a role in the release of  pyrroloquinoline-quinone from PqqC, second it could be involved in  binding of PqqB to PqqC, third it could function as the dioxygenase in  the pathway, PqqE is a family member of radical S-adenosylmethionine  enzymes and catalyzes a radical driven C-C bond formation required to  link the glutamate and tyrosine moieties at atoms C9 and C9a of  pyrroloquinoline-quinone, PqqF recognizes and cleaves all four peptide  bonds in PqqA <10>; #2# PqqC is part of a complex of six enzymes that  act together in pyrroloquinoline-quinone synthesis: PqqA serves as a  complex precursor for for pyrroloquinoline-quinone synthesis, PqqB is  not directly required for pyrroloquinoline-quinone biosynthesis, but a  carrier and responsible for its transport across the plasma-membrane  into the periplasm, PqqC does not contain a redox-active metal or other  cofactor and is responsible for the the last cyclization and oxidation  steps in pyrroloquinoline-quinone synthesis, PqqD has three possible  functions: first, it could play a role in the release of  pyrroloquinoline-quinone from PqqC, second it could be involved in  binding of PqqB to PqqC, third it could function as the dioxygenase in  the pathway, PqqE is a family member of radical S-adenosylmethionine  enzymes and catalyzes a radical driven C-C bond formation required to  link the glutamate and tyrosine moieties at atoms C9 and C9a of  pyrroloquinoline-quinone, PqqF recognizes and cleaves all four peptide  bonds in PqqA <10>; #1# PqqC is part of a complex of six enzymes that  act together in pyrroloquinoline-quinone synthesis: PqqA serves as a  complex precursor for for pyrroloquinoline-quinone synthesis, PqqB is  not directly required for pyrroloquinoline-quinone biosynthesis, but a  carrier and responsible for its transport across the plasma-membrane  into the periplasm, PqqC does not contain a redox-active metal or other  cofactorand is responsible for the the last cyclization and oxidation  steps in pyrroloquinoline-quinone synthesis, PqqD has three possible  functions: first, it could play a role in the release of  pyrroloquinoline-quinone from PqqC, second it could be involved in  binding of PqqB to PqqC, third it could function as the dioxygenase in  the pathway, PqqE is a family member of radical S-adenosylmethionine  enzymes and catalyzes a radical driven C-C bond formation required to  link the glutamate and tyrosine moieties at atoms C9 and C9a of  pyrroloquinoline-quinone, PqqF recognizes and cleaves all four peptide  bonds in PqqA <10>; #1# PqqC/D produces the reduced pyrroloquinoline  quinone from the intermediate in vivo <7>; #10# reaction mechanism  consisting of a series of base catalyzed proton abstractions followed  by quinoid/quinol tautomerizations and oxidations, overview <12>)  "
1.3.3.12," L-galactono-1,4-lactone + O2 = L-ascorbate + H2O2  "
1.3.3.13, cyclo(L-leucyl-L-phenylalanyl) + 2 O2 = albonoursin + 2 H2O2 
1.3.3.13," cyclo(L-leucyl-L-phenylalanyl) + O2 =  cyclo[(Z)-alpha,beta-didehydrophenylalanyl-L-leucyl] + H2O2 "
1.3.3.13," cyclo[(Z)-alpha,beta-didehydrophenylalanyl-L-leucyl] + O2 = albonoursin  + H2O2  "
1.3.3.14, aclacinomycin A + O2 = aclacinomycin Y + H2O2  
1.3.3.15, coproporphyrinogen III + 3 O2 = coproporphyrin III + 3 H2O2  
1.3.3.16," a [protein]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline +  O2 = a [protein]-(S)-2-(C-substituted-aminomethyl)-4-acyl-1,3-thiazole  + H2O2 "
1.3.3.16," a [protein]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-2-oxazoline + O2  = a [protein]-(S)-2-(C-substituted-aminomethyl)-4-acyl-1,3-oxazole +  H2O2 "
1.3.3.16," a  [protein]-(S  S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline + O2 = a  [protein]-(S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-1,3-oxazole  + H2O2  "
1.3.3.3," coproporphyrinogen III + O2 + 2 H+ = protoporphyrinogen-IX + 2 CO2 + 2  H2O (#8# active site structure <45>; #5# 2 possible catalytic pathways  of the reaction, overview, Tyrp274 is catalytically important, the  following residues are not important for enzyme activity: Cys167,  Tyr135, Tyr160, Tyr170, Tyr213, Tyr240, Tyr276, Trp36, Trp123, Trp166,  and Trp198 <44>; #1# analysis of catalytic mechanism, modeling of  active site structure <39>; #1,10# substrate binding at the active  site, structure and mechanism, catalytic mechanism <40>; #6# CPO  catalyzes two sequential oxidative decarboxylations of propionate  moieties on coproporphyrinogen-III forming protoporphyrinogen-IX  through the monovinyl intermediate harderoporphyrinogen <63>; #23#  reaction starts by O2 addition to the pyrrole substrate yielding a  hydroperoxide, which then abstracts a proton from the reactive  propionate substituent, and the reaction may then proceed through H2O  elimination, followed by decarboxylation <66>; #8# reaction mechanism,  substrate docking study and binding mode, involving residues H131,  R135, D274, and R275, and active site analysis using crystal  structures, molecular dynamics simulations, overview. Selectivity of  the active site, formed by His131, Asn133, and Ser117, toward  substituted tetrapyrroles, nonoccurrence of catalysis on the C and D  rings of the tetrapyrrole. The carbonyl oxygen of G276 intervenes in  the substrate anchoring by hydrogen bonding of the ring D pyrrole NH  group. The pyrrole ring is very unlikely to undergo deprotonation  during the catalytic cycle <77>)  "
1.3.3.4," protoporphyrinogen IX + 3 O2 = protoporphyrin IX + 3 H2O2 (#54#  reaction mechanism and active site structure <43>; #7# residues G40,  L85, G232, H281, V282, L295, V335, S350, L444, G453, L15, R38, L73,  V84, D143, R152, L154, V158, R168, A172, V290, and G453 are essential  for enzyme activity <42>; #49,54# reaction and substrate recognition  mechanisms, conformational analysis based on molecular docking,  molecular dynamics (MD) simulation, molecular  mechanic/Poisson-Boltzmann surface area (MM/PBSA) calculations,  umbrella sampling MD simulations, and potential of mean force (PMF)  calculations, overview <99>; #54# reaction scheme involving FAD,  overview <96>)  "
1.3.3.5," 2 bilirubin + O2 = 2 biliverdin + 2 H2O (#13# analyis of the oxygen  reduction reaction mechanism, detailed overview. Bilirubin oxidase  (BOD) is the best catalyst for converting oxygen directly to water  because of the very low overpotential necessary to catalyze the  reaction <64>)  "
1.3.3.6," acyl-CoA + O2 = trans-2,3-dehydroacyl-CoA + H2O2 (#5,14,18#  anti-elimination of pro-2R and pro-3R hydrogens of acyl-CoA <5,14>; #5#  inducible by growth on di-(2-ethylhexyl)phthalate <2,10>; #5#  structural analysis of enzyme complexed with 3-ketoacyl-CoA substrate  analogues <31>; #5,14# stereochemistry of the reaction <5>; #6# genetic  regulation <24>; #5# mechanism, substrate binding site, and active site  structure <30>; #49# in the reductive half-reaction, the substrate  acyl-CoA isalpha,beta-dehydrogenated into the corresponding  2-trans-enoyl-CoA, with electrons transferred to FAD, which becomes  reduced, whereas in the oxidative half-reaction reduced FAD is  reoxidized by molecular oxygen, generating hydrogen peroxide <76>)  "
1.3.3.7," 5,6-dihydrouracil + O2 = uracil + H2O2  "
1.3.3.8, (S)-tetrahydroberberine + 2 O2 = berberine + 2 H2O2 (#6# final step of  berberine biosynthesis <6>)  
1.3.4.1, fumarate + CoM + CoB = succinate + CoM-S-S-CoB  
1.3.5.1, succinate + a quinone = fumarate + a quinol (#10# can also function as  a fumarate reductase <87>)  
1.3.5.2," (S)-dihydroorotate + a quinone = orotate + a quinol (#4,8,9# ping-pong  mechanism <2,14,16>; #4# existence of 3 families differing in their  selectivity for oxidizing substrates: 1A are soluble, containing FMN  and use fumarate, 1B are soluble, one subunit contains an iron-sulfur  center, FAD and reduces NAD+, family 2 enzymes are membrane-bound,  contain FMN and are oxidized by ubiquinone. Mechanism consists of 3  reaction phases. Different binding-mechanisms for enzyme the  reaction-steps are suggested <3>; #4# different binding sites for  dihydroorotate and the electron acceptor, two-site ping-pong mechanism.  Cleavage site at R182 is conserved between the two major families of  dihydroorotate dehydrogenases, it is positioned in a loop, which is  crucial for catalysis but irrelevant for protein stability <2>; #11#  68% identity with type A enzyme of Lactococcus lactis, two-site  non-classical ping-pong kinetic mechanism <12>; #10# one-site ping-pong  mechanism, residues 129-137 form a flexible loop, responsible for  substrate binding <2>; #5# fourth step in biosynthesis of pyrimidines.  Two domains: alpha/beta-barrel domain containing the active site, one  alpha-helical domain that forms the opening of a tunnel leading to  active site <4>; #1,3,5,7,8,23# in liver, myocardium and skeletal  muscle tissues the activity intensities vary from animal to animal, but  are similar in ileum, colon and kidney cortex. Cardiac enzyme expresses  a pronounced oxidase activity <9>; #9# soluble quinones as second  substrate <14>; #19# two-site ping-pong mechanism <25>; #22# enzyme  uses a stepwise mechanism for dihydroorotate oxidation <40>; #4# the  active base S175 and the hydrogen bonding network including residues  T178 and F115 work together for efficient deprotonation of  dihydroorotate <41>)  "
1.3.5.3, protoporphyrinogen IX + 3 quinone = protoporphyrin IX + 3 quinol  
1.3.5.4, succinate + a quinone = fumarate + a quinol (#3# reduction of  menaquinone-7 is the rate-limiting step in succinate respiration <18>)  
1.3.5.5," 15-cis-phytoene + 2 plastoquinone = 9,15,9'-tricis-zeta-carotene + 2  plastoquinol (#3# overall reaction <13>; #19# overall reaction, ordered  ping-pong bi-bi mechanism, both lipophilic substrates are bound inside  the same substrate cavity that cannot be occupied by both  simultaneously. The central 15-cis configuration of phytoene mediates  the regiospecificity in catalysis <26>) "
1.3.5.5," 15-cis-phytoene + plastoquinone = 15,9'-dicis-phytofluene +  plastoquinol (#3# (1a) <13>) "
1.3.5.5," 15,9'-dicis-phytofluene + plastoquinone = 9,15,9'-tricis-zeta-carotene  + plastoquinol (#3# (1b) <13>)  "
1.3.5.6," 9,9'-dicis-zeta-carotene + 2 quinone = 7,9,7',9'-tetracis-lycopene + 2  quinol "
1.3.5.6," 9,9'-dicis-zeta-carotene + a quinone = 7,9,9'-tricis-neurosporene + a  quinol "
1.3.5.6," 7,9,9'-tricis-neurosporene + a quinone = 7,9,7',9'-tetracis-lycopene +  a quinol  "
1.3.7.1," 6-oxo-1,4,5,6-tetrahydronicotinate + oxidized ferredoxin =  6-hydroxynicotinate + reduced ferredoxin  "
1.3.7.11," a 2,3-bis-(O-phytanyl)-sn-glycero-phospholipid + 16 oxidized ferredoxin  [iron-sulfur] cluster = a  2,3-bis-(O-geranylgeranyl)-sn-glycero-phospholipid + 16 reduced  ferredoxin [iron-sulfur] cluster + 16 H+  "
1.3.7.12," primary fluorescent chlorophyll catabolite + 2 oxidized ferredoxin  [iron-sulfur] cluster = red chlorophyll catabolite + 2 reduced  ferredoxin [iron-sulfur] cluster + 2 H+ (#1,5,8,13,17,23,24# reaction  pathway overview <17>)  "
1.3.7.13," protochlorophyllide a + 2 oxidized ferredoxin [iron-sulfur] cluster =  3,8-divinyl protochlorophyllide a + 2 reduced ferredoxin [iron-sulfur]  cluster + 2 H+  "
1.3.7.14," bacteriochlorophyllide g + 2 oxidized ferredoxin [iron-sulfur] cluster  + ADP + phosphate = 3,8-divinyl chlorophyllide a + 2 reduced ferredoxin  [iron-sulfur] cluster + ATP + H2O + 2 H+  "
1.3.7.15," 3-deacetyl-3-vinylbacteriochlorophyllide a + 2 oxidized ferredoxin  [iron-sulfur] cluster + ADP + phosphate = chlorophyllide a + 2 reduced  ferredoxin [iron-sulfur] cluster + ATP + H2O + 2 H+ (#12# binding of  the substrate to (BchY/BchZ)2 is the initial step of COR catalysis,  which is followed by formation of the ternary complex between  (BchY/BchZ)2 and (BchX)2 <11>) "
1.3.7.15, bacteriochlorophyllide a + 2 oxidized ferredoxin [iron-sulfur] cluster  + ADP + phosphate = 3-acetyl-3-devinylchlorophyllide a + 2 reduced  ferredoxin [iron-sulfur] cluster + ATP + H2O + 2 H+ 
1.3.7.15, 3-deacetyl-3-(1-hydroxyethyl)bacteriochlorophyllide a + 2 oxidized  ferredoxin [iron-sulfur] cluster + ADP + phosphate =  3-devinyl-3-(1-hydroxyethyl)chlorophyllide a + 2 reduced ferredoxin  [iron-sulfur] cluster + ATP + H2O + 2 H+  
1.3.7.2," 15,16-dihydrobiliverdin + oxidized ferredoxin = biliverdin IXalpha +  reduced ferredoxin  "
1.3.7.3," (3Z)-phycoerythrobilin + oxidized ferredoxin = 15,16-dihydrobiliverdin  + reduced ferredoxin (#8# analysis of the reaction mechanism, after  binding of 15,16-dihydrobiliverdin (DHBV) to the enzyme, Asp99 delivers  a proton to the A-ring oxygen, forming a positively charged DHBVH+.  After acceptance of an electron from ferredoxin, the A-ring pyrrole  proton tautomerizes to the C2 position and is stabilized there. This is  facilitated by the catalytic action of the axial water, which is  activated/positioned by Asp219 and (indirectly) by Arg215. For the  second protonation step, the reprotonation of the A-ring nitrogen,  uptake of another electron, and a final tautomerization to yield the  product PEB is assumed, flipped binding mode for PEB biosynthesis <8>)  "
1.3.7.4, (3Z)-phytochromobilin + 2 oxidized ferredoxin = biliverdin IXalpha + 2  reduced ferredoxin  
1.3.7.5, (3Z)-phycocyanobilin + 4 oxidized ferredoxin = biliverdin IXalpha + 4  reduced ferredoxin  
1.3.7.6, (3Z)-phycoerythrobilin + 2 oxidized ferredoxin = biliverdin IXalpha + 2  reduced ferredoxin  
1.3.7.7," chlorophyllide a + oxidized ferredoxin + 2 ADP + 2 phosphate =  protochlorophyllide a + reduced ferredoxin + 2 ATP + 2 H2O (#3#  reaction mechanism for trans-specific reduction, overview <11>; #42#  dynamic switch mechanism of DPOR, catalytic mechanism and  structure-function analysis, detailed overview <21>; #1,3,6,8,9,41#  reaction mechanism and structure-function relationship, overview <22>)  "
1.3.7.8," cyclohexa-1,5-diene-1-carbonyl-CoA + oxidized ferredoxin + 2 ADP + 2  phosphate = benzoyl-CoA + reduced ferredoxin + 2 ATP + 2 H2O (#3#  ATP-binding switch is rather fast, reverse switch back of MgADP-bound  enzyme is considered rate-limiting, binding of nucleotides does not  affect redox potential of 4Fe-4S clusters <9>; #3#  ATP-hydrolysis-driven electron transfer with transient formation of a  phosphorylated enzyme, ATPase- and autophosphatase-partial activities  exhibit identical redox dependencies <10>; #3# Birch-like mechanism  <9>; #3# Birch-like reduction with base-catalyzed rearrangement to  1,5-diene <7>; #7# benzoyl-CoA reduction is initiated by a hydrogen  atom transfer from a W(IV) species with an aqua ligand, yielding  W(V)-[OH-] and a substrate radical intermediate. In the next step, a  proton-assisted second electron transfer takes place with a conserved  active-site histidine serving as the second proton donor. The electron  for the second reduction step is taken from the pyranopterin cofactors  rather than from the tungsten ion. The resulting cationic radical,  which is distributed over both pyranopterins, is stabilized by  conserved anionic amino acid residues, reaction mechanism, detailed  overview <21>; #22# class II BCRs drive BzCoA reduction by flavin-based  electron bifurcation (FBEB) <19>; #7# reaction mechanism, quantum  mechanical/molecular mechanical (QM/MM) calculations <20>)  "
1.3.8.1," a short-chain acyl-CoA + electron-transfer flavoprotein = a short-chain  trans-2,3-dehydroacyl-CoA + reduced electron-transfer flavoprotein  (#3,9# mechanism <19,21>; #3# mechanism for stereospecific catalysis  <52>; #24# bifurcating electron transferring flavoprotein (EtfAf) and  butyryl-CoA dehydrogenase (BcdAf) of Acidaminococcus fermentans,which  couple the exergonic reduction of crotonyl-CoA to butyryl-CoA to the  endergonic reduction of ferredoxin both with NADH. EtfAf contains one  FAD (alpha-FAD) in subunit alpha and a second FAD (beta-FAD) in subunit  beta. The distance between the two isoalloxazine rings is 18 A. The  EtfAf-NAD+ complex structure revealed beta-FAD as acceptor of the  hydride of NADH. The formed beta-FADH- is considered as the bifurcating  electron donor. As a result of a domain movement, alpha-FAD is able to  approach beta-FADH- by about 4 A and to take up one electron yielding a  stable anionic semiquinone, beta-FAD-, which donates this electron  further to Dh-FAD of BcdAf after a second domain movement. The  remaining nonstabilized neutral semiquinone, alpha-FADH-, immediately  reduces ferredoxin. Repetition of this process affords a second reduced  ferredoxin and Dh-FADH- that converts crotonyl-CoA to butyryl-CoA <89>)  "
1.3.8.10," cyclohex-1-ene-1-carbonyl-CoA + electron-transfer flavoprotein =  cyclohex-1,5-diene-1-carbonyl-CoA + reduced electron-transfer  flavoprotein  "
1.3.8.11, cyclohexane-1-carbonyl-CoA + electron-transfer flavoprotein =  cyclohex-1-ene-1-carbonyl-CoA + reduced electron-transfer flavoprotein  
1.3.8.12, (2S)-methylsuccinyl-CoA + electron-transfer flavoprotein =  2-methylfumaryl-CoA + reduced electron-transfer flavoprotein  
1.3.8.13, gamma-butyrobetainyl-CoA + electron-transfer flavoprotein =  crotonobetainyl-CoA + reduced electron-transfer flavoprotein  
1.3.8.14, L-prolyl-[peptidyl-carrier protein] + 2 electron-transfer flavoprotein  = 1H-pyrrole-2-carbonyl-[peptidyl-carrier protein] + 2 reduced  electron-transfer flavoprotein  
1.3.8.15, phloretate + electron-transfer flavoprotein = 4-coumarate + reduced  electron-transfer flavoprotein 
1.3.8.15, 3-phenylpropanoate + electron-transfer flavoprotein = trans-cinnamate +  reduced electron-transfer flavoprotein 
1.3.8.15, 3-(1H-indol-3-yl)propanoate + electron-transfer flavoprotein =  3-(indol-3-yl)acrylate + reduced electron-transfer flavoprotein  
1.3.8.16, (2S)-2-amino-4-deoxychorismate + FMN =  3-(1-carboxyvinyloxy)anthranilate + FMNH2  
1.3.8.17, oxidized coenzyme F420-0 + FMN = dehydro coenzyme F420-0 + FMNH2  
1.3.8.2," 15-cis-4,4'-diapophytoene + 4 FAD = all-trans-4,4'-diapolycopene + 4  FADH2 "
1.3.8.2," 15-cis-4,4'-diapophytoene + FAD = all-trans-4,4'-diapophytofluene +  FADH2 "
1.3.8.2," all-trans-4,4'-diapophytofluene + FAD =  all-trans-4,4'-diapo-zeta-carotene + FADH2 "
1.3.8.2," all-trans-4,4'-diapo-zeta-carotene + FAD =  all-trans-4,4'-diaponeurosporene + FADH2 "
1.3.8.2," all-trans-4,4'-diaponeurosporene + FAD = all-trans-4,4'-diapolycopene +  FADH2  "
1.3.8.3, (R)-2-benzylsuccinyl-CoA + electron-transfer flavoprotein =  (E)-2-benzylidenesuccinyl-CoA + reduced electron-transfer flavoprotein  
1.3.8.4, isovaleryl-CoA + electron-transfer flavoprotein = 3-methylcrotonyl-CoA  + reduced electron-transfer flavoprotein  
1.3.8.5," 2-methylbutanoyl-CoA + electron-transfer flavoprotein =  (E)-2-methylbut-2-enoyl-CoA + reduced electron-transfer flavoprotein +  H+ (#1,2# reaction mechanism determining substrate specificity <11>;  #3# the isovaleryl-CoA dehydrogenase 1, i.e. IVD1, EC 1.3.99.10, from  Solanum tuberosum shows maximal activity with 2-methylbutyryl-CoA, the  binding pockets of 2-methylbutyryl-CoA and isovaleryl-CoA dehydrogenase  are nearly identical, the enzyme therefore shall also be classified to  EC 1.3.99.12, active site structure, residues Met361, Ala365, Val88,  Val92, and Val96 are involved in catalysis <12>)  "
1.3.8.6," glutaryl-CoA + electron-transfer flavoprotein = crotonyl-CoA + CO2 +  reduced electron-transfer flavoprotein (#12# structural bases and  mechanism of dehydrogenation and decarboxylation reactions, active site  structure with and without bound substrate, Glu370 is important <18>) "
1.3.8.6, glutaryl-CoA + electron-transfer flavoprotein = (E)-glutaconyl-CoA +  reduced electron-transfer flavoprotein 
1.3.8.6, (E)-glutaconyl-CoA = crotonyl-CoA + CO2  
1.3.8.7," a medium-chain acyl-CoA + electron-transfer flavoprotein = a  medium-chain trans-2,3-dehydroacyl-CoA + reduced electron-transfer  flavoprotein (#2,5,6# mechanism, proton abstraction from C-2 of the  substrate and hydride transfer from C-3 to the N-5 position of the  flavin <7,9,21,23,31>; #4# the catalytic base responsible for the  alpha-proton abstraction is E376 in medium-chain acyl-CoA  dehydrogenase, while that in long-chain acyl-CoA dehydrogenase is E255  <58,59>; #6# charge transfer complex between reduced flavin as the  donor and trans-2-octenoyl-CoA as the acceptor <22>)  "
1.3.8.8," a long-chain acyl-CoA + electron-transfer flavoprotein = a long-chain  trans-2,3-dehydroacyl-CoA + reduced electron-transfer flavoprotein  "
1.3.8.9," a very-long-chain acyl-CoA + electron-transfer flavoprotein = a  very-long-chain trans-2,3-dehydroacyl-CoA + reduced electron-transfer  flavoprotein  "
1.3.98.1," (S)-dihydroorotate + fumarate = orotate + succinate (#7# ping-pong  mechanism <8>; #13# light sensitivity seems to result in a  conformational change and a partial loss of enzymatic activity <4>;  #10# mechanism, pyrimidine biosynthetic pathways <5>; #2,7# cysteine  and serine are active site base residues. One-site ping-pong mechanism  with fumarate as electron acceptor <6>; #13# sulfhydryl groups  suggested to be located near the active site, suggested that enzyme  produces superoxide free radicals upon reaction with oxygen <2>; #7#  the active site contains a water filled cavity buried beneath a highly  conserved and flexible loop. Orotate is bound by four conserved  asparagine side chains. Implications for differences in substrate  binding and in the catalytic mechanism between the different enzyme  families are given <7>; #11# ping-pong bi-bi mechanism <16>; #15#  two-site ping-pong mechanism, catalytic base is serine <12>)  "
1.3.98.3," coproporphyrinogen III + 2 S-adenosyl-L-methionine = protoporphyrinogen  IX + 2 CO2 + 2 L-methionine + 2 5'-deoxyadenosine (#11# mechanism <1>;  #3# catalytic, radical mechanism <2>; #3# this enzyme differs from EC  1.3.3.3, coproporphyrinogen oxidase, by using S-adenosyl-L-methionine,  AdoMet, instead of oxygen as oxidant, it occurs mainly in bacteria,  whereas eukaryotes use the oxygen-dependent oxidase, the reaction  starts by using an electron from the reduced form of the enzymeÂ’s  [4Fe-4S] cluster to split AdoMet into methionine and the radical  5Â’-deoxyadenosin-5Â’-yl, this radical initiates attack on the  2-carboxyethyl groups, leading to their conversion into vinyl groups.  The conversion of Â–.CH-CH2-COO- leading to Â–CH=CH2 + CO2 + e- replaces  the electron initially used, reaction mechanism <3>; #3# conversion of  coproporphyrinogen III to protoporphyrinogen IX via the reaction  intermediate harderoporphyrinogen. HemN contains a catalytically  essential [4Fe-4S] cluster that transfers an electron to bound  S-adenosyl-L-methionine, thereby producing methionine and a  5-deoxyadenosyl radical. This radical then abstracts a hydrogen atom  from the beta-carbon of the substrate propionate side chain, resulting  in the formation of a coproporphyrinogenyl radical, overview <11>)  "
1.3.98.4," tetracycline + oxidized coenzyme F420 = 5a,11a-dehydrotetracycline +  reduced coenzyme F420  "
1.3.98.5, Fe-coproporphyrin III + 2 H2O2 = protoheme + 2 CO2 + 4 H2O 
1.3.98.5, Fe-coproporphyrin III + H2O2 = harderoheme III + CO2 + 2 H2O 
1.3.98.5, harderoheme III + H2O2 = protoheme + CO2 + 2 H2O  
1.3.98.6, Fe-coproporphyrin III + 2 S-adenosyl-L-methionine = protoheme + 2 CO2 +  2 5'-deoxyadenosine + 2 L-methionine  
1.3.98.7, C-terminal [mycofactocin precursor peptide]-glycyl-L-valyl-L-tyrosine +  S-adenosyl-L-methionine = C-terminal [mycofactocin precursor  peptide]-glycyl-L-valyl-4-[2-aminoethenyl]phenol + CO2 +  5'-deoxyadenosine + L-methionine  
1.3.99.14, cyclohexanone + acceptor = cyclohex-2-enone + reduced acceptor  
1.3.99.16, Isoquinoline + acceptor + H2O = isoquinolin-1(2H)-one + reduced acceptor  
1.3.99.17, quinoline + acceptor + H2O = quinolin-2(1H)-one + reduced acceptor (#1#  putative substrate binding mode <11>)  
1.3.99.18, Quinaldate + acceptor + H2O = kynurenate + reduced acceptor  
1.3.99.19," quinoline-4-carboxylate + acceptor + H2O =  2-oxo-1,2-dihydroquinoline-4-carboxylate + reduced acceptor  "
1.3.99.23," all-trans-13,14-dihydroretinol + acceptor = all-trans-retinol + reduced  acceptor  "
1.3.99.25, (+)-dihydrocarvone + acceptor = (-)-carvone + reduced acceptor 
1.3.99.25, (-)-isodihydrocarvone + acceptor = (+)-carvone + reduced acceptor  
1.3.99.26, all-trans-zeta-carotene + 2 acceptor = all-trans-lycopene + 2 reduced  acceptor (#1# overall reaction <1>) 
1.3.99.26, all-trans-zeta-carotene + acceptor = all-trans-neurosporene + reduced  acceptor 
1.3.99.26, all-trans-neurosporene + acceptor = all-trans-lycopene + reduced  acceptor  
1.3.99.27," 1-hydroxy-1,2-dihydrolycopene + acceptor =  1-hydroxy-3,4-didehydro-1,2-dihydrolycopene + reduced acceptor  "
1.3.99.28, all-trans-zeta-carotene + acceptor = all-trans-neurosporene + reduced  acceptor 
1.3.99.28, 15-cis-phytoene + 3 acceptor = all-trans-neurosporene + 3 reduced  acceptor (#4# overall reaction <2>) 
1.3.99.28, 15-cis-phytoene + acceptor = all-trans-phytofluene + reduced acceptor 
1.3.99.28, all-trans-phytofluene + acceptor = all-trans-zeta-carotene + reduced  acceptor  
1.3.99.29, 15-cis-phytoene + acceptor = all-trans-phytofluene + reduced acceptor 
1.3.99.29, all-trans-phytofluene + acceptor = all-trans-zeta-carotene + reduced  acceptor 
1.3.99.29, 15-cis-phytoene + 2 acceptor = all-trans-zeta-carotene + 2 reduced  acceptor (#1# overall reaction <2>)  
1.3.99.30, all-trans-zeta-carotene + acceptor = all-trans-neurosporene + reduced  acceptor 
1.3.99.30, all-trans-neurosporene + acceptor = all-trans-lycopene + reduced  acceptor 
1.3.99.30, 15-cis-phytoene + acceptor = all-trans-phytofluene + reduced acceptor 
1.3.99.30, all-trans-phytofluene + acceptor = all-trans-zeta-carotene + reduced  acceptor 
1.3.99.30," 15-cis-phytoene + 5 acceptor = all-trans-3,4-didehydrolycopene + 5  reduced acceptor (#1# overall reaction <3>) "
1.3.99.30," all-trans-lycopene + acceptor = all-trans-3,4-didehydrolycopene +  reduced acceptor  "
1.3.99.31, all-trans-zeta-carotene + acceptor = all-trans-neurosporene + reduced  acceptor 
1.3.99.31, all-trans-neurosporene + acceptor = all-trans-lycopene + reduced  acceptor 
1.3.99.31, 15-cis-phytoene + acceptor = all-trans-phytofluene + reduced acceptor 
1.3.99.31, all-trans-phytofluene + acceptor = all-trans-zeta-carotene + reduced  acceptor 
1.3.99.31, 15-cis-phytoene + 4 acceptor = all-trans-lycopene + 4 reduced acceptor  
1.3.99.32," glutaryl-CoA + acceptor = (E)-glutaconyl-CoA + reduced acceptor (#1#  the structure of the GDHDes-glutaconyl-CoA complex is completely  compatible with the mechanism of the reductive half-reaction  established for acyl-CoA dehydrogenases, which is characterized by the  rupture of two kinetically stable C-H bonds. The substrate binds to the  re side of the FAD ring, and the C2-C3 bond is sandwiched between the  carboxylate group of Glu367 and the pyrimidine ring of FAD, mechanism,  overview <1>)  "
1.3.99.33," dihydrourocanate + acceptor = urocanate + reduced acceptor (#1#  reaction mechanism, overview. Apo-ADP enzyme represents an inactive  state, while the binding of FAD induces movement of the clamp domain  that enables binding of the substrate urocanate to form an active  complex with a solvent-accessible channel for water-mediated proton  delivery to Arg411, and subsequent protonation of the substrate. Once  urocanate is reduced to imidazole propionate, Arg411 turns away  accompanied by conformational changes, resulting in closure of the  solvent-accessible channel by the hydrophobic lid and release of  imidazole propionate, allowing for a new substrate molecule to enter  the active site. Binding is entropically driven for both urocanate and  imidazole propionate <2>)  "
1.3.99.36," cypemycin(1-18)-L-Cys-L-Leu-L-Val-L-Cys + acceptor =  C3.19,S21-cyclocypemycin(1-18)-L-Ala-L-Leu-N-thioethenyl-L-valinamide +  CO2 + H2S + reduced acceptor  "
1.3.99.37, dihydroisopentenyldehydrorhodopin + acceptor =  isopentenyldehydrorhodopin + reduced acceptor (#1# (1) <3>) 
1.3.99.37, dihydrobisanhydrobacterioruberin + acceptor = bisanhydrobacterioruberin  + reduced acceptor (#1# (2) <3>)  
1.3.99.38, menaquinone-9 + reduced acceptor = beta-dihydromenaquinone-9 + acceptor  
1.3.99.39, carotenoid beta-end group + 2 acceptor = carotenoid phi-end group + 2  reduced acceptor  
1.3.99.4," a 3-oxosteroid + acceptor = a 3-oxo-DELTA1-steroid + reduced acceptor  (#1# stereochemistry: trans-diaxial <8>; #34,40# ping-pong bi bi  mechanism <43>; #20# sequential linear mechanism <43>)  "
1.3.99.40, carotenoid beta-end group + 2 acceptor = carotenoid chi-end group + 2  reduced acceptor  
1.3.99.5, a 3-oxo-5alpha-steroid + acceptor = a 3-oxo-DELTA4-steroid + reduced  acceptor  
1.3.99.6, a 3-oxo-5beta-steroid + acceptor = a 3-oxo-DELTA4-steroid + reduced  acceptor  
1.3.99.8, 2-furoyl-CoA + H2O + acceptor = S-(5-hydroxy-2-furoyl)-CoA + reduced  acceptor (#1# mechanism <3>)  
1.4.1.1," L-alanine + H2O + NAD+ = pyruvate + NH3 + NADH + H+ (#2# mechanism  <26>; #2# predominantly ordered kinetic mechanism in which NAD+ adds  before L-Ala, and ammonia, pyruvate, and NADH are released in that  order <25>; #9# sequential ordered ternary-binary mechanism, the enzyme  is A-stereospecific, the pro-R hydrogen at C-4 of the reduced  nicotinamide ring of NADH is exclusively transferred to pyruvate <38>;  #9# reductive amination proceeds through a sequential mechanism  containing partially random binding. NADH binds first to the enzyme,  and then pyruvate and ammonia bind in a random fashion <4>; #31# the  kinetic mechanism at pH 8.5 is determined to be ter-bi Theorell-Chance.  In the amination direction, the substrates add in the order: NADH,  NH4+, pyruvate, with NH4+ binding in rapid-equilibrium. In the reverse  direction, NAD adds first followed by L-Ala <51>; #6# reductive  amination: sequential mechanism with partially random binding <3>; #10#  sequential ordered binary-ternary mechanism. NAD+ binds first to the  enzyme, followed by L-Ala. The products are released in the order:  NH4+, pyruvate and NADH <60>; #15# oxidative deamination proceeds by an  random-ordered mechanism <53>)  "
1.4.1.10, glycine + H2O + NAD+ = glyoxylate + NH3 + NADH + H+  
1.4.1.11," L-erythro-3,5-diaminohexanoate + H2O + NAD+ =  (S)-5-amino-3-oxohexanoate + NH3 + NADH + H+  "
1.4.1.12," (2R,4S)-2,4-diaminopentanoate + H2O + NAD(P)+ =  (2R)-2-amino-4-oxopentanoate + NH3 + NAD(P)H + H+  "
1.4.1.13," 2 L-glutamate + NADP+ = L-glutamine + 2-oxoglutarate + NADPH + H+  (#2,12# mechanism <8,22>; #3# kinetic mechanism <5>; #8# hexa-uni ping  pong mechanism <10>) "
1.4.1.13, L-glutamate + NADP+ + H2O = NH3 + 2-oxoglutarate + NADPH + H+ 
1.4.1.13, L-glutamate + NH3 = L-glutamine + H2O  
1.4.1.14, 2 L-glutamate + NAD+ = L-glutamine + 2-oxoglutarate + NADH + H+ (#24#  kinetic mechanism <17>) 
1.4.1.14, L-glutamate + NH3 = L-glutamine + H2O 
1.4.1.14, L-glutamate + NAD+ + H2O = NH3 + 2-oxoglutarate + NADH + H+  
1.4.1.15," L-lysine + NAD+ = 1,2-didehydropiperidine-2-carboxylate + NH3 + NADH +  H+ (#9# the pro-R hydrogen at the prochiral C-6 carbon of L-lysine is  specifically abstracted and transferred to the pro-R position at C-4 of  NAD+ <4>)  "
1.4.1.16," meso-2,6-diaminoheptanedioate + H2O + NADP+ =  L-2-amino-6-oxoheptanedioate + NH3 + NADPH + H+ (#46# transfer of the  pro-R hydrogen, type A reductase <20>; #46# only amino acid  dehydrogenase which stereospecifically oxidizes a D-stereocenter <23>;  #11# enzyme may exhibit a random order of addition of substrates <22>;  #3# catalyzes the transfer of the pro-S hydrogen at C-4 of NADPH to the  substrate, enzyme is B-stereospecific <16>)  "
1.4.1.17, N-methyl-L-alanine + H2O + NADP+ = pyruvate + methylamine + NADPH + H+  
1.4.1.18," L-lysine + NAD+ + H2O = (S)-2-amino-6-oxohexanoate + NADH + H+ + NH3  (#18# reaction mechanism, overview <12>)  "
1.4.1.19, L-tryptophan + NAD(P)+ + H2O = (indol-3-yl)pyruvate + NH3 + NAD(P)H + H+  
1.4.1.2, L-glutamate + H2O + NAD+ = 2-oxoglutarate + NH3 + NADH + H+ (#49# bi  uni uni ping-pong addition sequence <7>; #20# partially random  mechanism <8>; #14# fully ordered reaction mechanism <5>; #14# NAD+  binds first followed by L-glutamate <5>; #14# formation of an  enzyme-NAD-oxoglutarate dead end complex <5>)  
1.4.1.20," L-phenylalanine + H2O + NAD+ = phenylpyruvate + NH3 + NADH + H+ (#7#  the reductive amination proceeds through a sequential ordered  ternary-binary mechanism <5>; #4# kinetic mechanism is ordered with  NAD+ binding prior to Phe and the products being released in the order  of ammonia, phenylpyruvate, and NADH <20>)  "
1.4.1.21, L-aspartate + H2O + NAD(P)+ = oxaloacetate + NH3 + NAD(P)H + H+  
1.4.1.23," L-valine + H2O + NAD+ = 3-methyl-2-oxobutanoate + NH3 + NADH + H+ (#2#  sequential ordered mechanism with non-competitive inhibition by valine  <2>; #4# the reductive amination proceeds through a sequential ordered  ternary-binary mechanism. NADH binds to the enzyme first, followed by  2-oxoisovalerate and NH3, and valine is released first, followed by  NAD+ <3>)  "
1.4.1.24," 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate + H2O + NAD+ =  3-dehydroquinate + NH3 + NADH + H+  "
1.4.1.25, L-arginine + H2O + NAD(P)+ = 5-guanidino-2-oxopentanoate + NH3 +  NAD(P)H + H+  
1.4.1.26," (2R,4S)-2,4-diaminopentanoate + H2O + NAD+ =  (2R)-2-amino-4-oxopentanoate + NH3 + NADH + H+  "
1.4.1.27," glycine + tetrahydrofolate + NAD+ = 5,10-methylenetetrahydrofolate +  NH3 + CO2 + NADH  "
1.4.1.3," L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+ (#9#  mechanism <1,21>; #9# alternative order mechanism at pH 9.5 <4>; #27#  kinetic data suggest either a rapid-equilibrium random mechanism or a  compulsory mechanism with binding sequence NH4+, NAD(P)H,  2-oxoglutarate <20>; #9# compulsory order mechanism at pH 8.8 <4,5>)  "
1.4.1.4, L-glutamate + H2O + NADP+ = 2-oxoglutarate + NH3 + NADPH + H+  
1.4.1.5, an L-amino acid + H2O + NAD+ = a 2-oxo carboxylate + NH3 + NADH + H+  
1.4.1.7, L-serine + H2O + NAD+ = 3-hydroxypyruvate + NH3 + NADH + H+  
1.4.1.8, L-valine + H2O + NADP+ = 3-methyl-2-oxobutanoate + NH3 + NADPH + H+  (#10# kinetic mechanism <5>)  
1.4.1.9," L-leucine + H2O + NAD+ = 4-methyl-2-oxopentanoate + NH3 + NADH + H+  (#3# ordered bi-ter mechanism, in which NAD+ and L-Leu are bound and  NH4+, 2-oxoisohexanoate, and NADH are released in that order <30>)  "
1.4.2.1, glycine + H2O + 2 ferricytochrome c = glyoxylate + NH3 + 2  ferrocytochrome c + 2 H+  
1.4.3.1, D-aspartate + H2O + O2 = oxaloacetate + NH3 + H2O2  
1.4.3.10, putrescine + O2 + H2O = 4-aminobutanal + NH3 + H2O2 (#4# mechanism <12>)  
1.4.3.11, L-glutamate + O2 + H2O = 2-oxoglutarate + NH3 + H2O2  
1.4.3.12, cyclohexylamine + O2 + H2O = cyclohexanone + NH3 + H2O2  
1.4.3.13," [protein]-L-lysine + O2 + H2O = [protein]-(S)-2-amino-6-oxohexanoate +  NH3 + H2O2 (#1# information about the activation mechanism of copper  <2>; #2# preprotein, lysyl oxidase gene family, amine oxidation through  ping pong bi ter kinetic mechanism <7>; #10# active site structure, a  unique funnel defines substrate specificity <10>; #4,5,8# ping-pong  mechanism of 2 half-reactions completing the catalytic cycle, overview  <14>)  "
1.4.3.14," L-lysine + O2 + H2O = 6-amino-2-oxohexanoate + NH3 + H2O2 (#2,4,5,6#  the substrate specificity of Trichoderma strains changes as a function  of the age of the culture and its morphological condition <1>; #1#  catabolic pathway of L-lysine through the pipecolic acid pathway <9>)  "
1.4.3.15, D-aspartate + H2O + O2 = oxaloacetate + NH3 + H2O2 
1.4.3.15, D-glutamate + H2O + O2 = 2-oxoglutarate + NH3 + H2O2  
1.4.3.16, L-aspartate + O2 = iminosuccinate + H2O2  
1.4.3.19," glycine + H2O + O2 = glyoxylate + NH3 + H2O2 (#1# ternary complex  sequential mechanism <2>; #1# reaction mechanism involving an  FADH2-imino acid complex, overview <15>) "
1.4.3.19, glycine + O2 = 2-iminoacetate + H2O2 
1.4.3.19, 2-iminoacetate + H2O = glyoxylate + NH3  
1.4.3.2," an L-amino acid + H2O + O2 = a 2-oxo carboxylate + NH3 + H2O2  (#9,23,42,70# mechanism <1,2,13,25,30,46>; #11# ping-pong mechanism  with binary complexes, derived from kinetic data <23>; #42# allosteric  effects, activation energy <35>; #24# hydride transfer mechanism <80>;  #37# reaction mechanism. Catalytic amino acids are H223 in two  conformations, G464 and R322 <79>)  "
1.4.3.20, L-lysine + O2 + H2O = (S)-2-amino-6-oxohexanoate + H2O2 + NH3  
1.4.3.21," RCH2NH2 + H2O + O2 = RCHO + NH3 + H2O2 (#14# role of copper in enzyme  activity <10>; #14# proposed mechanism, crystal structure <9>)  "
1.4.3.22," histamine + H2O + O2 = (imidazol-4-yl)acetaldehyde + NH3 + H2O2 (#7#  mechanism <7>; #13# ping-pong mechanism is suggested <6>; #38# a  mechanistic proposal for O2 reduction is advanced on the basis of  thermodynamic considerations together with kinetic studies, the  identification of steady-state intermediates, and the analysis of  competitive oxygen kinetic isotope effects. The 18O kinetic isotope  effect: 1.0136 at pH 7.2 is independent of temperature from 5Â°C to 47Â°C  and insignificantly changed to 1.0122 upon raising the pH to 9, thus  indicating the absence of kinetic complexity <66>)  "
1.4.3.23, 7-chloro-L-tryptophan + O2 = 2-imino-3-(7-chloroindol-3-yl)propanoate +  H2O2  
1.4.3.24, 4-(methylamino)-1-(pyridin-3-yl)butan-1-one + H2O + O2 =  4-oxo-4-(pyridin-3-yl)butanal + methylamine + H2O2  
1.4.3.25, L-arginine + H2O + O2 = 5-guanidino-2-oxopentanoate + NH3 + H2O2  
1.4.3.26," 3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one + O2 +  H2O = 5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidine-2,3-dione +  NH3 + H2O2 "
1.4.3.26," 3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one + O2 =  5-[(4-hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one + H2O2 "
1.4.3.26," 5-[(4-hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one + H2O  = 5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidine-2,3-dione + NH3  "
1.4.3.3," a D-amino acid + H2O + O2 = a 2-oxo carboxylate + NH3 + H2O2 (#14# ping  pong bi bi mechanism <9>; #57# catalytic mechanism, reductive  half-reaction mechanism, wild-type and S19G/S120P/Q144R/K321M/A345V  mutant enzymes, overview <119>)  "
1.4.3.4," RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2 (#3,6# mechanism <29,30>;  #3,6# mechanism of monoamine oxidase A and B <9>; #4,5,9# ping-pong  kinetic mechanism <13,15>; #3# mechanism of monoamine oxidase A <29>;  #37,42# catalysis occur via proton abstraction mechanisms <148>; #6#  reaction mechanism of C-H bond cleavage, MAO B shows H tunneling to  contribute in the H transfer step, overview <211>; #2,4# reaction  mechanism of C-H bond cleavage, overview <211>; #3# reaction mechanism  of C-H bond cleavage, overview. MAO oxidation of benzylamines and  phenethylamines exhibit large deuterium kinetic isotope effects  showing, in most instances, that C-H bond cleavage is rate limiting in  catalysis <211>)  "
1.4.3.5," pyridoxamine 5'-phosphate + H2O + O2 = pyridoxal 5'-phosphate + NH3 +  H2O2 (#11# reaction mechanism <24>; #11# enzyme is not stereospecific  and catalyzes removal of either pro-R or pro-S hydrogen from  4-methylene of pyridoxamine 5 phosphate <6>; #48# enzyme is specific  for removal of the pro-R hydrogen atom from the prochiral C4 carbon  atom of pyridoxamine 5-phosphate, hydride ion mechanism is suggested  <40>; #11# kinetic mechanims via either a binary or a ternary complex  mechanism, depending on nature of substrate, ternary complex mechanism  with pyridoxamine 5-phosphate <12>; #48# reaction mechanism, the  oxidation involves a stereospecific hydride-ion transfer between C4 of  pyridoxal 5-phosphate and N5 of FMN, structure-function relationship,  substrate binding and active site structure <45>) "
1.4.3.5," pyridoxine 5'-phosphate + O2 = pyridoxal 5'-phosphate + H2O2 (#11#  reaction mechanism <24>; #48# reaction mechanism, the oxidation  involves a stereospecific hydride-ion transfer between C4 of pyridoxal  5-phosphate and N5 of FMN, structure-function relationship, substrate  binding and active site structure <45>)  "
1.4.3.7, D-glutamate + H2O + O2 = 2-oxoglutarate + NH3 + H2O2  
1.4.3.8, ethanolamine + H2O + O2 = glycolaldehyde + NH3 + H2O2  
1.4.4.2," glycine + [glycine-cleavage complex H protein]-N6-lipoyl-L-lysine =  [glycine-cleavage complex H  protein]-S-aminomethyl-N6-dihydrolipoyl-L-lysine + CO2 (#1,8# mechanism  <8,9>; #1# H-protein ping-pong mechanism <1>; #1# sequential random bi  bi mechanism in which no abortive dead end complex is formed <9>; #29#  mechanism of the GLDC-catalyzed reaction, detailed overview. GLDC is an  unusual PLP-containing alpha-amino acid decarboxylase that removes  carbon dioxide from the glycine substrate without releasing the  expected amine (methylamine, a metabolic precursor of toxic  formaldehyde) as a product. In an unusual decarboxylation mechanism,  the resulting aminomethyl moiety is instead transferred to an accessory  H-protein. (1) H-Protein is not required for glycine decarboxylation  but, instead, is required for the release of the aminomethyl moiety  from the quinonoid adduct. (2) Glycine decarboxylation is reversible  and presumably proceeds through a stable quinonoid intermediate. (3)  The physiological product of glycine decarboxylation is  H-protein-S-aminomethyl dihydrolipoyllysine and not methylamine (in the  absence of H-protein, the aminomethyl moiety remains as a quinonoid  adduct) <48>)  "
1.4.5.1, a D-amino acid + H2O + a quinone = a 2-oxo carboxylate + NH3 + a quinol  
1.4.7.1, 2 L-glutamate + 2 oxidized ferredoxin = L-glutamine + 2-oxoglutarate +  2 reduced ferredoxin + 2 H+ (#17# proposed electron-transfer pathway  <2>) 
1.4.7.1, L-glutamate + 2 oxidized ferredoxin + H2O = NH3 + 2-oxoglutarate + 2  reduced ferredoxin + 2 H+ 
1.4.7.1, L-glutamate + NH3 = L-glutamine + H2O  
1.4.9.1," methylamine + H2O + 2 amicyanin = formaldehyde + NH3 + 2 reduced  amicyanin (#1# in the rate-determining step, a proton is transferred  from the methyl group of the substrate to residue D76. Only one of the  oxygen atoms of D76 can act as an acceptor of the proton, the other  interacts with T122 via a strong hydrogen bond <30>; #1# model of  electron transfer reaction between enzyme and transfer protein  amicyanin <27>; #1# reduction of Cu2+ of electron transfer protein  amicyanin by enzyme is a true electron transfer reaction <26>; #10# the  rate-determining step in the reductive half-reaction of the bacterial  enzyme methylamine dehydrogenase is the proton abstraction from the  native substrate methylamine, ab initio QM/MM molecular dynamics  simulations, average flow of electronic charge within the QM subsystem  during proton transfer to OD1 computed from randomly selected subsets  of the reactant, model comparisons, detailed overview <56>)  "
1.4.9.2," ArCH2NH2 + H2O + 2 azurin = ArCHO + NH3 + 2 reduced azurin (#4#  ping-pong mechanism <9>; #1# breakage of the substrate C-H bond occurs  via quantum mechanical tunneling. In steady-state reactions with  benzylamine, breakage of C-H bond is only partially rate-limiting <11>;  #1# mechanism. In presence of substrate a covalent N-semiquinone  substrate adduct is observed. Tryptophan tryptophylquinone redox state  influences interprotein electron transfer <12>; #1# proton transfer  occurs predominantly to oxygen O2 of D128 in beta subunit in a reaction  dominated by tunneling over 0.6 Angstroms. Tunneling is promoted by a  short-range motion modulating proton-acceptor distance and no  long-range coupled motion is required <13>)  "
1.4.99.2, taurine + H2O + acceptor = 2-sulfoacetaldehyde + NH3 + reduced acceptor  
1.4.99.5, glycine + 2 acceptor = hydrogen cyanide + CO2 + 2 reduced acceptor  
1.4.99.6, D-arginine + acceptor + H2O = 5-guanidino-2-oxopentanoate + NH3 +  reduced acceptor 
1.4.99.6, D-arginine + acceptor = iminoarginine + reduced acceptor 
1.4.99.6, iminoarginine + H2O = 5-guanidino-2-oxopentanoate + NH3  
1.5.1.1, L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+ (#11#  Mobile domains I and II of protein change their conformations to  produce the catalytic form. Preference for NADPH over NADH is explained  by the cofactor binding site architecture <4>) 
1.5.1.1, L-pipecolate + NAD(P)+ = 1-piperideine-2-carboxylate + NAD(P)H + H+  
1.5.1.10," N6-(L-1,3-dicarboxypropyl)-L-lysine + NADP+ + H2O = L-glutamate +  (S)-2-amino-6-oxohexanoate + NADPH + H+ (#12# ordered kinetic  mechanism, the reduced dinucleotide substrate binds to enzyme first  followed by L-alpha-aminoadipate-delta-semialdehyde, which adds in  rapid equilibrium prior to L-glutamate, saccharopine is released prior  to NADP+, primary deuterium kinetic isotope effects and solvent  deuterium kinetic isotope effects, overview. A conformational change to  open the site and release products (in the direction of saccharopine  formation) is the rate limiting step. Two groups are involved in the  acid-base chemistry of the reaction. An enzyme group with a pKa of 5.6  accepts a proton from the alpha-amine of glutamate to generate the  neutral amine that can act as a nucleophile. The alpha-amine of  glutamate attacks the carbonyl of the semialdehyde to generate the  carbinolamine, which is protonated by a second enzyme group with a pKa  of about 7.8-8.0. Ionizable residues that might play a role in the  acid-base mechanism of the enzyme are D126, C154 and/or Y99 <16>)  "
1.5.1.11," N2-(D-1-carboxyethyl)-L-arginine + NAD+ + H2O = L-arginine + pyruvate +  NADH + H+ (#36# kinetic mechanism <16>; #36# NADH binds to the enzyme  first followed by L-Arg and pyruvate, which bind randomly <11>; #36#  bi-ter sequential mechanism where NAD+ binds first to the enzyme  followed by D-octopine, and the products are released in the order  L-Arg, pyruvate and NADH <24>; #41# partially random mechanism in which  NADH is the obligatory first substrate, and Arg and pyruvate bind  randomly to the enzyme-NADH complex. Ordered sequential addition of  NAD+ and octopine in octopine oxidation <9>; #36# in the direction of  octopine oxidation NAD binds to the enzyme before octopine in a rapid  equilibrium fashion. The products L-Arg and pyruvate are released in a  random fashion <11>; #3# partially ordered mechanism. NADPH binds first  followed by the random order, rapid-equilibrium-binding of Arg and  pyruvate. Orn probably binds before pyruvate <32>; #2,36# the enzyme  removes the pro-S hydrogen atom of the dihydronicotinamide ring with  transfer of label to the solvent and to the product octopine  (N-2-(1-carboxyethyl)-L-arginine ) <34>; #87# substrates bind in an  ordered sequential manner. First NADH binds to OcDH followed by  L-arginine. The binding of the guanidinium headgroup of L-arginine  induces a conformational change, resulting in the formation of the  pyruvate binding site. The reduction of pyruvate can only occur in the  presence of L-arginine, which than forms octopine and prevents lactate  formation <40>)  "
1.5.1.15," 5,10-methylenetetrahydrofolate + NAD+ = 5,10-methenyltetrahydrofolate +  NADH + H+  "
1.5.1.16, N2-(D-1-carboxyethyl)-L-lysine + NADP+ + H2O = L-lysine + pyruvate +  NADPH + H+  
1.5.1.17," 2,2'-iminodipropanoate + NAD+ + H2O = L-alanine + pyruvate + NADH + H+  "
1.5.1.18, (-)-ephedrine + NAD+ = (R)-2-methylimino-1-phenylpropan-1-ol + NADH + H+  
1.5.1.19," N2-(D-1,3-dicarboxypropyl)-L-arginine + NADP+ + H2O = L-arginine +  2-oxoglutarate + NADPH + H+ (#1# ter-bi rapid-equilibrium random-order  mechanism <1>)  "
1.5.1.2, L-proline + NAD(P)+ = 1-pyrroline-5-carboxylate + NAD(P)H + H+  
1.5.1.20," 5-methyltetrahydrofolate + NAD(P)+ = 5,10-methylenetetrahydrofolate +  NAD(P)H + H+ (#7# mechanism <4,6>; #7# mechanism, acceptor is free FAD,  stereochemistry <20>; #4# ping-pong bi-bi mechanism, in which NAD(P)+  release precedes the binding of methylenetetrahydrofolate <34>; #4#  substrate binding and catalyic mechanism involve Asp120, half-reaction  mechanisms <39>; #4# NADH adopts a hairpin conformation and is  sandwiched between a conserved phenylalanine, F223, and the  isoalloxazine ring of FAD, resulting in a complex competent for hydride  transfer. The binding sites of the two substrates overlap. Pinog-pong  reaction is facilitated by motions of loops L2, L3, L4 <46>)  "
1.5.1.21, L-pipecolate + NADP+ = 1-piperideine-2-carboxylate + NADPH + H+ 
1.5.1.21, L-proline + NADP+ = 1-pyrroline-2-carboxylate + NADPH + H+  
1.5.1.22, N-(carboxymethyl)-D-alanine + NAD+ + H2O = glycine + pyruvate + NADH +  H+  
1.5.1.23, tauropine + NAD+ + H2O = taurine + pyruvate + NADH + H+ (#88# Cys146  might be essential for the catalytic reaction <11>)  
1.5.1.24, N5-(L-1-carboxyethyl)-L-ornithine + NADP+ + H2O = L-ornithine +  pyruvate + NADPH + H+  
1.5.1.25," thiomorpholine 3-carboxylate + NAD(P)+ =  3,4-dehydro-thiomorpholine-3-carboxylate + NAD(P)H + H+ (#4,5#  classical ping-pong mechanism <1,2>; #1,5# in silico docking of various  ligands into the active site of the X-ray structure of the enzyme  suggests an unusual catalytic mechanism involving an arginine residue  as a proton donor <5>; #2# in silico docking of various ligands into  the active site of the X-ray structure of the enzyme suggests an  unusual catalytic mechanism involving an arginine residue as a proton  donor, proposed mechanism for the reaction catalyzed by ketimine  reductase/CRYM, overview <5>; #7# the enzyme binds 2-oxo acids, such as  pyruvate, in solution, and catalyzes the formation of N-alkyl-amino  acids from alkylamines and 2-oxo acids via reduction of imine  intermediates. Mechanistically, ketimine reductase/CRYM acts as a  classical imine reductase <4>)  "
1.5.1.26, beta-alanopine + NAD+ + H2O = beta-alanine + pyruvate + NADH + H+  
1.5.1.27," (R)-reticuline + NADP+ = 1,2-dehydroreticulinium + NADPH + H+  "
1.5.1.28, (2S)-2-{[1-(R)-carboxyethyl]amino}pentanoate + NAD+ + H2O =  L-2-aminopentanoic acid + pyruvate + NADH + H+  
1.5.1.3," 5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+ (#11#  kinetic mechanism <20>; #7# rapid equilibrium random mechanism <1>;  #7,11,33,35,39,65# catalytic mechanism <1,2,6>; #9,27,40# bifunctional  proteins with DHFR and thymidylate synthase activity <84>; #33#  pteridine-binding site <11>; #11# rapid random equilibrium mechanism  with NADPH and reduced acetylpyridine adenine nucleotide as cofactor  <20>; #11# cofactor binding mechanism, pH-dependence investigation <6>;  #2,10,11,12,13,14,16,25,33,35# inhibitor binding mechanism <4,5>; #7#  substrate and cofactor binding mechanism <1>; #55# substrate and  antifolate inhibitor methotrexate binding, modeling of  three-dimensional structure <86>; #91# analysis of higher energy  conformational substrates by NMR relaxation dispersion. The maximum  hydride transfer and steady-state turnover rates are governed by the  dynamics of transitions between ground and excited states of the  intermediates. Model of conformational changes during the catalytic  cycle <127>; #11# donor carbon at the hydride transfer transition state  resembles the reactant state more than the product state, whereas the  acceptor carbon is more productlike, a symptom of transition state  imbalance <115>; #11# kinetic isotope effect analysis, enzyme requires  no no donor-acceptor distance fluctuations and thus no gating <123>;  #91# model for hydrogen transfer includes contributions from quantum  mechanical tunnelling coupled with protein motions that actively  modulate the tunnelling distance <107>; #18# ordered kinetic mechanism  at elevated temperature around 60Â°C, with NADPH binding first. More  random mechanism at temperatures around 20Â°C with greatly reduced  Km-value for 7,8-dihydrofolate. Rate-limiting hydride-transfer with a  moderate enthalpy of activiation <108>; #91# study on enzyme ternary  complex with substrate analogue folates and oxidized NADP+ cofactor  using NMR relaxation methods. Conformational exchanges of protein  between a ground state with closed conformation of active site loops  and an excited state with loops in occluded conformation. Fluctuations  include motions of the nicotinamide ring of the cofactor into and out  of the active site <122>; #71# binding of NADPH is accompanied by  release of 38 water molecules, while binding of dihydrofolate is  accompanied by the net uptake of water <159>; #88# in Plasmodium  bifunctional thymidylate synthase-dihydrofolate reductase, the overall  rate-limiting step is thymidylate synthase catalysis.If thymidylate  synthase is in an activated liganded conformation, the dihydrofolate  reductase is 2-fold activated. The thymidylate synthase rate is also  reciprocally activated by 1.5-fold if dihydrolfolate reductase is in an  activated, ligand-bound conformation <141>; #91# the active-site loop  dynamics access a closed conformation, and the accompanying closed to  occluded rate constant is comparable to the maximum pH-independent  hydride transfer rate constant. The closed to occluded conformational  transition in the product ternary complex is a prerequisite for  progression through the catalytic cycle. The rate of this process  places an effective limit on the maximum rate of the hydride transfer  step. The dynamics of the C-terminally associated region is  pH-dependent, but the dynamics of the active-site loops and cofactor  binding cleft are pH-independent <143>; #43# Ala16, Ile51, Cys59,  Ser108 and Ile164 are active site residues <209>; #43# Ala16, Ile51,  Cys59, Ser108 and Ile164 are active site residues, catalytic mechanism,  overview <210>; #98# the product (tetrahydrofolate) dissociation step  that is the rate-limiting step in Escherichia coli DHFR is  significantly accelerated in spDHFR so that hydride transfer or a  preceding step is rate-limiting <224>; #91# transfer of a proR hydride  from the C4 atom of NADPH to the C6 position of the dihydropterin ring  of DHF, mechanism of the proton and hydride transfer reaction, active  site residues D27 and Y100 play a synergistic role in facilitating both  the proton transfer and subsequent hydride transfer steps. Residue D27  appears to have a greater effect on the overall rate of conversion of  DHF to tetrahydrofolate, Y100 plays an important electrostatic role in  modulating the pKa of the N5 of DHF to enable the preprotonation of DHF  by an active site water molecule. The D27 and Y100 residues function  synergistically to provide an active site environment for the  solvent-assisted protonation of N5 and to position the reacting  substrates, NADPH and DHF, properly <264>)  "
1.5.1.30," reduced riboflavin + NADP+ = riboflavin + NADPH + H+ (#1,9# ping-pong  mechanism <24>; #9# catalytic mechanism <15>; #2# bi-bi ternary  mechanism, i.e. both FMN and NADPH must bind to the active site before  catalysis can occur <19>; #9# binding of FMN by apoenzyme is  noncooperative, exothermic and primarily enthalpy driven with  significant conformational changes in enzyme upon binding. The  kinetically deduced ping-pong mechanism is supported by measurement of  binding affinities of the oxidized and reduced FMN cofoactors <18>; #9#  FRP:luciferase coupled reaction can utilize reduced flavin by both free  diffusion and direct transfer <17>; #3# single-enzyme kinetic assay,  SsuE follows ordered sequential mechanism with NADPH as the first  substrate to bind and NADP+ as the last product to leave. In presence  of monooxygenase SsuD and octanesulfonate mechanism is altered to rapid  equilibrium ordered mechanism, and Km-value for FMN increases 10fold  <12>; #14# the nicotinamide of NAD+ stacks the isoalloxazine ring of  FMN so that NADH can directly transfer hydride. The bound NADP+ also  has a compact conformation but is bound in a reverse direction, which  is not suitable for hydride transfer <20>; #2# the enzyme catalysis  obeys the ping-pong Bi-Bi kinetic mechanism with substrate FMN as well  as substrate nitrofurazone, but upon coupling with the bioluminescent  reaction of luciferase, it changes to the sequential mechanism <35>)  "
1.5.1.31, (R)-canadine + 2 NADP+ = berberine + 2 NADPH + H+  
1.5.1.32," 1,2-dihydrovomilenine + NADP+ = vomilenine + NADPH + H+  "
1.5.1.33," 5,6,7,8-tetrahydrobiopterin + 2 NADP+ = biopterin + 2 NADPH + 2 H+ (#5#  ordered sequential reaction mechanism <3>; #5# ordered ternary complex  mechanism with NADPH binding first and NADP+ dissociating after the  reduced pteridine. The enzyme transfers the pro-S hydride of NADPH to  carbon 6 on the si face of dihydrofolate <8>; #7# conserved residue  Tyr194 forms hydrogen bonds with the nucleophilic center of the  substrate and stabilizes the transition state, conserved residue Lys198  lowers the pKa of the tyrosine, helps to stabilize the transition  state, and may function as proton source for the tyrosine <11>; #5# the  enzyme exhhibits a ping-pong mechanism <31>)  "
1.5.1.34," a 5,6,7,8-tetrahydropteridine + NAD(P)+ = a 6,7-dihydropteridine +  NAD(P)H + H+ (#4# ordered bi-bi mechanism, binding of NADH first and  dissociation of NAD+ last <13>; #5# structural and mechanistic  characteristics <46>; #14# catalytic triad consists of Y182, K186, and  D169 <57>)  "
1.5.1.36, reduced flavin + NAD+ = flavin + NADH + H+ (#10# FAD reduction by  recombinant His10-tagged SMOB-ADP1 follows a random sequential  mechanism <10>)  
1.5.1.37, FADH2 + NAD+ = FAD + NADH + H+  
1.5.1.38," FMNH2 + NADP+ = FMN + NADPH + H+ (#3# reaction mechanism, overview  <13>; #2# ping-pong kinetic pattern <3>; #2# the enzyme exhibits double  displacement or ping-pong kinetics <2>; #4# the first step in  catalysis, which is hydride transfer from C4 of NADPH to cofactor FMN,  involves addition to the re face of the FMN, probably at the N5  position. The limited accessibility of the FMN binding pocket and the  extensive FMN-protein hydrogen bond network are consistent with the  observed ping-pong bisubstrate-biproduct reaction kinetics <5>)  "
1.5.1.39, FMNH2 + NAD(P)+ = FMN + NAD(P)H + H+ (#1# sequential reaction mechanism  <1>)  
1.5.1.40, reduced coenzyme F420 + NADP+ = oxidized coenzyme F420 + NADPH + H+  
1.5.1.41, reduced riboflavin + NAD(P)+ = riboflavin + NAD(P)H + H+  
1.5.1.42," FMNH2 + NAD+ = FMN + NADH + H+ (#2# the enzyme exhibits single  displacement kinetics <2>; #3# catalytic reaction mechanism with active  site Thr residue, hybrid quantum mechanics/molecular mechanics  simulation methods, overview <9>)  "
1.5.1.43," carboxynorspermidine + H2O + NADP+ = L-aspartate 4-semialdehyde +  propane-1,3-diamine + NADPH + H+ "
1.5.1.43, carboxyspermidine + H2O + NADP+ = L-aspartate 4-semialdehyde +  putrescine + NADPH + H+  
1.5.1.44," festuclavine + NAD+ = 6,8-dimethyl-6,7-didehydroergoline + NADH + H+  "
1.5.1.45, FADH2 + NAD(P)+ = FAD + NAD(P)H + H+  
1.5.1.46," agroclavine + NADP+ = 6,8-dimethyl-6,7,8,9-tetradehydroergoline + NADPH  + H+  "
1.5.1.47," 5,6,7,8-tetrahydromethanopterin + NAD(P)+ = 7,8-dihydromethanopterin +  NAD(P)H + H+  "
1.5.1.48, (R)-2-methylpyrrolidine + NADP+ = 2-methyl-1-pyrroline + NADPH + H+  
1.5.1.49, L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+  
1.5.1.5," 5,10-methylenetetrahydrofolate + NADP+ = 5,10-methenyltetrahydrofolate  + NADPH + H+  "
1.5.1.50," 5,6,7,8-tetrahydromonapterin + NADP+ = 7,8-dihydromonapterin + NADPH +  H+  "
1.5.1.51," N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate + NAD+ + H2O =  2-oxoglutarate + L-2,3-diaminopropanoate + NADH + H+  "
1.5.1.52, staphylopine + NADP+ + H2O =  (2S)-2-amino-4-{[(1R)-1-carboxy-2-(1H-imidazol-4  yl)ethyl]amino}butanoate + pyruvate + NADPH + H+  
1.5.1.53," 5-methyltetrahydrofolate + NADP+ = 5,10-methylenetetrahydrofolate +  NADPH + H+  "
1.5.1.54," 5-methyltetrahydrofolate + NAD+ = 5,10-methylenetetrahydrofolate + NADH  + H+  "
1.5.1.6," 10-formyltetrahydrofolate + NADP+ + H2O = tetrahydrofolate + CO2 +  NADPH + H+ (#4# reaction mechanism <8,12>; #4# sequential mechanism of  substrate addition <7>; #4# FDH catalyzes the hydrolytic cleavage of  the formyl group in the N-terminal catalytic domain, followed by  NADP+-dependent oxidation of the formyl group toCO2 in the C-terminal  aldehyde dehydrogenase domain <29>)  "
1.5.1.7," N6-(L-1,3-dicarboxypropyl)-L-lysine + NAD+ + H2O = L-lysine +  2-oxoglutarate + NADH + H+ (#1# mechanism <6,7,14,19>; #1# model of  proton shuttle mechanism. Concerted proton and hydride transfer, proton  transfer exists in at least two sequential transition states <22>; #1#  ordered addition of NAD followed by saccharopine in the physiologic  reaction direction. In the opposite direction, NADH adds to the enzyme  first, while there is no preference for the order of binding of  alpha-ketoglutarate and lysine <21>)  "
1.5.1.8," N6-(L-1,3-dicarboxypropyl)-L-lysine + NADP+ + H2O = L-lysine +  2-oxoglutarate + NADPH + H+ (#3# reaction mechanism <5>; #20# ordered  sequence mechanism, where 2-oxoglutarate is first substrate and  saccharopine is last product <15>)  "
1.5.1.9," N6-(L-1,3-dicarboxypropyl)-L-lysine + NAD+ + H2O = L-glutamate +  (S)-2-amino-6-oxohexanoate + NADH + H+  "
1.5.3.1," sarcosine + H2O + O2 = glycine + formaldehyde + H2O2 (#5,6,7# mechanism  <11,14,24,25,29,30>; #5# ping-pong bi-bi mechanism <13>; #6# modified  ping-pong-mechanism in which oxygen reacts with EredP prior to the  dissociation of the imino acid product <32>; #17# enzyme forms a  charge-transfer Michaelis complex with sarcosine, kinetics of formation  of the Michaelis charge transfer complex can be directly monitored at  5Â°C. No redox intermediate is detectable during sarcosine oxidation  <40>; #6# L-proline is the ionizable group in the ES complex. Y317 may  play a role in substrate activation and optimizing of binding <38>;  #6,16,17# mechanism suggested <46,47,48>; #19# molecular dynamics  investigation by random acceleration molecular dynamics simulations  with an ensemble made of the bacterial monomeric sarcosine oxidase  (2GF3), O2, and the inhibitor furoic acid to mimic sarcosine <57>; #18#  molecular dynamics simulation study for the heterotetrameric sarcosine  oxidase-dimethylglycine complex gives insight to understand the  dynamics of the enzyme. A cluster analysis on the small rectangular  cells with high water probabilities results in the detection of eleven  water channels. CH1, CH2, CH3, and CH4 correspond to the tunnels from  the large cavity in the previous study. CH6, CH7, and the combined CH8  and CH9 are narrow channels from the large cavity. CH5 and the combined  CH10 and CH11 are not connected with the cavity. No permeation of water  molecules between the channels is found except in the combined  channels. The results of the present analysis are consistent with the  selective transport hypothesis <56>; #6# the simulation method of  Markovian milestoning molecular dynamics simulations is used to compute  the entry and exit kinetics of O2 in the enzyme. The rate of flavin  oxidation by O2 is likely not strongly limited by diffusion from the  solvent to the active site. The predicted faster entry and slower exit  of O2 for the bound state indicate a longer residence time within the  enzyme, increasing the likelihood of collisions with the flavin  isoalloxazine ring, a step required for reduction of molecular O2 and  subsequent reoxidation of the flavin <61>)  "
1.5.3.10," N,N-dimethylglycine + H2O + O2 = sarcosine + formaldehyde + H2O2 (#1#  reaction mechanism, substrate binding structures, bifunctional enzyme  catalyzing the formation of 5,10-methylne tetrahydrofolate and the  oxidation of N,N-dimethylglycine, active site structures, Tyr259 and  His225 are involved in catalysis <3>; #1# tetrahydrofolate-binding site  of enzyme is highly specific for reduced folate compounds and enhances  the nucleophilic character of the tetrahydrofolate N10 position <4>)  "
1.5.3.12, dihydrosanguinarine + O2 = sanguinarine + H2O2 
1.5.3.12, dihydrochelirubine + O2 = chelirubine + H2O2 
1.5.3.12, dihydromacarpine + O2 = macarpine + H2O2  
1.5.3.13, N1-acetylspermine + O2 + H2O = spermidine + 3-acetamidopropanal + H2O2 
1.5.3.13, N1-acetylspermidine + O2 + H2O = putrescine + 3-acetamidopropanal + H2O2  
1.5.3.14," spermidine + O2 + H2O = propane-1,3-diamine + 4-aminobutanal + H2O2  "
1.5.3.15," N8-acetylspermidine + O2 + H2O = propane-1,3-diamine +  4-acetamidobutanal + H2O2  "
1.5.3.16, spermine + O2 + H2O = spermidine + 3-aminopropanal + H2O2  
1.5.3.17, spermine + O2 + H2O = spermidine + 3-aminopropanal + H2O2 
1.5.3.17, spermidine + O2 + H2O = putrescine + 3-aminopropanal + H2O2 
1.5.3.17, N1-acetylspermine + O2 + H2O = spermidine + 3-acetamidopropanal + H2O2 
1.5.3.17, N1-acetylspermidine + O2 + H2O = putrescine + 3-acetamidopropanal + H2O2  
1.5.3.18," N6-(L-1,3-dicarboxypropyl)-L-lysine + H2O + O2 =  (S)-2-amino-6-oxohexanoate + L-glutamate + H2O2  "
1.5.3.19, 4-methylaminobutanoate + O2 + H2O = 4-aminobutanoate + formaldehyde +  H2O2  
1.5.3.2, an N-methyl-L-amino acid + H2O + O2 = an L-amino acid + formaldehyde +  H2O2 (#1# reaction mechanism <1>)  
1.5.3.20, N-alkylglycine + H2O + O2 = alkylamine + glyoxalate + H2O2  
1.5.3.21, 4-methylaminobutanoate + O2 + H2O = succinate semialdehyde +  methylamine + H2O2  
1.5.3.22, 2 reduced coenzyme F420 + O2 = 2 oxidized coenzyme F420 + 2 H2O  
1.5.3.23, 2 glyphosate + O2 = 2 aminomethylphosphonate + 2 glyoxylate  
1.5.3.4, N6-methyl-L-lysine + H2O + O2 = L-lysine + formaldehyde + H2O2 (#4#  mechanism <1>)  
1.5.3.5," (S)-6-hydroxynicotine + H2O + O2 =  1-(6-hydroxypyridin-3-yl)-4-(methylamino)butan-1-one + H2O2 (#2#  mechanism and roles of active site residues: Asn166 and Tyr311 bind the  substrate, while Lys287 forms a water-mediated hydrogen bond with  flavin N5 <19>) "
1.5.3.5," (S)-6-hydroxynicotine + O2 =  5-(N-methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol + H2O2 "
1.5.3.5," 5-(N-methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol + H2O =  1-(6-hydroxypyridin-3-yl)-4-(methylamino)butan-1-one  "
1.5.3.6, (R)-6-hydroxynicotine + H2O + O2 =  1-(6-hydroxypyridin-3-yl)-4-(methylamino)butan-1-one + H2O2 
1.5.3.6," 5-(N-methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol + H2O =  1-(6-hydroxypyridin-3-yl)-4-(methylamino)butan-1-one "
1.5.3.6," (R)-6-hydroxynicotine + O2 =  5-(N-methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol + H2O2  "
1.5.3.7," L-pipecolate + O2 = (S)-2,3,4,5-tetrahydropyridine-2-carboxylate + H2O2  "
1.5.4.1," 2-amino-6-acetyl-3,7,8,9-tetrahydro-3H-pyrimido[4,5-b][1  4]diazepin-4-one + glutathione disulfide + H2O =  6-pyruvoyltetrahydropterin + 2 glutathione (#2# active site contains  the sequence Cys-Pro-Tyr-Cys <2>)  "
1.5.5.1," reduced electron-transferring flavoprotein + ubiquinone =  electron-transferring flavoprotein + ubiquinol (#5# electrostatic  interaction between enzyme and electron-transferring flavoprotein <5>;  #5# when enzyme is reduced to a two-electron reduced state, with one  electron at each redox center, it is primed to reduce ubiquinone via  FAD <19>)  "
1.5.5.2, L-proline + a quinone = (S)-1-pyrroline-5-carboxylate + a quinol (#1#  switching of enzyme from a cytosolic DNA-binding protein to a  membrane-bound enzyme involves W211 in a flexible domain near the  proline dehydrogenase active site and occurs in a time scale 10fold  lower than the turnover number <13>)  
1.5.5.3," trans-4-hydroxy-L-proline + a quinone =  (3R,5S)-3-hydroxy-1-pyrroline-5-carboxylate + a quinol  "
1.5.7.1," 5-methyltetrahydrofolate + 2 oxidized ferredoxin =  5,10-methylenetetrahydrofolate + 2 reduced ferredoxin + 2 H+  "
1.5.7.2, reduced coenzyme F420 + 2 oxidized ferredoxin = oxidized coenzyme F420  + 2 reduced ferredoxin + 2 H+  
1.5.8.1, dimethylamine + H2O + electron-transfer flavoprotein = methylamine +  formaldehyde + reduced electron-transfer flavoprotein (#2# the enzyme  functions as a 2:1e- transformase. The flavin component accepts two  electrons from the substrate while the [4Fe-4S] cluster provides an  output of single electrons to a flavoprotein which functions as a  one-electron acceptor <1>)  
1.5.8.2," trimethylamine + H2O + electron-transfer flavoprotein = dimethylamine +  formaldehyde + reduced electron-transfer flavoprotein (#2# detailed  reaction mechanism <43>; #2# redox mediation mechanism, overview <42>)  "
1.5.8.3, sarcosine + H2O + electron-transfer flavoprotein = glycine +  formaldehyde + reduced electron-transfer flavoprotein  
1.5.8.4," N,N-dimethylglycine + 5,6,7,8-tetrahydrofolate + electron-transfer  flavoprotein = sarcosine + 5,10-methylenetetrahydrofolate + reduced  electron-transfer flavoprotein  "
1.5.98.1," 5,10-methylenetetrahydromethanopterin + oxidized coenzyme F420 =  5,10-methenyltetrahydromethanopterin + reduced coenzyme F420 (#1,2,5#  ternary complex mechanism <5,7,9>; #4# si face specific at C5 of F420  <10>; #2# reversible stereospecific transfer of a hydride ion from the  re face at C14a of N5,N10-methylenetetrahydromethanopterin to the si  face at C5 of coenzyme F420 <6>)  "
1.5.98.2," 5-methyltetrahydromethanopterin + oxidized coenzyme F420 =  5,10-methylenetetrahydromethanopterin + reduced coenzyme F420 (#3#  stereochemistry <5>)  "
1.5.98.3, reduced coenzyme F420 + methanophenazine = oxidized coenzyme F420 +  dihydromethanophenazine  
1.5.99.12," N6-dimethylallyladenine + acceptor + H2O = adenine + 3-methylbut-2-enal  + reduced acceptor (#12# reaction might also be catalyzed by a  different enzyme in Dictyostelium discoideum, since no related sequence  has been found <17>; #37# reaction scheme and mechanism, reduction of  N6-(2-isopentenyl)adenine is rapidly performed, the reaction with O2 is  slowly <14>; #37# reaction scheme and mechanism, the substrate displays  a plug-into-socket binding mode that seals the catalytic site and  precisely positions the carbon atom undergoing oxidation in close  contact with the reactive locus of the flavin, bipartite architecture  of the catalytic centre, which consists of a funnel-shaped region on  the protein surface and an internal cavity lined by the flavin ring,  the 3 active site regions are connected by a pore of about 4 A diameter  <16>; #48# Asp162 and Glu275 involved in substrate binding <39>)  "
1.5.99.13, D-proline + acceptor = 1-pyrroline-2-carboxylate + reduced acceptor  
1.5.99.14," 1-(6-hydroxypyridin-3-yl)-4-(methylamino)butan-1-one + acceptor + H2O =  1-(2,6-dihydroxypyridin-3-yl)-4-(methylamino)butan-1-one + reduced  acceptor  "
1.5.99.15," 5,6,7,8-tetrahydromethanopterin + oxidized acceptor =  7,8-dihydromethanopterin + reduced acceptor (#3# DmrB uses a ping-pong  mechanism to transfer reducing equivalents from FMN to the pterin  substrate, modeling, overview <3>)  "
1.5.99.3," L-pipecolate + acceptor = (S)-2,3,4,5-tetrahydropyridine-2-carboxylate  + reduced acceptor  "
1.5.99.4, (S)-nicotine + acceptor + H2O = (S)-6-hydroxynicotine + reduced acceptor  
1.5.99.5, N-methyl-L-glutamate + acceptor + H2O = L-glutamate + formaldehyde +  reduced acceptor  
1.5.99.6," spermidine + acceptor + H2O = propane-1,3-diamine + 4-aminobutanal +  reduced acceptor  "
1.6.1.1," NADPH + NAD+ = NADP+ + NADH (#5,9,10# mechanism <21>)  "
1.6.1.2," NADPH + NAD+ = NADP+ + NADH (#3,8,9,14# mechanism <3,45>; #9#  stereochemistry <30>; #9# proposed proton-pump mechanism <29>; #9#  mitochondrial proton-motive force accelerates the rate of NADPH  formation 10-12fold and shifts the equilibrium in the direction of  product formation <58>; #6,9,14# hypothetical mechanism <65>; #6,9,14#  enzyme is stereospecific for the 4A hydrogen of NADH and the 4B  hydrogen of NADPH <45>)  "
1.6.1.3, NADPH + NAD+ = NADP+ + NADH  
1.6.1.4, NADH + H+ + 2 NADP+ + 2 reduced ferredoxin [iron-sulfur] cluster = NAD+  + 2 NADPH + 2 oxidized ferredoxin [iron-sulfur] cluster  
1.6.2.2," NADH + 2 ferricytochrome b5 = NAD+ + H+ + 2 ferrocytochrome b5 (#9#  ordered bi bi mechanism <26>; #5,6,8,9# hypothetical mechanism <39>;  #6# electron-transport chain from NADH to a terminal oxidase  desaturase, proposed electron transfer mechanism <20>; #4# reaction  mechanism, overview <107>; #37# Y93 forms contact with the FAD, but  neither P92 nor Y93 preceeding the conserved motif RxYTSxxSN  coordinating flavin binding are critical for flavin incorporation <81>)  "
1.6.2.4," NADPH + H+ + n oxidized hemoprotein = NADP+ + n reduced hemoprotein  (#76# at high ionic strength nonclassical two-site ping pong mechanism,  at low ionic strength a sequential bisubstrate mechanism <86>; #8,9#  catalytic cycle and the rate-limiting step, which is at or after the  introduction of the second electron from the reductase to the heme iron  <176>; #122# kinetic mechanism, overview <180>)  "
1.6.2.5, NADPH + 2 ferricytochrome c2 = NADP+ + H+ + 2 ferrocytochrome c2  
1.6.2.6, NAD(P)H + H+ + 2 ferrileghemoglobin = NAD(P)+ + 2 ferroleghemoglobin  
1.6.3.1," NAD(P)H + H+ + O2 = NAD(P)+ + H2O2 (#4# model of electron transport  from NADPH to the terminal electron acceptor O2 <4>; #3# in stable  conformation, the active site adopts a closed conformation not allowing  the substrate to bind. In presence of urea, an open conformation of the  active site with 0.9 nm distance between the indole ring of W47 and the  isoalloxazine ring of FMN412 is favored <45>; #4# a cytosolic  C-terminal dehydrogenase domain includes an FAD cofactor and an NADPH  substrate binding site. On activation, electrons are transferred from  NADPH to FAD and across the membrane, via heme irons, to molecular  oxygen, thus producing superoxide anion, which can be dismutated into  hydrogen peroxide <219>)  "
1.6.3.2, 2 NAD(P)H + 2 H+ + O2 = 2 NAD(P)+ + 2 H2O  
1.6.3.3, NADH + H+ + O2 = NAD+ + H2O2  
1.6.3.4, 2 NADH + 2 H+ + O2 = 2 NAD+ + 2 H2O  
1.6.3.5," 1,2-dihydro-beta-NAD(P) + H+ + O2 = beta-NAD(P)+ + H2O2 "
1.6.3.5," 1,6-dihydro-beta-NAD(P) + H+ + O2 = beta-NAD(P)+ + H2O2  "
1.6.5.10, NADPH + H+ + a quinone = NADP+ + a quinol (#14# ping pong reaction  mechanism <21>)  
1.6.5.12, demethylphylloquinone + NADPH + H+ = demethylphylloquinol + NADP+  
1.6.5.2, NAD(P)H + H+ + a quinone = NAD(P)+ + a hydroquinone (#28# ping-pong  mechanism <8>; #16# reaction mechanism <69>; #29# ordered bi-bi  mechanism <13>; #8# ping-pong reaction mechanism <117>; #32# specific  conformations of Y128 and F232 on the surface of the catalytic pocket  are important for interaction of enzyme with p53 and other client  proteins <51>; #43# ping-pong mechanism with substrate inhibition  <119>; #46# the activity obeys the standard bi-bi ping-pong reaction  mechanism <132>)  
1.6.5.4," NADH + H+ + 2 monodehydroascorbate = NAD+ + 2 ascorbate (#21# mechanism  <23>; #21# ping-pong mechanism <30>; #21,27# ping pong mechanism  <8,26>; #39,40,41# PpMDHARs follow a ping-pong kinetic mechanism <44>)  "
1.6.5.5," NADPH + H+ + 2 quinone = NADP+ + 2 semiquinone (#11# reaction with  9,10-phenanthrenequinone and NADPH proceeds through a ping-pong  mechanism <10>; #11# reaction with 2,6-dichlorophenolindophenol and  NADPH proceeds through a ping-pong mechanism <5>; #1# enzyme acts  through a one-electron transfer process <1>; #10# ping pong reaction  mechanism <23>; #3# catalytic mechanism analysis, two (four)-electron  reduction of nitrobenzenes and single-step (H-) hydride transfer  mechanism. NfsA follows a ping-pong mechanism, overview <25>)  "
1.6.5.6, NADPH + H+ + p-benzoquinone = NADP+ + hydroquinone  
1.6.5.7," 2-hydroxy-1,4-benzoquinone + NADH + H+ = hydroxyquinol + NAD+  "
1.6.5.9, NADH + H+ + a quinone = NAD+ + a quinol  
1.6.99.1," NADPH + H+ + acceptor = NADP+ + reduced acceptor (#3# mechanism <4>;  #13# reaction mechanism involving a conserved triad of  Glu193-His284-Arg249, overview <38>)  "
1.7.1.1, nitrite + NAD+ + H2O = nitrate + NADH + H+ (#31# random bi bi mechanism  <5>; #29# two-site ping-pong mechanism <14>; #11# catalytic rate is  determined by a combination of rates with no overall rate limiting  individual process <79>; #7# hexa uni ping pong mechanism <6>)  
1.7.1.10," NH3 + NAD+ + H2O = hydroxylamine + NADH + H+  (#1,2,3,6,8,9,11,13,14,17,18# also acts on hydroxamates <5>)  "
1.7.1.11, 4-(dimethylamino)phenylazobenzene + NADP+ + H2O =  4-(dimethylamino)phenylazoxybenzene + NADPH + H+  
1.7.1.12, 2-acetamidofluorene + NAD(P)+ + H2O = N-hydroxy-2-acetamidofluorene +  NAD(P)H + H+  
1.7.1.13, 7-aminomethyl-7-carbaguanine + 2 NADP+ = 7-cyano-7-carbaguanine + 2  NADPH + 2 H+  
1.7.1.14, N2O + NAD(P)+ + H2O = 2 NO + NAD(P)H + H+  
1.7.1.15, NH3 + 3 NAD+ + 2 H2O = nitrite + 3 NADH + 5 H+  
1.7.1.16, N-phenylhydroxylamine + 2 NADP+ + H2O = nitrobenzene + 2 NADPH + 2 H+ 
1.7.1.16, N-phenylhydroxylamine + NADP+ = nitrosobenzene + NADPH + H+ 
1.7.1.16, nitrosobenzene + NADP+ + H2O = nitrobenzene + NADPH + H+  
1.7.1.17," anthranilate + N,N-dimethyl-1,4-phenylenediamine + 2 NAD+ =  2-(4-dimethylaminophenyl)diazenylbenzoate + 2 NADH + 2 H+ (#5#  ping-pong reaction mechanism <1,2>; #5# ping-pong reaction mechanism,  overview <3>; #5# ping-pong reaction mechanism. Enzymatic reaction  involves an electron transfer from nicotinamide dinucleotide (NADH) to  flavin mononucleotide (FMN) (ping) followed by a transfer from FMNH2 to  the substrate (pong), key role of flavin <5>)  "
1.7.1.2, nitrite + NAD(P)+ + H2O = nitrate + NAD(P)H + H+  
1.7.1.3," nitrite + NADP+ + H2O = nitrate + NADPH + H+ (#2# multicenter redox  enzyme. Ser920, Arg921 and Arg932 are suggested to be the key enzymes  to investigate for a role in determining pyridine nucleotide  specificity. Arg932 may be playing a role in binding the adenine ring  of NADPH <10>; #1# random order rapid-equilibrium mechanism, two  functional parts: 1. heat labile, FAD and haemoprotein containing,  binds NADPH and transfers electrons from NADPH via FAD and perhaps  cytochrome b to acceptors such as cytochrome c, 2. heat stable,  molybdenum containing, accepts electrons from reduced viologen dyes and  transfers them to nitrate <2>; #2# sulfhydryl groups may participate in  the binding of the protein subunits <15>)  "
1.7.1.4, NH3 + 3 NAD(P)+ + 2 H2O = nitrite + 3 NAD(P)H + 5 H+  
1.7.1.5, 2 hydroxylamine + 2 NAD+ = hyponitrous acid + 2 NADH + 2 H+  
1.7.1.6," N,N-dimethyl-1,4-phenylenediamine + aniline + 2 NADP+ =  4-(dimethylamino)azobenzene + 2 NADPH + 2 H+ (#13# ping-pong mechanism  <59>; #4,10,15,19,62,73# the catalytic reaction requires  tautomerisation of the azo compound to a quinoneimine and provides a  unifying mechanism for the reduction of azo substrates by azoreductases  <64>; #6# the catalytic reaction requires tautomerisation of the azo  compound to a quinoneimine and provides a unifying mechanism for the  reduction of azo substrates by azoreductases, mechanism for  azoreduction by FMN-dependent azoreductases, overview. N5 of FMN  accepts a hydride during oxidation of NAD(P)H and donates it upon  reduction of the substrate <64>)  "
1.7.1.7," IMP + NH3 + NADP+ = GMP + NADPH + H+ (#4# first order reaction <12>;  #4# mechanism: ordered sequential with GMP binding first <9>; #3#  ordered bi-bi kinetic mechanism, in which GMP binds first to the enzyme  followed by NADPH binding, and NADP+ dissociates first followed by IMP  release. GMP and IMP binding are thermodynamically favorable processes.  Hydride transfer contributes to the rate-limiting step, and protonation  and hydride transfer steps take place in the same transition state,  lending support to a concerted mechanism. Product release does not  contribute to the rate-limiting step of the reaction <21>; #3# ordered  biÂ–bi kinetic mechanism, in which GMP binds first to the enzyme  followed by NADPH binding, and NADP+ dissociates first followed by IMP  release <21>; #12# catalytic reaction mechanism, overview. GMPR  catalyzes two different chemical transformations at the same active  site via two different cofactor conformations, analysis by subtesla  high resolution field cycling NMR relaxometry <23>)  "
1.7.1.9, 4-(hydroxyamino)quinoline N-oxide + 2 NAD(P)+ + H2O = 4-nitroquinoline  N-oxide + 2 NAD(P)H + 2 H+ (#5# 4-(hydroxyamino)quinoline N-oxide may  be the active intermediate essential in the carcinogenic process of  4-nitroquinoline N-oxide <1>)  
1.7.2.1," nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c +  2 H+ (#16# mechanism <25>; #9# electron transfer from c heme to d1 heme  is very slow, order of seconds <11>; #9# electron-transfer mechanism  <7>; #24# rate constants of intermolecular electron transfer <13>; #9#  proposed reaction mechanism <3>; #13# a copper protein, cytochrome  c-552 or cytochrome c-553 from Pseudomonas denitrificans acts as  acceptor <21>; #36# ordered mechanism in which electron transfer is  gated by binding of nitrite to the type 2 Cu centre <84>;  #42,43,44,46,47,49,51,53,54,55# catalytic mechansim, overview <96>;  #45# reaction mechanism, overview. Mobility of two residues essential  to catalytic activity, Asp98 and His244, are sterically restricted in  GtNIR by Phe109 on a characteristic loop structure that is found above  Asp98 and by an unusually short CH-O hydrogen bond observed between  His244 and water, respectively. Analysis of the hydrogen-bond networks  around His244 and the flow path of protons consumed by nitrite  reduction. The electron transfer reaction is coupled with the proton  transfer reaction <98>; #38# reaction mechanism, overview. The  transformation from the initial O-coordination of substrate to the  final N-coordination of product is achieved by electron transfer from  T1 copper to T2 copper, rather than by the previously reported side-on  coordination of a NO intermediate, which only takes place in the  reduced enzyme. Role of structural change in the critical residue  Asp98, which affects the energetics of substrate attachment and product  release at the T2 copper reaction center, while it does not  significantly affect the activation energy and reaction pathways of the  nitrite reduction process <92>; #45# the proposed mechanisms for the  reduction of nitrite by CuNiRs include intramolecular electron and  proton transfers, proton-coupled electron transfer is one of the key  processes in enzyme reactions, density functional theory calculations  analysis. The reduction of T2 Cu site promotes the proton transfer, and  the hydrogen bond network around the binding site has an important role  not only to stabilize the nitrite binding but also to promote the  proton transfer to nitrite. Reaction mechanism, overview <93>)  "
1.7.2.2," NH3 + 2 H2O + 6 ferricytochrome c = nitrite + 6 ferrocytochrome c + 7  H+ (#3# reaction mechanism, overview. NO2- binds to the enzyme ccNIR  catalytic heme in the Fe2+ state, accepts two protons, and releases H2O  to form a moiety formally written as Fe(II)-[NO+]. The key mechanistic  challenge in reducing NO2- is to avoid or overcome formation of the  terminal Fe(II)-NO thermodynamic sink through one-electron reduction of  Fe(II)-[NO+]. Enzyme ccNIR achieves this by two proton-coupled electron  transfer reductions that promptly reduce Fe(II)-[NO+] to Fe(II)-[HNO].  The process involves recharging of the catalytic heme with electrons  obtained through transfer from the other hemes of the enzyme and of the  heme environment with protons <43>)  "
1.7.2.3," trimethylamine + 2 (ferricytochrome c)-subunit + H2O = trimethylamine  N-oxide + 2 (ferrocytochrome c)-subunit + 2 H+ (#3# molybdenum serves  as electron donor within the enzyme, enzyme-MoIV + (CH3)3NdO + 2H+ =  enzyme-MoVI + (CH3)3N + H2O <38>)  "
1.7.2.4," nitrogen + H2O + 2 ferricytochrome c = nitrous oxide + 2  ferrocytochrome c + 2 H+ (#33# spectroscopic definition of the CuZ*  intermediate in turnover of nitrous oxide reductase and molecular  insight into the catalytic mechanism. The nature of N2O binding and  reduction, specifies a molecular mechanism in which N2O coordinates in  a mu-1,3 fashion to the fully reduced state, with hydrogen bonding from  Lys397, and two electrons are transferred from the fully reduced  mu4S2-bridged tetranuclear copper cluster to N2O via a single Cu atom  to accomplish N-O bond cleavage <62>)  "
1.7.2.5," nitrous oxide + 2 ferricytochrome c + H2O = 2 nitric oxide + 2  ferrocytochrome c + 2 H+ (#58# proton transfer by a trans-mechanism,  not by cis-heme b3 mechanism,analysis, overview <72>; #11# the reaction  is nonelectrogenic, generation of a free energy profile for the entire  catalytic cycle by hybrid density functional calculations. The energy  profile shows that the reduction steps are endergonic and that the  entire process is rate-limited by high proton uptake barriers during  the reduction steps. Catalytic cycle and mechanism involving 2  different Fe atoms, modelling, detailed overview. Electrons and protons  are taken from the same side of the membrane. The catalytic cycle can  be divided into two parts. One part starts from the oxidized resting  state with an oxo-bridge state 1, includes the two proton coupled  reduction steps and results in the formation of a water molecule and  the two-electron-reduced binuclear active site, states 3 and 4. The  second part starts from the reduced state 4 and includes the main  chemistry, that is, the reaction of two NO molecules with the reduced  binuclear active site, formation and release of the nitrous oxide (N2O)  molecule and ending up with the reformation of the oxidized state 1  <74>)  "
1.7.2.6, hydroxylamine + H2O + 4 ferricytochrome c = nitrite + 4 ferrocytochrome  c + 5 H+  
1.7.2.7, hydrazine + H2O + 3 ferricytochrome c = nitric oxide + ammonium + 3  ferrocytochrome c  
1.7.2.8, hydrazine + 4 ferricytochrome c = N2 + 4 ferrocytochrome c 
1.7.2.8," hydroxylamine + NH3 + acceptor = N2 + H2O + reduced acceptor (#1#  catalytic mechanism, overview <5>; #1# the meso tyrosyl residue  enhances the binding of hydroxylamine, and increases the stability of a  FeIIINO intermediate, while behaving indifferently in the FeIINO form,  catalytic mechanism, modelling, overview <7>)  "
1.7.2.9, hydroxylamine + 3 ferricytochrome c = nitric oxide + 3 ferrocytochrome  c + 3 H+  
1.7.3.1," a nitroalkane + H2O + O2 = an aldehyde or ketone + nitrite + H2O2 (#3#  mechanism <3>; #3# ping pong kinetic mechanism <2>; #3# Asp402 acts as  the active site base of the enzyme, mechanism, substrate CH-bond  cleavage is rate limiting for the reduction of the enzyme by  nitroethane <9>; #3# Asp402 acts as the active site base of the enzyme,  mechanism: catalysis is initiated by the active site base Asp402 that  deprotonates the neutral substrate to yield a carbanion that can attack  the N-5 position of the oxidized flavin, CH-bond cleavage is rate  limiting for the reduction of the enzyme by nitroethane <10>; #3#  detailed mechanism, with carbanion reaction intermediate formation, an  aspartate residue is the active site base, substrate CH-bond cleavage  is rate limiting for the reduction of the enzyme by nitroethane, the  active site of the enzyme is a hydrophobic channel, tunneling, overview  <8>; #3# mechanism, involves removal of a proton from the nitroalkane,  forming a carbanion which adds to the N5 of the flavin, elimination of  nitrite from the resulting adduct forms an electrophilic imine  intermediate which can be attacked by hydroxide <12>; #3# mechanism,  transition-state stabilization is essential, protein-substrate  interactions in the transition state, reaction involves quantum  mechaniscal tunneling, Asp402 is involved in initial abstraction of a  proton from the neutral substrate, overview <11>; #3# critical  importance of the interaction between Asp402 and Arg409 for proton  abstraction by nitroalkane oxidase <14>)  "
1.7.3.2, N-acetylindoxyl + O2 = N-acetylisatin + ?  
1.7.3.3," urate + O2 + H2O = 5-hydroxyisourate + H2O2 (#54# catalytic mechanism,  overview <92,94>)  "
1.7.3.5, 3-aci-nitropropanoate + O2 + H2O = 3-oxopropanoate + nitrite + H2O2  (#1# primary products of the enzymatic reaction probably is the  nitropropanoate free radical and superoxide <1>)  
1.7.3.6, hydroxylamine + O2 = nitrite + H2O + H+ 
1.7.3.6, hydroxylamine + 2 ferricytochrome c = nitroxyl + 2 ferrocytochrome c +  2 H+ 
1.7.3.6, nitroxyl + 2 ferrocytochrome c + O2 + H+ = nitrite + 2 ferricytochrome  c + H2O  
1.7.5.1," nitrate + a quinol = nitrite + a quinone + H2O (#11,15,16# electrons  flow in the overall thermodynamically downhill direction from  menaquinol (MQ) or ubiquinol (UQ) through the two hemes of NarI, the  four [Fe-S] clusters of NarH, and then through the single [4Fe-4S]  cluster of NarG to the Mo-bisPGD cofactor, where nitrate is reduced to  nitrite <31>)  "
1.7.5.2, 2 nitric oxide + menaquinol = nitrous oxide + menaquinone + H2O  
1.7.6.1, 3 nitrite + 2 H+ = 2 nitric oxide + nitrate + H2O  
1.7.7.1," NH3 + 2 H2O + 6 oxidized ferredoxin = nitrite + 6 reduced ferredoxin +  7 H+ (#2,6,9,13,21,25,27# mechanism <1,11>; #6# sequential reaction  scheme <5>)  "
1.7.7.2, nitrite + H2O + 2 oxidized ferredoxin = nitrate + 2 reduced ferredoxin  + 2 H+  
1.7.99.1, NH3 + H2O + acceptor = hydroxylamine + reduced acceptor  
1.8.1.10, CoA + glutathione + NADP+ = CoA-glutathione + NADPH + H+  
1.8.1.11," 3-mercapto-2-mercaptomethylpropanoate + NAD+ = asparagusate + NADH + H+  (#1# exhibits lipoyl dehydrogenase activity <1,2,3>; #1# exhibits  diaphorase activity <2,3>)  "
1.8.1.12," trypanothione + NADP+ = trypanothione disulfide + NADPH + H+ (#22#  molecular modeling of inhibitor binding using X-ray data <25>; #12#  hydride ion transfer reaction of the pro-S-hydrogen of NADPH to N5 of  FAD, redox potentials <17>; #4# neither the alpha-carboxy nor the  alpha-amino function of the L-gamma-glutamyl group is essential for  activity, can be replaced by uncharged benzyloxycarbonyl or  tert-butyloxycarbonyl groups <24>; #6# substrate binding mechanism,  complex structure analysis, protease-like catalytic triade and  electronic induced fit <18>; #12# substrate binding structure,  structural model <24>; #6# mechanistic reaction scheme,  structure-function relation <5,27>; #4,6,12# mechanistic scheme for  NAD(P)H:disulfide oxidoreductases <2>; #19# reducing catalytic site  CVNVGC <32>)  "
1.8.1.13, 2 gamma-glutamylcysteine + NADP+ = bis-gamma-glutamylcystine + NADPH +  H+  
1.8.1.14, 2 CoA + NADP+ = CoA-disulfide + NADPH + H+ (#5# mechanism <2>)  
1.8.1.15, 2 mycothiol + NAD(P)+ = mycothione + NAD(P)H + H+  
1.8.1.16, 2 glutathione amide + NAD+ = glutathione amide disulfide + NADH + H+  
1.8.1.17, dimethyl sulfoxide + H2O + NAD+ = dimethyl sulfone + NADH + H+  
1.8.1.18, hydrogen sulfide + NAD(P)+ = sulfur + NAD(P)H + H+  
1.8.1.19, hydrogen sulfide + (sulfide)n + NADP+ = (sulfide)n+1 + NADPH + H+  
1.8.1.2," hydrogen sulfide + 3 NADP+ + 3 H2O = sulfite + 3 NADPH + 3 H+ (#4#  ping-pong mechanism <8>; #3# mechanism of electron transfer <13,14>;  #1,3# electron flow sequence: NADPH-FAD-FMN <3>)  "
1.8.1.20," 2 4-sulfanylbutanoate + NAD+ = 4,4'-disulfanediyldibutanoate + NADH + H+  "
1.8.1.21, 2 methanethiol + NAD+ = dimethyl disulfide + NADH + H+  
1.8.1.3, hypotaurine + H2O + NAD+ = taurine + NADH + H+  
1.8.1.4," protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine +  NADH + H+ (#6,12,36,64# ping-pong mechanism <28,45,46,48>; #9# ping  pong mechanism <65>; #23# involvement of a reversibly reducible  disulfide bond in catalytic mechanism <21>; #7# Asp473 is important for  efficient catalytic function of the enzyme <64>; #36# formation of a  FADH2-NAD+ intermediate in catalysis, reaction mechanism of reductive  and oxidative half-reactions involving enzyme, FAD/FADH2, and NAD+/NADH  <54>; #36# in the two-electron-reduced enzyme, the disulfide is reduced  while the FAD cofactor is oxidized, in the four-electron-reduced  enzyme, both redox centers are reduced, mechanism of the diaphorase  reaction which occurs when the enzyme is in the four-electron-reduced  state <55>; #45# the mitochondrial isozyme shows ping pong kinetic  mechanism <53>; #86# in the physiological direction, dihydrolipoamide,  which is covalently tethered to another enzymatic subunit in the  multienzyme complex, binds to the disulfide-exchange site near the si  face of the FAD cofactor. Ddihydrolipoamide is thought to donate a  hydride to the disulfide and a proton to an active-site base forming a  stable charge-transfer complex between the thiolate of the mixed  disulfide and the oxidized FAD cofactor. In the presence of NAD+,  electrons are passed to FAD and then to NAD+ on the re face of the  flavin, forming NADH with the release of a proton, mechanism modelling,  detailed overview <129>; #80,91# in the physiological direction,  dihydrolipoamide, which is covalently tethered to another enzymatic  subunit in the multienzyme complex, binds to the disulfide-exchange  site near the si face of the FAD cofactor. Dihydrolipoamide is thought  to donate a hydride to the disulfide and a proton to an active-site  base forming a stable charge-transfer complex between the thiolate of  the mixed disulfide and the oxidized FAD cofactor. In the presence of  NAD+, electrons are passed to FAD and then to NAD+ on the re face of  the flavin, forming NADH with the release of a proton, mechanism  modelling, detailed overview <129>; #80# kinetic mechanism of human E3  enzyme is a ping-pong mechanism. In human E3, dihydrolipoamide binds to  the si-face of FAD, whereas NAD+ binds to the re-face. These two  spatially separate substrate binding sites can allow the enzyme to form  a ternary complex with two substrates, which is an essential feature of  the sequential mechanism <131>)  "
1.8.1.5," 2-mercaptoethanesulfonate + acetoacetate + NADP+ =  2-(2-oxopropylthio)ethanesulfonate + CO2 + NADPH (#3# detailed reaction  mechanism in a catalytic cycle, active site structure <4>; #3# reaction  mechanism for 2-KPCC begins with formation of enzyme-substrate  disulfide adduct by the reduced form of the redox active disulfide.  This step is followed by release of enolacetone anion intermediates for  2-KPCC. The primary catalytic fate of the enolacetone intermediate for  the wild-type (Phe501) or variant (His501) 2-KPCC is acetoacetate or  acetone, respectively <9>)  "
1.8.1.6, 2 L-cysteine + NAD+ = L-cystine + NADH + H+  
1.8.1.7," 2 glutathione + NADP+ = glutathione disulfide + NADPH + H+  (#7,8,9,11,18,28,31# mechanism <3,9,25,47,55,69,72>; #8,11,19#  ping-pong mechanism <13>; #8,42,85# member of pyridine-nucleotide  disulfide oxidoreductase family of flavoenzymes <66,69,70>; #13#  sulfhydryl groups and histidine residues are essential for the  catalytic properties of the enzyme <68>; #85# recombinant  glutathione-trypanothione reductase-like enzyme, substrate binding,  three dimensional structure, complex formation <70>; #8# inhibition  mechanism <56>; #63,64# analogous to trypanothione reductase <56>; #8#  catalytic cycle <69>; #5# branching mechanism <59>; #8# GSSG-binding  site <3>; #8,42# substrate and cofactor binding site, three-dimensional  structure <24,66,69>; #8,14# cofactor binding of glutathione reductase  with FAD analogues, reconstitution <25,30>; #12# molecular modeling of  enzyme inactivation by peroxynitrite, structure analysis <62>; #85#  active site structure <85>; #31# active site structure, Cys39/Cys44 are  involved <85>; #9# enzyme contains a catalytic selenocysteine <82>;  #68# the multifunctional enzyme possesses both thioredoxin reductase  activity, EC 1.8.1.9, glutathione reductase activity, EC 1.8.1.7, and  glutaredoxin activity <87>; #12# the enzyme follows the Ping Pong  mechanism <118>)  "
1.8.1.8, protein-dithiol + NAD(P)+ = protein-disulfide + NAD(P)H + H+ (#11#  detailed reaction mechanism <3>)  
1.8.1.9," thioredoxin + NADP+ = thioredoxin disulfide + NADPH + H+ (#9,35#  catalytic mechanism <1,9,30,35,43>; #9,10# inhibition mechanism  <8,16,38>; #9,29,35# oxidation-reduction cycle of thioredoxin  <2,4,25,30,35,50>; #9# 2 conformations possible, termed FR and FO  conformation, which differ in their fluorescence spectroscopic  behaviour, their accessibility for inhibitors and in the efficiency of  electron transfer to FAD, involving position 138 in the wild-type and  the mutant C138S <45>; #10# conformational change upon reduction wth  NADPH or tris-(2-carboxyethyl)phosphine <51>; #2,10# UV-light radical  reduction mechanism <15>; #10# three-dimensional structure <31>;  #9,10,35# electron transfer in the enzyme complex of apoenzyme, FAD and  thioredoxin with NADPH <32,38,40,43,45>)  "
1.8.2.1," sulfite + 2 ferricytochrome c + H2O = sulfate + 2 ferrocytochrome c + 2  H+ (#6# ping-pong mechanism <14>; #3# mechanism of electrochemically  mediated, enzyme SorT-catalyzed sulfite oxidation <41>)  "
1.8.2.2," 2 thiosulfate + 2 ferricytochrome c = tetrathionate + 2 ferrocytochrome  c (#19# Cys96 is an essential residue for catalysis, the TsdA reaction  cycle involves the transient presence of heme 1 in the high-spin state  caused by movement of the S atom of Cys96 out of the iron coordination  sphere <28>)  "
1.8.2.3, hydrogen sulfide + 2 ferricytochrome c = sulfur + 2 ferrocytochrome c +  2 H+  
1.8.2.4, dimethyl sulfide + 2 ferricytochrome c2 + H2O = dimethyl sulfoxide + 2  ferrocytochrome c2 + 2 H+  
1.8.2.5, sulfite + hydrogen sulfide + 2 ferricytochrome c3 = thiosulfate + 2  ferrocytochrome c3  
1.8.2.6, [SoxY protein]-S-disulfanyl-L-cysteine + 6 ferricytochrome c + 3 H2O =  [SoxY protein]-S-sulfosulfanyl-L-cysteine + 6 ferrocytochrome c + 6 H+  
1.8.2.7, thiocyanate + 2 ferricytochrome c + H2O = cyanate + sulfur + 2  ferrocytochrome c + 2 H+  
1.8.3.1," sulfite + O2 + H2O = sulfate + H2O2 (#1,8# ping-pong mechanism <25,26>;  #6# this direct reduction of O2 is prevented completely in presence of  cytochrome c <19>; #1# x-ray absorption spectroscopy of oxidation  states <29>; #1# intramolecular electron transfer and effect of  solution viscosity <45>; #1# kinetics and proposed mechanism <30,46>;  #1,6# mechanism and kinetics of electron transfer <35,39,48>; #47#  catalytic cycle and electron transfer steps, and proposed oxidation  state changes occurring at the Mo and Fe centers of one subunit of  human sulfite oxidase during the catalytic oxidation of sulfite and the  concomitant reduction of (cyt c)ox, overview <115>; #47#  electrocatalytic mechanism of HSO, overview <112>; #47#  quantum-mechanical study/quantum-mechanical cluster calculations of the  reaction mechanism of sulfite oxidase using protonated and deprotonated  substrates. The lowest barriers are obtained for a mechanism where the  substrate attacks a Mo-bound oxo ligand, directly forming a Mo-bound  sulfate complex, which then dissociates into the products. The  activation energy is dominated by the Coulomb repulsion between the Mo  complex and the substrate. The general catalytic cycle for sulfite  oxidase includes the molybdenum ion refering to the molybdenum  cofactor, and the iron ion refering to the heme, at the start of the  catalytic cycle, Mo is in the oxidized +VI state and the heme group is  in the Fe(III) state. Then SO3- binds and is oxidized to SO42-, while  the Mo ion is reduced to the +IV state. To complete the catalytic  cycle, the reduced Mo ion binds water and is reoxidized to the +VI  state in two coupled one-electron/proton-transfer steps, proceeding via  a transient Mo(V)-OH-state to form the active Mo(VI)=O form of the  cofactor. The electrons are transferred via reduction of the heme,  which subsequently is reoxidized by cytochrome c. Molecular mechanism  of the oxo-atom transfer, modeling, detailed overview <114>)  "
1.8.3.2," 2 R'C(R)SH + O2 = R'C(R)S-S(R)CR' + H2O2 (#22# reaction mechanism <40>;  #8# ter bi substituted mechanism, O2 binds first <6>; #1,4,7# enzyme  contains a functionally involved redox-active motif CXXC <37,38>; #28#  enzyme contains a functionally involved redox-active motif YPCCXXC  <33>; #1# mechanistic scheme <27>; #7# the CXXC motif in the active  site sequence of Erv2p is catalytically essential, reaction mechanism  involving reactive cysteine residues C121 and C124 of the A subunit,  and C176 and C178 of the B subunit <27>; #29# the N-terminal cysteine  pair of the enzyme is essential for in vivo activity and interacts with  the primary redox centre <32>; #4# catalytic mechanism model using DTT  and O2, overview. Stabilization of mixed disulfide intermediates in  enzyme sfALR <73>;  #21,24,25,30,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55  56,57# electron transfer pathway through QSOX domains, overview. Two  electrons are accepted from the substrate by the CXXC motif of the QSOX  Trx1 domain, within the oxidoreductase module of QSOX. From the Trx1  domain, the electrons are transferred to the sulfhydryl oxidase module  of the QSOX enzyme, first to the CXXC motif of the Erv domain, then to  the FAD cofactor. Ultimately, the two electrons are transferred to  molecular oxygen, the terminal electron acceptor <74>)  "
1.8.3.3, 2 glutathione + O2 = glutathione disulfide + H2O2  
1.8.3.4, methanethiol + O2 + H2O = formaldehyde + hydrogen sulfide + H2O2  
1.8.3.5," an S-prenyl-L-cysteine + O2 + H2O = a prenal + L-cysteine + H2O2 (#5#  kinetics and catalytic mechanism, overview <6>)  "
1.8.3.6," S-(2E,6E)-farnesyl-L-cysteine + O2 + H2O = (2E,6E)-farnesal +  L-cysteine + H2O2 (#1# kinetics and catalytic mechanism, overview <1>)  "
1.8.3.7, a [sulfatase]-L-cysteine + O2 + 2 a thiol = a  [sulfatase]-3-oxo-L-alanine + hydrogen sulfide + a disulfide + H2O  
1.8.4.1, 2 glutathione + homocystine = glutathione disulfide + 2 homocysteine  
1.8.4.10," AMP + sulfite + thioredoxin disulfide = 5'-adenylyl sulfate +  thioredoxin (#13# the reaction catalyzed by APR can be divided into  three steps. In the first step, APS binds to the protein, and a  reductive transfer results in sulfite bound to the active-site cysteine  in a stable reaction intermediate. In the second step, free sulfite is  released by the action of free thioredoxin. In the third step, the  thioredoxin is regenerated by reduction with thioredoxin reductase <11>)  "
1.8.4.11," L-methionine (S)-sulfoxide + thioredoxin = L-methionine + thioredoxin  disulfide + H2O (#11,26# reaction mechanism <10,12>; #11,26# 3-step  ping pong reaction mechanism involving catalytic and recycling cysteine  residues, formation of a sulfenic acid reaction intermediate, overview  <21>; #9,36# 3-step reaction mechanism involving catalytic and  recycling cysteine residues, formation of a sulfenic acid reaction  intermediate, overview <21>; #9,26,31,44,51,75,83,85# catalytic  mechanism and structural features, roles of cysteine residues, active  site structure <22>; #5,7,8,9,11,17,25,26,29,32,33,41,47# catalytic  mechanism involves the formation of a sulfenic acid intermediate <20>;  #11# catalytic mechanism involving the formation of a sulfenic acid  intermediate, Cys52 is involved <18>; #16# catalytic mechanism  involving the formation of a sulfenic acid intermediate, Cys72, Cys218  and Cys228 are involved <18>; #29# catalytic mechanism of MsrA, active  site structure, modeling of protein-bound methionine sulfoxide  recognition and repair from the crystal structure <26>; #26# catalytic  mechanism of MsrA, the rate limiting step occurs after formation of the  sulfenic acid intermediate and is associated with either the  Cys51/Cys198 disulfide bond formation or the thioredoxin reduction  process <27>; #51# reaction mechanism, modeling of substrate binding at  the active site, Cys72 is involved <32>) "
1.8.4.11, L-methionine + thioredoxin disulfide + H2O = L-methionine (S)-S-oxide +  thioredoxin (#82# proposed catalytic mechanism of the reductase step of  MsrA <56>) 
1.8.4.11," peptide-L-methionine + thioredoxin disulfide + H2O =  peptide-L-methionine (S)-S-oxide + thioredoxin (#16# catalytic  mechanism, Cys72 is essential for activity forming disulfide bonds with  either Cys218 or Cys227 <6>; #26# catalytic mechanism, rate-limiting  reduction of the Cys51-Cys198 disulfide bond by thioredoxin and  formation of the thiosulfenic acid intermediate on Cys51 <27>; #26#  presence of at least two binding subsites. The first one, whose  contribution is major in the efficiency of the reductase step and in  which the epsilon-methyl group of MetSO binds, is the hydrophobic  pocket formed by Phe52 and Trp53, the position of the indole ring being  stabilized by interactions with His186 and Tyr189. The second subsite  composed of Asp129 and Tyr197 contributes to the binding of the main  chain of the substrate but to a lesser extent <74>)  "
1.8.4.12," L-methionine (R)-sulfoxide + thioredoxin = L-methionine + thioredoxin  disulfide + H2O (#9,25# 3-step ping pong reaction mechanism involving  catalytic and recycling cysteine residues, formation of a sulfenic acid  reaction intermediate, overview <16>; #7,33# 3-step reaction mechanism  involving catalytic and recycling cysteine residues, formation of a  sulfenic acid reaction intermediate, overview <16>;  #4,6,7,9,15,24,25,28,30,31,37,41# catalytic mechanism involves the  formation of a sulfenic acid intermediate <15>; #9,14# catalytic  mechanism involving the formation of a sulfenic acid intermediate <13>;  #3,9,25,45# mechanism, active site structure, conserved catalytic Cys  residues are essential for activity, Cys residue recycling, overview  <17>; #20,36,54# mechanism, active site structure, conserved catalytic  Cys residues, situated in the C-terminal end, are essential for  activity, Cys residue recycling, overview <17>; #25# reaction  mechanism, Cys494 and Cys439 are involved <4>; #45# reaction mechanism,  modeling of substrate binding at the active site, Cys444 and Cys495 are  involved <25>; #8# selenomethionine is essential for MsrB activity <9>;  #10# the active site selenocysteine SeC169 is essential for enzyme  activity <19>; #25# three-step catalytic mechanism, influence of pH on  reaction mechanism, overview <12>) "
1.8.4.12, L-methionine + thioredoxin disulfide + H2O = L-methionine (S)-S-oxide +  thioredoxin (#83# proposed catalytic mechanism of the reductase step of  MsrB <40>) 
1.8.4.12," peptide-L-methionine + thioredoxin disulfide + H2O =  peptide-L-methionine (S)-S-oxide + thioredoxin (#25# formation of the  MsrB substrate complex leads to an activation of the catalytic Cys-117  characterized by a decreased pKapp of about 2.7 pH units. The catalytic  active MsrB form is the Cys117-/His103+ species with a pKapp of 6.6 and  8.3, respectively. His103 and to a lesser extent His100, Asn119, and  Thr26 (via a water molecule) participate in the stabilization of the  polarized form of the sulfoxide function and of the transition state.  Trp65 is essential for the catalytic efficiency of the reductase step  by optimizing the position of the substrate in the active site <55>) "
1.8.4.12," peptide-L-methionine + thioredoxin disulfide + H2O =  peptide-L-methionine (R)-S-oxide + thioredoxin (#9,10# catalytic  mechanism and the role of cofactor recycling in vivo <36>; #8,10#  catalytic mechanism involving residues at positions 95, 41, 97, 77, and  80, molecular modeling, role of selenocysteine- and cysteine residues  in catalysis, overview <35>; #9,25# catalytic mechanism, overview <38>)  "
1.8.4.13, L-methionine + thioredoxin disulfide + H2O = L-methionine (S)-S-oxide +  thioredoxin  
1.8.4.14, L-methionine + thioredoxin disulfide + H2O = L-methionine (R)-S-oxide +  thioredoxin  
1.8.4.15, a [DsbA protein] carrying a disulfide bond + a [protein] with reduced  L-cysteine residues = a [DsbA protein] with reduced L-cysteine residues  + a [protein] carrying a disulfide bond  
1.8.4.16, a [protein] with reduced L-cysteine residues + thioredoxin disulfide =  a [protein] carrying a disulfide bond + thioredoxin 
1.8.4.16, a [DsbD protein] with reduced L-cysteine residues + thioredoxin  disulfide = a [DsbD protein] carrying a disulfide bond + thioredoxin 
1.8.4.16, a [DsbD protein] carrying a disulfide bond + a [protein] with reduced  L-cysteine residues = a [DsbD protein] with reduced L-cysteine residues  + a [protein] carrying a disulfide bond  
1.8.4.2," 2 glutathione + protein-disulfide = glutathione-disulfide +  protein-dithiol (#13# mechanism <47>; #10# random mechanism <43>;  #3,7,8# C-X-X-C motif in active site for disulfide bonding, either  oxidizing, reducing and isomerising activity <44,46,48,49,50,54>; #7#  zinc finger protein with several CXXC motifs <49>; #9# high similarity  between enzymes of different species and sources, respectively <10>;  #8,9,10# random and allosteric mechanism via multiple distinct reaction  sites <5>; #8# insulin inducible <34>)  "
1.8.4.3, CoA + glutathione disulfide = CoA-glutathione + glutathione  
1.8.4.4, 2 glutathione + cystine = glutathione disulfide + 2 cysteine  
1.8.4.5, L-methionine + thioredoxin disulfide + H2O = L-methionine S-oxide +  thioredoxin  
1.8.4.7," [xanthine dehydrogenase] + glutathione disulfide = [xanthine oxidase] +  2 glutathione (#3# thioltransferase, GSH:insulin transhydrogenase and  ricin-disulphide-bond reductase activity <1>; #3# thioltransferase  activity with cysteine as substrate. Mainly D-form of enzyme exists <2>)  "
1.8.4.8," adenosine 3',5'-bisphosphate + sulfite + thioredoxin disulfide =  3'-phosphoadenylyl sulfate + thioredoxin (#2# special ping-pong  mechanism with 5-phosphoadenosine 3-phosphosulfate reacting with the  reduced enzyme isomer in a Theorell-Chance mechanism <4>; #3# from the  kinetic data it is concluded that the enzyme follows an ordered  mechanism with thioredoxin as the first substrate followed by  5-phosphoadenosine 3-phosphosulfate as the second <1>; #2# ping pong  type reaction mechanism <8>; #2# ping pong type reaction mechanism,  Cys239 is the active site residue <9>)  "
1.8.4.9," AMP + sulfite + glutathione disulfide = adenylyl sulfate + 2  glutathione (#7# the reaction catalyzed by APR can be divided into  three steps. In the first step, APS binds to the protein, and a  reductive transfer results in sulfite bound to the active-site cysteine  in a stable reaction intermediate. In the second step, free sulfite is  released by the action of the C-terminal domain. In the third step, the  glutaredoxin active site is regenerated by reduction with GSH reductase  <15>)  "
1.8.5.1, 2 glutathione + dehydroascorbate = glutathione disulfide + ascorbate  (#4# catalytic mechanism <20>)  
1.8.5.2, 2 thiosulfate + 6-decylubiquinone = tetrathionate + 6-decylubiquinol  
1.8.5.3," dimethylsulfide + menaquinone + H2O = dimethylsulfoxide + menaquinol  (#7# according to density functional theory, the reaction between  dimethyl sulfoxide and the model complex [Mo(OPh)(C2S2H2)2]- proceeds  in one associative step. In the optimized transition state, the bond  between the metal and dimethyl sulfoxide is being formed through the  oxygen atom of dimethyl sulfoxide while the S-O bond in the substrate  is weakening <28>; #7# computational studies show that the enzyme  follows a two-step associative mechanism with the binding of  dimethylsulfoxide in the first step and the oxygen-atom transfer and  dissociation of the dimethylsulfide product in the second step. The  first transition state is close in energy to the intermediate (within  about 10 kJ/mol), whereas the rate-limiting barrier is observed for the  second step <30>)  "
1.8.5.4, n HS- + n quinone = polysulfide + n quinol  
1.8.5.5, sulfite + hydrogen sulfide + a quinone = thiosulfate + a quinol  
1.8.5.6, sulfite + a quinone + H2O = sulfate + a quinol  
1.8.5.7, glutathione + 2-(glutathione-S-yl)-hydroquinone = glutathione disulfide  + hydroquinone  
1.8.5.8, hydrogen sulfide + glutathione + a quinone = S-sulfanylglutathione + a  quinol  
1.8.5.9, a [DsbA protein] with reduced L-cysteine residues + a quinone = a [DsbA  protein] carrying a disulfide bond + a quinol 
1.8.5.9, a [DsbA protein] with reduced L-cysteine residues + a [DsbB protein]  carrying a disulfide bond = a [DsbA protein] carrying a disulfide bond  + a [DsbB protein] with reduced L-cysteine residues 
1.8.5.9, a [DsbB protein] with reduced L-cysteine residues + a quinone = a [DsbB  protein] carrying a disulfide bond + a quinol  
1.8.7.1, hydrogen sulfide + 6 oxidized ferredoxin [iron-sulfur] cluster + 3 H2O  = sulfite + 6 reduced ferredoxin [iron-sulfur] cluster + 6 H+ (#6#  extracted protein probably dual function as a major constituent of the  organellar nucleoid and as the redox enzyme ferredoxin-sulfite  reductase <21>)  
1.8.7.2, 2 reduced ferredoxin + thioredoxin disulfide = 2 oxidized ferredoxin +  thioredoxin + 2 H+  
1.8.7.3, 2 oxidized ferredoxin [iron-sulfur] cluster + CoB + CoM = 2 reduced  ferredoxin [iron-sulfur] cluster + CoM-S-S-CoB + 2 H+  
1.8.98.1, CoB + CoM + methanophenazine = CoM-S-S-CoB + dihydromethanophenazine  
1.8.98.2, peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 R-SH =  peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + R-S-S-R  
1.8.98.3, hydrogen sulfide + 3 oxidized coenzyme F420 + 3 H2O = sulfite + 3  reduced coenzyme F420  
1.8.98.4, 2 oxidized coenzyme F420 + 2 reduced ferredoxin [iron-sulfur] cluster +  CoB + CoM + 2 H+ = 2 reduced coenzyme F420 + 2 oxidized ferredoxin  [iron-sulfur] cluster + CoM-S-S-CoB  
1.8.98.5, 2 reduced ferredoxin [iron-sulfur] cluster + CoB + CoM + 2 H+ = 2 H2 +  2 oxidized ferredoxin [iron-sulfur] cluster + CoM-S-S-CoB  
1.8.98.6, 2 CO2 + 2 reduced ferredoxin [iron-sulfur] cluster + CoB + CoM + 2 H+ =  2 formate + 2 oxidized ferredoxin [iron-sulfur] cluster + CoM-S-S-CoB  
1.8.98.7, S-adenosyl-L-methionine + a [sulfatase]-L-cysteine + H2O = a  [sulfatase]-3-oxo-L-alanine + 5'-deoxyadenosine + L-methionine +  hydrogen sulfide  
1.8.99.2," AMP + sulfite + acceptor = adenylyl sulfate + reduced acceptor  (#21,24,26,28# mechanism <22,29>; #28# catalysis involves a  nucleophilic attack of the N5-atom of reduced FAD on the sulfur atom of  the enzyme <13>)  "
1.8.99.5," hydrogen sulfide + a [DsrC protein]-disulfide + 2 acceptor + 3 H2O =  sulfite + a [DsrC protein]-dithiol + 2 reduced acceptor + 2 H+ (#24#  sulfite is bound at an oxidation state of S1IV and immediately  dehydrated. All oxygen atoms are fixed in a tight hydrogen-bonding  network, upon transfer of two electrons to yield an S1II state, a  second oxygen atom is released as water, but held within the  active-site cavity. A further two-electron reduction leads to the S0  state, weakening the remaining S-O bond. With the final transfer of two  electrons, the state of sulfide (S2II) is reached and a third water is  released, catalytic mechanism overview. The heterobimetallic  active-site heme 2 has a Cu(I) ion juxtaposed to a heme c at a Fe-Cu  distance of 4.4 A. While the combination of metals is reminiscent of  respiratory heme-copper oxidases, the oxidation-labile Cu(I) centre of  MccA does not seem to undergo a redox transition during catalysis.  Intact MccA tightly binds SO2 at heme 2, a dehydration product of the  substrate sulfite that is partially turned over due to photoreduction  by X-ray irradiation, yielding the reaction intermediate SO. Structure  of sulfite reduction at heme2 of MccA, sulfite binds to the resting  state of the enzyme, but the active-site architecture shifts the  reversible dehydration equilibrium to SO2 + H2O. Reduction by two  electrons occurs through photoreduction in the X-ray beam and leads to  release of a second H2O after protonation, with SO remaining bound to  the active site. A tight network of hydrogen bonds surrounds the  bimetal centre and the bound substrate, holding the reaction products  in place. The sulfite substrate only oxidizes half the heme groups of  reduced MccA, emphasizing that the total electron charge of the  multiheme enzyme is of high relevance for catalysis <25>) "
1.8.99.5, hydrogen sulfide + a [DsrC protein]-disulfide = a [DsrC  protein]-S-sulfanyl-L-cysteine 
1.8.99.5, a [DsrC protein]-S-sulfanyl-L-cysteine + 2 acceptor + 3 H2O = sulfite +  a [DsrC protein]-dithiol + 2 reduced acceptor + 2 H+ 
1.8.99.5, a [DsrC protein]-S-sulfanyl-L-cysteine + 3 acceptor + 3 H2O = sulfite +  a [DsrC protein]-disulfide + 3 reduced acceptor + 2 H+ 
1.8.99.5, a [DsrC protein]-S-sulfanyl-L-cysteine + 3 acceptor + 3 H2O = a  [DsrC]-S-sulfo-L-cysteine + 3 reduced acceptor + H+ 
1.8.99.5, a [DsrC]-S-sulfo-L-cysteine = sulfite + a [DsrC protein]-disulfide  
1.9.6.1," 2 ferrocytochrome + 2 H+ + nitrate = 2 ferricytochrome + nitrite  (#4,9,15,34,35,36,38# sulfur-shift mechanism catalytic mechanism,  defined by a change in the Mo ion coordination, which involves a  first-to-second shell displacement (shift) of the sulfur from the Cys,  resulting in a free coordination position that is used by the enzyme to  bind the substrate with a low energy cost, molybdenum coordinates an  oxygen atom from the substrate, an oxygen atom from the substrate is  transferred to the Mo ion, and later released as a water molecule. The  reaction requires two electrons, which are provided by external  reducing species, and two protons that are obtained from the solvent  either directly or indirectly mediated by residues from the enzyme  catalytic pocket <24>; #17,20,30,31,32,33,40# sulfur-shift mechanism  catalytic mechanism, detailed overview. The mechanism is defined by a  change in the Mo ion coordination, which involves a first-to-second  shell displacement (shift) of the sulfur from the Cys, resulting in a  free coordination position that is used by the enzyme to bind the  substrate with a low energy cost, molybdenum coordinates an oxygen atom  from the substrate, an oxygen atom from the substrate is transferred to  the Mo ion, and later released as a water molecule. The reaction  requires two electrons, which are provided by external reducing  species, and two protons that are obtained from the solvent either  directly or indirectly mediated by residues from the enzyme catalytic  pocket <22,24>; #17# sulfur-shift mechanism catalytic mechanism. The  second sphere type of mechanism is supported by the recent X-ray  structures of Nap from Desulfovibrio desulf uricans ATCC 27774 and  Cupriavidus necator H16, in which the sixth sulfur ligand of the Mo  interacts with the sulfur from the cysteine residue and generates a  bidentate persulfido ligand that sterically blocks the access of the  substrate to the Mo ion, modelling <28>)  "
1.9.98.1, ferrocytochrome c + Fe3+ = ferricytochrome c + Fe2+  
1.97.1.1, reduced acceptor + chlorate = acceptor + H2O + chlorite  
1.97.1.12, reduced plastocyanin + oxidized ferredoxin + hnu = oxidized  plastocyanin + reduced ferredoxin  
1.97.1.2," 1,2,3,5-tetrahydroxybenzene + 1,2,3-trihydroxybenzene =  1,3,5-trihydroxybenzene + 1,2,3,5-tetrahydroxybenzene (#1# a mechanism  is proposed which combines an oxidative hydroxylation with a reductive  dehydroxylation via molybdenum cofactor <5,6>; #1# transfer of the  hydroxy group occurs via 2,4,3Â’,4Â’,5Â’-hexahydroxydiphenyl ether as an  intermediate. The 1-OH group of pyrogallol coordinates to the MoVI atom  of Moco and is oxidized to the orthoquinone form, while H144 accepts  the phenolic proton. the 2-OH group of 1,2,3,5-tetrahydroxybenzene adds  to the quinone in a Michael-type reaction, which is assisted by proton  transfer from D174. The substrate-cocatalyst adduct is tautomerized  with the assistance of Y404 as a proton donor. In the last stage, the  paraquinone form of the tetrahydroxybenzene is reduced by Mo(IV) <9>)  "
1.97.1.4," S-adenosyl-L-methionine + dihydroflavodoxin + [formate  C-acetyltransferase]-glycine = 5'-deoxyadenosine + L-methionine +  flavodoxin semiquinone + [formate C-acetyltransferase]-glycin-2-yl  radical (#2# the glycyl radical in pyruvate formate-lyase is produced  by stereospecific abstraction of the pro-S hydrogen of Gly734 by the  5-deoxyadenosine radical generated in the active center of the enzyme  <4>; #2# mechanism, a deoxyadenosyl radical intermediate, generated by  the reductive cleavage of S-adenosylmethionine serves as the actual H  atom abstracting species <6>; #2# 4Fe-4S cluster is involved in  catalysis by coordinating S-adenosyl-L-methionine <13>)  "
1.97.1.9, selenite + H2O + acceptor = selenate + reduced acceptor (#11# active  site molybdenum <3>; #10# electron transport mechanism <1>; #2#  selenate transport mechanism <6>)  
2.1.1.1, S-adenosyl-L-methionine + nicotinamide = S-adenosyl-L-homocysteine +  1-methylnicotinamide  
2.1.1.10," S-methyl-L-methionine + L-homocysteine = 2 L-methionine (#3# high  homology to betaine-homocysteine methyltransferase (BHMT, EC 2.1.1.5),  betaine is not a substrate for BHMT-2 but high activity with  S-methyl-L-methionine <11>)  "
2.1.1.100," S-adenosyl-L-methionine + protein C-terminal S-farnesyl-L-cysteine =  S-adenosyl-L-homocysteine + protein C-terminal S-farnesyl-L-cysteine  methyl ester (#5# kinetic mechanism <6>; #2# ordered bi bi mechanism,  S-adenosyl-L-methionine binds first, S-adenosyl-L-homocysteine departs  last <15>)  "
2.1.1.101, S-adenosyl-L-methionine + macrocin = S-adenosyl-L-homocysteine + tylosin  
2.1.1.102, S-adenosyl-L-methionine + demethylmacrocin = S-adenosyl-L-homocysteine  + macrocin  
2.1.1.103, S-adenosyl-L-methionine + ethanolamine phosphate =  S-adenosyl-L-homocysteine + N-methylethanolamine phosphate (#9# random  sequential kinetic mechanism <16>)  
2.1.1.104, S-adenosyl-L-methionine + caffeoyl-CoA = S-adenosyl-L-homocysteine +  feruloyl-CoA  
2.1.1.105, S-adenosyl-L-methionine + N-benzoyl-4-hydroxyanthranilate =  S-adenosyl-L-homocysteine + N-benzoyl-4-methoxyanthranilate  
2.1.1.106, S-adenosyl-L-methionine + L-tryptophan = S-adenosyl-L-homocysteine +  L-2-methyltryptophan  
2.1.1.107, S-adenosyl-L-methionine + uroporphyrinogen III =  S-adenosyl-L-homocysteine + precorrin-1 
2.1.1.107, S-adenosyl-L-methionine + precorrin-1 = S-adenosyl-L-homocysteine +  precorrin-2 
2.1.1.107, 2 S-adenosyl-L-methionine + uroporphyrinogen III = 2  S-adenosyl-L-homocysteine + precorrin-2  
2.1.1.108, S-adenosyl-L-methionine + 6-hydroxymellein = S-adenosyl-L-homocysteine  + 6-methoxymellein (#1# mechanism <3>)  
2.1.1.109, S-adenosyl-L-methionine + 6-demethylsterigmatocystin =  S-adenosyl-L-homocysteine + sterigmatocystin  
2.1.1.11, S-adenosyl-L-methionine + magnesium protoporphyrin IX =  S-adenosyl-L-homocysteine + magnesium protoporphyrin IX 13-methyl ester  (#2# ping-pong mechanism <2>; #3# random bi-bi mechanism with 2  dead-end ternary complexes <4>; #4# equilibrium-ordered bi bi mechanism  <3>; #10# ternary complex is likely to be formed either by a random or  ordered addition of substrates <13>)  
2.1.1.110, S-adenosyl-L-methionine + sterigmatocystin = S-adenosyl-L-homocysteine  + 8-O-methylsterigmatocystin 
2.1.1.110, S-adenosyl-L-methionine + dihydrosterigmatocystin =  S-adenosyl-L-homocysteine + 8-O-methyldihydrosterigmatocystin  
2.1.1.111, S-adenosyl-L-methionine + anthranilate = S-adenosyl-L-homocysteine +  N-methylanthranilate  
2.1.1.112, S-adenosyl-L-methionine + glucuronoxylan D-glucuronate =  S-adenosyl-L-homocysteine + glucuronoxylan 4-O-methyl-D-glucuronate  
2.1.1.113," S-adenosyl-L-methionine + DNA cytosine = S-adenosyl-L-homocysteine +  DNA N4-methylcytosine (#7# the product inhibition pattern consistent  with a steady-state random bi-bi mechanism in which the dominant order  of substrate binding and product release: S-adenosyl-L-methionine,  methylated DNA, DNAMe, S-adenosyl-L-homocysteine <3,5>)  "
2.1.1.114," S-adenosyl-L-methionine + 3,4-dihydroxy-5-all-trans-polyprenylbenzoate  = S-adenosyl-L-homocysteine +  3-methoxy-4-hydroxy-5-all-trans-polyprenylbenzoate  "
2.1.1.115," S-adenosyl-L-methionine + (RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline  = S-adenosyl-L-homocysteine +  N-methyl-(RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline  "
2.1.1.116, S-adenosyl-L-methionine + 3'-hydroxy-N-methyl-(S)-coclaurine =  S-adenosyl-L-homocysteine + (S)-reticuline  
2.1.1.117, S-adenosyl-L-methionine + (S)-scoulerine = S-adenosyl-L-homocysteine +  (S)-tetrahydrocolumbamine  
2.1.1.118, S-adenosyl-L-methionine + columbamine = S-adenosyl-L-homocysteine +  palmatine  
2.1.1.119, S-adenosyl-L-methionine + 10-hydroxydihydrosanguinarine =  S-adenosyl-L-homocysteine + dihydrochelirubine  
2.1.1.12, S-adenosyl-L-methionine + L-methionine = S-adenosyl-L-homocysteine +  S-methyl-L-methionine (#15# ordered bi bi mechanism with  S-adenosylmethionine the first reactant to bind and  S-adenosylhomocysteine the last product to be released <3>)  
2.1.1.120, S-adenosyl-L-methionine + 12-hydroxydihydrochelirubine =  S-adenosyl-L-homocysteine + dihydromacarpine  
2.1.1.121, S-adenosyl-L-methionine + 6-O-methylnorlaudanosoline =  S-adenosyl-L-homocysteine + nororientaline  
2.1.1.122," S-adenosyl-L-methionine + (S)-7,8,13,14-tetrahydroprotoberberine =  S-adenosyl-L-homocysteine +  cis-N-methyl-(S)-7,8,13,14-tetrahydroprotoberberine  "
2.1.1.123, S-adenosyl-L-methionine + [cytochrome c]-methionine =  S-adenosyl-L-homocysteine + [cytochrome c]-S-methyl-methionine  
2.1.1.127," 3 S-adenosyl-L-methionine + [ribulose-1,5-bisphosphate  carboxylase]-L-lysine = 3 S-adenosyl-L-homocysteine +  [ribulose-1,5-bisphosphate carboxylase]-N6,N6,N6-trimethyl-L-lysine  (#2# catalytic reaction mechanism and specificity, molecular dynamics  and hybrid quantum mechanics/molecular mechanics, overview <11>; #2#  substrate binding, leucine-rich motifscontribute to the contact surface  with Rubisco, overview <12>) "
2.1.1.127," S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine  + histone N6-methyl-L-lysine (#2# catalytic mechanism <5>; #2#  substrate and inhibitor binding site <5>; #2# amino acid sequence  comparison <5>; #2# enzyme is encoded on genes containing the  SET-domain sequence, substrate specificity is connected to SET sequence  <5,6>; #2# SET structure <6>)  "
2.1.1.128, S-adenosyl-L-methionine + (RS)-norcoclaurine =  S-adenosyl-L-homocysteine + (RS)-coclaurine (#3# bi-bi ping-pong  mechanism <2>)  
2.1.1.129, S-adenosyl-L-methionine + myo-inositol = S-adenosyl-L-homocysteine +  1D-4-O-methyl-myo-inositol  
2.1.1.13," 5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate +  L-methionine (#1,2,5,6,7,8,9,13,15,17,22# mechanism  <10,14,15,19,25,32,33,39,48>; #8# ordered sequential mechanism <32>;  #5# review, detailed mechanism <29>; #5,28# remethylation of  inactivated enzyme and interaction with flavodoxin <34,35>; #5# enzyme  exists in two different conformations that interconvert in the  cob(II)alamin oxidation state, control of reactivity <37>)  "
2.1.1.130, S-adenosyl-L-methionine + precorrin-2 = S-adenosyl-L-homocysteine +  precorrin-3A  
2.1.1.131, S-adenosyl-L-methionine + precorrin-3B = S-adenosyl-L-homocysteine +  precorrin-4 (#1# mechanism for ring contraction <3>)  
2.1.1.132," 2 S-adenosyl-L-methionine + precorrin-6B = 2 S-adenosyl-L-homocysteine  + precorrin-8X + CO2 (#2# CbiT: substrate and cofactor binding, active  site structure, mechanism <6>) "
2.1.1.132, S-adenosyl-L-methionine + precorrin-6B = S-adenosyl-L-homocysteine +  precorrin-7 + CO2 
2.1.1.132, S-adenosyl-L-methionine + precorrin-7 = S-adenosyl-L-homocysteine +  precorrin-8X  
2.1.1.133, S-adenosyl-L-methionine + precorrin-4 = S-adenosyl-L-homocysteine +  precorrin-5  
2.1.1.136, S-adenosyl-L-methionine + trichlorophenol = S-adenosyl-L-homocysteine +  trichloroanisole  
2.1.1.137," S-adenosyl-L-methionine + arsenite = S-adenosyl-L-homocysteine +  methylarsonate (#40# reaction mechanism, overview <16>;  #1,2,8,11,13,14,21,24,38,39# reaction modelling, overview <12>) "
2.1.1.137, S-adenosyl-L-methionine + arsenic triglutathione + thioredoxin + 2 H2O  = S-adenosyl-L-homocysteine + methylarsonous acid + 3 glutathione +  thioredoxin disulfide 
2.1.1.137, 2 S-adenosyl-L-methionine + arsenic triglutathione + 2 thioredoxin +  H2O = S-adenosyl-L-homocysteine + dimethylarsinous acid + 3 glutathione  + 2 thioredoxin disulfide 
2.1.1.137, 3 S-adenosyl-L-methionine + arsenic triglutathione + 3 thioredoxin =  S-adenosyl-L-homocysteine + trimethylarsane + 3 glutathione + 3  thioredoxin disulfide  
2.1.1.139, S-adenosyl-L-methionine + 3'-demethylstaurosporine =  S-adenosyl-L-homocysteine + staurosporine  
2.1.1.14," 5-methyltetrahydropteroyltri-L-glutamate + L-homocysteine =  tetrahydropteroyltri-L-glutamate + L-methionine (#4# mechanism <3,4>;  #4,7,8,9,15,21# final step in methionine synthesis <5,10>)  "
2.1.1.140, S-adenosyl-L-methionine + (S)-coclaurine = S-adenosyl-L-homocysteine +  (S)-N-methylcoclaurine  
2.1.1.141, S-adenosyl-L-methionine + jasmonate = S-adenosyl-L-homocysteine +  methyl jasmonate  
2.1.1.142," S-adenosyl-L-methionine + cycloartenol = S-adenosyl-L-homocysteine +  cyclolaudenol (#7# mechanism <1>; #7# structure-function relationship  <1>; #7# mechanism, S-adenosyl-L-methionine mehtylates the Si face of  the 24(25)-double bond with elimination of a hydrogen atom from the  pro-Z methyl group at C-25 <1>; #7# kinetic and inhibition mechanism  <1>; #7# steric substrate preferences: 3beta-hydroxy group, planar  nucleus, side chain orientated into right-handed structure <1>) "
2.1.1.142," S-adenosyl-L-methionine + 5alpha-cholesta-8,24-dien-3beta-ol =  S-adenosyl-L-homocysteine + 24-methylene-5alpha-cholest-8-en-3beta-ol  (#5# mechanism <3>)  "
2.1.1.143, S-adenosyl-L-methionine + 24-methylenelophenol =  S-adenosyl-L-homocysteine + (Z)-24-ethylidenelophenol  
2.1.1.144, S-adenosyl-L-methionine + trans-aconitate = S-adenosyl-L-homocysteine +  (E)-3-(methoxycarbonyl)pent-2-enedioate  
2.1.1.145, S-adenosyl-L-methionine + trans-aconitate = S-adenosyl-L-homocysteine +  (E)-2-(methoxycarbonylmethyl)butenedioate  
2.1.1.146, S-adenosyl-L-methionine + isoeugenol = S-adenosyl-L-homocysteine +  isomethyleugenol  
2.1.1.147, S-adenosyl-L-methionine + palmatine + 2 NADPH + H+ =  S-adenosyl-L-homocysteine + corydaline + 2 NADP+  
2.1.1.148," 5,10-methylenetetrahydrofolate + dUMP + NADPH + H+ = dTMP +  tetrahydrofolate + NADP+ (#40# a hydride equivalent is transferred from  the reduced flavin cofactor directly to the uracil ring, followed by an  isomerization of the intermediate to form the product,  2-deoxythymidine-5-monophosphate <23>)  "
2.1.1.15, S-adenosyl-L-methionine + a fatty acid = S-adenosyl-L-homocysteine + a  fatty acid methyl ester  
2.1.1.150, S-adenosyl-L-methionine + a 7-hydroxyisoflavone =  S-adenosyl-L-homocysteine + a 7-methoxyisoflavone  
2.1.1.151," S-adenosyl-L-methionine + cobalt-factor II = S-adenosyl-L-homocysteine  + cobalt-factor III (#4# Gly11, Gly103 and Asp104 involved in  S-adenosyl-L-methionine binding <5>; #5# the conserved Tyr226 residue  in CbiL catalyzes the direct transfer of a methyl group from  S-adenosylmethionine to the substrate through an SN2-like mechanism,  S-adenosyl-L-homocysteine binds to Pro14, Asp106, Phe109, Ala135, and  Val205, as well as to Val104 and Phe136 via a water molecule <4>)  "
2.1.1.152, S-adenosyl-L-methionine + precorrin-5 + H2O = S-adenosyl-L-homocysteine  + precorrin-6A + acetate  
2.1.1.153," S-adenosyl-L-methionine + vitexin 2''-O-beta-L-rhamnoside =  S-adenosyl-L-homocysteine + 7-O-methylvitexin 2''-O-beta-L-rhamnoside  (#1# the flavonoids vitexin and isovitexin 2Â’Â’-O-arabinoside do not act  as substrates for the enzyme from oats, Avena sativa, kinetic  mechanism, mono-iso Theorell-Chance mechanism <1>)  "
2.1.1.154, S-adenosyl-L-methionine + isoliquiritigenin = S-adenosyl-L-homocysteine  + 2'-O-methylisoliquiritigenin (#1# sequential Bi Bi mechanism <2>)  
2.1.1.155," S-adenosyl-L-methionine + kaempferol = S-adenosyl-L-homocysteine +  kaempferide (#2# the enzyme acts on the hydroxy group in the 4-position  of some flavones, flavanones and isoflavones, kaempferol, apigenin and  kaempferol triglucoside are substrates, as is genistein, which reacts  more slowly, compounds with a hydroxy group in the 3 and 4 positions,  such as quercetin and eriodictyol, do not act as substrates, similar to  EC 2.1.1.75, apigenin 4-O-methyltransferase and EC 2.1.1.83,  3,7-dimethylquercitin 4-O-methyltransferase, ping-pong mechanism  excluding the formation of a ternary complex <1>)  "
2.1.1.156, S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine +  sarcosine 
2.1.1.156," S-adenosyl-L-methionine + sarcosine = S-adenosyl-L-homocysteine +  N,N-dimethylglycine  "
2.1.1.157," S-adenosyl-L-methionine + sarcosine = S-adenosyl-L-homocysteine +  N,N-dimethylglycine (#4# (1a) <2>) "
2.1.1.157," S-adenosyl-L-methionine + N,N-dimethylglycine =  S-adenosyl-L-homocysteine + betaine (#4# (1b) <2>) "
2.1.1.157, 2 S-adenosyl-L-methionine + sarcosine = 2 S-adenosyl-L-homocysteine +  betaine (#4# (overall reaction) <2>)  
2.1.1.158," S-adenosyl-L-methionine + xanthosine = S-adenosyl-L-homocysteine +  7-methylxanthosine (#6# a catalytic residue is Gln161, cosubstrate and  substrate binding site structures involving the Ser316 for xanthosine  recognition, overview <11>)  "
2.1.1.159," S-adenosyl-L-methionine + 7-methylxanthine = S-adenosyl-L-homocysteine  + 3,7-dimethylxanthine (#4# residues His160, and Phe266 are involved in  catalysis, cosubstrate and substrate binding site structures, overview  <12>)  "
2.1.1.16, S-adenosyl-L-methionine + phospholipid olefinic fatty acid =  S-adenosyl-L-homocysteine + phospholipid methylene fatty acid  
2.1.1.160," S-adenosyl-L-methionine + 7-methylxanthine = S-adenosyl-L-homocysteine  + 3,7-dimethylxanthine "
2.1.1.160," S-adenosyl-L-methionine + 3,7-dimethylxanthine =  S-adenosyl-L-homocysteine + 1,3,7-trimethylxanthine (#8# residues  His160, and Phe266 are involved in catalysis, cosubstrate and substrate  binding site structures, overview <13>) "
2.1.1.160," S-adenosyl-L-methionine + 1,7-dimethylxanthine =  S-adenosyl-L-homocysteine + 1,3,7-trimethylxanthine  "
2.1.1.161," S-adenosyl-L-methionine + N,N-dimethylglycine =  S-adenosyl-L-homocysteine + betaine  "
2.1.1.162, S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine +  sarcosine (#1# (1a) <1>) 
2.1.1.162," S-adenosyl-L-methionine + sarcosine = S-adenosyl-L-homocysteine +  N,N-dimethylglycine (#1# (1b) <1>) "
2.1.1.162," S-adenosyl-L-methionine + N,N-dimethylglycine =  S-adenosyl-L-homocysteine + betaine (#1# (1c) <1>) "
2.1.1.162, 3 S-adenosyl-L-methionine + glycine = 3 S-adenosyl-L-homocysteine +  betaine (#1# (overall reaction) <1>)  
2.1.1.163, a demethylmenaquinol + S-adenosyl-L-methionine = a menaquinol +  S-adenosyl-L-homocysteine  
2.1.1.164, 4'-demethylrebeccamycin + S-adenosyl-L-methionine = rebeccamycin +  S-adenosyl-L-homocysteine  
2.1.1.165, S-adenosyl-L-methionine + iodide = S-adenosyl-L-homocysteine + methyl  iodide  
2.1.1.166," S-adenosyl-L-methionine + uridine2552 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methyluridine2552 in 23S rRNA (#3# a  reaction mechanism for the methyltransfer activity of RrmJ is proposed  <7>; #3# mechanism, based on modeling studies and the structure of the  50S ribosome, a two-step model is proposed where the A loop undocks  from the tightly packed 50S ribosomal subunit, allowing RrmJ to gain  access to the substrate nucleotide U2552, and where U2552 undergoes  base flipping, allowing the enzyme to methylate the 2-O position of the  ribose <5>)  "
2.1.1.167, S-adenosyl-L-methionine + guanosine2922 in 27S pre-rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylguanosine2922 in 27S pre-rRNA  
2.1.1.168, S-adenosyl-L-methionine + uridine2791 in 21S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methyluridine2791 in 21S rRNA  
2.1.1.169," S-adenosyl-L-methionine + 3'-hydroxyflavone = S-adenosyl-L-homocysteine  + 3'-methoxyflavone (#1# unique structural features of TaOMT2 which  permit the stepwise methylation of tricetin is disclosed. Substrate  binding is mediated by an extensive network of H-bonds and van der  Waals interactions. The partly buried tricetin active site, as well as  proximity and orientation effects ensure sequential methylation of the  substrate within the same pocket. Stepwise methylation of tricetin  involves deprotonation of its hydroxyl groups by a His262-Asp263 pair  followed by nucleophilic attack of SAM-methyl groups <4>) "
2.1.1.169," 3 S-adenosyl-L-methionine + tricetin = 3 S-adenosyl-L-homocysteine +  3',4',5'-O-trimethyltricetin "
2.1.1.169," S-adenosyl-L-methionine + tricetin = S-adenosyl-L-homocysteine +  3'-O-methyltricetin (#1# mechanism for the sequential methylation of  tricetin, overview <4>) "
2.1.1.169," S-adenosyl-L-methionine + 3'-O-methyltricetin =  S-adenosyl-L-homocysteine + 3',5'-O-dimethyltricetin (#1# mechanism for  the sequential methylation of tricetin, overview <4>) "
2.1.1.169," S-adenosyl-L-methionine + 3',5'-O-dimethyltricetin =  S-adenosyl-L-homocysteine + 3',4',5'-O-trimethyltricetin (#1# mechanism  for the sequential methylation of tricetin, overview <4>)  "
2.1.1.17, S-adenosyl-L-methionine + phosphatidylethanolamine =  S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine  
2.1.1.170, S-adenosyl-L-methionine + guanine527 in 16S rRNA =  S-adenosyl-L-homocysteine + N7-methylguanine527 in 16S rRNA  
2.1.1.171, S-adenosyl-L-methionine + guanine966 in 16S rRNA =  S-adenosyl-L-homocysteine + N2-methylguanine966 in 16S rRNA (#2#  proposed model of rRNA/RsmD interactions in the active site <1>)  
2.1.1.172, S-adenosyl-L-methionine + guanine1207 in 16S rRNA =  S-adenosyl-L-homocysteine + N2-methylguanine1207 in 16S rRNA  
2.1.1.173, S-adenosyl-L-methionine + guanine2445 in 23S rRNA =  S-adenosyl-L-homocysteine + N2-methylguanine2445 in 23S rRNA  
2.1.1.174," S-adenosyl-L-methionine + guanine1835 in 23S rRNA =  S-adenosyl-L-homocysteine + N2-methylguanine1835 in 23S rRNA (#3#  catalytic mechanism, overview <4>)  "
2.1.1.175, S-adenosyl-L-methionine + tricetin = S-adenosyl-L-homocysteine +  3'-O-methyltricetin 
2.1.1.175," S-adenosyl-L-methionine + 3'-O-methyltricetin =  S-adenosyl-L-homocysteine + 3',5'-O-dimethyltricetin "
2.1.1.175," 2 S-adenosyl-L-methionine + tricetin = 2 S-adenosyl-L-homocysteine +  3',5'-O-dimethyltricetin  "
2.1.1.176, S-adenosyl-L-methionine + cytosine967 in 16S rRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine967 in 16S rRNA (#3# a  model for the reaction mechanism is proposed <3>)  
2.1.1.177, S-adenosyl-L-methionine + pseudouridine1915 in 23S rRNA =  S-adenosyl-L-homocysteine + N3-methylpseudouridine1915 in 23S rRNA (#1#  mechanism: the enzyme docks into the ribosomal A site without  encroaching into the P site. YbeA makes extensive interface contacts  with both the 30S and 50S subunits to align its active site cofactor  adjacent to nucleotide C1915 <3>)  
2.1.1.178, S-adenosyl-L-methionine + cytosine1407 in 16S rRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine1407 in 16S rRNA (#2# the  YebU structure is used to propose the most likely mechanism for its  substrate specificity and recognition <2>)  
2.1.1.179, S-adenosyl-L-methionine + guanine1405 in 16S rRNA =  S-adenosyl-L-homocysteine + N7-methylguanine1405 in 16S rRNA (#4#  analysis of sequenceÂ–function relationships of Sgm MTase by limited  proteolysis and site-directed and random mutagenesis <1>; #4# the  mechanism of methylation of G1405 by Sgm is proposed and compared with  other m7G methyltransferases <7>)  
2.1.1.18, S-adenosyl-L-methionine + a (1->4)-alpha-D-glucooligosaccharide =  S-adenosyl-L-homocysteine + an oligosaccharide containing  6-methyl-D-glucose units  
2.1.1.180, S-adenosyl-L-methionine + adenine1408 in 16S rRNA =  S-adenosyl-L-homocysteine + N1-methyladenine1408 in 16S rRNA  
2.1.1.181, S-adenosyl-L-methionine + adenine1618 in 23S rRNA =  S-adenosyl-L-homocysteine + N6-methyladenine1618 in 23S rRNA  
2.1.1.182," 4 S-adenosyl-L-methionine + adenine1518/adenine1519 in 16S rRNA = 4  S-adenosyl-L-homocysteine +  N6-dimethyladenine1518/N6-dimethyladenine1519 in 16S rRNA (#3# reaction  mechanism, overview <20>)  "
2.1.1.183, 4 S-adenosyl-L-methionine + adenine1779/adenine1780 in 18S rRNA = 4  S-adenosyl-L-homocysteine +  N6-dimethyladenine1779/N6-dimethyladenine1780 in 18S rRNA  
2.1.1.184, 2 S-adenosyl-L-methionine + adenine2085 in 23S rRNA = 2  S-adenosyl-L-homocysteine + N6-dimethyladenine2085 in 23S rRNA (#2# a  model for the transition-state based on the atomic details of the  active site is consistent with a one-step methyl-transfer <10>; #2# a  model of RNA-ErmC interaction involving multiple binding sites is  proposed from the kinetic data <9>; #2# ermC methylase reaction  involves a sequential mechanism occurring by two consecutive random bi  bi reactions <2>)  
2.1.1.185, S-adenosyl-L-methionine + guanosine2251 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylguanosine2251 in 23S rRNA  
2.1.1.186, S-adenosyl-L-methionine + cytidine2498 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine2498 in 23S rRNA  
2.1.1.187, S-adenosyl-L-methionine + guanine745 in 23S rRNA =  S-adenosyl-L-homocysteine + N1-methylguanine745 in 23S rRNA  
2.1.1.188, S-adenosyl-L-methionine + guanine748 in 23S rRNA =  S-adenosyl-L-homocysteine + N1-methylguanine748 in 23S rRNA  
2.1.1.189, S-adenosyl-L-methionine + uracil747 in 23S rRNA =  S-adenosyl-L-homocysteine + 5-methyluracil747 in 23S rRNA  
2.1.1.19, trimethylsulfonium + tetrahydrofolate = dimethylsulfide +  5-methyltetrahydrofolate  
2.1.1.190, S-adenosyl-L-methionine + uracil1939 in 23S rRNA =  S-adenosyl-L-homocysteine + 5-methyluracil1939 in 23S rRNA  
2.1.1.191, S-adenosyl-L-methionine + cytosine1962 in 23S rRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine1962 in 23S rRNA  
2.1.1.192," 2 S-adenosyl-L-methionine + adenine2503 in 23S rRNA + 2 reduced  [2Fe-2S] ferredoxin = S-adenosyl-L-homocysteine + L-methionine +  5'-deoxyadenosine + 2-methyladenine2503 in 23S rRNA + 2 oxidized  [2Fe-2S] ferredoxin (#4# the enzyme catalyzes adenosine methylation by  using a radical mechanism for substrate activation. The radical  chemistry is enabled by the [4Fe-4S] cluster <1>; #1# reaction  mechanism modeling, overview <9>; #6,7# the enzyme uses a mechanism  involving radical S-adenosyl methionine to methylate RNA via an  intermediate with a methylated cysteine in the enzyme and a transient  cross-linking to the RNA <5>) "
2.1.1.192, 2 S-adenosyl-L-methionine + adenine37 in tRNA + 2 reduced [2Fe-2S]  ferredoxin = S-adenosyl-L-homocysteine + L-methionine +  5'-deoxyadenosine + 2-methyladenine37 in tRNA + 2 oxidized [2Fe-2S]  ferredoxin  
2.1.1.193," S-adenosyl-L-methionine + uracil1498 in 16S rRNA =  S-adenosyl-L-homocysteine + N3-methyluracil1498 in 16S rRNA (#1#  structure-function relationship and catalytic mechanism, overview <3>)  "
2.1.1.195, cobalt-precorrin-5B + S-adenosyl-L-methionine = cobalt-precorrin-6A +  S-adenosyl-L-homocysteine  
2.1.1.196, cobalt-precorrin-6B + S-adenosyl-L-methionine = cobalt-precorrin-7 +  S-adenosyl-L-homocysteine + CO2  
2.1.1.197, S-adenosyl-L-methionine + malonyl-[acyl-carrier protein] =  S-adenosyl-L-homocysteine + malonyl-[acyl-carrier protein] methyl ester  
2.1.1.198, S-adenosyl-L-methionine + cytidine1402 in 16S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine1402 in 16S rRNA  
2.1.1.199, S-adenosyl-L-methionine + cytosine1402 in 16S rRNA =  S-adenosyl-L-homocysteine + N4-methylcytosine1402 in 16S rRNA  
2.1.1.2," S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine  + creatine (#8# mechanism <16>; #8# computer model of the reaction  mechanism: by self-consistent-charge density functional tight  binding/molecular mechanics, the bond lengths in the concerted  mechanisms transition state is 1.26 A for both the OD1 (Asp-134)-HE  (guanidinoacetate) and HE (guanidinoacetate)-NE (guanidinoacetate)  bonds, and 2.47 and 2.03 A for the S8 (S-adenosyl-L-methionine)-C9  (S-adenosyl-L-methionine) and C9 (S-adenosyl-L-methionine)-NE  (guanidinoacetate) bonds, respectively. The potential-energy barrier  (delta E++) determined by single-point B3LYP/6-31+G*"
2.1.1.2,"MM is 18.9  kcal/mol. The contributions of the entropy (-TdeltaS++) and zero-point  energy corrections delta(ZPE)++ by normal mode analysis are 2.3  kcal/mol and -1.7 kcal/mol, respectively. The activation enthalpy of  this concerted mechanism is deltaH++ = 17.2 kcal/mol. The calculated  free-energy barrier for the concerted mechanism is deltaG++ = 19.5  kcal/mol. <22>; #8# the hybrid density functional theory (DFT) method  B3LYP is used to examine the reaction mechanism: The methyl group  transfer from S-adenosylmethionine to NE of guanidinoacetate occurs  concertedly with a proton transfer from NE to the neighboring OD1 of  Asp134. <19>)  "
2.1.1.20," S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine +  sarcosine (#11# mechanism <9,10>; #3# N-terminal acetylation or  deprotonation is required for cooperative reaction mechanism <13>;  #1,2,3,5# overview mechanism <15>; #3# enzyme is also a polycyclic  aromatic hydrocarbon binding protein <11>; #3# homodimer of enzyme acts  as polycyclic aromatic hydrocarbon binding protein involved in  cytochrome P-450IA1 expression <12,14>)  "
2.1.1.200, S-adenosyl-L-methionine + cytidine32 in tRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine32 in tRNA 
2.1.1.200, S-adenosyl-L-methionine + uridine32 in tRNA = S-adenosyl-L-homocysteine  + 2'-O-methyluridine32 in tRNA  
2.1.1.201," S-adenosyl-L-methionine +  2-methoxy-6-all-trans-polyprenyl-1,4-benzoquinol =  S-adenosyl-L-homocysteine +  6-methoxy-3-methyl-2-all-trans-polyprenyl-1,4-benzoquinol (#5# a  putative catalytic mechanism of Coq5 is proposed in which Arg201 acts  as a general base to initiate catalysis with the help of a water  molecule, Arg201 abstracts a proton from the water molecule <10>)  "
2.1.1.202, S-adenosyl-L-methionine + cytosine34 in tRNA precursor =  S-adenosyl-L-homocysteine + 5-methylcytosine34 in tRNA precursor (#9#  the formation of 5-methylcytosine34 is a strictly intron-dependent  process <1>; #1# the enzyme forms a covalent enzyme-substrate  intermediate with its target <12>) 
2.1.1.202, S-adenosyl-L-methionine + cytosine40 in tRNA precursor =  S-adenosyl-L-homocysteine + 5-methylcytosine40 in tRNA precursor (#9#  the formation of 5-methylcytosine34 is a strictly intron-dependent  process <1>; #1# the enzyme forms a covalent enzyme-substrate  intermediate with its target <12>) 
2.1.1.202, S-adenosyl-L-methionine + cytosine48 in tRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine48 in tRNA (#9# the  formation of 5-methylcytosine48 is an intron-independent process <1>;  #1# the enzyme forms a covalent enzyme-substrate intermediate with its  target <12>) 
2.1.1.202, S-adenosyl-L-methionine + cytosine49 in tRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine49 in tRNA (#9# the  formation of 5-methylcytosine49 is an intron-independent process <1>;  #1# the enzyme forms a covalent enzyme-substrate intermediate with its  target <12>)  
2.1.1.203, S-adenosyl-L-methionine + cytosine34 in tRNA precursor =  S-adenosyl-L-homocysteine + 5-methylcytosine34 in tRNA precursor (#4#  the formation of 5-methylcytosine34 is a strictly intron-dependent  process <1>)  
2.1.1.204, S-adenosyl-L-methionine + cytosine38 in tRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine38 in tRNA (#2# the enzyme  forms a covalent enzyme-substrate intermediate with its target <12>)  
2.1.1.205, S-adenosyl-L-methionine + cytidine32/guanosine34 in tRNA =  S-adenosyl-L-homocysteine +  2'-O-methylcytidine32/2'-O-methylguanosine34 in tRNA  
2.1.1.206, S-adenosyl-L-methionine + cytidine56 in tRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine56 in tRNA  
2.1.1.207, S-adenosyl-L-methionine + cytidine34 in tRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine34 in tRNA 
2.1.1.207, S-adenosyl-L-methionine + 5-carboxymethylaminomethyluridine34 in  tRNALeu = S-adenosyl-L-homocysteine +  5-carboxymethylaminomethyl-2'-O-methyluridine34 in tRNALeu  
2.1.1.208, S-adenosyl-L-methionine + uridine2479 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methyluridine2479 in 23S rRNA  
2.1.1.209, S-adenosyl-L-methionine + guanine2535 in 23S rRNA =  S-adenosyl-L-homocysteine + N1-methylguanine2535 in 23S rRNA  
2.1.1.21, methylamine + L-glutamate = NH3 + N-methyl-L-glutamate  
2.1.1.210, S-adenosyl-L-methionine + demethylspheroidene =  S-adenosyl-L-homocysteine + spheroidene  
2.1.1.211, S-adenosyl-L-methionine + uridine44 in tRNASer =  S-adenosyl-L-homocysteine + 2'-O-methyluridine44 in tRNASer  
2.1.1.212," S-adenosyl-L-methionine + 2,4',7-trihydroxyisoflavanone =  S-adenosyl-L-homocysteine + 2,7-dihydroxy-4'-methoxyisoflavanone  "
2.1.1.213, 2 S-adenosyl-L-methionine + guanine10 in tRNA = 2  S-adenosyl-L-homocysteine + N2-dimethylguanine10 in tRNA 
2.1.1.213, S-adenosyl-L-methionine + guanine10 in tRNA = S-adenosyl-L-homocysteine  + N2-methylguanine10 in tRNA (#2# (1a) <1>) 
2.1.1.213, S-adenosyl-L-methionine + N2-methylguanine10 in tRNA =  S-adenosyl-L-homocysteine + N2-dimethylguanine10 in tRNA (#2# (1b) <1>)  
2.1.1.214, S-adenosyl-L-methionine + guanine10 in tRNA = S-adenosyl-L-homocysteine  + N2-methylguanine10 in tRNA  
2.1.1.215," 4 S-adenosyl-L-methionine + guanine26/guanine27 in tRNA = 4  S-adenosyl-L-homocysteine + N2-dimethylguanine26/N2-dimethylguanine27  in tRNA (#2# reaction mechanism, overview <4>)  "
2.1.1.216, 2 S-adenosyl-L-methionine + guanine26 in tRNA = 2  S-adenosyl-L-homocysteine + N2-dimethylguanine26 in tRNA  
2.1.1.217, S-adenosyl-L-methionine + adenine22 in tRNA = S-adenosyl-L-homocysteine  + N1-methyladenine22 in tRNA  
2.1.1.218, S-adenosyl-L-methionine + adenine9 in tRNA = S-adenosyl-L-homocysteine  + N1-methyladenine9 in tRNA  
2.1.1.219, 2 S-adenosyl-L-methionine + adenine57/adenine58 in tRNA = 2  S-adenosyl-L-homocysteine + N1-methyladenine57/N1-methyladenine58 in  tRNA  
2.1.1.22, S-adenosyl-L-methionine + carnosine = S-adenosyl-L-homocysteine +  anserine  
2.1.1.220," S-adenosyl-L-methionine + adenine58 in tRNA = S-adenosyl-L-homocysteine  + N1-methyladenine58 in tRNA (#3# TRM61 is the subunit that binds  S-adenosyl-l-methionine and both subunits contribute to target tRNA  binding, catalytic mechanism, overview <9>; #8# two possible mechanisms  for methyl transfer: (A) with deprotonation of the amino exocyclic  group of the adenine ring and via the intermediate imino tautomer of  m1A, (B) by direct transfer of the methyl, without intermediate,  detailed overview <12>)  "
2.1.1.221," S-adenosyl-L-methionine + guanine9 in tRNA = S-adenosyl-L-homocysteine  + N1-methylguanine9 in tRNA (#2,3# catalytic mechanism and recognition  of tRNA substrate, overview. The N-terminal extension of Trm10 is  necessary for substrate tRNA recognition <3>)  "
2.1.1.222," S-adenosyl-L-methionine + 3-(all-trans-polyprenyl)benzene-1,2-diol =  S-adenosyl-L-homocysteine + 2-methoxy-6-(all-trans-polyprenyl)phenol  "
2.1.1.223, S-adenosyl-L-methionine + adenine37 in tRNA1Val =  S-adenosyl-L-homocysteine + N6-methyladenine37 in tRNA1Val  
2.1.1.224," 2 S-adenosyl-L-methionine + adenine2503 in 23S rRNA + 2 reduced  [2Fe-2S] ferredoxin = S-adenosyl-L-homocysteine + L-methionine +  5'-deoxyadenosine + 8-methyladenine2503 in 23S rRNA + 2 oxidized  [2Fe-2S] ferredoxin (#2# the enzyme catalyzes adenosine methylation by  using a radical mechanism for substrate activation. The radical  chemistry is enabled by the [4Fe-4S] cluster <2>; #2# the methyl group  is not transferred directly from S-adenosyl-L-methionine to the RNA.  Reaction proceeds by a ping-pong mechanism involving intermediate  methylation of a conserved cysteine residue <8>; #1# enzyme Cfr  consumes two AdoMet equivalents per reaction cycle to support both  methyl transfer to Cfr Cys338 (AdoMet1, step 1) and subsequently  generation of the 59dA. radical (AdoMet2, step2) <14>; #13# reaction  mechanism modeling overview <16>; #11# the enzyme uses a mechanism  involving radical S-adenosyl methionine to methylate RNA via an  intermediate with a methylated cysteine in the enzyme and a transient  cross-linking to the RNA <13>)  "
2.1.1.225, S-adenosyl-L-methionine + cytidine4 in tRNAPro =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine4 in tRNAPro (#1# (1)  <2>) 
2.1.1.225, S-adenosyl-L-methionine + cytidine4 in tRNAGly(GCC) =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine4 in tRNAGly(GCC) (#1#  (2) <2>) 
2.1.1.225, S-adenosyl-L-methionine + adenosine4 in tRNAHis =  S-adenosyl-L-homocysteine + 2'-O-methyladenosine4 in tRNAHis (#1# (3)  <2>)  
2.1.1.226, S-adenosyl-L-methionine + cytidine1920 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine1920 in 23S rRNA  
2.1.1.227, S-adenosyl-L-methionine + cytidine1409 in 16S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methylcytidine1409 in 16S rRNA  
2.1.1.228," S-adenosyl-L-methionine + guanine37 in tRNA = S-adenosyl-L-homocysteine  + N1-methylguanine37 in tRNA (#12# mechanism of N-methylation by the  tRNA m1G37 methyltransferase Trm5 involving proton abstraction during  docking of G37 in the active site by a general base , E185 <15>; #3,9#  substrate recognition and reaction mechanisms, overview <17>; #18# a  highly conserved aspartate residue, D275 in Homo sapiens Trm5, in the  flexible loop preceding the proposed general base E288 may be involved  in the induced-fit movement of the catalytic process <23>; #3#  catalytic mechanism in which the role of Mg2+ is to help to increase  the nucleophilicity of N1 of G37 and stabilize the negative developing  charge on O6 during attack on the methyl sulfonium of  S-adenosyl-L-methionine. Substrate binding to EcTrmD is in rapid  equilibrium to form the enzyme-tRNA-S-adenosyl-L-methionine complex, a  proton abstraction step is rate limiting in methyl transfer <20>;  #2,10# mechanism by which TrmD binds the substrate tRNA in an  S-adenosyl-L-methionine-dependent manner: The trefoil-knot center,  which is structurally conserved among SPOUTMTases, accommodates the  adenosine moiety of S-adenosyl-L-methionine by loosening/retightening  of the knot. The TrmD-specific regions surrounding the trefoil knot  recognize the methionine moiety of S-adenosyl-L-methionine, and thereby  establish the entire TrmD structure for global interactions with tRNA  and sequential and specific accommodations of G37 and G36, resulting in  the synthesis of m1G37-tRNA <22>)  "
2.1.1.229," S-adenosyl-L-methionine + carboxymethyluridine34 in tRNA =  S-adenosyl-L-homocysteine + 5-(2-methoxy-2-oxoethyl)uridine34 in tRNA  (#6# aspects of substrate recognition and catalytic mechanism. overview  <9>; #8# the C-terminal domain catalyzes the FAD-dependent oxidation of  the Calpha-N bond in carboxymethylaminomethyl uridine34. The resulting  imine intermediate is (presumably) non-enzymatically hydrolyzes to  5-aminomethyl uridine, followed by S-adenosyl Lmethionine-dependent  methylation to yield methylaminomethyl uridine34 in the N-terminal  domain active site <12>; #1# the C-terminal domain catalyzes the  FAD-dependent oxidation of the Calpha-N bond in  carboxymethylaminomethyl uridine34. The resulting imine intermediate is  (presumably) non-enzymatically hydrolyzes to 5-aminomethyl uridine,  followed by S-adenosyl-L-methionine-dependent methylation to yield  methylaminomethyl uridine34 in the N-terminal domain active site <11>)  "
2.1.1.230, S-adenosyl-L-methionine + adenosine1067 in 23S rRNA =  S-adenosyl-L-homocysteine + 2'-O-methyladenosine1067 in 23S rRNA  
2.1.1.231, S-adenosyl-L-methionine + a 4'-hydroxyflavanone =  S-adenosyl-L-homocysteine + a 4'-methoxyflavanone (#2# kinetic analysis  indicates a Ping-Pong mechanism and excludes the formation of a ternary  complex <1>)  
2.1.1.232, S-adenosyl-L-methionine + (2S)-naringenin = S-adenosyl-L-homocysteine +  (2S)-sakuranetin  
2.1.1.233, S-adenosyl-L-methionine + [phosphatase 2A protein]-leucine =  S-adenosyl-L-homocysteine + [phosphatase 2A protein]-leucine methyl  ester  
2.1.1.234," 2 S-adenosyl-L-methionine +  dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranose = 2  S-adenosyl-L-homocysteine +  dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose  "
2.1.1.235," 2 S-adenosyl-L-methionine +  dTDP-3-amino-3,6-dideoxy-alpha-D-glucopyranose = 2  S-adenosyl-L-homocysteine +  dTDP-3-dimethylamino-3,6-dideoxy-alpha-D-glucopyranose  "
2.1.1.236," 2 S-adenosyl-L-methionine +  dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose = 2  S-adenosyl-L-homocysteine +  dTDP-3-dimethylamino-3,6-dideoxy-alpha-D-galactopyranose  "
2.1.1.237, S-adenosyl-L-methionine + mycinamicin III = S-adenosyl-L-homocysteine +  mycinamicin IV  
2.1.1.238, S-adenosyl-L-methionine + mycinamicin VI = S-adenosyl-L-homocysteine +  mycinamicin III  
2.1.1.239, S-adenosyl-L-methionine + L-olivosyl-oleandolide =  S-adenosyl-L-homocysteine + L-oleandrosyl-oleandolide  
2.1.1.240, 2 S-adenosyl-L-methionine + trans-resveratrol = 2  S-adenosyl-L-homocysteine + pterostilbene (#2# overall reaction <2>) 
2.1.1.240," S-adenosyl-L-methionine + trans-resveratrol = S-adenosyl-L-homocysteine  + 3-methoxy-4',5-dihydroxy-trans-stilbene (#2# (1a) <2>) "
2.1.1.240," S-adenosyl-L-methionine + 3-methoxy-4',5-dihydroxy-trans-stilbene =  S-adenosyl-L-homocysteine + pterostilbene (#2# (1b) <2>)  "
2.1.1.241," S-adenosyl-L-methionine +  (2R)-4,7-dihydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside = S-adenosyl-L-homocysteine +  (2R)-4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside  "
2.1.1.242, S-adenosyl-L-methionine + guanine1516 in 16S rRNA =  S-adenosyl-L-homocysteine + N2-methylguanine1516 in 16S rRNA  
2.1.1.243, S-adenosyl-L-methionine + 5-guanidino-2-oxopentanoate =  S-adenosyl-L-homocysteine + 5-guanidino-3-methyl-2-oxopentanoate  
2.1.1.244," 3 S-adenosyl-L-methionine + N-terminal-(A,S)PK-[protein] = 3  S-adenosyl-L-homocysteine +  N-terminal-N,N,N-trimethyl-N-(A,S)PK-[protein] "
2.1.1.244," S-adenosyl-L-methionine + N-terminal-(A,S)PK-[protein] =  S-adenosyl-L-homocysteine + N-terminal-N-methyl-N-(A,S)PK-[protein] "
2.1.1.244," S-adenosyl-L-methionine + N-terminal-N-methyl-N-(A,S)PK-[protein] =  S-adenosyl-L-homocysteine + N-terminal-N,N-dimethyl-N-(A,S)PK-[protein] "
2.1.1.244," S-adenosyl-L-methionine +  N-terminal-N,N-dimethyl-N-(A,S)PK-serine-[protein] =  S-adenosyl-L-homocysteine +  N-terminal-N,N,N-trimethyl-N-(A,S)PK-[protein] "
2.1.1.244," 2 S-adenosyl-L-methionine + N-terminal-PPK-[protein] = 2  S-adenosyl-L-homocysteine + N-terminal-N,N-dimethyl-N-PPK-[protein] "
2.1.1.244, S-adenosyl-L-methionine + N-terminal-PPK-[protein] =  S-adenosyl-L-homocysteine + N-terminal-N-methyl-N-PPK-[protein] 
2.1.1.244," S-adenosyl-L-methionine + N-terminal-N-methyl-N-PPK-[protein] =  S-adenosyl-L-homocysteine + N-terminal-N,N-dimethyl-N-PPK-[protein]  "
2.1.1.245," a [methyl-Co(III) corrinoid Fe-S protein] + tetrahydrosarcinapterin = a  [Co(I) corrinoid Fe-S protein] + 5-methyltetrahydrosarcinapterin (#2#  random Bi-Bi mechanism of transfer of the methyl group from  (6S)-methyltetrahydrofolate to the corrinoid/iron-sulfur protein:  CH3-H4folate binds to MeTr in the unprotonated form and then undergoes  rapid protonation. This protonation enhances the electrophilicity of  the methyl group, in agreement with a 10fold increase in the pKa at N5  of CH3-H4folate. Next, the Co(I)-CFeSP attacks the methyl group in a  rate-limiting SN2 reaction to form methylcob(III)amide. Finally, the  products randomly dissociate. A pH-dependent conformational change is  required for methyl transfer in the forward and reverse directions, a  rate-limiting ionization of MeTr, not of CH3-H4folate, is responsible  for the pH dependence of the methyl transfer reaction <1>)  "
2.1.1.246, a [methyl-Co(III) methanol-specific corrinoid protein] + CoM =  methyl-CoM + a [Co(I) methanol-specific corrinoid protein] (#1#  coenzyme M binds with its thiol group to the zinc in the active site of  MtaA forming a coenzyme M thiolate zinc complex <7>)  
2.1.1.247," a [methyl-Co(III) methylamine-specific corrinoid protein] + CoM =  methyl-CoM + a [Co(I) methylamine-specific corrinoid protein] (#2#  catalysis by MT2 proceeds by nucleophilic substitution, with attack of  CoM on the methylcorrinoid Co3+-methyl group and expulsion of the  demethylated corrinoid in the Co1+ form <2>)  "
2.1.1.248, methylamine + a [Co(I) methylamine-specific corrinoid protein] = a  [methyl-Co(III) methylamine-specific corrinoid protein] + NH3  
2.1.1.249," dimethylamine + a [Co(I) dimethylamine-specific corrinoid protein] = a  [methyl-Co(III) dimethylamine-specific corrinoid protein] + methylamine  (#1# mechanism of the dimethylamine/coenzyme M methyltransfer, detailed  overview <4>)  "
2.1.1.25, S-adenosyl-L-methionine + phenol = S-adenosyl-L-homocysteine + anisole  
2.1.1.250, trimethylamine + a [Co(I) trimethylamine-specific corrinoid protein] =  a [methyl-Co(III) trimethylamine-specific corrinoid protein] +  dimethylamine  
2.1.1.251, methanethiol + CoM = methyl-CoM + hydrogen sulfide 
2.1.1.251, methanethiol + a [Co(I) methylated-thiol-specific corrinoid protein] =  a [methyl-Co(III) methylated-thiol-specific corrinoid protein] +  hydrogen sulfide 
2.1.1.251, a [methyl-Co(III) methylated-thiol-specific corrinoid protein] + CoM =  methyl-CoM + a [Co(I) methylated-thiol-specific corrinoid protein] (#2#  mechanism of corrinoid binding by proteins involved in methylotrophic  methanogenesis <2>)  
2.1.1.252, tetramethylammonium + a [Co(I) tetramethylammonium-specific corrinoid  protein] = a [methyl-Co(III) tetramethylammonium-specific corrinoid  protein] + trimethylamine  
2.1.1.253, a [methyl-Co(III) tetramethylammonium-specific corrinoid protein] + CoM  = methyl-CoM + a [Co(I) tetramethylammonium-specific corrinoid protein]  
2.1.1.254, S-adenosyl-L-methionine + erythromycin C = S-adenosyl-L-homocysteine +  erythromycin A (#1# (1) <3>) 
2.1.1.254, S-adenosyl-L-methionine + erythromycin D = S-adenosyl-L-homocysteine +  erythromycin B  
2.1.1.255," S-adenosyl-L-methionine + geranyl diphosphate =  S-adenosyl-L-homocysteine + (E)-2-methylgeranyl diphosphate (#2,3,4,10#  biosynthetic mechanism, overview <5>; #8# catalytic reaction mechanism,  detailed overview <6>)  "
2.1.1.256, S-adenosyl-L-methionine + guanine6 in tRNA = S-adenosyl-L-homocysteine  + N2-methylguanine6 in tRNA  
2.1.1.257, S-adenosyl-L-methionine + pseudouridine54 in tRNA =  S-adenosyl-L-homocysteine + N1-methylpseudouridine54 in tRNA  
2.1.1.258, a [methyl-Co(III) corrinoid Fe-S protein] + tetrahydrofolate = a [Co(I)  corrinoid Fe-S protein] + 5-methyltetrahydrofolate  
2.1.1.259," 3 S-adenosyl-L-methionine + [fructose-bisphosphate aldolase]-L-lysine =  3 S-adenosyl-L-homocysteine + [fructose-bisphosphate  aldolase]-N6,N6,N6-trimethyl-L-lysine  "
2.1.1.26, S-adenosyl-L-methionine + 2-iodophenol = S-adenosyl-L-homocysteine +  2-iodophenol methyl ether  
2.1.1.260, S-adenosyl-L-methionine + pseudouridine1191 in yeast 18S rRNA =  S-adenosyl-L-homocysteine + N1-methylpseudouridine1191 in yeast 18S rRNA  
2.1.1.261, S-adenosyl-L-methionine + 4-dimethylallyl-L-tryptophan =  S-adenosyl-L-homocysteine + 4-dimethylallyl-L-abrine  
2.1.1.262," 2 S-adenosyl-L-methionine + squalene = 2 S-adenosyl-L-homocysteine +  3,22-dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualene "
2.1.1.262," S-adenosyl-L-methionine + squalene = S-adenosyl-L-homocysteine +  3-methyl-1,2-didehydro-2,3-dihydrosqualene "
2.1.1.262," S-adenosyl-L-methionine + 3-methyl-1,2-didehydro-2,3-dihydrosqualene =  S-adenosyl-L-homocysteine +  3,22-dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualene  "
2.1.1.263," 2 S-adenosyl-L-methionine + C30 botryococcene = 2  S-adenosyl-L-homocysteine +  3,20-dimethyl-1,2,21,22-tetradehydro-2,3,20,21-tetrahydrobotryococcene "
2.1.1.263," S-adenosyl-L-methionine + C30 botryococcene = S-adenosyl-L-homocysteine  + 3-methyl-1,2-didehydro-2,3-dihydrobotryococcene "
2.1.1.263," S-adenosyl-L-methionine +  3-methyl-1,2-didehydro-2,3-dihydrobotryococcene =  S-adenosyl-L-homocysteine +  3,20-dimethyl-1,2,21,22-tetradehydro-2,3,20,21-tetrahydrobotryococcene "
2.1.1.263," S-adenosyl-L-methionine + C30 botryococcene = S-adenosyl-L-homocysteine  + 20-methyl-21,22-didehydro-20,21-dihydrobotryococcene "
2.1.1.263," S-adenosyl-L-methionine +  20-methyl-21,22-didehydro-20,21-dihydrobotryococcene =  S-adenosyl-L-homocysteine +  3,20-dimethyl-1,2,21,22-tetradehydro-2,3,20,21-tetrahydrobotryococcene  "
2.1.1.264, S-adenosyl-L-methionine + guanine2069 in 23S rRNA =  S-adenosyl-L-homocysteine + N7-methylguanine2069 in 23S rRNA  
2.1.1.265, S-adenosyl-L-methionine + tellurite = S-adenosyl-L-homocysteine +  methanetelluronate  
2.1.1.266, S-adenosyl-L-methionine + adenine2030 in 23S rRNA =  S-adenosyl-L-homocysteine + N6-methyladenine2030 in 23S rRNA  
2.1.1.267," S-adenosyl-L-methionine + a 5'-hydroxy-3'-methoxyflavonoid =  S-adenosyl-L-homocysteine + a 3',5'-dimethoxyflavonoid "
2.1.1.267, S-adenosyl-L-methionine + a 3'-hydroxyflavonoid =  S-adenosyl-L-homocysteine + a 3'-methoxyflavonoid  
2.1.1.268, S-adenosyl-L-methionine + cytosine32 in tRNAThr =  S-adenosyl-L-homocysteine + N3-methylcytosine32 in tRNAThr (#1# (1) <2>) 
2.1.1.268, S-adenosyl-L-methionine + cytosine32 in tRNASer =  S-adenosyl-L-homocysteine + N3-methylcytosine32 in tRNASer (#1# (2) <2>)  
2.1.1.269," S,S-dimethyl-beta-propiothetin + tetrahydrofolate =  3-(methylsulfanyl)propanoate + 5-methyltetrahydrofolate (#4# DmdA  catalyzes a redox-neutral methyl transfer reaction to produce  5-methyltetrahydrofolate, mechanism, overview <4>; #7# concerted  mechanism in which methyl transfer is coupled to proton transfer <4>)  "
2.1.1.27, S-adenosyl-L-methionine + tyramine = S-adenosyl-L-homocysteine +  N-methyltyramine  
2.1.1.270, S-adenosyl-L-methionine + (+)-6a-hydroxymaackiain =  S-adenosyl-L-homocysteine + (+)-pisatin  
2.1.1.271, S-adenosyl-L-methionine + precorrin-4 = S-adenosyl-L-homocysteine +  precorrin-5 
2.1.1.271, S-adenosyl-L-methionine + cobalt-precorrin-4 =  S-adenosyl-L-homocysteine + cobalt-precorrin-5A  
2.1.1.272, S-adenosyl-L-methionine + cobalt-factor III + reduced acceptor =  S-adenosyl-L-homocysteine + cobalt-precorrin-4 + acceptor  
2.1.1.273," S-adenosyl-L-methionine + benzoate = S-adenosyl-L-homocysteine + methyl  benzoate (#3# ordered biÂ–bi mechanism, derived from kinetic analysis,  S-adenosyl-L-methionine appears to be the first substrate to bind to  the enzyme and methyl benzoate would be the first to be released and  S-adenosyl-L-homocysteine the last <4>)  "
2.1.1.274," S-adenosyl-L-methionine + salicylate = S-adenosyl-L-homocysteine +  methyl salicylate (#12# the enzyme, which is found in flowering plants,  also has the activity of EC 2.1.1.273, benzoate O-methyltransferase <1>)  "
2.1.1.275, S-adenosyl-L-methionine + gibberellin A9 = S-adenosyl-L-homocysteine +  methyl gibberellin A9  
2.1.1.276, S-adenosyl-L-methionine + gibberellin A4 = S-adenosyl-L-homocysteine +  methyl gibberellin A4  
2.1.1.277, S-adenosyl-L-methionine + anthranilate = S-adenosyl-L-homocysteine +  O-methyl anthranilate  
2.1.1.278, S-adenosyl-L-methionine + (indol-3-yl)acetate =  S-adenosyl-L-homocysteine + methyl (indol-3-yl)acetate  
2.1.1.279, S-adenosyl-L-methionine + isoeugenol = S-adenosyl-L-homocysteine +  isomethyleugenol (#2# (2) <1>) 
2.1.1.279, S-adenosyl-L-methionine + trans-anol = S-adenosyl-L-homocysteine +  trans-anethole (#2# (1) <1>)  
2.1.1.28," S-adenosyl-L-methionine + phenylethanolamine =  S-adenosyl-L-homocysteine + N-methylphenylethanolamine (#5# random  binding mechanism with a kinetically preferred order of binding where  S-adenosyl-L-methionine is the preferred first substrate <2>; #6#  ordered sequential reaction <7>; #3# to elucidate the detailed  mechanism of enzymatic catalysis of PNMT, combined  quantum-mechanical/molecular-mechanical (QM/MM) calculations are  performed. The calculation results reveal that this catalysis contains  three elementary steps: the deprotonation of protonated norepinphrine,  the methyl transferring step and deprotonation of the methylated  norepinphrine. The methyl transferring step is proved to be the  rate-determining step undergoing a SN2 mechanism with an energy barrier  of 16.4 kcal/mol <51>)  "
2.1.1.280, S-methyl-L-methionine + L-selenocysteine = L-methionine +  Se-methyl-L-selenocysteine + H+ 
2.1.1.280, S-methyl-L-methionine + L-selenocysteine = L-methionine +  Se-methyl-L-selenocysteine  
2.1.1.281," S-adenosyl-L-methionine + 3-phenylpyruvate = S-adenosyl-L-homocysteine  + (3S)-2-oxo-3-phenylbutanoate (#2# the enzyme methylates the benzylic  C atom of phenylpyruvate to give 3-methylpyruvate, reaction mechanism,  structure-function analysis, overview <2>)  "
2.1.1.282, S-adenosyl-L-methionine +  7-[(3S)-(3-amino-3-carboxypropyl)]-4-demethylwyosine37 in tRNAPhe =  S-adenosyl-L-homocysteine + 7-[(3S)-(3-amino-3-carboxypropyl)]wyosine37  in tRNAPhe  
2.1.1.283, S-adenosyl-L-methionine + emodin = S-adenosyl-L-homocysteine + questin  
2.1.1.284, S-adenosyl-L-methionine + 8-demethylnovobiocic acid =  S-adenosyl-L-homocysteine + novobiocic acid  
2.1.1.285, S-adenosyl-L-methionine + demethyldecarbamoylnovobiocin =  S-adenosyl-L-homocysteine + decarbamoylnovobiocin  
2.1.1.286, S-adenosyl-L-methionine + adenine2142 in 25S rRNA =  S-adenosyl-L-homocysteine + N1-methyladenine2142 in 25S rRNA  
2.1.1.287, S-adenosyl-L-methionine + adenine645 in 25S rRNA =  S-adenosyl-L-homocysteine + N1-methyladenine645 in 25S rRNA  
2.1.1.288, S-adenosyl-L-methionine + aklanonate = S-adenosyl-L-homocysteine +  methyl aklanonate  
2.1.1.289, cobalt-precorrin-7 + S-adenosyl-L-methionine = cobalt-precorrin-8 +  S-adenosyl-L-homocysteine  
2.1.1.290, S-adenosyl-L-methionine + 7-[(3S)-3-amino-3-carboxypropyl]wyosine37 in  tRNAPhe = S-adenosyl-L-homocysteine +  7-[(3S)-3-amino-3-(methoxycarbonyl)propyl]wyosine37 in tRNAPhe  
2.1.1.291, S-adenosyl-L-methionine + (S)-reticuline = S-adenosyl-L-homocysteine +  (S)-laudanine (#2# (1) <2>) 
2.1.1.291, S-adenosyl-L-methionine + (R)-reticuline = S-adenosyl-L-homocysteine +  (R)-laudanine  
2.1.1.292, S-adenosyl-L-methionine + carminomycin = S-adenosyl-L-homocysteine +  daunorubicin  
2.1.1.293, S-adenosyl-L-methionine + 6-hydroxytryprostatin B =  S-adenosyl-L-homocysteine + tryprostatin A  
2.1.1.294," S-adenosyl-L-methionine +  3-O-phospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)  alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man  (1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho  ditrans,octacis-undecaprenol = S-adenosyl-L-homocysteine +  3-O-methylphospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1  >3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D  Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc  diphospho-ditrans,octacis-undecaprenol  "
2.1.1.295," S-adenosyl-L-methionine + 2-methyl-6-phytylbenzene-1,4-diol =  S-adenosyl-L-homocysteine + 2,3-dimethyl-6-phytylbenzene-1,4-diol (#1#  (1) <1>) "
2.1.1.295," S-adenosyl-L-methionine +  2-methyl-6-all-trans-nonaprenylbenzene-1,4-diol =  S-adenosyl-L-homocysteine + plastoquinol (#1# (2) <1>) "
2.1.1.295," S-adenosyl-L-methionine + 6-geranylgeranyl-2-methylbenzene-1,4-diol =  S-adenosyl-L-homocysteine +  6-geranylgeranyl-2,3-dimethylbenzene-1,4-diol (#1# (3) <1>)  "
2.1.1.296, S-adenosyl-L-methionine + a 5'-(N7-methyl  5'-triphosphoguanosine)-(2'-O-methyl-ribonucleotide)-(ribonucleotide)  [mRNA] = S-adenosyl-L-homocysteine + a 5'-(N7-methyl  5'-triphosphoguanosine)-(2'-O-methyl-ribonucleotide)-(2'-O-methyl  ribonucleotide)-[mRNA]  
2.1.1.297, S-adenosyl-L-methionine + [peptide chain release factor 1 or  2]-L-glutamine = S-adenosyl-L-homocysteine + [peptide chain release  factor 1 or 2]-N5-methyl-L-glutamine  
2.1.1.298, S-adenosyl-L-methionine + [ribosomal protein L3]-L-glutamine =  S-adenosyl-L-homocysteine + [ribosomal protein L3]-N5-methyl-L-glutamine  
2.1.1.299," S-adenosyl-L-methionine + N-terminal-(A,P,S)PK-[protein] =  S-adenosyl-L-homocysteine + N-terminal-N-methyl-N-(A,P,S)PK-[protein]  "
2.1.1.3, dimethylsulfonioacetate + L-homocysteine = (methylsulfanyl)acetate +  L-methionine (#1# mechanism <1>)  
2.1.1.300, S-adenosyl-L-methionine + (+/-)-pavine = S-adenosyl-L-homocysteine +  N-methylpavine  
2.1.1.301," 2 S-adenosyl-L-methionine + N-terminal L-alanine-[cypemycin] = 2  S-adenosyl-L-homocysteine + N-terminal  N,N-dimethyl-L-alanine-[cypemycin]  "
2.1.1.302, S-adenosyl-L-methionine + 3-hydroxy-5-methyl-1-naphthoate =  S-adenosyl-L-homocysteine + 3-methoxy-5-methyl-1-naphthoate  
2.1.1.303," S-adenosyl-L-methionine + 2,7-dihydroxy-5-methyl-1-naphthoate =  S-adenosyl-L-homocysteine + 2-hydroxy-7-methoxy-5-methyl-1-naphthoate  "
2.1.1.304, S-adenosyl-L-methionine + L-tyrosine = S-adenosyl-L-homocysteine +  3-methyl-L-tyrosine  
2.1.1.305, S-adenosyl-L-methionine + 8-demethyl-8-alpha-L-rhamnosyltetracenomycin  C = S-adenosyl-L-homocysteine +  8-demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C  
2.1.1.306," S-adenosyl-L-methionine +  8-demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C =  S-adenosyl-L-homocysteine +  8-demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C  "
2.1.1.307," S-adenosyl-L-methionine +  8-demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C =  S-adenosyl-L-homocysteine +  8-demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C  "
2.1.1.308," 2 S-adenosyl-L-methionine + cytidine  5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate} + reduced acceptor =  S-adenosyl-L-homocysteine + 5'-deoxyadenosine + L-methionine + cytidine  5'-{[hydroxy(2-hydroxypropyl)phosphonoyl]phosphate} + oxidized acceptor  (#2# proposed mechanism: a 5-deoxyadenosine radical generated from  reductive cleavage of S-adenosyl-L-methionine is used to abstract the  hydrogen atom from the C-H bond of the substrate resulting in a  substrate radical that reacts with methylcobalamin yielding  (S)-2-hydroxypropylphosphonate and cob(II)alamin <3>; #2# proposed  mechanism: one electron is transferred from the reduced ironÂ–sulfur  cluster to S-adenosyl-L-methionine to form an adenosyl radical and  methionine. The adenosyl radical abstracts the pro-R hydrogen atom from  C2 of (S)-2-hydroxyethylphosphonate, and the resulting substrate  radical reacts with methylcobalamin yielding  (S)-2-hydroxypropylphosphonate and cob(II)alamin. The enzyme is then  returned to the active state by reduction of the 4Fe4S cluster back to  the +1 state and binding of S-adenosyl-L-methionine and  methylcobalamin. Alternatively, cob(II)alamin might be reduced to  cob(I)alamin and methylated while bound to the enzyme <2>)  "
2.1.1.309, S-adenosyl-L-methionine + guanine1575 in 18S rRNA =  S-adenosyl-L-homocysteine + N7-methylguanine1575 in 18S rRNA  
2.1.1.310," S-adenosyl-L-methionine + cytosine2870 in 25S rRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine2870 in 25S rRNA (#2# one  of the catalytic cysteines in the m5C-MTase active site is required for  initial attack to target cytosine, while the second serves for  recycling function during the product release <2>)  "
2.1.1.311, S-adenosyl-L-methionine + cytosine2278 in 25S rRNA =  S-adenosyl-L-homocysteine + 5-methylcytosine2278 in 25S rRNA  
2.1.1.312, S-adenosyl-L-methionine + uracil2843 in 25S rRNA =  S-adenosyl-L-homocysteine + N3-methyluracil2843 in 25S rRNA  
2.1.1.313, S-adenosyl-L-methionine + uracil2634 in 25S rRNA =  S-adenosyl-L-homocysteine + N3-methyluracil2634 in 25S rRNA  
2.1.1.314, 4 S-adenosyl-L-methionine +  2-[(3S)-3-carboxy-3-aminopropyl]-L-histidine-[translation elongation  factor 2] = 4 S-adenosyl-L-homocysteine + diphthine methyl  ester-[translation elongation factor 2]  
2.1.1.315, S-adenosyl-L-methionine + 27-O-demethylrifamycin SV =  S-adenosyl-L-homocysteine + rifamycin SV  
2.1.1.316, S-adenosyl-L-methionine + 6-demethylmitomycin A =  S-adenosyl-L-homocysteine + mitomycin A (#1# (1) <2>) 
2.1.1.316, S-adenosyl-L-methionine + 6-demethylmitomycin B =  S-adenosyl-L-homocysteine + mitomycin B (#1# (2) <2>)  
2.1.1.317," S-adenosyl-L-methionine + a (4E,8E)-sphinga-4,8-dienine ceramide =  S-adenosyl-L-homocysteine + a 9-methyl-(4E,8E)-sphinga-4,8-dienine  ceramide  "
2.1.1.318, S-adenosyl-L-methionine + [trehalose-6-phosphate synthase]-L-cysteine =  S-adenosyl-L-homocysteine + [trehalose-6-phosphate  synthase]-S-methyl-L-cysteine  
2.1.1.319," 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2  S-adenosyl-L-homocysteine + [protein]-Nomega,Nomega-dimethyl-L-arginine "
2.1.1.319, S-adenosyl-L-methionine + [protein]-L-arginine =  S-adenosyl-L-homocysteine + [protein]-Nomega-methyl-L-arginine 
2.1.1.319," S-adenosyl-L-methionine + [protein]-Nomega-methyl-L-arginine =  S-adenosyl-L-homocysteine + [protein]-Nomega,Nomega-dimethyl-L-arginine  "
2.1.1.320, S-adenosyl-L-methionine + [protein]-L-arginine =  S-adenosyl-L-homocysteine + [protein]-Nomega-methyl-L-arginine 
2.1.1.320," 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2  S-adenosyl-L-homocysteine + [protein]-Nomega,Nomega'-dimethyl-L-arginine "
2.1.1.320," S-adenosyl-L-methionine + [protein]-Nomega-methyl-L-arginine =  S-adenosyl-L-homocysteine + [protein]-Nomega,Nomega'-dimethyl-L-arginine  "
2.1.1.321, S-adenosyl-L-methionine + [protein]-L-arginine =  S-adenosyl-L-homocysteine + [protein]-Nomega-methyl-L-arginine  
2.1.1.322, S-adenosyl-L-methionine + [protein]-L-arginine =  S-adenosyl-L-homocysteine + [protein]-N5-methyl-L-arginine  
2.1.1.323, S-adenosyl-L-methionine + (-)-pluviatolide = S-adenosyl-L-homocysteine  + (-)-bursehernin  
2.1.1.324," 2 S-adenosyl-L-methionine +  dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose = 2  S-adenosyl-L-homocysteine + dTDP-alpha-D-forosamine "
2.1.1.324," S-adenosyl-L-methionine +  dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose =  S-adenosyl-L-homocysteine +  dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose "
2.1.1.324," S-adenosyl-L-methionine +  dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose =  S-adenosyl-L-homocysteine + dTDP-alpha-D-forosamine  "
2.1.1.325," S-adenosyl-L-methionine + (2E,6E)-farnesoate =  S-adenosyl-L-homocysteine + methyl (2E,6E)-farnesoate "
2.1.1.325, S-adenosyl-L-methionine + juvenile hormone III acid =  S-adenosyl-L-homocysteine + juvenile hormone III  
2.1.1.326, 2 S-adenosyl-L-methionine + N-acetyldemethylphosphinothricin + reduced  acceptor = S-adenosyl-L-homocysteine + 5'-deoxyadenosine + L-methionine  + N-acetylphosphinothricin + oxidized acceptor  
2.1.1.327, S-adenosyl-L-methionine + phenazine-1-carboxylate =  S-adenosyl-L-homocysteine + 5-methylphenazine-1-carboxylate  
2.1.1.328, S-adenosyl-L-methionine + N-demethylindolmycin =  S-adenosyl-L-homocysteine + indolmycin  
2.1.1.329, S-adenosyl-L-methionine + demethylphylloquinol =  S-adenosyl-L-homocysteine + phylloquinol  
2.1.1.33, S-adenosyl-L-methionine + guanine46 in tRNA = S-adenosyl-L-homocysteine  + N7-methylguanine46 in tRNA (#1# mechanism <9>)  
2.1.1.330, S-adenosyl-L-methionine + (-)-5'-demethylyatein =  S-adenosyl-L-homocysteine + (-)-yatein  
2.1.1.331," S-adenosyl-L-methionine +  8-ethyl-12-methyl-3-vinylbacteriochlorophyllide d =  S-adenosyl-L-homocysteine + 8,12-diethyl-3-vinylbacteriochlorophyllide d  "
2.1.1.332," S-adenosyl-L-methionine + 8,12-diethyl-3-vinylbacteriochlorophyllide d  = S-adenosyl-L-homocysteine +  12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d "
2.1.1.332, S-adenosyl-L-methionine +  12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d =  S-adenosyl-L-homocysteine +  12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d  
2.1.1.333, S-adenosyl-L-methionine + a bacteriochlorophyllide d =  S-adenosyl-L-homocysteine + a bacteriochlorophyllide c  
2.1.1.334, S-adenosyl-L-methionine + methanethiol = S-adenosyl-L-homocysteine +  dimethyl sulfide  
2.1.1.335, S-adenosyl-L-methionine +  4-amino-4-de(dimethylamino)anhydrotetracycline =  S-adenosyl-L-homocysteine +  4-methylamino-4-de(dimethylamino)anhydrotetracycline 
2.1.1.335, S-adenosyl-L-methionine +  4-methylamino-4-de(dimethylamino)anhydrotetracycline =  S-adenosyl-L-homocysteine + anhydrotetracycline  
2.1.1.336, S-adenosyl-L-methionine + norbelladine = S-adenosyl-L-homocysteine +  4'-O-methylnorbelladine  
2.1.1.337, S-adenosyl-L-methionine + (S)-reticuline = S-adenosyl-L-homocysteine +  (S)-tembetarine 
2.1.1.337, S-adenosyl-L-methionine + (S)-corytuberine = S-adenosyl-L-homocysteine  + (S)-magnoflorine  
2.1.1.338, S-adenosyl-L-methionine + desmethylxanthohumol =  S-adenosyl-L-homocysteine + xanthohumol  
2.1.1.339, S-adenosyl-L-methionine + xanthohumol = S-adenosyl-L-homocysteine +  4-O-methylxanthohumol  
2.1.1.34," S-adenosyl-L-methionine + guanosine18 in tRNA =  S-adenosyl-L-homocysteine + 2'-O-methylguanosine18 in tRNA (#1#  substrate recognition sites and mechanism <3,5,6,7>; #1# G18, G19 and  the D-stem of the tRNA are required for Gm-methylase recognition <7,8>;  #6# methylation site <9>; #6# mechanism, upon binding of guanine 18, a  RNA main chain phosphate group activates R41, which then deprotonates  the 2-OH-group for methylation <13>)  "
2.1.1.340, 2 S-adenosyl-L-methionine + 3-(aminomethyl)indole = 2  S-adenosyl-L-homocysteine + gramine 
2.1.1.340, S-adenosyl-L-methionine + 3-(aminomethyl)indole =  S-adenosyl-L-homocysteine + (1H-indol-3-yl)-N-methylmethanamine 
2.1.1.340, S-adenosyl-L-methionine + (1H-indol-3-yl)-N-methylmethanamine =  S-adenosyl-L-homocysteine + gramine  
2.1.1.341, vanillate + tetrahydrofolate = protocatechuate +  5-methyltetrahydrofolate 
2.1.1.341, 3-O-methylgallate + tetrahydrofolate = gallate +  5-methyltetrahydrofolate  
2.1.1.342, 2 S-adenosyl-L-methionine + protoheme + 2 reduced flavodoxin =  S-adenosyl-L-homocysteine + L-methionine + 5'-deoxyadenosine +  anaerobilin + Fe2+ + 2 oxidized flavodoxin  
2.1.1.343," 2 S-adenosyl-L-methionine + 8-amino-8-demethylriboflavin = 2  S-adenosyl-L-homocysteine + roseoflavin (#1# roseoflavin, i.e.  1-deoxy-1-[8-(dimethylamino)-7-methyl-2,4-dioxo-3  4-dihydrobenzo[g]pteridin-10(2H)-yl]pentitol, a two-step methylation  reaction <1>) "
2.1.1.343, S-adenosyl-L-methionine + 8-amino-8-demethylriboflavin =  S-adenosyl-L-homocysteine + 8-demethyl-8-(methylamino)riboflavin (#1#  1a <1>) 
2.1.1.343, S-adenosyl-L-methionine + 8-demethyl-8-(methylamino)riboflavin =  S-adenosyl-L-homocysteine + roseoflavin (#1# 1b <1>)  
2.1.1.344," 3 S-adenosyl-L-methionine + an ornithine lipid = 3  S-adenosyl-L-homocysteine + an N,N,N-trimethylornithine lipid "
2.1.1.344, S-adenosyl-L-methionine + an ornithine lipid =  S-adenosyl-L-homocysteine + an N-methylornithine lipid 
2.1.1.344," S-adenosyl-L-methionine + an N-methylornithine lipid =  S-adenosyl-L-homocysteine + an N,N-dimethylornithine lipid "
2.1.1.344," S-adenosyl-L-methionine + an N,N-dimethylornithine lipid =  S-adenosyl-L-homocysteine + an N,N,N-trimethylornithine lipid  "
2.1.1.345, 2 S-adenosyl-L-methionine + 4-hydroxytryptamine 4-phosphate = 2  S-adenosyl-L-homocysteine + psilocybin 
2.1.1.345, S-adenosyl-L-methionine + 4-hydroxytryptamine 4-phosphate =  S-adenosyl-L-homocysteine + 4-hydroxy-N-methyltryptamine 4-phosphate 
2.1.1.345, S-adenosyl-L-methionine + 4-hydroxy-N-methyltryptamine 4-phosphate =  S-adenosyl-L-homocysteine + psilocybin  
2.1.1.346, S-adenosyl-L-methionine + adenine in U6 snRNA =  S-adenosyl-L-homocysteine + N6-methyladenine in U6 snRNA  
2.1.1.347, S-adenosyl-L-methionine + adenine in U6 snRNA =  S-adenosyl-L-homocysteine + N6-methyladenine in U6 snRNA 
2.1.1.347, S-adenosyl-L-methionine + (+)-kolavelool = S-adenosyl-L-homocysteine +  (+)-O-methylkolavelool  
2.1.1.348, S-adenosyl-L-methionine + adenine in mRNA = S-adenosyl-L-homocysteine +  N6-methyladenine in mRNA  
2.1.1.349," S-adenosyl-L-methionine + 1,6-didemethyltoxoflavin =  S-adenosyl-L-homocysteine + reumycin "
2.1.1.349, S-adenosyl-L-methionine + reumycin = S-adenosyl-L-homocysteine +  toxoflavin  
2.1.1.35," S-adenosyl-L-methionine + uracil54 in tRNA = S-adenosyl-L-homocysteine  + 5-methyluracil54 in tRNA (#3# catalytic mechanism <9,11,18,19,23>;  #3# steric course of methyl transfer <14,16,19>; #3# single SN2  displacement mechanism <14,16>; #3# detailed chemical and enzymatic  mechanism <16>; #3# kinetic, sequential mechanism <10>)  "
2.1.1.350, 2 S-adenosyl-L-methionine + a menaquinone + reduced flavodoxin =  S-adenosyl-L-homocysteine + L-methionine + 5'-deoxyadenosine + an  8-methylmenaquinone + oxidized flavodoxin 
2.1.1.350, 2 S-adenosyl-L-methionine + a 2-demethylmenaquinone + reduced  flavodoxin = S-adenosyl-L-homocysteine + L-methionine +  5'-deoxyadenosine + a 2-demethyl-8-methylmenaquinone + oxidized  flavodoxin  
2.1.1.351, S-adenosyl-L-methionine + nocamycin E = S-adenosyl-L-homocysteine +  nocamycin I  
2.1.1.352, S-adenosyl-L-methionine + 3-O-acetyl-4'-O-demethylpapaveroxine =  S-adenosyl-L-homocysteine + 3-O-acetylpapaveroxine  
2.1.1.353, S-adenosyl-L-methionine + demethylluteothin = S-adenosyl-L-homocysteine  + luteothin  
2.1.1.354," S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine  + histone N6-methyl-L-lysine (#3# enzyme is encoded on genes containing  the SET-domain sequence, substrate specificity is connected to SET  sequence <1>; #3# SET structure <1>) "
2.1.1.354," 3 S-adenosyl-L-methionine + a [histone H3]-L-lysine4 = 3  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine4 "
2.1.1.354, S-adenosyl-L-methionine + a [histone H3]-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine4 
2.1.1.354," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine4 "
2.1.1.354," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine4  "
2.1.1.355," S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine  + histone N6-methyl-L-lysine (#5# enzyme is encoded on genes containing  the SET-domain sequence, substrate specificity is connected to SET  sequence <2>; #5# SET structure <2>; #2,5# H3-Lys9 methylation is  catalyzed by the Suv39h family proteins <1,2>) "
2.1.1.355," 3 S-adenosyl-L-methionine + a [histone H3]-L-lysine9 = 3  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine9 "
2.1.1.355, S-adenosyl-L-methionine + a [histone H3]-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine9 
2.1.1.355," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine9 "
2.1.1.355," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine9  "
2.1.1.356," 3 S-adenosyl-L-methionine + a [histone H3]-L-lysine27 = 3  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine27 "
2.1.1.356, S-adenosyl-L-methionine + a [histone H3]-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine27 
2.1.1.356," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine27 "
2.1.1.356," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine27  "
2.1.1.357," 2 S-adenosyl-L-methionine + a [histone H3]-L-lysine36 = 2  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine36 "
2.1.1.357, S-adenosyl-L-methionine + a [histone H3]-L-lysine36 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine36 
2.1.1.357," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine36 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine36  "
2.1.1.359, S-adenosyl-L-methionine + a [histone H3]-L-lysine36 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine36 
2.1.1.359," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine36 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine36 "
2.1.1.359," 3 S-adenosyl-L-methionine + a [histone H3]-L-lysine36 = 3  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine36 "
2.1.1.359," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine36 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine36  "
2.1.1.360," 3 S-adenosyl-L-methionine + a [histone H3]-L-lysine79 = 3  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine79 "
2.1.1.360, S-adenosyl-L-methionine + a [histone H3]-L-lysine79 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine79 
2.1.1.360," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine79 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine79 "
2.1.1.360," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine79 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine79  "
2.1.1.361, S-adenosyl-L-methionine + a [histone H4]-L-lysine20 =  S-adenosyl-L-homocysteine + a [histone H4]-N6-methyl-L-lysine20  
2.1.1.362," S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine  + histone N6-methyl-L-lysine (#3,4# amino acid sequence comparison <1>;  #1,3,4# enzyme is encoded on genes containing the SET-domain sequence,  substrate specificity is connected to SET sequence <1>) "
2.1.1.362," S-adenosyl-L-methionine + a [histone H4]-N6-methyl-L-lysine20 =  S-adenosyl-L-homocysteine + a [histone H4]-N6,N6-dimethyl-L-lysine20  "
2.1.1.363," S-adenosyl-L-methionine + (2E,6E)-farnesyl diphosphate =  S-adenosyl-L-homocysteine + pre-sodorifen diphosphate  "
2.1.1.364, S-adenosyl-L-methionine + a [histone H3]-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine4  
2.1.1.365," S-adenosyl-L-methionine + 3,3'-di-O-methyl-4alpha-mannobiose =  S-adenosyl-L-homocysteine + 1,3,3'-tri-O-methyl-4alpha-mannobiose  "
2.1.1.366," S-adenosyl-L-methionine + a [histone H3]-N6,N6-dimethyl-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6,N6-trimethyl-L-lysine9  "
2.1.1.367, S-adenosyl-L-methionine + a [histone H3]-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine9  
2.1.1.368, S-adenosyl-L-methionine + a [histone H3]-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine9 
2.1.1.368," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine9 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine9 "
2.1.1.368," 2 S-adenosyl-L-methionine + a [histone H3]-L-lysine9 = 2  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine9  "
2.1.1.369, S-adenosyl-L-methionine + a [histone H3]-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine27  
2.1.1.37," S-adenosyl-L-methionine + DNA containing cytosine =  S-adenosyl-L-homocysteine + DNA containing 5-methylcytosine (#33#  sequential mechanism <31>; #8# random sequential mechanism <14>; #4#  sequential ordered bi-bi kinetic mechanism in which DNA binds to the  enzyme first, followed by S-adenosyl-L-homocysteine and methylated DNA  are released, formation of an enzyme-DNA-DNA ternary complex <29>; #19#  catalytic reaction mechanism <66>; #33# catalytic reaction mechanism of  Dnmt1, allosteric regulation with fast equilibrium, and substrate  specificity. Base-flipping and base-stacking are the key mechanism in  control of enzymatic activity, detailed overview <71>; #6# catalytic  reaction mechanism of Dnmt1, overview <70>; #23# the TSM biosensor  method to study the interaction of M.SsoII with a 60 bp double-stranded  DNA immobilized on the surface of a thickness shear mode (TSM) acoustic  transducer. M.SsoII demonstrates a strong binding with any DNA duplex  immobilized on the TSM transducer surface <92>)  "
2.1.1.370, S-adenosyl-L-methionine + a [histone H3]-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine4 
2.1.1.370," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine4 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine4 "
2.1.1.370," 2 S-adenosyl-L-methionine + a [histone H3]-L-lysine4 = 2  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine4  "
2.1.1.371, S-adenosyl-L-methionine + a [histone H3]-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6-methyl-L-lysine27 
2.1.1.371," S-adenosyl-L-methionine + a [histone H3]-N6-methyl-L-lysine27 =  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine27 "
2.1.1.371," 2 S-adenosyl-L-methionine + a [histone H3]-L-lysine27 = 2  S-adenosyl-L-homocysteine + a [histone H3]-N6,N6-dimethyl-L-lysine27  "
2.1.1.372, S-adenosyl-L-methionine + a [histone H4]-L-lysine20 =  S-adenosyl-L-homocysteine + a [histone H4]-N6-methyl-L-lysine20 
2.1.1.372," S-adenosyl-L-methionine + a [histone H4]-N6-methyl-L-lysine20 =  S-adenosyl-L-homocysteine + a [histone H4]-N6,N6-dimethyl-L-lysine20 "
2.1.1.372," 3 S-adenosyl-L-methionine + a [histone H4]-L-lysine20 = 3  S-adenosyl-L-homocysteine + a [histone H4]-N6,N6,N6-trimethyl-L-lysine20 "
2.1.1.372," S-adenosyl-L-methionine + a [histone H4]-N6,N6-dimethyl-L-lysine20 =  S-adenosyl-L-homocysteine + a [histone H4]-N6,N6,N6-trimethyl-L-lysine20  "
2.1.1.373, S-adenosyl-L-methionine + (2R)-2-hydroxy-4-(methylsulfanyl)butanoate =  S-adenosyl-L-homocysteine +  (2R)-4-(dimethylsulfaniumyl)-2-hydroxybutanoate  
2.1.1.374, S-adenosyl-L-methionine + 2-heptyl-1-hydroxyquinolin-4(1H)-one =  S-adenosyl-L-homocysteine + 2-heptyl-1-methoxyquinolin-4(1H)-one  
2.1.1.375, 2 S-adenosyl-L-methionine + G(5')pppAACA-[mRNA] = 2  S-adenosyl-L-homocysteine + m7G(5')pppAmACA-[mRNA] 
2.1.1.375, S-adenosyl-L-methionine + G(5')pppAACA-[mRNA] =  S-adenosyl-L-homocysteine + G(5')pppAmACA-[mRNA] 
2.1.1.375, S-adenosyl-L-methionine + G(5')pppAmACA-[mRNA] =  S-adenosyl-L-homocysteine + m7G(5')pppAmACA-[mRNA]  
2.1.1.376," glycine betaine + a [Co(I) glycine betaine-specific corrinoid protein]  = N,N-dimethylglycine + a [methyl-Co(III) glycine betaine-specific  corrinoid protein]  "
2.1.1.377, a [methyl-Co(III) glycine betaine-specific corrinoid protein] + CoM =  methyl-CoM + a [Co(I) glycine betaine-specific corrinoid protein]  
2.1.1.378, a [methyl-Co(III) glycine betaine-specific corrinoid protein] +  tetrahydrofolate = a [Co(I) glycine betaine-specific corrinoid protein]  + 5-methyltetrahydrofolate  
2.1.1.379, 2 S-adenosyl-L-methionine + a [methyl coenzyme-M reductase]-L-arginine  + reduced acceptor = S-adenosyl-L-homocysteine + L-methionine +  5'-deoxyadenosine + a [methyl coenzyme-M  reductase]-(5S)-C-methyl-L-arginine + acceptor  
2.1.1.38, S-adenosyl-L-methionine + O-demethylpuromycin =  S-adenosyl-L-homocysteine + puromycin  
2.1.1.380," S-adenosyl-L-methionine + 3-amino-2,4-dihydroxybenzoate =  S-adenosyl-L-homocysteine + 3-amino-2-hydroxy-4-methoxybenzoate  "
2.1.1.381, S-adenosyl-L-methionine + L-arginine = S-adenosyl-L-homocysteine +  Nomega-methyl-L-arginine  
2.1.1.383, L-carnitine + a [Co(I) quaternary-amine-specific corrinoid protein] = a  [methyl-Co(III) quaternary-amine-specific corrinoid protein] +  L-norcarnitine  
2.1.1.39, S-adenosyl-L-methionine + myo-inositol = S-adenosyl-L-homocysteine +  1D-3-O-methyl-myo-inositol  
2.1.1.4," S-adenosyl-L-methionine + N-acetylserotonin = S-adenosyl-L-homocysteine  + melatonin (#1,3,4,5,14# reaction sequence is ordered bi-bi type  <5,6>; #1,3,4,5,15# addition of S-adenosyl-L-methionine occuring first  followed by N-acetylserotonin <5,14>; #16# modeling of the catalytic  mechanism <37>)  "
2.1.1.40, S-adenosyl-L-methionine + myo-inositol = S-adenosyl-L-homocysteine +  1D-1-O-methyl-myo-inositol  
2.1.1.41," S-adenosyl-L-methionine + 5alpha-cholesta-8,24-dien-3beta-ol =  S-adenosyl-L-homocysteine + 24-methylene-5alpha-cholest-8-en-3beta-ol  (#1,4# mechanism <2,8,9,10,11,13>; #1# substrate analogue inhibitor  binding site structure <14>; #1# kinetic and inhibition mechanism  <9,10,13>; #1,4# active site model, termed steric-electric plug model,  consists of a non-covalent mechanism involving the intermediacy of a  24beta-methyl (or ethyl) sterol bound to the ternary complex <8>;  #1,4,7# substrate binding, amino acid sequence <8,11,12>)  "
2.1.1.42, S-adenosyl-L-methionine + 3'-hydroxyflavone = S-adenosyl-L-homocysteine  + 3'-methoxyflavone  
2.1.1.44," S-adenosyl-L-methionine + Nalpha,Nalpha-dimethyl-L-histidine =  S-adenosyl-L-homocysteine + hercynine "
2.1.1.44, S-adenosyl-L-methionine + L-histidine = S-adenosyl-L-homocysteine +  Nalpha-methyl-L-histidine 
2.1.1.44," S-adenosyl-L-methionine + Nalpha-methyl-L-histidine =  S-adenosyl-L-homocysteine + Nalpha,Nalpha-dimethyl-L-histidine "
2.1.1.44, 3 S-adenosyl-L-methionine + L-histidine = 3 S-adenosyl-L-homocysteine +  hercynine  
2.1.1.45," 5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP (#77# O2  and methylenetetrahydrofolate compete for the reduced enzyme after dUMP  binding. dUMP enhances the rate of the oxidative half reaction and  while the oxidase reaction is faster than the reaction with  methylenetetrahydrofolate, this cofactor slows down the consumption of  NADPH in the presence of O2 in accordance with substrate competition.  dUMP, the substrate of the oxidative half reaction does not affect the  reductive half reaction. In the absence of the second substrate  methylenetetrahydrofolate, dUMP enhances the reaction of molecular  oxygen with the reduced enzyme <88>)  "
2.1.1.46, S-adenosyl-L-methionine + a 4'-hydroxyisoflavone =  S-adenosyl-L-homocysteine + a 4'-methoxyisoflavone  
2.1.1.47, S-adenosyl-L-methionine + (indol-3-yl)pyruvate =  S-adenosyl-L-homocysteine + (R)-3-(indol-3-yl)-2-oxobutanoate  
2.1.1.49, S-adenosyl-L-methionine + an amine = S-adenosyl-L-homocysteine + a  methylated amine  
2.1.1.5," betaine + L-homocysteine = dimethylglycine + L-methionine (#4#  mechanism <7>; #5# ordered bi-bi mechanism with homocysteine the first  substrate to be added and methionine the last product released <3,8>)  "
2.1.1.50, S-adenosyl-L-methionine + loganate = S-adenosyl-L-homocysteine + loganin  
2.1.1.53, S-adenosyl-L-methionine + putrescine = S-adenosyl-L-homocysteine +  N-methylputrescine  
2.1.1.54," 5,10-methylenetetrahydrofolate + dCMP = dihydrofolate +  deoxy-5-methylcytidylate  "
2.1.1.55, S-adenosyl-L-methionine + tRNA = S-adenosyl-L-homocysteine + tRNA  containing N6-methyladenine  
2.1.1.56," S-adenosyl-L-methionine + a 5'-(5'-triphosphoguanosine)-[mRNA] =  S-adenosyl-L-homocysteine + a 5'-(N7-methyl  5'-triphosphoguanosine)-[mRNA] (#6# subunit interaction in vitro and in  vivo is a necessary condition for full enzyme activity <19>;  #6,10,12,13,14# RNA triphosphatase, RNA guanylyltransferase, and RNA  (guanine-N7-)methyltransferase form the mRNA capping enzyme complex  consiting of a small and a large subunit <6,7,14,16,18,19,21,23>; #6#  substrate binding sites <23>; #6# active site is located at His682 and  Tyr683 <19>; #10# lipid-binding site, membrane binding activity of  wild-type and diverse mutants <16>; #18# in-line mechanism of methyl  transfer without direct contact between the enzyme and the N7 atom of  guanine, which is the attacking nucleophile, the methyl carbon of  S-adenosyl-L-methionine, or the sulfur of  S-adenosyl-L-methionine/S-adenosyl-L-homocysteine, enzyme-ligand  structures, active site structure <25>)  "
2.1.1.57," S-adenosyl-L-methionine + a 5'-(N7-methyl  5'-triphosphoguanosine)-(ribonucleotide)-[mRNA] =  S-adenosyl-L-homocysteine + a 5'-(N7-methyl  5'-triphosphoguanosine)-(2'-O-methyl-ribonucleotide)-[mRNA] (#2#  binding sites of the enzyme for the terminal cap nucleotide, m7G, the  cap-proximal RNA, and for RNA, immediately downstream, are  characterized <10>; #2# R may be guanine or adenosine, mechanism <5>;  #14# nucleotide binding analysis based on crystal structure <11>; #2#  simple one-step reaction mechanism, only the positively charged keto  tautomer of the cap is recognized and bound. Binding is achieved almost  entirely by the interactions of m7guanosine with two aromatic residues  in a cation-pi sandwich <14>)  "
2.1.1.59," S-adenosyl-L-methionine + [cytochrome c]-L-lysine =  S-adenosyl-L-homocysteine + [cytochrome c]-N6-methyl-L-lysine (#3,4#  specific methylation site, 1 lysine in cytochrome c, comparison  <1,2,3>; #3# hybrid ping-pong mechanism <6>)  "
2.1.1.6," S-adenosyl-L-methionine + a catechol = S-adenosyl-L-homocysteine + a  guaiacol (#4,5# mechanism <16,40>; #4,5# ordered reaction mechanism  with S-adenosyl-L-methionine as the leading substrate <4,18,28,30>; #5#  study on mechanism <49>)  "
2.1.1.60, S-adenosyl-L-methionine + calmodulin L-lysine =  S-adenosyl-L-homocysteine + calmodulin N6-methyl-L-lysine (#3# Bi Bi  sequential mechanism <8>)  
2.1.1.61, S-adenosyl-L-methionine + tRNA containing 5-(aminomethyl)-2-thiouridine  = S-adenosyl-L-homocysteine + tRNA containing  5-[(methylamino)methyl]-2-thiouridylate (#2# mechanismn <2>)  
2.1.1.62," S-adenosyl-L-methionine + a 5-(N7-methyl  5-triphosphoguanosine)-2'-O-methyladenosine-[mRNA] =  S-adenosyl-L-homocysteine + a 5-(N7-methyl  5-triphosphoguanosine)-N6,2'-O-dimethyladenosine-[mRNA]  "
2.1.1.63, DNA (containing 6-O-methylguanine) + protein L-cysteine = DNA (without  6-O-methylguanine) + protein S-methyl-L-cysteine 
2.1.1.63, DNA (containing 4-O-methylthymine) + protein L-cysteine = DNA (without  4-O-methylthymine) + protein S-methyl-L-cysteine  
2.1.1.64, S-adenosyl-L-methionine + 3-demethylubiquinol-n =  S-adenosyl-L-homocysteine + ubiquinol-n  
2.1.1.65, S-adenosyl-L-methionine + licodione = S-adenosyl-L-homocysteine +  2'-O-methyllicodione  
2.1.1.67, S-adenosyl-L-methionine + a thiopurine = S-adenosyl-L-homocysteine + a  thiopurine S-methylether  
2.1.1.68," S-adenosyl-L-methionine + 3,4-dihydroxy-trans-cinnamate =  S-adenosyl-L-homocysteine + 3-methoxy-4-hydroxy-trans-cinnamate (#8#  mechanism <16>)  "
2.1.1.69, S-adenosyl-L-methionine + a 5-hydroxyfurocoumarin =  S-adenosyl-L-homocysteine + a 5-methoxyfurocoumarin 
2.1.1.69, S-adenosyl-L-methionine + bergaptol = S-adenosyl-L-homocysteine +  bergapten  
2.1.1.7, S-adenosyl-L-methionine + nicotinate = S-adenosyl-L-homocysteine +  N-methylnicotinate  
2.1.1.70, S-adenosyl-L-methionine + an 8-hydroxyfurocoumarin =  S-adenosyl-L-homocysteine + an 8-methoxyfurocoumarin 
2.1.1.70, S-adenosyl-L-methionine + xanthotoxol = S-adenosyl-L-homocysteine +  xanthotoxin  
2.1.1.71, S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine =  S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine  
2.1.1.72," S-adenosyl-L-methionine + adenine in DNA = S-adenosyl-L-homocysteine +  N6-methyladenine in DNA (#24# steady-state-ordered bi-bi mechanism in  which the order of substrate binding and product release is  S-adenosyl-L-methionine, DNA, DNAMe, S-adenosyl-L-homocysteine <6>;  #60# active site structure, enzyme-methyl donor product interactions,  substrate binding mechanism and conformational changes, overview <29>;  #7# D181 and Y184 are essential for activity <26>; #24# molecular  mechanism, effector action of substrates, progressive methylation of  extended DNA containing more than one methylation site <27>; #24#  ordered bi bi mechanism during progressive methylation process <23>;  #22# ordered bi bi mechanism with S-adenosyl-L-homocysteine leaving at  last, cooperative binding of 2 molecules of enzyme per DNA is required  for activity <24>; #7# ordered bi bi mechanism with  S-adenosyl-L-methionine binding first, fast methyl transfer, slow  product release <25>; #25# reaction scheme and random bi bi kinetic  mechanism <20>; #24# two distinct stages of methylation under single  turnover conditions <22>)  "
2.1.1.74," 5,10-methylenetetrahydrofolate + uracil54 in tRNA + NAD(P)H + H+ =  tetrahydrofolate + 5-methyluracil54 in tRNA + NAD(P)+ (#14# catalytic  mechanism and active site structure, the methylene of MTHF is directly  transferred onto U54, and then the exocyclic methylene of U54 is  reduced by FADH2, overview <7>)  "
2.1.1.75, S-adenosyl-L-methionine + apigenin = S-adenosyl-L-homocysteine +  acacetin  
2.1.1.76," S-adenosyl-L-methionine + 3,5,7,3',4'-pentahydroxyflavone =  S-adenosyl-L-homocysteine + 3-methoxy-5,7,3',4'-tetrahydroxyflavone  (#7# ordered sequential bi-bi mechanism <6>)  "
2.1.1.77, S-adenosyl-L-methionine + protein L-isoaspartate =  S-adenosyl-L-homocysteine + protein L-isoaspartate alpha-methyl ester  
2.1.1.78, S-adenosyl-L-methionine + isoorientin = S-adenosyl-L-homocysteine +  isoscoparin  
2.1.1.79," S-adenosyl-L-methionine + phospholipid olefinic fatty acid =  S-adenosyl-L-homocysteine + phospholipid cyclopropane fatty acid (#3#  both chemical steps of the enzymatic cyclopropanation, the methyl  addition onto the double bond and the deprotonation step, are rate  determining <26>)  "
2.1.1.8," S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine +  Ntau-methylhistamine (#1# 2 half-reactions in a ping pong mechanism  with the intermediate formation of a methylated enzyme <18>; #3#  ordered sequential bi bi reaction mechanism with S-adenosylmethionine  as the first substrate and histamine as the second substrate,  1-methylhistamine is the first product to leave and  S-adenosylhomocysteine the second <4>; #3# sequential reaction  mechanism <4>; #6# ordered steady state mechanism with  S-adenosylmethionine being the first substrate to bind to the enzyme  and N-methylhistamine being the first product to dissociate <12>)  "
2.1.1.80," S-adenosyl-L-methionine + protein L-glutamate =  S-adenosyl-L-homocysteine + protein L-glutamate methyl ester (#1#  random mechanism with no abortive complexes being formed, sequential  random bi bi mechanism <10>)  "
2.1.1.82," S-adenosyl-L-methionine + 5,7,3',4'-tetrahydroxy-3-methoxyflavone =  S-adenosyl-L-homocysteine + 5,3',4'-trihydroxy-3,7-dimethoxyflavone  (#3# ordered bi bi mechanism, S-adenosyl-L-methionine binds first,  S-adenosyl-L-homocysteine is the last product released <2>)  "
2.1.1.83," S-adenosyl-L-methionine + 5,3',4'-trihydroxy-3,7-dimethoxyflavone =  S-adenosyl-L-homocysteine + 5,3'-dihydroxy-3,7,4'-trimethoxyflavone  (#1# mechanism <2>)  "
2.1.1.84," S-adenosyl-L-methionine + 5,6,3',4'-tetrahydroxy-3,7-dimethoxyflavone =  S-adenosyl-L-homocysteine + 5,3',4'-trihydroxy-3,6,7-trimethoxyflavone  (#1# mechanism <2>)  "
2.1.1.85, S-adenosyl-L-methionine + protein L-histidine =  S-adenosyl-L-homocysteine + protein Ntau-methyl-L-histidine  
2.1.1.86," 5-methyl-5,6,7,8-tetrahydromethanopterin + CoM + 2 Na+/in =  5,6,7,8-tetrahydromethanopterin + 2-(methylsulfanyl)ethane-1-sulfonate  + 2 Na+/out  "
2.1.1.87, S-adenosyl-L-methionine + pyridine = S-adenosyl-L-homocysteine +  N-methylpyridinium  
2.1.1.88," S-adenosyl-L-methionine + 3,5,7,8,3',4'-hexahydroxyflavone =  S-adenosyl-L-homocysteine + 3,5,7,3',4'-pentahydroxy-8-methoxyflavone  (#1# mechanism <1>)  "
2.1.1.89," S-adenosyl-L-methionine + 5,8,13,13a-tetrahydrocolumbamine =  S-adenosyl-L-homocysteine + tetrahydropalmatine  "
2.1.1.9, S-adenosyl-L-methionine + a thiol = S-adenosyl-L-homocysteine + a  methyl thioether (#5# mechanism <3>)  
2.1.1.90, methanol + a [Co(I) methanol-specific corrinoid protein] = a  [methyl-Co(III) methanol-specific corrinoid protein] + H2O  
2.1.1.91, S-adenosyl-L-methionine + 2-methylpropanal oxime =  S-adenosyl-L-homocysteine + 2-methylpropanal O-methyloxime  
2.1.1.94, S-adenosyl-L-methionine + 16-hydroxytabersonine =  S-adenosyl-L-homocysteine + 16-methoxytabersonine  
2.1.1.95, S-adenosyl-L-methionine + gamma-tocopherol = S-adenosyl-L-homocysteine  + alpha-tocopherol 
2.1.1.95, S-adenosyl-L-methionine + delta-tocopherol = S-adenosyl-L-homocysteine  + beta-tocopherol 
2.1.1.95, S-adenosyl-L-methionine + gamma-tocotrienol = S-adenosyl-L-homocysteine  + alpha-tocotrienol 
2.1.1.95, S-adenosyl-L-methionine + delta-tocotrienol = S-adenosyl-L-homocysteine  + beta-tocotrienol  
2.1.1.96, S-adenosyl-L-methionine + dimethyl sulfide = S-adenosyl-L-homocysteine  + trimethylsulfonium  
2.1.1.97, S-adenosyl-L-methionine + 3-hydroxyanthranilate =  S-adenosyl-L-homocysteine + 3-hydroxy-4-methylanthranilate  
2.1.1.98, 3 S-adenosyl-L-methionine +  2-[(3S)-3-carboxy-3-aminopropyl]-L-histidine-[translation elongation  factor 2] = 3 S-adenosyl-L-homocysteine + diphthine-[translation  elongation factor 2] 
2.1.1.98, S-adenosyl-L-methionine +  2-[(3S)-3-carboxy-3-aminopropyl]-L-histidine-[translation elongation  factor 2] = S-adenosyl-L-homocysteine +  2-[(3S)-3-carboxy-3-(methylamino)propyl]-L-histidine-[translation  elongation factor 2] 
2.1.1.98, S-adenosyl-L-methionine +  2-[(3S)-3-carboxy-3-(methylamino)propyl]-L-histidine-[translation  elongation factor 2] = S-adenosyl-L-homocysteine +  2-[(3S)-3-carboxy-3-(dimethylamino)propyl]-L-histidine-[translation  elongation factor 2] 
2.1.1.98, S-adenosyl-L-methionine +  2-[(3S)-3-carboxy-3-(dimethylamino)propyl]-L-histidine-[translation  elongation factor 2] = S-adenosyl-L-homocysteine +  diphthine-[translation elongation factor 2]  
2.1.1.99," S-adenosyl-L-methionine + 3-hydroxy-16-methoxy-2,3-dihydrotabersonine =  S-adenosyl-L-homocysteine + deacetoxyvindoline (#1# summerization of  biosynthetic pathway of vindoline <2,3>)  "
2.1.2.1," 5,10-methylenetetrahydrofolate + glycine + H2O = tetrahydrofolate +  L-serine (#1,2,4,5,6,9,11,13,14,17,22,42,67# mechanism  <10,11,12,13,14,19,21,22,23,24,25,26,30,36,38,40,42>; #1,2,9,11,14,17#  stereochemistry <23,25,26>; #2,5,6,7,11,14,17,20,27# enzyme exhibits  threonine aldolase activity (EC 4.1.2.5), but the two enzymes are  distinct <40>; #13# evidence for a direct transfer mechanism for the  enzyme catalysed reaction <37>; #3,5# general mechanism of pyridoxal  5-phosphate-catalyzed aldolic cleavage, racemisation, and  transamination reactions, and catalytic mechanism of the  transaldimination reaction involving Tyr55, His228, and Arg235,  overview. Tyr55 is contributed by the symmetry-related monomer, with  respect to the pyridoxal 5-phosphate-binding subunit, and functions as  the general acid-base catalyst in this proton transfer <94>)  "
2.1.2.10," [protein]-S8-aminomethyldihydrolipoyllysine + tetrahydrofolate =  [protein]-dihydrolipoyllysine + 5,10-methylenetetrahydrofolate + NH3  (#12# 5-methyltetrahydrofolate is bound in a kinked shape with the  pteridine group deeply buried into the hydrophobic pocket ant the  glutamyl group pointed to the C-terminal side surface. R292 interacts  through water molecules with the folate polyglutamate tail <11>; #3#  formation of a folate-binding cavity via the interaction of enzyme with  H-protein <9>; #8# tetrahydrofolate is bound near the center of the  tripartite enzyme, lipoic acid is bound adjacent to the  tetrahydrofolate binding pocket <10>; #3# T-protein recognition of  lipoyl protein substrate and reaction mechanism, overview. The  reversible transfer of the methylene group between the lipoate and  tetrahydrofolate proceeds through the electron relay-assisted iminium  intermediate formation <16>)  "
2.1.2.11," 5,10-methylenetetrahydrofolate + 3-methyl-2-oxobutanoate + H2O =  tetrahydrofolate + 2-dehydropantoate (#3,5# stereochemistry <4,5,6,12>;  #3# class II aldolase <2,3,4,6>; #5# sequential kinetic mechanism,  chemical mechanism <12>)  "
2.1.2.13," 10-formyltetrahydrofolate + UDP-4-amino-4-deoxy-beta-L-arabinopyranose  = 5,6,7,8-tetrahydrofolate +  UDP-4-deoxy-4-formamido-beta-L-arabinopyranose  "
2.1.2.14, 10-formyltetrahydrofolate + GDP-alpha-D-perosamine = tetrahydrofolate +  GDP-N-formyl-alpha-D-perosamine  
2.1.2.2, 10-formyltetrahydrofolate + N1-(5-phospho-D-ribosyl)glycinamide =  tetrahydrofolate + N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide  
2.1.2.3, 10-formyltetrahydrofolate +  5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide =  tetrahydrofolate +  5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (#5#  mechanism <21>)  
2.1.2.4, 5-formimidoyltetrahydrofolate + glycine = tetrahydrofolate +  N-formimidoylglycine  
2.1.2.5," 5-formimidoyltetrahydrofolate + L-glutamate = tetrahydrofolate +  N-formimidoyl-L-glutamate (#6,7# mechanism <5,7>; #6# catalytic  mechanism <11>)  "
2.1.2.7," 5,10-methylenetetrahydrofolate + D-alanine + H2O = tetrahydrofolate +  2-methylserine  "
2.1.2.8," 5,10-methylenetetrahydrofolate + H2O + deoxycytidylate =  tetrahydrofolate + 5-hydroxymethyldeoxycytidylate (#2# mechanism  <8,10>; #2# ordered bi-bi mechanism <12>; #2,6# catalytic mechanism  <11,12,13>)  "
2.1.2.9, 10-formyltetrahydrofolate + L-methionyl-tRNAfMet = tetrahydrofolate +  N-formylmethionyl-tRNAfMet  
2.1.3.1," (S)-methylmalonyl-CoA + pyruvate = propanoyl-CoA + oxaloacetate (#3,8#  mechanism <2,6,7,9,11,12>; #3# partial reaction 1 is catalysed  specifically by the 12S subunit, partial reaction 2 is catalysed  specifically by the 5S subunit <12,13,14,15,16>; #10# homology model of  human pyruvate carboxyltransferase, conserved mechanism <22>)  "
2.1.3.10, a malonyl-[acyl-carrier protein] + a biotinyl-[protein] = an  acetyl-[acyl-carrier protein] + a carboxybiotinyl-[protein]  
2.1.3.11, carbamoyl phosphate + N2-succinyl-L-ornithine = phosphate +  N-succinyl-L-citrulline  
2.1.3.12, carbamoyl phosphate + decarbamoylnovobiocin = phosphate + novobiocin  
2.1.3.15, [biotin carboxyl-carrier protein]-N6-carboxybiotinyl-L-lysine +  acetyl-CoA = [biotin carboxyl-carrier protein]-N6-biotinyl-L-lysine +  malonyl-CoA  
2.1.3.16, carbamoyl phosphate + (S)-(carbamoylamino)glycine = phosphate +  allantoate  
2.1.3.2," carbamoyl phosphate + L-aspartate = phosphate + N-carbamoyl-L-aspartate  (#1,2,4,5,6,8,9,10,11,13,16,17,18,21,23,25,27,33,34,44# reaction  mechanism <5,6,24,25,26,29,31>; #6# reaction proceeds via a  nucleophilic attack by the free amino group of L-aspartate on the  carbon of carbamoylphosphate <11>; #2# kinetic data suggest an ordered  bi bi mechanism <31>; #6# enzyme exhibits homotropic cooperativity for  aspartate, is heterotropically activated by ATP and is heterotropically  inhibited by CTP and UTP <6,38>; #6# allosteric enzyme, in absence of  effectors, two-state, concerted transition model <66>; #45# cooperative  mechanism of substrate binding <60>; #6# ordered substrate binding with  induced fit <69>; #6# significant role of protein-solvent interactions  in regulatory conformational changes <57>; #6# ATCase follows an  ordered Bi Bi reaction mechanism in which carbamoyl phosphate must bind  before L-aspartate and the product N-carbamoyl-L-aspartate leaves the  active site before inorganic phosphate <96>; #6# catalytic and  regulatory mechanisms, overview. The enzyme undergoes as it shifts  between its low-activity, low-affinity form, T state, to its  high-activity, high-affinity form, R state, and allosteric effectors  modulate the activity. The ATCase-catalyzed reaction is regulated by  nucleotide binding some 60 A from the active site, inducing structural  alterations that modulate catalytic activity. The catalytic mechanism  is ordered, carbamoyl phosphate binds before aspartate, and carbamoyl  aspartate leaves before phosphate. Cooperativity is induced by  aspartate binding <94>; #55# the catalytic cycle of ATCase leads from  the ordered binding of the substrates to the formation and  decomposition of the tetrahedral intermediate and to the ordered  release of the products from the active site, ordered-binding  mechanism, detailed overview <101>)  "
2.1.3.3," carbamoyl phosphate + L-ornithine = phosphate + L-citrulline  (#1,8,15,25,29# mechanism <6,11,21,24,35>; #9# ping-pong reaction  mechanism <97>; #25# ping pong mechanism <21>; #10# ordered mechanism,  carbamoylphosphate binds first <27>; #30# ordered sequential mechanism,  carbamoylphosphate binds first, followed by L-ornithine, L-citrulline  leaves first, followed by phosphate <29>; #18# ordered bi-bi-sequential  reaction mechanism, carbamoylphosphate binds first followed by  L-ornithine, L-citrulline leaves first followed by phosphate <58>; #27#  ordered mechanism with carbamoyl phosphate first substrate to bind <61>)  "
2.1.3.5, carbamoyl phosphate + oxamate = phosphate + N-carbamoyl-2-oxoglycine  
2.1.3.6," carbamoyl phosphate + putrescine = phosphate + N-carbamoylputrescine  (#1,4# multifunctional enzyme that catalyzes the reactions of EC  2.1.3.3 ornithine carbamoyltransferase, EC 2.7.2.2 carbamate kinase and  EC 3.5.3.12 agmatine deiminase, thus acting as putrescine synthase,  converting agmatine and ornithine into putrescine and citrulline,  respectively <1,2>)  "
2.1.3.7, carbamoyl phosphate + a 3-hydroxymethylceph-3-em-4-carboxylate =  phosphate + a 3-carbamoyloxymethylcephem  
2.1.3.8, carbamoyl phosphate + L-lysine = phosphate + L-homocitrulline  
2.1.3.9," carbamoyl phosphate + N2-acetyl-L-ornithine = phosphate +  N-acetyl-L-citrulline (#1# substrate binding and catalytic mechanism,  modeling of the transition state complex <2>)  "
2.1.4.1," L-arginine + glycine = L-ornithine + guanidinoacetate (#22# reaction  and kinetic mechanisms, overview <31>)  "
2.1.4.2, L-arginine + 1-amino-1-deoxy-scyllo-inositol 4-phosphate = L-ornithine  + 1-guanidino-1-deoxy-scyllo-inositol 4-phosphate  
2.1.4.3, L-arginine + L-lysine = L-ornithine + L-homoarginine  
2.1.5.1," (+)-sesamin + tetrahydrofolate = (+)-demethylpiperitol +  5,10-methylenetetrahydrofolate "
2.1.5.1," (+)-demethylpiperitol + tetrahydrofolate = (+)-didemethylpinoresinol +  5,10-methylenetetrahydrofolate  "
2.10.1.1, adenylyl-molybdopterin + molybdate = molybdenum cofactor + AMP + H2O  
2.2.1.1," sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-ribose  5-phosphate + D-xylulose 5-phosphate (#9# donor substrate, but not  acceptor substrate, enhances affinity of cofactor to apoenzyme to a  different degree for the two active centers, resulting in a negative  cooperativity for cofactor binding. Reaction intermediate is a  2-(alpha,beta-dihydroxyethyl)-thiamine diphosphate, which exhibits a  higher affinity for the enzyme than thiamine diphosphate <39>; #13#  equilibrium binding constants, first order rates of binding of cofactor  <37>; #9# H103 stabilizes reaction intermediate, kinetics <41>; #9#  negative cooperativity between apoenzyme and thiamine diphosphate in  presence of Ca2+ or Mg2+, caused by increase in the rate of  conformational transfer after the thiamine diphosphate binding  completion in both active centers, kinetic analysis <42>; #27#  formation of the central 1,2-dihydroxyethyl-thiamine diphosphate  carbanion-enamine intermediate is thermodynamically favored with  increasing carbon chain length of the donor ketose substrate <101>)  "
2.2.1.10," L-aspartate 4-semialdehyde + 1-deoxy-D-threo-hexo-2,5-diulose  6-phosphate = 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate +  2,3-dioxopropyl phosphate (#1# possible catalytic residues are Lys184,  which is responsible for formation of the Schiff base intermediate, and  Asp33 and Tyr153, which are candidates for the general acid/base  catalysis, ADHS active site structure, modeling of the DKFP Schiff base  intermediate in the active site, overview <3>)  "
2.2.1.11," 2-oxopropanal + D-fructose 1,6-bisphosphate = D-glyceraldehyde  3-phosphate + 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate "
2.2.1.11," 2-oxopropanal + D-fructose 1-phosphate = D-glyceraldehyde +  1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate  "
2.2.1.12, pyruvate + (E)-oct-2-enal = (S)-3-acetyloctanal + CO2  
2.2.1.13, apulose 4-phosphate + D-glyceraldehyde 3-phosphate = D-xylulose  5-phosphate + glycerone phosphate  
2.2.1.14, 6-deoxy-6-sulfo-D-fructose + D-glyceraldehyde 3-phosphate =  (2S)-3-sulfolactaldehyde + beta-D-fructofuranose 6-phosphate  
2.2.1.2," sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate = D-erythrose  4-phosphate + D-fructose 6-phosphate  (#2,3,5,6,7,8,9,10,11,17,20,24,25,29,30# mechanism <1,2,3>; #12#  ping-pong kinetics with sedoheptulose 7-phosphate adding first <4>)  "
2.2.1.3," D-xylulose 5-phosphate + formaldehyde = D-glyceraldehyde 3-phosphate +  glycerone (#1# mechanism (yeast,  ), #1,2# <1-3, 5> <1>)  "
2.2.1.4, 3-hydroxybutan-2-one + D-ribose 5-phosphate = acetaldehyde +  1-deoxy-D-altro-heptulose 7-phosphate  
2.2.1.5, 2-oxoglutarate + glyoxylate = 2-hydroxy-3-oxoadipate + CO2 (#9#  mechanism <5>; #4# various alternative mechanisms proposed <8>)  
2.2.1.6," 2 pyruvate = 2-acetolactate + CO2 (#12# Breslows mechanism <36>; #13#  acid-base chemical mechanism <66>; #4# specificity of carboligation and  product liberation may be cumulative if the former is not completely  committed <71>; #4# structural model of enzyme <61>; #13# uni uni ping  pong bi bi mechanism <63>; #5# action model for the regulatory subunit  <75>; #79# catalytic mechanism and active site structure, covalent  intermediates <90>; #4# catalytic mechanism via thiamine  diphosphate-bound intermediates, structure-activity relationship of  isozyme AHAS II <82>; #4# catalytic mechanism, covalent intermediates  <90>; #13# residue W573 is structurally important for FAD binding, the  maintainance of the active site structure, and catalysis <81>; #13#  residues R141, R372, and R376 are located in the active site and are  essential for cofactor binding and activity <86>; #4# the enzyme  catalyzes the decarboxylation of bound pyruvate to form a  hydroxyethyl-thiamine diphosphate anion/enamine intermediate, which  normally reacts with a second molecule of an alpha-ketoacid to form an  acetohydroxyacid, but can also perform several side reactions  proceeding through the hydroxyethyl-thiamine diphosphate anion/enamine  intermediate <76>; #14# catalytic mechanism of the catalytic subunit  involving the thiamine diphopshtae cofactor, overview <115>; #65#  catalytic mechanism of the catalytic subunit involving the thiamine  diphosphate cofactor, overview <115>; #13,20,38# catalytic mechanism of  the catalytic subunit involving the thiamine diphosphtae cofactor,  overview <115>; #1,5,18,86,97,98# catalytic mechanism, detailed  overview <143>; #102# catalytic mechanism, detailed overview. An  intermediate step involves the attack of the ThDP carbanion on the  pyruvate to form lactyl ThDP. The second substrate (the acceptor)  carbonyl is attacked by hydroxyethylthiamine diphosphate enamine to  give the product-ThDP adduct, which then dissociates to form ThDP and  the free product. Direct competition that exists between the acceptor  substrates for the bound HE-ThDP determines the ratio of formation of  the products. The product ratio depends only on the relative amounts of  the acceptor substrates in wild-type enzymes and the kcat is virtually  independent of the amount of the acceptors. The rate determining step  of the process is the one just before product determining carboligation  step from which kcat is determined, the other steps of the process have  little effect on the overall rate of reaction <143>; #101# the reaction  proceeds via the formation of a common substrate-cofactor-enzyme  complex. The carbonyl addition of pyruvate to thiamine diphosphate  yields a predecarboxylation intermediate followed by the elimination of  carbon dioxide, resulting in the formation of a central and highly  reactive intermediate, 2-hydroxyethyl-thiamine diphosphate. The  carboligation between 2-hydroxyethyl-TPP and the second pyruvate  molecule leads to the liberation of the reaction product, acetolactate,  and the catalytic cycle is completed <154>)  "
2.2.1.7," pyruvate + D-glyceraldehyde 3-phosphate = 1-deoxy-D-xylulose  5-phosphate + CO2 (#2,20# active site structure <18>; #2# reaction  follows a random sequential mechanism <38>)  "
2.2.1.8, L-threonine + fluoroacetaldehyde = acetaldehyde + 4-fluoro-L-threonine  
2.2.1.9," isochorismate + 2-oxoglutarate =  5-enolpyruvoyl-6-hydroxy-2-succinyl-cyclohex-3-ene-1-carboxylate + CO2  (#1# reaction follows a ping-pong bi-bi mechanism <6>; #6# two-stage  mechanism that is primarily driven by the chemical properties of the  cofactor thiamine diphosphate <7>; #7# proposed mechanism for formation  of the tetrahedral intermediate in MenD catalysis. The strong  interaction at the terminal carboxylate is proposed to restrict the  rotation around C2-C2alpha so that no hydrogen bond is formed between  C2alpha-OH and N4 of the cofactor throughout the reaction process. This  disables the formation of the enamine intermediate and enables the  formation of the tetrahedral intermediate. Modeling, overview <8>)  "
2.3.1.1, acetyl-CoA + L-glutamate = CoA + N-acetyl-L-glutamate (#5#  rapid-equilibrium random bi bi mechanism <14>; #15# sequential kinetic  mechanism <24>)  
2.3.1.10, acetyl-CoA + hydrogen sulfide = CoA + thioacetate  
2.3.1.100, palmitoyl-CoA + [myelin proteolipid] = CoA + O-palmitoyl-[myelin  proteolipid]  
2.3.1.101," formylmethanofuran + 5,6,7,8-tetrahydromethanopterin = methanofuran +  5-formyl-5,6,7,8-tetrahydromethanopterin (#5# enzyme complex renamed  formyltransferase/hydrolase complex <13>; #1,2,3,4# ternary complex  type mechanism <2,4,5,7>; #5# pathway via enzyme complex <12,13>)  "
2.3.1.102, acetyl-CoA + N6-hydroxy-L-lysine = CoA + N6-acetyl-N6-hydroxy-L-lysine  
2.3.1.103," 2 1-O-sinapoyl-beta-D-glucose = D-glucose +  1,2-bis-O-sinapoyl-beta-D-glucose  "
2.3.1.105, acetyl-CoA + 1-alkyl-sn-glycero-3-phosphate = CoA +  1-alkyl-2-acetyl-sn-glycero-3-phosphate  
2.3.1.106, sinapoyl-CoA + 2-hydroxymalonate = CoA + sinapoyltartronate  
2.3.1.107, acetyl-CoA + deacetylvindoline = CoA + vindoline  
2.3.1.108, acetyl-CoA + [alpha-tubulin]-L-lysine = CoA +  [alpha-tubulin]-N6-acetyl-L-lysine  
2.3.1.109," succinyl-CoA + L-arginine = CoA + N2-succinyl-L-arginine (#2# catalytic  mechanism involving Glu121, His229, and Leu125, catalytic domain  structure <7>)  "
2.3.1.11, acetyl-CoA + 2-aminoethanethiol = CoA + S-(2-aminoethyl)thioacetate  
2.3.1.110, feruloyl-CoA + tyramine = CoA + N-feruloyltyramine (#3# mechanism <7>)  
2.3.1.111, a long-chain acyl-[mycocerosic acid synthase] + 3 methylmalonyl-CoA + 6  NADPH + 6 H+ = a trimethylated-mycocerosoyl-[mycocerosate synthase] + 3  CoA + 3 CO2 + 6 NADP+ + 3 H2O 
2.3.1.111, a long-chain acyl-[mycocerosic acid synthase] + 4 methylmalonyl-CoA + 8  NADPH + 8 H+ = a tetramethylated-mycocerosoyl-[mycocerosate synthase] +  4 CoA + 4 CO2 + 8 NADP+ + 4 H2O  
2.3.1.112, malonyl-CoA + D-tryptophan = CoA + N2-malonyl-D-tryptophan  
2.3.1.113, malonyl-CoA + anthranilate = CoA + N-malonylanthranilate  
2.3.1.114," malonyl-CoA + 3,4-dichloroaniline = CoA +  N-(3,4-dichlorophenyl)-malonamate  "
2.3.1.115, malonyl-CoA + biochanin A 7-O-beta-D-glucoside = CoA + biochanin A  7-O-(6-O-malonyl-beta-D-glucoside)  
2.3.1.116, malonyl-CoA + flavonol 3-O-beta-D-glucoside = CoA + flavonol  3-O-(6-O-malonyl-beta-D-glucoside)  
2.3.1.117," succinyl-CoA + (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + H2O =  CoA + N-succinyl-L-2-amino-6-oxoheptanedioate  "
2.3.1.118, acetyl-CoA + an N-hydroxyarylamine = CoA + an N-acetoxyarylamine  
2.3.1.12," acetyl-CoA + enzyme N6-(dihydrolipoyl)lysine = CoA + enzyme  N6-(S-acetyldihydrolipoyl)lysine (#10,11# reaction mechanism <50,60>)  "
2.3.1.121, acyl-CoA + 1-alkenylglycerophosphoethanolamine = CoA +  1-alkenyl-2-acylglycerophosphoethanolamine  
2.3.1.122," 2 alpha,alpha-trehalose 6-mycolate = alpha,alpha-trehalose +  alpha,alpha-trehalose 6,6'-bismycolate (#5# reaction catalyzed by  antigen 85B complex involved in cell wall biosynthesis. Previously  unsuspected role of 85B protein in pathogenesis of tuberculosis <2>;  #5# reaction catalyzed by 3 members of the Ag85 complex in vitro,  namely FbpA, FbpB and FbpC2 <3>; #2,9# reaction mechanism via enzyme  complexed with the tetrahedral transition state and mycolic acid  covalently attached to the enzyme, the catalytic triad is formed by  Ser124, Glu228 and His260 <6,8>)  "
2.3.1.123, palmitoyl-CoA + dolichol = CoA + dolichyl palmitate  
2.3.1.125, acyl-CoA + 1-O-alkyl-2-acetyl-sn-glycerol = CoA +  1-O-alkyl-2-acetyl-3-acyl-sn-glycerol  
2.3.1.126, caffeoyl-CoA + isocitrate = CoA + 2-O-caffeoylisocitrate  
2.3.1.127," 2 benzoyl-CoA + L-ornithine = 2 CoA + N2,N5-dibenzoyl-L-ornithine  "
2.3.1.129," a (3R)-3-hydroxyacyl-[acyl-carrier protein] +  UDP-N-acetyl-alpha-D-glucosamine = an [acyl-carrier protein] + a  UDP-3-O-[(3R)-3-hydroxyacyl]-N-acetyl-alpha-D-glucosamine (#17#  mechanism involving essential His125 <16>; #24# reaction mechanism,  acylation occurs via nucleophilic attack of deprotonated UDP-GlcNAc on  the acyl donor in a general base-catalyzed mechanism involving a  catalytic dyad of His125 and Asp126, His125, the general base,  interacts with the 3-hydroxyl group of UDP-GlcNAc to generate the  nucleophile, the Asp126 side-chain accepts a hydrogen bond from His125  and helps orient the general base to participate in catalysis <20>;  #24# reaction mechanism, acylation occurs via nucleophilic attack of  deprotonated UDP-GlcNAc on the acyl donor in a general base-catalyzed  mechanism involving a catalytic dyad of His125 and Asp126, His125, the  general base, interacts with the 3-hydroxyl group of UDP-GlcNAc to  generate the nucleophile, the Asp126 side-chain accepts a hydrogen bond  from His125 and helps orientate the general base to participate in  catalysis <20>)  "
2.3.1.13," acyl-CoA + glycine = CoA + N-acylglycine (#4# sequential reaction  mechanism, acyl-CoA substrate adds to the enzyme first, glycine adds  before CoA leaves and the peptide product dissociates last <1>; #10#  residue Glu226 functions to deprotonate glycine, facilitating  nucleophilic attack on the acyl-CoA substrate <14>)  "
2.3.1.130, feruloyl-CoA + galactarate = CoA + O-feruloylgalactarate  
2.3.1.131, sinapoyl-CoA + glucarate = CoA + O-sinapoylglucarate  
2.3.1.132, sinapoyl-CoA + glucarolactone = CoA + O-sinapoylglucarolactone  
2.3.1.133, 4-coumaroyl-CoA + shikimate = CoA + 4-coumaroylshikimate (#14#  quasi-independent bi-bi random mechanism <6>)  
2.3.1.134, 2 mono-beta-D-galactosyldiacylglycerol =  acylmono-beta-D-galactosyldiacylglycerol +  mono-beta-D-galactosylacylglycerol  
2.3.1.135," phosphatidylcholine + retinol-[cellular-retinol-binding-protein] =  2-acylglycerophosphocholine +  retinyl-ester-[cellular-retinol-binding-protein] (#7# C161 and H60 form  a catalytic dyad essential for activity, Q177 and D67 may play a  non-essential role in catalysis, identification of the active site,  reaction mechanism <19>; #7# mechanism, Cys161 and Tyr154 are essential  for activity <21>; #5# enzyme mechanism and role in the visual cycle  <25>)  "
2.3.1.136," acetyl-CoA + an alpha-2,8-linked polymer of sialic acid = CoA +  polysialic acid acetylated at O-7 or O-9 (#1# identification of highly  conserved active site residues and catalytic mechanism, residues  His147, Trp171, His119, and Trp143 are important, overview <8>)  "
2.3.1.137," octanoyl-CoA + L-carnitine = CoA + L-octanoylcarnitine (#15#  acyl-binding hydrophobic pocket structure involving residues G553,  C323, and Met335, the acyl-CoA substrate chain length specificity is  determined by G553, Met335 is important for catalysis <25>; #3#  acyl-CoA substrate specificity is determined by Gly553, active site  structure and substrate positioning modeling <24>; #5# catalytic  mechanism, active site structure, substrate recognition mechanism,  amino acid residues 343, 564 and 553 determine the acyl-CoA substrate  specificity, catalytic residue is His343 <22>)  "
2.3.1.138, caffeoyl-CoA + putrescine = CoA + N-caffeoylputrescine  
2.3.1.139, palmitoyl-CoA + ecdysone = CoA + ecdysone palmitate  
2.3.1.14, phenylacetyl-CoA + L-glutamine = CoA + alpha-N-phenylacetyl-L-glutamine  
2.3.1.140," caffeoyl-CoA + (R)-3-(3,4-dihydroxyphenyl)lactate = CoA + rosmarinate  "
2.3.1.141," an acyl-[acyl-carrier protein] + a  2-acyl-3-O-(beta-D-galactosyl)-sn-glycerol = an [acyl-carrier protein]  + a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol  "
2.3.1.142, palmitoyl-CoA + mucus glycoprotein = CoA + O-palmitoylglycoprotein  
2.3.1.143," 1-O-galloyl-beta-D-glucose + 1,2,3,6-tetrakis-O-galloyl-beta-D-glucose  = D-glucose + 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose (#1#  stoichiometry <1>)  "
2.3.1.144, benzoyl-CoA + anthranilate = CoA + N-benzoylanthranilate  
2.3.1.145," (E,E)-piperoyl-CoA + piperidine = CoA + N-[(E,E)-piperoyl]-piperidine  "
2.3.1.146, 3 malonyl-CoA + cinnamoyl-CoA = 4 CoA + pinosylvin + 4 CO2  
2.3.1.147, 1-organyl-2-arachidonoyl-sn-glycero-3-phosphocholine +  1-organyl-2-lyso-sn-glycero-3-phosphoethanolamine =  1-organyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine +  1-organyl-2-lyso-sn-glycero-3-phosphocholine (#3# formation of an  acyl-enzyme intermediate <4>)  
2.3.1.148, 1-organyl-2-acyl-sn-glycero-3-phosphocholine +  1-organyl-2-lyso-sn-glycero-3-phosphoethanolamine =  1-organyl-2-acyl-sn-glycero-3-phosphoethanolamine +  1-organyl-2-lyso-sn-glycero-3-phosphocholine  
2.3.1.149, 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine +  1-organyl-2-lyso-sn-glycero-3-phospholipid =  1-alkyl-2-lyso-sn-glycero-3-phosphocholine +  1-organyl-2-acetyl-sn-glycero-3-phospholipid  
2.3.1.15, acyl-CoA + sn-glycerol 3-phosphate = CoA + 1-acyl-sn-glycerol  3-phosphate (#5# mechanism <29>; #27# reaction proceeds via a  compulsory-ordered ternary with acyl-ACP binding before glycerol  3-phosphate <62>; #4# the active site is composed of homology regions  I-IV <67>)  
2.3.1.150, acetyl-CoA + salutaridinol = CoA + 7-O-acetylsalutaridinol  
2.3.1.151," 3 Malonyl-CoA + 3-hydroxybenzoyl-CoA = 4 CoA +  2,3',4,6-tetrahydroxybenzophenone + 3 CO2 (#2# reaction mechanism,  multiple decarboxylative condensation with malonyl-CoA followed by  cyclization and aromatization of the inter,ediate tetraketide <3>)  "
2.3.1.152, 1-O-trans-Cinnamoyl-beta-D-glucopyranose + ROH = alkyl cinnamate +  glucose (#1# sequential binding mechanism <1>)  
2.3.1.153," 4-hydroxycinnamoyl-CoA + an anthocyanidin 3,5-di-O-beta-D-glucoside =  CoA + anthocyanidin 3-O-beta-D-glucoside  5-O-beta-D-(6-O-4-hydroxycinnamoylglucoside)  "
2.3.1.155, myristoyl-CoA + acetyl-CoA = CoA + 3-oxopalmitoyl-CoA  
2.3.1.156," isovaleryl-CoA + 3 malonyl-CoA = 4 CoA + 3 CO2 + phlorisovalerophenone  (#3# Closely related to EC 2.3.1.74, chalcone synthase. The product,  3-methyl-1-(2,4,6-trihydroxyphenyl)butan-1-one, is  chloroisovalerophenone. Also acts on isobutyryl-CoA as substrate to  give phlorisobutyrophenone. The products are intermediates in the  biosynthesis of the bitter alpha-acids in hops, Humulus lupulus <1,2>) "
2.3.1.156, isobutyryl-CoA + 3 malonyl-CoA = 4 CoA + 3 CO2 + phlorisobutyrophenone  
2.3.1.157," acetyl-CoA + alpha-D-glucosamine 1-phosphate = CoA +  N-acetyl-alpha-D-glucosamine 1-phosphate (#4# the enzyme from several  bacteria (e.g., Escherichia coli, Bacillus subtilis and Haemophilus  influenzae) has been shown to be bifunctional and also to possess the  activity of EC 2.7.7.23, UDP-N-acetylglucosamine diphosphorylase <1>;  #4# the 2-amino group of glucosamine-1-phosphate is positioned in  proximity to the acetyl-CoA to facilitate direct attack on its  thioester by a ternary complex mechanism <8>; #12# also  N-acetyl-alpha-D-glucosamine 1-phosphate + UTP =  UDP-N-acetyl-D-glucosamine + diphosphate <9>; #8# both reactions of  bifunctional GlmU follow Michaelis Menten ordered bi-bi mechanism  involving an obligatory order of binding of substrates to the enzyme  <23>; #8# substrate recognition, and catalytic mechanism for  acetyltransfer involving His374, Asn397 and Ala391, overview <22>; #16#  the multifunctional enzyme from Sulfolobus tokodaii {7} is also active  with acetyl-CoA + alpha-D-galactosamine 1-phosphate  (galactosamine-1-phosphate N-acetyltransferase), UTP +  N-acetylglucosamine 1-phosphate (EC 2.7.7.23, UDP-N-acetylglucosamine  diphosphorylase) and UTP + N-acetyl-alpha-D-galactosamine 1-phosphate  (EC 2.7.7.83, UDP-N-acetylgalactosamine diphosphorylase) <24>; #12# the  catalytic mechanism is a SN2, bimolecular nucleophilic substitution  reaction, catalyzed by the C-terminal domain. His374 and Asn397 act as  catalytic residues by enhancing the nucleophilicity of the attacking  amino group of glucosamine 1-phosphate. Ser416 and Trp460, on a short  helix, provide important interactions for substrate binding <22>)  "
2.3.1.158," phospholipid + 1,2-diacyl-sn-glycerol = lysophospholipid +  triacylglycerol  "
2.3.1.159," 3 malonyl-CoA + N-methylanthraniloyl-CoA = 4 CoA +  1,3-dihydroxy-N-methylacridone + 3 CO2 (#1# two-step mechanism <6,7>;  #1# the starter substrates for chalcone synthase or acridone synthase  reaction are placed in different topographies in the active site pocket  of the enzymes. Therefore conformational changes in the periphery  beyond the active site cavity volumes determine the product formation  and interconversion of enzymes by mutation of the active sites is  insufficient <9>)  "
2.3.1.16," acyl-CoA + acetyl-CoA = CoA + 3-oxoacyl-CoA (#6# ping-pong mechanism  <8,12>; #31# reaction mechanism <32>; #17# stoichiometry <29>; #4#  multienzyme complex: 3-hydroxyacyl-coenzyme A epimerase,  cis-DELTA3-trans-DELTA2-enoyl-CoA isomerase, enoyl-CoA hydratase,  L-3-hydroxyacyl-CoA thiolase <1>; #4,16# multienzyme complex: EC  4.2.1.17, EC 1.1.1.35, EC 5.3.3.3, EC 5.1.2.3, EC 2.3.1.16 <2,3>;  #6,22# multifunctional enzyme: 2-enoyl-CoA hydratase, 3-ketoacyl-CoA  thiolase, 3-hydroxyacyl-CoA dehydrogenase <13,22>; #4# multienzyme  complex contains enoyl-CoA hydratase, L-3-hydroxyacyl-CoA  dehydrogenase, 3-ketoacyl-CoA thiolase, 3-hydroxyacyl-CoA epimerase :  EC 5.1.2.3 and DELTA3-cis-DELTA-trans-enoyl-CoA isomerase: EC 5.3.3.3  <4>; #7,9# Claisen condensation <23>; #5# multifunctional enzyme:  2-enoyl-CoA hydratase, 3-ketoacyl-CoA thiolase and long-chain specific  3-hydroxyacyl-CoA dehydrogenase <20>; #6# sterol carrier protein X is a  3-oxoacyl CoA thiolase with intrinsic sterol carrier and lipid transfer  activity <8>; #3# ping-pong mechanism, a cysteine residue in involved  in the active site <46>; #23# the active site involves residues Cys138,  in loop beta4Â–alpha3 on domain I, His393 on the segment linking alpha10  and alpha11 of domain III, and Cys425 at the C-terminal end of beta12,  detailed reaction mechanism, overview <45>; #34# mechanism of the  reverse, degradative thiolase reaction, overview. The mode of binding  of the acyl moiety favours its transfer to CoA compared with water.  Both the thiolytic cleavage and the condensation reaction are catalysed  via covalent modification of the nucleophilic cysteine (Cys92) and by  stabilization of the negatively charged reaction intermediates by  oxyanion holes. The nucleophilic cysteine attacks the beta-carbon of  the 3-ketoacyl-CoA and becomes covalently modified. Another cysteine,  Cys382, acts first as an acid providing a proton for the leaving  acetyl-CoA and next as a base abstracting a proton from the incoming  CoA. The activated CoA molecule then attacks the carbonyl C atom of the  acylated cysteine and the fatty acyl-CoA is released. The cysteine  acting as the nucleophile is activated by a conserved histidine residue  (His352). This protonated histidine subsequently forms OAH1 together  with a water molecule which is hydrogen-bonded to Asn320. The  rate-limiting steps are different in the degradative and biosynthetic  thiolases <63>) "
2.3.1.16, [acetyl-CoA C-acyltransferase]-S-acyl-L-cysteine + acetyl-CoA =  3-oxoacyl-CoA + [acetyl-CoA C-acyltransferase]-L-cysteine 
2.3.1.16, acyl-CoA + [acetyl-CoA C-acyltransferase]-L-cysteine = [acetyl-CoA  C-acyltransferase]-S-acyl-L-cysteine + CoA  
2.3.1.160," acetyl-CoA + 16-epivellosimine = CoA + vinorine (#3# His160 and Asp164  are catalytic site residues of the non-triad motif HxxxD <4>; #4#  His160 of the HxxxD motif functions as a general base in catalysis,  located at the center of the reaction channel at the interface of both  domains and is accessible from both sides <5>)  "
2.3.1.161, 9 malonyl-CoA + 11 NADPH + 10 H+ + S-adenosyl-L-methionine +  holo-[lovastatin nonaketide synthase] = dihydromonacolin L-[lovastatin  nonaketide synthase] + 9 CoA + 9 CO2 + 11 NADP+ +  S-adenosyl-L-homocysteine + 6 H2O (#1# reaction mechanism <4>)  
2.3.1.162," acetyl-CoA + taxa-4(20),11-dien-5alpha-ol = CoA +  taxa-4(20),11-dien-5alpha-yl acetate (#4# summary of taxol biosynthesis  <1>)  "
2.3.1.163, acetyl-CoA + 10-desacetyltaxuyunnanin C = CoA + taxuyunnanin C  
2.3.1.164, phenylacetyl-CoA + isopenicillin N + H2O = CoA + penicillin G +  L-2-aminohexanedioate  
2.3.1.165," acetyl-CoA + 3 malonyl-CoA + NADPH + H+ = 6-methylsalicylate + 4 CoA +  3 CO2 + NADP+ + H2O (#2# a multienzyme complex with a  4-phosphopantetheine prosthetic group on the acyl carrier protein, it  has a similar sequence to vertebrate type I fatty acid synthase,  acetoacetyl-CoA can also act as a starter molecule <3>; #2# steric  course of the reaction, mechanism <4>; #1# 6-methylsalicylate synthesis  proceeds without catalytic dehydration of the beta-hydroxy triketide  intermediate by DH domain which is therefore not required for  tetraketide formation. The subsequent aldol cyclization and  aromatization of the tetraketide intermediate then form  6-methylsalicylate covalently bound to the ACP phosphopantetheine arm  as the thioester. 6-methylsalicylate is released hydrolytically from  ATX by the action of the domain hitherto called DH domain, i.e. the  thioester hydrolase catalytic domain <19>)  "
2.3.1.166, benzoyl-CoA + 10-deacetyl-2-debenzoylbaccatin III = CoA +  10-deacetylbaccatin III  
2.3.1.167, acetyl-CoA + 10-deacetylbaccatin III = CoA + baccatin III  
2.3.1.168, 2-methylpropanoyl-CoA + enzyme N6-(dihydrolipoyl)lysine = CoA + enzyme  N6-(S-[2-methylpropanoyl]dihydrolipoyl)lysine (#9# random bi bi  mechanism <1>; #9# His391 is involved in the catalytic reaction <4>;  #9# the active site is located in the inner core domain <9>)  
2.3.1.169," acetyl-CoA + a [Co(I) corrinoid Fe-S protein] = CO + CoA + a  [methyl-Co(III) corrinoid Fe-S protein] (#1,2# pathway  <2,4,5,8,11,14,15>; #2# kinetics of methyl group transfer between the  cobalt of the corrinoid/iron-sulfur protein and the nickel of  Ni-X-Fe4S4 cluster, called the A-cluster of enzyme, the reaction is  reversible <14>; #1,2# The transfer of Co bound methyl group from  methylated corrinoid/iron-sulfur protein to acetyl-CoA synthase is an  SN2 attack of a nucleophilic center of enzyme, presumably Ni4, on the  methyl-Co(III) stat of the corrinoid/iron-sulfur protein, generating  Co(I) and methylating acetyl-CoA synthase. <17>; #2# enzyme contains  binding sites for the methyl, carbonyl, and CoA moieties of acetyl-CoA  and catalyses the assembly of acetyl-CoA from these enzyme-bound  groups, under optimal conditions the rate-limiting step involves  methylation of enzyme by the methylated corrinoid/iron-sulfur protein  <5>; #1# the corronoid protein functions as methyl group carrier during  acetyl-CoA synthesis and decomposition <2>; #3# the multienzyme complex  contains at least two protein components: a CO-oxidizing Ni/Fe-S  component and a Co/Fe-S component <10>; #2# the FeS cluster is present  to relay electrons from enzyme to CO <6,12>; #2# Enzyme accepts the  methyl group from the methylated corrinoid/iron-sulfur protein, binds a  carbonyl group from CO, CO2, or the carboxyl of pyruvate, and binds  coenzyme A. Then the enzyme catalyses the synthesis of acetyl-CoA from  these enzyme bound groups. Additionally the enzyme catalyses two  exchange reactions between the methylated corrinoid/iron-sulfur protein  and methylated enzyme and between methylated enzyme and the methyl  moiety of acetyl-CoA. <4,8>; #2# the transfer of methyl group to enzyme  occurs by SN2-type nucleophilic displacement, not a radical, reaction  <6,12>; #2# the Ni-Fe4S4-5C cluster of enzyme catalyses the reversible  reduction of CO2 to CO and is located in the beta-subunit. CO generated  at this site migrates through the tunnel to the A-cluster, located in  the alpha-subunit, where it reacts with CoA and a methyl group to  generate acetyl-CoA. During catalysis, the two sites are  mechanistically coupled. <15>; #2# the enzyme-bound complex is an  [NiFe3-4S4]-acetyl complex <4>; #6# investigation of putative  intermediate states from the catalytic cycle by hybrid density  functional theory. A mononuclear mechanism in which CO and CH3 bind the  proximal nickel is favored over the binuclear mechanism in which CO and  CH3 bind the proximal and distal nickel ions resp. The formation of a  disulfide bond in the active site could provide the two electrons  necessary for the reaction if methylation occurs simultaneously. The  crystallographic closed form of the active site needs to open to  accomodate ligands in the equatorial state <24>; #2# stopped-flow  analysis of two steps within the catalytic cycle. Vast majority of  enzymes within a population should be in the methylated form suggesting  that the following CO insertion step is rate limiting. Reaction rate is  most sensitively affected by a change in the rate coefficient  associated with the CO insertion step <25>; #2# two electrons are  required for reductive activation of enzyme, starting from the oxidized  state containing Ni2+. A Ni0 state may form upon reductive activation  and reform after each catalytic cycle <23>; #2# CO migrates to the  A-cluster through two pathways, one involving and one not involving the  tunnel <29>; #8# CoA is the last substrate to bind and CO and the  methyl group bind randomly as the first substrate in acetyl-CoA  synthesis <28>; #3,5# chemical steps and conformational changes in the  mechanism of acetyl-CoA synthase, overview <35>; #2# the methyl and  carbonyl groups bind to ACS in a random manner before the strictly  ordered binding of the third substrate, CoA, mechanism of acetyl-CoA  synthesis by ACS, overview <33>)  "
2.3.1.17, acetyl-CoA + L-aspartate = CoA + N-acetyl-L-aspartate  
2.3.1.170, 3 malonyl-CoA + 4-coumaroyl-CoA + NADPH + H+ = 4 CoA +  isoliquiritigenin + 3 CO2 + NADP+ + H2O  
2.3.1.171, malonyl-CoA + an anthocyanidin 3-O-beta-D-glucoside = CoA + an  anthocyanidin 3-O-(6-O-malonyl-beta-D-glucoside)  
2.3.1.172," malonyl-CoA + pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside)  5-O-beta-D-glucoside = CoA + 4'''-demalonylsalvianin (#1# reaction  mechanism, kinetic mechanism <1>; #1# specific for the penultimate step  in salvianin biosynthesis, the enzyme also catalyses the malonylation  of shisonin to malonylshisonin [cyanidin  3-O-(6-O-p-coumaryl-beta-D-glucoside)-5-(6-O-malonyl-beta-D-glucoside)]   the compounds 4-demalonylsalvianin, salvianin, pelargonidin  3,5-diglucoside and delphinidin 3,5-diglucoside cannot act as  substrates <2>)  "
2.3.1.173, 4-coumaroyl-CoA + a flavonol  3-O-[beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside] =  CoA + a flavonol  3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta  D-glucoside]  
2.3.1.174, succinyl-CoA + acetyl-CoA = CoA + 3-oxoadipyl-CoA  
2.3.1.175, acetyl-CoA + deacetylcephalosporin C = CoA + cephalosporin C  
2.3.1.176," 3alpha,7alpha,12alpha-trihydroxy-5beta-cholanoyl-CoA + propanoyl-CoA =  CoA + 3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-CoA  "
2.3.1.177," 3 malonyl-CoA + benzoyl-CoA = 4 CoA + 3,5-dihydroxybiphenyl + 4 CO2  "
2.3.1.178," acetyl-CoA + L-2,4-diaminobutanoate = CoA +  (2S)-4-acetamido-2-aminobutanoate  "
2.3.1.179," a (Z)-hexadec-9-enoyl-[acyl-carrier protein] + a malonyl-[acyl-carrier  protein] = a (Z)-3-oxooctadec-11-enoyl-[acyl-carrier protein] + CO2 +  an [acyl-carrier protein] (#10# elongation condensing enzyme, catalytic  mechanism involving Cys134, His337, and His303, forming the catalytic  triad, as well as Phe396, and a water molecule bound to the active  site, analysis of residues involved in the different reaction steps,  overview <14>; #9# the enzyme catalyzes the Claisen condensation  reaction by a ping-pong mechanism <33>; #27# two-stage mechanism,  driven by a dipole moment, the active site cysteine, Cys164 in YpFabF  attacks the acyl group of a fatty acyl donor, transferring the acyl  group to the enzyme. The bound fatty acyl donor molecule is displaced,  and the receiving molecule or fatty acyl thioester to be elongated  binds, initiating the transfer of the acyl group from the condensing  enzyme to the recipient. The remaining residues of the catalytic triad,  His304 and His341, are thought to stabilise the fatty acyl intermediate  during transition states <36>)  "
2.3.1.18," acetyl-CoA + a beta-D-galactoside = CoA + a 6-acetyl-beta-D-galactoside  (#1# ordered bi-bi reaction mechanism with acetyl-CoA and CoA as the  first substrate and final product, respectively <3>; #1# Tyr83 is  essential for enzyme activity <10>)  "
2.3.1.180," acetyl-CoA + a malonyl-[acyl-carrier protein] = an  acetoacetyl-[acyl-carrier protein] + CoA + CO2 (#16# active site  structure a catayltic triad of Cys-His-Asn residues <25>; #54# active  site structure and catalytic reaction mechanism, T97, R46, W42, C122,  R161, H258, and N289 are important for activity, structure-function  relationship <10>; #36# active site structure contains a catalytic  triad of His249-Asn279-Cys112 residues <7>; #16# active site structure  with a CoA/malonyl-ACP-binding channel leading from the enzyme surface  to the buried active site Cys residue, a second channel leads from the  active site to the surface with a threonine residue controlling the  passage of longer acyl chains <26>; #54# catalytic reaction mechanism  for decarboxylation and condensation <11>; #55# catalytic reaction  mechanism might include a water molecule or a hydroxyl anion in Cys112  deprotonation, large conformational changes in the active site e.g.  through disordering of four essential loops and the movement of the two  catalytic residues Cys112 and His244 <28>; #4# catalytic reaction  mechanism via a tetrahedral transition state, active site structure  contains an oxyanion hole and a tunnel, catalytic residues are Cys112,  His244, and Asn274, which are all required for condensation activity of  the enzyme, additionally His244 and Asp274 are required for  decarboxylation, Cys112 is essential for transacylation, overview <34>;  #4# catalytic residues are Cys112, His244, and Asn274, catalytic  reaction mechanism includes acetylation of Cys112 in the primer binding  pocket, structure and reaction mechanism modeling <24>; #45# catalytic  residues are Cys123, His323, and Asn353 <33>; #27# ping pong reaction  mechanism, catalysis involves His261, Arg150, and Arg306, determination  of substrate binding site <18>; #1# ping pong reaction mechanism,  catalytically important residues are Phe298 and His238 <12>; #42# the  active site is formed by Ala-Cys-Ala <22>; #54# data support a new  model for catalysis, in which FabH exists in an open form that permits  binding of the long chain acyl-coenzyme A substrate binding and release  of the corresponding 3-ketoacyl ACP product. Catalysis and intermediate  steps in the process are proposed to occur in a closed form of the  mtFabH. These conformational changes may be critical for binding and  dissociation steps in other enzymes of the FAS pathways, including  transfers between the type I and type II FASII components of  Mycobacterium tuberculosis <40>; #63# proposed mechanism of  condensation reaction in Streptococcus gordonii FabH between catalytic  residues His249, Asn279 and Cys112 <74>; #36,38,54,55,65,66,67# the  enzyme catalyzes the Claisen condensation reaction by a ping-pong  mechanism <69>; #68# two-stage mechanism, driven by a dipole moment,  the active site cysteine, Cys112 in YpFabH attacks the acyl group of a  fatty acyl donor, transferring the acyl group to the enzyme. The bound  fatty acyl donor molecule is displaced, and the receiving molecule or  fatty acyl thioester to be elongated binds, initiating the transfer of  the acyl group from the condensing enzyme to the recipient. The  remaining residues of the catalytic triad, His243 and Asn273, are  thought to stabilise the fatty acyl intermediate during transition  states <76>)  "
2.3.1.181," an octanoyl-[acyl-carrier protein] + a protein = a protein  N6-(octanoyl)lysine + an [acyl-carrier protein] (#9# enzyme functions  as a cysteine/lysine dyad acyltransferase, where K142 and C176 are  acid/base catalysts. Reaction proceeds via an internal thioester  intermediate <7>)  "
2.3.1.183, acetyl-CoA + phosphinothricin = CoA + N-acetylphosphinothricin  
2.3.1.184," an acyl-[acyl-carrier protein] + S-adenosyl-L-methionine = an  [acyl-carrier protein] + S-methyl-5'-thioadenosine + an  N-acyl-L-homoserine lactone (#3# substrate binding structure <10>; #18#  functional sites and evolutionary relations, e.g. to the  N-acetyltransferase superfamily, ligand docking <13>; #21# molecular  basis of acyl chain length specificity <8>; #23# RhlI contains no  active site cysteine, residues R24, F28, W34, E46, D48, D51, G68, C67,  R71, E101, S103, and R104 are critical for catalytic activity <9>; #3#  RhlI shows a sequential, ordered ping-pong reaction mechanism with  S-adenosyl-L-methionine binding first <12>; #3# structures of  substrate, product, and transition state, overview <3>; #22# Thr140 in  the acyl-chain binding pocket directs the enzyme towards production of  3-oxohomoserine lactones and is involved in determination of substrate  specificity of EsaI <6>)  "
2.3.1.185, an acyl-CoA + tropine = CoA + an O-acyltropine  
2.3.1.186, an acyl-CoA + pseudotropine = CoA + an O-acylpseudotropine  
2.3.1.187, an acetyl-[acyl-carrier protein] + malonate = a malonyl-[acyl-carrier  protein] + acetate  
2.3.1.188, feruloyl-CoA + 16-hydroxypalmitate = CoA + 16-feruloyloxypalmitate  
2.3.1.189, desacetylmycothiol + acetyl-CoA = CoA + mycothiol  
2.3.1.19, butanoyl-CoA + phosphate = CoA + butanoyl phosphate  
2.3.1.190, acetoin + CoA + NAD+ = acetaldehyde + acetyl-CoA + NADH + H+  
2.3.1.191," a (3R)-3-hydroxyacyl-[acyl-carrier protein] + a  UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamine = a  UDP-2-N,3-O-bis[(3R)-3-hydroxyacyl]-alpha-D-glucosamine + a  holo-[acyl-carrier protein]  "
2.3.1.192," phenylacetyl-CoA + glycine = CoA + phenylacetylglycine (#2# sequential  reaction mechanism in which the acyl-CoA substrate adds to the enzyme  first, glycine adds before CoA leaves, and the peptide product  dissociates last <1>)  "
2.3.1.193, [elongator tRNAMet]-cytidine34 + ATP + acetyl-CoA + H2O = CoA +  [elongator tRNAMet]-N4-acetylcytidine34 + ADP + phosphate  
2.3.1.194," acetyl-CoA + malonyl-CoA = acetoacetyl-CoA + CoA + CO2 (#2# the highly  conserved catalytic triad is formed by residues Cys115, His256, and  Asn286 in NphT7, reaction mechanism, overview <1>)  "
2.3.1.195, acetyl-CoA + (3Z)-hex-3-en-1-ol = CoA + (3Z)-hex-3-en-1-yl acetate  
2.3.1.196, benzoyl-CoA + benzyl alcohol = CoA + benzyl benzoate  
2.3.1.197," acetyl-CoA + dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose = CoA +  dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose  "
2.3.1.198, an acyl-CoA + sn-glycerol 3-phosphate = CoA + a 2-acyl-sn-glycerol  3-phosphate  
2.3.1.199, a very-long-chain acyl-CoA + malonyl-CoA = a very-long-chain  3-oxoacyl-CoA + CO2 + CoA  
2.3.1.2, acetyl-CoA + imidazole = CoA + N-acetylimidazole  
2.3.1.20," acyl-CoA + 1,2-diacyl-sn-glycerol = CoA + triacylglycerol (#3# the  conserved sequence 161HPHG164 is important for activity <63>)  "
2.3.1.200, [glycine cleavage system H]-N6-lipoyl-L-lysine + a [lipoyl-carrier  protein] = glycine cleavage system H + a [lipoyl-carrier  protein]-N6-lipoyl-L-lysine  
2.3.1.201," acetyl-CoA + UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate =  CoA + UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate  "
2.3.1.202," acetyl-CoA + UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine = CoA  + UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose  "
2.3.1.203," acetyl-CoA + UDP-N-acetylbacillosamine = CoA +  UDP-N,N'-diacetylbacillosamine  "
2.3.1.204, [glycine cleavage system H]-N6-octanoyl-L-lysine + a [lipoyl-carrier  protein] = glycine cleavage system H + a [lipoyl-carrier  protein]-N6-octanoyl-L-lysine  
2.3.1.205, acetyl-CoA + fumigaclavine B = CoA + fumigaclavine A  
2.3.1.206," 3 malonyl-CoA + hexanoyl-CoA = 3 CoA + 3,5,7-trioxododecanoyl-CoA + 3  CO2  "
2.3.1.207, octanoyl-CoA + a malonyl-[acyl-carrier protein] = a  3-oxodecanoyl-[acyl-carrier protein] + CoA + CO2  
2.3.1.208, malonyl-CoA + 2-hydroxybenzoyl-CoA = 2 CoA + 4-hydroxycoumarin + CO2  
2.3.1.209," acetyl-CoA + dTDP-4-amino-4,6-dideoxy-alpha-D-glucose = CoA +  dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose  "
2.3.1.21," palmitoyl-CoA + L-carnitine = CoA + L-palmitoylcarnitine (#8# random  sequential mechanism <3>; #6# 2 independent inhibitory sites <50>; #8#  sigmoidal kinetics with both substrates <2>; #8# rapid-equilibrium  random-order mechanism <7>; #8# flexible active site <9>; #6# active  site three-dimensional structure model <1>; #6# CPT I acts at 2  distinct sites, a regulatory and an active site <50>; #5# the catalytic  triad is composed of Cys305, His473, and Asp454, with Cys305 serving as  a probable nucleophile, thus acting as a site for covalent attachment  of the acyl molecule and formation of a stable acyl-enzyme  intermediate, mechanism <85>)  "
2.3.1.210," acetyl-CoA + dTDP-4-amino-4,6-dideoxy-alpha-D-galactose = CoA +  dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose  "
2.3.1.211," 2 4-coumaroyl-CoA + malonyl-CoA + H2O = 3 CoA + bisdemethoxycurcumin +  2 CO2 (#1# curcuminoid synthase catalyzes the formation of diketide-CoA  by condensing 4-coumaroyl-CoA and malonyl-CoA. The resulting  diketide-CoA is hydrolyzed and converted to a beta-keto acid. Finally,  curcuminoid synthase catalyzes a decarboxylative condensation of the  beta-keto acid with another molecule of 4-coumaroyl-CoA, to synthesize  curcuminoid <5>; #4# no head-to-tail synthesis, the reaction begins  with the thioesterification of the thiol moiety of Cys-174 by a starter  molecule, 4-coumaroyl-CoA. Decarboxylative condensation of the first  extender substrate, malonyl-CoA, onto the thioester of 4-coumarate  results in the formation of a diketide-CoA intermediate. Subsequent  hydrolysis of the intermediate yields a beta-keto acid, which in turn  acts as the second extender substrate. The beta-keto acid is then  joined to the Cys-174-bound 4-coumarate by decarboxylative condensation  to form bisdemethoxycurcumin <7>; #1# the reaction proceeds in three  steps via formation of 4-coumaroyldiketide-CoA and 4-coumaroyl  beta-keto acid, overview <2,4>)  "
2.3.1.212," 4-coumaroyl-CoA + malonyl-CoA + H2O = 2 CoA + 4-hydroxybenzalacetone +  2 CO2 (#6# the enzyme shows remarkable substrate tolerance and  catalytic versatility, structure-function relationship and functional  diversity of type III PKS enzymes, the enzyme catalytic mechanism for  the thioester bond cleavage of the enzyme-bound diketide intermediate  and the decarboxylation reaction to produce benzalacetone involves  Cys164, His33, and Asn336, overview. RpBAS initially accepts the  aminoacyl-CoA as a starter, and then recruits malonyl-CoA for a Claisen  condensation to generate the gamma-amino-beta-ketothioester. The free  gamma-amino group of the enzyme-bound intermediate can cleave the  thioester bond, with concomitant intramolecular lactamization <7>)  "
2.3.1.213, 1-O-(4-hydroxycinnamoyl)-beta-D-glucose + cyanidin  3-O-(6-O-beta-D-glucosyl-2-O-beta-D-xylosyl-beta-D-galactoside) =  beta-D-glucose + cyanidin  3-O-[6-O-(6-O-4-hydroxycinnamoyl-beta-D-glucosyl)-2-O-beta-D-xylosyl  beta-D-galactoside]  
2.3.1.214, malonyl-CoA + 4'''-demalonylsalvianin = CoA + salvianin  
2.3.1.215, 4-hydroxycinnamoyl-CoA + an anthocyanidin 3-O-beta-D-glucoside = CoA +  an anthocyanidin 3-O-[6-O-(4-hydroxycinnamoyl)-beta-D-glucoside]  
2.3.1.216," 5 malonyl-CoA = 5 CoA + 5,7-dihydroxy-2-methyl-4H-chromen-4-one + 5 CO2  + H2O  "
2.3.1.217, feruloyl-CoA + feruloylacetyl-CoA + H2O = 2 CoA + curcumin + CO2  
2.3.1.218, feruloyl-CoA + malonyl-CoA = feruloylacetyl-CoA + CO2 + CoA 
2.3.1.218, 4-coumaroyl-CoA + malonyl-CoA = (4-coumaroyl)acetyl-CoA + CO2 + CoA  
2.3.1.219, 4-coumaroyl-CoA + feruloylacetyl-CoA + H2O = 2 CoA + demethoxycurcumin  + CO2 (#1# (1) <1>) 
2.3.1.219, 4-coumaroyl-CoA + (4-coumaroyl)acetyl-CoA + H2O = 2 CoA +  bisdemethoxycurcumin + CO2 (#1# (2) <1>)  
2.3.1.22, acyl-CoA + 2-acylglycerol = CoA + diacylglycerol  
2.3.1.220," 3 malonyl-CoA + benzoyl-CoA = 4 CoA + 2,4,6-trihydroxybenzophenone + 3  CO2 (#1# the enzyme catalyzes the iterative condensation of benzoyl-CoA  with three molecules of malonyl-CoA to give a linear tetraketide  intermediate, which is subsequently cyclized into  2,4,6-trihydroxybenzophenone via intramolecular Claisen condensation,  catalytic mechanism, overview <3>)  "
2.3.1.221," 7 malonyl-CoA + hexanoyl-[acyl-carrier protein] = 7 CoA + norsolorinic  acid anthrone + [acyl-carrier protein] + 7 CO2 + 2 H2O (#1# a product  template domain unites with the ketosynthase and thioesterase in this  IPKS system to assemble precisely seven malonyl-derived building blocks  to a hexanoyl starter unit and mediate a specific cyclization cascade.  These mechanistic features are general for IPKS-catalyzed production of  aromatic polyketides <1>; #3# mechanism of thioesterase/Claisen  cyclase-catalyzed chain-termination of fungal aromatic polyketide  biosynthesis. The ACP of the ACP-bound substrate is displaced upon  thioesterase-catalyzed transesterification. Rotation of the substrate  side chain can occur once the ACP leaves the pocket, and the  thioesterase can then close. Thioesterase conformational constraints as  observed in the closed-form crystal structure guide Claisen-type  cyclization to release noranthrone, i.e. norsolorinic acid anthrone,  the polyketide precursor of aflatoxin B1. Domain structure and reaction  mechanism, detailed overview <5>; #1# reaction mechanism, overview. The  SAT domain in PksA selects a hexanoyl starter unit. The MAT domain  loads the free ACP with malonyl units. After seven successive  condensation events with malonyl-ACP catalysed in te ketoacyl synthase  domain, the linear ACP-bound polyketide is cyclized (C4-C9 and C2-C11  cyclization events) and aromatized in the product template domain to  give the bicyclic intermediate. The thioesterase domain catalyses C-C  cyclization to release anthrone, which undergoes oxidation to the  anthraquinone norsolorinic acid, to initiate the complex biosynthetic  pathway to aflatoxin B1 <4>)  "
2.3.1.222, propanoyl-CoA + phosphate = CoA + propanoyl phosphate  
2.3.1.223," 2,3-didehydroadipoyl-CoA + acetyl-CoA = CoA +  3-oxo-5,6-didehydrosuberoyl-CoA  "
2.3.1.224, acetyl-CoA + benzyl alcohol = CoA + benzyl acetate (#4# (1) <2>) 
2.3.1.224, acetyl-CoA + cinnamyl alcohol = CoA + cinnamyl acetate (#4# (2) <2>)  
2.3.1.225," palmitoyl-CoA + [protein]-L-cysteine = [protein]-S-palmitoyl-L-cysteine  + CoA (#2,28# two-step transfer mechanism, ping-pong kinetic mechanism  <8>)  "
2.3.1.226," malonyl-CoA + (S)-1-pyrroline-5-carboxylate + H2O = CoA +  (2S,5S)-5-carboxymethylproline + CO2  "
2.3.1.227," acetyl-CoA + GDP-4-amino-4,6-dideoxy-alpha-D-mannose = CoA +  GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose  "
2.3.1.228, isovaleryl-CoA + S-adenosyl-L-methionine = CoA +  S-methyl-5'-thioadenosine + N-isovaleryl-L-homoserine lactone  
2.3.1.229, 4-coumaroyl-CoA + S-adenosyl-L-methionine = CoA +  S-methyl-5'-thioadenosine + N-(4-coumaroyl)-L-homoserine lactone  
2.3.1.23," acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine = CoA +  1,2-diacyl-sn-glycero-3-phosphocholine (#10# lung enzyme displays an  iso-ping-pong mechanism <12,14>)  "
2.3.1.230, octanoyl-CoA + (2-aminobenzoyl)acetate = 2-heptyl-4-quinolone + CoA +  CO2 + H2O 
2.3.1.230, octanoyl-CoA + L-cysteinyl-[PqsC protein] =  S-octanoyl-L-cysteinyl-[PqsC protein] + CoA 
2.3.1.230," S-octanoyl-L-cysteinyl-[PqsC protein] + (2-aminobenzoyl)acetate =  1-(2-aminophenyl)decane-1,3-dione + CO2 + L-cysteinyl-[PqsC protein] "
2.3.1.230," 1-(2-aminophenyl)decane-1,3-dione = 2-heptyl-4-quinolone + H2O  "
2.3.1.231, S-adenosyl-L-methionine +  7-[(3S)-3-amino-3-(methoxycarbonyl)propyl]wyosine37 in tRNAPhe + CO2 =  S-adenosyl-L-homocysteine + wybutosine37 in tRNAPhe  
2.3.1.232, anthraniloyl-CoA + methanol = CoA + O-methyl anthranilate  
2.3.1.233," 5 malonyl-CoA = 1,3,6,8-tetrahydroxynaphthalene + 5 CoA + 5 CO2 + H2O  "
2.3.1.234, L-threonylcarbamoyladenylate + adenine37 in tRNA = AMP +  N6-L-threonylcarbamoyladenine37 in tRNA  
2.3.1.235, 10 malonyl-CoA = tetracenomycin F2 + 10 CoA + 10 CO2 + 2 H2O  
2.3.1.236, acetyl-CoA + 5 malonyl-CoA + 3 NADPH + 3 H+ = 5-methyl-1-naphthoate + 6  CoA + 5 CO2 + 4 H2O + 3 NADP+  
2.3.1.237, acetyl-CoA + 5 malonyl-CoA + 2 NADPH + 2 H+ =  2-hydroxy-5-methyl-1-naphthoate + 6 CoA + 5 CO2 + 3 H2O + 2 NADP+  
2.3.1.238, monacolin J acid + (S)-2-methylbutanoyl-[2-methylbutanoate polyketide  synthase] = lovastatin acid + [2-methylbutanoate polyketide synthase]  
2.3.1.239," malonyl-CoA + 5 (2S)-methylmalonyl-CoA + 5 NADPH + 5 H+ =  10-deoxymethynolide + 6 CoA + 6 CO2 + 5 NADP+ + 2 H2O (#2# electron  cryo-microscopy (cryo-EM) structures of a full-length polyketide  synthase module in three key biochemical states of its catalytic cycle  reveals the dynamics of the intramodule acyl carrier protein for  sequential binding to catalytic domains within the reaction chamber,  and for transferring the elongated and processed polyketide substrate  to the next module in the polyketide synthase pathway. During the  enzymatic cycle the ketoreductase domain undergoes dramatic  conformational rearrangements that enable optimal positioning for  reductive processing of the acyl carrier protein-bound polyketide chain  elongation intermediate <7>)  "
2.3.1.24, acyl-CoA + sphingosine = CoA + a ceramide  
2.3.1.240," malonyl-CoA + 6 (2S)-methylmalonyl-CoA + 5 NADPH + 5 H+ = narbonolide +  7 CoA + 7 CO2 + 5 NADP+ + 2 H2O (#2# electron cryo-microscopy (cryo-EM)  structures of a full-length polyketide synthase module in three key  biochemical states of its catalytic cycle reveals the dynamics of the  intramodule acyl carrier protein for sequential binding to catalytic  domains within the reaction chamber, and for transferring the elongated  and processed polyketide substrate to the next module in the polyketide  synthase pathway. During the enzymatic cycle the ketoreductase domain  undergoes dramatic conformational rearrangements that enable optimal  positioning for reductive processing of the acyl carrier protein-bound  polyketide chain elongation intermediate <7>)  "
2.3.1.241, a fatty acyl-[acyl-carrier protein] + an  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[lipid IVA] = an  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-(acyl)-[lipid IVA] + an [acyl-carrier  protein]  
2.3.1.242, a (9Z)-hexadec-9-enoyl-[acyl-carrier protein] + Kdo2-lipid IVA =  (9Z)-hexadec-9-enoyl-Kdo2-lipid IVA + an [acyl-carrier protein]  
2.3.1.243, a fatty acyl-[acyl-carrier protein] + an  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-(acyl)-[lipid IVA] = an  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-(acyl)2-[lipid IVA] + an  [acyl-carrier protein]  
2.3.1.244, 2 malonyl-CoA + [2-methylbutanoate polyketide synthase] + 2 NADPH + 3  H+ + S-adenosyl-L-methionine = (S)-2-methylbutanoyl-[2-methylbutanoate  polyketide synthase] + 2 CoA + 2 CO2 + 2 NADP+ +  S-adenosyl-L-homocysteine + H2O  
2.3.1.245," glycerone phosphate + acetyl-CoA = 3-hydroxy-2,4-dioxopentyl phosphate  + CoA  "
2.3.1.246," 4 malonyl-CoA = (3,5-dihydroxyphenylacetyl)-CoA + 3 CoA + 4 CO2 + H2O  "
2.3.1.247," (5S)-5-amino-3-oxohexanoate + acetyl-CoA = L-3-aminobutanoyl-CoA +  acetoacetate (#3# the enzyme shows a catalytic reaction mechanism that  proceeds through deprotonation of the 3-keto-5-aminohexanoate  substrate, nucleophilic addition onto an incoming acetyl-CoA,  intramolecular transfer of the CoA moiety, and final retro-Claisen  reaction leading to acetoacetate and 3-aminobutyryl-CoA,  structure-function analysis, docking study and molecular modeling,  detailed overview. Absence of detection of any covalent acyl-enzyme  intermediate <4>)  "
2.3.1.248," 2 sinapoyl-CoA + spermidine = 2 CoA + N1,N8-bis(sinapoyl)-spermidine  "
2.3.1.249," 2 4-coumaroyl-CoA + spermidine = 2 CoA +  N1,N8-bis(4-coumaroyl)-spermidine  "
2.3.1.25, acyl-CoA + 1-O-(alk-1-enyl)glycero-3-phosphocholine = CoA +  plasmenylcholine  
2.3.1.250, (9Z)-hexadec-9-enoyl-CoA + [Wnt]-L-serine = CoA +  [Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine  
2.3.1.251, 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine + hexa-acyl lipid A =  2-acyl-sn-glycero-3-phosphocholine + hepta-acyl lipid A 
2.3.1.251, 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine + lipid IIA =  2-acyl-sn-glycero-3-phosphocholine + lipid IIB 
2.3.1.251, 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine + lipid IVA =  2-acyl-sn-glycero-3-phosphocholine + lipid IVB  
2.3.1.252, a long-chain acyl-CoA + 3 (S)-methylmalonyl-CoA + 6 NADPH + 6 H+ +  holo-[mycolipanoate synthase] = mycolipanoyl-[mycolipanoate synthase] +  4 CoA + 3 CO2 + 6 NADP+ + 3 H2O  
2.3.1.253, 3 malonyl-CoA = phloroglucinol + 3 CO2 + 3 CoA  
2.3.1.254, acetyl-CoA + an N-terminal L-methionyl-L-asparaginyl-[protein] = an  N-terminal Nalpha-acetyl-L-methionyl-L-asparaginyl-[protein] + CoA 
2.3.1.254, acetyl-CoA + an N-terminal L-methionyl-L-glutaminyl-[protein] = an  N-terminal Nalpha-acetyl-L-methionyl-L-glutaminyl-[protein] + CoA 
2.3.1.254, acetyl-CoA + an N-terminal L-methionyl-L-aspartyl-[protein] = an  N-terminal Nalpha-acetyl-L-methionyl-L-aspartyl-[protein] + CoA 
2.3.1.254, acetyl-CoA + an N-terminal L-methionyl-L-glutamyl-[protein] = an  N-terminal Nalpha-acetyl-L-methionyl-L-glutamyl-[protein] + CoA  
2.3.1.255, acetyl-CoA + an N-terminal-glycyl-[protein] = an  N-terminal-Nalpha-acetyl-glycyl-[protein] + CoA 
2.3.1.255, acetyl-CoA + an N-terminal-L-alanyl-[protein] = an  N-terminal-Nalpha-acetyl-L-alanyl-[protein] + CoA 
2.3.1.255, acetyl-CoA + an N-terminal-L-seryl-[protein] = an  N-terminal-Nalpha-acetyl-L-seryl-[protein] + CoA 
2.3.1.255, acetyl-CoA + an N-terminal-L-valyl-[protein] = an  N-terminal-Nalpha-acetyl-L-valyl-[protein] + CoA 
2.3.1.255, acetyl-CoA + an N-terminal-L-cysteinyl-[protein] = an  N-terminal-Nalpha-acetyl-L-cysteinyl-[protein] + CoA 
2.3.1.255, acetyl-CoA + an N-terminal-L-threonyl-[protein] = an  N-terminal-Nalpha-acetyl-L-threonyl-[protein] + CoA  
2.3.1.256, acetyl-CoA + an N-terminal-L-methionyl-L-leucyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-leucyl-[protein] + CoA 
2.3.1.256, acetyl-CoA + an N-terminal-L-methionyl-L-isoleucyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-isoleucyl-[protein] + CoA 
2.3.1.256, acetyl-CoA + an N-terminal-L-methionyl-L-phenylalanyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-phenylalanyl-[protein] + CoA 
2.3.1.256, acetyl-CoA + an N-terminal-L-methionyl-L-tryptophyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-tryptophyl-[protein] + CoA 
2.3.1.256, acetyl-CoA + an N-terminal-L-methionyl-L-tyrosyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-tyrosyl-[protein] + CoA  
2.3.1.257, acetyl-CoA + an N-terminal-L-seryl-[histone H4] = an  N-terminal-Nalpha-acetyl-L-seryl-[histone H4] + CoA 
2.3.1.257, acetyl-CoA + an N-terminal-L-seryl-[histone H2A] = an  N-terminal-Nalpha-acetyl-L-seryl-[histone H2A] + CoA  
2.3.1.258," acetyl-CoA + an N-terminal-L-methionyl-L-leucyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-leucyl-[protein] + CoA (#2#  hNaa50p utilizes an ordered bi bi reaction of the Theorell-Chance type,  substarte binding study and dynamics using NMR spectroscopy. Acetyl-CoA  induces a conformational change that is required for the peptide to  bind to the active site. Addition of peptide in the absence of  acetyl-CoA does not alter the structure of the protein <3>) "
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-tyrosyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-tyrosyl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-alanyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-alanyl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-seryl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-seryl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-valyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-valyl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-threonyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-threonyl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-lysyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-lysyl-[protein] + CoA 
2.3.1.258, acetyl-CoA + an N-terminal-L-methionyl-L-phenylalanyl-[protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-L-phenylalany-[protein] + CoA  
2.3.1.259, acetyl-CoA + an N-terminal-L-methionyl-[transmembrane protein] = an  N-terminal-Nalpha-acetyl-L-methionyl-[transmembrane protein] + CoA  
2.3.1.26," a long-chain acyl-CoA + a sterol = CoA + a long-chain 3-hydroxysterol  ester (#11# mechanism, a histidine is implicated in the catalytic  mechanism of the enzyme <10>)  "
2.3.1.260," malonamoyl-[OxyC acyl-carrier protein] + 8 malonyl-CoA =  18-carbamoyl-3,5,7,9,11,13,15,17-octaoxooctadecanoyl-[OxyC acyl-carrier  protein] + 8 CO2 + 8 CoA  "
2.3.1.261, 4-hydroxybenzoyl-[(4-hydroxyphenyl)alkanoate synthase] + 8 malonyl-CoA  + 16 NADPH + 16 H+ =  17-(4-hydroxyphenyl)heptadecanoyl-[(4-hydroxyphenyl)alkanoate synthase]  + 8 CO2 + 8 CoA + 16 NADP+ + 8 H2O 
2.3.1.261, 4-hydroxybenzoyl-[(4-hydroxyphenyl)alkanoate synthase] + 9 malonyl-CoA  + 18 NADPH + 18 H+ + holo-[(4-hydroxyphenyl)alkanoate synthase] =  19-(4-hydroxyphenyl)nonadecanoyl-[(4-hydroxyphenyl)alkanoate synthase]  + 9 CO2 + 9 CoA + 18 NADP+ + 9 H2O  
2.3.1.262, anthraniloyl-CoA + malonyl-CoA = 2-aminobenzoylacetyl-CoA + CoA + CO2 
2.3.1.262, anthraniloyl-CoA + L-cysteinyl-[PqsD protein] =  S-anthraniloyl-L-cysteinyl-[PqsD protein] + CoA 
2.3.1.262, S-anthraniloyl-L-cysteinyl-[PqsD protein] + malonyl-CoA =  2-aminobenzoylacetyl-CoA + CO2 + L-cysteinyl-[PqsD protein]  
2.3.1.263, acetyl-CoA + D-alanine = CoA + (2R)-2-amino-4-oxopentanoate  
2.3.1.264," acetyl-CoA + (3S)-3,6-diaminohexanoate = CoA +  (3S)-6-acetamido-3-aminohexanoate  "
2.3.1.265," an acyl-CoA + 2,6-di-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol  = CoA +  2-O-(6-O-acyl-alpha-D-mannosyl)-6-O-alpha-D-mannosyl-1-phosphatidyl-1D  myo-inositol "
2.3.1.265, an acyl-CoA + 2-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol = CoA  + 2-O-(6-O-acyl-alpha-D-mannosyl)-1-phosphatidyl-1D-myo-inositol  
2.3.1.266, acetyl-CoA + an N-terminal L-alanyl-[S18 protein of 30S ribosome] = CoA  + an N-terminal N-acetyl-L-alanyl-[S18 protein of 30S ribosome]  
2.3.1.267, acetyl-CoA + an N-terminal L-alanyl-[S5 protein of 30S ribosome] = CoA  + an N-terminal N-acetyl-L-alanyl-[S5 protein of 30S ribosome]  
2.3.1.268, ethanol + acetyl-CoA = ethyl acetate + CoA  
2.3.1.269," a phosphoglycerolipid + an  [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine = a  1-lyso-phosphoglycerolipid + a  [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine  "
2.3.1.27, acetyl-CoA + cortisol = CoA + cortisol 21-acetate  
2.3.1.270, a lyso-ornithine lipid + an acyl-[acyl-carrier protein] = an ornithine  lipid + a holo-[acyl-carrier protein]  
2.3.1.271, acetyl-CoA + L-glutamate-5-semialdehyde = CoA + N-acetyl-L-glutamate  5-semialdehyde  
2.3.1.272," 2 2-acetylphloroglucinol = 2,4-diacetylphloroglucinol + phloroglucinol  "
2.3.1.273, octanoyl-CoA +  2-O-[alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate  =  2-O-[6-O-octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]  D-glycerate + CoA  
2.3.1.274, an acyl-[acyl-carrier protein] + phosphate = an acyl phosphate + an  [acyl-carrier protein]  
2.3.1.275, an acyl phosphate + sn-glycerol 3-phosphate = a 1-acyl-sn-glycerol  3-phosphate + phosphate  
2.3.1.276, acetyl-CoA + alpha-D-galactosamine 1-phosphate = CoA +  N-acetyl-alpha-D-galactosamine 1-phosphate  
2.3.1.277, a medium-chain 3-oxoacyl-[acyl-carrier protein] + glycerone phosphate =  2-oxo-3-(phosphooxy)propyl 3-oxoalkanoate + a holo-[acyl-carrier  protein]  
2.3.1.278, a mycolipenoyl-CoA + a 2-(long-chain-fatty acyl)-trehalose = a  2-(long-chain-fatty acyl)-3-mycolipenoyl-trehalose + CoA  
2.3.1.279," a long-chain-fatty acyl-CoA + alpha,alpha-trehalose = a  2-(long-chain-fatty acyl)-trehalose + CoA  "
2.3.1.28, acetyl-CoA + chloramphenicol = CoA + chloramphenicol 3-acetate (#4#  ternary complex mechanism with a rapid equilibrium and essentially  random order of addition of substrates <9>)  
2.3.1.280, acetyl-CoA + (aminomethyl)phosphonate = CoA +  (acetamidomethyl)phosphonate  
2.3.1.281," 6 malonyl-CoA + 5 NADPH + NADH + 6 H+ =  (2E,5S,6E,8E,10E)-5-hydroxydodeca-2,6,8,10-tetraenal + 6 CoA + 5 NADP+  + NAD+ + 6 CO2 + 4 H2O  "
2.3.1.282, 2 a mycocerosyl-[mycocerosic acid synthase] + a phthiocerol = a  dimycocerosyl phthiocerol + 2 holo-[mycocerosic acid synthase] 
2.3.1.282, 2 a mycocerosyl-[mycocerosic acid synthase] + a phthiodiolone = a  dimycocerosyl phthiodiolone + 2 holo-[mycocerosic acid synthase] 
2.3.1.282, 2 a mycocerosyl-[mycocerosic acid synthase] + a phenolphthiocerol = a  dimycocerosyl phenolphthiocerol + 2 holo-[mycocerosic acid synthase]  
2.3.1.283," a (hydroxy)phthioceranyl-[(hydroxy)phthioceranic acid synthase] +  2'-palmitoyl/stearoyl-2-O-sulfo-alpha,alpha-trehalose = a  3'-(hydroxy)phthioceranyl-2'-palmitoyl/stearoyl-2-O-sulfo-alpha  alpha-trehalose + holo-[(hydroxy)phthioceranic acid synthase]  "
2.3.1.284," 3  3'-(hydroxy)phthioceranyl-2'-palmitoyl(stearoyl)-2-O-sulfo-alpha  alpha-trehalose =  3,6  6'-tris-(hydroxy)phthioceranyl-2-palmitoyl(stearoyl)-2'-sulfo-alpha  alpha-trehalose + 2  2'-palmitoyl/stearoyl-2-O-sulfo-alpha,alpha-trehalose  "
2.3.1.285," acetyl-CoA + (13S,14R)-1,13-dihydroxy-N-methylcanadine =  (13S,14R)-13-O-acetyl-1-hydroxy-N-methylcanadine + CoA  "
2.3.1.286, [protein]-N6-acetyl-L-lysine + NAD+ + H2O = [protein]-L-lysine +  2''-O-acetyl-ADP-D-ribose + nicotinamide (#16# broad specificity with  respect to chain length of the acyl chain <15>) 
2.3.1.286," [protein]-N6-acetyl-L-lysine + NAD+ =  [protein]-N6-[1,1-(5-adenosylyl-alpha-D-ribose-1  2-di-O-yl)ethyl]-L-lysine + nicotinamide "
2.3.1.286," [protein]-N6-[1,1-(5-adenosylyl-alpha-D-ribose-1  2-di-O-yl)ethyl]-L-lysine + H2O = [protein]-L-lysine +  2''-O-acetyl-ADP-D-ribose  "
2.3.1.287, 8 (S)-methylmalonyl-CoA + palmitoyl-[(hydroxy)phthioceranic acid  synthase] + 16 NADPH + 16 H+ = 8 CoA +  C40-phthioceranyl-[(hydroxy)phthioceranic acid synthase] + 16 NADP+ + 8  CO2 + 8 H2O 
2.3.1.287, 7 (S)-methylmalonyl-CoA + palmitoyl-[(hydroxy)phthioceranic acid  synthase] + 14 NADPH + 14 H+ = 7 CO2 +  C37-phthioceranyl-[(hydroxy)phthioceranic acid synthase] + 14 NADP+ + 7  CoA + 7 H2O  
2.3.1.288," stearoyl-CoA + 2-O-sulfo-alpha,alpha-trehalose =  2-O-sulfo-2'-stearoyl-alpha,alpha-trehalose + CoA "
2.3.1.288," palmitoyl-CoA + 2-O-sulfo-alpha,alpha-trehalose =  2-O-sulfo-2'-palmitoyl-alpha,alpha-trehalose + CoA  "
2.3.1.289, 4-nitrobenzoyl-CoA + malonyl-CoA + 4 (S)-methylmalonyl-CoA + 4 NADPH +  4 H+ = demethylluteothin + 5 CO2 + 6 CoA + 4 NADP+ + 3 H2O  
2.3.1.29," acetyl-CoA + glycine = CoA + L-2-amino-3-oxobutanoate (#6,9# reaction  mechanism <1,10>; #6# physical interaction between threonine  dehydrogenase and aminoacetone synthetase demonstrated, the two enzymes  form a complex <1>; #4# the condensation process involves the loss of  the pro-R hydrogen atom of glycine and occurs with the inversion of  stereochemistry <11>)  "
2.3.1.290, 4-nitrobenzoyl-CoA + malonyl-CoA + 6 (S)-methylmalonyl-CoA + 6 NADPH +  4 H+ = demethyldeoxyspectinabilin + 7 CO2 + 8 CoA + 6 NADP+ + 5 H2O  
2.3.1.291, palmitoyl-CoA + a sphingoid base = an N-(palmitoyl)-sphingoid base + CoA  
2.3.1.292, 3 malonyl-CoA + 2 (S)-methylmalonyl-CoA +  icosanoyl-[(phenol)carboxyphthiodiolenone synthase] + 5 NADPH =  C32-carboxyphthiodiolenone-[(phenol)carboxyphthiodiolenone synthase] +  5 CoA + 5 NADP+ + 5 CO2 + 2 H2O 
2.3.1.292, 3 malonyl-CoA + 2 (S)-methylmalonyl-CoA +  docosanoyl-[(phenol)carboxyphthiodiolenone synthase] + 5 NADPH =  C34-carboxyphthiodiolenone-[(phenol)carboxyphthiodiolenone synthase] +  5 CoA + 5 NADP+ + 5 CO2 + 2 H2O 
2.3.1.292, 3 malonyl-CoA + 2 (S)-methylmalonyl-CoA +  19-(4-hydroxyphenyl)-nonadecanoyl-[(phenol)carboxyphthiodiolenone  synthase] + 5 NADPH =  C37-(phenol)carboxyphthiodiolenone-[(phenol)carboxyphthiodiolenone  synthase] + 5 CoA + 5 NADP+ + 5 CO2 + 2 H2O 
2.3.1.292, 3 malonyl-CoA + 2 (S)-methylmalonyl-CoA +  17-(4-hydroxyphenyl)heptadecanoyl-[(phenol)carboxyphthiodiolenone  synthase] + 5 NADPH =  C35-(phenol)carboxyphthiodiolenone-[(phenol)carboxyphthiodiolenone  synthase] + 5 CoA + 5 NADP+ + 5 CO2 + 2 H2O  
2.3.1.293, an ultra-long-chain mono-unsaturated acyl-[acyl-carrier protein] + a  malonyl-[acyl-carrier protein] = an ultra-long-chain mono-unsaturated  3-oxo-fatty acyl-[acyl-carrier protein] + CO2 + a holo-[acyl-carrier  protein]  
2.3.1.294," a (Z)-hexadec-11-enoyl-[acyl-carrier protein] + a malonyl-[acyl-carrier  protein] = a (Z)-3-oxooctadec-13-enoyl-[acyl-carrier protein] + CO2 +  an [acyl-carrier protein] (#2# active site structure with the  Cys-His-His active site triad and the acyl binding channel, reaction  mechanism, modeling <1>) "
2.3.1.294, an ultra-long-chain di-unsaturated acyl-[acyl-carrier protein] + a  malonyl-[acyl-carrier protein] = an ultra-long-chain di-unsaturated  3-oxo-fatty acyl-[acyl-carrier protein] + CO2 + a holo-[acyl-carrier  protein]  
2.3.1.295, a medium-chain acyl-CoA + 5 malonyl-CoA + 5 (S)-methylmalonyl-CoA + 22  NADPH + 22 H+ = a mycoketide-CoA + 10 CO2 + 10 CoA + 22 NADP+ + 11 H2O  
2.3.1.296, a linoleate-containing triacyl-sn-glycerol + an ultra-long-chain  omega-hydroxyceramide = a diacyl-sn-glycerol + a linoleate-esterified  acylceramide  
2.3.1.297, a very-long-chain fatty acyl-CoA + a sphingoid base = a very-long-chain  ceramide + CoA  
2.3.1.298, an ultra-long-chain fatty acyl-CoA + a sphingoid base = an  ultra-long-chain ceramide + CoA  
2.3.1.299, stearoyl-CoA + a sphingoid base = an N-(stearoyl)-sphingoid base + CoA  
2.3.1.3, acetyl-CoA + D-glucosamine = CoA + N-acetyl-D-glucosamine  
2.3.1.30," acetyl-CoA + L-serine = CoA + O-acetyl-L-serine (#1# ping pong bi bi  mechanism <10>; #8# steady-state random-order mechanism <27>;  #26,27,30# a C-terminal hexapeptide-repeat domain is common for  Arabidopsis thaliana isoforms and several other enzyme DNA sequences,  it has a catalytic bifunctionality as serine acetyltransferase and in  interaction with O-acetylserine (thiol) lyase and is involved in  cysteine biosynthesis regulation, computational modeling <23>; #8#  binding motif for O-acetylserine (thiol) lyase is located within 10  amino acid residues at the C-terminal end <26>; #5# ordered kinetic  mechanism with acetyl CoA bound prior to L-serine and O-acetyl-L-serine  released prior to CoA. The rate-limiting step along the reaction  pathway is the nucleophilic attack of the serine hydroxyl on the  thioester of acetyl CoA. Product release contributes to rate-limitation  at saturating concentrations of reactants. The reaction is catalyzed by  an active site general base with a pK of 7, which accepts a proton from  the serine hydroxyl as a tetrahedral intermediate is formed between the  reactants, and donates it to the thiol of CoA as the intermediate  collapses to give products <41>; #55# there is no conformational  difference in the enzyme between the apo and the substrate-bound  states, indicating lock and key binding and the absence of an induced  fit mechanism <60>)  "
2.3.1.300, 3-methylbutanoyl-CoA + a malonyl-[acyl-carrier protein] = a  5-methyl-3-oxohexanoyl-[acyl-carrier-protein] + CoA + CO2 
2.3.1.300, 2-methylpropanoyl-CoA + a malonyl-[acyl-carrier protein] = a  4-methyl-3-oxopentanoyl-[acyl-carrier-protein] + CoA + CO2 
2.3.1.300, (2S)-2-methylbutanoyl-CoA + a malonyl-[acyl-carrier protein] = a  (4S)-4-methyl-3-oxohexanoyl-[acyl-carrier-protein] + CoA + CO2  
2.3.1.301, dodecanoyl-CoA + a malonyl-[acyl-carrier protein] = a  3-oxotetradecanoyl-[acyl-carrier protein] + CoA + CO2  
2.3.1.302, (E)-4-coumaroyl-CoA + 5-hydroxyanthranilate = avenanthramide A + CoA 
2.3.1.302, (E)-caffeoyl-CoA + 5-hydroxyanthranilate = avenanthramide C + CoA  
2.3.1.303, acetyl-CoA +  alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP  Und = CoA +  2-O-acetyl-alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)  alpha-D-Gal-PP-Und  
2.3.1.304, (R)-3-hydroxybutanoyl-CoA + [(R)-3-hydroxybutanoate]n =  [(R)-3-hydroxybutanoate]n+1 + CoA 
2.3.1.304, 3-hydroxyacyl-CoA + [(R)-3-hydroxyacyl]n = [(R)-3-hydroxyacyl]n+1 + CoA 
2.3.1.304, 3-hydroxybutyryl-CoA + [(R)-3-hydroxybutanoate]n =  [(R)-3-hydroxybutanoate]n+1 + CoA 
2.3.1.304, (3R)-3-hydroxyacyl-CoA + poly[(R)-3-hydroxyalkanoate]n = CoA +  poly[(R)-3-hydroxyalkanoate]n+1  
2.3.1.305," a (3R)-3-hydroxyacyl-[acyl-carrier protein] +  UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose = an  [acyl-carrier protein] + a  UDP-2-acetamido-2  3-dideoxy-3-([(3R)-3-hydroxyacyl]amino)-alpha-D-glucopyranose  "
2.3.1.306, acetyl-CoA + L-lysine = CoA + N6-acetyl-L-lysine  
2.3.1.307, acetyl-CoA + 6-diazo-5-oxo-L-norleucine = CoA +  N-acetyl-6-diazo-5-oxo-L-norleucine  
2.3.1.31," acetyl-CoA + L-homoserine = CoA + O-acetyl-L-homoserine (#2,3,6,8#  ping-pong reaction mechanism <1,3,10>; #11# enzyme utilizes a ping-pong  kinetic mechanism in which the acetate group of acetyl-CoA is initially  transferred to an enzyme nucleophile before subsequent transfer to  homoserine <15>)  "
2.3.1.32, acetyl phosphate + L-lysine = phosphate + N6-acetyl-L-lysine  
2.3.1.33, acetyl-CoA + L-histidine = CoA + N-acetyl-L-histidine  
2.3.1.34, acetyl-CoA + D-tryptophan = CoA + N-acetyl-D-tryptophan  
2.3.1.35," N2-acetyl-L-ornithine + L-glutamate = L-ornithine +  N-acetyl-L-glutamate (#18# substrate binding structure, oxyanion  stabilization mechanism of the enzyme-substrate complex, the ping pong  reaction mechanism involves Gly112 and Thr181, active site structure  <12>; #18# residue T181 becomes acetylated and the carbonyl oxygen of  the acyl-enzyme complex is located in an oxyanion hole and positioned  to hydrogen bond with the backbone amide-NH of G112 and the alcohol of  T111. Presence of two distinct acyl-enzyme complex structures which can  interconvert by movement of the T111 side-chain alcohol hydrogen away  from the oxyanion hole to hydrogen bond with the backbone carbonyl of  the acylated residue, T181 <18>)  "
2.3.1.36," acetyl-CoA + a D-amino acid = CoA + an N-acetyl-D-amino acid (#1#  ordered bi bi mechanism with acetyl-CoA being the first substrate to be  bound and CoA the last product to be released, involving acetylation of  Cys304 <2>)  "
2.3.1.37," succinyl-CoA + glycine = 5-aminolevulinate + CoA + CO2  (#1,2,4,6,8,9,10,11,12,14,16,20,23# mechanism <6,12,13,14,19,38,43,52>;  #6# covalent binding of pyridoxal 5-phosphate and glycine to active  site Lys131 is required for optimal activity <42>; #6# Tyr121, Asp279,  Arg439, and Lys313 are involved in substrate and cofactor binding,  mechanism, subunit localisation <42,44,45,48,49,50>; #6# cysteine in  heme-regulatory motif <43>; #6# Lys313 acts as a general base during  formation of the quinonoid reaction intermediates <52>; #6,10# the  active site is located at the subunit interface and contains  catalytically essential residues from the two subunits <45>; #6#  three-step kinetic process, ordered kinetic mechanism, reaction  mechanism <54>; #6# pyridoxal 5-phosphate binding site, sequence and  function of glycine-rich motif <43,44>; #14# ordered bi-bi mechanism in  which glycine binds first and 5-aminolevulinic acid dissociates last  <38,43>; #30# mechanism, aldimine linkage between pyridoxal  5Â’-phosphate and enzyme <58>; #6# 5-aminolevulinate synthase operates  under the stereoelectronic control predicted by DunathanÂ’s hypothesis  <69>; #35# proposed chemical mechanism of enzyme ALAS2 via (I) internal  aldimine complex, (II) glycine-external aldimine, (III) quinonoid  intermediate I, (IV) glycine-succinyl-CoA condensation intermediate,  (V) 2-amino-3-ketoadipate intermediate, (VI) enol intermediate, (VII)  quinonoid intermediate II, and (VIII) 5-aminolevulinate-external  aldimine <94>; #35# proposed chemical mechanism of enzyme ALAS2. via  (I) internal aldimine complex, (II) glycine-external aldimine, (III)  quinonoid intermediate I, (IV) glycineÂ–succinyl-CoA condensation  intermediate, (V) 2-amino-3-ketoadipate intermediate, (VI) enol  intermediate, (VII) quinonoid intermediate II, and (VIII)  5-aminolevulinate-external aldimine <92>; #35# the rate of  5-aminolevulinate release is controlled by a hysteretic kinetic  mechanism initiated by conformational changes of the enzyme. The active  site residue Thr148 modulates the enzymes strict amino acid substrate  specificity. Catalytic mechanism, overview <93>)  "
2.3.1.38," acetyl-CoA + an [acyl-carrier protein] = CoA + an acetyl-[acyl-carrier  protein] (#2# mechanism <12>; #2# Arg-606 is responsible for  malonyl-CoA specificity of the bifunctional enzyme <12>; #1# Bi Bi ping  pong mechanism, acetyl-enzyme intermediate <8>)  "
2.3.1.39," malonyl-CoA + an [acyl-carrier protein] = CoA + a malonyl-[acyl-carrier  protein] (#1# isolation and characterization of an enzyme-intermediate  <12,13>; #1# mechanism, formation of a malonyl-enzyme intermediate  <6,7,11,12>; #5,13,18# mechanism, kinetic studies <16,18>; #13#  catalytic mechanism, [acyl-carrier protein] binding site, residues  Phe200 and Met126 are involved <33>; #13# putative active site  structure and involved catalytic residues <29>; #1,14# the catalytic  malonyl transferase activity is intrinsic to an individual acyl carrier  protein. An arginine/lysine in loop II and an arginine/glutamine in  helix III are the catalytic residues for transferase function. The  hydrogen bonding properties of these residues are indespensible for the  transferase reaction <45>; #34# residues Arg113, Ser88 and His188  constitute the enzymes catalytic triad, catalytic mechanism, detailed  overview. Malonyl-CoA binds to MCAT, involving Ser88, Arg113, Met117  and Phe187. The second step forming an ACP-MCAT-malonyl intermediate is  rate-limiting instead of the malonyl-CoA-MCAT intermediate formed in  the first step. His87, Arg113 and Ser88 render different contributions  for the two intermediates <51>)  "
2.3.1.4, acetyl-CoA + D-glucosamine 6-phosphate = CoA + N-acetyl-D-glucosamine  6-phosphate (#5# ping pong bi bi mechanism <5>)  
2.3.1.40," an acyl-[acyl-carrier protein] +  O-(2-acyl-sn-glycero-3-phospho)ethanolamine = an [acyl-carrier protein]  + O-(1,2-diacyl-sn-glycero-3-phospho)ethanolamine (#1,3# bifunctional  protein exhibits both 2-acylglycerophosphoethanolamine acyltransferase  and acyl-acyl carrier protein synhtase activities in vitro <3,4>)  "
2.3.1.41," an acyl-[acyl-carrier protein] + a malonyl-[acyl-carrier protein] = a  3-oxoacyl-[acyl-carrier protein] + CO2 + an [acyl-carrier protein]  (#4,6# mechanism <4,5,30>; #4# mechanism and active site structure and  function <29>; #23# structure of active site, substrate binding pocket,  and subunit structure in relation to substrate specificity of the 3  isozyme types <27>; #2,4,29# synthaseIII/FabH: His-Asn-Cys catalytic  triad <26,28>; #4# structure <8>; #17# acetylation of the synthase  III-like polyketid synthase at Ser118 <21>; #4# synthaseII/FabB:  His-HIs-Cys catalytic triad <28>; #6,19,23,27# active site cysteine  <23,25,27,30,33>; #4# comparison of active sites in isoforms KAS I, KAS  II and related enzymes, geometry and catalytic role of equivalent  residues <43>; #15# mechanism, roles of H303, H337, C164 <35>; #4#  beta-ketoacyl-acyl-carrier protein synthase enzyme joins short carbon  units to construct fatty acyl chains by a three-step Claisen  condensation reaction, the reaction starts with a trans  thioesterification of the acyl primer substrate from ACP to the enzyme,  subsequently, the donor substrate malonyl-ACP is decarboxylated to form  a carbanion intermediate, which in the third step attacks C1 of the  primer substrate giving rise to an elongated acyl chain, H298 serves as  a catalytic base in the decarboxylation step, the enzyme possesses a  Cys-His-His catalytic triad, Lys328 has a dual role in catalysis: its  charge influences acyl transfer to the active site Cys, and the steric  restraint imposed on H333, as an obligate hydrogen bond donor at Ne, is  of critical importance for decarboxylation activity, active sites of  the wild-type KAS I, its H298 mutants, and their acyl complexes,  overview <45>; #37# catalytic active site residues are Cys163 and  His333, the active site contains two oxyanion holes, stabilizing the  thioester oxyanion of acetylated CoA and of acetylated Cys92,  respectively <41>; #34# structure-activity analysis, reaction mechanism  <50>)  "
2.3.1.42, acyl-CoA + glycerone phosphate = CoA + acylglycerone phosphate  
2.3.1.43," phosphatidylcholine + a sterol = 1-acylglycerophosphocholine + a sterol  ester (#2# reaction mechanism, His377, Asp345, and Ser181 form the  catalytic triad <59>; #2# structure-function analysis via 3D-modeling  of the core and catalytic site of the enzyme <58>)  "
2.3.1.44, acetyl-CoA + N-acetylneuraminate = CoA + N-acetyl-4-O-acetylneuraminate  
2.3.1.45," acetyl-CoA + N-acetylneuraminate = CoA + N-acetyl-7-O(or  9-O)-acetylneuraminate (#5,6,7,8,9,12# 7-O-acetyl groups can migrate to  the 9-position <1,4,9,10>)  "
2.3.1.46," succinyl-CoA + L-homoserine = CoA + O-succinyl-L-homoserine (#2#  ping-pong mechanism, enzyme contains a cysteine in the active site,  member of the acyltransferase family <4>; #2# succinyl is covalently  bound to one of two adjacent lysine residues at positions 45 and 46  <5>; #2# ping pong catalytic reaction mechanism, roles of essential  functional groups, the catalytic triad is formed by the nucleophile  Cys142, the essential base His235, and Glu237, required for proper  orientation of His235, Lys46 is required for interaction with  succinyl-CoA, and Arg193 is involved in binding of L-Homoserine <7>;  #2# ping pong catalytic reaction mechanism, the residues Cys142,  His235, and Lys47 are essential for catalytic activity, Cys142 acts as  nucleophile to which the succinyl moiety is transferred during the  reaction followed by transfer to homoserine to form  O-succinylhomoserine, Lys47 is involved in the first half-reaction, and  His235 is the active site base <8>)  "
2.3.1.47," pimeloyl-[acyl-carrier protein] + L-alanine = 8-amino-7-oxononanoate +  CO2 + holo-[acyl-carrier protein] (#3,6,24# reaction mechanism  <7,10,11,12>; #3,6# binding study of L-alanine and D-alanine to the  enzyme <8,12>; #6# Schiff base formation between D- or L-alanine and  pyridoxal-5-phophate in the active site <8>; #6# binding of  pimeloyl-CoA causes a conformational change in the active site <8>; #6#  reaction mechanism, formation of the pyridoxal-phosphate-stabilized  carbanion by abstraction of the C2-H proton of the  alanine-pyridoxal-phosphate aldimine, followed by acylation and  decarboxylation <7,10>; #6# reaction mechanism could be shared by all  alpha-oxoamine synthases <7>; #3# analysis of the reaction mechanism  via an enzyme-bound intermediate beta-ketoacid pyridoxal-5-phosphate  aldimine, presence of multiple catalytic residues in the Escherichia  coli enzyme <13>; #3# detailed catalytic reaction mechanism, overview  <15>; #13# formation of an external intermediate beta-ketoacid  pyridoxal-5-phosphate aldimine, preference for L-alanine <14>; #21# via  an AtbioF-PLP internal aldimine complex, i.e. a Schiff base formed  between PLP and a Lys residue in the protein <16>)  "
2.3.1.48," acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N6-acetyl-L-lysine  (#9# ping-pong mechanism <16>; #6# ping-pong mechanism, enzyme form NII  <11>; #5,8,11,20# acetylation of lysine 5, 8, 12, and 16 of free  histone H4 <28,32,35>; #6# rapid equilibrium ordered bireactant  mechanism <14>; #5,8,20# mechanisms <31,32,44>; #5,33# MORF protein is  also active as transcription factor <32>; #5,8# ternary complexed  mechanism for PCAF and Gnc5 <38,39>; #5,8,26# enzymes are also active  as transcription coactivators and corepressors of transcription factors  in gene regulation, acetylation of transcription factors, overview  <31>; #5,8# PCAF and Gcn5 protein, fully ordered Bi-Bi kinetic  mechanism with acetyl-CoA binding before histone H3 <37,38,39>;  #5,8,20# binding motifs <44>; #45# ordered sequential catalytic  mechanism of the MYST HAT with a direct-attack mechanism and direct  acetyl transfer mechanism, not mediated by Cys304, within an  Esa1Â‚acetyl-CoAÂ‚histone ternary complex, acetyl-CoA binds first and CoA  is the last product released <62>; #5# conserved catalytic mechanisms  of HATs, overview. p300 utilizes a special type of sequential mechanism  with a short-lived ternary complex, known as a Theorell-Chance  mechanism <104>; #8# conserved catalytic mechanisms of HATs, overview.  p300 utilizes a special type of sequential mechanism with a short-lived  ternary complex, known as a Theorell-Chance mechanism. For Gcn5, p/CAF,  and p300, only 3 to 5 residues on either side of the substrate lysine  are required for efficient binding and catalysis by the catalytic  domain <104>; #8# non-processive mechanism, where the NuA4 histone  acetyltransferasecomplex dissociates from substrate after each  acetylation event <130>; #55# sequential mechanism in which acetyl-CoA  and H3 bind to a complex of isoform Rtt109 and histone chaperone Vps75  without obligate order, followed by the direct attack of the  unprotonated epsilon-amino group on acetyl-CoA, transferring the  acetyl-group to H3 lysine residues The chemical attack of substrate  lysine on the bound acetyl-CoA is the rate-limiting step of catalysis  <129>; #40# ping-pong catalytic mechanism of bi-substrate histone  acetyltransferase KAT8 <162>)  "
2.3.1.49, S-acetylphosphopantetheine + holo-[citrate (pro-3S)-lyase] =  phosphopantetheine + acetyl-[citrate (pro-3S)-lyase]  
2.3.1.5," acetyl-CoA + an arylamine = CoA + an N-acetylarylamine  (#1,4,6,7,10,21,22# ping-pong bi-bi mechanism <16,18,27>; #21#  mechanism and inactivation <33>; #10,46# mechanism and characterization  of active site <13,22>; #63# a conserved active site loop is involved  in substrate recognition, structure analysis, Ser125 in NAT2 is  proximal to the catalytic triad and faces a passageway to the catalytic  core <72>; #65# Cys69, His108, and Asp125 form the catalytic triad  <81>; #56# molecular mechanism of arylamine acetylation by the  catalytic triad of NAT1, overview, the catalytic triad is formed by  Cys68, His107, and Asp122 <80>; #13# ping pong reaction mechanism,  kinetic mechanism, overview <75>; #55# ping pong reaction mechanism,  the enzyme contains a strictly conserved a Cys-His-Asp catalytic triad,  acetylation of the hamster NAT2 is dependent on a thiolate-imidazolium  ion pair, Cys-S--His-ImH+, and not a general acid-base catalysis, a  deacetylation mechanism dominated by nucleophilic attack of the thiol  ester for arylamines <73>; #56,63# structure-function analysis,  Cys68-His107-Asp122 catalytic triad <78>; #21# it is shown that the  formation of a thiolate-imidazolium ion pair by Cys68 and His107 is  involved in the catylytic mechanism. Asp122 is required for optimal  catalysis and structural stability. Enzyme deacetylation step proceeds  via nucleophilic attack for acceptor amines with pKa values less than  5.5 and by deprotonation of a tetrahedral intermediate for amines with  pKa values greater than 5.5 <102>; #20# steady-state kinetic analysis  of TBNAT reveals that the enzyme catalyzes the reaction via a bi-bi  ping-pong kinetic mechanism: enzyme initially reacts with AcCoA to  generate the first product, CoA, and the acetyl-enzyme intermediate  (E-Ac). The amine binds and reacts with E-Ac to generate the second  product, acetylated amine, and regenerate the free enzyme. The pH  dependence of the kinetic parameters reveals that one enzyme group must  be deprotonated for optimal catalytic activity and that two amino acid  residues at the active site of the free enzyme are involved in binding  and/or catalysis. Solvent kinetic isotope effects suggest that proton  transfer steps are not rate-limiting in the overall reaction for  substituted aniline substrates but become rate-limiting when poor  hydrazide substrates are used <98>; #21# residue Y190 is critical for  maximizing the acetylation rate of NAT2 and the transacetylation rate  of substrate p-aminobenzoic acid. Y190 also plays an important role in  determining the pKa of the active site Cys during acetylation, as well  as the pH versus the rate profile for transacetylation <135>)  "
2.3.1.50," palmitoyl-CoA + L-serine = CoA + 3-dehydro-D-sphinganine + CO2 (#3,5,9#  mechanism <3,19>; #7# ordered bi-bi mechanism <17>; #14# formation of  the external aldimine intermediate <20>; #14# using 1HNMR the exchange  of the alpha-proton of L-serine with the solvent in the presence and  absence of S-(2- oxoheptadecyl)-CoA, the structural analogue of  palmitoyl-CoA is investagated. Results demonstrate the presence of  substrate synergism, in which the alpha-proton of L-serine is activated  by the binding of the second substrate palmitoyl-CoA <40>; #7# the  enzyme forms a pyridoxal 5-phosphate-L-serine-aldimine intermediate  during the reaction, His159 plays multiple roles in the reaction  mechanism by exploiting the stereochemistry of DunathanÂ’s conjecture.  His159 promotes both the Claisen-type condensation as an acid catalyst  and the protonation at Calpha of the second quinonoid to form the  pyridoxal 5-phosphate-KDS aldimine, spectral analysis, overview <50>;  #14# the enzyme forms an external aldimine intermediate, as well as  dunathan and quinoid intermediates, and followed by external beta-keto  acid intermediate, and finally product quinoid and product external  aldimine intermediates, reaction cycle, overview <51>; #3# the enzyme  forms an external aldimine intermediate, as well as dunathan and  quinoid intermediates, followed by external beta-keto acid  intermediate, and finally product quinoid and product external aldimine  intermediates, reaction cycle, overview <51>; #17# via reaction  intermediate pyridoxal 5-phosphate-L-serine aldimine, His138 changes  its hydrogen bond partner from the carboxyl group of L-serine to the  carbonyl group of palmitoyl-CoA upon the binding of palmitoyl-CoA,  making the L-serine CaÂ–H bond perpendicular to the pyridoxal  5-phosphate-Schiff base plane, reaction mechanism with substrate  synergism in the SPT reaction, overview. Modelling of reaction  intermediates <49>; #14# pyridoxal 5-phosphate dependent reaction  mechanism, key active site residues are His159, Asp231, His234, and  Lys265 <69>; #14,27# the reaction proceeds via a key  carbanion/quinonoid species and an internal aldimine/PLP-bound form of  the enzyme <65>; #14# the reaction proceeds via several intermediate  states, the pyridoxal 5-phosphate cofactor binds to an active site  lysine residue as an internal aldimine/SchiffÂ’s base (I). The L-serine  displaces the lysine residue (Lys265) to form the PLP-L-serine external  aldimine (II). Deprotonation of II gives a carbanion/quinonoid species  (III) which condenses in a Claisen-like manner with the acyl-CoA  thioester substrate to form a PLP-beta-keto acid, which then  decarboxylates to generate the PLP-KDS product quinonoid (IV). This  then reprotonates to form PLP-KDS aldimine (V) which is finally  displaced by Lys265. The step releasing CoA and CO2 and producing the  quinonoid intermediate species is irreversible. Interaction between the  hydroxyl group of the L-serine substrate and the 5-phosphate group of  pyridoxal 5-phosphate occurs in the formation of the external aldimine  II, overview <66>)  "
2.3.1.51," acyl-CoA + 1-acyl-sn-glycerol 3-phosphate = CoA +  1,2-diacyl-sn-glycerol 3-phosphate  "
2.3.1.52," acyl-CoA + 2-acyl-sn-glycerol 3-phosphate = CoA +  1,2-diacyl-sn-glycerol 3-phosphate  "
2.3.1.53, acetyl-CoA + L-phenylalanine = CoA + N-acetyl-L-phenylalanine  
2.3.1.54," acetyl-CoA + formate = CoA + pyruvate (#4# modelling study proposes a  four-step mechanism. The reaction is initiated by H transfer from C418  via C410 to the glycyl radical G734. H transfer from C419 to G734 is  the rate-limiting process <27>; #29# part of a bacterial-type  mixed-acid fermentation in combination with alcohol dehydrogenase E  <28>; #17# active site structure includes an active site tunnel,  substrate binding at Asp447 at the protein surface <38>; #4# catalytic  mechanism involving residues Gly734, Cys418 and Cys419, transition  state, modeling, overview <36>; #4# reaction via glycyl radical <34>;  #4# the reaction mechanism proceeds via generation of a catalytically  essential glycyl radical at Gly734 <32>)  "
2.3.1.56," N-hydroxy-4-acetylaminobiphenyl + N-hydroxy-4-aminobiphenyl =  N-hydroxy-4-aminobiphenyl + N-acetoxy-4-aminobiphenyl (#2,3,4,5,7#  mechanism <11>; #2,4,5,7# a single cytosolic protein catalyzes  N-acetylation, O-acetylation and N,O-acetylation <11>; #4# ratio of  N-acetylation of arylamines, O-aectylation of arylhydroxylamines and  N,O-acetylation of arylhydroxamic acids, which are all performed by a  single protein, may be highly dependent on the conformation of the  enzyme <10>)  "
2.3.1.57," acetyl-CoA + an alkane-alpha,omega-diamine = CoA + an N-acetyldiamine  (#10,12,13# sequential mechanism <1>; #16# Glu92 functions as a  catalytic base to drive an otherwise unfavorable deprotonation step at  physiological pH. Spermine and the enzyme and form a proton wire  between the side chain of Glu92 and the N1 amine of spermine, a single  water molecule forms hydrogen bonds with the side chains of Glu92,  Asp93, and the N4 amine of spermine, substrate binding structure,  overview <41>; #6# the acetylation proceeds by Bi-Bi mechanism <39>)  "
2.3.1.58," oxalyl-CoA + L-2,3-diaminopropanoate = CoA +  N3-oxalyl-L-2,3-diaminopropanoate  "
2.3.1.59, acetyl-CoA + gentamicin C1a = CoA + N2'-acetylgentamicin C1a  
2.3.1.6, acetyl-CoA + choline = CoA + O-acetylcholine  
2.3.1.60, acetyl-CoA + gentamicin C = CoA + N3-acetylgentamicin C  
2.3.1.61, succinyl-CoA + enzyme N6-(dihydrolipoyl)lysine = CoA + enzyme  N6-(S-succinyldihydrolipoyl)lysine  
2.3.1.62, acyl-CoA + 2-acyl-sn-glycero-3-phosphocholine = CoA +  phosphatidylcholine  
2.3.1.63, acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine = CoA +  2-acyl-1-alkyl-sn-glycero-3-phosphocholine  
2.3.1.64, 4-coumaroyl-CoA + agmatine = CoA +  N-(4-guanidinobutyl)-4-hydroxycinnamamide  
2.3.1.65," choloyl-CoA + glycine = CoA + glycocholate (#6# ping-pong mechanism  <2,3>; #3# catalytic mechanism <9>)  "
2.3.1.66, acetyl-CoA + L-leucine = CoA + N-acetyl-L-leucine  
2.3.1.67, acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine = CoA +  2-acetyl-1-alkyl-sn-glycero-3-phosphocholine  
2.3.1.68, acyl-CoA + L-glutamine = CoA + N-acyl-L-glutamine  
2.3.1.69, acetyl-CoA + a monoterpenol = CoA + a monoterpenol acetate ester  
2.3.1.7," acetyl-CoA + carnitine = CoA + O-acetylcarnitine (#3,4# reaction  mechanism <38,39>; #3,4# mechanism of reaction <43>)  "
2.3.1.71," benzoyl-CoA + glycine = CoA + hippurate (#3# sequential reaction  mechanism in which the acyl-CoA substrate adds to the enzyme first,  glycine adds before CoA leaves and the peptide product dissociates last  <2>; #3# sequential two-substrate mechanism <3>; #5# residue Glu226  functions to deprotonate glycine, facilitating nucleophilic attack on  the acyl-CoA substrate <11>)  "
2.3.1.72, 1-O-(indol-3-yl)acetyl-beta-D-glucose + myo-inositol = D-glucose +  O-(indol-3-yl)acetyl-myo-inositol  
2.3.1.73," a 1,2-diacyl-sn-glycerol + sterol = a 1-acyl-sn-glycerol + sterol ester  "
2.3.1.74," 3 malonyl-CoA + 4-coumaroyl-CoA = 4 CoA + naringenin chalcone + 3 CO2  (#67# reaction mechanism analysis by quantum mechanics calculations,  overview. In loading step, only a tetrahedral intermediate is located  without transition state. His303 acts as a H31 donor, but not a  hydrogen bond donor, to stabilize the intermediate formation. In  decarboxylation step, the reaction proceeds via a transition state and  is sensitive to the environment. In elongation step, a tetrahedral  transition state is located, structure-function analysis, overview <70>)  "
2.3.1.75, acyl-CoA + a long-chain alcohol = CoA + a long-chain ester (#13#  reaction mechanism <11>; #7# the catalytic domain contains the highly  conserved HHXXXDG motif <12>)  
2.3.1.76, acyl-CoA + retinol = CoA + retinyl ester (#5# enzyme mechanism and role  in the visual cycle <11>)  
2.3.1.77, triacylglycerol + a 3beta-hydroxysteroid = diacylglycerol + a  3beta-hydroxysteroid ester  
2.3.1.78," acetyl-CoA + heparan sulfate alpha-D-glucosaminide = CoA + heparan  sulfate N-acetyl-alpha-D-glucosaminide (#2# di-iso ping-pong mechanism  <3,5>; #2# transmembranal reaction mechanism <4,5>)  "
2.3.1.79, acetyl-CoA + maltose = CoA +  6-O-acetyl-alpha-D-glucopyranosyl-(1->4)-D-glucose  
2.3.1.8," acetyl-CoA + phosphate = CoA + acetyl phosphate (#12# reaction  mechanism <7,10,22,23>; #12# evidence against an acyl-enzyme  intermediate <7>; #9,19# rapid equilibrium random bi-bi reaction  mechanism <6,11>; #15# ternary complex kinetic echanism rather than a  ping-pong kinetic mechanism. Sustrates bind to the enzyme in a random  order <39>)  "
2.3.1.80, acetyl-CoA + an L-cysteine-S-conjugate = CoA + an  N-acetyl-L-cysteine-S-conjugate  
2.3.1.81, acetyl-CoA + a 2-deoxystreptamine antibiotic = CoA +  N3-acetyl-2-deoxystreptamine antibiotic  
2.3.1.82, acetyl-CoA + kanamycin-B = CoA + N6'-acetylkanamycin-B (#1# mechanism  <5>)  
2.3.1.83, 3-sn-phosphatidylcholine + dolichol =  1-acyl-sn-glycero-3-phosphocholine + acyldolichol  
2.3.1.84, acetyl-CoA + a primary alcohol = CoA + an acetyl ester  
2.3.1.85," acetyl-CoA + n malonyl-CoA + 2n NADPH + 2n H+ = a long-chain fatty acid  + (n+1) CoA + n CO2 + 2n NADP+ (#1,2,4,5,8,9,10,15,18# reaction  mechanism <1,10,11,16>; #1,2,4,5,8,9,10,14,15,18# structure and  regulation <10,14,15,16>; #5# scheme of functional interactions between  constituent domains. A single subunit, in context of a dimer, is able  to catalyze the entire biosynthetic pathway <40>)  "
2.3.1.86," acetyl-CoA + n malonyl-CoA + 2n NADPH + 4n H+ = long-chain-acyl-CoA + n  CoA + n CO2 + 2n NADP+ (#3,4# reaction mechanism <3,11,13>; #3#  structure <3,12,13,14>; #3# structure and regulation <3>)  "
2.3.1.87," acetyl-CoA + a 2-arylethylamine = CoA + an N-acetyl-2-arylethylamine  (#2,8# mechanism <17,23>; #8# ordered bi-bi sequential mechanism <20>;  #17,18,20,25,39,47,48# catalytic reaction mechanism, overview <63>)  "
2.3.1.89," acetyl-CoA + (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + H2O =  CoA + L-2-acetamido-6-oxoheptanedioate  "
2.3.1.9," 2 acetyl-CoA = CoA + acetoacetyl-CoA (#6,9,23# mechanism <15,17,25>;  #11,23# ping-pong mechanism <25,26>; #12# bi bi ping pong mechanism  <10>; #35# reaction involves 2 chemically distinct steps: acetyl group  transfer from acetyl-CoA to Cys89, and transfer of this acetyl group to  a second acetyl-CoA in the Claisen condensation step to form  acetoacetyl-CoA <37>; #12# proposed two-step ping pong mechanism <35>;  #4,35,36# Claisen condensation, mechanism <41>) "
2.3.1.9, acetyl-CoA + [acetyl-CoA C-acetyltransferase]-L-cysteine = [acetyl-CoA  C-acetyltransferase]-S-acetyl-L-cysteine + CoA 
2.3.1.9, [acetyl-CoA C-acetyltransferase]-S-acetyl-L-cysteine + acetyl-CoA =  acetoacetyl-CoA + [acetyl-CoA C-acetyltransferase]-L-cysteine  
2.3.1.90," 2 1-O-galloyl-beta-D-glucose = D-glucose +  1-O,6-O-digalloyl-beta-D-glucose  "
2.3.1.91," 1-O-sinapoyl-beta-D-glucose + choline = D-glucose + sinapoylcholine  (#1# catalytic mechanism, a double displacement ping-pong mechanism  would require water exclusion from the active center to prevent  hydrolysis. Since this assumption is not supported by the SCT structure  model <11>; #24# Ser-His-Asp catalytic triad, catalytic mechanism, a  double displacement ping-pong mechanism would require water exclusion  from the active center to prevent hydrolysis, overview. Since this  assumption is not supported by the SCT structure model <11>)  "
2.3.1.92, 1-O-sinapoyl-beta-D-glucose + (S)-malate = D-glucose +  sinapoyl-(S)-malate (#3# mechanism <3>)  
2.3.1.93, (E)-2-methylcrotonoyl-CoA + 13-hydroxylupanine = CoA +  13-[(E)-2-methylcrotonoyl]oxylupanine  
2.3.1.94, propanoyl-CoA + 6 (2S)-methylmalonyl-CoA + 6 NADPH + 6 H+ =  6-deoxyerythronolide B + 7 CoA + 6 CO2 + H2O + 6 NADP+  
2.3.1.95, 3 malonyl-CoA + 4-coumaroyl-CoA = 4 CoA + trans-resveratrol + 4 CO2  (#1# proposed mechanism <3>)  
2.3.1.97," tetradecanoyl-CoA + an N-terminal-glycyl-[protein] = CoA + an  N-terminal-N-tetradecanoylglycyl-[protein] (#4# mechanism <1,12,16>;  #4# ordered mechanism <7>; #4,34# ordered bi bi mechanism  <27,29,38,40>; #34# detailed mechanism <45>; #4,34# kinetic analysis  <38,40>; #4# interactions between enzyme and acyl-CoA and peptide  substrates, formation of a high affinity reaction intermediate <16>;  #4,34# peptide binding site <7,27,29,45>; #34# active site <38>; #4,34#  myristoyl-CoA binding site <29,45>; #4# requires alanine at position 5  of substrate peptides <2>; #4,34# binding of myristoyl-CoA to the  enzyme occurs through at least a 2-step process, X-ray data structure  analysis of a binary complex between enzyme and inhibitor  S-(2-oxo)-pentadecyl-CoA and ternary with peptide substrate <38,40,45>;  #2# Glu290, Val-291 and His293 within conserved region EEVEH, are  essential for catalysis <36>; #5# PEST regions for recognition by  clapains, putative regulatory enzymes <34>; #4# cooperativity between  acyl-CoA and peptide binding sites <18>; #4,8,12,13,14,17,21#  myristoylation by NMT proceeds via an ordered bi-bi reaction mechanism  in which binding of myristoyl-CoA generates a second binding pocket for  the docking of the substrate protein. The myristate group from  myristoyl-CoA is then transferred to the N-terminal glycine of the  bound protein in a nucleophilic addition-elimination reaction. This is  followed by stepwise release, first of the free CoA and then the  N-myristoylated protein <69>; #1,2,3# N-myristoylation follows an  ordered bi bi reaction mechanism in which myristoyl-CoA first binds to  the NMT molecule inducing a conformational change and thus allowing for  substrate binding followed by a direct nucleophilic  addition-elimination reaction and the sequential release of CoA and the  myristoyl-peptide <82>)  "
2.3.1.98, chlorogenate + glucarate = quinate + 2-O-caffeoylglucarate  
2.3.1.99, feruloyl-CoA + quinate = CoA + O-feruloylquinate  
2.3.2.1, L(or D)-glutamine + (gamma-D-glutamyl)n-[peptide] = NH3 +  (gamma-D-glutamyl)n+1-[peptide] 
2.3.2.1, D-glutamine + D-glutamate = NH3 + gamma-D-glutamyl-D-glutamate  
2.3.2.10, L-alanyl-tRNAAla +  UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D  alanine = tRNAAla +  UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-N6-(L-alanyl)-L-lysyl  D-alanyl-D-alanine (#1# transfer of L-Ala to epsilon-amino group of  L-lysine of UDP-UDP-acetylmuramoylpentapeptide in an ordered sequential  mechanism <2>; #1# catalysis via a ternary complex <2>)  
2.3.2.11, L-alanyl-tRNAAla + phosphatidylglycerol = tRNAAla +  3-O-L-alanyl-1-O-phosphatidylglycerol  
2.3.2.12," peptidyl-tRNA1 + aminoacyl-tRNA2 = tRNA1 + peptidyl(aminoacyl-tRNA2)  (#9# The peptidyl transferase reaction involves aminolysis by the  alpha-amino group of the A-site aminoacyl-tRNA of the ester bond that  links the nascent peptide to the 3 hydroxyl of the 3 terminal ribose of  the P-site tRNA. The termination reaction involves the transfer of the  peptidyl moiety of P-site located peptidyl-tRNA to a water molecule, in  the course of the reaction the nucleophilic attack of an activated  water molecule in the peptidyl transferase center acceptor site onto  the carbonyl carbon of the peptidyl-tRNA ester leads to formation of a  tetrahedral intermediate, a proton from the water is subsequently  transferred to the 2(3)-hydroxyl of the 3-terminal adenosine of  peptidyl-tRNA, breaking the ester bond between the peptide and tRNA  <31>; #1,5,15# The peptidyl transferase reaction involves aminolysis by  the alpha-amino group of the A-site aminoacyl-tRNA of the ester bond  that links the nascent peptide to the 3-hydroxyl of the 3-terminal  ribose of the P-site tRNA. The termination reaction involves the  transfer of the peptidyl moiety of P-site located peptidyl-tRNA to a  water molecule, in the course of the reaction the nucleophilic attack  of an activated water molecule in the peptidyl transferase center  acceptor site onto the carbonyl carbon of the peptidyl-tRNA ester leads  to formation of a tetrahedral intermediate, a proton from the water is  subsequently transferred to the 2(3)-hydroxyl of the 3-terminal  adenosine of peptidyl-tRNA, breaking the ester bond between the peptide  and tRNA <31>)  "
2.3.2.13," protein glutamine + alkylamine = protein N5-alkylglutamine + NH3 (#53#  ping-pong mechanism <250>; #4# liver transglutaminase, Q155 and Q159  are putative sites in bovine beta-lactoglobulin that incorporate  putrescine <24>; #4,8# mechanism and structure <2,16>; #4,7,8,9#  structure, function, evolution <12,17,39>; #4# putative incorporation  site of putrescine in beta-casein <23>; #4# modified double  displacement mechanism i.e. modified ping pong reaction <15,16>; #4,8#  complex kinetic mechanism with substrate Z-Gln-Gly involving Gln  hydrolysis, intramolecular transpeptidation, intermolecular  transpeptidation, transamidation by added nucleophile <66>; #8#  mechanism of regulation by guanine nucleotides and Ca2+/Mg2+, GTPase  cycle <80>; #54# mechanism, Ca2+ binding in both sites two and three  cooperate in opening a channel through the enzyme <76>; #28# model for  binding and reaction of small peptide substrates, via Michaelis-complex  <86>; #8# the first step in both types of modifications is the  acylation of the active site cysteine (Cys277) of TG2 by a  protein-bound glutamine residue, resulting in the liberation of ammonia  and the formation of a thioester intermediate between TG2 and the  glutamine bearing protein substrate. In TG2 catalyzed transamidation,  the thioester intermediate is attacked by a nucleophilic primary amine,  either a small molecule amine such as putrescine or the epsilon-amino  group of protein-bound lysine residues. This results in the formation  of relatively stable isopeptide bonds <135>; #63# the catalytic  reaction follows a modified ping-pong mechanism in which a  glutamine-containing protein or peptide, the acyl-donor substrate,  reacts with the catalytic cysteine residue to form a thioester bond.  The resulting covalent acyl-enzyme intermediate then reacts with a  second substrate, the acyl-acceptor, to yield the isopeptide-containing  product and free enzyme in a transamidation reaction. Substrate  specificity of the enzyme, detailed overview <249>)  "
2.3.2.14, L-glutamine + D-alanine = NH3 + gamma-L-glutamyl-D-alanine  
2.3.2.15, glutathione + [Glu(-Cys)]n-Gly = Gly + [Glu(-Cys)]n+1-Gly  
2.3.2.16," MurNAc-L-Ala-D-isoglutaminyl-L-Lys-D-Ala-D-Ala-diphospho-ditrans  octacis-undecaprenyl-GlcNAc + glycyl-tRNAGly =  MurNAc-L-Ala-D-isoglutaminyl-L-Lys-(N6-Gly)-D-Ala-D-Ala-diphospho  ditrans,octacis-undecaprenyl-GlcNAc + tRNAGly  "
2.3.2.17," MurNAc-L-Ala-D-isoglutaminyl-L-Lys-(N6-Gly)-D-Ala-D-Ala-diphospho  ditrans,octacis-undecaprenyl-GlcNAc + 2 glycyl-tRNAGly =  MurNAc-L-Ala-D-isoglutaminyl-L-Lys-(N6-tri-Gly)-D-Ala-D-Ala-diphospho  ditrans,octacis-undecaprenyl-GlcNAc + 2 tRNAGly  "
2.3.2.18," MurNAc-L-Ala-D-isoglutaminyl-L-Lys-(N6-tri-Gly)-D-Ala-D-Ala-diphospho  ditrans,octacis-undecaprenyl-GlcNAc + 2 glycyl-tRNAGly =  MurNAc-L-Ala-D-isoglutaminyl-L-Lys-(N6-penta-Gly)-D-Ala-D-Ala-diphospho  ditrans,octacis-undecaprenyl-GlcNAc + 2 tRNAGly  "
2.3.2.19, 4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoyl-[BtrI acyl-carrier  protein] + ribostamycin = gamma-L-glutamyl-butirosin B + BtrI  acyl-carrier protein  
2.3.2.2," a (5-L-glutamyl)-peptide + an amino acid = a peptide + a 5-L-glutamyl  amino acid (#1,2,4,7,8,10,11,13# mechanism <25,27,29,33,34,35,58>;  #2,4,6,7# structure <20,35,43>; #7# active site <75>; #7# almost the  entire glutamyl moiety is necessary for recognition in the binding site  of the donor substrate <75>; #11# kinetic mechanism, pH-dependence  <25>; #6,7# active site on small subunit <20,22,36>; #6,7,8,9,11,13,19#  kinetic study <25,29,32,33,34,56,66,67,68,70,73>; #8# ping-pong bi bi  mechanism <11>; #6# the enzyme binds glutathione as donor substrate and  initially forms a gamma-glutamyl enzyme that can then react with a  water molecule or an acceptor substrate (usually an amino acid or a  dipeptide) to form glutamate or a product containing a new  gamma-glutamyl isopeptide bond, respectively, thus regenerating the  free enzyme <103>; #6# in the human enzyme, a specific residue in the  Cys-Gly binding site plays a critical role in recognizing the Cys-Gly  moiety or the acceptor molecules by interacting with the C-terminal  carboxy group, whereas the Cys side chain and the Cys-Gly amide bond  are not recognized significantly <118>; #5# the Escherichia coli enzyme  is a nonselective enzyme that accommodates substrates without  specifically recognizing the C-terminal carboxy group of the Cys-Gly  moiety of gamma-glutamyl compounds or the acceptor molecules <118>)  "
2.3.2.20, L-leucyl-tRNALeu + L-phenylalanyl-tRNAPhe = tRNALeu + tRNAPhe +  cyclo(L-leucyl-L-phenylalanyl) (#3# ping-pong mechanism with a covalent  intermediate in which L-Phe is transferred from Phe-tRNA(Phe) to an  active serine <2>)  
2.3.2.21," 2 L-tyrosyl-tRNATyr = 2 tRNATyr + cyclo(L-tyrosyl-L-tyrosyl) (#3#  reaction proceeds via a covalent intermediate in which L-tyrosine is  transferred from Tyr-tRNATyr to an active site serine, S88, by  transesterification and with residue E233 serving as a critical base  catalyzing dipeptide bond formation <2>)  "
2.3.2.22," 2 L-leucyl-tRNALeu = 2 tRNALeu + cyclo(L-leucyl-L-leucyl) (#3#  sequential catalytic mechanism, with the successive attachment of two  leucine residues on the enzyme via a conserved serine residue <2>)  "
2.3.2.23," S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2  ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating  enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating  enzyme]-L-cysteine (#1# E2 enzymes autoubiquitinate both their active  sites cysteine, described for this enzyme and lysine residues <10>)  "
2.3.2.24," [E1 ubiquitin-activating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine +  [acceptor protein]-N6-monoubiquitinyl-L-lysine (#23# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues,  the latter described for this enzyme. E2 enzymes catalyze polyubiquitin  formation with a specific lysine preference or a limited subset of  lysine residues of ubiquitin. Accepts ubiquitin from the E1 complex and  catalyzes its covalent attachment to other proteins. In vitro catalyzes  Lys11, as well as Lys48-linked polyubiquitination <2>; #1,17,18,19,20#  E2 enzymes autoubiquitinate both their active sites cysteine and lysine  residues, the latter described for this enzyme. E2 enzymes catalyze  polyubiquitin formation with a specific lysine preference or a limited  subset of lysine residues of ubiquitin. Accepts ubiquitin from the E1  complex and catalyzes its covalent attachment to other proteins. In  vitro catalyzes Lys48-linked polyubiquitination <2>; #17# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues,  the latter described for this enzyme. E2 enzymes catalyze polyubiquitin  formation with a specific lysine preference or a limited subset of  lysine residues of ubiquitin. Polyubiquination occurs through all seven  lysines of ubiquitin, with Lys11 as common as those of Lys48. Accepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins <2>; #21# E2 enzymes autoubiquitinate both their active  sites cysteine and lysine residues, the latter described for this  enzyme. E2 enzymes catalyze polyubiquitin formation with a specific  lysine preference or a limited subset of lysine residues of ubiquitin.  The UBE2V1-UBE2N heterodimer catalyzes the synthesis of non-canonical  polyubiquitin chains that are linked through Lys63 <2>; #22# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues,  the latter described for this enzyme. E2 enzymes catalyze polyubiquitin  formation with a specific lysine preference or a limited subset of  lysine residues of ubiquitin. The UBE2V2/UBE2N heterodimer catalyzes  the synthesis of non-canonical poly-ubiquitin chains that are linked  through Lys63. This type of poly-ubiquitination does not lead to  protein degradation by the proteasome <2>; #25# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  Accepts ubiquitin from the E1 complex and catalyzes its covalent  attachment to other proteins. In vitro catalyzes Lys11-and Lys48-, as  well as Lys63-linked polyubiquitination. <2>; #14# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin. Accepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins. Catalyzes Lys11-linked polyubiquitination. In vitro  able to promote polyubiquitination using all 7 ubiquitin Lys residues,  except Lys48-linked polyubiquitination <2>; #15# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin. Accepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins. Catalyzes monoubiquitination. In vitro able to promote  polyubiquitination using all 7 ubiquitin Lys residues, but may prefer  Lys11-, Lys27-, Lys48-, and Lys-63-linked polyubiquitination <2>; #16#  E2 enzymes autoubiquitinate both their active sites cysteine and lysine  residues. E2 enzymes catalyze polyubiquitin formation with a specific  lysine preference or a limited subset of lysine residues of ubiquitin.  Accepts ubiquitin from the E1 complex and catalyzes its covalent  attachment to other proteins. Catalyzes monoubiquitination. In vitro  catalyzes Lys11-linked polyubiquitination <2>; #10,11# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin. Accepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins. In vitro catalyzes Lys11- and Lys48-linked  polyubiquitination <2>; #9# E2 enzymes autoubiquitinate both their  active sites cysteine and lysine residues. E2 enzymes catalyze  polyubiquitin formation with a specific lysine preference or a limited  subset of lysine residues of ubiquitin. Accepts ubiquitin from the E1  complex and catalyzes its covalent attachment to other proteins. In  vitro catalyzes Lys11-, as well as Lys48- and Lys63-linked  polyubiquitination <2>; #5# E2 enzymes autoubiquitinate both their  active sites cysteine and lysine residues. E2 enzymes catalyze  polyubiquitin formation with a specific lysine preference or a limited  subset of lysine residues of ubiquitin. Accepts ubiquitin from the E1  complex and catalyzes its covalent attachment to other proteins. In  vitro catalyzes Lys11-linked polyubiquitination <2>; #6,8# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin. Accepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins. In vitro catalyzes Lys48-linked polyubiquitination <2>;  #7# E2 enzymes autoubiquitinate both their active sites cysteine and  lysine residues. E2 enzymes catalyze polyubiquitin formation with a  specific lysine preference or a limited subset of lysine residues of  ubiquitin. Accepts ubiquitin from the E1 complex and catalyzes its  covalent attachment to other proteins. In vitro catalyzes  monoubiquitination and Lys48-linked polyubiquitination <2>; #12# E2  enzymes autoubiquitinate both their active sites cysteine and lysine  residues. E2 enzymes catalyze polyubiquitin formation with a specific  lysine preference or a limited subset of lysine residues of ubiquitin.  Accepts ubiquitin from the E1 complex and catalyzes its covalent  attachment to other proteins. In vitro, in the presence or in the  absence of BRCA1-BARD1 E3 ubiquitin-protein ligase complex, catalyzes  the synthesis of Lys48-linked polyubiquitin chains. Does not transfer  ubiquitin directly to but elongates monoubiquitinated substrate protein  <2>; #27# E2 enzymes autoubiquitinate both their active sites cysteine  and lysine residues. E2 enzymes catalyze polyubiquitin formation with a  specific lysine preference or a limited subset of lysine residues of  ubiquitin. Polyubiquination occurs through all seven lysines of  ubiquitin, with Lys11 as common as those of Lys48 <2>; #24# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin.  Polyubiquination occurs through all seven lysines of ubiquitin, with  Lys11 as common as those of Lys48. Accepts ubiquitin from the E1  complex and catalyzes its covalent attachment to other proteins <2>;  #26# E2 enzymes autoubiquitinate both their active sites cysteine and  lysine residues. E2 enzymes catalyze polyubiquitin formation with a  specific lysine preference or a limited subset of lysine residues of  ubiquitin. Polyubiquination occurs through all seven lysines of  ubiquitin. Accepts ubiquitin from the E1 complex and catalyzes its  covalent attachment to other proteins. In vitro catalyzes Lys11- and  Lys48-, as well as Lys63-linked polyubiquitination <2>; #4# E2 enzymes  autoubiquitinate both their active sites cysteine and lysine residues.  E2 enzymes catalyze polyubiquitin formation with a specific lysine  preference or a limited subset of lysine residues of ubiquitin.  Polyubiquination occurs through all seven lysines of ubiquitinAccepts  ubiquitin from the E1 complex and catalyzes its covalent attachment to  other proteins. In vitro catalyzes Lys48-linked polyubiquitination <2>;  #13# E2 enzymes autoubiquitinate both their active sites cysteine and  lysine residues. E2 enzymes catalyze polyubiquitin formation with a  specific lysine preference or a limited subset of lysine residues of  ubiquitin. The UBE2V1-UBE2N and UBE2V2-UBE2N heterodimers catalyze the  synthesis of non-canonical Lys63-linked polyubiquitin chains. This type  of polyubiquitination does not lead to protein degradation by the  proteasome <2>; #3# the enzyme forms a labile ubiquitin adduct in the  presence of E1, ubiquitin, and MgATP and catalyzes the conjugation of  ubiquitin to protein substrates, independent of E3 <1>) "
2.3.2.24, [E1 ubiquitin-activating enzyme]-S-ubiquitinyl-L-cysteine +  [(E3-independent) E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1  ubiquitin-activating enzyme]-L-cysteine + [(E3-independent)  ubiquitin-conjugating enzyme]-S-monoubiquitinyl-L-cysteine 
2.3.2.24, [(E3-independent) E2 ubiquitin-conjugating E2  enzyme]-S-monoubiquitinyl-L-cysteine + [acceptor protein]-L-lysine =  [(E3-independent) E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-N6-monoubiquitinyl-L-lysine  
2.3.2.25," S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor  protein]-N-terminal-amino acid = [E1 ubiquitin-activating  enzyme]-L-cysteine + N-terminal-ubiquitinyl-[acceptor protein] (#1# in  contrast to other ubiquitin-conjugating enzymes which form an  isopeptide bond, this enzyme catalyzes the formation of a peptide bond  at the N-terminus of the acceptor protein <2>) "
2.3.2.25, S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [N-terminal  E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating  enzyme]-L-cysteine + S-ubiquitinyl-[N-terminal ubiquitin-conjugating  enzyme]-L-cysteine 
2.3.2.25, S-ubiquitinyl-[N-terminal E2 ubiquitin-conjugating E2  enzyme]-L-cysteine + [acceptor protein]-N-terminal-amino acid =  [N-terminal E2 ubiquitin-conjugating enzyme]-L-cysteine +  N-ubiquitinyl-[acceptor protein]-N-terminal amino acid  
2.3.2.26," [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-N6-ubiquitinyl-L-lysine (#14# HECT ligases directly  catalyse protein ubiquitination and non-covalently interact with  ubiquitin. The ubiquitin bindung surface on the HECT might act to bind  a ubiquitin moiety that is already conjugated to a protein substrate,  thus promoting polyubiquitination. Mutation in the ubiquitin bindung  surface strongly impairs free-chain fdormation and ubiquitination of  all substrates tested <9>) "
2.3.2.26, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [HECT-type  E3 ubiquitin transferase]-L-cysteine = [E2 ubiquitin-conjugating  enzyme]-L-cysteine + [HECT-type E3 ubiquitin  transferase]-S-ubiquitinyl-L-cysteine 
2.3.2.26, [HECT-type E3 ubiquitin transferase]-S-ubiquitinyl-L-cysteine +  [acceptor protein]-L-lysine = [HECT-type E3 ubiquitin  transferase]-L-cysteine + [acceptor protein]-N6-ubiquitinyl-L-lysine  
2.3.2.27," [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-N6-ubiquitinyl-L-lysine (#3# Ubr1 is an ubiquitin  ligase, which is able to recignize N-end rule substrates. These  substrates occur at two sites, type1 and type-2, specific for  reecognition of basic N-terminal amino acid residues and responsible  for recognition of bulky hydrophobic amino acid residues of proteins  <18>)  "
2.3.2.28, L-allo-isoleucyl-[CmaA peptidyl-carrier protein] + holo-[CmaD  peptidyl-carrier protein] = L-allo-isoleucyl-[CmaD peptidyl-carrier  protein] + holo-[CmaA peptidyl-carrier protein]  
2.3.2.29, L-leucyl-tRNALeu + N-terminal L-glutamyl-[protein] = tRNALeu +  N-terminal L-leucyl-L-glutamyl-[protein] 
2.3.2.29, L-leucyl-tRNALeu + N-terminal L-aspartyl-[protein] = tRNALeu +  N-terminal L-leucyl-L-aspartyl-[protein]  
2.3.2.3, L-lysyl-tRNALys + phosphatidylglycerol = tRNALys +  3-O-L-lysyl-1-O-phosphatidylglycerol  
2.3.2.30, L-ornithine + a (3R)-3-hydroxyacyl-[acyl-carrier protein] = a  lyso-ornithine lipid + a holo-[acyl-carrier protein]  
2.3.2.31, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-N6-ubiquitinyl-L-lysine 
2.3.2.31, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [RBR-type  E3 ubiquitin transferase]-L-cysteine = [E2 ubiquitin-conjugating  enzyme]-L-cysteine + [RBR-type E3 ubiquitin  transferase]-S-ubiquitinyl-L-cysteine 
2.3.2.31, [RBR-type E3 ubiquitin transferase]-S-ubiquitinyl-L-cysteine +  [acceptor protein]-L-lysine = [RBR-type E3 ubiquitin  transferase]-L-cysteine + [acceptor protein]-N6-ubiquitinyl-L-lysine  
2.3.2.32, [E2 NEDD8-conjugating enzyme]-S-[NEDD8-protein]-yl-L-cysteine +  [cullin]-L-lysine = [E2 NEDD8-conjugating enzyme]-L-cysteine +  [cullin]-N6-[NEDD8-protein]-yl-L-lysine  
2.3.2.33, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-threonine = [E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-3-O-ubiquitinyl-L-threonine 
2.3.2.33, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [RCR-type  E3 ubiquitin transferase]-L-cysteine = [E2 ubiquitin-conjugating  enzyme]-L-cysteine + [RCR-type E3 ubiquitin  transferase]-S-ubiquitinyl-L-cysteine 
2.3.2.33, [RCR-type E3 ubiquitin transferase]-S-ubiquitinyl-L-cysteine +  [acceptor protein]-L-threonine = [RCR-type E3 ubiquitin  transferase]-L-cysteine + [acceptor protein]-3-O-ubiquitinyl-L-threonine  
2.3.2.34, [E1 NEDD8-activating enzyme]-S-[NEDD8 protein]-yl-L-cysteine + [E2  NEDD8-conjugating enzyme]-L-cysteine = [E1 NEDD8-activating  enzyme]-L-cysteine + [E2 NEDD8-conjugating  enzyme]-S-[NEDD8-protein]-yl-L-cysteine  
2.3.2.35, (6E)-8-methylnon-6-enoyl-CoA + vanillylamine = CoA + capsaicin  
2.3.2.36, [E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine + [acceptor  protein]-L-cysteine = [E2 ubiquitin-conjugating enzyme]-L-cysteine +  [acceptor protein]-S-ubiquitinyl-L-cysteine  
2.3.2.5," L-glutaminyl-peptide = 5-oxoprolyl-peptide + NH3 (#13# general  acid/base working mechanism, pivoting around a strictly conserved  glutamate <23>; #17# DFT theoretical investigation on the catalytic  mechanism of glutaminyl cyclase <35>)  "
2.3.2.6," L-leucyl-tRNALeu + N-terminal L-lysyl-[protein] = tRNALeu + N-terminal  L-leucyl-L-lysyl-[protein] (#2# the electron relay from Asp 186 to Gln  188 helps Gln 188 to attract a proton from the a-amino group of the  N-terminal Arg of the acceptor peptide. This generates the attacking  nucleophile for the carbonyl carbon of the aminoacyl bond of the  aminoacyl-tRNA, thus facilitating peptide-bond formation <16>) "
2.3.2.6, L-leucyl-tRNALeu + N-terminal L-arginyl-[protein] = tRNALeu +  N-terminal L-leucyl-L-arginyl-[protein]  
2.3.2.7, L-asparagine + hydroxylamine = NH3 + beta-L-aspartylhydroxamate  
2.3.2.8, L-arginyl-tRNAArg + protein = tRNAArg + L-arginyl-[protein]  
2.3.2.9, agaritine + acceptor = 4-hydroxymethylphenylhydrazine +  gamma-L-glutamyl-acceptor  
2.3.3.1, acetyl-CoA + H2O + oxaloacetate = citrate + CoA (#5# mechanism <2>; #5#  active site His320 <2>; #1# high-level ab initio quantum  mechanical/molecular mechanical modelling of citryl-CoA formation in  citrate synthase reveals that an arginine residue acts as the proton  donor <14>)  
2.3.3.10, acetyl-CoA + H2O + acetoacetyl-CoA = (S)-3-hydroxy-3-methylglutaryl-CoA  + CoA  
2.3.3.11, propanoyl-CoA + H2O + glyoxylate = 2-hydroxyglutarate + CoA  
2.3.3.12, pentanoyl-CoA + H2O + glyoxylate = 3-propylmalate + CoA  
2.3.3.13," acetyl-CoA + 3-methyl-2-oxobutanoate + H2O = (2S)-2-isopropylmalate +  CoA (#16# nonrapid equilibrium bi-bi kinetic mechanism, with a  preferred pathway to the ternary complex. Hydrolysis of  alpha-isopropylmalyl-CoA is direct, without the formation of a cyclic  anhydride intermediate <34>)  "
2.3.3.14," acetyl-CoA + H2O + 2-oxoglutarate =  (2R)-2-hydroxybutane-1,2,4-tricarboxylate + CoA (#12# sequential  mechanism <2>; #2# mechanism: 2-oxoglutarate first binds to the active  site zinc via its alpha-carboxylate and 2-oxo groups, followed by  acetyl-CoA. A general base then accepts a proton from the methyl of  acetyl-CoA, and a general acid protonates the carbonyl of  2-oxoglutarate in the formation of homocitryl-CoA. The general acid  then acts as a base in deprotonating Zn-OH2 in the hydrolysis of  homocitryl-CoA to give homocitrate and CoA <28>)  "
2.3.3.15," acetyl phosphate + sulfite = 2-sulfoacetaldehyde + phosphate (#4#  requires Mg2+, phosphate, thiamin diphosphate <1>)  "
2.3.3.16," acetyl-CoA + H2O + oxaloacetate = citrate + CoA (#2,82# mechanism  <25,47>; #24# ordered sequential mechanism <6>; #9,32,82,83# active  site <16,45,47>; #10# free diffusion mechanism, no channeling of  oxaloacetate from malate dehydrogenase <41>; #6,22,35# random  sequential reaction order mechanism <4>)  "
2.3.3.17, an omega-(methylsulfanyl)-2-oxoalkanoate + acetyl-CoA + H2O = a  2-[omega-(methylsulfanyl)alkyl]malate + CoA  
2.3.3.18, acetyl-CoA + H2O + 3-(hydroxyphosphinoyl)pyruvate =  phosphinomethylmalate + CoA  
2.3.3.19, acetyl-CoA + H2O + 3-phosphonopyruvate = (R)-2-(phosphonomethyl)malate  + CoA  
2.3.3.2," lauroyl-CoA + H2O + oxaloacetate =  (2S,3S)-2-hydroxytridecane-1,2,3-tricarboxylate + CoA  "
2.3.3.20, 2 an acyl-CoA + H2O = a (2R)-2-alkyl-3-oxoalkanoate + 2 CoA  
2.3.3.21, acetyl-CoA + pyruvate + H2O = CoA + (2R)-2-hydroxy-2-methylbutanedioate  
2.3.3.3, acetyl-CoA + H2O + oxaloacetate = citrate + CoA  
2.3.3.4," dodecanoyl-CoA + H2O + 2-oxoglutarate =  (3S,4S)-3-hydroxytetradecane-1,3,4-tricarboxylate + CoA  "
2.3.3.5," propanoyl-CoA + H2O + oxaloacetate =  (2S,3S)-2-hydroxybutane-1,2,3-tricarboxylate + CoA  "
2.3.3.6, acetyl-CoA + H2O + 2-oxobutanoate = (R)-2-ethylmalate + CoA (#1# also  acts on (R)-2-(n-propyl)-malate <1>)  
2.3.3.7, butanoyl-CoA + H2O + glyoxylate = 3-ethylmalate + CoA  
2.3.3.8," ADP + phosphate + acetyl-CoA + oxaloacetate = ATP + citrate + CoA (#5#  mechanism <1,31>; #5# in the absence of the CoA acceptor, the enzyme  contains a freely diffusible highly reactive intermediate, with similar  properties to other high-free-energy phosphotransfer intermediates such  as aminoacyl adenylates <31>; #2# ordered mechanism where the phosphate  group of ATP is first covalently bound to the His273 catalytic residue,  and subsequently transferred to the citrate molecule to form citryl  phosphate <43>; #1# cleaves citrate with inversion of configuration  <22>; #2# citrate cleavage is of the si-type <8>; #5#  double-displacement mechanism with a phosphoenzyme intermediate <5>)  "
2.3.3.9," acetyl-CoA + glyoxylate + H2O = (S)-malate + CoA (#2,17# mechanism  <33,38>; #30# sequential bireactant mechanism <10>; #3# sequencial  random mechanism <11>; #8# compulsory-order mechanism, glyoxylate being  the first-binding substrate, glyoxylate triggers a conformational  change in the enzyme and as a consequence, the correctly shaped binding  site for acetyl-CoA is created <31>; #2# mechanism: D631 and R338 act  in concert to form the enolate anion of acetyl-CoA in the rate limiting  step. C617 is oxidized to cysteine-sulfenic acid <46>)  "
2.4.1.1," [(1->4)-alpha-D-glucosyl]n + phosphate = [(1->4)-alpha-D-glucosyl]n-1 +  alpha-D-glucose 1-phosphate (#36# sequential mechanism <70>; #75#  proposal for catalytic mechanism <81>; #16# sequential bi-bi mechanism  <151>; #36# catalytic mechanism of alpha-retaining glucosyl transfer,  His334 is involved in selectively stabilizing the oxycarbenium ion-like  transition state of the reaction, ligand binding <84>; #64# catalytic  site structure <85>; #9# determination and analysis of rgulatory  binding sites <96>; #62# sequential random bi bi mechanism <92>; #79#  sequential bi-bi catalytic mechanism <151>)  "
2.4.1.10," sucrose + [6)-beta-D-fructofuranosyl-(2->]n alpha-D-glucopyranoside =  D-glucose + [6)-beta-D-fructofuranosyl-(2->]n+1 alpha-D-glucopyranoside  (#1# mechanism <9>; #1,36# ping-pong mechanism <4,38>; #36# formation  of a transient fructosyl-enzyme intermediate, kinetics of the  hydrolase, exchange and transfructosylation reaction <38>; #15,37#  N-terminal catalytic domain, C-terminal glucan-binding domain with  glycine-rich repeats <24>; #1# reaction kinetics are dependent on  sucrose concentration <25>; #15# Glu278, located in DXXER conserved  motif, and Asp194, located in conserved RDP motif, and His296 are  involved in catalysis <36>; #38# Asp309 is involved in catalytic  ping-pong mechanism, localization in conserved RDP-motif <33>)  "
2.4.1.100," [beta-D-fructosyl-(2->1)-]m + [beta-D-fructosyl-(2->1)-]n =  [beta-D-fructosyl-(2->1)-]m-1 + [beta-D-fructosyl-(2->1)-]n+1 (#8,11#  ping-pong mechansim <16>)  "
2.4.1.101," UDP-N-acetyl-alpha-D-glucosamine + Man5GlcNAc2-[protein] = UDP +  Man5GlcNAc3-[protein] (#9# mechanism <10>; #20,22# active site <18,22>;  #22# ordered sequential bi bi mechanism <18>; #20# R303 is important  for enzyme activity, conserved throughout all species <22>; #22# SGC  domain of SGC superfamily <18>; #22# DxD motif <18>; #20# D212 is the  central residue of the DxD motif, conserved throughout all species  <22>; #22# modeling study provides detailed insight into the mechanism  of the GlcNAc transfer <34>)  "
2.4.1.102," UDP-N-acetyl-alpha-D-glucosamine +  O3-[beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl]-L  seryl/threonyl-[protein] = UDP +  O3-{beta-D-galactosyl-(1->3)-[N-acetyl-beta-D-glucosaminyl-(1->6)]-N  acetyl-alpha-D-galactosaminyl}-L-seryl/threonyl-[protein] (#18# C2GnT  operates through an inverting mechanism following a SN2-like reaction  in which the enzyme provides a catalytic base that activates the  nucleophile (in C2GnT, this is the C6 hydroxyl group from a GalNAc  residue) to displace the uridine 5-diphosphate (UDP) leaving group from  the UDP-GlcNAc donor in a concerted process. It is assumed that C2GnT  follows the ordered bi-bi catalytic mechanism with the UDP-GlcNAc  bindings first, followed by the disaccharide acceptor binding over the  nucleotide sugar. Reaction mechanism, quantum mechanical/molecular  modeling, overview <49>)  "
2.4.1.103," UDP-glucose + 1,2-dihydroxy-9,10-anthraquinone = UDP +  1-hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone (#1# mechanism <1>)  "
2.4.1.104," UDP-glucose + 7,8-dihydroxycoumarin = UDP + daphnin  "
2.4.1.105, UDP-glucose + vitexin = UDP + vitexin 2''-O-beta-D-glucoside  
2.4.1.106, UDP-glucose + isovitexin = UDP + isovitexin 2''-O-beta-D-glucoside  
2.4.1.109, dolichyl beta-D-mannosyl phosphate + L-threonyl-[protein] = dolichyl  phosphate + 3-O-(alpha-D-mannosyl)-L-threonyl-[protein] (#6#  structure-function analysis <15>) 
2.4.1.109, dolichyl beta-D-mannosyl phosphate + L-seryl-[protein] = dolichyl  phosphate + 3-O-(alpha-D-mannosyl)-L-seryl-[protein]  
2.4.1.11," UDP-alpha-D-glucose + [(1->4)-alpha-D-glucosyl]n = UDP +  [(1->4)-alpha-D-glucosyl]n+1 (#4,5,8,13# reaction mechanism  <17,18,22,26,29>; #24# glycogen synthase performs a stepwise SNi-like  mechanism, involving the concerted departure of the leaving group and  the attack of the incoming nucleophile, via ion-pair intermediate  1,5-anhydro-D-arabino-hex-1-enitol or its tautomeric form,  1,5-anhydro-D-fructose, bound at the catalytic site. Even in the  absence of a glucosyl acceptor, glycogen synthase promotes the  formation of the cationic intermediate, which, by eliminating the  proton of the adjacent C2 carbon atom, yields  1,5-anhydro-D-arabino-hex-1-enitol, overview <95>)  "
2.4.1.110, GDP-mannose + tRNAAsp-queuosine = GDP +  tRNAAsp-O-5''-beta-D-mannosylqueuosine  
2.4.1.111, UDP-glucose + coniferyl alcohol = UDP + coniferin (#4# mechanism <3>)  
2.4.1.113, ADP-glucose + protein = ADP + alpha-D-glucosyl-protein  
2.4.1.114, UDP-glucose + trans-2-hydroxycinnamate = UDP +  trans-beta-D-glucosyl-2-hydroxycinnamate  
2.4.1.115, UDP-D-glucose + an anthocyanidin = UDP + an  anthocyanidin-3-O-beta-D-glucoside  
2.4.1.116," UDP-alpha-D-glucose + cyanidin-3-O-rutinoside = UDP + cyanidin  3-O-rutinoside 5-O-beta-D-glucoside (#1# also acts on  pelargonidin-3-rutinoside, the enzyme does not catalyse the  glucosylation of the 5-hydroxy group of cyanidin-3-glucoside <1>)  "
2.4.1.117, UDP-alpha-D-glucose + dolichyl phosphate = UDP + dolichyl  beta-D-glucosyl phosphate (#3# sequential mechanism <6>)  
2.4.1.118, UDP-glucose + an N6-alkylaminopurine = UDP + an  N6-alkylaminopurine-7-beta-D-glucoside  
2.4.1.12, UDP-alpha-D-glucose + [(1->4)-beta-D-glucosyl]n = UDP +  [(1->4)-beta-D-glucosyl]n+1  
2.4.1.120, UDP-alpha-D-glucose + sinapate = UDP + 1-O-sinapoyl-beta-D-glucose (#4#  sequential mechanism <1>; #5# random bi bi mechanism <6>; #2# mechanism  fits a random bi bi model <4>)  
2.4.1.121, UDP-glucose + (indol-3-yl)acetate = UDP +  1-O-(indol-3-yl)acetyl-beta-D-glucose  
2.4.1.122, UDP-alpha-D-galactose + N-acetyl-alpha-D-galactosaminyl-R = UDP +  beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R (#5#  charge-charge interactions between enzyme and substrate <7>)  
2.4.1.123, UDP-alpha-D-galactose + myo-inositol = UDP +  O-alpha-D-galactosyl-(1->3)-1D-myo-inositol  
2.4.1.125, sucrose + [(1->6)-alpha-D-glucosyl]n = D-fructose +  [(1->6)-alpha-D-glucosyl]n+1 
2.4.1.125, sucrose + [(1->6)-alpha-D-glucosyl]n = D-fructose +  (1->3)-alpha-D-glucosyl-[(1->6)-alpha-D-glucosyl]n  
2.4.1.126, UDP-glucose + trans-4-hydroxycinnamate = UDP +  4-O-beta-D-glucosyl-4-hydroxycinnamate  
2.4.1.127, UDP-glucose + (-)-menthol = UDP + (-)-menthyl O-beta-D-glucoside  
2.4.1.128, UDP-glucose + scopoletin = UDP + scopolin  
2.4.1.129, [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n  diphosphoundecaprenol +  GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)  diphosphoundecaprenol =  [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1  diphosphoundecaprenol + undecaprenyl diphosphate  
2.4.1.13," NDP-alpha-D-glucose + D-fructose = NDP + sucrose (#1,5,8,21,46#  mechanism <3,8,15,25,28>)  "
2.4.1.131, 2 GDP-alpha-D-mannose +  alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc  (1->4)-alpha-D-GlcNAc-diphosphodolichol = 2 GDP +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc  diphosphodolichol  
2.4.1.132, GDP-alpha-D-mannose +  beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol  = GDP +  alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D  GlcNAc-diphosphodolichol  
2.4.1.133," UDP-alpha-D-galactose + [protein]-3-O-(beta-D-xylosyl)-L-serine = UDP +  [protein]-3-O-(beta-D-galactosyl-(1->4)-beta-D-xylosyl)-L-serine  (#10,13# catalytic mechanism, oveview <36>)  "
2.4.1.134, UDP-alpha-D-galactose +  [protein]-3-O-(beta-D-galactosyl-(1->4)-beta-D-xylosyl)-L-serine = UDP  +  [protein]-3-O-(beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D  xylosyl)-L-serine  
2.4.1.135, UDP-alpha-D-glucuronate +  [protein]-3-O-(beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D  xylosyl)-L-serine = UDP +  [protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)  beta-D-Xyl)-L-serine  
2.4.1.136, UDP-glucose + gallate = UDP + 1-galloyl-beta-D-glucose  
2.4.1.137, UDP-alpha-D-galactose + sn-glycerol 3-phosphate = UDP +  2-(alpha-D-galactosyl)-sn-glycerol 3-phosphate  
2.4.1.138, UDP-N-acetyl-alpha-D-glucosamine +  alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-D-Man = UDP +  alpha-D-Man-(1->3)-[alpha-D-GlcNAc-(1->2)]-alpha-D-Man-(1->2)-alpha-D  Man-(1->2)-D-Man  
2.4.1.139, 2 alpha-D-glucose 1-phosphate + H2O = maltose + 2 phosphate  
2.4.1.14, UDP-alpha-D-glucose + D-fructose 6-phosphate = UDP + sucrose  6F-phosphate  
2.4.1.140," Transfers alternately an alpha-D-glucosyl residue from sucrose to the  6-position and the 3-position of the non-reducing terminal residue of  an alpha-D-glucan, thus producing a glucan having alternating  alpha-(1->6)- and alpha-(1->3)-linkages  "
2.4.1.141, UDP-N-acetyl-alpha-D-glucosamine +  N-acetyl-alpha-D-glucosaminyl-diphosphodolichol = UDP +  N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphosphodolichol  
2.4.1.142, GDP-alpha-D-mannose +  N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphosphodolichol = GDP +  beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl  alpha-D-glucosaminyl-diphosphodolichol  
2.4.1.143, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man  (1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] = UDP +  beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha-D  Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn  [protein]  
2.4.1.144," UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha-D  Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn  [protein] = UDP +  beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha-D  Man-(1->6)]-[beta-D-GlcNAc-(1->4)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1  >4)-beta-D-GlcNAc-N-Asn-[protein] (#5# sequential, random or partially  random mechanism <16>)  "
2.4.1.145, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha-D  Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn  [protein] = UDP +  beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D  GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1  >4)-beta-D-GlcNAc-N-Asn-[protein]  
2.4.1.146, UDP-N-acetyl-alpha-D-glucosamine +  3-O-{beta-D-galactosyl-(1->3)-[N-acetyl-beta-D-glucosaminyl-(1->6)]-N  acetyl-alpha-D-galactosaminyl}-L-seryl/threonyl-[protein] = UDP +  3-O-{N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-[N  acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl}-L  seryl/threonyl-[protein]  
2.4.1.147, UDP-N-acetyl-alpha-D-glucosamine +  O3-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl/L-seryl-[protein] = UDP  +  O3-[N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D  galactosaminyl]-L-threonyl/L-seryl-[protein]  
2.4.1.148," UDP-N-acetyl-D-glucosamine +  N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-D-galactosaminyl-R = UDP +  N-acetyl-beta-D-glucosaminyl-(1->6)-[N-acetyl-beta-D-glucosaminyl-(1  >3)]-N-acetyl-D-galactosaminyl-R (#5# the cystine pair pattern  influences the substrate specificity of the enzyme, comparison to the  enzyme from mouse <7>)  "
2.4.1.149, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R = UDP +  N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl  beta-D-glucosaminyl-R  
2.4.1.15," UDP-alpha-D-glucose + D-glucose 6-phosphate = UDP +  alpha,alpha-trehalose 6-phosphate (#4# reaction mechanism <31>; #20#  ordered bi-bi mechanism <2>; #11# complex bimodal kinetics <5>)  "
2.4.1.150," UDP-N-acetyl-alpha-D-glucosamine +  beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc  R = UDP +  beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D  Gal-(1->4)-beta-D-GlcNAc-R (#6# mechanism, model for regulation by  putrescine <10>)  "
2.4.1.152, GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl-R  = GDP +  beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D  glucosaminyl-R  
2.4.1.153, UDP-N-acetyl-alpha-D-glucosamine + dolichyl phosphate = UDP + dolichyl  N-acetyl-alpha-D-glucosaminyl phosphate  
2.4.1.155, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D  GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1  >4)-beta-D-GlcNAc-N-Asn-[protein] = UDP +  beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D  GlcNAc-(1->2)-[beta-D-GlcNAc-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1  >4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] (#5# mechanism  <6>)  
2.4.1.156, UDP-alpha-D-galactose + (indol-3-yl)acetyl-myo-inositol = UDP +  5-O-(indol-3-yl)acetyl-myo-inositol D-galactoside  
2.4.1.158, UDP-glucose + 13-hydroxydocosanoate = UDP +  13-beta-D-glucosyloxydocosanoate  
2.4.1.159, UDP-beta-L-rhamnose + a flavonol 3-O-beta-D-glucoside = UDP + a  flavonol 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside]  
2.4.1.16, UDP-N-acetyl-alpha-D-glucosamine +  [(1->4)-N-acetyl-beta-D-glucosaminyl]n = UDP +  [(1->4)-N-acetyl-beta-D-glucosaminyl]n+1 (#2# mechanism <15>)  
2.4.1.160, UDP-glucose + pyridoxine = UDP + 5'-O-beta-D-glucosylpyridoxine  
2.4.1.161," transfers the non-reducing terminal alpha-D-glucose residue from a  (1->4)-alpha-D-glucan to the 4-position of a free glucose or of a  glucosyl residue at the non-reducing terminus of a  (1->4)-alpha-D-glucan, thus bringing about the rearrangement of  oligosaccharides  "
2.4.1.162, alpha-D-aldosyl1 beta-D-fructoside + D-aldose2 = D-aldose1 +  alpha-D-aldosyl2 beta-D-fructoside  
2.4.1.165, UDP-N-acetyl-alpha-D-galactosamine +  alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D  glucosyl-(1<->1)-ceramide = UDP +  N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide  
2.4.1.166, 2 raffinose = 1F-alpha-D-galactosylraffinose + sucrose  
2.4.1.167, UDP-alpha-D-galactose + sucrose = UDP + 6F-alpha-D-galactosylsucrose  
2.4.1.168," Transfers a beta-D-glucosyl residue from UDP-glucose on to a glucose  residue in xyloglucan, forming a beta-(1->4)-D-glucosyl-D-glucose  linkage  "
2.4.1.17," UDP-alpha-D-glucuronate + acceptor = UDP + acceptor  beta-D-glucuronoside (#7# sequential bireactant mechanism <30,33>;  #24,26,27,30# aspartic acid residues, especially Asp150 and Asp488, and  histidine residues mediate the acid-base reaction mechanism and the  substrate specificity of the human subfamily of  UDP-D-glucuronosyltransferases 1A catalyzing the nucleophilic attack of  phenolic xenobiotics on UDP-D-glucuronic acid, leading to the formation  of water-soluble glucuronides, overview <185>; #6# compulsory ordered  bi bi mechanism <193>; #6# reaction mechanism, structure-activity  relationship, docking of UDP-glucuronic acid to a model of isozyme  UGT1A1 <198>)  "
2.4.1.170, UDP-glucose + an isoflavone = UDP + an isoflavone 7-O-beta-D-glucoside  
2.4.1.171, UDP-glucose + methyl-ONN-azoxymethanol = UDP + cycasin  
2.4.1.172, UDP-glucose + salicyl alcohol = UDP + salicin  
2.4.1.173, UDP-glucose + a sterol = UDP + a sterol 3-beta-D-glucoside  
2.4.1.174, UDP-N-acetyl-alpha-D-galactosamine +  [protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)  beta-D-Xyl)-L-serine = UDP +  [protein]-3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1  >3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine (#1# the enzyme mainly  regulates CS synthesis in cartilage <5>)  
2.4.1.175, UDP-N-acetyl-alpha-D-galactosamine +  [protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1  >3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine = UDP +  [protein]-3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-GalNAc-(1  >4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)  L-serine (#10# enzyme contains 2 distinct catalytic site for GalNAc and  GlcNAc transferase activity <10>) 
2.4.1.175, UDP-N-acetyl-alpha-D-galactosamine +  [protein]-3-O-(beta-D-GlcA-(1->3)-[beta-D-GalNAc-(1->4)-beta-D-GlcA-(1  >3)]n-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D  Gal-(1->4)-beta-D-Xyl)-L-serine = UDP +  [protein]-3-O-([beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)]n+1-beta-D  GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)  beta-D-Xyl)-L-serine  
2.4.1.176, UDP-glucose + gibberellin = UDP + gibberellin 2-O-beta-D-glucoside  
2.4.1.177, UDP-glucose + trans-cinnamate = UDP + trans-cinnamoyl beta-D-glucoside  
2.4.1.178, UDP-glucose + 4-hydroxymandelonitrile = UDP + taxiphyllin  
2.4.1.179, UDP-alpha-D-galactose + beta-D-galactosyl-(1->4)-beta-D-glucosyl-R =  UDP +  beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-R  
2.4.1.18, Transfers a segment of a (1->4)-alpha-D-glucan chain to a primary  hydroxy group in a similar glucan chain (#44# interchain mechanism <74>)  
2.4.1.180," UDP-N-acetyl-alpha-D-mannosaminouronate +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  N-acetyl-beta-D-mannosaminouronyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol  "
2.4.1.181, UDP-glucose + an hydroxyanthraquinone = UDP + a glucosyloxyanthraquinone  
2.4.1.182," a UDP-2-N,3-O-bis[(3R)-3-hydroxyacyl]-alpha-D-glucosamine + a lipid X =  UDP + a lipid A disaccharide (#8# enzyme LpxB catalyzes the  nucleophilic attack of the 6-hydroxyl of lipid X (1) on the anomeric  carbon of UDP-DAG (2) with UDP as the leaving group. As for other  inverting GT-B enzymes, this reaction is thought to proceed by an SN2  mechanism <14>)  "
2.4.1.183, UDP-glucose + [alpha-D-glucosyl-(1->3)]n = UDP +  [alpha-D-glucosyl-(1->3)]n+1  
2.4.1.184," 2 a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol = a  1,2-diacyl-3-O-[beta-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol  + a 1,2-diacyl-sn-glycerol  "
2.4.1.185, UDP-glucose + a flavanone = UDP + a flavanone 7-O-beta-D-glucoside  
2.4.1.186," UDP-alpha-D-glucose + glycogenin = UDP + alpha-D-glucosylglycogenin  (#9# independent active sites for glucosylation of exogenous and  self-acceptors <4>; #8# initiation of glycogen biosynthesis is a 2-step  mechanism, requiring first the covalent attachment of a glucose residue  to Tyr-194 of glycogenin and then elongation to form an oligosaccharide  chain <6>; #3,5,7,8,9# highly conserved protein <2,4,6>; #5,7,8#  stereochemistry and mechanism <2>; #15# conformational plasticity of  glycogenin and coexistence of two modes of glucosylation as integral to  its catalytic mechanism, possible SNi-like mechanism for  glucosyl-transfer, overview <27>)  "
2.4.1.187," UDP-N-acetyl-alpha-D-mannosamine +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol (#2# the enzyme utilize a  sequential mechanism in which both substrates bind prior to product  release. The mechanism is not a rapid equilibrium ordered mechanism.  <2>)  "
2.4.1.188," UDP-alpha-D-glucose +  N-acetyl-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol = UDP +  beta-D-glucosyl-(1->4)-N-acetyl-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol  "
2.4.1.189, UDP-alpha-D-glucuronate + luteolin = UDP + luteolin  7-O-beta-D-glucuronide  
2.4.1.19," Cyclizes part of a (1->4)-alpha-D-glucan chain by formation of a  (1->4)-alpha-D-glucosidic bond (#19# reaction in four steps via  cyclization, disproportionation, hydrolysis, and coupling. The second  step of the reaction involves the transfer of the covalently bound  saccharide to an acceptor molecule <82>)  "
2.4.1.190, UDP-alpha-D-glucuronate + luteolin 7-O-beta-D-glucuronide = UDP +  luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]  
2.4.1.191, UDP-alpha-D-glucuronate + luteolin  7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide] = UDP + luteolin  7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D  glucuronide  
2.4.1.192," UDP-glucose + (20S,22S,25S)-22,25-epoxyfurost-5-ene-3beta,26-diol = UDP  + (20S,22S,25S)-22,25-epoxyfurost-5-ene-3beta,26-diol  3-O-beta-D-glucoside  "
2.4.1.193, UDP-glucose + (25S)-5beta-spirostan-3beta-ol = UDP +  (25S)-5beta-spirostan-3beta-ol 3-O-beta-D-glucoside  
2.4.1.194, UDP-glucose + 4-hydroxybenzoate = UDP + 4-(beta-D-glucosyloxy)benzoate  
2.4.1.195, UDP-alpha-D-glucose + (Z)-2-phenyl-1-thioacetohydroximate = UDP +  desulfoglucotropeolin 
2.4.1.195, UDP-alpha-D-glucose + an  (E)-omega-(methylsulfanyl)alkyl-thiohydroximate = UDP + an aliphatic  desulfoglucosinolate 
2.4.1.195, UDP-alpha-D-glucose + (E)-2-(1H-indol-3-yl)-1-thioacetohydroximate =  UDP + desulfoglucobrassicin  
2.4.1.196, UDP-glucose + nicotinate = UDP + N-glucosylnicotinate  
2.4.1.197, Transfers an N-acetyl-D-glucosamine residue from  UDP-N-acetyl-D-glucosamine to the 4-position of a mannose linked  alpha-(1->6) to the core mannose of high-mannose oligosaccharides  produced by Dictyostelium discoideum  
2.4.1.198, UDP-N-acetyl-alpha-D-glucosamine + 1-phosphatidyl-1D-myo-inositol = UDP  + 6-(N-acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol  
2.4.1.199, beta-D-mannosylphosphodecaprenol +  (1->6)-alpha-D-mannosyloligosaccharide = decaprenol phosphate +  (1->6)-alpha-D-mannosyl-(1->6)-alpha-D-mannosyl-oligosaccharide  
2.4.1.2, [(1->4)-alpha-D-glucosyl]n + [(1->6)-alpha-D-glucosyl]m =  [(1->4)-alpha-D-glucosyl]n-1 + [(1->6)-alpha-D-glucosyl]m+1 (#1#  mechanism <3>; #1# reaction mode and mechanism <9>)  
2.4.1.20," cellobiose + phosphate = alpha-D-glucose 1-phosphate + D-glucose (#7#  computational analyses to elucidate the conformational itinerary along  the reaction pathway of this enzyme using the substrate binding  structure determined from crystal structure, predicted reaction  pathway, overview <22>; #1# reaction proceeds through a random-ordered  bi-bi mechanism, by which phosphate and cellobiose bind in random order  and D-glucose is released before glucose 1-phosphate <29>)  "
2.4.1.201, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D  GlcNAc-(1->2)-[beta-D-GlcNAc-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1  >4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] = UDP +  beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D  GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-[beta-D-GlcNAc-(1->6)]-alpha-D-Man  (1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn  [protein]  
2.4.1.202," UDP-alpha-D-glucose +  2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one = UDP +  (2R)-4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside "
2.4.1.202," UDP-alpha-D-glucose + 2,4-dihydroxy-2H-1,4-benzoxazin-3(4H)-one = UDP +  (2R)-4-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside  "
2.4.1.203, UDP-glucose + trans-zeatin = UDP + O-beta-D-glucosyl-trans-zeatin (#6#  localisation of site determining the substrate specificity for the  UDP-sugar donors <3>)  
2.4.1.205, UDP-alpha-D-galactose + galactogen = UDP +  (1->6)-beta-D-galactosylgalactogen  
2.4.1.206, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP +  N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D  glucosyl-(1<->1)-ceramide  
2.4.1.207," breaks a beta-(1->4) bond in the backbone of a xyloglucan and transfers  the xyloglucanyl segment on to O-4 of the non-reducing terminal glucose  residue of an acceptor, which can be a xyloglucan or an oligosaccharide  of xyloglucan (#22# sequential mechanism <16>; #7,37# reaction  mechanism <22>; #1,7,18,20,37# transglycosylic mechanism, i.e. random  splitting of the beta-1,4-linked polyglucose backbone of xyloglucan  molecules and rejoining the newly created reducing ends by beta-1,4  glycosidic bonds to nonreducing ends of other xyloglucan molecules or  xyloglucan subunit oligosaccharides <14,20>; #37# ping-pong bi bi  reaction mechanism <20>; #37# double-displacement reaction mechanism  <28>; #37# determination of cleavage sites within the donor substrate  of isozymes <35>; #120# enzyme possesss the catalytic sequence motif  EIDFE conserved in the glycosyl hydrolase family 16 <30>; #69#  substrate binding and catalytic mechanism, active site structure,  structure-function study <32>; #69# the enzyme contains a catalytic  sequence motif conserved in the glycosyl hydrolase family 16 <31>)  "
2.4.1.208," UDP-alpha-D-glucose +  1,2-diacyl-3-O-(alpha-D-glucopyranosyl)-sn-glycerol =  1  2-diacyl-3-O-[alpha-D-glucopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]  sn-glycerol + UDP (#4# the enzyme is made from  1,2-diacylglycerol-3-glucosyltransferase, EC 2.4.1.157, in membranes  with more unsaturated or longer acyl chains, increased temperature or  increased amount of cholesterol <8>)  "
2.4.1.209, UDP-glucose + cis-p-coumarate = 4'-O-beta-D-glucosyl-cis-p-coumarate +  UDP  
2.4.1.21, ADP-alpha-D-glucose + [(1->4)-alpha-D-glucosyl]n = ADP +  [(1->4)-alpha-D-glucosyl]n+1  
2.4.1.210," UDP-glucose + limonin = glucosyl-limonin + UDP (#2# the enzyme purified  from navel orange albedo tissue also acts on the related  tetranortriterpenoid nomilin <1,2>; #9# catalytic reaction mechanism,  overview <8>)  "
2.4.1.211," beta-D-galactopyranosyl-(1->3)-N-acetyl-D-glucosamine + phosphate =  alpha-D-galactopyranose 1-phosphate + N-acetyl-D-glucosamine (#1#  reaction also occurs with  beta-D-galactopyranosyl-(1->3)-N-acetyl-D-galactosamine as the  substrate, giving N-acetyl-D-galactosamine as the product <1>)  "
2.4.1.212," UDP-N-acetyl-alpha-D-glucosamine +  beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-[nascent  hyaluronan] = UDP +  N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-N-acetyl  beta-D-glucosaminyl-(1->4)-[nascent hyaluronan] (#14# catalytic  mechanism <20>; #14# 2 active sites, the 2 DXD motifs of the  transferase sites in the C-terminus, residues 686-703, are essential  for activity <17>; #1,9# addition of monosaccharides to the reducing  end to form a linear heteropolysaccharide chain <25>; #9# catalytic  mechanism, no covalent intermediates <20>; #1# catalytically relevant  Cys226 and Cys262 are located near the UDP-binding site and might be  cross-linked, structural and functional role of cysteine residues,  overview <18>; #8# Cys307 might be a catalytic residue or be involved  in maintaining structure, Cys337 is involved in UDP-sugar substrate  binding, enzyme amino acid residues involved in interactions with the  substrate, overview <22>; #28# a mechanistic shift from a steady-state  ordered bi-bi to rapid equilibrium ordered bi-bi mechanism is observed  at the NAc-site between the HA6 and HA8 elongation <84>) "
2.4.1.212, UDP-alpha-D-glucuronate +  N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-[nascent  hyaluronan] = UDP +  beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D  glucuronosyl-(1->3)-[nascent hyaluronan] (#28# a mechanistic shift from  a steady-state ordered bi-bi to rapid equilibrium ordered bi-bi  mechanism is observed at the NAc-site between the HA6 and HA8  elongation <84>)  
2.4.1.213, ADP-alpha-D-glucose + sn-glycerol 3-phosphate =  2-(alpha-D-glucopyranosyl)-sn-glycerol 3-phosphate + ADP  
2.4.1.214," GDP-beta-L-fucose +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc]-L  asparaginyl-[protein] = GDP +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1  >3)]-beta-D-GlcNAc]-L-asparaginyl-[protein] (#4# the enzyme contains  the conserved alpha 1,3 FucT motif, which is crucial for activity and  nucleotide sugar binding <14>)  "
2.4.1.215, UDP-glucose + cis-zeatin = UDP + O-beta-D-glucosyl-cis-zeatin  
2.4.1.216," alpha,alpha-trehalose 6-phosphate + phosphate = glucose 6-phosphate +  beta-D-glucose 1-phosphate  "
2.4.1.217," GDP-mannose + 3-phospho-D-glycerate = GDP +  2-(alpha-D-mannosyl)-3-phosphoglycerate (#5# the enzyme is bifunctional  exhibiting both mannosyl-3-phosphoglycerate synthase, EC 2.4.1.217, and  mannosyl-3-phosphoglycerate phosphatase, EC 3.1.3.70, activities,  catalyzing the consecutive synthesis and dephosphorylation of  mannosyl-3-phosphoglycerate in mannosylglycerate biosynthesis <4>; #2#  front-face SNi-like reaction mechanism, detailed overview. The binding  of GDP-mannose:Mn2+ to the enzyme from Rhodothermus marinus induces  significant conformational changes in the flexible loop. In particular,  Tyr220 plays a pivotal role both in D-glycerate binding and in  catalysis: it is reoriented towards the pocket interior and either  interacts with the a phosphate of GDP-mannose <12>; #1# front-face  SNi-like reaction mechanism, overview <12>)  "
2.4.1.218," UDP-glucose + hydroquinone = UDP +  hydroquinone-O-beta-D-glucopyranoside (#2# reaction mechanism, the NRD  domain with residue Glu368 is required for activity, His360 is crucial  for activity <4>)  "
2.4.1.219, UDP-glucose + vomilenine = UDP + raucaffricine  
2.4.1.22, UDP-alpha-D-galactose + D-glucose = UDP + lactose (#7# random or  ordered bi bi mechanism <12>)  
2.4.1.220, UDP-glucose + indoxyl = UDP + indican  
2.4.1.221," transfers an alpha-L-fucosyl residue from GDP-beta-L-fucose to the  serine hydroxy group of a protein acceptor (#13# catalytic mechanism  and substrate specificity, overview <25>; #14# catalytic mechanism of  isozyme POFUT2 and its preference for threonine over serine residues  <32>)  "
2.4.1.222, transfers a beta-D-GlcNAc residue from UDP-D-GlcNAc to the fucose  residue of a fucosylated protein acceptor (#1# mechanism <6>; #1#  co-expressing of Notch and Fringe in Drosophila SL2 cells results in an  increase of binding of ligand Delta to Notch <2>; #1# GlcNAc-transfer  activity of Fringe is essential for it to modulate Notch signalling <1>)  
2.4.1.223, UDP-N-acetyl-alpha-D-glucosamine +  [protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)  beta-D-Xyl)-L-serine = UDP +  [protein]-3-O-(alpha-D-GlcNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1  >3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine  
2.4.1.224, UDP-N-acetyl-D-glucosamine +  beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan =  UDP +  N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-proteoglycan  
2.4.1.225, UDP-alpha-D-glucuronate +  N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan =  UDP +  beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D  glucuronosyl-proteoglycan  
2.4.1.226," UDP-alpha-D-glucuronate +  [protein]-3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1  >3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine = UDP +  [protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1  >3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine (#4#  transfer to the acceptor through a beta-linkage <2>; #2,3,4,5# transfer  to polymer most likely through a beta(1-3) linkage <1>; #8# enzyme has  dual function possessing both glucuronyltransferase and  N-acetylgalactosaminyltransferase activities <4,5>) "
2.4.1.226, UDP-alpha-D-glucuronate +  [protein]-3-O-([beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)]n-beta-D-GalNAc  (1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D  Xyl)-L-serine = UDP +  [protein]-3-O-(beta-D-GlcA-(1->3)-[beta-D-GalNAc-(1->4)-beta-D-GlcA-(1  >3)]n-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D  Gal-(1->4)-beta-D-Xyl)-L-serine  
2.4.1.227, UDP-N-acetyl-alpha-D-glucosamine +  Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol =  UDP +  beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)  diphosphoundecaprenol (#3# MurG utilizes an ordered Bi Bi mechanism in  which the donor binds first <7>)  
2.4.1.228, UDP-alpha-D-galactose +  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP +  alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<  >1)-ceramide  
2.4.1.229, UDP-N-acetyl-alpha-D-glucosamine +  [Skp1-protein]-trans-4-hydroxy-L-proline = UDP +  [Skp1-protein]-O-(N-acetyl-alpha-D-glucosaminyl)-trans-4-hydroxy-L  proline  
2.4.1.23, UDP-alpha-D-galactose + sphingosine = UDP + psychosine  
2.4.1.230, 2-alpha-D-glucosyl-D-glucose + phosphate = D-glucose + beta-D-glucose  1-phosphate  
2.4.1.231," alpha,alpha-trehalose + phosphate = alpha-D-glucose + alpha-D-glucose  1-phosphate (#2,5# mechanism <2,3,4,11>; #5# saturation transfer  difference NMR spectroscopy shows that the binding of  alpha,alpha-trehalose and alpha-D-glucose to ScTPase depend on  additional binding of a co-substrate <15>)  "
2.4.1.232," Transfers an alpha-D-mannosyl residue from GDP-mannose into  lipid-linked oligosaccharide, forming an  alpha-(1->6)-D-mannosyl-D-mannose linkage (#8# requires Mn2+, in  Saccharomyces cerevisiae, this enzyme catalyses an essential step in  the outer chain elongation of N-linked oligosaccharides, Man8GlcNAc and  Man9GlcNAc are equally good substrates <12>)  "
2.4.1.234," UDP-alpha-D-galactose + kaempferol = UDP + kaempferol  3-O-beta-D-galactoside (#5# acts on the endogenous flavonols kaempferol  and quercetin, to a lesser extend on myricetin and fisetin, and weakly  on galangin and isorhamnetin, the reaction can occur equally well in  both directions <1>)  "
2.4.1.236," UDP-beta-L-rhamnose + a flavanone 7-O-beta-D-glucoside = UDP + a  flavanone 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside] (#3# acts on  the 7-O-glucoside of naringenin and hesperetin, also the flavone  7-O-glucosides of luteolin and apigenin <2>)  "
2.4.1.237," UDP-glucose + a flavonol = UDP + a flavonol 7-O-beta-D-glucoside (#6#  acts on the flavonols gossypetin (8-hydroxyquercetin) and to a lesser  extend on quercetin, kaempferol and myricetin <4>)  "
2.4.1.238," UDP-alpha-D-glucose + delphinidin 3,5-di-O-beta-D-glucoside = UDP +  delphinidin 3,3',5-tri-O-beta-D-glucoside (#1# this enzyme specifically  glucosylates the 3-hydroxy group of  delphinidin-3-O-glucosyl-5-O-(6-O-caffeoylglucosyl)-3-O-(6-O  caffeoylglucoside)-type anthocyanins containing glucose groups at the 3  and 5 positions, acts on delphinidin 3,5-di-O-glucoside in gentian,  Gentiana triflora <1>)  "
2.4.1.239," UDP-glucose + a flavonol 3-O-beta-D-glucoside = UDP + a flavonol  3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside (#1# one of three specific  glucosyltransferases in pea, Pisum sativum, that successively add a  beta-D-glucosyl group first to O-3 of kaempferol, and then to O-2 of  the previously added glucosyl group giving the 3-O-sophoroside and then  the 3-O-sophorotrioside, see also EC 2.4.1.91, flavonol  3-O-glucosyltransferase and EC 2.4.1.240, flavonol-3-O-glycoside  glucosyltransferase, TDP-glucose can replace UDP-glucose as the glucose  donor but the reaction proceeds more slowly <2>)  "
2.4.1.24," Transfers an alpha-D-glucosyl residue in a (1->4)-alpha-D-glucan to the  primary hydroxy group of glucose, free or combined in a  (1->4)-alpha-D-glucan  "
2.4.1.240," UDP-glucose + a flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside =  UDP + a flavonol  3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside (#1#  one of three specific glucosyltransferases in pea, Pisum sativum, that  successively add a beta-D-glucosyl group first to O-3 of kaempferol,  and then to O-2 of the previously added glucosyl group giving the  3-O-sophoroside and then the 3-O-sophorotrioside, see also EC 2.4.1.91  flavonol 3-O-glucosyltransferase, and EC 2.4.1.239  flavonol-3-O-glucoside glucosyltransferase <2>)  "
2.4.1.241," UDP-alpha-D-galactose + 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol  = UDP +  1,2-diacyl-3-O-[alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol  "
2.4.1.242, NDP-glucose + [(1->4)-alpha-D-glucosyl]n = NDP +  [(1->4)-alpha-D-glucosyl]n+1  
2.4.1.243, [1-beta-D-fructofuranosyl-(2->1)-]m+1-alpha-D-glucopyranoside +  [1-beta-D-fructofuranosyl-(2->1)-]n-alpha-D-glucopyranoside =  [1-beta-D-fructofuranosyl-(2->1)-]m-alpha-D-glucopyranoside +  [1-beta-D-fructofuranosyl-(2->1)-]n-beta-D-fructofuranosyl-(2->6)-alpha  D-glucopyranoside (m > 0; n >= 0)  
2.4.1.244, UDP-N-acetyl-alpha-D-galactosamine + N-acetyl-beta-D-glucosaminyl group  = UDP +  N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl group  
2.4.1.245," NDP-alpha-D-glucose + D-glucose = alpha,alpha-trehalose + NDP (#6#  reaction mechanism, overview. The acceptor binding site of TreT shows a  wide and commodious groove and lacks the long flexible loop that plays  a gating role in ligand binding in trehalose phosphate synthase, TPS,  EC 2.4.1.15. A wide space at the fissure between two domains and the  relative shift of the N-domain in one of the crystal forms suggest that  an interactive conformational change between two domains would occur,  allowing a more compact architecture for catalysis <6>)  "
2.4.1.246, GDP-mannose + D-fructose 6-phosphate = GDP +  beta-D-fructofuranosyl-alpha-D-mannopyranoside 6F-phosphate  
2.4.1.247, beta-D-galactosyl-(1->4)-L-rhamnose + phosphate = L-rhamnose +  alpha-D-galactose 1-phosphate  
2.4.1.248, cyclizes part of a (1->6)-alpha-D-glucan chain by formation of a  (1->6)-alpha-D-glucosidic bond  
2.4.1.249," UDP-glucose + delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside = UDP +  delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside-3'-O-beta-D-glucoside  (#1# UDP-glucose:anthocyanin 3,5-O-glucosyltransferase has both, UA3GT  and UA5GT activities, highly regioselective to the 3 and 5 OH groups  <1>) "
2.4.1.249," UDP-glucose + delphinidin  3-O-(6''-O-malonyl)-beta-D-glucoside-3'-O-beta-D-glucoside = UDP +  delphinidin  3-O-(6''-O-malonyl)-beta-D-glucoside-3',5'-di-O-beta-D-glucoside (#1#  UDP-glucose:anthocyanin 3,5-O-glucosyltransferase has both, UA3GT and  UA5GT activities, highly regioselective to the 3 and 5 OH groups <1>)  "
2.4.1.25," Transfers a segment of a (1->4)-alpha-D-glucan to a new position in an  acceptor, which may be glucose or a (1->4)-alpha-D-glucan (#69#  catalytic mechanism and domain structure and function <55>; #70#  reaction mechanism and catalytic cycle, the catalytic nucleophile  changes conformation dramatically during the reaction, Gln256 on the  250s loop is involved in orienting the substrate in the +1 site. The  absence of a suitable base in the covalent intermediate structure  explains the low hydrolysis activity, overview <54>)  "
2.4.1.250, UDP-N-acetyl-alpha-D-glucosamine + 1D-myo-inositol 3-phosphate =  1-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol  3-phosphate + UDP (#3# 1D-myo-inositol 3-phosphate i.e. 1L-myo-inositol  1-phosphate <1>)  
2.4.1.251," GDP-mannose +  GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1  diphospho-ditrans,octacis-undecaprenol = GDP + D-Man-beta-(1->4)-  GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1  diphospho-ditrans,octacis-undecaprenol  "
2.4.1.252," GDP-mannose +  D-Glc-beta-(1->4)-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol =  GDP +  D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans  octacis-undecaprenol  "
2.4.1.253, UDP-D-glucuronate + baicalein = UDP + baicalin  
2.4.1.254, UDP-alpha-D-glucuronate + cyanidin 3-O-beta-D-glucoside = UDP +  cyanidin 3-O-(2-O-beta-D-glucuronosyl)-beta-D-glucoside  
2.4.1.255, UDP-N-acetyl-alpha-D-glucosamine + [protein]-L-serine = UDP +  [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine 
2.4.1.255, UDP-N-acetyl-alpha-D-glucosamine + [protein]-L-threonine = UDP +  [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine  
2.4.1.256, dolichyl beta-D-glucosyl phosphate +  alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1  >2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D  Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)  beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol =  alpha-D-Glc-(1->2)-alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1  >2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D  Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]  beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol  + dolichyl phosphate  
2.4.1.257, GDP-alpha-D-mannose +  alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D  GlcNAc-diphosphodolichol = GDP +  alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc  (1->4)-alpha-D-GlcNAc-diphosphodolichol  
2.4.1.258, dolichyl beta-D-mannosyl phosphate +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc  diphosphodolichol =  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->3)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha  D-GlcNAc-diphosphodolichol + dolichyl phosphate  
2.4.1.259, dolichyl beta-D-mannosyl phosphate +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->3)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha  D-GlcNAc-diphosphodolichol =  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->2)-alpha-D-Man-(1->3)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D  GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol + dolichyl phosphate  
2.4.1.26," Transfers an alpha-D-glucosyl residue from UDP-glucose to an  hydroxymethylcytosine residue in DNA (#1# catalytic mechanism, DNA  binding and base flipping mechanism <4>)  "
2.4.1.260, dolichyl beta-D-mannosyl phosphate +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->2)-alpha-D-Man-(1->3)-alpha-D-Man-(1->6)]-beta-D-Man-beta-(1->4)  beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol =  alpha-D-Man-alpha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D  Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]  beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol  + dolichyl phosphate  
2.4.1.261, dolichyl beta-D-mannosyl phosphate +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta  D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol =  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc  diphosphodolichol + dolichyl phosphate  
2.4.1.262, UDP-alpha-D-glucuronate + soyasapogenol B = UDP + soyasapogenol B  3-O-beta-D-glucuronide  
2.4.1.263, UDP-alpha-D-glucose + abscisate = UDP + beta-D-glucopyranosyl abscisate  
2.4.1.264," UDP-alpha-D-glucuronate +  alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1-diphospho-ditrans  octacis-undecaprenol = UDP +  beta-D-GlcA-(1->2)-alpha-D-Man-(1->3)-beta-D-Glc-(1->4)-alpha-D-Glc-1  diphospho-ditrans,octacis-undecaprenol  "
2.4.1.265, dolichyl beta-D-glucosyl phosphate +  alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1  >3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D  Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)  alpha-D-GlcNAc-diphosphodolichol =  alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1  >2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D  Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)  beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol + dolichyl  phosphate  
2.4.1.266," NDP-glucose + 3-phospho-D-glycerate = NDP +  2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate (#11# reaction model  wherein the catalytic site is essentially preformed, with a few  conformational changes of lateral chain residues as the protein  proceeds along the catalytic cycle <11>; #6# front-side  substrate-assisted SNi-type reaction <13>; #6# ordered kinetic  mechanism with 3-phosphoglycerate binding first, followed by  UDP-glucose <14>)  "
2.4.1.267, dolichyl beta-D-glucosyl phosphate +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man  (1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc  diphosphodolichol =  alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1  >3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D  Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)  alpha-D-GlcNAc-diphosphodolichol + dolichyl phosphate  
2.4.1.268, ADP-glucose + D-glycerate = 2-O-(alpha-D-glucopyranosyl)-D-glycerate +  ADP  
2.4.1.269, GDP-alpha-D-mannose + D-glycerate = GDP +  2-O-(alpha-D-mannopyranosyl)-D-glycerate  
2.4.1.27," Transfers a beta-D-glucosyl residue from UDP-alpha-D-glucose to an  hydroxymethylcytosine residue in DNA (#1# catalytic mechanism <5>; #2#  base-flipping mechanism <6>; #1# catalytic mechanism, substrate binding  structures, overview <9>)  "
2.4.1.270, GDP-mannose + 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate = GDP  +  2-O-[2-O-(alpha-D-mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D  glycerate  
2.4.1.271, UDP-alpha-D-glucose + crocetin = UDP + beta-D-glucosyl crocetin 
2.4.1.271, UDP-alpha-D-glucose + beta-D-glucosyl crocetin = UDP +  bis(beta-D-glucosyl) crocetin 
2.4.1.271, UDP-alpha-D-glucose + beta-D-gentiobiosyl crocetin = UDP +  beta-D-gentiobiosyl beta-D-glucosyl crocetin  
2.4.1.272, UDP-alpha-D-galactose + soyasapogenol B 3-O-beta-D-glucuronide = UDP +  soyasaponin III  
2.4.1.273, UDP-beta-L-rhamnose + soyasaponin III = UDP + soyasaponin I  
2.4.1.274, UDP-alpha-D-galactose + beta-D-glucosyl-(1<->1)-ceramide = UDP +  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide  
2.4.1.275, UDP-alpha-D-galactose +  N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D  glucosyl-(1<->1)-ceramide = UDP +  beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D  galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide  
2.4.1.276," 2 UDP-glucose + zeaxanthin = 2 UDP + zeaxanthin bis(beta-D-glucoside)  (#3# binding of zeaxanthin is the rate-limiting step for the reaction  sequence. The monoglucoside, as an intermediate, never reaches very  high levels compared with zeaxanthin <3>)  "
2.4.1.277," dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose +  10-deoxymethynolide = dTDP + 10-deoxymethymycin  "
2.4.1.278, dTDP-D-desosamine + 3-alpha-L-mycarosylerythronolide B = dTDP +  erythromycin D  
2.4.1.279, 3-O-alpha-D-glucopyranosyl-D-glucopyranose + phosphate = D-glucose +  beta-D-glucose 1-phosphate (#1# sequential bi-bi mechanism <1>)  
2.4.1.28, transfers a beta-D-glucosyl residue from UDP-alpha-D-glucose to a  glucosylhydroxymethylcytosine residue in DNA  
2.4.1.280," N,N'-diacetylchitobiose + phosphate = N-acetyl-D-glucosamine +  N-acetyl-alpha-D-glucosamine 1-phosphate  "
2.4.1.281, 4-O-beta-D-mannopyranosyl-D-glucopyranose + phosphate = D-glucose +  alpha-D-mannose 1-phosphate (#4# sequential Bi Bi mechanism <2>; #1#  sequential bi-bi mechanism involving ternary complex formation <3>)  
2.4.1.282, 3-O-alpha-D-glucopyranosyl-L-rhamnopyranose + phosphate =  L-rhamnopyranose + beta-D-glucose 1-phosphate  
2.4.1.283, UDP-N-acetyl-alpha-D-glucosamine + 2-deoxystreptamine = UDP +  2'-N-acetylparomamine  
2.4.1.284, UDP-alpha-D-glucose + 2-deoxystreptamine = UDP +  2'-deamino-2'-hydroxyparomamine  
2.4.1.285, UDP-N-acetyl-alpha-D-glucosamine + ribostamycin = UDP +  2'''-acetyl-6'''-hydroxyneomycin C  
2.4.1.286," UDP-alpha-D-glucose + naringenin chalcone = UDP +  2',4,4',6'-tetrahydroxychalcone 4'-O-beta-D-glucoside "
2.4.1.286," UDP-alpha-D-glucose + 2',3,4,4',6'-pentahydroxychalcone = UDP +  2',3,4,4',6'-pentahydroxychalcone 4'-O-beta-D-glucoside  "
2.4.1.287," 2 UDP-alpha-D-galactofuranose +  alpha-L-rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho  trans,octacis-decaprenol = 2 UDP +  beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L  rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans  octacis-decaprenol "
2.4.1.287, UDP-alpha-D-galactofuranose +  alpha-L-rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho  trans-octacis-decaprenol = UDP +  beta-D-galactofuranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-N-acetyl  alpha-D-glucosaminyl-diphospho-trans-octacis-decaprenol 
2.4.1.287, UDP-alpha-D-galactofuranose +  beta-D-galactofuranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-N-acetyl  alpha-D-glucosaminyl-diphospho-trans-octacis-decaprenol = UDP +  beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L  rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans  octacis-decaprenol  
2.4.1.288, 28 UDP-alpha-D-galactofuranose +  beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L  rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans  octacis-decaprenol = 28 UDP +  [beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->6)]14-beta  D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L  rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans  octacis-decaprenol  
2.4.1.289," dTDP-6-deoxy-beta-L-mannose +  N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol = dTDP  +  alpha-L-rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho  trans,octacis-decaprenol (#1# kinetic analysis shows that WbbL uses a  ternary complex mechanism reaction <3>)  "
2.4.1.29, GDP-alpha-D-glucose + [(1->4)-beta-D-glucosyl]n = GDP +  [(1->4)-beta-D-glucosyl]n+1  
2.4.1.290," UDP-N-acetyl-alpha-D-galactosamine +  N,N'-diacetyl-alpha-D-bacillosaminyl-diphospho-tritrans  heptacis-undecaprenol = UDP +  N-acetyl-D-galactosaminyl-alpha-(1->3)-N  N'-diacetyl-alpha-D-bacillosaminyl-diphospho-tritrans  heptacis-undecaprenol  "
2.4.1.291," UDP-N-acetyl-alpha-D-galactosamine +  N-acetyl-D-galactosaminyl-alpha-(1->3)-N  N'-diacetyl-alpha-D-bacillosaminyl-diphospho-tritrans  heptacis-undecaprenol = UDP +  N-acetyl-D-galactosaminyl-alpha-(1->4)-N-acetyl-D-galactosaminyl-alpha  (1->3)-N,N'-diacetyl-alpha-D-bacillosaminyl-diphospho-tritrans  heptacis-undecaprenol  "
2.4.1.292," 3 UDP-N-acetyl-alpha-D-galactosamine +  GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-tritrans  heptacis-undecaprenol = 3 UDP +  [GalNAc-alpha-(1->4)]4-GalNAc-alpha-(1->3)-diNAcBac-PP-tritrans  heptacis-undecaprenol (#3# PglH might follow a SN1-like mechanism,  where the nucleophilic attack from the acceptor substrate and the  departure of the leaving UDP occur from the same side. This would  require the leaving group to act as a catalytic base to activate the  incoming nucleophile. Glycan counting mechanism during PglH reaction,  overview <8>)  "
2.4.1.293," UDP-alpha-D-glucose +  [GalNAc-alpha-(1->4)]4-GalNAc-alpha-(1->3)-diNAcBac-diphospho-tritrans  heptacis-undecaprenol = UDP +  [GalNAc-alpha-(1->4)]2-[Glc-beta-(1->3)]-[GalNAc-alpha-(1->4)]2-GalNAc  alpha-(1->3)-diNAcBac-diphospho-tritrans,heptacis-undecaprenol  "
2.4.1.294, UDP-alpha-D-galactose + cyanidin = UDP + cyanidin 3-O-beta-D-galactoside  
2.4.1.295, UDP-alpha-D-glucose + an anthocyanidin 3-O-beta-D-sambubioside = UDP +  an anthocyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside  
2.4.1.296, UDP-alpha-D-glucose + an anthocyanidin  3-O-[2-O-(4-coumaroyl)-alpha-L-rhamnosyl-(1->6)-beta-D-glucoside] = UDP  + an anthocyanidin  3-O-[2-O-(4-coumaroyl)-alpha-L-rhamnosyl-(1->6)-beta-D-glucoside]  5-O-beta-D-glucoside  
2.4.1.297, UDP-alpha-D-glucose + an anthocyanidin 3-O-beta-D-glucoside = UDP + an  anthocyanidin 3-O-sophoroside  
2.4.1.298," UDP-alpha-D-glucose + an anthocyanidin 3-O-beta-D-glucoside = UDP + an  anthocyanidin 3,5-di-O-beta-D-glucoside  "
2.4.1.299," 1-O-sinapoyl-beta-D-glucose + cyanidin 3-O-beta-D-glucoside = sinapate  + cyanidin 3,5-di-O-beta-D-glucoside  "
2.4.1.30, [(1->3)-beta-D-glucosyl]n + phosphate = [(1->3)-beta-D-glucosyl]n-1 +  alpha-D-glucose 1-phosphate (#2# inversion mechanism <4>)  
2.4.1.300," 1-O-vanilloyl-beta-D-glucose + cyanidin 3-O-beta-D-glucoside =  vanillate + cyanidin 3,7-di-O-beta-D-glucoside  "
2.4.1.301, UDP-alpha-D-kanosamine + 2'-deamino-2'-hydroxyneamine = UDP + kanamycin  A (#1# (1) <2>) 
2.4.1.301, UDP-alpha-D-kanosamine + neamine = UDP + kanamycin B (#1# (2) <2>) 
2.4.1.301, UDP-alpha-D-kanosamine + paromamine = UDP + kanamycin C (#1# (3) <2>) 
2.4.1.301, UDP-alpha-D-kanosamine + 2'-deamino-2'-hydroxyparomamine = UDP +  kanamycin X (#1# (4) <2>)  
2.4.1.302, dTDP-4-O-demethyl-beta-L-noviose + novobiocic acid = dTDP +  demethyldecarbamoyl novobiocin  
2.4.1.303," UDP-alpha-D-galactose +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  beta-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.304," UDP-alpha-D-galactose +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  beta-D-Gal-(1->4)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.305," UDP-alpha-D-glucose +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  beta-D-Glc-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.306," UDP-N-acetyl-alpha-D-galactosamine +  N-acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol  = UDP +  alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans  octacis-undecaprenol  "
2.4.1.308," GDP-beta-L-fucose +  beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho  ditrans,octacis-undecaprenol = GDP +  alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D  GalNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.309," UDP-alpha-D-galactose +  alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D  GalNAc-diphospho-ditrans,octacis-undecaprenol = UDP +  alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-alpha-D  GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.31," 3-beta-D-glucosyl-D-glucose + phosphate = D-glucose + alpha-D-glucose  1-phosphate (#1# ordered bi-bi mechanism <2,5>)  "
2.4.1.310, UDP-alpha-D-glucose + vancomycin aglycone = UDP +  devancosaminyl-vancomycin  
2.4.1.311, dTDP-beta-L-4-epi-vancosamine + desvancosaminyl-vancomycin = dTDP +  chloroorienticin B  
2.4.1.312, UDP-N-acetyl-alpha-D-glucosamine +  3-O-(alpha-D-mannosyl)-L-threonyl-[protein] = UDP +  3-O-[N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl  [protein]  
2.4.1.313, UDP-N-acetyl-alpha-D-galactosamine +  3-O-[N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl  [protein] = UDP +  3-O-[N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl  (1->4)-alpha-D-mannosyl]-L-threonyl-[protein]  
2.4.1.314, UDP-alpha-D-glucose + ginsenoside Rd = UDP + ginsenoside Rb1  
2.4.1.315," UDP-alpha-D-glucose +  1,2-diacyl-3-O-(beta-D-glucopyranosyl)-sn-glycerol =  1  2-diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-sn  glycerol + UDP (#2# (1) <2>) "
2.4.1.315, UDP-alpha-D-glucose +  1  2-diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-sn  glycerol =  1  2-diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)  O-beta-D-glucopyranosyl]-sn-glycerol + UDP (#2# (2) <2>)  
2.4.1.316, tylactone + dTDP-alpha-D-mycaminose = dTDP +  5-O-beta-D-mycaminosyltylactone  
2.4.1.317, 5-O-beta-D-mycaminosyltylonolide + dTDP-6-deoxy-alpha-D-allose = dTDP +  demethyllactenocin  
2.4.1.318, dTDP-beta-L-mycarose + demethyllactenocin = dTDP + demethylmacrocin  
2.4.1.319," [(1->4)-beta-D-mannosyl]n + phosphate = [(1->4)-beta-D-mannosyl]n-1 +  alpha-D-mannose 1-phosphate (#1# n>=3, sequential bi-bi mechanism <1>)  "
2.4.1.32, GDP-mannose + (glucomannan)n = GDP + (glucomannan)n+1  
2.4.1.320, 4-O-beta-D-mannopyranosyl-N-acetyl-D-glucosamine + phosphate =  N-acetyl-D-glucosamine + alpha-D-mannose 1-phosphate (#2# sequential Bi  Bi mechanism <1>)  
2.4.1.321, 4-O-beta-D-glucopyranosyl-D-gluconate + phosphate = alpha-D-glucose  1-phosphate + D-gluconate  
2.4.1.322, dTDP-beta-L-vancosamine + devancosaminyl-vancomycin = dTDP + vancomycin  
2.4.1.323, UDP-alpha-D-glucose + 7-deoxyloganetate = UDP + 7-deoxyloganate  
2.4.1.324, UDP-alpha-D-glucose + 7-deoxyloganetin = UDP + 7-deoxyloganin  
2.4.1.325," dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose +  N-acetyl-beta-D-mannosaminouronyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol = dTDP +  4-acetamido-4  6-dideoxy-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-mannosaminouronyl  (1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol  "
2.4.1.326, dTDP-beta-L-rhodosamine + aklavinone = dTDP + aclacinomycin T  
2.4.1.327, dTDP-2-deoxy-beta-L-fucose + aclacinomycin T = dTDP + aclacinomycin S  
2.4.1.328, dTDP-beta-L-mycarose + erythronolide B = dTDP +  3-alpha-L-mycarosylerythronolide B  
2.4.1.329, sucrose 6F-phosphate + phosphate = alpha-D-glucopyranose 1-phosphate +  beta-D-fructofuranose 6-phosphate  
2.4.1.33, GDP-alpha-D-mannuronate + [(1->4)-beta-D-mannuronosyl]n = GDP +  [(1->4)-beta-D-mannuronosyl]n+1  
2.4.1.330, UDP-alpha-D-glucose + beta-D-glucosyl crocetin = UDP +  beta-D-gentiobiosyl crocetin (#1# (1) <1>) 
2.4.1.330, UDP-alpha-D-glucose + bis(beta-D-glucosyl) crocetin = UDP +  beta-D-gentiobiosyl beta-D-glucosyl crocetin (#1# (2) <1>) 
2.4.1.330, UDP-alpha-D-glucose + beta-D-gentiobiosyl beta-D-glucosyl crocetin =  UDP + crocin (#1# (3) <1>)  
2.4.1.331, dTDP-beta-L-rhamnose + 8-demethyltetracenomycin C = dTDP +  8-demethyl-8-alpha-L-rhamnosyltetracenomycin C  
2.4.1.332, 2-O-alpha-D-glucopyranosyl-glycerol + phosphate = beta-D-glucose  1-phosphate + glycerol  
2.4.1.333, [(1->2)-beta-D-glucosyl]n + phosphate = [(1->2)-beta-D-glucosyl]n-1 +  alpha-D-glucose 1-phosphate  
2.4.1.334, [(1->3)-alpha-D-glucosyl]n + phosphate = [(1->3)-alpha-D-glucosyl]n-1 +  beta-D-glucose 1-phosphate  
2.4.1.335," UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate + an archaeal  dolichyl N-acetyl-alpha-D-glucosaminyl phosphate = UDP + an archaeal  dolichyl  3-O-(2,3-diacetamido-2  3-dideoxy-beta-D-glucuronsyl)-N-acetyl-alpha-D-glucosaminyl phosphate  "
2.4.1.336," UDP-alpha-D-glucose + a 1,2-diacyl-sn-glycerol = UDP + a  1,2-diacyl-3-O-(beta-D-glucopyranosyl)-sn-glycerol  "
2.4.1.337," UDP-glucose + 1,2-diacyl-sn-glycerol = UDP +  3-D-glucosyl-1,2-diacyl-sn-glycerol (#1# electrostatic association of  the enzyme with membrane surface is accompanied by hydrophobic  interactions and a conformational change. Binding kinetics fit a  two-state model <4>) "
2.4.1.337," UDP-alpha-D-glucose + a 1,2-diacyl-sn-glycerol = UDP + a  1,2-diacyl-3-O-(alpha-D-glucopyranosyl)-sn-glycerol  "
2.4.1.338, UDP-alpha-D-glucose + validoxylamine A = UDP + validamycin A  
2.4.1.339, beta-D-mannopyranosyl-(1->2)-D-mannopyranose + phosphate =  D-mannopyranose + alpha-D-mannose 1-phosphate  
2.4.1.34, UDP-glucose + [(1->3)-beta-D-glucosyl]n = UDP +  [(1->3)-beta-D-glucosyl]n+1 (#31# model of donor-binding region <45>)  
2.4.1.340, [(1->2)-beta-D-mannosyl]n + phosphate = [(1->2)-beta-D-mannosyl]n-1 +  alpha-D-mannose 1-phosphate  
2.4.1.341, GDP-beta-L-colitose +  beta-D-galactopyranosyl-(1->3)-N-acetyl-D-glucosamine = GDP +  alpha-L-colitosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine  
2.4.1.342, ADP-alpha-D-glucose + alpha-D-glucose-1-phosphate = ADP +  alpha-maltose-1-phosphate  
2.4.1.343," UDP-alpha-D-galactose +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  UDP +  alpha-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.344, GDP-beta-L-fucose +  beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R = GDP +  alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D  glucosaminyl-R  
2.4.1.345," transfers one or more alpha-D-mannose residues from GDP-mannose to  positions 2,6 and others in 1-phosphatidyl-myo-inositol (#1# based on  structural, calorimetric, and mutagenesis studies, a model is proposed  wherein PimA attaches to the membrane through its N-terminal domain,  and this association leads to enzyme activation <4>) "
2.4.1.345, GDP-alpha-D-mannose + 1-phosphatidyl-1D-myo-inositol = GDP +  2-O-(alpha-D-mannosyl)-1-phosphatidyl-1D-myo-inositol  
2.4.1.346, GDP-alpha-D-mannose +  2-O-(6-O-acyl-alpha-D-mannosyl)-1-phosphatidyl-1D-myo-inositol = GDP +  2-O-(6-O-acyl-alpha-D-mannosyl)-6-O-alpha-D-mannosyl-1-phosphatidyl-1D  myo-inositol 
2.4.1.346," GDP-alpha-D-mannose +  2-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol = GDP +  2,6-di-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol  "
2.4.1.347," ADP-alpha-D-glucose + D-glucose 6-phosphate = ADP +  alpha,alpha-trehalose 6-phosphate  "
2.4.1.348," GDP-alpha-D-mannose +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  GDP +  alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol  "
2.4.1.349," 2 GDP-alpha-D-mannose +  alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol = 2 GDP +  alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.35, UDP-glucose + a phenol = UDP + an aryl beta-D-glucoside  
2.4.1.350, UDP-alpha-D-glucose + mogrol = mogroside IE + UDP  
2.4.1.351, UDP-beta-L-rhamnose +  alpha-D-galacturonosyl-[(1->2)-alpha-L-rhamnosyl-(1->4)-alpha-D  galacturonosyl]n = UDP +  [(1->2)-alpha-L-rhamnosyl-(1->4)-alpha-D-galacturonosyl]n+1  
2.4.1.352, 2-O-(alpha-D-glucopyranosyl)-D-glycerate + phosphate =  alpha-D-glucopyranose 1-phosphate + D-glycerate  
2.4.1.353, GDP-6-deoxy-alpha-D-altrose + sordaricin = 4'-O-demethylsordarin + GDP  
2.4.1.354, UDP-alpha-D-glucose + (R)-mandelonitrile = UDP + (R)-prunasin  
2.4.1.355," n UDP-N-acetyl-alpha-D-glucosamine +  4-O-(D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol = n UDP +  4-O-(2-N-acetyl-beta-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1  glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D  glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.356, UDP-alpha-D-glucuronate + an archaeal dolichyl alpha-D-glucosyl  phosphate = UDP + an archaeal dolichyl  beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate  
2.4.1.357, UDP-alpha-D-glucose + phloretin = UDP + phlorizin  
2.4.1.358, UDP-alpha-D-glucose + 2-acylphloroglucinol = UDP + 2-acylphloroglucinol  1-O-beta-D-glucoside  
2.4.1.359, 2-O-alpha-D-glucopyranosyl-glycerol + phosphate = alpha-D-glucose  1-phosphate + glycerol  
2.4.1.36," GDP-glucose + glucose 6-phosphate = GDP + alpha,alpha-trehalose  6-phosphate  "
2.4.1.360, UDP-alpha-D-glucose + a 2'-hydroxy-beta-oxodihydrochalcone = UDP + a  3'-(beta-D-glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone  
2.4.1.361," 2 GDP-alpha-D-mannose + bis(myo-inositol) 1,3'-phosphate = 2 GDP +  2-O-(beta-D-mannosyl-(1->2)-beta-D-mannosyl)-bis(myo-inositol)  1,3'-phosphate "
2.4.1.361," GDP-alpha-D-mannose + bis(myo-inositol) 1,3'-phosphate = GDP +  2-O-(beta-D-mannosyl)-bis(myo-inositol) 1,3'-phosphate "
2.4.1.361," GDP-alpha-D-mannose + 2-O-(beta-D-mannosyl)-bis(myo-inositol)  1,3'-phosphate = GDP +  2-O-(beta-D-mannosyl-(1->2)-beta-D-mannosyl)-bis(myo-inositol)  1,3'-phosphate  "
2.4.1.362, sucrose + a (1->6)-alpha-D-glucan = D-fructose + a  (1->6)-alpha-D-glucan containing a (1->3)-alpha-D-glucose branch  
2.4.1.363, UDP-alpha-D-glucose + (20S)-protopanaxadiol = UDP + ginsenoside C-K  
2.4.1.364, UDP-alpha-D-glucose + (20S)-protopanaxadiol = UDP + (20S)-ginsenoside  Rh2 
2.4.1.364, UDP-alpha-D-glucose + ginsenoside C-K = UDP + ginsenoside F2  
2.4.1.365, UDP-alpha-D-glucose + (20S)-ginsenoside Rh2 = UDP + (20S)-ginsenoside  Rg3 
2.4.1.365, UDP-alpha-D-glucose + ginsenoside F2 = UDP + ginsenoside Rd  
2.4.1.366, UDP-alpha-D-glucose + ginsenoside F1 = UDP + (20S)-ginsenoside Rg1  
2.4.1.367, UDP-alpha-D-glucose + ginsenoside F1 = UDP + (20S)-ginsenoside Rg1 
2.4.1.367, UDP-alpha-D-glucose + protopanaxatriol = UDP + ginsenoside Rh1  
2.4.1.368, UDP-alpha-D-glucose + oleanolate = UDP + oleanolate 3-O-beta-D-glucoside  
2.4.1.369, UDP-alpha-D-glucose + enterobactin = UDP + monoglucosyl-enterobactin 
2.4.1.369, UDP-alpha-D-glucose + monoglucosyl-enterobactin = UDP +  diglucosyl-enterobactin 
2.4.1.369, UDP-alpha-D-glucose + diglucosyl-enterobactin = UDP +  triglucosyl-enterobactin  
2.4.1.37," UDP-alpha-D-galactose + alpha-L-fucosyl-(1->2)-D-galactosyl-R = UDP +  alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl(1->2)]-D-galactosyl-R (where  R can be OH, an oligosaccharide or a glycoconjugate)  "
2.4.1.370, GDP-alpha-D-mannose + a very-long-chain inositol  phospho-(2'R)-2'-hydroxyphytoceramide = a very-long-chain  mannosylinositol phospho-(2'R)-2'-hydroxyphytoceramide + GDP  
2.4.1.371," 2 GDP-alpha-D-mannose +  [alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man  (1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha  D-GlcNAc-diphospho-ditrans,octacis-undecaprenol = 2 GDP +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man  (1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha  D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans  octacis-undecaprenol "
2.4.1.371," 2 GDP-alpha-D-mannose +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man  (1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha  D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans  octacis-undecaprenol = 2 GDP +  [alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man  (1->2)]n+1-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)  alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.372, sucrose + [(1->3)-alpha-D-glucosyl]n = D-fructose +  [(1->3)-alpha-D-glucosyl]n+1  
2.4.1.373, sucrose + a (1->6)-alpha-D-glucan = D-fructose + a  (1->6)-alpha-D-glucan containing a (1->2)-alpha-D-glucose branch  
2.4.1.374, GDP-alpha-D-mannose + [(1->2)-beta-D-mannosyl]n = GDP +  [(1->2)-beta-D-mannosyl]n+1  
2.4.1.375, Transfer of a beta-galactosyl residue in a beta-(1->4) linkage from  UDP-alpha-D-galactose to rhamnosyl residues within the  rhamnogalacturonan I backbone  
2.4.1.376, UDP-alpha-D-glucose + [protein with EGF-like domain]-L-serine = UDP +  [protein with EGF-like domain]-3-O-(beta-D-glucosyl)-L-serine  
2.4.1.377," dTDP-beta-L-rhamnose +  alpha-D-galactosyl-diphospho-ditrans,octacis-undecaprenol = dTDP +  alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und  "
2.4.1.378, GDP-alpha-D-mannose + alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und = GDP +  alpha-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und  
2.4.1.379, GDP-alpha-D-mannose +  alpha-D-galactosyl-diphospho-ditrans-octacis-undecaprenol = GDP +  alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und  
2.4.1.38," UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide = UDP  + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide  (#6# mechanism <33>; #2# the sequences of cDNA isolated from mammary  and F9 cell lines are identical, thus indicating that EC 2.4.1.38 and  EC 2.4.1.90 are non-distinguishable <8>; #3# functional role of Trp310  residue located in the small loop near the active site of the enzyme  <79>; #3,6# reaction mechanism and structural changes <81>; #3#  reaction mechanism, structure-function relationship, upon binding of  metal ion and sugar-nucleotide, the flexible loops undergo a marked  conformational change, from an open to a closed conformation.  Conformational change simultaneously creates at the C-terminal region  of the flexible loop an oligosaccharide acceptor binding site that did  not exist before. The loop acts as a lid covering the bound donor  substrate. After completion of the transfer of the glycosyl unit to the  acceptor, the saccharide product is ejected and the loop reverts to its  native conformation to release the remaining nucleotide moiety <91>)  "
2.4.1.380, GDP-alpha-D-mannose + alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und = GDP +  alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und  
2.4.1.381, dTDP-beta-L-rhamnose +  alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und = dTDP +  alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP  Und  
2.4.1.382, CDP-alpha-D-abequose +  2-O-acetyl-alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)  alpha-D-Gal-PP-Und = CDP +  alpha-D-Abe-(1->3)-2-O-acetyl-alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)  alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und  
2.4.1.383, GDP-alpha-D-mannose + alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und = GDP +  beta-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und  
2.4.1.384, an NDP-glycose + an acceptor = a glycosylated acceptor + NDP  
2.4.1.385," UDP-alpha-D-glucose + a 27-hydroxysteroid = UDP + a sterol  27-beta-D-glucoside (#1# enzyme transferes beta-D-glucose to beta-OH  present at C-20, C-21 and C-27 positions in sterols/withanolides,  provided the sterol posesses a 17beta-OH group. Does not glycosylate  sterols at the C-3 position <1>)  "
2.4.1.386, UDP-N-acetyl-alpha-D-glucosamine +  beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R = UDP +  beta-D-GlcNAc-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D  GlcNAc-R  
2.4.1.39, UDP-N-acetyl-alpha-D-glucosamine + estradiol-17alpha 3-D-glucuronoside  = UDP + 17alpha-(N-acetyl-D-glucosaminyl)-estradiol 3-D-glucuronoside  
2.4.1.4," sucrose + [(1->4)-alpha-D-glucosyl]n = D-fructose +  [(1->4)-alpha-D-glucosyl]n+1 (#11# alpha-retaining mechanism via a  double-displacement similar to that described for alpha-amylases <14>;  #13# DgAS binds the furanoid tautomers of fructose through a weak  network of interactions to enable turanose formation. Such topology at  subsite +1 is likely favoring other possible fructose binding modes as  reported for Neisseria polysaccharea NpAS in agreement with the higher  amount of trehalulose formed by DgAS. Residues Glu326 and Asp284 of  DgAS are the general acid/base and the nucleophile, respectively,  involved in the formation of the beta-glucosyl intermediate occurring  in the alpha-retaining mechanism <34>; #14# in Neisseria polysaccharea  NpAS key residues force the fructosyl moiety to bind in an open state  with the O3 ideally positioned to explain the preferential formation of  turanose by NpAS. Residues Glu328 and Asp286 of NpAS are the general  acid/base and the nucleophile, respectively, involved in the formation  of the beta-glucosyl intermediate occurring in the alpha-retaining  mechanism <34>; #3# the elongation mechanism involves enzyme  conformational changes to allow the entry of sucrose to the active site  <38>)  "
2.4.1.40, UDP-N-acetyl-alpha-D-galactosamine +  glycoprotein-alpha-L-fucosyl-(1->2)-D-galactose = UDP +  glycoprotein-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1  >2)]-D-galactose  
2.4.1.41, UDP-N-acetyl-alpha-D-galactosamine + [protein]-L-serine = UDP +  [protein]-3-O-(N-acetyl-alpha-D-galactosaminyl)-L-serine (#7# mechanism  <34>) 
2.4.1.41, UDP-N-acetyl-alpha-D-galactosamine + [protein]-L-threonine = UDP +  [protein]-3-O-(N-acetyl-alpha-D-galactosaminyl)-L-threonine  
2.4.1.43, UDP-alpha-D-galacturonate + [(1->4)-alpha-D-galacturonosyl]n = UDP +  [(1->4)-alpha-D-galacturonosyl]n+1  
2.4.1.44, UDP-alpha-D-galactose + lipopolysaccharide = UDP +  3-alpha-D-galactosyl-[lipopolysaccharide glucose]  
2.4.1.46," UDP-alpha-D-galactose + a 1,2-diacyl-sn-glycerol = UDP + a  1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol  "
2.4.1.47, UDP-alpha-D-galactose + a ceramide = UDP + a beta-D-galactosylceramide  
2.4.1.48, GDP-mannose + heteroglycan = GDP + 2(or 3)-alpha-D-mannosyl-heteroglycan  
2.4.1.49, [(1->4)-beta-D-glucosyl]n + phosphate = [(1->4)-beta-D-glucosyl]n-1 +  alpha-D-glucose 1-phosphate (#2# ordered bi bi mechanism <4>)  
2.4.1.5," sucrose + [(1->6)-alpha-D-glucosyl]n = D-fructose +  [(1->6)-alpha-D-glucosyl]n+1 (#3# involvement of the three conserved  amino acids (Asp551, Glu589, and Asp662) in the organic reaction enzyme  mechanism for the biosynthesis of dextran at the active site of  dextransucrase by the insertion mechanism addition of D-glucose to the  reducing-end of a growing dextran chain <80>; #3# catalytic reaction  mechanism for dextran elongation, overview <103>)  "
2.4.1.50, UDP-alpha-D-galactose + [procollagen]-(5R)-5-hydroxy-L-lysine = UDP +  [procollagen]-(5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysine  
2.4.1.52," n UDP-alpha-D-glucose +  4-O-{poly[(2R)-glycerophospho]-(2R)-glycerophospho}-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol = n UDP +  4-O-{poly[(2R)-2-alpha-D-glucosyl-1-glycerophospho]-(2R)  glycerophospho}-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D  glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.53," n UDP-alpha-D-glucose +  4-O-[(1-D-ribitylphospho)n-(1-D-ribitylphospho)-(2R)-1-glycerophospho]  N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol = n UDP +  4-O-[(2-beta-D-glucosyl-1-D-ribitylphospho)n-(1-D-ribitylphospho)-(2R)  1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D  glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.54, GDP-alpha-D-mannose + undecaprenyl phosphate = GDP +  D-mannosyl-1-phosphoundecaprenol  
2.4.1.56, UDP-N-acetyl-alpha-D-glucosamine + lipopolysaccharide = UDP +  N-acetyl-alpha-D-glucosaminyllipopolysaccharide  
2.4.1.58, UDP-glucose + lipopolysaccharide = UDP + D-glucosyl-lipopolysaccharide  
2.4.1.60, CDP-alpha-D-abequose +  alpha-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und = CDP +  alpha-D-Abe-(1->3)-alpha-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP  Und  
2.4.1.62, UDP-alpha-D-galactose + an  N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-acetylneuraminyl-(2->3)]  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP + a  beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N  acetylneuraminyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<  >1)-ceramide  
2.4.1.63, UDP-glucose + 2-hydroxy-2-methylpropanenitrile = UDP + linamarin  
2.4.1.64," alpha,alpha-trehalose + phosphate = D-glucose + beta-D-glucose  1-phosphate  "
2.4.1.65, GDP-beta-L-fucose +  beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = GDP +  beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D  glucosaminyl-R  
2.4.1.66," UDP-alpha-D-glucose +  [procollagen]-(5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysine = UDP +  [procollagen]-(5R)-5-O-[alpha-D-glucosyl-(1->2)-beta-D-galactosyl]-5  hydroxy-L-lysine (#1# sequential ordered mechanism <9>; #1,4# reaction  mechanism <1,20>; #1# ordered mechanism <15>)  "
2.4.1.67, alpha-D-galactosyl-(1->3)-1D-myo-inositol + raffinose = myo-inositol +  stachyose (#12# minimum double displacement mechanism <9>)  
2.4.1.68," GDP-beta-L-fucose +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc]-L  asparaginyl-[protein] = GDP +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1  >6)]-beta-D-GlcNAc]-L-asparaginyl-[protein] (#14,15# type II  transmembrane protein <13>; #3# fucosyltransferase gene superfamily  <13>; #12,14,15,16# alpha-2- and alpha-6-fucosyltransferases, from  eukaryotic and prokaryotic origin, are grouped into a superfamily due  to structural features and consensus peptide motifs in the catalytic  domain <11>)  "
2.4.1.69, GDP-beta-L-fucose +  beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = GDP +  alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D  glucosaminyl-R (#5# either a rapid equilibrium random kinetic mechanism  or a steady state ordered mechanism with GDP-L-fucose binding first <3>)  
2.4.1.7," sucrose + phosphate = D-fructose + alpha-D-glucose 1-phosphate (#1,3#  ping-pong mechanism <4,11>; #1# reaction mechanism <28>; #3# double  displacement mechanism <2>; #7# reaction mechanism, substrate access  channel structure, catalytic active site residues are Asp192 and Glu232  <15>; #1# reaction mechanism, acid-base catalysis in the two-step  enzymatic mechanism of alpha-retaining glucosyl transfer by Leuconostoc  mesenteroides sucrose phosphorylase, Glu237 is the catalytic acid-base  of sucrose phosphorylase <24>; #1# reaction mechanism, overview,  sucrose phosphorylase utilizes a glycoside hydrolase-like double  displacement mechanism to convert its disaccharide substrate and  phosphate into alpha-D-glucose 1-phosphate and D-fructose, roles of  Asp196 and Glu237 as catalytic nucleophile and acid-base, respectively.  The side chain of Asp295 facilitates the catalytic steps of  glucosylation and deglucosylation of Asp196 through a strong hydrogen  bond with the 2-hydroxyl of the glucosyl oxocarbenium ion-like species  formed in the transition states flanking the beta-glucosyl enzyme  intermediate <27>; #1# reaction mechanism, the side chain of Asp295,  through a strong hydrogen bond with the equatorial sugar 2-hydroxyl,  stabilizes the transition states flanking the bglucosyl enzyme  intermediate <20>; #7# a two-step catalytic mechanism: Asp192 is the  catalytic nucleophile, Glu232 is the catalytic acid-base, and Asp290  functions as a transition state stabilizer. By forming a strong  hydrogen bond with the hydroxyl groups at C2 and C3 of the glucosyl  residue being transferred, the anionic side chain of Asp290 is  suggested to provide selective stabilization to oxocarbenium ion-like  transition states flanking the covalent alpha-glucosyl enzyme  intermediate <32>; #1,3,4# sucrose phosphorylase catalyzes glucosyl  transfer with retention of the alpha-anomeric configuration of the  donor substrate in the resulting glucosidic product, double  displacement-like catalytic mechanism <32>; #1# catalytic mechanism of  sucrose phosphorylase utilized for phosphorolysis of sucrose,  hydrolysis, and transfer to acceptors. The requirement for base  catalytic facilitation by Glu237 during deglucosylation of the enzyme  will depend on the acceptor used, overview <42>; #1# reaction mechanism  of transglucosylation, overview. Formation of 2-O- and 4-O-glycosidic  isomers of alpha-D-glucopyranosyl glucose suggests that catalytic  glucosyl transfer by the phosphorylase involves two different binding  modes for the D-glucose acceptor <39>)  "
2.4.1.70," n UDP-N-acetyl-alpha-D-glucosamine +  4-O-(D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol = n UDP +  4-O-(2-N-acetyl-alpha-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1  glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D  glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.4.1.71, UDP-glucose + an arylamine = UDP + an N-D-glucosylarylamine  
2.4.1.73, UDP-glucose + lipopolysaccharide = UDP +  alpha-D-glucosyl-lipopolysaccharide  
2.4.1.74, UDP-alpha-D-galactose + glycosaminoglycan = UDP +  D-galactosylglycosaminoglycan  
2.4.1.78, UDP-glucose + polyprenyl phosphate = UDP + polyprenylphosphate-glucose  
2.4.1.79, UDP-N-acetyl-alpha-D-galactosamine +  alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<  >1)-ceramide = UDP +  N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D  galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide  
2.4.1.8," maltose + phosphate = D-glucose + beta-D-glucose 1-phosphate (#2,4#  mechanism <4,6>; #13# sequential Bi Bi mechanism <22>; #8# the forward  reaction proceeds via bi bi mechanism, the reverse reaction shows broad  acceptor specificity and transfers the D-glucosyl moiety to verious  sugars <20>)  "
2.4.1.80," UDP-alpha-D-glucose + an N-acylsphingosine = UDP + a  beta-D-glucosyl-N-acylsphingosine (#21# UDP-glucose and inhibitor  D-PDMP binding region overlap and contain His193 <16,20>; #21# enzyme  DNA sequence contains conserved D1,D2,D3,QXXRW motif found also in  other progressive beta-glycosyltransferases, putative active site,  Cys207 and His193 involved <20>)  "
2.4.1.81," UDP-glucose + 5,7,3',4'-tetrahydroxyflavone = UDP +  7-O-beta-D-glucosyl-5,7,3',4'-tetrahydroxyflavone (#7# GTs are  generally regarded as unidirectional catalysts that drive the formation  of glycosidic bonds from NDP-sugar donors and aglycon acceptors  according to a nucleophilic substitution mechanism (SN2). An SN2 attack  by the aromatic hydroxyl or carboxylate oxygen to the anomeric carbon  of UDP-glucose is performed in the aromatic O-glucoside or acyl-glucose  ester forming reactions <8>; #8# GTs are generally regarded as  unidirectional catalysts that drive the formation of glycosidic bonds  from NDP-sugar donors and aglycon acceptors according to a nucleophilic  substitution mechanism (SN2). An SN2 attack by the aromatic hydroxyl or  carboxylate oxygen to the anomeric carbon of UDP-glucose is performed  in the aromatic O-glucoside or acyl-glucoseester forming reactions <8>)  "
2.4.1.82, alpha-D-galactosyl-(1->3)-1D-myo-inositol + sucrose = myo-inositol +  raffinose (#10# ping-pong reaction mechanism <3>)  
2.4.1.83," GDP-alpha-D-mannose + dolichyl phosphate = GDP + dolichyl  beta-D-mannosyl phosphate (#1# sequential mechanism <14>; #28#  catalytic mechanism of PfDPMS, overview. Catalytic mechanism of the  transfer reaction, nucleophilic attack by the Dol-P phosphate oxygen on  the mannosyl C1 carbon yields GDP and Dol-P-Man. Asp91 and Gln93  coordinate the GDP-Man diphosphate groups via the metal ion, while the  key side chains for positioning the Dol-P phosphate group for mannosyl  transfer are Ser135 and Arg117. The Dol-P phosphate group is  pre-activated for nucleophilic attack, and not dependent on a catalytic  base for activation <56>)  "
2.4.1.85, UDP-alpha-D-glucose + (S)-4-hydroxymandelonitrile = UDP +  (S)-4-hydroxymandelonitrile beta-D-glucoside  
2.4.1.86, UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminyl-R = UDP +  beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R  
2.4.1.87," UDP-alpha-D-galactose +  beta-D-galactosyl-(1->4)-beta-N-acetyl-D-glucosaminyl-R = UDP +  alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N  acetylglucosaminyl-R (where R can be OH, an oligosaccharide or a  glycoconjugate) (#17# structure-function relationship <16>; #27# E317  is not the catalytic nucleophile proposed in the double-displacement  mechanism. Either a different amino acid may act as the catalytic  nucleophile or the reaction must proceed by a different mechanism <28>)  "
2.4.1.88," UDP-N-acetyl-alpha-D-galactosamine +  N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D  galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP +  N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl  (1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D  glucosyl-(1<->1)-ceramide (#8# catalytic mechanism, substrate binding  and active site structure <8>)  "
2.4.1.9," sucrose + [(2->1)-beta-D-fructosyl]n = glucose +  [(2->1)-beta-D-fructosyl]n+1 (#9# catalytic triad formed by essential  residues D272, D424, and E523 <8>)  "
2.4.1.90," UDP-alpha-D-galactose + N-acetyl-D-glucosamine = UDP +  N-acetyllactosamine (#6# mechanism <33>; #2# the sequences of cDNA  isolated from mammary and F9 cell lines are identical, thus indicating  that EC 2.4.1.38 and EC 2.4.1.90 are non-distinguishable <8>; #6#  catalytic mechanism, enzyme undergoes critical conformational changes  upon substrate binding from an open, conf-I, to a closed conformation,  conf-II, involving 2 flexible loops, a small and a long one, with  Trp314 of the small loop being critical for the change interacting with  both substrates, catalytic site structure <69>; #2# catalytic  mechanism, enzyme undergoes critical conformational changes upon  substrate binding from an open, conf-I, to a closed conformation,  conf-II, involving 2 flexible loops, a small and a long one, with  Trp314 of the small loop being critical for the change interacting with  both substrates, catalytic site structure, substrate binding structure  <69>; #3# sequential ordered catalytic mechanism, enzyme undergoes  critical conformational changes upon substrate binding from an open,  conf-I, to a closed conformation, conf-II, involving 2 flexible loops,  a small and a long one, catalytic site structure, Tyr286 determines the  specificity for UDP-Gal <68>; #6# sequential ordered catalytic  mechanism, enzyme undergoes critical conformational changes upon  substrate binding from an open, conf-I, to a closed conformation,  conf-II, involving 2 flexible loops, a small and a long one, with  Trp314 of the small loop being critical for the change interacting with  both substrates, catalytic site structure, Tyr289 determines the  specificity for UDP-Gal, the conformational changes create the  oligosaccharide-acceptor substrate binding site <68>; #6# the GlcNAc  residue at the nonreducing end of chitobiose makes extensive  hydrophobic interactions with the highly conserved Tyr286 <66>)  "
2.4.1.91," UDP-glucose + a flavonol = UDP + a flavonol 3-O-beta-D-glucoside (#20#  His22 acts as the catalytic base, and Asp121 is a key residue that may  assist deprotonation of the acceptor by forming an electron transfer  chain with the catalytic base, both residues, as well as Glu381, are  essential in donor substrate binding and enzyme activity, acceptor  substrate binding site structure <21>)  "
2.4.1.92," UDP-N-acetyl-alpha-D-galactosamine +  O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)  beta-D-glucopyranosyl-(1<->1)-ceramide = UDP +  O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->4)-O-[N-acetyl  alpha-neuraminyl-(2->3)]-O-beta-D-galactopyranosyl-(1->4)-beta-D  glucopyranosyl-(1<->1)-ceramide (#5# mechanism <6>; #2,4# residue 285  determines the donor substrate specificity of the enzyme, catalytic  binding pocket structure, overview <29>)  "
2.4.1.94," UDP-N-acetyl-D-glucosamine + [protein]-L-asparagine = UDP +  [protein]-N4-(N-acetyl-D-glucosaminyl)-L-asparagine (#2,3# sequence  Asn-X-Thr(Ser) at glycosylation site Asn-34 is necessary <1,2>)  "
2.4.1.96, UDP-alpha-D-galactose + sn-glycerol 3-phosphate = UDP +  1-O-alpha-D-galactosyl-sn-glycerol 3-phosphate  
2.4.1.97," [(1->3)-beta-D-glucosyl]n + phosphate = [(1->3)-beta-D-glucosyl]n-1 +  alpha-D-glucose 1-phosphate (#2# the enzyme also synthesizes  1,3-beta-glucan from alpha-D-glucose 1-phosphate and laminaribiose.  Kinetic analysis indicate a sequential bi bi reaction mechanism <3>)  "
2.4.1.99, 2 sucrose = D-glucose +  beta-D-fructofuranosyl-(2->1)-beta-D-fructofuranosyl  alpha-D-glucopyranoside  
2.4.2.1," purine ribonucleoside + phosphate = purine + alpha-D-ribose 1-phosphate  (#62# sequential mechanism <2>; #10,13# Theorell-Chance mechanism  <8,32>; #14# sequential bireactant mechanism <37>; #13# rapid  equilibrium random bi-bi mechanism with formation of abortive complexes  <28>; #2# rapid equilibrium bi bi reaction <7>; #10# ordered bi-bi  mechanism with nucleoside being the first substrate to add and base  product to leave <26>; #72# mechanism: 1. random binding of substrates,  2. potent binding and slow release of some reaction products leading to  the circumstances that the chamical step is not the slowest one and  that rapid-equilibrium assumptions do not hold, 3. dual role of  phosphate, as substrate and as reaction modifier <81>; #32#  steady-state ordered bi bi kinetic mechanism, in which phosphate binds  first followed by 2-deoxyguanosine, and ribose 1-phosphate dissociates  first followed by guanine. A general acid is essential for both  catalysis and 2-deoxyguanosine binding, and deprotonation of a group  abolishes phosphate binding. Product release contributes to the  rate-limiting step <115>; #104# molecular reaction mechanism, overview  <197>; #83# molecular mechanism of catalysis involving protonation of  the purine ring position N7, open and closed active site conformations,  overview <195>; #103# the protonation of the purine base at position  N(7) by the side chain of Asp204 is the first step in the catalytic  cleavage of the glycosidic bond <196>; #73# the structure of hPNP is a  homotrimer with the catalytic sites near the subunit interfaces. The  ternary complex of hPNP includes the binding of inosine and hydrogen  phosphate to the active site. The reaction consists of a phosphorolysis  at C1 of inosines ribose with inversion of stereochemistry at this  position. Reaction occurs via an SN1-like mechanism where hydrogen  phosphate nucleophile and the purine base leaving group are separated  from the oxocarbenium ion, defining a dissociative transition state. It  has to be pointed out that the reaction involves annihilation of  charges in going from the reactant state to the product state. Reaction  mechanism analysis, quantum mechanical and molecular mechanical (QM/MM)  molecular dynamics (MD) simulations, detailed overview <188>; #72# the  trimeric PNPs show that there is no acidic residue in the vicinity of  the purine ring N7, only the side-chain of Asn243 (Asn246 in  Cellulomonas PNP) is found there. Moreover, in the latter structure,  Asn246 interacts with purine through a water molecule, questioning the  protonation mechanism in the catalysis. The molecular mechanism of  catalysis of trimeric PNPs involves either protonation of the purine  ring N7, or a negatively charged purine intermediate stabilized by  hydrogen bonds of purine N(7) with Asn243, or of the purine N1H with  Glu201 (Glu204 in Cellulomonas PNP). Ordered water molecules provide a  proton transfer bridge to O6 and N7 and permit reversible formation of  these hydrogen bonds. The alternative mechanism assumes a negatively  charged purine ring in the transition state stabilized by a hydrogen  bond from Asn243 to purine ring N7. Key catalytic role of Glu204 <195>;  #74,106# the trimeric PNPs show that there is no acidic residue in the  vicinity of the purine ring N7, only the side-chain of Asn243 is found  there. The molecular mechanism of catalysis of trimeric PNPs involves  either protonation of the purine ring N7, or a negatively charged  purine intermediate stabilized by hydrogen bonds of purine N(7) with  Asn243, or of the purine N1H with Glu201. Ordered water molecules  provide a proton transfer bridge to O6 and N7 and permit reversible  formation of these hydrogen bonds. The alternative mechanism assumes a  negatively charged purine ring in the transition state stabilized by a  hydrogen bond from Asn243 to purine ring N7. Key catalytic role of  Glu201 <195>) "
2.4.2.1, purine 2'-deoxyribonucleoside + phosphate = purine +  2-deoxy-alpha-D-ribose 1-phosphate  
2.4.2.10," orotidine 5'-phosphate + diphosphate = orotate +  5-phospho-alpha-D-ribose 1-diphosphate (#1,6# mechanism <7,13,18>; #6#  ping pong mechanism is not operable, NMR exchange experiments <23>; #6#  mechanism is bi bi ping pong <9>; #17# random sequential kinetic  mechanism <31>; #6# reaction scheme, half-of-sites binding of orotidine  5-phosphate and alpha-D-5-phosphorylribose 1-diphosphate to the enzyme  supports an alternative variant of the Theorell-Chance mechanism with  alternating site catalysis, in addition to a ping-pong bi-bi kinetic  mechanism, overview <33>)  "
2.4.2.12, nicotinamide D-ribonucleotide + diphosphate = nicotinamide +  5-phospho-alpha-D-ribose 1-diphosphate (#3# mechanism <3>)  
2.4.2.14," 5-phospho-beta-D-ribosylamine + diphosphate + L-glutamate = L-glutamine  + 5-phospho-alpha-D-ribose 1-diphosphate + H2O (#6# binding of  5-phospho-alpha-D-ribose 1-diphosphate activates the enzyme by a  structural change that lowers the Km for glutamine 100fold and couples  glutamine hydrolysis to synthesis of 5-phospho-beta-D-ribosylamine  <23>; #4,6# mechanism of glutamine amide transfer <11>)  "
2.4.2.15, guanosine + phosphate = guanine + alpha-D-ribose 1-phosphate  
2.4.2.16, urate D-ribonucleoside + phosphate = urate + alpha-D-ribose 1-phosphate  
2.4.2.17," 1-(5-phospho-beta-D-ribosyl)-ATP + diphosphate = ATP +  5-phospho-alpha-D-ribose 1-diphosphate (#1,2# sequential kinetic  mechanism in biosynthetic direction, ordered bi-bi mechanism with ATP  binding first to free enzyme and phosphoribosyl-ATP dissociating last  from enzyme-product complexes <2,3,10,11>; #2# double displacement  mechanism <2>; #5# substrate binding sites, active site structure,  switch between active and inactive conformation <16>; #16# substrate  binding sites, e.g. Cys104, Asn75, Ser154, Glu156, and Val155, reaction  mechanism <17>)  "
2.4.2.18, N-(5-phospho-D-ribosyl)-anthranilate + diphosphate = anthranilate +  5-phospho-alpha-D-ribose 1-diphosphate (#25# reaction mechanism <8>)  
2.4.2.19," beta-nicotinate D-ribonucleotide + diphosphate + CO2 =  pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate  (#6# formation of a ternary complex consisting the enzyme,  pyridine-2,3-dicarboxylate and 5-phospho-alpha-D-ribose 1-diphosphate  <6>; #14# formation of a ternary complex comprising the enzyme,  quinolinate and 5-phosphoribosyl-1-diphosphate <20>; #1# predominantly  ordered kinetic mechanism in which productive binding of quinolinate  precedes that of 5-phospho-alpha-D-ribose 1-diphosphate <26>; #23#  ordered binding mechanism <11>)  "
2.4.2.2, 2'-deoxyuridine + phosphate = uracil + 2-deoxy-alpha-D-ribose  1-phosphate 
2.4.2.2, thymidine + phosphate = thymine + 2-deoxy-alpha-D-ribose 1-phosphate 
2.4.2.2, uridine + phosphate = uracil + alpha-D-ribose 1-phosphate 
2.4.2.2, cytidine + phosphate = cytosine + alpha-D-ribose 1-phosphate  
2.4.2.20," a 2,4-dioxotetrahydropyrimidine D-ribonucleotide + diphosphate = a  2,4-dioxotetrahydropyrimidine + 5-phospho-alpha-D-ribose 1-diphosphate  "
2.4.2.21," beta-nicotinate D-ribonucleotide + 5,6-dimethylbenzimidazole =  nicotinate + alpha-ribazole 5'-phosphate (#5# mechanism <6,7>; #4#  single displacement mechanism <2>)  "
2.4.2.22, XMP + diphosphate = 5-phospho-alpha-D-ribose 1-diphosphate + xanthine  
2.4.2.24, UDP-D-xylose + [(1->4)-beta-D-xylan]n = UDP + [(1->4)-beta-D-xylan]n+1  
2.4.2.25, UDP-alpha-D-apiose + apigenin 7-O-beta-D-glucoside = UDP + apigenin  7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside]  
2.4.2.26," UDP-alpha-D-xylose + [protein]-L-serine = UDP +  [protein]-3-O-(beta-D-xylosyl)-L-serine (#6# most probable mechanism:  ordered single displacement with UDPxylose as the leading substrate and  the xylosylated peptide as the first product released <5>; #5#  chondroitin sulfate attachment site, determination of the consensus  sequence for the recognition signal of the enzyme <6>; #5# isoform XT-I  contains the DxD motif at position 183, which has shown to be essential  for binding of nucleotide sugars in glycosyltransferases <10>)  "
2.4.2.27, dTDP-L-dihydrostreptose + streptidine 6-phosphate = dTDP +  O-(1->4)-alpha-L-dihydrostreptosyl-streptidine 6-phosphate  
2.4.2.28," S-methyl-5'-thioadenosine + phosphate = adenine +  S-methyl-5-thio-alpha-D-ribose 1-phosphate (#14,17# sequential  mechanism <5,14>; #4,14# catalytic mechanism <26,30>; #4,14# active and  substrate-binding sites, three-dimensional structures <26,30>; #4,5,17#  phosphorolytic mechanism <1,2,3,20>; #1# ordered bisubstrate biproduct  reaction with methylthioadenosine the first substrate to add and  adenine the last product to leave the enzyme <11>; #5#  equilibrium-ordered reaction, 5-methylthioadenosine is the first  substrate to bind and 5-methylthioribose 1-phosphate is the first  product to be released <3>; #14# subunit structure, model <30>; #4# 3  binding sites between substrate and enzyme <15>; #4# transition state  structure, computational modeling of the transition state, overview  <42>)  "
2.4.2.29, guanine34 in tRNA + 7-aminomethyl-7-carbaguanine =  7-aminomethyl-7-carbaguanine34 in tRNA + guanine  
2.4.2.3," uridine + phosphate = uracil + alpha-D-ribose 1-phosphate (#18,20,23#  sequential mechanism <28,30,32>; #5# rapid-equilibrium random mechanism  <20>; #7,14# ordered bi-bi mechanism <17,24,25>; #5# random mechanism  <22>; #7# phosphate binds before uridine and ribose 1-phosphate is  released after uracil <24,25>; #15# sequential rather than ping-pong  mechanism, addition of substrate is random <5>; #6# ordered bi-bi  mechanism, phosphate binds before uridine and alpha-D-ribose  1-phosphate is released after uracil <8>; #16# binding isotope effects  indicate ground-state stabilization in the Michaelis complex, such as  bonding environment, ribosyl pucker, and natural bond orbital charges  <68>; #16# steady-state random kinetic mechanism. Reaction follows an  ANDN/SN2 mechanism where chemistry contributes significantly to the  overall rate-limiting step of the reaction. No kinetically significant  proton transfer step is involved at the transition state. Proton  transfer to neutralize the leaving group is not part of transition  state formation, consistent with an enzyme-stabilized anionic uracil as  the leaving group. Kinetic analysis as a function of pH indicates one  protonated group essential for catalysis and for substrate binding  <67>; #38# mutational analysis supports for the push-pull model of  catalysis, proposed catalytic mechanism of PcUP1, modeling, overview.  Deprotonation of phosphate by Arg104, increases the negative charge on  the phosphate oxygen, leading to repulsion between the electrons of  phosphate oxygen and electron pairs of the endocylic ribosyl oxygen and  the formation of an intermediate oxocarbenium ion. At the same time,  the Gln206, Arg208 and Arg264-N1 hydrogen network-bond pulls electrons  from the glycosidic bond onto the pyrimidine ring. These two actions  work in concert to weaken the glycosidic bond. Arg39 pivots, to  physically push the phosphate closer to the ribose moiety. After  glycosidic bond cleavage, ribose-1-phosphate dissociates from the  active pocket, and then an active water reprotonates the negatively  charged purine. The final step is to release the neutral purine base  <93>)  "
2.4.2.30," NAD+ + (ADP-D-ribosyl)n-acceptor = nicotinamide +  (ADP-D-ribosyl)n+1-acceptor + H+ (#17# E219 and Gln217 of the  ARTT-motif, i.e. ADP-ribosylating turn-turn motif, are essential for  activity <53>; #7# L428 is essential for activity <59>; #3# mechanism  and physiological function, overview <57>;  #3,19,20,21,22,23,24,25,26,27# the pART catalytic domain is found  associated in Lego-like fashion with a variety of domains, including  nucleic acid-binding, protein-protein interaction, and ubiquitylation  domains <55>)  "
2.4.2.31, NAD+ + protein L-arginine = nicotinamide +  Nomega-(ADP-D-ribosyl)-protein-L-arginine (#2# rapid equilibrium random  sequential mechanism <8>)  
2.4.2.32, UDP-D-xylose + dolichyl phosphate = UDP + dolichyl D-xylosyl phosphate  
2.4.2.33, dolichyl D-xylosyl phosphate + protein = dolichyl phosphate +  D-xylosylprotein  
2.4.2.34, UDP-L-arabinose + (indol-3-yl)acetyl-1D-myo-inositol = UDP +  (indol-3-yl)acetyl-myo-inositol 3-L-arabinoside  
2.4.2.35, UDP-alpha-D-xylose + a flavonol 3-O-glycoside = UDP + a flavonol  3-[beta-D-xylosyl-(1->2)-beta-D-glycoside]  
2.4.2.36, NAD+ + diphthamide-[translation elongation factor 2] = nicotinamide +  N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2]  
2.4.2.37," NAD+ + [dinitrogen reductase]-L-arginine = nicotinamide + [dinitrogen  reductase]-Nomega-alpha-(ADP-D-ribosyl)-L-arginine (#2# regulation of  nitrogenase by enzyme and dinitrogenase reductase activating  glycohydrolase <8,12>; #1,2# regulation of enzyme, signal pathways <9>)  "
2.4.2.38, UDP-D-xylose +  N4-{N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-[N  acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->6)]-beta-D  mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D  glucosaminyl}asparagine = UDP +  N4-{N-acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->3)-[N  acetyl-beta-D-glucosaminyl-(1->2)-alpha-D-mannosyl-(1->6)]-[beta-D  xylosyl-(1->2)]-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1  >4)-N-acetyl-beta-D-glucosaminyl}asparagine 
2.4.2.38, UDP-alpha-D-xylose +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc]-L  asparaginyl-[protein] = UDP +  N4-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha  D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1  >4)-beta-D-GlcNAc]-L-asparaginyl-[protein] (#5# the catalytic domain of  XylT encompasses residues Lys57-Cys534 <9>) 
2.4.2.38," UDP-D-xylose +  N4-{N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1  3)-[N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1  6)]-beta-D-mannosyl-(1,4)-N-acetyl-beta-D-glucosaminyl-(1  4)-N-acetyl-beta-D-glucosaminyl}asparagine = UDP +  N4-{N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1  3)-[N-acetyl-beta-D-glucosaminyl-(1,2)-alpha-D-mannosyl-(1  6)]-[beta-D-xylosyl-(1,2)]-beta-D-mannosyl-(1  4)-N-acetyl-beta-D-glucosaminyl-(1  4)-N-acetyl-beta-D-glucosaminyl}asparagine  "
2.4.2.39," Transfers an alpha-D-xylosyl residue from UDP-D-xylose to a glucose  residue in xyloglucan, forming an alpha-(1->6)-D-xylosyl-D-glucose  linkage  "
2.4.2.4," thymidine + phosphate = thymine + 2-deoxy-alpha-D-ribose 1-phosphate  (#4,9# mechanism <14,16,27>; #3# rapid equilibrium random bi-bi  mechanism with an enzyme-phosphate-thymine dead-end complex <10>; #4#  ordered sequential reaction mechanism, phosphate is the first substrate  to bind to and deoxyribose the last product to dissociate from the  enzyme <6>; #1# ordered bi bi mechanism with the nucleoside the first  substrate to add, and the pyrimidine base the last product to leave  <12>; #4,11# SN2-type catalytic mechanism <112>; #11,12# sequential  random bi-bi mechanism <154>; #11# SN1- and SN2-like transition states  are proposed for the hTP-catalyzed reaction, overview <155>)  "
2.4.2.40, UDP-D-xylose + zeatin = UDP + O-beta-D-xylosylzeatin (#1# localisation  of site determining the substrate specificity for the UDP-sugar donors  <1>)  
2.4.2.41," Transfers a xylosyl residue from UDP-D-xylose to a D-galactose residue  in xylogalacturonan, forming a beta-1,3-D-xylosyl-D-galactose linkage.  "
2.4.2.42, UDP-alpha-D-xylose + [protein with EGF-like  domain]-3-O-(beta-D-glucosyl)-L-serine = UDP + [protein with EGF-like  domain]-3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-serine  
2.4.2.43," 4-amino-4-deoxy-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl  phosphate + lipid IVA = lipid IIA + ditrans,octacis-undecaprenyl  phosphate (#1# lipid IV(A) =  2-deoxy-2-[[(3R)-3-hydroxypentadecanoyl]amino]-3-O-[(3R)-3  hydroxytetradecanoyl]-4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2  deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[[(3R)-3  hydroxytetradecanoyl]amino]-1-O-phosphono-alpha-D-glucopyranose. Lipid  II(A) =  2-deoxy-2-[[(3R)-3-hydroxypentadecanoyl]amino]-3-O-[(3R)-3  hydroxytetradecanoyl]-4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2  deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[[(3R)-3  hydroxytetradecanoyl]amino]-1-alpha-D-glucopyranose <1>) "
2.4.2.43," 4-amino-4-deoxy-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl  phosphate + alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid A =  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid A +  ditrans,octacis-undecaprenyl phosphate "
2.4.2.43," 4-amino-4-deoxy-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl  phosphate + alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA =  4'-alpha-L-Ara4N-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA +  ditrans,octacis-undecaprenyl phosphate  "
2.4.2.44, S-methyl-5'-thioinosine + phosphate = hypoxanthine +  S-methyl-5-thio-alpha-D-ribose 1-phosphate  
2.4.2.45," trans,octacis-decaprenyl phosphate + 5-phospho-alpha-D-ribose  1-diphosphate = trans,octacis-decaprenylphospho-beta-D-ribofuranose  5-phosphate + diphosphate  "
2.4.2.46," Adds an alpha-D-arabinofuranosyl group from  trans,octacis-decaprenylphospho-beta-D-arabinofuranose at the  5-O-position of the eighth, tenth and twelfth galactofuranose unit of  the galactofuranan chain of  [beta-D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->6)]14-beta  D-galactofuranosyl-(1->5)-beta-D-galactofuranosyl-(1->4)-alpha-L  rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans  octacis-decaprenol  "
2.4.2.47," Adds an alpha-D-arabinofuranosyl group from  trans,octacis-decaprenylphospho-beta-D-arabinofuranose at the  3-O-position of an alpha-(1->5)-arabinofuranan chain attached to a  beta-(1->5)-galactofuranan chain  "
2.4.2.48, guanine15 in tRNA + 7-cyano-7-carbaguanine = 7-cyano-7-carbaguanine15  in tRNA + guanine  
2.4.2.49, neamine + 5-phospho-alpha-D-ribose 1-diphosphate =  5''-phosphoribostamycin + diphosphate  
2.4.2.5, D-ribosyl-base1 + base2 = D-ribosyl-base2 + base1  
2.4.2.50, UDP-alpha-D-xylose + cyanidin 3-O-beta-D-galactoside = UDP + cyanidin  3-O-(beta-D-xylosyl-(1->2)-beta-D-galactoside)  
2.4.2.51, UDP-alpha-D-xylose + an anthocyanidin 3-O-beta-D-glucoside = UDP + an  anthocyanidin 3-O-beta-D-sambubioside  
2.4.2.52, ATP + 3'-dephospho-CoA =  2'-(5-triphospho-alpha-D-ribosyl)-3'-dephospho-CoA + adenine (#1#  2-(5-triphosphoribosyl)-3-dephospho-CoA is the prosthetic group  precursor of the gamma-subunit of the citrate lyase EC 4.1.3.6 <2>)  
2.4.2.53," UDP-4-deoxy-4-formamido-beta-L-arabinopyranose +  ditrans,octacis-undecaprenyl phosphate = UDP +  4-deoxy-4-formamido-alpha-L-arabinopyranosyl  ditrans,octacis-undecaprenyl phosphate  "
2.4.2.54, 5-phospho-alpha-D-ribose 1-diphosphate + 4-hydroxybenzoate =  4-(beta-D-ribofuranosyl)phenol 5'-phosphate + CO2 + diphosphate  
2.4.2.55, nicotinate D-ribonucleotide + phenol = nicotinate + phenyl  5-phospho-alpha-D-ribofuranoside  
2.4.2.56, UDP-alpha-D-xylose + kaempferol = UDP + kaempferol 3-O-beta-D-xyloside  
2.4.2.57," AMP + phosphate = adenine + alpha-D-ribose 1,5-bisphosphate (#1# (1)  <1,3>) "
2.4.2.57," CMP + phosphate = cytosine + alpha-D-ribose 1,5-bisphosphate (#1# (2)  <1,3>) "
2.4.2.57," UMP + phosphate = uracil + alpha-D-ribose 1,5-bisphosphate (#1# (3)  <1,3>)  "
2.4.2.58, UDP-beta-L-arabinofuranose + [protein]-trans-4-hydroxy-L-proline = UDP  + [protein]-O-(beta-L-arabinofuranosyl)-trans-4-hydroxy-L-proline 
2.4.2.58, UDP-beta-L-arabinofuranose + [protein]-trans-4-hydroxy-L-proline = UDP  + [protein]-trans-4-(beta-L-arabinofuranosyl)oxy-L-proline  
2.4.2.59, NAD+ + glycine + sulfide = nicotinamide +  ADP-5-ethyl-4-methylthiazole-2-carboxylate + 3 H2O  
2.4.2.6," 2-deoxy-D-ribosyl-base1 + base2 = 2-deoxy-D-ribosyl-base2 + base1 (#10#  ping-pong bi bi mechanism <3,5,6>; #1# Glu105, Asp-99 and Asn-172 are  catalytic active site residues <18>; #3# Glu90 is a catalytic active  site residue, ligand binding and active site structures, overview <19>;  #17# reaction mechanism with oxocarbenium ion as the reaction  intermediate, overview <42>)  "
2.4.2.60, NAD+ + glycine + [ADP-thiazole synthase]-L-cysteine = nicotinamide +  ADP-5-ethyl-4-methylthiazole-2-carboxylate + [ADP-thiazole  synthase]-dehydroalanine + 3 H2O  
2.4.2.61, UDP-alpha-D-xylose +  3-O-[Rib-ol-P-Rib-ol-P-3-beta-D-GalNAc-(1->3)-beta-D-GlcNAc-(1->4)-O-6  P-alpha-D-Man]-Ser/Thr-[protein] = UDP +  3-O-[beta-D-Xyl-(1->4)-Rib-ol-P-Rib-ol-P-3-beta-D-GalNAc-(1->3)-beta-D  GlcNAc-(1->4)-O-6-P-alpha-D-Man]-Ser/Thr-[protein]  
2.4.2.62, UDP-alpha-D-xylose + [protein with EGF-like  domain]-3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-serine = UDP +  [protein with EGF-like  domain]-3-O-[alpha-D-xylosyl-(1->3)-alpha-D-xylosyl-(1->3)-beta-D  glucosyl]-L-serine  
2.4.2.63, UDP-alpha-D-xylose + [protein with EGF-like domain]-L-serine = UDP +  [protein with EGF-like domain]-3-O-(beta-D-xylosyl)-L-serine  
2.4.2.64, guanine34 in tRNA + queuine = queuine34 in tRNA + guanine (#4#  ping-pong kinetic mechanism <4>)  
2.4.2.7," AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate  (#18,26# mechanism <21,24>; #3# ping-pong mechanism <4>; #6# catalytic  site: amino acid residues 106-108 <27>; #26# forward reaction follows a  random bi-bi mechanism <23>; #6,24,26# active site structure  <22,24,27>; #13# ordered bi-bi mechanism, kinetics <20>; #25# molecular  reaction mechanism in both directions of the reaction for hAPRT: in the  forward reaction, SN2-type molecular mechanism including some SN1  characteristics, and in the reverse reaction, a proposed  magnesium-assisted SN2-type mechanism, detailed overview <63>; #25# the  enzyme with reversible activities has an ordered sequential bibi  reaction mechanism <59>)  "
2.4.2.8," IMP + diphosphate = hypoxanthine + 5-phospho-alpha-D-ribose  1-diphosphate (#31# reaction mechanism <52>; #6# kinetic mechanism  <28>; #12,24# ordered bi-bi mechanism <29,34>; #6,24,26,34# catalytic  mechanism <25,26,28,31,36,37,41>; #18,24,26,34# active site structure  <25,26,31,36,38,41,42>; #6# residues I99-L121 form the catalytic loop  <37>; #24# Thr47 binds diphosphate <29>; #17# essential role of  Ser95-Tyr96 dyade in catalysis <27>; #24# kinetic model <29>; #18#  during catalysis a long flexible loop closes over the active site,  functional role <38>; #19# ordered bi bi kinetic mechanism with  5-phospho-alpha-D-ribose 1-diphosphate binding first followed by the  purine base <48>; #18# ordered bi bi reaction mechanism, formation of  dead-end complexes with purine substrates and diphosphate <47>; #18#  reaction mechanism, function and influence of invariant active site  loop I residues on enzyme efficiency in forward and reverse reaction  <46>; #18# reaction mechanism, the flexible loop II, comprising 12  amino acid residues, closes over the active site of the enzyme as it  approaches the transition state, the loop is required for full  activity, structure-function relationship for the conserved residues  <45>; #32# residue F36 is responsible for substrate specificity,  structure-function relationship <44>; #19# residue L44 is responsible  for substrate specificity, structure-function relationship <44>; #6#  sequential mechanism with 5-phospho-alpha-D-ribose 1-diphosphate  binding first, active site helix comprising D137-D153 with key active  site residues K68, D137, and K165, substrate binding sites and  structures, overview <50>; #30# substrate binding structure and  mechanism, a non-proline cis-peptide may be essential for activity  <49>; #6# binding structure involving residue K68 at the AB-dimer  interface and residues V96 and D97 of the opposing subunit, overview.  Residues E133 and D137 block the binding of 5-phospho-alpha-D-ribose  1-diphosphate, mechanism, overview <72>; #32# ordered reaction  mechanism, 5-phospho-alpha-D-ribose 1-diphosphate-Mg2+ binds first  followed by the purine base. After the covalent reaction, diphosphate  then dissociates from the complex and the nucleoside monophosphate is  released in the rate-limiting step <69>; #32# ordered reaction  mechanism. The substrates bind in a functionally ordered fashion, with  5-phospho-alpha-D-ribose 1-diphosphate binding first in the forward  direction and IMP or GMP first in the reverse reaction, transition  state structure and 5-phosphate binding structure on HGPRT, overview  <65>)  "
2.4.2.9," UMP + diphosphate = uracil + 5-phospho-alpha-D-ribose 1-diphosphate  (#13# ping-pong reaction mechanism <6>; #3,21# sequential reaction  mechanism <15,17>; #20# modelling of enzyme-5-phospho-alpha-D-ribose  1-diphosphate complex <18>; #3# Pro131 is of little importance for  5-phospho-alpha-D-ribose 1-diphosphate binding, but critical for  binding of uracil to the enzyme-5-phospho-alpha-D-ribose 1-diphosphate  complex <15>; #1# ping pong steady state kinetic pattern, ordered bi-bi  mechanism, model, no formation of the phosphoribosyl-enzyme  intermediate predicted by classic ping pong kinetics <14>; #20# active  sites pointing away from each other, a long arm from each monomer  subunit wraps around the other subunit <18>; #8# rapid-random  equilibrium mechanism <11>)  "
2.4.99.1, CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R = CMP +  N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R (#7# mechanism  <17>; #15# Val220 participates in binding the common cytidine moiety in  substrate CMP-NeuAc and inhibitor CDP <23>)  
2.4.99.12, lipid IVA + CMP-beta-Kdo = alpha-Kdo-(2->6)-lipid IVA + CMP (#3# lipid  IV(A) =  2-deoxy-2-[[(3R)-3-hydroxypentadecanoyl]amino]-3-O[(3R)-3  hydroxytetradecanoyl]-4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2  deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[[(3R)-3  hydroxytetradecanoyl]amino]-1-O-phosphono-alpha-D-glucopyranose.  (KDO)-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose <6>)  
2.4.99.13, CMP-beta-Kdo + an alpha-Kdo-(2->6)-[lipid IVA] = CMP + an  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[lipid IVA] (#2# (KDO)-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose. (KDO)2-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->4)-3-deoxy-alpha-D-manno  oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose <5>)  
2.4.99.14, alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA + CMP-beta-Kdo =  alpha-Kdo-(2->8)-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA + CMP (#4#  (KDO)2-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->4)-3-deoxy-alpha-D-manno  oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose. (KDO)3-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->8)-3-deoxy-alpha-D-manno  oct-2-ulopyranosyl-(2->4)-3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2  >6)-2-deoxy-2-[[(3R)-3-hydroxypentadecanoyl]amino]-3-O[(3R)-3  hydroxytetradecanoyl]-4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2  deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[[(3R)-3  hydroxytetradecanoyl]amino]-1-O-phosphono-alpha-D-glucopyranose <5>)  
2.4.99.15, alpha-Kdo-(2->8)-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA +  CMP-beta-Kdo =  alpha-Kdo-(2->8)-[alpha-Kdo-(2->4)]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)  lipid IVA + CMP (#1# (KDO)3-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->8)-3-deoxy-alpha-D-manno  oct-2-ulopyranosyl-(2->4)-3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2  >6)-2-deoxy-2-[[(3R)-3-hydroxypentadecanoyl]amino]-3-O[(3R)-3  hydroxytetradecanoyl]-4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2  deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-[[(3R)-3  hydroxytetradecanoyl]amino]-1-O-phosphono-alpha-D-glucopyranose.  (KDO)4-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->8)-[3-deoxy-alpha-D-manno  oct-2-ulopyranosyl-(2->4)]-3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2  >4)-3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose <2>)  
2.4.99.16, alpha-maltose 1-phosphate + [(1->4)-alpha-D-glucosyl]n = phosphate +  [(1->4)-alpha-D-glucosyl]n+2  
2.4.99.17, S-adenosyl-L-methionine + 7-aminomethyl-7-carbaguanosine34 in tRNA =  L-methionine + adenine + epoxyqueuosine34 in tRNA  
2.4.99.18, dolichyl diphosphooligosaccharide + [protein]-L-asparagine = dolichyl  diphosphate + a glycoprotein with the oligosaccharide chain attached by  N-beta-D-glycosyl linkage to a protein L-asparagine  
2.4.99.19," tritrans,heptacis-undecaprenyl diphosphooligosaccharide +  [protein]-L-asparagine = tritrans,heptacis-undecaprenyl diphosphate + a  glycoprotein with the oligosaccharide chain attached by  N-beta-D-glycosyl linkage to protein L-asparagine  "
2.4.99.2, CMP-N-acetyl-beta-neuraminate + a  beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R = CMP + an  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta  D-galactosaminyl-R  
2.4.99.20," NADP+ + nicotinate = nicotinate-adenine dinucleotide phosphate +  nicotinamide (#4# overall reaction. The multifunctional enzyme  catalyses both the removal of nicotinamide from NADP+, forming  2-phospho-cyclic ADP-ribose, and the addition of nicotinate to the  cyclic product, forming nicotinic acid-adenine dinucleotide phosphate,  a calcium messenger that can mobilize intracellular Ca2+ stores and  activate Ca2+ influx to regulate a wide range of physiological  processes <1>) "
2.4.99.20, NADP+ = 2'-phospho-cyclic ADP-ribose + nicotinamide (#4# reaction 1a  <1>) 
2.4.99.20, 2'-phospho-cyclic ADP-ribose + nicotinate = nicotinate-adenine  dinucleotide phosphate (#4# reaction 1 b <1>)  
2.4.99.21, an archaeal dolichyl phosphooligosaccharide + [protein]-L-asparagine =  an archaeal dolichyl phosphate + a glycoprotein with the  oligosaccharide chain attached by N-beta-D-glycosyl linkage to a  protein L-asparagine  
2.4.99.22, CMP-N-acetyl-beta-neuraminate +  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta  D-glucosaminyl-R = CMP +  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl  alpha-neuraminyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-R  
2.4.99.3, CMP-N-acetylneuraminate +  glycano-(1->3)-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP +  glycano-[(2->6)-alpha-N-acetylneuraminyl]-(N-acetyl-D-galactosaminyl)  glycoprotein (#5# mechanism <1>)  
2.4.99.4, CMP-N-acetylneuraminate +  beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R = CMP +  alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha  D-galactosaminyl-R  
2.4.99.5," CMP-N-acetyl-beta-neuraminate +  1,2-diacyl-3-beta-D-galactosyl-sn-glycerol = CMP +  1  2-diacyl-3-[3-(N-acetyl-alpha-D-neuraminyl)-beta-D-galactosyl]-sn  glycerol  "
2.4.99.6, CMP-N-acetylneuraminate +  beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D  galactosyl-(1->4)-D-glucosyl-(1<->1)-ceramide = CMP +  alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta  D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucosyl-(1<->1)  ceramide 
2.4.99.6, CMP-N-acetyl-beta-neuraminate +  beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R = CMP +  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta  D-glucosaminyl-R  
2.4.99.7, CMP-N-acetylneuraminate +  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-D  galactosaminyl-R = CMP +  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl  alpha-neuraminyl-(2->6)]-N-acetyl-D-galactosaminyl-R  
2.4.99.8, CMP-N-acetylneuraminate +  alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-R = CMP +  alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)-beta-D  galactosyl-R  
2.4.99.9, CMP-N-acetylneuraminate +  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = CMP +  alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D  glucosyl-(1<->1)-ceramide  
2.5.1.1, dimethylallyl diphosphate + isopentenyl diphosphate = diphosphate +  geranyl diphosphate  
2.5.1.10," geranyl diphosphate + isopentenyl diphosphate = diphosphate +  (2E,6E)-farnesyl diphosphate (#4# bimolecular nucleophilic  substitution, SN2 reaction, proceeds with an inversion of configuration  at the diphosphate-bearing carbon of the allylic substrate and removal  of the pro-R hydrogen from the C-2 of isopentenyl diphosphate in these  trans-polyprenol synthetic reactions <4>)  "
2.5.1.100, fumigaclavine A + dimethylallyl diphosphate = fumigaclavine C +  diphosphate  
2.5.1.101," 2,4-diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose +  phosphoenolpyruvate + H2O = N,N'-diacetyllegionaminate + phosphate (#1#  C-O bond cleavage process reaction via a oxocarbenium ion intermediate  generated by an initial attack of C-3 of phosphoenolpyruvate on the  aldehyde of 2,4-diacetamido-2,4,6-trideoxymannose. This attack is  facilitated by the divalent cation that serves as an electrophilic  catalyst and polarizes the carbonyl of the aldehyde. Water then adds to  the oxocarbenium ion intermediate to give a tetrahedral intermediate  that subsequently collapses to generate phosphate and the product 2-oxo  acid, overview <1>)  "
2.5.1.102," geranyl diphosphate + 2,4-dihydroxy-6-pentylbenzoate = diphosphate +  cannabigerolate  "
2.5.1.103," 2 (2E,6E)-farnesyl diphosphate = presqualene diphosphate + diphosphate  "
2.5.1.104, S-adenosyl 3-(methylsulfanyl)propylamine + agmatine =  S-methyl-5'-thioadenosine + N1-(3-aminopropyl)agmatine  
2.5.1.105," (7,8-dihydropterin-6-yl)methyl diphosphate +  4-(beta-D-ribofuranosyl)aniline 5'-phosphate =  N-[(7,8-dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline  5'-phosphate + diphosphate  "
2.5.1.106, dimethylallyl diphosphate + brevianamide F = diphosphate + tryprostatin  B  
2.5.1.107, dimethylallyl diphosphate + verruculogen = diphosphate + fumitremorgin A  
2.5.1.108," S-adenosyl-L-methionine + L-histidine-[translation elongation factor 2]  = S-methyl-5'-thioadenosine +  2-[(3S)-3-amino-3-carboxypropyl]-L-histidine-[translation elongation  factor 2] (#4# The relevant histidine of translation elongation factor  2 is His715 in mammals, His699 in yeast and His600 in Pyrococcus  horikoshii <1>; #6# unlike the enzymes in the radical  S-adenosyl-L-methionine superfamily, Dph2 does not form the canonical  5-deoxyadenosyl radical. Instead, it breaks the Cgamma,Met-S bond of  S-adenosyl-L-methionine and generates a 3-amino-3-carboxylpropyl  radical <3>)  "
2.5.1.109, dimethylallyl diphosphate + brevianamide F = diphosphate +  deoxybrevianamide E  
2.5.1.110," dimethylallyl diphosphate + 12alpha,13alpha-dihydroxyfumitremorgin C =  diphosphate + fumitremorgin B  "
2.5.1.111, dimethylallyl diphosphate + 4-hydroxyphenylpyruvate = diphosphate +  3-dimethylallyl-4-hydroxyphenylpyruvate  
2.5.1.112, dimethylallyl diphosphate + ADP = diphosphate +  N6-(dimethylallyl)adenosine 5'-diphosphate 
2.5.1.112, dimethylallyl diphosphate + ATP = diphosphate +  N6-(dimethylallyl)adenosine 5'-triphosphate  
2.5.1.113, O-phospho-L-serine + [CysO sulfur-carrier protein]-Gly-NH-CH2-C(O)SH =  [CysO sulfur-carrier protein]-Gly-NH-CH2-C(O)-S-L-cysteine + phosphate  
2.5.1.114, S-adenosyl-L-methionine + 4-demethylwyosine37 in tRNAPhe =  S-methyl-5'-thioadenosine +  7-[(3S)-3-amino-3-carboxypropyl]-4-demethylwyosine37 in tRNAPhe  
2.5.1.115," phytyl diphosphate + homogentisate = diphosphate +  2-methyl-6-phytylbenzene-1,4-diol + CO2  "
2.5.1.116," geranylgeranyl diphosphate + homogentisate = diphosphate +  6-geranylgeranyl-2-methylbenzene-1,4-diol + CO2  "
2.5.1.117," all-trans-nonaprenyl diphosphate + homogentisate = diphosphate +  2-methyl-6-all-trans-nonaprenylbenzene-1,4-diol + CO2  "
2.5.1.118, O-acetyl-L-serine + isoxazolin-5-one =  3-(5-oxoisoxazolin-2-yl)-L-alanine + acetate  
2.5.1.119, O-acetyl-L-serine + isoxazolin-5-one =  3-(5-oxoisoxazolin-4-yl)-L-alanine + acetate  
2.5.1.120, S-adenosyl-L-methionine + 3-[(1-carboxyvinyl)oxy]benzoate + H2O =  6-amino-6-deoxyfutalosine + L-methionine + HCO3-  
2.5.1.121," dimethylallyl diphosphate + 5,10-dihydrophenazine-1-carboxylate =  diphosphate + 9-(dimethylallyl)-5,10-dihydrophenazine-1-carboxylate  "
2.5.1.122, dimethylallyl diphosphate + L-tyrosine = diphosphate +  4-O-dimethylallyl-L-tyrosine  
2.5.1.123, geranyl diphosphate + flaviolin = 3-linalylflaviolin + diphosphate  
2.5.1.124," geranyl diphosphate + 2-O,3-dimethylflaviolin = diphosphate +  6-linalyl-2-O,3-dimethylflaviolin  "
2.5.1.125," geranyl diphosphate + 2-O,3-dimethylflaviolin = diphosphate +  7-O-geranyl-2-O,3-dimethylflaviolin  "
2.5.1.126, S-adenosyl 3-(methylsulfanyl)propylamine + norspermidine =  S-methyl-5'-thioadenosine + norspermine  
2.5.1.127, S-adenosyl 3-(methylsulfanyl)propylamine + norspermine =  S-methyl-5'-thioadenosine + caldopentamine  
2.5.1.128, 2 S-adenosyl 3-(methylsulfanyl)propylamine + spermidine = 2  S-methyl-5'-thioadenosine + N4-bis(aminopropyl)spermidine (#1# overall  reaction <1>) 
2.5.1.128, S-adenosyl 3-(methylsulfanyl)propylamine + spermidine =  S-methyl-5'-thioadenosine + N4-aminopropylspermidine (#1# (1a) <1>) 
2.5.1.128, S-adenosyl 3-(methylsulfanyl)propylamine + N4-aminopropylspermidine =  S-methyl-5'-thioadenosine + N4-bis(aminopropyl)spermidine (#1# (1b) <1>)  
2.5.1.129," dimethylallyl phosphate + FMNH2 = prenylated FMNH2 + phosphate (#1# the  prenyltransferase mechanism of UbiX resembles that of the terpene  synthases. The active site environment is dominated by Pi systems,  which assist phosphate-C1 bond breakage following FMN reduction,  leading to formation of the N5-C19 bond. UbiX then acts as a chaperone  for adduct reorientation, via transient carbocation species, leading  ultimately to formation of the dimethylallyl C39-C6 bond, reaction  mechanism, overvie. Stopped-flow experiments mixing reduced FMNH2-UbiX  with dimethylallyl phosphate under anaerobic conditions reveal  transient formation of a distinct spectral species before formation of  the prFMNreduced product. The dimethylallyl phosphate substrate is  located directly above the FMN isoalloxazine re face, with the  dimethylallyl moiety sandwiched between the FMN and A89-S90. The  dimethylallyl group is furthermore surrounded by aromatic ring systems  of W84, Y169 and W200 that, together with the FMN dimethylbenzene  moiety, resemble the Pi-cage found in other prenyltransferases or  terpene synthases <1>)  "
2.5.1.130," phytyl diphosphate + 2-carboxy-1,4-naphthoquinone =  demethylphylloquinone + diphosphate + CO2  "
2.5.1.131, [5-(aminomethyl)furan-3-yl]methyl diphosphate +  gamma-L-glutamyltyramine =  (4-{4-[2-(gamma-L-glutamylamino)ethyl]phenoxymethyl}furan-2  yl)methanamine + diphosphate  
2.5.1.132, phosphoenolpyruvate + D-mannose 6-phosphate + H2O =  3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate 9-phosphate +  phosphate  
2.5.1.133, geranylgeranyl diphosphate + bacteriochlorophyllide a =  geranylgeranyl-bacteriochlorophyllide a + diphosphate  
2.5.1.134, O-acetyl-L-serine + L-homocysteine = L-cystathionine + acetate  
2.5.1.135, GDP-valienol + validamine 7-phosphate = validoxylamine A 7'-phosphate +  GDP  
2.5.1.136, dimethylallyl diphosphate + a 2-acylphloroglucinol = diphosphate + a  2-acyl-4-prenylphloroglucinol  
2.5.1.137," dimethylallyl diphosphate + a 2-acyl-4-prenylphloroglucinol =  diphosphate + a 2-acyl-4,6-bisprenylphloroglucinol "
2.5.1.137," dimethylallyl diphosphate + a 2-acyl-4,6-bisprenylphloroglucinol =  diphosphate + a 2-acyl-4,6,6-trisprenylcyclohexa-2,4-dien-1-one  "
2.5.1.138, geranyl diphosphate + umbelliferone = diphosphate +  8-geranylumbelliferone 
2.5.1.138, geranyl diphosphate + esculetin = diphosphate + 8-geranylesculetin  
2.5.1.139, dimethylallyl diphosphate + umbelliferone = diphosphate +  demethylsuberosin  
2.5.1.140, O-phospho-L-serine + L-glutamate =  N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate + phosphate  
2.5.1.141," (2E,6E)-farnesyl diphosphate + protoheme IX + H2O = diphosphate +  ferroheme o  "
2.5.1.142, dimethylallyl diphosphate + 3 isopentenyl diphosphate = 3 diphosphate +  nerylneryl diphosphate  
2.5.1.143," deamido-NAD+ + hydrogencarbonate = AMP + pyridinium-3,5-biscarboxylate  mononucleotide  "
2.5.1.144, O-acetyl-L-serine + thiosulfate = S-sulfo-L-cysteine + acetate (#5#  ping pong bi bi kinetic mechanism <9>)  
2.5.1.145," L-1-phosphatidyl-sn-glycerol + a [prolipoprotein]-L-cysteine =  sn-glycerol 1-phosphate + an  [prolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine  "
2.5.1.146, geranyl diphosphate + 3-[(Z)-2-isocyanoethenyl]-1H-indole =  3-geranyl-3-[(Z)-2-isocyanoethenyl]-1H-indole + diphosphate  
2.5.1.147," 5-amino-6-(D-ribitylamino)uracil + L-tyrosine + S-adenosyl-L-methionine  = 5-amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil +  2-iminoacetate + L-methionine + 5'-deoxyadenosine  "
2.5.1.148, 2 geranylgeranyl diphosphate = diphosphate + prephytoene diphosphate 
2.5.1.148, 2 geranylgeranyl diphosphate + NADPH + H+ = lycopaoctaene + 2  diphosphate + NADP+ 
2.5.1.148, prephytoene diphosphate + NADPH + H+ = lycopaoctaene + diphosphate +  NADP+  
2.5.1.149, dimethylallyl diphosphate + all-trans-lycopene + acceptor + H2O =  nonaflavuxanthin + reduced electron acceptor + diphosphate 
2.5.1.149, dimethylallyl diphosphate + nonaflavuxanthin + acceptor + H2O =  flavuxanthin + reduced electron acceptor + diphosphate  
2.5.1.15," (7,8-dihydropterin-6-yl)methyl diphosphate + 4-aminobenzoate =  diphosphate + 7,8-dihydropteroate (#11,19# SN1 reaction mechanism via  formation of a novel cationic pterin intermediate, quantum chemical  modelling of the initial step, overview. Two conserved loops generate a  substructure during catalysis that creates a specific binding pocket  for 4-aminobenzoic acid, one of the two DHPS substrates. The  carboxylate moiety of 4-aminobenzoic acid is accommodated by Ser221 and  the helix dipole of helix alphaLoop7 <57>; #19# the reaction catalyzed  by DHPS involves a nucleophilic attack by the amino nitrogen of  4-aminobenzoate on the exocyclic methyl carbon of DHPP. This results in  the formation of the N-C bond and the elimination of the pyrophosphate  moiety as a leaving group. A partial carbocation intermediate is  believed to form at the extra-cyclic methylene in the transition state,  which is stabilized by delocalization of the charge in the adjacent  double bond of the pterin ring. Evidence supporting transient  carbocation intermediate is shown by the inability of the oxidized form  of DHPP (pterin-6-hydroxymethyl pyrophosphate) to act as a DHPS  substrate <53>)  "
2.5.1.150, dimethylallyl diphosphate + all-trans-lycopene + H2O =  dihydroisopentenyldehydrorhodopin + diphosphate 
2.5.1.150, dimethylallyl diphosphate + isopentenyldehydrorhodopin + H2O =  dihydrobisanhydrobacterioruberin + diphosphate  
2.5.1.151, methylcob(III)alamin + [alkylcobalamin dealkylase] + glutathione =  cob(I)alamin-[alkylcobalamin dealkylase] + an S-methyl glutathione 
2.5.1.151, adenosylcob(III)alamin + [alkylcobalamin dealkylase] + glutathione =  cob(I)alamin-[alkylcobalamin dealkylase] + S-adenosyl glutathione  
2.5.1.152, S-adenosyl-L-methionine + D-histidine =  N-[(3S)-3-amino-3-carboxypropyl]-D-histidine + S-methyl-5'-thioadenosine  
2.5.1.153, tuberculosinyl diphosphate + adenosine = 1-tuberculosinyladenosine +  diphosphate 
2.5.1.153, tuberculosinyl diphosphate + H2O = (13S)-isotuberculosinol + diphosphate  
2.5.1.154, 2 cob(II)alamin + 2 [corrinoid adenosyltransferase] = 2 [corrinoid  adenosyltransferase]-cob(II)alamin 
2.5.1.154, a reduced flavoprotein + 2 [corrinoid  adenosyltransferase]-cob(II)alamin = an oxidized flavoprotein + 2  [corrinoid adenosyltransferase]-cob(I)alamin 
2.5.1.154, 2 ATP + 2 cob(II)alamin + a reduced flavoprotein = 2 diphosphate + 2  phosphate + 2 adenosylcob(III)alamin + an oxidized flavoprotein 
2.5.1.154, 2 ATP + 2 [corrinoid adenosyltransferase]-cob(I)alamin = 2 diphosphate  + 2 phosphate + 2 adenosylcob(III)alamin + 2 [corrinoid  adenosyltransferase]  
2.5.1.16," S-adenosyl 3-(methylsulfanyl)propylamine + putrescine =  S-methyl-5'-thioadenosine + spermidine (#4# Michaelis-Menten kinetics  <7>; #3# first discovered <22>; #12# uni uni uni uni ping pong  mechanism <31>; #3# ping-pong mechanism with a propylaminated form of  the enzyme as an obligatory intermediate <21>; #3,14,15# single  displacement reaction <21>; #39,40# general mechanistic hypothesis for  the aminopropyl transfer reaction <45>; #19# reaction mechanism  involving a gate-keeping loop, active site and substrate binding  structures and involved residues, structure-function relationship  analysis by molecular dynamics simulations of a homology model <47>;  #18# the enzyme possesses a Rossmann-like fold with a distinct active  site, the enzyme from Helicobacter pylori lacks the gatekeeping loop  that facilitates substrate binding in other PAPTs, active site  structure <52>; #42# Escherichia coli SPDS follows the ping-pong  mechanism, in which an aminopropylated enzyme intermediate was formed  by the interaction of SPDS with dcSAM, prior to reaction with  putrescine <74>; #39# this mechanism depends on a conserved Asp  (residue 173 in hSpdS) in the active site that interacts with the bound  amine substrate to deprotonate the attacking nitrogen atom of the  amine. This interaction is reinforced by additional interactions of  this nitrogen atom with the hydroxyl group of a conserved Tyr (residue  79 in hSpdS) and a backbone carbonyl group (Ser174 in hSpdS). These  interactions allow the attack on the methylene carbon atom of the  aminopropyl group attached to the sulfonium center of dcAdoMet.  Electron transfer to this sulfur atom completes the reaction forming  S-methyl-5-thioadenosine and the polyamine product. The positively  charged sulfonium ion is a critical part of the reaction <78>; #8#  random order or ordered mechanism in which both substrates bind before  the release of the products <16>)  "
2.5.1.17," 2 ATP + 2 cob(II)yrinic acid a,c-diamide + a reduced flavoprotein = 2  triphosphate + 2 adenosylcob(III)yrinic acid a,c-diamide + an oxidized  flavoprotein (#7# reaction mechanism <21>; #13# active site and  substrate binding sites and structures, molecular architecture <23>;  #7# Cys79, Cys80, and Cys83 are important for catalysis <22>; #13,16#  not yet confimed <26,30>; #7# residues Phe91 and Trp93 play a critical  role in the mechanism of four-coordinate Cob(II)alamin formation in the  active site of the Salmonella enterica ATP:Co(I)rrinoid  adenosyltransferase enzyme, overview.. The enzyme adopts a closed  conformation and residues Phe91 and Trp93 displace  5,6-dimethylbenzimidazole, the lower nucleotide ligand base of  cobalamin, to generate a transient four-coordinate cobalamin, which is  critical in the formation of the AdoCbl Co-C bond, important role of  bulky hydrophobic side chains in the active site. CobA and PduO  increase the redox potential of the cob(II)alamin/cob(I)alamin couple  to facilitate formation of the Co-C bond, in both cases the polar  coordination of the lower ligand to the cobalt ion is eliminated by  placing that face of the corrin ring adjacent to a cluster of bulky  hydrophobic side chains <39>) "
2.5.1.17," 2 ATP + 2 cob(II)alamin + a reduced flavoprotein = 2 triphosphate + 2  adenosylcob(III)alamin + an oxidized flavoprotein (#7# reaction  mechanism <21>; #7# reaction mechanism, substrate structure <15>; #13#  active site and substrate binding sites and structures, molecular  architecture <23>; #7# Cys79, Cys80, and Cys83 are important for  catalysis <22>; #13# nucleophilic attack from reduced Co1+ ion of  cob(I)alamin to the C-5Â’ carbon of ATP, ordered substrate binding  mechanism with ATP being first and essential for catalysis <28>; #7#  residues Phe91 and Trp93 play a critical role in the mechanism of  four-coordinate Cob(II)alamin formation in the active site of the  Salmonella enterica ATP:Co(I)rrinoid adenosyltransferase enzyme,  overview. The enzyme adopts a closed conformation and residues Phe91  and Trp93 displace 5,6-dimethylbenzimidazole, the lower nucleotide  ligand base of cobalamin, to generate a transient four-coordinate  cobalamin, which is critical in the formation of the AdoCbl Co-C bond,  important role of bulky hydrophobic side chains in the active site.  CobA and PduO increase the redox potential of the  cob(II)alamin/cob(I)alamin couple to facilitate formation of the Co-C  bond, in both cases the polar coordination of the lower ligand to the  cobalt ion is eliminated by placing that face of the corrin ring  adjacent to a cluster of bulky hydrophobic side chains <39>; #13# to  overcome the thermodynamically challenging Co2+ -> Co1+ reduction, the  enzyme drastically weakens the axial ligand-Co2+ bond so as to generate  effectively four-coordinate Co2+-corrinoid species, mechanism,  overview. The entire hydrophobic pocket below the corrin ring, and not  just residue F112, is critical for the removal of the axial ligand from  the cobalt center of the Co2+-corrinoids. Large role of the ATP-induced  active-site conformational changes with respect to the formation of 4c  Co(II)Cbl <40>) "
2.5.1.17, 2 cob(II)alamin + 2 [corrinoid adenosyltransferase] = 2 [corrinoid  adenosyltransferase]-cob(II)alamin 
2.5.1.17, a reduced flavoprotein + 2 [corrinoid  adenosyltransferase]-cob(II)alamin = an oxidized flavoprotein + 2  [corrinoid adenosyltransferase]-cob(I)alamin 
2.5.1.17, 2 ATP + 2 [corrinoid adenosyltransferase]-cob(I)alamin = 2 triphosphate  + 2 adenosylcob(III)alamin + 2 [corrinoid adenosyltransferase] 
2.5.1.17," 2 cob(II)yrinic acid a,c-diamide + 2 [corrinoid adenosyltransferase] =  2 [corrinoid adenosyltransferase]-cob(II)yrinic acid a,c-diamide "
2.5.1.17," a reduced flavoprotein + 2 [corrinoid  adenosyltransferase]-cob(II)yrinic acid a,c-diamide = an oxidized  flavoprotein + 2 [corrinoid adenosyltransferase]-cob(I)yrinic acid  a,c-diamide "
2.5.1.17," 2 ATP + 2 [corrinoid adenosyltransferase]-cob(I)yrinic acid a,c-diamide  = 2 triphosphate + 2 adenosylcob(III)yrinic acid a,c-diamide + 2  [corrinoid adenosyltransferase]  "
2.5.1.18," RX + glutathione = HX + R-S-glutathione (#11,12,45,79# mechanism  <15,50,61>; #6,11# kinetic mechanism <51,54>; #90# random steady state  mechanism <33>; #11# active site involving residue Trp234, and  substrate binding structure, isozyme GST T1-1 <133>; #45# mechanisms  for formation of specific mono(glutathionyl) or bis(glutathionyl)  conjugates <114>; #43# substrate binding: Tyr9 is responsible for the  deprotonation of GSH and Lys15, but also Gln71 are involved, active  site and substrate binding structure, overview <146>; #24# the enzyme  uses a rapid equilibrium random sequential bi-bi mechanism with  intrasubunit modulation between GSH binding site, the G-site, and  electrophile binding site, the H-site, Trp12, Phe35 and Ile118 are  involved in substrate binding, Phe35 is important for catalytic  activity <144>; #102# the enzyme uses a rapid-equilibrium random-order  ternary-complex mechanism or a compulsory order ternary-complex  mechanism <129>;  #100,141,159,171,181,182,187,188,190,191,192,193,236,250,251,252#  active site structure and catalytic mechanism, overview <241>; #163#  active site structure: Tyr111 indirectly stabilizes glutathione  binding, Tyr119 modulates hydrophobic substrate binding, and Phe123  indirectly modulates catalysis. An aromatic zipper in the H-site  contributing a network of aromatic pi-pi interactions. Several residues  of the cluster directly interact with the hydrophobic substrate while  others indirectly maintain conformational stability of the dimeric  structure through the C-terminal domain II <203>; #51# catalytic  mechanism of isozyme GSTH1-1 <254>; #11# catalytic mechanism of kappa  class GST, overview. Substrate binding induces a conformational change  of the active site from an open conformation in the apo-form to a  closed conformation in the S-hexylglutathione-bound complex,  facilitating formations of the G site (GSH-binding site) and the H site  (hydrophobic substrate-binding site). The conserved Ser16 at the G site  functions as the catalytic residue in the deprotonation of the thiol  group and the conserved Asp69, Ser200,Asp201 andArg202 form a network  of interactions with gamma -glutamyl carboxylate to stabilize the  thiolate anion. The H site is a large hydrophobic pocket with  conformational flexibility to allow the binding of different  hydrophobic substrates. The kinetic mechanism of hGSTk conforms to a  rapid equilibrium random sequential Bi Bi model <237>; #249# catalytic  mechanism, ovverview <239>; #248# substrate binding structure and  reaction mechanism, conformational changes, detailed overview <246>;  #3# substrate specificity and catalytic mechanism, overview <253>;  #247# the mutant C169A exhibits cooperative behaviour and a ping pong  mechanism whereby liberation of a proton from a reduced  enzyme-glutathione complex to form an enzyme-unprotonated glutathione  complex is essentially irreversible <243>)  "
2.5.1.19," phosphoenolpyruvate + 3-phosphoshikimate = phosphate +  5-O-(1-carboxyvinyl)-3-phosphoshikimate (#5# proposed mechanism  <7,8,29>; #59# binding of shikimate 3-phosphate leads to a saturable  and stable conformational change in the isolated N-terminal domain  <34>; #59# catalytic mechanism, tetrahedral reaction intermediate,  active site structure, wild-type and mutant D313A <44>; #59# catalytic  mechanism, tetrahedral reaction intermediate, catalytic cycle of the  enzyme, overview <41>; #5# enolpyruvylshikimate 3-phosphate ketal is  catalytically formed as side product upon enolpyruvyl activation  through protonation by an intramolecular nucleophilic addition of O4 to  C2Â’ of the enolpyruvyl moiety <47>; #2# ordered substrate binding with  3-phosphoshikimate being bound first <60>; #59# via formation of a  tetrahedral intermediate (TI) after which residue His385 is in a  neutral form while residues Lys22, Lys340 and Lys411 are protonated,  Asp313 mediates attack of the TI C4-OH group (as oxyanion,  shikimate-3-phosphate moiety) at the TI C3-methyl group  (phosphoenolpyruvate moiety), Lys22 serves as general acid catalyst for  TI breakdown <58>)  "
2.5.1.2, thiamine + pyridine =  1-[(4-amino-2-methylpyrimidin-5-yl)methyl]pyridinium +  4-methyl-5-(2-hydroxyethyl)thiazole  
2.5.1.20, polycis-polyprenyl diphosphate + isopentenyl diphosphate = diphosphate  + a polycis-polyprenyl diphosphate longer by one C5 unit  
2.5.1.21," 2 (2E,6E)-farnesyl diphosphate + NAD(P)H + H+ = squalene + 2  diphosphate + NAD(P)+ (#7,32# mechanism <7,27,31>; #7# overview  mechanism, kinetics <30>; #7,10,17# enzyme also catalyses the reduction  of presqualene diphosphate by NADPH to squalene <19,27,32,33>; #4#  overall reaction, reaction mechanism, overview <62>) "
2.5.1.21, presqualene diphosphate + NAD(P)H + H+ = squalene + diphosphate +  NAD(P)+ 
2.5.1.21," 2 (2E,6E)-farnesyl diphosphate = diphosphate + presqualene diphosphate  "
2.5.1.22, S-adenosyl 3-(methylsulfanyl)propylamine + spermidine =  S-methyl-5'-thioadenosine + spermine (#5# mechanism <13>)  
2.5.1.23," S-adenosyl 3-(methylsulfanyl)propylamine + propane-1,3-diamine =  S-methyl-5'-thioadenosine + bis(3-aminopropyl)amine  "
2.5.1.24, S-adenosyl-L-methionine + N6-(DELTA2-isopentenyl)-adenine =  S-methyl-5'-thioadenosine + discadenine  
2.5.1.25, S-adenosyl-L-methionine + a uridine in tRNA = S-methyl-5'-thioadenosine  + a 3-[(3S)-3-amino-3-carboxypropyl]uridine in tRNA  
2.5.1.26," 1-acyl-glycerone 3-phosphate + a long-chain alcohol = an  alkyl-glycerone 3-phosphate + a long-chain acid anion (#2,3# mechanism  <3,4,18>; #2,3# ping-pong mechanism <2,5,10>; #3# enzyme also catalyzes  the following reactions: 1. acyl exchange reaction in which palmitic  acid is incorporated into palmitoyldihydroxyacetone phosphate, 2. alkyl  exchange reaction in which hexadecanol is incorporated into  hexadecyldihydroxyacetone phosphate <2>)  "
2.5.1.27, dimethylallyl diphosphate + AMP = diphosphate +  N6-(dimethylallyl)adenosine 5'-phosphate (#19# the  carbon-nitrogen-based prenylation proceeds by the SN2-reaction  mechanism <20>)  
2.5.1.28, dimethylallyl diphosphate + isopentenyl diphosphate = diphosphate +  neryl diphosphate  
2.5.1.29," (2E,6E)-farnesyl diphosphate + isopentenyl diphosphate = diphosphate +  geranylgeranyl diphosphate (#9# ordered-sequential bi bi mechanism  <12>; #7# reaction mechanism and residues involved in substrate  specificity and product chain lengt determination, overview <42>; #68#  the condensation of isopentenyl diphosphate to (2E,6E)-farnesyl  diphosphate by GGPPS is a bi-substrate/biproduct (bi-bi) reaction,  where the two products are geranylgeranyl diphosphate and diphosphate,  which is cleaved from (2E,6E)-farnesyl diphosphate. The inhibitory  pattern observed by geranylgeranyl diphosphate indicates a compulsory  ordered mechanism for isopentenyl diphosphate and (2E,6E)-farnesyl  diphosphate binding the enzyme from Choristoneura fumiferana <92>)  "
2.5.1.3," 4-amino-2-methyl-5-(diphosphomethyl)pyrimidine +  2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate =  diphosphate + thiamine phosphate + CO2 (#2# dissociative SN1 mechanism  <6>) "
2.5.1.3, 4-amino-2-methyl-5-(diphosphomethyl)pyrimidine +  2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate = diphosphate +  thiamine phosphate + CO2 
2.5.1.3, 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine +  4-methyl-5-(2-phosphooxyethyl)thiazole = diphosphate + thiamine  phosphate  
2.5.1.30," (2E,6E)-farnesyl diphosphate + 4 isopentenyl diphosphate = 4  diphosphate + all-trans-heptaprenyl diphosphate (#1# a common mechanism  controls the product chain length of both short-chain and medium-chain  prenyl diphosphate synthases. In wild-type heptaprenyl diphosphate  synthase, the prenyl chain can grow on the surface of the small  residues at positions 79 and 80, and the elongation is precisely  blocked at the length of C35 by Ile76 <7>; #1# enzyme component I,  enzyme component II, and farnesyl diphosphate-Mg2+ form a ternary  complex during catalysis and that neither isopentenyl diphosphate nor  the product, heptaprenyl diphosphate, is included in this complex,  which probably represents a catalytically active state of the HepPP  synthase. Component I is involved in allylic substrate recognition <4>;  #1# initially the substrate farnesyl diphosphate binds to subunit II  using Mg2+, followed by the formation of the subunit I-farnesyl  diphosphate-Mg2+-subunit II complex <10>; #1# the C-C bond formation in  the heptaprenyl diphosphate synthase reaction takes place at the si  face of the double bond of isopentenyl diphosphate <11>)  "
2.5.1.31," (2E,6E)-farnesyl diphosphate + 8 isopentenyl diphosphate = 8  diphosphate + ditrans,octacis-undecaprenyl diphosphate (#4# active site  structure and catalytic mechanism <25>; #4,11# active site structure,  detailed catalytic mechanism, substrate binding mechanism, D26, H43,  S71, N74, and R77 are involved <26>; #4# substrate binding mode and  catalytic mechanism involving active site residue Asp26 which serves as  general base, overview <27>; #4,7,17# catalytic mechanism, overview  <40>; #4# ditrans,octacis-undecaprenyl diphosphate  substrate binding  mode and catalytic mechanism involving active site residue Asp26 which  serves as general base, overview <27>)  "
2.5.1.32, 2 geranylgeranyl diphosphate = diphosphate + prephytoene diphosphate 
2.5.1.32, prephytoene diphosphate = 15-cis-phytoene + diphosphate 
2.5.1.32, 2 geranylgeranyl diphosphate = 15-cis-phytoene + 2 diphosphate  
2.5.1.34," dimethylallyl diphosphate + L-tryptophan = diphosphate +  4-(3-methylbut-2-enyl)-L-tryptophan (#2# sequential mechanism <1>; #2#  random sequential mechanism <5>; #2# stereochemistry, direct attack of  dimethylallyl diphosphate on C-4 of the indole <2>; #8# catalytic  reaction mechanism, overview <18>; #4# studies are presented that  strongly support the dissociative mechanism for the DMAT synthase  reaction. The observation of positional isotope exchange (PIX) in  isotopically labeled DMAPP provides evidence for the existence of a  dimethylallyl carbocation intermediate <13>; #1# ability of  dimethylallyltryptophan synthase to prenylate at five different sites  on the indole nucleus, with normal and reverse prenylation at one of  the sites, is consistent with a dissociative electrophilic alkylation  of the indole ring, where orientation of the substrates within the  active site and substituent electronic effects determine the position  and type of prenylation <18>; #4# Cope mechanism for the reaction  catalyzed by DMAT synthase, overview <17>; #1# enzyme-catalyzed  sigmatropic process in the C-4 prenylation of indole alkaloids, an  initial reverse prenylation of tryptophan at C-3 with dimethylallyl  diphosphate, the subsequent Cope rearrangement shifts the prenyl moiety  to the C-4 position and re-aromatization gives dimethylallyltryptophan,  reaction mechanism,overview <15>; #4# reaction mechanism and substrate  specificity, overview <20>; #5# SN1-like mechanism involving a discrete  carbocation intermediate involving initial ion pair formation followed  by a reverse prenylation at the nucleophilic C-3 position, detailed  overview <21>; #5# the mechanism of this enzyme-catalyzed  FriedelÂ–Crafts reaction represents strict regioselectivity at the C4  position of the indole ring of L-tryptophan, proposed reaction  mechanism for Aspergillus fummigatus FgaPT2 involving Glu89 and Lys174  <24>)  "
2.5.1.35, 2 dimethylallyl diphosphate + aspulvinone E = 2 diphosphate +  aspulvinone H  
2.5.1.36," dimethylallyl diphosphate + (6aS,11aS)-3,6a,9-trihydroxypterocarpan =  diphosphate + 2-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan "
2.5.1.36," dimethylallyl diphosphate + (6aS,11aS)-3,6a,9-trihydroxypterocarpan =  diphosphate + 4-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan  "
2.5.1.38, S-adenosyl-L-methionine + nocardicin G = S-methyl-5'-thioadenosine +  isonocardicin C  
2.5.1.39," a polyprenyl diphosphate + 4-hydroxybenzoate = diphosphate + a  4-hydroxy-3-polyprenylbenzoate (#3# a near SN1 mechanism for the  cleavage of the diphosphate ion from the isoprenyl unit. The  4-hydroxybenzoic acid appears not to be activated as benzoate anion but  rather as phenolate anion to allow attack of the isoprenyl cation to  the phenolate, which appear to be the rate limiting step of the whole  process according to our quantum chemical calculations <26>)  "
2.5.1.4, S-adenosyl-L-methionine = S-methyl-5'-thioadenosine +  2-aminobutan-4-olide (#5# mechanism <2>)  
2.5.1.41, geranylgeranyl diphosphate + sn-glycerol 1-phosphate = diphosphate +  3-(O-geranylgeranyl)-sn-glycerol 1-phosphate  
2.5.1.42," geranylgeranyl diphosphate + 3-(O-geranylgeranyl)-sn-glycerol  1-phosphate = diphosphate + 2,3-bis-(O-geranylgeranyl)-sn-glycerol  1-phosphate  "
2.5.1.43," 3 S-adenosyl-L-methionine = 3 S-methyl-5'-thioadenosine + nicotianamine  (#4# reaction mechanism of the archaeal enzyme, overview. The  polymerization mechanism occurs at a single active site with stepwise  translocation of the reaction intermediate  N-(3-amino-3-carboxypropyl)glutamic acid <24>)  "
2.5.1.44," 2 putrescine = sym-homospermidine + NH3 + H+ (#12# the reaction  mechanism emphasizes cation-Pi interaction through a conserved Trp  residue as a key stabilizer of high energetic transition states. The  enzyme has two distinct substrate binding sites, one of which is highly  specific for putrescine. Enzyme HSS features a side pocket in the  direct vicinity of the active site formed by conserved amino acids and  a potential substrate discrimination, guiding, and sensing mechanism  <10>) "
2.5.1.44," putrescine + spermidine = sym-homospermidine + propane-1,3-diamine  (#12# the reaction mechanism emphasizes cation-Pi interaction through a  conserved Trp residue as a key stabilizer of high energetic transition  states. The enzyme has two distinct substrate binding sites, one of  which is highly specific for putrescine. Enzyme HSS features a side  pocket in the direct vicinity of the active site formed by conserved  amino acids and a potential substrate discrimination, guiding, and  sensing mechanism <10>)  "
2.5.1.45," spermidine + putrescine = sym-homospermidine + propane-1,3-diamine  "
2.5.1.46," [eIF5A-precursor]-lysine + spermidine = [eIF5A-precursor]-deoxyhypusine  + propane-1,3-diamine "
2.5.1.46, spermidine + NAD+ = dehydrospermidine + NADH 
2.5.1.46," dehydrospermidine + [enzyme]-lysine =  N-(4-aminobutylidene)-[enzyme]-lysine + propane-1,3-diamine "
2.5.1.46, N-(4-aminobutylidene)-[enzyme]-lysine + [eIF5A-precursor]-lysine =  N-(4-aminobutylidene)-[eIF5A-precursor]-lysine + [enzyme]-lysine 
2.5.1.46, N-(4-aminobutylidene)-[eIF5A-precursor]-lysine + NADH + H+ =  [eIF5A-precursor]-deoxyhypusine + NAD+  
2.5.1.47," O-acetyl-L-serine + hydrogen sulfide = L-cysteine + acetate (#1,17#  mechanism <44,50>; #9# ping-pong bi-bi mechanism <144>; #1# mechanism  interpreted in structural context, conformational changes during  catalysis <45>; #10# mechanism similar to those of other pyridoxal  enzymes <12>; #1# identification and spectral characterization of the  external aldimine of the reaction, mechanism <51>; #9# mechanism of  reverse reaction <1>; #38# model of reaction mechanism <19>; #81#  geometric model of reaction, comparison isoenzyme CysK <69>)  "
2.5.1.48," O4-succinyl-L-homoserine + L-cysteine = L-cystathionine + succinate  (#8,12# ping-pong mechanism <26,32>; #1# can also use hydrogen sulfide  and methanethiol as substrates producing homocysteine and methionine  respectively. In the absence of thiol, the enzyme can also catalyse  beta,gamma-elimination to form 2-oxobutanoate, succinate and ammonia  <6>; #6# enzyme performs an elimination or a replacement reaction,  reaction mechanism, formation of an aldimine intermediate, overview  <37>)  "
2.5.1.49, O-acetyl-L-homoserine + methanethiol = L-methionine + acetate  
2.5.1.5," eliminates sulfate from the D-galactose 6-sulfate residues of  porphyran, producing 3,6-anhydrogalactose residues  "
2.5.1.50, O-acetyl-L-serine + zeatin = lupinate + acetate (#1# ping pong bi bi  mechanism <2>)  
2.5.1.51, O-acetyl-L-serine + pyrazole = 3-(pyrazol-1-yl)-L-alanine + acetate  
2.5.1.52," O-acetyl-L-serine + 3,4-dihydroxypyridine =  3-(3,4-dihydroxypyridin-1-yl)-L-alanine + acetate  "
2.5.1.53, O-acetyl-L-serine + uracil = 3-(uracil-1-yl)-L-alanine + acetate  
2.5.1.54," phosphoenolpyruvate + D-erythrose 4-phosphate + H2O =  3-deoxy-D-arabino-hept-2-ulosonate 7-phosphate + phosphate (#4,34#  mechanism <1,2,3,8,9,69>; #1,4,5,41# sequential mechanism <6,11,28,56>;  #23# ordered sequential mechanism <59>; #4# His268 is located in the  active site <49>; #1,4,6,30# ordered ping-pong bi-bi mechanism  <4,6,9,26>; #6,30,41# first substrate is phosphoenolpyruvate <4,26,56>;  #16# Cys67 and Cys145 are important for the catalytic reaction <53>;  #6# rapid equilibrium ordered mechanism, in which phosphoenolpyruvate  is the first substrate to bind and 3-deoxy-D-arabinoheptulosonate  7-phosphate is the second product to be released <24>; #41# Lys186 is  involved in hydrogen bonding with phosphoenolpyruvate <56>; #4# active  site cysteines: Cys61 and Cys328 <33>; #4# product release is  rate-limiting, rate constant for product formation is higher with Mn2+  than with Zn2+ or Cu2+. Role of metal ion is to position the amino  acids with the appropriate geometry required to coordinate and activate  the water molecule <67>; #44# simultaneous presence of a metal ion and  phosphoenolpyruvate result in an ordering of the protein into a  conformation that is prepared for binding the second substrate  erythrose 4-phosphate. Initial step of reaction is a nucleophilic  attack of the double bond of phosphoenolpyruvate on the metal-activated  carbonyl group of erythrose 4-phosphate <68>; #49# proposed mechanism  of catalysis of NmeDAH7PS showing key nucleophilic role for active site  WAT1, overview <91>)  "
2.5.1.55," phosphoenolpyruvate + D-arabinose 5-phosphate + H2O =  3-deoxy-D-manno-octulosonate 8-phosphate + phosphate (#4# mechanism  <11,16>; #4# stereochemistry <8>; #4# steady-state kinetic mechanism,  where phosphoenolpyruvate binding precedes that of  D-arabinose-5-phosphate, followed by the ordered release of phosphate  and 3-deoxy-D-manno-2-octulosonate 8-phosphate <15>; #4# bisphosphate  intermediate formed during the initial step of synthesis may have the  pyranose structure with the anomeric phosphate located in the  beta-configuration <16>; #43# the synthesis of  2-dehydro-3-deoxy-D-octonate 8-phosphate proceeds through the formation  of a linear rather than a cyclic intermediate <21>; #4# reaction  pathway involves an acyclic bisphosphate intermediate <9>; #52# quantum  mechanical/molecular mechanical simulations of both the enzymatic and  non-enzymatic synthesis of 2-dehydro-3-deoxy-D-octonate 8-phosphate  reveal the mechanism underlying the switch between metal and non-metal  dependent catalysis. The conversion is possible because the metal is  not involved in an activation process, but primarily contributes to  orienting properly the reactants to lower the activation energy, an  action easily mimicked by amino acid side-chains <50>; #4# the  catalytic mechanism is thought to occur by correct substrate proximity  and orientation through a series of sequential conformational changes  in which phosphoenolpyruvate binding precedes that of D-arabinose  5-phosphate and the release of inorganic phosphate (Pi) precedes  dissociation of the 3-deoxy-D-manno-octulosonate 8-phosphate product  <54>)  "
2.5.1.56," phosphoenolpyruvate + N-acetyl-D-mannosamine + H2O = phosphate +  N-acetylneuraminate (#2# mechanism, essential role for divalent metal  ion as an electrophilic catalyst that activates the N-acetylmannosamine  carbonyl prior to the addition of phosphoenolpyruvate <12>)  "
2.5.1.57, phosphoenolpyruvate + N-acyl-D-mannosamine 6-phosphate + H2O =  N-acylneuraminate 9-phosphate + phosphate  
2.5.1.58," farnesyl diphosphate + protein-cysteine = S-farnesyl protein +  diphosphate (#4,5# kinetic mechanism <1,2,4,5,15,16,25>; #4,5# enzyme  constitutes the protein prenyltransferase family of enzymes <1,5,9,25>;  #4# farnesyl diphosphate binds exclusively to the beta subunit <7>;  #4,5# farnesyl diphosphate binds the enzyme in a two step process that  may involve an enzyme conformational change, the enzyme-substrate  complex then rapidly reacts with the peptide substrate to form a  product, and product release is the rate-limiting step in catalysis  <1,2>; #4# both subunits would appear to have a role in binding and  orienting the leaving group of farnesyl diphosphate approximately for  catalysis <23>; #5# The enzyme preferentially farnesylates CaaX  sequences ending in methionine, cysteine or serine. Enzyme also  attaches geranylgeraniol to some CaaX sequences ending in methionine,  leucine and cysteine. Substrate overlap may occur between the  Saccharomyces cerevisae farnesyl transferase and  geranylgeranyltransferase types I in vivo <9>)  "
2.5.1.59," geranylgeranyl diphosphate + protein-cysteine =  S-geranylgeranyl-protein + diphosphate (#5,8# random sequential  mechanism <3,4>; #8# enzyme and geranylgeranyl diphosphate produce a  stable binary complex and the tightly bound geranylgeranyl diphosphate  is transferred to a peptide acceptor, without the equilibration of  enzyme-bound geranylgeranyl diphosphate with free geranylgeranyl  diphosphate <2,3>; #7# an ordered binding mechanism for enzyme where  geranylgeranyl diphosphate adds before peptide <8>; #7# catalyses the  formation of a thioether linkage between the C-1 atom of the  geranylgeranyl group and a cysteine residue fourth from the C-terminus  of the protein, these protein acceptors have the C-terminal sequence  CA1A2X, where the terminal residue, X, is preferably leucine, but  serine, methionine, alanine or glutamine makes the protein a substrate  for EC 2.5.1.58, the enzymes are relaxed in specificity for A1, but  cannot act if A2 is aromatic, known targets of this enzyme include most  g-subunits of heterotrimeric G proteins and Ras-related GTPases such as  members of the Ras and Rac/Rho families <1,10>; #5,7,8,10# this enzyme,  along with protein farnesyltransferase, EC 2.5.1.58 and protein  geranylgeranyltransferase type II, EC 2.5.1.60, constitutes the protein  prenyltransferase family of enzymes <1,3,4,5,7,8,10,12,13>)  "
2.5.1.6," ATP + L-methionine + H2O = phosphate + diphosphate +  S-adenosyl-L-methionine (#10# mechanism <1>; #5# steady state ordered  Bi Ter mechanism with ATP adding before L-methionine and  S-adenosylmethionine being the first product released, random release  of phosphate and diphosphate <15>; #61# mechanism of inhibiton by  product analogues and implications for reaction <46>; #50# mechanism,  key role of K182 in the correct positioning of the substrates, and D135  in stabilizing the sulfonium group formed in the product <53>; #61#  neutral H14 acts as an acid to cleave the C5Â’-O5Â’ bond of ATP, S of  methionine makes a nucleophilic attack on the C5Â’ to form the product  <45>; #61# catalysis of a SN2 reaction through hydrogen bonding of the  liberated oxygen-5 to the histidine, charge neutralization by the two  Mg2+ ions, and stabilization of the product sulfonium cation through a  close, non-bonded, contact between the sulfur and the ribose oxygen-4  <86>)  "
2.5.1.60," geranylgeranyl diphosphate + protein-cysteine =  S-geranylgeranyl-protein + diphosphate (#3# mechanism <5,6>; #3,4#  enzyme is unique in the protein prenyltransferase family, consisting  protein farnesyltransferase, EC 2.5.1.58, protein  geranylgeranyltransferase type I, EC 2.5.1.59 and Rab  geranylgeranyltransferase <1,5,8,11,16>; #3# mechanism, geranylgeranyl  diphosphate first acts as an allosteric regulator of enzyme, second  acts as the phosphoisoprenoid donor in the prenylation reaction and  third senses the completion of catalysis and concomitantly triggers  substrate release by increasing the dissociation rate of the product  <8>; #3# mechanism, recombinant enzyme"
2.5.1.60,"/P-1 complex catalyzes the  geranylgeranylation of both adjacent cysteines in Rab1A, Rab3A and  Rab5A <4>; #3# mechanism of enzyme"
2.5.1.60,"/P-complex formation <12>; #3,4#  mammalian enzyme have revealed two alternative pathways for the  assembly of catalytic complex. The classical pathway: the Rab protein  forms a stable complex with "
2.5.1.60,"P. Enzyme covalently attaches the  geranylgeranyl groups to two C-terminal cysteines of the Rab protein.  Upon prenylation, the Rab"
2.5.1.60,"/P complex remains tightly associated with  the enzyme until binding of a new molecule of isoprenoid decreases its  affinity for the prenylated complex. The prenylated complex dissociated  from enzyme and delivers Rab protein to its target membrane. In the  alternative pathway, enzyme and "
2.5.1.60,"P form a tight complex in the  presence of the phosphoisoprenoid. This complex is catalytically  competent and can recruit and prenylate Rab protein. <11,12>; #3#  mechanism, phosphoisoprenoid acts both as a substrate and as a sensor  governing the kinetics of protein protein interactions in the double  prenylation reaction <7>; #4# the yeast enzyme follows only the  classical pathway <11>; #4# prenylation mechanism of Rab potein by the  RabGGTase:GGpp complex, overview <21>)  "
2.5.1.61," 4 porphobilinogen + H2O = hydroxymethylbilane + 4 NH3 (#1,10,17#  mechanism <9>; #5# catalytic cycle, cofactor assembly and tetrapyrrole  chain polymerization mechanism, C261 is involved, residues D99 and R167  are essential for activity, overview <34>; #29# four molecules of the  pyrrole porphobilinogen are condensed to form the linear tetrapyrrole  preuroporphyrinogen (hydroxymethylbilane). Hydrolysis of the linkage  between the first substrate moiety and the cofactor releases the  tetrapyrrole product preuroporphyrinogen <54>; #28# reaction mechanism  with active site residues R11, D84 and R176 that appear to be involved  in controlling crucial steps during tetrapyrrole, detailed interaction  analysis, overview. The compactness of the overall protein decreases  progressively with addition of each pyrrole ring. domains move apart  while the cofactor turn region moves towards the second domain, thus  creating space for the pyrrole rings added at each stage. Residues of  the flexible active site loop play a significant role in its  modulation. During this movement, loop residue D50 interacts with R149  and K55 interacts with Q243, E305 and V306 with an occupancy of 41%  along the trajectory. Upon removal of hydroxymethylbilane, the  structure of the enzyme gradually relaxes to resemble its initial stage  structure, indicating its readiness to resume a new catalytic cycle  <58>)  "
2.5.1.62," chlorophyllide a + phytyl diphosphate = chlorophyll a + diphosphate  (#6# ping-pong mechanism <1>; #6# active site structure, substrate  binding mechanism <13>)  "
2.5.1.63," S-adenosyl-L-methionine + fluoride = 5'-deoxy-5'-fluoroadenosine +  L-methionine (#1# reaction mechanism, inversion of configuration  consistent with a SN2 reaction mechanism <3>; #1# substrate binding  structure involving F156, S158, Y177, and T80, nucleophilic  substitution reaction mechanism <4>; #1# C-F bond formation, the enzyme  catalyses an SN2 type reaction mechanism <5>; #1# reaction mechanism,  overview <6>; #8# SN2 substitution reaction mechanism, where fluoride  ion mediates a nucleophilic attack to the 5-carbon of the ribose ring  of S-adenosyl-L-methionine to give 5-deoxy-5-fluoroadenosine. The  reaction proceeds with an inversion of configuration at the C-5carbon  <20>)  "
2.5.1.65," O-phospho-L-serine + hydrogen sulfide = L-cysteine + phosphate (#2,4#  ping-pong bi-bi mechanism <3,9>; #2# a pyridoxal-phosphate protein, the  enzyme from Aeropyrum pernix acts on both O-phospho-L-serine and  O3-acetyl-L-serine, in contrast with EC 2.5.1.47, cysteine synthase,  which acts only on O3-acetyl-L-serine <2>; #2# active site structure,  modeling of substrate binding at the active site with Arg297 being  crucial for activity <4>; #5# catalytic cycle of CysK2 and related  cysteine synthases, catalytic raction mechanism of enzyme CysK2 via  formation of the enzyme-aminoacrylate intermediate, accompanied by the  release of a phosphate ion, commonly observed in the class of pyridoxal  5-phosphate-dependent enzymes, overview <11>; #4# ping-pong bi-bi  mechanism, the active site of ApOPSS contains pyridoxal 5-phosphate  linked to lysine 127 as an internal Schiff base. Binding of the primary  substrate O-phospho-L-serine displaces the lysine and forms an external  Schiff base, initiating the first half-reaction that yields an  alpha-aminoacrylate intermediate linked to pyridoxal 5-phosphate. The  second half-reaction involves the addition of a secondary substrate to  the alpha-aminoacrylate intermediate and generates an external Schiff  base with cysteine. The active-site lysine reacts with this external  Schiff base, releasing cysteine and regenerating the internal Schiff  base with K127. When other nucleophiles are used instead of sulfide,  enzyme ApOPSS produces the corresponding non-natural amino acid <10>)  "
2.5.1.66," D-glyceraldehyde 3-phosphate + L-arginine =  N2-(2-carboxyethyl)-L-arginine + phosphate (#1# mechanism <3>; #1# the  enzyme requires thiamine diphosphate and catalyses the first step in  the clavulanic-acid-biosynthesis pathway, the 2-hydroxy-3-oxo group  transferred from glyceraldehyde 3-phosphate is isomerized during  transfer to form the 2-carboxyethyl group, detailed mechanism <5>)  "
2.5.1.67," 2 dimethylallyl diphosphate = diphosphate + chrysanthemyl diphosphate  (#3# cyclopropanation reaction mechanism, overview <1>)  "
2.5.1.68," geranyl diphosphate + isopentenyl diphosphate = diphosphate +  (2Z,6E)-farnesyl diphosphate  "
2.5.1.69," 2 dimethylallyl diphosphate = diphosphate + lavandulyl diphosphate (#3#  the two dimethylallyl diphosphate molecules, both allylic diphosphates,  condense via a so-called head-to-middle condensation to form the (C10)  monterpene, lavandulyl diphosphate. The enzyme structure is similar to  that of the bacterial cis-prenyl synthase, undecaprenyl diphosphate  synthase, and contains an allylic site (S1) in which dimethylallyl  diphosphate ionizes and a second site (S2) which houses the  dimethylallyl diphosphate nucleophile. Both S-thiolo-dimethylallyl  diphosphate and S-thiolo-isopentenyl diphosphate bind intact to S2, but  are cleaved to (thio)diphosphate, in S1. His78 is essential for  catalysis and is proposed to facilitate diphosphate release in S1,  while the P1 phosphate in S2 abstracts a proton from the lavandulyl  carbocation to form the LPP product, structure-based catalytic  mechanism, overview <4>)  "
2.5.1.7," phosphoenolpyruvate + UDP-N-acetyl-alpha-D-glucosamine = phosphate +  UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine (#4,6,21#  mechanism <11,16,19,22>; #6# active site SH-group <8>; #4# the addition  step proceeds with protonation of C-3 of phosphoenolpyruvate from the  2-si face <10>; #6# D305 has a dual role as a general base and an  essential binding partner to UDP-GlcNAc <22>; #6# Cys115 in the active  site can act as proton donor, necessary for activity, or as a  nucleophile <19>; #21# thermodynamical investigation of substrate  binding and binding of inhibitory substrate analogue fosfomycin <21>;  #4,6# Cys115 is the active site nucleophile <12,13,14>; #6# N23 is  responsible for stabilization of transition states <22>; #6# Asn23 and  Asp305 are essential in the active site <22>; #6# mechanism, formation  of a covalent intermediate between enzyme and enolpyruvate moiety <3>;  #6,21# enyme exhibits an open conformation when substrate-free, and a  closed, tightly-packed conformation upon substrate binding <16,22>; #6#  structure analysis of conformational changes upon substrate binding  <15>; #21# Lys22 is located near the active site and involved in  substrate binding <17>; #2# exchange of cysteine to aspartate in the  active site <23>; #4# intramolecular general acid catalysis through  protonation of the bridging oxygen of the phosphate <26>; #6#  tetrahedral reaction intermediate, overall addition-elimination  reaction is halted after the addition step <27>)  "
2.5.1.70, dimethylallyl diphosphate + (-)-(2S)-naringenin = diphosphate +  sophoraflavanone B (#1# reaction mechanism <2>)  
2.5.1.71, dimethylallyl diphosphate + leachianone G = diphosphate +  sophoraflavanone G (#1# reaction mechanism <1>)  
2.5.1.72," glycerone phosphate + iminosuccinate = pyridine-2,3-dicarboxylate + 2  H2O + phosphate (#6# model of the catalytic state. Elimination of  phosphate from dihydroxyacetone phosphate may precede the condensation  reaction <9>; #9,10# reaction mechanism with an early release of  phosphate from dihydroxyacetone phosphate, that only, not glycerol  3-phosphate, can condense with iminoaspartate to form quinolinate. The  NadA three-dimensional structure shows that there is no room in the  active site to accommodate a condensation product on which the  phosphate group from dihydroxyacetone phosphate is still present,  overview. The enzyme has a triose phosphate isomerase activity  catalyzing the reversible isomerization of glycerol 3-phosphate into  dihydroxyacetone phosphate in an Fe/S-dependent manner <16>; #10# the  presence of the Fe4S4 cluster generates an internal tunnel and a cavity  to bind the substrate and and dehydrate it, which is initiated by the  conserved residue Tyr21. Tyr21 is close to a conserved Thr-His-Glu. All  of these residues are essential for activity and Tyr21 deprotonation,  to form the reactive nucleophilic phenoxide anion, is mediated by the  triad. NadA displays a dehydration mechanism significantly different  from the one found in archetypical dehydratases such as aconitase,  which use a serine residue deprotonated by an oxyanion hole <17>)  "
2.5.1.73, O-phospho-L-seryl-tRNACys + sulfide = L-cysteinyl-tRNACys + phosphate  
2.5.1.74," an all-trans-polyprenyl diphosphate + 1,4-dihydroxy-2-naphthoate = a  demethylmenaquinol + diphosphate + CO2  "
2.5.1.75," dimethylallyl diphosphate + adenine37 in tRNA = diphosphate +  N6-dimethylallyladenine37 in tRNA (#1# mechanism <8,11>; #1# ordered  sequential mechanism for substrate binding <18>; #15# ordered substrate  binding <21>)  "
2.5.1.76, O-phospho-L-serine + sulfite = L-cysteate + phosphate  
2.5.1.78," 1-deoxy-L-glycero-tetrulose 4-phosphate +  5-amino-6-(D-ribitylamino)uracil = 6,7-dimethyl-8-(D-ribityl)lumazine +  2 H2O + phosphate (#18# critical involvement of the active-site  residues Phe22, His88 and Arg127 in substrate binding and catalysis  <51>)  "
2.5.1.79, S-adenosyl 3-(methylsulfanyl)propylamine + spermidine =  S-methyl-5'-thioadenosine + thermospermine + H+  
2.5.1.80," dimethylallyl diphosphate + L-tryptophan = diphosphate +  7-(3-methylbut-2-enyl)-L-tryptophan (#6# catalytic reaction mechanism  involving Glu138, overview <11>)  "
2.5.1.81," geranylgeranyl diphosphate + isopentenyl diphosphate =  (2E,6E,10E,14E)-geranylfarnesyl diphosphate + diphosphate  "
2.5.1.82, geranylgeranyl diphosphate + 2 isopentenyl diphosphate = 2 diphosphate  + all-trans-hexaprenyl diphosphate  
2.5.1.83," (2E,6E)-farnesyl diphosphate + 3 isopentenyl diphosphate = 3  diphosphate + all-trans-hexaprenyl diphosphate (#3# mechanism: farnesyl  diphosphate binds to the components of the enzyme (A and B) to form an  aggregate, A-B-(farnesyl diphosphate)-Mg2+, which probably represents  an intermediary state of enzyme catalysis <7>)  "
2.5.1.84, geranyl diphosphate + 7 isopentenyl diphosphate = 7 diphosphate +  all-trans-nonaprenyl diphosphate  
2.5.1.85, geranylgeranyl diphosphate + 5 isopentenyl diphosphate = 5 diphosphate  + all-trans-nonaprenyl diphosphate  
2.5.1.86," (2Z,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate = 7  diphosphate + trans,octacis-decaprenyl diphosphate (#4# mechanism: 1.  the C5 unit of isopentenyl diphosphate adds to the a-end of the  polyisoprene polymer, 2. in processive enzymes such as Rv2361c, the  nascent chain (C15 to C45) moves to the polymer site displacing the  diphosphate, 3. the empty isopentenyl diphosphate site is then reloaded  and another C5 unit is added in an iterative fashion until the  physiologically relevant chain length is generated <3>)  "
2.5.1.87," (2E,6E)-farnesyl diphosphate + n isopentenyl diphosphate = n  diphosphate + ditrans,polycis-polyprenyl diphosphate (n: 10-55)  "
2.5.1.88," (2Z,6E)-farnesyl diphosphate + n isopentenyl diphosphate = n  diphosphate + trans,polycis-polyprenyl diphosphate (n: 9-11)  "
2.5.1.89," geranylgeranyl diphosphate + 7 isopentenyl diphosphate = 7 diphosphate  + tritrans,heptacis-undecaprenyl diphosphate  "
2.5.1.9," 2 6,7-dimethyl-8-(1-D-ribityl)lumazine = riboflavin +  4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine  (#1,2,3,4,6,11,12,25,27,29# reaction mechanism <1,3,15,19,23>; #3#  active site <21>; #33# Cys-48 plays a nucleophilic role in catalytic  mechanism <20>; #3,29# substrate binding site <19,23>; #33# active site  structure and catalytic mechanism <31>; #7,9,14# catalytic mechanism,  stereochemistry <26>; #3# catalytic mechanism, stereochemistry,  pentacyclic reaction intermediate which is diastereomeric to the  reaction intermediate of the enzyme from Methanococcus jannaschii <26>;  #22# catalytic mechanism, stereochemistry, pentacyclic reaction  intermediate, which is diastereomeric to the reaction intermediate of  the enzyme from Escherichia coli <26>; #29# detailed catalytic  mechanism, Cys48 is involved <29>; #3# detailed catalytic mechanism,  pentacyclic reaction intermediate <30>; #3# pentacyclic reaction  intermediate <27>; #2# formation of riboflavin by the lumazine  synthase/riboflavin synthase complex follows a leaky channel model <17>)  "
2.5.1.90," (2E,6E)-farnesyl diphosphate + 5 isopentenyl diphosphate = 5  diphosphate + all-trans-octaprenyl diphosphate (#1# sequential  mechanism <8>; #3# isopentenyl diphosphate condensation rather than  product release is rate limiting <12>)  "
2.5.1.91," (2E,6E)-farnesyl diphosphate + 7 isopentenyl diphosphate = 7  diphosphate + all-trans-decaprenyl diphosphate  "
2.5.1.92," dimethylallyl diphosphate + 2 isopentenyl diphosphate = 2 diphosphate +  (2Z,6Z)-farnesyl diphosphate  "
2.5.1.93, geranyl diphosphate + 4-hydroxybenzoate = 3-geranyl-4-hydroxybenzoate +  diphosphate  
2.5.1.94, S-adenosyl-L-methionine + chloride = 5-deoxy-5-chloroadenosine +  L-methionine  
2.5.1.95," phosphoenolpyruvate +  D-Man-beta-(1->4)-D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1  >4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol =  4  6-CH3(COO-)C-D-Man-beta-(1->4)-D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D  Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol +  phosphate  "
2.5.1.96," 2 (2E,6E)-farnesyl diphosphate = 15-cis-4,4'-diapophytoene + 2  diphosphate (#6# prenyl diphosphate binding site S1 farnesyl  diphosphate ionizes to form the 1-carbocation. This carbocation moves  down into the interior of the protein to react with C2,3 in the prenyl  diphosphate binding site S2 farnesyl diphosphate. The second PPi then  moves up into the S1 site to interact with the three Mg2+, and the  cyclopropylcarbinyl cation so formed then rearranges, forming  dehydrosqualene binds to the surface pocket <8>) "
2.5.1.96," 2 (2E,6E)-farnesyl diphosphate = diphosphate + presqualene diphosphate "
2.5.1.96," presqualene diphosphate = 15-cis-4,4'-diapophytoene + diphosphate  "
2.5.1.97," phosphoenolpyruvate +  2,4-bis(acetylamino)-2,4,6-trideoxy-beta-L-altropyranose + H2O =  5,7-bis(acetylamino)-3,5,7  9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid +  phosphate  "
2.5.1.98," phosphoenolpyruvate +  [beta-D-GlcA-(1->4)-2-O-Ac-beta-D-GlcA-(1->4)-beta-D-Glc-(1->4)-[3-O  (CH3CH(OH)CH2C(O))-4  6-CH3(COO-)C-beta-D-Gal-(1->4)-beta-D-Glc-(1->4)-beta-D-Glc-(1->4)-beta  D-Glc-(1->6)]-2(or 3)-O-Ac-alpha-D-Glc-(1->6)]n =  [beta-D-GlcA-(1->4)-2-O-Ac-beta-D-GlcA-(1->4)-beta-D-Glc-(1->4)-[3-O  (CH3CH(OH)CH2C(O))-4,6-CH3(COO-)C-beta-D-Gal-(1->3)-4  6-CH3(COO-)C-beta-D-Glc-(1->4)-beta-D-Glc-(1->4)-beta-D-Glc-(1->6)]  2(or 3)-O-Ac-alpha-D-Glc-(1->6)]n + phosphate  "
2.6.1.1," L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate (#6#  mechanism <34,59>; #1,3,5,6,8,9,13,22,27,37,42,57# bi bi ping pong  reaction kinetic <8,11,21,22,30,33,36,48,52,60,63,64,70>; #6,77# active  site structure, substrate recognition mechanism <62>; #6# intermediate  formation <59>; #68# catalytic reaction mechanism, overview <159>)  "
2.6.1.100, L-glutamine + 2-deoxy-scyllo-inosose = 2-oxoglutaramate +  2-deoxy-scyllo-inosamine  
2.6.1.101," L-glutamine + 3-amino-2,3-dideoxy-scyllo-inosose = 2-oxoglutaramate +  2-deoxystreptamine  "
2.6.1.102, GDP-alpha-D-perosamine + 2-oxoglutarate =  GDP-4-dehydro-alpha-D-rhamnose + L-glutamate  
2.6.1.103," (S)-3,5-dihydroxyphenylglycine + 2-oxoglutarate =  2-(3,5-dihydroxyphenyl)-2-oxoacetate + L-glutamate  "
2.6.1.104, kanosamine 6-phosphate + 2-oxoglutarate = 3-dehydro-D-glucose  6-phosphate + L-glutamate  
2.6.1.105," L-lysine + 8-amino-7-oxononanoate = (S)-2-amino-6-oxohexanoate +  7,8-diaminononanoate  "
2.6.1.106," dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose + 2-oxoglutarate =  dTDP-3-dehydro-4,6-deoxy-alpha-D-glucose + L-glutamate  "
2.6.1.107," (2S,3S)-3-methylphenylalanine + 2-oxoglutarate =  (3S)-2-oxo-3-phenylbutanoate + L-glutamate  "
2.6.1.108, L-alanine + (5-formylfuran-3-yl)methyl phosphate = pyruvate +  [5-(aminomethyl)furan-3-yl]methyl phosphate  
2.6.1.109," 8-amino-3,8-dideoxy-alpha-D-manno-octulosonate + 2-oxoglutarate =  8-dehydro-3-deoxy-alpha-D-manno-octulosonate + L-glutamate  "
2.6.1.11, N2-acetyl-L-ornithine + 2-oxoglutarate = N-acetyl-L-glutamate  5-semialdehyde + L-glutamate  
2.6.1.110," dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose +  2-oxoglutarate = dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-hexopyranose +  L-glutamate  "
2.6.1.111, 3-aminobutanoyl-CoA + 2-oxoglutarate = acetoacetyl-CoA + L-glutamate  
2.6.1.112, (S)-ureidoglycine + glyoxylate = N-carbamoyl-2-oxoglycine + glycine  
2.6.1.113, putrescine + pyruvate = 4-aminobutanal + alanine  
2.6.1.114, L-glutamate + FMN + O2 + H2O + 3 acceptor = 2-oxoglutarate +  8-amino-8-demethylriboflavin 5'-phosphate + CO2 + 3 reduced acceptor 
2.6.1.114, FMN + O2 = 8-demethyl-8-formylriboflavin 5'-phosphate + H2O 
2.6.1.114, 8-demethyl-8-formylriboflavin 5'-phosphate + H2O + acceptor =  8-carboxy-8-demethylriboflavin 5'-phosphate + reduced acceptor 
2.6.1.114, L-glutamate + 8-carboxy-8-demethylriboflavin 5'-phosphate + H2O + 2  acceptor = 2-oxoglutarate + 8-amino-8-demethylriboflavin 5'-phosphate +  CO2 + 2 reduced acceptor  
2.6.1.115," (2E,5S,6E,8E,10E)-1-aminododeca-2,6,8,10-tetraen-5-ol + pyruvate =  (2E,5S,6E,8E,10E)-5-hydroxydodeca-2,6,8,10-tetraenal + L-alanine  "
2.6.1.116, 6-aminohexanoate + 2-oxoglutarate = 6-oxohexanoate + L-glutamate  
2.6.1.117, L-glutamine + 4-(methylsulfanyl)-2-oxobutanoate = 2-oxoglutaramate +  L-methionine  
2.6.1.118, an [amino group carrier protein]-C-terminal-gamma-(L-lysyl)-L-glutamate  + 2-oxoglutarate = an [amino group carrier  protein]-C-terminal-N-(1-carboxy-5-oxopentan-1-yl)-L-glutamine +  L-glutamate  
2.6.1.119, L-alanine + vanillin = pyruvate + vanillylamine  
2.6.1.12, L-alanine + a 2-oxo carboxylate = pyruvate + an L-amino acid  
2.6.1.120, beta-alanine + 2-oxoglutarate = 3-oxopropanoate + L-glutamate  
2.6.1.121," (8S)-8-amino-7-oxononanoate + [protein]-L-lysine + CO2 =  (7R,8S)-8-amino-7-(carboxyamino)nonanoate +  [protein]-(S)-2-amino-6-oxohexanoate "
2.6.1.121," (8S)-8-amino-7-oxononanoate + [protein]-L-lysine + NAD(P)H =  [protein]-N6-[(2S,3R)-2-amino-8-carboxyoctan-3-yl]-L-lysine + H2O +  NAD(P)+ "
2.6.1.121," [protein]-N6-[(2S,3R)-2-amino-8-carboxyoctan-3-yl]-L-lysine + CO2 + H2O  + NAD(P)+ + H+ = (7R,8S)-8-amino-7-(carboxyamino)nonanoate +  [protein]-(S)-2-amino-6-oxohexanoate + NAD(P)H + H+  "
2.6.1.122," UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose +  2-oxoglutarate = UDP-N-acetyl-3-dehydro-alpha-D-glucosamine +  L-glutamate  "
2.6.1.123, chorismate + 2 L-glutamine + H2O = 4-amino-4-deoxychorismate + 2  L-glutamate + ammonia 
2.6.1.123, 2 L-glutamine + 2 H2O = 2 L-glutamate + 2 NH3 
2.6.1.123, chorismate + NH3 = (2S)-2-amino-4-deoxychorismate + H2O 
2.6.1.123, (2S)-2-amino-4-deoxychorismate + NH3 = 4-amino-4-deoxychorismate + NH3  
2.6.1.13," L-ornithine + a 2-oxo carboxylate = L-glutamate 5-semialdehyde + an  L-amino acid (#5,16# mechanism <33,40>; #38# mechanism of the  L-ornithine transamination catalysed by ornithine aminotransferase  (OAT) and reaction intermediate forms, detailed overview. Like every  PLP-dependent transaminases, OAT operates via a ping-pong mechanism, in  which two half-reactions complete a full transamination cycle. In the  first half-transamination reaction, L-ornithine reacts with the PLP  form of the enzyme (OAT-PLP) to yield L-glutamate 5-semialdehyde and  the pyridoxamine 5-phosphate form of the enzyme (OAT-PMP). In the  second half transamination, 2-oxoglutarate reacts with OAT-PMP to  reform OAT-PLP and L-glutamate <75>; #45# reaction mechanism and  kinetics, overview <72>; #38# the enzyme performs a OAT-like  PLP-dependent transaminase ping-pong mechanism, two half-reactions  completing a full transamination cycle. Like other transaminases,  ornithine delta-aminotransferase (OAT) in the absence of substrates  forms an internal aldimine with the PLP cofactor covalently bound on a  lysine residue through a Schiff base. In the first half-reaction,  ornithine forms an external aldimine with PLP, no longer covalently  bound to the enzyme, but retained in the active site through  non-covalent interactions. Enzyme OAT thus acts as an  omega-transaminase in the first half-reaction, and as an  alpha-transaminase in the second half-reaction: although the  alpha-amino group is more reactive then the distal one, in the first  half-reaction OAT transaminates the distal OAT amino group <73>;  #34,36,37,39,41,43,49,50,51# the enzyme performs a OAT-like  PLP-dependent transaminase ping-pong mechanism, two half-reactions  completing a full transamination cycle. Like other transaminases,  ornithine delta-aminotransferase in the absence of substrates forms an  internal aldimine with the PLP cofactor covalently bound on a lysine  residue through a Schiff base. In the first half-reaction, ornithine  forms an external aldimine with PLP, no longer covalently bound to the  enzyme, but retained in the active site through non-covalent  interactions. Enzyme OAT thus acts as an omega-transaminase in the  first half-reaction, and as an alpha-transaminase in the second  half-reaction: although the alpha-amino group is more reactive then the  distal one, in the first half-reaction OAT transaminates the distal OAT  amino group <73>)  "
2.6.1.14, L-asparagine + a 2-oxo carboxylate = 2-oxosuccinamate + an amino acid  (#2# ping-pong mechanism <2>)  
2.6.1.15, L-glutamine + pyruvate = 2-oxoglutaramate + L-alanine  
2.6.1.16," L-glutamine + D-fructose 6-phosphate = L-glutamate + D-glucosamine  6-phosphate (#2# rapid equilibrium random mechanism <15>; #31# analysis  of two catalytic mechanism variants (with neutral Cys1NH2 as the  activating base or with His71 as the activating base) by molecular  dynamics (MD) and quantum mechanics/molecular mechanics (QM/MM)  computational methods, detailed overview. Results shows that the most  likely catalytic mechanism is determined to involve a neutral Cys1NH2  group acting as the base that activates the Cys1 thiol <74>)  "
2.6.1.17," N-succinyl-L-2,6-diaminoheptanedioate + 2-oxoglutarate =  N-succinyl-L-2-amino-6-oxoheptanedioate + L-glutamate  "
2.6.1.18," L-alanine + 3-oxopropanoate = pyruvate + beta-alanine (#16# reaction  mechanism with beta-phenylalanine as an amino donor and 2-oxoglutarate  as an acceptor, detailed overview <20>; #15# the reaction mechanism of  transaminase-catalyzed reactions consists of two half-reactions and is  described as a ping-pong-bi-bi mechanism <21>)  "
2.6.1.19," 4-aminobutanoate + 2-oxoglutarate = succinate semialdehyde +  L-glutamate (#2,4,13,21# mechanism <20,21,23>; #3# gamma-aminobutyric  acid transaminase and beta-alanine transaminase are identical <47>;  #35# active site comparison with pig enzyme and with dialkylglycine  decarboxylase <52>; #36,37# catalytic mechanism of GABA-AT for  degradation of GABA into succinic semialdehyde, overview <110>)  "
2.6.1.2," L-alanine + 2-oxoglutarate = pyruvate + L-glutamate (#1,10,25# ping  pong bi bi mechanism <10,13,17>; #5# ping pong type reaction <11>)  "
2.6.1.21, D-alanine + 2-oxoglutarate = pyruvate + D-glutamate (#2# ping pong  mechanism <6>; #6# proposed reaction mechanism <16>)  
2.6.1.22, (S)-3-amino-2-methylpropanoate + 2-oxoglutarate =  2-methyl-3-oxopropanoate + L-glutamate  
2.6.1.23, erythro-4-hydroxy-L-glutamate + 2-oxoglutarate =  (4R)-4-hydroxy-2-oxoglutarate + L-glutamate  
2.6.1.24," 3,5-diiodo-L-tyrosine + 2-oxoglutarate =  4-hydroxy-3,5-diiodophenylpyruvate + L-glutamate  "
2.6.1.26," L-3,5,3'-triiodothyronine + 2-oxoglutarate =  3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-2-oxopropanoate +  L-glutamate  "
2.6.1.27, L-tryptophan + 2-oxoglutarate = (indol-3-yl)pyruvate + L-glutamate  
2.6.1.28, L-tryptophan + phenylpyruvate = (indol-3-yl)pyruvate + L-phenylalanine  
2.6.1.29," an alpha,omega-diamine + 2-oxoglutarate = an omega-aminoaldehyde +  L-glutamate  "
2.6.1.3, L-cysteine + 2-oxoglutarate = mercaptopyruvate + L-glutamate  
2.6.1.30," pyridoxamine + pyruvate = pyridoxal + L-alanine (#3# mechanism <5>; #6#  enzyme first binds pyridoxamine and then forms a Michaelis complex with  the incoming pyruvate. The ketimine is formed through nucleophilic  attack of the N-4 atom of pyridoxamine on the alpha-carbon atom of  pyruvate, which is followed by the release of a water molecule. The  stereospecific 1,3-prototropic shift between the ketimine and external  aldimine via the quinonoid intermediate is accomplished through general  base catalysis by Lys197. Pyridoxal and L-alanine are formed from the  external aldimine and released from enzyme <8>)  "
2.6.1.31, pyridoxamine + oxaloacetate = pyridoxal + L-aspartate  
2.6.1.32, L-valine + (S)-3-methyl-2-oxopentanoate = 3-methyl-2-oxobutanoate +  L-isoleucine  
2.6.1.33," dTDP-4-amino-4,6-dideoxy-alpha-D-glucose + 2-oxoglutarate =  dTDP-4-dehydro-6-deoxy-alpha-D-glucose + L-glutamate (#1# substrate  specificity might be related to conserved motifs VLalpha, VLbeta, and  VLgamma, around the active site <2>)  "
2.6.1.34," UDP-N-acetylbacillosamine + 2-oxoglutarate =  UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose + L-glutamate  "
2.6.1.35, glycine + oxaloacetate = glyoxylate + L-aspartate  
2.6.1.36, L-lysine + 2-oxoglutarate = (S)-2-amino-6-oxohexanoate + L-glutamate  (#5# stereochemistry <5>; #5# characterization of the half and overall  reactions <10>)  
2.6.1.37," (2-aminoethyl)phosphonate + pyruvate = 2-phosphonoacetaldehyde +  L-alanine (#3# bi-bi ping-pong mechanism <5>; #1# ping-pong bi-bi  mechanism <2>; #1# stereochemistry, 2-aminoethylphosphonate-pyruvate  transaminase catalyses the abstraction of the pro-S hydrogen atom at  the prochiral C2 carbon of 2-aminoethylphosphonate <3>)  "
2.6.1.38, L-histidine + 2-oxoglutarate = (imidazol-5-yl)pyruvate + L-glutamate  
2.6.1.39, L-2-aminoadipate + 2-oxoglutarate = 2-oxoadipate + L-glutamate  
2.6.1.4, glycine + 2-oxoglutarate = glyoxylate + L-glutamate  
2.6.1.40," (R)-3-amino-2-methylpropanoate + pyruvate = 2-methyl-3-oxopropanoate +  L-alanine (#3# may be identical with alanine-glyoxylate  aminotransferase, EC 2.6.1.44 <7>)  "
2.6.1.41, D-methionine + pyruvate = 4-(methylsulfanyl)-2-oxobutanoate + L-alanine  
2.6.1.42," L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate  (#56# bibi ping-pong mechanism. For good 2-oxoacid substrates, release  of 2-oxoglutarate is much slower than release of the product amino acid  during the transamination reaction <97>; #78# first transaminase  half-reaction via internal aldimine, external aldimine, ketimine, and  pyridoxamine (PMP)-bound form <113>; #54# MtIlvE displays a ping-pong  kinetic mechanism. The phosphate ester of the PLP cofactor, and the  alpha-amino group from L-glutamate and the active site Lys204, play  roles in acid-base catalysis and binding, respectively. An intrinsic  primary kinetic isotope effect is identified for the alpha-C-H bond  cleavage of L-glutamate. Large solvent kinetic isotope effect values  for the ping and pong half-reactions are also identified <112>;  #14,15,54,56,61,65,66,67,68,69,70,71,81# reaction mechanism of  aminotransferases via external aldimine, quinonoid intermediate,  ketimine, and carbinolamine, overview <111>; #57# transamination  functions through a ping pong kinetic mechanism involving two  half-reactions, characterised by the interconversion of its PLP and PMP  (pyridoxamine) form. In the first half reaction, binding of the BCAA  triggers transaldimination releasing the active lysine and an external  aldimine is formed between substrate and the PLP cofactor. The lysine  residue is the catalytic base in the next step, a 1,3-prototropic shift  that converts the external aldimine into a ketamine intermediate. Here,  a proton is abstracted from the ?-carbon of the substrate amino acid  and subsequent re-protonation of the aldehyde carbon of the coenzyme  yields the ketamine. The final step in the first half-reaction is the  hydrolysis of the ketamine to give the PMP form of the enzyme and an  2-oxo acid. The second half-reaction is the reversal of the first  half-reaction with a different 2-oxo acid. The committed step in the  complete oxidation of the BCAA is catalysed by the BCKD generating acyl  CoAs <106>; #44# transamination functions through a ping pong kinetic  mechanism involving two half-reactions, characterised by the  interconversion of its PLP and PMP (pyridoxamine) form. In the first  half reaction, binding of the BCAA triggers transaldimination releasing  the active lysine and an external aldimine is formed between substrate  and the PLP cofactor. The lysine residue is the catalytic base in the  next step, a 1,3-prototropic shift that converts the external aldimine  into a ketamine intermediate. Here, a proton is abstracted from the  alpha-carbon of the substrate amino acid and subsequent re-protonation  of the aldehyde carbon of the coenzyme yields the ketamine. The final  step in the first half-reaction is the hydrolysis of the ketamine to  give the PMP form of the enzyme and an 2-oxo acid. The second  half-reaction is the reversal of the first half-reaction with a  different 2-oxo acid. The committed step in the complete oxidation of  the BCAA is catalysed by the BCKD generating acyl CoAs. During  transamination, the BCAA substrate binds to the PLP cofactor at the  bottom of the active site and donates its nitrogen to PLP-BCATm <106>)  "
2.6.1.43," 5-aminolevulinate + pyruvate = 4,5-dioxopentanoate + L-alanine  "
2.6.1.44, L-alanine + glyoxylate = pyruvate + glycine (#3# pyridoxamine  5-phosphate remains bound to the enzyme during the catalytic cycle. The  enzyme-pyridoxamine 5-phosphate complex displays a reactivity towards  oxo acids higher than that of the apo-enzyme in presence of  pyridoxamine <42>)  
2.6.1.45," L-serine + glyoxylate = 3-hydroxypyruvate + glycine (#1,6,15# ping-pong  reaction mechanism <2,5,8,15,16>; #11# ping pong bi bi mechanism <9>;  #15# reaction is catalyzed via the initial formation of an external  Schiff base intermediate <16>)  "
2.6.1.46," L-2,4-diaminobutanoate + pyruvate = L-aspartate 4-semialdehyde +  L-alanine (#1# ping-pong kinetic mechanism <4>)  "
2.6.1.47, L-alanine + oxomalonate = pyruvate + aminomalonate  
2.6.1.48, 5-aminopentanoate + 2-oxoglutarate = 5-oxopentanoate + L-glutamate  
2.6.1.49," L-dopa + 2-oxoglutarate = 3,4-dihydroxyphenylpyruvate + L-glutamate  "
2.6.1.5, L-tyrosine + 2-oxoglutarate = 4-hydroxyphenylpyruvate + L-glutamate  
2.6.1.50," L-glutamine + 2,4,6/3,5-pentahydroxycyclohexanone = 2-oxoglutaramate +  1-amino-1-deoxy-scyllo-inositol (#1# mechanism, enzyme distinguishes  the enantiotopic amino groups of 2-deoxystreptamine but accepts both  enantiomers of 2-deoxy-scyllo-inosose to give a racemic product <7>)  "
2.6.1.51, L-serine + pyruvate = 3-hydroxypyruvate + L-alanine  
2.6.1.52," O-phospho-L-serine + 2-oxoglutarate = 3-phosphooxypyruvate +  L-glutamate (#13# mechanism of pyridoxal 5Â’-phosphate activation, X-ray  analysis of lysine-pyridoxal 5Â’-phosphate Schiff base <15>; #17#  bimolecular ping-pong mechanism, the transamination reaction catalyzed  by PSAT consists of two reversible half-reactions, detailed overview  <40>) "
2.6.1.52, 4-phosphooxy-L-threonine + 2-oxoglutarate =  (3R)-3-hydroxy-2-oxo-4-phosphooxybutanoate + L-glutamate  
2.6.1.54, pyridoxamine 5'-phosphate + 2-oxoglutarate = pyridoxal 5'-phosphate +  D-glutamate  
2.6.1.55, taurine + 2-oxoglutarate = 2-sulfoacetaldehyde + L-glutamate  
2.6.1.56," 1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol + pyruvate =  1D-1-guanidino-1-deoxy-3-dehydro-scyllo-inositol + L-alanine  "
2.6.1.57," an aromatic amino acid + 2-oxoglutarate = an aromatic oxo acid +  L-glutamate (#4# ping-pong mechanism <6>; #24# ping-pong bi-bi  mechanism <14>; #2# ping pong mechanism <18>; #4# proposed reaction  mechanism with aspartate and phenylalanine <30>; #31# two-step  mechanism with a pyridoxamine intermediate <7>; #28# the mechanism of  the transamination reaction of aminotransferases is a ping-pong bi-bi  mechanism, in which two half-reactions are required to complete one  catalytic cycle, consequently transferring the alpha-amino group from  an amino acid to an 2-oxo acid <52>)  "
2.6.1.58, L-phenylalanine + pyruvate = phenylpyruvate + L-alanine  
2.6.1.59," dTDP-4-amino-4,6-dideoxy-alpha-D-galactose + 2-oxoglutarate =  dTDP-4-dehydro-6-deoxy-alpha-D-galactose + L-glutamate  "
2.6.1.6, L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate  
2.6.1.60, an aromatic amino acid + glyoxylate = an aromatic oxo acid + glycine  
2.6.1.62," S-adenosyl-L-methionine + 8-amino-7-oxononanoate =  S-adenosyl-4-(methylsulfanyl)-2-oxobutanoate + 7,8-diaminononanoate  (#3# ping-pong mechanism <5>; #2# double displacement or ping pong  reaction mechanism <13>; #3# ping pong kinetics, reaction mechanism,  via a enzyme-pyridoxamine phosphate, a quinonoid intermediate <14>; #3#  reaction mechanism analysis, via a enzyme-pyridoxamine phosphate, a  S-adenosyl-L-methionine quinonoid intermediate, the substrate structure  is a major determinant of the thermodynamic and/or kinetic  accessibility of the quinonoid and ketimine intermediates <10>; #8#  reaction mechanism, substrate binding structure, detailed reversible  aminotransferase half-reaction, overview, residues Tyr17, Asp147, and  conserved Tyr144 and Arg253 are important for catalysis <12>; #3#  structural basis for reaction mechanism <11>; #10# enzyme shows a Ping  Pong Bi Bi kinetic mechanism with strong substrate inhibition <15>)  "
2.6.1.63," L-kynurenine + glyoxylate = 4-(2-aminophenyl)-2,4-dioxobutanoate +  glycine  "
2.6.1.64, L-glutamine + phenylpyruvate = 2-oxoglutaramate + L-phenylalanine  
2.6.1.65, 6-acetamido-3-aminohexanoate + 2-oxoglutarate =  6-acetamido-3-oxohexanoate + L-glutamate  
2.6.1.66, L-valine + pyruvate = 3-methyl-2-oxobutanoate + L-alanine  
2.6.1.67, L-2-aminohexanoate + 2-oxoglutarate = 2-oxohexanoate + L-glutamate  
2.6.1.7," L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate +  L-glutamate (#22# mechanism <12>; #3# transamination of the amino acid  to a transient keto acid intermediate which spontaneously undergoes  ring closure <5>)  "
2.6.1.70, L-aspartate + phenylpyruvate = oxaloacetate + L-phenylalanine  
2.6.1.71, L-lysine + pyruvate = (S)-2-amino-6-oxohexanoate + L-alanine  
2.6.1.72, D-4-hydroxyphenylglycine + 2-oxoglutarate = 4-hydroxyphenylglyoxylate +  L-glutamate  
2.6.1.73, L-methionine + glyoxylate = 4-(methylsulfanyl)-2-oxobutanoate + glycine  
2.6.1.74, (7R)-7-(5-carboxy-5-oxopentanoyl)aminocephalosporinate + D-glutamate =  cephalosporin C + 2-oxoglutarate  
2.6.1.75, S-(4-bromophenyl)-L-cysteine + 2-oxoglutarate =  S-(4-bromophenyl)mercaptopyruvate + L-glutamate  
2.6.1.76," L-2,4-diaminobutanoate + 2-oxoglutarate = L-aspartate 4-semialdehyde +  L-glutamate (#5# Involved in the formation of 1,3-diaminopropane in  Haemophilus influenzae and Acinetobacter baumannii. A product of the  ddc gene that also encodes L-2,4-diaminobutyrate decarboxylase in  Acinetobacter baumannii. Differs from EC 2.6.1.46  diaminobutyrate-pyruvate transaminase, which has pyruvate as the  amino-group acceptor <1,2>)  "
2.6.1.77, taurine + pyruvate = L-alanine + 2-sulfoacetaldehyde  
2.6.1.78," L-arogenate + oxaloacetate = prephenate + L-aspartate (#3# catalytic  reaction mechanism, overview <5>)  "
2.6.1.79," L-arogenate + 2-oxoglutarate = prephenate + L-glutamate (#11# catalytic  reaction mechanism, overview <8>)  "
2.6.1.8," 2,5-diaminopentanoate + 2-oxoglutarate = 5-amino-2-oxopentanoate +  L-glutamate  "
2.6.1.80, nicotianamine + 2-oxoglutarate = 3''-deamino-3''-oxonicotianamine +  L-glutamate  
2.6.1.81, N2-succinyl-L-ornithine + 2-oxoglutarate = N-succinyl-L-glutamate  5-semialdehyde + L-glutamate  
2.6.1.82, putrescine + 2-oxoglutarate = 4-aminobutanal + L-glutamate (#3# (1a)  <2>) 
2.6.1.82, 4-aminobutanal = 1-pyrroline + H2O (#3# (1b) <2>)  
2.6.1.83," LL-2,6-diaminoheptanedioate + 2-oxoglutarate =  (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + L-glutamate + H2O  "
2.6.1.84," L-arginine + pyruvate = 5-guanidino-2-oxopentanoate + L-alanine (#1#  ping-pong kinetic mechanism <2>; #1# aruF mutant with inducible  L-arginine:pyruvate transaminase activity <1>; #1# AruH catalyzes the  first step of the arginine transaminase pathway, representing one of  the multiple pathways for L-arginine catabolism <2>)  "
2.6.1.85," chorismate + L-glutamine = 4-amino-4-deoxychorismate + L-glutamate (#1#  the enzyme is composed of two parts, PabA and PabB <2,3>; #1#  association of PabA and PabB is greatly enhanced by 5 mM glutamine and  greatly reduced at cold temperatures <3>; #1# in the absence of PabA  and glutamine, PabB converts ammonia and chorismate into  4-amino-4-deoxychorismate (in the presence of Mg2+) <2>; #1# non linear  production of PABA in the ADC synthase-ADC lyase-coupled reaction  system, at different glutamine and chorismate concentrations, with  limiting PabB <2>; #1# mechanism includes nucleophile addition to C2 of  chorismate in an SN2 process <6>; #1# omega-amino group of K274 adds to  chorismate at C2, leading to elimination of the C4 hydroxyl in an SN2  displacement reaction. After attack of ammonia to intermediate, another  SN2 displacement expels K274 and forms aminodeoxychorismate <7>)  "
2.6.1.86, (2S)-2-amino-4-deoxychorismate + L-glutamate = chorismate + L-glutamine  
2.6.1.87, UDP-4-amino-4-deoxy-beta-L-arabinopyranose + 2-oxoglutarate =  UDP-beta-L-threo-pentapyranos-4-ulose + L-glutamate  
2.6.1.88, L-methionine + a 2-oxo carboxylate = 4-(methylsulfanyl)-2-oxobutanoate  + an L-amino acid  
2.6.1.89," dTDP-3-amino-3,6-dideoxy-alpha-D-glucopyranose + 2-oxoglutarate =  dTDP-3-dehydro-6-deoxy-alpha-D-glucopyranose + L-glutamate  "
2.6.1.9," L-histidinol phosphate + 2-oxoglutarate = 3-(imidazol-4-yl)-2-oxopropyl  phosphate + L-glutamate (#6# mechanism <10>; #1,2# ping-pong bi bi  mechanism <1,4>; #9# mechanism via gem-diamino, aldimine, and ketimine  reaction intermediates, active site structure analysis, overview <14>)  "
2.6.1.90," dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose + 2-oxoglutarate =  dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose + L-glutamate (#2# the  reaction occurs in the reverse direction <1>)  "
2.6.1.92," UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine + 2-oxoglutarate =  UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + L-glutamate  "
2.6.1.93, neamine + 2-oxoglutarate = 6'-dehydroparomamine + L-glutamate  
2.6.1.94, 2'-deamino-2'-hydroxyneamine + 2-oxoglutarate =  2'-deamino-2'-hydroxy-6'-dehydroparomamine + L-glutamate  
2.6.1.95, neomycin C + 2-oxoglutarate = 6'''-deamino-6'''-oxoneomycin C +  L-glutamate  
2.6.1.96, 4-aminobutanoate + pyruvate = succinate semialdehyde + L-alanine 
2.6.1.96, 4-aminobutanoate + glyoxylate = succinate semialdehyde + glycine  
2.6.1.97, L-glutamine + 7-cyano-7-carbaguanine15 in tRNA + H2O = L-glutamate +  archaeine15 in tRNA  
2.6.1.98," UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate +  2-oxoglutarate = UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate +  L-glutamate  "
2.6.1.99, L-tryptophan + pyruvate = indole-3-pyruvate + L-alanine  
2.6.3.1, pyruvate oxime + acetone = pyruvate + acetone oxime  
2.6.99.1, dATP + depurinated DNA = deoxyribose triphosphate + DNA  
2.6.99.2," 1-deoxy-D-xylulose 5-phosphate + 3-amino-2-oxopropyl phosphate =  pyridoxine 5'-phosphate + phosphate + 2 H2O (#3# reaction mechanism  <1>; #9# reaction energetics and mechanism, active site structure,  substrate binding structure, determination of conformation states of  the enzyme during reaction from apo to single occupied transitional  binding state and to fully occupied state <4>; #3# reaction mechanism,  active site structure, substrate and product binding structures,  structure-function relationship <5>; #9# reaction mechanism, active  site structure, substrate binding structure, structure-function  relationship <6>; #9# reaction mechanism, Arg20 is involved in  substrate binding, active site structure, structure-function  relationship <7>; #3# reaction mechanism, the enzyme shows  phosphomutase activity <2>)  "
2.6.99.3, O-acetyl-L-serine + hydroxyurea = O-ureido-L-serine + acetate  
2.7.1.1," ATP + D-hexose = ADP + D-hexose 6-phosphate (#46# random sequential  mechanism <48>; #24# random kinetic mechanism <7>; #25# equilibrium  random Bi Bi mechanism with formation of the abortive  enzyme-ADP-glucose complex <3>; #9# random process <46>; #12# rapid  random kinetic mechanism, erythrocyte enzyme and hexokinase I <4>; #9#  catalytic residues in the D-glucose binding site are Glu269, Glu302,  and Asp211 <83>; #7# non-cooperative conditions shows an ordered  kinetic mechanism with MgADP as the last product to be released <73>;  #61# substrate binding mechanism and structure <72>) "
2.7.1.1," ATP + D-glucose = ADP + D-glucose 6-phosphate (#87# positive  cooperation, mechanism <87>; #6# cutting-edge high-resolution nuclear  magnetic resonance methods are used to explore the kinetic properties  of glucokinase. Glucokinase samples a range of conformational states in  the absence of glucose. In the presence of glucose or a small-molecule  activator, the enzyme population shifts towards a more narrow,  well-structured ensemble of states <197>; #6# using intrinsic  tryptophan fluorescence a conformational change induced by the binding  of adenine nucleotides to human pancreatic glucokinase is determined.  The molecular dynamic simulations indicate that the binding triggers  molecular motion of the flexible surface /active site loop and partial  closure of the interdomain active site cleft. The modelled structure of  the hGK-ATP binary complex shows the residue contacts involved in ATP  binding at the active site <185>)  "
2.7.1.10," ATP + alpha-D-glucose 1-phosphate = ADP + alpha-D-glucose  1,6-bisphosphate  "
2.7.1.100, ATP + S-methyl-5-thio-D-ribose = ADP + S-methyl-5-thio-alpha-D-ribose  1-phosphate  
2.7.1.101, ATP + D-tagatose = ADP + D-tagatose 6-phosphate  
2.7.1.102, ATP + D-hamamelose = ADP + D-hamamelose 2'-phosphate  
2.7.1.103, ATP + viomycin = ADP + O-phosphoviomycin  
2.7.1.105," ATP + beta-D-fructose 6-phosphate = ADP + beta-D-fructose  2,6-bisphosphate (#5,29# mechanism <18,54>; #5# kinetic mechanism <63>;  #31# random mechanism <55>; #2,3,4,5,7,21,22,23,29,31# bifunctional  protein: 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase, reverse  reaction catalysed by fructose 2,6-bisphosphatase: 3.1.3.46  <7,8,9,10,11,15,17,18,19,21,22,23,26,28,29,30,31,32,33,34,35,36,38,48  49,50,51,52,53,54,55,56,57,58,59,60,61,63>; #4,5# high  6-phosphofructo-2-kinase activity compared to the fructose  2,6-bisphosphatase <8,11>; #5# bifunctional enzyme comprises both  6-phosphofructo-2-kinase and fructose-2,6-bisphosphatase, EC 3.1.3.46,  activities <69>; #26# bifunctional enzyme comprises both  6-phosphofructo-2-kinase and fructose-2,6-bisphosphatase, EC 3.1.3.46,  activities, residues K51, T52, D128, and K172 are key catalytic  residues for the 6-phosphofructo-2-kinase activity <70>; #27# HBP1 and  HBP2 both show a random order equilibrium bi bi mechanism, bifunctional  enzyme comprises both 6-phosphofructo-2-kinase and  fructose-2,6-bisphosphatase, EC 3.1.3.46, activities <67>; #3# ordered  bi bi mechanism, structural and functional roles of Cys-238 and Cys-295  <68>)  "
2.7.1.106," 3-phospho-D-glyceroyl phosphate + alpha-D-glucose 1-phosphate =  3-phospho-D-glycerate + alpha-D-glucose 1,6-bisphosphate  "
2.7.1.107," ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-diacyl-sn-glycerol 3-phosphate  (#7# random equilibrium mechanism <37>; #10# C-terminal active site  comprises residues 371-501, the C1 domain is absolutely required for  catalytic activity, residues Asp434, Asp650, Asp465, and Asp497 are  involved <41>; #14# catalytic and regulatory mechanisms <44>; #8#  conserved residues in the extended cysteine-rich domain CRD are  essential for activity. e.g. G236, P244, and P245 <45>; #42# analysis  of the catalytic kinase mechanism molecular dynamics and quantum  mechanics calculations, and density functional theory calculations,  overview. The active site is relatively open and able to accommodate  ligands in multiple orientations, suggesting that the optimization of  binding orientations and conformational changes occurs prior to actual  phosphoryl transfer <143>; #42# analysis of the catalytic mechanism  using crystal structure anaysis, structure-function analysis,  mutagenesis studies, molecular dynamics simulations, and density  functional theory modelling, overview <141>)  "
2.7.1.108, CTP + dolichol = CDP + dolichyl phosphate  
2.7.1.109, ATP + [hydroxymethylglutaryl-CoA reductase (NADPH)] = ADP +  [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate  
2.7.1.11," ATP + beta-D-fructofuranose 6-phosphate = ADP + beta-D-fructofuranose  1,6-bisphosphate (#10,15# mechanism <42,64>; #78# probably a random or  compulsory-order ternary complex mechanism at pH 8.0 <37>; #41#  iso-ordered bi-bi mechanism <10>; #10# K-type allosteric enzyme,  ordered sequential mechanism at pH 6.4 <49>; #4# allosteric regulated  enzyme, ping-pong bi-bi mechanism or according to Sumi and Ui,  allosteric ping-pong II mechanism <39>; #10# structure-oriented  allosteric four-state model describing substrate and effector actions  on PFK <42>; #68# sequential random mechanism <22>)  "
2.7.1.110, ATP + dephospho-{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase}  = ADP + {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase}  
2.7.1.112, ATP + protein tyrosine = ADP + protein tyrosine phosphate  
2.7.1.113," ATP + deoxyguanosine = ADP + dGMP (#1# sequential Bi Bi mechanism <13>;  #3# active site residues are Glu70, Lys142, and Arg142 <25>; #10#  substrate interactions and binding mechanism, and active site structure  <28>; #10# substrate interactions, reaction mechanism <24>)  "
2.7.1.114, AMP + thymidine = adenosine + dTMP  
2.7.1.118, ADP + thymidine = AMP + dTMP  
2.7.1.119, ATP + hygromycin B = ADP + 7''-O-phosphohygromycin B  
2.7.1.12," ATP + D-gluconate = ADP + 6-phospho-D-gluconate (#5# sequential  probably random mechanism <8>; #15# reaction follows a ternary complex  mechanism, with ATP binding first <18>)  "
2.7.1.121, phosphoenolpyruvate + glycerone = pyruvate + glycerone phosphate  
2.7.1.122, ATP + xylitol = ADP + xylitol 5-phosphate  
2.7.1.127," ATP + 1D-myo-inositol 1,4,5-trisphosphate = ADP + 1D-myo-inositol  1,3,4,5-tetrakisphosphate (#8# catalytic core structure, substrate  binding and catalytic mechanism, structure-function realtionship <39>;  #8# catalytic mechanism involving the 3-hydroxygroup of the substrate,  substrate recognition <36>; #7# catalytic mechanism, ATP, substrate and  product binding <38>)  "
2.7.1.13, ATP + 2-dehydro-D-gluconate = ADP + 6-phospho-2-dehydro-D-gluconate  
2.7.1.130, ATP + a lipid A disaccharide = ADP + a lipid IVA 
2.7.1.130, ATP +  2-deoxy-2-([(3R)-3-hydroxyacyl]amino)-3-O-[(3R)-3-hydroxyacyl]-beta-D  glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2-([(3R)-3  hydroxyacyl]amino)-1-O-phospho-alpha-D-glucopyranose = ADP +  2-deoxy-2-([(3R)-3-hydroxyacyl]amino)-3-O-[(3R)-3-hydroxyacyl]-4-O  phospho-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxyacyl]-2  ([(3R)-3-hydroxyacyl]amino)-1-O-phospho-alpha-D-glucopyranose (#2#  ping-pong type mechanism with bi-substrate kinetics <5>)  
2.7.1.134," ATP + 1D-myo-inositol 3,4,5,6-tetrakisphosphate = ADP + 1D-myo-inositol  1,3,4,5,6-pentakisphosphate  "
2.7.1.135, ATP + tau-protein = ADP + O-phospho-tau-protein  
2.7.1.136, ATP + oleandomycin = ADP + oleandomycin 2'-O-phosphate  
2.7.1.137, ATP + 1-phosphatidyl-1D-myo-inositol = ADP +  1-phosphatidyl-1D-myo-inositol 3-phosphate  
2.7.1.138," ATP + ceramide = ADP + ceramide 1-phosphate (#3# Leu10 in the  pleckstrin homology domain of the enzyme is crucial for catalytic  activity <9>; #6# the secondary hydroxy group is not required for  substrate recognition, preference for the D-erythro isomer, the enzyme  is specific for th phosphorylation of the 1-hydroxy group <14>)  "
2.7.1.14, ATP + sedoheptulose = ADP + sedoheptulose 7-phosphate  
2.7.1.140," ATP + 1D-myo-inositol 1,3,4,6-tetrakisphosphate = ADP + 1D-myo-inositol  1,3,4,5,6-pentakisphosphate  "
2.7.1.142, sn-glycerol 3-phosphate + D-glucose = glycerol + D-glucose 6-phosphate  
2.7.1.143, diphosphate + a purine nucleoside = phosphate + a purine mononucleotide  
2.7.1.144," ATP + D-tagatose 6-phosphate = ADP + D-tagatose 1,6-bisphosphate (#8#  mechanism suggested <7>)  "
2.7.1.145," ATP + a 2'-deoxyribonucleoside = ADP + a 2'-deoxyribonucleoside  5'-phosphate (#1# compulsory ordered steady-state reaction mechanism  with formation of a ternary complex with the phosphate donor and  acceptor <2>; #2# positive cooperativity mechanism, substrate and  nucleotide interactions and binding sites, overview <10>; #5# straight  forward hyperbolic kinetic reaction mechanism following a compulsory  ordered steady-state reaction mechanism with formation of a ternary  complex, substrate interactions <10>; #5# substrate binding and  interactions <16>)  "
2.7.1.146," ADP + D-fructose 6-phosphate = AMP + D-fructose 1,6-bisphosphate  "
2.7.1.147," ADP + D-glucose = AMP + D-glucose 6-phosphate (#11# reaction mechanism,  the catalytic base Asp451 is essential <9>) "
2.7.1.147, ADP + D-glucosamine = AMP + D-glucosamine 6-phosphate  
2.7.1.148," ATP + 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol = ADP +  2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol (#2#  reaction mechanism <5>; #1# reaction mechanism involves K8 and D125  <4>; #5,6# catalyzes the fourth step of 2-C-methyl-D-erythritol  4-phosphate pathway <9>)  "
2.7.1.149," ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP +  1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate  "
2.7.1.15, ATP + D-ribose = ADP + D-ribose 5-phosphate  
2.7.1.150," ATP + 1-phosphatidyl-1D-myo-inositol 3-phosphate = ADP +  1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate  "
2.7.1.151," ATP + 1D-myo-inositol 1,4,5-trisphosphate = ADP + 1D-myo-inositol  1,4,5,6-tetrakisphosphate (#10# the catalytic site contains an  important Ser-Ser-Leu-Leu motif <9>) "
2.7.1.151," ATP + 1D-myo-inositol 1,4,5,6-tetrakisphosphate = ADP + 1D-myo-inositol  1,3,4,5,6-pentakisphosphate (#10# the catalytic site contains an  important Ser-Ser-Leu-Leu motif <9>)  "
2.7.1.153," ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP +  1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate  "
2.7.1.154," ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP +  1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate  "
2.7.1.156," RTP + adenosylcobinamide = adenosylcobinamide phosphate + RDP [where  RTP is either ATP or GTP] (#1# bifunctional enzyme showing  adenosylcobinamide kinase and adenosylcobinamide-phosphate  guanylyltransferase activities <7>; #1# Aminopropanol side chain of the  corrin cobinamide is activated by the addition of GDP. Synthesis of the  coenzyme pseudo-B12 cofactors requires the same enzymes (e.g. CobU)  which install 5,6-dimethylbenzimidazole in the formation of coenzyme  B12 <9>)  "
2.7.1.157," ATP + N-acetyl-alpha-D-galactosamine = ADP +  N-acetyl-alpha-D-galactosamine 1-phosphate (#1# ATP hydrolysis and  methanolysis reaction pathways, overview <5>; #1# ordered ternary  complex reaction mechanism, in which ATP binds first, overview.  Ionizable residues play a role in substrate binding and catalysis <6>)  "
2.7.1.158," ATP + 1D-myo-inositol 1,3,4,5,6-pentakisphosphate = ADP +  1D-myo-inositol hexakisphosphate  "
2.7.1.159," ATP + 1D-myo-inositol 1,3,4-trisphosphate = ADP + 1D-myo-inositol  1,3,4,5-tetrakisphosphate "
2.7.1.159," ATP + 1D-myo-inositol 1,3,4-trisphosphate = ADP + 1D-myo-inositol  1,3,4,6-tetrakisphosphate "
2.7.1.159," ATP + 1D-myo-inositol-1,3,4-trisphosphate = ADP +  1D-myo-inositol-1,3,4,5-tetrakisphosphate (#12# determination of  substrate binding sites, catalytic reaction mechanism <9>) "
2.7.1.159," ATP + 1D-myo-inositol-1,3,4-trisphosphate = ADP +  1D-myo-inositol-1,3,4,6-tetrakisphosphate (#12# determination of  substrate binding sites, catalytic reaction mechanism <9>)  "
2.7.1.16, ATP + L(or D)-ribulose = ADP + L(or D)-ribulose 5-phosphate  
2.7.1.160," 2'-phospho-[ligated tRNA] + NAD+ = mature tRNA + ADP-ribose  1'',2''-phosphate + nicotinamide  "
2.7.1.161, CTP + riboflavin = CDP + FMN  
2.7.1.162," ATP + N-acetyl-D-hexosamine = ADP + N-acetyl-alpha-D-hexosamine  1-phosphate (#4# enzyme acts by a sequential bi bi (two substrates-two  products) mechanism, with the reaction occurring after the binding of  both ATP and N-acetylhexosamine <1>; #4# openÂ–close conformational  change at the active site, structure overview <7>; #2,4# regio- and  stereoselectivity, catalytic mechanism, structure-function analysis,  overview. Nucleophilic attack on the gamma-phosphate atom in a  bond-breaking/bond formation manner of transfer (an SN2-like reaction).  The carboxyl group of residue Asp208 within hydrogen-bond distance of  C1 OH of GlcNAc/GalNAc is likely to serve as the active-site general  base <6>; #5# the N-acetylhexosamine 1-kinase shows a concerted  mechanism of two-magnesium-ion-assisted GlcNAc phosphorylation,  flexibility behavior of lid motif upon substrate recognition, and  water-assisted GlcNAc-1-P release <10>)  "
2.7.1.163, ATP + hygromycin B = ADP + 7''-O-phosphohygromycin B 
2.7.1.163, ATP + hygromycin B = ADP + 4-O-phosphohygromycin B  
2.7.1.164, ATP + L-seryl-tRNASec = ADP + O-phospho-L-seryl-tRNASec  
2.7.1.165, ATP + D-glycerate = ADP + 2-phospho-D-glycerate  
2.7.1.166, alpha-Kdo-(2->6)-lipid IVA + ATP = 4-O-phospho-alpha-Kdo-(2->6)-lipid  IVA + ADP (#3# (KDO)-lipid IV(A) =  3-deoxy-alpha-D-manno-oct-2-ulopyranosyl-(2->6)-2-deoxy-2-[[(3R)-3  hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O  phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose. (4-O-phospho-KDO)-lipid IV(A) =  3-deoxy-4-O-phosphono-alpha-D-manno-oct-2-ulopyranosyl-(2->6)-2-deoxy-2  [[(3R)-3-hydroxypentadecanoyl]amino]-3-O-[(3R)-3-hydroxytetradecanoyl]  4-O-phosphono-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3  hydroxytetradecanoyl]-2-[[(3R)-3-hydroxytetradecanoyl]amino]-1-O  phosphono-alpha-D-glucopyranose <4>)  
2.7.1.167," D-glycero-beta-D-manno-heptose 7-phosphate + ATP =  D-glycero-beta-D-manno-heptose 1,7-bisphosphate + ADP  "
2.7.1.168," D-glycero-alpha-D-manno-heptose 7-phosphate + ATP =  D-glycero-alpha-D-manno-heptose 1,7-bisphosphate + ADP  "
2.7.1.169, ATP + (R)-pantoate = ADP + (R)-4-phosphopantoate  
2.7.1.17, ATP + D-xylulose = ADP + D-xylulose 5-phosphate  
2.7.1.170," ATP + 1,6-anhydro-N-acetyl-beta-muramate + H2O = ADP + N-acetylmuramate  6-phosphate (#3,4# catalytic mechanism, molecular docking, dynamics  simulation <6>; #2# reaction mechanism, structure-function analysis,  overview. A one-step catalytic mechanism is proposed that involves  attack of water at the anomeric center leading to cleavage of the  1,6-anhydro ring and phosphoryl transfer. The reaction inverts the  anomeric center of MurNAc. Transient formation of an intermediate  (MurNAc) in a two-step mechanism may also be possible. It is also  possible that the gamma-phosphate leaves the ATP as a transient  metaphosphate prior to the anhydro-bond cleavage <5>; #2# the oxygen of  1,6-anhydro-N-acetyl-beta-muramate, that is to be phosphorylated, is  trapped in the anhydro ring structure and must first be cleaved prior  to phosphorylation. In order to do this, Asp182 is predicted to act as  a base to deprotonate a water molecule and enhance its nucleophilicity.  The water would then attack the anomeric carbon of the sugar  concomitant with transfer of the gamma-phosphate of ATP. The lone pair  electrons from the O5 position would assume partial double-bond  characteristics and stabilize the oxocarbenium ion that would otherwise  develop, with the anomeric carbon adopting an axial conformation in the  product acetylmuramate 6-phosphate, catalytic role of the conserved  residue Asp182 residue in catalysis <4>)  "
2.7.1.171, ATP + [protein]-N6-D-fructosyl-L-lysine = ADP +  [protein]-N6-(3-O-phospho-D-fructosyl)-L-lysine (#3# phosphorylation  destablilizes the fructoselysine adduct and leads to its spontaneous  decomposition <10>)  
2.7.1.172, ATP + [protein]-N6-D-ribulosyl-L-lysine = ADP +  [protein]-N6-(3-O-phospho-D-ribulosyl)-L-lysine  
2.7.1.173," ATP + beta-D-ribosylnicotinate = ADP + nicotinate beta-D-ribonucleotide  (#4# catalytic mechanism, overview <1>)  "
2.7.1.174," CTP + 1,2-diacyl-sn-glycerol = CDP + 1,2-diacyl-sn-glycerol 3-phosphate  "
2.7.1.175," ATP + maltose = ADP + alpha-maltose 1-phosphate (#7# substrate binding  structures and catalytic mechanism, overview <7>)  "
2.7.1.176, ATP + UDP-N-acetyl-alpha-D-glucosamine = ADP +  UDP-N-acetyl-alpha-D-glucosamine 3'-phosphate  
2.7.1.177, ATP + L-threonine = ADP + O-phospho-L-threonine (#2# steady-state  ordered BiBI mechanism <1>)  
2.7.1.178, ATP + 2-dehydro-3-deoxy-D-gluconate = ADP +  2-dehydro-3-deoxy-6-phospho-D-gluconate (#2# (1) <4>) 
2.7.1.178, ATP + 2-dehydro-3-deoxy-D-galactonate = ADP +  2-dehydro-3-deoxy-6-phospho-D-galactonate (#2# (2) <4>)  
2.7.1.179, ATP + kanosamine = ADP + kanosamine 6-phosphate  
2.7.1.18," ATP + D-ribose 5-phosphate = ADP + alpha-D-ribose 1,5-bisphosphate  "
2.7.1.180," FAD + [protein]-L-threonine = [protein]-FMN-L-threonine + AMP (#9# in  the random Bi Bi kinetic mechanism of ApbE reaction, His257 acts as a  general base that deprotonates the acceptor residue, which subsequently  performs a nucleophilic attack on FAD for flavin transfer <6>)  "
2.7.1.181," ATP +  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man  (1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha  D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans  octacis-undecaprenol = ADP +  3-O-phospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)  alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man  (1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho  ditrans,octacis-undecaprenol  "
2.7.1.182, CTP + phytol = CDP + phytyl phosphate  
2.7.1.183, ATP +  O3-[N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl  (1->4)-alpha-D-mannosyl]-L-threonyl/L-seryl-[protein] = ADP +  O3-[N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl  (1->4)-alpha-D-(6-phospho)mannosyl]-L-threonyl/L-seryl-[protein]  
2.7.1.184, ATP + 6-deoxy-6-sulfo-D-fructose = ADP + 6-deoxy-6-sulfo-D-fructose  1-phosphate  
2.7.1.185," ATP + (R)-mevalonate = ADP + (R)-3-phosphomevalonate (#1# catalytic  mechanism of this rare type of decarboxylase, the enzyme is  bifunctional showing the reactions of diphosphomevalonate decarboxylase  (EC 4.1.1.33) and mevalonate 3-kinase (EC 2.7.1.185), overview <6>)  "
2.7.1.186," ATP + (R)-3-phosphomevalonate = ADP + (R)-3,5-bisphosphomevalonate  "
2.7.1.187, ATP + acarbose = ADP + acarbose 7IV-phosphate  
2.7.1.188, ATP + 2-epi-5-epi-valiolone = ADP + 2-epi-5-epi-valiolone 7-phosphate  
2.7.1.189," ATP + (S)-4,5-dihydroxypentane-2,3-dione = ADP +  (S)-4-hydroxypentane-2,3-dione 5-phosphate (#4# apid equilibrium  ordered mechanism with ATP binding first <5>)  "
2.7.1.19," ATP + D-ribulose 5-phosphate = ADP + D-ribulose 1,5-bisphosphate (#3,8#  mechanism <34>)  "
2.7.1.190," GTP + gentamicin = GDP + gentamicin 2''-phosphate (#2# mechanism of the  phosphorylation of aminoglycoside antibiotics by APH(2) enzymes,  detailed overview <9>; #3# the reaction of APH(2)-IVa proceeds by a  Bi-Bi mechanism in which aminoglycoside and ATP or GTP bind randomly  <11>)  "
2.7.1.191, [protein]-Npi-phospho-L-histidine + D-mannose[side 1] =  [protein]-L-histidine + D-mannose 6-phosphate[side 2]  
2.7.1.192, [protein]-Npi-phospho-L-histidine + N-acetyl-D-muramate[side 1] =  [protein]-L-histidine + N-acetyl-D-muramate 6-phosphate[side 2]  
2.7.1.193, [protein]-Npi-phospho-L-histidine + N-acetyl-D-glucosamine[side 1] =  [protein]-L-histidine + N-acetyl-D-glucosamine 6-phosphate[side 2]  
2.7.1.194, [protein]-Npi-phospho-L-histidine + L-ascorbate[side 1] =  [protein]-L-histidine + L-ascorbate 6-phosphate[side 2]  
2.7.1.195, [protein]-Npi-phospho-L-histidine +  2-O-(alpha-D-mannopyranosyl)-D-glycerate [side 1] =  [protein]-L-histidine +  2-O-(6-phospho-alpha-D-mannopyranosyl)-D-glycerate [side 2]  
2.7.1.196," [protein]-Npi-phospho-L-histidine + N,N'-diacetylchitobiose[side 1] =  [protein]-L-histidine + N,N'-diacetylchitobiose 6'-phosphate[side 2]  "
2.7.1.197, [protein]-Npi-phospho-L-histidine + D-mannitol[side 1] =  [protein]-L-histidine + D-mannitol 1-phosphate[side 2]  
2.7.1.198, [protein]-Npi-phospho-L-histidine + D-sorbitol[side 1] =  [protein]-L-histidine + D-sorbitol 6-phosphate[side 2]  
2.7.1.199, [protein]-Npi-phospho-L-histidine + D-glucose[side 1] =  [protein]-L-histidine + D-glucose 6-phosphate[side 2]  
2.7.1.2," ATP + D-glucose = ADP + D-glucose 6-phosphate (#9# ordered mechanism in  which glucose binds first and glucose 6-phosphate dissociates last <2>;  #21# catalytic mechanism, substrate D-glucose interacts with Asn99,  Asp100, Glu157, His160, and Glu187 <20>; #13,14# rapid  equilibrium-ordered bi bi sequential mechanism, formation of a ternary  complex of enzyme-D-glucose-MgATP2- <22>; #15# the enzyme activity  requires 3 cysteine residues C175, C177, and C182 within the motif  CXCGX(2)GCXE that discriminates microbial glucokinases into two  lineages <18>)  "
2.7.1.20," ATP + adenosine = ADP + AMP (#4,5,6# mechanism <9,11,13,20,22>; #5,6#  ordered bi bi mechanism <11,20>; #1# catalytic mechanism, substrate and  product binding involving Asp239, Glu242, Asp316, and Arg148 <52>; #22#  residues G62, D299, R69, and R131 are crucial for catalytic activity  <45>)  "
2.7.1.200, [protein]-Npi-phospho-L-histidine + galactitol[side 1] =  [protein]-L-histidine + galactitol 1-phosphate[side 2]  
2.7.1.201," [protein]-Npi-phospho-L-histidine + alpha,alpha-trehalose[side 1] =  [protein]-L-histidine + alpha,alpha-trehalose 6-phosphate[side 2]  "
2.7.1.202, [protein]-Npi-phospho-L-histidine + D-fructose[side 1] =  [protein]-L-histidine + D-fructose 1-phosphate[side 2]  
2.7.1.203, [protein]-Npi-phospho-L-histidine + 2-amino-2-deoxy-D-gluconate[side 1]  = [protein]-L-histidine + 2-amino-2-deoxy-D-gluconate 6-phosphate[side  2]  
2.7.1.204, [protein]-Npi-phospho-L-histidine + D-galactose[side 1] =  [protein]-L-histidine + D-galactose 6-phosphate[side 2]  
2.7.1.205, [protein]-Npi-phospho-L-histidine + cellobiose[side 1] =  [protein]-L-histidine + 6-phospho-beta-D-glucosyl-(1->4)-D-glucose[side  2]  
2.7.1.206, [protein]-Npi-phospho-L-histidine + L-sorbose[side 1] =  [protein]-L-histidine + L-sorbose 1-phosphate[side 2]  
2.7.1.207, [protein]-Npi-phospho-L-histidine + lactose[side 1] =  [protein]-L-histidine + lactose 6'-phosphate[side 2]  
2.7.1.208, [protein]-Npi-phospho-L-histidine + maltose[side 1] =  [protein]-L-histidine + maltose 6'-phosphate[side 2]  
2.7.1.209, ATP + L-erythrulose = ADP + L-erythrulose 1-phosphate  
2.7.1.21," ATP + thymidine = ADP + dTMP (#3# mechanism <20>; #24,43,46# active  site structure <65>; #42# active site structure, E98 is involved in  catalysis <65>; #28# active site structure, substrate binding  structures <66>; #62# molecular docking of substrates and inhibitors,  active site structure modeling <61>; #22,42# substrate binding and  active site structure <67>; #45# substrate binding site structures,  structural basis for substrate specificity and activity <68>; #26# the  amino acid residues at positions 51, 83, and 185 are important for  enzyme activity <58>)  "
2.7.1.210, ATP + D-erythrulose = ADP + D-erythrulose 4-phosphate  
2.7.1.211, [protein]-Npi-phospho-L-histidine + sucrose[side 1] =  [protein]-L-histidine + sucrose 6G-phosphate[side 2]  
2.7.1.212," ADP + alpha-D-ribose 1-phosphate = AMP + alpha-D-ribose 1,5-bisphosphate  "
2.7.1.213, ATP + cytidine = ADP + CMP  
2.7.1.214, ATP + valienone = ADP + valienone 7-phosphate 
2.7.1.214, ATP + validone = ADP + validone 7-phosphate  
2.7.1.215, ATP + erythritol = ADP + D-erythritol 1-phosphate  
2.7.1.216," CTP + (2E,6E)-farnesol = CDP + (2E,6E)-farnesyl phosphate  "
2.7.1.217, ATP + 3-dehydro-L-erythronate = ADP + 3-dehydro-4-phospho-L-erythronate 
2.7.1.217, ATP + 3-dehydro-D-erythronate = ADP + 3-dehydro-4-phospho-D-erythronate  
2.7.1.218, ATP + N6-(D-fructosyl)-L-lysine = ADP +  N6-(6-phospho-D-fructosyl)-L-lysine  
2.7.1.219, ATP + D-threonate = ADP + 4-phospho-D-threonate  
2.7.1.22," ATP + 1-(beta-D-ribofuranosyl)-nicotinamide = ADP + beta-nicotinamide  D-ribonucleotide (#3,6,7# enzyme has both ribosylnicotinamide kinase,  i.e. EC 2.7.1.22, and nicotinamide mononucleotide adenylyltransferase,  i.e. EC 2.7.7.18, activity <3>; #6# bifunctional enzyme exhibiting  nicotinamide ribose kinase activity, EC 2.7.1.22, and weak  adenylyltransferase activity, EC 2.7.7.1 <4>)  "
2.7.1.220, ATP + D-erythronate = ADP + 4-phospho-D-erythronate  
2.7.1.221, ATP + N-acetyl-D-muramate = ADP + N-acetyl-alpha-D-muramate 1-phosphate  
2.7.1.222, ATP + 4-hydroxytryptamine = ADP + 4-hydroxytryptamine 4-phosphate  
2.7.1.223, ATP + 5-amino-1-(beta-D-ribosyl)imidazole = ADP +  5-amino-1-(5-phospho-beta-D-ribosyl)imidazole  
2.7.1.224, ATP + cytidine 5'-diphosphoramidate = ADP + cytidine  3'-phospho-5'-diphosphoramidate  
2.7.1.225, ATP + L-serine = ADP + O-phospho-L-serine  
2.7.1.226, ADP + L-serine = AMP + O-phospho-L-serine  
2.7.1.227," 1-phosphatidyl-1D-myo-inositol + a very-long-chain  (2'R)-2'-hydroxyphytoceramide = 1,2-diacyl-sn-glycerol + a  very-long-chain inositol phospho-(2'R)-2'-hydroxyphytoceramide  "
2.7.1.228," 1-phosphatidyl-1D-myo-inositol + a very-long-chain mannosylinositol  phospho-(2'R)-2'-hydroxyphytoceramide = 1,2-diacyl-sn-glycerol + a  very-long-chain mannosyl-diphosphoinositol-(2'R)-2'-hydroxyphytoceramide  "
2.7.1.229, ATP + 2-deoxy-D-ribose = ADP + 2-deoxy-D-ribose 5-phosphate  
2.7.1.23," ATP + NAD+ = ADP + NADP+ (#9# sequential mechanism <10>; #12# isoenzyme  1: ping-pong mechanism. Isoenzyme 2: sequential mechanism <17>; #45#  sequential addition of substrates <24>; #65# AMP portion of ATP uses  the same binding site as the nicotinamide ribose portion of NAD/NADP,  proposal for phosphate transfer mechanism <38>; #48# NAD+-binding mode  and intersubunit contact <31>)  "
2.7.1.230, ATP + amicoumacin A = ADP + amicoumacin A 2-phosphate  
2.7.1.231, ATP + 3-oxoisoapionate = ADP + 3-oxoisoapionate 4-phosphate  
2.7.1.232," ATP + 1,6-anhydro-beta-D-glucopyranose + H2O = ADP +  6-phospho-alpha-D-glucopyranose (#2,4# catalytic mechanism, molecular  docking, dynamics simulation <4>; #10# mechanism of 1,6-anhydro bond  cleavage, the enzyme binds levoglucosan in two distinct orientations,  in addition to cleavage of the 1,6-anhydro ring, the pyranose ring of  the levoglucosan is opened when the anomeric carbon of levoglucosan  migrates from its position in a 1C4 to a 4C1 conformation, increased  conformational strain during this reaction results in the linear form  of G6P as the initial product, which then equilibrates to a mixture of  both anomeric forms, structure-function analysis, detailed overview  <3>; #3,4# the catalytic mechanism involves both cleavage of the  1,6-intramolecular linkage as well as phosphorylation <2>) "
2.7.1.232, ATP + levoglucosan + H2O = ADP + D-glucose 6-phosphate  
2.7.1.233, ATP + apulose = ADP + apulose 4-phosphate  
2.7.1.234," ATP + D-tagatopyranose 1-phosphate = ADP + D-tagatofuranose  1,6-bisphosphate  "
2.7.1.235, ATP + an  alpha-Hep-(1->3)-alpha-Hep-(1->5)-[alpha-Kdo-(2->4)]-alpha-Kdo-(2->6)  [lipid A] = ADP + an  alpha-Hep-(1->3)-4-O-phospho-alpha-Hep-(1->5)-[alpha-Kdo-(2->4)]-alpha  Kdo-(2->6)-[lipid A]  
2.7.1.24," ATP + 3'-dephospho-CoA = ADP + CoA (#2,16# active site, mechanism  <14,15>)  "
2.7.1.25," ATP + adenylyl sulfate = ADP + 3'-phosphoadenylyl sulfate (#4,9#  mechanism <7,12,13>; #21# enzyme follows a compulsory ordered mechanism  in which MgATP2- binds before APS, and PAPS leaves before MgADP- <30>;  #4# kinetic scheme for APS kinase <25>)  "
2.7.1.26," ATP + riboflavin = ADP + FMN (#5# ordered bi bi mechanism in which  riboflavin binds first followed by ATP. ADP is released first followed  by FMN <5>; #16# ordered reaction mechanism, FMN binding o the binary  enzyme-MgADP complex induces important conformational changes <23>)  "
2.7.1.27, ATP + erythritol = ADP + D-erythritol 4-phosphate  
2.7.1.28, ATP + D-glyceraldehyde = ADP + D-glyceraldehyde 3-phosphate  
2.7.1.29," ATP + glycerone = ADP + glycerone phosphate (#8# covalent  substrate-binding and random bi bi kinetic mechanism <10>; #1,8#  nucleotide binding structure, mechanism, and function, overview <12>;  #16# substrates and products are bound in hemiaminal linkage to the  active site histidine, thereby not activating the cataltically reacting  hydroxyl group <10>; #22# reaction mechanism analysis using hybrid  quantum mechanics/molecular mechanics (QM/MM). Asp-assisted mechanism  for the phosphorylation reaction from I2 to PAsp, and  substrate-assisted mechanism, overview <27>)  "
2.7.1.3, ATP + D-fructose = ADP + D-fructose 1-phosphate (#7# random kinetic  mechanism with the formation of two dead-end complexes <6>)  
2.7.1.30," ATP + glycerol = ADP + sn-glycerol 3-phosphate (#14# mechanism <37>;  #1,60# ping-pong mechanism <4,7>; #29# random bi bi mechanism <3>;  #14,16# ordered mechanism <2>; #68# fructose 1,6-diphosphate regulates  equilibrium of dimer-tetramer, mechanism of inhibition <31>; #14#  ordered mechanism with glycerol as the first substrate to bind <26>;  #58# ordered bi bi mechanism with glycerol adding before the magnesium  nucleotide and L-glycerol 3-phosphate are released <20>; #72,81# the  structure of the TGK-pNPP complex, and structure-guided mutagenesis  implicate that enzyme residue T276 is important for the catalysis. The  enzyme is a bifunctional kinase/phosphatase. Proposed catalytic  mechanism for the phosphatase activity of TbgGK <86>)  "
2.7.1.31, ATP + D-glycerate = ADP + 3-phospho-D-glycerate (#7# sequential random  mechanism <9>; #15# sequential binding of substrates <5>)  
2.7.1.32," ATP + choline = ADP + phosphocholine (#8# random bi-bi mechanism <17>;  #1,3,5,7,23,28,29,30,31# choline kinase and ethanolamine kinase are 2  distinct enzymes <2,3,5>; #18# forward reaction: ordered mechanism with  MgATP2- binding first, followed by choline <20>; #7# ethanolamine  kinase II and choline kinase do not use a common active site <4>; #7#  forward reaction follows a sequentially ordered mechanism <28>; #7#  choline kinase and ethanolamine kinase may not have a common active  site in a single enzyme protein <1>; #9# choline kinase and  ethanolamine kinase activities are mediated by 2 distinct active sites,  possibly on a single protein <10>; #8# sequential bi bi reaction <33>;  #8# choline kinase and ethanolamine kinase are identical <30>; #7,21#  choline kinase and ethanolamine kinase activities reside on the same  protein and occur at the same active site <24,25>; #37# reaction  mechanism of choline kinase alpha, overview <99>)  "
2.7.1.33," ATP + (R)-pantothenate = ADP + (R)-4'-phosphopantothenate (#3# bi bi  mechanism <13>; #40# active site structure, mechanism, pantothenate  binding site structure, the reaction proceeds by a concerted mechanism  that involves a dissociative transition state, although the negative  charge neutralization of the gamma-phosphate by Arg243, Lys101, and  Mg2+ coupled with hydrogen bonding of the C1 of pantothenate to Asp127  suggests different interpretations of the phosphoryl transfer mechanism  of pantothenate kinase <22>)  "
2.7.1.34, ATP + pantetheine = ADP + pantetheine 4'-phosphate  
2.7.1.35, ATP + pyridoxal = ADP + pyridoxal 5'-phosphate (#13# mechanism <30>)  
2.7.1.36," ATP + (R)-mevalonate = ADP + (R)-5-phosphomevalonate (#8,15# sequential  mechanism <3,34>; #35# catalytic reaction mechanism, substrate binding  structure involves key residue His25 in a deep cavity lined by highly  conserved residues, Lys18, Asp155, Val202, and Thr283 are involved in  catalysis <35>; #6# role for residue E193 in interacting with the  cation of the MgATP substrate, and for D204 as the catalytic base that  facilitates deprotonation of the C5 hydroxyl of mevalonic acid <59>)  "
2.7.1.39, ATP + L-homoserine = ADP + O-phospho-L-homoserine (#8# rapid  equilibrium random bi bi mechanism <7>; #1# ordered random mechanism  with ATP preferentially binding before L-homoserine <4>; #17# the  catalytic mechanism of the enzyme does not involve a catalytic base for  activating the phosphoryl acceptor hydroxyl but instead is mediated via  a transition state stabilization mechanism <16>; #19# possible  catalytic mechanism of leishmanial homoserine kinase from molecular  simulations <31>)  
2.7.1.4, ATP + D-fructose = ADP + D-fructose 6-phosphate  
2.7.1.40," ATP + pyruvate = ADP + phosphoenolpyruvate (#6,23,32,49,69,70,92#  mechanism <5,92>; #69# compulsory-ordered tri-bi mechanism <100>; #104#  model for allosteric regulation <91>; #121,122# allosteric enzyme <98>;  #16,18,36# allosteric enzyme: homotropic <73,74,75>; #12# hyperbolic  kinetics <96>; #119# sigmoidal kinetics with respect to  phosphoenolpyruvate <93>; #52# catalyzes the addition of a proton and  the loss of a phosphoryl group which is transferred to ADP <48>; #98#  sigmoidal saturation curves with substrate and metal ions <89>; #141#  modeling of the catalytic mechanism, overview <248>; #150# the kinetic  mechanism is random order with a rapid equilibrium <255>)  "
2.7.1.41," 2 D-glucose 1-phosphate = D-glucose + D-glucose 1,6-bisphosphate  "
2.7.1.42, alpha-D-glucose 1-phosphate + riboflavin = D-glucose + FMN  
2.7.1.43, ATP + D-glucuronate = ADP + 1-phospho-alpha-D-glucuronate  
2.7.1.44, ATP + D-galacturonate = ADP + 1-phospho-alpha-D-galacturonate  
2.7.1.45," ATP + 2-dehydro-3-deoxy-D-gluconate = ADP +  2-dehydro-3-deoxy-6-phospho-D-gluconate (#1# active site structure,  substrate binding structure involving amino acid residues L11, G34,  A35, N38, Y89, Y103, R105, I134, R167, V247, E251, and E287,  2-dehydro-3-deoxy-D-gluconate is recognized as an open chain structure,  catalytic mechanism, Arg167 and Asp251 play a role in transferring the  gamma-phosphate of ATP to the 5-hydroxyl group of  2-dehydro-3-deoxy-D-gluconate <4>; #10# reaction is initiated by the  deprotonation of the hydroxyl group of the substrate by the catalytic  base Asp280. A nucleophilic attack on the gamma-phosphate of ATP by the  negatively charged hydroxyl group generates the transition state  intermediate <7>)  "
2.7.1.46, ATP + L-arabinose = ADP + beta-L-arabinose 1-phosphate  
2.7.1.47, ATP + D-ribulose = ADP + D-ribulose 5-phosphate (#1# random bi bi  reaction mechanism <2>)  
2.7.1.48," ATP + uridine = ADP + UMP (#5,8# ping-pong mechanism <6,9>; #1#  sequential mechanism <10>; #1# sequential addition of both substrates  to the enzyme to form a ternary complex <13>) "
2.7.1.48, ATP + cytidine = ADP + CMP  
2.7.1.49," ATP + 4-amino-5-hydroxymethyl-2-methylpyrimidine = ADP +  4-amino-2-methyl-5-(phosphooxymethyl)pyrimidine (#13,14# ordered  sequential mechanism <17>)  "
2.7.1.5, ATP + L-rhamnulose = ADP + L-rhamnulose 1-phosphate  
2.7.1.50," ATP + 4-methyl-5-(2-hydroxyethyl)thiazole = ADP +  4-methyl-5-(2-phosphooxyethyl)thiazole (#1# catalytic mechanism of  phosphoryl transfer reaction and role of active site residues, e.g.  R121 and C198, calculated on the basis of data on crystal structures of  ribokinase-like kinases, transition state stabilization involves an  oxyanion hole and a magnesium ion <4>; #5# SN2-like mechanism, with  gamma-phosphate acting as an alcohol-activation base. Mg2+ ion 2,  residues E126 and C198 play a major catalytic role, whereas Mg2+ ion 1  and C198 are responsible for product release <6>)  "
2.7.1.51, ATP + L-fuculose = ADP + L-fuculose 1-phosphate  
2.7.1.52, ATP + L-fucose = ADP + beta-L-fucose 1-phosphate (#3# the mechanism  involves anomeric oxygen retention <4>)  
2.7.1.53, ATP + L-xylulose = ADP + L-xylulose 5-phosphate  
2.7.1.54, ATP + D-arabinose = ADP + D-arabinose 5-phosphate  
2.7.1.55, ATP + D-allose = ADP + D-allose 6-phosphate  
2.7.1.56," ATP + D-fructose 1-phosphate = ADP + D-fructose 1,6-bisphosphate  "
2.7.1.58, ATP + 2-dehydro-3-deoxy-D-galactonate = ADP +  2-dehydro-3-deoxy-6-phospho-D-galactonate  
2.7.1.59, ATP + N-acetyl-D-glucosamine = ADP + N-acetyl-D-glucosamine 6-phosphate  
2.7.1.6, ATP + alpha-D-galactose = ADP + alpha-D-galactose 1-phosphate (#6# the  most likely kinetic mechanism is an ordered ternary complex in which  ATP is the first substrate to bind <25>; #11# mechanism of D-galactose  and nucleotide binding <31>; #12# mechanism of the reaction is  sequential in both directions. Residue Asp183 acts as a catalytic base  that deprotonates the C1 hydroxyl group of galactose. The pH-kcat  profile of the synthesis of galactose 1-phosphate has a pKa of 6.9  likely due to Asp183. The pH-kcat/KGal profile of the reverse reaction  lacks a key pKa required for a direct proton transfer mechanism. Arg36  may lower the pKa of the C1 hydroxyl to facilitate deprotonation <48>)  
2.7.1.60, ATP + N-acyl-D-mannosamine = ADP + N-acyl-D-mannosamine 6-phosphate  
2.7.1.61, acyl phosphate + D-hexose = a carboxylate + D-hexose phosphate (#1#  rapid equilibrium random bi bi mechanism <3>)  
2.7.1.62, phosphoramidate + D-hexose = NH3 + alpha-D-hexose 1-phosphate  
2.7.1.63," (phosphate)n + D-glucose = (phosphate)n-1 + D-glucose 6-phosphate (#4#  with long chain polyphosphates, the reaction proceeds by a processive  type mechanism, with short polyphosphates the mechanism is  nonprocessive <3>; #5# in the polyphosphate-dependent reaction the  enzyme follows an ordered bi bi sequential mechanism with polyphosphate  binding to the enzyme first and glucose 6-phosphate dissociating last.  The ATP-dependent glucokinase reaction is consistent with an ordered bi  bi sequential mechanism, with ATP binding to the enzyme first and  glucose 6-phosphate leaving last <9>; #6# glucose and phosphate  substrate binding site structures <14>)  "
2.7.1.64, ATP + myo-inositol = ADP + 1D-myo-inositol 3-phosphate  
2.7.1.65, ATP + 1-amino-1-deoxy-scyllo-inositol = ADP +  1-amino-1-deoxy-scyllo-inositol 4-phosphate  
2.7.1.66, ATP + undecaprenol = ADP + undecaprenyl phosphate  
2.7.1.67," ATP + 1-phosphatidyl-1D-myo-inositol = ADP +  1-phosphatidyl-1D-myo-inositol 4-phosphate (#7# sequential reaction  mechanism <18,36>; #7# sequential bi-bi reaction mechanism.  Phosphatidylinositol binds prior to ATP, and phosphatidylinositol  4-phosphate is the first product released in the reaction <8>)  "
2.7.1.68," ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP +  1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate (#1,2# an activation  loop spanning the catalytic domain is responsible for determination of  both substrate specificity and subcellular targeting <39>)  "
2.7.1.7," ATP + D-mannose = ADP + D-mannose 6-phosphate (#4# sequential bi-bi  mechanism with two dead-end ternary complexes <5>; #6# mechanism,  enzyme shows both mannokinase and glucokinase activities <2>)  "
2.7.1.71," ATP + shikimate = ADP + 3-phosphoshikimate (#14# the enzyme binds  substrates randomly and in a synergistic fashion <22>; #9# phosphoryl  transfer mechanism of shikimate kinase, overview <37>)  "
2.7.1.72, ATP + streptomycin = ADP + streptomycin 6-phosphate  
2.7.1.73, ATP + inosine = ADP + IMP (#2# ordered bi bi mechanism in which  guanosine is the first substrate to bind and GMP is the last product to  be released <7>)  
2.7.1.74," NTP + deoxycytidine = NDP + dCMP (#3,9# mechanism <15,25,31,43>; #3#  random bi-bi mechanism <38>; #3# ordered A-B random B-Q reaction  sequence <31>; #3# active site structure, substrate binding structure  simulation and analysis <49>; #11# substrate-enzyme interactions, bi bi  random reaction mechanism with ATP, but ordered with UTP binding before  the acceptor substrate, substrate binding site structures <50>)  "
2.7.1.76, ATP + 2'-deoxyadenosine = ADP + dAMP (#10# random sequential substrate  addition <8>)  
2.7.1.77, a nucleotide + a 2'-deoxyribonucleoside = a nucleoside + a  2'-deoxyribonucleoside 5'-phosphate (#4# ping pong kinetics <6>)  
2.7.1.78," ATP + 5'-dephospho-DNA = ADP + 5'-phospho-DNA (#9,16# reaction  mechanism <21,27>; #4# random reaction mechanism <6>; #9# structure of  the active sites for 5-polynucleotide kinase and 3phosphatase activity  of the bifunctional enzyme, substrate binding mechanism <27>; #9# 5  amino acids, Lys15, Ser116, Asp35, Arg38, and Arg126, comprise the  5-kinase active site, structure-activity relationships <25>; #4# random  order sequential mechanism <14>; #3# mechanism involves a ternary  complex of enzyme, ATP and DNA <29>; #25# Asp38, as general base,  activates the polynucleotide 5-OH for its nucleophilic attack on the  gamma phosphorus and Lys21 and Mg2+ stabilize the transition state,  catalytic mechanism, overview <50>)  "
2.7.1.79, diphosphate + glycerol = phosphate + glycerol 1-phosphate (#1# may be  identical with EC 3.1.3.9 <1>)  
2.7.1.8, ATP + D-glucosamine = ADP + D-glucosamine 6-phosphate  
2.7.1.80, diphosphate + L-serine = phosphate + O-phospho-L-serine (#1# binary or  ping-pong mechanism <1>)  
2.7.1.81, GTP + 5-hydroxy-L-lysine = GDP + 5-phosphooxy-L-lysine  
2.7.1.82," ATP + ethanolamine = ADP + O-phosphoethanolamine  (#1,2,4,6,13,15,17,21,22,23,24# choline kinase and ethanolamine kinase  are 2 distinct enzymes <3,4,6,9>; #6# ethanolamine kinase II and  choline kinase do not use a common active site <5>; #6# choline kinase  and ethanolamine kinase may not have a common active site in a single  enzyme protein <2>; #8# choline kinase and ethanolamine kinase  activities are mediated by 2 distinct active sites, possibly on a  single protein <8>; #6# major part of choline kinase and ethanolamine  kinase activities are catalyzed by the same enzyme <11>)  "
2.7.1.83, ATP + pseudouridine = ADP + pseudouridine 5'-phosphate  
2.7.1.84, ATP + O-alkylglycerone = ADP + O-alkylglycerone phosphate  
2.7.1.85, ATP + cellobiose = ADP + 6-phospho-beta-D-glucosyl-(1->4)-D-glucose  
2.7.1.86, ATP + NADH = ADP + NADPH  
2.7.1.87, ATP + streptomycin = ADP + streptomycin 3''-phosphate  
2.7.1.88," ATP + dihydrostreptomycin 6-phosphate = ADP + dihydrostreptomycin  3'alpha,6-bisphosphate  "
2.7.1.89, ATP + thiamine = ADP + thiamine phosphate  
2.7.1.90," diphosphate + D-fructose 6-phosphate = phosphate + D-fructose  1,6-bisphosphate (#1# mechanism <21>; #10# random bi bi mechanism <5>;  #12# rapid equilibrium random mechanism <15>; #10# Met249 plays a  critical role in the binding of fructose 6-phosphate and the  stabilization of the transition state <40>; #10# Arg423 and Tyr 420 are  involved in substrate binding and catalytic mechanism <42>; #25# random  terreactant or rapid equilibrium random bi-ter mechanism <12>)  "
2.7.1.91," ATP + a sphingoid base = ADP + a sphingoid base 1-phosphate  (#2,8,10,11,13# catalytic mechanism <33>; #3,8,15# overview on  regulation <17>; #21# Asp177 in C4 domain of isozyme SK1a is important  for sphingosine substrate recognition <35>; #4,5# catalytic mechanism,  the catalytic domain contains the C1-C5 sequence stretches and the  ATP-binding site <33>; #5# Lys103 is important in catalysis <36>)  "
2.7.1.92, ATP + 5-dehydro-2-deoxy-D-gluconate = ADP +  6-phospho-5-dehydro-2-deoxy-D-gluconate  
2.7.1.93, ATP + 1-O-alkyl-sn-glycerol = ADP + 1-O-alkyl-sn-glycerol 3-phosphate  
2.7.1.94, ATP + acylglycerol = ADP + acyl-sn-glycerol 3-phosphate  
2.7.1.95, ATP + kanamycin = ADP + kanamycin 3'-phosphate (#3# isoenzyme APH3-IIIa  follows a Theorell-Chance mechanism <7>)  
2.7.10.1," ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate  (#5# reaction mechanism <412>; #8# active site structure, activation  mechanism <421>; #5# regulation of enzyme activity involves the  activation loop, a polypeptide region outside the active site cleft,  which is reversibly phosphorylated <412>)  "
2.7.10.2," ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate  (#4# reaction mechanism <238>; #6# catalytic mechanism <379>; #4#  regulation of enzyme activity involves the activation loop, a  polypeptide region outside the active site cleft, which is reversibly  phosphorylated <237>; #6# structure-function relation ship, active site  structure, catalytic mechanism involving the catalytic base Asp386 and  enzyme regulation, overview <367>; #1,14# structure-function  relationship, active site structure, catalytic mechanism and enzyme  regulation, overview <367>; #6# substrate binding site involving  residues R279, R281, and R283, more distant residues S280, F382, S273,  and D276 are also important for activity <412>; #108# residue W1038 is  essential for catalytic activity <429>)  "
2.7.10.3, ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate  
2.7.11.1," ATP + a protein = ADP + a phosphoprotein (#19# active site structure  <427>; #6# active site and activation loop structure and conformation,  Lys233, Cys250, Asp368, and Thr386 are important for activity, the  substrate binding groove determines the substrate specificity via  residues Val318 and Ala448 <452>; #1,4,5,6,9,15,17,30# catalytic  mechanism and regulation of PKN <425>; #9# glycogen synthase  kinase-3beta also performs the tau-protein kinase reaction, EC  2.7.11.26 <426>; #19# Lys45 is important for PknH catalytic and  autophosphorylation activity <423>; #311# the enzyme shows  Mn2+-dependent serine/threonine kinase and Ca2+-dependent histidine  kinase, EC 2.7.13.3, activities <448>; #5# the CK1 family shows a  strong preference both in vitro and in vivo for primed,  pre-phosphorylated substrates. CK1 family members prefer acidic  substrates in vitro, most notably those with acidic residues in the N-3  position, e.g. D-X-X-S/T. The most effective motif contains a  phospho-residue in the N-3 position, such as pS/pT-X-X-S/T, where pS/pT  refers to a phospho-serine or phospho-threonine, X refers to any amino  acid, and the underlined residues refer to the target site <524>)  "
2.7.11.10, ATP + [IkB protein] = ADP + [IkB phosphoprotein] 
2.7.11.10, ATP + [IkappaB protein] = ADP + [IkappaB phosphoprotein] (#2#  activation and reaction mechanism <29>)  
2.7.11.11," ATP + a protein = ADP + a phosphoprotein (#8# catalytic mechanism <52>;  #12# activation mechanism <49,90>; #5# activation involves the  activation loop, a polypeptide region outside the active site cleft,  which is reversibly phosphorylated at Thr197, phosphorylation leads to  enzyme inhibition, activation mechanism, overview <4>; #6# active site  residues and structure, mechanism of ligand binding and ligand-induced  conformational changes <76>; #49# catalytic mechanism, active site  structure, Tyr204 is required and involved in the hydrophobic network,  substrate-induced interaction of Tyr204 and Asp166, overview <77>; #4#  catalytic site structure, Asp166 is the catalytic base invariant in all  kinases, activation mechanism, overview <3>; #5# random kinetic  mechanism, active site structure with key residues E91, K72, N171,  K168, the general base catalyst D166, and essential catalytic D184,  overview, reaction mechanism <5>; #49# substrate binding site structure  involving E230, the electrostatic surface is important for substrate  binding and catalysis, and also for the mechanism of closing the active  site cleft of subunit C, conformation and mechanism, overview, the  catalytic loop consists of residues Arg165-Asn171 <89>; #9# the  substrate binds to the regulatory subunit which is released from the  catalytic subunit for enzyme activity, mechanism and structure-function  relationship <48>; #11# conserved residues K336 and H338 are important  for catalytic activity, R324 is important in substrate binding <100>;  #6# phosphoryltransfer mechanism, substrate-binding site structure, the  phosphorylated Thr197 in the catalytic subunit of cAMP-dependent  protein is essential for activity, overview <111>)  "
2.7.11.12, ATP + a protein = ADP + a phosphoprotein  
2.7.11.13," ATP + a protein = ADP + a phosphoprotein (#5# regulation of enzyme  activity involves the activation loop, a polypeptide region outside the  active site cleft, which is reversibly phosphorylated at a Thr residue  <4>)  "
2.7.11.14," ATP + rhodopsin = ADP + phosphorhodopsin (#6# mechanism  <16,17,19,21,22>; #3# molecular mechanism of trans-phosphorylation <49>)  "
2.7.11.15," ATP + [beta-adrenergic receptor] = ADP + phospho-[beta-adrenergic  receptor] (#7# mechanism <17>; #7# sequential mechanism <24>; #3,4,5#  regulation mechanism <45>; #7# substrate and activator binding site  structure, active site structure, structure-function relationship,  overview <70>)  "
2.7.11.16, ATP + [G-protein-coupled receptor] = ADP + [G-protein-coupled receptor]  phosphate 
2.7.11.16," ATP + [G protein-coupled receptor] = ADP + [G protein-coupled  receptor]phosphate (#2,3# regulation mechanism <13>)  "
2.7.11.17," ATP + a protein = ADP + a phosphoprotein (#12# main phosphorylation  site: Ser-73 <61>; #12# casein kinase II as caldesmon kinase <61>;  #1,10# the reaction is an intramolecular autophosphorylation which is  site-specific: predominantly serine with some threonine and no tyrosine  residues are phosphorylated <58>; #1,10# enzyme appears to be identical  with caldesmon <58>; #1# p42/p44erk mitogen-activated protein kinase  appears to be the major caldesmon kinase, but a yet unidentified  kinase, rather than mitogen-activated protein kinase, may be involved  in regulation of the caldesmon function in vivo <63>; #1# not identical  but with strong binding affinity for caldesmon <62>; #4# catalytic  aspartate residue <11>; #34,35,45,54# sequential reaction mechanism in  which all substrates bind to enzyme before any product is released.  Binding of phospholamban to the enzyme decreases the affinity of the  enzyme toward ATP <153>)  "
2.7.11.18, ATP + [myosin light chain] = ADP + [myosin light chain] phosphate  
2.7.11.19," 2 ATP + phosphorylase b = 2 ADP + phosphorylase a (#10# mechanism  <46,72,78>; #3# catalytic aspartate residue <3>)  "
2.7.11.2," ATP + [pyruvate dehydrogenase (acetyl-transferring)] = ADP + [pyruvate  dehydrogenase (acetyl-transferring)] phosphate (#4,7,18# mechanism  <8,15,26,32>; #16# molecular modeling of the catalytic domain,  structure <24>; #4# structure of the nucleotide binding pocket with  responsible His115 residue and of the catalytic site <32>; #18# His121  is involved in the catalytic reaction <26>) "
2.7.11.2," ATP + [pyruvate dehydrogenase (acetyl-transferring)] = ADP + [pyruvate  dehydrogenase (acetyl-transferring)]phosphate (#3# allosteric R-T  equilibrium as the mechanism for L2-stimulated PDK3 activity, the  active cleft undergoes a conformational change from closed to open  conformation upon stimulation by L2 binding releasing ADP <46>; #3#  ordered reaction mechanism with ATP binding before E1 <43>; #3# ordered  reaction mechanism with ATP binding first, overview <43>)  "
2.7.11.20, ATP + [elongation factor 2] = ADP + [elongation factor 2] phosphate  
2.7.11.21," ATP + a protein = ADP + a phosphoprotein (#4# consensus sequence of  Plk1 is D/E-X-S/T-hydrophobic amino acid-X-D/E, X can be any amino  acid, with neighbouring phosphorylation sequence L-Q-S-V-L-E being  phosphorylated at the serine residue <28,46>; #4# the Plk consensus  sequence is D/E-X-S/T-hydrophobic amino acid-X-D/E with X being any  amino acid <34>)  "
2.7.11.22," ATP + a protein = ADP + a phosphoprotein (#4# reaction mechanism <8>;  #4# activation involves the activation loop, a polypeptide region  outside the active site cleft, which is reversibly phosphorylated at a  Thr residue, phosphorylation leads to enzyme inhibition <7>; #6#  catalytic aspartate residue <6>; #19# active site amino acid sequences  of PK5 and mrk <178>)  "
2.7.11.23, ATP + [DNA-directed RNA polymerase] = ADP + phospho-[DNA-directed RNA  polymerase]  
2.7.11.24," ATP + a protein = ADP + a phosphoprotein (#3# reaction mechanism <9>;  #3# activation involves the activation loop, a polypeptide region  outside the active site cleft, which is reversibly phosphorylated <8>;  #2# catalytic aspartate residue <6>; #4# the kinetics of p38 MAPK  follow a rapid-equilibrium random-order ternary-complex mechanism, the  enzyme is highly specific for Ser-Pro or Thr-Pro motifs <134>)  "
2.7.11.25," ATP + a protein = ADP + a phosphoprotein (#4# Lys391 is the catalytic  residue <40>; #4# mechanism of ASK1 <25>; #3# molecular mechanism of  MEKK2 and MEKK3 <29>; #4# structure-function relationship of MAPKKKs  and MAPKKs, K1371 is the catalytic residue of MTK1, MTK1, TAK1, and  MEKK1 also possess lysine as catalytic residues <43>)  "
2.7.11.26, ATP + tau-protein = ADP + O-phospho-tau-protein 
2.7.11.26," ATP + [tau-protein] = ADP + O-phospho-[tau-protein] (#4# activation  loop structure, substrate binding structure, and catalytic site  structure and mechanism <57>; #6# glycogen synthase kinase-3beta also  performs serine/threonine protein kinase reaction, EC 2.7.11.1, with  other substrates than tau, e.g. it phosphorylates the glycogen synthase  <60>; #5# GSK-3 and PKA catalyze tau phosphorylation in the brain,  while GSK-3 performs phosphorylation of glycogen synthase, EC 2.7.11.1,  and other proteins in different tissues, and PKA performs  phosphorylation of other proteins in different tissues <65>)  "
2.7.11.27, ATP + [acetyl-CoA carboxylase] = ADP + [acetyl-CoA carboxylase]  phosphate  
2.7.11.28, ATP + tropomyosin = ADP + O-phosphotropomyosin  
2.7.11.29, ATP + [low-density-lipoprotein receptor]-L-serine = ADP +  [low-density-lipoprotein receptor]-O-phospho-L-serine  
2.7.11.3, ATP + dephospho-{[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase}  = ADP + {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase}  
2.7.11.30, ATP + [receptor-protein] = ADP + [receptor-protein] phosphate  
2.7.11.31, ATP + [hydroxymethylglutaryl-CoA reductase (NADPH)] = ADP +  [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate  
2.7.11.32," ADP + [pyruvate, phosphate dikinase] = AMP + [pyruvate, phosphate  dikinase] phosphate  "
2.7.11.33," ADP + [pyruvate, water dikinase] = AMP + [pyruvate, water dikinase]  phosphate  "
2.7.11.4, ATP + [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] =  ADP + [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)]  phosphate  
2.7.11.5, ATP + [isocitrate dehydrogenase (NADP+)] = ADP + [isocitrate  dehydrogenase (NADP+)] phosphate  
2.7.11.6, ATP + [tyrosine-3-monooxygenase] = ADP +  phospho-[tyrosine-3-monooxygenase]  
2.7.11.7," ATP + [myosin heavy-chain] = ADP + [myosin heavy-chain] phosphate (#11#  catalytic domain: amino acid residues 31-259 <14>; #4# catalytic domain  structure, modeling <21>; #4# residues Ser627, Thr631 and Thr632 are  essential for catalytic activity <21>; #4# activation of the enzyme by  autophosphorylation is necessary for full catalytic activity <5>; #5,6#  enzyme contains the C-terminal WD-domain, responsible for substrate  binding, the catalytic domain, and the N-terminal coiled-coil  translocation domain <15,26>; #8# major phosphorylation site: Ser8 <22>)  "
2.7.11.8, ATP + [Fas-activated serine/threonine protein] = ADP + [Fas-activated  serine/threonine phosphoprotein]  
2.7.11.9, ATP + [Goodpasture antigen-binding protein] = ADP + [Goodpasture  antigen-binding phosphoprotein]  
2.7.12.1, ATP + a protein = ADP + a phosphoprotein  
2.7.12.2, ATP + a protein = ADP + a phosphoprotein  
2.7.13.1, ATP + protein L-histidine = ADP + protein Npi-phospho-L-histidine  
2.7.13.2, ATP + protein L-histidine = ADP + protein Ntau-phospho-L-histidine  
2.7.13.3," ATP + protein L-histidine = ADP + protein N-phospho-L-histidine (#28#  catalytic mechanism for Brucella LOV-HK, molecular modeling and  simulations, overview <381>)  "
2.7.14.1, ATP + a [protein]-L-arginine = ADP + a  [protein]-Nomega-phospho-L-arginine  
2.7.2.1," ATP + acetate = ADP + acetyl phosphate (#34# residue F179 is essential  for catalysis <35>; #62# roles for the arginine residues Arg241 and  Arg91 in transition state stabilization for catalysis but not in  nucleotide binding determined, experimental evidence for domain motion  <42>) "
2.7.2.1, ATP + propanoate = ADP + propanoyl phosphate  
2.7.2.10, GTP + 3-phospho-D-glycerate = GDP + 3-phospho-D-glyceroyl phosphate  
2.7.2.11, ATP + L-glutamate = ADP + L-glutamate 5-phosphate  
2.7.2.12, diphosphate + acetate = phosphate + acetyl phosphate  
2.7.2.14, ATP + 2-methylpropanoate = ADP + 2-methylpropanoyl phosphate  
2.7.2.15, ATP + acetate = ADP + acetyl phosphate 
2.7.2.15, ATP + propanoate = ADP + propanoyl phosphate  
2.7.2.16," ATP + 2-phospho-D-glycerate = ADP + 2,3-diphospho-D-glycerate  "
2.7.2.17," ATP + an [amino group carrier  protein]-C-terminal-N-(1,4-dicarboxybutan-1-yl)-L-glutamine = ADP +  phosphate + an [amino group carrier  protein]-C-terminal-N-(1-carboxy-5-phosphooxy-5-oxopentan-1-yl)-L  glutamine  "
2.7.2.18, ATP + a fatty acid = ADP + a fatty acyl phosphate 
2.7.2.18, ATP + a fatty acid-[fatty acid-binding protein] = ADP + a fatty acyl  phosphate-[fatty acid-binding protein] 
2.7.2.18, a fatty acyl phosphate-[fatty acid-binding protein] + a fatty acid = a  fatty acyl phosphate + a fatty acid-[fatty acid-binding protein]  
2.7.2.2," ATP + NH3 + hydrogencarbonate = ADP + carbamoyl phosphate + H2O  (#2,5,6,8,11,20# mechanism <5,9,11,12,15>; #10# random type reaction  mechanism <7>; #4# comparison of carbamate kinases and carbamoyl  phosphate synthases <19>; #22# the protein residues involved in ligand  binding, together with a model of the transition state, suggest that  catalysis follows an in-line, predominantly dissociative,  phosphotransfer reaction mechanism, and that closure of the flexible  auxiliary domain is required to protect the transition state from bulk  solvent. Model of the transition state, overview <30>) "
2.7.2.2, ATP + carbamate = ADP + carbamoyl phosphate 
2.7.2.2, NH3 + hydrogencarbonate = carbamate + H2O  
2.7.2.3," ATP + 3-phospho-D-glycerate = ADP + 3-phospho-D-glyceroyl phosphate  (#7,9,10,12,22,25,28,38,54,55,95# mechanism <19,20,54,67>; #46#  sequential mechanism <8>; #10# random sequential mechanism <3>; #10#  rapid equilibrium random mechanism <16,27>; #22# mechanism,  substrate-induced effects combine synergistically to induce major  conformational changes of the active site to catalytic status <52>;  #10# C-terminal part is important for full activity <48>; #70# residues  engaged in 3-phospho-D-glycerate binding: R22, D24, R144, E149, E150,  H191, R192, residues engaged in ATP binding: G236, G237, G263, G371,  G375, P372, E277, E377, G407, G408, G429-431 <47>; #95# substrate  binding conformations of the 2 enzyme domains <67>; #10# Pro204 is  important for stability and catalytic mechanism of the enzyme <59>;  #10,22# substrate binding <20,54>; #10# active site structure  containing 2 tryptophan residues, substrate binding <10>; #74# small  angle X-ray scattering (SAXS) data on complexes of human PGK (HsPGK) in  solution. In combination with deformable elastic network (DEN)  refinement a fully open conformation of the apoenzyme is defined, and  details are revealed of the relative time spent by the enzyme in the  open and closed conformations during catalytic turnover. Together with  the crystal structures it is demonstrated that the enzyme strongly  favors the open conformation <143>; #100# an ordered mechanism is  assumed where 3-phospho-D-glycerate and 3-phospho-D-glyceroyl phosphate  bind before ADP and ATP, respectively <148>; #7# catalytic mechanism  and cycle, conformational changes for substrate binding and  positioning, overview <155>)  "
2.7.2.4, ATP + L-aspartate = ADP + 4-phospho-L-aspartate  
2.7.2.6, ATP + formate = ADP + formyl phosphate  
2.7.2.7, ATP + butanoate = ADP + butanoyl phosphate  
2.7.2.8," ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamyl 5-phosphate  (#20# mechanism <11>; #5# random bi-bi mechanism <10>; #3# enzyme has  to interact stoichiometrically with acetylglutamate synthase in order  to be active <2,3>; #2# using an elastic network model representation a  normal mode analysis shows that the conformational mechanisms for  substrate binding by NAGK strongly correlate with the intrinsic  dynamics of the enzyme in the unbound form. The conformational change  observed between the open and closed forms of EcNAGK are essentially  accomplished by movements along a small subset of modes <35>; #21#  allosterically regulated mechanism for the enzyme from Maricaulis maris  with roles for Lys356, Arg386, Asn391 and Tyr397 in the catalytic  mechanism <38>)  "
2.7.3.1, ATP + guanidinoacetate = ADP + phosphoguanidinoacetate  
2.7.3.10, ATP + agmatine = ADP + N4-phosphoagmatine  
2.7.3.13, ATP + L-glutamine + H2O = AMP + phosphate + N5-phospho-L-glutamine  
2.7.3.2," ATP + creatine = ADP + phosphocreatine (#8# mechanism <55,76>; #5#  kinetic model of reaction <33>; #1,4,5,6,7,8,18,23# mitochondrial  enzymes, mechanism, overview <1>; #5# enzyme is functionally coupled to  ouabain-inhibited (Na+,K+)-ATPase <30>; #8# bireactant catalytic  mechanism, transition state stabilization by six arginines clustered in  the active site of the enzyme <83>; #51# catalytic cysteine, active  site residues are Glu226, Glu227, and Asp228, the enzyme follows a  random or an ordered bimolecular mechanism dependent on pH, direct  phosphoryl transfer, no phosphorylated intermediate, overview <86>;  #25# catalytic cysteine, active site structure involving His66 and  Asp326, overview, the enzyme follows a random or an ordered bimolecular  mechanism dependent on pH, direct phosphoryl transfer, no  phosphorylated intermediate, overview <86>; #4,7,8# catalytic cysteine,  the enzyme follows a random or an ordered bimolecular mechanism  dependent on pH, direct phosphoryl transfer, no phosphorylated  intermediate, overview <86>; #43# catalytic mechanism and substrate  binding involving 2 flexible loops and a specificity pocket formed by  Ile69 and Val325 determining substrate specificity, active site  structure <81>; #49# random-order rapid-equilibrium mechanism <80>)  "
2.7.3.3," ATP + L-arginine = ADP + Nomega-phospho-L-arginine (#5# rapid  equilibrium random mechanism <6>; #143,144# random-order, rapid  equilibrium kinetic mechanism <104>; #70,148,149# random-order,  rapid-equilibrium kinetic mechanism <110,113>; #159# the two-substrate  AK kinetics is explained by a random-order, rapid-equilibrium, kinetic  mechanism <106>)  "
2.7.3.4," ATP + taurocyamine = ADP + N-phosphotaurocyamine (#11# an arginine  residue of the phosphagen specificity loop is crucial for substrate  specificity, mechanism and structure-function relationship, overview  <15>)  "
2.7.3.5, ATP + lombricine = ADP + N-phospholombricine  
2.7.3.6, ATP + hypotaurocyamine = ADP + Nomega-phosphohypotaurocyamine  
2.7.3.7, ATP + guanidinoethyl methyl phosphate = ADP + N'-phosphoguanidinoethyl  methylphosphate  
2.7.3.8, ATP + NH3 = ADP + phosphoramide  
2.7.3.9," phosphoenolpyruvate + protein histidine = pyruvate + protein  Npi-phospho-L-histidine (#18# ping-pong mechanism <9>; #1,5# bi-bi  ping-pong mechanism <16,17>; #1# in a second reaction step phosphate is  transferred to the N-1 position of the imidazole ring of the histidine  containing-protein (i.e. HPr), the phospho group of the intermediate  phospho-enzyme I can also be transferred to pyruvate or 2-oxobutyrate  <18>; #1# in a first reaction step phosphate is transferred to the N-3  position of the imidazole ring of histidine <12,16>; #20# overview on  mechanism <30>) "
2.7.3.9, phosphoenolpyruvate + protein histidine = pyruvate + protein  N-pros-phosphohistidine  
2.7.4.1, ATP + (phosphate)n = ADP + (phosphate)n+1 (#20# mechanism <10>; #20#  short chain polyphosphates are incorporated at the ends of the long  chain product <9>; #20# both polyphosphate synthesis and polyphosphate  utilization follow a processive mechanism <10>)  
2.7.4.10, nucleoside triphosphate + AMP = nucleoside diphosphate + ADP (#4#  mechanism <1>)  
2.7.4.11, ATP + dAMP = ADP + dADP  
2.7.4.12, ATP + dGMP (or dTMP) = ADP + dGDP (or dTDP)  
2.7.4.13, ATP + a 2'-deoxyribonucleoside 5'-phosphate = ADP + a  2'-deoxyribonucleoside 5'-diphosphate  
2.7.4.14," ATP + UMP = ADP + UDP (#16# random bi-bi mechanism <16>; #4# reaction  mechanism is sequential and nonequilibrium in nature, substrates bind  to the enzyme in a random order, substrate binding is cooperative <14>;  #10# the mechanism is analogous to the phosphoryl transfer mechanism in  cAMP-dependent protein kinase that phosphorylates the hydroxyl groups  of serine residues <15>; #3# formation of a ternary complex, addition  of substrates is random <6>; #8# reaction proceeds by a sequential  mechanism, a ternary complex of the enzyme with both substrates is  formed as the central intermediate in the reaction <12>)  "
2.7.4.15, ATP + thiamine diphosphate = ADP + thiamine triphosphate  
2.7.4.16," ATP + thiamine phosphate = ADP + thiamine diphosphate (#4# Aquifex  aeolicus ThiL utilizes a direct, inline transfer of the gamma-phosphate  of ATP to TMP rather than a phosphorylated enzyme intermediate,  reaction mechanism, overview <4>)  "
2.7.4.17, 3-phospho-D-glyceroyl phosphate + (phosphate)n = 3-phosphoglycerate +  (phosphate)n+1  
2.7.4.18, ATP + farnesyl diphosphate = ADP + farnesyl triphosphate  
2.7.4.19, ATP + 5-methyldeoxycytidine 5'-phosphate = ADP + 5-methyldeoxycytidine  diphosphate  
2.7.4.2," ATP + (R)-5-phosphomevalonate = ADP + (R)-5-diphosphomevalonate (#5#  sequential mechanism <5>; #5# ordered mechanism <2>; #5# kinetic  mechanism, the enzyme follows hyperbolic kinetics and a sequential  mechanism <14>; #11# residue R110 is important to PMK catalysis, which  is also influenced by K48 and R73. R111 and R84 contribute to binding  of mevalonate 5-phosphate and R141 to binding of ATP <16>; #11# residue  R22 is important for catalysis <15>; #8# the phosphorylation reaction  mechanism of phosphomevalonate kinase is studied by using molecular  dynamics and hybrid QM/MM methods, overview. A conserved residue  (Ser106) is reorientated to anchor ATP via a stable H-bond interaction.  In addition, Ser213 located on the alpha-helix at the catalytic site is  repositioned to further approach the substrate, facilitating the proton  transfer during the phosphorylation. Lys101 functions to neutralize the  negative charge developed at the beta-, gamma-bridging oxygen atom of  ATP during phosphoryl transfer <32>)  "
2.7.4.20, dolichyl diphosphate + (phosphate)n = dolichyl phosphate +  (phosphate)n+1  
2.7.4.21," ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol  5-diphosphate 1,2,3,4,6-pentakisphosphate "
2.7.4.21," ATP + 1D-myo-inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate = ADP +  1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate  "
2.7.4.22," ATP + UMP = ADP + UDP (#18# a sequential bi-bi reaction mechanism and,  as a nucleophilic substitution reaction while both substrates are bound  to the enzyme <13>)  "
2.7.4.23," ATP + alpha-D-ribose 1,5-bisphosphate = ADP + 5-phospho-alpha-D-ribose  1-diphosphate  "
2.7.4.24," ATP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate = ADP +  1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate "
2.7.4.24," ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol  1-diphosphate 2,3,4,5,6-pentakisphosphate  "
2.7.4.25, ATP + (d)CMP = ADP + (d)CDP  
2.7.4.26, ATP + isopentenyl phosphate = ADP + isopentenyl diphosphate  
2.7.4.27," [pyruvate, phosphate dikinase] phosphate + phosphate = [pyruvate,  phosphate dikinase] + diphosphate (#4# enzyme PDRP contains a single  active site that catalyzes both phosphorylation and dephosphorylation,  cf. EC 2.7.11.32. Catalytic mechanism of PPDK regulatory protein,  overview <10>)  "
2.7.4.28," [pyruvate, water dikinase] phosphate + phosphate = [pyruvate, water  dikinase] + diphosphate  "
2.7.4.29, ditrans-octacis-undecaprenyl diphosphate +  alpha-D-Kdo-(2->4)-alpha-D-Kdo-(2->6)-lipid A =  ditrans-octacis-undecaprenyl phosphate +  alpha-D-Kdo-(2->4)-alpha-D-Kdo-(2->6)-lipid A 1-diphosphate  
2.7.4.3," ATP + AMP = 2 ADP (#4,7,8,10,12# mechanism  <2,4,6,7,12,15,16,17,18,19,42,62,67>; #12# iso-random bi-bi mechanism  <50>; #3,5,6,10,12# overview: mechanism <68>; #25# thermodynamics and  kinetics <49>; #29# associative mechanism for phosphoryl transfer <96>;  #68# binding of ATP induces a dynamic equilibrium in which the ATP  binding motif populates both the open and the closed conformations with  almost equal populations. A similar scenario is observed for AMP  binding, which induces an equilibrium between open and closed  conformations of the AMP binding motif. Simultaneous binding of AMP and  ATP is required to force both substrate binding motifs to close  cooperatively. Unidirectional energetic coupling between the ATP and  AMP binding sites <107>; #68# coarse-grained models and nonlinear  normal mode analysis. Intrinsic structural fluctuations dominate LID  domain motion, whereas ligand-protein interactions and local unfolding  are more important during NMP domain motion. LID-NMP domain  interactions are indispensable for efficient catalysis. LID domain  motion precedes NMP domain motion, during both opening and closing,  providing mechanistic explanation for the observed 1:1:1 correspondence  between LID domain closure, NMP domain closure, and substrate turnover  <114>; #5,6,9,13# induced-fit and change between open and closed  conformation, random Bi-Bi reaction mechanism, the conformational  change of the ADK enzyme very much follows two parallel stepwise  pathways as a functional requirement for the double substrate catalysis  <170>)  "
2.7.4.31, ATP + [5-(aminomethyl)furan-3-yl]methyl phosphate = ADP +  [5-(aminomethyl)furan-3-yl]methyl diphosphate  
2.7.4.32," CTP + (2E,6E)-farnesyl phosphate = CDP + (2E,6E)-farnesyl diphosphate  "
2.7.4.33," ADP + (phosphate)n = AMP + (phosphate)n+1 (#7# the mechanism of  polyphosphate degradation by polyphosphate:AMP phosphotransferase is  processive. Once bound, the polyphosphate chain does not dissociate  from the enzyme until it has been utilized completely <7>)  "
2.7.4.34, GTP + (phosphate)n = GDP + (phosphate)n+1  
2.7.4.4, ATP + nucleoside phosphate = ADP + nucleoside diphosphate  
2.7.4.6," ATP + nucleoside diphosphate = ADP + nucleoside triphosphate  (#10,14,31,99# mechanism <10,33,36,40,44>; #4,10,11,14,31,40# overview  on mechanism <53>; #10# mechanism, role of 3Â’-OH moiety of nucleotide  <43>; #1,10,21,35# the catalytic mechanism involves a phosphoenzyme  intermediate <17,19,27,28>; #10,13,22# phosphoenzyme intermediate with  2-4 mol phosphate per mol of enzyme <32>; #8# two-step ping-pong  mechanism <56>; #10# isozyme NDPKB shows a ping-pong phospho-transfer  mechanism, salt and nucleotide dependent NDPKB assembly is dynamic and  requires its catalytic activity <85>; #11,91# ping pong mechanism with  formation of an enzyme intermediate phosphorylated at His118 <97>;  #116# the reaction catalyzed by NDK starts with the transfer of a  phosphate from ATP to His117. ADP is then released and the acceptor  nucleoside diphosphate is bound and phosphorylated. Nucleotide  phosphates are coordinated by a network of basic Arg and His residues,  and a polar Thr. All NDKs follow a ping-pong enzymatic mechanism  involving a phosphorylated histidine residue in the active site <135>)  "
2.7.4.7," ATP + 4-amino-2-methyl-5-(phosphooxymethyl)pyrimidine = ADP +  4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine (#8,9# ordered  sequential mechanism <10>; #1# proposed reaction mechanism <4>)  "
2.7.4.8," ATP + GMP = ADP + GDP (#21# conformational changes and induced-fit  reaction mechanism of the allosteric enzyme, overview <30>; #31#  sequential catalytic mechanism <46>)  "
2.7.4.9," ATP + dTMP = ADP + dTDP (#16# addition of substrates to the enzyme is  random, while release of the products is ordered <5>; #24# binding of  D-dTMP is through a network of hydrogen bonds to the pyrimidine ring  involving residues R70, S97, and Q101, and the base is stacked by  residue Y66. The phosphate group is tightly coordinated by residues  R34, D91, and R92 <43>)  "
2.7.6.1," ATP + D-ribose 5-phosphate = AMP + 5-phospho-alpha-D-ribose  1-diphosphate (#1,2,4,5,6,7,12,18# mechanism <4>; #1,6# ordered bi-bi  reaction with ribose-5-phosphate binding first and 5-phosphoribose  diphosphate being released last <4,11>; #1,6,11# ordered bi-bi reaction  <4,11,23,32>; #3,6,11# sequential kinetic mechanism <7,23,24,32>; #5#  steady state ordered mechanism in which Mg2+ binds first and D-ribose  5-phosphate binds last <26>)  "
2.7.6.2, ATP + thiamine = AMP + thiamine diphosphate (#14# ping pong mechanism  <2>; #5# partial ping pong mechanism <10>)  
2.7.6.3," ATP + 6-hydroxymethyl-7,8-dihydropterin = AMP +  6-hydroxymethyl-7,8-dihydropterin diphosphate (#16# during its  catalytic cycle, the enzyme must assume at least five liganded forms:  the apoenzyme form (without either of the substrates), the binary  substrate complex with MgATP, the ternary substrate complex (Michaelis  complex) with MgATP and  2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine, the ternary  product complex with AMP and 6-hydroxymethyl-7,8-dihydropterin  diphosphate (HPPP), and the binary product complex with HPPP <33>; #16#  in the enzyme mechanism, the assembly of the pterin-binding pocket  depends on ATP-dependent conformational changes in the three active  site loops <34>; #18# ordered kinetic mechanism, with Mg2+-dependent  ATP binding followed by rapid addition of  2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine <35>)  "
2.7.6.4, ATP + nucleoside 5'-phosphate = AMP + 5'-phosphonucleoside  3'-diphosphate  
2.7.6.5," ATP + GTP = AMP + guanosine 3'-diphosphate 5'-triphosphate (#18#  bifunctional enzyme, additionally has polynucleotide phosphorylase  activities <7>; #20# the catalytic pathway of (p)ppGpp synthesis  involves a sequentially ordered substrate binding, activation of ATP in  a strained conformation, and transfer of diphosphate through a  nucleophilic substitution (SN2) reaction. pppGpp, but not ppGpp,  positively regulates the enzyme at an allosteric site <17>)  "
2.7.7.1," ATP + nicotinamide ribonucleotide = diphosphate + NAD+ (#10,12#  mechanism <2,6,8>; #36,37# catalytic mechanism, overview <46>)  "
2.7.7.10, UTP + alpha-D-galactose 1-phosphate = diphosphate +  UDP-alpha-D-galactose  
2.7.7.100, ATP + [SAMP]-Gly-Gly = diphosphate + [SAMP]-Gly-Gly-AMP  
2.7.7.101, ssDNA + n NTP = ssDNA/pppN(pN)n-1 hybrid + (n-1) diphosphate  
2.7.7.102, ssDNA + n NTP = ssDNA/pppN(pN)n-1 hybrid + (n-1) diphosphate 
2.7.7.102, ssDNA + n dNTP = ssDNA/pppdN(pdN)n-1 hybrid + (n-1) diphosphate  
2.7.7.103, CTP + N5-phospho-L-glutamine = diphosphate + N5-(cytidine  5'-diphosphoramidyl)-L-glutamine  
2.7.7.104, 2-hydroxyethylphosphonate + CTP = cytidine  5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate} + diphosphate  
2.7.7.105, phosphoenolpyruvate + GTP = enolpyruvoyl-2-diphospho-5'-guanosine +  diphosphate  
2.7.7.106, 3-phospho-D-glycerate + GTP = 3-(D-glyceryl)-diphospho-5'-guanosine +  diphosphate  
2.7.7.107, CTP + (2-aminoethyl)phosphonate = diphosphate +  CMP-(2-aminoethyl)phosphonate  
2.7.7.11, UTP + alpha-D-xylose 1-phosphate = diphosphate + UDP-xylose  
2.7.7.12," UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate = alpha-D-glucose  1-phosphate + UDP-alpha-D-galactose (#2,18# Gln168 engages hydrogen  bonding with the phosphoryl oxygen of the UMP moiety in the covalently  formed reaction intermediate UMP-enzyme, UMP is bound to His166  <28,35,41>; #2# ping pong bi bi kinetic model <18,41>; #2,18#  double-displacement mechanism <5,18,28,36,38>; #2,3# Pro185 has a  critical role in facilitating the transferase reaction <33>; #2# mutant  H166G, random equilibrium, intrinsically ordered substrate binding  mechanism, ping pong kinetics <23>; #2,18# active site triad: His164,  His165, and His166, with His166 as nulceophilic catalyst, highly  conserved <36,41>; #2,3,18# active site nucleophil H166 <22,27,41>;  #2,18# formation of a stable nucleotidylated histidine intermediate  <28,41>; #18# amino acid residues of both subunits contribute to the  active site <27>; #2# SH-group in the active site <15>; #3# mechanism,  modeling <25>; #2# active site: C160SNPHP165 <41>; #2,18# active site  structure, enzyme complexed with UDP-galactose <38,41>; #18# mechanism  model <28>; #3# reaction mechanism of Duarte mutant N314D <24>; #3#  ping-pong catalytic mechanism, a UMP group is transferred from  UDP-glucose to His186 in the active site of the enzyme, overview <48>;  #2# ping-pong catalytic mechanism, overview. A UMP group is transferred  from UDP-glucose to His166 in the active site of the enzyme <48>)  "
2.7.7.13," GTP + alpha-D-mannose 1-phosphate = diphosphate + GDP-mannose (#18# PMI  and GMP activities are most probably located in catalytically distinct  domains <1>; #10# bifunctional enzyme with both phosphomannose  isomerase and GDP-D-mannose pyrophosphorylase activity <15>; #18#  enzyme has both phosphomannose isomerase, i.e. PIM, and guanosine  5-diphospho-D-mannose pyrophosphorylase, i.e. GMP, activity <2>)  "
2.7.7.14," CTP + ethanolamine phosphate = diphosphate + CDP-ethanolamine (#3#  ordered reaction mechanism <1,6>)  "
2.7.7.15," CTP + phosphocholine = diphosphate + CDP-choline (#5# catalytic  mechanism <31,36>; #5# random mechanism <5>)  "
2.7.7.18, ATP + beta-nicotinate D-ribonucleotide = diphosphate + deamido-NAD+  
2.7.7.19," ATP + RNAn = diphosphate + RNAn+1 (#1,4,5,6,7,9,21,28# mechanism <3>;  #9# binding of enzyme to nuclear poly(A) binding protein results in  80-fold increase in apparent affinity for RNA, mechanism <57>; #9#  SN2-in-line-mechanism <49>; #30,32,33,34# Arabidopsis possesses 4 genes  for PAP, these genes are expressed at the level of mRNA in  tissue-specific ways, transcripts from the four genes are alternatively  spliced so as to yield mRNAs encoding highly truncated polypeptides  <61>; #22# initial interaction between RNA and the enzyme is  characterized by a high enthalpy of association. The minimal RNA  binding site of the enzyme is eight nucleotides. Upon RNA binding, the  enzyme undergoes structural modifications, although the interaction  does not significantly modify the stability of the protein <81>; #21#  non-uniform isomerization of the polymerase-primer complex with time  consistent with a discontinuous (saltatory) translocation mechanism.  Three distinct translocatory phases can be discerned: a -10(U)-binding  site forward movement, a -27/-26(UU)-binding site jump to -10, then a  -27/-26(UU)-binding site movement further downstream. Poly(A) tail  elongation shows no apparent pauses during these isomerizations <74>)  "
2.7.7.2, ATP + FMN = diphosphate + FAD (#16# product release may be the  rate-limiting step of the reaction <33>)  
2.7.7.22, GDP + alpha-D-mannose 1-phosphate = phosphate + GDP-mannose  
2.7.7.23," UTP + N-acetyl-alpha-D-glucosamine 1-phosphate = diphosphate +  UDP-N-acetyl-alpha-D-glucosamine (#18# catalytic mechanism for the  uridyltransfer reaction in the bifunctional enzyme GlmU, overview. The  enzyme has distinct roles for Mg2+A and Mg2+B in substrate  stabilization, nucleophile activation and transition-state  stabilization <56>)  "
2.7.7.24, dTTP + alpha-D-glucose 1-phosphate = diphosphate + dTDP-alpha-D-glucose  (#26# ordered bi-bi mechanism <19>)  
2.7.7.27," ATP + alpha-D-glucose 1-phosphate = diphosphate + ADP-alpha-D-glucose  (#8,41# mechanism <31>; #17,77,82# the small and large subunits of the  enzyme define the catalytic and regulatory subunits <34,38,42>; #77#  evidence for circadian clock regulation of the small-subunit mRNA and  of corresponding enzyme activity <38>)  "
2.7.7.28, nucleoside triphosphate + alpha-D-aldose 1-phosphate = diphosphate +  NDP-hexose  
2.7.7.3, ATP + pantetheine 4'-phosphate = diphosphate + 3'-dephospho-CoA  
2.7.7.30, GTP + beta-L-fucose 1-phosphate = diphosphate + GDP-L-fucose  
2.7.7.31," a 2'-deoxyribonucleoside 5'-triphosphate + DNAn = diphosphate + DNAn+1  (#2,3,7# mechanism <10,12,27>; #3# rapid equilibrium random mechanism  <6,30>; #3# DNA polymerase lambda has enzymic activity, preferentially  adding pyrimidines to 3Â’-OH ends of DNA oligonucleotides and  elongationg RNA primers hybridized to a DNA template <37>; #7# effect  of P-chirality of primer <39>)  "
2.7.7.32, dTTP + alpha-D-galactose 1-phosphate = diphosphate + dTDP-galactose  
2.7.7.33, CTP + alpha-D-glucose 1-phosphate = diphosphate + CDP-glucose  
2.7.7.34, GTP + alpha-D-glucose 1-phosphate = diphosphate + GDP-glucose  
2.7.7.35, ADP + D-ribose 5-phosphate = phosphate + ADP-D-ribose (#1# ping-pong  reaction mechanism <1>)  
2.7.7.36, ADP + alpha-D-aldose 1-phosphate = phosphate + ADP-aldose  
2.7.7.37, NDP + alpha-D-aldose 1-phosphate = phosphate + NDP-aldose  
2.7.7.38, CTP + 3-deoxy-D-manno-octulosonate = diphosphate +  CMP-3-deoxy-D-manno-octulosonate  
2.7.7.39," CTP + sn-glycerol 3-phosphate = diphosphate + CDP-glycerol (#2,3#  mechanism <7,10>; #3# rapid equilibrium random order mechanism <3>)  "
2.7.7.4," ATP + sulfate = diphosphate + adenylyl sulfate (#60# obligatory ordered  kinetic mechanism with MgATP2- adding before MoO42- or SO42- and  Mg-diphosphate leaving before AMP + MoO42- or adenosine  5-phosphosulfate <32>; #3,4,49,57# ordered reaction mechanism, in which  ATP is the first substrate to react with the enzyme and diphosphate is  the first product released <35>; #10# sequential reaction mechanism in  which both substrates bind before any product is released <21>; #9#  sequential bi-bi reaction with ATP being the first substrate bound and  adenylysulfate the last product released <12>; #19# random sequence for  the forward reaction with adenylylsulfate release being partially rate  limiting <18>; #63# analysis of the bi bi substrate kinetic mechanism  of GmATPS1. The enzyme shows a kinetic mechanism in which ATP and APS  are the first substrates bound in the forward and reverse reactions,  respectively <71>; #63# reaction mechanism in which nucleophilic attack  by sulfate on the alpha-phosphate of ATP involves transition state  stabilization by Arg248, Asn249, His255, and Arg349. ATP sulfurylase  overcomes the energetic barrier of APS synthesis by distorting  nucleotide structure, identification of critical residues for  catalysis, overview <76>)  "
2.7.7.40, CTP + D-ribitol 5-phosphate = diphosphate + CDP-ribitol  
2.7.7.41," CTP + phosphatidate = diphosphate + CDP-diacylglycerol (#4# ping-pong  mechanism <10>; #7# sequential mechanism <12,18>; #11# sequential bi-bi  reaction: CDPdiacylglycerol synthase binds to CTP prior to  phosphatidate and diphosphate is released prior to CDPdiacylglycerol in  the reaction sequence <5>; #11# sequential bi bi reaction mechanism  <13>; #7# sequential ordered reaction mechanism <25>)  "
2.7.7.42, ATP + [glutamine synthetase]-L-tyrosine = diphosphate + [glutamine  synthetase]-O4-(5'-adenylyl)-L-tyrosine (#2# mechanism <4>)  
2.7.7.43, CTP + N-acylneuraminate = diphosphate + CMP-N-acylneuraminate (#16#  ping pong bi bi mechanism with CTP as the first substrate and CMP-NeuAc  as the last product <18>; #23# ordered bi-bi kinetic mechanism. CTP  binds first and CMP-NeuAc dissociates last. The rate-limiting step  appears to be dissociation of CMP-NeuAc <23>) 
2.7.7.43," CTP + N-acetylneuraminate = diphosphate + CMP-N-acylneuraminate (#28#  typical ordered-sequential kinetic behaviour, enzyme does not bind  N-acetylneuraminate in the absence of CTP <43>)  "
2.7.7.44, UTP + 1-phospho-alpha-D-glucuronate = diphosphate +  UDP-alpha-D-glucuronate (#3# Theorell-Chance mechanism <2>)  
2.7.7.45," 2 GTP = diphosphate + P1,P4-bis(5'-guanosyl) tetraphosphate (#1,3#  mechanism <2,5>; #2# ping-pong kinetics with a covalent  enzyme-guanylate intermediate containing a phosphoramidate linkage,  probably phospholysine <3>; #1# the alpha-phosphorus group of the GMP  of the covalent reaction intermediate is linked via the Nepsilon2 ring  nitrogen of a histidine residue of the enzyme <5,6>)  "
2.7.7.46, nucleoside triphosphate + gentamicin = diphosphate +  2''-nucleotidylgentamicin  
2.7.7.47, ATP + streptomycin = diphosphate + 3''-adenylylstreptomycin  
2.7.7.48, nucleoside triphosphate + RNAn = diphosphate + RNAn+1  
2.7.7.49, a 2'-deoxyribonucleoside 5'-triphosphate + DNAn = diphosphate + DNAn+1  
2.7.7.5, ADP + sulfate = phosphate + adenylyl sulfate  
2.7.7.50," GTP + (5')ppPur-mRNA = diphosphate + G(5')pppPur-mRNA (#6,17# active  site <24,33>; #22# ATP/GTP-binding-site motif A, residues 379-386 <35>;  #18# guanylyltransferase domain: residues 211-597 <28>; #12,18,21#  conserved KXDG-motif <26,32,34>; #11# active domain between residues  520 and 545, comprises both activities, the ATPase and  guanylyltransferase activity <25>; #18# Lys294 is located in the active  site in a KXDG-conserved motif <26>; #13# mechanism of intermediate  formation <29>; #4,5,11,16# mechanism of capping <10,11,21>;  #4,5,11,16# mRNA containing a guanosine residue linked 5 through three  phosphates to the 5 position of the terminal residue <10,11,21>; #12#  active site Lys177 <34>; #17# active site Lys190 <33>; #24# GTP:RNA  GTase, the GTase component of MimiCE, catalyzes a reversible two-step  ping-pong reaction. The first step entails nucleophilic attack of the  enzyme at the a phosphorus of GTP to form a covalent  enzyme-(lysyl-N)-GMP intermediate plus pyrophosphate. In the second  step, the beta-phosphate of 50 diphosphate-terminated RNA attacks the  enzyme-GMP intermediate to form the GpppRNA cap and expel the lysine  nucleophile <43>; #13# RNA guanylyltransferase activity is involved in  the synthesis of the cap structure found at the 5 end of eukaryotic  mRNAs. The RNA guanylyltransferase activity is a two-step ping-pong  reaction in which the enzyme first reacts with GTP to produce the  enzyme-GMP covalent intermediate with the concomitant release of  diphosphate. In the second step of the reaction, the GMP moiety is then  transferred to a diphosphorylated RNA. Both reactions are reversible.  The second step comprises the limiting steps for both the direct and  reverse overall reactions <42>; #26# magnesium binding likely activates  the lysine nucleophile by increasing its acidity and by biasing the  deprotonated nucleophile into conformations conducive to intermediate  formation <44>) "
2.7.7.50, GTP + a 5'-diphospho-[mRNA] = diphosphate + a  5'-(5'-triphosphoguanosine)-[mRNA]  
2.7.7.51, adenylyl sulfate + NH3 = adenosine 5'-phosphoramidate + sulfate  
2.7.7.52," UTP + RNAn = diphosphate + RNAn+1 (#3# mechanism, uridine insertion in  the editing process <9>)  "
2.7.7.53," ADP + ATP = phosphate + P1,P4-bis(5'-adenosyl) tetraphosphate  "
2.7.7.56, tRNAn+1 + phosphate = tRNAn + a nucleoside diphosphate  
2.7.7.57, CTP + N-methylethanolamine phosphate = diphosphate +  CDP-N-methylethanolamine  
2.7.7.59, UTP + [protein-PII] = diphosphate + uridylyl-[protein-PII]  
2.7.7.6, nucleoside triphosphate + RNAn = diphosphate + RNAn+1 (#72# reaction  mechanism <73>)  
2.7.7.60," CTP + 2-C-methyl-D-erythritol 4-phosphate = diphosphate + 4-(cytidine  5'-diphospho)-2-C-methyl-D-erythritol (#15# ordered sequential  mechanism <10>; #1# cytidyltransferase family. Active substrate site  consists of a glycine-rich loop spanning Pro13-Arg20. Three-dimensional  structure of enzyme is figured out <2>; #6# no kinetic evidence for  substrate channelling <12>; #3# third step in MEP pathway, isoprenoid  biosynthesis <17>; #17# conformational change of P-loop in the  catalysis, concerted movements of the P-loop and L2-loop may be  essential during the catalytic reaction, modeling <27>; #15# IspD of  Escherichia coli (EcIspD) follows stereochemical principles underlying  the catalysis mechanism <27>)  "
2.7.7.61," 2'-(5-triphosphoribosyl)-3'-dephospho-CoA + apo-[citrate  (pro-3S)-lyase] = diphosphate + holo-[citrate (pro-3S)-lyase] (#1#  2-(5""-triphosphoribosyl)-3-dephospho-CoA: prosthetic group of the  gamma-subunit of the citrate lyase <1>)  "
2.7.7.62, GTP + adenosylcobinamide phosphate = diphosphate +  adenosylcobinamide-GDP  
2.7.7.64," UTP + a monosaccharide 1-phosphate = diphosphate + UDP-monosaccharide  (#11# UDP-sugar-producing pyrophosphorylases catalyze reversible  reactions, require magnesium for catalysis, and act through an ordered  sequential Bi-Bi reaction mechanism. In the forward reaction, UTP binds  before the sugar 1-phosphate, and after catalysis, inorganic  diphosphate is released before the UDP-sugar <21>)  "
2.7.7.65," 2 GTP = 2 diphosphate + cyclic di-3',5'-guanylate  "
2.7.7.66, 2'-(5-triphosphoribosyl)-3'-dephospho-CoA + malonate decarboxylase  apo-[acyl-carrier protein] = malonate decarboxylase holo-[acyl-carrier  protein] + diphosphate  
2.7.7.67," CTP + 2,3-bis-(O-geranylgeranyl)-sn-glycerol 1-phosphate = diphosphate  + CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol  "
2.7.7.68, (2S)-2-phospholactate + GTP = (2S)-lactyl-2-diphospho-5'-guanosine +  diphosphate  
2.7.7.69, GDP-beta-L-galactose + alpha-D-mannose 1-phosphate = beta-L-galactose  1-phosphate + GDP-alpha-D-mannose 
2.7.7.69, GDP-alpha-D-glucose + alpha-D-mannose 1-phosphate = alpha-D-glucose  1-phosphate + GDP-alpha-D-mannose  
2.7.7.7," a 2'-deoxyribonucleoside 5'-triphosphate + DNAn = diphosphate + DNAn+1  (#1,2,4,5,8,11,12,13,15,34,36,40,42,51# mechanism  <4,5,6,7,8,44,71,72,79>; #51# reaction mechanism <180>; #11,40#  mechanism of exonuclease activity <73>; #2,12# overview: basic  mechanism of replicative DNA polymerases alpha and delta <4>; #2,12#  mechanism of polymerase translocation along templates <4>; #7,10#  binding mechanism <75>; #100# modelling and simulation of the reaction  mechanism, detailed overview <165>; #51# nucleotidyl-transfer reaction  mechanism, intermediate structures and energy profiles, overview <174>;  #51# reaction and kinetic mechanism, overview <181>)  "
2.7.7.70, D-glycero-beta-D-manno-heptose 1-phosphate + ATP =  ADP-D-glycero-beta-D-manno-heptose + diphosphate  
2.7.7.71, D-glycero-alpha-D-manno-heptose 1-phosphate + GTP =  GDP-D-glycero-alpha-D-manno-heptose + diphosphate  
2.7.7.72," a tRNA precursor + 2 CTP + ATP = a tRNA with a 3' CCA end + 3  diphosphate (#9,12# catalytic core and reaction mechanism of class I  CCA-adding enzymes, overview <14>; #2,4,5,13# catalytic core and  reaction mechanism of class II CCA-adding enzymes, overview <14>) "
2.7.7.72, a tRNA precursor + CTP = a tRNA with a 3' cytidine end + diphosphate 
2.7.7.72, a tRNA with a 3' cytidine + CTP = a tRNA with a 3' CC end + diphosphate 
2.7.7.72, a tRNA with a 3' CC end + ATP = a tRNA with a 3' CCA end + diphosphate  
2.7.7.73, ATP + [ThiS] = diphosphate + adenylyl-[ThiS]  
2.7.7.74, CTP + 1L-myo-inositol 1-phosphate = diphosphate + CDP-1L-myo-inositol  
2.7.7.75," ATP + molybdopterin = diphosphate + adenylyl-molybdopterin (#3#  comparative analyses reveal a possible role for the N- and C-terminal  residues of MoaB and MogA proteins, respectively, in stabilizing the  substrate and/or product molecule in the active site <4>)  "
2.7.7.76, CTP + molybdenum cofactor = diphosphate + cytidylyl molybdenum cofactor  
2.7.7.77, GTP + molybdenum cofactor = diphosphate + guanylyl molybdenum cofactor  
2.7.7.78, GDP-alpha-D-glucose + phosphate = alpha-D-glucose 1-phosphate + GDP  
2.7.7.79, p-tRNAHis + ATP + GTP + H2O = pGp-tRNAHis + AMP + 2 diphosphate (#8#  overall reaction <5>) 
2.7.7.79, p-tRNAHis + ATP = App-tRNAHis + diphosphate (#8# (1a) <5>) 
2.7.7.79, App-tRNAHis + GTP = pppGp-tRNAHis + AMP (#8# (1b) <5>) 
2.7.7.79, pppGp-tRNAHis + H2O = pGp-tRNAHis + diphosphate  
2.7.7.8," RNAn+1 + phosphate = RNAn + a nucleoside diphosphate (#12# stem-loops  of 7,9 or 11 bp block the processive 3-5 exonuclease action of PNPase  <31>; #1,3,4,5,12,13,14,20,23,24,26,31,48# mechanism of elongation,  overview <4>; #9,12# PNPase exhibits 3-to-5 exonucleolytic activity  <1,27>; #53# analysis of the different PNPase domains for  polymerization, degradation, and RNA binding properties <40>)  "
2.7.7.80, ATP + [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly =  diphosphate + [molybdopterin-synthase sulfur-carrier  protein]-Gly-Gly-AMP  
2.7.7.81," CTP +  5,7-diacetamido-3,5,7  9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid =  diphosphate +  CMP-5,7-diacetamido-3,5,7  9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid  "
2.7.7.82," CTP + N,N'-diacetyllegionaminate = CMP-N,N'-diacetyllegionaminate +  diphosphate  "
2.7.7.83, UTP + N-acetyl-alpha-D-galactosamine 1-phosphate = diphosphate +  UDP-N-acetyl-alpha-D-galactosamine  
2.7.7.84, 3 ATP = pppA2'p5'A2'p5'A + 2 diphosphate  
2.7.7.85," 2 ATP = 2 diphosphate + cyclic di-3',5'-adenylate  "
2.7.7.86," ATP + GTP = 2 diphosphate + cyclic Gp(2'-5')Ap(3'-5') (#3# catalytic  mechanism of cyclic GMP-AMP synthase (cGAS). AMP-2-GTP is produced in  significant abundance initially, while 2,3-cGAMP is not suggesting a  mechanism where the majority of substrate flows through AMP-2-GTP,  which is released to solution and then must rebind in competition with  ATP and GTP to form 2,3-cGAMP. AMP-2-GTP is not subject to ATP or GTP  competition <28>) "
2.7.7.86, ATP + GTP = pppGp(2'-5')A + diphosphate 
2.7.7.86, pppGp(2'-5')A = cyclic Gp(2'-5')Ap(3'-5') + diphosphate  
2.7.7.87, L-threonine + ATP + HCO3- = L-threonylcarbamoyladenylate + diphosphate  + H2O  
2.7.7.88, (5')pppAACA-[mRNA] + GDP = diphosphate + G(5')pppAACA-[mRNA] 
2.7.7.88, (5')pppAACA-[mRNA] + [protein L]-L-histidine = diphosphate + [protein  L]-L-histidyl-(5')phosphonato-AACA-[mRNA] + H2O 
2.7.7.88, [protein L]-L-histidyl-(5')phosphonato-AACA-[mRNA] + GDP + H2O =  [protein L]-L-histidine + G(5')pppAACA-[mRNA]  
2.7.7.89, [glutamine synthetase]-O4-(5'-adenylyl)-L-tyrosine + phosphate =  [glutamine synthetase]-L-tyrosine + ADP  
2.7.7.9," UTP + alpha-D-glucose 1-phosphate = diphosphate + UDP-glucose  (#1,2,5,6,7,9,10,11,13,16,19,20,26,27,36,51,52,53# mechanism <30>;  #4,38,50# sequential ordered bi bi reaction mechanism <10,25,34>; #6#  Trp333 and Arg391 are essential for activity, while His266, Arg389,  Arg422, Arg 445, and Trp218 are not <33>; #57# ordered bi-bi mechanism.  The molecular geometry at position 4 of glucose is responsible for  substrate specificity. The gamma-phosphate group of UTP is essential  for binding and for induction of the open conformation, which then  allows entry of glucose 1-phosphate <53>; #70# ordered sequential Bi Bi  mechanism, overview. Pyrimidine bases may approach the base binding  site, but they cannot form the tight interactions observed in the  HpUGPase/UDP-Glc complex. Thymine binding would be hindered by its  extra methyl group, and cytosine could not make specific hydrogen bonds  <83>)  "
2.7.7.90," CTP + 8-amino-3,8-dideoxy-alpha-D-manno-octulosonate = diphosphate +  CMP-8-amino-3,8-dideoxy-alpha-D-manno-octulosonate  "
2.7.7.91, GTP + valienol 1-phosphate = diphosphate + GDP-valienol  
2.7.7.92, CTP + 3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate = diphosphate +  CMP-3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate  
2.7.7.93, CTP + phosphonoformate = CMP-5'-phosphonoformate + diphosphate  
2.7.7.96, ATP + D-ribose 5-phosphate = diphosphate + ADP-D-ribose  
2.7.7.97, ATP + 3-hydroxy-4-methylanthranilate = diphosphate +  3-hydroxy-4-methylanthranilyl-adenylate  
2.7.7.99, UDP + N-acetyl-alpha-D-muramate 1-phosphate =  UDP-N-acetyl-alpha-D-muramate + phosphate  
2.7.8.1," CDP-ethanolamine + 1,2-diacyl-sn-glycerol = CMP + a  phosphatidylethanolamine (#4# chimeric constructs of  cholinephosphotransferase and choline/ethanolaminephosphotransferase,  study on mechanism of cation activation <28>; #4# chimeric constructs  of cholinephosphotransferase and  choline/ethanolaminephosphotransferase, study on enzyme regulation <29>)  "
2.7.8.10, CDP-choline + sphingosine = CMP + sphingosyl-phosphocholine  
2.7.8.11, CDP-diacylglycerol + myo-inositol = CMP + 1-phosphatidyl-1D-myo-inositol  
2.7.8.12," n CDP-glycerol +  4-O-[(2R)-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl  alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol = n CMP +  4-O-{poly[(2R)-glycerophospho]-(2R)-glycerophospho}-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol  "
2.7.8.13," UDP-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala) + undecaprenyl  phosphate = UMP +  Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol  (#12# a one-step, single displacement mechanism. The oxyanion of the  polyprenyl-phosphate attacks the b-phosphate of the nucleotide  substrate, leading to the formation of product lipid I and liberation  of UMP. The involvement of an invariant aspartyl residue in the  deprotonation of the lipid substrate is possible. Formation of a  covalent reaction intermediate <30>)  "
2.7.8.14," n CDP-ribitol +  4-O-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol = n  CMP +  4-O-(D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol (#1# mechanism <4>)  "
2.7.8.15, UDP-N-acetyl-alpha-D-glucosamine + dolichyl phosphate = UMP +  N-acetyl-alpha-D-glucosaminyl-diphosphodolichol  
2.7.8.17," UDP-N-acetyl-D-glucosamine + lysosomal-enzyme D-mannose = UMP +  lysosomal-enzyme N-acetyl-D-glucosaminyl-phospho-D-mannose (#3# the  alpa/beta subunits of GlcNAc-1-phosphotransferase recognize and bind  the conformation-dependent protein determinant of acid hydrolases as  well as critical lysines. The subunits then mediate the catalytic  function of the transferase. Interaction of the alpa/beta subunits with  the protein determinant of acid hydrolases stimulates the catalytic  function of the transferase. The gamma subunit enhances the rate of  GlcNAc-P transfer to the oligosaccharides of acid hydrolase acceptors.  The requirement for the gamma subunit to achieve optimal levels of  phosphorylation varies greatly among the different acid hydrolases, and  in some instances the gamma subunit is dispensable <21>)  "
2.7.8.18, UDP-alpha-D-galactose + UDP-N-acetyl-alpha-D-glucosamine = UMP +  UDP-N-acetyl-6-(alpha-D-galactose-1-phospho)-alpha-D-glucosamine  
2.7.8.19, UDP-glucose + glycoprotein D-mannose = UMP + glycoprotein  6-(D-glucose-1-phospho)-D-mannose  
2.7.8.2," CDP-choline + 1,2-diacyl-sn-glycerol = CMP + a phosphatidylcholine (#3#  sequential kinetic mechanism <17>; #7# chimeric constructs of  cholinephosphotransferase and choline/ethanolaminephosphotransferase,  study on mechanism of cation activation <49>; #2# mechanism of  regulation by thyroid hormone T3 <57>; #5# bi-bi sequential mechanism  involving a direct nucleophilic attack of diacylglycerol on CDP-choline  during the reaction <20>)  "
2.7.8.20," phosphatidylglycerol + membrane-derived-oligosaccharide D-glucose =  1,2-diacyl-sn-glycerol + membrane-derived-oligosaccharide  6-(glycerophospho)-D-glucose  "
2.7.8.21, transfer of a glycerophospho group from one membrane-derived  oligosaccharide to another  
2.7.8.22, CDP-choline + 1-alkenyl-2-acylglycerol = CMP + plasmenylcholine  
2.7.8.23, 1-carboxyvinyl carboxyphosphonate = 3-(hydroxyphosphinoyl)pyruvate + CO2  
2.7.8.24," CDP-diacylglycerol + choline = CMP + phosphatidylcholine (#20# the  enzyme reaction follows a reversible two-step reaction: in a first  choline- and manganese-independent reaction, CDP-diacylglycerol is  hydrolyzed releasing a CMP molecule. The resulting phosphatidyl  intermediate reacts with choline in a second manganese-dependent step  to form phosphatidylcholine <13>)  "
2.7.8.26, adenosylcobinamide-GDP + alpha-ribazole = GMP + adenosylcobalamin  
2.7.8.27," a ceramide + a phosphatidylcholine = a sphingomyelin + a  1,2-diacyl-sn-glycerol (#10# positive feedback mechanism from the  products to the reactants, in vivo via protein kinase D and the  ceramide transfer protein CERT, modeling <50>)  "
2.7.8.28," (2S)-lactyl-2-diphospho-5'-guanosine +  7,8-didemethyl-8-hydroxy-5-deazariboflavin = GMP + coenzyme F420-0 (#1#  coenzyme F420-0 is coenzyme F420 without glutamic acid <1>) "
2.7.8.28," (2S)-lactyl-2-diphospho-5'-guanosine +  7,8-didemethyl-8-hydroxy-5-deazariboflavin = GMP + factor 420-0 "
2.7.8.28," enolpyruvoyl-2-diphospho-5'-guanosine +  7,8-didemethyl-8-hydroxy-5-deazariboflavin = GMP + dehydro factor 420-0 "
2.7.8.28," 3-[(R)-glyceryl]-diphospho-5'-guanosine +  7,8-didemethyl-8-hydroxy-5-deazariboflavin = GMP + 3PG-factor 420-0  "
2.7.8.29, L-1-phosphatidylethanolamine + L-serine = L-1-phosphatidylserine +  ethanolamine  
2.7.8.3, CDP-choline + a ceramide = CMP + sphingomyelin  
2.7.8.31," UDP-glucose + ditrans,octacis-undecaprenyl phosphate = UMP +  alpha-D-glucopyranosyl-diphospho-ditrans,octacis-undecaprenol  "
2.7.8.32, UDP-xylose + 3-O-alpha-D-mannopyranosyl-alpha-D-mannopyranose = UMP +  3-O-(6-O-alpha-D-xylosylphospho-alpha-D-mannopyranosyl)-alpha-D  mannopyranose  
2.7.8.33," UDP-N-acetyl-alpha-D-glucosamine + ditrans,octacis-undecaprenyl  phosphate = UMP +  N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol  (#3# a one-step, single displacement mechanism. The oxyanion of the  polyprenyl-phosphate attacks the beta-phosphate of the nucleotide  substrate, leading to the formation of lipid product and the liberation  of UMP. The involvement of an invariant aspartyl residue in the  deprotonation of the lipid substrate is possible <9>)  "
2.7.8.34," CDP-1L-myo-inositol + 1L-myo-inositol 1-phosphate = CMP +  bis(1L-myo-inositol) 3,1'-phosphate 1-phosphate  "
2.7.8.35," UDP-N-acetyl-alpha-D-glucosamine + trans,octacis-decaprenyl phosphate =  UMP + N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol  "
2.7.8.36," UDP-N,N'-diacetylbacillosamine + tritrans,heptacis-undecaprenyl  phosphate = UMP +  N,N'-diacetyl-alpha-D-bacillosaminyl-diphospho-tritrans  heptacis-undecaprenol  "
2.7.8.37, ATP + methylphosphonate = alpha-D-ribose 1-methylphosphonate  5-triphosphate + adenine  
2.7.8.38," CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol + L-serine = CMP +  2,3-bis-(O-geranylgeranyl)-sn-glycero-1-phospho-L-serine (#2# (1) <1>) "
2.7.8.38," CDP-2,3-bis-(O-phytanyl)-sn-glycerol + L-serine = CMP +  2,3-bis-(O-phytanyl)-sn-glycero-1-phospho-L-serine  "
2.7.8.39," CDP-2,3-bis-(O-phytanyl)-sn-glycerol + 1L-myo-inositol 1-phosphate =  CMP + 1-archaetidyl-1D-myo-inositol 3-phosphate  "
2.7.8.4, CDP-ethanolamine + L-serine = CMP + L-serine-phosphoethanolamine  
2.7.8.40," UDP-N-acetyl-alpha-D-galactosamine + ditrans,octacis-undecaprenyl  phosphate = UMP +  N-acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.7.8.41, a CDP-diacylglycerol + a phosphatidylglycerol = a cardiolipin + CMP  
2.7.8.42, diacylphosphatidylethanolamine +  alpha-D-Kdo-(2->4)-alpha-D-Kdo-(2->6)-lipid A = diacylglycerol +  7-O-[2-aminoethoxy(hydroxy)phosphoryl]-alpha-D-Kdo-(2->4)-alpha-D-Kdo  (2->6)-lipid A 
2.7.8.42, diacylphosphatidylethanolamine +  alpha-D-Kdo-(2->4)-alpha-D-Kdo-(2->6)-lipid IVA = diacylglycerol +  7-O-[2-aminoethoxy(hydroxy)phosphoryl]-alpha-D-Kdo-(2->4)-alpha-D-Kdo  (2->6)-lipid IVA  
2.7.8.43, diacylphosphatidylethanolamine + lipid A = diacylglycerol + lipid A  1-(2-aminoethyl diphosphate) 
2.7.8.43, diacylphosphatidylethanolamine + lipid A = diacylglycerol + lipid A  4'-(2-aminoethyl diphosphate) 
2.7.8.43," diacylphosphatidylethanolamine + lipid A 1-(2-aminoethyl diphosphate) =  diacylglycerol + lipid A 1,4'-bis(2-aminoethyl diphosphate)  "
2.7.8.44," CDP-glycerol +  N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol = CDP +  4-O-[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.7.8.45," CDP-glycerol +  4-O-[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  CDP +  4-O-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol  "
2.7.8.46," CDP-ribitol +  4-O-[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N  acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  CMP +  4-O-[1-D-ribitylphospho-(2R)-1-glycerophospho]-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol  "
2.7.8.47," n CDP-ribitol +  4-O-[1-D-ribitylphospho-(2R)-1-glycerophospho]-N-acetyl-beta-D  mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans  octacis-undecaprenol = n CMP +  4-O-[(1-D-ribitylphospho)n-(1-D-ribitylphospho)-(2R)-1-glycerophospho]  N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl  diphospho-ditrans,octacis-undecaprenol  "
2.7.8.5," CDP-diacylglycerol + sn-glycerol 3-phosphate = CMP +  1-(3-sn-phosphatidyl)-sn-glycerol 3-phosphate (#3# ordered sequential  bi-bi reaction <5,8,9>)  "
2.7.8.6, UDP-alpha-D-galactose + undecaprenyl phosphate = UMP +  alpha-D-galactosyl-diphosphoundecaprenol  
2.7.8.7," CoA-[4'-phosphopantetheine] + apo-[acyl-carrier protein] = adenosine  3',5'-bisphosphate + holo-[acyl-carrier protein] (#38# sequential  binding mechanism: initial CoA- and Mg2+-binding followed by binding of  acyl-carrier protein (ACP), nucleophilic attack of  ACP-serine-hydroxylate on beta-phosphate of CoA followed by charge  migration, Lys185-protonation, diphosphate-cleavage, and product  dissociation, rate limiting step: release of 3,5-ADP, key acid/base  catalysts: residues E181 (CoA-binding) and K185 (Mg2+-binding) <39>)  "
2.7.8.8, CDP-diacylglycerol + L-serine = CMP + (3-sn-phosphatidyl)-L-serine (#2#  the enzyme appears to catalyze a ping-pong reaction <3>; #2# two-step  ping-pong reaction mechanism involving covalently bound  enzyme-phosphatidyl intermediate <4>)  
2.7.8.9, GDP-mannose + (phosphomannan)n = GMP + (phosphomannan)n+1  
2.7.9.1," ATP + pyruvate + phosphate = AMP + phosphoenolpyruvate + diphosphate  (#12,15,24,31,36# mechanism <10,12,13,14>; #31# contains several  structural domains. The catalytic histidine, the pyruvate binding site  and the ATP binding site are located in different domains >#4# two-step  bi bi uni uni mechanism <20> <29>; #7,36# sequential mechanism for the  addition of ATP and phosphate and a ping-pong mechanism for the  addition of pyruvate and release of phosphoenolpyruvate <11>; #4,31#  non-classical three-site tri ping-pong kinetics <20,22>; #2# increased  activity results in an alternative gluconeogenic pathway <38>)  "
2.7.9.2," ATP + pyruvate + H2O = AMP + phosphoenolpyruvate + phosphate (#1#  mechanism <5>; #1# reaction sequence <2,5>; #1# identification of  phosphohistidine in phosphoenzyme intermediate <8>; #7#  phosphoenolpyruvate synthase catalyzes the conversion of pyruvate to  phosphoenolpyruvate (PEP) using a two-step mechanism invoking a  phosphorylated-His intermediate <19>)  "
2.7.9.3," ATP + selenide + H2O = AMP + selenophosphate + phosphate (#6# mechanism  <13>; #6# no pyrophosphorylated enzyme intermediate detectable <10>;  #4# enzyme contains a selenocysteine residue at the active site <12>;  #6# the existence of a pyrophosphorylated enzyme intermediate can be  excluded <3>; #9# bovine active SPS2 does not contain selenocysteine  <26>; #9# catalytic mechanism of SPS2, overview <36>; #26# SPS  catalyzes the exchange of the ATP gamma-phosphate group in the absence  of selenide, suggesting that the beta-gamma-phosphate bond, but not the  alpha-beta-phosphate bond, could be the initial cleavage site,  formation of a phosphorylated enzyme intermediate, catalytic mechanism,  overview <34>)  "
2.7.9.4, ATP + alpha-glucan + H2O = AMP + phospho-alpha-glucan + phosphate (#4#  ping-pong reaction mechanism <4>)  
2.7.9.5, ATP + [phospho-alpha-glucan] + H2O = AMP +  O-phospho-[phospho-alpha-glucan] + phosphate  
2.7.9.6, ATP + rifampicin + H2O = AMP + 21-phosphorifampicin + phosphate  
2.7.99.1, triphosphate + [microsomal-membrane protein] = diphosphate +  phospho-[microsomal-membrane protein]  
2.8.1.1," thiosulfate + cyanide = sulfite + thiocyanate  (#3,6,7,9,10,12,14,15,18,19,22,23,28,31,36,40,49# mechanism <8>;  #6,8,9,17,21# double displacement mechanism <2,9,17,24,25>; #9#  involving a covalent sulfur-enzyme intermediate <9>; #7# rhodanese  activity is found to be a minor function of erythrocytic  beta-mercaptopyruvate <1>)  "
2.8.1.10," 1-deoxy-D-xylulose 5-phosphate + 2-iminoacetate +  thiocarboxy-[sulfur-carrier protein ThiS] =  2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate +  [sulfur-carrier protein ThiS] + 2 H2O (#2# final step of the  thiamin-thiazole biosynthesis is the concersion of a labile adenylated  thiazole tautomer to the adenylated thiazole product. The conversion  has an absolute requirement for enzyme catalysis <6>; #6# mechanism  involves the generation of a ketone at C3 of  1-deoxy-D-xylulose-5-phosphate by an Amadori-type rearrangement of the  imine followed by nucleophillic addition of the sulfur carrier protein  to this carbonyl group <5>; #7# the cofactor nicotinamide adenine  dinucleotide is converted into adenosine  diphospho-5-(beta-ethyl)-4-methylthiazole-2-carboxylic acid. The ADT  ligand is tightly bound and can be released in vitro only upon protein  denaturation. In this mechanism, cleavage of the N-glycosyl bond of NAD  gives ADP-ribose.The first step in thiazole formation is similar to the  chemistry used in ADP ribosylation <4>)  "
2.8.1.11, [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly-AMP + [cysteine  desulfurase]-S-sulfanyl-L-cysteine + reduced acceptor = AMP +  [molybdopterin-synthase sulfur-carrier protein]-Gly-NH-CH2-C(O)SH +  [cysteine desulfurase]-L-cysteine + oxidized acceptor (#4# double  displacement mechanism that requires the transient formation of a  stable persulfide-containing intermediate <2>)  
2.8.1.12," cyclic pyranopterin phosphate + 2 [molybdopterin-synthase  sulfur-carrier protein]-Gly-NH-CH2-C(O)SH + H2O = molybdopterin + 2  molybdopterin-synthase sulfur-carrier protein (#1,7# catalytic  mechanism, structure function-relationship, overview <2>; #7# catalytic  mechanism, structure-function relationshipp analysis, overview <5>; #3#  reaction mechanism via an intermediate, that remains tightly associated  with the protein, overview. Stoichiometry of 2 molecules of  thiocarboxylated MoaD per conversion of a single precursor Z molecule  to molybdopterin, protein-bound intermediate show a monosulfurated  structure that contains a terminal phosphate group similar to that  present in molybdopterin <6>; #3# two-step reaction of MPT synthesis  where the dithiolene is generated by two thiocarboxylates derived from  a single tetrameric MPT synthase, hypothetical model for the conversion  of precursor Z to molybdopterin in the MPT synthase reaction, overview  <4>)  "
2.8.1.13," a [protein]-S-sulfanyl-L-cysteine + uacil34 in tRNA + ATP + reduced  acceptor = a [protein]-L-cysteine + 2-thiouracil34 in tRNA + AMP +  diphosphate + acceptor (#3# on enzyme activation, an alpha-helix  overhanging the active site is restructured into an idiosyncratic  beta-hairpin-containing loop, which packs the flipped-out U34 deeply  into the catalytic pocket and triggers the activation of the catalytic  cysteine residues. The adenylated RNA intermediate is trapped. The  active closed-conformation of the complex ensures accurate sulfur  incorporation into the activated uridine carbon by forming a catalytic  chamber to prevent solvent from accessing the catalytic site <2>)  "
2.8.1.14, a [protein]-S-sulfanyl-L-cysteine + 5-taurinomethyluracil34 in tRNA +  ATP + reduced acceptor = a [protein]-L-cysteine +  5-taurinomethyl-2-thiouracil34 in tRNA + AMP + diphosphate + acceptor  
2.8.1.15, ATP + [TtuB sulfur-carrier protein]-Gly-NH-CH2-C(O)SH +  5-methyluracil54 in tRNA + H2O = AMP + diphosphate +  5-methyl-2-thiouracil54 in tRNA + [TtuB sulfur-carrier protein]-Gly-Gly 
2.8.1.15, ATP + [TtuB sulfur-carrier protein]-Gly-NH-CH2-C(O)SH + 5-methyuracil54  in tRNA + H2O = AMP + diphosphate + 5-methyl-2-thiouracil54 in tRNA +  [TtuB sulfur-carrier protein]-Gly-Gly  
2.8.1.16, hydrogen sulfide + L-aspartate 4-semialdehyde + 2 reduced ferredoxin  [iron-sulfur] cluster + 2 H+ = L-homocysteine + H2O + 2 oxidized  ferredoxin [iron-sulfur] cluster  
2.8.1.2," 3-mercaptopyruvate + reduced thioredoxin = pyruvate + hydrogen sulfide  + oxidized thioredoxin (#4,17# mechanism <16,22>; #5# rapid  equilibrium-ordered mechanism with 3-mercaptopyruvate as the first  substrate <7>; #5# sequential formal mechanism <7,10>; #5# when  2-mercaptoethanol is the sulfur acceptor addition of the substrate is  random <7>; #5# rapid equilibrium-ordered mechanism <8>; #17# sulfur  transfer mechanism involving C237 as the nucleophilic species and H66,  R102 and D262 as residues assisting catalysis <22>) "
2.8.1.2, 3-mercaptopyruvate + [3-mercaptopyruvate sulfurtransferase]-L-cysteine  = pyruvate + [3-mercaptopyruvate  sulfurtransferase]-S-sulfanyl-L-cysteine 
2.8.1.2, [3-mercaptopyruvate sulfurtransferase]-S-sulfanyl-L-cysteine + reduced  thioredoxin = hydrogen sulfide + [3-mercaptopyruvate  sulfurtransferase]-L-cysteine + oxidized thioredoxin  
2.8.1.3," thiosulfate + 2 glutathione = sulfite + glutathione disulfide + sulfide  (#1# mechanism <3>; #2# mechanism varies with the acceptor substrate  employed <1>; #1# mechanism, substrates add in a random fashion <2>)  "
2.8.1.4," ATP + [ThiI sulfur-carrier protein]-S-sulfanyl-L-cysteine + uracil in  tRNA + 2 reduced ferredoxin [iron-sulfur] cluster = AMP + diphosphate +  4-thiouracil in tRNA + [ThiI sulfur-carrier protein]-L-cysteine + 2  oxidized ferredoxin [iron-sulfur] cluster (#5# on enzyme activation, an  alpha-helix overhanging the active site is restructured into an  idiosyncratic beta-hairpin-containing loop, which packs the flipped-out  U34 deeply into the catalytic pocket and triggers the activation of the  catalytic cysteine residues. The adenylated RNA intermediate is  trapped. The active closed-conformation of the complex ensures accurate  sulfur incorporation into the activated uridine carbon by forming a  catalytic chamber to prevent solvent from accessing the catalytic site  <9>)  "
2.8.1.5," thiosulfate + dithioerythritol = sulfite +  4,5-cis-dihydroxy-1,2-dithiacyclohexane (i.e. oxidized  dithioerythritol) + sulfide  "
2.8.1.6," dethiobiotin + sulfur-(sulfur carrier) + 2 S-adenosyl-L-methionine + 2  reduced [2Fe-2S] ferredoxin = biotin + (sulfur carrier) + 2  L-methionine + 2 5'-deoxyadenosine + 2 oxidized [2Fe-2S] ferredoxin  (#2,6# mechanism <9,21,23,33,49>; #2# radical chemistry is involved in  the mechanism of biotin synthase <6>; #7# the reaction proceeds in two  distinct steps involving mercaptodethiobiotin as an intermediate <1>;  #2# reaction proceeds via intermediate involving the (2Fe-2S) cluster,  with a rate-determining step following the formation of this  intermediate <38>; #14# substrates are placed between the (4Fe-4S)  cluster, essential for radical generation, and the (2Fe-2S) cluster  <17>)  "
2.8.1.7," L-cysteine + acceptor = L-alanine + S-sulfanyl-acceptor (#2,6,15,17#  mechanism <2,6,14,15,16,21>; #12# enzyme NifS4 is involved in formation  of the Mo-S ligand of Moco. It mobilizes sulfur by formation of a  protein-bound persulfide intermediate and transfers this sulfur further  to Moco. Moco is sulfurated before the insertion into xanthine  dehydrogenase, while it is bound to XdhC <38>) "
2.8.1.7, L-cysteine + [enzyme]-cysteine = L-alanine + [enzyme]-S-sulfanylcysteine 
2.8.1.7, [enzyme]-S-sulfanylcysteine + acceptor = [enzyme]-cysteine +  S-sulfanyl-acceptor  
2.8.1.8," [protein]-N6-(octanoyl)-L-lysine + an [Fe-S] cluster scaffold protein  carrying a [4Fe-4S]2+ cluster + 2 S-adenosyl-L-methionine + 2 oxidized  [2Fe-2S] ferredoxin + 6 H+ = [protein]-N6-[(R)-dihydrolipoyl]-L-lysine  + an [Fe-S] cluster scaffold protein + 2 sulfide + 4 Fe3+ + 2  L-methionine + 2 5'-deoxyadenosine + 2 reduced [2Fe-2S] ferredoxin (#7#  mechanism: sulfur is first inserted at C6 of octanoyl substrate to form  an enzyme bound intermediate. In a subsequent rate determining step,  the second sulfur atom is inserted at C8, suggesting an energy profile  of the reaction reflecting the relative bond strengths of the primary  and secondary C-H bonds to be cleaved at C8 and C6, resp. <11>)  "
2.8.1.9, molybdenum cofactor + L-cysteine + reduced acceptor + 2 H+ =  thio-molybdenum cofactor + L-alanine + H2O + oxidized acceptor  
2.8.2.1," 3'-phosphoadenylyl sulfate + a phenol = adenosine 3',5'-bisphosphate +  an aryl sulfate (#2,3,4,5,12,15,16,18,19,20,21,22,23,24,25,26,27,28#  mechanism <48>; #4# ping-pong mechanism <32>; #3# Cys70 is not  essential for activity <21>; #13# structure modeling to determine Arg  residues involved in the catalytic reaction: Arg257 is essential,  located very close to 3-phosphoadenylyl sulfate, the negative charge of  Arg78 is not required, Arg130 is not critical <45>; #3# Glu146  determines the substrate specificity <28>; #3# isozyme M-PST: ordered  bisubstrate reaction mechanism <19>; #3# isozyme P-PST: sequential  ordered bisubstrate reaction mechanism <17>; #3# Asp86 is located at  the active site in the intercalating mobile loop and responsible for  substrate binding <44>; #4# the overall physiological reaction is a  transfer of the sulfate group between 2-naphthol and 4-nitrophenol with  the intermediate formation of 3-phosphoadenylyl sulfate <27>; #4# aryl  sulfotransferase IV: Cys66 acts as a redox switch, but is not directly  involved in the cataytic mechanism <32,48>; #3# random bi-bi mechanism  catalytic mechanism of SULTs, many family members have distinct, but  overlapping substrate specificities, the enzymes have a sequential  catalytic mechanism that is susceptible to substrate inhibition <85>)  "
2.8.2.10," 3'-phosphoadenylyl sulfate + Renilla luciferin = adenosine  3',5'-bisphosphate + luciferyl sulfate  "
2.8.2.11," 3'-phosphoadenylyl sulfate + a galactosylceramide = adenosine  3',5'-bisphosphate + a galactosylceramidesulfate (#1# the  N-glycosylation of Asn-312 and Asn-66 is necessary to form a fully  active enzyme <18>)  "
2.8.2.13," 3'-phosphoadenylyl sulfate + galactosylsphingosine = adenosine  3',5'-bisphosphate + psychosine sulfate  "
2.8.2.14," 3'-phosphoadenylyl sulfate + taurolithocholate = adenosine  3',5'-bisphosphate + taurolithocholate sulfate (#11# catalytic  mechanism of SULT2A8 <24>) "
2.8.2.14," 3'-phosphoadenylyl sulfate + glycolithocholate = adenosine  3',5'-bisphosphate + glycolithocholate 3-sulfate (#11# catalytic  mechanism of SULT2A8 <24>)  "
2.8.2.15," 3'-phosphoadenylyl sulfate + a phenolic steroid = adenosine  3',5'-bisphosphate + steroid O-sulfate  "
2.8.2.16," 3'-phosphoadenylyl sulfate + a thiol = adenosine 3',5'-bisphosphate +  an S-alkyl thiosulfate  "
2.8.2.17," 3'-phosphoadenylyl sulfate + chondroitin = adenosine 3',5'-bisphosphate  + chondroitin 6'-sulfate  "
2.8.2.18," 3'-phosphoadenylyl sulfate + cortisol = adenosine 3',5'-bisphosphate +  cortisol 21-sulfate (#3# mechanism <4>)  "
2.8.2.19," 3'-phosphoadenylyl sulfate +  alpha-D-glucosyl-(1->6)-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl-(1->3)  1-O-alkyl-2-O-acylglycerol = adenosine 3',5'-bisphosphate +  6-sulfo-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl-(1->6)-alpha-D  glucosyl-(1->3)-1-O-alkyl-2-O-acylglycerol  "
2.8.2.2," 3'-phosphoadenylyl sulfate + an alcohol = adenosine 3',5'-bisphosphate  + an alkyl sulfate (#15# random bi-bi mechanism catalytic mechanism of  SULTs, many family members have distinct, but overlapping substrate  specificities, the enzymes have a sequential catalytic mechanism that  is susceptible to substrate inhibition <44>)  "
2.8.2.20," 3'-phosphoadenylyl sulfate + protein tyrosine = adenosine  3',5'-bisphosphate + protein tyrosine-O-sulfate (#6# mechanism <4>; #5#  enzymatic mechanism and structure-function relationships, overview. The  catalytic mechanism follows the sequential steps: binding of PAPS,  binding of the target protein, sulfate transfer, release of the  sulfated target and release of 3,5-ADP <48>; #20# catalytic mechanism,  structure-function analysis <70>)  "
2.8.2.21," 3'-phosphoadenylyl sulfate + keratan = adenosine 3',5'-bisphosphate +  keratan 6'-sulfate (#4# mechanism <3>)  "
2.8.2.22," an aryl sulfate + a phenol = a phenol + an aryl sulfate (#2,8,9#  mechanism <1,2,11,12>)  "
2.8.2.23," 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine  3',5'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate  "
2.8.2.24," 3'-phosphoadenylyl sulfate + desulfoglucotropeolin = adenosine  3',5'-bisphosphate + glucotropeolin (#4# mechanism <4>) "
2.8.2.24," 3'-phosphoadenylyl sulfate + indolylmethyl-desulfoglucosinolate =  adenosine 3',5'-bisphosphate + glucobrassicin  "
2.8.2.25," 3'-phosphoadenylyl sulfate + quercetin = adenosine 3',5'-bisphosphate +  quercetin 3-sulfate (#1,2# overview on mechanism, substrates and  binding sites <8>)  "
2.8.2.26," 3'-phosphoadenylyl sulfate + quercetin 3-sulfate = adenosine  3',5'-bisphosphate + quercetin 3,3'-bissulfate  "
2.8.2.27," 3'-phosphoadenylyl sulfate + quercetin 3-sulfate = adenosine  3',5'-bisphosphate + quercetin 3,4'-bissulfate  "
2.8.2.28," 3'-phosphoadenylyl sulfate + quercetin 3,3'-bissulfate = adenosine  3',5'-bisphosphate + quercetin 3,7,3'-trissulfate  "
2.8.2.29," 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine  3',5'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate  "
2.8.2.3," 3'-phosphoadenylyl sulfate + an amine = adenosine 3',5'-bisphosphate +  a sulfamate  "
2.8.2.30," 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine  3',5'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate  "
2.8.2.31," 3'-phosphoadenylyl sulfate +  5alpha-cholan-3alpha,7alpha,12alpha,24-tetrol = adenosine  3',5'-bisphosphate + 5alpha-cholan-3alpha,7alpha,12alpha-triol  24-sulfate  "
2.8.2.32," 3'-phosphoadenylyl sulfate + 5beta-scymnol = adenosine  3',5'-bisphosphate + 5beta-scymnol sulfate  "
2.8.2.33," 3'-phospho-5'-adenylyl sulfate +  [chondroitin]-4-O-sulfo-N-acetyl-D-galactosamine = adenosine  3',5'-bisphosphate +  [chondroitin]-4,6-di-O-sulfo-N-acetyl-D-galactosamine "
2.8.2.33," 3'-phospho-5'-adenylyl sulfate +  [dermatan]-4-O-sulfo-N-acetyl-D-galactosamine = adenosine  3',5'-bisphosphate + [dermatan]-4,6-di-O-sulfo-N-acetyl-D-galactosamine  "
2.8.2.34," 3'-phosphoadenylyl sulfate + glycochenodeoxycholate = adenosine  3',5'-bisphosphate + glycochenodeoxycholate 7-sulfate (#2# the enzyme  is identical with the hydrosteroid sulfotransferase 2 <8>)  "
2.8.2.35," 3'-phospho-5'-adenylyl sulfate + [dermatan]-N-acetyl-D-galactosamine =  adenosine 3',5'-bisphosphate +  [dermatan]-4-O-sulfo-N-acetyl-D-galactosamine  "
2.8.2.36," 3'-phosphoadenylyl sulfate + desulfo-A47934 = adenosine  3',5'-bisphosphate + A47934  "
2.8.2.37," 3'-phosphoadenylyl sulfate + alpha,alpha-trehalose = adenosine  3',5'-bisphosphate + 2-O-sulfo-alpha,alpha-trehalose (#2# rapid  equilibrium random sequential Bi-Bi mechanism with formation of a  ternary complex intermediate <1>)  "
2.8.2.38," 3'-phosphoadenylyl sulfate + an aliphatic desulfoglucosinolate =  adenosine 3',5'-bisphosphate + an aliphatic glucosinolate  "
2.8.2.39," 3'-phosphoadenylyl-sulfate + 12-hydroxyjasmonate = adenosine  3',5'-bisphosphate + 12-sulfooxyjasmonate  "
2.8.2.4," 3'-phosphoadenylyl sulfate + estrone = adenosine 3',5'-bisphosphate +  estrone 3-sulfate (#3# a reaction transition state with substantial S-O  bond fission and partial charge neutralization of the leaving group  <55>; #11# random bi-bi mechanism catalytic mechanism of SULTs, many  family members have distinct, but overlapping substrate specificities,  the enzymes have a sequential catalytic mechanism that is susceptible  to substrate inhibition <58>; #11# the proposed reaction mechanism:  upon binding of PAPS, Ser137 forms an H-bond with Lys47, thus prevents  its interaction with the bridging oxygenin PAPS and its further  hydrolysis; His107 attracts a proton from the substrate hydroxyl (i.e.  of E2 or DHEA), and enables nucleophilic attack at the sulfur atom in  PAPS. In the next step, Lys47 interacts with the 5 phosphate of PAPS,  which helps in dissociation of the sulfuryl group and in its transfer  to the substrate. Finally, the reaction products, PAP and E1-S, are  released, which completes the catalytic cycle <112>)  "
2.8.2.40," 3'-phosphoadenylyl sulfate + omega-hydroxy-beta-dihydromenaquinone-9 =  adenosine 3',5'-bisphosphate + omega-sulfo-beta-dihydromenaquinone-9  "
2.8.2.5," 3'-phosphoadenylyl sulfate + chondroitin = adenosine 3',5'-bisphosphate  + chondroitin 4'-sulfate  "
2.8.2.6," 3'-phosphoadenylyl sulfate + choline = adenosine 3',5'-bisphosphate +  choline sulfate  "
2.8.2.7," 3'-phosphoadenylyl sulfate + UDP-N-acetyl-D-galactosamine 4-sulfate =  adenosine 3',5'-bisphosphate + UDP-N-acetyl-D-galactosamine  4,6-bissulfate  "
2.8.2.8," 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine  3',5'-bisphosphate + [heparan sulfate]-N-sulfoglucosamine (#5# binding  mechanism, interaction scheme, sulfuryl transfer mechanism <19>; #5#  residues 558-882 provide the sulfotransferase domain of the  bifunctional enzyme, with Lys614 as a catalytically important conserved  residue <14,19>; #5# important residue are Glu642, Lys614, Lys883, with  possible involvement of Thr617 and Thr618, in binding  3-phosphoadenosine 5-phosphosulfate <19>; #5# 5-phosphate binding and  active site structure <17>; #14,18,20,21# comparison of catalytic  mechanism aspects of the NDST isozymes, overview <45>; #5# complex  mechanism of GAG biosynthesis, mechanism of forward motion and hydrogen  bond network analysis, overview <46>)  "
2.8.2.9," 3'-phosphoadenylyl sulfate + L-tyrosine methyl ester = adenosine  3',5'-bisphosphate + L-tyrosine methyl ester 4-sulfate (#1# mechanism  <12>; #1# random rapid equilibrium bi bi kinetic mechanism <2,4>)  "
2.8.3.1, acetyl-CoA + propanoate = acetate + propanoyl-CoA  
2.8.3.10, acetyl-CoA + citrate = acetate + (3S)-citryl-CoA  
2.8.3.11, acetyl-CoA + citramalate = acetate + (3S)-citramalyl-CoA  
2.8.3.12," acetyl-CoA + (E)-glutaconate = acetate + glutaconyl-1-CoA (#3#  ping-pong mechanism <2,6>; #3# reaction mechanism <1,6,7>)  "
2.8.3.13, succinyl-CoA + 3-hydroxy-3-methylglutarate = succinate +  (S)-3-hydroxy-3-methylglutaryl-CoA  
2.8.3.14, acetyl-CoA + 5-hydroxypentanoate = acetate + 5-hydroxypentanoyl-CoA  
2.8.3.15," succinyl-CoA + (R)-2-benzylsuccinate = succinate +  (R)-2-benzylsuccinyl-CoA (#1# mechanism <3>; #1# mechanism via radical  intermediates <1>; #1# mechanism, overview on CoA-transferase families  <3>)  "
2.8.3.16," formyl-CoA + oxalate = formate + oxalyl-CoA (#16# CoA binding sites are  located at the interface between the subunits of the dimer <5>; #16#  reaction mechanism, no classical ping-pong mechanism <5>)  "
2.8.3.17, (E)-cinnamoyl-CoA + (R)-(phenyl)lactate = (E)-cinnamate +  (R)-(phenyl)lactoyl-CoA (#1# mechanism <1>) 
2.8.3.17, (E)-4-coumaroyl-CoA + (R)-3-(4-hydroxyphenyl)lactate = 4-coumarate +  (R)-3-(4-hydroxyphenyl)lactoyl-CoA 
2.8.3.17, 3-(indol-3-yl)acryloyl-CoA + (R)-3-(indol-3-yl)lactate =  3-(indol-3-yl)acrylate + (R)-3-(indol-3-yl)lactoyl-CoA  
2.8.3.18," succinyl-CoA + acetate = acetyl-CoA + succinate (#5# reaction displays  ping-pong kinetics and a modified-enzyme mechanism <2>; #5# the general  half-reaction for class I CoA-transferases shows two tetrahedral  oxyanion intermediates, which differ by whether CoA becomes attached to  the external carbonyl, provided by the acyl-CoA/carboxylate substrate,  or the internal carbonyl, provided by the essential active-site  glutamate. Following exchange of the carboxylate product, the second  half-reaction proceeds in the reverse order of the first half-reaction.  In the first half-reaction, the binary enzymeÂ·acyl-CoA complex is  converted into a CoA thiolate complex that also contains an  acylglutamyl anhydride adduct. Ping-pong kinetic mechanism. Val270 has  a dual influence on carboxylate substrate selectivity, as a gate and as  a clamp, Arg228 has an important kinetic role in carboxylate substrate  binding. The auxiliary site nonselectively binds carboxylates at the  threshold of the catalytic pocket, while selectivity is enforced by the  conserved gating residue Val270 and the interior of the catalytic pocke  <4>)  "
2.8.3.19, acetyl-CoA + oxalate = acetate + oxalyl-CoA  
2.8.3.2, succinyl-CoA + oxalate = succinate + oxalyl-CoA  
2.8.3.20, succinyl-CoA + (R)-citramalate = succinate + (R)-citramalyl-CoA (#1#  (1) <1>) 
2.8.3.20, succinyl-CoA + (R)-malate = succinate + (R)-malyl-CoA (#1# (2) <1>)  
2.8.3.21, (E)-4-(trimethylammonio)but-2-enoyl-CoA + L-carnitine =  (E)-4-(trimethylammonio)but-2-enoate + L-carnitinyl-CoA (#2# (1) <2>;  #3# sequential bisubstrate mechanism <1>) 
2.8.3.21, 4-trimethylammoniobutanoyl-CoA + L-carnitine =  4-trimethylammoniobutanoate + L-carnitinyl-CoA (#2# (2) <2>)  
2.8.3.22, succinyl-CoA + (S)-malate = succinate + (S)-malyl-CoA (#1# (1) <1>) 
2.8.3.22, succinyl-CoA + (S)-citramalate = succinate + (S)-citramalyl-CoA (#1#  (2) <1>)  
2.8.3.23," 3-(3,4-dihydroxyphenyl)propanoyl-CoA +  (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate =  3-(3,4-dihydroxyphenyl)propanoate +  (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl-CoA (#1# the enzyme uses a  ping-pong mechanism for CoA transfer, it has two catalytic domains on  one polypeptide chain. (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate =  caffeate. 3,4-dihydroxyphenylpropanoate = hydrocaffeate <1>)  "
2.8.3.24, 4-methylpentanoyl-CoA + (R)-2-hydroxy-4-methylpentanoate =  4-methylpentanoate + (R)-2-hydroxy-4-methylpentanoyl-CoA  
2.8.3.25, lithocholoyl-CoA + cholate = lithocholate + choloyl-CoA 
2.8.3.25, deoxycholoyl-CoA + cholate = deoxycholate + choloyl-CoA  
2.8.3.26, mesaconate + succinyl-CoA = 2-methylfumaryl-CoA + succinate  
2.8.3.3, acetyl-CoA + malonate = acetate + malonyl-CoA  
2.8.3.5," succinyl-CoA + a 3-oxo acid = succinate + a 3-oxoacyl-CoA (#5,6,8#  mechanism <2,8,15,20,22,23>; #6# catalytic mechanism via a  Glu-succinate anhydride, a Glu-CoA thioester, and a Glu-acetoacetate  anhydride intermediate, Glu305 is the catalytic residue in the active  site, overview <34>)  "
2.8.3.6, succinyl-CoA + 3-oxoadipate = succinate + 3-oxoadipyl-CoA  
2.8.3.8, acyl-CoA + acetate = a fatty acid anion + acetyl-CoA  
2.8.3.9, butanoyl-CoA + acetoacetate = butanoate + acetoacetyl-CoA  
2.8.4.1," methyl-CoM + CoB = CoM-S-S-CoB + methane (#3# proposed reaction  mechanism uses a radical intermediate and a nickel organic compound.  Suggested solutions for enzyme state, structure, reaction cycle and  binding mechanism for the enzyme are given <2>; #3# ternary complex  type <4>; #19# in the active site region of both isozymes, five  modified amino acids occur determined by mass spectrometry: thioglycine  alpha445, forming a thioxo peptide/thioamide bond with tyrosine  alpha446, S-methylcysteine alpha452, 2-(S)-methylglutamine alpha400,  1-N-methylhistidine alpha257 and 5-(S)-methylarginine alpha271 <31>;  #6,10# in the active site region of both isozymes, modified amino acids  occur determined by mass spectrometry: thioglycine alpha445, forming a  thioxo peptide/thioamide bond with tyrosine alpha446,  2-(S)-methylglutamine alpha400, 1-N-methylhistidine alpha257 and  5-(S)-methylarginine alpha271 <31>; #1# in the active site region of  both isozymes, modified amino acids occur determined by mass  spectrometry: thioglycine alpha445, forming a thioxo peptide/thioamide  bond with tyrosine alpha446, S-methylcysteine alpha452,  1-N-methylhistidine alpha257 and 5-(S)-methylarginine alpha271 <31>;  #13# in the active site region of both isozymes, modified amino acids  occur determined by mass spectrometry: thioglycine alpha445, forming a  thioxo peptide/thioamide bond with tyrosine alpha446, S-methylcysteine  alpha452, 2-(S)-methylglutamine alpha400, and 1-N-methylhistidine  alpha257 <31>; #17# in the active site region of both isozymes,  modified amino acids occur determined by mass spectrometry: thioglycine  alpha445, forming a thioxo peptide/thioamide bond with tyrosine  alpha446, S-methylcysteine alpha452, 2-(S)-methylglutamine alpha400,  and 5-(S)-methylarginine alpha271 <31>; #19# mechanism, nucleophilic  attack of Ni(I)-MCRred1 on the methyl group of methyl-SCoM generates a  methyl-Ni intermediate <30>; #19# two possible catalytic mechanisms,  overview <33>; #19# reaction mechanism, different varaints, the Ni(I)  center is assumed to attack the thioether sulfur of CH3-S-CoM,  generating -CH3 and the thiolate complex CoM-SÂ–Ni(II)F430 as  intermediates, detailed overview <38>; #19# Two reaction mechanisms for  methane formation distinguishable by the first step of catalysis,  overview <30>; #19# catalytic mechanism, the first step of the  mechanism is proposed to involve a nucleophilic attack of the NiI  active state, MCRred1, on Me-SCoM to form a NiIII-methyl intermediate,  spectroscopic analysis and structures, overview <43>; #19# the first  step of the mechanism is proposed to involve a nucleophilic attack of  the NiI active state, MCRred1, on Me-SCoM to form a NiIII-methyl  intermediate, spectroscopic analysis and structures, overview <41>;  #27# radical mechanism of biological methane synthesis by  methyl-coenzyme M reductase, overview. Transient kinetic, spectroscopic  [ultraviolet-visible (UV-Vis), EPR, and MCD], and computational studies  of the first step in the MCR catalytic mechanism are performed to trap  and identify the key intermediates that differ between proposed  mechanisms I and II <68>; #44# the proposed mechanism for methane  oxidation by MCR initiates with the attack of an F430-Ni(I) species  onto the sulfur of methyl-CoM, inducing the homolytic cleavage of the  C-S bond and formation of a methyl radical and an  F430-Ni(II)-thiolate(CoM) intermediate (step 1). The nascent methyl  radical abstracts a hydrogen atom from the CoB thiol, generating  methane and a CoB thiyl radical (step 2). The CoB thiyl radical attacks  the sulfur of the F430-Ni(II)-thiolate(CoM) intermediate, affording an  F430-Ni(I) species and releasing a CoB/CoM heterodisulfide  (CoB-S-S-CoM) (step 3). The addition of CoB and methyl-CoM to this form  of the enzyme allows for another round of turnover (step 4). It is  likely that the same mechanism proposed for MCR can be used for ethane  and even additional short-chain alkanes such as propane and butane. MCR  converts ethane to ethyl-CoM rather than methane to methyl-CoM <58>;  #30,39# the reaction proceeds via an unprecedented methyl radical  intermediate <57>)  "
2.8.4.2, arsenate + mycothiol = arseno-mycothiol + H2O  
2.8.4.3, N6-dimethylallyladenine37 in tRNA + sulfur-(sulfur carrier) + 2  S-adenosyl-L-methionine + reduced electron acceptor =  2-(methylsulfanyl)-N6-dimethylallyladenine37 in tRNA +  S-adenosyl-L-homocysteine + (sulfur carrier) + L-methionine +  5'-deoxyadenosine + electron acceptor (#1# (overall reaction) <1>) 
2.8.4.3, N6-dimethylallyladenine37 in tRNA + sulfur-(sulfur carrier) +  S-adenosyl-L-methionine + reduced electron acceptor =  2-sulfanyl-N6-dimethylallyladenine37 in tRNA + (sulfur carrier) +  L-methionine + 5'-deoxyadenosine + electron acceptor (#1# (1a) <1>) 
2.8.4.3, S-adenosyl-L-methionine + 2-sulfanyl-N6-dimethylallyladenine37 in tRNA  = S-adenosyl-L-homocysteine +  2-(methylsulfanyl)-N6-dimethylallyladenine37 in tRNA (#1# (1b) <1>)  
2.8.4.4, L-aspartate89-[ribosomal protein S12] + sulfur-(sulfur carrier) + 2  S-adenosyl-L-methionine + reduced acceptor =  3-(methylsulfanyl)-L-aspartate89-[ribosomal protein S12] +  S-adenosyl-L-homocysteine + (sulfur carrier) + L-methionine +  5'-deoxyadenosine + oxidized acceptor (#1# (overall reaction) <1>) 
2.8.4.4, S-adenosyl-L-methionine + L-aspartate89-[ribosomal protein S12] +  sulfur-(sulfur carrier) = S-adenosyl-L-homocysteine +  L-aspartate89-[ribosomal protein S12]-methanethiol + (sulfur carrier)  (#1# (1a) <1>) 
2.8.4.4, L-aspartate89-[ribosomal protein S12]-methanethiol +  S-adenosyl-L-methionine + reduced acceptor =  3-(methylsulfanyl)-L-aspartate89-[ribosomal protein S12] + L-methionine  + 5'-deoxyadenosine + oxidized acceptor (#1# (1b) <1>)  
2.8.4.5, N6-L-threonylcarbamoyladenine37 in tRNA + sulfur-(sulfur carrier) + 2  S-adenosyl-L-methionine + reduced electron acceptor =  2-(methylsulfanyl)-N6-L-threonylcarbamoyladenine37 in tRNA +  S-adenosyl-L-homocysteine + (sulfur carrier) + L-methionine +  5'-deoxyadenosine + electron acceptor (#1# (overall reaction) <1>) 
2.8.4.5, N6-L-threonylcarbamoyladenine37 in tRNA + sulfur-(sulfur carrier) +  S-adenosyl-L-methionine + reduced electron acceptor =  2-sulfanyl-N6-L-threonylcarbamoyladenine37 in tRNA + (sulfur carrier) +  L-methionine + 5'-deoxyadenosine + electron acceptor (#1# (1a) <1>) 
2.8.4.5, S-adenosyl-L-methionine + 2-sulfanyl-N6-L-threonylcarbamoyladenine37 in  tRNA = S-adenosyl-L-homocysteine +  2-(methylsulfanyl)-N6-L-threonylcarbamoyladenine37 in tRNA (#1# (1b)  <1>)  
2.8.4.6, S-methyl-1-thio-D-xylulose 5-phosphate + glutathione =  1-deoxy-D-xylulose 5-phosphate + S-(methylsulfanyl)glutathione  
2.8.5.1, 3-phospho-L-serine + thiosulfate = S-sulfo-L-cysteine + phosphate  
2.8.5.2, [SoxY protein]-L-cysteine + thiosulfate + 2 ferricytochrome c = [SoxY  protein]-S-sulfosulfanyl-L-cysteine + 2 ferrocytochrome c + 2 H+ 
2.8.5.2, [SoxY protein]-S-sulfanyl-L-cysteine + thiosulfate + 2 ferricytochrome  c = [SoxY protein]-S-(2-sulfodisulfanyl)-L-cysteine + 2 ferrocytochrome  c + 2 H+  
2.9.1.1," L-seryl-tRNASec + selenophosphate = L-selenocysteinyl-tRNASec +  phosphate (#3# the formyl group of pyridoxal phosphate forms a Schiff  base with the alpha-amino group of L-Ser with the subsequent  2,3-elimination of a water molecule and the generation of an  aminoacrylyl-tRNASecUCA intermediate <1>; #3# tRNA is bound near the  margin of the dimeric subunits, appears to bind only one seryl-tRNA Sec  per dimer <4>; #2# substrate binding and reaction mechanism <11>)  "
2.9.1.2," O-phospho-L-seryl-tRNASec + selenophosphate + H2O =  L-selenocysteinyl-tRNASec + 2 phosphate (#7# proposed pyridoxal  5-phosphate mechanism of L-phosphoseryl-tRNA to L-selenocysteinyl-tRNA  conversion: the reaction begins by the covalently attached  O-phospho-L-serine being brought into the proximity of the Schiff base  when L-phosphoseryl-tRNASec binds to the enzyme. The amino group of  O-phospho-L-serine can then attack the Schiff base formed between  Lys284 and pyridoxal 5-phosphate, which yields an external aldimine.  The reoriented side chain of Lys284 abstracts the Calpha proton from  O-phospho-L-serine, and the electron delocalization by the pyridine  ring assists in rapid beta-elimination of the phosphate group, which  produces an intermediate dehydroalanyl-tRNASec. After phosphate  dissociation and binding of selenophosphate, the concomitant attack of  water on the selenophosphate group and of the nucleophilic selenium  onto the highly reactive dehydroalanyl moiety yield an oxidized form of  L-phosphoseryl-tRNASec. The protonated Lys284, returns the proton to  the Calpha carbon and then attacks pyridoxal 5-phosphate to form an  internal aldimine. Finally, Sec-tRNASec is released from the active  site <5>)  "
2.9.1.3," selenophosphate + geranyl diphosphate +  5-methylaminomethyl-2-thiouridine34 in tRNA + H2O =  5-methylaminomethyl-2-selenouridine34 in tRNA +  (2E)-3,7-dimethylocta-2,6-diene-1-thiol + diphosphate + phosphate "
2.9.1.3, geranyl diphosphate + 5-methylaminomethyl-2-thiouridine34 in tRNA =  5-methylaminomethyl-2-(S-geranyl)thiouridine34 in tRNA + diphosphate 
2.9.1.3," selenophosphate + 5-methylaminomethyl-2-(S-geranyl)thiouridine34 in  tRNA = 5-methylaminomethyl-2-(Se-phospho)selenouridine34 in tRNA +  (2E)-3,7-dimethylocta-2,6-diene-1-thiol "
2.9.1.3, 5-methylaminomethyl-2-(Se-phospho)selenouridine34 in tRNA + H2O =  5-methylaminomethyl-2-selenouridine34 in tRNA + phosphate  
3.1.1.1," a carboxylic ester + H2O = an alcohol + a carboxylate (#9#  rapid-equilibrium random mechanism <17>; #11,64# reaction mechanism  <77,81>; #75# a catalytic triad is formed by residues Ser221, Glu353,  and His466 <71>; #75# a catalytic triad is formed by residues Ser224,  Glu341, and His452 <71>; #75# a catalytic triad is formed by residues  Ser227, Glu344, and His456 <71>; #75# a catalytic triad is formed by  residues Ser230, Glu347, and His459 <71>; #11# active site residues are  Ser203, His448, and Asp97 <67>; #8# active site structure, catalytic  triad consists of residues Ser82, His235, and Asp207 <79>; #64# active  site structure, substrate binding and reaction mechanism <80>; #80#  catalytic triad near the C-terminus includes His275 <61>; #6# reaction  and substrate binding mechanism, structure distinct binding pockets of  the wild-type and mutant enzymes, Gly105 plays an important role <68>;  #45# the catalytic triad consists of Ser160, His285, ans ASp255, and an  oxyanion hole binding the nucleophile is formed by Gly88, Gly89, and  Ala161 <83>; #29# catalytic triad consists of S162, H290, and D260 and  is located at the bottom of a solvent accessible pocket. The guanidine  moiety close to H290 confers a low pH shift of the catalytic His  molecule <103>; #94# catalytic triad consists of S325, D516, and H558  <92>; #97# catalytic mechanism for hydrolysis occurring at the methyl  ester group in CE-1-cocaine, quantum mechanical/molecular mechanical  (QM/MM) reaction-coordinate calculations, overview <304>; #2# the  carboxylesterases catalytic apparatus typically involves three residues  in a catalytic triad: a cysteine or serine, a glutamate or aspartate  and a histidine, and often the mechanism involves a nucleophilic attack  on a carbonyl carbon atom <300>)  "
3.1.1.10, atropine + H2O = tropine + tropate  
3.1.1.100, chlorophyllide a + H2O =  8-ethyl-12-methyl-3-vinyl-bacteriochlorophyllide d + methanol + CO2  
3.1.1.101, (ethylene terephthalate)n + H2O = (ethylene terephthalate)n-1 +  4-[(2-hydroxyethoxy)carbonyl]benzoate  
3.1.1.102, 4-[(2-hydroxyethoxy)carbonyl]benzoate + H2O = terephthalate + ethylene  glycol  
3.1.1.103, [(4-D-Ala)-(2-GlcNAc)-Rib-ol-P]n-[Gro-P]m-beta-D-ManNAc-(1->4)-alpha-D  GlcNAc-P-peptidoglycan + n H2O =  [(2-GlcNAc)-Rib-ol-P]n-[Gro-P]m-beta-D-ManNAc-(1->4)-alpha-D-GlcNAc-P  peptidoglycan + n D-alanine  
3.1.1.104," D-xylono-1,4-lactone 5-phosphate + H2O = 5-phospho-D-xylonate "
3.1.1.104," L-arabino-1,4-lactone 5-phosphate + H2O = 5-phospho-L-arabinate  "
3.1.1.105, 3-O-acetylpapaveroxine + H2O = narcotine hemiacetal + acetate  
3.1.1.106, 3''-O-acetyl-ADP-D-ribose + H2O = ADP-D-ribose + acetate 
3.1.1.106, 2''-O-acetyl-ADP-D-ribose + H2O = ADP-D-ribose + acetate  
3.1.1.107," enterobactin + H2O = N-(2,3-dihydroxybenzoyl)-L-serine trimer "
3.1.1.107," triglucosyl-enterobactin + H2O =  triglucosyl-(2,3-dihydroxybenzoylserine)3 "
3.1.1.107," diglucosyl-enterobactin + H2O = diglucosyl-(2,3-dihydroxybenzoylserine)3 "
3.1.1.107," monoglucosyl-enterobactin + H2O =  monoglucosyl-(2,3-dihydroxybenzoylserine)3  "
3.1.1.108," iron(III)-enterobactin + 3 H2O =  iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine complex + 2  N-(2,3-dihydroxybenzoyl)-L-serine "
3.1.1.108," iron(III)-enterobactin + H2O =  iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine trimer complex "
3.1.1.108," iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine trimer + H2O =  iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine dimer complex +  N-(2,3-dihydroxybenzoyl)-L-serine "
3.1.1.108," iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine dimer complex + H2O =  iron(III)-N-(2,3-dihydroxybenzoyl)-L-serine complex +  N-(2,3-dihydroxybenzoyl)-L-serine  "
3.1.1.109, iron(III)-[diglucosyl-enterobactin] complex + H2O =  iron(III)-[salmochelin S2] complex 
3.1.1.109," iron(III)-[monoglucosyl-enterobactin] complex + H2O =  iron(III)-[monoglucosyl-(2,3-dihydroxybenzoylserine)3] complex "
3.1.1.109," iron(III)-[salmochelin S2] complex + H2O =  iron(III)-[diglucosyl-(2,3-dihydroxybenzoylserine)2] complex +  N-(2,3-dihydroxybenzoyl)-L-serine "
3.1.1.109, iron(III)-[salmochelin S2] complex + H2O = iron(III)-[salmochelin S1]  complex + salmochelin SX 
3.1.1.109," iron(III)-[monoglucosyl-(2,3-dihydroxybenzoylserine)3] complex + H2O =  iron(III)-[salmochelin S1] complex + N-(2,3-dihydroxybenzoyl)-L-serine "
3.1.1.109," iron(III)-[diglucosyl-(2,3-dihydroxybenzoylserine)2] complex + H2O =  iron(III)-[salmochelin SX] complex + salmochelin SX  "
3.1.1.11," pectin + n H2O = n methanol + pectate (#8,133# mechanism <47,55>;  #19,29,35,128# reaction mechanism <80,94>; #12# reaction mechanism,  D157, stabilized by a hydrogen bond to R225, performs a nucleophilic  attack on the ester bond of the carboxymethyl group of HGA <94>; #133#  reaction mechanism, the active site contains two aspartic acid residues  D136 and D157 at the centre, which are distinguishing features of  aspartyl esterases, two glutamines Q113 and Q135 and one arginine  residue R225 <94>; #159# the catalytic residues Gln151, Gln173, Asp174,  Asp195, and Arg253 are conserved in Sal k 1 <81>; #28# two conserved  aspartates are the nucleophile and general acid-base in the reaction  mechanism, respectively, the catalytic site is formed by the conserved  resisues Asp178, Asp199, and Arg267, molecular basis of the processive  action of the enzyme, overview <82>)  "
3.1.1.110," D-xylono-1,5-lactone + H2O = D-xylonate  "
3.1.1.111, a phosphatidylserine + H2O = a 2-acyl-1-lyso-phosphatidylserine + a  fatty acid 
3.1.1.111, a 1-acyl-2-lyso-phosphatidylserine + H2O = glycerophosphoserine + a  fatty acid  
3.1.1.112, 3-methylbutyl acetate + H2O = 3-methylbutanol + acetate  
3.1.1.113, ethyl acetate + H2O = acetate + ethanol  
3.1.1.114, methyl acetate + H2O = acetate + methanol  
3.1.1.115, D-apionolactone + H2O = D-apionate  
3.1.1.116," a 1,2-diacyl-sn-glycerol + H2O = a 2-acylglycerol + a fatty acid  "
3.1.1.117," a 4-O-methyl-D-glucopyranuronate ester + H2O = 4-O-methyl-D-glucuronic  acid + an alcohol (#22# The serine and histidine residues of the  catalytic triad found in all solved GE structures (fungal and  bacterial) are conserved in TtCE15A: Ser281 and His427, only the  proposed canonical glutamate of the catalytic triad is absent (similar  to MZ0003), and this position is occupied by a serine residue, Ser304.  TtCE15A is fine-tuned to utilize Glu374 as the acidic residue in the  catalytic mechanism, supporting the enzymes high turnover rate, and  that the utilization of the residue in this position is distinct from  CE15 members exhibiting the canonical acidic residue <30>)  "
3.1.1.118, a 1-phosphatidyl-1D-myo-inositol + H2O = a  2-acyl-sn-glycero-3-phospho-1D-myo-inositol + a fatty acid 
3.1.1.118," a 1,2-diacyl-sn-glycerol 3-phosphate + H2O = a 2-acyl-sn-glycerol  3-phosphate + a fatty acid  "
3.1.1.13," a steryl ester + H2O = a sterol + a fatty acid (#1,2,3,4,6,11# a group  of enzymes of broad specificity, acting on esters of sterols and  long-chain fatty acids, that may also bring about the esterification of  sterols. Activated by bile salts <48,50,52,53,54>; #4# a group of  enzymes of broad specificity, acting on esters of sterols and  long-chain fatty acids, that may also bring about the esterification of  sterols. Activated by bile salts, reaction mechanism, catalytic triad  consists of Ser194, His435, and Asp320 <46>; #19# a group of enzymes of  broad specificity, acting on esters of sterols and long-chain fatty  acids, that may also bring about the esterification of sterols.  Activated by bile salts, the catalytic tiad is formed by Ser209,  Glu341, and His449 <42>)  "
3.1.1.14," chlorophyll + H2O = phytol + chlorophyllide (#1,6,11,25,41# also  catalyzes chlorophyllide transfer, e.g. converts chlorophyll to  methylchlorophyllide <30,31,32,33,34,36>; #30# also catalyzes  chlorophyllide transfer, e.g. converts chlorophyll to  methylchlorophyllide, catalytic mechanism, catalytic triad is composed  of Ser162, Asp191, and His262, and reveals the enzyme as a serine  hydrolase <35>)  "
3.1.1.15," L-arabinono-1,4-lactone + H2O = L-arabinonate  "
3.1.1.17," D-glucono-1,5-lactone + H2O = D-gluconate (#8# Acts on a wide range of  hexose-1,5-lactones. The hydrolysis of L-gulono-1,5-lactone was  previously listed as EC 3.1.1.18, aldonolactonase. <15>)  "
3.1.1.19," D-glucurono-6,2-lactone + H2O = D-glucuronate  "
3.1.1.2," a phenyl acetate + H2O = a phenol + acetate (#12# catalytic triad  consists of S94, D222 and H251, the active site is significantly  occluded <42>; #9# H115 acts as general base, H134 acts in a proton  shuttle mechanismto increase H115Â’s basicity <39>)  "
3.1.1.20, digallate + H2O = 2 gallate  
3.1.1.22," (R)-3-((R)-3-hydroxybutanoyloxy)butanoate + H2O = 2  (R)-3-hydroxybutanoate (#10# Ser359 is invlved in the catalytic  mechanism, active site residue <7>)  "
3.1.1.23," hydrolyses glycerol monoesters of long-chain fatty acids (#10#  mechanism <24>; #11# the catalytic triad is composed of Ser110, Asp226  and His256 residues <34>)  "
3.1.1.24," 3-oxoadipate enol-lactone + H2O = 3-oxoadipate (#3# two uptake systems  for 4-hydroxybenzoate and protocatechuate by the 3-oxoadipate pathway  <4>; #4# can not be separated from 4-carboxymuconolactone  decarboxylase, EC 4.1.1.44, which catalyzes the preceding reaction. The  gene pcaD, which encodes the 3-oxoadipate enol-lactone hydrolase is  fused to a second gene pcaC, which encodes the decarboxylase, a  protocatechuate catabolic gene cluster <5>)  "
3.1.1.25," a 1,4-lactone + H2O = a 4-hydroxyacid (#17# upon substrate binding, the  zinc-bridging hydroxide anion is effectively protected from  re-protonation by the plug-like function of the acyl tails whereupon  the ring-opening reaction can proceed. Subsequent protonation of the  products alkoxide group can then be accomplished by the intramolecular  proton transfer from the intermediate states carboxylic acid group  where the resulting carboxylate group better accommodates the  still-neighboring zinc ion <37>)  "
3.1.1.26," 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol + 2 H2O =  3-beta-D-galactosyl-sn-glycerol + 2 carboxylates  "
3.1.1.27, 4-pyridoxolactone + H2O = 4-pyridoxate  
3.1.1.28, O-acylcarnitine + H2O = a fatty acid + L-carnitine  
3.1.1.29," N-substituted aminoacyl-tRNA + H2O = N-substituted amino acid + tRNA  (#3# reaction mechanism, active-site residues N10, H20 and D93 are  crucial for catalysis <26>; #26# residues K18, D86, and T90 are  essential for catalytic activity, they are located in the N-part of  alpha1 and in the beta3-beta4 loop. K18 and D86, which form a salt  bridge, might play a role in the catalysis thanks to their acid and  basic functions, whereas the OH group of T90 could act as a nucleophile  <23>; #25# structure-function relationship, residues Asp95 and His115  are involved in catalysis, overview <25>)  "
3.1.1.3," triacylglycerol + H2O = diacylglycerol + a carboxylate (#21#  structure-function relationship <201>; #86# a tryptophan residue plays  an important role in maintaining the ative conformation of the enzyme  <92>; #8# activation mechanism <116>; #5,7# active site structure,  reaction mechanism <116>; #7# catalytic serine residue, deeply buried  under a domain called the extrusion domain, which is composed of a cap  and a lid segmentof 58 amino acids, catalytic reaction mechanism <71>;  #112# enzyme contains an active site serine <93>; #34# enzyme contains  the conserved pentapeptide Ala-Xaa-Ser-Xaa-Gly <66>; #55# enzyme form  L3: catalytic triad is formed by conserved Ser, His and Asp residues  <66>; #34# enzyme shows high enantioselectivity on racemic substrates  <75>; #74# Phe94 is involved in substrate binding and is responsible  for accommodating the acyl chain length of the substrate <69>; #109#  Ser207 is an active site serine <60>; #7,9,33,61,82,83,116,117# the  catalytic triad consists of Ser, His, and Asp residues, as for serine  proteases <76>; #74# the catalytic triad consists of Ser, His, and Asp  residues, as for serine proteases, enzyme contains the alpha-helical  lid structure <76>; #59# the catalytic triad consists of Ser, His, and  Asp residues, as for serine proteases, lipase contains no lid structure  <76>; #4# the catalytic triad consists of Ser, His, and Asp residues,  as for serine proteases, the enzyme contains no lid structure <76>;  #74,184,185# activity required deprotonation of the catalytic His  residue <110>; #59# activity required deprotonation of the catalytic  His188 residue, model of electrostatics in the active site, the active  site is essentially covered with lipod surface during catalysis <110>;  #130# the catalytic triad is composed of residues Ser173, Asp232, and  His285 <126>; #61# the catalytic triad is formed by Ser209, Glu341, and  His449, structure-function relationship and reaction mechanism,  substrate binding, activity occurs via an interfacial activation  process, a water-lipid interface is required for activity <143>; #21#  the catalytic triad is formed by Ser82, Asp229, and His251 <123>; #156#  the catalytic triad is formed by Ser82, Asp229, and His251, substrates  bind first to Ser82, position of the oxyanion hole and the three  pockets accomodating the sn-1, sn-2, and sn-3 fatty acid chains,  reaction mechanism, tetrahedral intermediate during acylation step  <132>; #21,124,129# the enzyme contains an active site serine residue  <111,114,133>; #135# the enzyme has a Ser-His-Asp catalytic triad  <122>; #47# activation of the pancreatic lipase is a mechanism allowing  accessibility of the active site to the substrate and resulting in the  unmasking of the catalytic triad of the enzyme induced by the motion of  the flap <174>; #148# LipA1 is a cold-adapted enzyme and has one  consensus motif GNSMG, containing the putative active-site serine,  which is conserved in other cold-adapted lipolytic enzymes <187>; #89#  mechanism of 1,3-specific alcoholysis, ping pong bi bi reaction  mechanism <182>; #9,74# ping pong bi bi kinetic mechanism <192>; #187#  residue Gly311 is essential for catalytic activity <206>; #33# the  catalytic center is formed by Ser145, Asp204, His257 <190>; #157,158#  the catalytic center is formed by Ser87, Asp264 and His285 <191>; #90#  the catalytic triad is formed by Ser236, Glu373, and His482 <193>;  #143# the enzyme possesses a putative active site, GDSAG, a catalytic  triad, formed by Ser148, Glu242 and His272, and a HGG motif <175>)  "
3.1.1.30," D-arabinono-1,4-lactone + H2O = D-arabinonate  "
3.1.1.31," 6-phospho-D-glucono-1,5-lactone + H2O = 6-phospho-D-gluconate (#3#  first order reaction <15>; #11# PfGluPho functions on the basis of a  rapid equilibrium random Bi Bi mechanism, where the binding of the  second substrate depends on the first substrate <32>)  "
3.1.1.32," phosphatidylcholine + H2O = 2-acylglycerophosphocholine + a carboxylate  (#3,4,6,8,9,13,43# structure-function relationship <63>)  "
3.1.1.33, 6-acetyl-D-glucose + H2O = D-glucose + acetate  
3.1.1.34, triacylglycerol + H2O = diacylglycerol + a carboxylate  
3.1.1.35, dihydrocoumarin + H2O = melilotate  
3.1.1.36, limonoate D-ring-lactone + H2O = limonoate  
3.1.1.37, testololactone + H2O = testolate  
3.1.1.38, triacetate lactone + H2O = triacetate  
3.1.1.39, actinomycin + H2O = actinomycinic monolactone  
3.1.1.4," phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate  (#25,125# mechanism <81,94>; #110# the active site His48 is conserved  in all venom PLA2s <173>; #120# Ca2+-independent catalytic mechanism,  overview <186>)  "
3.1.1.40, orsellinate depside + H2O = 2 orsellinate  
3.1.1.41, cephalosporin C + H2O = deacetylcephalosporin C + acetate (#14#  mechanism <19>; #15# a catalytic mechanism in which this Ser hydroxyl  rotation prevents reversal of the reaction and allows access of a water  molecule for completion of the reaction <26>)  
3.1.1.42, chlorogenate + H2O = caffeate + quinate  
3.1.1.43, an alpha-amino acid ester + H2O = an alpha-amino acid + an alcohol (#1#  hVACVase is a serine hydrolase with a catalytic triad S122-H255-D227  <16>)  
3.1.1.44, oxaloacetate 4-methyl ester + H2O = oxaloacetate + methanol  
3.1.1.45," 4-carboxymethylenebut-2-en-4-olide + H2O = 4-oxohex-2-enedioate (#11#  mechanism <7,8,9,10>; #11# esterase activity on chromophoric ester  substrate, p-nitrophenyl acetate and the synthetic active-site titrant,  trans-cinnamoyl imidazole <7>; #11# the catalytic triad Cys123, His202  and Asp171 is a hybrid of the standard triads found in cysteine:  Cys-His-Asn and serine: Ser-His-Asp proteases <8,10>; #11# similar  catalytic triads are found in alpha/beta hydrolase fold enzymes: DLH is  the simplest one <9,10,16>; #11# the active-site Cys123 residue is part  of a triad of residues consisting of Cys123, His202 and Asp171, and is  reminiscent of the serine/cysteine proteases <5,6,7,9,10,15>; #4#  wild-type enzyme catalytic triad: Cys-His-Asn, mutant enzyme catalytic  triad: Ser-His-Asn <18>)  "
3.1.1.46, deoxylimonate + H2O = deoxylimononic acid D-ring-lactone  
3.1.1.47," 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O =  1-alkyl-sn-glycero-3-phosphocholine + acetate (#7# mechanism <28>;  #4,15# stereochemistry <22>; #7# Arg29 and Arg22 in the one monomer  contribute to the catalytic competence of the active site across the  dimer interface, and complement the catalytic triad of Ser47, Asp192,  and His195 in the second monomer <38>; #4# hydrolysis and inactivation  of the lipid mediator platelet-activating factor PAF and/or oxidized  phospholipids <31>; #5# isozyme II of the enzyme also performs  platelet-activating factor-dependent transacetylation, transfer of an  acetyl group from platelet-activating factor to endogenous acceptor  lipids <30>; #4# mechanism, substrates can only bind in the aqueous  phase to the active site of the plasma isozyme at the membrane-water  interphase, catalytic triad is formed by Ser273, His351, and Asp296  <36>; #4# the catalytic triad of the extracellular plasma enzyme form  is of the alpha/beta-hydrolase type <23>; #4# the enzyme possesses both  acetylhydrolase and transacetylase activities which remove PAF and its  ether-linked analogues from LDL-particles upon LDL oxidation <20>)  "
3.1.1.48, N5-acyl-L-ornithine ester + H2O = N5-acyl-L-ornithine + an alcohol  
3.1.1.49, sinapoylcholine + H2O = sinapate + choline  
3.1.1.5, 2-lysophosphatidylcholine + H2O = glycerophosphocholine + a carboxylate  
3.1.1.50, a wax ester + H2O = a long-chain alcohol + a long-chain carboxylate  
3.1.1.51," phorbol 12,13-dibutanoate + H2O = phorbol 13-butanoate + butanoate  "
3.1.1.52, 1-phosphatidyl-D-myo-inositol + H2O = 1-acylglycerophosphoinositol + a  carboxylate  
3.1.1.53, N-acetyl-O-acetylneuraminate + H2O = N-acetylneuraminate + acetate  
3.1.1.54," 5-(4-acetoxybut-1-ynyl)-2,2'-bithiophene + H2O =  5-(4-hydroxybut-1-ynyl)-2,2'-bithiophene + acetate  "
3.1.1.55, acetylsalicylate + H2O = salicylate + acetate  
3.1.1.56, 4-methylumbelliferyl acetate + H2O = 4-methylumbelliferone + acetate  
3.1.1.57," 2-oxo-2H-pyran-4,6-dicarboxylate + H2O =  (1E)-4-oxobut-1-ene-1,2,4-tricarboxylate  "
3.1.1.58, N-acetyl-D-galactosaminoglycan + H2O = D-galactosaminoglycan + acetate  
3.1.1.59, juvenile hormone III + H2O = juvenile hormone III acid + methanol 
3.1.1.59, juvenile hormone I + H2O = juvenile hormone I acid + methanol  
3.1.1.6," an acetic ester + H2O = an alcohol + acetate (#19# active site serine,  active site structure, reaction and ligand binding mechanism <28>)  "
3.1.1.60, bis(2-ethylhexyl)phthalate + H2O = 2-ethylhexyl phthalate +  2-ethylhexan-1-ol  
3.1.1.61," protein L-glutamate O5-methyl ester + H2O = protein L-glutamate +  methanol (#3# mechanism <6>; #1# mechanism of regulation of enzyme  activity by the N-terminal domain <8>; #1# the enzyme is a response  regulator protein in the bacterial chemotaxis two-component signal  transduction pathway <13,14,15>; #3# enzyme is not necessary for the  aggregation of the chemoreceptor complex in vivo <16>; #3# the receptor  pentapeptide-binding site is located at the juncture between the  carboxyl-terminal end of alpha-5, the final piece of secondary  structure in the regulatory domain, and the linker that connects the  regulatory and catalytic domains <17>)  "
3.1.1.63, 11-cis-retinyl palmitate + H2O = 11-cis-retinol + palmitate  
3.1.1.64, an all-trans-retinyl ester + H2O = 11-cis-retinol + a fatty acid  
3.1.1.65," L-rhamnono-1,4-lactone + H2O = L-rhamnonate  "
3.1.1.66," 5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene + H2O =  5-(3-hydroxy-4-acetoxybut-1-ynyl)-2,2'-bithiophene + acetate  "
3.1.1.67, a long-chain-fatty-acyl ethyl ester + H2O = a long-chain-fatty acid +  ethanol (#2# mechanism <16>)  
3.1.1.68," D-xylono-1,4-lactone + H2O = D-xylonate  "
3.1.1.7," acetylcholine + H2O = choline + acetate (#4,5# mechanism <80,92>; #5#  computer-modelled comparison of ordered uni bi and ki kinetic  mechanism. ki model is accurate at equilibrium and when the inhibitor  concentration is well below its Kd value <155>; #3# mathematical  modelling of mechanism <115>; #92# formation of the trigonal  bipyramidal transition state <165>; #93# reaction mechanism,  structure-function relationship analysis, binding structure and  mechanism of substrate and product at both the peripheral and active  sites, overview <175>; #30# reaction mechanism, active site structure,  the catalytic triad comprises the residues Ser203, His447, Glu334,  residues Ser203 and His447 are directly involved in the reaction,  serving as nucleophilic attacking group and general acid base catalytic  elements, respectively, at the acylation stage of the enzymatic  reaction. Modern molecular modeling using tools including molecular  docking, molecular dynamics (MD), quantum chemistry and the combined  quantum mechanical-molecular mechanical method, overview <232>; #33#  the mechanism for AChE-catalyzed hydrolysis of substrate is formation  of the first tetrahedral intermediate via nucleophilic attack of the  active site serine <262>)  "
3.1.1.70, cetraxate benzyl ester + H2O = cetraxate + benzyl alcohol  
3.1.1.71, 2-Acetyl-1-alkyl-sn-glycerol + H2O = 1-alkyl-sn-glycerol + acetate  
3.1.1.72," Deacetylation of xylans and xylo-oligosaccharides (#4# catalyses the  hydrolysis of acetyl groups from polymeric xylan, acetylated xylose,  acetylated glucose, alpha-naphthyl acetate, p-nitrophenyl acetate but  not from triacetylglycerol. Does not act on acetylated mannan or  pectin, enzyme possesses a catalytic triad of Ser-His-Asp, catalytic  mechanism <22>; #33# catalyses the hydrolysis of acetyl groups from  polymeric xylan, acetylated xylose, acetylated glucose, alpha-naphthyl  acetate, p-nitrophenyl acetate but not from triacetylglycerol. Does not  act on acetylated mannan or pectin, reaction mechanism, catalytic triad  consists of Ser90, His187, and Asp175 <30>; #43# catalyses the  hydrolysis of acetyl groups from polymeric xylan, acetylated xylose,  acetylated glucose, alpha-naphthyl acetate, p-nitrophenyl acetate but  not from triacetylglycerol. Does not act on acetylated mannan or  pectin, reaction mechanism, enzyme is a serine esterase containing an  oxyanion hole and a catalytic triad build of Ser90, His187, and Asp175,  substrate binding model <32>; #5,17,20,21,28,32,33,34,35# catalyses the  hydrolysis of acetyl groups from polymeric xylan, acetylated xylose,  acetylated glucose, alpha-naphthyl acetate, p-nitrophenyl acetate but  not from triacetylglycerol. Does not act on acetylated mannan or  pectin. <21,23,24,25,26,27,28,29,31>)  "
3.1.1.73, feruloyl-polysaccharide + H2O = ferulate + polysaccharide  
3.1.1.74, cutin + H2O = cutin monomers  
3.1.1.75, [(R)-3-hydroxybutanoate]n + H2O = [(R)-3-hydroxybutanoate]n-x +  [(R)-3-hydroxybutanoate]x; x: 1-5  
3.1.1.76," Hydrolyses the polyester poly{oxycarbonyl[(R)-2-pentylethylene]} to  oligomers (#16# active site residues are Ser19, Asp101, and His135  located at the bottom of a crevice, two possible PHA degradation  reaction mechanisms <17>; #21,22# Asn111 and Ser110 function as  oxyanions important in transition-state stabilization of the hydrolytic  reaction <16>)  "
3.1.1.77, 3-(acyloxy)acyl group of bacterial toxin + H2O = 3-hydroxyacyl group of  bacterial toxin + a fatty acid  
3.1.1.78, polyneuridine aldehyde + H2O = 16-epivellosimine + CO2 + methanol  
3.1.1.79, triacylglycerol + H2O = diacylglycerol + a carboxylate 
3.1.1.79, diacylglycerol + H2O = monoacylglycerol + a carboxylate 
3.1.1.79, monoacylglycerol + H2O = glycerol + a carboxylate  
3.1.1.8," an acylcholine + H2O = choline + a carboxylate (#4,5,6,7,10,11,16,35#  mechanism <16,48,52>; #5# enzyme is able to stabilize covalent  tetrahedral intermediate adduct with substrate <83>; #5# molecular  dynamics simulation in aqueous solution, nucleophilic S198 and the  various binding subsites in the catalytic cavitiy are readily  accessible from the exterior of the protein, the catalytic triad  E325/H438/S198 is stablized by presence of a sodium ion <91>; #5# the  catalytic residue is Ser198 <97>; #88# the enzyme follows a mechanism  similar to that of a serine protease in which the activated serine  attacks the acyl-substrate to form an acyl-enzyme intermediate. The  acyl-enzyme intermediate then reacts directly with a water molecule at  the active site. Both the acylation and deacylation reactions occur  through a tetrahedral intermediate <214>)  "
3.1.1.80, 17-O-acetylajmaline + H2O = ajmaline + acetate 
3.1.1.80, 17-O-acetylnorajmaline + H2O = norajmaline + acetate  
3.1.1.81," an N-acyl-L-homoserine lactone + H2O = an N-acyl-L-homoserine (#33#  active site structure and substrate binding, catalytic mechanism,  overview <13>; #55,56# hydrolysis of the lactone ring <10>; #10#  residues H106, D108, and H109, as well as H169 are important for  catalytic activity <9>; #33# substrate binding and catalytic mecanism,  overview <14>; #67# catalytic mechanism of the quorum-quenching  metalloenzyme, overview <18>; #67# enzyme-substrate complex structure  and detailed mechanism for the ring-opening hydrolysis of acyl  homoserine lactone substrates as catalyzed by the AHL lactonase from  Bacillus thuringiensis, overview <18>; #67# reaction mechanism, and  active site structure and function modeling, Asp108 residue, and not  Tyr194, shuttles the proton during the reaction, overview <22>; #27#  AiiA degrades AHLs in a tail length independent manner. The presence of  the tail is required for activity. The putative oxyanion hole function  of Y194 toward the substrate seem to show efficacy in stabilizing the  intermediate state. Proton shuttling necessary for catalytic activity  might be mediated by both water and substrate-based intra-molecular  proton transfer <36>)  "
3.1.1.82, pheophorbide a + H2O = pyropheophorbide a + methanol + CO2 
3.1.1.82, pheophorbide a + H2O = C-132-carboxypyropheophorbide a + methanol 
3.1.1.82, C-132-carboxypyropheophorbide a = pyropheophorbide a + CO2  
3.1.1.83, isoprop(en)ylmethyloxepan-2-one + H2O =  6-hydroxyisoprop(en)ylmethylhexanoate 
3.1.1.83, 4-isopropenyl-7-methyloxepan-2-one + H2O =  6-hydroxy-3-isopropenylheptanoate 
3.1.1.83," 7-isopropyl-4-methyloxepan-2-one + H2O = 6-hydroxy-3,7-dimethyloctanoate  "
3.1.1.84," cocaine + H2O = ecgonine methyl ester + benzoate (#4# the entire  hydrolysis reaction consists of four reaction steps, including the  nucleophilic attack on the carbonyl carbon of benzoyl ester group by  the hydroxyl group of Ser117, dissociation of benzoyl ester group,  nucleophilic attack on the carbonyl carbon of benzoyl ester group by  water, and finally dissociation between the (-)-cocaine benzoyl group  and Ser117 of CocE. The third reaction step involving the nucleophilic  attack of a water molecule is rate-determining <7>)  "
3.1.1.85, pimeloyl-[acyl-carrier protein] methyl ester + H2O =  pimeloyl-[acyl-carrier protein] + methanol  
3.1.1.86, Hydrolytic cleavage of 2-O-acetyl- or 3-O-acetyl groups of  alpha-D-galacturonic acid in rhamnogalacturonan I.  
3.1.1.87," fumonisin B1 + 2 H2O = aminopentol + 2 propane-1,2,3-tricarboxylate  "
3.1.1.88," trans-permethrin + H2O = (3-phenoxyphenyl)methanol +  (1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate  "
3.1.1.89, [phosphatase 2A protein]-leucine methyl ester + H2O = [phosphatase 2A  protein]-leucine + methanol  
3.1.1.90, an all-trans-retinyl ester + H2O = 13-cis-retinol + a fatty acid  
3.1.1.91, 2-oxo-3-(5-oxofuran-2-ylidene)propanoate + H2O = maleylpyruvate  
3.1.1.92, 4-sulfomuconolactone + H2O = maleylacetate + sulfite  
3.1.1.93, mycophenolic acid O-acyl-glucuronide + H2O = mycophenolate +  D-glucuronate  
3.1.1.94, versiconal hemiacetal acetate + H2O = versiconal + acetate 
3.1.1.94, versiconol acetate + H2O = versiconol + acetate  
3.1.1.95, aclacinomycin T + H2O = 15-demethylaclacinomycin T + methanol  
3.1.1.96, a D-aminoacyl-tRNA + H2O = a D-amino acid + tRNA 
3.1.1.96, glycyl-tRNAAla + H2O = glycine + tRNAAla  
3.1.1.97, diphthine methyl ester-[translation elongation factor 2] + H2O =  diphthine-[translation elongation factor 2] + methanol  
3.1.1.98, [Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine + H2O = [Wnt]-L-serine +  (9Z)-hexadec-9-enoate  
3.1.1.99," 6-deoxy-6-sulfo-D-glucono-1,5-lactone + H2O =  6-deoxy-6-sulfo-D-gluconate  "
3.1.11.1," Exonucleolytic cleavage in the 3'- to 5'- direction to yield nucleoside  5'-phosphates (#2# mechanism <17>; #3# study of interaction between  enzyme and mismatch repair proteins MLH1, MLH2 and MLH3. The enzyme  binds strongly to MLH1 and forms an immunoprecipitable complex with  MLH1/MLH2 in vivo <16>; #1# the enzyme is involved in mismatch repair  and participates directly in somatic hypermutation and class-switch  recombination <25>)  "
3.1.11.2," Exonucleolytic cleavage in the 3'- to 5'- direction to yield nucleoside  5'-phosphates (#1# four activities of enzyme: 3Â’-5Â’ exonuclease, RNase  H, 3Â’-phosphatase and AP endonuclease <31>; #7# XthA exonuclease  converts the blunt ends of double-stranded DNA to 5 protruding ends in  the process of in vivo cloning. After the insert and the vector DNA  fragments are introduced into the Escherichia coli cell, XthA resects  the ends of the DNA fragments from the 3-to-5 direction, producing 5  overhanging ends. As the ends of insert and vector DNAs have mutually  complementary sequences, the 5 overhanging ends of the insert and the  vector DNA fragments hybridize to each other as cohesive ends. In  addition, the gaps are filled by DNA polymerases and the nicks are  repaired by DNA ligases <55>)  "
3.1.11.3, exonucleolytic cleavage in the 5'- to 3'-direction to yield nucleoside  5'-phosphates (#5# lambda exonuclease uses a classic two-metal  mechanism <23>)  
3.1.11.4, exonucleolytic cleavage in the 5'- to 3'-direction to yield nucleoside  5'-phosphates  
3.1.11.5," Exonucleolytic cleavage (in the presence of ATP) in either 5'- to 3'-  or 3'- to 5'-direction to yield 5'-phosphooligonucleotides (#5#  preference for double-stranded DNA, possesses DNA-dependent ATPase  activity, acts endonucleolytically on single-stranded circular DNA <4>;  #5# mechanism, The enzyme is an ATP-dependent DNA exonuclease and a  helicase, its exonuclease activity is subject to regulation by an  octameric nucleotide sequence called chi. <44>; #5# The enzyme  generates 3Â’ single-stranded DNA ends used by RecA for homologous  recombination. The exonuclease activity is altered when the enzyme  encounters a Chi sequence, 5Â’-GCTGGTGG-3Â’, in double-stranded DNA, an  event critical to generation of 3Â’ single-stranded DNA. Chi recognition  requires that Chi be flanked by DNA at either end. A specific site for  Chi recognition exists on enzyme, which binds Chi with greater affinity  than a non-Chi sequence and is probably adjacent to non-specific DNA  binding sites. <50>; #5# The enzyme is involved initiating DNA  recombination. The nuclease properties of the enzyme are regulated upon  recognition of a specific DNA sequence by the translocating enzyme.  This sequence, called chi, corresponds to the octamer 5Â’-GCTGGTGG-3Â’.  <48>; #5# The enzyme is required for homologous recombination and DNA  repair, the degradative and recombinational activities of enzyme, as  well as its structure, are regulated by a specific DNA sequence called  Chi. The recombination requires loading of RecA by RecBCD enzyme and  that the RecD subunit inhibits this reaction. <52>; #20# the enzyme  complex is activated once unwinding progresses. Extension of the 5-tail  of the unwound duplex induces a large conformational change in the RecD  subunit, that is transferred through the RecC subunit to activate the  nuclease domain of the RecB subunit. The process involves a SH3 domain  that binds to a region of the RecB subunit in a binding mode that is  distinct from others observed previously in SH3 domains <70>)  "
3.1.11.6, Exonucleolytic cleavage in either 5'- to 3'- or 3'- to 5'-direction to  yield nucleoside 5'-phosphates  
3.1.11.7," adenosine-5'-diphospho-5'-[DNA] + H2O = AMP + phospho-5'-[DNA] (#1# a  two-step mechanism for hydrolysis of 5-AMP from RNA-DNA and DNA, APTX  catalytic mechanism, overview. In the first step, the active site  nucleophile (His260 of the HIT loop in APTX) attacks the 5-adenylate  phosphoanhydride forming a transient enzyme-AMP intermediate and  releasing a DNA 5-phosphate product. Several hydrogen bonds with  active-site residues and peptide backbone amides stabilize the negative  charge on the transition-state of step 1. The nucleophile (His260) is  activated by a hydrogen bond to the carbonyl of His258, while His251 is  proposed to protonate the 5-phosphate leaving group. The second step  involves hydrolysis of the His260-AMP-RNA/DNA intermediate, using  chemistry that is essentially the reverse of the first step with water  replacing the 5-phosphate, and with His251 proposed to act as a general  base to deprotonate a water nucleophile <5>; #1# the catalytic reaction  proceeds in three steps: substrate protonation, DNA deadenylation and  histidine-AMP intermediate hydrolysis. The calculated activation  energies for the second and third reactions are 19.0 and 10.5 kcal/mol,  which can be attributed to a penta-coordinated AMP-phosphoryl formation  and closing of a water molecule, respectively. A histidine-AMP  intermediate is hydrolyzed easily in the third step when a water  molecule closes within 3 A to the phosphorus nucleus <1>) "
3.1.11.7," adenosine-5'-diphospho-5'-(ribonucleotide)-[DNA] + H2O = AMP +  5'-phospho-(ribonucleotide)-[DNA] (#1# a two-step mechanism for  hydrolysis of 5-AMP from RNA-DNA and DNA, APTX catalytic mechanism,  overview. In the first step, the active site nucleophile (His260 of the  HIT loop in APTX) attacks the 5-adenylate phosphoanhydride forming a  transient enzyme-AMP intermediate and releasing a DNA vphosphate  product. Several hydrogen bonds with active-site residues and peptide  backbone amides stabilize the negative charge on the transitin-state of  step 1. The nucleophile (His260) is activated by a hydrogen bond to the  carbonyl of His258, while His251 is proposed to protonate the  5-phosphate leaving group. The second step involves hydrolysis of the  His260-AMP-RNA/DNA intermediate, using chemistry that is essentially  the reverse of the first step with water replacing the 5-phosphate, and  with His251 proposed to act as a general base to deprotonate a water  nucleophile <5>; #1# the catalytic reaction proceeds in three steps:  substrate protonation, DNA deadenylation and histidine-AMP intermediate  hydrolysis. The calculated activation energies for the second and third  reactions are 19.0 and 10.5 kcal/mol, which can be attributed to a  penta-coordinated AMP-phosphoryl formation and closing of a water  molecule, respectively. A histidine-AMP intermediate is hydrolyzed  easily in the third step when a water molecule closes within 3 A to the  phosphorus nucleus <1>)  "
3.1.12.1, exonucleolytic cleavage in the 5'- to 3'-direction to yield nucleoside  3'-phosphates  
3.1.13.1," Exonucleolytic cleavage in the 3'- to 5'- direction to yield nucleoside  5'-phosphates (#6,7,8,9,10# acts in a processive manner  <2,5,6,8,9,11,13,14,17,18>; #7,16# can act as a endonuclease too <1,7>;  #7# sensitive to RNA secondary structures <12>)  "
3.1.13.2," 3'-end directed exonucleolytic cleavage of viral RNA-DNA hybrid  (#20,32# the enzyme reverse transcriptase has polymerase and RNase H  activities <14,17>; #20# The enzyme reverse transcriptase has  polymerase and RNase H activities, study of progressive cleavage  mechanism of enzyme. Because the residual RNAs vary in length, longer  RNAs require several additional cleavage events for complete removal.  <19>; #23# The multifunctional enzyme possesses both RNA- and  DNA-dependent DNA polymerase activity and an RNase H activity. The  activity of enzyme is coordinated by a catalytic triad, E478, D443,  D498, of acidic residues that bind divalent cations. <10>; #20# The  RNase H activity is necessary for strand transfers, which occur through  a two-step mechanism. The docking, which is the first step is most  efficient when the reverse transcriptase pauses in a way that makes a  series of adjacent RNase H cleavages. Invasion at the site is promote  at high acceptor concentration and by the presence of nucleocapsid. The  locking step is the second, which is most proficient in regions of weak  pausing that lack stable structure and is promoted by the chaperone  properties of nucleocapsid. <15>; #20# two activities are present in  the reverse transcriptase: polymerase and RNase H. RNase H is required  for removal of the viral RNA, primer formation and removal for the  synthesis of the (+) strand DNA, and specific removal of the primer  tRNA used in the synthesis of the (-) strand DNA. <12>; #23# RNase H  domain, part of reverse transcriptase: active site residue E478 is  essential for activity <23>; #13,20# the selection of 5-end-directed  cleavage sites by the retroviral RNase H results from a combination of  nucleotide sequence, permissible distance, and accessibility to the RNA  5-end <29>; #20# RNase H catalytic cleavage mechanism for end-directed  primary and secondary cleavages <37>; #13# RNase H domain structure and  mechanism of catalysis <40>; #32# RNase H utilizes a two-metal ion  mechanism of catalysis, the first metal ion A activates the  nucleophilic water molecule and the second metal ion B, possibly in  conjunction with metal ion A, stabilizes the transition state  intermediate, catalytic residues are Asp443, Glu478, Asp498 and Asp549,  substrate interactions, reaction mechanism and cleavage mode, overview  <42>; #13# RNase H utilizes a two-metal ion mechanism of catalysis, the  first metal ion A activates the nucleophilic water molecule and the  second metal ion B, possibly in conjunction with metal ion A,  stabilizes the transition state intermediate, substrate interactions,  reaction mechanism and cleavage mode, overview <42>)  "
3.1.13.3," exonucleolytic cleavage of oligonucleotides to yield nucleoside  5'-phosphates (#17# RNA binding and hydrolysis mechanism of  oligoribonuclease CpsORN, overview. The His158 residue shows inward  movement toward the active site to interact with the cleaved uridine  phosphate, in the two-uridine complex structure. The side chain of  His158 is also near the cleavage site of the U-U RNA substrate. The  His158 is an activator of the water molecule during the enzymatic  reaction of enzyme CpsORN. The manganese ion forms a new interaction  with the 3-oxygen of the ribose in the U1 ribonucleotide <24>)  "
3.1.13.4," exonucleolytic cleavage of poly(A) to 5'-AMP (#4# mechansim, substrate  recognition of mRNA for degradation <15>; #4# catalytic mechanism for  CNOT6L 3-5 deadenylation involving a pentacovalent phosphate  transition, overview <41>)  "
3.1.13.5, exonucleolytic cleavage that removes extra residues from the  3'-terminus of tRNA to produce 5'-mononucleotides  
3.1.14.1," exonucleolytic cleavage to nucleoside 3'-phosphates (#1,2,4,5,6,8,9#  exonucleolytic cleavage <1,2,3,4,5,6,7,8,9>; #2# conserved Tyr814 is  involved in catalysis and is essential for enzyme Dssp1 function and  mitochondrial biogenesis <11>)  "
3.1.15.1, Exonucleolytic cleavage in the 3'- to 5'- direction to yield nucleoside  5'-phosphates  
3.1.16.1, exonucleolytic cleavage in the 5'- to 3'-direction to yield nucleoside  3'-phosphates (#6# also degradation of thymine and adenine  polynucleotides to thymine and adenine <18>)  
3.1.2.1," acetyl-CoA + H2O = CoA + acetate (#6# the bifunctional enzyme is  identical with a 3-ketoacyl-CoA thiolase isozyme, i.e. THL, EC 2.3.1.9,  determined by internal peptide amino acid sequence comparison <35>; #4#  as shown by proton nuclear magnetic resonance spectroscopy the  disappearance of acetyl CH3 from acetyl Coenzyme A occurres  concomitantly with the appearance of a CH3 peak corresponding to that  of free acetate and suggesting that folate is not acetylated during the  reaction <42>; #5# as shown by proton nuclear magnetic resonance  spectroscopy the disappearance of acetyl CH3 from acetyl Coenzyme A  occurrs concomitantly with the appearance of a CH3 peak corresponding  to that of free acetate and suggesting that folate is not acetylated  during the reaction <42>)  "
3.1.2.10, formyl-CoA + H2O = CoA + formate  
3.1.2.11, acetoacetyl-CoA + H2O = CoA + acetoacetate  
3.1.2.12," S-formylglutathione + H2O = glutathione + formate (#8# Cys59 and Ser152  are involved in catalysis <19>; #3# Ser145, Asp233, and His256 are  essential for catalysis, representing a serine hydrolase catalytic  triad, Cys26 and Cys54 are not involved in catalysis, mechanism <18>)  "
3.1.2.13, S-succinylglutathione + H2O = glutathione + succinate  
3.1.2.14," an oleoyl-[acyl-carrier protein] + H2O = an [acyl-carrier protein] +  oleate (#44# catalytic residues are Asn227, Cys264 and His229, forming  a papain-like catalytic triad <27>)  "
3.1.2.16, acetyl-[citrate (pro-3S)-lyase] + H2O = holo-[citrate (pro-3S)-lyase] +  acetate  
3.1.2.17, (S)-methylmalonyl-CoA + H2O = methylmalonate + CoA  
3.1.2.18, acyl-CoA + H2O = CoA + a carboxylate  
3.1.2.19, acyl-CoA + H2O = CoA + a carboxylate  
3.1.2.2," palmitoyl-CoA + H2O = CoA + palmitate (#49# catalytic triad  D337-Q409-S359 <76>; #45# catalytic triad D233-S255-Q305 <81>; #44#  active site serine residue <80>; #8# specific catalyzation of the  deacylation of long-chain fatty acyl-CoA thioesters, enzyme possesses a  Ser-His-Asp catalytic triad <85>)  "
3.1.2.20," acyl-CoA + H2O = CoA + a carboxylate (#21# catalytic triad  D337-Q409-S359 <76>; #51# catalytic triad D233-S255-Q305 <81>; #50#  active site serine residue <80>; #10# based on the results of quantum  mechanics/molecular mechanics metadynamics techniques simulations, it  is demonstrated that hotdog-fold hTHEM2 follows a simple mechanism in  which a water molecule directly attacks the carbonyl carbon atom to  cleave the thioester bond without requiring an enzyme-substrate  covalent intermediate the reaction, providing evidence for the  formation of a tetrahedral-like transition state <113>; #57# molecular  dynamics studies show that certain residues of the substrate binding  tunnel are flexibel and thus modulate the length of the tunnel <114>)  "
3.1.2.21, a dodecanoyl-[acyl-carrier protein] + H2O = an [acyl-carrier protein] +  dodecanoate  
3.1.2.22," palmitoyl[protein] + H2O = palmitate + protein (#3,4,5,8# specific for  long-chain thioesters of fatty acids from S-acylated residues in  proteins, palmitoyl cysteine and palmitoyl-CoA  <12,13,14,15,16,17,18,20,21,22,23,24>; #4# specific for long-chain  thioesters of fatty acids from S-acylated residues in proteins,  palmitoyl cysteine and palmitoyl-CoA, catalytic triad consists of  Ser115, His289, and Asp233 <25>; #4# specific for long-chain thioesters  of fatty acids from S-acylated residues in proteins, palmitoyl cysteine  and palmitoyl-CoA, catalytic triad of PPT2 consists of Ser111, His283,  and Asp228, mechanism, both PPT1 and PPT2 have lipid-binding grooves  leading away from the active site <19>)  "
3.1.2.23," 4-Hydroxybenzoyl-CoA + H2O = 4-hydroxybenzoate + CoA (#1# mechanism  <3>; #2# active site structure and ligand binding mechanism, overview  <6>; #1# catalytic sites of wild-type and mutant enzymes, substrate  binding modifications, reaction kinetics <4>; #1# substrate and  inhibitor binding by wild-type and mutant D17N enzymes, reaction  mechanism and active site structure <5>)  "
3.1.2.25," phenylglyoxylyl-CoA + H2O = phenylglyoxylate + CoA (#2# This is the  second step in the conversion of phenylacetyl-CoA to phenylglyoxylate,  the first step being carried out by EC 1.17.5.1, phenylacetyl-CoA  dehydrogenase <2>)  "
3.1.2.27," choloyl-CoA + H2O = cholate + CoA (#2,4# the catalytic triad is formed  by Asp233, Ser255, and Gln305 <1,5>)  "
3.1.2.28," 1,4-dihydroxy-2-naphthoyl-CoA + H2O = 1,4-dihydroxy-2-naphthoate + CoA  "
3.1.2.29, fluoroacetyl-CoA + H2O = fluoroacetate + CoA  
3.1.2.3, succinyl-CoA + H2O = CoA + succinate  
3.1.2.30, (S)-malyl-CoA + H2O = (S)-malate + CoA  
3.1.2.31, dihydromonacolin L-[lovastatin nonaketide synthase] + H2O =  holo-[lovastatin nonaketide synthase] + dihydromonacolin L acid  
3.1.2.32, (2-aminobenzoyl)acetyl-CoA + H2O = (2-aminobenzoyl)acetate + CoA  
3.1.2.4," 3-hydroxy-2-methylpropanoyl-CoA + H2O = CoA +  3-hydroxy-2-methylpropanoate (#6# formation of an anhydride reaction  intermediate, catalytic mechanism <6>)  "
3.1.2.5, (S)-3-hydroxy-3-methylglutaryl-CoA + H2O = CoA +  3-hydroxy-3-methylglutarate  
3.1.2.6," S-(2-hydroxyacyl)glutathione + H2O = glutathione + a 2-hydroxy  carboxylate (#5# mechanism <7,13>; #6# reaction mechanism <42>; #31#  active site and reaction mechanism <43>; #4# active site residue Tyr175  contributes to the binding of glutathione derivatives by its hydroxyl  group which forms hydrogen binds to the glycine in the glutathione  moiety <41>)  "
3.1.2.7, S-acylglutathione + H2O = glutathione + a carboxylate  
3.1.21.1," endonucleolytic cleavage to 5'-phosphodinucleotide and  5'-phosphooligonucleotide end-products (#35# preference for  single-stranded DNA <55>; #46# Asp44 is involved in catalysis, while  Met118, Gln134, Glu190, and Met236 are not <51>; #31# catalytic  mechanism, the N-terminal 62 residues and the C-terminal 39 residues  have important roles in 3-exonuclease activity, residues 63-453 are  responsible for 5- and 3-exonuclease activities, residues 24-492 form a  region with 7fold higher catalytic activity than the intact enzyme  <45>; #43# conserved residues Glu79, His135, Asp213, and His 252 are  involved in catalysis <56>; #6# Glu128 is required for activity,  contains conserved sequence LEDFXR, endonuclease activity <46>;  #9,43,44,45,47,48,49# preference for double-stranded DNA  <49,51,57,59,60>; #50# preference for single-stranded DNA and 3AMP,  guanylic acid preferential endo-exonuclease, mode of action, overview  <53>)  "
3.1.21.10, endonucleolytic cleavage at a junction such as a reciprocal  single-stranded crossover between two homologous DNA duplexes (Holliday  junction)  
3.1.21.2, Endonucleolytic cleavage of ssDNA at apurinic/apyrimidinic sites to  5'-phosphooligonucleotide end-products (#1# reaction mechanism <2>; #4#  reaction mechanism modelling <3>)  
3.1.21.3, endonucleolytic cleavage of DNA to give random double-stranded  fragments with terminal 5'-phosphates; ATP is simultaneously hydrolysed  (#4# kinetic model for DNA-translocation and DNA cleavage <16>; #6#  monitoring of mechanism on 27 MHz quartz-crystal microbalance <17>)  
3.1.21.4," endonucleolytic cleavage of DNA to give specific double-stranded  fragments with terminal 5'-phosphates (#8# autoinhibition/activation  mechanism <20>; #75# residue H291 is the direct catalytic residue, N308  is important for the structural integrity of the betabetaalpha motif,  while D317 and D321 are involved in metal ion binding <55>; #8#  residues D311 and N334 coordinate the cofactor. H312 acts as a general  base actiating a water molecule for the nucleophilic attack. K337  together with R340 and D345 are located close to the active center and  are essential for correct folding of cataloytic motif, while D345, R264  and D273 may be directly involved in DNA binding <50>)  "
3.1.21.5," endonucleolytic cleavage of DNA to give specific double-stranded  fragments with terminal 5'-phosphates (#4,13# mechanism <14,15>; #4#  mechanism, formation of loop structures and DNA translocation <16>; #4#  mechanism, model of DNA translocation and cleavage, overview <17>)  "
3.1.21.6," Endonucleolytic cleavage to give 5'-phosphooligonucleotide  end-products, with a preference for cleavage within the sequence CC  "
3.1.21.7, endonucleolytic cleavage at apurinic or apyrimidinic sites to products  with a 5'-phosphate  
3.1.21.8, endonucleolytic nicking and cleavage of cytosine-containing  double-stranded DNA  
3.1.21.9, endonucleolytic cleavage of the 5' phosphodiester bond of deoxycytidine  in single-stranded DNA  
3.1.22.1," endonucleolytic cleavage to nucleoside 3'-phosphates and  3'-phosphooligonucleotide end-products (#7,24# deoxyribonuclease IIbeta  is a protein with considerably homology to DNase II <45>; #13# The  pathway for DNA degradation involves three distinct steps. The second  step is mediated by the NUC-1. <48>; #24# The protein is a single,  contiguous polypeptide chain, featuring N-linked sugar moieties and at  least one disulfide bridge <39>; #8# the signal-peptide leader sequence  is required for correct glycosylation and the N-glycosylation is  important for formation of the active enzyme <40>)  "
3.1.22.2, endonucleolytic cleavage to nucleoside 3'-phosphates and  3'-phosphooligonucleotide end-products  
3.1.22.5, endonucleolytic cleavage of supercoiled plasma DNA to linear DNA  duplexes  
3.1.25.1," endonucleolytic cleavage near pyrimidine dimers to products with  5'-phosphate (#5,7# specific for cis-syn cyclobutane pyrimidine dimers  <21,24>; #3,5,7# cleavage on the 5-side of dimers  <3,7,8,10,11,13,15,17,20,21>; #7# salt concentrations of more than 40  mM cause the endonuclease V to shift into a distributive search  mechanism instead of the processive mechanism <21>; #7# cleavage on the  3-side of the apyrimidinic site <2,4>; #5,7# minimum chain length:  longer than 10 nucleotides <9,15,18>; #5# Py-Py correndonuclease I  creates a terminus which is more single-stranded in character than that  produced by Py-Py correndonuclease II <15,18>; #5# dsDNA is an  effective substrate vor Py-Py correndonucleases I and II, only  correndonuclease I can degrade ssDNA <18>; #5# for DNA repair the  combined action of Py-Py correndonuclease I and II is necessary  <16,18>; #7# 2-step mechanism, pyrimidine dimer-DNA glycosylase and an  apurinic/apyrimidinic endonuclease <1,2,4,5,6,7,8,10,13,20,21>; #5,7#  processive <7,8,21,24>; #5,7# beta-elimination mechanism, imino  intermediate <21,23,24>; #7# damaged DNA substrate recognition  mechanism, 2 distinct catalytic activities: cleavage of the glycosyl  bond at the 5side of pyrimidine dimer and subsequent scission of the  phosphodiester bond at the 3 position of an abasic site through  beta-elimination, the enzyme also scans nontarget sequences to search  for lesions in DNA duplexes, glycosylase active site involves the  catalytic residues Arg3, Glu23, Arg22, and Arg26 and the amino terminus  which forms an imino-covalent intermediate with C1 of the 5 side of the  thymidine-dimer <26>; #9# substrate recognition mechanism: 2 flexible  loops are involved in binding and scanning along DNA duplex to search  for thymidine dimers within UV-damaged DNA, residues Arg22, Glu23,  Thr88 are involved in DNA binding and catalysis, and the regions of  Lys45-Phe60 and Lys86-Asp92 are involved in DNA binding and scanning  <25>; #3# reaction mechanisms of UvrA, UvrB, and UvrC <32>)  "
3.1.26.1," Endonucleolytic cleavage to a 5'-phosphomonoester (#1# purine  preference with regard to 3-terminal nucleotides <1>; #1# B1 site, i.e.  base recognition site for the base at 5-side of scissile phosphodiester  bond, and B2 site, i.e. base recognition site for the base at 3-side of  the scissile bond, identification <2>)  "
3.1.26.10, endonucleolytic cleavage of poly(U) or poly(C) to fragments terminated  by 3'-hydroxy and 5'-phosphate groups  
3.1.26.11," endonucleolytic cleavage of RNA, removing extra 3' nucleotides from  tRNA precursor, generating 3' termini of tRNAs. A 3'-hydroxy group is  left at the tRNA terminus and a 5'-phosphoryl group is left at the  trailer molecule  "
3.1.26.12," endonucleolytic cleavage of single-stranded RNA in A- and U-rich  regions (#19# catalytic mechanism, the 10-mer and 13-mer RNAs are bound  entirely by one tetramer, while the 15-mer RNA is long enough for it to  be shared between two different tetramers in the crystal lattice, and  this RNA extends from the 5 sensing pocket of one tetramer into the  binding channel and catalytic site of a symmetry-related tetramer. Two  molecules of 15-mer RNA pass each other in antiparallel orientations  and form a highly distorted duplex, Asp 303 and Asp 346 might act as  general bases to activate the attacking water <22>; #19# molecular  mechanism, residues A326 and L385 are involved in substrate binding  <34>)  "
3.1.26.13," Endohydrolysis of RNA in RNA/DNA hybrids. Three different cleavage  modes: 1. sequence-specific internal cleavage of RNA. Human  immunodeficiency virus type 1 and Moloney murine leukemia virus enzymes  prefer to cleave the RNA strand one nucleotide away from the RNA-DNA  junction. 2. RNA 5'-end directed cleavage 13-19 nucleotides from the  RNA end. 3. DNA 3'-end directed cleavage 15-20 nucleotides away from  the primer terminus. (#8# cleavage reaction mechanism and substrate  specificity of HIV-1 RNase H, overview <63>)  "
3.1.26.2, Endonucleolytic cleavage to a 5'-phosphomonoester  
3.1.26.3," Endonucleolytic cleavage to a 5'-phosphomonoester (#2,7,8,12,22#  catalytic active site and substrate binding site structure and number  determines the classification into classes I to III, overview <42>;  #35# catalytic active site and substrate binding site structure and  number determines the classification into classes I to III, overview,  mechanism <42>; #7# determination of specific cleavage site, Glu117 is  important for phosphodiester hydrolysis <41>; #7# Glu117 is essential  for phosphodiester hydrolysis but not for substrate binding, the  dsRNA-binding domain is important for substrate binding but not for  catalytic activity, while the catalytic domain is important for  catalytic activity but not for substrate binding <35>; #7# reaction  mechanism, conserved Mn2+-dependent Glu117 is required, overview <33>;  #10# RNA substrate forms a duplex structure with a terminal four-base  loop with the sequence AGNN, being an important determinant of the  substrate selectivity in the dsRNA binding domain dsRBD, the N-terminal  region is not required for selective cleavage in vitro but required for  full function and viability of yeast cells in vivo, substrate binding  modeling <46>; #8,10,21,48,56,61,63# catalytic mechanism, overview. The  enzyme activates water as a nucleophile to hydrolyze target site  phosphodiesters, creating 3-hydroxyl, 5-phosphomonoester product  termini <120>; #7# catalytic mechanism, overview. The enzyme activates  water as a nucleophile to hydrolyze target site phosphodiesters,  creating 3-hydroxyl, 5-phosphomonoester product termini, essential  irreversibility of the hydrolytic step <120>; #73# catalytic mechanism  of RNase III, overview. RNase III activates water as a nucleophile to  hydrolyze target site phosphodiesters, creating 3-hydroxyl,  5-phosphomonoester product termini, Mg2+ serves as the ion facilitating  departure of the 3-oxygen atom, while Mg2+ binds and activates the  water nucleophile. And both metal ions may coordinate to both the  nucleophile and the nonbridging phosphoryl oxygen to stabilize the  in-line geometry required for phosphoryl transfer reactions <127>; #47#  mechanism of RNase III catalytic action, overview. Endoribonucleolytic  activity of RNase III produces 2-nucleotide 3-OH overhang at the end of  dsRNA substrates <128>)  "
3.1.26.4," Endonucleolytic cleavage to a 5'-phosphomonoester (#8# random  endonucleolytic cleavage <20>; #4# active site residues are Asp10,  Gu48, Asp70, His124, Asp134 <59>; #52# active site structure, substrate  binding groove, molecular mechanism for specific RNA*DNA hybrid  substrate recognition, binding, and cleavage, a general nuclease  activity is necessary for catalysis <56>; #5# Asp10 is critical for  activity and involved in binding of divalent metal ion <61>; #51#  Asp10, Glu48, Asp70, and Asp134 are involved in catalysis, role of Mn2+  in catalysis, mechanism <49>; #23# Asp149 is essential for catalytic  activity, Asp7, Glu8 and Asp112 are invovled in metal ion binding <50>;  #16# structure-function relationship, a 42 amino acid noncanonical  spacer domain is essential for enzyme function, the nuclear  localization domain is not required for function but for RNA binding,  it modulates the enzyme manganese-dependent activity <47>; #27# the  catalytic reaction requires 4 acidic residues, catalytic center and  catalytic mechanism of type 1 and type 2 ribonucleases, type 1 enzyme  requires a histidine as general base, while type 2 enzyme does not,  substrate binding of type 2 enzyme <60>; #34# active site and substrate  binding site structures <69>; #5# active site residues D10, E48, D70,  and D134 are involved in metal ion binding, overview <68>; #4,5#  evolutionary conserved flexible regions are important for catalysis,  structure function relationship, enthalpic/entropic compensation  mechanism, overview <72>; #6# substrate structure influence on enzyme  activity, substrate binding, overview <67>; #39# the enzyme performs a  two-metal catalysis, with metal A activating the nucleophile and metal  B stabilizing the transition state, mechanism and structures, overview  <64>; #34# four acidic active-site residues of Bst-RNase HIII: Asp97,  Glu98, Asp202, and Glu232, substrate binding and site structure, active  site structure and reaction mechanism, overview <69>; #5# possible  mechanisms for the RNase HII-catalysed reaction consistent with the  pH-dependent behaviour of the enzyme, the active sites of RNase H  enzymes contain a cluster of four strictly conserved carboxylate  groups, requirement for ionisation of an active site carboxylic acid  for metal ion binding or correct positioning of metal ion in the  enzyme-substrate complex and a role for a second active site  carboxylate in general base catalysis <77>; #43# active site geometry  suggests a two-metal ion-dependent catalytic mechanism <95>; #26# in  the initial attack of the phosphate diester by water, the  oxygen-phosphorus distances alone are not sufficient as reaction  coordinates, resulting in substantial hysteresis in the proton degrees  of freedom and a barrier that is too low. If the proton degrees of  freedom are included in an extended reaction coordinate, we obtain a  barrier of 21.6 kcal/mol consistent with the experimental rates. As the  barrier is approached, the attacking water molecule transfers one of  its protons to the O1P oxygen of the phosphate group. At the barrier  top, the resulting hydroxide ion forms a penta-coordinated phosphate  intermediate <97>; #5# mechanism of RNase H mediated cleavage of the  RNA, overview <158>)  "
3.1.26.5," endonucleolytic cleavage of RNA, removing 5'-extranucleotides from tRNA  precursor (#14,17# an RNA-containing enzyme, essential for tRNA  processing, generates 5-termini or mature tRNA molecules  structure-function study, substrate recognition and catalytic mechanism  of the ribozyme <58>; #189# an RNA-containing enzyme, essential for  tRNA processing, generates 5-termini or mature tRNA molecules, amino  acids residues Arg90, Arg107, Lys123, Arg176, and Lys196 are involved  in interaction with enzyme RNA or with the pre-tRNA <54>; #28# an  RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, chloroplast enzyme does not use the  ribozyme-type pre-tRNA cleavage mechanism, distinct from bacterial  reaction mechanism <69>; #14,17# an RNA-containing enzyme, essential  for tRNA processing, generates 5-termini or mature tRNA molecules,  cleavage of ssRNA, mechanism <66>; #17# an RNA-containing enzyme,  essential for tRNA processing, generates 5-termini or mature tRNA  molecules, conserved residues in J5/15 are responsible for substrate  affinity and specificity of the ribozyme, nucleotide base N(-1) is  involved in substrate recognition in bacteria and archea <73>; #28# an  RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, non-RNA-based cleavage mechanism,  structure-function relationship of eukaryotic enzymes <62>; #18# an  RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, reaction mechanism in 3 consecutive  steps: pre-tRNA binding, hydrolysis of the scissile phosphodiester  bond, generating a 3-hydroxyl and a 5-phosphate group, possibly via a  trigonal bipyramide, intermediate, and the dissociation of the mature  tRNA and the 5-leader product, structure-function relationship of  eukaryotic enzymes <62>; #20# an RNA-containing enzyme, essential for  tRNA processing, generates 5-termini or mature tRNA molecules, reaction  mechanism in 3 consecutive steps: pre-tRNA binding, hydrolysis of the  scissile phosphodiester bond, generating a 3-hydroxyl and a 5-phosphate  group, possibly via a trigonal bipyramide, intermediate, and the  dissociation of the mature tRNA and the 5-leader product, substrate  recognition mechanism, overview, structure-function realtionship of  eukaryotic enzymes <62>; #20# an RNA-containing enzyme, essential for  tRNA processing, generates 5-termini or mature tRNA molecules,  RNA-based catalytic mechanism <70>; #17# an RNA-containing enzyme,  essential for tRNA processing, generates 5-termini or mature tRNA  molecules, secondary structural features, e.g. helix P4, sequence J5/15  or J18/2 in the RNA portion of the enzyme, are important for catalysis  <60>; #8# an RNA-containing enzyme, essential for tRNA processing,  generates 5-termini or mature tRNA molecules, structure-function study,  substrate recognition and catalytic mechanism of the ribozyme <58>;  #14# an RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, substrate recognition mechanism,  detection methods, the RNA and protein subunits cooperate to bind  different portions of the substrate structure, with the RNA subunit  predominantly interacting with the mature domain of tRNA and the  protein interacting with the 5-leader sequence, substrate recognition  and binding, reaction mechanism and detection methods <63>; #14# an  RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, substrate recognition, enzyme  possesses a single-stranded RNA binding cleft that interacts with the  unpaired 5-leader <62>; #14,17# an RNA-containing enzyme, essential for  tRNA processing, generates 5-termini or mature tRNA molecules, the  protein subunit is essential for substrate binding, the RNA subunit is  essential for catalysis <59>; #3,14,15,17,18,75# an RNA-containing  enzyme, essential for tRNA processing, generates 5-termini or mature  tRNA molecules, the RNA subunit is essential for catalytic activity,  divalent metal ion-dependent in-line SN2 displacement mechanism <61>;  #58# an RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, the RNA subunit is essential for  catalytic activity, except for the mitochondrial enzyme, divalent metal  ion-dependent in-line SN2 displacement mechanism <61>; #18# an  RNA-containing enzyme, essential for tRNA processing, generates  5-termini or mature tRNA molecules, the RNA subunit is the catalytic  unit, while protein subunit Rpp25 is involved in RNA substrate binding,  both interact with each other <72>; #3,18,26,28,30# an RNA-containing  enzyme, essential for tRNA processing, generates 5-termini or mature  tRNA molecules, tRNA precursor substrate recognition and cleavage  mechanism <53>; #14# an RNA-containing enzyme, essential for tRNA  processing, generates 5-termini or mature tRNA molecules, tRNA  precursor substrate recognition and cleavage mechanism, CR-IV region is  imporatnt for tRNA binding <53>; #17# an RNA-containing enzyme,  essential for tRNA processing, generates 5-termini or mature tRNA  molecules, tRNA precursor substrate recognition and cleavage mechanism,  CR-IV region is important for tRNA binding <53>; #20# an RNA-containing  enzyme, essential for tRNA processing, generates 5-termini or mature  tRNA molecules, tRNA precursor substrate recognition and cleavage  mechanism, structure-function relationship of the RNA subunit <53>)  "
3.1.26.6," endonucleolytic cleavage of poly(A) to fragments terminated by  3'-hydroxy and 5'-phosphate groups (#3# random cleavage <2>; #1,3#  forms oligonucleotides with an average chain length of 10 <1,2>)  "
3.1.26.7," endonucleolytic cleavage of RNA, removing 3'-extranucleotides from tRNA  precursor (#2# cleavage sites and pattern <3>)  "
3.1.26.8," endonucleolytic cleavage of RNA, removing 21 and 42 nucleotides,  respectively, from the 5'- and 3'-termini of a 5S-rRNA precursor (#1#  reaction scheme <10>)  "
3.1.26.9, endonucleolytic cleavage of poly(U) to fragments terminated by  3'-hydroxy and 5'-phosphate groups  
3.1.27.7," endonucleolytic cleavage of RNA precursor into two, leaving 5'-hydroxy  and 3'-phosphate groups  "
3.1.27.8," hydrolysis of poly(A), forming oligoribonucleotides and ultimately  3'-AMP  "
3.1.3.1," a phosphate monoester + H2O = an alcohol + phosphate (#125# double  in-line displacement mechanism involving two-metal ion catalysis <55>;  #4,10,11,12,13,15,19,26,27,32,40,41,42,45,70,73,78,91,93,94,95,96,125#  Wide specificity. Also catalyses transphosphorylations. Some enzymes  hydrolyse diphosphate  <81,82,83,84,85,86,87,88,89,90,91,92,93,94,96,97,98,99,101,102,103,104  105,106,108,109,110,111>; #138# Wide specificity. Also catalyses  transphosphorylations. Some enzymes hydrolyse diphosphate, active site  structure, highly conserved in evolution of alkaline phosphatases <95>;  #92# Wide specificity. Also catalyses transphosphorylations. Some  enzymes hydrolyse diphosphate, active site structure, mechanism <100>;  #11# Wide specificity. Also catalyses transphosphorylations. Some  enzymes hydrolyse diphosphate, catalytically active His153 and His328  <103>; #48# Wide specificity. Also catalyses transphosphorylations.  Some enzymes hydrolyse diphosphate, substrate binding and active site  structure <107>; #125# Arg166 contributes to catalysis through binding  interactions and through additional transition state stabilization that  may arise from complementarity of the guanidinum group to the geometry  of the trigonal bipyramidal transition state <187>)  "
3.1.3.10, alpha-D-glucose 1-phosphate + H2O = D-glucose + phosphate  
3.1.3.100, thiamine phosphate + H2O = thiamine + phosphate  
3.1.3.101, validoxylamine A 7'-phosphate + H2O = validoxylamine A + phosphate  
3.1.3.102, FMN + H2O = riboflavin + phosphate  
3.1.3.103, 3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate 9-phosphate + H2O =  3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate + phosphate  
3.1.3.104, 5-amino-6-(5-phospho-D-ribitylamino)uracil + H2O =  5-amino-6-(D-ribitylamino)uracil + phosphate  
3.1.3.105, N-acetyl-D-muramate 6-phosphate + H2O = N-acetyl-D-muramate + phosphate  
3.1.3.106, a 1-acyl-sn-glycerol 3-phosphate + H2O = a 1-acyl-sn-glycerol +  phosphate  
3.1.3.107, amicoumacin A 2-phosphate + H2O = amicoumacin A + phosphate  
3.1.3.108, NADPH + H2O = NADH + phosphate 
3.1.3.108, NADP+ + H2O = NAD+ + phosphate  
3.1.3.11," D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate  (#12# uni-bi mechanism <35>; #13# uni-bi mechanism in forward direction  <11>; #13# steady state ordered uni bi mechanism <59>; #15# all four  subunits are active in a single turnover event <60>; #68# loop 52-72 is  an essential element in the allosteric mechanism of enzyme <108>; #17#  the chloroplast enzyme of higher plants can occur in an active form  that is inactivated upon disulfide bridge formation between Cys155 and  Cys174 <100>; #15# in supramolecular complex with alpha-actinin and  aldolase, D-fructose 1,6-bisphosphate is transferred directly from  aldolase to enzyme without mixing with the bulk phase <120>; #112#  metal-dependent reaction mechanism, allosteric mechanism of the enzyme,  overview <242>; #74# the proposed mechanism involves two metal ions  near the cleavable phosphate: one to stabilize the negative charge on  the leaving group and one to coordinate the nucleophilic water <230>)  "
3.1.3.12," alpha,alpha-trehalose 6-phosphate + H2O = alpha,alpha-trehalose +  phosphate (#37,45,52,53,54# in the first step, trehalose-6-phosphate  binds to the open form of the enzyme, and it is assumed that the  occurrence of productive interactions between enzyme and substrate  cause the cap domain to rotate towards the core domain (step 2), thus  forming a closed substrate-bound form. Nucleophilic attack by an active  site aspartate side chain in the third step leads to a covalent  intermediate that is further hydrolysed into the two product molecules  (step 4). Finally, the enzyme is required to remove the cap from the  core domain in a conformational change (step 5). It can reasonably be  assumed that the steps involving domain movements (steps 2 and 5)  proceed much slower than the chemistry steps (3 and 4). These multiple  processes occur in a population of enzyme molecules in a  non-synchronised fashion. Additionally, it is possible that individual  enzyme molecules undergo a conformational change between open and  closed states in the absence of substrate molecules. Such  non-synchronised conformational changes will lead to a decrease in the  overall rate of the enzymatic reaction of a population of molecules  <69>; #37# molecular mechanism, overview. The catalytic mechanism  involves a nucleophilic attack by an aspartate in the active site  targeting the phosphorus of the phosphate group, which undergoes a  conformational change via a trigonal bipyramidal transition state. The  release of trehalose renders an enzyme-phosphate conjugate that is  hydrolyzed in a second step. It is generally believed that a water  molecule is activated by a second aspartate to form a hydroxyl ion that  performs a nucleophilic attack on the phosphorus, thus hydrolyzing the  aspartate-phosphoester and release of the phosphate. In contrast to  Asp213, the residue inferred to carry out the nucleophilic attack on  the substrate, Asp215 and Asp428 of enzyme BmTPP are involved in the  chemistry steps of enzymatic hydrolysis of the substrate <62>)  "
3.1.3.14, S-methyl-3-phospho-1-thio-D-glycerate + H2O =  S-methyl-1-thio-D-glycerate + phosphate  
3.1.3.15, L-histidinol phosphate + H2O = L-histidinol + phosphate  
3.1.3.16," [a protein]-serine/threonine phosphate + H2O = [a  protein]-serine/threonine + phosphate (#12# mechanism of calcineurin  catalysed reaction <26>; #32# catalytic mechanism, PstPpp catalytic  domain structure and active site structure, structure-function  relationship <168>; #8# Glu76 is involved in catalysis, active site  structure <140>; #8# mechanism of isozyme PP1, the enzyme also performs  the reaction of EC 3.1.3.53, myosin-light-chain-phosphatase <139>; #7#  mechanism of PP1 <139>; #8# regulation and function of the  calcium/calmodulin-dependent protein kinase IV/protein serine/threonine  phosphatase 2A signaling complex <148>; #93# structural basis for the  catalytic activity, the catalytic motif  Asp271-metal1:metal2-water1-His427-His304-Asp274 requires precise  substrate positioning, catalytic mechanism, metal-mediated substrate  hydrolysis <149>; #8# the enzyme also performs the reaction of EC  3.1.3.53, myosin-light-chain-phosphatase <154>; #41# the enzymes of  Synechocystis sp. also perform the protein tyrosine phosphatase  reaction, EC 3.1.3.48 <146>)  "
3.1.3.17, [phosphorylase a] + 4 H2O = 2 [phosphorylase b] + 4 phosphate  
3.1.3.18, 2-Phosphoglycolate + H2O = glycolate + phosphate  
3.1.3.19, glycerol 2-phosphate + H2O = glycerol + phosphate  
3.1.3.2," a phosphate monoester + H2O = an alcohol + phosphate (#18# formation of  a covalent phosphoryl-enzyme intermediate, kinetic pattern of a pseudo  uni-bi hydrolytic two-step reaction mechanism <1,2>; #185# active site  structure analysis, substrate binding, H295 and E365 are involved in  substrate orientation and stabilization of the transition state, oxygen  binding and bridging at the metal ion center, overview, reaction  mechanism <183>; #14# Asn91 and His92 are active site residues which  interact with the loop residue Asp146, this interaction and substrate  positioning by His92 is important for catalysis, Asn91 ia a ligand to  the divalent metal of the mixed-valent di-iron center <160>; #137#  detailed structure-based catalytic mechanism <171>; #137# modelling of  substrate binding in the active site <153>; #69,111# regioselective and  stereospecific phosphorylation of diverse substrates by the acid  phosphatase from Shigella flexneri and Salmonella enterica <145>; #128#  the enzyme is a Zn-metallophosphatase containing an essential zinc ion  in the active site <168>; #188# the dephosphorylation of  phosphotyrosine by PAP is a two-step process: the first step involves  the transfer of a phosphate group from the substrate to the histidine  (His12). A number of quantum models are constructed containing various  residues that are thought to play a role in the mechanism. In all these  models, the transition state displays an associative character. The  transition state is stabilized by three active site arginines (Arg11,  Arg15, and Arg79), two of which belong to the conserved motif  (RHGXRXP). His12 can act as a nucleophile. The enzyme is further  characterized by a His257-Asp258 motif. Asp258 acts as a proton donor  which becomes protonated when the substrate enters the binding pocket.  The transfer of a proton from Asp258 to the leaving group is possibly  mediated by a water molecule in the active site. The importance of  His257 in lowering the energy barrier for the nucleophilic attack is  shown <227>)  "
3.1.3.20, D-glycerate 2-phosphate + H2O = D-glycerate + phosphate  
3.1.3.21, glycerol 1-phosphate + H2O = glycerol + phosphate  
3.1.3.22, D-mannitol 1-phosphate + H2O = D-mannitol + phosphate  
3.1.3.23, sugar phosphate + H2O = sugar + phosphate  
3.1.3.24, sucrose 6F-phosphate + H2O = sucrose + phosphate (#48# N-terminal  catalytic domain <13>; #21# catalytic reaction is initiated by a  nucleophilic attack on the substrate by Asp9 and involves formation of  a covalent phospho-Asp9-enzyme intermediate <14>)  
3.1.3.25," myo-inositol phosphate + H2O = myo-inositol + phosphate (#3,19#  catalytic mechanism and stereospecificity <52>; #8# catalytic mechanism  and substrate-enzyme interactions, active site residues <55>; #13#  enzyme is both inositol monophosphatase and fructose-1,6-bisphosphatase  <50>; #23# the active site residues Tyr155, Glu175, Asp85, and Ser171  are required for the hydrogen bond network in the active site <51>;  #34# the catalytic mechanism involves three Mg2+ ions, modeling of the  reaction and the postreaction complex, active site structure, substrate  binding structure, overview <49>)  "
3.1.3.26," myo-inositol hexakisphosphate + H2O = 1D-myo-inositol  1,2,3,5,6-pentakisphosphate + phosphate  "
3.1.3.27, phosphatidylglycerophosphate + H2O = phosphatidylglycerol + phosphate  
3.1.3.28, 3-(ADP)-2-phosphoglycerate + H2O = 3-(ADP)-glycerate + phosphate  
3.1.3.29, N-acylneuraminate 9-phosphate + H2O = N-acylneuraminate + phosphate  
3.1.3.3, O-phospho-L(or D)-serine + H2O = L(or D)-serine + phosphate  
3.1.3.32," a 3'-phosphopolynucleotide + H2O = a polynucleotide + phosphate (#4,11#  mechanism <10,12>; #3,7# also 5-hydroxylkinase activity <1,2,5>)  "
3.1.3.33, a 5'-phosphopolynucleotide + H2O = a polynucleotide + phosphate  
3.1.3.34, a 2'-deoxyribonucleoside 3'-phosphate + H2O = a 2'-deoxyribonucleoside  + phosphate  
3.1.3.35, thymidylate + H2O = thymidine + phosphate  
3.1.3.36," 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate (#18# catalytic  and kinetic reaction mechanism, substrate binding, overview <25>)  "
3.1.3.37," sedoheptulose 1,7-bisphosphate + H2O = sedoheptulose 7-phosphate +  phosphate  "
3.1.3.38, D-glycerate 3-phosphate + H2O = D-glycerate + phosphate  
3.1.3.39, streptomycin 6-phosphate + H2O = streptomycin + phosphate  
3.1.3.4," a 1,2-diacylglycerol 3-phosphate + H2O = a 1,2-diacyl-sn-glycerol +  phosphate (#4# the active site of plasma membrane LPP-1, LPP-2, and  LPP-3 is outside the cell, the conserved phosphatase family amino acids  are essential for catalytic activity <56>; #10# catalytic site  structure within the transverse plane of the vacuole membrane, overview  <69>)  "
3.1.3.40, 1-guanidino-1-deoxy-scyllo-inositol 4-phosphate + H2O =  1-guanidino-1-deoxy-scyllo-inositol + phosphate  
3.1.3.41, 4-nitrophenyl phosphate + H2O = 4-nitrophenol + phosphate  
3.1.3.42, [glycogen-synthase D] + H2O = [glycogen-synthase I] + phosphate  
3.1.3.43," [pyruvate dehydrogenase (acetyl-transferring)] phosphate + H2O =  [pyruvate dehydrogenase (acetyl-transferring)] + phosphate (#8#  mechanism <50>; #2# mechanism, overview <46>; #5# mechanism, difference  in specificity of isoforms <47>; #2# overview on mechanism and  regulation of enzyme <43>)  "
3.1.3.44, [acetyl-CoA carboxylase] phosphate + H2O = [acetyl-CoA carboxylase] +  phosphate  
3.1.3.45, 3-deoxy-D-manno-octulosonate 8-phosphate + H2O =  3-deoxy-D-manno-octulosonate + phosphate  
3.1.3.46," beta-D-fructose 2,6-bisphosphate + H2O = D-fructose 6-phosphate +  phosphate (#7# mechanism <40,41>; #1,6,7,9,10,11,12,13,16,23,24,25,40#  bifunctional enzyme:  6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase  <1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21,22,23,24,25,26,27  28,29,30,31>; #7# mechanism, kinetic model <37>; #1# mechanism,  regulation <36>; #6# catalytic phosphorylation of His residues is  essential, overview <49>; #7# catalytic site structure and interactions  involving residues H258, E327, H392, R397, and H446, detailed molecular  mechanism and regulation in wild-type and mutant enzymes, overview,  catalytic phosphorylation of His residues is essential, overview <49>;  #18,21,22,26,29,30,31,32,33,34,35,36,37,38,39,40,41,42# FBPase performs  a reaction following a classical ping pong mechanism with formation of  a phosphoryl-enzyme intermediate on a histidine residue located in an  Arg-His-Gly triad, catalytic site structure, overview <50>; #36#  substrate binding loop structure and regulation mechanism, interactions  of enzyme and substrate involve residues K47, R74, R75, R98, and T126,  overview <55>; #8# beta-D-fructose 2,6-bisphosphate induces a global  conformational change in the absence of AMP <62>; #6# in-line  phosphoryl transfer initiated by a substrate-assisted mechanism <63>;  #5# the complex of E. coli FBPase with beta-D-fructose 2,6-bisphosphate  remains in the R-state with dynamic loops in the engaged conformation  <62>)  "
3.1.3.47, [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate + H2O =  [hydroxymethylglutaryl-CoA reductase (NADPH)] + phosphate  
3.1.3.48," [a protein]-tyrosine phosphate + H2O = [a protein]-tyrosine + phosphate  (#7,30,97# mechanism <34,39,66,72>; #3# mechanism, overview <68>; #7#  activation mechanism <79>; #3# comparison of kinetic properties of  different transmembrane and cytosolic isozymes <64>; #7# mechanism,  features required for substrate <73>; #30# mechanism, kinetic isotope  effects <63>; #43# mechanism, role of residue 182 <60>; #30# mechanism,  transition state of reaction, kinetic isotope effects, overview <57>;  #7,9,30# overview on mechanism and transition state <67>; #7#  thermodynamic parameters <62>; #35# arrangement of two metal ions, a  phosphate ion, and amino acid residues in the catalytic site is  identical to that of PS/Tpases <98>; #100# conformation of active site  is favorable for phosphotyrosine binding. Interaction of D115 and R13  to stabilize the conformation of the active cavity. A41 and G45 form a  noncharged surface around the active cavity, which is surrounded by a  flexible wall made of the loop region from F40 to T48 <97>; #35# H148  acts as a general acid catalyst, D115 assists the protonation of the  leaving group of a substrate, and D76 and D112 are involved in binding  of magnesium ions <91>; #43# in addition to active site, enzyme has a  low-affinity noncatalytic aryl phosphate-binding site <89>; #26# motif  H74C(X)5R81 is involved in catalysis <112>; #43# ping-pong mechanism,  catalysis proceeds through a two-step mechanism involving a  phosphocysteine intermediate. In the first step, a nucleophilic  cysteine thiolate attacks the phosphate ester moiety of the substrate,  resulting in formation of a phosphoenzyme intermediate with release of  the peptidyl tyrosine. The second step occurs via attack of water on  the phosphoenzyme intermediate, and yields the final products inorganic  phosphate and the regenerated enzyme. The central binding site for the  substrate is the P-loop, a region at the bottom of a pocket that  includes the nucleophilic cysteine and backbone amide groups oriented  in a horseshoe fashion, catalytic cycle, detailed overview <218>; #17#  mechanism of the dephosphorylation catalysed by MptpA <241>;  #36,43,105,109,119,120# for both alkyl and aryl substrates, including  the activated substrate 4-nitrophenyl phosphate with its particularly  good leaving group, general acid catalysis in PTPs is highly efficient  and fully neutralizes the leaving group in the transition state.  Mutating the conserved aspartic acid to glutamine causes the expected  reductions in rate of several orders of magnitude and loss of the basic  limb in pH-rate profiles, kinetic isotope effects, general acid  catalysis mechanism, overview <279>; #47,72# the phosphatase domain of  PTPRs catalyze a two-step phosphate monoester hydrolysis reaction  through a highly conserved sequence motif (H/V)CX5R(S/T) with a  nucleophilic cysteine <276>)  "
3.1.3.49, [pyruvate kinase] phosphate + H2O = [pyruvate kinase] + phosphate  
3.1.3.5, a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate (#11#  conserved motif I is involved in formation and stabilization of the  covalent enzyme-phosphate intermediate. T249 and K292 in motif II  contribute to stabilize the enzyme-phospho adduct. D351 and D356 in  motif III coordinate the magnesium ion required for catalysis <91>)  
3.1.3.50, sorbitol 6-phosphate + H2O = sorbitol + phosphate  
3.1.3.51, dolichyl phosphate + H2O = dolichol + phosphate  
3.1.3.52, [3-methyl-2-oxobutanoate dehydrogenase  (2-methylpropanoyl-transferring)] phosphate + H2O =  [3-methyl-2-oxobutanoate dehydrogenase  (2-methylpropanoyl-transferring)] + phosphate  
3.1.3.53, [myosin light-chain] phosphate + H2O = [myosin light-chain] + phosphate  
3.1.3.54," beta-D-fructose 2,6-bisphosphate + H2O = beta-D-fructofuranose  2-phosphate + phosphate  "
3.1.3.55, caldesmon phosphate + H2O = caldesmon + phosphate  
3.1.3.56," D-myo-inositol 1,4,5-trisphosphate + H2O = myo-inositol  1,4-bisphosphate + phosphate "
3.1.3.56," 1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O = 1D-myo-inositol  1,3,4-trisphosphate + phosphate (#3,11# catalytic and kinetic reaction  mechanism, substrate binding, overview <35>)  "
3.1.3.57," 1D-myo-inositol 1,4-bisphosphate + H2O = 1D-myo-inositol 4-phosphate +  phosphate (#5# mechanism <9>)  "
3.1.3.58, D-glucose 6-phosphate + H2O = D-glucose + phosphate  
3.1.3.59, 1-alkyl-2-acetyl-sn-glycero-3-phosphate + H2O =  1-alkyl-2-acetyl-sn-glycerol + phosphate  
3.1.3.6, a 3'-ribonucleotide + H2O = a ribonucleoside + phosphate  
3.1.3.60, phosphoenolpyruvate + H2O = pyruvate + phosphate  
3.1.3.62, myo-inositol hexakisphosphate + H2O = myo-inositol pentakisphosphate  (mixed isomers) + phosphate  
3.1.3.63, 2-carboxy-D-arabinitol 1-phosphate + H2O = 2-carboxy-D-arabinitol +  phosphate (#1# mechanism <5>)  
3.1.3.64, 1-phosphatidyl-1D-myo-inositol 3-phosphate + H2O =  1-phosphatidyl-1D-myo-inositol + phosphate (#2# two-step reaction  mechanism <4>; #11# hJUMPY has a phosphatidylinositol 3-phosphatase  activity and also shares the same substrate specificity as myotubularin  <8>)  
3.1.3.66," 1-phosphatidyl-myo-inositol 3,4-bisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 3-phosphate + phosphate  "
3.1.3.67," 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + phosphate  "
3.1.3.68, 2-deoxy-D-glucose 6-phosphate + H2O = 2-deoxy-D-glucose + phosphate  
3.1.3.69, 2-O-(alpha-D-glucosyl)-sn-glycerol-3-phosphate + H2O =  2-O-(alpha-D-glucopyranosyl)glycerol + phosphate  
3.1.3.7," adenosine 3',5'-bisphosphate + H2O = AMP + phosphate (#23# mechanism  <11>; #19# proposed catalytic mechanism for CysQ, Asp50 deprotonates  Thr96 that deprotonates the water (ligating a Mg2+), which attacks the  phosphate, the pentacovalent 3-phosphate transition state is stabilized  by the three Mg2+ ions, overview <26>)  "
3.1.3.70," 2-O-(alpha-D-mannosyl)-3-phosphoglycerate + H2O =  2-O-(alpha-D-mannosyl)-D-glycerate + phosphate (#4# in Thermus  thermophilus strain HB27 MpgP the phosphoryl-transfer undergoes a  concerted DNSN mechanism with assistance of proton transfer from the  general acid Asp8, forming a short-lived PO3- intermediate which is  attacked by a nucleophilic water molecule, structure-activity  relationship analysis, overview <5>)  "
3.1.3.71, (2R)-2-phospho-3-sulfolactate + H2O = (2R)-3-sulfolactate + phosphate  
3.1.3.72," myo-inositol hexakisphosphate + H2O = 1L-myo-inositol  1,2,3,4,6-pentakisphosphate + phosphate  "
3.1.3.73, alpha-ribazole 5'-phosphate + H2O = alpha-ribazole + phosphate 
3.1.3.73, adenosylcobalamin 5'-phosphate + H2O = coenzyme B12 + phosphate  
3.1.3.74," pyridoxal 5'-phosphate + H2O = pyridoxal + phosphate (#5# mechanism  <1>; #5# kinetic mechanism <2>; #4# requires Mg2+, this enzyme is  specific for phosphorylated vitamin B6 compounds: it acts not only on  pyridoxal phosphate (PLP), but also on pyridoxine phosphate (PNP),  pyridoxamine phosphate (PMP), 4-pyridoxic acid phosphate and  4-deoxypyridoxine phosphate, this reaction can also be carried out by  EC 3.1.3.1 (alkaline phosphatase) and EC 3.1.3.2 (acid phosphatase),  but these enzymes have very broad substrate specificities <3>)  "
3.1.3.75," O-phosphoethanolamine + H2O = ethanolamine + phosphate (#3# requires  active site Mg2+ but also works, to a lesser extend, with Co2+ and  Mn2+, the enzyme is highly specific for phosphoethanolamine and  phosphocholine <1>; #7# residues D32 and D203 of catalytic motifs are  essential for catalytic activity, residues D43 and D123 are important  for substrate binding and specificity <5>) "
3.1.3.75," phosphocholine + H2O = choline + phosphate (#3# requires active site  Mg2+ but also works, to a lesser extend, with Co2+ and Mn2+, the enzyme  is highly specific for phosphoethanolamine and phosphocholine <1>; #8#  catalytic mechanism, overview <19>) "
3.1.3.75," phosphoethanolamine + H2O = ethanolamine + phosphate (#8# catalytic  mechanism, overview <19>)  "
3.1.3.76," (9S,10S)-10-hydroxy-9-(phosphooxy)octadecanoate + H2O =  (9S,10S)-9,10-dihydroxyoctadecanoate + phosphate (#1,2,3# the  phosphatase activity of the enzyme is located at the N-terminal part,  the C-terminal part harbors the epoxide hydrolase activity of EC  3.3.2.10, both catalytic sites act independently <2,3,4,6,7>; #2# the  phosphatase activity of the enzyme is located at the N-terminal part,  the C-terminal part harbors the epoxide hydrolase activity of EC  3.3.2.10, both catalytic sites act independently, reaction mechanism  <5>; #2# the phosphatase activity of the enzyme is located at the  N-terminal part, the C-terminal part harbors the epoxide hydrolase  activity of EC 3.3.2.10, both catalytic sites act independently,  reaction mechanism, structure-mechanism relationship <1>)  "
3.1.3.77," 5-(methylsulfanyl)-2,3-dioxopentyl phosphate + H2O =  1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one + phosphate "
3.1.3.77," 5-(methylsulfanyl)-2,3-dioxopentyl phosphate =  2-hydroxy-5-(methylsulfanyl)-3-oxopent-1-enyl phosphate "
3.1.3.77," 2-hydroxy-5-(methylsulfanyl)-3-oxopent-1-enyl phosphate + H2O =  1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one + phosphate  "
3.1.3.78," 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 5-phosphate + phosphate  "
3.1.3.79, beta-D-fructofuranosyl-alpha-D-mannopyranoside 6F-phosphate + H2O =  beta-D-fructofuranosyl-alpha-D-mannopyranoside + phosphate  
3.1.3.8," myo-inositol hexakisphosphate + H2O = 1D-myo-inositol  1,2,4,5,6-pentakisphosphate + phosphate  "
3.1.3.80," 2,3-bisphospho-D-glycerate + H2O = 2-phospho-D-glycerate + phosphate  "
3.1.3.81," 1,2-diacyl-sn-glycerol 3-diphosphate + H2O = 1,2-diacyl-sn-glycerol  3-phosphate + phosphate (#3# the bifunctional enzyme also catalyzes the  phosphohydrolysis of phosphatidic acid to diacylglycerol, but is  distinct from the phosphatidate phosphatase, EC 3.1.3.4, being  Mg2+-independent and insensitive to N-ethylmaleimide, catalytic site  structure within the transverse plane of the vacuole membrane, overview  <12>; #3# the conserved residues Arg125, His169, and His223 within  domains 1, 2, and 3, respectively, play important roles in the DGPP  phosphatase and phosphatidic acid phosphatase reactions catalyzed by  the enzyme <3>)  "
3.1.3.82," D-glycero-beta-D-manno-heptose 1,7-bisphosphate + H2O =  D-glycero-beta-D-manno-heptose 1-phosphate + phosphate  "
3.1.3.83," D-glycero-alpha-D-manno-heptose 1,7-bisphosphate + H2O =  D-glycero-alpha-D-manno-heptose 1-phosphate + phosphate  "
3.1.3.84, ADP-D-ribose 1''-phosphate + H2O = ADP-D-ribose + phosphate  
3.1.3.85, 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate + H2O =  2-O-(alpha-D-glucopyranosyl)-D-glycerate + phosphate  
3.1.3.86," 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate  "
3.1.3.87," 2-hydroxy-5-(methylsulfanyl)-3-oxopent-1-enyl phosphate + H2O =  1,2-dihydroxy-5-(methylsulfanyl)pent-1-en-3-one + phosphate  "
3.1.3.88, 5''-phosphoribostamycin + H2O = ribostamycin + phosphate  
3.1.3.89, a 2'-deoxyribonucleoside 5'-monophosphate + H2O = a  2'-deoxyribonucleoside + phosphate  
3.1.3.9," D-glucose 6-phosphate + H2O = D-glucose + phosphate (#4# kinetic  mechanism applicable generally to both hydrolytic and synthetic  activities is a specific adaption of the generally applicable kinetic  mechanism for enzymes with modified ping pong bi bi kinetics <7>; #6#  reaction mechanism, His176 is the amino acid in enzyme that acts as the  nucleophile forming the phosphohistidine-enzyme intermediate during  catalysis <47>; #6# reaction mechanism: substrate-transport model <40>;  #6# The enzyme family comprises two active isozyme: the D-glucose  6-phosphatase-alpha, in which is His176 the amino acid in enzyme that  acts as the nucleophile forming the phosphohistidine-enzyme  intermediate during catalysis and the D-glucose 6-phosphatase-alpha, in  which is His167 the amino acid in enzyme that acts as the nucleophile  forming the phosphohistidine-enzyme intermediate during catalysis. Both  enzyme-alpha and enzyme-beta couple with the D-glucose 6-phosphate  transporter to form an active enzyme complex <49>; #6# two proposed  concepts of structure-function relationships for enzyme, According to  the substrate transport-catalytic unit concept, enzyme is a  multicomponent system consisting of a fairly non-specific catalytic  unit with its active site located on the lumental side of endoplasmic  reticulum, and at least three transmembrane-spanning translocases that  confer specificity to this system by allowing selective  substrates/products access to, or egress from, the sequestered  catalytic unit. According to the combined conformational  flexibility-substrate transport concept, enzyme is a multifunctional  enzyme embedded within the endoplasic reticulum membrane that possess  both catalytic and substrate/product transport activities. <45>)  "
3.1.3.90, maltose 6'-phosphate + H2O = maltose + phosphate  
3.1.3.91, N7-methyl-GMP + H2O = N7-methyl-guanosine + phosphate 
3.1.3.91, CMP + H2O = cytidine + phosphate  
3.1.3.92, kanosamine 6-phosphate + H2O = kanosamine + phosphate  
3.1.3.93, beta-L-galactose 1-phosphate + H2O = L-galactose + phosphate  
3.1.3.94, alpha-D-galactose 1-phosphate + H2O = D-galactose + phosphate  
3.1.3.95," 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate + H2O =  1-phosphatidyl-1D-myo-inositol 5-phosphate + phosphate  "
3.1.3.96, pseudouridine 5'-phosphate + H2O = pseudouridine + phosphate  
3.1.3.97," nucleoside 3',5'-bisphosphate + H2O = nucleoside 5'-phosphate +  phosphate  "
3.1.3.99, IMP + H2O = inosine + phosphate  
3.1.30.1, endonucleolytic cleavage to 5'-phosphomononucleotide and  5'-phosphooligonucleotide end-products (#11# endonuclease I catalyzes  the breakage of the P-O3 bond <60>)  
3.1.30.2," endonucleolytic cleavage to 5'-phosphomononucleotide and  5'-phosphooligonucleotide end-products (#6# mechanism <12>; #6# general  acid-base catalysis. The enzyme cleaves 3- and 5-phosphodiester bonds  to form 5-phosphorylated oligonucleotides. The hydrolysis of the  phosphodiester bonds proceeds as a result of the nucleophilic  displacement at the phosphorus atom. The enzyme active site is formed  at least by 8 amino acid residues, Arg57, Asp86, His89, Gln114, Asn119  and Glu127. Arg57, Asp86, His89 and Glu127 are important for the  catalytic activity of the enzyme. His89 is a potential candidate for  the function of a general base catalyst that accepts a proton from a  solvent H2O molecule, which is the attacking nucleophile. The reaction  is accompanied by the inversion of configuration at the phosphorus atom  and proceeds in accordance with an in-line mechanism <23>; #6# one-step  in line mechanism of enzymatic hydrolysis. The enzyme hydrolyzes  internucleotide phosphothioate linkages of Rp configuration with  inversion of configuration at the P-atom. The enzyme is stereoselective  towards internucleotide phosphothioate linkages of Rp configuration.  The involvement of a non-bridging oxygen in contact with a magnesium  ion is a critical discriminatory factor for selectivity towards  phosphothioate analogues <20>; #6# catalytic mechanism, enzyme  monomer-DNA binding complex, hydration sites and influence of solvent  on structure and reaction, active site structure <26>; #8# DNA cleavage  stereochemistry and mechanism involving interaction of DNA with three  zinc ions, the enzyme contains a cocatalytic zinc site <24>)  "
3.1.31.1," endonucleolytic cleavage to nucleoside 3'-phosphates and  3'-phosphooligonucleotide end-products (#1# mechanism <5,6>)  "
3.1.4.1," hydrolytically removes 5'-nucleotides successively from the 3'-hydroxy  termini of 3'-hydroxy-terminated oligonucleotides (#11# mechanism  <30,32>; #3# mechanism, overview <44>; #8# the enzyme may be able to  recognize nucleoside 5-monophosphates in the substrates and nick them  even if the phosphodiester bonds are closed covalently, although the  mode of action of this enzyme on oligo- or polynucleotides is typically  exonucleolytic <6>; #11# ping-pong type mechanism, with participation  of a covalent enzyme intermediate <32>; #11# active site residue is  threonine <30>; #4# enzyme is an exonuclease which needs a free end of  an oligonucleotide chain for activity <13>; #9# PC-1, enzymic  activities and regulation of PC-1 <26>; #37# mechanism, transition  state <43>; #54,55,56,57,58# catalytic mechanism, the enzyme has a  unique catalytic cycle, structure-function analysis overview <91>; #52#  catalytic mechanism, the enzyme has a unique catalytic cycle,  structure-function analysis overview. The enzymes N-terminal catalytic  His182 functions as a nucleophile (Hisnuc) to attack the  3-phospho-tyrosyl linkage. This results in dissociation of the tyrosine  (and by extension Topo1) from the DNA end and the formation of a  enzyme-DNA covalent reaction intermediate via a 3-phospho-histidyl  linkage <91>; #53# catalytic mechanism, the enzyme has a unique  catalytic cycle, structure-function analysis overview. The enzymes  N-terminal catalytic His263 functions as a nucleophile (Hisnuc) to  attack the 3-phospho-tyrosyl linkage. This results in dissociation of  the tyrosine (and by extension Topo1) from the DNA end and the  formation of a enzyme-DNA covalent reaction intermediate via a  3-phospho-histidyl linkage <91>)  "
3.1.4.11," 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O = 1D-myo-inositol  1,4,5-trisphosphate + diacylglycerol (#4,23# mechanism <49,50>; #2#  biochemical relationship between PLC and heterotrimeric G proteins  during NFs signaling in legumes <152>; #48# kinetic and catalytic  reaction mechanism, overview <156>)  "
3.1.4.12," a sphingomyelin + H2O = a ceramide + phosphocholine (#4,24# catalytic  mechanism, a number of key residues involved in metal binding and  catalysis are conserved in neutral sphingomyelinases <114>; #31#  catalytic mechanism, a number of key residues involved in metal binding  and catalysis are conserved in neutral sphingomyelinases, e.g. Glu53,  Asp126, Asp295, and His296 are essential, structure-function analysis,  overview <114>; #21# catalytic mechanism, a number of key residues  involved in metal binding and catalysis are conserved in neutral  sphingomyelinases, histidine residues, His136 and His272, are essential  for catalysis <114>; #1,14# catalytic mechanism, a number of key  residues involved in metal binding and catalysis are conserved in  neutral sphingomyelinases, overview <114>; #29# catalytic mechanism, a  number of key residues involved in metal binding and catalysis are  conserved in neutral sphingomyelinases, structure-function analysis,  overview <114>)  "
3.1.4.13, serine phosphoethanolamine + H2O = serine + ethanolamine phosphate  
3.1.4.14, holo-[acyl-carrier protein] + H2O = 4'-phosphopantetheine +  apo-[acyl-carrier protein]  
3.1.4.16," nucleoside 2',3'-cyclic phosphate + H2O = nucleoside 3'-phosphate  "
3.1.4.17," nucleoside 3',5'-cyclic phosphate + H2O = nucleoside 5'-phosphate (#23#  mechanism <38>)  "
3.1.4.2, sn-glycero-3-phosphocholine + H2O = choline + sn-glycerol 3-phosphate  
3.1.4.3," a phosphatidylcholine + H2O = 1,2-diacyl-sn-glycerol + phosphocholine  (#10,11,22,27,28,32,39,46,54,55,60,62,63,64,65,67# mode of action of  the plant enzyme family of non-specific phospholipases C, overview  <116>)  "
3.1.4.35," guanosine 3',5'-cyclic phosphate + H2O = GMP  "
3.1.4.37," nucleoside 2',3'-cyclic phosphate + H2O = nucleoside 2'-phosphate (#33#  catalytic mechanism <89>; #8# general acid/general base catalysis by  H310, H231 and a water molecule, mechanism <60>; #33# during catalytic  mechanism, a 2,3-cyclic nucleotide is converted into a 2-nucleotide  through a nucleophilic attack carried out by an activated water  molecule, dinucleotide binding mode, overview <85>)  "
3.1.4.38, sn-glycero-3-phosphocholine + H2O = glycerol + phosphocholine  
3.1.4.39, 1-alkyl-sn-glycero-3-phosphoethanolamine + H2O = 1-alkyl-sn-glycerol  3-phosphate + ethanolamine  
3.1.4.4," a phosphatidylcholine + H2O = choline + a phosphatidate (#4,18,34#  mechanism <36,37,50>; #36# acts also on other phosphatidyl esters <1>;  #34# mechanism, structural requirements of substrate <48>;  #52,57,59,71,119# catalytic mechanism, PLD uses a ping-pong type of  reaction through the formation of a covalent phosphatidyl-enzyme  intermediate, structure-function relationship, and substrate  recognition and specificity, overview <209>; #112# general reaction  mechanism through an SN2-type associative pathway for phospholipase  D-catalyzed hydrolysis of phospholipids, the formation of the  phosphohistidine intermediate involves the conserved histidine 167 of  the N-terminal HKD domain, overview <216>; #6# catalytic mechanisms of  PLD isozymes, overview <271>; #56,97# mode of substrate binding, the  catalysis proceeds via two-step reaction with the formation of  phosphatidyl-enzyme intermediate. Both of the two catalytic His  residues are critical in the reaction course, where one acts as a  nucleophile, while the other functions as a general acid/base, reaction  cycle overview <270>; #49,52,76,121,122# the catalysis proceeds via  two-step reaction with the formation of phosphatidyl-enzyme  intermediate. Both of the two catalytic His residues are critical in  the reaction course, where one acts as a nucleophile, while the other  functions as a general acid/base, reaction cycle overview <270>)  "
3.1.4.40, CMP-N-acylneuraminate + H2O = CMP + N-acylneuraminate  
3.1.4.41, sphingomyelin + H2O = ceramide phosphate + choline  
3.1.4.42," glycerol 1,2-cyclic phosphate + H2O = glycerol 1-phosphate  "
3.1.4.43, 1-(sn-glycero-3-phospho)-1D-myo-inositol + H2O = glycerol +  1D-myo-inositol 1-phosphate  
3.1.4.44, 1-(sn-glycero-3-phospho)-1D-myo-inositol + H2O = myo-inositol +  sn-glycerol 3-phosphate  
3.1.4.45, glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose + H2O =  N-acetyl-D-glucosamine + glycoprotein phospho-D-mannose  
3.1.4.46, a glycerophosphodiester + H2O = a primary alcohol + sn-glycerol  3-phosphate  
3.1.4.48, dolichyl beta-D-glucosyl phosphate + H2O = dolichyl phosphate +  D-glucose  
3.1.4.49, dolichyl beta-D-mannosyl phosphate + H2O = dolichyl phosphate +  D-mannose  
3.1.4.50, 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol + H2O =  6-(alpha-D-glucosaminyl)-1D-myo-inositol + 3-sn-phosphatidate  
3.1.4.51, 6-(D-glucose-1-phospho)-D-mannosylglycoprotein + H2O = alpha-D-glucose  1-phosphate + D-mannosylglycoprotein  
3.1.4.52," cyclic di-3',5'-guanylate + H2O = 5'-phosphoguanylyl(3'->5')guanosine  (#4# hydrolysis of cyclic di-GMP by a general base-catalyzed mechanism  with the assistance of a Mg2+ ion, the essential residue E352 functions  as a general base catalyst assisting the deprotonation of  Mg2+-coordinated water to generate the nucleophilic hydroxide ion,  reaction mechanism, residue positioning, and substrate binding,  overview <13>)  "
3.1.4.53," adenosine 3',5'-cyclic phosphate + H2O = AMP (#4# catalytic reaction  mechanism, overview <116>)  "
3.1.4.54," N-acylphosphatidylethanolamine + H2O = N-acylethanolamine + a  1,2-diacylglycerol 3-phosphate  "
3.1.4.55," 5-phospho-alpha-D-ribose 1,2-cyclic phosphate + H2O = alpha-D-ribose  1,5-bisphosphate  "
3.1.4.56," 7,8-dihydroneopterin 2',3'-cyclic phosphate + H2O =  7,8-dihydroneopterin 3'-phosphate (#1# (1) <1>) "
3.1.4.56," 7,8-dihydroneopterin 2',3'-cyclic phosphate + H2O =  7,8-dihydroneopterin 2'-phosphate (#1# (2) <1>)  "
3.1.4.57," 5-phospho-alpha-D-ribose 1,2-cyclic phosphate + H2O = D-ribofuranose  2,5-bisphosphate "
3.1.4.57," D-ribofuranose 2,5-bisphosphate + H2O = D-ribofuranose 5-phosphate +  phosphate  "
3.1.4.58," (ribonucleotide)n-2',3'-cyclic phosphate + H2O =  (ribonucleotide)n-2'-phosphate  "
3.1.4.59," cyclic di-3',5'-adenylate + H2O =  5'-O-phosphonoadenylyl-(3'->5')-adenosine  "
3.1.4.60, 5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O = 2 AMP  
3.1.4.61," cyclic 2,3-bisphosphoglycerate + H2O = 2,3-diphosphoglycerate  "
3.1.5.1, dGTP + H2O = deoxyguanosine + triphosphate  
3.1.6.1, an aryl sulfate + H2O = a phenol + sulfate  
3.1.6.10, 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine  6-sulfate + H2O =  4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine +  sulfate  
3.1.6.11," 2-N,6-O-disulfo-D-glucosamine + H2O = 2-N-sulfo-D-glucosamine + sulfate  "
3.1.6.12, hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine  4-sulfate units of chondroitin sulfate and dermatan sulfate  
3.1.6.13," hydrolysis of the 2-sulfate groups of the L-iduronate 2-sulfate units  of dermatan sulfate, heparan sulfate and heparin  "
3.1.6.14, hydrolysis of the 6-sulfate groups of the N-acetyl-D-glucosamine  6-sulfate units of heparan sulfate and keratan sulfate  
3.1.6.15, hydrolysis of the 3-sulfate groups of the N-sulfo-D-glucosamine  3-O-sulfate units of heparin  
3.1.6.16, Monomethyl sulfate + H2O = methanol + sulfate  
3.1.6.17, (R)-2-O-sulfolactate + H2O = (R)-lactate + sulfate  
3.1.6.18," hydrolysis of the 2-sulfate groups of the 2-O-sulfo-D-glucuronate  residues of chondroitin sulfate, heparin and heparitin sulfate  "
3.1.6.19, an (R)-secondary-alkyl sulfate + H2O = an (S)-secondary-alcohol +  sulfate  
3.1.6.2, 3beta-hydroxyandrost-5-en-17-one 3-sulfate + H2O =  3beta-hydroxyandrost-5-en-17-one + sulfate  
3.1.6.20, [SoxY protein]-S-sulfosulfanyl-L-cysteine + H2O = [SoxY  protein]-S-sulfanyl-L-cysteine + sulfate 
3.1.6.20, [SoxY protein]-S-(2-sulfodisulfanyl)-L-cysteine + H2O = [SoxY  protein]-S-disulfanyl-L-cysteine + sulfate  
3.1.6.21, a primary alkyl sulfate ester + H2O = an alcohol + sulfate  
3.1.6.22, 2-butyloctyl sulfate + H2O = 2-butyloctan-1-ol + sulfate  
3.1.6.3, D-glucose 6-sulfate + H2O = D-glucose + sulfate  
3.1.6.4, hydrolysis of the 6-sulfate groups of the N-acetyl-D-galactosamine  6-sulfate units of chondroitin sulfate and of the D-galactose 6-sulfate  units of keratan sulfate  
3.1.6.6," choline sulfate + H2O = choline + sulfate (#4,5# ordered bi-bi  mechanism <2>)  "
3.1.6.7, hydrolysis of the 2- and 3-sulfate groups of the polysulfates of  cellulose and charonin  
3.1.6.8," a cerebroside 3-sulfate + H2O = a cerebroside + sulfate  (#1,3,6,7,9,10,11,12,13,14,15,16,17,18# hydrolyses galactose-3-sulfate  residues in a number of lipids, also hydrolyses ascorbate 2-sulfate and  many phenol sulfates, enzymes catalyze in addition to reaction of EC  3.1.6.8 also arylsulfatase reaction EC 3.1.6.1 <2,10,12,18,19,21,22>;  #20# A detailed mechanism for sulfate ester cleavage is proposed,  involving an aldehyde hydrate as the functional group. <41>; #20# a  detailed mechanism for sulfate ester cleavage is proposed, involving an  aldehyde hydrate as the functional group <41>)  "
3.1.6.9, 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine  4-sulfate + H2O =  4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine +  sulfate  
3.1.7.1, prenyl diphosphate + H2O = prenol + diphosphate  
3.1.7.10," geranylgeranyl diphosphate + H2O = (13E)-labda-7,13-dien-15-ol +  diphosphate  "
3.1.7.11, geranyl diphosphate + H2O = geraniol + diphosphate (#2# the reaction  mechanism of GES is similar to that of other monoterpene synthases and  is different from the action of phosphatases <4>)  
3.1.7.12, (+)-kolavenyl diphosphate + H2O = (+)-kolavelool + diphosphate  
3.1.7.13, neryl diphosphate + H2O = nerol + diphosphate  
3.1.7.2," guanosine 3',5'-bis(diphosphate) + H2O = GDP + diphosphate (#8# RelMtb  is a dual-function enzyme carrying out ATP: GTP/GDP/ITP  3Â’-diphosphoryltransferase and (p)ppGpp 3Â’-diphosphohydrolase  reactions. The differential regulation of the opposing activities of  RelMtb is dependent on the ratio of uncharged to charged tRNA and the  association of enzyme with a complex containing tRNA, ribosomes, and  mRNA, i.e. RAC <10>; #1# RelSeq affects ppGpp synthesis and degradation  activities. The C-terminal domain of RelSeq is involved in reciprocal  regulation of the two opposing activities present in the N-terminal  domain <11>)  "
3.1.7.3, a monoterpenyl diphosphate + H2O = a monoterpenol + diphosphate  
3.1.7.5, geranylgeranyl diphosphate + H2O = geranylgeraniol + diphosphate  
3.1.7.6," (2E,6E)-farnesyl diphosphate + H2O = (2E,6E)-farnesol + diphosphate  "
3.1.8.1," an aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl alcohol  (#3,23# mechanism <42,43>; #24,38# catalytic mechanism <91,107>;  #22,23# kinetics and mechanism <26>; #3# no serine esterase <34,40>;  #47# catalytic mechanism and active site structure, substrate docking  mechanism <54>; #40# catalytic mechanism involving His134 and His115 as  well as a Ca2+ ion, active site structure, overview <71>; #38#  catalytic mechanism, the effects of substrate orientation on the  mechanism of the enzyme, energetic parameters, overview <72>; #47#  mechanism of hydrolysis of organophosphates by the bacterial  phosphotriesterase, reaction modelling, kinetic model <56>; #3#  structure-function analysis, catalytic mechanism involving the residue  His285, residues Leu69, His134, Phe222, and Cys284 are involved in  substrate binding, Ca2+ is required for activity and is involved in the  catalytic mechanism via coordinating residues Asp54, Asn168, Asn224,  and Asp269 <60>; #38# enzyme-substrate complex structure analysis and  reaction mechanism, the my-hydroxo bridge between the metal ions  initiates the hydrolytic reaction, roles of alpha- and beta-metal ions,  contribution of grouns-state destabilization to catalysis, overview,  Michaelis complex, transition state, and product structure, overview  <110>; #2# catalytic reaction with orpanophosphonates starts with  cleavageof the P-O bond. Reaction proceeds through a displacement  mechanism and generates a chiral product in situ with an inversion of  stereochemical configuration at the phosphorous atom <114>; #57#  catalytic reaction mechanism involving residue Asp269, and role of  Asp270 for the catalytic function, molecular dynamics and modelling,  overview. The reaction is supposed to proceed by a two-step  addition-elimination (An + Dn) mechanism, which goes through a common  pentavalent intermediate observed in phosphoryl transfer reactions. The  first step is the activation of H2O by Asp269 and Glu53 to form a  nucleophile hydroxide and a metastable pentavalent complex. Both the  residues Asn168 and Asn224 help the leaving group leave through  hydrogen bonds <240,249>; #40# hypothetic mechanism of C-P bond  cleavage in methylphosphonic acid by recombinant His6-tagged OPH,  overview <211>; #40# molecular details of the catalytic mechanism of  h-PON1 <209>; #61# reaction mechanism analysis, overview. The  phosphoryl oxygen and one of the ester oxygens bind in a bidentate  manner to the beta-metal allowing polarization of the phosphorus  center. The bridging hydroxide attacks the phosphorus center forming a  phosphorane-like transition state with delocalization of charge  supported by coordination to the metal as well as the electronegative  ester groups. Once the phosphorane species is formed, the pKa of the  attacking OH group will be drastically reduced and the proton can be  passed to Glu407. In the substrate-docked structure of Sb-PTE, the free  oxygen of Glu407 is 4.0 A from the leaving group oxygen, which would  enable transfer of the proton to the leaving group, facilitating the  collapse of the phosphorane intermediate into products <218>; #57#  reaction mechanism of lactonase activity and paraoxonase activity of  the enzyme PON1, overview <237>)  "
3.1.8.2," diisopropyl fluorophosphate + H2O = diisopropyl phosphate + fluoride  (#17# the enzyme exhibits stereoselectivity toward the hydrolysis of  chiral substrates with a preference for the S-P enantiomers <19>; #12#  catalytic mechanism, H287 is required for catalytic activity <18>; #17#  enzyme exhibits stereoselectivity toward the chiral phosphorus center  of the p-nitrophenyl analogs of sarin and soman <16>; #4,6,7,8,9,23#  squide-type enzyme: diisopropyl fluorophosphate hydrolysed more rapidly  than soman, Mazur-type enzyme: soman hydrolysed more rapidly than  diisopropyl fluorophosphate <7,20>; #27# calcium coordinating residue  D229, in concert with direct substrate activation by the metal ion,  renders the phosphorus atom of the substrate susceptible for attack of  water, through generation of a phosphoenzyme intermediate <28>; #27#  analysis of the catalytic reaction mechanism of the enzyme. Proposed  mechanism for phosphoenzyme intermediate formation involving Asp229 as  the nucleophile. (i) Asp229 attacks the phosphorus center of DFP to  form a pentavalent intermediate and (ii) the P-F bond dissociates to  form a tetrahedral phosphoenzyme intermediate. Hydrolysis of the  phosphoenzyme intermediate is not shown. And proposed mechanism for  hydrolysis involving an activated water as the nucleophile. (i) Asp229  abstracts a proton from a water molecule either stepwise or in concert  as (ii) water attacks the phosphorus center, (iii) Glu21 abstracts a  proton either stepwise or in concert as water forms a bond with  phosphorus, and (iv) the P-F bond dissociates <46>; #27# catalytic  reaction mechanism involving residue Asp269, molecular dynamics and  modelling, overview <47>; #28# molecular details of the catalytic  mechanism of h-PON1 <44>; #27# the catalytic mechanism of DFPase is  investigated using the hybrid density functional theory method B3LYP  with a large quantum chemical model of the active site abstracted from  the X-ray crystal structure. For the first step, two different pathways  are considered: (1) residue Asp229 as a nucleophile inline attacks on  the phosphorus center and (2) an activated water molecule as the  nucleophile attacks on the phosphorus center. Both the Asp229 and the  activated water molecule are capable of proceeding nucleophilic attack  on the substrate in the presence of Ca2+ ion with the associated  barriers 14.8 and 6.0 kcal/mol, respectively. The latter is much easier  to perform the nucleophile attack. From the phosphoenzyme intermediate  with the hexa-coordinated Ca2+, the uncoordinated Glu21 functions as a  general base activated an additional water molecule to attack the  carbon center of Asp229 and make the phosphate release. Residues Asn120  and Asn175 promote the elimination of the fluoride via donating strong  hydrogen bonds. Residue Asp229 plays a dual role during the hydrolysis  reaction process, either as a nucleophile or as a general base to  activate the water nucleophile. The role of the calcium ion is  providing a necessary conformation of the active site, facilitating the  nucleophile formation and substrate orientation <50,51>)  "
3.10.1.1," N-sulfo-D-glucosamine + H2O = D-glucosamine + sulfate (#6# catalytic  reaction mechanism: the active-site formylglycine (FGly70), which is  intrinsically reactive, undergoes hydration to form the resting state  of the enzyme with a gem-diol group (step 1). Coordination of one of  the hydroxyl groups of the gem-diol to a Ca2+ ion facilitates the  development of a negative charge on the O atom as its proton is lost to  a base. The negatively charged O atom nucleophilically attacks the  sulfur centre of the N-linked sulfate group on the glucosamine  substrate (step 2), resulting in a covalently bound enzyme-substrate  complex with a pentavalent sulfur transition state. An acid (possibly  His181) facilitates the cleavage of the S-N bond by protonating the  bridging N atom to form an amine leaving group on the N-desulfated  substrate, which diffuses away, leaving an O-sulfated enzyme (step 3).  Finally, in a step that underlines the importance of the formylglycine  residue, another base (His125) deprotonates the second hydroxyl group,  resulting in a negatively charged O atom (step 4) that forms a double  bond with the C atom as the C-O bond between it and the bridging O  atom of the sulfate group breaks, eliminating the sulfate ion and  regenerating the formylglycine residue (step 5) <29>)  "
3.10.1.2, cyclohexylsulfamate + H2O = cyclohexylamine + sulfate  
3.11.1.1," phosphonoacetaldehyde + H2O = acetaldehyde + phosphate (#1# mechanism  involves Schiff base formation with Lys53 followed by phosphoryl  transfer to Asp11 and at last hydrolysis at the imine and acyl  phosphate phosphorus <6>; #5# mechanism involves Schiff base formation  with Lys53 followed by phosphoryl transfer to Asp12 and at last  hydrolysis at the imine and acyl phosphate phosphorus <6>; #5#  bicovalent catalytic mechanism in which an active site nucleophile  abstracts the phosphoryl group from the Schiff-base intermediate formed  from Lys53 and phosphonoacetaldehyde <8>; #5# Schiff base formation  with catalytic Lys and phosphonoacetaldehyde, PC-bond cleavage in the  Schiff base takes place during the second partial reaction and  liberation of the acetaldehyde from the resulting enamine occurs during  the third partial reaction <7>; #5# double displacement mechanism  proceeding via protonated Schiff base and phosphoenzyme intermediates.  The mechanism involves P-C bond cleavage in a protonated Schiff base  intermediate by in-line displacement by an enzyme nucleophile.  Subsequent hydrolysis of the resultant acetaldehyde enamine and  phosphoenzyme groups then yield acetaldehyde and phosphate <4>; #5#  Schiff base mechanism <1>; #5# imine formation between the enzyme and  its substrate <2>; #7# active site structure <10>; #7# mechanism,  active site conformation during catalysis, Lys53 is involved <9>; #7#  mechanism, reaction pathway, Schiff base formation between an amine and  a ketone in aqueous solution, active site model <11>; #5# quantum  chemical study of the imine formation reaction, which precedes P-C bond  cleavage. The barrier of this reaction can be significantly lowered if  the reaction is assisted by a water molecule and the substrate is  protonated <15>; #5# alternative catalytic mechanism, involving proton  transfer that triggers P-C bond cleavage, transition states, TSd1,  TSm1, TSd2, TSm2, and theoretical QM/MM study using crystal structure  of an inhibitor-bound enzyme, overview. The bond breaking process is  facilitated by proton transfer from catalytic lysine residue to the  substrate. The common catalytic mechanism involves formation of a  Schiff base, overview <16>)  "
3.11.1.2," Phosphonoacetate + H2O = acetate + phosphate (#2# structure and  mechanism of the P-C bond cleaving enzyme, nucleophilic catalysis  involving a zinc ion, overview. Modeling of the catalytic mechanism  <10>)  "
3.11.1.3, 3-phosphonopyruvate + H2O = pyruvate + phosphate  
3.12.1.1, trithionate + H2O = thiosulfate + sulfate + 2 H+  
3.13.1.1," UDP-alpha-D-sulfoquinovopyranose + H2O = UDP-alpha-D-glucose + sulfite  (#9# a decrease in the internal phosphate concentration shows a  corresponding increase in the relative amount of sulfolipid with  UDP-sulfoquinovose as precursor <3>; #9# contains characteristic  conserved Y-XXX-K and glycine-rich sequence patterns <2>; #4# sequence  similarity to sugar nucleotide modifying enzymes, Thr228 seems to be  catalytically important <4>; #4,9# short-chain dehydrogenase/reductase  family <2,4>; #10# required NAD+ appears to oxidize the substrate to  UDP-4-dehydroglucose, which dehydrates to  UDP-4-dehydro-6-deoxygluc-5-enose, to which sulfite can add, the  reaction is completed when the substrate is rehydrogenated at C-4 <5>)  "
3.13.1.3, 2'-hydroxybiphenyl-2-sulfinate + H2O = 2-hydroxybiphenyl + sulfite (#4#  Cys26 is essential for activity <4>)  
3.13.1.4," 3-sulfinopropanoyl-CoA + H2O = propanoyl-CoA + sulfite (#5# reaction  mechanism, residues Arg84, Asp88 and Gln246 side chains and the  isoalloxazine ring of FAD define the enzymatic environment for the  desulfination reaction. FAD is not involved in electron transfer during  the reaction, essential role of Arg84 in catalysis. The enzymatic  reaction might progress with hydrogen-bond formation and charge  transfer between the guanidinium cation of Arg84 and  3-sulfinopropanoyl-CoA, which would favour nucleophilic attack of a  water molecule on the S atom of the sulfino group <4>)  "
3.13.1.5, carbon disulfide + 2 H2O = CO2 + 2 hydrogen sulfide (#2# overall  reaction <1>) 
3.13.1.5, carbon disulfide + H2O = carbonyl sulfide + hydrogen sulfide 
3.13.1.5, carbonyl sulfide + H2O = CO2 + hydrogen sulfide  
3.13.1.6, [CysO sulfur-carrier protein]-Gly-NH-CH2-C(O)-S-L-cysteine + H2O =  [CysO sulfur-carrier protein]-Gly-NH-CH2-COOH + L-cysteine  
3.13.1.7, carbonyl sulfide + H2O = hydrogen sulfide + CO2  
3.13.1.8, S-adenosyl-L-methionine + H2O = adenosine + L-methionine  
3.13.1.9, S-inosyl-L-homocysteine + H2O = inosine + L-homocysteine  
3.2.1.1," Endohydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides  containing three or more (1->4)-alpha-linked D-glucose units (#47# mode  of action <158>; #154# active site mobility and structure of the  psychrophilic alpha-amylase, ligand binding mechanism and  conformational changes, side chains involved in substrate binding are  strictly conserved, overview <175>; #8# endo mode of action <183>; #73#  isozyme Amyl III acts on the alpha-1,4-glycosidic linkage of the inner  granule and releases oligosaccharides, decomposition of granules into  G2 and G3 <170>; #22# PFTA is a bifunctional enzyme showing  alpha-amylase as well as cyclodextrin-hydrolyzing activity <143>; #37#  reaction mechanism and kinetic mechanism <151>; #169# residues Asp204,  Glu240, and Asp305 are involved in catalysis, residues His118, Ala206,  Lys207, and His304 are important for starch binding <145>; #224# the  active site structure involves the catalytic residues D197, E233, and  D300, reaction mechanism <148>; #223# the reaction mechanism involves  no typical conformational change of the flexible loop, residues  303-309, that constitutes the surface edge of the substrate binding  cleft, but only a small movement of the segment from residues 304/305,  conformational change of catalytic residue Asp300 upon substrate  binding, flexibility of the active site depends on the substrate  aglycon bound, overview <184>; #78# TVAII is a bifunctional enzyme  showing alpha-amylase as well as cyclodextrin-hydrolyzing activity, the  enzyme hydrolyzes alpha-1,4-glucosidic linkages and  alpha-1,6-glucosidic linkages, active site structure and substrate  binding structure, Trp356 is involved in substrate binding, and Tyr374  is involved in substrate orientation for catalysis <161>; #190# Tyr105  and Thr212 at outermost substrate binding subsites -6 and +4 control  substrate specificity, oligosaccharide cleavage patterns, and multiple  binding modes of alpha-amylase 1 <171>)  "
3.2.1.10," Hydrolysis of (1->6)-alpha-D-glucosidic linkages in some  oligosaccharides produced from starch and glycogen by EC 3.2.1.1  (alpha-amylase), and in isomaltose (#3,4,5,8,20,25,26# enzyme from  intestinal mucosa also catalyzes the reaction of sucrase  alpha-glucosidase, EC 3.2.1.48 <1,2,3,4,5,15,19,22,23,26,28,29>; #13#  active sites residues are Asp199, Glu255, and Asp329, substrate binding  residues are His103, and His328, catalytic mechanism from comparison  with other enzymes primary and crystal enzyme structures <34>; #6#  stereochemistry, molecular substrate recognition mechanism, catayltic  mechanism <39>)  "
3.2.1.100," Hydrolysis of (1->4)-beta-D-mannosidic linkages in  (1->4)-beta-D-mannans, to remove successive mannobiose residues from  the non-reducing chain ends  "
3.2.1.101," Random hydrolysis of (1->6)-alpha-D-mannosidic linkages in unbranched  (1->6)-mannans (#1# enzyme hydrolyzes alpha-1,6-D-mannosidic and not  beta-1,6-D-mannosidic linkages <1>)  "
3.2.1.102, Endohydrolysis of (1->4)-beta-D-galactosidic linkages in blood group A  and B substances  
3.2.1.103, Endohydrolysis of (1->4)-beta-D-galactosidic linkages in keratan sulfate  
3.2.1.104, cholesteryl-beta-D-glucoside + H2O = D-glucose + cholesterol  
3.2.1.105, strictosidine + H2O = D-glucose + strictosidine aglycone  
3.2.1.106," Glc3Man9GlcNAc2-[protein] + H2O = Glc2Man9GlcNAc2-[protein] +  beta-D-glucopyranose (#10,11# mechanism <10>; #8,11,14# glucosidase I  is a specific alpha-(1,2)-glucosidase <5,14,15>; #10,11#  stereochemistry, enzyme is an inverting glycosidase, operates with  inversion of anomeric configuration <10>)  "
3.2.1.107, [collagen]-(5R)-5-O-[alpha-D-glucosyl-(1->2)-beta-D-galactosyl]-5  hydroxy-L-lysine + H2O = D-glucose +  [collagen]-(5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysine  
3.2.1.108, lactose + H2O = D-galactose + D-glucose (#6# mechanism <1>)  
3.2.1.109, Endohydrolysis of (1->4)-alpha-D-galactosaminidic linkages in  poly(D-galactosamine)  
3.2.1.11, Endohydrolysis of (1->6)-alpha-D-glucosidic linkages in dextran  
3.2.1.111, Hydrolysis of (1->3)-linkages between alpha-L-fucose and  N-acetylglucosamine residues in glycoproteins  
3.2.1.112, a 2-deoxy-alpha-D-glucoside + H2O = 2-deoxy-D-glucose + a primary  alcohol  
3.2.1.113," Man9GlcNAc2-[protein] + 4 H2O = Man5GlcNAc2-[protein] + 4  beta-D-mannopyranose (#7# model for substrate and conformer  selectivity, mechanism, computational study <20>) "
3.2.1.113," Man9GlcNAc2-[protein] + H2O = Man8GlcNAc2-[protein] (isomer  8A1,2,3B1,2) + beta-D-mannopyranose "
3.2.1.113," Man8GlcNAc2-[protein] (isomer 8A1,2,3B1,2) + H2O =  Man7GlcNAc2-[protein] (isomer 7A1,2,3B2) + beta-D-mannopyranose "
3.2.1.113," Man7GlcNAc2-[protein] (isomer 7A1,2,3B2) + H2O = Man6GlcNAc2-[protein]  (isomer 6A1,2B2) + beta-D-mannopyranose "
3.2.1.113," Man6GlcNAc2-[protein] (isomer 6A1,2B2) + H2O = Man5GlcNAc2-[protein] +  beta-D-mannopyranose "
3.2.1.113," Man8GlcNAc2-[protein] (isomer 8A1,2,3B1,3) + 3 H2O =  Man5GlcNAc2-[protein] + 3 beta-D-mannopyranose "
3.2.1.113," Man8GlcNAc2-[protein] (isomer 8A1,2,3B1,3) + H2O =  Man7GlcNAc2-[protein] (isomer 7A1,2,3B1) + beta-D-mannopyranose "
3.2.1.113," Man7GlcNAc2-[protein] (isomer 7A1,2,3B1) + H2O = Man6GlcNAc2-[protein]  (isomer 6A1,2,3) + beta-D-mannopyranose "
3.2.1.113," Man6GlcNAc2-[protein] (isomer 6A1,2,3) + H2O = Man5GlcNAc2-[protein] +  beta-D-mannopyranose  "
3.2.1.114," Man5GlcNAc3-[protein] + 2 H2O = Man3GlcNAc3-[protein] + 2  alpha-D-mannopyranose (#2,19# catalytic mechanism <13,26>; #19# the  conformational change of the bound mannoside to a high-energy B2,5  conformation is facilitated by steric hindrance from, and the formation  of strong hydrogen bonds to, resiude D204 <53>; #23# reaction mechanism  via glycosyl-enzyme intermediate, overview <61>)  "
3.2.1.115," Hydrolysis of (1->2)-alpha-D-glucosidic linkages at the branch points  of dextrans and related polysaccharides, producing free D-glucose  "
3.2.1.116," Hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous  polysaccharides, to remove successive maltotriose residues from the  non-reducing chain ends  "
3.2.1.117," (R)-amygdalin + H2O = (R)-prunasin + D-glucose (#9,10# extracellular  enzyme that shows amygdalin as well as prunasin hydrolase activity  <1,10>; #9,10# prunasin hydrolysis is much slower than amygdalin  hydrolysis <10>; #12# high similarities with glycoside hydrolase family  1 enzymes <11>; #6# four isoforms found, AH I, AH I, AH II, AH II <3>)  "
3.2.1.118," (R)-prunasin + H2O = D-glucose + mandelonitrile (#5,6# extracellular  enzyme that shows amygdalin as well as prunasin hydrolase activity,  prunasin hydrolysis is much slower than amygdalin hydrolysis <5>; #6#  two isoforms found, PG I and PG II <5>; #3# three isoforms found, PH I,  PH IIa, PH IIb <2,7>; #3# five isoforms found, PH1-PH5, high sequence  similarities with glucoside hydrolase family 1 enzymes <6>)  "
3.2.1.119, (R)-vicianin + H2O = mandelonitrile + vicianose  
3.2.1.120, Hydrolysis of (1->4)-beta-D-glucosidic links in oligoxyloglucans so as  to remove successive isoprimeverose [i.e.  alpha-xylo-(1->6)-beta-D-glucosyl-] residues from the non-reducing  chain ends (#3# mechanism <1>; #8# stereoselective cleavage of  substrate <9>; #7# inverting mechanism <6>)  
3.2.1.121, endohydrolysis of the D-mannuronide linkages of polymannuronate  
3.2.1.122, alpha-maltose 6'-phosphate + H2O = D-glucose + D-glucose 6-phosphate  
3.2.1.123, oligoglycosylglucosyl-(1<->1)-ceramide + H2O = ceramide +  oligoglycosylglucose  
3.2.1.124, endohydrolysis of the beta-ketopyranosidic linkages of  3-deoxy-D-manno-2-octulosonate in capsular polysaccharides  
3.2.1.125, raucaffricine + H2O = D-glucose + vomilenine  
3.2.1.126, coniferin + H2O = D-glucose + coniferol (#6# mechanism <5>)  
3.2.1.127, Hydrolysis of (1->6)-linkages between alpha-L-fucose and  N-acetyl-D-glucosamine in glycopeptides such as immunoglobulin G  glycopeptide and fucosyl-asialo-agalacto-fetuin  
3.2.1.128," glycyrrhizin + H2O = beta-D-glucuronosyl-(1->2)-D-glucuronate +  glycyrrhetinate (#1# pathway <1>; #2,3# the glycyrrhizin-hydrolysing  enzyme is separated from the general beta-glucorinidase EC 3.2.1.31  <3,4,5>)  "
3.2.1.129, endohydrolysis of (2->8)-alpha-sialosyl linkages in oligo- or  poly(sialic) acids  
3.2.1.130," GlcMan9GlcNAc2-[protein] + H2O = Man8GlcNAc2-[protein] (isomer  8A1,2,3B1,2) + alpha-D-glucosyl-(1->3)-alpha-D-mannopyranose  "
3.2.1.131, Hydrolysis of (1->2)-alpha-D-(4-O-methyl)glucuronosyl links in the main  chain of hardwood xylans  
3.2.1.132, Endohydrolysis of beta-(1->4)-linkages between D-glucosamine residues  in a partly acetylated chitosan  
3.2.1.133, hydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides so  as to remove successive alpha-maltose residues from the non-reducing  ends of the chains  
3.2.1.135," hydrolysis of pullulan to panose (6-alpha-D-glucosylmaltose) (#3#  structure-function relationship <15>; #9# acidic residues determine the  substrate specificity, residues A357, Q359, and Y360, located in region  II, are involved in action pattern formation <18>; #3# residues E357,  D424, and D328 are involved in the catalytic reaction at the active  site, residues H423, E332, and N331 are involved in substrate  recognition <18>)  "
3.2.1.136, Endohydrolysis of (1->4)-beta-D-xylosyl links in some  glucuronoarabinoxylans  
3.2.1.137," Hydrolysis of (1->2)-alpha-D- and (1->6)-alpha-D- linkages in yeast  mannan, releasing D-mannose  "
3.2.1.139, an alpha-D-glucuronoside + H2O = an alcohol + D-glucuronate  
3.2.1.14," Random endo-hydrolysis of N-acetyl-beta-D-glucosaminide  (1->4)-beta-linkages in chitin and chitodextrins (#167# catalytic  reaction mechanism involving Glu119, overview <117>; #75# exo-type  substrate cleavage mechanism <113>; #189# reaction mechanism, Glu315 is  the acid/base during hydrolysis, the side-chain of the preceding Asp313  helps to position the N-acetyl moiety of the glycosyl sugar undergoing  hydrolysis correctly, mutation of the conserved Tryp167 in the  chitin-binding cleft of chitinase A enhances transglycosylation,  transglycosylation reaction scheme, overview <120>; #81# the enzyme  shows endo- and exo-hydrolytic activity, as well as transglycosylation  activity <110>; #213# catalytic mechanism, overview <203>; #217#  catalytic mechanism with an important role of Trp-33 on enzyme  processivity, CHI60 preferentially uses the endo-type mode on soluble  and amorphous substrates and the exo-type mode on crystalline  substrate, the enzyme hydrolyzes crystalline substrates with an  exo-type mode processively while remaining tightly bound to the  substrate. The prevalent mode of hydrolysis mediated by CHI60 is  regulated by ionic strength <213>; #25# chitooligosaccharide-binding  modes and catalytic mechanism, overview <231>; #38# mode of action of  ChiG, family 19 chitinases use a single-displacement reaction with  inversion of the configuration of the anomeric carbon, overview <206>;  #267# double displacement reaction mechanism, overview <310>)  "
3.2.1.140," beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc + H2O =  beta-D-Gal-(1->3)-D-GlcNAc + beta-D-Gal-(1->4)-D-Glc (#6# catalytic  reaction via Michaelis complex, transition state 1, oxazolinium ion  intermediate, and transition state 2, overview <6>; #6# the enzyme  performs a two-step catalytic mechanism involving substrate-assisted  catalysis that forms a transient oxazoline or oxazolinium ion  intermediate, mechanism overview <9>) "
3.2.1.140, lacto-N-tetraose + H2O = lacto-N-biose + lactose  
3.2.1.141, hydrolysis of (1->4)-alpha-D-glucosidic linkage in  4-alpha-D-[(1->4)-alpha-D-glucanosyl]n trehalose to yield trehalose and  (1->4)-alpha-D-glucan  
3.2.1.142," hydrolysis of (1->6)-alpha-D-glucosidic linkages in alpha- and  beta-limit dextrins of amylopectin and glycogen, and in amylopectin and  pullulan  "
3.2.1.143," hydrolyses poly(ADP-D-ribose) at glycosidic (1''-2') linkage of  ribose-ribose bond to produce free ADP-D-ribose (#19# canonical enzyme  catalytic mechanism, modelling, overview <64>; #17# catalytic  mechanism, modelling, overview <62>; #20# catalytic mechanism,  structure-function analysis, overview <68>; #16# enzyme catalytic  mechanism, overview <65>; #12# Asp314 is located proximal to the  1-O-linkage in substrates. Asp314 might protonate the leaving group  (general acid), forming an oxocarbenium ion intermediate, and then  activate the water (general base) for back-side attack. The W1 ligand  of MgB can serve as the nucleophile attacking the anomeric C1 of the  ribose <75>; #23# enzyme DrPARG possesses endoglycohydrolase activity  toward poly-ADP-ribose (PAR). DrPARG acts in both exo- and  endo-glycohydrolase modes <80>; #12# reaction mechanism and structure,  overview <76>)  "
3.2.1.144, 3-deoxyoctulosonyl-lipopolysaccharide + H2O = 3-deoxyoctulosonic acid +  lipopolysaccharide  
3.2.1.145," hydrolysis of terminal, non-reducing beta-D-galactose residues in  (1->3)-beta-D-galactopyranans  "
3.2.1.146," hydrolysis of terminal non-reducing beta-D-galactofuranosides,  releasing galactose  "
3.2.1.147," a thioglucoside + H2O = a sugar + a thiol (#56# reaction mechanism  <112>; #10# the mechanism involves a first step acid-base catalyzed  reaction with the formation of the glycosyl enzyme intermediate and the  benzyl isothiocyanate obtained by the enzyme-independent Lossen  rearrangement of the transient thiohydroximate-O-sulfonate, a sulfate  anion and a proton are also released <47>)  "
3.2.1.149, a 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside + H2O =  6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranose + an alcohol  
3.2.1.15," (1,4-alpha-D-galacturonosyl)n+m + H2O = (1,4-alpha-D-galacturonosyl)n +  (1,4-alpha-D-galacturonosyl)m  "
3.2.1.150," Hydrolysis of cellobiose from the reducing end of xyloglucans  consisting of a (1->4)-beta-linked glucan carrying alpha-D-xylosyl  groups on O-6 of the glucose residues. To be a substrate, the first  residue must be unsubstituted, the second residue may bear a xylosyl  group, whether further glycosylated or not, and the third residue,  which becomes the new terminus by the action of the enzyme, is  preferably xylosylated, but this xylose residue must not be further  substituted.  "
3.2.1.151, xyloglucan + H2O = xyloglucan oligosaccharides  
3.2.1.152, Hydrolysis of the  alpha-D-mannosyl-(1->6)-beta-D-mannosyl-(1->4)-N-acetyl-beta-D  glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl sequence of  glycoprotein to alpha-D-mannosyl-(1->6)-D-mannose and  N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl  sequences  
3.2.1.153," Hydrolysis of terminal, non-reducing (2->1)-linked  beta-D-fructofuranose residues in fructans  "
3.2.1.154," Hydrolysis of terminal, non-reducing (2->6)-linked  beta-D-fructofuranose residues in fructans  "
3.2.1.155," Hydrolysis of (1->4)-D-glucosidic linkages in xyloglucans so as to  successively remove oligosaccharides from the chain end. (#1# endo-type  reaction mode, overview <1>; #3,4# exo-type reaction mode, overview <1>)  "
3.2.1.156," Hydrolysis of (1->4)-beta-D-xylose residues from the reducing end of  oligosaccharides (#8# processivemodeof hydrolysis, overview. The  xylooligosaccharides are progressively degraded from Xn to Xn-1 and  then subsequently degraded in the same way to xylose and xylobiose <12>)  "
3.2.1.157," Endohydrolysis of (1->4)-beta-D-linkages between D-galactose 4-sulfate  and 3,6-anhydro-D-galactose-2-sulfate in iota-carrageenans (#12#  inverting mechanism for the degradation of carrageenan by  iota-carrageenases via single displacement reactions, overview <12>;  #1,5,11# the enzyme hydrolyses the beta-(1->4) linkages in  iota-carrageenans to produce a series of homologous, even-numbered  oligosaccharides. The cleavage of glycosidic linkage catalyzed by  iota-carrageenases also involves carboxylic acid-containing amino acid  residues but, in contrast to kappa-carrageenases, it occurs via a  direct, single displacement reaction by a water molecule, so that the  configuration in the anomeric position is inverted <16>)  "
3.2.1.158," Endohydrolysis of (1->3)-alpha-L-galactosidic linkages in agarose,  yielding agarotetraose as the major product  "
3.2.1.159," Hydrolysis of the (1->3)-alpha-L-galactosidic linkages of  neoagaro-oligosaccharides that are smaller than a hexamer, yielding  3,6-anhydro-L-galactose and D-galactose  "
3.2.1.161, 7-[beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranosyloxy]isoflavonoid +  H2O = a 7-hydroxyisoflavonoid + beta-D-apiofuranosyl-(1->6)-D-glucose  
3.2.1.162," Endohydrolysis of (1->4)-beta-linkages in the backbone of  lambda-carrageenan, resulting in the tetrasaccharide  alpha-D-Gal-p2,6S2-(1->3)-beta-D-Gal-p2S-(1->4)-alpha-D-Gal-p2  6S2-(1->3)-D-Gal-p2-S (#3# proceeds according to an endolytic mode of  action and a mechanism of inversion of the anomeric configuration <1>)  "
3.2.1.163, Hydrolysis of the (1->6)-linked alpha-D-mannose residues in  alpha-D-Manp-(1->6)-D-Manp  
3.2.1.164," Endohydrolysis of (1->6)-beta-D-galactosidic linkages in  arabinogalactan proteins and (1->3):(1->6)-beta-galactans to yield  galactose and (1->6)-beta-galactobiose as the final products (#2,4#  mode of action, overview <4,5>)  "
3.2.1.165, hydrolysis of chitosan or chitosan oligosaccharides to remove  successive D-glucosamine residues from the non-reducing termini (#9#  two-step mechanism and transglycosylation of the retaining glycoside  hydrolase forming a glycosyl-enzyme intermediate <19>)  
3.2.1.166," endohydrolysis of (1->4)-beta-D-glycosidic bonds of heparan sulfate  chains in heparan sulfate proteoglycan (#10# mode of action, overview  <58>; #10# reaction mechanism with transition states and  glycosyl-enzyme intermediate, overview <49>)  "
3.2.1.167, baicalin + H2O = baicalein + D-glucuronate  
3.2.1.168," hesperidin + H2O = hesperetin + rutinose (#1# diglycosidase activity,  catalyzing the transglycosylation and hydrolysis reactions <4>; #1#  diglycosidase activity, transglycosylation and hydrolysis <3>)  "
3.2.1.169, [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine + H2O =  [protein]-L-serine + N-acetyl-D-glucosamine 
3.2.1.169, [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-theronine + H2O =  [protein]-L-threonine + N-acetyl-D-glucosamine  
3.2.1.17," Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and  N-acetyl-D-glucosamine residues in a peptidoglycan and between  N-acetyl-D-glucosamine residues in chitodextrins (#88# crystallization  data and molecular dynamics simulations indicate that lysozyme is an  inverting enzyme, and Asp97 acts as a second carboxylate and that the  narrow space of the binding cleft at subsites EÂ–G in GEL may prohibit  the sugar chain to bind alternative site that might be essential for  transglycosylation <163>)  "
3.2.1.170, 2-O-(alpha-D-mannopyranosyl)-D-glycerate + H2O = D-mannopyranose +  D-glycerate  
3.2.1.171," Endohydrolysis of alpha-D-GalA-(1->2)-alpha-L-Rha glycosidic bond in  the rhamnogalacturonan I backbone with initial inversion of anomeric  configuration releasing oligosaccharides with beta-D-GalA at the  reducing end (#1,4,5# mode of action and site of action, overview. RGI  endo-hydrolases, RGHs, attack the RGI backbone randomly in an  endo-fashion and catalyse bond cleavage of alpha-(1->2) glycosidic  bonds between D-GalpA and L-Rhap. The mechanism involves an inversion  of the anomeric C1 configuration in galacturonic acid releasing  oligosaccharides with beta-D-GalpA at the reducing end and L-Rhap at  the non-reducing end as products <9>)  "
3.2.1.172," 2-O-(4-deoxy-beta-L-threo-hex-4-enopyranuronosyl)-alpha-L  rhamnopyranose + H2O = 5-dehydro-4-deoxy-D-glucuronate +  L-rhamnopyranose (#2# mode of action and site of action, overview. In  the active site of YesR Asp135 is most likely functioning as proton  donor <5>; #1# mode of action and site of action, overview. In the  active site of YteR Asp143 is most likely functioning as proton donor  <5>)  "
3.2.1.173," Exohydrolysis of the alpha-D-GalA-(1->2)-alpha-L-Rha bond in  rhamnogalacturonan oligosaccharides with initial inversion of  configuration releasing D-galacturonic acid from the non-reducing end  of rhamnogalacturonan oligosaccharides (#1# mode of action and site of  action, overview. RGI endo-hydrolases, RGHs, attack the RGI backbone  randomly in an endo-fashion and catalyse bond cleavage of alpha-(1->2)  glycosidic bonds between D-GalpA and L-Rhap. The mechanism involves an  inversion of the anomeric C1 configuration in galacturonic acid  releasing oligosaccharides with beta-D-GalpA at the reducing end and  L-Rhap at the non-reducing end as products <3>)  "
3.2.1.174," Exohydrolysis of the alpha-L-Rha-(1->4)-alpha-D-GalA bond in  rhamnogalacturonan oligosaccharides with initial inversion of  configuration releasing beta-L-rhamnose from the non-reducing end of  rhamnogalacturonan oligosaccharides (#1# mode of action and site of  action, overview <4>)  "
3.2.1.175, D-glucopyranosyl abscisate + H2O = D-glucose + abscisate  
3.2.1.176," Hydrolysis of (1->4)-beta-D-glucosidic linkages in cellulose and  cellotetraose, releasing cellobiose from the non-reducing ends of the  chains (#16# mechanism <15>; #7# double-displacement mechanism,  transition states, formation of an glycosyl-enzyme intermediate,  structure-reactivity studies, the catalytic triad is formed by Glu212,  Asp214, and Glu217, the glycosylation step is rate-limiting, overview  <17>; #43# substrate binding structure analysis of Cel7D <21>) "
3.2.1.176," Hydrolysis of (1->4)-beta-D-glucosidic linkages in cellulose and  similar substrates, releasing cellobiose from the reducing ends of the  chains.  "
3.2.1.177," Hydrolysis of terminal, non-reducing alpha-D-xylose residues with  release of alpha-D-xylose.  "
3.2.1.178, hydrolysis of  beta-D-galactopyranose-(1->4)-alpha-L-galactopyranose-6-sulfate  linkages in porphyran  
3.2.1.179," beta-D-4-deoxy-Delta4-GlcAp-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1  >3)-D-Glcp + H2O = 5-dehydro-4-deoxy-D-glucuronate +  beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp (#4# the enzyme triggers  a hydration reaction acting on the C-C double bond between the C-4 and  C-5 positions of the unsaturated uronic acid residue in GAG  disaccharide using the catalytic Asp residue (Asp-II) as a general acid  and base catalyst to protonate the C-4 atom of unsaturated uronic acid  residue and to deprotonate the water molecule. The deprotonated water  molecule attacks the C-5 atom of the unsaturated uronic acid residue to  yield unstable hemiketal, followed by its spontaneous conversion to  4-deoxy-L-threo-5-hexosulose-uronic acid and an amino sugar via  hemiacetal formation and cleavage of the glycoside bond <8>)  "
3.2.1.18," hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic  linkages of terminal sialic acid residues in oligosaccharides,  glycoproteins, glycolipids, colominic acid and synthetic substrates  (#107# active site, Arg498, Glu258, Tyr317, and Tyr262 are catalytic  residues, with the aromatic ring of the latter being important for  function <90>; #22# enzyme does not act on 4-O-acetylated sialic acids  <82>; #13,17,21,24,26,27,28,29,32,38,49,60# exo-glycosidase <83>; #52#  exo-glycosidase, active center contains essential cysteine residues  <83>; #19# exo-glycosidase, the active center contains essential  cysteine residues <83>; #57# reaction and kinetic mechanisms <85>; #16#  trans-sialidase preferring the transfer of sialic acids from  sialoglycoconjugates to beta-galactosyl acceptor molecules, ping-pong,  double diplacement catalytic mechanism, Tyr342 is important, Asp59 is  the acid/base residue, enzyme-substrate complex structure, covalent  sialyl-enzyme intermediate <93>; #99# catalytic chemistry involves the  formation of a covalent intermediate with an active site tyrosine  nucleophile <104>; #65# catalytic mechanism, overview <201>; #16#  ping-pong bi-bi kinetic mechanism. Residue D59 functions as acid/base  catalyst, and Y342 as active site nucleophile <136>)  "
3.2.1.180, beta-D-4-deoxy-DELTA4-GlcAp-(1->3)-beta-D-GalNAc6S + H2O =  5-dehydro-4-deoxy-D-glucuronate +  N-acetyl-beta-D-galactosamine-6-O-sulfate  
3.2.1.181," The enzyme specifically hydrolyses beta-1,3-galactan and  beta-1,3-galactooligosaccharides (#4# beta-1,4- and  beta-1,6-galactooligosaccharides, agarose, or keratan sulfate do not  serve as substrates <1>)  "
3.2.1.182," (2R)-4-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside + H2O =  2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one + D-glucose "
3.2.1.182," (2R)-4-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl  beta-D-glucopyranoside + H2O =  2,4-dihydroxy-2H-1,4-benzoxazin-3(4H)-one + D-glucose  "
3.2.1.183," UDP-N-acetyl-alpha-D-glucosamine + H2O = N-acetyl-D-mannosamine + UDP  (#5# catalytic and regulatory mechanisms <13>; #3# the epimerase  reaction is shown to proceed with a retention of stereochemistry at  C-1, and the loss of UDP is found to occur via a C-O bond cleavage  process. Results support a mechanism involving an anti-elimination of  UDP followed by the syn-hydration of 2-acetamidoglucal <4>; #4# the  mechanism is proposed to involve an anti elimination of UDP to form  2-acetamidoglucal as an intermediate, followed by the syn addition of  water <6>)  "
3.2.1.184," UDP-N,N'-diacetylbacillosamine + H2O = UDP +  2,4-diacetamido-2,4,6-trideoxy-D-mannopyranose (#1# the reaction  proceeds with an inversion of stereochemistry at C-2 and retention of  stereochemistry at C-1. Evidence of the cleavage of the C-1-O bond and  the C-2-H bond supports an elimination/hydration mechanism similar to  that of NeuC in sialic acid bisoynthesis <1>)  "
3.2.1.185, beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranose + H2O = 2  beta-L-arabinofuranose  
3.2.1.186, protodioscin + H2O = 26-deglucoprotodioscin + D-glucose  
3.2.1.187," 4-O-(beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-(1->2)-beta  L-arabinofuranosyl)-(2S,4S)-4-hydroxyproline + H2O =  4-O-(beta-L-arabinofuranosyl)-(2S,4S)-4-hydroxyproline +  beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranose  "
3.2.1.188, avenacoside B + H2O = 26-desgluco-avenacoside B + D-glucose  
3.2.1.189, 3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]diosgenin + 3  H2O = D-glucose + 2 L-rhamnose + diosgenin  
3.2.1.190, 3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]diosgenin + 2  H2O = 2 L-rhamnopyranose + diosgenin 3-O-beta-D-glucopyranoside  
3.2.1.191, a protopanaxadiol-type ginsenoside with two glucosyl residues at  position 3 + H2O = a protopanaxadiol-type ginsenoside with one glucosyl  residue at position 3 + D-glucopyranose 
3.2.1.191, a protopanaxadiol-type ginsenoside with two glucosyl residues at  position 3 + 2 H2O = a protopanaxadiol-type ginsenoside with no  glycosidic modification at position 3 + 2 D-glucopyranose (#9# overall  reaction <2>) 
3.2.1.191, a protopanaxadiol-type ginsenoside with one glucosyl residue at  position 3 + H2O = a protopanaxadiol-type ginsenoside with no  glycosidic modification at position 3 + D-glucopyranose  
3.2.1.192, ginsenoside Rb1 + 2 H2O = ginsenoside Rg3 + 2 D-glucopyranose (#4#  overall reaction <1>) 
3.2.1.192, ginsenoside Rb1 + H2O = ginsenoside Rd + D-glucopyranose 
3.2.1.192, ginsenoside Rd + H2O = ginsenoside Rg3 + D-glucopyranose  
3.2.1.193," a protopanaxadiol-type ginsenoside with two glucosyl residues at  position 3 + H2O = a protopanaxadiol-type ginsenoside with one glucosyl  residue at position 3 + D-glucopyranose (#8# Hydrolysis of the  3-O-beta-D-(1->2)-glucosidic bond, the 3-O-beta-D-glucopyranosyl bond  and the 20-O-beta-D-(1->6)-glycosidic bond of protopanaxadiol-type  ginsenosides. The enzyme usually leaves a single glucosyl residue  attached at position 20 and no glucosyl or one glucosyl residue at  position 3. Starting with a ginsenoside that is glycosylated at both  positions (e.g. ginsenoside Rb1, Rb2, Rb3, Rc or Rd), the most common  products are ginsenoside F2 and ginsenoside C-K with low amounts of  ginsenoside Rh2. <1>) "
3.2.1.193, a protopanaxadiol-type ginsenoside with one glucosyl residue at  position 3 + H2O = a protopanaxadiol-type ginsenoside with no  glycosidic modifications at position 3 + D-glucopyranose 
3.2.1.193, a protopanaxadiol-type ginsenoside with two glycosyl residues at  position 20 + H2O = a protopanaxadiol-type ginsenoside with a single  glucosyl residue at position 20 + a monosaccharide  
3.2.1.194, a protopanaxatriol-type ginsenoside with two glycosyl residues at  position 6 + 2 H2O = a protopanaxatriol-type ginsenoside with no  glycosidic modification at position 6 + D-glucopyranose + a  monosaccharide (#4# overall reaction <2>) 
3.2.1.194, a protopanaxatriol-type ginsenoside with two glycosyl residues at  position 6 + H2O = a protopanaxatriol-type ginsenoside with a single  glucosyl at position 6 + a monosaccharide 
3.2.1.194, a protopanaxatriol-type ginsenoside with a single glucosyl at position  6 + H2O = a protopanaxatriol-type ginsenoside with no glycosidic  modification at position 6 + D-glucopyranose  
3.2.1.195, a protopanaxadiol-type ginsenoside with two glycosyl residues at  position 20 + H2O = a protopanaxadiol-type ginsenoside with a single  glucosyl residue at position 20 + a monosaccharide  
3.2.1.196, Hydrolysis of (1->6)-alpha-D-glucosidic linkages to branches with  degrees of polymerization of three or four glucose residues in limit  dextrin.  
3.2.1.197, beta-D-mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-D  mannopyranose + H2O = beta-D-mannopyranosyl-(1->2)-D-mannopyranose +  alpha-D-mannopyranose  
3.2.1.198, Hydrolysis of the terminal alpha-D-mannosyl-(1->3)-alpha-D-mannose  disaccharide from  alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->2)  alpha-D-mannosyl side chains in fungal cell wall alpha-mannans  
3.2.1.199," an 6-sulfo-alpha-D-quinovosyl diacylglycerol + H2O =  6-sulfo-D-quinovose + a 1,2-diacylglycerol  "
3.2.1.2," Hydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides so  as to remove successive maltose units from the non-reducing ends of the  chains (#69# mechanism <59>; #7# multichain type mechanism <5>; #6,69#  catalytic mechanism <56,70>; #22# acts on starch, glycogen and related  polysaccharides and oligosaccharides producing beta-maltose by an  inversion, the term beta relates to the initial anomeric configuration  of the free sugar group released and not to the configuration of the  linkage hydrolysed <62>; #14# catalytic mechanism, reaction mechanism  <58>; #68# active site structure, carbohydrate binding subsites, role  of a conformational change of the inner loop in the catalytic  mechanism, T342 is involved, overview <69>; #11# general acid-base  catalytic reaction mechanism <79>; #69# Glu367 is important in  catalysis, the plant enzyme shows a reaction mechanism different from  the bacterial enzyme, overview <68>;  #2,5,21,22,24,26,27,31,34,45,50,57,58,59# mode of action of the  exo-amylase <67>; #10# roles of Glu186 and Glu380 as general acid and  general base catalyst in the catalytic reaction, reaction mechanism  involving residue T342 <79>; #68# roles of Glu186 and Glu380 as general  acid and general base catalyst in the catalytic reaction, substrate  binding and reaction mechanism <77>)  "
3.2.1.20," Hydrolysis of terminal, non-reducing (1->4)-linked alpha-D-glucose  residues with release of D-glucose (#71# ping-pong mechanism <34>; #75#  residues Asp198, Glu265, and Asp327 are involved in catalysis, His100  and His326 are involved in substrate binding <109>; #95# the enzyme has  both exo-alpha-1,4-glucosidase and oligo-alpha-1,6-glucosidase  activities <102>; #103# substrate recognition and catalytic mechanism,  active site structure, residues R400, D87, W284, M321, F327 are  involved in formation of the +1 subsite in the GH31 alpha-glucosidase  substrate binding <122>; #137# the enzyme prefers short substrates,  e.g. maltose and maltotriose, to longer substrates, and hydrolyzes  alpha-1,4-glucosidic linkages, but also acts on alpha-1,2-, alpha-1,3-,  and alpha-1,6-glucosidic linkages, the catalytic site contains three  subsites with different affinities <114>; #10# Val216 determines the  substrate specificity of the yeast enzyme, active site structure  modelling <118>)  "
3.2.1.200," Hydrolysis of N,N'-diacetylchitobiose from the non-reducing end of  chitin and chitodextrins  "
3.2.1.201," Hydrolysis of N,N'-diacetylchitobiose from the reducing end of chitin  and chitodextrins  "
3.2.1.202," Hydrolysis of chitodextrins, releasing N,N'-diacetylchitobiose and  small amounts of N,N',N''-triacetylchitotriose  "
3.2.1.203, Endohydrolysis of (1->4)-beta-D-glucosidic linkages in  (carboxymethyl)cellulose.  
3.2.1.204, cyclobis-(1->6)-alpha-nigerosyl + 2 H2O = 2 isomaltose 
3.2.1.204, cyclobis-(1->6)-alpha-nigerosyl + H2O =  alpha-isomaltosyl-(1->3)-isomaltose 
3.2.1.204, alpha-isomaltosyl-(1->3)-isomaltose + H2O = 2 isomaltose  
3.2.1.205, isomaltose + H2O = beta-D-glucose + D-glucose  
3.2.1.206, oleuropein + H2O = oleuropein aglycone + D-glucopyranose  
3.2.1.207," Glc2Man9GlcNAc2-[protein] + H2O = GlcMan9GlcNAc2-[protein] +  beta-D-glucopyranose (#4,7# Glc2Man9GlcNAc2 + H2O = Man9GlcNAc2 +  glucose <2,7,8,9>) "
3.2.1.207, GlcMan9GlcNAc2-[protein] + H2O = Man9GlcNAc2-[protein] +  beta-D-glucopyranose  
3.2.1.208, 2-O-(alpha-D-glucopyranosyl)-D-glycerate + H2O = D-glucopyranose +  D-glycerate  
3.2.1.209," Man9GlcNAc2-[protein] + H2O = Man8GlcNAc2-[protein] (isomer  8A1,2,3B1,3) + D-mannopyranose  "
3.2.1.21," Hydrolysis of terminal, non-reducing beta-D-glucosyl residues with  release of beta-D-glucose (#75# reaction and kinetic mechanisms <136>;  #184# residues E173 and E362 are essential for catalytic activity  <142>; #33# structural basis for substrate specificity, residues N259,  F261, and S462 are important, substrate binding mode and structure  <151>; #212# substrate binding mode and structure <151>; #142# the  enzyme contains a His residue which is important for catalytic activity  <137>; #260# molecular basis of the catalytic mechanism involving the  acid/base Glu167 and the nucleophilic Glu356, the structure of BglB  shows that several polar residues narrow the active site pocket and  contour additional subsites, detailed substrate-binding mode and  oligosaccharide-enzyme recognition pattern of BglB, overview,  oligomerization in BglA can assist in fine-tuning the specificity of  the active centre by modulating the loops surrounding the cavity <188>;  #199# the conserved Asp287 is the potential nucleophile in the  catalytic center <161>; #196,197# the putative acid/base catalyst is  Glu170 <170>; #213# the two catalytic glutamate residues are located on  strand 4, the acid/base Glu165, and on strand 7,the nucleophile Glu373  <187>; #203# the two glutamic acid residues Glu172 and Glu370 are  essential for enzyme activity of CellG <189>; #10# Trp49 is important  for transglucosylation catalytic activity <165>; #44# W293 of the SDW  segment, which is the residue next to the nucleophile D292 in family 3  BGL, is very important for hydrolytic reaction as a binder to a  substrate. G294 of the SDWG sequence might play an important role in  catalysis, interaction between the sugar rings and aromatic ring of  W293 at the entrance of the catalytic pocket enhances the substrate  recognition of beta-glucosidase <163>; #213# double replacement  mechanism, retaining the configuration. A water molecule may be  involved in the stabilization of transition states through a sugar  2-hydroxyl oxygen <200>)  "
3.2.1.210," Man8GlcNAc2-[protein] (isomer 8A1,2,3B1,3) + H2O =  Man7GlcNAc2-[protein] (isomer 7A1,2,3B3) + -D-mannopyranose  "
3.2.1.211, endohydrolysis of (1->3)-alpha-L-fucoside linkages in fucan  
3.2.1.212, endohydrolysis of (1->4)-alpha-L-fucoside linkages in fucan  
3.2.1.213, Hydrolysis of (1->6)-beta-D-galactosidic linkages in arabinogalactan  proteins and (1->3):(1->6)-beta-galactans to yield  (1->6)-beta-galactobiose as the final product.  
3.2.1.214, [(1->2)-beta-D-glucosyl]n + H2O = sophorose +  [(1->2)-beta-D-glucosyl]n-2  
3.2.1.215, Hydrolysis of alpha-D-Galp-(1->3)-L-Araf disaccharides from  non-reducing terminals in branches of type II arabinogalactan attached  to proteins.  
3.2.1.22, alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<  >1)-ceramide + H2O = D-galactose +  beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide 
3.2.1.22," Hydrolysis of terminal, non-reducing alpha-D-galactose residues in  alpha-D-galactosides, including galactose oligosaccharides,  galactomannans and galactolipids (#52# the recombinant enzyme catalyzes  the hydrolysis of phenyl R-galactosides via a redox  elimination-addition mechanism involving oxidation of the hydroxyl  group at C-3 and elimination of phenol across the C-1-C-2 bond to give  an enzyme-bound glycal intermediate <181>)  "
3.2.1.23," hydrolysis of terminal non-reducing beta-D-galactose residues in  beta-D-galactosides (#10# mechanism <3,5>; #217# catalytic mechanism,  active site structure,Glu157 acts as the acid/base in the catalytic  reaction <145>; #148# Glu184 acts as acid/base catalyst <153>; #135#  the conserved residues E482, M522, Y523 and E551 are important in  catalysis <164>)  "
3.2.1.24," hydrolysis of terminal, non-reducing alpha-D-mannose residues in  alpha-D-mannosides (#5# active site structure and catalytic residues,  e.g. Asn515 involved in substrate binding, reaction mechanism and  processing steps, overview <89>) "
3.2.1.24, Man9GlcNAc2-[protein] + 4 H2O = Man5GlcNAc2-[protein] + 4  beta-D-mannopyranose (#12# mechanism: ordered equilibrium <71>)  
3.2.1.25," hydrolysis of terminal, non-reducing beta-D-mannose residues in  beta-D-mannosides (#48# substrate adopts a B2,5 transition state <58>)  "
3.2.1.26," hydrolysis of terminal non-reducing beta-D-fructofuranoside residues in  beta-D-fructofuranosides (#111# double-displacement reaction mechanism,  cleavage of beta-fructopyranosidic linkages involving a nucleophilic  aspartate and a catalytic glutamic acid acting as general acid/base,  structure of the active site substrate binding pocket possessing three  binding subsites <94>; #111# the enzyme reaction mechanism with  retention of the anomeric configuration at the site of cleavage, active  site structure <104>; #32# the enzyme shows also transfructosylation  activity with cellobiose or cellotriose as acceptor and sucrose as  donor, mechanism <97>)  "
3.2.1.28," alpha,alpha-trehalose + H2O = beta-D-glucose + alpha-D-glucose (#31#  role of carboxyl, guanidine and imidazole groups in catalysis <60>;  #25# nucleophilic double, not single, displacement catalytic forward  reaction mechanism via oxocarbenium ion intermediate, detailed overview  <88>)  "
3.2.1.3," Hydrolysis of terminal (1->4)-linked alpha-D-glucose residues  successively from non-reducing ends of the chains with release of  beta-D-glucose (#12# mode of action <106>; #92,93# active site  structure, catalytic residue is Tyr464, catalytic domain and raw starch  binding site <96>; #6,7,11,16,17,22,31,32,36,40,42,45,48,88,89,90#  cleavage of alpha-1,4-linkages is preferred to cleavage of  alpha-1,6-linkages <93>; #81# reaction mechanism depends on the  substrate, i.e. hydrolysis or transglycosylation, overview <85>; #34#  residue Trp622 is important in substrate binding rather than in  determination of pH optimum, and probably does not interact with the  catalytic base <103>; #11# structure-function relationship, ligand  binding <89>; #86,120,121# the enzyme catalyses the cleavage of  alpha-1,4- and alpha-1,6-glycosidic bonds. Glucoamylases use a  classical acid/base Koshland-type inverting mechanism, releasing  alpha-glucose from the nonreducing end of an alpha-glucan chain <197>;  #118# the enzyme from Aspergillus tritici strain WZ99 degrades  alpha-1,4 glucoside linkages faster than alpha-1,6 glucoside linkages  <207>)  "
3.2.1.31," a beta-D-glucuronoside + H2O = D-glucuronate + an alcohol (#46#  reaction mechanism, active site with catalytic nucleophile E576,  residue E383 is also involved in catalysis <50>)  "
3.2.1.32, random endohydrolysis of (1->3)-beta-D-glycosidic linkages in  (1->3)-beta-D-xylans  
3.2.1.33," hydrolysis of (1->6)-alpha-D-glucosidic branch linkages in glycogen  phosphorylase limit dextrin (#9# mechanism <7,12,21,22,26,27,30,31>;  #9# stereochemistry <26>; #11# regulation of enzyme activity <29>; #9#  alpha-(1->6) linkage can be synthesized in the absence of  polysaccharide <22>; #9# thermodynamic data <30,31>)  "
3.2.1.35," Random hydrolysis of (1->4)-linkages between  N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate  (#2,3,6,7,36# also hydrolyses 1,4-beta-D-glycosidic linkages between  N-acetyl-galactosamine or N-acetylgalactosamine sulfate and glucuronic  acid in chondroitin, chondroitin 4- and 6-sulfates, and dermatan  <2,19,24,25,27>; #19# endoglycosidase with exoglycosidase activity  <20>; #58# enzyme is a beta-1,4-glucosidase, substrate binding groove,  enzyme-substrate complex structure, catalytic groups and reaction  mechanism <33>; #6# hydrolase mechanism <31>; #6# specifically  hydrolyses 1,4-beta-D-glycosidic linkages, reaction mechanism,  simulation of product formation process, active site <22>; #2# reaction  mechanism and three-dimensional structure <38>; #58# reaction mechanism  and three-dimensional structure, catalytic residue is Glu113, substrate  positioning residues, overview <38>; #6# reaction mechanism and  three-dimensional structure, catalytic residue is Glu149, substrate  positioning residues, overview <38>; #3# reaction mechanism and  three-dimensional structure, catalytic residues of isozymes Hyal1-Hyal4  are Glu131, Glu135, Glu129, and Glu147, respectively, substrate  positioning residues, active site structure of isozymes, overview <38>;  #53# the enzyme contains four hyaluronan binding sites [B(X)7B] <40>)  "
3.2.1.36, Random hydrolysis of (1->3)-linkages between beta-D-glucuronate and  N-acetyl-D-glucosamine residues in hyaluronate  
3.2.1.37," Hydrolysis of (1->4)-beta-D-xylans, to remove successive D-xylose  residues from the non-reducing termini (#16,36# mechanism <47,48,60>;  #16# kinetics <49>; #25# ordered bi-bi mechanism, kinetics <50>; #3#  Glu160 is the acid-base catalyst, kinetics <57>; #44# retention of  anomeric configuration, two-step mechanism, SN2-like transition state  <58>; #69# catalytic residues D15, D128, and E187 are essential for  activity, reaction mechanism <65>; #58# active site residues are D242  and E441 <81>; #25# active site residues are D264 and E464 <81>; #28#  hydrolysis of 4-nitrophenyl-beta-D-xylopyranoside with overall  retention of substrate anomeric configuration, double-displacement  mechanism. Deglycosylation is the rate-limiting step for the enzymatic  hydrolysis <79>)  "
3.2.1.38, hydrolysis of terminal non-reducing beta-D-fucose residues in  beta-D-fucosides (#7# reaction mechanism <18>)  
3.2.1.39," hydrolysis of (1->3)-beta-D-glucosidic linkages in  (1->3)-beta-D-glucans (#49# E94 reacts as nucleophile, E236 as proton  donor <68>; #100# AkLam36 mode of action, overview <98>; #37# D422,  E499 and E503 are involved in catalysis.E499 is the catalytic base,  F425 plays a major role in substrate binding possibly mediated by  aromatic ring stacking with the sugar substrate <106>; #103# the enzyme  is an endoglucanase that hydrolyzes beta-1,3-glucans as laminarin and  yeast beta-1,3-1,6-glucan, but is inactive toward other  polysaccharides, e.g. unbranched beta-1,3-glucans or mixed  beta-1,3-1,4-glucan from cereals, or disaccharides. TLam has two  ionizable groups involved in catalysis, and His, Tyr and Arg residues  plus a divalent ion at the active site. A Cys residue important for  TLam activity is exposed after laminarin binding. Residues E174, E179,  H204, Y304, R127 and R181 at the active site of the enzyme are  important for TLam activity <101>; #94# substrate binding structure and  catalytic mechanism, overview <122>)  "
3.2.1.4," endohydrolysis of (1->4)-beta-D-glucosidic linkages in cellulose,  lichenin and cereal beta-D-glucans (#93# proposed mechanism of action  of inverting glycoside hydrolases and structures of catalytic residues,  overview. The catalytic base is Asp392, catalytic acid residue is  Asp252 <217>)  "
3.2.1.40, hydrolysis of terminal non-reducing alpha-L-rhamnose residues in  alpha-L-rhamnosides  
3.2.1.41," Hydrolysis of (1->6)-alpha-D-glucosidic linkages in pullulan,  amylopectin and glycogen, and in the alpha- and beta-limit dextrins of  amylopectin and glycogen  "
3.2.1.42, GDP-glucose + H2O = D-glucose + GDP  
3.2.1.43," hydrolysis of terminal, non-reducing beta-L-rhamnose residues in  beta-L-rhamnosides  "
3.2.1.45," a D-glucosyl-N-acylsphingosine + H2O = D-glucose + a ceramide (#7# the  enzyme hydrolyses the beta-glucosidic linkage of glucosylceramide with  retention of anomeric conformation via a two-step, double-displacement  mechanism <42>)  "
3.2.1.46, a D-galactosyl-N-acylsphingosine + H2O = D-galactose + a ceramide  
3.2.1.48," hydrolysis of sucrose and maltose by an alpha-D-glucosidase-type action  (#6# The enzyme complex consists of two noncovalently linked subunits.  The active site of the sucrase subunit cleaves  alpha,beta-(1-2)glycosidic bonds and contains only two subsites and,  thus can bind only two monomeric parts of a substrate with positive  affinity. The isomaltase cleaves alpha-(1-6) and alpha-(1-1) glycoside  bonds <27>; #14# the protein with strong homology to a rabbit  sucrase-isomaltase is a cAMP-dependent epithelial chloride channel <29>)  "
3.2.1.49," Cleavage of non-reducing alpha-(1->3)-N-acetylgalactosamine residues  from human blood group A and AB mucin glycoproteins, Forssman hapten  and blood group A lacto series glycolipids (#1# double-displacement  mechanism. First step: an oxygen atom from Asp140 attacks the  electrophilic C1 of the hexose ring, cleaving the glycosidic linkage  and creating a covalent enzyme-substrate intermediate. The second step  involves a nucleophilic attack by a water molecule, which has been  deprotonated by Asp201, on the covalent intermediate. <36>; #3# the  enzyme exhibits an endo-enzyme activity in addition to an exo-activity  <33>; #36# double-displacement, or ping-pong, reaction mechanism and  active site structure, overview <46>; #41# a hydride at C3, activated  by the interaction of the OH-3 hydroxyl with the conserved His228, is  abstracted by NAD+ with oxidation of the OH-3 hydroxyl to a ketone.  This activates H2 for proton abstraction by Tyr179, accompanied by  elimination of the aglycone, thereby generating a 1,2-unsaturated  intermediate. Water is then added to the anomeric center, followed by  the reduction of the C3 ketone by the on-board NADH, completing the  catalytic sequence and restoring NADH to NAD+ and the enzyme to its  starting state to bind another substrate <47>; #19# E2 elimination  following hydride transfer from C3 <51>)  "
3.2.1.50, hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in  N-acetyl-alpha-D-glucosaminides  
3.2.1.51," an alpha-L-fucoside + H2O = L-fucose + an alcohol (#25# mechanism <50>;  #46# the enzyme catalyses the transfer of L-fucose from donor  structures such as alpha-L FucpOpNP and alpha-L-FucpF to various  GlcpNac derivates and glCP, forming alpha-(1-3)linkages <53>; #27# the  enzyme cleaves alpha1-6-, alpha1-3-, alpha1-4- and alpha1-2-O-fucolsyl  bonds in fucosylated oligosaccharides <57>)  "
3.2.1.52," hydrolysis of terminal non-reducing N-acetyl-D-hexosamine residues in  N-acetyl-beta-D-hexosaminides (#6,8# seperate active sites for  glucosaminidase and galactosaminidase activities <28,69>;  #6,7,8,10,12,14,38,55,65,82,93# same active site for N-glucosaminidase  and N-galactosaminidase activities  <11,18,29,32,33,36,42,44,54,55,79,84>; #30,36,93# endo-type reaction  <6,29,82>; #4,7,8,9,15,30,39,48,50,58,75,81# exo-type reaction  <8,19,34,42,43,53,60,61,64,66,68,71,72,76>)  "
3.2.1.53," hydrolysis of terminal non-reducing N-acetyl-D-galactosamine residues  in N-acetyl-beta-D-galactosaminides (#8# NgaP adopts substrate-assisted  catalysis in which residues Glu608 and Asp607 could function as a  proton donor and a stabilizer of the 2-acetamide group of the  beta-GalNAc at the active site, respectively <7>)  "
3.2.1.54," cyclomaltodextrin + H2O = linear maltodextrin (#33# active site  structure <23>; #13# also hydrolyses linear maltodextrin, model of  coupled hydrolysis and transglycosylation catalyzed by  cyclodextrin-degrading enzymes, catalytic mechanism of  double-displacement reaction, active site cleft structure, conserved  Glu332 plays an important role in the binding of oligosaccharide  acceptors <22>; #24# model of coupled hydrolysis and transglycosylation  catalyzed by cyclodextrin-degrading enzymes, catalytic mechanism of  double-displacement reaction, active site cleft structure,  catalytically important residues are Asp325, Glu354, and Asp421,  conserved Glu332 plays an important role in the binding of  oligosaccharide acceptors <22>; #2,3,5,8,9,16,17,20,23,27,28# model of  coupled hydrolysis and transglycosylation catalyzed by  cyclodextrin-degrading enzymes, catalytic mechanism of  double-displacement reaction, active site cleft structure, conserved  Glu332 plays an important role in the binding of oligosaccharide  acceptors <22>; #4# PFTA is a bifunctional enzyme showing alpha-amylase  as well as cyclodextrin-hydrolyzing activity <25>; #21# TVA II is a  bifunctional enzyme showing alpha-amylase as well as  cyclodextrin-hydrolyzing activity, the enzyme hydrolyzes  alpha-1,4-glucosidic linkages and alpha-1,6-glucosidic linkages, active  site structure and substrate binding structure, Trp356 is involved in  substrate binding, and Tyr374 is involved in substrate orientation for  catalysis <27>)  "
3.2.1.55," hydrolysis of terminal non-reducing alpha-L-arabinofuranoside residues  in alpha-L-arabinosides (#116# catalytic mechanism, 2 stable states in  the double displacement mechanism with formation of a transient  covalent arabinofuranosyl-enzyme intermediate, structure of  enzyme-substrate complex, substrate binding and specificity <53>; #116#  catalytic mechanism, Glu175 is the acid-base residue, Glu294 functions  as the catalytic nucleophile <55>; #42# endolytic mode of action <50>;  #113# enzyme shows 2 catalytic activities: alpha-L-arabinofuranosidase  and beta-D-xylosidase activity <56>; #114# exo-acting enzyme <47>;  #115# reaction mechanism, active site structure, Glu28, the catalytic  nucleophil, Glu176, the acid-base residue, and Glu298, responsible for  modulation of the ionization state of the acid-base and for substrate  fixation, are important for catalytic activity <58>; #55# the enzyme  also acts on alpha-L-arabinofuranosides, alpha-L-arabinans containing  (1,3)- and/or (1,5)-linkages, arabinoxylans and arabinogalactans, some  beta-galactosidases, EC 3.2.1.23, and beta-D-fucosidases, EC 3.2.1.38,  also hydrolyse alpha-L-arabinosides <45>; #66# catalytic mechanism and  substrate binding structure, overview <105>; #74# mode of action of  Penicillium funiculosum family 62 isozymes, overview <132>; #157# the  enzyme hydrolyze the glycosidic bond via the double-displacement  mechanism in the active site of a funnel-shaped pocket, catalytic  residues are the acid/base Glu172 and the enzymatic nucleophile Glu281  <138>)  "
3.2.1.56," 3-D-glucuronosyl-N2,6-disulfo-beta-D-glucosamine + H2O = D-glucuronate  + N2,6-disulfo-D-glucosamine  "
3.2.1.57, hydrolysis of pullulan to isopanose (6-alpha-maltosylglucose)  
3.2.1.58," Successive hydrolysis of beta-D-glucose units from the non-reducing  ends of (1->3)-beta-D-glucans, releasing alpha-glucose  "
3.2.1.59," Endohydrolysis of (1->3)-alpha-D-glucosidic linkages in isolichenin,  pseudonigeran and nigeran  "
3.2.1.6," Endohydrolysis of (1->3)- or (1->4)-linkages in beta-D-glucans when the  glucose residue whose reducing group is involved in the linkage to be  hydrolysed is itself substituted at C-3 (#41# reaction is not in rapid  equilibrium <30>; #42# substrates include laminarin, lichenin, and  cereal D-glucans, different from EC 3.2.1.52  beta-L-N-acetylhexosaminidase <31>)  "
3.2.1.60," hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous  polysaccharides, to remove successive maltotetraose residues from the  non-reducing chain ends (#3# exo-cleavage mechanism <12>; #1#  endo-acting mechanism producing maltotetraose in the alpha-anomeric  form <10>)  "
3.2.1.61," Endohydrolysis of (1->4)-alpha-D-glucosidic linkages in alpha-D-glucans  containing both (1->3)- and (1->4)-bonds (#1,3# enzyme hydrolyzes  nigeran tetrasaccharide by an endo-type of action <6,7>; #5,6#  endo-multichain mechanism <2,6>)  "
3.2.1.62, a glycosyl-N-acylsphingosine + H2O = a ceramide + a sugar (#7#  mechanism <1>)  
3.2.1.63," hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous  polysaccharides, to remove successive maltotetraose residues from the  non-reducing chain ends (#3# stepwise reaction mechanism, the first  step is the proton transfer from N423 to D766, and the second step  involves the hydrolysis reaction via the inversion mechanism catalyzed  by the amide group of N423. Assisted by D766, N423 serves as the  general base to activate the water molecule to attack the anomeric  carbon center. E566 is the general acid to facilitate the cleavage of  glycosidic bond between L-fucose and galactose units. The intrinsic  resonance structure for the side chain amide group of the asparagine  residue is the origin to the catalytic activity <15>) "
3.2.1.63, methyl-2-alpha-L-fucopyranosyl-beta-D-galactoside + H2O = L-fucose +  methyl beta-D-galactoside  
3.2.1.64," Hydrolysis of (2->6)-beta-D-fructofuranan, to remove successive  disaccharide residues as levanbiose, i.e.  6-(beta-D-fructofuranosyl)-D-fructose, from the end of the chain  "
3.2.1.65, Random hydrolysis of (2->6)-beta-D-fructofuranosidic linkages in  (2->6)-beta-D-fructans (levans) containing more than 3 fructose units  
3.2.1.67, [(1->4)-alpha-D-galacturonide]n + H2O =  [(1->4)-alpha-D-galacturonide]n-1 + D-galacturonate  
3.2.1.68," hydrolysis of (1->6)-alpha-D-glucosidic branch linkages in glycogen,  amylopectin and their beta-limit dextrins  "
3.2.1.7, Endohydrolysis of (2->1)-beta-D-fructosidic linkages in inulin  
3.2.1.70, Hydrolysis of (1->6)-alpha-D-glucosidic linkages in  (1->6)-alpha-D-glucans and derived oligosaccharides  
3.2.1.71, Random hydrolysis of (1->2)-glucosidic linkages in (1->2)-beta-D-glucans  
3.2.1.72, Hydrolysis of successive xylose residues from the non-reducing termini  of (1->3)-beta-D-xylans  
3.2.1.73," Hydrolysis of (1->4)-beta-D-glucosidic linkages in beta-D-glucans  containing (1->3)- and (1->4)-bonds (#9# mechanism, kinetic model <27>;  #9# allosteric activation mechanism, feedback inhibition <28>; #61#  beta-1,3-1,4-glucanase catalyzes strict endo-hydrolysis of the  beta-1,4-glycosidic linkage adjacent to a 3-O-substituted glucose  residue in the mixed-linked beta-glucans via a double-displacement  mechanism <79>; #40,65# the enzyme might carry out the hydrolysis via  retaining mechanism with E113 and E118 serving as the nucleophile and  general acid/base, respectively,catalytic mechanism, overview <85>)  "
3.2.1.74," Hydrolysis of (1->4)-linkages in (1->4)-beta-D-glucans, to remove  successive glucose units  "
3.2.1.75," Random hydrolysis of (1->6)-linkages in (1->6)-beta-D-glucans (#29#  hydrolytic cooperation of both an endo-type and saccharifying-type  reaction by a single enzyme, which plays a bifunctional role, leading  to complete hydrolysis of the glucan. the enzyme varies its mode of  action depending on the chain length derived from the glucan <35>)  "
3.2.1.76," hydrolysis of unsulfated alpha-L-iduronosidic linkages in dermatan  sulfate (#8# active site structure, active site residues, overview <35>)  "
3.2.1.77," Hydrolysis of (1->2)- and (1->3)-linkages in yeast mannan, releasing  mannose  "
3.2.1.78," Random hydrolysis of (1->4)-beta-D-mannosidic linkages in mannans,  galactomannans and glucomannans  "
3.2.1.8," Endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans  (#16,37,39# the catalytic residues are two conserved Glu residues,  which are located opposite to each other in an open active site cleft.  The catalytic mechanism resembles that of lysozyme. The role of one  glutamate is to act as an acid/base catalyst whereas the other is a  nucleophile and stabilizes the reaction intermediate <63>; #94#  (beta/alpha)8 barrel with 2 catalytic functions, the acid/base and the  nucleophile, at the C-terminal side <83>; #117# a lysine residue is  involved in substrate binding and is located at the binding site <88>;  #64# histidine, tryptophan residues and carboxylic groups are involved  in substrate binding or catalysis <92>; #19# mode of action and  hydrolysis pattern <86>; #69# mode of action, substrate specificity,  substrate binding mechanism <93>; #47# mode of attack on substrates  <107>; #123# role of the thermostabilizing N-terminal domain XBD on  enzyme activity, overview <109>; #18# substrate recognition and sites  of hydrolysis on the xylan substrates <103>; #118# the O-glycoside  hydrolase catalyzes the random hydrolysis of internal  beta-1,4-D-xylosidic linkages of xylan and xylooligosaccharides of  maximal 4 residue chain length, inverse stereoselectivity <104>; #118#  induced fit mechanism upon ligand binding <119>)  "
3.2.1.80," Hydrolysis of terminal, non-reducing (2->1)- and (2->6)-linked  beta-D-fructofuranose residues in fructans (#2# exclusive hydrolysis of  beta-2-6 bonds in fructan-producing plants <28>)  "
3.2.1.81," Hydrolysis of (1->4)-beta-D-galactosidic linkages in agarose, giving  the tetramer as the predominant product (#19# mechanism <23>; #18#  enzyme might be able to unwind the double-helical structure of  substrate prior to the catalytic cleavage <26>)  "
3.2.1.82, [(1->4)-alpha-D-galacturonosyl]n + H2O =  alpha-D-galacturonosyl-(1->4)-D-galacturonate +  [(1->4)-alpha-D-galacturonosyl]n-2  
3.2.1.83," Endohydrolysis of (1->4)-beta-D-linkages between D-galactose 4-sulfate  and 3,6-anhydro-D-galactose in kappa-carrageenans (#5# endo or random  mechanism <2>; #41# enzyme has an arginine residue at subsite -1,  mechanism <14>; #41# enzyme acts in solution as a random hydrolase <15>)  "
3.2.1.84, Hydrolysis of terminal (1->3)-alpha-D-glucosidic links in  (1->3)-alpha-D-glucans  
3.2.1.85, a 6-phospho-beta-D-galactoside + H2O = 6-phospho-D-galactose + an  alcohol  
3.2.1.86," 6-phospho-beta-D-glucosyl-(1->4)-D-glucose + H2O = D-glucose +  D-glucose 6-phosphate (#26# active site structure and double  displacement mechanism, overview <20>)  "
3.2.1.87, Random hydrolysis of (1->3)-alpha-D-galactosidic linkages in Aerobacter  aerogenes capsular polysaccharide  
3.2.1.88, removal of a terminal beta-L-arabinopyranose residue from the  non-reducing end of its substrate  
3.2.1.89," The enzyme specifically hydrolyses (1->4)-beta-D-galactosidic linkages  in type I arabinogalactans. (#16# active site and substrate binding  structures, overview <25>)  "
3.2.1.91," Hydrolysis of (1->4)-beta-D-glucosidic linkages in cellulose and  cellotetraose, releasing cellobiose from the non-reducing ends of the  chains (#12# progressivity and reaction mechanism of Cel7A <59>; #13#  exocellulase Cel6B acts by an inverting hydrolysis mechanism, that  involves a proton-transferring network to carry out the catalytic base  function <81>)  "
3.2.1.92," hydrolysis of terminal, non-reducing N-acetylmuramic residues  "
3.2.1.93," alpha,alpha-trehalose 6-phosphate + H2O = D-glucose + D-glucose  6-phosphate  "
3.2.1.94," Hydrolysis of (1->6)-alpha-D-glucosidic linkages in polysaccharides, to  remove successive isomaltose units from the non-reducing ends of the  chains (#1# mechanism <15>; #1# D266 acts as a general acid, D198 acts  as both nucleophile in the catalytic process and +binding the  substrate, D313 acts in substrate binding <20>)  "
3.2.1.95," Hydrolysis of (1->6)-alpha-D-glucosidic linkages in dextrans, to remove  successive isomaltotriose units from the non-reducing ends of the chains  "
3.2.1.96," Endohydrolysis of the N,N'-diacetylchitobiosyl unit in high-mannose  glycopeptides and glycoproteins containing the -[Man(GlcNAc)2]Asn-  structure. One N-acetyl-D-glucosamine residue remains attached to the  protein; the rest of the oligosaccharide is released intact (#52#  active site structure, catalytic mechanism in which residue E173 acts  as the catalytic acid/base for reaction via an oxazoline intermediate,  overview <89>)  "
3.2.1.97, beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-[glycoprotein]  L-serine/L-threonine + H2O =  beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine +  [glycoprotein]-L-serine/L-threonine  
3.2.1.98," Hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous  polysaccharides, to remove successive maltohexaose residues from the  non-reducing chain ends (#4# mechanism of transglycosylation <1,3>; #4#  exo-alpha amylase, products have alpha-configuration <2,4>; #4#  reaction mechanism is exo <4,7,8,9>; #6,8# alpha-amylase, product is  linear oligosaccharide containing alpha-1,4-glucosidic linkages <6,11>)  "
3.2.1.99," endohydrolysis of (1->5)-alpha-arabinofuranosidic linkages in  (1->5)-arabinans (#1,2,3# regulation, induction and carbon catabolite  repression of endo-1,5-alpha-arabinanase <9,15,18,20,21,22,23>; #20#  three catalytic carboxylates: Asp27, the general base, Glu201, the  general acid, and Asp147, the pKa modulator, substrate binding  structure and catalytic mechanism, overview <35>)  "
3.2.2.1," a purine nucleoside + H2O = D-ribose + a purine base (#1# main features  of transition state are activation of the heterocyclic base by  protonation of/or hydrogen bonding to O2, an extensively broken  C-N-glycosysic bond, formation of an oxocarbenium ion in the ribose  ring, C3Â’-exo ribose ring conformation, and almost no bond formation to  the attacking nucleophile <30>; #38# mechanism couples loop closure to  the positioning of active site residues. Relationship between the  dimeric form of the enzyme and its catalytic activity <31>; #38#  ordered bi-bi kinetic mechanism and high forward commitment with  inosine as substrate. The dominant energetic contribution towards  catalysis comes from ribosyl and water activation, leaving group  activation also makes a considerable contribution. The leaving group is  unlikely to be protonated prior to N-glycosidic bond cleavage and  active site binding interactions to the purine leaving group are  required for efficient ribosyl and/or water activation <34>)  "
3.2.2.10, a pyrimidine 5'-nucleotide + H2O = D-ribose 5-phosphate + a pyrimidine  base  
3.2.2.11," 1-beta-aspartyl-N-acetyl-D-glucosaminylamine + H2O = L-asparagine +  N-acetyl-D-glucosamine (#4# splits glycopeptides, containing the group  1-[beta-aspartyl]-N-glucosamine, only when the NH2-and CO2-group of the  aspartic acid are free <2>)  "
3.2.2.12, IMP + H2O = D-ribose 5-phosphate + hypoxanthine  
3.2.2.13, 1-methyladenosine + H2O = 1-methyladenine + D-ribose  
3.2.2.14, beta-nicotinamide D-ribonucleotide + H2O = D-ribose 5-phosphate +  nicotinamide  
3.2.2.15," hydrolyses DNA and polynucleotides, releasing free hypoxanthine (#1#  specific enzymatic cleavage of the glycosyl bond <2>)  "
3.2.2.16," S-methyl-5'-thioadenosine + H2O = S-methyl-5-thio-D-ribose + adenine  (#3# mechanism <15>; #1,9,13# early dissociative transition state <16>;  #9# early SN1 transition state with significant N-glycosidic bond order  at the transition state <18>; #3,10# late dissociative transition state  <16>; #10# SN1 transition state with no covalent participation of the  adenine or the water nucleophile. Isotope effects predict a 3-endo  conformation for the ribosyl oxacarbenium-ion transition state. The N7  of the leaving group adenine is not protonated in the transition state  <19>; #30# structure-function analysis and reaction mechanism,  overview. The proposed mechanism of action for the hydrolysis of  methylthioadenosine by the enzyme involves the essential acidic residue  in the lid of the active site and a water molecule that acts as a  nucleophile which is activated by an arginine and a glutamic acid  residue <33>; #3,15,19# transitions state analogues, overview <42>)  "
3.2.2.17, cleaves the N-glycosidic bond between the 5'-pyrimidine residue in  cyclobutadipyrimidine (in DNA) and the corresponding deoxy-D-ribose  residue (#4# hydrolysis of phosphodiester bonds <6>; #3# cleaves  N-glycosyl bond between pyrimidine and sugar without rupture of a  phosphodiester bond <7>; #4# scheme of reaction mechanism <24>)  
3.2.2.19, Nomega-(ADP-D-ribosyl)-L-arginine + H2O = ADP-D-ribose + L-arginine 
3.2.2.19, protein-Nomega-(ADP-D-ribosyl)-L-arginine + H2O = ADP-D-ribose +  protein-L-arginine  
3.2.2.2, inosine + H2O = D-ribose + hypoxanthine  
3.2.2.20," hydrolysis of alkylated DNA, releasing 3-methyladenine  "
3.2.2.21," hydrolysis of alkylated DNA, releasing 3-methyladenine,  3-methylguanine, 7-methylguanine and 7-methyladenine  "
3.2.2.22," hydrolysis of the N-glycosylic bond at A-4324 in 28S rRNA from rat  ribosomes (#4,6,11,18,20,21,24,28,37,41,45,47,48,50,56,61# catalytic  mechanism <42,49,72>; #11# active site structure and catalytic  mechanism, residue R213 is important for catalysis <58>; #21#  anti-viral mechanism of type 1 RIP pokeweed anti-viral protein PAP  <60>; #75# N70 of PAP is required for depurination catalytic activity,  N70 facilitates depurination in trans <44>; #45# substrate recogition  via glycoprotein binding, overview <41>)  "
3.2.2.23," hydrolysis of DNA containing ring-opened 7-methylguanine residues,  releasing 2,6-diamino-4-hydroxy-5-(N-methyl)formamidopyrimidine (#2#  mechanism <8,18,20,21>; #2# reaction mechanism <23>; #2# kinetic  mechanism <22>; #2# catalytic mechanism <2,3,10,22,24>; #2# several  fast sequential conformational changes occur in enzyme after binding to  its substrate, converting the protein into a catalytically active  conformation <31>; #2# formation of the transition state complex from  the reactants exhibits an overall free energy of 9.6 kcal/mol <52>;  #19# the damaged base is first destabilized by the enzyme binding and  then everted from DNA, followed by insertion of several amino acid  residues into DNA and isomerization of the enzyme into a pre-excision  complex <36>; #2# chemical reaction mechanism, overview. For the  catalysis to occur, the damaged base must be extruded from the DNA  helix and placed in the active site of enzyme, this is achieved in Fpg  by kinking DNA at the lesion point. The reaction mechanism involves  coupled conformational changes in the enzyme and DNA, which proceed  sequentially and assemble the catalytic groups in the active site <64>)  "
3.2.2.24," [dinitrogen reductase]-Nomega-alpha-(ADP-D-ribosyl)-L-arginine =  ADP-D-ribose + [dinitrogen reductase]-L-arginine (#3# regulation of  enzyme activity <8>; #9# substrate binding structure and detailed  catalytic mechanism for protein de-ADP-ribosylation involving ring  opening of the substrate ribose, overview <30>)  "
3.2.2.25, 7-methylxanthosine + H2O = 7-methylxanthine + D-ribose  
3.2.2.26, futalosine + H2O = dehypoxanthine futalosine + hypoxanthine  
3.2.2.27," Hydrolyses single-stranded DNA or mismatched double-stranded DNA and  polynucleotides, releasing free uracil (#28# a conserved asparagine  residue acts as a ligand to the catalytic water molecule, and another  water molecule acts as a barrier during substrate recognition, slide-in  mechanism for initial damage recognition, catalytic reaction mechanism,  overview <22>; #2# active site structure and catalytic mechanism,  overview <37>; #27# catalytic reaction mechanism, the active side  comprises the GEGPG motif, residues 40-44, the side-chain of Arg161 in  family 4 TthUDG might play a role in binding AP-DNA after catalysis  <21>; #26# catalytic reaction mechanism, the catalytic residue is Asp93  <19>; #20# the active site catalytic residue is Asp88 <31>; #3# the UDG  active center contorts the uracil and deoxyribose while the phosphates  5 and 3 of the uridine are anchored by interactions with a proline-rich  loop and a glycine-serine loop, UDG catalytic mechanism with channeling  of DNA repair intermediates, overview <29>; #26# uracil-DNA  glycosylases are widespread enzymes that are found in all living  organisms. UDGs form a central part of the DNA-repair machinery since  they initiate the DNA base-excision repair pathway by hydrolysing the  N-glycosidic bond between uracil and the deoxyribose sugar thereby  catalysing the removal of mis-incorporated uracil from DNA <1>)  "
3.2.2.28," Specifically hydrolyses mismatched double-stranded DNA and  polynucleotides, releasing free uracil  "
3.2.2.29," Hydrolyses mismatched double-stranded DNA and polynucleotides,  releasing free thymine.  "
3.2.2.3," uridine + H2O = D-ribose + uracil (#13# substrate binding site, active  site structure, His254 is important, catalytic mechanism <12>; #2#  catalytic mechanism with catalytic triad consisting of Tyr223, Tyr227,  and His239, overview <18>)  "
3.2.2.30, 6-amino-6-deoxyfutalosine + H2O = dehypoxanthine futalosine + adenine  
3.2.2.31," hydrolyses free adenine bases from 7,8-dihydro-8-oxoguanine:adenine  mismatched double-stranded DNA, leaving an apurinic site.  "
3.2.2.4," AMP + H2O = D-ribose 5-phosphate + adenine (#1# SN1-type catalytic  mechanism with formation of an oxocarbenium-like intermediate followed  by nucleophilic attack at the anomeric carbon, overview, substrate  binding site structure <36>)  "
3.2.2.5," NAD+ + H2O = ADP-D-ribose + nicotinamide (#5# the enzyme can also  hydrolyse NADP+ to yield phospho-ADP-ribose and nicotinamide, but more  slowly <46>; #28# residues E146, D147, and W125 work collaboratively to  facilitate the formation of the Michaelis complex <73>; #5# the polar  interactions between E226 and the substrate 2,3-OH groups are essential  for initiating catalysis. S193 has a regulatory role during catalysis  and is likely to be involved in intermediate stabilization <72>;  #14,28# reaction mechanism, and structure-function relationship,  overview <83>; #15# SPN shows an ordered uni-bi mechanism, with  ADP-ribose being released as a second product. The catalytic mechanism  requires an essential glutamic acid, Glu344, to stabilize an  oxycarbenium ion intermediate, which subsequently is attacked by a  nucleophile, a water molecule <84>)  "
3.2.2.6," NAD+ + H2O = ADP-D-ribose + nicotinamide (#2# also catalyses transfer  of ADP-ribose(P) residues <7>; #10# reaction mechanism, overview <13>;  #12# structure-function analysis and reaction mechanism, overview. The  nicotinamide-ribosyl bond of NAD+ is cleaved via a dissociative process  with a late transition state, leading to a ribooxocarbenium ion  reaction intermediate stabilized by the side-chain of invariant Glu218.  This rate-determining step is followed by two nucleophilic reactions in  competition: (i) an intermolecular pathway involving a rapid trapping  from the b-face of this intermediate by a water molecule (NAD+  glycohydrolase activity) or by competing neutral nucleophiles such as  pyridines (transglycosidation reactions) or alcohols (e.g.,  methanolysis), and (ii) an intramolecular reaction between N1 of the  adenine ring and C19 (anomeric carbon) of the oxocarbenium ion leading  to the formation of cyclic ADP-ribose (ADP-ribosyl cyclase activity).  This latter reaction represents a kinetically minor step relative to  solvolysis <20>; #12# substrate binding with a crucial role of Glu218,  which orients the substrate for cleavage by interacting with the  N-ribosyl 2-OH group of NAD+, stepwise ordered uni-bi kinetic  mechanism, overview. Residues Trp118, Glu138, Asp147, Trp181 stabilize  the ribooxocarbenium ion-like transition state mostly by electrostatic  interactions <15>) "
3.2.2.6, NAD+ = cyclic ADP-ribose + nicotinamide 
3.2.2.6, cyclic ADP-ribose + H2O = ADP-D-ribose  
3.2.2.7," adenosine + H2O = D-ribose + adenine (#3,7# also acts on adenosine  N-oxide <11,13>)  "
3.2.2.8," a pyrimidine nucleoside + H2O = D-ribose + a pyrimidine base (#1#  mechanism <7>; #13# catalytic mechanism, active site structure,  conformational transition between open and closed structure, product  release mechanism <9>)  "
3.2.2.9, S-adenosyl-L-homocysteine + H2O =  S-(5-deoxy-D-ribos-5-yl)-L-homocysteine + adenine (#29# mechanism <12>;  #8# early SN1 transition state with significant N-glycosidic bond order  at the transition state <22>) 
3.2.2.9, 5'-deoxyadenosine + H2O = 5-deoxy-D-ribose + adenine 
3.2.2.9, S-methyl-5'-thioadenosine + H2O = 5-(methylsulfanyl)-D-ribose + adenine  
3.3.1.1," S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine  (#1,2,4,5,6,8,9,10,11,12,13,14,19,22,30,33,44# reaction equilibrium is  in vitro strongly in direction of synthesis of  S-adenosyl-L-homocysteine  <2,3,4,13,15,16,17,18,19,22,25,26,27,28,29,30,32>; #66# catalytic  mechanism analysis <135>)  "
3.3.1.2," S-adenosyl-L-methionine + H2O = L-homoserine +  S-methyl-5'-thioadenosine (#3# when expressed in Escherichia coli, the  T3 phage adenosylmethionine hydrolase cleaves S-adenosyl-L-methionine  and the metK regulon is induced. In a met repressor (MetJ) deficient  backround, induction of the met regulon is even higher <11>; #3# when  expressed in Escherichia coli, the T3 phage adenosylmethionine  hydrolase cleaves S-adenosyl-L-methionine and the metK regulon is  induced. Methylthiodenosine is further cleaved to 5-methylthioribose,  which is then exported <10>)  "
3.3.2.1," isochorismate + H2O = (2S,3S)-2,3-dihydroxy-2,3-dihydrobenzoate +  pyruvate (#5# (1,5)-sigmatropic reaction mechanism that invokes  electrostatic catalysis <7>; #7,8,9# extended active site is formed by  inter-subunit association within a tetramer <8>)  "
3.3.2.10," an epoxide + H2O = a glycol (#44# detailed reaction mechanism,  molecular dynamics simulations, detailed analysis of substrate binding  to the active site and determination of the preferred conformation,  involving Tyr381, Tyr465, and His523 <56>; #7# reaction mechanism,  catalytic triad <26>; #6,7,44# the C-terminal part harbors the epoxide  hydrolase activity, the phosphatase activity of the enzyme is located  at the N-terminal part of EC 3.1.3.76, both catalytic sites act  independently <34,48,58,62>; #52# the C-terminal part harbors the  epoxide hydrolase activity, the phosphatase activity of the enzyme is  located at the N-terminal part of EC 3.1.3.76, both catalytic sites act  independently, the epoxide hydrolase reaction proceeds though an  alkyl-enzyme intermediate involving the catalytic Asp333, and hydrogen  bonds with Tyr381 and Tyr465, reaction mechanism, structure-mechanism  relationship <28>; #7# the catalytic triad is Asp333-His523-Asp495  <49>; #45# the catalytic triad is Asp334-His523-Asp495 <61>; #43# the  catalytic triad is formed by Asp126, Asp285, and His320 <52>; #42# the  catalytic triad is formed by Asp192, Asp348, and His374 <46>; #5# two  step mechanism with formation of of a hydroxyl-alkyl-enzyme  intermediate, catalytic triad is Asp333-His523-Asp495 with polarizing  residues Tyr381 and Tyr465, catalytic cycle <42>; #7# two step  mechanism with formation of of a hydroxyl-alkyl-enzyme intermediate,  the catalytic triad is Asp333-His523-Asp495, catalytic cycle <42>; #6#  two step mechanism with formation of of a hydroxyl-alkyl-enzyme  intermediate, the catalytic triad is Asp334-His523-Asp495 with  polarizing residues Tyr382 and Tyr465, catalytic cycle <42>; #44#  catalytic reaction mechanism involving Tyr465, Tyr381, Asp495, His523,  and Asp333, overview <130>; #6,44# the catalytic mechanism involves two  step processes, overview <127>)  "
3.3.2.11," 5,6alpha-epoxy-5alpha-cholestan-3beta-ol + H2O =  5alpha-cholestane-3beta,5alpha,6beta-triol (#3# positively charged  transition state <7>) "
3.3.2.11," 5,6beta-epoxy-5beta-cholestan-3beta-ol + H2O =  5alpha-cholestane-3beta,5alpha,6beta-triol (#3# positively charged  transition state <7>)  "
3.3.2.12," 2-oxepin-2(3H)-ylideneacetyl-CoA + H2O = 3-oxo-5,6-dehydrosuberyl-CoA  semialdehyde  "
3.3.2.13," chorismate + H2O =  (4R,5R)-4,5-dihydroxycyclohexa-1(6),2-diene-1-carboxylate + pyruvate  (#4# catalytic mechanism, the two carboxyl groups of chorismate form a  H-bond network with residues R228, Y215, Y155, and R162. These H-bonds  are maintained during the whole catalytic process, which may play a  role in stabilizing the negative charged substrate. The protonated E338  builds a strong H-bond with the 4-OH of chorismate. The distance  between HA of E338 and C3 of chorismate is 4.00 A. Two water molecules  enter the reactive center, which may function as mediators in the  catalytic reaction. The reaction steps are protonation of methylene  group, followed by nucleophilic attack of carbocation by (activated)  water molecule W1, and cleavage of C2-O8 bond <7>; #3# for the CH-FkbO  subfamily, an isochorismatase-like hydrolysis mechanism is suggested  where the acidic active site residue E338FkbO initially protonates the  C3 of chorismate. This resulting carbocation intermediate is  nucleophilically attacked by (activated) water leading to the formation  of an unstable tetrahedral intermediate (hemiketal), which decomposes  spontaneously into the products  3,4-trans-dihydroxy-cyclohexa-1,5-dienecarboxylate and pyruvate.  Hydrolysis reaction mechanism analysis, overview <5>; #4# reaction  steps are: 1. the protonation of the methylene group of chorismate, 2.  nucleophilic attack by activated water at the C2 carbocation, and 3.  the elimination of pyruvate <6>)  "
3.3.2.14," 2,4-dinitroanisole + H2O = methanol + 2,4-dinitrophenol  "
3.3.2.15," (5S,6S)-6-amino-5-[(1-carboxyethenyl)oxy]cyclohexa-1  3-diene-1-carboxylate + H2O =  (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylic acid +  pyruvate (#1# mechanism in which the carboxylate acts as a general acid  to protonate the substrate, yielding a carbocation/oxocarbonium ion  that is then rapidly hydrated to form a hemiketal intermediate, which  then decomposes spontaneously to products <1>) "
3.3.2.15," (2S)-2-amino-4-deoxychorismate + H2O =  (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate + pyruvate  "
3.3.2.2, 1-(1-alkenyl)-sn-glycero-3-phosphocholine + H2O = an aldehyde +  sn-glycero-3-phosphocholine 
3.3.2.2, 1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine + H2O = an aldehyde +  sn-glycero-3-phosphoethanolamine  
3.3.2.4," trans-2,3-epoxysuccinate + H2O = meso-tartrate  "
3.3.2.6," leukotriene A4 + H2O = leukotriene B4 (#3# mechanism <24>; #4# pathway  <43>; #1,3,4,5# His295, His299, Glu318, Glu271 are amino acids involved  in metallic binding and epoxid hydrolase activity, additional Glu296  and Tyr383 are required for the aminopeptidase activity <40>; #4# the  aminopeptidase activity is dependent upon an unmodified cysteine  residue, by modifying this cysteine with a small CH3S group it is  possible to separate the two enzymatic activities, the aminopeptidase  activity and epoxid hydrolase activity, from each other <47>; #14#  Asp375 acts as a critical determinant for the stereoselective  introduction of the 12R-hydroxyl group, possibly assisted by Gln134 and  thus the biological activity of leukotriene B4 <37>; #4# enzyme  contains two partly overlapping active sites which influence each other  <43,46,47>; #1,3,4,5,6# mechanistic models, Glu271 is specifically  required for the epoxid hydrolase activity and peptidase activity  <36,40>; #4# Ser415 plays a key role in regulating epoxid hydrolase  activity <46>; #1,3,4,5,6,8,14# bifunctional enzyme acting as an  epoxide hydrolase and also as an aminopeptidase  <6,10,11,16,17,18,24,25,26,27,32,34,35,36,37,40,43,44,46,47>)  "
3.3.2.7, hepoxilin A3 + H2O = trioxilin A3 (#2# pathway <3>)  
3.3.2.8," 1,2-epoxymenth-8-ene + H2O = menth-8-ene-1,2-diol (#1# catalyzes  simultaneous sequential and enantioconvergent epoxide conversion <1>;  #3# one-step mechanism <4>; #3# mechanism involves a concerted general  acid catalysis step involving the Asp101-Arg99-Asp132 triad. The water  molecule acting as nucleophilic reagent moves to the more substituted  oxirane carbon atom, its hydrogen atom transfers to Asp132, and  hydroxyl attacks at C1. Meanwhile, Asp101 donates a proton to the  epoxide oxygen opening the oxirane ring. This process has an energy  barrier of 16.9 kcal/mol and an endothermicity of 8.2 kcal/mol, and  yields (1R,2R,4S)-limonene-1,2-diol as product. Activation barriers of  16.9 and 25.1 kcal/mol are calculated at the B3LYP/6-31G(d,p)"
3.3.2.8,"CHARMM  level for nucleophilic attack on the more and less substituted epoxide  carbons, respectively <6>; #3# catalytic mechanism analyzed by quantum  mechanics/molecular mechanics (QM/MM) calculations, computational  model, overview. Enzyme LEH reacts by a single-step concerted general  acid-catalyzed mechanism, which is distinct from the two-step general  base-catalyzed mechanism typical for the alpha/beta-hydrolase class of  EHs. Overall, this mechanism is very similar to a borderline-SN2-type  mechanism leading to nucleophilic attack at the more substituted  oxirane carbon atom. Thus, no enzyme-substrate intermediate is detected  during the experiments <11>; #3# catalytic mechanism, quantum  mechanics/molecular mechanics (QM/MM) free energy calculations for the  reaction with molecular dynamics simulations <10>; #3,4,5# LEH  mechanism, substrate specificity and stereoselectivity <13>)  "
3.3.2.9," cis-stilbene oxide + H2O = (1R,2R)-1,2-diphenylethane-1,2-diol (#3#  active site structure, quantitative structure-activity relationships,  molecular modelling <58>; #8# formation of  threo-1,2-diphenyl-1,2-ethanediols from all epoxides involving  anti-stereospecific opening of the oxirane ring with about 90%  preference for the (S)-carbon to give nearly optically pure (R,R)-diols  <51>; #4,7,9,10,11,12,20,22,27# reaction mechanism, catalytic triad  <37>; #26# the catalytic triad is Asp223-Glu402-His429, the active site  includes an oxyanion hole <55>; #4# the catalytic triad is  Asp226-His431-Asp352, catalytic mechanism involving an ester  intermediate formed by alkylation of an active site carboxyl group  <50>; #2,4# two step mechanism with formation of of a  hydroxyl-alkyl-enzyme intermediate, catalytic triad <42>; #3# two step  mechanism with formation of of a hydroxyl-alkyl-enzyme intermediate,  the catalytic triad is Asp226-His431-Glu404 with polarizing residues  Tyr299 and Tyr374 <42>; #34# ring-opening reaction mechanism, overview  <116>) "
3.3.2.9, 1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-yl)methyl]methanamine  + H2O =  2-({[(4-methoxyphenyl)methyl](methyl)amino}methyl)-2-methylpropane-1  3-diol  
3.4.11.1," release of an N-terminal amino acid, Xaa-/-Yaa-, in which Xaa is  preferably Leu, but may be other amino acids including Pro although not  Arg or Lys, and Yaa may be Pro. Amino acid amides and methyl esters are  also readily hydrolysed, but rates on arylamides are exceedingly low  (#8,10# mechanism <2,42,43,46>; #24# catalytic residues are Arg431 and  Lys354 <62>; #8# exopeptidase <66>; #8# exoprotease, preference for  N-terminal Leu, Met and Arg residues, low activity when Xaa is Gly or  Trp, no activity when Xaa is Asp <61>; #24# exoprotease, preference for  N-terminal Leu, Met and Arg residues, low activity when Xaa is Gly or  Tyr, no activity when Xaa is Asp <61>; #5# exoprotease, preference for  N-terminal Leu, Met and Arg residues, low activity when Xaa is Gly, no  activity when Xaa is Asp <61>; #57# molecular modelling of  enzyme-substrate binding <55>; #42# prefers leucine and methionine as  N-terminal amino acids <65>; #10# reaction mechanism, active site  structure, conformation models using crystal structure <57>; #6# Lys528  is located near the entrance of the substrate pocket and is important  for maximal activity by maintaining the appropriate structure of the  substrate binding pocket <74>) "
3.4.11.1," release of an N-terminal amino acid, Xaa-/-Yaa-, in which Xaa is  preferably Leu, but may be other amino acids including Pro although not  Arg or Lys, and Yaa may be Pro. Amino acid mides and methyl esters are  also readily hydrolysed, but rates on arylamides are exceedingly low  (#29,69# endopeptidase <80>; #57# solid-state structure and structure  of hydrated intermediates of the active site, catalytic mechanism,  overview <82>; #57# substrate-enzyme complex structure, molecular  modeling <55>)  "
3.4.11.10," Release of an N-terminal amino acid, preferentially leucine, but not  glutamic or aspartic acids. (#12# presence of at least one active Tyr  and one carboxyl group demonstrated by chemical modifications of  enzyme: nitration, azotization, diethyldirocarbonate treatment,  1-ethyl-3(3-dimethylaminopropyl)-carbodiimide treatment <13>; #12#  mechanism. Substrate only binds to the first metal binding site <17>;  #4,12# catalytic mechanism <26,38>; #19# active site structure and  mechanism <24>; #19# active site structure, reaction mechanism <27>;  #12# substrate binding mechanism and structure <25>; #12,19# active  site residue Glu151 is essential for activity acting as a general  acid/base during the catalytic reaction, mechanism of peptide  hydrolysis <33,42>; #19# active site structure, reaction mechanism  involving divalent metal ions, overview <32>; #19# active site  structure, reaction mechanism involving the two zinc ions <27>; #4#  Glu354 is essential for Zn2+-binding and catalytic activity, Arg356 is  involved in catalysis acting as a general base that accepts a proton  and activates the water nucleophile, other active site residues are  Lys270, Glu354, ASp352, Lys282, Asp275, and Asp293, mechanism <39>;  #24# residues His345 and His378 play an important role in catalysis  <31>; #12# structure-activity relationship, active site structure  involving zinc-binding ligands His97, Asp117, Asp179, Glu151, Glu152,  and His256 <40>) "
3.4.11.10," release of an N-terminal amino acid, preferentially leucine, but not  glutamic or aspartic acids (#12# active site structure involving His97,  Asp117, Asp179, Glu151, Glu152, and His256 <35>)  "
3.4.11.13," Release of any N-terminal amino acid, including proline and  hydroxyproline, but no cleavage of Xaa-Pro- (#1# release of any  N-terminal amino acid, including Pro and hydroxyproline, but no  cleavage of XaaÂ—Pro, mechanism involves Co2+ <1>)  "
3.4.11.14," release of an N-terminal amino acid, preferentially alanine, from a  wide range of peptides, amides and arylamides  "
3.4.11.15," preferentially, release of N-terminal lysine  "
3.4.11.16," Release of a variety of N-terminal residues (especially glutamate and  leucine) from peptides, provided tryptophan (or at least phenylalanine  or tyrosine) is the penultimate residue. Also acts on Glu-/-Trp,  Leu-/-Trp and a number of other dipeptides  "
3.4.11.17, preferential release of N-terminal tryptophan  
3.4.11.18," release of N-terminal amino acids, preferentially methionine, from  peptides and arylamides (#37# reaction mechanism of monometalated  enzyme. Charge-charge interactions involving D97 and D108 position and  bind substrate. E204 acts as general base <62>)  "
3.4.11.19," Release of an N-terminal D-amino acid from a peptide, Xaa-/-Yaa-, in  which Xaa is preferably D-Ala, D-Ser or D-Thr. D-Amino acid amides and  methyl esters also are hydrolysed, as is glycine amide  "
3.4.11.2," Release of an N-terminal amino acid, Xaa-/-Yaa- from a peptide, amide  or arylamide. Xaa is preferably Ala, but may be most amino acids  including Pro (slow action). When a terminal hydrophobic residue is  followed by a prolyl residue, the two may be released as an intact  Xaa-Pro dipeptide (#5# residues E298 and Y381 located near the zinc  ion, are involved in peptide cleavage. Residue M260 functions as a  cushion to accept substrates with different N-terminal resiude sizes  <126>)  "
3.4.11.20, differs from other aminopeptidases in broad specificity for amino acids  in the P1 position and the ability to hydrolyse peptides of four or  five residues that contain Pro in the P1' position (#1# Glu387 is an  essential catalytic residue <5>)  
3.4.11.21," release of an N-terminal aspartate or glutamate from a peptide, with a  preference for aspartate (#2,4,8# the conserved residues His94, His170,  and His440 are essential for activity <11>)  "
3.4.11.22," Release of an N-terminal amino acid, preferably a neutral or  hydrophobic one, from a polypeptide. Aminoacyl-arylamides are poor  substrates (#12# active site structure, reaction mechanism <25>; #7#  catalysis depends on a catalytic metal, a carboxylate and a protonated  imidazole group, whereas substrate binding requires one phenol and one  carboxylate group <19>; #5# cobalt-dependent exopeptidase <23>; #14#  Gly-Gly bond is preferably hydrolyzed <24>)  "
3.4.11.23," release of an N-terminal amino acid, Xaa, from a peptide or arylamide.  Xaa is preferably Glu or Asp but may be other amino acids, including  Leu, Met, His, Cys and Gln (#1# residue K310 is involved in substrate  specificity determination <1>)  "
3.4.11.24," release of an N-terminal amino acid with a preference for large  hydrophobic amino-terminus residues (#3# catalytic mechanism, Asp160,  Met161, Gly201, Arg202, and Phe219 are involved, active site structure,  modeling of enzyme-substrate complex <1>; #3# catalytic mechanism, high  preference towards large hydrophobic amino terminus residues, active  site structure, Glu131 is involved in the catalytic mechanism,  enzyme-substrate and enzyme-product complex modeling <10>; #5#  hydrolyses peptide bonds formed by terminal hydrophobic amino acids  such as leucine, methionine, and phenylalanine <4>; #3# M161 is  involved in substrate binding at the active site cleft <8>; #3#  preference for hydrophobic residues at the ultimate and the penultimate  positions, D-amino acids at these positions reduce the activity,  activity is not restricted by the length of substrate chains <6>; #3#  catalytic pathway and reaction mechanism, catalytic residues are Glu131  and Tyr246, Tyr246 is involved in stabilization of the reaction  transition state intermediate, also residue Glu151 is involved <16>;  #3# raction mechanism, catalytic residues are Glu131 and Tyr246,  residues Arg202 and Asp160 stabilize the reaction intermediate together  with Glu131 <11>; #3# structure and reaction mechanism <18>; #3# the  enzyme prefers large hydrophobic aminoterminal residues, Glu131,  Asp160, and Arg202 are involved in binding of the N-terminal substrate  amino acid, substrate binding and reaction mechanism, tetrahedral  reaction intermediate, modelling of the enzyme-substrate and  enzyme-product complexes <1>; #3# catalytic reaction mechanism, a  single proton transfer is involved in catalysis at pH 8.0, whereas two  proton transfers are implicated at pH 6.5, involvement of a zinc-bound  hydroxide as the reaction nucleophile, Tyr246 polarizes the carbonyl  carbon and stabilizes the transition state, enzyme-substrate  interaction, overview <24>)  "
3.4.11.25, cleaves N-terminal beta-homoamino acids from peptides composed of 2 to  6 amino acids  
3.4.11.26, The enzyme cleaves the Pro36-Pro37 bond of cysteine desulfurase (EC  2.8.1.7) removing three amino acid residues (Tyr-Ser-Pro) from the  N-terminus after cleavage by mitochondrial processing peptidase.  
3.4.11.3," Release of an N-terminal amino acid, Cys-/-Xaa-, in which the  half-cystine residue is involved in a disulfide loop, notably in  oxytocin or vasopressin. Hydrolysis rates on a range of aminoacyl  arylamides exceed that for the cystinyl derivative, however  "
3.4.11.4, release of the N-terminal residue from a tripeptide  
3.4.11.5," release of N-terminal proline from a peptide (#17# substrate  recognition mechanism, Phe139 and Glu204 recognize the pyrrolidine ring  and the amino group of proline at the S1 site, Arg136 recognizes the P1  site <28>; #40# the enzyme exclusively hydrolyzes  N-terminal-proline-containing substrates <27>)  "
3.4.11.6," release of N-terminal Arg and Lys from oligopeptides when P1' is not  Pro. Also acts on arylamides of Arg and Lys (#4# exopeptidase, no  endoprotease activity, the enzyme is strictly specific for the removal  of N-terminal basic residues from peptides and proteins, no activity  with substrates possessing Pro at the P1 position <61>; #1,4,6#  exopeptidase, the enzyme is strictly specific for the removal of  N-terminal basic residues from peptides and proteins, no activity with  substrate possessing Pro at the P1 position <56,61>; #3# exopeptidase,  the enzyme is strictly specific for the removal of N-terminal basic  residues from peptides and proteins, no activity with substrates  possessing Pro at the P1 position <61>)  "
3.4.11.7," release of N-terminal glutamate (and to a lesser extent aspartate) from  a peptide (#5,6,7# active site structure and organization <38>; #4#  active site structure and organization, modeling, residues Glu352,  Glu386, Tyr471, and Glu408 are important in catalysis <38>)  "
3.4.11.9," release of any N-terminal amino acid, including proline, that is linked  to proline, even from a dipeptide or tripeptide (#4# mechanism,  cis-trans specificity <12>; #7# acive site configuration, modeling,  Asp449, Asp460, His523, Glu554, and Glu568 are in volved in metal  binding in the active site, His429 and His523 are involved in shuttling  protons during catalysis <30>; #26# isozyme APP-2 shows a preference  for Arg-Pro-Pro-, Arg-Pro-Lys-, Pro-Pro-Gly-, -Phe-Gly- in descending  order <34>; #30# H243 stabilizes substrate binding, H361 stabilizes  substrate binding and the gem-diol catalytic intermediate. H350 forms  part of a hydrophobic binding pocket that gives the enzyme its proline  specificity <42>; #4# R404 participates in proton relay and in the  hydrogen bond network <41>)  "
3.4.13.12, Hydrolysis of Met-/-Xaa dipeptides.  
3.4.13.17, hydrolysis of dipeptides containing either D- or L-amino acids or both  
3.4.13.18," hydrolysis of dipeptides, preferentially hydrophobic dipeptides  including prolyl amino acids  "
3.4.13.19, hydrolysis of dipeptides  
3.4.13.20," preferential hydrolysis of the beta-Ala-/-His dipeptide (carnosine),  and also anserine, Xaa-/-His dipeptides and other dipeptides including  homocarnosine  "
3.4.13.21," dipeptidase E catalyses the hydrolysis of dipeptides Asp-/-Xaa. It does  not act on peptides with N-terminal Glu, Asn or Gln, nor does it cleave  isoaspartyl peptides  "
3.4.13.22," D-Ala-D-Ala + H2O = 2 D-Ala (#7# reaction mechanism <3>; #4# active  site structure, substrate binding and mechanism <5>)  "
3.4.13.23, an [L-cysteinylglycine]-S-conjugate + H2O = an L-cysteine-S-conjugate +  glycine  
3.4.13.4," preferential hydrolysis of Xaa-/-Arg, Xaa-/-Lys or Xaa-/-ornithine  dipeptides  "
3.4.13.5," Hydrolysis of anserine (beta-alanyl-/-Npi-methyl-L-histidine),  carnosine, homocarnosine, glycyl-/-leucine and other dipeptides with  broad specificity.  "
3.4.13.7, hydrolysis of the Glu-/-Glu dipeptide  
3.4.13.9," hydrolysis of Xaa-/-Pro dipeptides; also acts on  aminoacyl-hydroxyproline analogs. No action on Pro-Pro (#5# catalytic  mechanism <68>; #5# cleaves imidodipeptides containing C-terminal  proline providing a large amount of proline for collagen resynthesis  <37,38>; #5# the enzyme cleaves N-terminal Xaa-Pro dipeptides from  proteins <40>; #5,10# catalytic mechanism and active site structure  <62>) "
3.4.13.9," hydrolysis of Xaa-/-Pro dipeptides; also acts on aminoacyl-hydroxyamine  analogues. No action on Pro-Pro (#10# mechanism of substrate  specificity and catalysis, detailed overview <90>; #5# mechanism of  substrate specificity and catalysis, overview <90>)  "
3.4.14.1," Release of an N-terminal dipeptide, Xaa-Yaa-/-Zaa-, except when Xaa is  Arg or Lys, or Yaa or Zaa is Pro  "
3.4.14.10, Release of an N-terminal tripeptide from a polypeptide  
3.4.14.11," Hydrolyses Xaa-Pro-/- bonds to release unblocked, N-terminal dipeptides  from substrates including Ala-Pro-/-p-nitroanilide and (sequentially)  Tyr-Pro-/-Phe-Pro-/-Gly-Pro-/-Ile  "
3.4.14.12, Hydrolysis of Xaa-Xaa-Pro-/-Yaa- releasing the N-terminal tripeptide of  a peptide with Pro as the third residue (position P1) and where Yaa is  not proline  
3.4.14.13, The enzyme releases L-Ala-gamma-D-Glu dipeptides from cell wall  peptides via cleavage of an L-Ala-gamma-D-Glu-/-L-Lys bond  
3.4.14.14," C-terminal [mycofactocin precursor  peptide]-glycyl-3-amino-5-[(4-hydroxyphenyl)methyl]-4  4-dimethylpyrrolidin-2-one + H2O = C-terminal [mycofactocin precursor  peptide]-glycine +  3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one  "
3.4.14.2," release of an N-terminal dipeptide, Xaa-Yaa-/-, preferentially when Yaa  is Ala or Pro. Substrates are oligopeptides, preferentially tripeptides  "
3.4.14.4," release of an N-terminal dipeptide from a peptide comprising four or  more residues, with broad specificity. Also acts on dipeptidyl  2-naphthylamides.  "
3.4.14.5," release of an N-terminal dipeptide, Xaa-Yaa-/-Zaa-, from a polypeptide,  preferentially when Yaa is Pro, provided Zaa is neither Pro nor  hydroxyproline (#5# reaction mechanism <91>; #31# active site structure  and accessibility <70>; #5# active site structure modeling and reaction  mechanism <77>; #32# active site structure, containing the catalytic  triad Ser630, Asp708, and His740, is located in a large cavity at the  interface of the 2 domains, substrate binding and catalytic mechanism,  serine exopeptidase <103>; #33# catalytic domain structure, active site  and substrate recognition study <100>; #3,4,5,6,7# cleaves dipeptides  containing proline or alanine or one of several other amino acids at  the penultimate position from the amino termini of substrates, contains  a Ser-His-Asp catalytic triad, active site structure, the Glu-Glu motif  is necessary for amino dipeptide selection <88>; #35# conserved  residues Ser624, Asp702, and His734 form a catalytic triad and are  involved in the catalytic reaction, Ser593 is likely to be the  catalytic serine of the serine protease <92>; #32# enzyme is a serine  protease, catalytic and substrate binding mechanism, active site  structure, catalytic triad Ser630, Asp708, His740 <98>; #7# enzyme is  an ectopeptidase <96>; #5# enzyme prefers Ala in P1 position, reduced  activity is observed with Ser, Gly, or Val at the P1 position, modeling  of reaction mechanism and substrate binding at the catalytic site <81>;  #5# exopeptidase that cleaves dipeptides from the N-terminus of oligo-  and polypeptides with the penultimate residue being proline or alanine  <75>; #5# prefers Pro or Ala at position P1, substrate recognition  involves the negatively charged active site residues E205 and E206,  reaction mechanism, active site structure and substrate binding <102>;  #5,7# proline specific serine protease <82>; #5,11# serine protease  <78,84,99>; #5# serine protease, catalytic triad Ser630, Asp708,  His740, active site architecture <71>; #22# specific for hydrolysis of  peptide bond on the carboxylic side of proline residues which are  penultimate from the amino terminus <94>)  "
3.4.14.6," preferential release of dipeptides from a tetrapeptide, e.g.  Ala-Gly-/-Ala-Gly. Acts more slowly on Ala-Ala-/-Ala-Ala and  Gly-Gly-/-Gly-Gly  "
3.4.14.9," Release of an N-terminal tripeptide from a polypeptide, but also has  endopeptidase activity (#13# the S4 subsite of TPP-I is occluded and  there is an electrostatic interaction of the positively charged  substrate N-terminus amino group and a negative locus in the region of  the enzyme active site <50>)  "
3.4.15.1," release of a C-terminal dipeptide, oligopeptide-/-Xaa-Yaa, when Xaa is  not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of  angiotensin I to angiotensin II, with increase in vasoconstrictor  activity, but no action on angiotensin II  "
3.4.15.4, release of a C-terminal dipeptide or exceptionally a tripeptide  
3.4.15.5," Hydrolysis of unblocked, C-terminal dipeptides from oligopeptides, with  broad specificity. Does not hydrolyse bonds in which P1' is Pro, or  both P1 and P1' are Gly  "
3.4.15.6, [L-Asp(4-L-Arg)]n + H2O = [L-Asp(4-L-Arg)]n-1 + L-Asp(4-L-Arg)  
3.4.16.2, Cleavage of a -Pro-/-Xaa bond to release a C-terminal amino acid  
3.4.16.4," Preferential cleavage: (Ac)2-L-Lys-D-Ala-/-D-Ala. Also transpeptidation  of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine  (#12# VanY, carboxypeptidase activity exclusively <32>)  "
3.4.16.5, release of a C-terminal amino acid with broad specificity  
3.4.16.6, preferential release of a C-terminal arginine or lysine residue  
3.4.17.1," release of a C-terminal amino acid, but little or no action with -Asp,  -Glu, -Arg, -Lys or -Pro (#6# mechanism  <1,3,6,24,27,28,29,32,35,36,39,44>; #6# relationships between structure  and mechanism, zinc environment and substrate complexes <28>; #6#  mechanisms elucidated from complex with inactivator  2-benzyl-3-iodo-propanoic acid <44>; #6# pK values of active site  residues, analysis of kinetics and mechanism under alkaline conditions  <32>; #6# molecular dynamics characterization of active cavity <42>;  #6# conceptual model of relationship between activity, mechanism and  conformational mobility <39>; #6# rapid release: Tyr, Phe, Trp, Leu,  Ile, Thr, Gln, His, Ala, Val, homoserine, slow release: Asn, Ser, Lys,  MetSO2, very slow release: Gly, Asp, Glu, CySO3H,  S-carboxymethylcysteine, not released: Pro, Hyp, Arg <2>; #6# evidence  of general base pathway <36>; #6# relationships between structure and  mechanism, different catalytic sites for esters and peptides, role of  mechanic strain discussed <27>; #6# correlations between mechanism,  kinetics, and structure, intermediates and rate-determining steps <1>;  #6# evidence for acyl-enzyme intermediates <35>; #6# cryospectrokinetic  characterization of intermediates, time-course of reaction <29>; #6#  promoted water pathway, mechanistic model <3>; #6# catalytic mechanism  involving the Zn2+ ion and residue Glu270 with ester or protein  substrates, the tetrahydrate transition state is stabilized by Arg127,  overview <80>; #27# residues Glu270 and Arg127 are important for  activity, the catalytic triad consists of Ile275, Tyr248, and Ala250,  residues at positions 202, 254, and 268 are important for substrate  specificity <78>)  "
3.4.17.10, release of C-terminal arginine or lysine residues from polypeptides  
3.4.17.11," release of C-terminal glutamate residues from a wide range of  N-acylating moieties, including peptidyl, aminoacyl, benzoyl,  benzyloxycarbonyl, folyl and pteroyl groups  "
3.4.17.12," cleavage of C-terminal arginine or lysine residues from polypeptides  (#8# catalytic mechanism, active site groove structure involving  residues Y242, W241, K228, K269, E264, R127, H66, E69, and H173,  substrate interactins <8>; #3# substrate binding via residue Tyr266 <9>)  "
3.4.17.13, hydrolysis of the bond:  N-acetyl-D-glucosaminyl-N-acetylmuramoyl-L-Ala-D-glutamyl-6-carboxy-L  lysyl-/-D-alanine (#9# the enzyme is a serine peptidase with a  Ser115-His285-Glu217 catalytic triad <11>)  
3.4.17.14, cleavage of the bond: (Ac)2-L-lysyl-D-alanyl-/-D-alanine  
3.4.17.15," Similar to that of carboxypeptidase A (EC 3.4.17.1), but with a  preference for bulkier C-terminal residues (#3# residues Glu270 and  Arg127 are important for activity, the catalytic triad consists of  Ile275, Tyr248, and Ala250, residues at positions 202, 254, and 268 are  important for substrate specificity <5>; #1# structure-function  relationship, activation mechanism <10>)  "
3.4.17.16," Release of a C-terminal residue other than proline, by preferential  cleavage of a prolyl bond  "
3.4.17.17, Cleavage of the -Glu!Tyr bond to release the C-terminal tyrosine  residue from the native tyrosinated tubulin. Inactive on Z-Glu-Tyr  
3.4.17.18," releases a C-terminal residue, which may be hydrophobic or positively  charged  "
3.4.17.19," Release of a C-terminal amino acid with broad specificity, except for  -Pro  "
3.4.17.2," preferential release of a C-terminal lysine or arginine amino acid  (#2,3,4,5# conserved catalytic residues are Glu270 and Asp127, residues  Ser207, Glu243, and Asp255 determine the substrate specificity <35>)  "
3.4.17.20," release of C-terminal Arg and Lys from a polypeptide (#3# reaction  mechanism <33>; #3# catalytic mechanism and substrate specificity <43>;  #3# catalytically important residues are G207, I243, I247, S254, and  I255, catalytic mechanism and substrate binding <45>; #2# substrate  binding involves residues ARg235, Tyr341, and Asn234, while catalysis  involves residues Glu363 and ARg217, mechanism of action of TAFI,  overview <31>; #3# substrate binding involves residues ARg235, Tyr341,  and Asn234, while catalysis involves residues Glu363 and ARg217,  mechanism of action of TAFI, overview, Zn2+ is important in the  catalytic mechanism <31>; #3# the enzyme prefers C-terminal arginine  over lysine <37>)  "
3.4.17.21," release of an unsubstituted, C-terminal glutamyl residue, typically  from Ac-Asp-Glu or folylpoly-gamma-glutamates (#10# active site  structure, substrate binding involving Asp210, and catalytic reaction  mechanism involving Glu424 and the Zn2+ ions, the substrate binding  cavity involves residues Arg463, Arg534, Arg536, stabilized by Glu457,  Asp465, and Ser454 <53>; #10# substrate recognition and induced-fit  substrate binding mode, active site structure, catalytic mechanism  involving Glu424 <37>; #2# T640 is involved in catalysis, the  N-glycosylation status is important for actalytic activity <56>)  "
3.4.17.22, releases C-terminal Arg and Lys from polypeptides (#9# a short region  at the N-terminus of domain C (residues 920 to 949) of carboxypeptidase  D is critical to Duck hepatitis virus binding and is a major  determinent for the host specificity of Duck hepatitis virus infection  <12>)  
3.4.17.23," angiotensin II + H2O = angiotensin-(1-7) + L-phenylalanine (#3# a  transmembrane glycoprotein with an extracellular catalytic domain. ACE2  functions as a carboxypeptidase, cleaving a single C-terminal residue  from a distinct range of substrates <41>; #10# ACE2 catalytic  efficiency is 400-fold higher with angiotensin II (1Â–8) as a substrate  than with angiotensin I (1Â–10). ACE2 also efficiently hydrolyzes  des-Arg9-bradykinin, but it does not hydrolyze bradykinin <8>)  "
3.4.17.24," This is a subfamily of enzymes that cleave C-terminal and/or side chain  amino acids from tubulins. The dual-specificity enzymes can cleave both  alpha- and gamma-linked L-glutamate from tubulins, removing the  posttranslationally added polyglutamyl side chains from the C-terminal  regions. In addition, the enzyme removes two glutamate residues from  the C-terminus of beta-tubulin and detyrosinated alpha-tubulin (from  which the C-terminal L-tyrosine has been removed by EC 3.4.17.17,  tubulinyl-Tyr carboxypeptidase). The latter is cleaved to  delta2-tubulin and further to delta3-tubulin. (#3# enzyme additionally  cleaves alpha-linked Glu from the C-terminus of alpha-tubulin and  alpha-linked Glu residues from the side chain of alpha- and  beta-tubulin <4>)  "
3.4.17.25, a glutathione-S-conjugate + H2O = a  [gamma-glutamyl-L-cysteine]-S-conjugate + glycine  
3.4.17.3," Release of a C-terminal basic amino acid, preferentially lysine  "
3.4.17.4," Release of a C-terminal amino acid from a peptide in which glycine is  the penultimate amino acid, e.g. Z-Gly-/-Leu  "
3.4.17.6, Release of a C-terminal alanine from a peptide or a variety of pteroyl  or acyl groups  
3.4.17.8," cleavage of the bond  UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D  alanyl-/-D-alanine (#6# catalytic mechanism and transition state  intermediates <16>; #2# catalytic mechanism involving active site  residues Lys47 and Lys213, Lys47 exists in the free-base form for  catalysis, Lys213 serves as an electrostatic anchor for the substrate  <18>)  "
3.4.18.1," Release of C-terminal amino acid residues with broad specificity, but  lacks action on C-terminal proline. Shows weak endopeptidase activity  (#6# the catalytic triad is formed by Cys84, His233, and Asn254 <18>)  "
3.4.19.1," cleavage of an N-acetyl or N-formyl amino acid from the N-terminus of a  polypeptide (#24# substrate binding and catalytic mechanisms, overview.  Three main pathways are observed most frequently, namely P1, P2A, and  P3, evaluation by comparing the average force profiles and potential of  mean force calculations revealing that P3 is the unbinding pathway. P1  is located in a tunnel in the beta-propeller domain and contained the  D158, R160, S157, S201, A200, S199, W250, D69, Q28, and R287 residues.  P2A is located between blades 1 and 2 (G86, E88, K85, H90, D82, and  N65), whereas P2D penetrates through blades 1 and 2 formed by loop A,  which is close to P2A (S481, F485, D482, L115, I114, R113, H90, E88,  R526, and S525). P3 is located between the beta-propeller domain and  alpha/beta hydrolase containing the residues M561, A564, L568, F381,  T380, I20, A21, F41, K24, G40, G44, and V46 <75>)  "
3.4.19.11, Hydrolysis of gamma-D-glutamyl bonds to the L-terminus (position 7) of  meso-diaminopimelic acid (meso-A2pm) in 7-(L-Ala-gamma-D-Glu)-meso-A2pm  and 7-(L-Ala-gamma-D-Glu)-7-(D-Ala)-meso-A2pm. It is required that the  D-terminal amino and carboxy groups of meso-A2pm are unsubstituted  
3.4.19.12," Thiol-dependent hydrolysis of ester, thioester, amide, peptide and  isopeptide bonds formed by the C-terminal Gly of ubiquitin (a  76-residue protein attached to proteins as an intracellular targeting  signal) (#7# Cys90 and His161 are involved in catalytic rate  enhancement <11>; #7# UCH-L1 is a neuro-specific multifunctional  enzyme, deubiquinating, ubiquitinyl ligase, and also stabilizing  ubiquitin monomers, C90 is the active site residue <31>)  "
3.4.19.13," glutathione + H2O = L-cysteinylglycine + L-glutamate (#18# ping-pong  kinetics mechanism, in which an acyl enzyme intermediate is formed <18>) "
3.4.19.13, a glutathione-S-conjugate + H2O = an (L-cysteinylglycine)-S-conjugate +  L-glutamate  
3.4.19.14, leukotriene C4 + H2O = leukotriene D4 + L-glutamate  
3.4.19.15, an N6-[small archaeal modifier protein]-[protein]-L-lysine + H2O = a  [protein]-L-lysine + a small archaeal modifier protein  
3.4.19.16, an  (E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)alkan-1-imine +  H2O = an  (E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)alkan-1  imine + L-glutamate 
3.4.19.16, (E)-1-(glutathion-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethan-1-imine + H2O  =  (E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethan-1-imine  + L-glutamate 
3.4.19.16, (glutathion-S-yl)(1H-indol-3-yl)acetonitrile + H2O =  (L-cysteinylglycin-S-yl)(1H-indol-3-yl)acetonitrile + L-glutamate 
3.4.19.16, (Z)-1-(glutathion-S-yl)-N-hydroxy-2-phenylethan-1-imine + H2O =  (Z)-1-(L-cysteinyglycin-S-yl)-N-hydroxy-2-phenylethan-1-imine +  L-glutamate  
3.4.19.2, cleavage of C-terminal glycinamide from polypeptides  
3.4.19.3," release of an N-terminal pyroglutamyl group from a polypeptide, the  second amino acid generally not being Pro  "
3.4.19.5, Cleavage of a beta-linked Asp residue from the N-terminus of a  polypeptide  
3.4.19.6, release of the N-terminal pyroglutamyl group from pGlu-/-His-Xaa  tripeptides and pGlu-/-His-Xaa-Gly tetrapeptides  
3.4.19.7," release of an N-terminal, formyl-methionyl residue from a polypeptide  "
3.4.19.9," tetrahydropteroyl-(gamma-glutamyl)n + (n-1) H2O =  5,6,7,8-tetrahydrofolate + (n-1) L-glutamate (#4,5# catalytic  mechanism, the enzyme releases mono- or di-glutamate <41>; #4,14# Tyr36  is catalytically essential <37>)  "
3.4.21.1," Preferential cleavage: Tyr-/-, Trp-/-, Phe-/-, Leu-/- (#5# specific  cleavage of the Phe18-Asp19 peptide bond in the trypsinogen activation  peptide and removal of the N-terminal tripeptide <62>)  "
3.4.21.10," preferential cleavage: Arg-/-, Lys-/-  "
3.4.21.100," Hydrolysis of the B chain of insulin at -Glu13-/-Ala-, -Leu15-/-Tyr-  and -Phe25-/-Tyr-, and angiotensin I at -Tyr4-/-Ile-. A good synthetic  substrate is Lys-Pro-Ile-Glu-Phe-/-Phe(NO2)-Arg-Leu  "
3.4.21.101, cleavage of casein  
3.4.21.102," the enzyme shows specific recognition of a C-terminal tripeptide,  Xaa-Yaa-Zaa, in which Xaa is preferably Ala or Leu, Yaa is preferably  Ala or Tyr, and Zaa is preferably Ala, but then cleaves at a variable  distance from the C-terminus. A typical cleavage is  -Ala-Ala-/-Arg-Ala-Ala-Lys-Glu-Asn-Tyr-Ala-Leu-Ala-Ala. In the plant  chloroplast, the enzyme removes the C-terminal extension of the D1  polypeptide of photosystem II (#23# mechanism, transit peptide binding  and removal are two separable steps of the reaction <20>; #6# substrate  recognition site is located between amino acids 206 and 334 where there  is also a putative PDZ domain <2>; #3,12,13,18,19,21,23,26,27# reaction  mechanism, process model, substrate recognition, overview <27>)  "
3.4.21.103," Milk clotting activity. Preferential cleavage of Gly8-/-Ser in B chain  of insulin most rapidly, followed by Leu11!Val, Cys(SO3H)19-/-Gly and  Phe24-/-Phe. No action on Ac-Phe-Tyr(I)2.  "
3.4.21.104," Selective cleavage after Arg223 in complement component C2  (-Ser-Leu-Gly-Arg-/-Lys-Ile-Gln-Ile) and after Arg76 in complement  component C4 (-Gly-Leu-Gln-Arg-/-Ala-Leu-Glu-Ile) (#7# mechanism <1>;  #2# catalytic serine residue is located on the light chain subunit  <12>; #5# structure-function analysis of the catalytic unit,  enzyme-substrate interaction is different from enzyme C1 which has the  same substrate specificity, MASP-2 shows a subsite flexibility in  substrate specificity, catalytic residues are Asp526 and His525, active  site structure, overview <14>; #3# substrate recognition mechanism,  mechanism of complement cascade activation <10>)  "
3.4.21.105," cleaves type-1 transmembrane domains using a catalytic dyad composed of  serine and histidine that are contributed by different transmembrane  domains (#5# active site structure and catalytic mechanism,  structure-function realationship <26>; #30# catalytic mechanism,  structure of the active site within the membrane, residues Ser201,  His150, and Asn154 are important in catalysis, overview <32>; #5,33#  rhomboid structure and catalytic mechanism, catalytic dyad id formed by  S201 and H254, structure-function modeling <23>; #1# rhomboid structure  and catalytic mechanism, structure-function modeling <23>; #39# ROM1 of  Toxoplasma gondii contains a catalytic triad consisting of asparagine,  histidine, and serine residues of in transmembrane domains 2, 6, and 4  <19>; #30# structure-function relationship, catalytic residues are  Ser201 of transmembrane helix 4 and His254 of transmembrane helix 6  <33>; #30# the active site structure, with a Ser 201 and His 254  catalytic dyad, is accessible by substrate through a large V-shaped  opening that faces laterally towards the lipid, but is blocked by a  half-submerged loop structure, catalytically involved residues and  water molecules, catalytic mechanism, overview <27>; #30# transmembrane  helix 5 is the lateral substrate gate, the enzyme contains a catalytic  serine recessed into the plane of the membrane, within a hydrophilic  cavity that opens to the extracellular face, but protected laterally  from membrane lipids by a ring of transmembrane segments,  structure-function analysis, transmembrane helix 5 movement to gate  lateral substrate entry is a rate-limiting step in intramembrane  proteolysis <34>)  "
3.4.21.106," cleavage after basic amino-acid residues, with Arg strongly preferred  to Lys  "
3.4.21.107," acts on substrates that are at least partially unfolded. The cleavage  site P1 residue is normally between a pair of hydrophobic residues,  such as Val-/-Val (#15# the trypsin-like serine protease catalytic  triad formed by His129, Asp158, and Ser240 <32>)  "
3.4.21.108," cleavage of non-polar aliphatic amino-acids at the P1 position, with a  preference for Val, Ile and Met. At the P2 and P3 positions, Arg is  selected most strongly with a secondary preference for other  hydrophilic residues  "
3.4.21.109," cleaves various synthetic substrates with Arg or Lys at the P1 position  and prefers small side-chain amino acids, such as Ala and Gly, at the  P2 position (#2# Asp771, His656, and Ser805 are the residues of the  catalytic triad <38>; #2,3,4,5,6,9# structure-function relationship,  overview <35>; #10# the basic group of the P1 arginine side chain makes  a salt bridge with Asp 756 at the bottom of the S1 pocket, substrate  docking study,overview <91>)  "
3.4.21.110, the primary cleavage site is at His67-/-Lys68 in human C5a with a minor  secondary cleavage site at Ala58-/-Ser59  
3.4.21.111, exhibits low specificity towards esters of amino acids with small  hydrophobic or aromatic residues at the P1 position  
3.4.21.112," processes precursors containing basic and hydrophobic/aliphatic  residues at P4 and P2, respectively, with a relatively relaxed  acceptance of amino acids at P1 and P3  "
3.4.21.113," Leu is conserved at position P1 for all four cleavage sites. Alanine is  found at position P1' of the NS4A-NS4B cleavage site, whereas serine is  found at position P1' of the NS3-NS4A, NS4B-NS5A and NS5A-NS5B cleavage  sites  "
3.4.21.114, cleavage of (Glu/Gln)-/-(Gly/Ser/Ala) in arterivirus replicase  translation products ORF1a and ORF1ab  
3.4.21.115, cleaves the (Ser/Thr)-Xaa-Ala-/-(Ser/Ala)-Gly motif in the polyprotein  NH2-pVP2-VP4-VP3-COOH of infectious pancreatic necrosis virus at the  pVP2-VP4 and VP4-VP3 junctions  
3.4.21.116," self-cleaves Val52-/-Asn53, Ala62-/-Phe63 and Val74-/-Thr75 at the  N-terminus of SpoIVB (#1# D137 is essential for catalytic activity,  mechanism model, enzyme contains conserved metalloprotease sequence  motifs HEXXH and NPDG, which are expected to form the catalytic center  and are required for catalytic activity <9>; #3# enzyme contains  conserved metalloprotease sequence motif HEXXH <2>) "
3.4.21.116," N-terminal cleavage of the pro-form of the sporulation protein sigmaK  (#1# enzyme belongs to S2P family of intramembrane-cleaving proteases  <10>; #1# enzyme is a metalloprotease with a transmembrane H43EXXH47  motif, E44 promotes nucleophilic attack by a water molecule on the  carbonyl atom of the substrate peptide bond <14>)  "
3.4.21.117," cleavage of proteins with aromatic side chains in the P1 position (#2#  specific for amino acid residues with aromatic side chains in the P1  position <7>; #3# enzyme exhibits a marked preference for cleavage  downstream of Arg residues <2>; #5# substrate binding pocket contains  an Asn residue <3>; #2,5# enzyme is a chymotrypsin-like serine protease  <4,5,6,7,8,9,10>)  "
3.4.21.118," cleavage of amide substrates following the basic amino acids Arg or Lys  at the P1 position, with a preference for Arg over Lys (#5# substrate  binding pocket contains an Asp residue <12>; #4,5# enzyme is a  trypsin-type serine protease <2,4,5,6,7,10>; #4# substrate binding site  structure defining the specificity for Arg and Lys in the S1 pocket  <6>; #4# the ordered kallikrein loop projects proline towards the  active site to restrict smaller residues or proline at the P2 position  of substrates <6>; #3# kallikrein k8 exhibit a marked preference for  cleavage downstream of Arg residues <11>)  "
3.4.21.119," Hydrolyses mouse Ren2 protein (a species of prorenin present in the  submandibular gland) on the carboxy side of the arginine residue at the  Lys-Arg-/- pair in the N-terminus, to yield mature renin (#1# substrate  binding <5>; #1,2,3# enzyme is a serine protease <5,6,7>; #1#  preference for Xaa-Arg-Arg- motif <2>; #1# active site is located in  the cleft between two beta-barrel domains, with an ordered kallikrein  loop conformation close to it <5>)  "
3.4.21.12," preferential cleavage: Ala-/-, Val-/- in bacterial cell walls, elastin  and other proteins (#3# the specificity mechanism of the enzyme is  influenced by dynamic motion around the S1 binding pocket in addition  to the static structural characteristics <16>)  "
3.4.21.120, preferential cleavage at Gly-Ser-Arg373-/- of glycoprotein gp43 in  Xenopus laevis coelemic egg envelope to yield gp41  
3.4.21.121, Cleavage of -Lys-Lys-/- and -Lys-Arg-/- bonds.  
3.4.21.19," Preferential cleavage: Glu-/-, Asp-/- (#1# absolutely specific for  cleavage sites Glu-/-Xaa and Asp-/-Xaa, cleavage exclusively at the  carboxylic side, active site Ser169 <10>; #1# catalytic tetrad of  His213, Asp102, Ser195, and Trp214, computer modeling of S1 and S1  sites of the enzymes active site <16>; #2# catalytic triad of His, Asp,  and Ser <16>; #5# catalytic triad of His, Asp, and Ser, computer  modeling of active site structure, S1-substrate binding site, and  substrate binding mechanism <16>; #6# catalytic triad of His, Asp, and  Ser, substrate binding mechanism and structure <16>; #7# specific for  cleavage on the carboxylic site of glutamic acid, catalytic site are  His47 and Ser171, the N-terminus is involved in formation of the  substrate binding pocket, a direct structural relation between zymogen  activation and substrate charge compensation exists <11>)  "
3.4.21.2," Preferential cleavage: Leu-/-, Tyr-/-, Phe-/-, Met-/-, Trp-/-, Gln-/-,  Asn-/-  "
3.4.21.20, specificity similar to chymotrypsin C (#2# active site structure <32>)  
3.4.21.21, Selective cleavage of Arg-/-Ile bond in factor X to form factor Xa  
3.4.21.22, Selective cleavage of Arg-/-Ile bond in factor X to form factor Xa (#3#  free of thrombin activity <1>)  
3.4.21.25, hydrolysis of proteins with broad specificity  
3.4.21.26," Hydrolysis of --Pro-/- and to a lesser extent --Ala-/- in oligopeptides  (#55# catalytic triad consists of Ser548-Asp631-His667 <56>;  #3,5,6,16,29,46# catalytic mechanism, structure-function relationship  <86>; #5,14,18,19,45# catalytic mechanism, structure-function  relationship, the enzyme contains a Ser-Asp-His catalytic triad,  substrate specificity and binding structure,overview <76>; #35#  catalytic mechanism, structure-function relationship, the substrate  induces an opening at the interface pf the peptidase and the  beta-propeller domains while entering into the active site, concerted  movements of the domains are required for enzyme activity <86>; #44#  catalytic residues are Ser477, Asp559, and His591 <83>; #18# the  catalytic triad is formed by conserved residues Ser548, Asp631, and  His667 <78>; #3,5,6,7,14,16,19,31,35# the catalytic triad Ser, Asp, His  is located in a large cavity at the interface of the two domains, the  serine residue is located on what is called a nucleophile elbow, at the  tip of a very sharp turn, it is surrounded by several small residues  that provide relatively little steric hindrance <77>; #5,7# the  catalytic triad Ser554, Asp641, His680 is located at the C-terminus in  a large cavity at the interface of the two domains, the serine residue  is located on what is called a nucleophile elbow, at the tip of a very  sharp turn, it is surrounded by several small residues that provide  relatively little steric hindrance, catalytic mechanism,  structure-function relationship, overview <80>)  "
3.4.21.27, Selective cleavage of Arg-/-Ala and Arg-/-Val bonds in factor IX to  form factor IXa  
3.4.21.3," Preferential cleavage: Tyr-/-, Phe-/-, Leu-/-; little action on Trp--/-  "
3.4.21.32," hydrolysis of proteins, with broad specificity for peptide bonds.  Native collagen is cleaved about 75% of the length of the molecule from  the N-terminus. Low activity on small molecule substrates of both  trypsin and chymotrypsin  "
3.4.21.34," selective cleavage of some Arg-/- and Lys-/- bonds, including Lys-/-Arg  and Arg-/-Ser in (human) kininogen to release bradykinin  "
3.4.21.35," Preferential cleavage of Arg-/- bonds in small molecule substrates.  Highly selective action to release kallidin (lysyl-bradykinin) from  kininogen involves hydrolysis of Met-/- or Leu-/-. The rat enzyme is  unusual in liberating bradykinin directly from autologous kininogens by  cleavage at two Arg-/- bonds (#11# substrate binding pocket contains an  Asp residue <4>; #2# S1 subsite accepts both Arg and Phe and has a  preference for basic residues <37>; #2# serine at position P1 and  arginine at position P2 result in high activity <15>; #11# trypsin-like  serine protease <4>; #2# strict preference for Arg in P1 position, wich  is further enhanced by Ser in P1 position <48>)  "
3.4.21.36," Hydrolysis of proteins, including elastin. Preferential cleavage: Ala-/-  "
3.4.21.37," Hydrolysis of proteins, including elastin. Preferential cleavage Val-/-  > Ala-/-  "
3.4.21.38, selective cleavage of Arg-/-Ile bonds in factor VII to form factor VIIa  and factor XI to form factor XIa  
3.4.21.39, preferential cleavage: Phe-/- > Tyr-/- > Trp-/- > Leu-/-  
3.4.21.4," preferential cleavage: Arg-/-, Lys-/- (#7# mechanism <1>; #7# catalytic  mechanism involving both His57 and Asp102, overview <242>)  "
3.4.21.41, Selective cleavage of Lys(or Arg)-/-Ile bond in complement subcomponent  C1s to form C_overbar_1s_ (EC 3.4.21.42)  
3.4.21.42," Cleavage of Arg-/-Ala bond in complement component C4 to form C4a and  C4b, and Lys(or Arg)-/-Lys bond in complement component C2 to form C2a  and C2b: the ""classical"" pathway C3 convertase  "
3.4.21.43," Selective cleavage of Arg-/-Ser bond in complement component C3  alpha-chain to form C3a and C3b, and Arg-/- bond in complement  component C5 alpha-chain to form C5a and C5b (#2# hydrolyses peptide  bond 77 (Arg-Ser) in complement component C3, and complement component  C5. Cleavage of C5 requires complement fragment C3b which binds C5 and  renders it susceptible to cleavage by the C4b,C2a complex <1>)  "
3.4.21.45," Inactivates complement subcomponents C3b, iC3b and C4b by proteolytic  cleavage  "
3.4.21.46, selective cleavage of Arg-/-Lys bond in complement factor B when in  complex with complement subcomponent C3b or with cobra venom factor  
3.4.21.47," Cleavage of Arg-/-Ser bond in complement component C3 alpha-chain to  yield C3a and C3b, and Arg-/- bond in complement component C5  alpha-chain to yield C5a and C5b (#2# the enzyme is a bimolecular  complex of complement fragment Bb with either C3b or cobra venom  factor. Bb contains the active site. Bb is formed by cleavage of  proenzyme factor B by factor D. Cleavage of complement component C5  requires additional C3b which binds C5 and renders it susceptible to  cleavage by C3b,Bb complex, , intermediate catalytic mechanism and a  kinetic mechanism of a tetra uni ping pong bi bi reaction reduced to a  uni bi reaction <4>; #7# factor B binding to C3b forms an open  activation state of C3bB. Factor D specifically binds the open  conformation of factor B through a site distant from the catalytic  center and is activated by the substrate, which displaces factor Ds  self-inhibitory loop. This concerted proteolytic mechanism, which is  cofactor-dependent and substrate-induced, restricts complement  amplification to C3b-tagged target cells <48>)  "
3.4.21.48," Hydrolysis of proteins with broad specificity, and of Bz-Arg-OEt  Ac-Tyr-OEt. Does not hydrolyse peptide amides  "
3.4.21.49, Hydrolysis of proteins including native collagen at -/-Ala bond leaving  an N-terminal (75%) and a C-terminal (25%) fragment  
3.4.21.5," selective cleavage of Arg-/-Gly bonds in fibrinogen to form fibrin and  release fibrinopeptides A and B (#2# mechanism, modeling <26>; #2#  active site and P1 interactions, overview <22>; #2# Asp189 is involved  in substrate recognition <30>; #2# catalytic tetrad, composed of His57,  Asp102, Ser195, and Ser214, at the bottom of a canyon-like cleft  shaping the catalytic pocket, further regulation of specificity by  recognition domains along with insertion loops <36>; #2# reaction  mechanism, substrate binding, preference at positions P1-P4, molecular  modeling of enzyme-substrate complex <37>; #2# serine protease <32>;  #2# serine protease, for substrate binding P1 and P2 residues must be  compatible with the geometry and chemistry of S1 and S2 specificity  sites in thrombin, a glycine in P5 position is necessary for conserved  substrate conformation, the hydrophobic residues, which occupy the aryl  binding site of the enzyme determine the substrate conformation further  away from the catalytic residues <29>; #2# serine protease, mechanism  and substrate binding <34>; #2,5# two active site loops, residues  214-222 and residues 126-132, undergo decreases in solvent  accessibility due to steric contacts with substrate. Two regions  outside the active site undergo solvent protection upon substrate  binding <50>)  "
3.4.21.50," Preferential cleavage: Lys-/-, including -Lys-/-Pro-  "
3.4.21.53," hydrolysis of proteins in presence of ATP (#3,6,8,9,10,20# hydrolysis  of proteins in presence of ATP, mechanism <6,8,9,22,23>; #28# active  site consists of catalytic Ser-Lys-Asp residues. Charged Lys-593  assists in lowering the pKa of the Ser550 hydroxyl group, and the water  in the cavity acts as a proton acceptor during catalysis <62>; #42#  active site contains a Ser-Lys dyad <55>; #6# binding of ATP induces a  conformational change that facilitates the coupling of nucleotide  hydrolysis with peptide substrate delivery to the peptidase activs site  <53>; #6# pre-steady state kinetic characterization. ATP hydrolysis  occurs before peptide cleavage, with the former displaying a burst and  the latter displaying a lag in the product production. ATP hydrolysis  is used to generate an active enzyme that hydrolyzes peptide <54>; #6#  presence of a catalytic Ser-Lys dyad. Definition of two enzyme  subfamilies LonA and LonB, based on the consensus sequences in the  active site of the proteolytic domain <56>; #6# reaction may involve a  substrate translocation step limiting the turnover rate <101>; #54#  proteolysis mechanism, overview <171>)  "
3.4.21.54," Cleavage of the Leu-/-Leu bond in synthetic tetradecapeptide renin  substrate (horse), to produce angiotensin I, but not active on natural  angiotensinogen, unlike renin (EC 3.4.23.15). Also hydrolyses  Bz-Arg-p-nitroanilide  "
3.4.21.55, Selective cleavage at Arg-/- bonds in fibrinogen to form fibrin and  release fibrinopeptides A and B  
3.4.21.57, Hydrolysis of proteins. Preferential cleavage: Leu-/- in small molecule  substrates  
3.4.21.59," Preferential cleavage: Arg-/-, Lys-/-, but with more restricted  specificity than trypsin  "
3.4.21.6," selective cleavage of Arg-/-Thr and then Arg-/-Ile bonds in prothrombin  to form thrombin (#1,2,3,4,5,6,7,8,10,12# scutelarin has similar  specificity  <17,18,19,20,21,23,24,25,26,28,29,30,31,32,33,34,35,36,37,38,39,40,42  43,45,46,47,48,50,52,53,54,55,56,57,58,59>; #3# scutelarin has similar  specificity, autolysis loop is formed by residues Arg143, Lys147,  Arg150, and Arg154 <22>; #3# scutelarin has similar specificity,  catalytic mechanism <27>; #3# scutelarin has similar specificity,  catalytic residues are Ser195 and His57, mechanism <51>; #3# scutelarin  has similar specificity, hydrolyzes two petide bonds in prothrombin  having (Glu/Asp)-Gly-Arg-(Thr/Ile) as P3-P2-P1-P1 residues, glycine is  not the best P2-residue, phenylalanine shows even higher activity at  this position <44>; #6# scutelarin has similar specificity, most  selective P2-position, less selective P1-position, and non-selective  P3-position <41>; #2# scutelarin has similar specificity, Ser89 is  critical for enzyme activity <49>; #12# residues His57, Asp102, and  Ser195 form the catalytic triad at the active site cleft between the  two subdomains <78>)  "
3.4.21.60, selective cleavage of Arg-/-Thr and Arg-/-Ile in prothrombin to form  thrombin and two inactive fragments  
3.4.21.61," Cleavage of -Lys-Arg-/- and -Arg-Arg-/- bonds to process yeast  alpha-factor pheromone and killer toxin precursors (#5# catalytic  residues are D175, H213, S385 <18>)  "
3.4.21.62," Hydrolysis of proteins with broad specificity for peptide bonds, and a  preference for a large uncharged residue in P1. Hydrolyses peptide  amides (#10,13# hydrolysis of proteins with broad specificity for  peptide bonds, and a preference for a large uncharged residue in P1.  Hydrolyzes peptide amides. Mechanism <3>; #10# importance of  tetrahedral intermediate formation in the catalytic mechanism of the  serine protease subtilisin. Substrate binding induces the formation of  a strong hydrogen bond or low-barrier hydrogen bond between  histidine-57 and aspartate-102 that increases the pK(a) of the active  site histidine, allowing it to be an effective general base catalyst  for the formation of the tetrahedral intermediate and increasing the  effective molarity of the catalytic hydroxyl group of serine-195,  catalytic mechanism, overview <163>)  "
3.4.21.63," Hydrolysis of proteins with broad specificity, and of Bz-Arg-OEt >  Ac-Tyr-OEt. Does not hydrolyse peptide amides  "
3.4.21.64," Hydrolysis of keratin, and of other proteins with subtilisin-like  specificity. Hydrolyses peptide amides  "
3.4.21.65," Rather nonspecific hydrolysis of proteins. Preferential cleavage:  Ala-/-, Tyr-/-, Phe-/- in small molecule substrates  "
3.4.21.66," Hydrolysis of proteins, including collagen  "
3.4.21.67," Hydrolysis of proteins, but not Bz-Tyr-OEt, Ac-Phe-beta-naphthylester,  or Bz-Arg-Oet  "
3.4.21.68, Specific cleavage of Arg-/-Val bond in plasminogen to form plasmin  
3.4.21.69," degradation of blood coagulation factors Va and VIIIa (#2# the  catalytic triad is formed by His211, Asp257, and Ser360 <73>)  "
3.4.21.7, Preferential cleavage: Lys-/- > Arg-/-; higher selectivity than  trypsin. Converts fibrin into soluble products  
3.4.21.70, Preferential cleavage: Ala-/-. Does not hydrolyse elastin  
3.4.21.71," Preferential cleavage: Leu-/-, Met-/- and Phe-/-. Hydrolyses elastin  "
3.4.21.72, Cleavage of immunoglobulin A molecules at certain Pro-/- bonds in the  hinge region. No small molecule substrates are known (#16# the  catalytic serine residue is Ser267 <19>)  
3.4.21.73, Specific cleavage of Arg-/-Val bond in plasminogen to form plasmin  
3.4.21.74," Selective cleavage of Arg-/- bond in fibrinogen, to form fibrin, and  release fibrinopeptide A. The specificity of further degradation of  fibrinogen varies with species origin of the enzyme  "
3.4.21.75," Release of mature proteins from their proproteins by cleavage of  -Arg-Xaa-Yaa-Arg-/- bonds, where Xaa can by any amino acid and Yaa is  Arg or Lys. Releases albumin, complement component C3 and von  Willebrand factor from their respective precursors  "
3.4.21.76," Hydrolysis of proteins, including elastin, by preferential cleavage:  -Ala-/- > -Val-/-  "
3.4.21.77," Preferential cleavage: -Tyr-/- (#2,4# enzyme is a serine protease  <2,15,16>; #4# enzyme contains a serine residue in the substrate  binding pocket <2>; #2,4# enzyme shows chymotrypsin-like activity  <2,11,12,16>; #2# cleaves at the C-terminal side of several amino acids  residues, like tyrosine, glutamine, histidine, asparic acid, leucine,  serine, and asparagine, not at arginine, lysine, phenylalanine,  tryptophan, or methionine residues <14>; #2# participation of His41,  Asp96 and Ser189 in the active site <5>; #2# enzyme shows a substrate  specificity different from trypsin, chymotrypsin, and kallikrein 1 and  2 <14>)  "
3.4.21.78," Hydrolysis of proteins, including fibronectin, type IV collagen and  nucleolin. Preferential cleavage: -Arg-/-, -Lys-/- >> -Phe-/- in small  molecule substrates  "
3.4.21.79," preferential cleavage: -Asp-/- >> -Asn-/- > -Met-/-, -Ser-/-  "
3.4.21.80, Hydrolysis of proteins with specificity similar to chymotrypsin  
3.4.21.81, Hydrolysis of proteins with trypsin-like specificity  
3.4.21.82, Preferential cleavage: -Glu-/- >> -Asp-/-. Preference for Pro or Leu at  P2 and Phe at P3. Cleavage of -Glu-/-Asp- and -Glu-/-Pro- bonds is slow  
3.4.21.83," Hydrolysis of -Arg-/-, -Lys-/- bonds in oligopeptides, even when P1'  residue is proline  "
3.4.21.84, Selective cleavage of -Arg103-/-Ser- and -Ile124-/-Ile- bonds in  limulus clotting factor B to form factor _overbar_B_. Cleavage of  -Pro-Arg-/- bonds in synthetic substrates  
3.4.21.85, Selective cleavage of -Arg98-/-Ile- bond in limulus proclotting enzyme  to form active clotting enzyme  
3.4.21.86, Selective cleavage of -Arg18-/- and -Arg47-/- bonds in coagulogen to  form coagulin and fragments  
3.4.21.88," Hydrolysis of Ala84-/-Gly bond in repressor LexA (#3# oxyanion hole is  formed by A84, S119, M118 <11>)  "
3.4.21.89," Cleavage of hydrophobic, N-terminal signal or leader sequences  (#2,7,10,15# mechanism <9,16,19>)  "
3.4.21.9, Activation of trypsinogen by selective cleavage of Lys6-/-Ile bond  
3.4.21.90, Autocatalytic release of the core protein from the N-terminus of the  togavirus structural polyprotein by hydrolysis of a -Trp-/-Ser- bond  
3.4.21.91, Selective hydrolysis of -Xaa-Xaa-/-Yaa- bonds in which each of the Xaa  can be either Arg or Lys and Yaa can be either Ser or Ala  
3.4.21.92," Hydrolysis of proteins to small peptides in the presence of ATP and  Mg2+. alpha-Casein is the usual test substrate. In the absence of ATP,  only oligopeptides shorter than five residues are hydrolysed (such as  succinyl-Leu-Tyr-/-NHMec; and Leu-Tyr-Leu-/-Tyr-Trp, in which cleavage  of the -Tyr-/-Leu- and -Tyr-/-Trp bonds also occurs) "
3.4.21.92," Hydrolysis of proteins to small peptides in the presence of ATP and  Mg2+. alpha-Casein is the usual test substrate. In the absence of ATP,  only oligopeptides shorter than five residues are hydrolysed (such as  succinyl-Leu-Tyr-/-NHMec, and Leu-Tyr-Leu-/-Tyr-Trp, in which cleavage  of the -Tyr-/-Leu- and -Tyr-/-Trp bonds also occurs) (#5# dual  mechanism in which translocation alternates with proteolysis, allowing  peptides of more or less unifirm length to be cleaved processively from  a translocating substrate <22>)  "
3.4.21.93," release of protein hormones, neuropeptides and renin from their  precursors, generally by hydrolysis of -Lys-Arg-/- bonds (#3# active  site and substrate binding structure, enzyme-substrate interactions at  prime and non-prime subsites <28>)  "
3.4.21.94," release of protein hormones and neuropeptides from their precursors,  generally by hydrolysis of -Lys-Arg-/- bonds (#3# active site and  substrate binding structure, enzyme-substrate interactions at prime and  non-prime subsites <17>; #6# the catalytic triad is formed by the  conserved residues Asp169, His210, and Ser386 <13>)  "
3.4.21.95," Fully activates human clotting factor V by a single cleavage at the  Trp-Tyr-Leu-Arg1545!Ser-Asn-Asn-Gly bond. Cattle, but not rabbit,  factor V is cleaved, and no other proteins of the clotting system are  attacked. Esterase activity is observed on Bz-Arg-OEt and Tos-Arg-OMe,  and amidase activity on Phe-pipecolyl-Arg-NHPhNO2  "
3.4.21.96," Endopeptidase activity with very broad specificity, although some  subsite preferences have been noted, e.g. large hydrophobic residues in  the P1 and P4 positions, and Pro in the P2 position. Best known for its  action on caseins, although it has been shown to hydrolyse hemoglobin  and oxidized insulin B chain  "
3.4.21.97, Cleaves -Ala-/-Ser- and -Ala-/-Ala- bonds in the scaffold protein (#4#  serine protease that operates by an induced-fit mechanism <37>)  
3.4.21.98," Hydrolysis of four peptide bonds in the viral precursor polyprotein,  commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser  or Ala in P1'  "
3.4.21.99," hydrolyses arginyl bonds, preferably with Pro in the P2 position  "
3.4.22.1," Hydrolysis of proteins with broad specificity for peptide bonds.  Preferentially cleaves -Arg-Arg-/- bonds in small molecule substrates  (thus differing from cathepsin L). In addition to being an  endopeptidase, shows peptidyl-dipeptidase activity, liberating  C-terminal dipeptides (#40# kinetics <63>; #57# non-active site residue  Gln109 and active site Cys115 play an important role in the catalytic  mechanism <154>; #3# cathepsin B possesses a long and narrow  substrate-binding active site cleft with catalytic residue Cys, the  surfaces of the S1 and S1 subsites are negatively charged due to  presence of Glu122 and Glu194, the occluding loop of residue 105-125 is  a structural feature containing the two positively charged His  residues, His110 and His111, overview <184>; #49# the catalytic residue  is Cys29 <183>)  "
3.4.22.10," preferential cleavage with hydrophobic residues at P2, P1 and P1' (#1#  catalytic residue Cys192 <26>; #1# the catalytic residue is His195  forming an ion pair with the single Cys47 residue <28>)  "
3.4.22.14, Similar to that of papain  
3.4.22.15," similar to that of papain. As compared to cathepsin B, cathepsin L  exhibits higher activity towards protein substrates, but has little  activity on Z-Arg-Arg-NHMec, and no peptidyl-dipeptidase activity  "
3.4.22.16," Hydrolysis of proteins, acting as an aminopeptidase (notably, cleaving  Arg-/- bonds) as well as an endopeptidase (#4# mini-chain has  definitive role in substrate-recognition, implications for enzyme  function <22>; #3# mechanism: specific interactions of an anionic  active site residue with the charged alpha-amino group of substrates  cause transition state stabilization which proves the enzyme to act  preferentially as an aminopeptidase <23>; #5# mechanism: interactive  catalytic-site system in which the nucleophilic character of the  sulphur atom is maintained in acidic media <14>; #3# number of possible  subsites: three <11>; #2# same catalytic mechanism as in papain and  actinidin <28>)  "
3.4.22.2," Hydrolysis of proteins with broad specificity for peptide bonds, but  preference for an amino acid bearing a large hydrophobic side chain at  the P2 position. Does not accept Val in P1' (#1# the His-Cys catalytic  diad in free papain is fully protonated, -NH(+)/-SH. The experimental  pKa of 8.62 for His159 imidazole in free papain is assigned to the  -NH(+)/-SH and  -N/-SH equilibrium <111>)  "
3.4.22.24," interconversion of the three forms of tyrosine aminotransferase, EC  2.6.1.5  "
3.4.22.25," preferential cleavage: Gly-/-, in proteins and small molecule  substrates (#1# specific for Gly at posotion P1 due to an exchange  conserved residues Gly23 to Glu and Gly65 to Arg, 2 free thiol  functions of cysteinyl residues are essential for the catalytic  competence of the enzyme <16>)  "
3.4.22.26, specific cleavage of Arg-/-Ile bond in Factor X to form Factor Xa  
3.4.22.27," similar to cathepsin L, but with much less activity on  Z-Phe-Arg-/-NHMec, and more activity on the Z-Val-Val-Arg-/- compound  (#2# the catalytic triad is formed by Cys25, His164, and Asn184, the  substrate binding site lies between the N-terminal and the C-terminal  domain, cysteine protease mechanism, overview <55>)  "
3.4.22.28," Selective cleavage of Gln-/-Gly bond in the poliovirus polyprotein. In  other picornavirus reactions Glu may be substituted for Gln, and Ser or  Thr for Gly  "
3.4.22.29, selective cleavage of Tyr-/-Gly bond in picornavirus polyprotein (#11#  substrate region exchanges in and out of a conformation in which it  occupies the active site with association and dissociation rates in the  range of 100 to 1000 per s <28>)  
3.4.22.3, Similar to that of papain (#3# active site structure <27>)  
3.4.22.30," hydrolysis of proteins with broad specificity for peptide bonds,  similar to those of papain and chymopapain (#1,2# mechanism <21,24,25>;  #1# Asp158 is not involved in ionization and catalytic competence <22>;  #1# mechanism, Asp158 is involved in catalysis <19>; #1# residue E50 is  part of the electrostatic switch required for catalytic activity,  mechanism, possible role of D158 <23>)  "
3.4.22.31," hydrolysis of proteins with broad specificity for peptide bonds. Best  reported small molecule substrate Bz-Phe-Val-Arg-/-NHMec, but broader  specificity than fruit bromelain (#2# from stem of pineapple plant,  Ananas comosus,. Differs from stem and fruit bromelains in being  inhibited by chicken cystatin, amino acid sequence, contains an insert  between residues 170 and 174 not present in stem bromelain or papain  and a hydropobic series of amino acids adjacent to His157, which  possibly contributes to the different substrate and inhibitor  specificities <6>; #2# from stem of pineapple plant, Ananas comosus,.  Differs from stem and fruit bromelains in being inhibited by chicken  cystatin, contains an active site His residue, active site structure  determination <7>)  "
3.4.22.32," broad specificity for cleavage of proteins, but strong preference for  Z-Arg-Arg-/-NHMec amongst small molecule substrates  "
3.4.22.33," Hydrolysis of proteins with broad specificity for peptide bonds.  Bz-Phe-Val-Arg-/-NHMec is a good synthetic substrate, but there is no  action on Z-Arg-Arg-NHMec (c.f. stem bromelain)  "
3.4.22.34," hydrolysis of proteins and small molecule substrates at -Asn-/-Xaa-  bonds (#28# active site His151 <27>; #38# active site His151 and Cys197  <27>; #4,5,6# the enzyme contains essential catalytic His and Cys  residues <26>)  "
3.4.22.35," hydrolysis of proteins, including basement membrane collagen and  azocasein. Preferential cleavage: Arg-Arg-/- in small molecule  substrates including Z-Arg-Arg-/-NHMec (#1# cleavage mechanism on mucin  substrate, overview <23>)  "
3.4.22.36, Strict requirement for an Asp residue at position P1 and has a  preferred cleavage sequence of Tyr-Val-Ala-Asp-/-  
3.4.22.37," hydrolysis of proteins and small molecule substrates, with a preference  for Arg in P1 (#1# active site structure <17>; #1# Cys244-His211  catalytic diad and a nearby Glu arranged around the S1 specificity  pocket, which carries an Asp residue to enforce preference for Arg-P1  residues, mechanism and binding mode at the active site <13>; #7#  proteolysis of selected proteins <15>; #1# active site structure, role  of the Sn binding pocket, molecular basis for substrate specificity  <26>)  "
3.4.22.38," Broad proteolytic activity. With small-molecule substrates and  inhibitors, the major determinant of specificity is P2, which is  preferably Leu, Met &gt; Phe, and not Arg  "
3.4.22.39," Cleaves proteins of the adenovirus and its host cell at two consensus  sites: -Yaa-Xaa-Gly-Gly-/-Xaa- and -Yaa-Xaa-Gly-Xaa-/-Gly- (in which  Yaa is Met, Ile or Leu, and Xaa is any amino acid) (#1# mechanism <15>;  #1# consensus sequences <1,3,6,10,14>; #1# the GXG consensus site is  cleaved more rapidly than the GGX site <10>)  "
3.4.22.40," Inactivates bleomycin B2 (a cytotoxic glycometallopeptide) by  hydrolysis of a carboxyamide bond of beta-aminoalanine, but also shows  general aminopeptidase activity. The specificity varies somewhat with  source, but amino acid arylamides of Met, Leu and Ala are preferred  (#17# acts as carboxypeptidase, aminopeptidase and peptide ligase <12>;  #1# endopeptidase and aminopeptidase activity <9>)  "
3.4.22.41," The recombinant enzyme cleaves synthetic substrates with Phe and Leu  (better than Val) in P2, with high specificity constant (kcat/Km)  comparable to that of cathepsin L  "
3.4.22.42, The recombinant human enzyme hydrolyses synthetic endopeptidase  substrates including Z-Phe-Arg-NHMec and Z-Arg-Arg-NHMec  
3.4.22.43," The recombinant enzyme hydrolyses proteins (serum albumin, collagen)  and synthetic substrates (Z-Phe-Arg-NHMec > Z-Leu-Arg-NHMec >  Z-Val-Arg-NHMec)  "
3.4.22.44," Hydrolyses glutaminyl bonds, and activity is further restricted by  preferences for the amino acids in P6 - P1' that vary with the species  of potyvirus, e.g. Glu-Xaa-Xaa-Tyr-Xaa-Gln-/-(Ser or Gly) for the  enzyme from tobacco etch virus. The natural substrate is the viral  polyprotein, but other proteins and oligopeptides containing the  appropriate consensus sequence are also cleaved.  "
3.4.22.45," hydrolyses a Gly-/-Gly bond at its own C-terminus, commonly in the  sequence -Tyr-Xaa-Val-Gly-/-Gly, in the processing of the potyviral  polyprotein  "
3.4.22.46," autocatalytically cleaves itself from the polyprotein of the  foot-and-mouth disease virus by hydrolysis of a Lys-/-Gly bond, but  then cleaves host cell initiation factor eIF-4G at bonds -Gly-/-Arg-  and -Lys-/-Arg-  "
3.4.22.47," endopeptidase with strict specificity for lysyl bonds (#1# active site  structure, role of the Sn binding pocket, molecular basis for substrate  specificity <19>)  "
3.4.22.48," broad endopeptidase action on proteins including elastin, but rather  limited hydrolysis of small-molecule substrates. Assays are  conveniently made with hemoglobin, casein or Z-Phe-Arg-NHMec as  substrate (#1# mechanism <1>; #1# active site structure <1>; #1# active  site and substrate binding subsite structures <8>; #1# active site  structure and topology of ScpA <6>)  "
3.4.22.49," all bonds known to be hydrolysed by this endopeptidase have arginine in  P1 and an acidic residue in P4. P6 is often occupied by an acidic  residue or by an hydroxy-amino-acid residue, the phosphorylation of  which enhances cleavage (#5# cohesin cleavage by human separase  requires DNA in a sequence-nonspecific manner (in vitro). Autocleavage  of separase is not stimulated by DNA. Cleavage of the  chromosome-associated cohesins is sensitive to nuclease treatment.  <42>; #10# unphosphorylatable form of cohesin subunit Rad21 is less  efficiently cleaved by Separase <40>)  "
3.4.22.50," endopeptidase of broad specificity, hydrolyzing substrates of both  cathepsin L and cathepsin B  "
3.4.22.51, broad endopeptidase specificity similar to that of cathepsin L  
3.4.22.52, broad endopeptidase specificity  
3.4.22.53, broad endopeptidase specificity  
3.4.22.54, broad endopeptidase specificity 
3.4.22.54, broad endopeptidase activity  
3.4.22.55," strict requirement for an Asp residue at P1, with Asp316 being  essential for proteolytic activity and has a preferred cleavage  sequence of Val-Asp-Val-Ala-Asp-/- (#2# catalysis is mediated by a  mechanism involving a catalytic dyad composed of a cysteine residue as  the catalytic nucleophile and a histidine residue <46>)  "
3.4.22.56," strict requirement for an Asp residue at positions P1 and P4. It has a  preferred cleavage sequence of Asp-Xaa-Xaa-Asp-/- with a hydrophobic  amino-acid residue at P2 and a hydrophilic amino-acid residue at P3,  although Val or Ala are also accepted at this position (#12#  hydrophobic S5 site, where the side-chains of F250 and F252 interact  with substrate. Kinetic importance of P5 site <64>)  "
3.4.22.57, strict requirement for Asp at the P1 position. It has a preferred  cleavage sequence of Tyr-Val-Ala-Asp-/- but also cleaves at  Asp-Glu-Val-Asp-/-  
3.4.22.58, strict requirement for Asp at the P1 position. It has a preferred  cleavage sequence of Tyr-Val-Ala-Asp-/- but also cleaves at  Asp-Glu-Val-Asp-/-  
3.4.22.59, strict requirement for Asp at position P1 and has a preferred cleavage  sequence of Val-Glu-His-Asp-/-  
3.4.22.6, Similar to that of papain  
3.4.22.60," strict requirement for an Asp residue at position P1 and has a  preferred cleavage sequence of Asp-Glu-Val-Asp-/- (#3# catalytic  mechanism of caspase-7 consisting of three distinct kinetic steps  leading to the protonation of the catalytic His144 and the  deprotonation of Cys186, which is activated as a nucleophile, DFT  computational investigation using crystal structure with PDB code 1FIJ,  the catalytic dyad is formed by His144 and Cys186, existence of an  alternative reaction channel leading directly from the initial complex  to the peptide bond cleavage in a single kinetic step, detailed  overview. The reaction pathway is characterized by a high energy  barrier <65>)  "
3.4.22.61, strict requirement for Asp at position P1 and has a preferred cleavage  sequence of (Leu/Asp/Val)-Glu-Thr-Asp-/-(Gly/Ser/Ala)  
3.4.22.62, strict requirement for an Asp residue at position P1 and with a marked  preference for His at position P2. It has a preferred cleavage sequence  of Leu-Gly-His-Asp-/-Xaa  
3.4.22.63, strict requirement for Asp at position P1 and has a preferred cleavage  sequence of Leu-Gln-Thr-Asp-/-Gly  
3.4.22.64, strict requirement for Asp at the P1 position and has a preferred  cleavage sequence of (Ile/Leu/Val/Phe)-Gly-His-Asp-/-  
3.4.22.65, broad endopeptidase specificity 
3.4.22.65, the proteolytic activity of Der f 1 is a major contributor to its  allergenicity. Cysteine protease activity of Der p 1 enhances total IgE  production  
3.4.22.66, endopeptidase with a preference for cleavage when the P1 position is  occupied by Glu-/- and the P1' position is occupied by Gly-/-  
3.4.22.67, preferential cleavage of peptides with a proline residue at the P2  position  
3.4.22.68," Hydrolysis of the alpha-linked peptide bond in the sequence  Gly-Gly-/-Ala-Thr-Tyr at the C-terminal end of the small ubiquitin-like  modifier (SUMO) propeptide, Smt3, leading to the mature form of the  protein. A second reaction involves the cleavage of an epsilon-linked  peptide bond between the C-terminal glycine of the mature SUMO and the  lysine epsilon-amino group of the target protein  "
3.4.22.69, TSAVLQ-/-SGFRK-NH2 and SGVTFQ-/-GKFKK the two peptides corresponding to  the two self-cleavage sites of the SARS 3C-like proteinase are the two  most reactive peptide substrates. The enzyme exhibits a strong  preference for substrates containing Gln at P1 position and Leu at P2  position.  
3.4.22.7, Similar to that of papain  
3.4.22.70, The enzyme catalyses a cell wall sorting reaction in which a surface  protein with a sorting signal containing a LPXTG motif is cleaved  between the Thr and Gly residue. The resulting threonine carboxyl end  of the protein is covalently attached to a pentaglycine cross-bridge of  peptidoglycan.  
3.4.22.71, The enzyme catalyses a cell wall sorting reaction in which a surface  protein with a sorting signal containing a NPXTN motif is cleaved. The  resulting threonine carboxyl end of the protein is covalently attached  to a pentaglycine cross-bridge of peptidoglycan.  
3.4.22.8," Preferential cleavage: Arg-/-, including Arg-/-Pro, but not Lys-  "
3.4.23.1," Preferential cleavage: hydrophobic, preferably aromatic, residues in P1  and P1' positions. Cleaves Phe1-/-Val, Gln4-/-His, Glu13-/-Ala,  Ala14-/-Leu, Leu15-/-Tyr, Tyr16-/-Leu, Gly23-/-Phe, Phe24-/-Phe and  Phe25-/-Tyr bonds in the B chain of insulin  "
3.4.23.12," Similar to pepsin, but also cleaves on either side of Asp and at  Lys-/-Arg (#3# splits peptide bonds at carboxyl and amino sides of  aspartic acid residue, at carboxyl side of alanine and probably  carboxyl side of lysine <3>; #4# predominantly specific for aspartic  acid residues at its carboxyl side or at its amino side, also to  tyrosine and alanine residues at carboxyl sides <1>)  "
3.4.23.15, cleavage of Leu-/- bond in angiotensinogen to generate angiotensin I  (#4# inhibits vasorelaxation induced by nitroso albumin <58>)  
3.4.23.16," specific for a P1 residue that is hydrophobic, and P1' variable, but  often Pro (#1# the kinetic mechanism of HIV-1 protease is random, in  which products bind to form both binary and ternary enzyme-product  complexes, depending on the substrate used <6>; #1# proteolysis  mechanism whereby only one active site Asp is initially protonated. The  steps of this mechanism are: asymmetric binding of the substrate,  hydration of the peptidic carbonyl by an active site water, proton  translocation between the active site Asp residue simultaneously with  carbonyl hydration <28>; #1# flap closing and conformational change  mechanism induced by substrate binding in HIV-1 aspartic protease, flap  conformations in the active site during the catalytic cycle, molecular  dynamic simulations, overview <60>; #1# the active site structure and  conformational flexibility <72>)  "
3.4.23.17," Cleavage at paired basic residues in certain prohormones, either  between them, or on the carboxyl side  "
3.4.23.18," hydrolysis of proteins with broad specificity. Generally favours  hydrophobic residues in P1 and P1', but also accepts Lys in P1, which  leads to activation of trypsinogen. Does not clot milk (#4# catalytic  residues are Asp32 and Asp214 connected by a complex network of  hydrogen bonds, a third catalytic residue is Asp76, which is essential  for trypsinogen activation at pH 3.0-4.5, the active site flap plays an  important role in recognition of basic P1 residues <24>)  "
3.4.23.19," preferential cleavage in B chain of insulin: Asn3-/-Gln, Gly13-/-Ala,  Tyr26-/-Thr (#2# catalytic residues are Glu219 and Glu133, numbering  from the preproform, Glu219 and Glu133 form a catalytic dyad <11>; #2#  catalytic residues are GluB110 and GluB24, catalytic mechanism <14>;  #2# catalytic residues are GluB110 and GluB24, detailed catalytic  mechanism, overview <15>)  "
3.4.23.2," degradation of gelatin; little activity on hemoglobin. Specificity on B  chain of insulin more restricted than that of pepsin A; does not cleave  at Phe1-Val, Gln4-His or Gly23-Phe (#2# mechanism, concerted action of  different pepsins <1>)  "
3.4.23.20," Hydrolysis of proteins with broad specificity similar to that of pepsin  A, preferring hydrophobic residues at P1 and P1', but also cleaving  Gly20-/-Glu in the B chain of insulin. Clots milk, and activates  trypsinogen  "
3.4.23.21," hydrolysis of proteins with broad specificity similar to that of pepsin  A, preferring hydrophobic residues at P1 and P1'. Clots milk and  activates trypsinogen. Does not cleave Gln4-His, but does cleave  His10-/-Leu and Val12-/-Glu in B chain of insulin (#1# aspartate  protease which requires also a His residue for catalytic activity <32>)  "
3.4.23.22," hydrolysis of proteins with specificity similar to that of pepsin A;  prefers hydrophobic residues at P1 and P1', but does not cleave  Ala14-Leu in the B chain of insulin or Z-Glu-Tyr. Clots milk (#1# the  enzyme contains a catalytic Asp dyad <19>; #1# catalytic mechanism,  X-ray, neutron and NMR studies <21>)  "
3.4.23.23," Hydrolysis of proteins, favouring hydrophobic residues at P1 and P1'.  Clots milk. Does not accept Lys at P1, and hence does not activate  trypsinogen  "
3.4.23.24," Preferential cleavage at the carboxyl of hydrophobic amino acids, but  fails to cleave Leu15-Tyr, Tyr16-Leu and Phe24-Phe of insulin B chain.  Activates trypsinogen, and degrades keratin  "
3.4.23.25," Hydrolysis of proteins with broad specificity for peptide bonds.  Cleaves -Leu-Leu-/-Val-Tyr bond in a synthetic substrate. Does not act  on esters of Tyr or Arg (#1# Asp-32 and Tyr-75 residues involved in  catalysis <32>; #5# description of mechanism, two catalytically active  aspartic acid residues, Asp32 and Asp215 <28>)  "
3.4.23.26, Specificity similar to that of pepsin A. Cleaves Z-Lys-/-Ala-Ala-Ala  and activates trypsinogen  
3.4.23.28," Preference for hydrophobic residues at P1 and P1'. Action on the B  chain of insulin is generally similar to that of pepsin A, but it also  cleaves Leu6-/-Cys(SO3H), Glu21-/-Arg and Asn3-/-Gln, although not  Gln4-His  "
3.4.23.29," Milk clotting activity, broad specificity, but fails to cleave  Leu15-Tyr or Tyr16-Leu of insulin B chain (#1# catalytic mechanism,  transition state model, substrate binding structure and mechanism <6>)  "
3.4.23.3," more restricted specificity than pepsin A, but shows preferential  cleavage at Tyr-/- bonds. High activity on hemoglobin (#1,3# acid  endopeptidase <29>)  "
3.4.23.30," Similar to pepsin A, but narrower, cleaving only three bonds in the B  chain of insulin: Ala14-/-Leu, Tyr16-/-Leu, and Phe24-/-Phe  "
3.4.23.31," Hydrolysis of proteins with specificity similar to that of pepsin A,  but also cleaves Cys(SO3H)7-/-Gly and Leu17-/-Val in the B chain of  insulin  "
3.4.23.32," Hydrolysis of proteins with broad specificity, cleaving Phe24-/-Phe,  but not Leu15-Tyr and Phe25-Tyr in the B chain of insulin (#2# active  site structure and substrate binding structure and mechanism,  hydrolysis mechanism <12>; #2# catalytic residues are Glu53 and Asp98  <11>)  "
3.4.23.34," similar to cathepsin D, but slightly broader specificity  "
3.4.23.35, Selective cleavage of -Leu6-/-Lys- bond in the pheromone alpha-mating  factor  
3.4.23.36," Release of signal peptides from bacterial membrane prolipoproteins  including murein prolipoprotein. Hydrolyses  -Xaa-Yaa-Zaa-/-(S,diacylglyceryl)Cys-, in which Xaa is hydrophobic  (preferably Leu), and Yaa (Ala or Ser) and Zaa (Gly or Ala) have small,  neutral sidechains  "
3.4.23.38," hydrolysis of the -Phe33-/-Leu- bond in the alpha-chain of hemoglobin,  leading to denaturation of the molecule  "
3.4.23.39, Hydrolysis of the bonds linking certain hydrophobic residues in  hemoglobin or globin. Also cleaves the small molecule substrates such  as Ala-Leu-Glu-Arg-Thr-Phe!Phe(NO2)-Ser-Phe-Pro-Thr  
3.4.23.4, Broad specificity similar to that of pepsin A. Clots milk by cleavage  of a single Ser-Phe105-/-Met-Ala bond in kappa-chain of casein  
3.4.23.40," Prefers hydrophobic residues Phe, Val, Ile, Leu, and Ala at P1 and P1',  but also cleaves -Phe-/-Asp- and -Asp-/-Asp- bonds in 2S albumin from  plant seeds  "
3.4.23.41," hydrolyses various precursor proteins with Arg or Lys in P1, and  commonly Arg or Lys also in P2. The P3 amino acid is usually non-polar,  but otherwise additional basic amino acids are favourable in both  non-prime and prime positions (#1# cleavage is enhanced in substrates  having additional basic residues flanking the P1 site <1>; #1# cleaves  at mono-, di-, and multi-basic cleavage sites <3,5>)  "
3.4.23.42," similar in specificity to pepsin A preferring bulky hydrophobic amino  acids in P1 and P1' (#1# prefers large hydrophobic residues at both  sides of the scissile bond <1,5>)  "
3.4.23.43," typically cleaves a -Gly-/-Phe- bond to release an N-terminal, basic  peptide of 5-8 residues from type IV prepilin, and then N-methylates  the new N-terminal amino group, the methyl donor being  S-adenosyl-L-methionine (#3# Asp17 and Asp78 are the catalytic residues  <10>; #21# Asp80 and Asp23 are the catalytic residues <9>)  "
3.4.23.44," hydrolysis of an asparaginyl bond involved in the maturation of the  structural protein of the virus, typically -Asn-/-Ala- or -Asn-/-Phe-  "
3.4.23.45," broad endopeptidase specificity. Cleaves  Glu-Val-Asn-Leu-/-Asp-Ala-Glu-Phe in the Swedish variant of Alzheimer's  amyloid precursor protein (#2# active site structure, substrate binding  structure, tetrahedral transition state intermediate <12>; #2# cleavage  at the beta-site but more effectively at a different site within A-beta  <18>; #2# preferential cleavage of amyloid precursor protein downstream  of the alpha-site of A-beta (after Phe19, theta-site), resulting  N-terminal sequence of product is FAEDVGSN <19>; #2# preferential  cleavage of the amyloid precursor protein between Phe690 and Phe691 or  Phe691 and Ala692 <16>; #2# preferential cleavage within the A-beta  region at Phe19 or Phe20 <17>)  "
3.4.23.46," broad endopeptidase specificity. Cleaves  Glu-Val-Asn-Leu-/-Asp-Ala-Glu-Phe in the Swedish variant of Alzheimer's  amyloid precursor protein (#2,3# mechanism for enzyme regulation <12>;  #3# suggested to be the major ""beta-secretase"" responsible for the  cleavage of the beta-amyloid precursor protein to form the  amyloidogenic beta-peptide that is implicated in the pathology of  Alzheimers disease <8>; #3# memapsin 1 and 2 have overlapping yet  distinct sequence preference <8>; #3# enzyme is an aspartic protease  but is atypical in containing a C-terminal membrane-spanning domain <7>)  "
3.4.23.47," Endopeptidase for which the P1 residue is preferably hydrophobic (#1#  substrate binding pocket structure and reaction mechanism, the enzyme  prefers the cleavage site sequence VSQNY*PIVQ with Glu being preferred  at the P2 site <14>)  "
3.4.23.48," Converts human Glu-plasminogen to plasmin by cleaving the Arg560-/-Val  peptide bond that is also hydrolysed by the mammalian u-plasminogen  activator and t-plasminogen activator. Also cleaves arginyl bonds in  other proteins (#6# distribution of residues within the active site  cleft strongly suggests that the arginine side chain of the substrate  will bind in a deep, negatively charged pocket formed by Pla residues  E29, D204, D206, and E217. The two valine residues C-terminal to the  scissile bond will likely bind in the shallow, hydrophobic pocket  located on the other side of the plane formed by the active site  residues D84, H208, and the nucleophilic water molecule <23>)  "
3.4.23.49," Has a virtual requirement for Arg in the P1 position and a slightly  less stringent preference for this residue in the P1' position, which  can also contain Lys, Gly or Val. (#2# active site structure, catalytic  residues are Asp210 an His212, molecular dynamic simulations reveal  substrate binding structure and structural requirements for the  catalytic mechanism <15>; #2# the consensus sequence of OmpT is R/K-A,  the enzyme is highly selective for a basic amino acid residue at  position P1, but less exclusive at P1, where several non-basic amino  acids are tolerated, enzyme residue Asp97 is responsible for  interaction with P1 position substrate residue <14>; #8# the enzyme  contains a Ser-Asp-His catalytic triad, active site, the consensus  sequence of OmpT is R/K*-R/K, the enzyme is highly selective for a  basic amino acid residue at position P1, but less exclusive at P1,  where several amino acids are tolerated e,g, Lys, Val, and Gly, at P2  common residues are Ala or Val, at P3 and P4 the enzyme prefers Trp or  Arg <18>; #2# the enzyme contains a Ser-Asp-His catalytic triad, active  site, the consensus sequence of OmpT is R/K-R/K-A, the enzyme is highly  selective for a basic amino acid residue at position P1, but less  exclusive at P1, where several amino acids are tolerated, OmpP shows  similar specificity, minor sequence variations in the surface loops  near the catalytic residue have profound effects on the target  specificity of the enzyme <17>; #3,4,9# the enzyme contains a  Ser-Asp-His catalytic triad, active site, the enzyme prefers a basic  amino acid residue at position P1, but is less exclusive at P1, where  several amino acids are tolerated, minor sequence variations in the  surface loops near the catalytic residue have profound effects on the  target specificity of the enzyme <17>; #10# the enzyme contains a  Ser-Asp-His catalytic triad, active site, the nezyme prefers a basic  amino acid residue at position P1, but is less exclusive at P1, where  several amino acids are tolerated, minor sequence variations in the  surface loops near the catalytic residue have profound effects on the  target specificity of the enzyme <17>)  "
3.4.23.5," Specificity similar to, but narrower than, that of pepsin A. Does not  cleave the Gln4-His bond in B chain of insulin  "
3.4.23.50," Processing at the authentic HIV-1 PR recognition site and release of  the mature p17 matrix and the p24 capsid protein, as a result of the  cleavage of the -SQNY-/-PIVQ- cleavage site. (#1# the enzyme contains  the aspartic protease triad Asp-Thr-Gly in the catalytic site <6>)  "
3.4.23.51, This enzyme specifically removes a 32-amino acid peptide from the  C-terminus of the precursor of the large subunit of hydrogenase 3 in  Escherichia coli by cleavage at the C-terminal side of Arg537.  
3.4.23.52," Cleaves the signal peptide of 3 to 12 amino acids from the N-terminal  of preflagellin, usually at Arg-Gly-/- or Lys-Gly-/-, to release  flagellin.  "
3.4.24.1," Cleavage of Asn3-/-Gln, His5-/-Leu, His10-/-Leu, Ala14-/-Leu and  Tyr16-/-Leu in insulin B chain; removes C-terminal Leu from small  peptides  "
3.4.24.11," preferential cleavage of polypeptides between hydrophobic residues,  particularly with Phe or Tyr at P1'  "
3.4.24.12, Hydrolysis of proteins of the fertilization envelope and dimethylcasein  
3.4.24.13, Cleavage of Pro-/-Thr bond in the hinge region of the heavy chain of  human IgA (#1# localization of the cleavage site specificity  determinant <4>)  
3.4.24.14, Cleaves the N-propeptide of collagen chain alpha1(I) at Pro-/-Gln and  of alpha1(II) and alpha2(I) at Ala-/-Gln  
3.4.24.15," Preferential cleavage of bonds with hydrophobic residues at P1, P2 and  P3' and a small residue at P1' in substrates of 5-15 residues  "
3.4.24.16, Preferential cleavage in neurotensin: Pro10-/-Tyr  
3.4.24.17," preferential cleavage where P1', P2' and P3' are hydrophobic residues  "
3.4.24.18, Hydrolysis of protein and peptide substrates preferentially on carboxyl  side of hydrophobic residues  
3.4.24.19, cleavage of the C-terminal propeptide at Ala-/-Asp in type I and II  procollagens and at Arg-/-Asp in type III  
3.4.24.20, Preferential cleavage in proteins: -Xaa-/-Lys- (in which Xaa may be Pro)  
3.4.24.21," Hydrolysis of peptide bonds in substrates containing five or more amino  acids, preferentially with Ala in P1', and Pro in P2' (#20# proposed  reaction mechanism for astacin <31>)  "
3.4.24.22," Similar to stromelysin 1, but action on collagen types III, IV and V is  weak  "
3.4.24.23," Cleavage of Ala14-/-Leu and Tyr16-/-Leu in B chain of insulin. No  action on collagen types I, II, IV, V. Cleaves gelatin chain alpha2(I)  > alpha1(I)  "
3.4.24.24," Cleavage of gelatin type I and collagen types IV, V, VII, X. Cleaves  the collagen-like sequence Pro-Gln-Gly-/-Ile-Ala-Gly-Gln  "
3.4.24.25," Preferential cleavage of bonds with bulky hydrophobic groups in P2 and  P1'. Phe at P1' is the most favoured residue, which distinguished this  enzyme from thermolysin  "
3.4.24.26," Hydrolysis of proteins including elastin, collagen types III and IV,  fibronectin and immunoglobulin A, generally with bulky hydrophobic  group at P1'. Insulin B chain cleavage pattern identical to that of  thermolysin, but specificity differs in other respects  "
3.4.24.27," preferential cleavage: -/-Leu > -/-Phe (#6# classical molecular  dynamics simulation., and ab initio quantum mechanics/molecular  mechanics, QM/MM, investigation of the Glu143-assisted water addition  mechanism in thermolysin peptide hydrolysis. The mechanism consists of  three distinct steps: (i) a Zn-bound water molecule is deprotonated by  Glu143 and attacks the carbonyl bond of the substrate; (ii) Glu143  transfers the proton to the amide nitrogen atom; (iii) the nitrogen  atom is protonated and the peptide bond is irreversibly broken.  Transition state stabilization for nucleophilic attack is achieved by  formation of a weak coordination bond between the substrate carbonyl  oxygen atom and the Zn ion and of three strong hydrogen bonds between  the substrate and protonated His231 and two solvent molecules, overview  <73>; #6# substrate turnover is associated with hinge bending that  leads to a closed conformation. Product release regenerates the open  form, such that steady-state catalysis involves a continuous  closing/opening cycle. Elements in the periphery of the two lobes are  most mobile. These peripheral regions undergo quite pronounced  structural changes during the catalytic cycle. In contrast, active site  residues exhibit only a moderate degree of backbone flexibility, and  the central zinc appears to be in a fairly rigid environment. The  hydrogen/deuterium exchange behavior of catalytically active  thermolysin is indistinguishable from that of the free enzyme <80>)  "
3.4.24.28," similar, but not identical, to that of thermolysin  "
3.4.24.29," Cleavage of insulin B chain with specificity similar to that of  thermolysin, preferring hydrophobic P1' residue. Activates the glutamyl  endopeptidase (EC 3.4.21.19) of Staphylococcus aureus  "
3.4.24.3," Digestion of native collagen in the triple helical region at -/-Gly  bonds. With synthetic peptides, a preference is shown for Gly at P3 and  P1', Pro and Ala at P2 and P2', and hydroxyproline, Ala or Arg at P3'  "
3.4.24.30," Preferential cleavage: -/-Leu, -/-Phe, -/-Tyr, -/-Ala  "
3.4.24.31, Preferential cleavage of bonds with hydrophobic residues in P1'  
3.4.24.32," Cleavage of N-acetylmuramoyl-/-Ala, and of the insulin B chain at  Gly23-/-Phe > Val18-/-Cya  "
3.4.24.33," Cleavage of Xaa-/-Asp, Xaa-/-Glu and Xaa-/-cysteic acid bonds  "
3.4.24.34," Cleavage of interstitial collagens in the triple helical domain. Unlike  EC 3.4.24.7, interstitial collagenase, this enzyme cleaves type III  collagen more slowly than type I  "
3.4.24.35, Cleavage of gelatin types I and V and collagen types IV and V  
3.4.24.36, Preference for hydrophobic residues at P1 and P1' and basic residues at  P2' and P3'. A model nonapeptide is cleaved at -Ala-Tyr-/-Leu-Lys-Lys-  
3.4.24.37, Cleavage of Pro-/-Phe and Ala-/-Ala bonds  
3.4.24.38," Cleavage of the proline- and hydroxyproline-rich proteins of the  Chlamydomonas cell wall; also cleaves azocasein, gelatin and  Leu-Trp-Met-/-Arg-Phe-Ala  "
3.4.24.39, Preferential cleavage of bonds with hydrophobic residues in P1'; also  Asn3-/-Gln and Gly8-/-Ser bonds in insulin B chain  
3.4.24.40, Preferential cleavage of bonds with hydrophobic residues in P1'  
3.4.24.41," Cleavage of His5-/-Leu, His10-/-Leu, Ala14-/-Leu, Tyr16-/-Leu and  Gly23-/-Phe of insulin B chain; identical to the cleavage of insulin B  chain by atrolysin C. Also cleaves -/-Ser bonds in glucagon  "
3.4.24.42," Cleavage of His5-/-Leu, His10-/-Leu, Ala14-/-Leu, Tyr16-/-Leu and  Gly23-/-Phe bonds in B chain of insulin. With small molecule substrates  prefers hydrophobic residue at P2' and small residue such as Ala, Gly  at P1  "
3.4.24.43," Cleavage of His5-/-Leu, Ser9-/-His, His10-/-Leu, Ala14-/-Leu and  Tyr16-/-Leu of insulin B chain  "
3.4.24.44," Cleavage of Asn3-/-Gln, Ser9-/-His and Ala14-/-Leu bonds in insulin B  chain and Tyr14-/-Gln and Thr8-/-Ser in A chain. Cleaves type IV  collagen at Ala73-/-Gln in alpha1(IV) and at Gly7-/-Leu in alpha2(IV)  "
3.4.24.45," Cleavage of Val2-/-Asn, Gln4-/-His, Leu6-/-Cys, His10-/-Leu,  Ala14-/-Leu and Tyr16-/-Leu bonds in insulin B chain  "
3.4.24.46," Cleavage of Phe1-/-Val, His5-/-Leu, His10-/-Leu, Ala14-/-Leu,  Leu15-/-Tyr, and Tyr16-/-Leu of insulin B chain  "
3.4.24.47," Cleavage of only the single bond Ala14-/-Leu in the insulin B chain,  Ser12-/-Leu in the A chain, and Ile-/-Gly, Pro-/-Ala, and Ser-/-Trp in  melittin  "
3.4.24.48," Cleavage of His10-/-Leu, Ala14-/-Leu, Tyr16-/-Leu and Gly23-/-Phe bonds  in the B chain of insulin; His-/-Pro, Pro-/-Phe, and Trp-/-Ser of  angiotensin I; and Gly-/-Phe of Met enkephalin  "
3.4.24.49," Cleavage of His5-/-Leu, His10-/-Leu, Ala14-/-Leu, Tyr16-/-Leu and  Phe24-/-Phe in insulin B chain  "
3.4.24.50," Cleavage of Gln4-/-His, Ser9-/-His and Ala14-/-Leu of insulin B chain  and Pro-/-Phe of angiotensin I  "
3.4.24.51," Cleavage of Asn3-/-Gln, Gln4-/-His, His10-/-Leu, Ala14-/-Leu, and  Tyr16-/-Leu in insulin B chain  "
3.4.24.52, Cleavage of only two bonds His10-/-Leu and Ala14-/-Leu in the insulin B  chain  
3.4.24.53," Cleavage of Asn3-/-Gln, His10-/-Leu and Ala14-/-Leu in the insulin B  chain, and the bond Z-Gly-Pro-/-Leu-Gly-Pro in a small molecule  substrate of microbial collagenase  "
3.4.24.54," Cleavage of Ser9-/-His, His10-/-Leu, Ala14-/-Leu, Leu15-/-Tyr and  Tyr16-/-Leu bonds in insulin B chain  "
3.4.24.55, Preferential cleavage of -Tyr16-/- Leu- and -Phe25-/- Tyr-bonds of  oxidized insulin B chain. Also acts on other substrates of less than 7  kDa such as insulin and glucagon  
3.4.24.56," Degradation of insulin, glucagon and other polypeptides. No action on  proteins (#15# Glu111 serves as a base to activate a catalytic water  molecule within the active site of the enzyme, mediating peptide  hydrolysis, mutation of this residue to glutamine renders IDE inactive,  the catalytic water that is coordinated by a zinc ion also interacts  with a glutamate residue, which serves as the general acid/base  catalyst, catalytic mechanism <61>; #5# ability of substrates to  properly anchor their N-terminus to the exosite of IDE and undergo a  conformational switch upon binding to the catalytic chamber of IDE can  also contribute to the selective degradation of structurally related  growth factors. The high dipole moment of substrates complements the  charge distribution of the IDE catalytic chamber for the substrate  selectivity <93>; #5# molecular basis of catalytic chamber-assisted  unfolding and cleavage of human insulin by human insulin-degrading  enzyme, IDE utilizes the interaction of its exosite with the N-terminus  of the insulin A chain, overview. The unique size, shape, charge  distribution, and exosite of the IDE catalytic chamber contribute to  its high affinity for insulin <91>; #5# reaction mechanism, active-site  model, detailed overview <90>)  "
3.4.24.57," Hydrolysis of O-sialoglycoproteins; cleaves -Arg31-/-Asp- bond in  glycophorin A. Does not cleave unglycosylated proteins, desialylated  glycoproteins or glycoproteins that are only N-glycosylated  "
3.4.24.58," Specifically activates several components of the blood clotting system,  including coagulation factor X, coagulation factor IX and protein C by  cleavage of -Arg-/- bonds. Has no action on insulin B chain  "
3.4.24.59, release of an N-terminal octapeptide as second stage of processing of  some proteins imported into the mitochondrion  
3.4.24.6," Cleavage of Phe1-/-Val, His5-/-Leu, Ala14-/-Leu, Gly20-/-Glu,  Gly23-/-Phe and Phe24-/-Phe bonds in insulin B chain as well as  N-blocked dipeptides  "
3.4.24.60," Hydrolysis of peptides of at least six residues, with bulky hydrophobic  residues in the P1' position. Shows a preference for hydrophobic  doublets such as -Phe-/-Phe- and -Phe-/-Leu- in  somatostatin-(1-14)-peptide and dynorphin A-(1-6)-peptide, respectively  "
3.4.24.61," hydrolysis of polypeptides, preferably at -Xaa-/-Arg-Lys-, and less  commonly at -Arg-/-Arg-Xaa-, in which Xaa is not Arg or Lys  "
3.4.24.62," Hydrolysis of polypeptides with Arg or Lys in P1 and P2, e.g. to  hydrolyse pro-oxytocin at -Lys-Arg-/-Ala-Val-. The specificity further  depends on the organization of a beta-turn-alpha-helix of nine or more  residues containing the paired basic amino acids near the centre  "
3.4.24.63," Hydrolysis of proteins, including azocasein, and peptides. Hydrolysis  of -His5-/-Leu-, -Leu6-/-Cys-, -Ala14-/-Leu- and -Cys19-/-Gly- bonds in  insulin B chain  "
3.4.24.64," Release of N-terminal targetting peptides from precursor proteins  imported into the mitochondrion, typically with Arg in position P2  (#4,9# mechanism <16,19>; #4# limited proteolysis: cleaves precursors  of mitochondrial proteins to their mature form, not further <5>; #4#  cleaves amino-terminal matrix-targeting sequences from imported  mitochondrial precursor proteins <9>; #7,9# structure-function  relationship <14,19>; #4# the amino acid residues on the C-terminal  side of the cleavage site in the preprotein are orientated tail out  from the large cavity of MPP and interact with the glycine-rich loop of  the alpha-MPP subunit. Thus, MPP orientates preproteins at the specific  cleft between the catalytic domain and the flexible glycine-rich loop,  which seems to pinch the extended polypeptide, catalytic mechanism,  overview <44>)  "
3.4.24.65, Hydrolysis of soluble and insoluble elastin. Specific cleavages are  also produced at -Ala14-/-Leu- and -Tyr16-/-Leu- in the B chain of  insulin  
3.4.24.66, Hydrolysis of the inner layer of fish egg envelope. Also hydrolysis of  casein and small molecule substrates such as  succinyl-Leu-Leu-Val-Tyr-/-7-(4-methyl)coumarylamide  
3.4.24.67, Hydrolysis of the inner layer of fish egg envelope. Also hydrolysis of  casein and small molecule substrates such as  succinyl-Leu-Leu-Val-Tyr-/-7-(4-methyl)coumarylamide  
3.4.24.68," Hydrolysis of -Gln76-/-Phe- bond in synaptobrevin (also known as  neuronal vesicle-associated membrane protein, VAMP) (#1# structure and  mechanism <2,5,6>)  "
3.4.24.69," Limited hydrolysis of proteins of the neuroexocytosis apparatus,  synaptobrevin (also known as neuronal vesicle-associated membrane  protein, VAMP), synaptosome-associated protein of 25 kDa (SNAP25) or  syntaxin. No detected action on small molecule substrates (#4#  mechanism <2>; #17# reaction mechanism <52>; #1,4,5# structure/function  relationship <3>; #4# active site structure and structure-function  relationship <56>; #17# enzyme-substrate interaction at the active  site, Tyr366 and Arg363 are important for catalysis, the S1 site is  formed by Phe194, Thr215, Thr220, Asp370, and Arg363, reaction  mechanism, overview <61>; #1,5# mechanism of action of botulinum  neurotoxin <136>; #4# mechanism of action of botulinum neurotoxin,  botulinum toxin binds to a receptor on the neuronal surface, e.g. SV2  receptor for BoNT/A, or synaptotagmin I and II for BoNT/B and BoNT/G,  and is subsequently internalized through endocytosis, schematic  overview <136>)  "
3.4.24.7," Cleavage of the triple helix of collagen at about three-quarters of the  length of the molecule from the N-terminus, at Gly775-/-Ile in the  alpha1(I) chain. Cleaves synthetic substrates and alpha-macroglobulins  at bonds where P1' is a hydrophobic residue  "
3.4.24.70," hydrolysis of oligopeptides, with broad specificity. Gly or Ala  commonly occur as P1 or P1' residues, but more distant residues are  also important, as is shown by the fact that  Z-Gly-Pro-Gly-/-Gly-Pro-Ala is cleaved, but not Z-(Gly)5 (#3# the  Tyr607 residue is involved in the recognition of the substrate with a  key role in catalysis, it plays an important role in the  enzyme-substrate interaction and in the hydrolytic activity <10>)  "
3.4.24.71," Hydrolysis of the -Trp21-/-Val- bond in big endothelin to form  endothelin 1 (#2# ECE-1 promotes the recycling and re-sensitization of  NK1 receptors, by degrading endocytosed substance P in endothelial cell  endosomes. ECE-1 promotes CGRP and somatostatin receptor recycling  <40>; #2# ECE-1 regulates re-sensitization of substance P signalling in  HMEC-1-NK1 receptor cells <41>)  "
3.4.24.72, Hydrolysis of -Ala14-/-Leu- in insulin B chain and -Lys413-/-Leu- in  Aalpha-chain of fibrinogen  
3.4.24.73," Hydrolysis of -His10-/-Leu-, -Ala14-/-Leu-, -Tyr16-/-Leu-and  -Phe24-/-Phe- bonds in insulin B chain (#1# degradation of alpha- and  beta-chains of fibrin and fibrinogen with very little degradation of  the gamma-chains <17>)  "
3.4.24.74," Broad proteolytic specificity, bonds hydrolysed including -Gly-/-Leu-,  -Met-/-Leu-, -Phe-/-Leu-, -Cys-/-Leu-, Leu-/-Gly  "
3.4.24.75," Hydrolysis of the -Gly-/-Gly- bond in the pentaglycine inter-peptide  link joining staphylococcal cell wall peptidoglycans (#7# a two-stage  reaction controlled by two ionogenic groups of the active site, the  active site of lysostaphin contains glutamic acid and lysine <31>)  "
3.4.24.76, Hydrolyses polypeptides on the amino-side of Asp in -Xaa-/-Asp-. Acts  very slowly on -Xaa-/-Glu  
3.4.24.77," hydrolyses proteins with a preference for Tyr or Phe in the P1'  position. Has no action on amino-acid p-nitroanilides (#7# the enzyme  prefers Phe and Tyr at the P1 position, a hydrophobic or basic residue  at the P2 position, and a basic or small residue at the P3 position <9>)  "
3.4.24.78," Endopeptidase action with P4 Glu or Asp, P1 preferably Glu &gt; Asp,  P1' hydrophobic and P2' Ala  "
3.4.24.79," Cleavage of the Met135-/-Lys bond in insulin-like growth factor binding  protein (IGFBP)-4, and the Ser143-/-Lys bond in IGFBP-5 (#3# mechanism  <5,7,8>; #14# a 400-kDa disulfide-linked dimer that circulates in human  pregnancy mainly as a complex with the proform of eosinophil major  basic protein, which acts as an inhibitor of the peptidase <2>; #3# the  mechanism of IGF-modulated proteolysis of IGFBP-4 and -5 involves  changes in both the recognition of substrate and the turnover rate <18>)  "
3.4.24.80," endopeptidase activity. Activates progelatinase A by cleavage of the  propeptide at Asn37-/-Leu. Other bonds hydrolysed include Gly35-/-Ile  in the propeptide of collagenase 3, and Asn341-/-Phe, Asp441-/-Leu and  Gln354-/-Thr in the aggrecan interglobular domain  "
3.4.24.81, endopeptidase of broad specificity  
3.4.24.82, Glutamyl endopeptidase; bonds cleaved include  -Thr-Glu-Gly-Glu373-/-Ala-Arg-Gly-Ser- in the interglobular domain of  mammalian aggrecan  
3.4.24.83," Preferred amino acids around the cleavage site can be denoted  BBBBxHx-/-H, in which B denotes Arg or Lys, H denotes a hydrophobic  amino acid, and x is any amino acid. The only known protein substrates  are mitogen-activated protein (MAP) kinase kinases (#2# mechanism  <4,5>; #2# From the bacterium Bacilus anthracis that causes anthrax.  One of three proteins that are collectively termed anthrax toxin.  Cleaves several MAP kinase kinases near their N-termini, preventing  them from phosphorylating the downstream mitogen-activated protein  kinases <2>; #2# pre-steady-state kinetics of anthrax lethal factor  proteolysis follows a four-step mechanism as follows: initial substrate  binding, rearrangement of the enzyme-substrate complex, a rate-limiting  cleavage step, and product release <60>)  "
3.4.24.84," The peptide bond hydrolysed can be designated -C-/-aaX in which C is an  S-isoprenylated cysteine residue, a is usually aliphatic and X is the  C-terminal residue of the substrate protein, and may be any of several  amino acids  "
3.4.24.85, Cleaves several transcription factors that are type-2 transmembrane  proteins within membrane-spanning domains. Known substrates include  sterol regulatory element-binding protein (S
3.4.24.85,"BP) -1, S"
3.4.24.85,BP-2 and forms  of the transcriptional activator ATF6. S
3.4.24.85,"BP-2 is cleaved at the site  DRSR_ILL_483-/-CVLTFLCLSFNPLTSLLQWGGA, in which the membrane-spanning  segment is underlined. The residues NP (bold), 11 residues distal to  the site of cleavage in the membrane-spanning domain, are important for  cleavage by S2P endopeptidase. Replacement of either of these residues  does not prevent cleavage, but there is no cleavage if both of these  residues are replaced.  "
3.4.24.86," Narrow endopeptidase specificity. Cleaves  Pro-Leu-Ala-Gln-Ala-/-Val-Arg-Ser-Ser-Ser in the membrane-bound, 26-kDa  form of tumor necrosis factor alpha (TNFalpha). Similarly cleaves other  membrane-anchored, cell-surface proteins to ""shed"" the extracellular  domains  "
3.4.24.87," The enzyme cleaves the von Willebrand factor at bond Tyr842-/-Met843  within the A2 domain (#3# active site sequence HEIGHSFGLEHE 150 amino  acid residues from the N-terminus of the protein <8>; #9# active site  sequence HEXXHXXGXXHD <10>; #3# enzyme is a hemostatic factor <5>; #3#  the cysteine-rich/spacer domains are essential for the proteolytic  activity <4>; #3# the spacer region is essential, while the C-terminal  thrombospondin type 1 motif and the CUB domain are dispensable in vitro  <11>)  "
3.4.24.89, The enzyme catalyses the hydrolytic cleavage of peptide bonds between  two proline residues (#1# preference for cleaving Pro-Pro bonds <1>)  
3.4.25.1," cleavage of peptide bonds with very broad specificity (#16# mechanism  <27,29,37>; #29# chymotrypsin-like activity and peptidylglutamyl  peptide hydrolase activity <3>; #5,8# ATPase activity <37>; #11#  Staphylococcus aureus V8 protease like activity <9>; #33#  peptidylglutamyl peptide hydrolase, chymotrypsin-like and trypsin-like  activities <24>; #23# chymotrypsin-like activity <20>; #36#  chymotrypsin-like, trypsin-like and V8 protease like activities <19>;  #30# trypsin-like, chymotrypsin-like activities, peptidylglutamyl  peptide hydrolase and branched-chain amino acid preferring and  caseinolytic activities <6>; #11# ATPase activity, chymotrypsin-like  activity, trypsin-like activity <8>)  "
3.4.25.2," ATP-dependent cleavage of peptide bonds with broad specificity. (#4#  model for a proteolytic cycle by HslVU protease, overview <48>)  "
3.5.1.1," L-asparagine + H2O = L-aspartate + NH3 (#17# active site structure  involving Thr193, autocatalytic activation mechanism involving Thr193  <54>; #80# active site structure with a flexible loop that is  stabilized by a beta-hairpin formation and intracellular interaction  with the alpha-helical region, modelling <43>; #61# kinetic model,  substrate specificity, and catalytic mechanism, active site residues  are Asp115 and Glu82, the structural transition of the enzyme is  rate-limiting in the reaction, entropy changes are the main  determinants for the substrate specificity <51>)  "
3.5.1.10," 10-formyltetrahydrofolate + H2O = formate + tetrahydrofolate (#1#  mechanism <4>; #1# dehydrogenase reaction requires full length enzyme,  hydrolase reaction occurs in amino-terminal domain of enzyme <3>)  "
3.5.1.100, (R)-piperazine-2-carboxamide + H2O = (R)-piperazine-2-carboxylate + NH3 
3.5.1.100, beta-alaninamide + H2O = beta-alanine + NH3  
3.5.1.101, (S)-piperidine-2-carboxamide + H2O = (S)-piperidine-2-carboxylate + NH3 
3.5.1.101, L-prolinamide + H2O = L-proline + NH3  
3.5.1.102," 2-amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one +  H2O = 2,5-diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one +  formate  "
3.5.1.103," 1-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + H2O  = 1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol +  acetate (#3# proposed catalytic mechanism: the substrate binds to MshB  so that the carbonyl oxygen of the acetyl group replaces the second  water molecule on the Zn2+ ion. This leaves the first water molecule in  an ideal position for general base-assisted nucleophilic attack of the  carbonyl carbon of the acetyl group. The general base is the  carboxylate of Asp-15. The tetrahedral transition state would then have  a negatively charged oxygen atom that is stabilized by the positively  charged Zn2+ and by the imidazolium side chain of His-144. Proton  transfer to the nitrogen of the leaving group (GlcN-Ins) would be via  the general acid function of the carboxyl group of Asp-15 <6>; #1#  general acid-base pair mechanism with the side chain of Asp-15  functioning as the general base catalyst and His-144 serving as the  general acid catalyst, whereas the side chain of Tyr-142 probably  assists in polarizing substrate/stabilizing the oxyanion intermediate.  Tyr-142 is a dynamic side chain that plays key roles in catalysis,  modulating substrate binding, chemistry, and product release <12>; #3#  proposed catalytic mechanism of MshB, overview. MshB uses a general  acid-base mechanism in which Asp15 and His144 act as the general base  and acid catalysts respectively, while Tyr142 plays a dynamic role that  includes stabilization of the oxyanion intermediate <15>)  "
3.5.1.104, peptidoglycan-N-acetyl-D-glucosamine + H2O =  peptidoglycan-D-glucosamine + acetate  
3.5.1.105," N,N'-diacetylchitobiose + H2O =  N-acetyl-beta-D-glucosaminyl-(1->4)-D-glucosamine + acetate  "
3.5.1.106, N-formylmaleamic acid + H2O = maleamate + formate  
3.5.1.107, maleamate + H2O = maleate + NH3 (#3# hydrolysis of maleamate is  proposed to proceed by a nucleophilic addition?elimination sequence  involving the thiolate side chain of Cys150 <2>)  
3.5.1.108, a UDP-3-O-[(3R)-3-hydroxyacyl]-N-acetyl-alpha-D-glucosamine + H2O = a  UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamine + acetate  
3.5.1.109, an N-acyl-sphingosylphosphorylcholine + H2O = a fatty acid +  sphingosylphosphorylcholine (#1# (1) <1>) 
3.5.1.109, a D-glucosyl-N-acylsphingosine + H2O = a fatty acid +  D-glucosyl-sphingosine (#1# (2) <1>)  
3.5.1.11," penicillin + H2O = a carboxylate + 6-aminopenicillanate (#4# F24 in  beta-subunit has a fixed position, whereas F146 of alpha-subunit acts  as a flexible lid on the binding site <72>; #2# structural model and  catalytic mechanism, and energetics of the reaction, acylation is the  rate-limiting step of hydrolysis. The collapse of the tetrahedral  intermediate proceeds via synchronous bond breaking and formation, and  the accumulation of charge on the amidic nitrogen due to the presence  of a substituent is disfavored <124>)  "
3.5.1.110, (Z)-3-ureidoacrylate + H2O = (Z)-3-aminoacrylate + CO2 + NH3 
3.5.1.110, (Z)-3-ureidoacrylate + H2O = (Z)-3-aminoacrylate + carbamate 
3.5.1.110, carbamate = CO2 + NH3 
3.5.1.110, (Z)-2-methylureidoacrylate + H2O = (Z)-2-methylaminoacrylate + CO2 + NH3 
3.5.1.110, (Z)-2-methylureidoacrylate + H2O = (Z)-2-methylaminoacrylate + carbamate  
3.5.1.111, 2-oxoglutaramate + H2O = 2-oxoglutarate + NH3  
3.5.1.112, 2'-N-acetylparomamine + H2O = paromamine + acetate  
3.5.1.113, 2'''-acetyl-6'''-deamino-6'''-hydroxyneomycin C + H2O =  6'''-deamino-6'''-hydroxyneomycin C + acetate  
3.5.1.114, an N-acyl-aromatic-L-amino acid + H2O = an aromatic-L-amino acid + a  carboxylate 
3.5.1.114, an N-acetyl-L-cysteine-S-conjugate + H2O = an L-cysteine-S-conjugate +  acetate  
3.5.1.115, a mycothiol S-conjugate + H2O = an N-acetyl L-cysteine-S-conjugate +  1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol  
3.5.1.116, (S)-ureidoglycolate + H2O = glyoxylate + 2 NH3 + CO2  
3.5.1.117," [N-(6-aminohexanoyl)]n + H2O = [N-(6-aminohexanoyl)]n-x +  [N-(6-aminohexanoyl)]x (#3# NylB active site with a tyrosine residue  Tyr170, cleavage mechanism of the Ald amide bond in acylation of NylB  is as a two-step reaction, various intermediate states, catalytic  mechanism, hybrid QM/MM dynamics in combination with free-energy  sampling simulations, detailed overview <10>; #3# the Tyr170 residue  points the NH group towards the proton-acceptor site of an artificial  amide bond, reaction mechanism, overview <12>)  "
3.5.1.118, gamma-L-glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide + H2O =  S-(hercyn-2-yl)-L-cysteine S-oxide + L-glutamate  
3.5.1.119, [prokaryotic ubiquitin-like protein]-L-glutamine + H2O = [prokaryotic  ubiquitin-like protein]-L-glutamate + NH3  
3.5.1.12, biotin amide + H2O = biotin + NH3 (#3# also acts on biotin esters <23>)  
3.5.1.121, N-terminal L-asparaginyl-[protein] + H2O = N-terminal  L-aspartyl-[protein] + NH3  
3.5.1.122," N-terminal L-glutaminyl-[protein] + H2O = N-terminal  L-glutamyl-[protein] + NH3 (#3# catalytic mechanism determination of  hNtaq1 based on the crystal structure of hNtaq1 and docking study. In  the first step, nucleophilic sulfhydryl group of Cys28 approaches Cd of  the amide group of the N-terminal glutamine and becomes deprotonated by  His81. The sulfhydryl group of Cys28 plays a crucial role in the  nucleophilic attack on acyl group in the N-terminal glutamine side  chain of substrates, which results in formation of a tetrahedral  intermediate. Asp97 facilitates the process by forming a hydrogen bond  and electrostatic interactions with His81. The ammonia is released upon  productive collapse of the tetrahedral intermediate and a water  molecule enters the active site cavity and attacks S-acyl intermediate  to convert glutamine to a glutamate. As the final step, the glutamate  side chain is cleaved from S-acyl of Cys28. His81 first acts as a  general base activation water for a nucleophilic attack on the S-acyl  intermediate, and then upon collapse of the tetrahedral intermediate  acts a general acid to protonate the leaving group, i.e. the thiolate  of Cys28. The substrate peptide with newly formed N-terminal glutamate  is released from the binding cleft at this stage and the enzyme is  ready for another round of catalysis <3>)  "
3.5.1.123, N5-phenyl-L-glutamine + H2O = L-glutamate + aniline  
3.5.1.124, an Nomega-(1-hydroxy-2-oxopropyl)-[protein]-L-arginine + H2O = a  [protein]-L-arginine + lactate 
3.5.1.124," an N6-(1-hydroxy-2-oxopropyl)-[protein]-L-lysine + H2O = a  [protein]-L-lysine + lactate (#4,5# reaction mechanism via spontaneous  aminocarbinol formation, H migration catalyzed by deglycase, and  amidolysis by deglycase. The mechnaism is similar for L-cysteine and  L-arginine deglycation <2>) "
3.5.1.124, an S-(1-hydroxy-2-oxopropyl)-[protein]-L-cysteine + H2O = a  [protein]-L-cysteine + (R)-lactate  
3.5.1.125," (2S)-2-acetamido-4-aminobutanoate + H2O = L-2,4-diaminobutanoate +  acetate  "
3.5.1.126, oxamate + H2O = oxalate + NH3  
3.5.1.127, a jasmonoyl-L-amino acid + H2O = jasmonate + an L-amino acid  
3.5.1.128, N-(4-oxoglutaryl)-L-cysteinylglycine + H2O = 2-oxoglutarate +  L-cysteinylglycine  
3.5.1.129, N5-(cytidine 5'-diphosphoramidyl)-L-glutamine + H2O = cytidine  5'-diphosphoramidate + L-glutamate  
3.5.1.13," an anilide + H2O = a carboxylate + aniline (#3# acetylcholinesterase,  EC 3.1.1.7, and butyrylcholinesterase, EC 3.1.1.8, also show aryl  acylamidase activity using the same active site for both reactions,  overview <32>; #1# mechanism of substrate specificity and reactivity  change of the enzyme, acetylcholinesterase, EC 3.1.1.7, and  butyrylcholinesterase, EC 3.1.1.8, are known to exhibit aryl  acylamidase activities, overview <34>)  "
3.5.1.130, [amino group carrier protein]-C-terminal-gamma-(L-lysyl)-L-glutamate +  H2O = [amino group carrier protein]-C-terminal-L-glutamate + L-lysine  
3.5.1.131," 1-carboxybiuret + H2O = urea-1,3-dicarboxylate + NH3  "
3.5.1.132, [amino group carrier protein]-C-terminal-gamma-(L-ornithyl)-L-glutamate  + H2O = [amino group carrier protein]-C-terminal-L-glutamate +  L-ornithine  
3.5.1.133, an Nalpha-acyl-L-glutamine + H2O = L-glutamine + a carboxylate  
3.5.1.134, (indol-3-yl)acetyl-L-aspartate + H2O = (indol-3-yl)acetate + L-aspartate  
3.5.1.135, N4-acetylcytidine + H2O = cytidine + acetate  
3.5.1.136," N,N'-diacetylchitobiose + H2O =  beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine + acetate  "
3.5.1.137, an N-methyl carbamate ester + H2O = an alcohol + methylamine + CO2  
3.5.1.14," an N-acyl-aliphatic-L-amino acid + H2O = an aliphatic L-amino acid + a  carboxylate (#4# active site structure, catalysis involves residues  H206, N263, R276, and D274, the dimerization domain residues play  important roles in binding and catalysis, overview <36>; #27# active  site structure, molecular modelling to determine Asp82 function in  catalysis, Asp82 ensures a proper protonation of the catalytic His  residue, overview <34>) "
3.5.1.14, an N-acetyl-L-cysteine-S-conjugate + H2O = an L-cysteine-S-conjugate +  acetate  
3.5.1.15," N-acyl-L-aspartate + H2O = a carboxylate + L-aspartate (#3# reaction  mechanism involving Glu178, molecular modeling <16>)  "
3.5.1.16, N2-acetyl-L-ornithine + H2O = acetate + L-ornithine  
3.5.1.17, N6-acyl-L-lysine + H2O = a carboxylate + L-lysine  
3.5.1.18," N-succinyl-LL-2,6-diaminoheptanedioate + H2O = succinate +  LL-2,6-diaminoheptanedioate (#11# structure-activity relationship and  catalytic mechanism of peptide bond cleavage by DapE enzymes, overview.  The catalytic domain is composed of residues 1-179 and 293-376 <10>;  #2# the catalytic reaction progresses via a general acid-base  hydrolysis mechanism where Glu134 first acts as a Lewis base by  activating the catalytic water molecule in the active site, followed by  guiding the resulting hydroxyl ion for a nucleophilic attack on the  substrate, and finally acts as a Lewis acid by donating a proton to the  substrate. Catalytic mechanism and intermediates and transition states,  hybrid QM/MM computational method analysis, overview. A conformational  change in the side chain of Asp100, which bridges the two Zn centers of  the enzyme, is observed which facilitates the enzymatic action by  lowering the activation energy and leads to the formation of a  different intermediate during the catalytic reaction. The nucleophilic  attack is the rate determining step <15>)  "
3.5.1.19," nicotinamide + H2O = nicotinate + NH3 (#30# the active site Cys159,  conserved and essential, is located at the N-terminus of a6 at one side  of the active site with the Zn2+ ion positioned on the other side. The  metal ion is bound tightly in the AbPncA active site. The reaction  proceeds in a four-stage mechanism via a tetrahedral and an acyl  intermediate, overview <35>; #15# catalytic mechanism in two stages:  (i) formation of a tetrahedral thioester enzyme-substrate intermediate  (with the sulfur of Cys136 nucleophilically attacks the nicotinamidase  substrates carbonyl carbon while concomitantly the Cys136-SH thiol  proton is transferred onto the substrates amide group nitrogen) and  (ii) hydrolysis of the thioester bond to give the products, overview.  The catalytic triad comprises Lys103, Asp9, and Cys136, substrate  binding and roles of active site residues of the enzyme from  Streptococcus pneumoniae. The active site Lys103 likely plays a role in  stabilizing the thiolate of Cys136 during the reaction <45>)  "
3.5.1.2," L-glutamine + H2O = L-glutamate + NH3 (#5# mechanism <16>; #14# active  site structure, the enzyme contains a catalytic dyad formed by S64 and  K67 <40>; #46# structure-function relationship and catalytic mechanism,  detailed overview <89>)  "
3.5.1.20, L-citrulline + H2O = L-ornithine + CO2 + NH3  
3.5.1.21, N-acetyl-beta-alanine + H2O = acetate + beta-alanine  
3.5.1.22, (R)-pantothenate + H2O = (R)-pantoate + beta-alanine  
3.5.1.23," a ceramide + H2O = a carboxylate + sphingosine (#6# kinetic mechanism  <12>; #18# catalytic mechanism <23>; #21# the enzyme has a catalytic  residue Ser354 within a very highly conserved hexapeptide sequence  GDVSPN in the middle of a larger conserved sequence, namely  NXGDVSPNXXGP/XXC, catalytic mechanism <23>;  #7,9,10,12,15,18,21,24,27,33,34,35,36,42# neutral CDase contains a zinc  ion in the active site that functions as a catalytic center, and the  hydrolysis of the N-acyl linkage in ceramide proceeds through a  mechanism that is similar to that described for zinc-dependent  carboxypeptidase, reaction mechanism, overview <82>)  "
3.5.1.24," glycocholate + H2O = cholate + glycine (#48# substrate binding pocket  and active site structure, taurine has a reversed orientation pointing  with its sulfo group towards Cys2 and leaving the active site with its  amino group ahead, overview <14>; #26# substrate specificity and active  site structure, residues Cys1, Arg17, Asp20, Asn174, and Arg227 are  important for catalysis, Trp21 plays a selective role in binding of  bile salt while it suppresses productive binding of substrate analogue  penicillin V <17>)  "
3.5.1.25," N-acetyl-D-glucosamine 6-phosphate + H2O = D-glucosamine 6-phosphate +  acetate (#2# mechanism <13>; #3# sequential mechanism with ordered  release of products and a slow isomerization of the enzyme-acetate  complex <9>; #14# active site structure at the bottom of the  alpha-domain cavity, catalytic mechanism <16>; #3# catalytic mechanism,  enzyme-substrate interaction analysis <14>)  "
3.5.1.26," N4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine + H2O =  N-acetyl-beta-D-glucosaminylamine + L-aspartate (#3,10# mechanism  <24,25>)  "
3.5.1.28, Hydrolyses the link between N-acetylmuramoyl residues and L-amino acid  residues in certain cell-wall glycopeptides (#16# catalytic mechanism  <33>)  
3.5.1.29, 2-(acetamidomethylene)succinate + 2 H2O = acetate + succinate  semialdehyde + NH3 + CO2  
3.5.1.3," a monoamide of a dicarboxylate + H2O = a dicarboxylate + NH3 (#7#  mechanism <9,10>; #7# kinetic evidence for an acyl-enzyme intermediate  <5>; #7# two-step mechanism <5>; #7# acyl-enzyme mechanism <5,6>; #7#  catalytic sequence involves two steps and an acyl-enzyme intermediate  <1,5>; #7# double displacement or ping-pong mechanism <5>)  "
3.5.1.30, 5-aminopentanamide + H2O = 5-aminopentanoate + NH3  
3.5.1.31, N-formyl-L-methionine + H2O = formate + L-methionine  
3.5.1.32," hippurate + H2O = benzoate + glycine (#29# residues Asp76, Aps104,  Glu134, Glu135, His161 and His356 are involved in zinc-binding and  enzyme catalysis <6>)  "
3.5.1.33, N-acetyl-D-glucosamine + H2O = D-glucosamine + acetate  
3.5.1.35, D-glutamine + H2O = D-glutamate + NH3  
3.5.1.36, N-methyl-2-oxoglutaramate + H2O = 2-oxoglutarate + methylamine  
3.5.1.38, L-glutamine + H2O = L-glutamate + NH3  
3.5.1.39, N-methylhexanamide + H2O = hexanoate + methylamine  
3.5.1.4," a monocarboxylic acid amide + H2O = a monocarboxylate + NH3 (#10#  hydrolysis of aliphatic amide <17>; #10# ping-pong mechanism,  substitution mechanism <17>; #22# hydrolysis of ester and aromatic  amide <16>; #21# stereospecific hydrolysis of 2-arylpropionamides <4>;  #37# catalytic role of an arginine dyad, the catalytic motif is  revealed in the model structure of amide hydrolyzing antibody 312D6,  the antibody induces catalysis by transition-state mimicry and  torsional activation, and accelerates the hydrolysis of amides by a  factor of 1000, overview <51>; #10# the enzyme contains a nitrilase  catalytic triad at the bottom of a 13-A deep, funnel-shaped pocket,  accessible from the solvent through a narrow neck with 3-A diameter  <59>; #61# amino acid residues Ser171, Ser195 and Lys96 are essential  for catalytic activity, molecular mechanism of substrate recognition,  overview <91>)  "
3.5.1.40, benzoylagmatine + H2O = benzoate + agmatine  
3.5.1.41," chitin + H2O = chitosan + acetate (#33,41# prefers nascent to preformed  chitin <1,13>; #32# multiple chain mechanism <10>; #48# ligand binding  to the enzyme, computational docking analysis, catalytic mechanism via  a tetrahedral oxyanion intermediate, and active site structure with a  conserved metal-binding triad consisting of His104, His108, and Asp50  <19>)  "
3.5.1.42," beta-nicotinamide D-ribonucleotide + H2O = beta-nicotinate  D-ribonucleotide + NH3 (#21# catalytic mechanism, overview <13>; #2#  proposed mechanism of nicotinamide D-ribonucleotide deamidation by the  enzyme via three reaction intermediates, which is a Ser/Lys hydrolase  employing a Ser/Lys catalytic dyad, active site structure, overview  <12>)  "
3.5.1.43, alpha-N-peptidyl-L-glutamine + H2O = alpha-N-peptidyl-L-glutamate + NH3  
3.5.1.44, protein L-glutamine + H2O = protein L-glutamate + NH3  
3.5.1.46," N-(6-aminohexanoyl)-6-aminohexanoate + H2O = 2 6-aminohexanoate (#2#  structure-function relationship <6>; #2# Ser112 is a nucleophilic  catalytic residue, Asp181 and Asn226 are also required <8>; #2#  structure-function relationship, residues 370 and 181 are imporatant  for enzyme activity <7>) "
3.5.1.46, [N-(6-aminohexanoyl)]n + H2O = [N-(6-aminohexanoyl)]n-1 +  6-aminohexanoate  
3.5.1.47," N-acetyl-LL-2,6-diaminoheptanedioate + H2O = acetate +  LL-2,6-diaminoheptanedioate  "
3.5.1.48, N8-acetylspermidine + H2O = acetate + spermidine  
3.5.1.49, formamide + H2O = formate + NH3  
3.5.1.5," urea + H2O = CO2 + 2 NH3 (#9# mechanism <30>; #29# active site contains  three ionazable groups with pKa-values of 5.3, 6.6 and 9.0 that  participate both in catalysis and substrate binding <53>)  "
3.5.1.50, pentanamide + H2O = pentanoate + NH3  
3.5.1.51, 4-acetamidobutanoyl-CoA + H2O = acetate + 4-aminobutanoyl-CoA  
3.5.1.52," Hydrolysis of an N4-(acetyl-beta-D-glucosaminyl)asparagine residue in  which the glucosamine residue may be further glycosylated, to yield a  (substituted) N-acetyl-beta-D-glucosaminylamine and a peptide  containing an aspartate residue (#22#  Asn-Asn(oligosaccharide)-Glu-Ser-Ser + H2O = Asn-Asp-Glu-Ser-Ser +  1-amino-N-acetylglucosamine-oligosaccharide, step 1, catalysed by the  enzyme, 1-amino-N-acetylglucosamine-oligosaccharide + H2O =  N-acetylglucosamine-oligosaccharide + NH3, step 2 <4>; #7# mechanism  and catalytic center <30>; #3# active site structure and catalytic  mechanism <37>; #7# the catalytic triad is formed by Cys191, His218,  and Asp235 <32,36>)  "
3.5.1.53, N-carbamoylputrescine + H2O = putrescine + CO2 + NH3  
3.5.1.54," urea-1-carboxylate + H2O = 2 CO2 + 2 NH3 (#10# the catalytic triad  consists of residues Ser177, Ser153, and Lys79 <7>; #12# two-step  reaction catalytic mechanism of the C-domain, overview. The C-domain  probably catalyzes a distinct form of decarboxylation reaction <13>)  "
3.5.1.55, N-long-chain-fatty-acyl-L-glutamate + H2O = a long-chain carboxylate +  L-glutamate  
3.5.1.56," N,N-dimethylformamide + H2O = dimethylamine + formate (#4# an enzyme of  high substrate specificity that catalyzes the first step in the  degradation of N,N-dimethylformamide <4>)  "
3.5.1.57, L-tryptophanamide + H2O = L-tryptophan + NH3  
3.5.1.58, N-benzyloxycarbonylglycine + H2O = benzyl alcohol + CO2 + glycine  
3.5.1.59, N-carbamoylsarcosine + H2O = sarcosine + CO2 + NH3 (#3# tentative  catalytic mechanism <5>)  
3.5.1.6," 3-ureidopropanoate + H2O = beta-alanine + CO2 + NH3 (#9# mechanism  <18>; #30# detailed reaction mechanism, catalytic mechanism <16>; #28#  the animal enzyme also acts on beta-ureidoisobutyrate <15>)  "
3.5.1.60, N-(long-chain-acyl)ethanolamine + H2O = a long-chain carboxylate +  ethanolamine  
3.5.1.61, (S)-2-amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate + H2O =  3-hydroxy-4H-pyrid-4-one + L-serine  
3.5.1.62, N-acetylputrescine + H2O = acetate + putrescine  
3.5.1.63, 4-acetamidobutanoate + H2O = acetate + 4-aminobutanoate  
3.5.1.64, Nalpha-benzyloxycarbonyl-L-leucine + H2O = benzyl alcohol + CO2 +  L-leucine  
3.5.1.65," N5-ethyl-L-glutamine + H2O = L-glutamate + ethylamine (#1,2,3#  stoichiometry of reaction <3>)  "
3.5.1.66, 2-(hydroxymethyl)-3-(acetamidomethylene)succinate + 2 H2O = acetate +  2-(hydroxymethyl)-4-oxobutanoate + NH3 + CO2  
3.5.1.67, 4-methylene-L-glutamine + H2O = 4-methylene-L-glutamate + NH3  
3.5.1.68," N-formyl-L-glutamate + H2O = formate + L-glutamate (#2# regulation,  induction and catabolite repression of formylglutamate amidohydrolase  <1,4>)  "
3.5.1.69," hydrolysis of gangliosides and neutral glycosphingolipids, releasing  fatty acids to form the lyso-derivatives (#4# in addition to its  primary deacylation function, this enzyme is able to reacylate  lyso-sphingolipids under specific conditions <5>)  "
3.5.1.7, N-carbamoyl-L-aspartate + H2O = L-aspartate + CO2 + NH3  
3.5.1.70," hydrolysis of the amide bond in aculeacin A and related neutral  lipopeptide antibiotics, releasing the long-chain fatty acid side-chain  "
3.5.1.71, N-feruloylglycine + H2O = ferulate + glycine (#1# thermodynamic data  <1>)  
3.5.1.72, N-benzoyl-D-arginine-4-nitroanilide + H2O = N-benzoyl-D-arginine +  4-nitroaniline  
3.5.1.73, L-carnitinamide + H2O = L-carnitine + NH3  
3.5.1.74, chenodeoxycholoyltaurine + H2O = chenodeoxycholate + taurine  
3.5.1.75, urethane + H2O = ethanol + CO2 + NH3 (#4# thermodynamic data <5>)  
3.5.1.76, N-Acetylarylalkylamine + H2O = arylalkylamine + acetate  
3.5.1.77, an N-carbamoyl-D-amino acid + H2O = a D-amino acid + NH3 + CO2  
3.5.1.78," glutathionylspermidine + H2O = glutathione + spermidine (#1# evidence  for a glutathionyl-enzyme intermediate in the amidase activity of the  bifunctional enzyme <4>; #1# glutathionylspermidine + H2O = glutathione  + spermidine, , nucleophilic attack mechanism involving Cys as the  catalytic nucleophile <4>)  "
3.5.1.79, A phthalylamide + H2O = phthalic acid + a substituted amine (#1#  mechanism <1>)  
3.5.1.8, N-formyl-L-aspartate + H2O = formate + L-aspartate  
3.5.1.81, N-acyl-D-amino acid + H2O = a carboxylate + D-amino acid  
3.5.1.82, N-acyl-D-glutamate + H2O = a carboxylate + D-glutamate  
3.5.1.83, N-acyl-D-aspartate + H2O = a carboxylate + D-aspartate  
3.5.1.84, biuret + H2O = urea-1-carboxylate + NH3  
3.5.1.85, N-acetylphenylethylamine + H2O = phenylethylamine + acetate (#1#  induction of (S)-N-acetyl-1-phenylethylamine hydrolase <1>)  
3.5.1.86, (R)-mandelamide + H2O = (R)-mandelate + NH3  
3.5.1.87," an N-carbamoyl-L-2-amino acid (a 2-ureido carboxylate) + H2O = an  L-2-amino acid + NH3 + CO2 (#2# recombinant BsLcar is able to hydrolyze  N-acetyl and N-formyl-amino acids in addition to N-carbamoyl-amino  acids, showing strict L-enantioselectivity for all the three.  Additionally, the enzyme shows the fastest amidohydrolase activity on  the N-formyl-amino acid followed by N-carbamoyl and N-acetyl ones <15>)  "
3.5.1.88, formyl-L-methionyl peptide + H2O = formate + methionyl peptide  
3.5.1.89, 6-(N-acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol + H2O  = 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol + acetate  (#8# a general acid-base pair catalytic mechanism that involves enzyme  residues Asp46 and His140 <16>)  
3.5.1.9," N-formyl-L-kynurenine + H2O = formate + L-kynurenine (#29# the  catalytic triad is formed by residues Ser162, Asp247, and His279 <24>;  #35,36,37# the presence of a bridging water/hydroxide ligand in  conjunction with the placement of an active site histidine supports a  distinctive amidation mechanism, proposed mechanism with intermediate  state, overview <29>; #33# via tetrahedral intermediate, enzyme  structure and catalytic mechanism, overview <28>)  "
3.5.1.90, adenosylcobinamide + H2O = adenosylcobyric acid + (R)-1-aminopropan-2-ol  
3.5.1.91," N-benzylformamide + H2O = formate + benzylamine (#1# the reverse  reaction of this enzyme proceeds via an ordered two-substrate,  two-product (bi-bi) mechanism in which formate binds first to the  enzyme active site, followed by benzylamine binding and the subsequent  release of N-benzylformamide, kinetic mechanism, overview <4>)  "
3.5.1.92, (R)-pantetheine + H2O = (R)-pantothenate + 2-aminoethanethiol  
3.5.1.93, (7R)-7-(4-carboxybutanamido)cephalosporanate + H2O =  (7R)-7-aminocephalosporanate + glutarate  
3.5.1.94, 4-(gamma-L-glutamylamino)butanoate + H2O = 4-aminobutanoate +  L-glutamate  
3.5.1.95, 3-oxo-3-ureidopropanoate + H2O = malonate + urea  
3.5.1.96, N-succinyl-L-glutamate + H2O = succinate + L-glutamate  
3.5.1.97, an N-acyl-L-homoserine lactone + H2O = L-homoserine lactone + a  carboxylate (#20# AHL-acylase is a quorum quenching enzyme and degrades  N-acylhomoserine lactones (AHLs) by removing the fatty acid side chain  from the homoserine lactone ring of AHLs. This blocks AHL accumulation  and pathogenic phenotypes in quorum sensing bacteria <8>)  
3.5.1.98, hydrolysis of an N6-acetyl-lysine residue of a histone to yield a  deacetylated histone  
3.5.1.99," oleamide + H2O = oleic acid + NH3 (#9# structure-function relationship  and catalytic mechanism, overview <39>) "
3.5.1.99," anandamide + H2O = arachidonic acid + ethanolamine (#9#  structure-function relationship and catalytic mechanism, overview <39>)  "
3.5.2.1, barbiturate + H2O = 3-oxo-3-ureidopropanoate  
3.5.2.10," creatinine + H2O = creatine (#8# mechanism <8,9>; #8# catalytic  mechanism: a first water molecule is a hydroxide ion that is bound as a  bridge between the two metal ions and attacks the carbonyl carbon of  the substrate. A second water molecule is bound to the carboxyl group  of Glu122 and functions as a proton donor in catalysis <12>)  "
3.5.2.11, (S)-2-aminohexano-6-lactam + H2O = L-lysine  
3.5.2.12," 1,8-diazacyclotetradecane-2,9-dione + H2O =  N-(6-aminohexanoyl)-6-aminohexanoate (#3# a Ser174-cis-Ser150-Lys72  triad constitutes the catalytic center, the backbone N in Ala171 and  Ala172 are involved in oxyanion stabilization, Cys316-S forms a  hydrogen bond with nitrogen N7 of 6-amino-hexanoate cyclic dimer at the  uncleaved amide bond in two equivalent amide bonds of 6-amino-hexanoate  cyclic dimer <11>)  "
3.5.2.13," 2,5-dioxopiperazine + H2O = glycylglycine  "
3.5.2.14, ATP + N-methylhydantoin + 2 H2O = ADP + phosphate + N-carbamoylsarcosine  
3.5.2.15, cyanuric acid + H2O = 1-carboxybiuret  
3.5.2.16, maleimide + H2O = maleamic acid  
3.5.2.17," 5-hydroxyisourate + H2O =  5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate  "
3.5.2.18," 6-oxo-1,4,5,6-tetrahydronicotinate + 2 H2O = 2-formylglutarate + NH3  "
3.5.2.19, streptothricin-F + H2O = streptothricin-F acid  
3.5.2.2," 5,6-dihydrouracil + H2O = 3-ureidopropanoate  "
3.5.2.20, isatin + H2O = isatinate  
3.5.2.3," (S)-dihydroorotate + H2O = N-carbamoyl-L-aspartate (#23# complex  formation of enzyme with aspartate transcarbamoylase drives reaction in  the biosynthetic direction <29>; #3# unique catalytic mechanism <27>;  #10# catalytic mechanism, overview <52>)  "
3.5.2.4, L-5-carboxymethylhydantoin + H2O = N-carbamoyl-L-aspartate  
3.5.2.5," (S)-allantoin + H2O = allantoate (#18# catalytic mechanism, overview  <40>)  "
3.5.2.6," a beta-lactam + H2O = a substituted beta-amino acid (#141# 2-step  mechanism: in the first step, the catalytic Ser64 attacks the carbonyl  carbon of the beta-lactam ring, forming an acyl intermediate, in the  second step, a deacylating water hydrolyzes the ester bond to  regenerate the enzyme and the reaction product, hydrolyzed antibiotic  <64>; #132# active site, Asp120 is important for catalysis, as well as  substrate and Zn2+ binding <74>; #161# Arg234 is involved in catalysis  <63>; #166# catalytic mechanism of enzyme class D, unique in comparison  with classes A and C, active site structure with elements S-X-X-K,  S-X-N, and K-T/S-G <75>; #5# enzyme-ligand interaction-structure,  computational analysis, residues K67, N152, Y150, and K315 are involved  in substrate binding, tetrahedral intermediate <68>; #160# Glu166 is  important for catalysis, mechanism <65>; #5# reaction and kinetic  mechanism <67>; #4# reaction mechanism, Lys70 is involved in catalysis,  active site structure <78>; #76# VIM-2 catalytic Cys221, located in the  Cys site, shows a high tendency to be strongly oxidized becoming a  cysteinesulfonic residue, active site structure, overview <183>; #196#  overall mechanism for beta-lactamase-inhibitor reaction, Quantum  mechanical/molecular mechanical calculations and Raman spectral  analysis, overview <274>; #127# overall mechanism for  beta-lactamase-inhibitor reaction, Quantum mechanical/molecular  mechanical calculations and Raman spectral analysis, overview. The  protonation of the zeta-nitrogen leads to a barrierless decarboxylation  of the lysine carbamate <274>)  "
3.5.2.7," (S)-3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate + H2O =  N-formimidoyl-L-glutamate + H+  "
3.5.2.9, ATP + 5-oxo-L-proline + 2 H2O = ADP + phosphate + L-glutamate  
3.5.3.1," L-arginine + H2O = L-ornithine + urea (#7# thermodynamic data <30>; #6#  also hydrolyses alpha-N-substituted L-arginines and canavanine <42>;  #7# Asn130 and Ser137 are involved in substrate binding and catalysis  <47>; #6# hydrolysis via a metall-activated hydroxide mechanism,  substrate binding structure <46>; #6# substrate binding structure <44>;  #53# H141 as general acid to protonate the leaving amino group of  L-ornithine during catalysis <83>; #7# H141 serves as an acid/base  catalyst, deprotonating the metal-bridging water molecule to generate  the metal-bridging hydroxide nucleophile, and by protonating the amino  group of the product to facilitate its departure <56>)  "
3.5.3.10," D-arginine + H2O = D-ornithine + urea (#9# enzyme is identical with  guanidinobutyrase, EC 3.5.3.7, substrate guanidino group binding  sequence <2>)  "
3.5.3.11, agmatine + H2O = putrescine + urea  
3.5.3.12," agmatine + H2O = N-carbamoylputrescine + NH3 (#15# the enzyme does not  show activity of EC 2.1.3.3, ornithine carbamoyltransferase, EC  2.1.3.6, putrescine carbamoyltransferase, and EC 2.7.2.2, carbamate  kinase, while putrescine synthase is a multifunctional enzyme, overview  <14>; #35# the plant enzyme also catalyzes the reactions of EC 2.1.3.3,  ornithine carbamoyltransferase, EC 2.1.3.6, putrescine  carbamoyltransferase, and EC 2.7.2.2, carbamate kinase, thus  functioning as a putrescine synthase, converting agmatine and ornithine  into putrescine and citrulline, respectively, Cys180 and Cys366 are  involved in catalysis but are not essential, residues are located in  the substrate binding pocket <13>; #13,23,25# like other GME hydrolases  the enzyme possesses a high pKa active site Cys, suggesting that the  enzyme employs a reverse protonation mechanism <28>)  "
3.5.3.13, N-formimidoyl-L-glutamate + H2O = N-formyl-L-glutamate + NH3  
3.5.3.14, N-amidino-L-aspartate + H2O = L-aspartate + urea  
3.5.3.15, protein L-arginine + H2O = protein L-citrulline + NH3  
3.5.3.16, methylguanidine + H2O = methylamine + urea  
3.5.3.17, 3-Guanidinopropanoate + H2O = beta-alanine + urea  
3.5.3.18," Nomega,Nomega'-dimethyl-L-arginine + H2O = dimethylamine + L-citrulline  "
3.5.3.2, guanidinoacetate + H2O = glycine + urea  
3.5.3.20," 1,4-diguanidinobutane + H2O = agmatine + urea  "
3.5.3.21, methylenediurea + 2 H2O = N-(hydroxymethyl)urea + 2 NH3 + CO2 
3.5.3.21, methylenediurea + H2O = N-(carboxyaminomethyl)urea + NH3 
3.5.3.21, N-(carboxyaminomethyl)urea = N-(aminomethyl)urea + CO2 
3.5.3.21, N-(aminomethyl)urea + H2O = N-(hydroxymethyl)urea + NH3  
3.5.3.22," amidinoproclavaminate + H2O = proclavaminate + urea (#1# mechanism <4>;  #1# forms part of the pathway for the biosynthesis of the  beta-lactamase inhibitor clavulanate in Streptomyces clavuligerus, it  carries out an intermediary reaction between the first reaction of EC  1.14.11.21, clavaminate synthase, and the second and third reactions of  that enzyme, overview <2>)  "
3.5.3.23," N2-succinyl-L-arginine + 2 H2O = N2-succinyl-L-ornithine + 2 NH3 + CO2  (#4# mechanism consists of two cycles of hydrolysis and ammonia  release, with each cycle utilizing a mechanism similar to that proposed  for arginine deiminases <4,5>)  "
3.5.3.24, N1-aminopropylagmatine + H2O = spermidine + urea  
3.5.3.25, Nomega-hydroxy-L-arginine + H2O = L-ornithine + hydroxyurea  
3.5.3.26, (S)-2-ureidoglycine + H2O = (S)-ureidoglycolate + NH3  
3.5.3.3, creatine + H2O = sarcosine + urea (#2# mechanism <11>)  
3.5.3.4, allantoate + H2O = (S)-ureidoglycolate + urea (#1# thermodynamic data  <14>)  
3.5.3.5, N-formimidoyl-L-aspartate + H2O = N-formyl-L-aspartate + NH3  
3.5.3.6," L-arginine + H2O = L-citrulline + NH3 (#35# mechanistic study <5>; #7#  catalytic mechanism, substrate binding mode <29>; #7# mechanism,  nucleophilic catalysis <28>; #54# substrate binding and catalytic  mechanism <30>; #44# Cys406, His278, Asp280, and Asp166 residues form  the catalytic motif, function of Cys406 in nucleophilic catalysis,  detailed reaction mechanism and enzyme-intermediate structures,  substrate-induced fit in ADI catalysis, overview <37>; #25# catalytic  mechanism, active site residues Asp160, Glu212, His268, and Asp270 are  highly conserved and crucial for activity <48>; #7# residues Cys406,  His278, and Asp166 and the contribution from the neighboring Asp280 are  important in catalysis of the formation and hydrolysis of the  Cys406-alkyluronium intermediate, structure and kinetic analysis <31>;  #33# the catalytic triad is formed by Cys398, His269, and Glu213,  active site and substrate binding structure, six-step reaction  mechanism with two key reaction intermediates, Cys398 is responsible  for the nucleophilic attack, His269 is the proton acceptor <40>; #7#  the catalytic triad is formed by Cys406, His278, and Glu224, active  site and substrate binding structure, reaction mechanism with Cys406  being the key residue for the nucleophilic attack, and His278 as  general base in the proton transfer chain <40>; #2,6,7,12,40# the  chemical mechanism for ADI catalysis involves initial formation and  subsequent hydrolysis of a Cys-alkylthiouronium ion intermediate <42>;  #44# chemical mechanism for ADI catalysis involves initial formation  and subsequent hydrolysis of a Cys-alkylthiouronium ion intermediate,  PaADI employs an active site Cys in nucleophilic catalysis <42>)  "
3.5.3.7," 4-guanidinobutanoate + H2O = 4-aminobutanoate + urea (#29# enzyme is  identical with D-arginase, EC 3.5.3.10, substrate guanidino group  binding sequence <13>)  "
3.5.3.8, N-formimidoyl-L-glutamate + H2O = L-glutamate + formamide  
3.5.3.9," allantoate + H2O = (S)-ureidoglycine + NH3 + CO2 (#8# catalytic  mechanism, substrate specificity, and structure-function relationship,  functional role of hinge regions during catalysis for open and closed  conformations, overview <13>)  "
3.5.4.1," cytosine + H2O = uracil + NH3 (#48# active site architecture and  substrate binding, catalytic mechanism <28>; #49# substrate binding  involves a significant conformational change that sequesters the  reaction complex from solvent, active site architecture and substrate  binding, catalytic mechanism <29>; #9# E64 side-chain carboxyl group  acts as proton shuttle between the Zn-bound water molecule and  cytosine. In course of reaction, cytosine reorients to favor  nucleophilic attack by a Zn-bound hydroxide. F114 may be important for  reactant binding and product release <38>)  "
3.5.4.10," IMP + H2O = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide  (#15# mechanism <18>; #6# mechanism,kinetics, enzyme reaction draws the  overall bifunctional reaction towards the IMP product <17>; #6# orbital  steering mechanism <16>; #12# catalytic mechanism, Glu104 is essential  for catalysis <25>; #9# two possible catalytic mechanisms for  cyclization, Glu102 is essential for catalysis <25>)  "
3.5.4.11," a 2-amino-4-hydroxypteridine + H2O = a 2,4-dihydroxypteridine + NH3  "
3.5.4.12," dCMP + H2O = dUMP + NH3 (#5,14,18# mechanism <2,6,16,17,18,20>;  #1,2,3,5,6,8,12,13,14,17,18,20# regulation, allosteric end-product  regulation <1,2,3,4,6,8,9,12,13,14,15,16,17,18,19,20,21,22,24>; #5#  most dramatic allosteric response at substrate levels 0.1 mM dCMP or  less <22>; #1,5,6,8,14,18# feedback regulation <13,16,20,21,24>;  #1,2,3,4,5,6,8,12,13,14,17,18,20# highly regulated allosteric enzyme  <1,3,4,6,7,9,10,12,13,14,15,16,17,18,19,21,22,24>; #8# zinc ion-based  reaction mechanism, substrate binding structure <26>)  "
3.5.4.13," dCTP + H2O = dUTP + NH3 (#7# mechanism of bifunctional enzyme activity  and feedback inhibition by dTTP <10>; #9# reaction involves S111, A124,  E138 and two water molecules <12>; #10# the mechanism for the  deamination of dCTP involves the four residues Ser102, Arg106, Ala115  and Glu129, structure-function relationship of the bifunctional enzyme,  overview <15>)  "
3.5.4.15, guanosine + H2O = xanthosine + NH3  
3.5.4.16," GTP + H2O = formate + 7,8-dihydroneopterin 3'-triphosphate (#9#  allosteric regulation mechanism, active site structure <31>; #7# enzyme  contains to thiol groups per active site, reaction mechanism <35>; #9#  reaction and regulation mechanism, enzyme forms a stimulatory complex  with the GTP cyclohydrolase I feedback regulatory protein, i.e. GFRP  <36>; #7# reaction mechanism involving reaction intermediates <33>;  #28# reaction mechanism, active site structure, GTP binding strcuture  <34>; #7# reaction mechanism, six consecutive unimolecular reaction  steps, the first of which being reversible <28>; #20# The reaction  involves hydrolysis of two C-N bonds and isomerization of the pentose  unit, the recyclization may be non-enzymic, reaction mechanism <35>;  #29# substrate binding and reaction mechanism, transition state  structure, modelling, overview <44>)  "
3.5.4.17, AMP + H2O = IMP + NH3 
3.5.4.17, ADP + H2O = IDP + NH3 
3.5.4.17, ATP + H2O = ITP + NH3  
3.5.4.18, ATP + H2O = ITP + NH3  
3.5.4.19, 1-(5-phospho-beta-D-ribosyl)-AMP + H2O =  1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D  ribosylamino)methylideneamino]imidazole-4-carboxamide  
3.5.4.2, adenine + H2O = hypoxanthine + NH3  
3.5.4.20, 1-(4-amino-2-methylpyrimid-5-ylmethyl)-3-(2-hydroxyethyl)-2  methylpyridinium + H2O =  1-(4-hydroxy-2-methylpyrimid-5-ylmethyl)-3-(2-hydroxyethyl)-2  methylpyridinium + NH3  
3.5.4.21, creatinine + H2O = N-methylhydantoin + NH3  
3.5.4.22," 1-pyrroline-4-hydroxy-2-carboxylate + H2O = 2,5-dioxopentanoate + NH3  "
3.5.4.23," blasticidin S + H2O = deaminohydroxyblasticidin S + NH3 (#5# catalyses  the deamination of the cytosine moiety of the antibiotics blasticidin  S, cytomycin and acetylblasticidin S, Glu56 is required for catalysis,  and Cys91 is required for structural maintenance <12>; #12# the  C-terminal flexible region appears to be directly involved in  enzyme-substrate interaction facilitating the access of substrate to  the active site, Tyr126, Trp128, and Gly130 are key residues <13>)  "
3.5.4.24, sepiapterin + H2O = xanthopterin-B2 + NH3  
3.5.4.25," GTP + 3 H2O = formate +  2,5-diamino-6-hydroxy-4-(5-phospho-D-ribosylamino)pyrimidine +  diphosphate (#2# reaction mechanism <10>; #2# 2 C-N bonds are  hydrolysed, releasing formate, with simultaneous removal of the  terminal diphosphate, reaction mechanism <9>; #2# ordered reaction  mechanism, in which the hydrolytic release of diphosphate preceeds the  hydrolytic attack of the imidazole ring, ring opening and formate  release are dependent on zinc bound to the active site, overview <8>;  #1# RibA is a bifunctional enzyme possessing 3,4-dihydroxy-2-butanone  4-phosphate synthase activity, EC 4.1.99.12, located in the N-terminal  half of the protein and GTP cyclohydrolase II activity of the  C-terminal domain, overview <12>)  "
3.5.4.26," 2,5-diamino-6-hydroxy-4-(5-phospho-D-ribosylamino)pyrimidine + H2O =  5-amino-6-(5-phospho-D-ribosylamino)uracil + NH3  "
3.5.4.27," 5,10-methenyl-5,6,7,8-tetrahydromethanopterin + H2O =  5-formyl-5,6,7,8-tetrahydromethanopterin  "
3.5.4.28, S-adenosyl-L-homocysteine + H2O = S-inosyl-L-homocysteine + NH3  
3.5.4.29," GTP + 3 H2O =  2-amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one +  2 phosphate (#1# although phosphate is the product of the enzymes  phosphohydrolase activity, diphosphate is a likely intermediate <1>)  "
3.5.4.3," guanine + H2O = xanthine + NH3 (#28# mechanism <21>; #3# catalytic  mechanism, quantum mechanical calculations using multilayered ONIOM and  molecular dynamics study, the active-site residues of the enzyme do not  affect the tautomeric state of guanine, Glu55 and Asp114 play important  roles in proton shuttling in the reaction, proton transfer from a  Zn-bound water to protonate Asp114, which can then transfer its proton  to the N3 of the bound guanine, facilitating the nucleophilic attack on  C2 of the guanine by the Zn-bound hydroxide to form a tetrahedral  intermediate. Glu55 then transfers a proton from the Zn-hydroxide to  the amino group of the reaction intermediate, ammonia leaves the active  site, and xanthine is freed by the cleavage of the Zn-O2 bond <28>)  "
3.5.4.30, dCTP + 2 H2O = dUMP + diphosphate + NH3  
3.5.4.31, S-methyl-5'-thioadenosine + H2O = S-methyl-5'-thioinosine + NH3  
3.5.4.32, 8-oxoguanine + H2O = urate + NH3  
3.5.4.33, adenine34 in tRNA + H2O = hypoxanthine34 in tRNA + NH3  
3.5.4.34, adenine37 in tRNAAla + H2O = hypoxanthine37 in tRNAAla + NH3  
3.5.4.35, cytosine8 in tRNA + H2O = uracil8 in tRNA + NH3  
3.5.4.36, cytosine6666 in apolipoprotein B mRNA + H2O = uracil6666 in  apolipoprotein B mRNA + NH3  
3.5.4.37, adenine in double-stranded RNA + H2O = hypoxanthine in double-stranded  RNA + NH3  
3.5.4.38, cytosine in single-stranded DNA + H2O = uracil in single-stranded DNA +  NH3  
3.5.4.39," GTP + H2O = 7,8-dihydroneopterin 2',3'-cyclic phosphate + formate +  diphosphate  "
3.5.4.4," adenosine + H2O = inosine + NH3 (#6,9# reaction mechanism,  structure-function relationship of ADA and dipeptidyl peptidase IV  <42>; #9# structure-activity relationships <54>)  "
3.5.4.40, 6-amino-6-deoxyfutalosine + H2O = futalosine + NH3  
3.5.4.41, 5'-deoxyadenosine + H2O = 5'-deoxyinosine + NH3  
3.5.4.42, N-isopropylammelide + H2O = cyanuric acid + isopropylamine  
3.5.4.43, hydroxyatrazine + H2O = N-isopropylammelide + ethylamine  
3.5.4.44, ectoine + H2O = (2S)-2-acetamido-4-aminobutanoate  
3.5.4.45, melamine + H2O = ammeline + NH3 
3.5.4.45, ammeline + H2O = ammelide + NH3  
3.5.4.46," 3',5'-cyclic AMP + H2O = 3',5'-cyclic IMP + NH3  "
3.5.4.5, 2'-deoxycytidine + H2O = 2'-deoxyuridine + NH3 
3.5.4.5," cytidine + H2O = uridine + NH3 (#40# quantum chemical study on  mechanism, the extra water molecule from solvent may support catalysis.  Proposal of catalytic cycle <47>)  "
3.5.4.6, AMP + H2O = IMP + NH3 (#7# enzyme is associated to the  histidine-proline-rich-glycoprotein HPRG via its catalytic subunit in a  protein-protein complex <46>)  
3.5.4.7, ADP + H2O = IDP + NH3  
3.5.4.8, 4-aminoimidazole + H2O = imidazol-4-one + NH3  
3.5.4.9," 5,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate (#47#  catalytic mechanism, Glu100 is responsible for activation of the  critical Lys56 for cyclohydrolase catalysis, Asp125 is involved in  binding of the 10-formyltetrahydrofolate substrate <28>; #9# In  eukaryotes, the enzyme occurs as a trifunctional enzyme that also has  methylenetetrahydrofolate dehydrogenase (NADP+), EC 1.5.1.5, and  formate-tetrahydrofolate ligase, EC 6.3.4.3, activity. In some  prokaryotes, it occurs as a bifunctional enzyme, that also has  methylenetetrahydrofolate dehydrogenase (NADP+), EC 1.5.1.5, activity  or formiminotetrahydrofolate cyclodeaminase, EC 4.3.1.4, activity,  residue Arg173 is critical for binding of NADP+ with Ser197 playing a  supporting role, both residues interact with the 2-phosphate of NADP+  <27>)  "
3.5.5.1," a nitrile + 2 H2O = a carboxylate + NH3 (#24# acts on a wide range of  aromatic nitriles including (indole-3-yl)-acetonitrile, and also on  some aliphatic nitriles, and on the corresponding acid amines <24>;  #66# Cys179 is essential for catalytic activity <26>; #66# Cys186 is  essential for catalytic activity <26>; #65,68# enzyme structure and  reaction mechanism <25>)  "
3.5.5.2, ricinine + 2 H2O = 3-carboxy-4-methoxy-N-methyl-2-pyridone + NH3  
3.5.5.4, 3-cyano-L-alanine + 2 H2O = L-aspartate + NH3  
3.5.5.5," 4-chlorophenylacetonitrile + 2 H2O = 4-chlorophenylacetate + NH3 (#1#  reaction mechanism, overview <23>)  "
3.5.5.6," 3,5-dibromo-4-hydroxybenzonitrile + 2 H2O =  3,5-dibromo-4-hydroxybenzoate + NH3  "
3.5.5.7," R-CN + 2 H2O = R-COOH + NH3 (#27# enzyme structure and reaction  mechanism <7>; #37# enzyme structure, covalent mechanism, formation of  an enzyme-thioimidate intermediate rather than addition of water to the  nitrile <7>; #4# preferentially hydrolyses aliphatic nitriles, some of  which are apparently not substrates for other known nitrilases, EC  3.5.5.1. Substrates include crotonitrile, acrylnitrile and  glutaronitrile <4>; #37# hydrolysis of substrates probably involves the  conjugated pi-electron system of the aromatic ring of substrate or  Tyr-142 as an electron acceptor <11>)  "
3.5.5.8, thiocyanate + 2 H2O = carbonyl sulfide + NH3 + HO-  
3.5.99.1, riboflavin + H2O = ribitol + lumichrome  
3.5.99.10, 2-iminobutanoate + H2O = 2-oxobutanoate + NH3 (#1# (1) <1>) 
3.5.99.10, 2-iminopropanoate + H2O = pyruvate + NH3 (#1# (2) <1>)  
3.5.99.11," 2-aminomuconate + H2O = (2Z,4E)-2-hydroxyhexa-2,4-dienedioate + NH3  "
3.5.99.2, 4-amino-5-aminomethyl-2-methylpyrimidine + H2O =  4-amino-5-hydroxymethyl-2-methylpyrimidine + NH3 
3.5.99.2, thiamine + H2O = 4-amino-5-hydroxymethyl-2-methylpyrimidine +  5-(2-hydroxyethyl)-4-methylthiazole  
3.5.99.5, 2-aminomuconate + H2O = (3E)-2-oxohex-3-enedioate + NH3  
3.5.99.6," alpha-D-glucosamine 6-phosphate + H2O = D-fructose 6-phosphate + NH3  (#3# reaction mechanism involves a ring-opening step, followed by an  enolization step that proceeds through a cis-enolamine and its  tautomeric imine as reaction intermediates <7>; #3# the mechanism  comprises steps to open the pyranose ring of the substrate and a  sequence of general base-catalyzed reactions to bring about  isomerization and deamination, with Asp72 playing a key role as a  proton exchanger <15>; #21# His143 has many functional roles in the  active site of enzyme <25>; #3# thermodynamic study, the allosteric  behavior of enzyme can be described by the Monod-Wyman-Changeux model  <29>; #21# enzyme-activator and enzyme-inhibitor complex have  strucutral differences that also differ from ternary complex  enzyme-activator-inhibitor. The occupation of the active site generates  structural perturbations which extend to the other subunits, resulting  in predominance of the R over the T forms in the population of  deaminase hexamers <32>; #21# residue R172 has a specific role in  binding the substrate to the enzyme in the T state <31>)  "
3.5.99.7," 1-aminocyclopropane-1-carboxylate + H2O = 2-oxobutanoate + NH3  (#7,28,72# mechanism <9,25,26,27>; #7# stereochemistry <6,7>; #7# ring  cleavage is regiospecific and only occurs between the pro-S and the  alpha-carbon of 1-aminocyclopropane-1-carboxylate <6>; #7# ring  cleavage of 1-aminocyclopropane-1-carboxylate is a  nucleophilic-addition initiated event <12>; #71# ring cleavage is  induced by a nucleophilic attack at the pro-S-beta-methylene carbon of  substrate, with Tyr294 as the nucleophile. Alternatively, ring opening  is acid-catalyzed and may be facilitated by charge relay through  pyridoxal 5Â’-phosphate, with Tyr294 as general acid <29>; #7# reaction  mechanism, detailed overview <60>) "
3.5.99.7, 2-iminobutanoate + H2O = 2-oxobutanoate + NH3 
3.5.99.7, 2-aminobut-2-enoate = 2-iminobutanoate 
3.5.99.7, 1-aminocyclopropane-1-carboxylate = 2-aminobut-2-enoate  
3.5.99.8, 5-nitroanthranilate + H2O = 5-nitrosalicylate + NH3  
3.5.99.9, 2-nitroimidazole + H2O = imidazol-2-one + nitrite  
3.6.1.1," diphosphate + H2O = 2 phosphate (#47# active site structure <78>; #30#  catalytic mechanism involving residues Lys28, Tyr140, Glu20, Asp64,  Asp69, Asp96, and Asp101, active site structure <70>; #89# substrate  binding structure and catalytic mechanism <95>; #96# the catalytic  mechanism of the HAD superfamily including a phosphorylated enzyme  intermediate, overview <120>)  "
3.6.1.10, polyphosphate + n H2O = (n+1) oligophosphate  
3.6.1.11," (polyphosphate)n + H2O = (polyphosphate)n-1 + phosphate (#2# the  interaction of the enzyme with polyphosphate is independent on cation  concentration, binding is not driven by entropy from release of  polyelectrolyte condensed cations <13>; #4# hydrolyzes poly-phosphates  with an average chain length of 208 to 15 phosphate residues <17>)  "
3.6.1.12, dCTP + H2O = dCMP + diphosphate  
3.6.1.13," ADP-D-ribose + H2O = AMP + D-ribose 5-phosphate (#4# molecular  catalytic mechanism involving Arg51, Arg111, Glu112, and Glu116, active  site structure, substrate binding involving Arg51, Leu98, Trp28 and  Trp46 and transition-state structure, structure-function relationship,  and kinetic analysis <30>; #19,20# substrate binding mode in the active  site of the ADPRase domain and catalytic mechanism <31>)  "
3.6.1.14, adenosine 5'-tetraphosphate + H2O = ATP + phosphate  
3.6.1.15, a nucleoside triphosphate + H2O = a nucleoside diphosphate + phosphate  
3.6.1.16, CDP-glycerol + H2O = CMP + sn-glycerol 3-phosphate  
3.6.1.17," P1,P4-bis(5'-guanosyl) tetraphosphate + H2O = GTP + GMP  "
3.6.1.18, FAD + H2O = AMP + FMN  
3.6.1.2, trimetaphosphate + H2O = triphosphate  
3.6.1.20, 5'-acylphosphoadenosine + H2O = AMP + a carboxylate  
3.6.1.21, ADP-sugar + H2O = AMP + alpha-D-aldose 1-phosphate  
3.6.1.22, NAD(H) + H2O = AMP + NMN(H) 
3.6.1.22, NADH + H2O = AMP + NMNH  
3.6.1.23," dUTP + H2O = dUMP + diphosphate (#5,32# mechanism <27,32>; #46#  catalytic mechanism <78>; #29# active site structure, R84 and S81 are  involved in substrate binding, molecular modeling <59>; #25# product  and substrate active site binding structure, catalytic mechanism of the  monomeric enzyme in comparison to trimeric dUTPases, overview <67>;  #13# structural and catalytic mechanism <65>; #1,5# structural and  catalytic mechanism involving Mg2+ <61>; #2,5,8,13,21,33,46# structural  organization and substrate binding modes <60>; #40# catalytic reaction  mechanism, overview <82>)  "
3.6.1.24, Hydrolyses mixed phospho-anhydride bonds  
3.6.1.25, triphosphate + H2O = diphosphate + phosphate  
3.6.1.26, CDP-diacylglycerol + H2O = CMP + phosphatidate  
3.6.1.27," ditrans,octacis-undecaprenyl diphosphate + H2O =  ditrans,octacis-undecaprenyl phosphate + phosphate  "
3.6.1.28, thiamine triphosphate + H2O = thiamine diphosphate + phosphate (#12#  catalytic mechanism <26>)  
3.6.1.29," P1,P3-bis(5'-adenosyl) triphosphate + H2O = ADP + AMP (#11# the dimeric  enzyme contains a catalytic histidine triad with H96 forming a covalent  intermediate at the alpha-phosphate of  P1,P3-bis(5-adenosyl)triphosphate, S128, H96 and H98 are essential for  the reaction, structure overview <24>; #2# two-step reaction mechanism  via a fragile histidine triad Fhit-AMP intermediate and release of  MgADP-, kinetic of the reaction steps, overview <23>)  "
3.6.1.31, 1-(5-phospho-beta-D-ribosyl)-ATP + H2O =  1-(5-phospho-beta-D-ribosyl)-AMP + diphosphate  
3.6.1.39, dTTP + H2O = dTDP + phosphate  
3.6.1.40," guanosine 5'-triphosphate 3'-diphosphate + H2O = guanosine  3',5'-bis(diphosphate) + phosphate (#2# the hydrolytic base is E119,  the dual specificity typical for the exopolyphosphatase/guanosine  pentaphosphate phosphohydrolase protein family is due to a common  active site for guanosine pentaphosphate and polyphosphate hydrolysis,  R22 and R267, residing in different domains, are crucial for guanosine  pentaphosphate specificity as they interact with the unique 3-ribose  phosphorylation <5>)  "
3.6.1.41," P1,P4-bis(5'-adenosyl) tetraphosphate + H2O = 2 ADP  "
3.6.1.42, GDP + H2O = GMP + phosphate (#4# stoichiometry of reaction <1>; #6#  also acts on UDP <10>; #12# also acts on UDP but not on other  nucleoside diphosphates and triphosphates <8>)  
3.6.1.43, dolichyl diphosphate + H2O = dolichyl phosphate + phosphate  
3.6.1.44, oligosaccharide-diphosphodolichol + H2O = oligosaccharide phosphate +  dolichyl phosphate  
3.6.1.45," UDP-sugar + H2O = UMP + alpha-D-aldose 1-phosphate (#9# UDP-sugar is  the best substrate, although other nucleoside-sugar diphosphates are  used as substrates with similar Km values but much lower maximum  velocities <14>)  "
3.6.1.5, a nucleoside 5'-triphosphate + 2 H2O = a nucleoside 5'-phosphate + 2  phosphate 
3.6.1.5, a nucleoside 5'-triphosphate + H2O = a nucleoside 5'-diphosphate +  phosphate 
3.6.1.5, a nucleoside 5'-diphosphate + H2O = a nucleoside 5'-phosphate +  phosphate  
3.6.1.52, diphospho-myo-inositol polyphosphate + H2O = myo-inositol polyphosphate  + phosphate  
3.6.1.53, ADP-D-ribose + H2O = AMP + D-ribose 5-phosphate 
3.6.1.53, CDP-choline + H2O = CMP + phosphocholine  
3.6.1.54," a UDP-2-N,3-O-bis[(3R)-3-hydroxyacyl]-alpha-D-glucosamine + H2O = a  lipid X + UMP  "
3.6.1.55, 8-oxo-dGTP + H2O = 8-oxo-dGMP + diphosphate  
3.6.1.56, 2-hydroxy-dATP + H2O = 2-hydroxy-dAMP + diphosphate  
3.6.1.57," UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose + H2O =  2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose + UDP  "
3.6.1.58, 8-oxo-dGDP + H2O = 8-oxo-dGMP + phosphate  
3.6.1.59, a 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] + H2O =  N7-methylguanosine 5'-phosphate + a 5'-diphospho-[mRNA] (#3# (1) <5>)  
3.6.1.6, a nucleoside diphosphate + H2O = a nucleoside phosphate + phosphate  
3.6.1.60," P1,P6-bis(5'-adenosyl)hexaphosphate + H2O = adenosine 5'-pentaphosphate  + AMP (#1# (1) <2>) "
3.6.1.60," P1,P5-bis(5'-adenosyl)pentaphosphate + H2O = adenosine  5'-tetraphosphate + AMP (#1,4# (2) <2,3>) "
3.6.1.60," P1,P6-bis(5'-adenosyl)hexaphosphate + H2O = adenosine 5'-tetraphosphate  + ADP (#4# (1) <3>)  "
3.6.1.61," P1,P6-bis(5'-adenosyl)hexaphosphate + H2O = 2 ATP (#2# (1) <3>) "
3.6.1.61," P1,P5-bis(5'-adenosyl)pentaphosphate + H2O = ATP + ADP (#2# (2) <3>) "
3.6.1.61," P1,P4-bis(5'-adenosyl)tetraphosphate + H2O = ATP + AMP (#2#  nucleophilic double, not single, displacement catalytic forward  reaction mechanism via oxocarbenium ion intermediate, detailed overview  <3>)  "
3.6.1.62, a 5'-(N7-methylguanosine 5'-triphospho)-[mRNA] + H2O =  N7-methylguanosine 5'-diphosphate + a 5'-phospho-[mRNA]  
3.6.1.63," alpha-D-ribose 1-methylphosphonate 5-triphosphate + H2O =  alpha-D-ribose 1-methylphosphonate 5-phosphate + diphosphate (#1# when  the hydrolysis reaction of D-ribose-5-triphosphate catalyzed by PhnM is  conducted in oxygen-18 labeled water, the oxygen-18 is found  exclusively in D-ribose-5-phosphate and not in diphosphate. Therefore,  water attacks the alpha-phosphoryl group of D-ribose-5-triphosphate  rather than the beta-phosphoryl group <3>)  "
3.6.1.64, IDP + H2O = IMP + phosphate (#1# (1) <1>) 
3.6.1.64, dIDP + H2O = dIMP + phosphate (#1# (2) <1>)  
3.6.1.65, dCTP + H2O = dCMP + diphosphate 
3.6.1.65, CTP + H2O = CMP + diphosphate  
3.6.1.66, dITP + H2O = dIMP + diphosphate 
3.6.1.66, XTP + H2O = XMP + diphosphate  
3.6.1.67," 7,8-dihydroneopterin 3'-triphosphate + H2O = 7,8-dihydroneopterin  3'-phosphate + diphosphate  "
3.6.1.68, geranyl diphosphate + H2O = geranyl phosphate + phosphate  
3.6.1.69, 8-oxo-GTP + H2O = 8-oxo-GDP + phosphate 
3.6.1.69, 8-oxo-dGTP + H2O = 8-oxo-dGDP + phosphate  
3.6.1.7," an acylphosphate + H2O = a carboxylate + phosphate (#1,7,11# reaction  mechanism <13,18,27,28,30>; #2,7,14# thermodynamic data <9,19,28>;  #1,7# catalytic mechanism <25,26,30>; #7# thermodynamic analysis,  studies and data <29>)  "
3.6.1.70, guanosine-5'-diphospho-5'-[DNA] + H2O = phospho-5'-[DNA] + GMP  
3.6.1.71," adenosine-5'-diphospho-5'-[DNA] + H2O = AMP + phospho-5'-[DNA] (#3# a  two-step mechanism for hydrolysis of 5-AMP from RNA-DNA and DNA, APTX  catalytic mechanism, overview. In the first step, the active site  nucleophile (His260 of the HIT loop in APTX) attacks the 5-adenylate  phosphoanhydride forming a transient enzyme-AMP intermediate and  releasing a DNA 5-phosphate product. Several hydrogen bonds with  active-site residues and peptide backbone amides stabilize the negative  charge on the transition-state of step 1. The nucleophile (His260) is  activated by a hydrogen bond to the carbonyl of His258, while His251 is  proposed to protonate the 5-phosphate leaving group. The second step  involves hydrolysis of the His260-AMP-RNA/DNA intermediate, using  chemistry that is essentially the reverse of the first step with water  replacing the 5-phosphate, and with His251 proposed to act as a general  base to deprotonate a water nucleophile <21>; #3# the catalytic  reaction proceeds in three steps: substrate protonation, DNA  deadenylation and histidine-AMP intermediate hydrolysis. The calculated  activation energies for the second and third reactions are 19.0 and  10.5 kcal/mol, which can be attributed to a penta-coordinated  AMP-phosphoryl formation and closing of a water molecule, respectively.  A histidine-AMP intermediate is hydrolyzed easily in the third step  when a water molecule closes within 3 A to the phosphorus nucleus <17>) "
3.6.1.71," adenosine-5'-diphospho-5'-(ribonucleotide)-[DNA] + H2O = AMP +  5'-phospho-(ribonucleotide)-[DNA] (#3# a two-step mechanism for  hydrolysis of 5-AMP from RNA-DNA and DNA, APTX catalytic mechanism,  overview. In the first step, the active site nucleophile (His260 of the  HIT loop in APTX) attacks the 5-adenylate phosphoanhydride forming a  transient enzyme-AMP intermediate and releasing a DNA vphosphate  product. Several hydrogen bonds with active-site residues and peptide  backbone amides stabilize the negative charge on the transitin-state of  step 1. The nucleophile (His260) is activated by a hydrogen bond to the  carbonyl of His258, while His251 is proposed to protonate the  5-phosphate leaving group. The second step involves hydrolysis of the  His260-AMP-RNA/DNA intermediate, using chemistry that is essentially  the reverse of the first step with water replacing the 5-phosphate, and  with His251 proposed to act as a general base to deprotonate a water  nucleophile <21>; #3# the catalytic reaction proceeds in three steps:  substrate protonation, DNA deadenylation and histidine-AMP intermediate  hydrolysis. The calculated activation energies for the second and third  reactions are 19.0 and 10.5 kcal/mol, which can be attributed to a  penta-coordinated AMP-phosphoryl formation and closing of a water  molecule, respectively. A histidine-AMP intermediate is hydrolyzed  easily in the third step when a water molecule closes within 3 A to the  phosphorus nucleus <17>)  "
3.6.1.72, [DNA]-3'-diphospho-5'-guanosine + H2O = [DNA]-3'-phosphate + GMP  
3.6.1.73, inosine 5'-triphosphate + H2O = inosine 5'-diphosphate + phosphate 
3.6.1.73, xanthosine 5'-triphosphate + H2O = xanthosine 5'-diphosphate + phosphate  
3.6.1.74, a 5'-triphospho-[mRNA] + H2O = a 5'-diphospho-[mRNA] + phosphate  
3.6.1.8, ATP + H2O = AMP + diphosphate  
3.6.1.9," a nucleoside triphosphate + H2O = a nucleotide + diphosphate (#16,25#  substrates include NAD+, NADP+, FAD, CoA and also ATP and ADP <6,9>)  "
3.6.2.1, adenylyl sulfate + H2O = AMP + sulfate  
3.6.2.2," 3'-phosphoadenylyl sulfate + H2O = adenosine 3',5'-bisphosphate +  sulfate  "
3.6.3.45, ATP + H2O + steroid/in = ADP + phosphate + steroid/out  
3.6.4.10," ATP + H2O = ADP + phosphate (#1,2,3,5,6,7,9,10,11,13,15,16,22,30#  highly diverse group of enzymes that perform many functions that are  similar to those of chaperonins. They comprise a number of  heat-shock-cognate proteins. They are also active in clathrin uncoating  and in the oligomerization of actin  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20>; #4# ClpB captures  substrates on the upper surface of the AAA-1 ring before threading them  through the ClpB hexamer in an ATP hydrolysis-driven step <75>)  "
3.6.4.13," a nucleoside triphosphate + H2O = a nucleoside diphosphate + phosphate  (#15# catalytic mechanism involving a bound sulfate ion, NTPase active  site structure, nucleic acid binding site <4>) "
3.6.4.13," ATP + H2O = ADP + phosphate (#6# models: DbpA functions as an active  monomer that possesses two distinct RNA binding sites, one in the  helicase core domain and the other in the carboxyl-terminal domain that  recognizes 23 S rRNA and interacts specifically with hairpin 92 of the  peptidyl transferase center <25>; #6# quantitative kinetic and  equilibrium characterization of the rRNA-activated ATPase cycle  mechanism of DbpA <26>)  "
3.6.4.6," ATP + H2O = ADP + phosphate (#2,5,6,7,8,11,12,13,14,16,22,29# large  family of ATP-hydrolysing enzymes involved in the heterotypic fusion of  membrane vesicles with target membranes and the homotypic fusion of  various membrane compartments. They belong to the AAA-type (ATPase  associated with a variety of cell activities) ATPase superfamily. They  include peroxin, which apparently is involved in Zellweger s syndrome.  <1,2,3,4,5,6,7,8,9,10,11>; #8# Vps4 disassembles the ESCRT-III protein  polymer, thereby changing the morphology of the underlying membrane  <56>)  "
3.6.4.7," ATP + H2O = ADP + phosphate (#1,3,4,5,8,9,11# an extremely diversified  group of enzymes that use the energy of ATP hydrolysis to import and  assemble peroxisome components into the organelle. Their molecular  masses range from 25 to 600 kDa <1,2,3,4,5,6,7>; #15,16# ATP hydrolysis  occurs in a unidirectional manner around the ring, with one subunit  primarily affecting ATP hydrolysis of only one of the neighboring  subunits. ATP binding is initiated on one side of the ring at the  nucleotide-free sites where the subunits are most widely spaced <25>)  "
3.6.5.1," GTP + H2O = GDP + phosphate (#3# binding and hydrolysis of GTP triggers  reciprocal conformational changes within a switch region within the  catalytic domain <12>; #6# mechanism of membrane translocation <28>;  #12# in the classic paradigm of G-protein signaling, GDP-bound Galpha  remains associated with the non-dissociable betagamma subunits and, in  combination with a G-protein coupled receptor (GPCR), represents the  inactive state of the signaling pathway. Signal perception by GPCR  facilitates the exchange of GTP for bound GDP on Galpha. The GTP-bound  Galpha dissociates from the Gbetagamma dimer and both entities can  interact with specific downstream effectors to transduce the signal.  Galpha is restored to its GDP-bound conformation by its own intrinsic  GTPase activity which leads to its reassociation with the Gbetagamma  dimer and GPCR. The switch-like signaling mechanism has two distinct  regulatory steps: the rate of GDP-GTP exchange facilitated by a cognate  GPCR, which involves GDP release and GTP binding; and the rate of GTP  hydrolysis by the Galpha protein <59>)  "
3.6.5.2," GTP + H2O = GDP + phosphate (#36# a family of about 50 enzymes with a  molecular mass of 21 kDa that are distantly related to the  alpha-subunit of heterotrimeric G-protein GTPase, EC 3.6.1.46, they are  involved in cell-growth regulation, Ras subfamily, membrane vesicle  traffic and uncoating, Rab and ARF subfamilies, nuclear protein import,  Ran subfamily, and organization of the cytoskeleton, Rho and Rac  subfamilies <30>; #10# mechanism, biphasic reaction <29>)  "
3.6.5.3," GTP + H2O = GDP + phosphate (#7,8# reaction mechanism, overview <100>;  #17# catalytic mechanism, structure-function relationship, overview  <103>; #58# conformational changes of the protein upon nucleotide  binding, in particular in the P-loop region, which extend to the  functionally relevant switch II region. The latter carries a  catalytically important and conserved histidine residue which is  observed in different conformations in the GTP and GDP complexes.  Activation of GTP hydrolysis may occur by a conformational  repositioning of the histidine residue <99>)  "
3.6.5.4," GTP + H2O = GDP + phosphate (#21# activity is associated with the  signal-recognition particle, a protein- and RNA-containing structure  involved in endoplasmic-reticulum-associated protein synthesis <24>;  #5# kinetic and thermodynamic data <19>)  "
3.6.5.5, GTP + H2O = GDP + phosphate (#8# an enzyme with a molecular mass of  about 100 kDa that is involved in endocytosis and is instrumental in  pinching off membrane vesicles <24>; #35# analysis of the GTPase  mechanism of MxA <102>)  
3.6.5.6, GTP + H2O = GDP + phosphate (#4# mechanism <16>)  
3.7.1.1, oxaloacetate + H2O = oxalate + acetate (#1# unknown mechanism <5>)  
3.7.1.10," cyclohexane-1,3-dione + H2O = 5-oxohexanoate  "
3.7.1.11," cyclohexane-1,2-dione + H2O = 6-oxohexanoate (#2# catalytic reaction  mechanism, overview <3,4>; #1# reaction starts with the monohydrated  ketone of cyclohexane-1,2-dione and the thiamine diphosphate-ylide  which undergoes a nucleophilic attack on the carbonyl group of  cyclohexane-1,2-dione. The subsequent cleavage of the CÂ–C bond yields  an alpha-carbanion, which is in equilibrium with its corresponding  enamine. In the following step, the carbonic acid protonates the  alpha-carbanion yielding 6-hydroxyhexanoate-thiamine diphosphate.  Finally, the product 6-oxohexanoate is released <2>; #2# the C-C bond  cleavage is assumed to be initiated by the attack of the ThDP ylide on  the C=O bond of the monohydrate 6 of 1,2-diketone 4 to form the ThDP  adduct, a tetrahedral intermediate which breaks down to a carboxylic  acid <5>; #2# the thiamine diphosphate-dependent enzyme involves a C-C  bond ring cleavage of alicyclic compound, catalytic mechanism analysis  by quantum mechanics/molecular mechanics, molecular docking simulations  and modeling <8>)  "
3.7.1.12, cobalt-precorrin-5A + H2O = cobalt-precorrin-5B + acetaldehyde + 2 H+  
3.7.1.13," (2E,4E)-6-(2-aminophenyl)-2-hydroxy-6-oxohexa-2,4-dienoate + H2O =  anthranilate + (2E)-2-hydroxypenta-2,4-dienoate  "
3.7.1.14," (2Z,4E)-2-hydroxy-6-oxonona-2,4-diene-1,9-dioate + H2O =  (2Z)-2-hydroxypenta-2,4-dienoate + succinate (#2# a catalytic mechanism  is proposed involving stabilisation of reactive intermediates and  activation of a nucleophilic water molecule by Ser110 <7>; #2# although  MCP hydrolases have a catalytic serine in the active site, the  mechanism proceeds via a geminal diol, rather than an acyl-enzyme  intermediate, reaction mechanism of the hydrolysis reaction, overview.  MCP hydrolases accept alternative nucleophiles in addition to water,  and accepts hydroxylamine in the C-C cleavage reaction. MhpC has a  typical serine-hydrolase catalytic triad (Ser107, Asp228 and His256),  but mechanistic studies indicate that the serine in the active site  does not act as a nucleophile in the hydrolysis, but rather the  reaction proceeds via general base catalysis.The serine in the active  site might stabilise the oxyanion intermediate by hydrogen bonding <9>) "
3.7.1.14," (2Z,4E,7E)-2-hydroxy-6-oxonona-2,4,7-triene-1,9-dioate + H2O =  (2Z)-2-hydroxypenta-2,4-dienoate + fumarate (#2# a catalytic mechanism  is proposed involving stabilisation of reactive intermediates and  activation of a nucleophilic water molecule by Ser110 <7>)  "
3.7.1.17," (1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10)  2-dien-4-oate + H2O =  3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate  + (2Z,4Z)-2-hydroxyhexa-2,4-dienoate  "
3.7.1.18," bornane-2,6-dione + H2O =  [(1S)-4-hydroxy-2,2,3-trimethylcyclopent-3-enyl]acetate (#1# analysis  of the molecular determinants of both mechanism and enantiotopic  selectivity in reactions catalysed by OCH and reaction mechanism,  putative Asp154-His145 dyad, overview <1>; #3# involvement of five  residues, His45, His122, His145, Asp154, and Glu244, in catalysis,  catalytic His145/Asp154 dyad. The the pendant acetate of the product  (2S,4S)-alpha-campholinic acid hydrogen bonded to a His145/Asp154 dyad  and the endocyclic carbonyl of the cyclopentane ring hydrogen bonds to  Trp40, prochiral selectivity, base-catalyzed mechanism of C-C bond  cleavage, overview <4>; #2# mechanism of carbon-carbon bond cleavage by  6-oxo camphor hydrolase <3>)  "
3.7.1.19," 1-(2,6-dihydroxypyridin-3-yl)-4-(methylamino)butan-1-one + H2O =  2,6-dihydroxypyridine + 4-methylaminobutanoate  "
3.7.1.2," 4-fumarylacetoacetate + H2O = acetoacetate + fumarate (#3# also acts on  other 3,5- and 2,4-dioxo acids, mechanism involves a catalytic metal  ion, a Glu/His catalyic diad, and a charged oxyanion hole <21>; #1#  also acts on other 3,5- and 2,4-dioxo acids, mechanism involves a  catalytic metal ion, a Glu/His catalyic diad, and a charged oxyanion  hole, side chain mobility in the active site <21>)  "
3.7.1.20, 3-fumarylpyruvate + H2O = fumarate + pyruvate  
3.7.1.21, 6-oxocyclohex-1-ene-1-carbonyl-CoA + 2 H2O = 3-hydroxypimeloyl-CoA (#7#  (overall reaction) <1>) 
3.7.1.21, 6-oxocyclohex-1-ene-1-carbonyl-CoA + H2O =  2-hydroxy-6-oxocyclohexane-1-carbonyl-CoA (#7# (1a) <1>) 
3.7.1.21, 2-hydroxy-6-oxocyclohexane-1-carbonyl-CoA + H2O = 3-hydroxypimeloyl-CoA  (#7# (1b) <1>)  
3.7.1.22," 3D-3,5/4-trihydroxycyclohexa-1,2-dione + H2O = 5-deoxy-D-glucuronate  "
3.7.1.23, 3-maleylpyruvate + H2O = maleate + pyruvate  
3.7.1.24," 2,4-diacetylphloroglucinol + H2O = 2-acetylphloroglucinol + acetate  (#3# catalytic reaction mechanism, overview. A water molecule, bound by  the zinc, is responsible for initiating the CÂ–C bond cleavage reaction  through nucleophilic attack at the acyl carbonyl carbon atom <6>; #3#  cleavage of the 2,4-diacetylphloroglucinol C-C bond proceeds via  nucleophilic attack by a water molecule, which is coordinated by a zinc  ion. Residues Tyr121, Tyr229, and Asn132, which are predicted to be  hydrogen-bonded to the hydroxyl groups and unhydrolyzed acetyl group,  can finely tune and position the bound substrate in a reactive  orientation, catalytic reaction mechanism, overview <4>)  "
3.7.1.25," (2Z,4E)-2-hydroxy-6-oxohepta-2,4-dienoate + H2O =  (2Z)-2-hydroxypenta-2,4-dienoate + acetate  "
3.7.1.26," 2,4-didehydro-3-deoxy-L-rhamnonate + H2O = pyruvate + (S)-lactate  "
3.7.1.28, 3-oxoisoapionate 4-phosphate + H2O = glycolate + 3-phospho-D-glycerate  
3.7.1.3," L-kynurenine + H2O = anthranilate + L-alanine (#27,29# catalytic  reaction mechanism via several intermediates, e.g. external aldimine,  quinonoid, ketimine, Gem-diolate, and enamine <50>; #29# the proposed  mechanism of the retro-Claisen reaction requires extensive acid/base  catalysis, the phosphate of pyridoxal 5-phosphate is an acid/base  catalyst in the mechanism of Pseudomonas fluorescens kynureninase,  Tyr226 hydrogen bonds to the phosphate of the pyridoxal 5-phosphate  cofactor. Tyr226 mediates proton transfer between the substrate and the  phosphate, which accelerates formation of external aldimine and  gem-diol intermediates, catalytic reaction mechanism via several  intermediates, e.g. external aldimine, quinonoid, ketimine,  Gem-diolate, and enamine, overview <51>)  "
3.7.1.4," phloretin + H2O = phloretate + phloroglucinol (#2,3,9# also hydrolyses  other C-acetylated phenols related to phloretin <5,6,7>)  "
3.7.1.5, a 3-acylpyruvate + H2O = a carboxylate + pyruvate  
3.7.1.6, acetylpyruvate + H2O = acetate + pyruvate  
3.7.1.7," nonane-4,6-dione + H2O = pentan-2-one + butanoate (#1# putative serine  hydrolase <3>; #5,6# reaction mechanism, the reaction catalyzed by OPH  is typical of alpha/beta-hydrolases, except that the cleaved bond is  between two carbon atoms. Here electron delocalization seems to play an  essential role. Upon C-C bond breaking, the negative charge on CO1 is  probably stabilized by hydrogen bonds to the backbone NH of Ser66 and  Val67, thus forming a second oxyanion hole. This anion-binding  beta3-alpha1 loop might promote spontaneous oxidation of Cys172 to a  sulfonate <11>)  "
3.7.1.8," 2,6-dioxo-6-phenylhexa-3-enoate + H2O = benzoate + 2-oxopent-4-enoate  (#10# mechanism may involve an Asp-Ser-His catalytic triad <3>; #12#  formation of a catalytic intermediate carbanion during hydrolysis, the  carbanion abstracts a proton from Ser112, thereby completing  tautomerization and generating a serinate for nucleophilic attack on  the C6-carbonyl, catalytic mechanism, overview. BphD is a half-site  reactive enzyme with versatility of the Ser-His-Asp triad, role of the  catalytic His in acylation and deacylation <19>; #9# general base and  nucleophilic catalytic reaction mechanisms, overview <18>; #12,14#  although MCP hydrolases have a catalytic serine in the active site, the  mechanism proceeds via a geminal diol, rather than an acyl-enzyme  intermediate, reaction mechanism of the hydrolysis reaction, overview.  MCP hydrolases accept alternative nucleophiles in addition to water,  and accepts hydroxylamine in the C-C cleavage reaction. The Ser-His-Asp  triad containing enzyme BphD most likely shows the formation of a  covalent acyl enzyme intermediate, reaction mechanism, overview <21>;  #9# catalytic mechanism involving enol-to-keto tautomerization that  consists of two elementary reactions, the calculated Boltzmann weighted  average barriers favor a substrate-assisted acylation mechanism, and  the most feasible acylation pathway involves a catalytic triad,  Ser-His-Asp. The product (2-hydroxypenta-2,4-dienoic acid) of the  acylation process is replaced by three water molecules, and one of  which is involved in the deacylation process, quantum  mechanics/molecular mechanics study, overview <23>)  "
3.7.1.9, 2-hydroxymuconate-6-semialdehyde + H2O = formate + 2-oxopent-4-enoate  
3.8.1.10," (S)-2-haloacid + H2O = (R)-2-hydroxyacid + halide (#10# group I  enzymes, including DL-2-haloacid dehalogenase and D-2-haloacid  dehalogenase, catalyze the reaction without forming an ester  intermediate. Instead, a solvent water molecule directly attacks the  alpha-carbon atom of the substrate to release the halide ion.  DL-2-haloacid dehalogenase acts on both enantiomers of the substrate  <19>) "
3.8.1.10," (R)-2-haloacid + H2O = (S)-2-hydroxyacid + halide (#10# group I  enzymes, including DL-2-haloacid dehalogenase and D-2-haloacid  dehalogenase, catalyze the reaction without forming an ester  intermediate. Instead, a solvent water molecule directly attacks the  alpha-carbon atom of the substrate to release the halide ion.  DL-2-haloacid dehalogenase acts on both enantiomers of the substrate  <19>)  "
3.8.1.11, (S)-2-haloacid + H2O = (S)-2-hydroxyacid + halide 
3.8.1.11, (R)-2-haloacid + H2O = (R)-2-hydroxyacid + halide  
3.8.1.2," (S)-2-haloacid + H2O = (R)-2-hydroxyacid + halide (#1# mechanism <4>;  #2# the stereochemistry of the product obtained from racemic  2-brompropionic acid by the action of celite-immobilized disrupted  cells in dimethylsulfoxid differs from that of the enantiomer obtained  in an aqueous buffer <29>; #1,2# Asp10 of the enzyme functions as a  catalytic nucleophile: the residue attacks the alpha-carbon of the  substrate to form an ester intermediate, which is subsequently  hydrolysed to release the product <4,7,10,30>; #1# functional residue:  Asp 10 <24,26>; #1# reaction mechanism, overview <42>; #23#  structure-function analysis, catalytic mechanism, modeling. Asp181 is  proposed to participate in the activation of the catalytic water  molecule required for hydrolysis of the ester intermediate, Asp186 and  Lys157 in DehRhb are responsible for deprotonation of the catalytic  water molecule in the second part of the enzyme reaction. In DehRhb,  the catalytic water molecule is coordinated by His183 and the conserved  Asp186. This residue makes an ion pair with the conserved Lys157. The  His183 makes an H-bond with the catalytic Asp18 on one side and an ion  pair with Glu21 on the other side. This forms a catalytic triad similar  to that observed in the haloalkane dehalogenases <47>; #24# it is  hypothesized that, in DehL, catalysis is initiated by a nucleophilic  attack launched by the side-chain carboxyl of Asp13 on the C2 of L-2CP  to form an ester intermediate, which is subsequently hydrolyzed by a  water molecule activated by His184 followed by product release <52>)  "
3.8.1.3," haloacetate + H2O = glycolate + halide (#8# As105 is a catalytic site  residue functioning as a nucleophil attacking the alpha-carbon atom of  the substrate to displace the fluorine atom, catalytic mechanism,  possibly involving an imidate as intermediate <16>; #3# enzyme contains  the conserved motif Asp-Xaa-Asp-Xaa-Thr, open reaction conformation  <15>; #14# reaction mechanism of fluoroacetate dehalogenase, overview.  Asp104 serves as nucleophile to attack the alpha-carbon atom of the  substrate to displace the fluorine atom leading to the formation of an  ester intermediate. The ester intermediate is subsequently hydrolyzed  by a water molecule activated by His271, which yields glycosylate and  regenerates the carboxylate group of Asp104. The catalytic triad is  formed by Asp104-His271-Asp128 <21>; #9# reaction mechanism of  fluoroacetate dehalogenase, overview. Asp105 serves as nucleophile to  attack the alpha-carbon atom of the substrate to displace the fluorine  atom leading to the formation of an ester intermediate. The ester  intermediate is subsequently hydrolyzed by a water molecule activated  by His272, which yields glycosylate and regenerates the carboxylate  group of Asp105 <21>; #4# the fluoroacetate dehalogenase catalyzes  fluoroacetate degradation through a two step process initiated by an  SN2 reaction in which the aspartate residue performs a nucleophilic  attack on the carbon bonded to the fluorine; the second step is  hydrolysis that releases the product as glycolate, reaction activation  and mechanism, overview. The activation of this catalytic step is  associated to the interaction of the halogen with residues His155,  Trp156, and Tyr219 (numbering according to PDB ID 3R3U from  Rhodopseudomonas palustris), which may facilitate the Calpha-F bond  dissociation <26>; #18# besides residues Arg111, Arg114, His155,  Trp156, and Tyr219, the important role of residues His109, Asp134,  Lys181, and His280 during the defluorination process is highlighted  <27>; #17# the role of the enzyme machinery and particularly of the  halogen pocket in the SN2 reaction is explored by using computational  tools <28>)  "
3.8.1.5," 1-haloalkane + H2O = a primary alcohol + halide (#1# catalytic  mechanism <9>; #38# GJ10, three-step reaction mechanism with covalent  alkyl-enzyme ester intermediate <17>; #22# GJ10, four-step reaction  mechanism with covalent ester intermediate <12,19>; #5,6,13,22#  distinction of 3 different substrate classes for haloalkane  dehalogenases after profound statistical reaction rate analysis <13>;  #14,22,38# alpha/beta hydrolase with catalytic triad, i.e. nucleophile  (Asp124)-histidine (H289)-acid (Asp260), during catalytic reaction  <14,16,17,19,24>; #38# GJ10, detailed reaction mechanism and energetics  calculated from computational model <24>; #22# two-step mechanism  involving an ester intermediate covalently bound at Asp124, His 289 is  important for hydrolysis <7,16>; #14# 3 features are important for  catalytic performance: i. a catalytic triad, ii. anoxyanion hole, and  iii. the halide-stabilizing residues, which are not conserved among  different haloalkane dehalogenases, active site structure, Asn38 is  involved, SN2 reaction mechanism, modeling, overview <26>; #13# 3  features are important for catalytic performance: i. a catalytic triad,  ii. anoxyanion hole, and iii. the halide-stabilizing residues, which  are not conserved among different haloalkane dehalogenases, active site  structure, Asn41 is involved, SN2 reaction mechanism, modeling,  overview <26>; #38# 3 features are important for catalytic performance:  i. a catalytic triad, ii. anoxyanion hole, and iii. the  halide-stabilizing residues, which are not conserved among different  haloalkane dehalogenases, active site structure, Glu56 is involved, SN2  reaction mechanism, modeling, overview <26>; #4# acts on a wide range  of 1-haloalkanes, haloalcohols, haloalkenes and some haloaromatic  compounds <30>; #14# catalytic nucleophile Asp108, which is the most  disordered catalytic residue, catalytic base His272, structure-based  reaction mechanism, active site structure, overview <29>; #14# low  activity with small, chlorinated alkanes, importance of active site  water molecules and reaction products in molecular docking <27>; #14#  substrate specificity is influenced by the size and shape of their  entrance tunnel, surface residue Leu177 is involved and located at the  tunnel opening <32>; #13# activation energy of reaction 59.5 kJ/mol  <46>; #7# catalytic triad consists of D123, H279, D250, with a first  halide-stabilizing W124 and a secong stabilizing residue W164. Two-step  reaction mechanism <45>; #14# H272 singly protonated at Ndelta1 and  D108 in conformation A give the most exothermic reactionwith DeltaH of  -22 kcal/mol <29>; #38# hydrogen bond interactions between substrate  and the environment are significantly different in aqueous solution and  in the enzyme. Structure of the enzyme active site provides a more  adequate interaction pattern for the reaction process <43>; #39#  Asp103, Glu127 and His280 are involved in the catalytic reaction, and  two H-bond donating residues, Asn38 and Trp104, are involved in  stabilization of a halogen group of the substrate <68>; #33# reaction  mechanism, overview. The bromide release is the rate-limiting step of  the catalytic cycle, overview <69>; #50# structural basis for its  reaction mechanism <73>)  "
3.8.1.6, 4-chlorobenzoate + H2O = 4-hydroxybenzoate + chloride  
3.8.1.7," 4-chlorobenzoyl-CoA + H2O = 4-hydroxybenzoyl CoA + chloride (#2#  formation of an aryl intermediate <8>; #2# it is proposed that Asp125  functions as the active site nucleophile, that Trp137 serves as a  hydrogen bond donor to the Asp145 carbonyl group , and that His90  serves to deprotonate the bound H2O molecule <9>; #6# Asp145 provides  the side-chain carboxylate group that adds to form the Meisenheimer  intermediate and His90 serves as the general base in the subsequent  hydrolysis step <6>; #3# formation of an aryl-enzyme intermediate that  is converted to a hydroxamic acid upon attack by hydroxylamine. The  dehalogenation appears to occur via an SNAr mechanism <10>; #2#  specific for dehalogenation at the 4-position, can dehalogenate  substrates bearing fluorine, chlorine, bromine and iodine in the  4-position, mechanism, Asp145 acts as a nucleophil on the C(4) of the  substrates benzoyl ring to form a Meisenheimer intermediate, followed  by expulsion of chloride ion to form an arylated enzyme intermediate,  and ester hydrolysis to form 4-hydroxybenzoyl-CoA, active site  structure <13>; #6# specific for dehalogenation at the 4-position, can  dehalogenate substrates bearing fluorine, chlorine, bromine and iodine  in the 4-position, mechanism, attack of Asp145 on the C(4) of the  substrates benzoyl ring to form a Meisenheimer intermediate, followed  by expulsion of chloride ion to form an arylated enzyme intermediate,  and ester hydrolysis to form 4-hydroxybenzoyl-CoA, active site residue  His90 is involved and important for the regeneration of the active  enzyme <11>; #2# specific for dehalogenation at the 4-position, can  dehalogenate substrates bearing fluorine, chlorine, bromine and iodine  in the 4-position, multistep mechanism, attack of Asp145 on the C(4) of  the substrates benzoyl ring to form a Meisenheimer intermediate,  followed by expulsion of chloride ion to form an arylated enzyme  intermediate, and ester hydrolysis to form 4-hydroxybenzoyl-CoA, active  site structure <12>; #1# specific for dehalogenation at the 4-position,  can dehalogenate substrates bearing fluorine, chlorine, bromine and  iodine in the 4-position, SNAr mechanism <14>; #2# specific for  dehalogenation at the 4-position, can dehalogenate substrates bearing  fluorine, chlorine, bromine and iodine in the 4-position, SNAr reaction  mechanism, the substrate is bound in the active site primariliy formed  by 2 of 3 subunits, reaction is initiated by the nucleophilic attack at  the C4 of the benzoyl group of the substrate by carboxylate of Asp145  to form a Meisenheimer intermediate, general base for the hydrolysis is  His90, the benzoyl group is surrounded by F64, F82, W89, and W137,  active site conformations of wild-type and mutant W137F <15>)  "
3.8.1.8," atrazine + H2O = hydroxyatrazine + chloride (#12# catalytic mechanism,  the Glu241 side chain provides a proton to N-1 of the s-triazine  substrate to facilitate nucleophilic displacement at the adjacent C-2,  overview <19>; #17# two plausible reaction mechanisms are proposed  involving either bidentate (a) or mondentate (b) coordination of the  atrazine Cl atom to the Fe2+ centre of the AtzA active site,  comparisons, overview <21>)  "
3.8.1.9," (R)-2-haloacid + H2O = (S)-2-hydroxyacid + halide (#5# proposed  reaction mechanism, conserved residue Arg134 plays a key role in the  dehalogenation process. Residues Arg107, Arg134 and Tyr135 interact  with the substrates and are the catalytic residues of DehD that are  involved in the dehalogenation of D-2-chloropropionate and  D-2-bromopropionate, while Glu20 activates the water molecule that  attacks the carbon halogen bond on the alpha-carbon, thereby releasing  chloride ion <8>; #5# the reaction mechanism of dehalogenation is  catalysed by hydrolytic SN2-substitution reaction <7>)  "
3.9.1.1," N-phosphocreatine + H2O = creatine + phosphate (#1,3# reaction  mechanism <2,3>; #2,3# also acts on N-phospho-arginine and other  phosphoamides <1,2>)  "
3.9.1.2, a [protein]-Nomega-phospho-L-arginine + H2O = a [protein]-L-arginine +  phosphate  
3.9.1.3, a [protein]-N-phospho-L-histidine + H2O = a [protein]-L-histidine +  phosphate  
4.1.1.1," a 2-oxo carboxylate = an aldehyde + CO2 (#4# mechanism <6,36,37,43>;  #4,26,46,79# catalytic mechanism <35,38,39,46,52>; #4# catalytic and  kinetic mechanism, catalyzes carboligation as side reaction <42>; #4#  catalytic mechanism, catalyzes the carboligation of 2 aldehydes as side  reaction, mechanism <40>; #4# catalyzes the carboligation of 2  aldehydes as a side reaction, mechanisms of both reactions <48>; #26#  catalyzes the carboligation of 2 aldehydes as a side reaction,  mechanisms of both reactions, thermodynamic data <48>; #4# mechanism,  catalyzes carboligation as side reaction <41>; #4# enzyme forms  covalent intermediate C2-alpha-lactylthiamine diphosphate. Rate of  reaction is limited by release of thiamine diphosphate <63>; #4# Glu51  is the most important residue in formation of the ylide and the release  of acetaldehyde. Glu477 and Asp28 are involved in decarboxylation of  lactylthiamine diphosphate. Protonation of alpha-carbanion to form  2-(1-hydroxyethyl)-thiamine diphosphate goes through a concerted double  proton transfer transition state involving both Asp28 and His115.  Decarboxylation of lactylthiamine diphosphate and protonation of  alpha-carbanion are two rate-limiting steps <66>; #79# in absence of  substrate, equilibrium is shifted to 4-aminopyridine thiamine  diphosphate. Carbonyl group of substrate forms a hydrogen bond to  Tyr290, geometry of substrate is well-suited for a nucleophilic attack  by ylide-thiamine diphosphate <59>; #4# reaction mechanism, overview  <71>; #4# mechanism of catalytic cycle of yeast pyruvate decarboxylase,  overview. Pyruvate and analogues induce active site asymmetry in the  wild-type yeast enzyme and mutant variants. The rare  1,4-iminopyrimidine thiamine diphosphate tautomer participates in  formation of thiamine diphosphate-bound intermediates.  Propionylphosphinate also binds at the regulatory site and its binding  is reflected by catalytic events at the active site 20 A away. The  yeast enzyme stabilizes an electrostatic model for the  4-aminopyrimidinium ionization state, an important contribution of the  protein to catalysis <121>)  "
4.1.1.100," prephenate = 3-[(4R)-4-hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate  + CO2  "
4.1.1.101, (S)-malate = (S)-lactate + CO2  
4.1.1.102, 4-coumarate = 4-vinylphenol + CO2 
4.1.1.102, trans-cinnamate = styrene + CO2 
4.1.1.102, ferulate = 4-vinylguaiacol + CO2  
4.1.1.103," 2,6-dihydroxybenzoate = 1,3-dihydroxybenzene + CO2  "
4.1.1.104, 3-dehydro-4-phospho-D-erythronate = glycerone phosphate + CO2 
4.1.1.104, 3-dehydro-4-phospho-L-erythronate = glycerone phosphate + CO2  
4.1.1.105, L-tryptophan = tryptamine + CO2  
4.1.1.106, a long-chain fatty acid + hnu = a long-chain alkane + CO2  
4.1.1.107," L-dopa + O2 + H2O = 3,4-dihydroxyphenylacetaldehyde + CO2 + NH3 + H2O2  "
4.1.1.108, L-tyrosine + O2 + H2O = (4-hydroxyphenyl)acetaldehyde + CO2 + NH3 + H2O2  
4.1.1.109, L-phenylalanine + O2 + H2O = phenylacetaldehyde + CO2 + NH3 + H2O2  
4.1.1.11," L-aspartate = beta-alanine + CO2 (#2# detailed catalytic mechanism <7>;  #15# in the apo structure, N-terminal Ser25 of alpha chain is converted  to pyruvoyl group. Substrate analogue isoasparagine becomes covalently  attached to the pyruvoyl group forming the Schiff base intermediate  prior to decarboxylation <11>)  "
4.1.1.110," (R)-3,5-bisphosphomevalonate = isopentenyl phosphate + CO2 + phosphate  "
4.1.1.111," siroheme = 12,18-didecarboxysiroheme + 2 CO2  "
4.1.1.112," oxaloacetate = pyruvate + CO2 (#14# Keq: 0.00213 1/mM, decarboxylation  favored <1>; #14,19# pyruvate + CO2 = oxaloacetae <1,10>; #7,22#  catalytic mechanism, overview. Carboxybiotin transits to the  membrane-bound beta-subunit where it is decarboxylated to biotin and  CO2 in a reaction that consumes a periplasmic proton and is coupled to  Na+ translocation from the cytoplasm to the periplasm. The reaction is  initiated by the enzyme-catalyzed decarboxylation of oxaloacetate in  the carboxyltransferase domain of the alpha-subunit, yielding pyruvate  and carboxybiotin. Subsequently, the C-terminal biotin carboxyl carrier  protein domain on the alpha-subunit translocates to the beta-subunit  where its decarboxylation is coupled to Na+ translocation. The OADC  pump is reversible: at high concentrations of extracellular Na+, the  pump will couple the downhill movement of Na+ into the cytosol with the  carboxylation of pyruvate, to form oxaloacetate <31>)  "
4.1.1.113, trans-aconitate = itaconate + CO2  
4.1.1.114, a cis-3-alkyl-4-alkyloxetan-2-one = a cis-alkene + CO2  
4.1.1.115, (1H-indol-3-yl)acetate = skatole + CO2  
4.1.1.116, D-ornithine = putrescine + CO2 (#2# (2) <1>) 
4.1.1.116, D-lysine = cadaverine + CO2 (#2# (1) <1>)  
4.1.1.117, 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate =  2-[(2-aminoethylcarbamoyl)methyl]-2-hydroxybutanedioate + CO2  
4.1.1.118, isophthalyl-CoA = benzoyl-CoA + CO2  
4.1.1.119, phenylacetate = toluene + CO2  
4.1.1.12, L-aspartate = L-alanine + CO2 (#2# mechanism <16>; #2# replacement of  the beta-carboxyl group of Asp by hydrogen occurs in an inversion mode  <17>)  
4.1.1.120, 3-oxoisoapionate = L-erythrulose + CO2  
4.1.1.121, 3-oxoisoapionate 4-phosphate = L-erythrulose 1-phosphate + CO2  
4.1.1.14, L-valine = 2-methylpropanamine + CO2  
4.1.1.15, L-glutamate = 4-aminobutanoate + CO2 (#5# reaction proceeds via radical  mechanism <40>)  
4.1.1.16, 3-hydroxy-L-glutamate = 4-amino-3-hydroxybutanoate + CO2  
4.1.1.17," L-ornithine = putrescine + CO2 (#20# mechanism, reaction proceeds via  formation of a Schiff base intermediate <34>)  "
4.1.1.18," L-lysine = cadaverine + CO2 (#13# reaction proceeds with retention of  configuration at C-2, stereochemistry <14>)  "
4.1.1.19," L-arginine = agmatine + CO2 (#72# reaction mechanism via geminal  diamine intermediate <60>; #64# the K148-loop movement may be  kinetically linked to the rate-limiting step of product release, active  site structure, mechanism <59>)  "
4.1.1.2," oxalate + H+ = formate + CO2 (#22# mechanism <13>; #5# reaction  proceeds with a single electron transfer <3>; #3,22# catalytic  mechanism <7,14,21>; #3# detailed catalytic mechanism, kinetic  mechanism <9>; #22# catalytic mechanism of oxalate decarboxylase  compared to oxalate oxidase, EC 1.2.3.4 <20>; #3# catalytic mechanism,  the N-terminal Mn-binding site can mediate catalysis involving the  important residue Asp92 <17>; #22# minimal, two step kinetic mechanism  for enzyme-catalyzed decarboxylation proton-coupled electron transfer  and decarboxylation <40>)  "
4.1.1.20," meso-2,6-Diaminoheptanedioate = L-lysine + CO2 (#10,14# stereochemistry  <11,16>)  "
4.1.1.21, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate =  5-amino-1-(5-phospho-D-ribosyl)imidazole + CO2  
4.1.1.22," L-histidine = histamine + CO2 (#62# structure-activity relationship,  active site structure, molecular modeling, the imidazole ring is  located in a pocket composed of residues Tyr-81B, Asn-302B, Ser-304B,  Lys-305B, Leu-102A, Phe-104A, and Ser-354A <60>; #62# catalytic  mechanism, quantum mechanics-molecular mechanics study and molecular  dynamics simulations using the enzymes crystal structure, PDB ID 4E1O,  overview. The reaction involves two sequential steps: the  decarboxylation of L-histidine and the protonation of the generated  intermediate from which results histamine. The rate-limiting step is  the first one with an activation barrier of 17.9 kcal/mol. In contrast,  the second step is very fast and exergonic. When the substrate  L-histidine is available in the active site of HDC, it binds to the  pyridoxal 5-phosphate cofactor. In this process, the imine bond formed  between pyridoxal 5-phosphate and Lys305A is cleaved and a new external  aldimine intermediate is created between the pyridoxal 5-phosphate  cofactor and the amino group of the substrate <113>)  "
4.1.1.23," orotidine 5'-phosphate = UMP + CO2 (#2,4,7,9# mechanism  <19,25,27,30,32,33,40>; #7# nitrogen ylide mechanism <15>; #7#  catalytic mechanism with freely reversible binding, a very limited  contribution to the overall rate is made by chemical steps preceding  decarboxylation <14>; #7,27# reaction mechanism <26,42,53>; #7# kinetic  mechanism <28>; #4,7,9# catalytic mechanism <29,34,43>; #9# mechanism,  thermodynamic data <35,38>; #14# decarboxylation mechanism, substrate  recognition mechanism with dynamic structural changes, as well as the  rearrangement of the hydrogen bond array at the active site <57>; #7#  direct decarboxylation mechanism, modeling with 6-carbanion derivatives  of uracil analogues, overview <60>; #7# reaction mechanism involving  the active site aspartate residue Asp91, electrostatic stress furnishes  the majority of the catalytic driving force for OMP decarboxylation,  ylide generation is not the rate-limiting step in the ODCase reaction  <54>; #28# catalysis by OMPDC is due to stabilization of the  decarboxylation transition state by interactions with the protein  catalyst leading to a 1023-fold rate acceleration. The falloff in the  second-order rate constants for OMPDC-catalyzed decarboxylation  observed upon the truncation of the phosphodianion and the ribosyl  phosphate from the substrate orotidine 5-phosphate (OMP), catalytic  mechanism, detailed overview. Interaction between the side chains of  Ser154 and Gln215 wild-type ScOMPDC is required to hold the amide side  chain in a position to interact with the substrate phosphodianion. The  dianion binding interactions with Gln215, Tyr217, and Arg235 serve the  exclusive function of activating OMPDC for catalysis at the pyrimidine  binding site <90>)  "
4.1.1.24, 4(or 2)-aminobenzoate = aniline + CO2  
4.1.1.25, L-tyrosine = tyramine + CO2  
4.1.1.28," L-dopa = dopamine + CO2 (#8# investigation of the mechanism by using  the absorption spectrum of the bound coenzyme as an indicator of events  <6>; #41,63# decarboxylation reaction mechanism, overview <142>; #69#  decarboxylation reaction mechanism, overview. Reaction via a Michaelis  complex and a N4-protonated external aldimine, respectively, the  substrate L-dopa preferentially binds unprotonated to the N4-protonated  internal Schiff base <142>) "
4.1.1.28, 5-hydroxy-L-tryptophan = 5-hydroxytryptamine + CO2  
4.1.1.29," 3-sulfino-L-alanine = hypotaurine + CO2 (#4# stereochemistry,  replacement of carboxyl by solvent hydrogen proceeds with retention of  configuration <10>; #5# reaction proceeds via radical mechanism <25>)  "
4.1.1.30, N-[(R)-pantothenoyl]-L-cysteine = pantetheine + CO2  
4.1.1.31, phosphate + oxaloacetate = phosphoenolpyruvate + HCO3- (#25# rapid  equilibrium random bi bi mechanism with a dead end complex  enzyme-bicarbonate <25>)  
4.1.1.32," GTP + oxaloacetate = GDP + phosphoenolpyruvate + CO2 (#1,4# the enzyme  decarboxylates oxaloacetate to form the enolate of pyruvate which is  then phosphorylated by MgGTP2- on the enzyme <24>; #6# two-step  mechanism: phosphorylation followed by decarboxylation, transition  state with carbocationic character <19>; #12# catalytic mechanism <28>)  "
4.1.1.33," ATP + (R)-5-diphosphomevalonate = ADP + phosphate + isopentenyl  diphosphate + CO2 (#8# mechanism <2>; #1# sequential mechanism <5>; #1#  thiophosphoryl group transfer proceeds with inversion of configuration  at phosphorus <10>; #1# ordered sequential mechanism with mevalonate  5-diphosphate as the first substrate to bind to the enzyme <16>; #28#  catalytic mechanism of this rare type of decarboxylase, the enzyme is  bifunctional showing the reactions of diphosphomevalonate decarboxylase  (EC 4.1.1.33) and mevalonate 3-kinase (EC 2.7.1.185), overview <66>)  "
4.1.1.34, 3-dehydro-L-gulonate = L-xylulose + CO2  
4.1.1.35, UDP-D-glucuronate = UDP-D-xylose + CO2 (#3# mechanism <4>)  
4.1.1.36, N-[(R)-4'-phosphopantothenoyl]-L-cysteine = pantotheine 4'-phosphate +  CO2 (#4# stereochemistry and mechanisms <8>; #3# C173 serves as an  active site acid in the protonation of the enethiolate intermediate  <20>)  
4.1.1.37," uroporphyrinogen III = coproporphyrinogen III + 4 CO2 (#1# mechanism  and stereochemistry <5>; #16# the decarboxylation of uroporphyrinogen  occurs in two stages, via 7 COOH and then 6 and 5 COOH intermediates,  with the decarboxylation of the 7 COOH compound being the rate-limiting  step for the reaction <51>)  "
4.1.1.38, diphosphate + oxaloacetate = phosphate + phosphoenolpyruvate + CO2 (#1#  the mechanism involves the formation of pentavalent  diphosphoenolpyruvate which then is carboxylated to yield oxaloacetate  and diphosphate <5>; #1# in the reverse direction the addition of CO2  is only to the si face of phosphoenolpyruvate <2>)  
4.1.1.39," 2 3-phospho-D-glycerate + 2 H+ = D-ribulose 1,5-bisphosphate + CO2 +  H2O (#39# mechanism <35>;  #1,2,3,5,6,10,11,14,15,16,18,20,21,22,23,25,30,33,35,36,39,42,43,45,47  48,49,50,51,57,64,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83  84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99# D-ribulose  1,5-bisphosphate + CO2 = 2 3-phospho-D-glycerate, carboxylase reaction  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26  27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50  51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70>;  #16,18,20,21,22,25,33,36,42,45,48,49,50,51,64,66,67,68,71,73,74,75,76  77,78,79,80,81,86,89,91# D-Ribulose 1,5-bisphosphate + O2 =  D-3-phosphoglycerate + 2-phosphoglycolate, oxygenase reaction  <2,9,13,17,23,26,28,42,44,52>)  "
4.1.1.4," acetoacetate + H+ = acetone + CO2 (#4# mechanism <11,19>; #4#  stereochemistry <4>; #4# Schiff base intermediate <19>; #4# the enzyme  catalyzes the reaction with net racemization <3>)  "
4.1.1.40, hydroxypyruvate = glycolaldehyde + CO2  
4.1.1.42, Carnitine = 2-methylcholine + CO2  
4.1.1.43, phenylpyruvate = phenylacetaldehyde + CO2  
4.1.1.44," (R)-2-carboxy-2,5-dihydro-5-oxofuran-2-acetate =  4,5-dihydro-5-oxofuran-2-acetate + CO2 (#4# syn-reaction <2>)  "
4.1.1.45," 2-amino-3-(3-oxoprop-1-en-1-yl)but-2-enedioate = 2-aminomuconate  semialdehyde + CO2 (#5# the decarboxylation occurs first to generate an  unstable alpha-aminomuconate-epsilon-semialdehyde intermediate, which  then undergoes a relatively slow release from the enzyme and a much  slower cyclization to yield the final product <22>)  "
4.1.1.46," 2,3-dihydroxybenzoate = catechol + CO2  "
4.1.1.47, 2 glyoxylate = 2-hydroxy-3-oxopropanoate + CO2  
4.1.1.48," 1-(2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate =  1-C-(indol-3-yl)glycerol 3-phosphate + CO2 + H2O (#35# mechanism,  structures of two putative catalytic intermediates <29>; #35# molecular  dynamics simulation study of the enzyme-substrate complex at room  temperature and at 110Â°C. Relative specific activity increases 4200fold  up to 110Â°C. Active site residues K53 and K110 control the binding of  substrate in the favorable orientation for the general acid-catalyzed  intramolecular ring formation reaction <32>; #35# molecular dynamics  study at different temperatures. K110 is the general acid, E210 the  general base. At higher temperature, the enzyme-substrate electrostatic  interaction favors the binding of the substrate in near attack  conformation, at lower temperature, the substrate is bound in  nonreactive conformation <33>)  "
4.1.1.49, ATP + oxaloacetate = ADP + phosphoenolpyruvate + CO2 (#6# sequential  mechanism <9>)  
4.1.1.5," (2S)-2-hydroxy-2-methyl-3-oxobutanoate = (3R)-3-hydroxybutan-2-one +  CO2 (#3# mechanism <23>; #9# the carboxy group of alpha-acetolactate is  replaced regiospecifically by hydrogen. This process takes place with  overall inversion of configuration <7>; #153# catalytic decarboxylation  mechanism, overview <34>)  "
4.1.1.50," S-adenosyl-L-methionine = S-adenosyl 3-(methylsulfanyl)propylamine +  CO2 (#5# mechanism <42>; #19# kinetic analysis, inverse solvent isotope  effect <43>; #31# kinetics, mechanism <55>; #4# allosteric metal ion  activation <75>)  "
4.1.1.51," 3-hydroxy-2-methylpyridine-4,5-dicarboxylate =  3-hydroxy-2-methylpyridine-5-carboxylate + CO2  "
4.1.1.52, 6-methylsalicylate = 3-methylphenol + CO2  
4.1.1.53, L-phenylalanine = phenylethylamine + CO2  
4.1.1.54, dihydroxyfumarate = 2-hydroxy-3-oxopropanoate + CO2  
4.1.1.55," 4,5-dihydroxyphthalate = 3,4-dihydroxybenzoate + CO2  "
4.1.1.56, 3-oxododecanoate = 2-undecanone + CO2  
4.1.1.57, L-methionine = 3-(methylsulfanyl)propanamine + CO2 (#1# reaction with  retention of configuration at Calpha <4>; #2# a His residue operates at  Calpha of the quinoid intermediate <5>)  
4.1.1.58, orsellinate = orcinol + CO2 (#2# mechanism <1>)  
4.1.1.59," 3,4,5-trihydroxybenzoate = 1,2,3-trihydroxybenzene + CO2  "
4.1.1.6, cis-aconitate = itaconate + CO2  
4.1.1.60, stipitatonate = stipitatate + CO2  
4.1.1.61, 4-hydroxybenzoate = phenol + CO2 (#4# mechanism <9>; #3# biological  Kolbe-Schmitt carboxylation. The formation of an enzyme-bound phenolate  anion from the activated phenolic compound is the rate-determining step  in the carboxylation reaction <4>)  
4.1.1.62," 2,5-dihydroxybenzoate = hydroquinone + CO2  "
4.1.1.63," 3,4-dihydroxybenzoate = catechol + CO2  "
4.1.1.64," 2,2-dialkylglycine + pyruvate = dialkyl ketone + CO2 + L-alanine  (#2,11# mechanism <9,16>; #2# cooperativity does not play a role in  catalysis or regulation <6>; #2# model in which the interaction between  a carboxylate group in the B subsite and Arg406 is a prerequisite to  proton donation to and removal from Calpha <7>; #2# pH-studies on the  mechanism <9>; #2# the reaction of the slower substrates  L-phenylglycine and 1-aminocyclohexane-1-carboxylate may have external  aldimine formation as the rate-determining step. The biphasic reactions  of 2-methyl-2-aminomalonate, 1-aminocyclopentane-1-carboxylate,  isopropylamine and Gly all have external aldimine formation as the  rapid observable step <8>; #11# kinetics of inhibition <14>; #2#  kinetics, a rate-limiting, concerted  Calpha-decarboxylation/c4Â’-protonation mechanism for the AIB  decarboxylation reaction and rapid equilibrium quinoid formation  followed by rate-limiting protonation to the ketimine intermediate for  the L-alanine transamination half-reaction <13>)  "
4.1.1.65, phosphatidyl-L-serine = phosphatidylethanolamine + CO2 (#6#  decarboxylation via Schiff base formation between a covalently bound  pyruvoyl prosthetic group and the amine of serine <25>; #6# a Schiff  base is formed by addition of the amino group of phosphatidylserine to  the pyruvate residue of the enzyme as an essential step in the action  of the decarboxylase <9>; #6# reaction is completely stereospecific  with overall retention of configuration <20>)  
4.1.1.66, uracil 5-carboxylate = uracil + CO2  
4.1.1.67, UDP-D-galacturonate = UDP-L-arabinose + CO2  
4.1.1.68," (3E,5R)-5-carboxy-2-oxohept-3-enedioate = (4Z)-2-oxohept-4-enedioate +  CO2 "
4.1.1.68," (3E,5R)-5-carboxy-2-oxohept-3-enedioate =  (2Z,4Z)-2-hydroxyhepta-2,4-dienedioate + CO2 "
4.1.1.68," (2Z,4Z)-2-hydroxyhepta-2,4-dienedioate = (4Z)-2-oxohept-4-enedioate  "
4.1.1.69," 3,4-dihydroxyphthalate = 3,4-dihydroxybenzoate + CO2  "
4.1.1.7, phenylglyoxylate = benzaldehyde + CO2 (#4# the reaction has two  partially rate-determining steps: initial tetrahedral adduct formation  and decarboxylation <2>)  
4.1.1.71, 2-oxoglutarate = succinate semialdehyde + CO2  
4.1.1.72, (3S)-3-methyl-2-oxopentanoate = 2-methylbutanal + CO2 (#2# binding of  cofactor thiamine diphosphate to E1b component of enzyme induces a  disorder-to-order transition of the conserved phosphorylation loop  carrying phosphorylation sites S292 and S302 <9>)  
4.1.1.73," (R,R)-tartrate = D-glycerate + CO2 (#1# reduction proceeds  concomitantly with decarboxylation, but at a much lower rate <3>)  "
4.1.1.74," 3-(indol-3-yl)pyruvate = 2-(indol-3-yl)acetaldehyde + CO2 (#1,5#  mechanism <7,8>; #1# residues E468, D29, and H115 are involved in  binding of all substrates and decarboxlation of the respective  tetrahedral thiamine-diphosphate-substrate adducts. Residue E383 is  central to substrate specificity <9>)  "
4.1.1.75, 5-guanidino-2-oxopentanoate = 4-guanidinobutanal + CO2  
4.1.1.76, 2-aryl-2-methylmalonate = 2-arylpropanoate + CO2 (#2# a hydrophobic  interaction between the enzyme and its substrate via their aromatic  rings is especially important for the enzyme function <4>)  
4.1.1.77," (3E)-2-oxohex-3-enedioate = 2-oxopent-4-enoate + CO2 (#2# mechanism  <4,5>)  "
4.1.1.78, acetylenedicarboxylate + H2O = pyruvate + CO2  
4.1.1.79, 3-sulfopyruvate = 2-sulfoacetaldehyde + CO2  
4.1.1.8, oxalyl-CoA = formyl-CoA + CO2  
4.1.1.80, 4-hydroxyphenylpyruvate = 4-hydroxyphenylacetaldehyde + CO2  
4.1.1.81, L-threonine O-3-phosphate = (R)-1-aminopropan-2-yl phosphate + CO2  
4.1.1.82, 3-phosphonopyruvate = 2-phosphonoacetaldehyde + CO2  
4.1.1.83, (4-hydroxyphenyl)acetate + H+ = 4-methylphenol + CO2  
4.1.1.84," D-dopachrome = 5,6-dihydroxyindole + CO2 (#2# animal experiments with  CCl4 injections, results suggest that the increase in DDT is a response  to liver damage, accelerates melanin biosynthesis and protects the  liver from oxidative stress induced by CCl4 <11>)  "
4.1.1.85," 3-dehydro-L-gulonate 6-phosphate + H+ = L-xylulose 5-phosphate + CO2  (#5# active site structure, substrate binding structure, formation of a  cis-1,2-enediolate anion intermediate, intermediate structure and  reaction mechanism involving residues Lys64, Asp67, and His136,  overview <2>; #6# active site structure, substrate binding structure,  structure-function relationship, overview <6>; #3# catalytic mechanism,  formation and Mg2+-stabilization of an cis-1,2-enediolate anion  intermediate, important residues for the stereospecific exchange of the  pro-1S hydrogen are Lys64, Asp67, Glu112, Arg139, and Lys64, the latter  stabilizes the intermediate via hydrogen bonds to O1 and O2 of the  intermediate involving conserved active site residue Asp67, His136  takes part in hydrogen exchange with solvent of the 1-hydroxymethylene  group of the product, overview <3>; #5# formation and stabilization of  an 1,2-enediolate anion intermediate, protonation of the intermediate  involving residues Glu112, His136, and Arg139, active site  structure-function relationship, overview <4>; #5# formation and  stabilization of an enediolate anion intermediate is part of reaction  mechanism, mechanism overview, the active site is located at the dimer  interface, structure-function relationship, overview <1>)  "
4.1.1.86," L-2,4-diaminobutanoate = propane-1,3-diamine + CO2  "
4.1.1.87, a malonyl-[acyl-carrier protein] + H+ = an acetyl-[acyl-carrier  protein] + CO2 (#1# malonate decarboxylation proceeds in two steps: the  acetyl residue on the acyl carrier protein is first replaced by a  malonyl residue which subsequently undergoes decarboxylation thereby  regenerating the acetyl-S-acyl carrier protein <1>)  
4.1.1.88," malonate + H+ + Na+[side 1] = acetate + CO2 + Na+[side 2] (#2# malonate  decarboxylation proceeds by a catalytic cycle in which the acetyl group  on the active enzyme is displaced by malonate, which binds covalently  to a thiol group on the enzyme and is subsequently decarboxylated <8>;  #3# malonate decarboxylation proceeds in two steps: the acetyl residue  on the acyl carrier protein is first replaced by a malonyl residue  which subsequently undergoes decarboxylation thereby regenerating the  acetyl-S-acyl carrier protein <4>; #1,2# reaction proceeds with  retention of configuration <1>)  "
4.1.1.9," malonyl-CoA = acetyl-CoA + CO2 (#14# stereospecific reaction,  replacement of the carboxyl group by hydrogen occurs with retention of  configuration <11>; #21# half-of-the-sites reaction mechanism, overview  <64>)  "
4.1.1.90," peptidyl-4-carboxyglutamate + 2,3-epoxyphylloquinone + H2O =  peptidyl-glutamate + CO2 + O2 + phylloquinol (#3# in the physiological  process reaction runs in reversed direction <4>)  "
4.1.1.91, salicylate = phenol + CO2  
4.1.1.92, indole-3-carboxylate = indole + CO2  
4.1.1.93," pyrrole-2-carboxylate = pyrrole + CO2 (#1# the enzyme catalyses both  the carboxylation and decarboxylation reactions. However, while  bicarbonate is the preferred substrate for the carboxylation reaction,  decarboxylation produces carbon dioxide <2>) "
4.1.1.93," pyrrole-2-carboxylate + H2O = pyrrole + HCO3- (#1# the enzyme catalyses  both the carboxylation and decarboxylation reactions. However, while  bicarbonate is the preferred substrate for the carboxylation reaction,  decarboxylation produces carbon dioxide <2>)  "
4.1.1.94, (S)-ethylmalonyl-CoA = butanoyl-CoA + CO2  
4.1.1.95, L-glutamyl-[BtrI acyl-carrier protein] = 4-amino butanoyl-[BtrI  acyl-carrier protein] + CO2  
4.1.1.96, carboxynorspermidine = bis(3-aminopropyl)amine + CO2 
4.1.1.96, carboxyspermidine = spermidine + CO2  
4.1.1.97," 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate =  (S)-allantoin + CO2  "
4.1.1.98, a 4-hydroxy-3-polyprenylbenzoate = a 2-polyprenylphenol + CO2  
4.1.1.99, ATP + (R)-5-phosphomevalonate = ADP + phosphate + isopentenyl phosphate  + CO2  
4.1.2.10," (R)-mandelonitrile = cyanide + benzaldehyde (#13# based on the binding  geometry, a reaction mechanism is proposed that involves one of the two  conserved active site histidine residues acting as a general base  abstracting the proton from the cyanohydrin hydroxyl group.  Site-directed mutagenesis shows that both active site histidines are  required for the reaction to occur <23>)  "
4.1.2.11, (S)-4-Hydroxymandelonitrile = cyanide + 4-hydroxybenzaldehyde  
4.1.2.12, 2-dehydropantoate = 3-methyl-2-oxobutanoate + formaldehyde  
4.1.2.13," D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde  3-phosphate (#12,13# mechanism <70,72,82>; #13# Schiff base  intermediate is formed at the epsilon-amino group of Lys229 <63>;  #1,19,44# in class I fructose diphosphate aldolases a Schiff base  intermediate is formed between glycerone phosphate or fructose  1,6-diphosphate and an epsilon-amino group of a Lys residue at the  active site of the enzyme <2,8,21>; #24# ordered uni-bi reaction  mechanism <41>; #19# proton-transfer mechanism involving Lys-229,  Glu-187 and Lys-146 <37>; #6,7# mechanism and energetic aspects of  class I aldolases <40>; #12# the enzyme binds and utilizes only the  carbonyl forms of fructose 1,6-diphosphate and glycerone phosphate  <42>; #139# mechanism of class II aldolase <81>; #42#  fructose-1,6-bisphosphate aldolase cytosolic class I as an NMH7 MADS  domain-associated protein <126>)  "
4.1.2.14," 2-dehydro-3-deoxy-6-phospho-D-gluconate = pyruvate + D-glyceraldehyde  3-phosphate (#5,22# mechanism <7,26>; #5# stereochemistry, both the  exchanging proton from water and D-glyceraldehyde-3-phosphate attack  the same face of the enzyme-bound pyruvyleneamine <9>; #5# Schiff base  formation between a lysine epsilon-amino group and carbonyl compounds  6-phospho-2-dehydro-3-deoxy-D-gluconate <7>; #19# a mechanism is  proposed that is based on the crystallographic studies <29>; #2# a  mechanism is proposed that is based on the crystallographic studies of  mutant enzyme E45N <29>)  "
4.1.2.17, L-Fuculose 1-phosphate = glycerone phosphate + (S)-lactaldehyde (#2#  mechanism <6>)  
4.1.2.18, 2-Dehydro-3-deoxy-L-pentonate = pyruvate + glycolaldehyde  
4.1.2.19, L-Rhamnulose 1-phosphate = glycerone phosphate + (S)-lactaldehyde  
4.1.2.2, erythrulose 1-phosphate = glycerone phosphate + formaldehyde  
4.1.2.20, 2-dehydro-3-deoxy-D-glucarate = pyruvate + 2-hydroxy-3-oxopropanoate  (#7# mechanism <8>)  
4.1.2.21, 2-dehydro-3-deoxy-6-phospho-D-galactonate = pyruvate + D-glyceraldehyde  3-phosphate  
4.1.2.22, D-Fructose 6-phosphate + phosphate = acetyl phosphate + D-erythrose  4-phosphate + H2O  
4.1.2.23, 3-deoxy-D-manno-octulosonate = pyruvate + D-arabinose (#12# attack of  pyruvate takes place on the re face of the carbonyl group of aceptor  substrates <6>; #12# the enzyme may accept the open form of aldoses as  acceptors in the aldol condensation <4>)  
4.1.2.24," N,N-dimethylaniline N-oxide = N-methylaniline + formaldehyde  "
4.1.2.25," 7,8-dihydroneopterin = 6-(hydroxymethyl)-7,8-dihydropterin +  glycolaldehyde (#1,3# mechanism <8,10>; #3# polarization of the  2-hydroxy group of the substrate can serve as the initial reaction step  for the aldolase <7>)  "
4.1.2.26, L-threo-3-Phenylserine = glycine + benzaldehyde  
4.1.2.27," Sphinganine 1-phosphate = phosphoethanolamine + palmitaldehyde (#3#  mechanism <17>; #6# possible reaction mechanism for the enzyme  <2,4,5,6>; #6# irreversible reaction <1>; #8# enzyme is stereospecific  for the D-erythro sphingoid base <10>; #6# enzyme-catalyzed conversion  of (2S,3R)-sphinganine 1-phosphate to ethanolamine 1-phosphate involves  the stereospecific incorporation of one atom of solvent hydrogen at  carbon atom 2 of the latter compound <6>; #6# pyridoxal phosphate  dependent catalysis <1>; #1,4,5,6,7,10,13,16# enzyme has been  classified within the group of carbon-carbon lyases a subclass of  aldehyde-lyases (Enzyme Nomenclature 1984) <8>)  "
4.1.2.28, 2-Dehydro-3-deoxy-D-pentonate = pyruvate + glycolaldehyde  
4.1.2.29, 5-dehydro-2-deoxy-D-gluconate 6-phosphate = glycerone phosphate +  malonate semialdehyde  
4.1.2.32," trimethylamine N-oxide = dimethylamine + formaldehyde (#2#  non-oxidative, non-hydrolytic cleavage <1>)  "
4.1.2.33," (24R,241R)-fucosterol epoxide = desmosterol + acetaldehyde  "
4.1.2.34, (3Z)-4-(2-carboxyphenyl)-2-oxobut-3-enoate + H2O = 2-formylbenzoate +  pyruvate  
4.1.2.35, 4-hydroxy-3-hexanone = 2 propanal  
4.1.2.36, (S)-lactate = formate + acetaldehyde  
4.1.2.38," 2-hydroxy-1,2-diphenylethanone = 2 benzaldehyde  "
4.1.2.4," 2-deoxy-D-ribose 5-phosphate = D-glyceraldehyde 3-phosphate +  acetaldehyde (#3# mechanism <10>; #1,6# Schiff base intermediate  <1,16>; #1# forms a Schiff base intermediate with the substrate  acetaldehyde <6>; #1# complete equilibration of the methyl-group  protons of the product, acetaldehyde, occurs before its release from  the enzyme surface <17>)  "
4.1.2.40," D-tagatose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde  3-phosphate (#2# mechanism <7>; #2# kinetics <6>)  "
4.1.2.42, D-threonine = glycine + acetaldehyde (#3# mechanism <3>) 
4.1.2.42, D-allothreonine = glycine + acetaldehyde  
4.1.2.43, D-arabino-hex-3-ulose 6-phosphate = D-ribulose 5-phosphate +  formaldehyde  
4.1.2.44," 2,3-epoxy-2,3-dihydrobenzoyl-CoA + 2 H2O = (3Z)-6-oxohex-3-enoyl-CoA +  formate  "
4.1.2.45, (3E)-4-(2-hydroxyphenyl)-2-oxobut-3-enoate + H2O = salicylaldehyde +  pyruvate  
4.1.2.46, (2R)-2-hydroxy-2-methylbutanenitrile = cyanide + butan-2-one  
4.1.2.47," an aliphatic (S)-hydroxynitrile = cyanide + an aliphatic aldehyde or  ketone (#6# proposed reaction mechanism: in free enzyme, the hydroxyl  group of Ser80 is hydrogen-bonded to the imidazole nitrogen of His236,  which in turn is stabilized by a hydrogen bond with Asp208. If the  enzyme encounters a substrate molecule, the proton of Ser80 is rapidly  transferred to an imidazole nitrogen of His236. The resulting oxyanion  of Ser80 functions as a strong base in a nucleophilic attack of the  substrate hydroxyl proton, leading to a negatively charged oxyanion on  the substrate. This oxyanion could be stabilized by an oxygen hole  formed by amide nitrogen of the backbone of Ser80 and Gly78. Both  residues belong to the consensus motif, which is typical for  nucleophils located in a catalytic triad. The stabilized oxyanion could  further increase the local positive charge on the alpha-C atom of the  cyanohydrin, allowing the cyanide group to leave the molecule <60>) "
4.1.2.47, an aromatic (S)-hydroxynitrile = cyanide + an aromatic aldehyde  
4.1.2.48, L-threonine = glycine + acetaldehyde 
4.1.2.48, L-allo-threonine = glycine + acetaldehyde  
4.1.2.49, L-allo-threonine = glycine + acetaldehyde  
4.1.2.5, L-threonine = glycine + acetaldehyde  
4.1.2.50," 7,8-dihydroneopterin 3'-triphosphate + H2O =  6-carboxy-5,6,7,8-tetrahydropterin + acetaldehyde + triphosphate (#2#  reaction mechanism, overview <1>)  "
4.1.2.51, 2-dehydro-3-deoxy-D-gluconate = pyruvate + D-glyceraldehyde  
4.1.2.52, 4-hydroxy-2-oxoheptanedioate = pyruvate + succinate semialdehyde (#1#  rapid equilibrium random order mechanism <1>)  
4.1.2.53, 2-dehydro-3-deoxy-L-rhamnonate = pyruvate + (S)-lactaldehyde  
4.1.2.54, 2-dehydro-3-deoxy-L-galactonate = pyruvate + L-glyceraldehyde  
4.1.2.55, 2-dehydro-3-deoxy-6-phospho-D-gluconate = pyruvate + D-glyceraldehyde  3-phosphate (#5# (1) <11>) 
4.1.2.55, 2-dehydro-3-deoxy-6-phospho-D-galactonate = pyruvate + D-glyceraldehyde  3-phosphate (#5# (2) <11>)  
4.1.2.56," 2-amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate = glycerone  phosphate + L-aspartate 4-semialdehyde  "
4.1.2.57, 6-deoxy-6-sulfo-D-fructose 1-phosphate = glycerone phosphate +  2-hydroxy-3-oxopropane-1-sulfonate  
4.1.2.58," 2-dehydro-3,6-dideoxy-6-sulfo-D-gluconate = (2S)-3-sulfolactaldehyde +  pyruvate  "
4.1.2.59," 7,8-dihydroneopterin 3'-phosphate = 6-(hydroxymethyl)-7,8-dihydropterin  + glycolaldehyde phosphate  "
4.1.2.60," 7,8-dihydroneopterin 3'-triphosphate =  6-(hydroxymethyl)-7,8-dihydropterin + glycolaldehyde triphosphate  "
4.1.2.61, 4-hydroxy-3-methoxyphenyl-beta-hydroxypropanoyl-CoA = feruloyl-CoA + H2O 
4.1.2.61, 3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoyl-CoA = vanillin +  acetyl-CoA 
4.1.2.61, feruloyl-CoA + H2O =  3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoyl-CoA 
4.1.2.61, feruloyl-CoA + H2O = vanillin + acetyl-CoA  
4.1.2.62, 5-deoxy-D-ribulose 1-phosphate = glycerone phosphate + acetaldehyde 
4.1.2.62, S-methyl-5-thio-D-ribulose 1-phosphate = glycerone phosphate +  (2-methylsulfanyl)acetaldehyde  
4.1.2.63, a 2-hydroxy-3-methyl-Cn-fatty-acyl-CoA = a 2-methyl-branched Cn-1-fatty  aldehyde + formyl-CoA 
4.1.2.63, a (2R)-2-hydroxy-Cn-long-chain fatty acyl-CoA = a Cn-1-long-chain fatty  aldehyde + formyl-CoA  
4.1.2.8," (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate = indole +  D-glyceraldehyde 3-phosphate (#7# the indole is further converted to  2,4-dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one, a secondary plant  metabolite. BX1 cleaves indole-3-glycerol phosphate significantly  faster to indole and glyceraldehyde 3-phosphate than the homologous  alpha-subunit of tryptophan synthase, EC 4.2.1.20. In the primary  metabolism, indole diffuses through the connecting tunnel to the  beta-active site where it is condensed with serine to form tryptophan  and water <1>)  "
4.1.2.9, D-Xylulose 5-phosphate + phosphate = acetyl phosphate +  D-glyceraldehyde 3-phosphate + H2O  
4.1.3.1," isocitrate = succinate + glyoxylate (#52# kinetic mechanism is the same  in microgravity and in standard g controls <48>; #27# common mechanism  for catalysis with succinate: (1) an unfavorable prebinding  isomerization of the active site Cys191-His193 pair to the  thiolate-imidazolium form, a process that is favored in D2O, and (2)  the transfer of a proton from succinate or 3-NP to Cys191 <110>)  "
4.1.3.13, 3-Oxalomalate = oxaloacetate + glyoxylate  
4.1.3.14, L-erythro-3-hydroxy-aspartate = glycine + glyoxylate  
4.1.3.16, 4-hydroxy-2-oxoglutarate = pyruvate + glyoxylate  
4.1.3.17, 4-hydroxy-4-methyl-2-oxoglutarate = 2 pyruvate 
4.1.3.17," 2-hydroxy-4-oxobutane-1,2,4-tricarboxylate = oxaloacetate + pyruvate  "
4.1.3.22, (2S)-2-hydroxy-2-methylbutanedioate = acetate + pyruvate (#2#  reversible nucleophilic addition of acetyl thioester to carbonyl groups  with inversion of congfiguration <6>)  
4.1.3.24, (S)-malyl-CoA = acetyl-CoA + glyoxylate (#2# in the reverse direction  ordered sequential mechanism with glyoxylate binding prior to  acetyl-CoA <5>) 
4.1.3.24," (2R,3S)-2-methylmalyl-CoA = propanoyl-CoA + glyoxylate  "
4.1.3.25, (3S)-citramalyl-CoA = acetyl-CoA + pyruvate  
4.1.3.26, 3-hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA =  7-methyl-3-oxooct-6-enoyl-CoA + acetate  
4.1.3.27," chorismate + L-glutamine = anthranilate + pyruvate + L-glutamate  (#43,52# mechanism <44,45>; #4,35# sequential mechanism <2,16>; #1#  trans-6-amino-5-[(2-carboxyethenyl)-oxy]-1  3-cyclohexadiene-1-carboxylic acid is an enzyme-bound inhibitor <28>;  #1# thermodynamics <40>)  "
4.1.3.3," aceneuramate = N-acetyl-D-mannosamine + pyruvate (#2,7,11# mechanism  <2,26,28,30,31>; #2# the enzyme catalyzes a Bi-Uni ordered condensation  reaction in which pyruvate binds first to the enzyme to form a  catalytically important Schiff base. Tyr137 acts as the proton donor to  the aldehyde oxygen of ManNAc during the reaction, the activation  barrier is dominated by carbon-carbon bond formation, and proton  transfer from Tyr137 is required to obtain a stable Neu5Ac-Lys165  Schiff base complex. A triad of residues, Tyr137, Ser47, and Tyr110  from a neighboring subunit, are required to correctly position Tyr137  for its function <55>)  "
4.1.3.30," (2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate = succinate + pyruvate  (#1,10# mechanism <6,9>)  "
4.1.3.32," (2R,3S)-2,3-dimethylmalate = propanoate + pyruvate (#3# cleavage  reaction on (2R,3S)-2,3-dimethylmalate lyase proceeds with inversion of  configuration at C-3 of the substrate which becomes C-2 of propanoate  <3>)  "
4.1.3.34, (3S)-citryl-CoA = acetyl-CoA + oxaloacetate  
4.1.3.35, (1-hydroxycyclohexan-1-yl)acetyl-CoA = acetyl-CoA + cyclohexanone  
4.1.3.36," 4-(2-carboxyphenyl)-4-oxobutanoyl-CoA = 1,4-dihydroxy-2-naphthoyl-CoA +  H2O (#10# the enzyme is an essential enzyme in vitamin K biosynthesis,  which is responsible for conversion of o-succinylbenzoyl-CoA to  1,4-dihydroxy-2-naphthoyl-CoA via catalysis of a multiple-step  intramolecular Claisen condensation reaction, proposed reaction  mechanism, overview <15>; #2# the enzyme is an essential enzyme in  vitamin K biosynthesis, which is responsible for conversion of  o-succinylbenzoyl-CoA to DHNACoA via catalysis of a multiple-step  intramolecular Claisen condensation reaction, proposed reaction  mechanism, overview <15>; #2,10# unique induced-fit catalytic mechanism  which involves intersubunit interactions, overview <16>)  "
4.1.3.38," 4-amino-4-deoxychorismate = 4-aminobenzoate + pyruvate (#11# catalytic  mechanism, overview <12>)  "
4.1.3.39," (S)-4-hydroxy-2-oxopentanoate = acetaldehyde + pyruvate (#2# reaction  mechanism <2>; #6# rapid equilibrium random order mechanism <6>; #2#  active site structure, molecular channeling of substrate and  intermediate <3>; #3# compulsory order mechanism, with pyruvate binding  first <6>)  "
4.1.3.4," (S)-3-Hydroxy-3-methylglutaryl-CoA = acetyl-CoA + acetoacetate (#1,2#  identification of reactive cysteines, possibly regulatory mechanism via  thiol/disulfide exchange <11,14>; #5# enzyme is stereospecific and  proceeds with inversion of configuration <6>; #2# identification of  functionally important S69 <13>; #13# C237 is crucial for catalysis <7>)  "
4.1.3.40, chorismate = 4-hydroxybenzoate + pyruvate  
4.1.3.41, threo-3-hydroxy-D-aspartate = glycine + glyoxylate 
4.1.3.41, D-erythro-3-hydroxyaspartate = glycine + glyoxylate  
4.1.3.42, (4S)-4-hydroxy-2-oxoglutarate = pyruvate + glyoxylate  
4.1.3.43, (S)-4-hydroxy-2-oxohexanoate = propanal + pyruvate  
4.1.3.44, N1-methylguanine37 in tRNAPhe + pyruvate + S-adenosyl-L-methionine =  4-demethylwyosine37 in tRNAPhe + L-methionine + 5'-deoxyadenosine + CO2  + H2O  
4.1.3.45," chorismate = 3-hydroxybenzoate + pyruvate (#5# a hydrolysis-elimination  mechanism for CH-Hyg5 is observed. No external oxygen is incorporated  into the Hyg5 products indicated an intramolecular mechanism for the  Hyg5 reaction. A pericyclic mechanism, as described for  chorismate-converting enzymes producing the 2- and 4-regioisomeric  hydroxybenzoates, can also be ruled out due to the position of the  hydroxyl group in 3-hydroxybenzoate. Arene oxide reaction mechansim  analysis, overview <5>; #5# intramolecular mechanism catalyzed by  enzyme Hyg5, overview. Reaction steps are: 1. the protonation of the  methylene group of CHO, 2. nucleophilic attack of the activated  4-hydroxyl group, and 3. rearrangement of the arene oxide <7>; #5# the  reaction of Hyg5 undergoes an arene oxide mechanism. First is,  accompanied by the protonation of the methylene group, the C3-O8 bond  cleavage, a concerted but asynchronous process with an energy barrier  of 26.3 kcal/mol. The subsequent arene oxide formation step is quite  rapid with an energy barrier of 3.7 kcal/mol. The last step is the  selective ring-opening directed by C327. Residue E334 plays key roles  in the formation and opening of the arene oxide intermediate <8>)  "
4.1.3.46, (3R)-citramalyl-CoA = acetyl-CoA + pyruvate  
4.1.3.6, citrate = acetate + oxaloacetate  
4.1.99.1," L-tryptophan + H2O = indole + pyruvate + NH3 (#1,6# mechanism  <34,35,38>; #1# in the reverse direction NH4+ interacts with bound  pyridoxal 5-phosphate to form an imine. Pyruvate is the second  substrate, indole the third. alpha-Aminoacrylate functions as a common  enzyme-bound intermediate in both synthetic and degradative reactions  <24>; #1# mechanism that requires two catalytic bases <1>; #1#  mechanism, solvent effects <37>; #1# reaction mechanism, overview <71>;  #1# quinonoid intermediate formation involving Tyr71 and Cys298,  mechanism, active site preorganization, overview <70>; #44# an active  site base is essential for activity, and alpha-deuterated substrate  exhibits modest primary isotope effects on kcat and kcat/Km, suggesting  that substrate deprotonation is partially rate-limiting. Pre-steady  state kinetics with enzyme TIL show rapid formation of an external  aldimine intermediate, followed by deprotonation to give a quinonoid  intermediate absorbing at about 500 nm. The mechanism of TIL requires  both substrate strain and acid/base catalysis, and substrate strain is  probably responsible for the very high substrate specificity of TIL.  Acid-base catalysis mechanism of TIL, overview. The indole ring is  preorganized into the active conformation before alpha-deprotonation  occurs <82>; #47# an active site base is essential for activity, and  alpha-deuterated substrate exhibits modest primary isotope effects on  kcat and kcat/Km, suggesting that substrate deprotonation is partially  rate-limiting. Pre-steady state kinetics with enzyme TIL show rapid  formation of external an aldimine intermediate, followed by  deprotonation to give a quinonoid intermediate absorbing at about 500  nm. The mechanism of TIL requires both substrate strain and acid/base  catalysis, and substrate strain is probably responsible for the very  high substrate specificity of TIL. Acid-base catalysis mechanism of  TIL, overview. The indole ring is preorganized into the active  conformation before alpha-deprotonation occurs <82>; #44# catalyses the  reaction in which L-tryptophan is degraded to indole, pyruvate and  ammonia via alpha,beta-elimination and beta-replacement mechanisms  <75>; #44# proposed mechanism of tryptophan indole-lyase, overview  <80>; #44# reaction via formation of quinonoid intermediate <74>)  "
4.1.99.11," benzylsuccinate = toluene + fumarate (#2# mechanism <10>; #3#  stereospecific radical addition of toluene to fumarate, enzyme carries  a stable organic free radical, most probably located on glycine residue  828 <1>; #17# substrate binding stabilizing the active site and  reaction mechanism via glycyl radical, detailed overview. Syn addition  of toluene to fumaric acid and facilitation of a mechanism that retains  the hydrogen abstracted from the methyl group of toluene within the  succinyl moiety. The stability of substrates at the active site and the  occurrence of feasible radical transfer distances between the thiyl  radical, substrates, and the active site glycine indicate a  substrate-assisted radical transfer pathway governing fumarate addition  <19>; #22# benzylsuccinate synthase (BSS) catalyzes the formation of a  C-C bond between toluene and fumarate by a radical mechanism, overview.  An enzyme-bound glycyl radical cofactor transiently forms a  catalytically essential enzyme-bound thiyl (Cys) radical <24>; #22#  benzylsuccinate synthase (BSS) catalyzes the formation of a C-C bond  between toluene and fumarate by a radical mechanism. BSS binds  substrates in a buried active site and uses conformational changes to  gate access. The C-C bond-forming reaction performed by BSS requires an  oxygen-sensitive radical cofactor. BSS contains a backbone glycyl  radical in its activated form. The two substrates adopt orientations  that appear ideal for radical-mediated C-C bond formation, the methyl  group of toluene is positioned between fumarate and a cysteine that  forms a thiyl radical during catalysis, which is in turn adjacent to  the glycine that serves as a radical storage residue. Toluene is held  in place by fumarate on one face and tight packing by hydrophobic  residues on the other face and sides. These hydrophobic residues appear  to become ordered, thus encapsulating toluene, only in the presence of  BSSbeta, a small protein subunit that forms a tight complex with  BSSalpha, the catalytic subunit. Substrates can enter the active site  through a channel, which can be blocked by subunit beta, BSSbeta plays  a role in gating active site accessibility <22>; #11,22,23# DFT model  of the reaction mechanism of BSS, mechanistic modeling <23>; #22#  reaction mechanism of enzymatic radical C-C coupling by benzylsuccinate  synthase, molecular dynamics (MD) simulations and quantum mechanics  (QM) modeling, detailed overview. The enzyme is a glycyl radical enzyme  that catalyzes the enantiospecific fumarate addition to toluene  initiating its anaerobic metabolism in the denitrifying bacterium  Thauera aromatica, and this reaction represents the general mechanism  of toluene degradation in all known anaerobic degraders. The  enantiospecificity of the enzyme seems to be enforced by a  thermodynamic preference for binding of fumarate in the  pro-(R)-orientation and reverse preference of benzyl radical attack on  fumarate in pro-(S)-pathway which results with prohibitively high  energy barrier of the radical quenching <21>)  "
4.1.99.12," D-ribulose 5-phosphate = formate + L-3,4-dihydroxybutan-2-one  4-phosphate (#2# reaction mechanism <13>; #2,4,10# catalytic mechanism  <5,7,14>; #14# active site and reaction mechanism, structure-function  relationship, structural coordination spheres are important, residues  of the first coordination sphere involved in metal binding are  indispensable for catalytic activity, Glu185 is essential for catalytic  activity <10>; #5# active site architecture <2>; #6# active site  structure and catalytic mechanism, modeling of the substrate ribulose  5-phosphate bound in the active site with the phosphate group anchored  at the sulfate site and the placement of the ribulose group guided by  the glycerol site, the catalytic reaction involves residues Asp41,  Cys66, and Glu174, and the Asp99-His136 dyad <4>; #13# catalytic  reaction mechanism, substrate recognition and active site structure,  active site consists of three glutamates, two aspartates, two  histidines, and a cysteine which may provide the means for general acid  and base catalysis and for coordinating the Mg2+ cofactor within the  active site <16>; #5# reaction mechanism involving intramolecular  skeletal rearrangement, a cluster of charged amino acid residues  comprising Arg25, Glu26 and Glu28, Asp21 and Asp30 is essential for  catalytic activity, as well as His164 and Glu185 <8>; #9# reaction  mechanism, the enzyme possesses an essential acidic active-site loop  <12>; #1# RibA is a bifunctional enzyme possessing  3,4-dihydroxy-2-butanone 4-phosphate synthase activity located in the  N-terminal half of the protein and GTP cyclohydrolase II activity, EC  3.5.4.25, of the C-terminal domain, overview <11>; #19# reaction  mechanism, detailed overview <26>)  "
4.1.99.13," (6-4) photoproduct (in DNA) = 2 pyrimidine residues (in DNA) (#4# A  mechanism is proposed in which the histidines residues His 354 and His  358 catalyze the formation of the four-membered ring intermediate in  the repair process of this enzyme. When deuterium oxide is used as a  solvent, the repair activity is decreased. The proton transfer shown by  this isotope effect supports the proposed mechanism <2>; #1,2,3,4,5,6#  The overall repair reaction consists of two distinct steps, one of  which is light-independent and the other one light-dependent. In the  initial light-independent step, a 6-iminium ion is thought to be  generated via proton transfer induced by two histidines highly  conserved among the (6-4) photolyases.This intermediate spontaneously  rearranges to form an oxetane intermediate by intramolecular  nucleophilic attack. In the subsequent light-driven reaction, one  electron is believed to be transferred from the fully reduced FAD  cofactor (FADH-) to the oxetane intermediate thus forming a neutral  FADH radical and an anionic oxetane radical, which spontaneously  fractures. The excess electron is then back-transferred to the flavin  radical restoring the fully reduced flavin cofactor and a pair of  pyrimidine bases <5,6,7,8,11,12,13,14,15,16,17,18,19,20>; #4# Fourier  transform infrared spectroscopy is applied to (6-4)DNA photolyase.  Differences in FTIR spectra that correspond to (6-4)DNA photolyase  photoactivation, substrate binding, and light-dependent DNA repair  processes are reported. The presence of DNA carrying a single (6-4) PP  uniquely influences vibrations of the protein backbone and a protonated  carboxylic acid, whereas photoactivation produces IR spectral changes  for the FAD cofactor and the surrounding protein. Difference FTIR  spectra for the light-dependent DNA damage repair reaction directly  show significant DNA structural changes in the (6-4) lesion and the  neighboring phosphate group. Time-dependent illumination of samples  with different enzyme:substrate stoichiometries successfully  distinguish signals characteristic of structural changes in the protein  and the DNA resulting from binding and catalysis <29>; #12# repair of  Dewar valence isomers by (6-4) photolyases involves the rearrangement  of the Dewar lesions into the corresponding (6-4) lesions. This  reaction requires electron injection. (6-4) photolyases have two  catalytic functions: Splitting (6-4) lesions and catalyzing the formal  4pi sigmatropic rearrangement of Dewar isomers to (6-4) lesions <32>;  #4# time-resolved measurements are performed of radical formation,  diffusion, and protein conformational changes during light-dependent  repair by full-length (6-4) photolyase on DNA carrying a single  UV-induced damage. The (6-4) photolyase shows significant volume  changes after blue-light activation, indicating protein conformational  changes distant from the flavin cofactor. A drastic diffusion change is  observed only in the presence of both (6-4) photolyase and damaged DNA,  and not for (6-4) photolyase alone or with undamaged DNA <33>; #3#  ultrafast spectroscopy is used to show that the key step in the repair  photocycle is a cyclic proton transfer between the enzyme and the  substrate. By femtosecond synchronization of the enzymatic dynamics  with the repair function, direct electron transfer from the excited  flavin cofactor to the 6-4 photoproduct is observed in 225 ps but fast  back electron transfer in 50 ps without repair. The catalytic proton  transfer between a histidine residue in the active site and the 6-4  photoproduct, induced by the initial photoinduced electron transfer  from the excited flavin cofactor to 6-4 photoproduct, occurs in 425 ps  and leads to 6-4 photoproduct repair in tens of nanoseconds <34>; #1#  using quantum mechanics/molecular mechanics studies, a repair mechanism  is proposed, which involves two photoexcitations. The flavin  chromophore, initially being in its reduced anionic form, is  photoexcited and donates an electron to the (6-4) form of the  photolesion. The photolesion is then protonated by the neighboring  histidine residue and forms a radical intermediate. A second  photoexcitation of the flavin promotes another electron transfer to the  oxetane. Proton donation from the same histidine residue allows for the  splitting of the four-membered ring, hence opening an efficient pathway  to the final repaired form <31>; #1# repair photocycle of (6-4) thymine  photoproduct by (6-4) photolyase, which involves light absorption by  the 8-HDF cofactor and transfer of the excitation energy to the FADH-.  Intermolecular Coulombic decay resulting in an electron transfer from  FADH? to the dimer initiating the splitting process, mechanism,  detailed overview. The mechanism requires the C5-OH transfer from C5 of  the 5 thymine to the C4 of the 3 thymine followed by H transfer to the  N3 of the 3 thymine. Of two conserved histidine residues, only His365  is protonated <38>; #22# in the formation of the (6-4) PPs, a  Paterno-Buechi reaction first yields an oxetane-bridged (or  azetidine-bridged for cytosine at 3) intermediate. This structure is  thermodynamically unstable and rearranges to form a (6-4) PP. During  this reaction, the O4 (or N4H) in the 3 component is transferred to the  5-component and has thus to be returned to 3 during the repair  reaction. Reaction mechanism of repair of (6-4) lesions by (6-4)  photolyase, detailed overview. The repair-active redox state of the FAD  cofactor is fully reduced FADH- and (6-4) PP-containing substrates are  bound in a specific manner. No thermal oxetane formation <48>; #17#  photoreduction of PhrB differs from the typical pattern because the  amino acid of the electron cascade next to FAD is a tyrosine (Tyr391),  whereas photolyases and cryptochromes of other groups have a tryptophan  as direct electron donor of FAD. Residues Trp342 and Trp390 are  essential for charge transfer, Trp342 is located at the periphery of  PhrB, while Trp390 connects Trp342 and Tyr391. Charge transfer occurs  via the triad 391-390-342. Charge transfer simulations reveal an  unusual stabilization of the positive charge on site 391 compared to  other photolyases or cryptochromes. Water molecules near Tyr391 offer a  polar environment which stabilizes the positive charge on this site,  thereby lowering the energetic barrier intrinsic to tyrosine. This  opens a second charge transfer channel in addition to tunnelling  through the tyrosine barrier, based on hopping and therefore transient  oxidation of Tyr391, which enables a fast charge transfer similar to  proteins utilizing a tryptophan-triad <42>; #13# reaction mechanism of  repair of (6-4) lesions by (6-4) photolyase, detailed overview. The  repair-active redox state of the FAD cofactor is fully reduced FADH-  and (6-4) PP-containing substrates are bound in a specific manner <48>;  #18# reaction mechanism of repair of (6-4) lesions by (6-4) photolyase,  detailed overview. The repair-active redox state of the FAD cofactor is  fully reduced FADH- and (6-4) PP-containing substrates are bound in a  specific manner. Occurrence of a two-photon mechanism for the repair of  a T(6-4)T lesion by the (6-4) PL of Xenopus laevis <48>; #18# two  histidines in the active center, H354 and H358, must work in a  concerted manner in the active center of the wild-type enzyme, which  significantly raises the repair efficiency, molecular mechanism of the  repair reaction by enzyme (6-4) PHR, overview <41>)  "
4.1.99.14," (5R)-5,6-dihydro-5-(thymidin-7-yl)thymidine (in double-helical DNA) =  thymidylyl-(3'->5')-thymidylate (in double-helical DNA) (#1# reaction  mechanism, overview <9>; #4# reaction mechanism, two different routes,  overview <12>; #6# the enzyme catalyzes the spore photoproduct repair  reaction and combines specific features of radical  S-adenosyl-L-methionine and DNA repair enzymes to enable a complex  radical-based repair reaction to take place <13>; #1# the enzyme  catalyzes the spore photoproduct repair reaction via a radical mediated  direct reverse mechanism. At the 1+ oxidation state, the [4Fe-4S]  cluster provides an electron to the S-adenosyl-L-methionine, which  binds to the cluster in a bidentate manner as the fourth and fifth  ligands, to reductively cleave the C-S bond associated with the  sulfonium ion in S-adenosyl-L-methionine, generating a reactive  5-deoxyadenosyl radical. This 5-dA radical abstracts the proR hydrogen  atom from the C6 carbon of spore photoproduct to initiate the repair  process. The resulting spore photoproduct radical subsequently  fragments to generate a putative thymine methyl radical, which accepts  a back-donated H atom to yield the repaired  thymidylyl-(3->5)-thymidylate. Cys141 is involved in the catalytic  mechanism as the potential H atom donor to the thymine methyl radical,  reaction mechanism, detailed overview. A a thiyl radical is  subsequently generated on Cys141 <11>; #1# the enzyme is a radical  S-adenosyl-L-methionine enzyme, which uses a [4Fe-4S]1+ cluster to  reduce the S-adenosyl-L-methionine, generating a catalytic  5-deoxyadenosyl radical. This in turn abstracts an H atom from spore  product, generating an spore product radical that undergoes beta  scission to form a repaired 5-thymine and a 3-thymine allylic radical.  A conserved cysteine donates an H atom to the thymine radical,  resulting in a putative thiyl radical. Two conserved tyrosines are also  critical in enzyme catalysis. One, Y99, is downstream of the cysteine,  suggesting that the enzyme uses a hydrogen atom transfer pathway with a  pair of cysteine-tyrosine residues to regenerate  S-adenosyl-L-methionine. The other tyrosine, Y97, has a structural role  to facilitate S-adenosyl-L-methionine binding. It may also contribute  to the S-adenosyl-L-methionine regeneration process by interacting with  the putative Y99 radical and/or 5-dA radical intermediates to lower the  energy barrier for the second H-abstraction step. Irreversible first  step and tightly coupled radical relay mechanism <10>; #7# SP repair is  initiated by abstraction of a H atom from C6 of SP. The SP(C6)  substrate radical is thought to promote a radical-mediated  beta-scission of the C-C bond linking the two thymines; the resulting  product radical then abstracts an H atom to generate repaired thymine.  S-adenosyl-L-methionine as a substrate utilize a defined dinucleotide  or dinucleoside SP, rather than SP in intact DNA, suggesting the  possibility that stoichiometric SAM cleavage is favored with  non-optimal substrates <19>; #6# SPL is a radical S-adenosylmethionine  (SAM) enzyme, reaction mechanism, detailed overview. Radicals are  quenched to close the catalytic cycle. The characteristic CXXXCXXC  motif is involved in catalysis, although other tri-cysteine motifs may  also facilitate this radical chemistry. Enzyme SPL directly directly  reverts SP thymine photodimer. The conserved solvent-accessible  cysteine 140 is the intrinsic hydrogen atom donor <18>; #8# SPL is a  radical S-adenosylmethionine (SAM) enzyme, reaction mechanism, detailed  overview. Radicals are quenched to close the catalytic cycle. The  characteristic CXXXCXXC motif is involved in catalysis, although other  tri-cysteine motifs may also facilitate this radical chemistry. Enzyme  SPL directly reverts SP thymine photodimer. The conserved  solvent-accessible cysteine 141 is the intrinsic hydrogen atom donor to  the thymine radical <18>; #6,7,8# SPL is a radical S-adenosylmethionine  (SAM) enzyme, via a 3-thymine allylic radical intermediate, reaction  mechanism, detailed overview <21>; #7# spore photoproduct lyase (SPL)  repairs 5-thyminyl-5,6-dihydrothymine (i.e., the spore photoproduct  (SP)) using a radical transfer pathway that includes at least a  cysteine and a tyrosine in germinating endospores. The cysteine (at  position 74) and tyrosine are located on the opposite sides of a  substrate binding pocket that has to collapse to bring the two residues  into proximity, enabling the C->Y radical passage <20>; #8# thymine  dimers can be repaired via direct reversal mechanism <17>)  "
4.1.99.16," (1E,4S,5E,7R)-germacra-1(10),5-dien-11-ol + H2O = (-)-geosmin + acetone  (#1# conversion of germacradienol to geosmin results in the release of  the three-carbon side chain as acetone and involves a 1,2-hydride shift  of the bridgehead hydrogen exclusively into ring B of geosmin <2>; #1#  the active site in the N-terminal domain of enzyme ScGS catalyzes the  ionization-dependent cyclization of FPP to form diphosphate and two  cyclic products: germacradienol (major product, 85%) and germacrene D  (minor product, 15%). After dissociation from the N-terminal domain,  germacradienol is rebound to the active site of the C-terminal domain  where it is converted to geosmin in a protonation-dependent cyclization  reaction accompanied by the elimination of acetone through a  retro-Prins reaction. The tandem cyclization-fragmentation reactions  catalyzed by ScGS require two distinct active sites, a unique  alphaalpha domain architecture is predicted for ScGS based on primary  structure analysis <6>)  "
4.1.99.17," 5-amino-1-(5-phospho-D-ribosyl)imidazole + S-adenosyl-L-methionine =  4-amino-2-methyl-5-(phosphooxymethyl)pyrimidine + 5'-deoxyadenosine +  L-methionine + formate + CO (#1# mechanistic analysis <1>; #4,8#  radical reaction mechanism, overview <11>; #3# the enzyme uses a  [4Fe-4S] cluster to reductively cleave AdoMet to methionine and a  5-deoxyadenosyl radical that initiates catalysis <12>)  "
4.1.99.19," L-tyrosine + S-adenosyl-L-methionine + NADPH = 2-iminoacetate +  4-methylphenol + 5'-deoxyadenosine + L-methionine + NADP+ + H+ (#2#  ThiH is a member of the radical-S-adenosyl-L-methionine family.  Proposed mechanism of ThiH-dependent cleavage of L-tyrosine:  S-adenosyl-L-methionine is reductively cleaved to yield a highly  reactive 5-deoxyadenosyl radical. This radical is proposed to abstract  the phenolic hydrogen atom from tyrosine, and the resultant substrate  radical cleaves to yield dehydroglycine, which is required by ThiG for  the thiazole cyclization reaction <5>)  "
4.1.99.2," L-tyrosine + H2O = phenol + pyruvate + NH3 (#6,7,8,17# mechanism  <13,27,33,34,36,37,38,40,41>; #8# single-base racemization mechanism,  proceeds with retention of configuration at C-beta <4>; #6,7# mechanism  appears to require two bases, one of which abstracts the proton from  the 2-position of the substrate to form a quinonoid intermediate and  the second of which acting in concert with proton transfer from the  first group to C-1 of the phenolic ring, abstracts the substrate  hydroxyl group to facilitate cyclohexadienone formation and subsequent  elimination of phenol <1>; #8# NH3 is the first substrate which  interacts with bound pyridoxal 5-phosphate, pyruvate is the second  substrate <7>; #7# reversible cleavage of the Cbeta-Cgamma bond of  L-tyrosine in the final stage of the beta-elimination, via  intermediates: internal aldimine, external aldimine, quinoid,  ketoquinoid, alpha-aminoacrylate, and internal aldimine, stepwise  mechanism, overview <65>; #17# an active site base is essential for  activity, and alpha-deuterated substrate exhibits modest primary  isotope effects on kcat and kcat/Km, suggesting that substrate  deprotonation is partially rate-limiting. Pre-steady state kinetics  with enzyme TPL show rapid formation of external aldimine intermediate,  followed by deprotonation to give a quinonoid intermediate absorbing at  about 500 nm. The mechanism of TPL requires both substrate strain and  acid/base catalysis, and substrate strain is probably responsible for  the very high substrate specificity of TPL. Acid-base catalysis  mechanism of TPL, overview <69>; #17# mechanism of  alpha,beta-elimination of L-tyrosine catalyzed by enzyme TPL <68>; #17#  mechanism of alpha,beta-elimination of L-tyrosine catalyzed by enzyme  TPL, detailed overview <66>)  "
4.1.99.20," 2-amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate =  3-amino-4-hydroxybenzoate + phosphate + 2 H2O  "
4.1.99.22," GTP = cyclic pyranopterin phosphate + diphosphate (#1# proposed  mechanism for the MoaA/MoaC-catalyzed reaction, detailed overview.  MoaA/MoaC catalyzes a remarkable rearrangement reaction in which the C8  of GTP is inserted into the ribose C2-C3 bond, several radical reaction  intermediates, mass spectrometric analysis <9>; #1# the N-terminal  [4Fe-4S] cluster is likely to be responsible for the reductive cleavage  of SAM to the 5-deoxyadenosyl radical and L-methionine and the second  cluster binds to N1 of GTP. Upon generation of the 5-deoxyadenosyl  radical, GTP is transformed into  (2-amino-7-hydroxy-4,6-dioxo-4,5,5a,6,7,8,9a,10-octahydro-3H-pyrano[3  2-g]pteridin-8-yl)methyl triphosphate via a complex rearrangement  reaction where the C8 atom of the purine is inserted between the C2 and  the C3 atoms of the ribose moiety. MoaC then catalyzes the  intramolecular cyclization reaction of  (2-amino-7-hydroxy-4,6-dioxo-4,5,5a,6,7,8,9a,10-octahydro-3H-pyrano[3  2-g]pteridin-8-yl)methyl triphosphate to  (2-amino-7-hydroxy-4,6-dioxo-4,5,5a,6,7,8,9a,10-octahydro-3H-pyrano[3  2-g]pteridin-8-yl)methyl triphosphate which is oxidized to  2-amino-6-(2,5-dihydroxy-2-oxido-1,3  2-dioxaphosphinane-4-carbonyl)pteridin-4(3H)-one prior to analysis  because of the instability of  (2-amino-7-hydroxy-4,6-dioxo-4,5,5a,6,7,8,9a,10-octahydro-3H-pyrano[3  2-g]pteridin-8-yl)methyl triphosphate <7>) "
4.1.99.22," GTP + S-adenosyl-L-methionine + reduced electron acceptor =  (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate +  5'-deoxyadenosine + L-methionine + oxidized electron acceptor  "
4.1.99.23, 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole + S-adenosyl-L-methionine  + reduced acceptor = 5-hydroxybenzimidazole + 5'-deoxyadenosine +  L-methionine + formate + NH3 + phosphate + oxidized acceptor  
4.1.99.24, L-tyrosine + D-ribulose 5-phosphate =  (2S)-3-(4-hydroxyphenyl)-2-isocyanopropanoate + hydroxyacetone +  formaldehyde + phosphate + H2O  
4.1.99.25, L-tryptophan + D-ribulose 5-phosphate =  (2S)-3-(1H-indol-3-yl)-2-isocyanopropanoate + hydroxyacetone +  formaldehyde + phosphate + H2O  
4.1.99.26," C-terminal [mycofactocin precursor  peptide]-glycyl-3-amino-5-[(4-hydroxyphenyl)methyl]-4  4-dimethylpyrrolidin-2-one + 5'-deoxyadenosine + L-methionine + A =  C-terminal [mycofactocin precursor  peptide]-glycyl-L-valyl-4-[2-aminoethenyl]phenol +  S-adenosyl-L-methionine + AH2 (#2# enzyme mechanism, detailed overview.  MftC catalyzes the formation of two products from substrate MftA, 13C  NMR and 1H NMR analysis of substrate, intermediates and products. The  major product of the MftC reaction is a Val-Tyr* crosslinked peptide  formed through two S-adenosylmethionine-dependent turnovers. The  hydroxyl group on MftA Tyr30 is required for MftC catalysis <5>; #2#  enzyme mechanism, overview <3>; #4# MftC abstracts a hydrogen atom from  the beta-carbon of the C-terminal Tyr residue. The resulting radical  species is stabilized by the adjacent phenol ring. One can envision at  least two plausible routes both ending with the oxidative  decarboxylation of the C-terminus. The top pathway shows transfer of  the unpaired spin from the radical intermediate to a [4Fe-4S] cluster  concomitant with decarboxylation to form the final product.  Alternatively, the Calpha-COOH bond can be homolytically cleaved  resulting in the formation of a radical-COOH species that can either be  quenched to formate or CO2 <6>)  "
4.1.99.3," cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in DNA)  (#3,8,10,17,21,22,25,89# mechanism <35,40,45,56>; #101# reaction  mechanism <163>; #8# the reaction is initiated by blue light and  proceeds through long-range energy transfer, single electron transfer  and enzyme catalysis by a radical mechanism <30>; #8# mechanism of  photoactivation <55>; #8# reaction mechanism, overview <145>; #3# by  molecular dynamics simulation and quantum mechanical calculations it is  shown that indirect electron tunneling via the protein medium is as  important as direct electron transfer from the donor (FADH-) to the  acceptor (cyclobutane pyrimidine dimmer). At Met353 site busy electron  tunneling traffic is observed. <76>; #90# results support the electron  hopping mechanism by which electron transfer from W306 to the flavin is  mediated in a three-step electron hopping process (W306 to W359 to W382  to FADH) <73>; #3# on top of the transient formation of tryptophan  radicals during photoactivation, evidence is found for oxidation of a  tyrosine residue by a tryptophan radical. The tyrosine radical thus  formed is reduced by an extrinsic reductant, suggesting that in this  case the terminal intrinsic electron donor is tyrosine rather than  tryptophan <136>; #44# reaction mechanism, detailed overview <146>; #8#  upon absorption of a visible photon, the photoexcited flavin radical  FADH abstracts an electron from nearby W382. The tryptophanyl radical  W382 thus formed abstracts an electron from the nearby middle  tryptophan, W359. W359 radical abstracts an electron from W306. As the  second and third steps are faster than the first one, the intermediate  states are not populated in wild-type photolyase to any significant  extent and escape spectroscopic detection. The described forward  electron transfer steps between the tryptophans are in competition with  back electron transfer from FADH- to the respective tryptophanyl cation  radical, so that the quantum yield of formation of the terminal W306  radical is only 20%. W306 radical releases a proton to the aqueous  phase in 200 ns. The resulting neutral radical W306 radical can be  reduced by extrinsic reductants, leaving a photolyase that contains  FADH as required for photorepair of DNA <136>; #14# using a transient  absorption setup, cyclobutane thymine dimer repair in the main UV  absorption band of intact thymine at 266 nm is monitored. Flavin  transitions that overlay DNA-based absorption changes at 266 nm are  monitored independently in the visible and subtracted to obtain the  true repair kinetics. Restoration of intact thymine show a short lag  and a biexponential rise with time constants of 0.2 and 1.5 ns. The two  time constants are assigned to splitting of the intradimer bonds  (creating one intact thymine and one thymine anion radical T-) and  electron return from T- to the FAD cofactor with recovery of the second  thymine, respectively <143>; #8# cyclic electron-transfer radical  mechanism with two fundamental processes, electron-tunneling pathways  and cyclobutane ring splitting, the cyclobutane pyrimidine dimer splits  in two sequential steps within 90 ps and the electron tunnels between  the cofactor and substrate through a remarkable route with an  intervening adenine, dynamics and mechanism of cyclobutane pyrimidine  dimer repair by DNA photolyase, overview <154>; #59# substrate/cofactor  binding and reaction mechanism, catalytic active site Met397, overview  <147>; #8# the DNA repair enzyme recognizes a solvent-exposed  cyclobutadipyrimidine as part of its damage recognition mechanism  <150>; #90# dynamics and mechanism of CPD repair by photolyase,  detailed overview. In contrast to the computational reaction model the  thymine dimer splits by a sequential pathway <172>; #98# molecular  mechanism of the electron transfer, overview. The electronic coupling  matrix element is 36/cm from the donor (FADH-) to the acceptor (CPD) by  Mulliken-Hush (GMH) method and the bridge green function (GF) methods,  and the estimated electron transfer time is 386 ps. Molecular dynamics  simulations and ab initio molecular orbital calculations, and  exploration of the electron tunneling pathway for 20 different  structures during the MD trajectory, QM/MM calculation. The electron  transfer route via Asn349 is the dominant pathway among the five major  routes via (adenine/Asn349), (adenine/Glu283),  (adenine/Glu283/Asn349/Met353), (Met353/Asn349), and (Asn349),  indicating that Asn349 is an essential amino acid residue in the  electron transfer reaction <166>; #90,91,98,99,100,110# photo-induced  intramolecular electron transfer in photolyases and initial  electron-transfer bifurcation in repair complexes. Seven  electron-transfer reactions in 10 elementary steps in all classes of  CPD photolyases. Unified electron-transfer pathway through a conserved  structural configuration that bifurcates to favor direct tunneling in  prokaryotes and a two step hopping mechanism in eukaryotes. Complete  photocycles of CPD repair by class I and class II PLs, overview <173>;  #90# radical mechanism through a cyclic redox reaction. Photolyase  binds DNA containing a CPD because the thymine dimer distorts the  backbone of the DNA. Upon binding to damaged DNA, through ionic  interactions between the positively charged groove on the photolyase  surface and negatively charged DNA phosphodiester backbone the enzyme  pulls the thymine dimer out from within the helix and into the core of  the enzyme so that the thymine dimer is within Van der Waals contact  with FADH-. It makes a very staple complex, and nothing happens until  folate absorbs a photon and transfers the excitation energy to the  flavin cofactor. The excited-state flavin, FADH- radical, repairs the  thymine dimer by a cyclic redox reaction, and then the enzyme  dissociates from the DNA to go on in search of other damage sites to  carry out the repair reactions again <155>; #104,105,106# reaction  mechanisms of CPD DNA photolyase and cytochrome DASH, detailed overview  <171>; #90# reaction mechanisms of CPD DNA photolyase and cytochrome  DASH, detailed overview. Proposed intraprotein electron transfer from  W306 to FADH radical is not a part of the normal photolyase photocycle  in vivo <171>; #90# reduced anionic flavin adenine dinucleotide (FADH-)  is the critical cofactor in DNA photolyase (PL) for the repair of  cyclobutane pyrimidine dimers (CPD) in UV-damaged DNA. The initial step  involves photoinduced electron transfer from FADH- radical to the CPD.  The adenine (Ade) moiety is nearly stacked with the flavin ring, an  unusual conformation compared to other FAD-dependent proteins <169>;  #90,91,93,98,99,100# the repair of CPD reveals seven electron-transfer  (ET) reactions among ten elementary steps by a cyclic ET radical  mechanism through bifurcating ET pathways, a direct tunneling route  mediated by the intervening adenine and a two-step hopping path bridged  by the intermediate adenine from the cofactor to damaged DNA, through  the conserved folded flavin at the active site. Repair photocycle of  the PLs and development of a unified repair mechanism for all CPD PLs  with the critical, bifurcating electron transfer pathways through the  folded flavin cofactor in the conserved active site structure, overview  <157>)  "
4.1.99.5," a long-chain aldehyde + O2 + 2 NADPH + 2 H+ = an alkane + formate + H2O  + 2 NADP+ (#9# reaction mechanism, overview <26>; #5# possible reaction  mechanism, overview. Formate is the coproduct of alkane production by  the Np AD, (ii) the aldehyde hydrogen of the substrate is retained in  the formate, and (iii) the hydrogen added to C2 derives (at least in  part) from solvent <8>; #4# mechanism of the unusual iron-catalysed  decarbonylation reaction <15>; #2,3,4,5# mechanistic proposal for the  oxygen-independent formation of alkanes by the enzyme. In this  mechanism the external reducing system functions catalytically to  generate a reactive ketyl radical anion and facilitate carbon-carbon  bond cleavage <12>; #5# proposed mechanism of cADO involving homolytic  cleavage of the C1-C2 bond of aldehyde by di-iron peroxo species, and  proposed mechanism for deformylation involving heterolytic cleavage of  the C1-C2 bond <11>; #8# the catalytic mechanism involves attack on the  carbonyl of the bound substrate by the reduced O2 moiety to form a Fe2  III/III peroxyhemiacetal complex, which undergoes reductive O-O-bond  cleavage, leading to C1-C2 radical fragmentation and formation of the  alk(a/e)ne and formate products, detailed overview <16>; #8#  aldehyde-deformylating oxygenase (ADO) catalyzes conversion of a fatty  aldehyde to the corresponding alk(a/e)ne and formate, consuming four  electrons and one molecule of O2 per turnover and incorporating one  atom from O2 into the formate coproduct. A cyanobacterial [2Fe-2S]  ferredoxin (PetF), reduced by ferredoxin-NADP+ reductase (FNR) using  NADPH, is implicated. Rapid reduction of the diferric-peroxyhemiacetal  intermediate in ADO by a cyanobacterial ferredoxin. The enzyme follows  a free-radical mechanism via radical and Fe2 III/III?PHA intermediate,  reaction overview <25>; #13# enzyme structures representing the  different states during catalytic reaction <29>; #9# proposed mechanism  for deformylation of aldehydes by cADO, overview. The rate of alkane  formation is the same in D2O or H2O, implying that proton transfer is  not a kinetically significant step. When the ratio of protium to  deuterium in the product alkane is measured as a function of the mole  fraction of D2O, a D2OSIEobs of 2.19 is observed. The SIE is invariant  with the mole fraction of D2O, indicating the involvement of a single  protic site in the reaction. An iron-bound water molecule is the proton  donor to the alkane in the reaction <20>; #9# the aldehyde proton is  retained in formate and one of the oxygen atoms derives from molecular  oxygen, whereas the proton in the product alkane derives from the  solvent. Initial formation of a diferric intermediate in the cADO  catalyzed reaction. Addition of a further electron to this complex is  proposed to lead to its breakdown and scission of the C1-C2 bond. A  radical mechanism for C1-C2 bond cleavage is supported by the observed  ring-opening of cyclopropyl aldehydes and oxiranyl aldehydes designed  to act as radical clocks during deformylation by cADO.  Structure-function analysis <18>)  "
4.2.1.1," H2CO3 = CO2 + H2O (#14# mechanism <70>; #35# carbonic anhydrase III is  limited in rate by a step occuring outside the actual interconversion  of CO2 and HCO3- and involving a change in bonding to hydrogen  exchangeable with solvent water <5>; #22# zinc-hydroxide mechanism,  rate-determining H+ transfer step in catalytic mechanism <69>; #158#  reaction mechanism, overview <289>; #60,85# reaction mechanism, model  of the active site designed on the basis of the X-ray crystal  structure, proposed for both metal ions similar reaction pathways  consisting in the nucleophilic attack by the metal bound hydroxide to  the carbon dioxide with bicarbonate formation, in a next internal  rotation of this last fragment, and then in the formation of a species  ready for the product removal, overview <312>; #14# the rate limiting  step in catalysis of bicarbonate dehydration by HCA II is an  intramolecular proton transfer from His64 to the zinc-bound hydroxide  <287>; #195# interconversion of CO2 and water to bicarbonate and a  proton. The general catalysis of CA is a metal-hydroxide ping-pong  mechanism composed of two independent steps. The first step of  catalysis is initiated by nucleophilic attack on the carbon of CO2 by  the metal-bound hydroxide to yield bicarbonate, which is subsequently  displaced by a water molecule. The second step is the removal of a  proton from the now metal-bound water via an ordered water network and  a residue acting as a weak base, which is typically a His at the  opening of the active site <350>; #117# reaction mechanism, analysis of  the restoring step of the carbonic anhydrase catalytic cycle for  natural and promiscuous substrates, natural HCO3-x02and promiscuous  H2NCOHN- products, catalytic reaction mechanism, NPT molecular dynamics  simulations, overview <351>;  #60,117,173,176,177,178,179,180,181,182,183,184,185# the catalytic  mechanism for the CO2 hydration reaction consists of two steps. In the  first step a zinc-bound hydroxide leads the nucleophilic attack on a  CO2 molecule with formation of bicarbonate bound to the zinc ion, which  is then substituted by a water molecule. The second step, the rate  limiting one, consists of the regeneration of the enzyme reactive  species, the zinc-bound hydroxide, via a proton transfer reaction,  which occurs from the zinc-bound water molecule to the external buffer.  This process is generally assisted by an enzyme residue which acts as  proton shuttle <376>)  "
4.2.1.10," 3-dehydroquinate = 3-dehydroshikimate + H2O (#34# mechanism <34>; #14#  the first step of the reaction involves the formation of an imine  intermediate between the oxo group of the 3-dehydroquinate and the  enzyme <18>; #27# type I dehydroquinase catalyzes cis-dehydration of  3-dehydroquinate via a covalent imine intermediate <23>; #14,15,41#  type II dehydroquinase catalyzes a trans-dehydration via an enolate  intermediate <23>; #14# type I and type II DHQases are quite distinct  from one another in terms of amino acid sequences and three-dimensional  structures. Type I enzymes involve a syn elimination and catalyse the  biosynthetic reaction. By contrast type II enzymes, which can catalyse  either the biosynthetic or catabolic reactions, involve and anti  elimination reaction <31>; #15# type I and type II DHQases have  different biochemical and biophysical properties, and no sequence  similarity exists between them <33>; #12,14,15# DHQ2 catalyzes the  reversible dehydration of 3-dehydroquinic acid to form  3-dehydroshikimic acid through anti elimination of water, with the loss  of the more acidic pro-S hydrogen from C-2 of 3-dehydroquinate. The  elimination proceeds by a stepwise E1CB mechanism involving an enol  intermediate. In the first step, an essential tyrosine in the active  site removes the pro-S hydrogen from C-2 of 1. The final step is the  acid-catalyzed elimination of the C-1 hydroxy group, a reaction  catalyzed by a histidine, which acts as a proton donor, reaction  mechanism, overview <59>)  "
4.2.1.100," 6-hydroxycyclohex-1-ene-1-carbonyl-CoA =  cyclohexa-1,5-diene-1-carbonyl-CoA + H2O  "
4.2.1.103," N-cyclohexylformamide = cyclohexyl isocyanide + H2O (#2# the enzyme  from Pseudomonas putida strain N19-2 can also catalyse the hydration of  other isonitriles to the corresponding N-substituted formamides, active  site Cys101 and T102 are essential for activity, while Glu79 and Glu81  are not <2>)  "
4.2.1.104," cyanate + HCO3- + 2 H+ = NH3 + 2 CO2 (#1# mechanism <3>; #1# rapid  equilibrium random mechanism <7,11>; #6# the enzyme requires  bicarbonate as a cofactor. Its mechanism is to catalyse the attack of  bicarbonate on cyanate, with elimination of carbon dioxide, thus  catalysing hydration of the cyanate to carbamae. The carbamate  spontaneously hydrolyses to ammonia and carbon dioxide <13>; #1# the  enzyme requires bicarbonate as a cofactor. Its mechanism is to catalyse  the attack of bicarbonate on cyanate, with elimination of carbon  dioxide, thus catalysing hydration of the cyanate to carbamae. The  carbamate spontaneously hydrolyses to ammonia and carbon dioxide, the  decamer shows half-side binding of substrates and substrate analogues,  catalytic mechanism, catalytic site involves Arg96, Glu99, and Ser122  <14>; #8# the enzyme requires bicarbonate as a cofactor. Its mechanism  is to catalyse the attack of bicarbonate on cyanate, with elimination  of carbon dioxide, thus catalysing hydration of the cyanate to  carbamate. The carbamate spontaneously hydrolyses to ammonia and carbon  dioxide <13>) "
4.2.1.104, cyanate + HCO3- + H+ = carbamate + CO2 
4.2.1.104, carbamate + H+ = NH3 + CO2  
4.2.1.105," 2,4',7-trihydroxyisoflavanone = daidzein + H2O (#3# (1) <1>) "
4.2.1.105," 2,4',5,7-tetrahydroxyisoflavanone = genistein + H2O  "
4.2.1.106," 7alpha,12alpha-dihydroxy-3-oxochol-4-en-24-oyl-CoA =  12alpha-hydroxy-3-oxochola-4,6-dien-24-oyl-CoA + H2O  "
4.2.1.107," (24R,25R)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestanoyl-CoA  = (24E)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA +  H2O  "
4.2.1.108, (2S)-4-acetamido-2-aminobutanoate = L-ectoine + H2O  
4.2.1.109," 5-(methylsulfanyl)-D-ribulose 1-phosphate =  5-(methylsulfanyl)-2,3-dioxopentyl phosphate + H2O (#6# active site  architecture and catalytic mechanism, overview <8>)  "
4.2.1.11," 2-phospho-D-glycerate = phosphoenolpyruvate + H2O (#9,11,90# mechanism  <3,43,45>)  "
4.2.1.110," 1,5-anhydro-D-fructose = 2-hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one  + H2O (#9# reaction scheme of the bifunctional enzyme, overview <6>) "
4.2.1.110," 1,5-anhydro-D-fructose = 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose  + H2O "
4.2.1.110," 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose =  2-hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one  "
4.2.1.111," 1,5-anhydro-D-fructose = 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose  + H2O  "
4.2.1.112," acetaldehyde = acetylene + H2O (#6# active site channel structure and  detailed catalytic mechanism <6>; #6# reaction mechanism involving  molybdenum-cofactor and tungsten/iron-sulfur cluster,  structure-function modeling, overview <4>; #6# active-site access,  active-site architecture, and reaction mechanism, overview <10>; #6#  active-site modeling and reaction mechanism involving direct  coordination of the substrate to the tungsten ion, followed by a  nucleophilic attack by a water molecule concerted with a proton  transfer to a second-shell aspartate, which then reprotonates the  substrate. A tungsten-bound hydroxide plays the key role performed by  Asp13 in the enzyme, rate-limiting proton transfer step from Asp13  residue to the C2 center of the vinyl anion <9>; #6# active-site  modeling and reaction mechanism, detailed overview. The mechanism  starts with a ligand exchange step, in which the acetylene substrate  displaces the tungsten-bound water molecule and binds to the metal in  an eta2 fashion. Then the nucleophilic attack takes place nearly  perpendicularly to the W-C-C plane, concerted nucleophilic  attack-proton transfer transition state and the resulting vinyl anion  intermediate, W=C=CH2 vinylidene intermediate, overview. To complete  the reaction, the vinyl alcohol now needs only to tautomerize to  acetaldehyde. At this point, the vinyl alcohol can be released and the  interconversion can take place outside the active site. Alternative  mechanisms, overview <11>; #2,3,4,7,9,10# acetylene hydratase harbors  two pyranopterins bound to tungsten, and a [4Fe-4S] cluster. Tungsten  is coordinated by four dithiolene sulfur atoms, one cysteine sulfur,  and one oxygen ligand. The enzyme activity requires a strong reductant  suggesting (IV) as the active oxidation state. Two different types of  reaction pathways have been proposed, the reaction does not involve a  net electron transfer <13>; #8# acetylene hydratase harbors two  pyranopterins bound to tungsten, and a [4Fe-4S] cluster. Tungsten is  coordinated by four dithiolene sulfur atoms, one cysteine sulfur, and  one oxygen ligand. The enzyme activity requires a strong reductant  suggesting (IV) as the active oxidation state. Two different types of  reaction pathways have been proposed, the reaction does not involve a  net electron transfer. The nature of the oxygen ligand of the W center  in the enzyme is crucial to formulate a reaction mechanism. Residue  Asp13 is catalytically important because it activates the oxygen atom  for the addition to the C-C triple bond. Reaction mechanism analysis,  overview <14>; #8# acetylene hydratase harbors two pyranopterins bound  to tungsten, and a [4Fe-4S] cluster. Tungsten is coordinated by four  dithiolene sulfur atoms, one cysteine sulfur, and one oxygen ligand.  The enzyme activity requires a strong reductant suggesting (IV) as the  active oxidation state. Two different types of reaction pathways have  been proposed, the reaction does not involve a net electron transfer.  The nature of the oxygen ligand of the W center in the enzyme is  crucial to formulate a reaction mechanism. Residue Asp13 is  catalytically important because it activates the oxygen atom for the  addition to the C-C triple bond. Representation of the five-step  catalytic cycle, with Asp13 acting as a key player in the mechanism,  and W binding and activating C2H2, and providing electrostatic  stabilization to the transition states and intermediates <13>)  "
4.2.1.113," (1R,6R)-6-hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate =  2-succinylbenzoate + H2O  "
4.2.1.114," (R)-2-hydroxybutane-1,2,4-tricarboxylate =  (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate "
4.2.1.114," (R)-2-hydroxybutane-1,2,4-tricarboxylate =  (Z)-but-1-ene-1,2,4-tricarboxylate + H2O "
4.2.1.114," (Z)-but-1-ene-1,2,4-tricarboxylate + H2O =  (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate  "
4.2.1.115," UDP-N-acetyl-alpha-D-glucosamine =  UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + H2O (#8#  reaction mechanism <12>; #2# Asp126, Lys127, and Tyr135 are the active  site residues <1>; #4# reaction mechanism of WbpM <10>; #1# reaction  mechanism, FlaA1 is a UDP-GlcNAc 4,6-dehydratase that additionally  inverts the chirality at the C-5 position <8>; #7# catalytic mechanism  of CapE, overview. Tyr164 does not act as the general base as it does  in SDR enzymes displaying the SYK triad motif <11>)  "
4.2.1.116," 3-hydroxypropanoyl-CoA = acryloyl-CoA + H2O (#2# molecular mechanism,  overview <4>)  "
4.2.1.117," (2S,3S)-2-methylcitrate = 2-methyl-trans-aconitate + H2O  "
4.2.1.118," 3-dehydro-shikimate = 3,4-dihydroxybenzoate + H2O  "
4.2.1.119, (3R)-3-hydroxyacyl-CoA = (2E)-2-enoyl-CoA + H2O  
4.2.1.12," 6-phospho-D-gluconate = 2-dehydro-3-deoxy-6-phospho-D-gluconate + H2O  (#5# mechanism: 6-phosphogluconate is dehydrated to form  enol-2-keto-3-deoxy-6-phosphogluconate, which is spontaneously  ketonized <13>)  "
4.2.1.120," 4-hydroxybutanoyl-CoA = (E)-but-2-enoyl-CoA + H2O (#2# cleavage is  achieved by a FAD-dependent oxidation of 4-hydroxybutanoyl-CoA to  4-hydroxycrotonyl-CoA. In a second step, the hydroxyl group is  substituted by a hydride derived from the now reduced FAD in an SN2  reaction leading to vinylacetyl-CoA. Isomerization yields crotonyl-CoA  <2>; #2# mechanism includes a direct dehydration of of  4-hydroxybutanoyl-CoA to vinylacetyl-CoA <9>; #2# mechanism involves  transient one-electron oxidation of the substrate to activate the  beta-C-H-bond. the 4Fe-4S-center could serve a structural role and/or  as Lewis acid facilitating the leaving of the hydroxyl group <5>; #2#  the pro-(S) hydrogen atom is stereospecifically abstracted from C-3 of  4-hydroxybutanoyl-CoA, and this atom is not returned to C-4 <7>; #4#  substrate-induced radical formation in 4-hydroxybutyryl-CoA dehydratase  from Clostridium aminobutyricum. The conversion of 4-hydroxybutyryl-CoA  to crotonyl-CoA involves the abstraction of the 2Re and 3Si protons.  The FAD semiquinone rather than the FAD quinone oxidizes the enolate  (or, in the reverse direction, the dienolate) to the enoxy radical  (dienoxy radical). The FADH- anion formed, in combination with the  T190/E257 dyad, probably acts as a more efficient base to remove the  3Si proton. Reaction mechanism with amino acids proposed to be  involved, overview. The release of H2O from Fe1 of the [4Fe-4S]2+  cluster can be facilitated by reduction to [4Fe-4S]+ <15>)  "
4.2.1.121," (9S,10E,12Z)-9-hydroperoxyoctadeca-10,12-dienoate =  (8E)-9-[(1E,3Z)-nona-1,3-dien-1-yloxy]non-8-enoate + H2O (#1#  intervention of an epoxycarbonium ion intermediate. A mechanism is  proposed <6>; #1# selective removal of the pro-R hydrogen at C-8 in the  biosynthesis of colneleic acid <1,7>; #1# the oxygen inserted  enzymically between carbons 9- and 10- of the C-18 chain in forming  colneleic acid originates from 18O2 gas via the hydroperoxide group of  linoleic acid. A mechanism is proposed <5>)  "
4.2.1.122," L-serine + indole = L-tryptophan + H2O (#1# reaction mechanism,  overview <4>)  "
4.2.1.123," tetrahymanol = squalene + H2O (#2# overall mechanism of the  polycyclization reaction of SHCs and structures of squalene cyclization  products, overview <3>)  "
4.2.1.124," arabidiol = (3S)-2,3-epoxy-2,3-dihydrosqualene + H2O  "
4.2.1.125," dammarenediol II = (3S)-2,3-epoxy-2,3-dihydrosqualene + H2O (#2#  cyclization initiated by protonation at the oxirane ring proceeds to  form tetracycles. The resulting dammarenyl cation is trapped by  stereospecific addition of water at C20 without further rearrangement  <1>; #4# an unusually complex and flexible reaction mechanism generates  this ring system. As a general mechanism, firstly  (3S)-2,3-oxidosqualene adopts a preorganized chair-chair-chair  conformation, and activated by cationic attack. Then the oxirane ring  of (3S)-2,3-oxidosqualene opens, following with a cascade of  cation-olefin cyclizations, and generates a cyclic C-20 dammarenyl  cation <12>)  "
4.2.1.126," (R)-lactate + N-acetyl-D-glucosamine 6-phosphate = N-acetylmuramate  6-phosphate + H2O (#6# the reaction of Haemophilus influenzae MurQ  hydrolase proceeds in the reverse direction, reaction mechanism,  overview. A ring opening of MurNAc 6P, likely enzyme-catalyzed, first  serves to generate the C1 aldehyde and consequently acidifies the  hydrogen at the C2 position. This hydrogen is deprotonated by an active  site acid/base residue (B1) to generate a resonance-stabilized enolate  anion. The enolate then undergoes a syn elimination of D-lactate, aided  by a catalytic acid/base residue (B2), to generate a  DELTA2,3-unsaturated (E)-alkene intermediate. In a sequence that  mirrors the elimination of lactate, B2 first serves to deprotonate an  incoming water molecule for addition at the C3 position of the alkene  intermediate to generate the enolate anion. This enolate is then  protonated at the C2 position by B1 to generate the open chain form of  GlcNAc 6P. Ring closure then generates the two anomers of the pyranose  form of N-acetyl-D-glucosamine 6-phosphate <8>)  "
4.2.1.127," (3S)-linalool = myrcene + H2O (#1# reaction mechanism, overview <8>;  #1# catalytic mechanism of enzyme LinD by a combined quantum mechanics  and molecular mechanics (QM/MM), computational modeling <9>; #1#  reaction mechanism via one acid-base mechanism via a carbocation  intermediate. Residues C171, Y45 and D39 act as general acid and base  for the protonation of the hydroxyl leaving group of the substrate  (S)-linalool and the dehydration at the chiral carbon atom. Water is  activated by H129 or C180 and added to the covalent or carbocation  intermediate <6>; #1# the substrates are embedded inside a hydrophobic  channel between two monomers of the (alpha,alpha)6 barrel fold class  and flanked by three clusters of polar residues involved in acid-base  catalysis. Catalytic mechanism, structure-function analysis, overview  <7>)  "
4.2.1.128," lupan-3beta,20-diol = (3S)-2,3-epoxy-2,3-dihydrosqualene + H2O  "
4.2.1.129," hopan-22-ol = squalene + H2O (#1,2,3,4,5,6,9# overall mechanism of the  polycyclization reaction of SHCs and structures of squalene cyclization  products, overview <3>)  "
4.2.1.130," (R)-lactate = 2-oxopropanal + H2O (#6# proton transfer mechanism in the  enzyme reaction of DJ-1 glyoxalase, whose stereospecificity is  determined by the location of neighboring His residues. hDJ-1 contains  a single His residue (H126) <10>)  "
4.2.1.131," 1-hydroxy-1,2-dihydrolycopene = lycopene + H2O "
4.2.1.131," 1,1'-dihydroxy-1,1',2,2'-tetrahydrolycopene =  1-hydroxy-1,2-dihydrolycopene + H2O  "
4.2.1.132," 4-hydroxy-2-oxohexanoate = (2Z,4Z)-2-hydroxyhexa-2,4-dienoate + H2O  "
4.2.1.133," (13E)-8alpha-hydroxylabd-13-en-15-yl diphosphate = geranylgeranyl  diphosphate + H2O (#6# the class II diTPS reaction, which forms the  bicyclic decalin core of labdanetype diterpenoids, is terminated either  by deprotonation or by water capture of the diphosphate carbocation <3>)  "
4.2.1.134," a very-long-chain (3R)-3-hydroxyacyl-CoA = a very-long-chain  trans-2,3-dehydroacyl-CoA + H2O  "
4.2.1.135," UDP-N-acetyl-alpha-D-glucosamine =  UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose + H2O  "
4.2.1.136," ADP + (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine  dinucleotide = AMP + phosphate + NADH "
4.2.1.136," ADP + (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine  dinucleotide phosphate = AMP + phosphate + NADPH  "
4.2.1.137, sporulenol = tetraprenyl-beta-curcumene + H2O  
4.2.1.138, (+)-beta-caryophyllene + H2O = (+)-caryolan-1-ol  
4.2.1.139," a (4R)-4,2'-dihydroxyisoflavan = a pterocarpan + H2O  "
4.2.1.140, D-gluconate = 2-dehydro-3-deoxy-D-gluconate + H2O (#3# (1) <2>) 
4.2.1.140, D-galactonate = 2-dehydro-3-deoxy-D-galactonate + H2O (#3# (2) <2>)  
4.2.1.141," 2-dehydro-3-deoxy-D-arabinonate = 2,5-dioxopentanoate + H2O  "
4.2.1.142," 5'-oxoaverantin = (1'S,5'S)-averufin + H2O  "
4.2.1.143, versiconal = versicolorin B + H2O  
4.2.1.144, 5-amino-5-deoxy-3-dehydroshikimate = 3-amino-5-hydroxybenzoate + H2O  
4.2.1.145," (2S,3S)-3-hydroxyarginine = (2S,3R)-capreomycidine + H2O  "
4.2.1.146, L-galactonate = 2-dehydro-3-deoxy-L-galactonate + H2O  
4.2.1.147," 5,6,7,8-tetrahydromethanopterin + formaldehyde =  5,10-methylenetetrahydromethanopterin + H2O  "
4.2.1.148," (2R,3S)-2-methylmalyl-CoA = 2-methylfumaryl-CoA + H2O  "
4.2.1.149, L-carnitinyl-CoA = (E)-4-(trimethylammonio)but-2-enoyl-CoA + H2O  
4.2.1.150," a short-chain (3S)-3-hydroxyacyl-CoA = a short-chain trans-2-enoyl-CoA  + H2O (#7# the Mr-Crt catalytic mechanism constitutes a concerted  attack by the two glutamate residues. While Glu143 of Mr-Crt protonates  the substrate, Glu123 abstracts a proton from a bound water molecule.  The Gly120 activates the substrate by a hydrogen bond to the oxygen of  the enoyl moiety of the CoA ester. The binding pocket for the CoA  moiety is formed by characteristic hydrophobic amino acids and lysine  residues <9>)  "
4.2.1.151, chorismate = 3-[(1-carboxyvinyl)oxy]benzoate + H2O  
4.2.1.152, a hydroperoxyicosatetraenoate = an oxoicosatetraenoate + H2O  
4.2.1.153, (S)-citramalyl-CoA = 3-methylfumaryl-CoA + H2O  
4.2.1.154, tetracenomycin F2 = tetracenomycin F1 + H2O  
4.2.1.155, 3-(methylsulfanyl)acryloyl-CoA + 2 H2O = acetaldehyde + methanethiol +  CoA + CO2 (#1# overall reaction <2>) 
4.2.1.155, 3-(methylsulfanyl)acryloyl-CoA + H2O =  3-hydroxy-3-(methylsulfanyl)propanoyl-CoA (#1# (1a) <2>) 
4.2.1.155, 3-hydroxy-3-(methylsulfanyl)propanoyl-CoA = 3-oxopropanoyl-CoA +  methanethiol (#1# (1b) <2>) 
4.2.1.155, 3-oxopropanoyl-CoA + H2O = 3-oxopropanoate + CoA (#1# (1c) <2>) 
4.2.1.155, 3-oxopropanoate = acetaldehyde + CO2 (#1# (1d) <2>)  
4.2.1.156, L-altarate = 5-dehydro-4-deoxy-D-glucarate + H2O  
4.2.1.157, (R)-2-hydroxy-4-methylpentanoyl-CoA = 4-methylpent-2-enoyl-CoA + H2O  
4.2.1.158," galactarate = (2S,3R)-2,3-dihydroxy-5-oxohexanedioate + H2O  "
4.2.1.159," dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose =  dTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose + H2O "
4.2.1.159," dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose =  dTDP-2,6-dideoxy-D-glycero-hex-2-enos-4-ulose + H2O "
4.2.1.159," dTDP-2,6-dideoxy-D-glycero-hex-2-enos-4-ulose =  dTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose  "
4.2.1.160," 2,5-diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one =  7,8-dihydroneopterin 3'-phosphate + H2O  "
4.2.1.161, bacterioruberin = bisanhydrobacterioruberin + 2 H2O (#1# (overall  reaction) <1>) 
4.2.1.161, bacterioruberin = monoanhydrobacterioruberin + H2O (#1# (1a) <1>) 
4.2.1.161, monoanhydrobacterioruberin = bisanhydrobacterioruberin + H2O (#1# (1b)  <1>)  
4.2.1.162," 6-deoxy-6-sulfo-D-gluconate = 2-dehydro-3,6-dideoxy-6-sulfo-D-gluconate  + H2O  "
4.2.1.163, (4Z)-2-oxohept-4-enedioate + H2O = (4S)-4-hydroxy-2-oxoheptanedioate  
4.2.1.164," dTDP-4-dehydro-2,6-dideoxy-alpha-D-glucose + 2 reduced ferredoxin  [iron-sulfur] cluster + 2 H+ =  dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-hexopyranose + H2O + 2 oxidized  ferredoxin [iron-sulfur] cluster  "
4.2.1.165, 3-devinyl-3-(1-hydroxyethyl)chlorophyllide a = chlorophyllide a + H2O 
4.2.1.165, 3-deacetyl-3-(1-hydroxyethyl)bacteriochlorophyllide a =  3-deacetyl-3-vinylbacteriochlorophyllide a + H2O  
4.2.1.166, 2-(hydroxyphosphonoylmethyl)malate = 3-(hydroxyphosphonoylmethyl)malate 
4.2.1.166, 2-(hydroxyphosphonoylmethyl)malate =  2-(phosphinatomethylidene)butanedioate + H2O 
4.2.1.166, 2-(phosphinatomethylidene)butanedioate + H2O =  3-(hydroxyphosphonoylmethyl)malate  
4.2.1.167, (R)-2-hydroxyglutaryl-CoA = (E)-glutaconyl-CoA + H2O  
4.2.1.168," GDP-4-dehydro-alpha-D-rhamnose + L-glutamate =  GDP-4-dehydro-3,6-dideoxy-alpha-D-mannose + 2-oxoglutarate + NH3 "
4.2.1.168," GDP-4-dehydro-alpha-D-rhamnose + L-glutamate =  2-GDP-[(2S,3S,6R)-5-amino-6-methyl-3,6-dihydro-2H-pyran-3-ol] +  2-oxoglutarate + H2O "
4.2.1.168," 2-GDP-[(2S,3S,6R)-5-amino-6-methyl-3,6-dihydro-2H-pyran-3-ol] =  2-GDP-[(2S,3S,6R)-5-imino-6-methyloxan-3-ol] "
4.2.1.168," GDP-2-[(2S,3S,6R)-5-imino-6-methyloxan-3-ol] + H2O =  GDP-4-dehydro-3,6-dideoxy-alpha-D-mannose + NH3  "
4.2.1.169, a 3-(1-hydroxyethyl) bacteriochlorophyllide d = a 3-vinyl  bacteriochlorophyllide d + H2O  
4.2.1.17," (3S)-3-hydroxyacyl-CoA = trans-2(or 3)-enoyl-CoA + H2O (#4# reaction  mechanism, overview <33>; #17# reaction mechansim of enoyl-CoA  hydration, overview <44>; #16# the CoA moiety of the substrate adopts  the typical horseshoe conformation in a binding pocket formed from two  adjacent monomers, while the active site catalytic residues are  provided by a single monomer. The active site of rat liver  mitochondrial ECH contains an oxyanion hole formed from the backbone  amides of Gly141 and Ala98, which serves to polarize the carbonyl group  of the alpha,beta-unsaturated enoyl-CoA substrate and stabilize the  enolate intermediate. Two active site glutamate residues (Glu144 and  Glu164) are proposed to act as a general base(s) for the conjugate  addition of water onto the substrate enone and to protonate the  resultant enolate <43>)  "
4.2.1.170, a 2-[(omega-methylsulfanyl)alkyl]malate = a  2-[(omega-methylsulfanyl)alkyl]maleate + H2O 
4.2.1.170, a 3-[(omega-methylsulfanyl)alkyl]malate = a  2-[(omega-methylsulfanyl)alkyl]maleate + H2O  
4.2.1.171, cis-3-hydroxy-L-proline = 1-pyrroline-2-carboxylate + H2O  
4.2.1.172, trans-4-hydroxy-L-proline = (S)-1-pyrroline-5-carboxylate + H2O  
4.2.1.173, ent-8alpha-hydroxylabd-13-en-15-yl diphosphate = geranylgeranyl  diphosphate + H2O  
4.2.1.174," peregrinol diphosphate = geranylgeranyl diphosphate + H2O (#1# in  contrast with previously known diterpene synthases that introduce a  hydroxyl group at carbon C-8 of the labdane backbone, the  MvCPS1-catalyzed reaction proceeds via oxygenation of an intermediate  carbocation at C-9, yielding the bicyclic peregrinol diphosphate <1>)  "
4.2.1.175, (R)-3-(phenyl)lactoyl-CoA = (E)-cinnamoyl-CoA + H2O 
4.2.1.175, (R)-3-(4-hydroxyphenyl)lactoyl-CoA = (E)-4-coumaroyl-CoA + H2O 
4.2.1.175, (R)-3-(indol-3-yl)lactoyl-CoA = 3-(indol-3-yl)acryloyl-CoA + H2O  
4.2.1.176, L-lyxonate = 2-dehydro-3-deoxy-L-arabinonate + H2O  
4.2.1.177," (2S)-2,3-dihydroxypropane-1-sulfonate = 3-oxopropane-1-sulfonate + H2O  "
4.2.1.178," inulobiose = alpha-D-fructofuranose-beta-D-fructofuranose  2',1:2,3'-dianhydride + H2O  "
4.2.1.179," inulobiose = bis-D-fructose 2',1:2,1'-dianhydride + H2O  "
4.2.1.18, (S)-3-hydroxy-3-methylglutaryl-CoA = trans-3-methylglutaconyl-CoA + H2O  (#3# syn-addition-elimination of H2O <1>)  
4.2.1.19," D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate =  3-(imidazol-4-yl)-2-oxopropyl phosphate + H2O (#4# energy of activation  15900 cal/mol <5>; #3# highly stereospecific, inversion of  configuration at C3 <15>; #1# energy of activation 14700 cal/mol <6>)  "
4.2.1.2," (S)-malate = fumarate + H2O (#7# mechanism <1,2>; #7# the enzyme  follows a fully reversible 11-tate multistep catalytic mechanism,  detailed overview <79>)  "
4.2.1.20," L-serine + 1-C-(indol-3-yl)glycerol 3-phosphate = L-tryptophan +  D-glyceraldehyde 3-phosphate + H2O (#1,4# mechanism <20>;  #1,4,10,26,27,36# also catalyses the conversion of serine and indole  into tryptophan and water, and of indoleglycerol phosphate into indole  and glyceraldehyde phosphate (the latter reaction was listed formerly  as EC 4.2.1.8) <37,38,39,40,41,43,44,48,49,51,58,64,65,66,67,68,69,72>;  #1,4# also catalyses the conversion of serine and indole into  tryptophan and water, and of indoleglycerol phosphate into indole and  glyceraldehyde phosphate (the latter reaction was listed formerly as EC  4.2.1.8), allostery and substrate channeling <56>; #1# also catalyses  the conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), catalytic mechanism  <50>; #1# also catalyses the conversion of serine and indole into  tryptophan and water, and of indoleglycerol phosphate into indole and  glyceraldehyde phosphate (the latter reaction was listed formerly as EC  4.2.1.8), catalytic mechanism of beta-reaction <52>; #1# also catalyses  the conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), catalytic  mechanism, allosteric ligand binding <59>; #1# also catalyses the  conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), detailed  alpha-subunit catalytic mechanism <42>; #1# also catalyses the  conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), detailed mechanism  of the beta-reaction, beta-active site structure <70>; #1# also  catalyses the conversion of serine and indole into tryptophan and  water, and of indoleglycerol phosphate into indole and glyceraldehyde  phosphate (the latter reaction was listed formerly as EC 4.2.1.8),  interaction of residues G181 and S178 are essential for the quilibrium  between active closed and inactive open conformation of the  alpha-active site <55>; #1# also catalyses the conversion of serine and  indole into tryptophan and water, and of indoleglycerol phosphate into  indole and glyceraldehyde phosphate (the latter reaction was listed  formerly as EC 4.2.1.8), mechanism <57,62>; #1# also catalyses the  conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), mechanism,  intermediate formation, reaction equilibrium, conformational states of  the catalytic cycle <47>; #1# also catalyses the conversion of serine  and indole into tryptophan and water, and of indoleglycerol phosphate  into indole and glyceraldehyde phosphate (the latter reaction was  listed formerly as EC 4.2.1.8), mechanism, ligand binding, unique  ligand-mediated long-range cooperativity for substrate channeling,  allosteric control, coordination of metabolic cycles <45>; #1# also  catalyses the conversion of serine and indole into tryptophan and  water, and of indoleglycerol phosphate into indole and glyceraldehyde  phosphate (the latter reaction was listed formerly as EC 4.2.1.8),  mechanisms of alpha-and beta-reaction, active site structures <54>; #1#  also catalyses the conversion of serine and indole into tryptophan and  water, and of indoleglycerol phosphate into indole and glyceraldehyde  phosphate (the latter reaction was listed formerly as EC 4.2.1.8),  reaction mechanism and intermediates <60>; #1# also catalyses the  conversion of serine and indole into tryptophan and water, and of  indoleglycerol phosphate into indole and glyceraldehyde phosphate (the  latter reaction was listed formerly as EC 4.2.1.8), reaction mechanism  of alpha- and beta-reaction step, T183 and D60 are involved <71>; #1#  also catalyses the conversion of serine and indole into tryptophan and  water, and of indoleglycerol phosphate into indole and glyceraldehyde  phosphate (the latter reaction was listed formerly as EC 4.2.1.8),  reaction mechanism, formation of intermediates in the alpha-reaction  <61>; #1# also catalyses the conversion of serine and indole into  tryptophan and water, and of indoleglycerol phosphate into indole and  glyceraldehyde phosphate (the latter reaction was listed formerly as EC  4.2.1.8), reaction mechanism, formation of quinoid reaction  intermediates in the beta-active site upon reaction with the substrates  <63>; #1# also catalyses the conversion of serine and indole into  tryptophan and water, and of indoleglycerol phosphate into indole and  glyceraldehyde phosphate (the latter reaction was listed formerly as EC  4.2.1.8), reaction mechanism, pyridoxal 5-phosphate in beta-reaction,  formation of an alpha-aminoacrylate Schiff base intermediate <46>; #1#  also catalyses the conversion of serine and indole into tryptophan and  water, and of indoleglycerol phosphate into indole and glyceraldehyde  phosphate (the latter reaction was listed formerly as EC 4.2.1.8), salt  bridge betaAsp305-betaArg141 plays a crucial role in both the formation  of the closed conformation of the beta-site and the transmission of  allosteric signals between the alpha- and beta-sites that switch the  alpha-site on and off, mechanism <53>; #1# pressure perturbation is  used to quantify the effects of monovalent cations, ligands, and  mutations on the conformational equilibrium of Trp synthase. P-jump  kinetics in the presence of Na+, NH4+, and Na+ together with  benzimidazole are also examined. The plots of lnk versus P are  nonlinear and require a compressibility (beta0) term to obtain a good  fit. Compressibility (beta0) is positive for the Na+ enzyme but  negative for NH4+ and Na+ with benzimidazole. These results suggest  that there is a large contribution of solvation to the kinetics of the  conformational change of Trp synthase <105>; #19# catalytic mechanism  via an indoline quinonoid intermediate, with importance of an  equilibrium between tautomeric forms of the substrate, with the  protonation state of the major isomer directing the next catalytic  step, active site structure, and indoline and beta-site reactions by  NMR spectroscopy, overview <113>; #20# catalyzed reaction and structure  of the tryptophan synthase complex, mechanism, overview. Model of the  catalytic cycle of the transient enzyme complex, overview <109>) "
4.2.1.20, L-serine + indole = L-tryptophan + H2O 
4.2.1.20, 1-C-(indol-3-yl)glycerol 3-phosphate = indole + D-glyceraldehyde  3-phosphate  
4.2.1.22," L-serine + L-homocysteine = L-cystathionine + H2O (#7,10# mechanism  <30,33,38,41,42>; #10,43# ping-pong mechanism <36,46>; #24,25#  sequential bisubstrate mechanism in which no product release occurs  until both substrates are bound to the enzyme to form a ternary complex  <14>; #40# carbanion and aminacrylate intermediates in the  CBS-catalyzed reaction, arrangement of the protein residues and  pyridoxal 5-phosphate cofactor in the active site pocket, and reaction  mechanism, overview <117>)  "
4.2.1.24," 2 5-aminolevulinate = porphobilinogen + 2 H2O (#74# mechanism <50>;  #19,23# substrate is covalently bound through a Schiff base <24,46>;  #18# requires an active Arg residue and the formation of a Schiff base  between the enzyme and 5-aminolevulinate <9>; #73# catalytic mechanism  in which the C-C bond linking both substrates in the intermediate is  formed before the C-N bond <53>; #74# catalytic mechanism initiated by  a C-C bond formation between A and P-side 5-aminolevulinic acid,  followed by the formation of the intersubstrate Schiff base yielding  the product porphobilinogen <60>; #10# reaction mechanism involving  asymmetric addition and cyclization of two 5-aminolevulinate molecules,  modeling, detailed overview. The active site consists of several  invariant residues, including two lysyl residues Lys210 and Lys263 that  bind the two substrate moieties as Schiff bases, active site structure  and substrate binding, overview. The intersubstrate C-N bond is formed  first have a rate-limiting barrier that is lower than those in which  the intersubstrate C-C bond is formed first <119>)  "
4.2.1.25, L-Arabinonate = 2-dehydro-3-deoxy-L-arabinonate + H2O  
4.2.1.27, 3-oxopropanoate = propynoate + H2O  
4.2.1.28," propane-1,2-diol = propanal + H2O (#3# mechanism <13>; #3# possible  role of sulfhydryl groups <2>; #9# radical mechanism involved <18,26>;  #3# general mechanism and stereochemistry, role of coenzyme in OH-group  transfer, mechanism of overall reaction, role of free radicals during  reaction, studies with coenzyme analogues <4,13>; #3# mechanism: group  migration involved, stereospecificity: replacement of C2-OH-group  proceeds with inversion of configuration of both isomers, mechanism of  hydrogen transfer, role of cobalt: dissociation of C-Co bond of the  coenzyme and Co-binding to substrate <1>; #13# binding of the substrate  to the active site converts a hexacoordinated complex of K+ into the  heptacoordinated one. A relatively large binding energy is released  upon coordination of the two hydroxyl groups to K+, displacing a sixth  ligand, H2O. Interaction of the coenzyme with the enzyme cleaves its  Co-C bond, forming an adenosyl radical and cob(II)alamin. The radical  abstracts the pro-S hydrogen of the S-enantiomer forming a  substrate-derived radical and 5-deoxyadenosine. The substrate-radical  undergoes the 1,2-shift of the hydroxyl group, forming a  product-derived gem-diol radical. The C2 of the product radical,  abstracts a hydrogen back from deoxyadenosine with inversion of the  configuration of C2, producing a 1,1-gem-diol, which undergoes  dehydration, forming propionaldehyde and H2O <34>; #3,13# enzymatic  radical catalysis, with adenosylcobalamin, coenzyme B12, as a cofactor.  Dehydration of 1,2-diols to the corresponding aldehydes. The substrate  and an essential potassium ion are located inside a betaalpha8 barrel.  Two hydroxyl groups of the substrate coordinate directly to the  potassium ion which binds to the negatively charged inner part of the  cavity. Cobalamin bound covers the cavity to isolate the active site  from the solvent. The initial migration of the hydroxyl group is  stereospecific and the dehydration of a gem-diol undergoes steric  control by the enzyme <30>; #1# radical mechanism. Abstraction of a  hydrogen atom from C1 of the substrate by the 5-deoxyadenosyl radical  produces a substrate radical which undergoes further transformation  into the radical precursor of hydrated propionaldehyde. If dehydration  of the radical is by acid catalysis, a resonance-stabilized radical  cationic intermediate is formed. The radical cation is then hydrated to  the radical precursor of propionaldehyde hydrate. If base catalysis  takes place, a ketyl radical is initially generated, and it eliminates  hydroxide to form a resonance-stabilized aldehyde radical. Addition of  hydroxide to the aldehydic group generates the radical precursor to  propionaldehyde hydrate. The planar cationic radical from  acid-catalyzed dehydration can lose a proton to form the semidione  radical. In the base-catalyzed dehydration, the ketyl radical can  eliminate hydroxide to form the semidione radical <29>; #13# the  enzyme-bound adenosylcobalamin serves as an intermediate hydrogen  carrier, accepting a hydrogen atom from C1 of the substrate to C5 of  the coenzyme and giving a hydrogen back to C2 of the product. R and S  enantiomers are bound to the active site of the enzyme in a symmetrical  mode with respect to the plane <33>; #13# minimal mechanism for  AdoCbl-dependent diol dehydratase involving the cob(II)alamin cofactor  and active-site structure of the enzyme, overview <44>; #13# reaction  mechanism, quantum mechanical/molecular mechanical, QM/MM, modeling of  diol dehydratase based on the crystal structure of diol  dehydratase-adeninylpentylcobalamin complex, overview. The hydrogen  recombination is the rate-determining step for the overall reaction  <51>)  "
4.2.1.3, citrate = cis-aconitate + H2O  
4.2.1.30," glycerol = 3-hydroxypropanal + H2O (#7# mechanism <23>;  #2,3,4,5,6,7,8,10,12# mechanism of enzyme reaction <21>; #2# role of  structural components of adenosylcobalamin in the formation of active  site of the enzyme <10>; #2,6# mechanism of hydrogen transfer <1>)  "
4.2.1.31," (R)-malate = maleate + H2O (#1# stereochemistry of overall reaction is  trans, according to magnetic resonance spectroscopy and optical  rotatory properties <4>; #1# Fe-S cluster involved in catalysis, trans  hydration <1,3>;  #3,4,6,7,8,9,10,11,12,13,14,15,16,18,19,20,21,22,23,24,25,26,27,28,29  30# generally high streospecificity for D-malate production <6>)  "
4.2.1.32," (R,R)-Tartrate = oxaloacetate + H2O  "
4.2.1.33," (2R,3S)-3-isopropylmalate = 2-isopropylmaleate + H2O (#7# stoichiometry  of reaction, enzyme also hydrates 2-isopropylmaleate to  3-hydroxy-4-methyl-3-carboxypentanoate, interconversion between the 2  isomers <1>; #3# equilibrium concentration ratios <4>; #3# feedback  regulation by leucine <5>; #2# mechanism, equilibrium in vitro favors  reaction opposite the direction of leucine biosynthesis <2>; #2#  transcriptional feedback regulation by leucine <6>) "
4.2.1.33, 2-isopropylmaleate + H2O = (2S)-2-isopropylmalate 
4.2.1.33," (2R,3S)-3-isopropylmalate = (2S)-2-isopropylmalate  "
4.2.1.34, (S)-2-Methylmalate = 2-methylfumarate + H2O  
4.2.1.35, (R)-2-Methylmalate = 2-methylmaleate + H2O  
4.2.1.36," (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate =  (Z)-but-1-ene-1,2,4-tricarboxylate + H2O  "
4.2.1.39, D-gluconate = 2-dehydro-3-deoxy-D-gluconate + H2O  
4.2.1.40, D-glucarate = 5-dehydro-4-deoxy-D-glucarate + H2O (#6# mechanism <9>;  #6# regiospecific <8>)  
4.2.1.41," 5-Dehydro-4-deoxy-D-glucarate = 2,5-dioxopentanoate + H2O + CO2  "
4.2.1.42," galactarate = (2R,3S)-2,3-dihydroxy-5-oxohexanedioate + H2O  "
4.2.1.43," 2-dehydro-3-deoxy-L-arabinonate = 2,5-dioxopentanoate + H2O (#1# Schiff  base intermediate <2>)  "
4.2.1.44," 2,4,6/3,5-Pentahydroxycyclohexanone =  3,5/4-trihydroxycyclohexa-1,2-dione + H2O (#1# mechanism <1>)  "
4.2.1.45," CDP-glucose = CDP-4-dehydro-6-deoxy-D-glucose + H2O (#3#  stereochemistry, intramolecular oxidation-reduction that involves an  internal hydrogen transfer from C-4 of the substrate to C-6 of the  resulting product <7>; #3# displacement of the hydroxyl-group at C-6 is  stereospecific and occurs with inversion <9>)  "
4.2.1.46, dTDP-alpha-D-glucose = dTDP-4-dehydro-6-deoxy-alpha-D-glucose + H2O  
4.2.1.47," GDP-alpha-D-mannose = GDP-4-dehydro-alpha-D-rhamnose + H2O (#6,13#  mechanism <16,17>)  "
4.2.1.48, D-glutamate = 5-oxo-D-proline + H2O  
4.2.1.49," 3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate = urocanate + H2O (#4#  enzyme catalyzes a complex reaction involving an intramolecular  oxidation-reduction with the addition of a molecule of water and a  conversion of the imidazole ring into a highly unstable imidazolone  ring <1>; #10# investigation of a regulation mechanism not dependent on  light <25>; #10# identification of the enol tautomer of imidazolone  propionate as the reaction product <21>; #10# investigation of the  mechanism and stereospecificity by using 1H-NMR and C-NMR spectroscopy  #1,2,4-8,12-14# <3,19,21,30,34,35>; #10# catalytic and thermodynamic  properties of the reaction <10>; #2,3,4,6,7,9,10,11,14,15# reaction  mechanism <2,26,30,34>)  "
4.2.1.5, D-Arabinonate = 2-dehydro-3-deoxy-D-arabinonate + H2O  
4.2.1.50, L-serine + pyrazole = 3-(pyrazol-1-yl)-L-alanine + H2O  
4.2.1.51," prephenate = phenylpyruvate + H2O + CO2 (#22# this enzyme in the  enteric bacteria also possesses chorismate mutase activity, EC  5.4.99.5, and converts chorismate into prephenate <35>; #4# this enzyme  in the enteric bacteria also possesses chorismate mutase activity, EC  5.4.99.5, and converts chorismate into prephenate, catalytic mechanism,  T278 is involved in catalysis <34>; #11# this enzyme in the enteric  bacteria also possesses chorismate mutase activity, EC 5.4.99.5, and  converts chorismate into prephenate, residues Glu64, Thr183, Arg184,  and Phe185 might be involved in catalysis and substrate binding <33>)  "
4.2.1.53, (R)-10-Hydroxystearate = oleate + H2O (#1# stereochemistry <2>)  
4.2.1.54," (R)-lactoyl-CoA = acryloyl-CoA + H2O (#6# 3Si hydrogen is removed, no  radical mechanism <5>; #6# addition in the reverse direction is syn <6>)  "
4.2.1.55, (3R)-3-hydroxybutanoyl-CoA = crotonoyl-CoA + H2O (#4# stereochemistry  <1>)  
4.2.1.56, Citramalyl-CoA = itaconyl-CoA + H2O  
4.2.1.57, 3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA =  3-(4-methylpent-3-en-1-yl)pent-2-enedioyl-CoA + H2O (#1# mechanism <1>)  
4.2.1.59, a (3R)-3-hydroxyacyl-[acyl-carrier protein] = a  trans-2-enoyl-[acyl-carrier protein] + H2O  
4.2.1.6," D-galactonate = 2-dehydro-3-deoxy-D-galactonate + H2O (#3#  stereochemistry <10>; #3# it is proposed that the mechanism of the  enzyme-catalyzed reaction is initiated by abstraction of the  alpha-proton to form a stabilized enolic ion. If the substrate binds at  the active site in the extended conformation the stereochemical course  of the beta-elimination reaction is expected to be anti <12>; #5# the  immediate dehydration product is the enol which undergoes spontaneous  ketonization <5,7>)  "
4.2.1.62," 5alpha-Ergosta-7,22-diene-3beta,5-diol = ergosterol + H2O (#1#  mechanism <2>)  "
4.2.1.65, L-Asparagine = 3-cyanoalanine + H2O  
4.2.1.66," formamide = cyanide + H2O (#6,7,9,10,19,21# reaction mechanism <10>;  #19# reaction proceeds irreversibly in opposite direction <6>; #25#  Phe170 is an active site residue <9>)  "
4.2.1.67, D-Fuconate = 2-dehydro-3-deoxy-D-fuconate + H2O  
4.2.1.68, L-fuconate = 2-dehydro-3-deoxy-L-fuconate + H2O  
4.2.1.69, urea = cyanamide + H2O  
4.2.1.7, D-altronate = 2-dehydro-3-deoxy-D-gluconate + H2O  
4.2.1.70, uracil + D-ribose 5-phosphate = pseudouridine 5'-phosphate + H2O  
4.2.1.73, Protoaphin aglucone = xanthoaphin + H2O  
4.2.1.74, a long-chain (3S)-3-hydroxyacyl-CoA = a long-chain trans-2-enoyl-CoA +  H2O  
4.2.1.75," hydroxymethylbilane = uroporphyrinogen III + H2O (#6,16# in the  presence of hydroxymethylbilane synthase EC 4.3.1.8, enzyme forms  uroporphyrinogen III from porphobilinogen, reaction mechanism, does not  require acid/base catalysis, active site structure <18,19>; #2# in the  presence of hydroxymethylbilane synthase EC 4.3.1.8, enzyme forms  uroporphyrinogen III from porphobilinogen, Tyr166 is essential for  catalysis and/or substrate binding <20>; #17# reaction mechanism via  azafulvene and azofulvene intermediates, the product binds between the  two domains and is held in place by a network of hydrogen bonds between  the productÂ’s side chain carboxylates and the proteinÂ’s main chain  amides. Interactions of the product A and B ring carboxylate side  chains with both structural domains of U3S appear to dictate the  relative orientation of the domains in the closed enzyme conformation  and likely remain intact during catalysis. The product C and D rings  are less constrained in the structure, consistent with the  conformational changes required for the catalytic cyclization with  inversion of D ring orientation. A conserved tyrosine residue is  potentially positioned to facilitate loss of a hydroxyl from the  substrate to initiate the catalytic reaction, overview <28>; #16#  reaction mechanism, modelling, overview <31>; #6# reaction mechanism,  modeling involving Tyr168, overview <36>)  "
4.2.1.76, UDP-alpha-D-glucose = UDP-4-dehydro-6-deoxy-alpha-D-glucose + H2O  
4.2.1.77, trans-3-hydroxy-L-proline = 1-pyrroline 2-carboxylate + H2O  
4.2.1.78," 4-hydroxyphenylacetaldehyde + dopamine = (S)-norcoclaurine + H2O  (#2,3,20# the reaction makes a six-membered ring by forming a bond  between C-6 of the 3,4-dihydroxyphenyl group of the dopamine and C-1 of  the aldehyde in the imine formed between the substrates, the product is  the precursor of the benzylisoquinoline alkaloids in plants, the  enzyme, formerly known as (S)-norleudanosoline synthase, will also  catalyse the reaction of 4-(2-aminoethyl)benzene-1,2-diol +  (di-3,4-hydroxyphenyl)acetaldehyde to form (S)-norlaudanosoline, but  this alkaloid has not been found to occur in plants, cooperativity  between substrate binding sites <4>; #20# the reaction makes a  six-membered ring by forming a bond between C-6 of the  3,4-dihydroxyphenyl group of the dopamine and C-1 of the aldehyde in  the imine formed between the substrates, the product is the precursor  of the benzylisoquinoline alkaloids in plants, the enzyme, formerly  known as (S)-norleudanosoline synthase, will also catalyse the reaction  of 4-(2-aminoethyl)benzene-1,2-diol +  (di-3,4-hydroxyphenyl)acetaldehyde to form (S)-norlaudanosoline, but  this alkaloid has not been found to occur in plants, iso-ordered bi-uni  mechanism with 4-hydroxyphenylacetaldehyde binding before dopamine <3>)  "
4.2.1.79," (2S,3S)-2-hydroxybutane-1,2,3-tricarboxylate =  (Z)-but-2-ene-1,2,3-tricarboxylate + H2O  "
4.2.1.8, D-Mannonate = 2-dehydro-3-deoxy-D-gluconate + H2O  
4.2.1.80," (S)-4-hydroxy-2-oxopentanoate = (2Z)-2-hydroxypenta-2,4-dienoate + H2O  "
4.2.1.81," (S,S)-tartrate = oxaloacetate + H2O  "
4.2.1.82, D-xylonate = 2-dehydro-3-deoxy-D-arabinonate + H2O  
4.2.1.83," 2-hydroxy-4-oxobutane-1,2,4-tricarboxylate =  (1E,3E)-4-hydroxybuta-1,3-diene-1,2,4-tricarboxylate + H2O  "
4.2.1.84," an aliphatic amide = a nitrile + H2O (#15# the iron-type enzyme is  photoreactive, it loses the catalytic activity through aerobic  incubation in the dark and recovers it by light irradiation <21>; #15#  N-771 and N-774 strains can be inactivated in the dark and reactivated  by light <9>; #15# the activity of the enzyme in intact cells increases  on light irradiation and gradually decreases in the dark. For purified  enzyme no differences are detected when kept in dark or  light-irradiated <20>; #15# monitoring of binding of substrates and  their analogues to the active pocket via the NO bands <45>; #36#  substrate binding occurs via breathing and flip-flop mechanisms <42>;  #36# possible role of water and active center residues in reaction  mechanism is shown <61>; #36# reaction mechanism, overview <66>; #16#  first- and second-shell reaction mechanism, a tyrosine residue acts as  catalytic base, modelling, detailed overview <68>; #48# modeling of the  catalytic mechanism of nitrile hydratase by semi-empirical quantum  mechanical calculation using the enzyme crystal structure, PDB code  1I"
4.2.1.84,", overview. Active site activation is the first step of NHase  catalysis, in which the Co2+ coordinated to a water molecule forms a  Co-OH complex mediated by the oxidized alpha-CEA113. Then the oxygen  atom in the Co-OH attacks the C atom in the -CN triple bond of  acrylonitrile, forming a precursor of acrylamide, proton rearrangement  happens transforming the precursor into the final product of  acrylamide, under the assistance of the hydrogen atom in the -OH group  of alpha-Ser112 <74>; #36# reaction mechanism, first-shell mechanism of  CoIII-NHase involving Tyr68 as catalytic base, deprotonated Tyr68 is  proposed to abstract a proton from the nucleophilic water molecule,  thus activating it for attack on the metal-bound substrate, modelling,  detailed overview <68>; #11,48# thermal-stable mechanism of  thermophilic nitrile hydratases, molecular dynamic simulation, overview  <75>; #15# water dynamics and catalytic mechanism, a water molecule  bound to the metal ion directly attacks the nitrile carbon, overview.  Dynamics of the active site channel, NO diffusion paths, and water  molecules positions are key components in the functioning of this  important industrial enzyme <65>; #32# role of residues in the active  site and enzymatic reaction mechanism. Cys146 acts as the nucleophile,  Glu42 as the general base, Lys113/Glu42 as the general acid, WatA as  the hydrolytic water and Nf_Lys113 and N_Phe147 form the oxyanion hole,  hydrogen bonding network in the active site of Nit structure, overview  <97>; #16# detailed reaction mechanism using large quantum-mechanical  active site models, overview. The attack of Cys114-SO- on the  coordinated nitrile forms a cyclic intermediate. Cys109-S-S-Cys114  disulfide formation promotes cleavage of the latter to give the amide.  Active-site regeneration occurs through attack of water on the  disulfide, putative cyclic intermediate structure, overview <106>;  #48,59# mechanism of action for the hydration of nitriles by NHase,  overview. The cysteine-sulfenic acid ligand acts as the catalytic  nucleophile. The first step in catalysis involves the direct ligation  of the nitrile to the active site lowspin, trivalent metal ion. One  proton transfer occurs between the alphaCys113-OH ligand and the  nitrile N-atom, while the second transfer occurs between the water  molecule that reforms alphaCys113-OH and the newly forming imidate  N-atom <107>)  "
4.2.1.85," (2R,3S)-2,3-dimethylmalate = dimethylmaleate + H2O  "
4.2.1.87, 1-(4-hydroxyphenyl)-2-aminoethanol = (4-hydroxyphenyl)acetaldehyde + NH3  
4.2.1.88," (R)-synephrine = (4-hydroxyphenyl)acetaldehyde + methylamine (#1#  removal of H2O from (+/-)-synephrine produces a 2,3-enamine, which  hydrolyzes to the products <1>)  "
4.2.1.9," 2,3-dihydroxy-3-methylbutanoate = 3-methyl-2-oxobutanoate + H2O (#1#  stereochemistry, elimination and protonation steps are stereospecific,  enol-keto conversion takes place with proton addition at C-3 to the  same face of the enol as that of the departing hydroxy-group <12>; #7#  polar but concerted elimination mechanism which should proceed through  an anti transition state <27>)  "
4.2.1.90," L-rhamnonate = 2-dehydro-3-deoxy-L-rhamnonate + H2O (#7,8# reaction  mechanism of the RhamD-catalyzed reaction, overview <4>)  "
4.2.1.91, L-arogenate = L-phenylalanine + H2O + CO2  
4.2.1.92," (9Z,11E,15Z)-(13S)-hydroperoxyoctadeca-9,11,15-trienoate =  (9Z,15Z)-(13S)-12,13-epoxyoctadeca-9,11,15-trienoate + H2O  (#3,20,26,34# mechanism <2,18,19>; #11# reaction mechanisms of  wild-type AOS and mutant F137L, QM/MM calculations, overview <27>)  "
4.2.1.93," ATP + (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine  dinucleotide = ADP + phosphate + NADH "
4.2.1.93," ATP + (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine  dinucleotide phosphate = ADP + phosphate + NADPH  "
4.2.1.94," scytalone = 1,3,8-trihydroxynaphthalene + H2O (#3# mechanism,  stereochemistry <7>; #3# syn elimination through E1cb-like mechanism  <8>; #3# syn elimination mechanism <6>; #3# mechanism, modeled  enzyme-substrate complex <10>)  "
4.2.1.95, kievitone hydrate = kievitone + H2O  
4.2.1.96," 4a-hydroxytetrahydrobiopterin = 6,7-dihydrobiopterin + H2O (#5#  mechanism <5>; #1# the mechanism of dehydration involves base catalysis  at the N(5)-H group of the substrate by His61 <9>; #9# His61 and His79  act as acid catalysts for the stereospecific elimination of the 4a(R)-  and 4a(S)-hydroxyl groups, respectively. The role of His62 is primarily  binding substrate with additional component of base catalysis <16>)  "
4.2.1.97, Phaseollidin hydrate = phaseollidin + H2O  
4.2.1.98," 16alpha-Hydroxyprogesterone = 16,17-didehydroprogesterone + H2O  "
4.2.1.99," (2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate =  (Z)-but-2-ene-1,2,3-tricarboxylate + H2O  "
4.2.2.1," Cleaves hyaluronate chains at a beta-D-GalNAc-(1->4)-beta-D-GlcA bond,  ultimately breaking the polysaccharide down to  3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine (#64#  active site structure <44>; #6# 5-step reaction mechanism, catalytic  residues are Arg349, His399, Tyr40, residues responsible for substrate  binding and translocation of the remaining substrate are Arg243and  Asn580, enzyme and acitive site strucure <27>; #37# active site  structure and substrate binding of wild-type and mutant enzymes with  chondroitin, mode of action <35>;  #7,8,9,10,12,13,14,16,18,19,20,21,22,24,26,27,28,29,30,32,35,36,37,38  39,40,41,42,43,45,46,47,49,101# also acts on chondroitin, the product  is more systematically known as  3-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic  acid)-2-acetamido-2-deoxy-D-glucose <18,20,23,26,28>; #17# also acts on  chondroitin, the product is more systematically known as  3-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic  acid)-2-acetamido-2-deoxy-D-glucose, catalytic mechanism <21>; #31,44#  also acts on chondroitin, the product is more systematically known as  3-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic  acid)-2-acetamido-2-deoxy-D-glucose, substrate binding site <26>; #6#  Asn349, His399, and Tyr408 are involved in catalysis, flexible,  allosteric behavior of the enzyme, mechanism, active site structure and  substrate binding and interactions, overview <31>; #6# catalytic  mechanism, substrate binding, structure modeling, residues Tyr408,  Asn349, and His399 are involved in catalysis and important <24>; #48#  catalytic mechanism, the flexibility of the enzyme structure is  important, the beta-domain is involved in the progressive catalytic  process, enzyme substrate interactions <32>; #6# enzyme-product  interaction from crystal structure, catalytic mechanism, interaction  with substrate binding site, Tyr408, Asn349, and His399 are involved  <36>; #17# His479 is critical for activity, active site structure,  mechanism <37>; #45# lyase mechanism, elimination process <19>; #37#  processive reaction mode, catalytic mechanism, catalytic residues are  Asn349, His399, and Tyr408, residues responsible for product release  are Glu388, Asp398, and Thr400, the socalled negative patch, residues  responsible for correct substrate positioning are Trp291, Trp292, and  Phe343, the socalled hydrophobic patch, substrate binding structure of  wild-type and mutant enzymes <34>; #25# rapid elimination mechanism  <22>; #48# substrate binding, structure and mechanims, and reaction  mechanism, catalytic residues are His479, Tyr488, and Asn429, modeling  of binding of a tetrasaccharide in the active site cleft <30>; #37,48#  active site structure and hydrophobic patch, molecular mechanism,  enzyme flexibility and structural requirements <45>; #37# binding of  negatively charged hydrophobic substrates is facilitated by the  predominantly positive and hydrophobic cleft located at distorted  (alpha/alpha)5-6 barrel, mechanism of hyaluronan degradation, active  site residues are Asn349, His399, and Tyr408, overview <40>; #17#  binding of negatively charged hydrophobic substrates is facilitated by  the predominantly positive and hydrophobic cleft located at distorted  (alpha/alpha)5-6 barrel, mechanism of hyaluronan degradation, overview  <40>; #6# catalytic reaction mechanism and structural requirements,  catalytic residues are Asn349, His399, and Tyr408 <41>; #17# catalytic  reaction mechanism and structural requirements, catalytic residues are  Asn429, His479, and Tyr488, a required hydrophobic patch is composed of  residues Glu468, Asp478, and Thr480 <41>;  #50,51,52,53,54,55,56,57,58,59,60,61,62,63,66,67# catalytic residues  are Asn349, His399, and Tyr408 <43,46>; #45# mechanism of hyaluronan  degradation, random endolytic action pattern, overview <40>; #6# along  with the substrate binding, the phenylhydroxyl hydrogen atom of Tyr408  will transfer to nearby His399 via a near barrierless transition state,  which results in a negatively charged Tyr408 and positively charged  His399. The Tyr408, rather than the previously proposed His399, acts as  the general base for the subsequent beta-elimination reaction. The  His399 has the function of neutralizing the C5-carboxyl group, reaction  mechanism, overview <68>; #6# binding of the substrate molecule can  lead to the ionization of Y408 and protonation of H399, Y408 serves as  the general base in the proton abstraction, while general acid is the  next proton donation step. The reaction can be classified into syn  elimination reaction mechanism, reaction mechanism analysis, detailed  overview <69>)  "
4.2.2.10," Eliminative cleavage of (1->4)-alpha-D-galacturonan methyl ester to  give oligosaccharides with  4-deoxy-6-O-methyl-alpha-D-galact-4-enuronosyl groups at their  non-reducing ends (#4# reaction mechanism <32>; #25# acts antagonistic  to pectinesterase, EC 3.1.1.11 <22>; #4# favours pectin, the  methylester, over pectate, the anion, which is the preferred substrate  of EC 4.2.2.2, pectate lyase. Demethylation progressively slows its  action, it can nevertheless cleave on either side of a demethylated  residue if the residue at the other end of the scissile bond is  methylated <31>; #64# reaction mechanism, catalytic residues Arg236,  Arg176, and Lys239 are essentially involved in catalysis <26>)  "
4.2.2.11," Eliminative cleavage of alginate to give oligosaccharides with  4-deoxy-alpha-L-erythro-hex-4-enuronosyl groups at their non-reducing  ends and alpha-L-guluronate at their reducing end (#35# AlyA1PL7  alginate lyase acts via the beta-elimination mechanism, producing the  4,5-unsaturated 4-deoxy-L-erythro-hex-4-enepyranosyluronate (DELTA) on  the nonreducing end, catalytic mechanism of G-specific alginate lyases,  overview <38>; #34# AlyA1PL7 alginate lyase acts via the  beta-elimination mechanism, producing the 4,5-unsaturated  4-deoxy-L-erythro-hex-4-enepyranosyluronate (DELTA) on the nonreducing  end, catalytic mechanism of guluronate-specific alginate lyases,  overview <38>; #38# substrate binding, structural change and exolytic  mechanism of alginate depolymerization by Alg17c, overview <39>)  "
4.2.2.12," Eliminative cleavage of the terminal  beta-D-mannosyl-(1->4)-beta-D-glucuronosyl linkage of the side-chain of  the polysaccharide xanthan, leaving a  4-deoxy-alpha-L-threo-hex-4-enuronosyl group at the terminus of the  side-chain (#2# mechanism <5>)  "
4.2.2.13," linear alpha-glucan = (n-1) 1,5-anhydro-D-fructose + D-glucose (#7#  reaction mechanism occurred by an acid-catalysed formation of a  covalent glycosyl-enzyme intermediate via the nucleophilic aspartic  acid residue Asp 553 followed by the E1-like E2 elimination of the  enzyme carboxylate to generate 1,5-anhydrofructose <10>)  "
4.2.2.14, Eliminative cleavage of (1->4)-beta-D-glucuronans to give  oligosaccharides with 4-deoxy-beta-D-gluc-4-enuronosyl groups at their  non-reducing ends. Complete degradation of glucuronans results in the  formation of tetrasaccharides. (#1# complete degradation of glucuronans  results in the formation of tetrasaccharides <1>)  
4.2.2.15," elimination of alpha-sialyl groups in N-acetylneuraminic acid  glycosides, releasing 2,7-anhydro-alpha-N-acetylneuraminate  "
4.2.2.16," produces di-beta-D-fructofuranose 2,6':2',6-dianhydride (DFA IV) by  successively eliminating the diminishing (2->6)-beta-D-fructan (levan)  chain from the terminal D-fructosyl-D-fructosyl disaccharide  "
4.2.2.17," Produces alpha-D-fructofuranose beta-D-fructofuranose  1,2':2,1'-dianhydride (DFA I) by successively eliminating the  diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal  D-fructosyl-D-fructosyl disaccharide.  "
4.2.2.18," Produces alpha-D-fructofuranose beta-D-fructofuranose  1,2':2,3'-dianhydride (DFA III) by successively eliminating the  diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal  D-fructosyl-D-fructosyl disaccharide.  "
4.2.2.19," Eliminative cleavage of dermatan sulfate containing  (1->4)-beta-D-hexosaminyl and (1->3)-beta-D-glucurosonyl or  (1->3)-alpha-L-iduronosyl linkages to disaccharides containing  4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated  dermatan-sulfate disaccharide (DeltaUA-GalNAc-4S). (#3# acts on  dermatan sulfate as sole substrate, active site structure involving  Lys250, Arg271, His272, and Glu333, substrate binding mechanism  involving Arg363 and Arg364 <7>; #3# acts on dermatan sulfate as sole  substrate, catalytic mechanism, Glu333 is involved, substrate binding  mechanism involving Arg318 and Arg364 interacting with the sulfate  group <10>; #3# acts on dermatan sulfate as sole substrate, enzyme  cleaves the beta(1,4)-linkage of dermatan sulfate in a random manner,  yielding 4,5-unsaturated dermatan sulfate disaccharides,  calcium-dependent catalytic mechanism, active site structure <8>)  "
4.2.2.2, Eliminative cleavage of (1->4)-alpha-D-galacturonan to give  oligosaccharides with 4-deoxy-alpha-D-galact-4-enuronosyl groups at  their non-reducing ends  
4.2.2.20, Endolytic cleavage of (1->4)-beta-galactosaminic bonds between  N-acetylgalactosamine and either D-glucuronic acid or L-iduronic acid  to produce a mixture of Delta4-unsaturated oligosaccharides of  different sizes that are ultimately degraded to Delta4-unsaturated  tetra- and disaccharides (#3# related enzyme EC 4.2.2.21 <2>)  
4.2.2.21," Exolytic removal of Delta4-unsaturated disaccharide residues from the  non-reducing ends of both polymeric chondroitin/dermatan sulfates and  their oligosaccharide fragments. (#1# related enzyme EC 4.2.2.20 <9>;  #6# only disaccharide products and no tetrasaccharide for each of the  substrates tested are found during the course of digestion, consistent  with an exolytic mode of action for the enzyme <15>)  "
4.2.2.22, eliminative cleavage of unsaturated trigalacturonate as the major  product from the reducing end of polygalacturonic acid/pectate  
4.2.2.23," Endotype eliminative cleavage of  L-alpha-rhamnopyranosyl-(1->4)-alpha-D-galactopyranosyluronic acid  bonds of rhamnogalacturonan I domains in ramified hairy regions of  pectin leaving L-rhamnopyranose at the reducing end and  4-deoxy-4,5-unsaturated D-galactopyranosyluronic acid at the  non-reducing end.  "
4.2.2.24," Exotype eliminative cleavage of  alpha-L-rhamnopyranosyl-(1->4)-alpha-D-galactopyranosyluronic acid  bonds of rhamnogalacturonan I oligosacharides containing  alpha-L-rhamnopyranose at the reducing end and 4-deoxy-4,5-unsaturated  D-galactopyranosyluronic acid at the non-reducing end. The products are  the disaccharide  2-O-(4-deoxy-beta-L-threo-hex-4-enopyranuronosyl)-alpha-L  rhamnopyranose and the shortened rhamnogalacturonan oligosaccharide  containing one 4-deoxy-4,5-unsaturated D-galactopyranosyluronic acid at  the non-reducing end.  "
4.2.2.25," Eliminative cleavage of  beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyluronate bonds of  gellan backbone releasing tetrasaccharides containing a  4-deoxy-4,5-unsaturated D-glucopyranosyluronic acid at the non-reducing  end. The tetrasaccharide produced from deacetylated gellan is  beta-D-4-deoxy-Delta4-GlcAp-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1  >3)-beta-D-Glcp.  "
4.2.2.26, Cleavage of poly(4-deoxy-alpha-L-erythro-hexopyranuronoside)  oligosaccharides with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl  groups at their non-reducing ends into  4-deoxy-alpha-L-erythro-hex-4-enopyranuronate monosaccharides  
4.2.2.27," (1,4-alpha-D-galacturonosyl methyl ester)n =  (1,4-alpha-D-galacturonosyl methyl ester)n-1 +  4-deoxy-6-O-methyl-L-threo-hex-4-enopyranuronate  "
4.2.2.3," Eliminative cleavage of alginate to give oligosaccharides with  4-deoxy-alpha-L-erythro-hex-4-enuronosyl groups at their non-reducing  ends and beta-D-mannuronate at their reducing end. (#8# alginate lyase  activity and mannuronan C-5-epimerase activity of the bifunctional  enzyme might use the same active site <31>; #40# also performs reaction  of EC 4.2.2.11, the enzyme molecule shows a cleft which might bear the  active site with a tryptophan residue being involved in the catalytic  reaction <26>;  #3,5,9,10,13,19,21,23,24,26,27,29,30,31,34,35,38,39,42,44,45,46,47,48  49,50,51,52,53,54,55,56,57,58,59,60,61,62,64,65,66,67,69#  beta-elimination mechanism, substrate binding and catalytic site <22>;  #37# enzyme seems to have 6 substrate binding sites, also performs  reaction of EC 4.2.2.11 <23>; #38# His192 is an active site residue,  essential for activity <32>; #38# substrate binding site structure,  active site cleft, catalytic mechanism <34>; #38# A1-II with a  glove-like beta-sandwich as a basic scaffold forms a cleft covered with  two lid loops (L1/L2). Loop flexibility for substrate binding and  structural determinants for broad substrate recognition and catalytic  reaction is shown. The two loops associate mutually over the cleft  through the formation of a hydrogen bond between their edges (Asn141  and Asn199) <69>; #11# residues Asn138, Arg143, Asn217, and Lys308 are  involved in the catalytic reaction, and van der Waals interactions are  responsible for binding with the catalytic His200 and Tyr312 residues,  substrate binding mode, overview <103>; #92# substrate binding,  strutural change and exolytic mechanism of alginate depolymerization by  Alg17c, overview <110>)  "
4.2.2.5," Eliminative degradation of polysaccharides containing  1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl linkages to  disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups (#4#  random attack <5>; #6# stepwise attack <5>; #4,6,8,9# acts on  chondroitin 4-sulfate and chondroitin 6-sulfate, but less well on  hyaluronate <16,17,20,22>; #6# acts on chondroitin 4-sulfate and  chondroitin 6-sulfate, but less well on hyaluronate, lytic mechanism  with Tyr242 acting as a general base that abstracts the proton from the  C5 position of glucuronic acid while Asn183 and His233 neutralize the  charge on the glucuronate acidic group, substrate binding site <23>;  #9# acts on chondroitin 4-sulfate and chondroitin 6-sulfate, but less  well on hyaluronate, mechanism, active site structure, His225, Tyr234,  Arg288, and Glu371 form a catalytic tetrad <18>; #4# acts on  chondroitin 4-sulfate and chondroitin 6-sulfate, but less well on  hyaluronate, random endolytic elimination mechanism <15>; #4# acts on  chondroitin 4-sulfate and chondroitin 6-sulfate, but less well on  hyaluronate, reaction mechanism <19>; #4# acts on chondroitin 4-sulfate  and chondroitin 6-sulfate, but less well on hyaluronate, stepwise  reaction mechanism <21>)  "
4.2.2.6," 4-(4-deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate = 2  5-dehydro-4-deoxy-D-glucuronate (#2# also catalyses eliminative removal  of unsaturated terminal residues from oligosaccharides of  D-galacturonate <7>; #4# active site structure modeling and  beta-elimination reaction mechanism, overview <9>)  "
4.2.2.7, Eliminative cleavage of polysaccharides containing (1->4)-linked  D-glucuronate or L-iduronate residues and (1->4)-alpha-linked  2-sulfoamino-2-deoxy-6-sulfo-D-glucose residues to give  oligosaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups  at their non-reducing ends  
4.2.2.8, elimination of sulfate; appears to act on linkages between  N-acetyl-D-glucosamine and uronate. Product is an unsaturated sugar.  (#3# His295 and His510 are essential for catalytic activity <11>)  
4.2.2.9," (1,4-alpha-D-galacturonosyl)n = (1,4-alpha-D-galacturonosyl)n-2 +  4-(4-deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate (#5#  trans-elimination mechanism <4>)  "
4.2.3.1," O-phospho-L-homoserine + H2O = L-threonine + phosphate (#2,4,9,15#  mechanism <7,9,17,18>; #6# reaction proceeds via phospate removal and  isomerization from primary to secondary alcohol <1>; #2# mechanism of  phosphohomoserine dephosphorylation/deamination activity <3>; #4#  inhibitor studies concerning mechanism, model of stepwise catalytic  mechanism <16>; #4,10,19# reaction proceeds via phosphate removal and  isomerization from primary to secondary alcohol <25,26,27>; #17#  analyzed crystal structure gives new insights into the catalytic  mechanism of threonine synthase in general, specifically by suggesting  the direct involvement of the phosphate moiety of the cofactor, rather  than the inorganic phosphate product, in transferring a proton from C4  to Cgamma in the formation of the alphabeta-unsaturated aldimine <32>;  #18# the phosphate ion released from O-phospho-L-homoserine by  gamma-elimination acts as the base catalyst for the addition of water  at Cbeta of the alpha-aminocrotonate aldimine, thereby providing the  basis of the reaction specificity. The phosphate ion also accelerates  the protonation/deprotonation at Cgamma <31>)  "
4.2.3.10," geranyl diphosphate + H2O = (-)-endo-fenchol + diphosphate (#1#  reaction mechanism <2,3>; #1# (3R)-linalyl diphosphate is an  intermediate in the reaction <2,3>)  "
4.2.3.100," (2E,6E)-farnesyl diphosphate = bicyclogermacrene + diphosphate  "
4.2.3.101," (2E,6E)-farnesyl diphosphate = 7-epi-sesquithujene + diphosphate  "
4.2.3.102," (2E,6E)-farnesyl diphosphate = sesquithujene + diphosphate  "
4.2.3.103, ent-copalyl diphosphate = ent-isokaurene + diphosphate  
4.2.3.104," (2E,6E)-farnesyl diphosphate = alpha-humulene + diphosphate  "
4.2.3.105, geranyl diphosphate = tricyclene + diphosphate  
4.2.3.106," geranyl diphosphate = (E)-beta-ocimene + diphosphate (#3# protein does  not contain the RRx8W motif,suggesting that the reaction mechanism does  not proceed via an RR-dependent isomerization of geranyl diphosphate to  3S-linalyl diphosphate <2>)  "
4.2.3.107, geranyl diphosphate = (+)-car-3-ene + diphosphate  
4.2.3.108," geranyl diphosphate + H2O = 1,8-cineole + diphosphate (#5# substrate in  left-hynded screw-sense orientation isomerizes to (3R)-linalyl  diphosphate which in anti,endo-conformation cyclizes to the  (4R)-alpha-terpinyl intermediate and thence to cineole following the  addition of water <3>; #5# syn-stereochemistry for both  C-O-bond-forming steps. Reaction starts with allylic rearrangement of  geranyl diphosphate to (R)-linalyl diphosphate, followed by SN  cyclization to alpha-terpineol and proton-induced cyclization of the  C=C-double bond and the tertiary hydroxyl groups <5>; #14# proposed  mechanism for the formation of 1,8-cineole, the reaction can proceed  via (R)-alpha-terpinyl cation and (R)-alpha-terpineol, as well as via  (S)-alpha-terpinyl cation and (S)-alpha-terpineol, the catalytic dyad  is formed by H502 and E249. Depending on the stereochemistry of the  intermediate, the protonation of the double bond of the alpha-terpinyl  cation is provided by a proton relay via the hydroxyl groups of either  Tyr496 or Thr278. The substrate GPP is ionized by diphosphate  elimination, resulting in the geranyl cation. Subsequently, this cation  is converted into the linalyl cation and alpha-terpinyl cation. The  intermediate alpha-terpinyl cation is the precursor for all cyclic  monoterpenes. 1,8-Cineol is possibly directly formed from geranyl  diphosphate, and a cyclization reaction resulting in 1,8-cineole uses  alpha-terpineol as a precursor. alpha-Terpineol is formed after water  capture of the alpha-terpinyl cation <18>; #3# the substrate GPP is  ionized by diphosphate elimination, resulting in the geranyl cation.  Subsequently, this cation is converted into the linalyl cation and  alpha-terpinyl cation. The intermediate alpha-terpinyl cation is the  precursor for all cyclic monoterpenes. 1,8-Cineol is possibly directly  formed from geranyl diphosphate, and a cyclization reaction resulting  in 1,8-cineole uses alpha-terpineol as a precursor. alpha-Terpineol is  formed after water capture of the alpha-terpinyl cation. Proposed  mechanism for the formation of 1,8-cineole <18>)  "
4.2.3.109, geranyl diphosphate = (-)-sabinene + diphosphate  
4.2.3.11," geranyl diphosphate + H2O = sabinene hydrate + diphosphate (#1# both  cis- and trans-isomers of sabinene hydrate are formed. (3R)-Linalyl  diphosphate is an intermediate in the reaction, mechanism and  stereochemistry <1>)  "
4.2.3.110," geranyl diphosphate = (+)-sabinene + diphosphate (#4# major products  sabinene and gamma-terpinene are formed by a cyclization mechanism  involving a 1,2-hydride shift in the a-terpinyl cation intermediate  <1>; #2,3,4,6,7,8,9,11# proposed reaction mechanism of sabinene  synthase via (3R)-3-linalyl diphosphate and (3R)-3-alpha-terpinyl  cation <6>)  "
4.2.3.111," geranyl diphosphate + H2O = (-)-alpha-terpineol + diphosphate (#4# the  substrate geranyl diphosphate is ionized by diphosphate elimination,  resulting in the geranyl cation. Subsequently, this cation is converted  into the linalyl cation and alpha-terpinyl cation. The intermediate  alpha-terpinyl cation is the precursor for all cyclic monoterpenes.  alpha-Terpineol is formed after water capture of the alpha-terpinyl  cation. A cyclization reaction resulting in 1,8-cineole uses  alpha-terpineol as a precursor <6>)  "
4.2.3.112, geranyl diphosphate + H2O = (+)-alpha-terpineol + diphosphate  
4.2.3.113, geranyl diphosphate = terpinolene + diphosphate  
4.2.3.114," geranyl diphosphate = gamma-terpinene + diphosphate (#5# ionization of  geranyl diphosphate folded in left-handed helical form gives, by  syn-isomerization, (3R)-linalyl diphosphate, which by rotation about  C2-C3 provides the cisoid, anti-endo conformation. Ionization and  cyclization of this bound intermediate yield the (4R)-alpha-terpinyl  cation that, following the 1,2-hydride shift, affords the terpinen-4-yl  cation. Loss of the (5S)-proton terminates the reaction to generate  gamma-terpinene <3>; #3# major products sabinene and gamma-terpinene  are formed by a cyclization mechanism involving a 1,2-hydride shift in  the alpha-terpinyl cation intermediate <1>; #5# mechanism involves the  cyclizazion of the acyclic precursor, loss of a proton from C5 to form  the delta4 double bond, and a 1,2-hydride shift fom C4 to C8 to give  gamma-terpinene <4>)  "
4.2.3.115," geranyl diphosphate = alpha-terpinene + diphosphate (#1# the  isomerization-cyclization involves a 1,2-hydride shift in the terpinyl  cation to the terpin-4-yl-cation <1>)  "
4.2.3.116, geranyl diphosphate = (+)-camphene + diphosphate  
4.2.3.117, geranyl diphosphate = (-)-camphene + diphosphate  
4.2.3.118," (E)-2-methylgeranyl diphosphate + H2O = 2-methylisoborneol +  diphosphate (#1,7# catalytic mechanism, overview <9>)  "
4.2.3.119, geranyl diphosphate = (-)-alpha-pinene + diphosphate  
4.2.3.12," 7,8-dihydroneopterin 3'-triphosphate =  6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate (#6# mechanism <5>;  #4# the enzyme catalyzes the elimination of triphosphate as well as a  series of tautomerization reactions. Incorporation of protons into  positions C6 and C3 of the product <20>)  "
4.2.3.120, geranyl diphosphate = (-)-beta-pinene + diphosphate  
4.2.3.121, geranyl diphosphate = (+)-alpha-pinene + diphosphate  
4.2.3.122, geranyl diphosphate = (+)-beta-pinene + diphosphate  
4.2.3.123," (2E,6E)-farnesyl diphosphate = beta-sesquiphellandrene + diphosphate  "
4.2.3.124," D-glucose 6-phosphate = 2-deoxy-L-scyllo-inosose + phosphate (#1,6#  reaction mechanism, overview <9,10,15>; #6# catalyric reaction  mechanism and substrate specificity, overview <4>; #6# DOIS catalyzes  the multi-step and direct cyclization reaction of G-6-P consisting five  crucial transformations, which include the initial NAD+-dependent  dehydrogenation at C-4, the elimination of a phosphate from C-5 and  C-6, the hydride comeback to C-4 to form a cyclic enol ether, and the  finial aldol-type intramolecular condensation between C-6 and C-1 <2>;  #6# reaction and stereochemical mechanisms, overview <8>; #6# reaction  mechanism of the multistep reaction, stereochemistry of the phosphate  elimination reaction, proceeding through syn-elimination assisted by  Glu 243, and the cyclization, an aldol condensation that proceeds via a  boat conformation, overview <16>; #6# the reaction mechanism includes  oxidation of C-4, beta-elimination of phosphate, reduction of C-4, ring  opening, and intramolecular aldol cyclization. Completely conserved  E243 of BtrC is catalytically involved in the phosphate elimination  step <3>)  "
4.2.3.125," (2E,6E)-farnesyl diphosphate = alpha-muurolene + diphosphate  "
4.2.3.126," (2E,6E)-farnesyl diphosphate = gamma-muurolene + diphosphate  "
4.2.3.127," (2E,6E)-farnesyl diphosphate = beta-copaene + diphosphate (#1#  cyclization reaction mechanism, overview <3>; #1# the reaction  mechanism requires first the isomerization of all-trans (E,E)-FPP at  the 2,3 double bond to generate a cisoid-farnesyl cation. Cop4 then  catalyzes a 1,10 ring closure of this farnesyl cation isomer to form  the secondary cis-germacrene-dienyl cation. Cop4 generates a tertiary  cadinyl cation which upon deprotonation yields its major cyclization  product delta-cadinene. The cadinyl cation reacts further to yield  other cyclization products beta-cubebene, cubebol, beta-copaene, and  sativene <1>)  "
4.2.3.128," (2E,6E)-farnesyl diphosphate = beta-cubebene + diphosphate (#3#  reaction mechanism, overview <4>; #2# reaction mechanism,  structure-function relationship, overview. The reaction mechanism for  (E,E)-FPP cyclization by Cop4 involves the 1,10-cyclization of a cisoid  neryl cation to form a (Z,E)-germacradienyl cation, which undergoes a  1,3-hydride shift to form an allylic carbocation that is either  deprotonated to yield (-)-germacrene D, the major product of Cop4, or  1,6 cyclized to the bicyclic cadinyl cation <3>)  "
4.2.3.129," (2E,6E)-farnesyl diphosphate = (+)-sativene + diphosphate  "
4.2.3.13," (2E,6E)-farnesyl diphosphate = (+)-delta-cadinene + diphosphate (#2,4#  cyclization reaction <7>; #6# catalytic mechanism, overview <21>)  "
4.2.3.130, all-trans-heptaprenyl diphosphate = tetraprenyl-beta-curcumene +  diphosphate  
4.2.3.131, (+)-copalyl diphosphate = miltiradiene + diphosphate  
4.2.3.132, (+)-copalyl diphosphate = neoabietadiene + diphosphate  
4.2.3.133," (2E,6E)-farnesyl diphosphate = (-)-alpha-copaene + diphosphate  "
4.2.3.134, (5R)-5-phosphooxy-L-lysine + H2O = (S)-2-amino-6-oxohexanoate + NH3 +  phosphate  
4.2.3.135," (2E,6E)-farnesyl diphosphate = DELTA6-protoilludene + diphosphate (#2#  1,11-ring closure of (2E,6E)-farnsyl diphosphate yields a highly  reactive trans-humulyl carbocation. A 1,2-hydride shift followed by  further ring closures results in the protoilludyl cation, which  undergoes a final deprotonation to give DELTA6-protoilludene <3>; #2#  in the presence of Ca2+, DELTA6-protoilludene synthases catalyze  diverse cyclization reactions. DELTA6-Protoilludene and  (E)-beta-caryophyllene result from a 1,11 cyclization of  (2E,6E)-farnesyl diphosphate following metal ion mediated ionization.  The intermediate trans-humulyl cation may undergo a hydride shift  followed by two cyclizations and a deprotonation to yield  DELTA6-protoilludene. Proposed mechanisms for sesquiterpene production  by DELTA6-protoilludene synthases, overview <4>; #1# in the presence of  Ca2+, DELTA6-protoilludene synthases catalyze diverse cyclization  reactions. DELTA6-Protoilludene and (E)-beta-caryophyllene result from  a 1,11 cyclization of (2E,6E)-FPP following metal ion mediated  ionization. The intermediate trans-humulyl cation may undergo a hydride  shift followed by two cyclizations and a deprotonation to yield  DELTA6-protoilludene. Proposed mechanisms for sesquiterpene production  by DELTA6-protoilludene synthases, overview <4>; #2# in the presence of  Ca2+, DELTA6-protoilludene synthases catalyze diverse cyclization  reactions. DELTA6-Protoilludene and (E)-beta-caryophyllene result from  a 1,11-cyclization of (2E,6E)-farnesyl diphosphate following metal ion  mediated ionization. The intermediate trans-humulyl cation may undergo  a hydride shift followed by two cyclizations and a deprotonation to  yield DELTA6-protoilludene. Proposed mechanisms for sesquiterpene  production by DELTA6-protoilludene synthases, overview <4>)  "
4.2.3.136," (2E,6E)-farnesyl diphosphate = (-)-alpha-isocomene + diphosphate (#2#  reaction proceeds through caryophyllyl and presilphiperfolanyl cations  and involves the protonation of a stable (-)-(E)-beta-caryophyllene  intermediate <2>)  "
4.2.3.137," (2E,6E)-farnesyl diphosphate = (E)-2-epi-beta-caryophyllene +  diphosphate  "
4.2.3.138," (2E,6E)-farnesyl diphosphate + H2O = (+)-epi-alpha-bisabolol +  diphosphate  "
4.2.3.139," (2E,6E)-farnesyl diphosphate = valerena-4,7(11)-diene + diphosphate  "
4.2.3.140, (13E)-8alpha-hydroxylabd-13-en-15-yl diphosphate = cis-abienol +  diphosphate  
4.2.3.141, (13E)-8alpha-hydroxylabd-13-en-15-yl diphosphate + H2O = sclareol +  diphosphate (#2# via a 13-yl-carbocation <2>)  
4.2.3.142," (2Z,6Z)-farnesyl diphosphate = 7-epizingiberene + diphosphate  "
4.2.3.143," (2E,6E)-farnesyl diphosphate + H2O = kunzeaol + diphosphate  "
4.2.3.144," geranylgeranyl diphosphate + H2O = (6E,10E)-geranyllinalool +  diphosphate  "
4.2.3.145," (2E,6E,10E,14E)-geranylfarnesyl diphosphate + H2O = ophiobolin F +  diphosphate  "
4.2.3.146," geranylgeranyl diphosphate + H2O = cyclooctat-9-en-7-ol + diphosphate  (#3# cyclization reaction mechanism analysis using three  regiospecifically deuterated samples of geranylgeranyl diphosphate, the  reaction proceeds via several cationic intermediates, detailed  overview. Enzyme CotB2 catalyzes an unusually complex regiospecific and  stereospecific cyclization that involves a unique carbon-carbon bond  rearrangement and multiple hydride shifts, which all take place at a  single active site <4>; #3# proposed cyclization mechanism for CotB2.  Bound to the enzyme, geranylgeranyl dithiophosphate (GGSPP) is folded  into a unique S-shaped conformation in the active site pocket. GGSPP  cannot undergo ionization and generate a reactive carbocation  intermediate due to the C-S bond that links the thiodiphosphate moiety  and the C20 chain. Therefore, the observed conformation of bound GGSPP  is thought to represent the preionization state of the natural CotB2  substrate geranylgeranyl diphosphate <3>)  "
4.2.3.147," (+)-copalyl diphosphate = pimara-8(14),15-diene + diphosphate  "
4.2.3.148, geranylgeranyl diphosphate = cembrene C + diphosphate  
4.2.3.149, geranylgeranyl diphosphate + H2O = (R)-nephthenol + diphosphate  
4.2.3.15, geranyl diphosphate = myrcene + diphosphate  
4.2.3.150," geranylgeranyl diphosphate = (R)-cembrene A + diphosphate (#4# the  cyclization mechanism from geranylgeranyl diphosphate to cembrene A  requires a 1,14-cyclization to the ent-cembranyl cation and  deprotonation of one of the geminal methyl groups, reaction mechanism,  overview <3>)  "
4.2.3.151," geranylgeranyl diphosphate + H2O =  (1S,4E,8E,12E)-2,2,5,9,13-pentamethylcyclopentadeca-4,8,12-trien-1-ol +  diphosphate  "
4.2.3.152, alpha-D-sedoheptulopyranose 7-phosphate = 2-epi-5-epi-valiolone +  phosphate  
4.2.3.153," 2 D-glyceraldehyde 3-phosphate = (5-formylfuran-3-yl)methyl phosphate +  phosphate + 2 H2O (#1# a phosphate elimination reaction and a triose  phosphate isomerase-like reaction occur at the glyceraldehyde  3-phosphate binding site I and II, respectively, prior to the aldol  condensation between the enzyme-bound enol form of methylglyoxal and  dihydroxyacetone phosphate, after which the catalytic cycle is  completed by a cyclization and two dehydration reactions assisted by  several general acids/bases at the same active site <4>)  "
4.2.3.154, D-sedoheptulose 7-phosphate = demethyl-4-deoxygadusol + phosphate + H2O  
4.2.3.155, D-sedoheptulose 7-phosphate = 2-epi-valiolone + phosphate  
4.2.3.156, presqualene diphosphate + H2O = hydroxysqualene + diphosphate  
4.2.3.157," (2E,6E)-farnesyl diphosphate + H2O = (+)-isoafricanol + diphosphate  "
4.2.3.158, geranylgeranyl diphosphate = (-)-spiroviolene + diphosphate  
4.2.3.159, geranylgeranyl diphosphate = tsukubadiene + diphosphate  
4.2.3.16, geranyl diphosphate = (S)-limonene + diphosphate  
4.2.3.160," (2E,6E)-farnesyl diphosphate = (2S,3R,6S,9S)-(-)-protoillud-7-ene +  diphosphate  "
4.2.3.161," (2E,6E)-farnesyl diphosphate = (3S)-(+)-asterisca-2(9),6-diene +  diphosphate  "
4.2.3.162," (2E,6E)-farnesyl diphosphate = (-)-alpha-amorphene + diphosphate  "
4.2.3.163," (2E,6E)-farnesyl diphosphate + H2O = (+)-corvol ether B + diphosphate  "
4.2.3.164," (2E,6E)-farnesyl diphosphate = (+)-eremophilene + diphosphate  "
4.2.3.165," (2E,6E)-farnesyl diphosphate = (1R,4R,5S)-(-)-guaia-6,10(14)-diene +  diphosphate  "
4.2.3.166," (2E,6E)-farnesyl diphosphate + H2O =  (+)-(1E,4E,6S,7R)-germacra-1(10),4-dien-6-ol + diphosphate  "
4.2.3.167," geranylgeranyl diphosphate + H2O = (3E,7E)-dolabella-3,7-dien-18-ol +  diphosphate  "
4.2.3.168," geranylgeranyl diphosphate = (3E,7E)-dolathalia-3,7,11-triene +  diphosphate  "
4.2.3.169," (2E,6E)-farnesyl diphosphate + H2O = 7-epi-alpha-eudesmol + diphosphate  "
4.2.3.17," geranylgeranyl diphosphate = taxa-4,11-diene + diphosphate  "
4.2.3.170," (2E,6E)-farnesyl diphosphate + H2O = 4-epi-cubebol + diphosphate  "
4.2.3.171," (2E,6E)-farnesyl diphosphate + H2O = (+)-corvol ether A + diphosphate  "
4.2.3.172," (2E,6E)-farnesyl diphosphate + H2O = 10-epi-juneol + diphosphate  "
4.2.3.173," (2E,6E)-farnesyl diphosphate + H2O = tau-cadinol + diphosphate  "
4.2.3.174," (2E,6E)-farnesyl diphosphate + H2O = (2E,6E)-hedycaryol + diphosphate  "
4.2.3.175," (2E,6E)-farnesyl diphosphate + H2O = 10-epi-cubebol + diphosphate  "
4.2.3.176," (2E,6E,10E,14E)-geranylfarnesyl diphosphate + H2O = sesterfisherol +  diphosphate  "
4.2.3.177, geranyl diphosphate = beta-thujene + diphosphate  
4.2.3.178," (2E,6E,10E,14E)-geranylfarnesyl diphosphate = stellata-2,6,19-triene +  diphosphate  "
4.2.3.179," (2E,6E)-farnesyl diphosphate = guaia-4,6-diene + diphosphate  "
4.2.3.18," (+)-copalyl diphosphate = abieta-7,13-diene + diphosphate (#8#  reactions leading from intermediate abieta-8(14)-en-13-yl cation to  product are driven by the electrostatic effect of the ionized  diphopshate group <10>; #5# gas-phase and enzyme-free post-transition  state direct dynamics simulation gas-phase reveal that abietadiene  synthase must intervene in order to produce abietadiene selectively,  steering this reaction to avoid the generation of a sevenmembered ring  containing product which is formed in the enzyme-free reaction <14>;  #2# reaction mechanism proceeds via water quenching of the  abieta-8(14)-en-13-yl carbocation, resulting in  13-hydroxy-8(14)-abietene <15>)  "
4.2.3.180, geranylgeranyl diphosphate = pseudolaratriene + diphosphate  
4.2.3.181," (2E,6E)-farnesyl diphosphate = selina-4(15),7(11)-diene + diphosphate  "
4.2.3.182," (2E,6E)-farnesyl diphosphate + H2O = (+)-(2S,3R,9R)-pristinol +  diphosphate  "
4.2.3.183, (+)-copalyl diphosphate + H2O = nezukol + diphosphate  
4.2.3.184," (2E,6E)-farnesyl diphosphate + H2O = 5-hydroxy-alpha-gurjunene +  diphosphate  "
4.2.3.185, ent-copalyl diphosphate = ent-atiserene + diphosphate  
4.2.3.186, ent-8alpha-hydroxylabd-13-en-15-yl diphosphate = ent-13-epi-manoyl  oxide + diphosphate  
4.2.3.187," (2E,6E)-farnesyl diphosphate + H2O = (2Z,6E)-hedycaryol + diphosphate  "
4.2.3.188, all-trans-geranylfarnesyl diphosphate = beta-geranylfarnesene +  diphosphate 
4.2.3.188, all-trans-hexaprenyl diphosphate = beta-hexaprene + diphosphate 
4.2.3.188, all-trans-heptaprenyl diphosphate = beta-heptaprene + diphosphate  
4.2.3.189," peregrinol diphosphate = (13xi)-9,13-epoxylabda-14-ene + diphosphate  "
4.2.3.19," ent-copalyl diphosphate = ent-kaurene + diphosphate (#37# reaction  mechanism, overview <41>; #24# the determination of the final products  of CPS/KSs in bryophytes depends on the sequence and structure of the  C-terminal regions of CPS/KSs. Thus, the type A cyclization reaction of  both PpCPS/KS and JsCPS /KS occurs near the C-terminal region of the  polypeptides <24>; #17# the hydrophobicity and size of the side chain  residue at the bifunctional CPS/KS amino acid 710 is responsible for  quenching the ent-kauranyl cation by the addition of a water molecule.  The determination of the final products of CPS/KSs in bryophytes  depends on the sequence and structure of the C-terminal regions of  CPS/KSs. Thus, the type A cyclization reaction of both PpCPS/KS and  JsCPS /KS occurs near the C-terminal region of the polypeptides <24>;  #17,18,27,33,34,35# cyclization mechanism catalyzed by KSs and the Ile  mutants, via ent-pimar-15-en-8-yl, ent-beyeran-16-yl, and  ent-kauran-16-yl intermediates, detailed overview <36>; #29#  cyclization mechanism derived from quantum chemical calculation for the  formation of ent-kaurene and related diterpenes, overview <38>)  "
4.2.3.190, (13E)-8alpha-hydroxylabd-13-en-15-yl diphosphate = manoyl oxide +  diphosphate  
4.2.3.191, geranylgeranyl diphosphate = cycloaraneosene + diphosphate  
4.2.3.192," (13E)-labda-7,13-dienyl diphosphate = labda-7,13(16),14-triene +  diphosphate  "
4.2.3.193," (+)-copalyl diphosphate = (12E)-labda-8(17),12,14-triene + diphosphate  "
4.2.3.194," (2E,6E)-farnesyl diphosphate + H2O = (-)-drimenol + diphosphate  "
4.2.3.195, geranylgeranyl diphosphate = rhizathalene A + diphosphate  
4.2.3.196, ent-copalyl diphosphate = dolabradiene + diphosphate  
4.2.3.197," (2E,6E)-farnesyl diphosphate + 2 H2O = 7-epi-ent-eudesmane-5,11-diol +  diphosphate  "
4.2.3.198," (2E,6E)-farnesyl diphosphate = alpha-selinene + diphosphate  "
4.2.3.199," (2E,6E)-farnesyl-diphosphate = (-)-5-epieremophilene + diphosphate  "
4.2.3.2, ethanolamine phosphate + H2O = acetaldehyde + NH3 + phosphate  
4.2.3.20, geranyl diphosphate = (R)-limonene + diphosphate (#7# requires a  divalent metal ion (preferably Mn2+) for catalysis <2>; #6# forms the  first step of carvone biosynthesis in caraway <1>)  
4.2.3.200, geranylgeranyl diphosphate = beta-pinacene + diphosphate  
4.2.3.201, geranylgeranyl diphosphate = hydropyrene + diphosphate  
4.2.3.202, geranylgeranyl diphosphate + H2O = hydropyrenol + diphosphate  
4.2.3.203, geranylgeranyl diphosphate = isoelisabethatriene + diphosphate  
4.2.3.204," (2E,6E)-farnesyl diphosphate + H2O = valerianol + diphosphate  "
4.2.3.205, pre-sodorifen diphosphate = sodorifen + diphosphate  
4.2.3.21," (2E,6E)-farnesyl diphosphate = vetispiradiene + diphosphate  "
4.2.3.22," (2E,6E)-farnesyl diphosphate + H2O =  (1E,4S,5E,7R)-germacra-1(10),5-dien-11-ol + diphosphate (#1# reaction  mechanism <3>; #1# catalytic mechanism via intermediate is  (7R)-germacra-1(10),4-diene-11-ol <1>)  "
4.2.3.23," (2E,6E)-farnesyl diphosphate = (+)-(R)-gemacrene A + diphosphate (#4,5#  structure modeling and reaction mechanism, overview <6>; #6# the  catalytic site is located at the N-terminal 44 amino acid residues <3>)  "
4.2.3.24," (2E,6E)-farnesyl diphosphate = amorpha-4,11-diene + diphosphate (#1#  enzyme first catalyzes a 1,6 ring closure with a subsequent 1,10  closure <1>; #1# mechanism includes a bisabolyl carbocation and  1,3-hydride shift, detailed analysis <5>; #1# mechanism involves  isomerzation of farnesyl diphosphate to (R)-nerolidyl diphosphate,  ionization, and C-1,C-6-ring closure to generate a bisabolyl cation,  followed by a 1,3-hydride shift, 1,10-ring closure, and deprotonation  at either C-12 or C-13 <4>)  "
4.2.3.25, geranyl diphosphate + H2O = (3S)-linalool + diphosphate (#7# reaction  mechanism <1>)  
4.2.3.26, geranyl diphosphate + H2O = (3R)-linalool + diphosphate  
4.2.3.27, dimethylallyl diphosphate = isoprene + diphosphate (#16# the generation  of isoprene from substrate dimethylallyl diphosphate occurs via a  syn-periplanar elimination mechanism in which the diphosphate-leaving  group serves as a general base <28>)  
4.2.3.28," ent-copalyl diphosphate = ent-cassa-12,15-diene + diphosphate  "
4.2.3.29," ent-copalyl diphosphate = ent-sandaracopimara-8(14),15-diene +  diphosphate (#1# reaction via ent-isopimaranyl intermediate <6>)  "
4.2.3.3," glycerone phosphate = 2-oxopropanal + phosphate (#2,24# mechanism  <21,22,23,25>; #8# stereospecific deprotonation of the pro-S hydrogen  at C-3 of dihydroxyacetone, the true product of the enzymatic reaction  is the enol form of methylglyoxal which is ketonized in solution <8>;  #8# since the enzyme accepts the trans-enediol-phosphate as a  substrate, it is likely that it or the trans-enediolate is an  intermediate in the catalytic reaction with dihydroxyacetone phosphate  <11>; #24# catalytic mechanism <24>)  "
4.2.3.30," ent-copalyl diphosphate = ent-pimara-8(14),15-diene + diphosphate  "
4.2.3.31," ent-copalyl diphosphate = ent-pimara-9(11),15-diene + diphosphate  "
4.2.3.32," (+)-copalyl diphosphate = abieta-8(14),12-diene + diphosphate  "
4.2.3.33, 9alpha-copalyl diphosphate = stemar-13-ene + diphosphate  
4.2.3.34, 9alpha-copalyl diphosphate = stemod-13(17)-ene + diphosphate  
4.2.3.35," 9alpha-copalyl diphosphate = 9beta-pimara-7,15-diene + diphosphate  "
4.2.3.36, terpentedienyl diphosphate = terpentetriene + diphosphate  
4.2.3.37," (2E,6E)-farnesyl diphosphate = (+)-epi-isozizaene + diphosphate (#2#  ionization and isomerization of farnesyl diphosphate will give  (3R)-nerolidyl diphosphate. Rotation about the newly generated C-2/C-3  bond generates the corresponding cisoid nerolidyl diphosphate conformer  which can undergo ionization and cyclization to form a bisabolyl  cation. Following 1,2-hydride shift and spirocyclization, the resultant  acorenyl cation can undergo further cyclization, ring contraction,  methyl migration, and deprotonation to yield (+)-epi-isozizaene <1>)  "
4.2.3.38," (2E,6E)-farnesyl diphosphate = (E)-alpha-bisabolene + diphosphate (#4#  electrophilic reaction mechanism <4>)  "
4.2.3.39," (2E,6E)-farnesyl diphosphate + H2O = 8-epi-cedrol + diphosphate (#2#  reaction mechanism, overview <2>; #2# reaction mechanism and  cyclization of 8-epi-cedrol. Allylic carbocation formation,  isomerization to nerolidyl diphosphate, and cyclization generate the  monocyclic bisabolyl cation, a hydride shift is followed by two  cyclizations to yield the cedryl cation, and the reaction is terminated  by quenching the tricyclic cation with a hydroxide equivalent to form  8-epicedrol, overview <1>)  "
4.2.3.4, 3-deoxy-D-arabino-hept-2-ulosonate 7-phosphate = 3-dehydroquinate +  phosphate (#27# reaction follows a rapid-equilibrium random mechanism  <37>)  
4.2.3.40," (2E,6E)-farnesyl diphosphate = (Z)-gamma-bisabolene + diphosphate  "
4.2.3.41, geranylgeranyl diphosphate = elisabethatriene + diphosphate  
4.2.3.42," 9alpha-copalyl diphosphate + H2O = aphidicolan-16beta-ol + diphosphate  (#1# the reaction includes a Wagner-Meerwein rearrangement and proceeds  via several cation intermediates stages, modeling, overview <4>)  "
4.2.3.43," geranylgeranyl diphosphate = fusicocca-2,10(14)-diene + diphosphate  "
4.2.3.44," (+)-copalyl diphosphate = isopimara-7,15-diene + diphosphate (#1#  proposed reaction scheme <1>)  "
4.2.3.45, (+)-copalyl diphosphate + H2O = phyllocladan-16alpha-ol + diphosphate  
4.2.3.46," (2E,6E)-farnesyl diphosphate = (3E,6E)-alpha-farnesene + diphosphate  "
4.2.3.47," (2E,6E)-farnesyl diphosphate = (E)-beta-farnesene + diphosphate  "
4.2.3.48," (2E,6E)-farnesyl diphosphate + H2O = (3S,6E)-nerolidol + diphosphate  "
4.2.3.49," (2E,6E)-farnesyl diphosphate + H2O = (3R,6E)-nerolidol + diphosphate  "
4.2.3.5," 5-O-(1-carboxyvinyl)-3-phosphoshikimate = chorismate + phosphate (#3#  mechanism <21>; #3# stereochemistry <10>; #2,4,5,6# combination with  flavin reductase activity <7,14,15,19>; #6# combination with diaphorase  activity <3,8>)  "
4.2.3.50," (2Z,6Z)-farnesyl diphosphate = (+)-alpha-santalene + diphosphate (#1#  following dephosphorylation of (2Z,6Z)-farnesyl diphosphate, the  (2Z,6Z)-farnesyl carbocation is converted to either the (6R)- or the  (6S)-bisabolyl cations depending on the stereochemistry of the 6,1  closure. The (6R)-bisabolyl cation will then lead to the formation of  (+)-alpha-santalene, while the (6S)-bisabolyl cation will give rise to  (-)-endo-alpha-bergamotene and (+)-endo-beta-bergamotene. Small amounts  of (-)-epi-beta-santalene are also formed from the (6R)-bisabolyl  cation and small amounts of (-)-exo-alpha-bergamotene are formed from  the (6S)-bisabolyl cation <1>)  "
4.2.3.51, neryl diphosphate = beta-phellandrene + diphosphate  
4.2.3.52," geranyl diphosphate = (4S)-beta-phellandrene + diphosphate (#1# a  1,3-hydride shift from C3 to C8 of the cyclohexene nucleus is involved  in the formation of phellandrene <1>)  "
4.2.3.53," (2Z,6Z)-farnesyl diphosphate = (+)-endo-beta-bergamotene + diphosphate  (#1# following dephosphorylation of (2Z,6Z)-farnesyl diphosphate, the  (2Z,6Z)-farnesyl carbocation is converted to either the (6R)- or the  (6S)-bisabolyl cations depending on the stereochemistry of the 6,1  closure. The (6R)-bisabolyl cation will then lead to the formation of  (+)-alpha-santalene, while the (6S)-bisabolyl cation will give rise to  (-)-endo-alpha-bergamotene and (+)-endo-beta-bergamotene. Small amounts  of (-)-epi-beta-santalene are also formed from the (6R)-bisabolyl  cation and small amounts of (-)-exo-alpha-bergamotene are formed from  the (6S)-bisabolyl cation <1>)  "
4.2.3.54," (2Z,6Z)-farnesyl diphosphate = (-)-endo-alpha-bergamotene + diphosphate  (#1# following dephosphorylation of (2Z,6Z)-farnesyl diphosphate, the  (2Z,6Z)-farnesyl carbocation is converted to either the (6R)- or the  (6S)-bisabolyl cations depending on the stereochemistry of the 6,1  closure. The (6R)-bisabolyl cation will then lead to the formation of  (+)-alpha-santalene, while the (6S)-bisabolyl cation will give rise to  (-)-endo-alpha-bergamotene and (+)-endo-beta-bergamotene. Small amounts  of (-)-epi-beta-santalene are also formed from the (6R)-bisabolyl  cation and small amounts of (-)-exo-alpha-bergamotene are formed from  the (6S)-bisabolyl cation <1>)  "
4.2.3.55," (2E,6E)-farnesyl diphosphate = (S)-beta-bisabolene + diphosphate (#1#  (S)-beta-bisabolene is a stable intermediate. (S)-beta-Macrocarpene  formation requires a protonation of the intermediate <1>; #2# The  synthesis of (S)-beta-macrocarpene from (2E,6E)-farnesyl diphosphate  proceeds in two steps. The first step is the cyclization to  (S)-beta-bisabolene. The second steps is the isomerization to  (S)-beta-macrocarpene (c.f. EC 5.5.1.a, (S)-beta-macrocarpene  synthase). The enzyme requires Mg2+ or Mn2+ for activity. <1>)  "
4.2.3.56," (2E,6E)-farnesyl diphosphate = gamma-humulene + diphosphate  "
4.2.3.57," (2E,6E)-farnesyl diphosphate = (-)-beta-caryophyllene + diphosphate  (#8# possible mechanism of sesquiterpene synthases from Piper nigrum,  the reaction mechanism includes a 1,10-ring closure, overview <7>)  "
4.2.3.58," (2E,6E)-farnesyl diphosphate = longifolene + diphosphate  "
4.2.3.59," (2E,6E)-farnesyl diphosphate = (E)-gamma-bisabolene + diphosphate  "
4.2.3.6," (2E,6E)-farnesyl diphosphate = trichodiene + diphosphate (#6,7,8#  mechanism <4,5,6,7,16,17>; #7# mechanism, kinetics, isomerization of  farnesyl diphosphate to nerolidyl diphosphate is the rate limiting step  <13>; #1# stereochemistry, mechanism <5>)  "
4.2.3.60," (2E,6E)-farnesyl diphosphate = germacrene C + diphosphate  "
4.2.3.61," (2E,6E)-farnesyl diphosphate = (+)-5-epiaristolochene + diphosphate  "
4.2.3.62," (2Z,6E)-farnesyl diphosphate = (-)-gamma-cadinene + diphosphate  "
4.2.3.63," (2E,6E)-farnesyl diphosphate = (+)-cubenene + diphosphate (#1# the  initial isomerization of farnesyl diphosphate to (3R)-nerolidyl  diphosphate takes place with suprafacial stereochemistry. Ionization of  (3R)-nerolidyl diphosphate and attack by the 10-11 double bond on the  re face of the cisoid allylic cation-diphosphate anion pair generates  the cis-germacradienyl cation. A second electrophilic cyclization gives  the cadinanyl cation, which upon a 1.2-hydride shift and syn capture of  water generates epicubenol <2>)  "
4.2.3.64," (2E,6E)-farnesyl diphosphate + H2O = (+)-epicubenol + diphosphate (#1#  the initial isomerization of farnesyl diphosphate to (3R)-nerolidyl  diphosphate takes place with suprafacial stereochemistry. Ionization of  (3R)-nerolidyl diphosphate and attack by the 10-11 double bond on the  re face of the cisoid allylic cation-diphosphate anion pair generates  the cis-germacradienyl cation. A second electrophilic cyclization gives  the cadinanyl cation, which upon a 1.2-hydride shift and syn capture of  water generates epicubenol <3>)  "
4.2.3.65," (2E,6E)-farnesyl diphosphate = zingiberene + diphosphate  "
4.2.3.66," (2E,6E)-farnesyl diphosphate = beta-selinene + diphosphate  "
4.2.3.67," (2E,6E)-farnesyl diphosphate = cis-muurola-3,5-diene + diphosphate "
4.2.3.67," (2E,6E)-farnesyl diphosphate = cis-muurola-4(14),5-diene + diphosphate  "
4.2.3.68," (2E,6E)-farnesyl diphosphate + H2O = beta-eudesmol + diphosphate  "
4.2.3.69," (2E,6E)-farnesyl diphosphate = (+)-alpha-barbatene + diphosphate  "
4.2.3.7," (2E,6E)-farnesyl diphosphate = pentalenene + diphosphate (#1# mechanism  <4,7>; #1# stereochemistry <3,4>; #1# stereochemistry, SEÂ’ reaction  type <6>)  "
4.2.3.70," (2E,6E)-farnesyl diphosphate + H2O = patchoulol + diphosphate  "
4.2.3.71," (2E,6E)-farnesyl diphosphate = (E,E)-germacrene B + diphosphate  "
4.2.3.72," (2E,6E)-farnesyl diphosphate = (-)-alpha-gurjunene + diphosphate  "
4.2.3.73," (2E,6E)-farnesyl diphosphate = (+)-valencene + diphosphate  "
4.2.3.74," (2E,6E)-farnesyl diphosphate + H2O = presilphiperfolan-8beta-ol +  diphosphate  "
4.2.3.75," (2E,6E)-farnesyl diphosphate = (-)-germacrene D + diphosphate (#4#  action of (-)-germacrene D synthase involves a 1,3-hydride shift.  Pro-R-H-1 of the substrate (2E,6E)-farnesyl diphosphate becomes H-11 of  (-)-germacrene D, while pro-S-H-1 of (2E,6E)-farnesyl diphosphate  becomes H-6 of (-)-germacrene D and H-10 of (2E,6E)-farnesyl  diphosphate becomes H-7 of (-)-germacrene D <2>; #1# formation of  (-)-germacrene D involves a stereospecific 1,3-hydride shift of H-1si  of farnesyl diphosphate <3>)  "
4.2.3.76," (2E,6E)-farnesyl diphosphate = (+)-delta-selinene + diphosphate (#1#  enzyme utilizes both cisoid and transoid-nerolidyl diphosphate as  cyclization intermediates <2>)  "
4.2.3.77," (2E,6E)-farnesyl diphosphate = (+)-germacrene D + diphosphate (#1# the  initial step is abstraction of the diphosphate moiety under ring  closure to yield germacrenyl cation. The next step is a 1,2-hydride  shift of H-7 into the isopropyl group, generating a germacrenyl cation  with the positive charge at position 7. The cation undergoes a  1,2-hydride shift of H-6 yielding a cation with positive charge at  position 6. During this step the configuration at C-7 is fixed.  Finally, the cation is deprotonated at C-15 and the positive charge is  quenched by two electron pair shifts to generate (+)-germacrene D <2>)  "
4.2.3.78," (2E,6E)-farnesyl diphosphate = (+)-beta-chamigrene + diphosphate  "
4.2.3.79," (2E,6E)-farnesyl diphosphate = (+)-thujopsene + diphosphate  "
4.2.3.8, geranylgeranyl diphosphate = casbene + diphosphate  
4.2.3.80," (2E,6E)-farnesyl diphosphate = alpha-longipinene + diphosphate  "
4.2.3.81," (2E,6E)-farnesyl diphosphate = (-)-exo-alpha-bergamotene + diphosphate  "
4.2.3.82," (2E,6E)-farnesyl diphosphate = (+)-alpha-santalene + diphosphate  "
4.2.3.83," (2E,6E)-farnesyl diphosphate = (-)-beta-santalene + diphosphate  "
4.2.3.84," (2E,6E)-farnesyl diphosphate + H2O = 10-epi-gamma-eudesmol + diphosphate  "
4.2.3.85," (2E,6E)-farnesyl diphosphate + H2O = alpha-eudesmol + diphosphate  "
4.2.3.86," (2E,6E)-farnesyl diphosphate = 7-epi-alpha-selinene + diphosphate  "
4.2.3.87," (2E,6E)-farnesyl diphosphate = alpha-guaiene + diphosphate  "
4.2.3.88," (2E,6E)-farnesyl diphosphate = viridiflorene + diphosphate  "
4.2.3.89," (2E,6E)-farnesyl diphosphate = (+)-beta-caryophyllene + diphosphate  (#4# possible mechanism of sesquiterpene synthases from Piper nigrum,  the reaction mechanism includes a 1,10-ring closure, overview <2>)  "
4.2.3.9," (2E,6E)-farnesyl diphosphate = aristolochene + diphosphate  "
4.2.3.90," (2E,6E)-farnesyl diphosphate = 5-epi-alpha-selinene + diphosphate  "
4.2.3.91," (2E,6E)-farnesyl diphosphate + H2O = cubebol + diphosphate  "
4.2.3.92," (2E,6E)-farnesyl diphosphate = (+)-gamma-cadinene + diphosphate  "
4.2.3.93," (2E,6E)-farnesyl diphosphate = delta-guaiene + diphosphate  "
4.2.3.94," (2E,6E)-farnesyl diphosphate = gamma-curcumene + diphosphate  "
4.2.3.95," (2E,6E)-farnesyl diphosphate = (-)-alpha-cuprenene + diphosphate  "
4.2.3.96," (2E,6E)-farnesyl diphosphate + H2O = avermitilol + diphosphate  "
4.2.3.97," (2E,6E)-farnesyl diphosphate = (-)-delta-cadinene + diphosphate (#1#  cyclization mechanism involves an intermediate nerolidyl diphosphate  leading to a helminthogermacradienyl cation. Following a 1,3-hydride  shift of the original H-1si of FPP, cyclization and deprotonation will  give (-)-delta-cadinene <1>)  "
4.2.3.98," (2E,6E)-farnesyl diphosphate + H2O = (+)-T-muurolol + diphosphate (#1#  cyclization mechanism involves an intermediate nerolidyl diphosphate  leading to a helminthogermacradienyl cation. After a 1,3-hydride shift  of the original H-1si of FPP, cyclization and deprotonation result in  product (+)-T-muurolol <1>)  "
4.2.3.99," 9alpha-copalyl diphosphate = (12E)-9alpha-labda-8(17),12,14-triene +  diphosphate  "
4.2.99.12, carboxymethyloxysuccinate = fumarate + glycolate  
4.2.99.18," the C-O-P bond 3' to the apurinic or apyrimidinic site in DNA is broken  by a beta-elimination reaction, leaving a 3'-terminal unsaturated sugar  and a product with a terminal 5'-phosphate (#8,9,12,21# mechanism  <3,39,40,65,66,68>; #21# T4 endonuclease V (EC 3.1.25.1) possesses both  pyrimidine dimer DNA glycosylase activity and apurinic/apyrimidinic DNA  endonuclease (EC 4.2.99.18) activity in a single polypeptide chain <1>)  "
4.2.99.20," 5-enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate =  (1R,6R)-6-hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate +  pyruvate (#3# the nucleophilicity of the catalyitc  serine-histidine-aspartate triad is shielded and its catalytic role is  limited to being a specific general base by an open-closed  conformational change. The enzyme adopts an open conformation without a  functional triad in its ligand-free form and a closed conformation with  a fully functional catalytic triad in the presence of its reaction  product. The open-to-closed conformational transition involves movement  of half of the alpha-helical cap domain, which causes extensive  structural changes in the apha/beta-domain and forces the side chainof  the triad histidine to adopt an energetically disfavored gauche  conformation to form the functional triad. The inactive open  conformation without a triad prevails in ligand-free solution and is  converted to the closed conformation with a properly formed triad by  the reaction product <5>)  "
4.2.99.21," isochorismate = salicylate + pyruvate (#4# [1,5]-sigmatropic reaction  mechanism that invokes electrostatic catalysis in analogy to the  [3,3]-pericyclic rearrangement of chorismate in chorismate mutase <1>;  #4# a reactive substrate conformation is formed upon loop closure of  the active site and ordering of the loop contributes to the entropic  penalty for converting the enzyme substrate complex to the transition  state. The thermodynamic parameters of the physiological lyase activity  of PchB show that the reaction is clearly enthalpically driven, and has  a very large entropic penalty of 24.3 cal/(mol K), which is more than  1.5-fold greater than that of the uncatalyzed reaction of 15.77  cal/(mol K) <20>; #4# kinetic mechanism and transition state of the  elimination reaction, overview <20>; #4# reaction mechanism with  catalytic residue Lys42, modeling, overview <21>; #4# reaction  mechanism, the IPL reaction is a concerted but asynchronous hydrogen  transfer, by a proposed [1,5]-sigmatropic reaction mechanism with a  pericyclic transition state, quantum mechanical/molecular-mechanical  calculations and simulations, overview <22>; #10# the enzyme achieves  catalysis of both pericyclic reactions, isochorismate-pyruvate lyase  and chorismate-pyruvate lyase, EC 4.1.3.40, in part by the  stabilization of reactive conformations and in part by electrostatic  transition-state stabilization. Both, substrate organization and  electrostatic transition state stabilization, contribute to catalysis  <19>; #4# the lysine42 residue is required in a specific conformation  to stabilize the transition state <24>; #6,7,11# overall reaction,  salicylate sythase converts chorismate into salicylate via an  isochorismate intermediate <25>; #11# overall reaction, salicylate  sythase converts chorismate into salicylate via an isochorismate  intermediate. In the second reaction, pyruvate is eliminated through an  intramolecular [3,3]-sigmatropic rearrangement, formerly a retro-Ene  reaction, to afford salicylic acid via bicyclic transition state TS2  <26>)  "
4.2.99.22," 6-tuliposide A = tulipalin A + D-glucose (#2,3# putative reaction  mechanism of TCE enzymes, overview. The reaction begins with a  nucleophilic attack by the catalytic Ser, whose hydroxyl group is  activated by the charge relay of the catalytic triad, on the carbonyl  carbon of 6-Pos. This is followed by the formation of a tetrahedral  intermediate, which is stabilized by the oxyanion hole structure  contributed by the two Gly residues of the HGG motif. Then, following  the elimination of glucose, the acyl-enzyme complex is formed, and an  intramolecular nucleophilic attack by a terminal hydroxyl group of  6-Pos, but not by water, occurs. This nucleophilic attack results in  the formation of the five-membered ring structure of Pa. If the  acylenzyme complex is subjected to a nucleophilic attack by activated  water, then gamma-hydroxy acids are released as hydrolytic products,  but this process never occurs in the TCE reactions <6>)  "
4.2.99.23," 6-tuliposide B = tulipalin B + D-glucose (#1# putative reaction  mechanism of TCE enzymes, overview. The reaction begins with a  nucleophilic attack by the catalytic Ser, whose hydroxyl group is  activated by the charge relay of the catalytic triad, on the carbonyl  carbon of 6-Pos. This is followed by the formation of a tetrahedral  intermediate, which is stabilized by the oxyanion hole structure  contributed by the two Gly residues of the HGG motif. Then, following  the elimination of glucose, the acyl-enzyme complex is formed, and an  intramolecular nucleophilic attack by a terminal hydroxyl group of  6-Pos, but not by water, occurs. This nucleophilic attack results in  the formation of the five-membered ring structure of Pa. If the  acylenzyme complex is subjected to a nucleophilic attack by activated  water, then ?-hydroxy acids are released as hydrolytic products, but  this process never occurs in the TCE reactions <3>)  "
4.2.99.24, salutaridinol 7-O-acetate = thebaine + acetate  
4.3.1.1," L-aspartate = fumarate + NH3 (#4,13,17,23# mechanism  <1,6,16,21,23,25,31,35,43,44,47>; #17# mechanism, kinetics <39>; #17#  mechanism: overview <35>; #22# the catalytic mechanism is studied by  using a combined quantum-mechanical/molecular-mechanical (QM/MM)  approach. Two elementary steps are calculated: The first step is the  abstraction of Cbeta proton of L-aspartate by Ser318, which is  calculated to be rate limiting. The second step is the cleavage of  Calpha- N bond of L-aspartate to form fumarate and ammonia. Ser318  functions as the catalytic base, whereas His188 is a dispensable  residue, but its protonation state can influence the active site  structure <65>)  "
4.3.1.10, L-serine O-sulfate + H2O = pyruvate + NH3 + sulfate (#3# mechanism <3>)  
4.3.1.12, L-ornithine = L-proline + NH3 (#8# mechanism <3>)  
4.3.1.13, O-carbamoyl-L-serine + H2O = pyruvate + 2 NH3 + CO2  
4.3.1.14, L-3-aminobutyryl-CoA = crotonoyl-CoA + NH3  
4.3.1.15," 2,3-diaminopropanoate + H2O = pyruvate + 2 NH3  "
4.3.1.16, threo-3-hydroxy-L-aspartate = oxaloacetate + NH3  
4.3.1.17," L-serine = pyruvate + NH3 (#32# catalytic mechanism <52>; #31# reaction  analysis by ab initio quantum mechanical/molecular mechanical method,  the reaction involves a Schiff base formation step and a  proton-relaying mechanism involving the phosphate of the cofactor in  the beta-hydroxyl-leaving step following sequentially after the  elimination of the alpha-proton, leading to a single but sequential  alpha,beta-elimination step. The rate-limiting transition state is  specifically stabilized by the enzyme environment, catalytic mechanism  involving Lys41 in the active site, detailed overview <54>; #17#  pre-steady-state kinetic analysis of L-serine binding to lpLSD  demonstrates that L-serine binds to a second noncatalytic site and  produces a conformational change in the enzyme. The rate of this  conformational change is too slow for its participation in the  catalytic cycle but rather occurs prior to catalysis to produce an  activated form of the enzyme <61>) "
4.3.1.17, L-serine = 2-aminoprop-2-enoate + H2O 
4.3.1.17, 2-aminoprop-2-enoate = 2-iminopropanoate 
4.3.1.17, 2-iminopropanoate + H2O = pyruvate + NH3  
4.3.1.18," D-Serine = pyruvate + NH3 (#3# reaction mechanism, the phosphate group  of the substrate-pyridoxal-phosphate complex serves as the main  anchoring point during catalysis, intermediate is the Schiff base of  alpha-aminoacrylate and pyridoxal 5-phosphate <7>; #3# transimination  of the enzyme-linked cofactor pyridoxal 5-phosphate is at least a  two-step process, the first step of which is probably formation of a  noncovalent complex between the enzyme and the amino acid <4>)  "
4.3.1.19, L-threonine = 2-oxobutanoate + NH3 
4.3.1.19, 2-iminobutanoate + H2O = 2-oxobutanoate + NH3 
4.3.1.19, L-threonine = 2-aminobut-2-enoate + H2O 
4.3.1.19, 2-aminobut-2-enoate = 2-iminobutanoate  
4.3.1.2," L-threo-3-methylaspartate = mesaconate + NH3 (#3,4,5,6,7,8# mechanism  <1,4,6,8,9,10,16>; #4# kinetic mechanism <11>; #2,4# carbon mechanism  <2,11,16,18>; #1,2,4# stereochemical mechanism <7,8,14,19>)  "
4.3.1.20, erythro-3-hydroxy-L-aspartate = oxaloacetate + NH3  
4.3.1.22," L-dopa + NADH = 3,4-dihydroxyphenylpropanoate + NAD+ + NH3  "
4.3.1.23, L-tyrosine = trans-p-hydroxycinnamate + NH3  
4.3.1.24," L-phenylalanine = trans-cinnamate + NH3 (#106# E1cb mechanism <58>;  #42# analysis of active-site structure analysis and reaction mechanism  in which the amino group of the phenylalanine substrate is attacked  directly by the 4-methylidene-imidazole-5-one prosthetic group, the  reaction proceeds through a carbanion intermediate, Tyr78 acts as a  general base, helix-to-loop conformational switch in the helices  flanking the inner active-site loop that regulates accessibility of the  active site, modeling, overview <85>)  "
4.3.1.25, L-phenylalanine = trans-cinnamate + NH3 (#5# ordered uni-bi reaction  sequence <4>) 
4.3.1.25, L-tyrosine = trans-p-hydroxycinnamate + NH3  
4.3.1.27, threo-3-hydroxy-D-aspartate = oxaloacetate + NH3  
4.3.1.28, L-lysine = L-pipecolate + NH3  
4.3.1.29, 2-amino-2-deoxy-D-gluconate 6-phosphate =  2-dehydro-3-deoxy-6-phospho-D-gluconate + NH3  
4.3.1.3," L-histidine = urocanate + NH3 (#1,5,7,8,12,13,14,15,16,20,23,29#  mechanism <2,10,14,16,34,37>)  "
4.3.1.30," dTDP-4-amino-4,6-dideoxy-alpha-D-glucopyranose +  S-adenosyl-L-methionine + reduced acceptor =  dTDP-3-dehydro-4,6-dideoxy-alpha-D-glucopyranose + NH3 + L-methionine +  5'-deoxyadenosine + acceptor (#2# DesII must be in the correct  protonation state to form the initial alpha-hydroxyalkyl radical and  that it is subsequently deprotonated either before or concerted with  its oxidation <4>)  "
4.3.1.31, L-tryptophan = 3-indoleacrylate + NH3  
4.3.1.32," 5-amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil +  S-adenosyl-L-methionine = 7,8-didemethyl-8-hydroxy-5-deazariboflavin +  NH3 + L-methionine + 5'-deoxyadenosine  "
4.3.1.4," 5-formimidoyltetrahydrofolate = 5,10-methenyltetrahydrofolate + NH3  (#5,8# mechanism <1,19>)  "
4.3.1.6, beta-alanyl-CoA = acryloyl-CoA + NH3  
4.3.1.7, ethanolamine = acetaldehyde + NH3 (#7# hydrogen transfer mechanism  involves a second intermediate hydrogen carrier in addition to the  cofactor <5>; #1# the C-Co bond of adenosylcob(III)alamin undergoes  homolysis to produce the 5-deoxyadenosyl radical and cob(II)-alamin  radical pair <4>)  
4.3.1.9, 2-amino-2-deoxy-D-gluconate = 2-dehydro-3-deoxy-D-gluconate + NH3 
4.3.1.9," 2-amino-2-deoxy-D-gluconate =  (2Z,4S,5R)-2-amino-4,5,6-trihydroxyhex-2-enoate + H2O "
4.3.1.9," (2Z,4S,5R)-2-amino-4,5,6-trihydroxyhex-2-enoate =  (4S,5R)-4,5,6-trihydroxy-2-iminohexanoate "
4.3.1.9," (4S,5R)-4,5,6-trihydroxy-2-iminohexanoate + H2O =  2-dehydro-3-deoxy-D-gluconate + NH3  "
4.3.2.1," 2-(Nomega-L-arginino)succinate = fumarate + L-arginine (#16# 5 residues  are essential for catalytic activity: R115, N116, T161, S283, and E296  <29>; #10# random mechanism with the formation of two dead-end  complexes: enzyme-argininosuccinate-fumarate and  enzyme-argininosuccinate-arginine <9>; #16# stepwise E1cB mechanism,  rate-limiting step probably at the C-N bond-cleavage step <18>;  #1,16,19# random uni-bi kinetic mechanism <24>)  "
4.3.2.10, L-glutamine + H2O = L-glutamate + NH3 
4.3.2.10, 5-[(5-phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5  phospho-beta-D-ribosyl)imidazole-4-carboxamide + L-glutamine =  5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide +  D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate + L-glutamate 
4.3.2.10, 5-[(5-phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5  phospho-beta-D-ribosyl)imidazole-4-carboxamide + NH3 =  5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide +  D-erythro-1-(imidazol-4-yl)glycerol 3-phosphate + H2O  
4.3.2.2," N6-(1,2-dicarboxyethyl)AMP = fumarate + AMP (#15# uni bi-ordered  mechanism <6>; #17# kinetic and catalytic mechanism, the enzyme follows  a rapid equilibrium ordered bi-uni mechanism in the reverse direction  in which AMP binds first to the enzyme followed by fumarate, key role  for the conserved Ser298 in catalysis and pivotal role of the substrate  in the activation of the catalytic base, detailed overview <31>; #2,18#  uni-bi mechanism, where fumarate is removed by beta-elimination via a  general base-general acid mechanism <35>) "
4.3.2.2," (S)-2-[5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate  = fumarate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide  (#17# kinetic and catalytic uni-bi rapid equilibrium ordered mechanism,  key role for the conserved Ser298 in catalysis and pivotal role of the  substrate in the activation of the catalytic base, detailed overview  <31>; #2,18# uni-bi mechanism, where fumarate is removed by  beta-elimination via a general base-general acid mechanism <35>)  "
4.3.2.3, (S)-ureidoglycolate = glyoxylate + urea  
4.3.2.4," DNA 4,6-diamino-5-formamidopyrimidine = DNA adenine + H2O  "
4.3.2.5, [peptide]-(2S)-2-hydroxyglycine = [peptide]-amide + glyoxylate  
4.3.2.6, gamma-L-glutamyl-butirosin B = butirosin B + 5-oxo-L-proline  
4.3.2.7, glutathione = L-cysteinylglycine + 5-oxo-L-proline  
4.3.2.8, epsilon-(gamma-L-glutamyl)-L-lysine = L-lysine + 5-oxo-L-proline  
4.3.2.9, alpha-(gamma-L-glutamyl)-L-amino acid = alpha-L-amino acid +  5-oxo-L-proline (#3# mechanism <12>)  
4.3.3.1," 4-nitrophenyl-3-ketovalidamine = 4-nitroaniline +  5-D-(5/6)-5-C-(hydroxymethyl)-2,6-dihydroxycyclohex-2-en-1-one  "
4.3.3.2, 3-alpha(S)-strictosidine + H2O = tryptamine + secologanin (#30#  catalytic reaction mechanism <28>)  
4.3.3.3, deacetylisoipecoside + H2O = dopamine + secologanin  
4.3.3.4, deacetylipecoside + H2O = dopamine + secologanin  
4.3.3.5, 4'-O-demethylrebeccamycin + H2O = dichloro-arcyriaflavin A +  beta-D-glucose  
4.3.3.6, L-glutamine + H2O = L-glutamate + NH3 
4.3.3.6, D-ribose 5-phosphate + D-glyceraldehyde 3-phosphate + NH3 = pyridoxal  5'-phosphate + 4 H2O + phosphate 
4.3.3.6, D-ribose 5-phosphate + D-glyceraldehyde 3-phosphate + L-glutamine =  pyridoxal 5'-phosphate + L-glutamate + 3 H2O + phosphate  
4.3.3.7," pyruvate + L-aspartate-4-semialdehyde =  (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate + H2O (#4# pyruvate  binds to the enzyme first by forming a Schiff base with the  epsilon-amino group of Lys161. After release of the first water  molecule L-aspartate-4-semialdehyde binds to the active site and the  condensation reaction to form 2,3-dihydrodipicolinate takes place <12>;  #22# the reaction is initiated by an nucleophilic attack of the  epsilon-amino group of active site lysine to the C2 atom of pyruvate  with subsequent imine formation. Tautomerization of the imine to the  enamine creates the nucleophile necessary for the attack of the  aldehyde group of L-aspartate semialdehyde. Cyclization of the  substrate coupled with transamination leads to stepwise detachment from  the active site <21>; #4# ping-pong mechanism, pyruvate binds as a  Schiff base to Lys161. After aldol reaction with  L-aspartate-4-semialdehyde and transamination the product is released  <22>; #33# ping-pong kinetic and catalytic mechanism involves a  catalytic triad which consists of Tyr133, Thr44, and Tyr107, overview  <26>; #18# reaction mechanism including Schiff base formation,  tautomerization, and cyclization, overview <69>; #28# ping-pong kinetic  reaction mechanism <79>; #53# ping-pong mechanism, in which pyruvate  binds as a Schiff base to an active-site lysine residue (Lys162 in  Agrobacterium tumefaciens) <76>; #59# reaction steps, overview <81>;  #33# the enzyme-catalyzed reaction is initiated by condensation of  pyruvate with an active site lysine residue (Lys161 in Escherichia coli  DHDPS) forming a Schiff base, ping-pong kinetic reaction mechanism via  enamine intermediate, overview <85>; #58# the reaction proceeds via a  ping-pong kinetic mechanism in which pyruvate binds and forms a Schiff  base to an active-site lysine residue (Lys184 in Vitis vinifera  enzyme). L-aspartate-4-semialdehyde then reacts with the resultant  enamine and following cyclization forms the product  (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate <83>)  "
4.3.99.3," 6-carboxy-5,6,7,8-tetrahydropterin = 7-carboxy-7-carbaguanine + NH3  (#1# reaction mechanism <2>)  "
4.3.99.4," choline = trimethylamine + acetaldehyde (#2# radical reaction or  rearrangement mechanism, overview <2>)  "
4.3.99.5, 2-nitrobutanedioate = fumarate + nitrite  
4.4.1.1," L-cystathionine + H2O = L-cysteine + 2-oxobutanoate + NH3 (#6,54#  mechanism <33,36>; #22# the active site consists of two subsites. One  recognizes the L-form of amino acids and the other shows affinity for  thiol compounds with a carbonyl group <6>) "
4.4.1.1, 2-iminobutanoate + H2O = 2-oxobutanoate + NH3 
4.4.1.1, 2-aminobut-2-enoate = 2-iminobutanoate 
4.4.1.1, L-cystathionine = L-cysteine + 2-aminobut-2-enoate  
4.4.1.10, L-cysteine + sulfite = L-cysteate + hydrogen sulfide (#1#  beta-replacement reaction <1>)  
4.4.1.11," L-methionine + H2O = methanethiol + NH3 + 2-oxobutanoate (#10,15,22#  mechanism <9,16>; #10,13# cleavage of C-N bond in addition to C-S, C-Se  and C-O bond at beta-position of amino acids by elimination and  replacement reactions <2,20>; #14# rate determining stage of the  enzymatic reaction is deamination of aminocrotonate, important  contribution of the sulfur atom and methylene groups to the efficiency  of binding of substrates and inhibitors <67>; #45# gamma-elimination  reaction mechanism and intermediates, overview <73>)  "
4.4.1.13," an L-cysteine-S-conjugate + H2O = a thiol + NH3 + pyruvate (#37#  stereochemistry <62>; #37# activation energy for reaction with  L-djenkolate is 53.1 kJ/mol <25>; #7# with an amino acid containing a  good leaving group in the beta position, beta-elemination is greatly  favoured over transamination <63>) "
4.4.1.13, L-cystathionine + H2O = L-homocysteine + pyruvate + NH3 (#6# mechanism  <60>) 
4.4.1.13, 2-aminoprop-2-enoate = 2-iminopropanoate 
4.4.1.13, 2-iminopropanoate + H2O = pyruvate + NH3 
4.4.1.13, an L-cysteine-S-conjugate = a thiol + 2-aminoprop-2-enoate 
4.4.1.13, L-cystathionine = L-homocysteine + 2-aminoprop-2-enoate  
4.4.1.14, S-adenosyl-L-methionine = 1-aminocyclopropane-1-carboxylate +  methylthioadenosine (#11# stereochemistry <9>) 
4.4.1.14, S-adenosyl-L-methionine = 1-aminocyclopropane-1-carboxylate +  S-methyl-5'-thioadenosine  
4.4.1.15, D-cysteine + H2O = sulfide + NH3 + pyruvate  
4.4.1.16," L-selenocysteine + reduced acceptor = selenide + L-alanine + acceptor  (#21# reaction mechanism and mechanism of substrate recognition, model,  overview. A pyridoxal 5-phosphate-substrate intermediate is attacked by  a deprotonated active site Cys, producing the protein-bound persulfide  or sulfoselenide, formation of the external Cys-aldimine intermediate.  <27>)  "
4.4.1.17, Holocytochrome c = apocytochrome c + heme  
4.4.1.19," (2R)-2-O-phospho-3-sulfolactate = phosphoenolpyruvate + sulfite (#2#  mechanism, enzyme is not a member of the enolase superfamily <2>; #4#  catalyses the Michael addition of sulfite to phosphoenolpyruvate,  requires Mg2+, specifically requires phosphoenolpyruvate and its broad  alkaline pH optimum suggests that it uses sulfite rather than bisulfite  <1>)  "
4.4.1.2, L-homocysteine + H2O = hydrogen sulfide + NH3 + 2-oxobutanoate 
4.4.1.2, 2-iminobutanoate + H2O = 2-oxobutanoate + NH3 
4.4.1.2, 2-aminobut-2-enoate = 2-iminobutanoate 
4.4.1.2, L-homocysteine = hydrogen sulfide + 2-aminobut-2-enoate  
4.4.1.20," leukotriene C4 = leukotriene A4 + glutathione (#3# random rapid  equilibrium mechanism <6>; #3# the thiolate of glutathione acts as a  nucleophile attacking C6 of leukotriene A4 forming a S-C6 bond, a  proton is transferred from the guanidinium of Arg31 to the epoxide ring  oxygen resulting in opening of the epoxide ring and stabilization of  the LTC4 product complex. The tail-to-head orientation appears to be  the most likely substrate orientation <68>)  "
4.4.1.21," S-(5-deoxy-D-ribos-5-yl)-L-homocysteine = L-homocysteine +  (4S)-4,5-dihydroxypentan-2,3-dione (#4# catalytic mechanism in which  the metal ion catalyzes an intramolecular redox reaction, shifting the  carbonyl group from the C-1 position to the C-3 position of the ribose.  Subsequent beta-elimination at the C-4 and C-5 position releases  homocysteine as a free thiol <3>; #4# catalytic mechanism, the  substrate may bind within the active site when its ribosyl moiety is in  the alpha- or beta-furanose configuration or as a linear aldose,  docking and molecular dynamics simulations <52>)  "
4.4.1.22," S-(hydroxymethyl)glutathione = glutathione + formaldehyde (#1# the  enzyme from Paracoccus denitrificans accelerates the spontaneous  reaction in which the adduct of formaldehyde and glutathione is formed,  i.e. the substrate for EC 1.1.1.284, S-(hydroxymethyl)glutathione  dehydrogenase, in the formaldehyde-detoxification pathway <1>; #2# GSH  reacts with HCHO via its nucleophilic thiol group to form the  intermediate S-hydroxymethylglutathione (HMG). The catalysis of enzyme  glutathione-dependent formaldehyde-activating enzyme (GFA) is proposed  to proceed via a highly unusual mechanism involving translocation of  this second zinc ion to another undefined site on the protein. HMG  formation is subsequently catalysed at this site before the zinc ion  returns to the trigonal planar site after catalysis <3>)  "
4.4.1.23," (R)-2-hydroxypropyl-CoM = (R)-1,2-epoxypropane + HS-CoM "
4.4.1.23," (S)-2-hydroxypropyl-CoM = (S)-1,2-epoxypropane + HS-CoM  "
4.4.1.24, (2R)-3-sulfolactate = pyruvate + hydrogensulfite (#1# putative reaction  mechanism <1>)  
4.4.1.25, L-cysteate + H2O = hydrogensulfite + pyruvate + NH3 
4.4.1.25, 2-aminoprop-2-enoate = 2-iminopropanoate 
4.4.1.25, 2-iminopropanoate + H2O = pyruvate + NH3 
4.4.1.25, L-cysteate = hydrogensulfite + 2-aminoprop-2-enoate  
4.4.1.26," 3,5,7-trioxododecanoyl-CoA = CoA + 2,4-dihydroxy-6-pentylbenzoate  "
4.4.1.28," 2-aminoprop-2-enoate = 2-iminopropanoate (#3# (1b), spontaneous <3>) "
4.4.1.28," 2-iminopropanoate + H2O = pyruvate + NH3 (#3# (1c), spontaneous <3>) "
4.4.1.28, L-cysteine + H2O = sulfide + NH3 + pyruvate (#3# overall reaction <3>) 
4.4.1.28, L-cysteine = 2-aminoprop-2-enoate + sulfide (#3# (1a) <3>)  
4.4.1.29," [C-phycocyanin beta-subunit]-Cys84-phycocyanobilin = apo-[C-phycocyanin  beta-subunit] + (2R,3E)-phycocyanobilin (#3# (1) <1>) "
4.4.1.29," [phycoerythrocyanin beta-subunit]-Cys84-phycocyanobilin =  apo-[phycoerythrocyanin beta-subunit] + (2R,3E)-phycocyanobilin (#3#  (2) <1>) "
4.4.1.29," [allophycocyanin alpha-subunit]-Cys84-phycocyanobilin =  apo-[allophycocyanin alpha-subunit] + (2R,3E)-phycocyanobilin (#3# (3)  <1>) "
4.4.1.29," [allophycocyanin beta-subunit]-Cys84-phycocyanobilin =  apo-[allophycocyanin beta-subunit] + (2R,3E)-phycocyanobilin (#3# (4)  <1>) "
4.4.1.29," [C-phycoerythrin alpha-subunit]-Cys84-phycoerythrobilin =  apo-[C-phycoerythrin alpha-subunit] + (2R,3E)-phycoerythrobilin (#3#  (5) <1>) "
4.4.1.29," [C-phycoerythrin beta-subunit]-Cys84-phycoerythrobilin =  apo-[C-phycoerythrin beta-subunit] + (2R,3E)-phycoerythrobilin (#3# (6)  <1>)  "
4.4.1.3," S,S-dimethyl-beta-propiothetin = dimethyl sulfide + acrylate (#1,11#  mechanism <8,9>)  "
4.4.1.30," [C-phycocyanin beta-subunit]-Cys155-phycocyanobilin =  apo-[C-phycocyanin beta-subunit] + (2R,3E)-phycocyanobilin (#3# (1) <4>) "
4.4.1.30," [phycoerythrocyanin beta-subunit]-Cys155-phycocyanobilin =  apo-[phycoerythrocyanin beta-subunit] + (2R,3E)-phycocyanobilin (#3#  (2) <4>)  "
4.4.1.31," [phycoerythrocyanin alpha-subunit]-Cys84-phycoviolobilin =  apo-[phycoerythrocyanin alpha-subunit] + (2R,3E)-phycocyanobilin  "
4.4.1.32," [C-phycocyanin alpha-subunit]-Cys84-phycocyanobilin =  apo-[C-phycocyanin alpha-subunit] + (2R,3E)-phycocyanobilin  "
4.4.1.33," [R-phycocyanin alpha-subunit]-Cys84-phycourobilin = apo-[R-phycocyanin  alpha-subunit] + (2R,3E)-phycoerythrobilin  "
4.4.1.34," 2-(glutathion-S-yl)-2-methylbut-3-en-1-ol =  (3R)-3,4-epoxy-3-methylbut-1-ene + glutathione  "
4.4.1.35, 2-aminoprop-2-enoate = 2-iminopropanoate 
4.4.1.35, 2-iminopropanoate + H2O = pyruvate + NH3 
4.4.1.35, L-cystine + H2O = L-thiocysteine + pyruvate + NH3 
4.4.1.35, L-cystine = L-thiocysteine + 2-aminoprop-2-enoate  
4.4.1.36, S-(hercyn-2-yl)-L-cysteine S-oxide + reduced acceptor = ergothioneine +  pyruvate + NH3 + acceptor 
4.4.1.36, S-(hercyn-2-yl)-L-cysteine S-oxide + H2O = 2-(hydroxysulfanyl)hercynine  + pyruvate + NH3 
4.4.1.36, 2-(hydroxysulfanyl)hercynine + reduced acceptor = ergothioneine +  acceptor + H2O  
4.4.1.37," [LarE]-L-cysteine + pyridin-1-ium-3,5-dicarboxylate mononucleotide +  ATP = [LarE]-dehydroalanine +  pyridin-1-ium-3-carboxylate-5-thiocarboxylate mononucleotide + AMP +  diphosphate "
4.4.1.37," ATP + pyridin-1-ium-3,5-dicarboxylate mononucleotide = diphosphate +  5-carboxy-1-(5-O-phospho-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl  adenylate "
4.4.1.37, 5-carboxy-1-(5-O-phospho-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl  adenylate + [LarE]-L-cysteine = AMP +  [LarE]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium  3-carbonyl]-L-cysteine 
4.4.1.37, [LarE]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium  3-carbonyl]-L-cysteine = [LarE]-dehydroalanine +  pyridin-1-ium-3-carboxylate-5-thiocarboxylate mononucleotide 
4.4.1.37," [LarE]-L-cysteine + pyridin-1-ium-3-carboxylate-5-thiocarboxylate  mononucleotide + ATP = [LarE]-dehydroalanine +  pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide + AMP + diphosphate "
4.4.1.37, ATP + pyridin-1-ium-3-carboxylate-5-thiocarboxylate mononucleotide =  diphosphate +  1-(5-O-phospho-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium  3-carbonyl adenylate 
4.4.1.37, 1-(5-O-phospho-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium  3-carbonyl adenylate + [LarE]-L-cysteine = AMP +  [LarE]-S-[1-(5-O-phosphono-beta-D-ribofuranosyl)-5  (sulfanylcarbonyl)pyridin-1-ium-3-carbonyl]-L-cysteine 
4.4.1.37," [LarE]-S-[1-(5-O-phosphono-beta-D-ribofuranosyl)-5  (sulfanylcarbonyl)pyridin-1-ium-3-carbonyl]-L-cysteine =  [LarE]-dehydroalanine + pyridin-1-ium-3,5-bisthiocarboxylate  mononucleotide  "
4.4.1.38, isethionate = acetaldehyde + sulfite  
4.4.1.39, a [C-phycoerythrin alpha-subunit]-Cys82-phycoerythrobilin =  apo-[C-phycocyanin alpha-subunit] + (3E)-phycoerythrobilin  
4.4.1.4, an S-alkyl-L-cysteine S-oxide = an alkyl sulfenate + 2-aminoacrylate  
4.4.1.40, a [C-phycoerythrin beta-subunit]-Cys48/59-phycoerythrobilin =  apo-[C-phycocyanin beta-subunit] + (3E)-phycoerythrobilin  
4.4.1.41," (2S)-2,3-dihydroxypropane-1-sulfonate = hydroxyacetone + sulfite  "
4.4.1.5," (R)-S-lactoylglutathione = glutathione + 2-oxopropanal  (#6,7,8,9,10,11,14,15,40# mechanism <2>; #6# there is a single site for  the binding of the hemimercaptal of methylglyoxal and glutathione, for  the binding of glutathione, and for the binding of S-substituted  derivatives of glutathione. One-substrate reaction mechanism with  hemimercaptal being the substrate, but does not rule out the  possibility of the alternate branches <17>; #9# intramolecular hydride  migration is the rate-determining step <16>; #34,53# comparative study  of methylgloxal metabolism in trypanosomatids: Trypanosoma brucei,  Trypanosoma cruzi und Leishmania major. Trypanosoma brucei lacks GLO1  activity. Overexpression of GLO1 from Trypanosoma cruzi in Trypanosoma  brucei results in restoration of the glyoxalase system resulting in an  increased resistance to methylglyoxal and increased conversion of  methylglyoxal to D-lactate, demonstratong that glyoxalase II (GLO2, EC  3.1.2.6) is functional in vivo <105>; #9# investigation of the  biological role of GLO I in renal hypoxic diseases by using the rat  ischemia/reperfusion (I/R) injury model. I/R induces the reduction of  renal GLO I activity associated with morphological changes and renal  dysfunction <92>; #75# methylglyoxal and glutathione form an  intermediate, the hemithioacetal, which is catalyzed to  S-D-lactoylglutathione by GlxI. Subsequently S-D-lactoylglutathione is  hydrolyzed to D-lactate and glutathione by GlxII (EC 3.1.2.6) <97>)  "
4.4.1.9, L-cysteine + hydrogen cyanide = L-3-cyanoalanine + hydrogen sulfide  (#2# stereochemistry <14>)  
4.5.1.1," 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane =  1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene + chloride  "
4.5.1.2, 3-chloro-D-alanine + H2O = pyruvate + chloride + NH3  
4.5.1.3, dichloromethane + H2O = formaldehyde + 2 chloride (#7# nucleophilic  attack of glutathione on CH2Cl2 to produce a halomethylthioether  intermediate <4>)  
4.5.1.4, L-2-amino-4-chloropent-4-enoate + H2O = 2-oxopent-4-enoate + chloride +  NH3  
4.5.1.5, 3-chloro-L-alanine + thioglycolate = S-carboxymethyl-L-cysteine +  chloride  
4.6.1.1," ATP = 3',5'-cyclic AMP + diphosphate  "
4.6.1.12," 2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol =  2-C-methyl-D-erythritol 2,4-cyclodiphosphate + CMP  "
4.6.1.13," 1-phosphatidyl-1D-myo-inositol = 1D-myo-inositol 1,2-cyclic phosphate +  1,2-diacyl-sn-glycerol (#2,3,9# mechanism <11,12,13,17,21>; #9# general  acid/general base mechanism <14>)  "
4.6.1.14," 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol =  6-(alpha-D-glucosaminyl)-1D-myo-inositol 1,2-cyclic phosphate +  1,2-diacyl-sn-glycerol  "
4.6.1.15," FAD = AMP + riboflavin cyclic-4',5'-phosphate  "
4.6.1.16," pretRNA = a 3'-half-tRNA molecule with a 5'-OH end + a 5'-half-tRNA  molecule with a 2',3'-cyclic phosphate end + an intron with a  2',3'-cyclic phosphate and a 5'-hydroxyl terminus (#8,12# mechanism  <11,17>; #5,6# structural requirements of substrate <22>; #4,7,8,11#  mechanism of substrate recognition <12,13,18>; #13# active site  structure, the catalytic triad is formed by His257, Lys287, and Tyr246  <23>; #13# substrate recognition and binding structure and mechanism,  catalytic mechanism, the catalytic triad is formed by His257, Lys287,  and Tyr246, overview <28>; #16# substrate recognition mechanism <27>)  "
4.6.1.17," GTP = cyclic pyranopterin phosphate + diphosphate (#4# mechanisms  proposed for the first step of the Moco biosynthesis pathway, overview  <6>) "
4.6.1.17," (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate = cyclic  pyranopterin phosphate + diphosphate  "
4.6.1.18," an [RNA] containing cytidine + H2O = an [RNA]-3'-cytidine-3'-phosphate  + a 5'-hydroxy-ribonucleotide-3'-[RNA] (#3# Gly38 and Glu111 are  crucial for the catalytic activity <47>; #20# His12, His119 and Lys41  comprise the catalytic site, and several other amino acid residues  serve as substrate binding subsites. The mutagenic replacement of  Phe120 causes a positional change in His119 and that is a major cause  in decreasing the activity of the enzyme. Phe120 is important in fixing  the proper spatial position of His119 near the C-terminal region for  efficient activity. Phe120 interacts not directly with His119, but with  the hydrophobic core <63>; #3# protein of 128 amino acid residues,  catalyses the cleavage of RNA specifically on the 3-side of pyrimidine  bases. The catalytic triad comprises His12, Lys41 and His119. The amino  acid sequence of the enzyme is longer than that of its bovine  counterpart, with four extra amino acid residues at the C-terminal  region <61>; #6# protein with 124 amino acid residues and four  intra-molecular disulfide bonds. In the presence of oxidized and  reduced dithiothreitol at pH 8.0 and 25ÂºC, the enzyme folds through  pathways involving a rapid pre-equilibrium resulting in an ensemble of  three-disulfide intermediate species. Protein disulfide isomerase  catalyzes the conversion of the intermediates to the native enzyme, by  acting as both a chaperone and an oxidase on the on-pathway  intermediate <54>; #6# pyrimidine-specific endoribonuclease which  cleaves 3,5-phosphodiester bonds of single strand RNA via  transphosphorylation and subsequent hydrolysis reactions <60>; #6#  sequential binding of the monomeric substrate in a  concentration-dependent manner makes up the active site of the enzyme  <62>; #50# specifically located basic residues, together with the lack  of a negative charge and/or the presence of a glycine at position 38,  may contribute to make the enzymatic degradation of the polyanionic  double-helical substrate more efficient <48>; #20# the catalytic site  of the enzyme is mainly composed of His12, His119, Gln11, Lys41 and  Asp121. The conformation of Lys41 and Gln11 are pH dependent and their  occurrence is correlated to the release of a sulfate ion from the  active site at neutral pH. The sulfate anion is progressively released  with pH and water molecules occupy the active site at pH 7.1. The  enzyme adopts different conformational states in different pH  conditions. In the protonated state, Lys41 points towards the active  site both in the presence and in the absence of sulfate and acts as a  general base during catalysis <46>; #20# the enzyme is composed of 124  amino acid residues. The amino acid residues involved in catalysis are  His12, His119 and Lys41. The enzyme has six substrate binding subsites.  One of them, B1, binds only to pyrimidine nucleotides and prefers to  bind cytidine rather than uridine. Thr45 of the B1 subsite contributes  to the enzyme substrate specificity and plays an important role in  catalysis. Phe120 in the B1 subsite enhances substrate binding with the  aid of its pi electron and hydrophobicity. Asn71 in the B2 subsite is  responsible for productive interactions leading to efficient activity,  and Glu111 in the same subsite contributes to substrate binding only in  the binding of guanosine. Lys7, Arg10 and Gln11 in the P2 subsite also  play an important role in catalysis. Some amino acid residues are  located in the vicinity of the catalytic residues and contribute to the  catalytic reaction by interacting with catalytic residues. Lys7, Arg10  and Lys66 maintain the optimum pKa of His12 and His119. Asp121  positions the proper tautomer of His119. Phe120 is responsible for the  strict positioning of His119, and contributes to conformational  stability. Tyr97 is involved in maintaining the correct position of  Lys41. Cys65-Cys72 are located close to the catalytic and substrate  binding residues and contribute to the proper spatial alignment of  these residues <59>; #6# two isoforms of dimeric enzyme, D-I and D-II  <53>; #6# His119 and His12 play an important structural role in active  site of RNase A <74>; #6# enzymatic reaction mechanism, analysis of  different versions, e.g. mechanism of Mathias and Rabin for catalysis  of the hydrolysis of cytidine 2,3-cyclic phosphate by RNase A,  overview. Model of the RNase A-substrate complex, subsites of RNase A.  Bn, Rn, and Rho_n are nucleobase-, ribose-, and phosphate-binding  subsites, respectively <165>; #1,3,25,28,51,54# RNase A catalyzes a  well-characterized acid-base mechanism involving two histidines (His12  and His119) and a transition state stabilizing positive charge (Lys41).  The transphosphorylation of a single-stranded RNA molecule by the  enzyme yields a 2,3-cyclic phosphomonoester intermediate, which can be  expelled from the active site or hydrolyzed in a microscopic reverse  reaction involving the same two histidines <180>) "
4.6.1.18," an [RNA] containing cytidine = an  [RNA]-3'-cytidine-2',3'-cyclophosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA] "
4.6.1.18," an [RNA]-3'-cytidine-2',3'-cyclophosphate + H2O = an  [RNA]-3'-cytidine-3'-phosphate "
4.6.1.18, an [RNA] containing uridine + H2O = an [RNA]-3'-uridine-3'-phosphate +  a 5'-hydroxy-ribonucleotide-3'-[RNA] 
4.6.1.18," an [RNA] containing uridine = an [RNA]-3'-uridine-2',3'-cyclophosphate  + a 5'-hydroxy-ribonucleotide-3'-[RNA] "
4.6.1.18," an [RNA]-3'-uridine-2',3'-cyclophosphate + H2O = an  [RNA]-3'-uridine-3'-phosphate  "
4.6.1.19," RNA + H2O = an [RNA fragment]-3'-nucleoside-3'-phosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] (#25# mechanism <9>;  #25,28# reaction mechanism <41>; #16# similar enzyme with possilbly  exonucleolytic mechanism <19>; #25# two-stage endonucleolytic cleavage  to 3-phosphomononucleotides and 3-phosphooligonucleotides with  2,3-cyclic phosphate intermediates: first step reversible cleavage of  phosphodiester bond between 3-adenylic acid group and 5-hydroxyl group  at adjacent nucleotides in RNA chain with formation of nucleoside  2,3-cyclic phosphates and oligonucleotides with 2,3-cyclic phosphate at  3-terminal, second step: hydrolysis of terminal cyclic phosphate groups  with formation of corresponding 3-phosphates <1>; #33# active site  structure, Glu32 is an essential part of the B2-substrate recognition  and binding site <37>; #50# catalytic hydrolysis mechanism, active site  structure, the conserved active site residues His39, His92, and His 97  are essential for activity, Glu93 and Lys96 are important <39>; #33#  Phe101 is important for catalytic activity <34>; #33# reaction  mechanism, His109, Lys108, His104, and His46 are involved <41>; #43#  residues His34, His 83, Glu84, Lys87, and His88 may be involved in  catalysis <35>; #43# substrate recognition, binding and specificity,  Asn71 and Leu73 are involved <33>; #58# mechanism of RNA recognition,  binding and cleavage by RNase L, overview <76>) "
4.6.1.19," RNA = an [RNA fragment]-3'-nucleoside-2',3'-cyclophosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] "
4.6.1.19," an [RNA fragment]-3'-nucleoside-2',3'-cyclophosphate + H2O = an [RNA  fragment]-3'-nucleoside-3'-phosphate  "
4.6.1.2," GTP = 3',5'-cyclic GMP + diphosphate (#48,52# reaction mechanism,  overview <196>; #3,5,6,7,8,10,15,59# reaction mechanism,  structure-function relationship <136>)  "
4.6.1.20, [RNA] containing guanosine + H2O = an [RNA  fragment]-3'-guanosine-3'-phosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] 
4.6.1.20, [RNA] containing adenosine + H2O = an [RNA  fragment]-3'-adenosine-3'-phosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] 
4.6.1.20," [RNA] containing adenosine = an [RNA  fragment]-3'-adenosine-2',3'-cyclophosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] "
4.6.1.20," an [RNA fragment]-3'-adenosine-2',3'-cyclophosphate + H2O = an [RNA  fragment]-3'-adenosine -3'-phosphate "
4.6.1.20," [RNA] containing guanosine = an [RNA  fragment]-3'-guanosine-2',3'-cyclophosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] "
4.6.1.20," an [RNA fragment]-3'-guanosine-2',3'-cyclophosphate + H2O = an [RNA  fragment]-3'- guanosine-3'-phosphate  "
4.6.1.21, RNA containing adenosine-cytidine + H2O = an [RNA  fragment]-3'-cytidine-3'-phosphate + a 5'-a hydroxy-adenosine -3'-[RNA  fragment] 
4.6.1.21," RNA containing adenosine-cytidine = an [RNA  fragment]-3'-cytidine-2',3'-cyclophosphate + a 5'-a hydroxy-adenosine  -3'-[RNA fragment] "
4.6.1.21," an [RNA fragment]-3'-cytidine-2',3'-cyclophosphate + H2O = an [RNA  fragment]-3'-cytidine-3'-phosphate  "
4.6.1.22," RNA = a 5'-hydroxy-ribonucleotide + n nucleoside-2',3'-cyclophosphates  (#2# no convertion to 3-mononucleotides <4>; #2# combined activity with  the cyclic phosphodiesterase to degrade RNA <4>)  "
4.6.1.23, a 28S rRNA containing guanosine-adenosine pair + H2O = an [RNA  fragment]-3'-adenosine-3'-phosphate + a 5'-hydroxy-guanosine-3'-[RNA  fragment] 
4.6.1.23," a 28S rRNA containing guanosine-adenosine pair = an [RNA  fragment]-3'-adenosine-2',3'-cyclophosphate + a  5'-hydroxy-guanosine-3'-[RNA fragment] "
4.6.1.23," an [RNA fragment]-3'-adenosine-2',3'-cyclophosphate + H2O = an [RNA  fragment]-3'-adenosine-3'-phosphate  "
4.6.1.24," [RNA] containing guanosine + H2O = an [RNA  fragment]-3'-guanosine-3'-phosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] (#13# mechanism <1,10>;  #26# hydrolysis of the phosphodiester bonds of single-stranded RNA at  the 3-side of guanosine nucleotides occurs with high specificity <30>;  #13# small single-domain protein of 104 amino acid residues that  cleaves single-stranded RNA specifically at the 3-side of guanine  residues in a two-step mechanism <34>; #13# the conjugate base of the  gamma-carboxyl group of Clu46 is required for tight binding of guanine  and hypoxanthine moieties at the primary recognition site of the enzyme  <31>; #13# the enzyme is composed of 104 amino acid residues and it  cleaves single-stranded RNA specifically after guanosine residues to  produce mono or oligo-ribonucleotides with terminal 3-phosphate <35>;  #13# the reaction is a transphosphorylation yielding a  2,3-cyclophosphate. This cyclic intermediate is hydrolyzed by a water  molecule to a 3-phosphate in a separate step which is the reversal of  the transphosphorylation. The transphosphorylation consists of a  nucleophilic in-line inversion displacement at the phosphorous atom of  the 5-leaving group by the entering 2-oxygen. Tyr38, His40, Glu58,  His92 and Phe100 are involved in the catalysis of RNA degradation.  During cyclization, Glu58 and His92 serve as the catalytic base and  acid, respectively <36>; #13# the side chain carboxyl of Glu54 accepts  a proton from the ribose 2OH group and the protonated imidazole ring of  His85 donates a proton to the leaving 5O group. The positively charged  side chain of Arg65 is to promote the formation of a negatively  charged, pentacovalent intermediate state of the phosphate group <40>) "
4.6.1.24," [RNA] containing guanosine = [RNA  fragment]-3'-guanosine-2',3'-cyclophosphate + a  5'-hydroxy-ribonucleotide-3'-[RNA fragment] "
4.6.1.24," [RNA fragment]-3'-guanosine-2',3'-cyclophosphate + H2O = [RNA  fragment]-3'-guanosine-3'-phosphate  "
4.6.1.25, a [pre-mRNA]-containing guanosine-adenosine + H2O = a 5'  hydroxy-guanosine-[pre-mRNA fragment] + a [pre-mRNA  fragment]-3'-adenosine-3'-phosphate 
4.6.1.25," a [pre-mRNA]-containing guanosine-adenosine + H2O = a 5'  hydroxy-guanosine-[pre-mRNA fragment] + a [pre-mRNA  fragment]-adenosine-2',3'-cyclophosphate "
4.6.1.25," a [pre-mRNA fragment]- adenosine-2',3'-cyclophosphate + H2O = a  [pre-mRNAfragment]-3'-adenosine-3'-phosphate  "
4.6.1.6," CTP = 3',5'-cyclic CMP + diphosphate  "
4.7.1.1," alpha-D-ribose 1-methylphosphonate 5-phosphate +  S-adenosyl-L-methionine + reduced electron acceptor = alpha-D-ribose  1,2-cyclic phosphate 5-phosphate + methane + L-methionine +  5'-deoxyadenosine + oxidized electron acceptor  "
4.8.1.1," N5-hydroxy-L-ornithine = (3S)-1,2-diazinane-3-carboxylate + H2O  "
4.8.1.2, an aliphatic aldoxime = an aliphatic nitrile + H2O  
4.8.1.3, (indol-3-yl)acetaldehyde oxime = (indol-3-yl)acetonitrile + H2O  
4.8.1.4," (Z)-phenylacetaldehyde oxime = phenylacetonitrile + H2O (#2# oxidation  state of heme controls the coordination structure of a substrate-hem  complex, which regulates enzyme activity <4>)  "
4.98.1.1," protoheme + 2 H+ = protoporphyrin + Fe2+ (#5,41,43# mechanism  <50,51,52,60>; #46# catalytic model <62>; #4,5,8,14,41# mechanism:  overview <54,58>; #11# structural model <47>)  "
4.99.1.10, chlorophyll a + 2 H+ = pheophytin a + Mg2+ 
4.99.1.10, chlorophyllide a + 2 H+ = pheophorbide a + Mg2+  
4.99.1.11, Ni-sirohydrochlorin + 2 H+ = sirohydrochlorin + Ni2+  
4.99.1.12," Ni(II)-pyridinium-3,5-bisthiocarboxylate mononucleotide =  pyridinium-3,5-bisthiocarboxylate mononucleotide + Ni2+  "
4.99.1.2," an alkylmercury + H+ = an alkane + Hg2+ (#3# mechanism <1,2,3>; #5# SE2  mechanism <14>)  "
4.99.1.3, cobalt-sirohydrochlorin + 2 H+ = sirohydrochlorin + Co2+  
4.99.1.4," siroheme + 2 H+ = sirohydrochlorin + Fe2+ (#1# the enzyme from  Pseudomonas chloroaphis contains Ca2+ and protoheme IX, the iron of  which must be in the form Fe2+ for activity, the enzyme exhibits a  strong preference for aliphatic aldoximes, such as butyraldoxime and  acetaldoxime, over aromatic aldoximes, such as pyridine-2-aldoxime,  which is a poor substrate, no activity was found with the aromatic  aldoximes benzaldoxime and pyridine-4-aldoxime, mechanism <3>)  "
4.99.1.8, 2 ferriprotoporphyrin IX = beta-hematin  
4.99.1.9, Fe-coproporphyrin III + 2 H+ = coproporphyrin III + Fe2+  
5.1.1.1," L-alanine = D-alanine (#8# the alanine racemase builds two different  bases in the active site. The base for D-Ala may be closer to the  enzyme surface, and that for L-Ala inside <18>; #5# the active site of  the alanine racemase reacts asymmetrically with the enantiomers of the  substrate and has a conformation which greatly favors the D-enantiomer  <4>; #58# consensus water sites at the interface between the two enzyme  monomers maintain and stabilize dimer and supply the active site  continuously with water molecules to allow rapid equilibration of  active site protons <64>; #24# reaction mechanism, overview <104>)  "
5.1.1.10," an L-amino acid = a D-amino acid (#4,6# the results of the mechanistic  studies argue against a single base mechanism and are best rationalized  in terms of a double base model where only one of the bases undergoes  proton exchange with the solvent while the amino acid is enzyme-bound  <12>; #4# enzyme abstracts a hydrogen nonstereospecifically from C-4 of  the coenzyme <9>; #4# single base mechanism <7>; #4# significant  internal return of the alpha-hydrogen <7>; #11# the racemization of ACL  racemase proceeds via a two-base mechanism <33>)  "
5.1.1.11," ATP + L-phenylalanine + H2O = AMP + diphosphate + D-phenylalanine (#1#  the enzyme activates both L-Phe and D-Phe to form L-phenylalanyl  adenylate and D-phenylalanyl adenylate bound to the enzyme,  respectively, and then transfers the L-Phe and D-Phe moiety to the  thiol group of the enzyme followed by conversion of its configuration,  the D-isomer being the more favorable configuration <16>; #1# racemizes  Phe in the thioester-bound stage <18>; #1# phenylalanine racemase  catalyzes the exchange between a proton in the medium and  alpha-hydrogen of Phe. Probably a sulfhydryl group, on the enzyme  functions as proton donor and acceptor during the reaction <17>; #1#  the amino group of Phe is essential for its binding to the aminoacyl  adenylate reaction center. The carbonyl group is not at all or only  weakly bound. The benzene ring of Phe which determines substrate  recognition also seems to be of minor importance for substrate binding  <3>)  "
5.1.1.12, L-ornithine = D-ornithine  
5.1.1.13," L-aspartate = D-aspartate (#14# removal of alpha-hydrogen of the  substrate is at least partially rate-determining <3>; #22# the enzyme  racemizes only aspartate and no other amino acids but the enzyme also  shows a dehydratase activity toward L-threo-3-hydroxyaspartate <18>;  #29# one-base mechanism, residue C194 plays the role of the base for  not only L-aspartate but also D-aspartate <19>)  "
5.1.1.14, isonocardicin A = nocardicin A 
5.1.1.14, isonocardicin C = nocardicin C  
5.1.1.15," (S)-2-aminohexano-6-lactam = (R)-2-aminohexano-6-lactam (#2# single  base mechanism <1>; #2# D- and L-amino acids are produced from L- and  D-amino acid amides by D-aminopeptidase from Ochrobactrum anthropi  C1-38 and L-amino acid amidase from Pseudomonas azotoformans IAM 1603,  respectively, in the presence of alpha-amino-epsilon-caprolactam  racemase from Achromobacter obae. Substrate: L-alanine amide, product:  D-alanine (100% yield), substrate: L-2-aminobutyric amide, product:  D-2-aminobutyric acid (100% yield), substrate: L-serine amide, product:  D-serine (94% yield), substrate: L-methionine amide, product:  D-methionine (100% yield), substrate: D-alanine amide, product:  L-alanine (100% yield), substrate: D-leucine amide, product: L-leucine  (100% yield), substrate: D-methionine amide, product: L-methionine  (100% yield) <11>; #5# the racemization of ACL racemase proceeds via a  two-base mechanism <13>)  "
5.1.1.16, [Protein]-L-serine = [protein]-D-serine  
5.1.1.17, isopenicillin N = penicillin N  
5.1.1.18," L-serine = D-serine (#19# reaction mechanism, overview <45>; #3,14#  racemase and dehydratase reaction mechanism of serine racemase,  overview <47>; #19# substrate recognition mechanism and catalytic  mechanisms of both reactions, the racemization and the dehydration of  serine, residues Lys57 and Ser82 located on the protein and solvent  sides, respectively, with respect to the cofactor plane, are acid-base  catalysts that shuttle protons to the substrate. Racemization mechanism  via carbanion intermediate, alpha-aminoacrylate intermediate, and  pyridoxal 5-phosphate-lysine-D-alanine Schiff base <46>; #14# L-serine  forms Schiff base with the cofactor pyridoxal 5-phosphate, the free  (non-pyridoxal 5-phosphate cofactor binding) amino group of K56 is in  the vicinity of the hydrogen on the Calpha atom, allowing the side  chain of K56 to extract the proton away from the Ca atom and form a  planar intermediate. the hydroxyl group of S84, on the re-face of this  planar intermediate, donates its hydrogen to the Calpha atom of the  intermediate resulting in the formation of D-serine. The subsequent  attack of K56 on the cofactor forms the Schiff base and releases  D-serine as the product. If the starting substrate is D-serine, S84 is  likely to be protonated, favoring the extraction of hydrogen from the  Calpha atom of pyridoxal 5-phosphate-D-serine. The resulting planar  intermediate allows K56 amino group to provide a proton from the  si-face, restoring the L-serine intermediate. As a result, K56 reacts  with pyridoxal 5-phosphate to form the Schiff base and releases the  L-serine as the final product. Catalytic mechanism, overview <70>; #5#  the abstraction and addition of alpha-hydrogen to L- and D-serine are  conducted by residues K56 and S81 at the si- and re-sides,  respectively, of pyridoxal 5-phosphate, K56 functions as a residue that  abstracts the alpha-hydrogen from the Schiff base intermediate,  two-base catalytic mechanism, overview <61>; #6# two-base racemization  mechanism, overview. The enzyme utilizes a two-base mechanism wherein  one enantiospecific Broensted base abstracts the proton from the  L-Ser-pyridoxal 5-phosphate aldimine and the conjugate acid of a second  enantiospecific Bronsted base protonates the intermediate to form the  D-Ser-pyridoxal 5-phosphate aldimine, and vice versa <62>; #14,17#  analysis of the catalytic reaction mechanism and intermediate  stabilization in mammalian serine racemase using multiscale  quantum-classical simulations, hybrid quantum mechanics/molecular  mechanics molecular dynamics simulations in conjunction with umbrella  sampling are performed, overview. The unprotonated pyridoxal  5-phosphate-substrate intermediate is stabilized mostly due to  solvation effects contributed by water molecules and active-site  residues, as well as long-range electrostatic interactions with the  enzyme environment <74>; #13,14# reaction mechanism, the enzyme  catalyzes the racemization of serine, but also the  alpha,beta-elimination of serine forming pyruvate. Mechanicistically,  the racemization and alpha,beta-elimination reactions share the same  intermediate, represented by a resonance-stabilized carbanion. The  intermediate forms a partition between the two pathways. L-Serine binds  to pyridoxal 5-phosphate, yielding an external aldimine intermediate,  followed by the abstraction of the alpha-proton by Lys56 and formation  of a planar resonance-stabilized carbanion. At this point, protonation  in the opposite side of the carbanion intermediate (mediated by the  Ser84-OH group) generates D-serine. Since the proton abstraction and  the reprotonation steps are performed by different residues (Lys56 and  Ser84) that work as acid/base catalysts, serine racemase racemization  is consistent with a two-base mechanism <80>; #22# reversible  racemization and irreversible dehydration reactions are catalyzed by  eukaryotic serine racemase, overview <71>; #13# SRR catalyses Ser  racemization via a two-base mechanism in which two catalytic residues,  Lys56 and Ser84 play vital roles in the abstraction and donation of  alpha-proton of L-Ser and D-Ser, respectively <82>)  "
5.1.1.19," O-ureido-L-serine = O-ureido-D-serine (#1# the enzyme employs a  two-base mechanism, with a thiolateÂ–thiol pair in the active site <2>)  "
5.1.1.2, L-methionine = D-methionine  
5.1.1.20," L-alanyl-D-glutamate = L-alanyl-L-glutamate (#3,4# a two-base reaction  mechanism typical for enolase superfamily enzymes, Mg2+-assisted  general base-catalyzed abstraction of the alpha-proton of a carboxylic  acid and stabilization of an enolate anion intermediate, overview <6>)  "
5.1.1.21," L-isoleucine = D-allo-isoleucine (#1# L-isoleucine epimerization  proceeds through abstraction of the alpha-hydrogen of the substrate by  Lys280, while Asp222 serves as the catalytic residue adding an  alpha-hydrogen to the quinonoid intermediate to form D-allo-isoleucine,  structure-function relationship <2>; #1# the racemization reaction by  the fold-type I racemases may generally occur thanks to a revised  two-base mechanism. Conformational changes provoked by pyridoxal  5-phosphate binding suggesting an induced fit of the active site  entrance door necessary to accommodate pyridoxal 5-phosphate and  substrate molecules <3>)  "
5.1.1.22, trans-4-hydroxy-L-proline betaine = cis-4-hydroxy-D-proline betaine 
5.1.1.22, L-proline betaine = D-proline betaine  
5.1.1.23, ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-L-glutamate + H2O = AMP +  diphosphate + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate  
5.1.1.24, L-histidine = D-histidine  
5.1.1.3," L-glutamate = D-glutamate (#18# deprotonation/protonation mechanism for  racemization in which the breaking of the carbon-hydrogen bond at C-2  is partially rate-determining <24>; #17# initial step is the proton  abstraction from the substrate alpha-carbon atom, which is mediated by  an amino acid residue in the enzyme protein <26>; #17# two base  mechanism, removal of alpha-hydrogen is the rate determining step <15>;  #15# the enzyme uses a two-base mechanism in which two Cys thiolates  serve as the general base/acid catalysts. An initial deprotonation  event produces a resonance-stabilized carbanionic intermediate that is  subsequently protonated on the opposite face to generate the  enantiomeric product <7>; #18# deprotonation/protonation mechanism.  Two-base mechanism in which one enzymic base deprotonates the  substrate, and the conjugate acid of a second enzymic base protonates  the resulting intermediate from the opposite face <25>; #15# the enzyme  uses a two-base mechanism involving a deprotonation of the substrate at  the alpha-position to form an anionic intermediate, followed by a  reprotonation in the opposite stereochemical sense. Cys73 is  responsible for the deprotonation of D-glutamate and Cys184 is  responsible for the deprotonation of L-glutamate <27>; #4# analysis of  active site, mechanism <39>; #32# molecular dynamics simulations,  mechanism by which binding mismatches are propagated into an opening of  the active site <36>; #32# glutamate racemase faces the difficult task  of deprotonating a relatively low acidicity proton, the amino acidÂ’s  R-hydrogen, with a relatively poor base, a cysteine. The titration  curves and the pK1/2 values of all of the ionizable residues for  different structures leading from reactants to products are analyzed.  From these results a concerted mechanism is proposed in which the Cys70  residue deprotonates the R-hydrogen of the substrate while, at the same  time, being deprotonated by the Asp7 residue <44>; #13# the molecular  mechanism involves deprotonation of the glutamate alpha-proton,  followed by substrate reprotonation on the opposite stereochemical face  <66>; #41# MurI is a member of the two-base mechanism (dual-cysteine)  racemase family, where two essential active-site cysteine residues act  as catalytic base and acid to stereospecifically de- and reprotonate,  respectively, the alpha position of glutamate in order to enact  substrate racemization <69>; #28# MurI is a member of the two-base  mechanism (dual-cysteine) racemase family, where two essential  active-site cysteine residues act as catalytic base and acid to  stereospecifically de- and reprotonate, respectively, the alpha  position of glutamate in order to enact substrate racemization. C185 of  BsMurI corresponds to the essential catalytic cysteine residue that  deprotonates an incoming L-glutamate substrate (or reprotonates a  carbanionic intermediate to form the D-stereoconfiguration) <69>)  "
5.1.1.4," L-proline = D-proline (#2# mechanism <5>; #2# two-base mechanism in  which one base on the enzyme removes the substrate alpha-hydrogen as a  proton and the conjugate acid of another base donates a proton to the  opposite side of the alpha-carbon <4>; #2# the substrate and product  ""on-off"" steps are faster than the racemization step and the  racemization reaction proceeds either in a concerted manner or in a  stepwise fashion involving enzyme catalytic groups, e.g. thiols <11>;  #2# enzyme exists in two states, one of which binds and isomerizes  L-Pro and the other of which binds and isomerizes D-Pro. It seems  likely that the two enzyme forms differ only in the protonation states  of the acidic and basic groups at the active site <8>; #2# stepwise  reaction for the interconversion of the free enzyme forms in which a  proton is abstracted from a bound water molecule to give a reaction  intermediate having a hydroxide ion bound to the diprotonated form of  the enzyme <7>; #2# racemization is accompanied by deuterium  incorporation from the solvent into the alpha position of Pro,  participation of two equivalent hydrogen acceptor sites <1>; #2#  energetics of proline racemase: transition-state fractionation factors  for the two protons involved in the catalytic steps <6>; #2# mechanism  is best accomodated by a route that involves a transition state or  unstable intermediate in which the proline carbanion is flanked by the  two catalytic thiols of the enzyme <10>; #2# fractionation factors for  the essential catalytic groups in the enzyme-substrate complexes <9>;  #1# a new combined quantum mechanical and molecular mechanical (QM/MM)  potential to study the reaction mechanism of proline racemase is used.  Three critical points are identified: two almost isoenergetic minima  (M1a and M2a), in which the enzyme is bound to L- and D-Pro,  respectively, and a transition state (TSCa), unveiling a highly  asynchronous concerted process <15>; #1# quantum mechanical and  molecular mechanical study reveals two almost isoenergetic minima M1a  and M2a, in which the enzyme is bound to L-proline and D-proline,  respectively, and a transition state TSCa, unveiling a highly  asynchronous concerted process. Residues Asn133, Asp296, and Gly301  destabilize M2a. Conversely, both Gly131and Gly303 stabilize M2a.  Residues Gly131, Gly301, and Thr302 stabilize TSCa <15>)  "
5.1.1.5, L-lysine = D-lysine  
5.1.1.6, L-threonine = D-threonine  
5.1.1.7," LL-2,6-diaminoheptanedioate = meso-diaminoheptanedioate (#3# molecular  dynamics simulations show that the configuration of the distal carbon  CÂ–6 of L,L-DAP is critical for complex formation since both amino and  carboxylate groups are involved in HÂ–bonding interactions with the  active site residues. Furthermore, the interactions occurring between  the functional groups bonded to the CÂ–2 and some residues of the  binding cavity immobilize the ligand in a position appropriate for the  epimerization reaction, i.e., exactly in the middle of the two  catalytic residues Cys73 and Cys217 as confirmed by DFT  (density-functional theory) quantum mechanical computation of the  Michaelis complex <27>; #29# molecular mechanism of the enzyme,  reversible disulfide bond formation at the active site of CgDapF and  disulfide bond-mediated conformational change in CgDapF, domain  movement in CgDapF, CgDapF is regulated by redox-switch modulation, via  reversible disulfide bond formation, overview <38>)  "
5.1.1.8, trans-4-Hydroxy-L-proline = cis-4-hydroxy-D-proline (#4# the  alpha-hydrogen exchanges during enzymatic racemization at the  alpha-carbon <4>; #4# a single hydrogen of 4-hydroxyproline is  labilized and exchanges with H2O in the medium <5>; #4# one hydrogen in  the substrate is labilized during the reaction <2>)  
5.1.1.9, L-arginine = D-arginine  
5.1.2.1," (S)-Lactate = (R)-lactate (#10# direct internal hydride transfer  mechanism, symmetrical alpha-carbon intermediate <3>; #10# transient  carbonyl intermediate, carbonyl is in the alpha-position of the  enzyme-bound lactic acid <2>; #14# the enzyme does not follow a  proton-coupled electron transfer mechanism, but a proton-coupled  hydride transfer (PCHT) mechanism. The nickel-pincer cofactor  facilitates a proton-coupled hydride transfer (PCHT) mechanism during  LarA-catalyzed lactate racemization <11>; #14# the Ni-tethered pincer  cofactor in enzyme LarA increases reaction barriers and destabilizes  NADH-like pyruvate intermediates, due to the less electrophilic Ni  cofactor and to the ring strain in the pyruvate intermediates, reaction  mechanism, active and transition state structure, modeling <13>)  "
5.1.2.2," (S)-mandelate = (R)-mandelate (#1# free energy profile for racemization  <29>; #2# His297 and Asp270 function together as a catalytic dyad <14>;  #1# enzyme does not catalyze an intermolecular proton transfer to  achieve racemization. The enzyme operates via a one-acceptor mechanism,  in which the proton abstracted from one stereochemical face of a  substrate molecule is returned to the opposite face of the same carbon  of the substrate molecule <16>; #1# reaction proceeds via a two-base  mechanism in which Lys166 abstracts the alpha-proton from (S)-mandelate  and His297 abstracts the alpha-proton from (R)-mandelate <20>; #1#  two-base mechanism <22>; #1# pathway involving a carbanion intermediate  <5,7,17>; #1# two-base mechanism in which the conjugate acid of the  R-specific base is monoprotic and in which the S-specific base may be  an amino group <23>; #1# the enzyme contains two distinct general  acid/base catalysts: Lys166 which abstracts the alpha-proton from  (S)-mandelate, and His297, which abstracts the alpha-proton from  (R)-mandelate <20>; #1# one-base acceptor mechanism, functional  asymmetry at the active site <6>; #1# one pot enantioconvergent  synthesis of R-mandelic acid ester from racemic mandelic acid is  achieved by a novel aqueous/organic two-phase system with two-enzyme  process consisting of (1) lipase-catalyzed enantioselective  esterification of racemic mandelic acid in organic solvent and (2) in  situ racemization of unreacted isomer, S-mandelic acid in aqueous phase  by recombinant mandelate racemase <43>; #2# the enzyme utilizes a  two-base mechanism with Lys166 and His297 acting as Broensted acid and  base catalysts, respectively, in the R -> S reaction direction. In the  S -> R reaction direction, their roles are reversed <55>)  "
5.1.2.3," (S)-3-Hydroxybutanoyl-CoA = (R)-3-hydroxybutanoyl-CoA (#3#  epimerization of D-3-hydroxyacyl-CoA does not occur directly but  proceeds instead via 2-trans-enoyl-CoA as an intermediate by combined  actions of a novel D-specific enoyl-CoA hydratase, D-hydratase, and an  L-specific enoyl-CoA hydratase <5>; #2# the multienzyme complex  catalyzes the rapid and direct dehydration of  D-3-hydroxy-4-trans-decenoyl-CoA to 2-trans,4-trans-decadienoyl-CoA,  which is slowly hydated to L-3-hydroxy-4-trans-decenoyl-CoA <8>; #3#  epimerization in rat liver is not catalyzed by a single protein but  probably occurs via two steps <6>; #2# epimerization occurs solely by a  dehydration/hydration mechanism <8,9>)  "
5.1.2.4, (S)-Acetoin = (R)-acetoin  
5.1.2.5," (R,R)-Tartrate = meso-tartrate  "
5.1.2.6," (1R,2S)-1-hydroxypropane-1,2,3-tricarboxylate =  (1S,2S)-1-hydroxypropane-1,2,3-tricarboxylate  "
5.1.2.7, D-tagaturonate = D-fructuronate  
5.1.3.1, D-ribulose 5-phosphate = D-xylulose 5-phosphate  
5.1.3.10, CDP-alpha-D-paratose = CDP-alpha-D-tyvelose  
5.1.3.11," cellobiose = 4-O-beta-D-glucopyranosyl-D-mannose (#1# direct reaction  at carbon-2 of the reducing moiety of the disaccharide <2>; #1# a  carbanion-type but no keto intermediate <1>; #9# mechanism of  reversible epimerization involving three histidine residues, overview.  His390 is closely related to ring opening/closure by transferring a  proton between the O5 and O1 atoms of the ligand. His259 abstracts the  H2 proton of the D-mannose residue at the reducing end, and  consistently forms the cis-enediol intermediate by facilitated  depolarization of the 2-OH group mediated by hydrogen bonding  interaction with His200. His390 subsequently donates the proton to the  C2 atom of the intermediate to form a D-glucose residue. The reverse  reaction is mediated by the three histidines with the inverse roles of  acid/base catalysts <16>; #1# the enzymes catalytic mechanism involvies  three histidine residues, His374 and His243 act as a general acid/base  catalyst, and His184 is essential for the enzyme activity, overview  <15>; #3,4,5,6,9,10,14,16,17,18,19,20,21,22,24,25,28# reaction  mechansim, overview <20>)  "
5.1.3.13, dTDP-4-dehydro-6-deoxy-alpha-D-glucose = dTDP-4-dehydro-beta-L-rhamnose  (#1# dTDP-4-keto-L-rhamnose is formed as intermediate <1>)  
5.1.3.14," UDP-N-acetyl-alpha-D-glucosamine = UDP-N-acetyl-alpha-D-mannosamine  (#5# during epimerization, tritium from tritium-enriched water is  incorporated into both UDP-N-acetyl-D-glucosamine and  UDP-N-acetyl-D-mannosamine <7>; #5# mechanism proceeds via cleavage of  the anomeric C-O bond, with 2-acetamidoglucal and UDP as enzyme-bound  intermediates. It is likely that E1-eliminations via oxocarbenium  intermediates are involved in the reaction <23>; #7#  UDP-N-acetyl-D-mannosamine is not an intermediate <1,2>; #7# products:  UDP + N-acetyl-D-mannosamine <1,2,3,4>; #5# the mechanism involves a  trans-elimination of monoprotic UDP to form 2-acetamidoglucal. Followed  by a syn-addition, in the direction of UDP-N-acetyl-D-mannosamine  formation <18>; #7# ordered mechanism, where UDP is the first product  released followed by irreversible formation of N-acetyl-mannosamine. A  two step mechanism is proposed which involves the elimination of UDP  from UDP-N-acetylglucosamine to give a 2-acetamidoglucal intermediate  which is subsequently converted to N-acetylmannosamine <4>; #22,23#  2-epimerase-catalyzed elimination and readdition of UDP to the glycal  intermediate may proceed through a transition state with significant  oxocarbenium ion-like character <62>)  "
5.1.3.15, alpha-D-glucose 6-phosphate = beta-D-glucose 6-phosphate  
5.1.3.16, UDP-alpha-D-glucosamine = UDP-alpha-D-galactosamine  
5.1.3.17," Epimerization of D-glucuronate in heparosan-N-sulfate to L-iduronate  (#4# proposed catalytic mechanisms of C5-epi, overview <17>)  "
5.1.3.18, GDP-alpha-D-mannose = GDP-beta-L-galactose (#3# epimerization proceeds  via ene-diol intermediates <4>; #3# beta-L-galactopyranosyl phosphate  is an intermediate <3>) 
5.1.3.18, GDP-alpha-D-mannose = GDP-beta-L-gulose  
5.1.3.19," Chondroitin D-glucuronate = dermatan L-iduronate (#2# two-base reaction  mechanism, involving a monoprotic L-iso-specific base and a polyprotic  D-gluco-specific base <6>; #2# after inversion, a hydrogen from the  medium is reinserted into the uronosyl residue <2>; #7# His-450  functions as a general base abstracting the C5 proton from glucuronic  acid. Subsequent cleavage of the glycosidic linkage by Tyr-261  generates a 4,5-unsaturated hexuronic intermediate, which is protonated  at the C5 carbon by His-205 from the side of the sugar plane opposite  to the side of previous proton abstraction. Concomitant recreation of  the glycosidic linkage ends the reaction, generating iduronic acid,  proposed molecular mechanism of epimerization, overview <9>; #2#  processive reducing to non-reducing end mode of action of DS-epi1, in  silico modeling of site-specific information <14>)  "
5.1.3.2," UDP-alpha-D-glucose = UDP-alpha-D-galactose (#6# a nucleoside  diphospho-4-ulose of the configuration D-xylo-4-hexosulose is an  intermediate in the reaction <20>; #50,61,62,63,64,65# reaction  mechanism, overview <115>; #6# structurereactivity studies and  reaction mode, acid-base catalysis of hydride transfer, overview <105>;  #53# revolving door reaction mechanism, Tyr149 is the base catalyst for  hydride transfer, overview. The enzyme undergoes a conformational  change upon binding of the UDP sugar, which is in fact a result of the  binding of the UMP-moiety of the substrate. The conserved lysine from  the YxxxK motif plays an important role in the activation of the  cofactor, as due to the conformational change, the 6-ammonium group is  hydrogen-bonded to both the 2- and 3-hydroxylgroups of the nicotinamide  riboside of NAD+ <115>)  "
5.1.3.20," ADP-D-glycero-D-manno-heptose = ADP-L-glycero-D-manno-heptose (#7#  catalytic one-base reaction mechanism from docking study, overview. The  key point in the catalytic process of AGME is the inversion at the C6  stereocentre of ADP-D,D-Hep mediated by the reversible redox reactions  of NADP+/NADPH <17>)  "
5.1.3.21, alpha-maltose = beta-maltose  
5.1.3.22, L-ribulose 5-phosphate = L-xylulose 5-phosphate  
5.1.3.23," UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate =  UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate  "
5.1.3.24, N-acetyl-alpha-neuraminate = N-acetyl-beta-neuraminate 
5.1.3.24, N-acetyl-alpha-neuraminate = aceneuramate 
5.1.3.24, aceneuramate = N-acetyl-beta-neuraminate  
5.1.3.25, dTDP-6-deoxy-beta-L-talose = dTDP-beta-L-rhamnose  
5.1.3.26," N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol =  N-acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol  "
5.1.3.27, dTDP-4-dehydro-6-deoxy-alpha-D-glucose =  dTDP-4-dehydro-6-deoxy-alpha-D-gulose  
5.1.3.28," UDP-2-acetamido-2,6-dideoxy-beta-L-talose =  UDP-N-acetyl-beta-L-fucosamine  "
5.1.3.29, alpha-L-fucopyranose = beta-L-fucopyranose  
5.1.3.3," alpha-D-glucose = beta-D-glucose (#5# the mechanism of the  enzymatically catalyzed mutarotation is basically different from that  of the nonenzymatically catalyzed mutarotation. The mutarotase acts  primarily as a base catalyst. The enzymatically catalyzed mutarotation  proceeds via the acyclic aldehyde form of the aldose <5>; #10# Trp is  involved as glucose-binding site and catalysis of the mutarotation  reaction is accomplished by a ring-distortion type of mechanism <7>;  #14# reaction mechanism does not involve dehydration, any  dehydrogenation reaction on carbon-bound hydrogen, or the hydrated  derivative of glucose aldehyde, nor is a single displacement mechanism  involved. The enzyme-catalyzed mutarotation is essentially similar to  the spontaneous or acid catalyzed process. Mutarotase is an enzyme with  a proton-transferring function #2# <4>; #5# concerted general  acid/general base mechanism <26>; #6# E307 and H176 may act as  catalytic acid and catalytic base, respectively <32>; #33# mechanism,  one of the catalytic groups H104, H175, or E309, shuttles a proton to  and from the endocyclic oxygen and the other two shuttle protons to the  anomeric oxygen atoms. Ring opening of alpha-D-glucose limits the rate  at low pH, but ring closure does not become rate limiting at pH up to  8.5 <27>; #16# residues E304 and H170 are critical for catalysis and  H96 and D243 are important for substrate positioning <34>; #16#  residues responsible for anchoring the sugar include R71, H96, H170,  D243 and E304. E304 may act as general acid/base <30>)  "
5.1.3.30, D-psicose = D-fructose  
5.1.3.31, D-psicose = D-fructose (#2# (2) <2>) 
5.1.3.31, D-tagatose = D-sorbose (#2# (1) <2>)  
5.1.3.32, alpha-L-rhamnopyranose = beta-L-rhamnopyranose  
5.1.3.33, 2-epi-5-epi-valiolone = 5-epi-valiolone (#1# proposed reaction  mechanism <1>)  
5.1.3.34," a 1,2-diacyl-3-O-(beta-D-glucopyranosyl)-sn-glycerol = a  1,2-diacyl-3-O-(beta-D-galactopyranosyl)-sn-glycerol  "
5.1.3.35, 2-epi-5-epi-valiolone 7-phosphate = 5-epi-valiolone 7-phosphate  
5.1.3.36, [heparosan]-D-glucuronate = [acharan]-L-iduronate  
5.1.3.37, [mannuronan]-beta-D-mannuronate = [alginate]-alpha-L-guluronate (#1#  beta-elimination mechanism <4>)  
5.1.3.38, D-erythrulose 1-phosphate = L-erythrulose 1-phosphate  
5.1.3.4, L-Ribulose 5-phosphate = D-xylulose 5-phosphate (#5# mechanism does not  involve oxidation-reduction at carbon 4 <7>; #4# intramolecular  hydrogen transfer <1>)  
5.1.3.40, D-tagatose 6-phosphate = D-fructose 6-phosphate  
5.1.3.41, N6-(D-fructosyl)-L-lysine = N6-(D-psicosyl)-L-lysine  
5.1.3.42, D-glucosamine 6-phosphate = D-galactosamine 6-phosphate  
5.1.3.43, 6-sulfo-alpha-D-quinovose = 6-sulfo-beta-D-quinovose  
5.1.3.44, beta-D-mannopyranose = beta-D-glucopyranose  
5.1.3.5, UDP-L-arabinose = UDP-D-xylose  
5.1.3.6, UDP-glucuronate = UDP-D-galacturonate (#7# formation of a 4-keto  intermediate <3>)  
5.1.3.7, UDP-N-acetyl-alpha-D-glucosamine = UDP-N-acetyl-alpha-D-galactosamine  (#26# reaction mechanism of KfoA <28>)  
5.1.3.8," N-acyl-D-glucosamine = N-acyl-D-mannosamine (#15,16# various amino acid  residues of the enzyme are involved in the reaction mechanism <28>)  "
5.1.3.9, N-acyl-D-glucosamine 6-phosphate = N-acyl-D-mannosamine 6-phosphate  
5.1.99.1," (R)-methylmalonyl-CoA = (S)-methylmalonyl-CoA (#5# with  (2R)-methylmalonyl-CoA as substrate: two enzyme bases act respectively  as proton donor and acceptor, the release of product is slow, and the  reprotonation step on the enzyme is reversible, without leading to  isotopic exchange with the solvent <2>; #3# mechanism involving loss of  the alpha-hydrogen atom with subsequent incorporation of a proton from  the medium <6>; #5# enzyme acts to labilize the proton on the tertiary  carbon atom of methylmalonyl-CoA, and thus causes a rapid exchange of  this proton with those of water <7>; #5# two enzyme bases are involved  in catalysis. One base removes the proton from the substrate, the  second provides the new proton. There is no fast isotopic exchange  between enzyme-bound intermediates and solvent protons <3>)  "
5.1.99.2, 16alpha-Hydroxysteroid = 16beta-hydroxysteroid  
5.1.99.3, (S)(+)-Allantoin = (R)(-)-allantoin (#1# mechanism of enzymic  racemization differs from that of non-enzymic racemization <1>)  
5.1.99.4," (2S)-2-methylacyl-CoA = (2R)-2-methylacyl-CoA (#9# reaction mechanism,  overview, the catalysis of the 1,1-proton transfer by  alpha-methyl-acyl-CoA racemase is coupled to a movement of the fatty  acyl moiety over a hydrophobic, methionine-rich surface, the mechanism  involves the acid/base-pair residues His126 and Asp156, active site  geometry, the thioester oxygen atom and the 2-methyl group are in a  cisconformation with respect to each other, the thioester oxygen atom  fits into an oxyanion hole and the 2-methyl group points into a  hydrophobic pocket, Asp127A is a prominent residue in the active site  and is located at the bottom of the catalytic site <25>)  "
5.1.99.5, D-5-monosubstituted hydantoin = L-5-monosubstituted hydantoin (#3#  keto-enol automerism of 5-monosubstituted hydantoins is responsible for  racemization <4>; #1# two-base mechanism for the racemization of  5-monosubstituted hydantoins <12>)  
5.1.99.6," (6R)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide  = (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide "
5.1.99.6," (6R)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide  phosphate = (6S)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine  dinucleotide phosphate  "
5.1.99.7," 7,8-dihydroneopterin 3'-triphosphate = 7,8-dihydromonapterin  3'-triphosphate (#1# reaction mechanism of the epimerase, overview. The  reaction can be initiated by protonation of N-5 followed by  deprotonation at the acidic C-19 of dihydroneopterin- or  dihydromonapterin-type substrates. Epimerization at C-2 might result  from reversal of the cleavage reaction without stereochemical control  <1>)  "
5.1.99.8," 7,8-dihydroneopterin = 7,8-dihydromonapterin  "
5.2.1.1, Maleate = fumarate  
5.2.1.10," cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide =  trans-2-chloro-4-carboxymethylenebut-2-en-1,4-olide  "
5.2.1.12," 9,15,9'-tricis-zeta-carotene = 9,9'-dicis-zeta-carotene  "
5.2.1.13," 7,9,7',9'-tetracis-lycopene = all-trans-lycopene (#1# the mechanism of  isomerization relies on acid-base catalysis <1>)  "
5.2.1.14," all-trans-beta-carotene = 9-cis-beta-carotene (#4# mechanism of  isomerization catalysed by OsD27 involving a 1-electron transfer from  the polyene p-system of beta-carotene to a [2Fe2S] cluster, generating  a radical cation, which is able to rotate about the C-C single bond.  Electron transfer back from the reduced [2Fe2S] cluster then generates  the 9-cis-beta-carotene product. A mechanism involving single electron  transfer from a [2Fe2S] cluster to form a radical anion intermediate is  also possible. OsD27 retains catalytic activity under anaerobic  conditions, therefore it does not require dioxygen for activity <4>)  "
5.2.1.2," 4-Maleylacetoacetate = 4-fumarylacetoacetate (#12# ordered sequence of  binding: maleylacetone first followed by glutathione <6>; #12#  mechanism, preferred binding order is maleylacetone followed by  glutathione <5>; #15# tyrosine degradation leads to the formation of  homogentisate, maleylacetoacetate isomerase, homogentisate dioxygenase  and fumarylacetoacetate hydrolase are expressed in Arabidopsis thaliana  to generate fumarate and acetoacetate <19>)  "
5.2.1.4, 3-Maleylpyruvate = 3-fumarylpyruvate  
5.2.1.5," 9-cis,12-cis-octadecadienoate = 9-cis,11-trans-octadecadienoate (#6,7#  mechanism of the biocatalysis of linoleic acid to conjugated linoleic  acid, which are a group of geometrical and positional isomers of  linoleic acid with conjugated double bonds <7>)  "
5.2.1.6, (E)-2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide =  (Z)-2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (#2# mechanism <1>)  
5.2.1.8," peptidylproline (omega=180) = peptidylproline (omega=0) (#8# the  refolding mechanism is similar in the presence and absence of the  enzyme <7>; #9# mechanism that involves distortion of bound substrate  with a twisted, 90Â° , peptidyl-propyl amide bond <33>; #11# covalent  mechanism which involves an approximately tetravalent carbon of the  prolyl imidic bond for the transition state of reaction <6>; #49#  simple twisted amide transition state catalytic mechanism, modeling,  overview. The serine carbonyl does not rehybridize from sp2 to sp3 in  the rate-determining step, ruling out a nucleophilic addition mechanism  <192>)  "
5.2.1.9," (2E,6E)-farnesol = (2Z,6E)-farnesol  "
5.3.1.1," D-Glyceraldehyde 3-phosphate = glycerone phosphate (#34# mechanism  <24>; #7# in situ magnetic resonance probes of the enzyme-bound  substrates to test the question of whether the equilibrium  concentrations are perturbed by the enzyme. In the exergonic conversion  of glycerinaldehyde 3-phosphate to dihydroxyacetone phosphate the high  discrimination against solvent isotope uptake is consistent with  chemistry protected by a water-tight active-site loop, therefore  introducing asymmetry into the reversible reaction <88>; #9# intrinsic  binding energy of the substrate phosphodianion group is utilized to  drive closing of the mobile loop and a protein conformational change  that leads to formation of an active site environment that is optimally  organized for stabilization of the transition state for proton transfer  from R-carbonyl carbon <77>; #73# upon binding of ligand, the side  chain of Glu167 flips from the inactive swung-out to the active  swung-in conformation. A concerted movement of loop 6 and loop 7 from  unliganded-open to liganded-closed is facilitated by the interactions  of the phosphate moiety with loop 7. Rotation of the Gly211-Gly212  peptide plane of 90Â° is involved in this concerted movement <75>; #9#  the active site of free enzyme, which has an open conformation needed  to allow substrate binding, adopts a closed conformation at the  enediolate-complex intermediate where the catalytic side chain is  sequestered from interaction with imidazole dissolved in D2O <105>;  #53# reaction mechanism via enediolate intermediate through proton  abstraction by the catalytic base Glu167, overview <129>)  "
5.3.1.12," D-Glucuronate = D-fructuronate (#4,6# reaction mechanism, overview <8>;  #5# reaction mechanisms in which an active site base abstracts the  proton from C2 of D-glucuronate to form a cisenediol intermediate. The  conjugate acid then transfers this proton to C1 of the cis-enediol  intermediate to form D-fructuronate <6>)  "
5.3.1.13, D-Arabinose 5-phosphate = D-ribulose 5-phosphate (#1# mechanism is  envisioned to involve an enediol intermediate <4>)  
5.3.1.14, L-rhamnopyranose = L-rhamnulose  
5.3.1.15, D-Lyxose = D-xylulose  
5.3.1.16," 1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D  ribosylamino)methylideneamino]imidazole-4-carboxamide =  5-[(5-phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5  phospho-beta-D-ribosyl)imidazole-4-carboxamide (#1# Amadori  rearrangement <1>; #2,6# enzyme catalyzes Amadori rearrangement of a  thermolabile aminoaldolase into the corresponding aminoketose, reaction  mechanism involving general acid-base catalysis and a Schiff base  intermediate is proposed <4>)  "
5.3.1.17," 5-dehydro-4-deoxy-D-glucuronate = 3-deoxy-D-glycero-2,5-hexodiulosonate  "
5.3.1.20, D-Ribose = D-ribulose  
5.3.1.21, 11-Deoxycorticosterone = 20-hydroxy-3-oxopregn-4-en-21-al (#11# the  reversible interconversion of the ketol and aldol forms of the  corticosteroid side chain is accompanied by epimerization at position  20 and 21 <3>)  
5.3.1.22, Hydroxypyruvate = 2-hydroxy-3-oxopropanoate  
5.3.1.23," S-methyl-5-thio-alpha-D-ribose 1-phosphate = S-methyl-5-thio-D-ribulose  1-phosphate (#8# catalytic reaction mechanism, structure-function  relationship, overview. Proposed reaction mechanism of M1Pi proceeds  via a cis-phosphoenolate intermediate and through the following steps:  (1) transfer of proton from Asp247 to the O4 atom of MTR-1-P, (2)  proton abstraction from C2 atom of the substrate by the thiolate anion  of Cys167 as well as cleavage of the C1-O4 bond, (3) simultaneous  proton abstraction from O2 atom by the deprotonated Asp247 and transfer  of proton from the thiol group of Cys167 to C1 atom, and (4) generation  of the product, MTRu-1-P <14>; #6# proposed reaction mechanism probably  including residue Asp240, overview <13>; #6# structure-function  analysis and catalytic mechanism, overview. Two variants of  isomerization mechanism are possible, the enediol and the hydride  transfer mechanism, overview <15>)  "
5.3.1.24," N-(5-phospho-beta-D-ribosyl)anthranilate =  1-(2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate (#3,4# kinetic  mechanism <11>; #3,4,29# catalytic mechanism <11,25>)  "
5.3.1.25, L-fucopyranose = L-fuculose (#2# protein environment suggests strongly  that the reaction belongs to the ene-diol type <13>)  
5.3.1.26, D-Galactose 6-phosphate = D-tagatose 6-phosphate  
5.3.1.27, D-arabino-hex-3-ulose 6-phosphate = D-fructose 6-phosphate  
5.3.1.28, D-sedoheptulose 7-phosphate = D-glycero-D-manno-heptose 7-phosphate  
5.3.1.29," alpha-D-ribose 1,5-bisphosphate = D-ribulose 1,5-bisphosphate  "
5.3.1.3, D-Arabinose = D-ribulose (#2# protein environment suggests strongly  that the reaction belongs to the ene-diol type <13>)  
5.3.1.30, 5-deoxy-D-glucuronate = 5-dehydro-2-deoxy-D-gluconate  
5.3.1.31, sulfoquinovose = 6-deoxy-6-sulfo-D-fructose  
5.3.1.32," (4S)-4-hydroxy-5-phosphooxypentane-2,3-dione =  3-hydroxy-5-phosphooxypentane-2,4-dione  "
5.3.1.33, L-erythrulose 1-phosphate = D-erythrulose 4-phosphate  
5.3.1.34, D-erythrulose 4-phosphate = D-erythrose 4-phosphate  
5.3.1.35, 2-dehydro-L-erythronate = 3-dehydro-L-erythronate 
5.3.1.35, 2-dehydro-D-erythronate = 3-dehydro-D-erythronate  
5.3.1.36, D-apiose = apulose  
5.3.1.4, L-Arabinose = L-ribulose (#4# proton transfer mechanism <14>; #13#  compulsory ordered mechanism that involves the formation of a ternary  complex of enzyme-Mn-substrate <8>)  
5.3.1.5, D-xylopyranose = D-xylulose  
5.3.1.6, D-Ribose 5-phosphate = D-ribulose 5-phosphate  
5.3.1.7, D-Mannose = D-fructose  
5.3.1.8," D-Mannose 6-phosphate = D-fructose 6-phosphate (#6# analysis of  enzyme-substrate and enzyme-inhibitor complexes by ESI-FTICR mass  spectrometry <28>; #53# cis-enediol mechanism <29>; #53# mechanism does  not involve trans-enediol. Instead, activity may result from additional  space in the active site which permits rotation of the C2-C3 bond <34>;  #7# hydride transfer mechanism of a alpha-hydrogen bond between the C1  and C2 positions of substrate. Mechanism involves Zn2+ mediating the  movement of a proton between O1 and O2, and the hydrophobic environment  formed in part by T278 promoting transfer of a hydride ion <42>; #48#  reaction mechanism, overview. Zn2+ binding induces structural order in  the loop consisting of residues 50-54. The metal atom appears to play a  role in substrate binding and is probably also important for  maintaining the architecture of the active site. Isomerization probably  follows a cis-enediol mechanism, overall folding pattern of the central  catalytic domain, overview <56>)  "
5.3.1.9," alpha-D-glucose 6-phosphate = beta-D-fructofuranose 6-phosphate (#69#  mechanism is based on an enediol intermediate <62>; #72# multistep  catalytic mechanism, model including catalytically active amino acids  <63>; #70# push-pull mechanism of ring opening in which H388 breaks the  O5-C1 bond by donating a proton, and simultaneously, K518 abstracts a  proton from the C1 hydroxyl group <61>; #69# cis-endiol intermediate  based mechanism with Glu97 acting as the catalytic base responsible for  isomerization <70>; #69# in hydride shift mechanism of catalysis Fe2+  is responsible for proton transfer between O1 and O2, and the hydride  shift between C1 and C2 is favored by a markedly hydrophobic  environment in the active site. The absence of any obvious enzymatic  machinery for catalyzing ring opening of the sugar substrates suggests  that the pyrococcal enzyme has a preference for straight chain  substrates <99>; #19# on the basis of the calculations and simulations,  a zwitterionic intermediate mechanism for the low-energy enzymatic  reaction is proposed, involving both proton and hydride transfers <97>)  "
5.3.2.1, Keto-phenylpyruvate = enol-phenylpyruvate  
5.3.2.2, keto-Oxaloacetate = enol-oxaloacetate  
5.3.2.3, dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose =  dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose  
5.3.2.4, dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose =  dTDP-3-dehydro-6-deoxy-alpha-D-glucopyranose  
5.3.2.5," 5-(methylsulfanyl)-2,3-dioxopentyl phosphate =  2-hydroxy-5-(methylsulfanyl)-3-oxopent-1-enyl phosphate (#1,2,4,7,8#  reaction mechanism, overview <3>; #1,9# structure-function relationship  and reaction mechanism, overview <2>)  "
5.3.2.6," (2Z,4E)-2-hydroxyhexa-2,4-dienedioate = (3E)-2-oxohex-3-enedioate (#4#  catalytic reaction mechanism, detailed overview <4>; #4# catalytic  reaction mechanism, detailed overview. Quantum mechanics/molecular  mechanics simulation of proton transfer reaction and structure-function  analysis, the ketonization mechanism in 4-OT depends on the enzymatic  model used, detailed overview <12>; #7# substrate specificity and  one-base molecular mechanism, overview <2>)  "
5.3.2.7," 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose =  1,5-anhydro-4-deoxy-D-glycero-hex-1-en-3-ulose  "
5.3.2.8," (1E)-4-oxobut-1-ene-1,2,4-tricarboxylate =  (1E,3E)-4-hydroxybuta-1,3-diene-1,2,4-tricarboxylate  "
5.3.3.1," a 3-oxo-DELTA5-steroid = a 3-oxo-DELTA4-steroid (#8# mechanism in which  the transition state for enolization is dienolate-like, characterized  by relatively little proton transfer from Tyr14 in the transition  state, and the intermediate in the overall reaction is dienol-like. An  alternative mechanism in which the intermediate is stabilized by a  short, strong hydrogen bond can also be consistent with the data <22>;  #8# ""flip-flop"" mechanism may be involved <11>; #7# catalytic  mechanism, phenolate binding to the oxyanion hole of ketosteroid  isomerase via hydrogen bonding, electrostatic contributions and  geometric and electrostatic changes, overview, the KSI reaction  involves changes in both geometry and charge distribution as the  reaction proceeds from its ground state to its intermediate <66>; #8#  catalytic mechanism, phenolate binding to the oxyanion hole of  ketosteroid isomerase via hydrogen bonding, electrostatic contributions  and geometric and electrostatic changes, overview, the KSI reaction  involves changes in both geometry and charge distribution as the  reaction proceeds from its ground state to its intermediate, Tyr16 and  Asp103 are important in catalysis <66>; #6# two-step reaction first,  Asp38 acts as a base, abstracting the 4beta-H atom from C-4 of the  steroid to form a dienolate as the intermediate, next, the intermediate  is reketonized by proton transfer to the 6beta-position, each step goes  through its own transition state, catalytic mechanism, theoretical  model involving residues Tyr14, Asp38 and Asp99 <67>; #8# enzyme  enhances the coupled motion/hydrogen tunneling contribution to the rate  acceleration over the solution reaction <71>)  "
5.3.3.10," 5-carboxymethyl-2-hydroxymuconate =  (3E,5R)-5-carboxy-2-oxohept-3-enedioate (#1# mechanism <5>)  "
5.3.3.11," Isopiperitenone = piperitenone (#1# double bond migration catalyzed by  this enzyme involves an intramolecular 1,3-hydrogen transfer <1>)  "
5.3.3.12," L-dopachrome = 5,6-dihydroxyindole-2-carboxylate (#1# mechanism <9>)  "
5.3.3.13," (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate =  (5Z,7E,9E,14Z,17Z)-icosapentaenoate (#2# mechansim of hydrogen  transfers in the isomerization reaction including a diene intermediate  <3>; #2# regio- and stereochemistry of the isomerization reaction,  mechanism <1>)  "
5.3.3.14," a trans-dec-2-enoyl-[acyl-carrier protein] = a  cis-dec-3-enoyl-[acyl-carrier protein] (#1# the reactions of EC  4.2.1.60 and EC 5.3.3.14 are carried out by the same active site  carrying a His and a Asp residue in a hydrophobic environment <10>; #1#  reaction of EC4.2.1.60 and isomerization reaction, both catalyzed by  the enzyme, share the common intermediate, enzyme-bound  alpha,beta-decenoate <8>)  "
5.3.3.17," (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxyate =  (1R,6S)-6-amino-5-oxocyclohex-2-ene-1-carboxylate  "
5.3.3.18," 2-(1,2-epoxy-1,2-dihydrophenyl)acetyl-CoA =  2-oxepin-2(3H)-ylideneacetyl-CoA  "
5.3.3.19," 3-[(4R)-4-hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate =  3-[(1E,4R)-4-hydroxycyclohex-2-en-1-ylidene]-2-oxopropanoate (#2# (2)  <3>)  "
5.3.3.2," Isopentenyl diphosphate = dimethylallyl diphosphate (#50# catalytic  mechanism in which a cysteine initiates the reaction by protonating the  carbon-carbon double bond, with the antarafacial rearrangement  ultimately achieved by one of the glutamates involved in the metal  coordination sphere <32>; #50# reaction involves protonation and  deprotonation of the isoprenoid unit and proceeds through a  carbocationic transition state. Glu116/Tyr104 and Cys67 are involved in  the antarafacial addition/elimination of protons during isomerization  <37>; #5# the mechanism of isomerizaion reaction involves protonation  of the unactivated carbon-carbon double bond in the substrate, Glu116  is involved in the protonation step and Cys67 is involved in the  elimination step <39>; #42# interconversion of substrate is catalyzed  by a stereoselective antarafacial [1.3] transposition of a proton  involving residues C87, E149, W197 and Y137 <55>; #2# in the rate  determining step, the C2-H bond of isopentenyl diphosphate is cleaved.  General acid/base catalysis may be involved during turnover <58>)  "
5.3.3.21," a (3E,5Z)-alka-3,5-dienoyl-CoA = a (2E,4E)-alka-2,4-dienoyl-CoA  "
5.3.3.22, lutein = meso-zeaxanthin  
5.3.3.23," S-methyl-5-thio-D-ribulose 1-phosphate = S-methyl-1-thio-D-xylulose  5-phosphate (#1# (1), the enzyme from Rhodospirillum rubrum catalyzes  an isomerization reaction (overall 1,3-proton transfer reaction,  likely, two 1,2-proton transfer reactions) that converts  5-methylthio-D-ribulose 1-phosphate to a 3:1 mixture of  1-methylthioxylulose 5-phosphate and 1-methylthioribulose 5-phosphate  <1>) "
5.3.3.23," S-methyl-5-thio-D-ribulose 1-phosphate = S-methyl-1-thio-D-ribulose  5-phosphate (#1# (2), the enzyme from Rhodospirillum rubrum catalyzes  an isomerization reaction (overall 1,3-proton transfer reaction,  likely, two 1,2-proton transfer reactions) that converts  5-methylthio-D-ribulose 1-phosphate to a 3:1 mixture of  1-methylthioxylulose 5-phosphate and 1-methylthioribulose 5-phosphate  <1>)  "
5.3.3.3, vinylacetyl-CoA = (E)-but-2-enoyl-CoA (#8# mechanism <4>)  
5.3.3.4," (+)-muconolactone = (4,5-dihydro-5-oxofuran-2-yl)-acetate (#1,2#  stereochemical course <9>)  "
5.3.3.5, 5alpha-Cholest-7-en-3beta-ol = 5alpha-cholest-8-en-3beta-ol  
5.3.3.6," methylitaconate = 2,3-dimethylmaleate  "
5.3.3.7," trans-aconitate = cis-aconitate (#9# a single catalytic base is found  on the enzyme surface, the mechanism involves deprotonation to form a  carbanion <1,3>)  "
5.3.3.8, a (3Z)-alk-3-enoyl-CoA = a (2E)-alk-2-enoyl-CoA 
5.3.3.8, a (3E)-alk-3-enoyl-CoA = a (2E)-alk-2-enoyl-CoA  
5.3.3.9," (13E)-(15S)-15-hydroxy-9-oxoprosta-10,13-dienoate =  (13E)-(15S)-15-hydroxy-9-oxoprosta-11,13-dienoate  "
5.3.4.1," catalyses the rearrangement of -S-S- bonds in proteins (#6,10,11,14#  mechanism <1,60>; #9# reaction mechanism <145>; #13# active site  structure <117>; #7,9,21,73,84# substrate binding and catalytic  mechanism <156>; #13# active site location, structure, and redox state  <109>; #9,10,11,14# disulfide formation and isomerization mechanism by  domains a and a, during transfer of oxidizing or reducing equivalents  to substrates, the CXXC active site cycles between its oxidized,  disulfide and reduced, thiol states <107>; #13# PDI introduces  disulfides into proteins, oxidase activity, and provides quality  control by catalyzing the rearrangement of incorrect disulfides,  isomerase activity <114>; #9# protein with nonconsecutive disulfie  bonds require activity of DsbC for their full activity, the disulfide  bonds are formed during the translocation across the cytoplasmic  membrane <116>; #9# structure of oxidized and reduced active site, the  active site motif is -C-X-X-C- <104>; #9# the catalytic domain,  residues 88-231, shows a thioredoxin fold with a helical insert, and an  active site motif -C-X-X-C-, active site structure <123>; #64#  mechanism of enzyme-assisted folding of plant cyclotides <146>; #73#  the nucleophilic C36 thiol of the protein disulfide isomerase a domain  is positioned over the N-terminus of the alpha2 helix. The H38 amide in  the reduced enzyme exhibits a maximum rate of exchange at pH 5 due to  efficient general base catalysis by the neutral imidazole of its own  side chain and suppression of its exchange by the ionization of the C36  thiol. Ionization of this thiol and deprotonation of the H38 side chain  suppress the C39 amide hydroxide-catalyzed exchange by a million-fold.  The electrostatic potential within the active site stabilizes the two  distinct transition states that lead to substrate reduction and  oxidation <168>)  "
5.3.99.10," 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate =  2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate (#1# reaction  mechanism, overview <1>)  "
5.3.99.11," 2,4,6/3,5-pentahydroxycyclohexanone =  2D-2,3,5/4,6-pentahydroxycyclohexanone  "
5.3.99.12, (E)-alk-1-en-1-SO-peroxol = (Z)-alkanethial oxide  
5.3.99.2," (5Z,13E,15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate =  (5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate  "
5.3.99.3," (13E)-(15S)-15-hydroxy-9-oxoprosta-10,13-dienoate =  (13E)-(15S)-15-hydroxy-9-oxoprosta-11,13-dienoate "
5.3.99.3," (5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate =  (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate (#22#  catalytic mechanism of mPGES-2, hydrogen bond-forming residues Y107,  C113, C110, and F112 are involved, substrate binding and catalytic  sites <23>)  "
5.3.99.4," (5Z,13E,15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate =  (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate  (#2,4,5# mechanism <2,18,19>; #4# prostaglandin endoperoxyde PGH2  prostacyclin PGI2 , a mechanism with the participation of a  heme-thiolate protein is proposed <8>; #8# radical-mediated  isomerizytion with high product fidelity <43>)  "
5.3.99.5," (5Z,13E)-(15S)-9alpha,11alpha-epidioxy-15-hydroxyprosta-5,13-dienoate =  (5Z,13E)-(15S)-9alpha,11alpha-epoxy-15-hydroxythromboxa-5,13-dienoate  (#3# mechanism <37>; #3# role of the thiolate ligand in the oxygen  activation mechanism <6>)  "
5.3.99.6," (9Z)-(13S)-12,13-epoxyoctadeca-9,11,15-trienoate =  (15Z)-12-oxophyto-10,15-dienoate (#6# reaction is promoted by  anchimeric assistance through a conserved Glu residue. The transition  state with a pentadienyl carbocation and an oxyanion is stabilized by a  strongly bound water molecule and favorable pi-pi interactions with  aromatic residues in the cavity <9>; #24,27,28# the transition state  with a pentadienyl carbocation and an oxyanion is stabilized by a  strongly bound water molecule and favorable pi-pi interactions with  aromatic residues in the cavity. Stereoselectivity results from steric  restrictions to the necessary substrate isomerizations imposed by the  protein environment <13>; #33,34# catalytic mechanism of AOC isozymes:  (1) a resting state of the apo enzyme with a closed conformation, (2) a  first shallow binding mode, followed by (3) a tight binding of the  substrate accompanied by conformational changes in the binding pocket,  and (4) initiation of the catalytic cycle by opening of the epoxide  ring. Cyclization of the allene oxide seems to be initiated by one  particular Glu residue in the active site of AOC that leads to an  opening of the epoxy ring, conformational changes, and a concerted  pericyclic ring closure <22>)  "
5.3.99.7, styrene oxide = phenylacetaldehyde  
5.3.99.8, violaxanthin = capsorubin 
5.3.99.8, antheraxanthin = capsanthin  
5.3.99.9, violaxanthin = neoxanthin  
5.4.1.1, 2-Lysolecithin = 3-lysolecithin  
5.4.1.3, 2-methylfumaryl-CoA = 3-methylfumaryl-CoA  
5.4.1.4," D-galactaro-1,5-lactone = D-galactaro-1,4-lactone  "
5.4.2.10, alpha-D-glucosamine 1-phosphate = D-glucosamine 6-phosphate  
5.4.2.11," 2-phospho-D-glycerate = 3-phospho-D-glycerate (#7# mechanism: after the  active site His-8 is phosphorylated by the cofactor  2,3-diphosphoglycerate a substrate molecule binds. Subsequently a  phospho-transfer takes place via a ping-pong-mechanism. After release  of the product the enzyme remains phosphorylated and catalytically  competent <14>; #7,9# ping-pong mechanism via a phosphorylated  His-intermediate <19>; #4# ping-pong or phosphoenzyme mechanism <45>;  #22# mechanism of BPGM begins with an unphosphorylated enzyme, the  active site histidine of which performs a nucleophilic SN2 attack on  the 1,3-bisphosphoglycerate substrate to produce phosphohistidine and  3-phosphoglycerate. The 2-hydroxyl group then performs a second  nucleophilic attack that transfers the phosphate from the active site  histidine to the substrate, forming 2,3-bisphosphoglycerate <60>) "
5.4.2.11," [enzyme]-L-histidine + 2,3-bisphospho-D-glycerate =  [enzyme]-Ntau-phospho-L-histidine + 2/3-phospho-D-glycerate "
5.4.2.11," [enzyme]-Ntau-phospho-L-histidine + 2-phospho-D-glycerate =  [enzyme]-L-histidine + 2,3-bisphospho-D-glycerate "
5.4.2.11," [enzyme]-L-histidine + 2,3-bisphospho-D-glycerate =  [enzyme]-Ntau-phospho-L-histidine + 3-phospho-D-glycerate "
5.4.2.11," [enzyme]-Ntau-phospho-L-histidine + 2/3-bisphospho-D-glycerate =  [enzyme]-L-histidine + 2,3-bisphospho-D-glycerate  "
5.4.2.12," 2-phospho-D-glycerate = 3-phospho-D-glycerate (#43# in the  phospho-D-glycerate-free state the enzyme assumes an open conformation.  Upon substrate binding the enzyme closes to the catalytically  functional conformation, in the closed form the enzyme catalyzes  2/3-phospho-D-glycerate isomerization resulting in product release.  Product release causes opening of the enzyme and return to the open  conformation <34>)  "
5.4.2.13, D-galactosamine 6-phosphate = alpha-D-galactosamine-1-phosphate  
5.4.2.2," alpha-D-glucose 1-phosphate = D-glucose 6-phosphate (#7# in the forward  reaction a phosphate from the enzyme is transferred to C-6 of glucose  1-phosphate which results in a dephosphoenzyme intermediate. In the  second step phosphate from the C-1 of glucose is transferred to the  enzyme for its regeneration. The reverse reaction proceeds via a  similar mechanism <20>; #24# ping-pong mechanism <32>; #7# reaction  sequence <1>; #15# acid-base catalysis mechanism, key role for  conformational change in its multistep reaction, which requires a  dramatic 180 degree reorientation of the intermediate within the active  site. Modeling shows that increased enzyme flexibility facilitates the  reorientation of the reaction intermediate, coupling changes in  structural dynamics with the unique catalytic mechanism of this enzyme  <75>; #15# acid-base catalysis mechanism, overview. His329 is  appropriately positioned to abstract a proton from the O1/O6 hydroxyl  of the phosphosugar substrates, and thus may serve as the general base  in the reaction <72>)  "
5.4.2.3," N-acetyl-alpha-D-glucosamine 1-phosphate = N-acetyl-D-glucosamine  6-phosphate (#2# ping-pong mechanism <2>; #11# the N-acetyl group of  the substrate is recognized by V370 and N389 in domain 3, from which  the substrate specificity arises. Substrate rotates about 180Â° on the  axis linking C4 and the midpoint of the C5-O5 bond in the reaction <14>)  "
5.4.2.4," 3-phospho-D-glyceroyl phosphate = 2,3-bisphospho-D-glycerate (#3#  mechanism <1>)  "
5.4.2.5, alpha-D-glucose 1-phosphate = D-glucose 6-phosphate  
5.4.2.6," beta-D-Glucose 1-phosphate = beta-D-glucose 6-phosphate (#10# a single  Mg2+ coordination site accomodates water, phosphate, and the  phosphorane intermediate during catalytic turnover. Bi-bi ping-pong  mechanism, substrate induced-fit mechanism allows phosphomutase  activity to dominate over the intrinsic phosphatase activity <12>; #10#  mechanism is a nucleophilic substitution via an associative pathway,  enzyme stablizes the phosphorane intermediate along that pathway <13>;  #3# phosphoryl transfer rather than ligand binding is rate-limiting.  Beta-D-glucose 1,6-bisphosphate is a reaction intermediate and binds to  the active site in two different orientations with roughly the same  efficiency. Reorientation of the beta-D-glucose 1,6-bisphosphate  intermediate occurs by diffusion into solvent followed by binding in  the opposite orientation <14>; #3# reaction mechanism of the phosphoryl  transfer starting from the bisphosphate intermediate  beta-D-glucose-1,6-(bis)phosphate in both directions of the reversible  reaction, overview. The calculated energy barrier of the reaction for  the beta-D-glucose 1-phosphate to beta-D-glucose 1,6-diphosphate step  is only slightly higher than for the beta-G1,6diP to beta-G6P step.  Residues Ser114 and Lys145 and Mg2+ play important roles in stabilizing  the large negative charge on the phosphate through strong coordination  with the phosphate oxygens and guiding the phosphate group throughout  the catalytic process <21>)  "
5.4.2.7, alpha-D-ribose 1-phosphate = D-ribose 5-phosphate  
5.4.2.8," alpha-D-glucose 1-phosphate = D-glucose 6-phosphate (#11# acid-base  catalysis mechanism, key role for conformational change in its  multistep reaction, which requires a dramatic 180 degree reorientation  of the intermediate within the active site. Modeling shows that  increased enzyme flexibility facilitates the reorientation of the  reaction intermediate, coupling changes in structural dynamics with the  unique catalytic mechanism of this enzyme <46>) "
5.4.2.8," alpha-D-mannose 1-phosphate = D-mannose 6-phosphate (#12,13# the  cosubstrate glucose-1,6-diphosphate is converted to the corresponding  sugar monophosphate while the substrate is converted to the sugar  biphosphate in each reaction cycle <13>; #1# enzyme is activated by  transfer of a phosphate group from mannose-1,6-diphosphate <13>)  "
5.4.2.9," phosphoenolpyruvate = 3-phosphonopyruvate (#1,4,5,8# mechanism  <7,10,13,16,19>; #1# stereochemistry <11,12>)  "
5.4.3.10," L-phenylalanine = L-beta-phenylalanine (#2,4,6,7# (R)-selective PAM  reaction mechanism, overview <4>)  "
5.4.3.11," L-phenylalanine = D-beta-phenylalanine (#3# reaction mechanism,  detailed overview. Proposed elimination mechanisms for the displacement  of the NH2-MIO adduct. The final reaction sequence of the MIO-dependent  aminomutases involves an alpha,beta-addition reaction, where the  NH2-MIO and a proton add across the double bond of the acrylate  intermediate. Alternatively, PaPAM can use a stepwise addition sequence  where the nucleophile (NH2-MIO) couples to form a 1,4-Michael adduct.  This conjugate addition route benefits from an electropositive (delta+)  Cbeta by delocalizing the Pi-electrons toward the carboxylate of the  substrate <5>; #3# the proposed mechanism of action of PaPAM: starting  from either direction with the cooperation of two catalytically  essential tyrosine residues (Tyr1 and Tyr2) and the MIO prosthetic  group, N-MIO intermediates of alpha- or beta-phenylalanine are formed  which interconvert by a alpha - beta migration of the amino group  involving a postulated (E)-cinnamate intermediate. PaPAM-catalysed  kinetic resolutions starting from racemic alpha-arylalanines or racemic  beta-arylalanines result in the opposite enantiomers as products vs.  unreacted enantiomers. Mechanism, overview. Formation of significant  amounts of (E)-arylacrylates is observed with many substrates  indicating substantial lyase-activity of enzyme PaPAM <8>)  "
5.4.3.2," L-lysine = (3S)-3,6-diaminohexanoate (#4,6# mechanism <9,10,11>; #6#  reaction proceeds by a substrate radical rearrangement mechanism, in  which the external aldimine formed between pyridoxal phosphate and Lys  is initially converted into a lysyl-radical intermediate by hydrogen  abstraction from C3 <14>; #6# only the migrating (3-pro-R) hydrogen of  alpha-Lys is involved in the intermolecular exchange <10>; #4# lysine  radicals participate in the rearrangement mechanism <20>; #4# evidence  for participation of pyridoxal 5-phosphate in a radical rearrangement,  formation of an aldimine linkage between the pyridoxal 5-phosphate and  the beta-nitrogen of (3S)-3,6-diaminohexanoic acid <18>; #4# mechanism  of radical rearrangement in the reaction <13>; #6# substantially or  completely intermolecular hydrogen transfer <5>; #4# activation of the  enzyme may involve a transformation of S-adenosylmethionine into a form  that promotes the generation of an adenosyl-5 free radical, which  abstracts hydrogen from Lys to form 5-deoxyadenosine as an intermediate  <17>; #4# structure of a substrate radical intermediate in the reaction  <19>; #4# formation of substrate radicals as intermediates <11>; #6#  the active site facilitates hydrogen atom transfer by enforcing van der  Waals contact between radicals and their reacting partners thus  minimizing side reactions of the highly active species <33>; #2# LAM  catalytic cycle and reaction intermediate analysis for lysine  2,3-aminomutase <40>; #9# lysine 2,3-aminomutase (LAM) is a radical  S-adenosyl-L-methionine (SAM) enzyme, catalysis is initiated by  reductive cleavage of the S-adenosyl-L-methionine S-C5 bond, which  creates the highly reactive 5-deoxyadenosyl radical, the same radical  generated by homolytic Co-C bond cleavage in B12 radical enzymes. The  S-adenosyl-L-methionine surrogate S-3,4-anhydroadenosyl-L-methionine  can replace S-adenosyl-L-methionine as a cofactor in the isomerization  of L-alpha-lysine to L-beta-lysine by 2,3-LAM, via the stable allylic  anhydroadenosyl radical. The holoenzyme coordinates a pyridoxal  5-phosphate cofactor through formation of an internal aldimine with  Lys337. As L-alpha-lysine binds, pyridoxal 5-phosphate forms an  external aldimine linkage to the alpha-amine group of the substrate.  Reductive cleavage of S-adenosyl-L-methionine leads to formation of  5-dA radical. Electron transfer from the [4Fe4S]1+ cluster initiates  radical S-adenosyl-L-methionine reactions by reductive cleavage of the  S-C5 bond to create the highly reactive 5-deoxyadenosyl radical  <42>;  #9# lysine 2,3-aminomutase catalyzes S-adenosylmethionine and pyridoxal  5-phosphate-dependent interconversion of L-lysine and L-beta-lysine,  the reaction follows the pattern of adenosylcobalamin-dependent  rearrangements, with hydrogen transfer from lysine through the  adenosyl-C5 of S-adenosyl-L-methionine to beta-lysine.  S-Adenosyl-L-methionine is cleaved to form 5-deoxyadenosine-5-yl  followed by abstraction of C3(H) from  pyridoxal-5-phosphate-alpha-lysine aldimine to form PLP-R-lysine-3-yl.  Pyridoxal 5-phosphate-alpha-lysine-3-yl isomerizes to  pyridoxal-beta-lysine-2-yl, and a hydrogen abstraction from  5-deoxyadenosine regenerates 5-deoxyadenosine-5-yl and releases  beta-lysine, 4 radicals in the reaction. Identification of radical  intermediates. Reaction mechanism, detailed overview <41>)  "
5.4.3.3," (3S)-3,6-diaminohexanoate = (3S,5S)-3,5-diaminohexanoate (#1# steric  course and mechanistic aspects <5>; #1,3# catalytic mechanism, overview  <18>; #4# reaction mechanism, detailed overview <21>; #1,2# catalytic  mechanism, the closed-state of the enzyme is required to bring the  cofactors adenosylcobalamin and pyridoxal 5-phosphate and the substrate  into proximity for the radical-mediated 1,2-amino group migration. This  process is achieved by transaldimination of the pyridoxal  5-phosphate-Lys144beta internal aldimine with the pyridoxal  5-phosphate-substrate external aldimine <20>; #1# radical catalytic  mechanism <17>; #1# radical stabilization is crucial in the mechanism  of action of lysine 5,6-aminomutase, role of Tyr263alpha. The enzyme  utilizes free radical intermediates to mediate 1,2-amino group  rearrangement, during which an elusive high-energy aziridincarbinyl  radical is proposed to be central in the mechanism of action. The  aziridincarbinyl radical acts either as a spin-relay device or serves  as an anchor for the pyridine ring of pyridoxal-5 -phosphate through  aromatic PI-stacking interactions during spin transfer, detailed  overview <19>; #4# in the first step of the proposed catalytic cycle  the enzyme accepts the substrate in the open state. Substrate  interactions with the active site residues initiate an external  aldimine formation with PLP breaking the pyridoxal  5-phosphate-lys144beta internal aldimine, which results in two  simultaneous events: (1) the domain motion brings dAdoCbl close to the  pyridoxal 5-phosphate-substrate adduct and locks the enzyme in the  catalytically active closed state and (2) cleavage of the Co-C bond of  dAdoCbl generates the 5-deoxyadenosyl radical and cob(II)alamin.  Hydrogen abstraction by 5-deoxyadenosyl radical from the substrate  generates deoxyadenosine and the substrate related radical that  undergoes radical isomerization via a hypothetical  azacyclopropylcarbinyl radical to afford the product related radical.  Hydrogen abstraction by the product related radical from deoxyadenosine  generates the product-pyridoxal 5-phosphate adduct and 5-deoxyadenosyl  radical. Finally, transition from the closed state to open state  occurs, which allows the release of the product and reformation of  dAdoCbl and the internal aldimine <23>) "
5.4.3.3," D-lysine = (2R,5S)-2,5-diaminohexanoate (#1,3# catalytic mechanism,  overview <18>; #1,2# catalytic mechanism, the closed-state of the  enzyme is required to bring the cofactors adenosylcobalamin and  pyridoxal 5-phosphate and the substrate into proximity for the  radical-mediated 1,2-amino group migration. This process is achieved by  transaldimination of the pyridoxal 5-phosphate-Lys144beta internal  aldimine with the pyridoxal 5-phosphate-substrate external aldimine  <20>; #1# radical stabilization is crucial in the mechanism of action  of lysine 5,6-aminomutase, role of Tyr263alpha. The enzyme utilizes  free radical intermediates to mediate 1,2-amino group rearrangement,  during which an elusive high-energy aziridincarbinyl radical is  proposed to be central in the mechanism of action. The aziridincarbinyl  radical acts either as a spin-relay device or serves as an anchor for  the pyridine ring of pyridoxal-5 -phosphate through aromatic  PI-stacking interactions during spin transfer, detailed overview <19>)  "
5.4.3.5," D-ornithine = (2R,4S)-2,4-diaminopentanoate (#1# catalytic mechanism,  overview <10>; #9# mechanism, overview, a gradual weakening of the  electrostatic energy between the protein and the ribose leads to a  progressive increase in the activation energy barrier for  adenosylcobalamin Co-C bond homolysis, key role for the conserved polar  glutamate residue in controlling the initial generation of radical  species <8>; #8# mechanism, overview, a gradual weakening of the  electrostatic energy between the protein and the ribose leads to a  progressive increase in the activation energy barrier for  adenosylcobalamin Co?C bond homolysis, key role for the conserved polar  glutamate residue in controlling the initial generation of radical  species <8>; #1# radical-based catalysis mechanism, closed, active  enzyme form modeling, overview <11>; #9# radical-based catalysis that  is initiated and propagated by the enzymes adenosylcobalamin and  pyridoxal 5-phosphate cofactors. Following transaldimination, the Co-C  bond of adenosylcobalamin undergoes homolytic rupture, generating a  highly reactive carbon-centered 5-deoxyadenosyl radical and  cob(II)alamin. The 5-deoxyadenosyl radical abstracts the C4 hydrogen  atom from the D-ornithinyl-pyridoxal 5-phosphate aldimine producing a  substrate radical, which undergoes internal addition to the imine N to  form an aziridylcarbinyl-pyridoxal 5-phosphate radical adduct. Ring  opening leads to formation of a product-like radical intermediate 3,  which reabstracts a hydrogen atom from 5-deoxyadenosine.  Adenosylcobalamin is reformed with geminate recombination between the  5-deoxyadenosyl radical and cob(II)alamin. Release of product from  pyridoxal 5-phosphate completes the catalytic cycle <9>; #8#  radical-based catalysis that is initiated and propagated by the enzymes  adenosylcobalamin and pyridoxal 5-phosphate cofactors. Following  transaldimination, the Co-C bond of adenosylcobalamin undergoes  homolytic rupture, generating a highly reactive carbon-centered  5-deoxyadenosyl radical and cob(II)alamin. The 5-deoxyadenosyl radical  abstracts the C4 hydrogen atom from the D-ornithinylÂ–pyridoxal  5-phosphate aldimine producing a substrate radical, which undergoes  internal addition to the imine N to form an aziridylcarbinyl-pyridoxal  5-phosphate radical adduct. Ring opening leads to formation of a  product-like radical intermediate 3, which reabstracts a hydrogen atom  from 5-deoxyadenosine. Adenosylcobalamin is reformed with geminate  recombination between the 5-deoxyadenosyl radical and cob(II)alamin.  Release of product from pyridoxal 5-phosphate completes the catalytic  cycle <9>; #13# catalytic mechanism of ornithine 4,5-aminomutase.  Substrate binding results in formation of a Schiff base between the  terminal amino group of the substrate and the imine nitrogen of the PLP  cofactor. Subsequent homolysis of the Co-C bond generates cob(II)alamin  and the highly reactive 5-deoxyadenosyl radical, which abstracts a  hydrogen atom from the C4 of the substrate. The substrate radical  intermediate then rearranges to the product-like radical intermediate  via a proposed cyclic intermediate. Re-abstraction of a hydrogen atom  from 5-deoxyadenosine regenerates the 5-deoxyadenosyl radical. Product  release and recombination between cob(II)alamin and the 5-deoxyadenosyl  radical completes the catalytic cycle <13>; #13# catalytic mechanism,  detailed overview. The substrate forms a covalent Schiff base linkage  with the imine nitrogen of the pyridoxal 5-phosphate cofactor. In  particular, Tyr187 forms a Pi-stacking interaction with the pyridine  ring of pyridoxal 5-phosphate, the guanidinium side chain of Arg297  forms a salt bridge with the alpha-carboxylate group of the substrate,  and residues His225, His182, Asn226, Glu81, and Ser162 provide  additional hydrogen bonding interactions with the substrate and  cofactor <12>; #13# the proposed catalytic cycle of OAM starts with  substrate binding, which triggers homolytic rupture of the Co-C bond to  generate cob(II)alamin and the transient 5-deoxyadenosyl radical  (AdoCH2C), which subsequently abstracts a hydrogen atom from the  pyridoxal 5-phosphate-bound substrate. This results in a pyridoxal  5-phosphate-bound substrate radical (CYC-1) that isomerises to form a  pyridoxal 5-phosphate-bound product radical (CYC+1) via a cyclic  aziridinylcarbinyl intermediate (CYC). Re-abstraction of the hydrogen  atom from 5-deoxyadenosine (AdoCH3) by CYC+1 produces AdoCH2C, which  recombines with cob(II)alamin to regenerate the  5-deoxyadenosylcobalamin Co-C bond <14>)  "
5.4.3.6," L-tyrosine = 3-amino-3-(4-hydroxyphenyl)propanoate (#1# mechanism <2>;  #8# pH-dependent stereochemic mechanism, detailed overview. The enzyme  uses a retention-of-configuration mechanism at the amino migration  terminus <9>; #2# MIO  (3,5-dihydro-5-methylidene-4H-imidazol-4-one)-dependent aminomutases  begin their reactions by adding the amino group of the substrate to the  methylidene carbon of the MIO prosthesis. The enzyme removes the NH2/H  pair from the substrate, yielding an NH2-MIO adduct, a tightly bound  acrylate intermediate, and protonated catalytic Tyr <10>; #2# the  3,5-dihydro-5-methylidene-4H-imidazol-4-one (MIO) group in the enzymes  active site N-alkylates the NH2 of the alpha-amino acid substrates and  promotes the removal of an intermediary NH2-MIO adduct. Concomitant  removal of a beta-proton from the substrate (NH2-MIO adduct) by a  catalytic tyrosine yields an acrylate intermediate. The aminomutase  reaction continues by vicinal reprotonation and reamination at the  alpha- and beta-carbons, respectively, of the acrylate to produce the  beta-amino acid. Mechanism of MIO-dependent aminomutase, overview <11>)  "
5.4.3.7, (2S)-alpha-leucine = (3R)-beta-leucine  
5.4.3.8," L-glutamate 1-semialdehyde = 5-aminolevulinate (#5# mechanism <24>; #8#  ping-pong bi-bi mechanism in which 4,5-diaminovalerate is the second  substrate and 4,5-dioxovalerate is an alternative first substrate <23>;  #1# intermolecular transamination occurs during conversion of  (S)-4-amino-5-oxopentanoate to 5-amino-4-oxopentanoate <6>; #8#  wild-type enzyme and gabaculine-resistant mutant enzyme use a ping-pong  bi-bi mechanism in which 4,5-diaminovalerate is a likely intermediate  <12>; #5# the catalytic mechanism includes enzyme-bound diaminovalerate  as a central intermediate <21>; #12# enzyme shows an active-site gating  loop, which undergoes a dramatic conformational change during  catalysis, that is simultaneously open in one subunit and closed in the  other. Loop movement requires a beta-sheet-to-alpha-helix transition to  assume the closed conformation, thus facilitating transport of  substrate toward, and concomitantly forming, an integral part of the  active site. The accompanying intersubunit cross-talk controls negative  cooperativity between the allosteric pair <32>; #8# catalytic mechanism  via external aldimine and Gem-diamine intermediates, overview <37>)  "
5.4.3.9, L-glutamate = 3-aminopentanedioate  
5.4.4.1," (hydroxyamino)benzene = 2-aminophenol (#2# intramolecular hydroxyl  transfer <3,4>; #2# proposed intramolecular rearrangment mechanism,  different from the nonenzymatic Bamberger reaction which proceeds via  intermolecular hydroxyl transfer <4>)  "
5.4.4.2," chorismate = isochorismate (#22# K90 is the base that activates water  for nucleophilic attack at the chorismate C2 carbon <17>; #7# general  acid-general base catalysis with a lysine as the base and a glutamic  acid as the acid, in reverse protonation states and with a  conformational or binding step as the slow step <29>; #22#  isochorismate synthase (IS) performs a 1,5-displacement mechanism  during the chorismate conversion to intermediates through the use of a  nucleophile, which is water in the case of IS, but might also be  possible with ammonia. The hydroxyl group in the isochorismate is  generated from water and not through an intramolecular rearrangement  <34>; #27# isochorismate synthase performs a 1,5-displacement mechanism  during the chorismate conversion to intermediates through the use of a  nucleophile, which is water in the case of isochorismate synthase, but  might also be possible with ammonia. The hydroxyl group in the  isochorismate is generated from water and not through an intramolecular  rearrangement <34>; #8# overall reaction, salicylate sythase converts  chorismate into salicylate via an isochorismate intermediate. The  isochorismatase activity of bifunctional enzyme MbtI requires Lys205,  which nucleophilically activates a water molecule for attack on  chorismate at C-6 and Glu252 that polarizes the C-4 hydroxyl-leaving  group <35>)  "
5.4.4.3," 3-hydroxyaminophenol = aminohydroquinone (#1# enzyme requires neither a  cofactor nor oxygen for the enzymatic reaction, enzyme catalyzes a  Bamberg-type rearrangement <1>)  "
5.4.4.4, geraniol = (3S)-linalool  
5.4.4.5," (8R,9Z,12Z)-8-hydroperoxyoctadeca-9,12-dienoate =  (5S,8R,9Z,12Z)-5,8-dihydroxyoctadeca-9,12-dienoate  "
5.4.4.6," (8R,9Z,12Z)-8-hydroperoxyoctadeca-9,12-dienoate =  (7S,8S,9Z,12Z)-7,8-dihydroxyoctadeca-9,12-dienoate  "
5.4.4.7, a hydroperoxyicosatetraenoate = a hydroxyepoxyicosatrienoate  
5.4.4.8, (RS)-linalool = geraniol  
5.4.99.1," L-threo-3-methylaspartate = L-glutamate (#13# mechanism <3,8,11>; #13#  hydrogen transfer occurs directly between coenzyme and product and  provides no evidence for the formation of a protein radical <9>; #7#  the reaction is initiated through hydrogen atom abstraction from C-4 of  Glu by 5-deoxyadenosyl radical which is derived by homolysis of the  Co-C sigma-bond of coenzyme B12 <1>; #7,13# requires Co(II) for  coordiation of the acrylate, in order to enable the addition of the  radical fragment to the alpha-carbon of this intermediate, leading to  the branched product <12>; #7# the 4-glutamyl radical is an  intermediate in the carbon skeleton rearrangement catalyzed the enzyme  <1>; #7# the catalytic mechanism proceeds via a  fragmentation/recombination sequence with intermediates stabilized by  partial protonation/deprotonation <25>; #7# kinetic study of deuterium  effects, an isotopically insensitive step is partially rate-determining  <33>; #7# kinetic study of tritium effects, reaction has a late  transition state <31>; #7# no significant activation of coenzyme  adenosylcobalamin in absence of substrate <34>; #7# study of Co-C bond  activation, cofactor/active site interactions give rise to a fairly  uniform stabilization of the Co 3d orbitals <32>; #7# motions of the  5Â’-hydrogen atoms are coupled in the transition state to the motion of  the hydrogen undergoing transfer, in a reaction that involves a large  degree of quantum tunneling <39>; #7# conversion of glutamate to  methylaspartate catalyzed by glutamate mutase is investigated by  quantum mechanical/molecular mechanical simulations based on coupled  cluster and density functional calculations, overview. Binding of the  Glu substrate induces a homolytic cleavage of the cobalt-carbon bond of  the cofactor, which yields a 5-deoxyadenosyl radical and cob(II)alamin,  atom tunneling mechanism <48>; #7# radical mechanism of the conversion  of glutamate to methylaspartate catalyzed by glutamate mutase by  quantum mechanical/molecular mechanical simulations based on density  functional theory, crystal structure analysis <47>)  "
5.4.99.11," Sucrose = 6-O-alpha-D-glucopyranosyl-D-fructofuranose (#2#  intramolecular transglycosylation mechanism in which both glucose and  fructose residues appear to be enzyme-bound <2>; #3# Glu295 plays a  role as the general acid catalyst to protonate the oxygen of the  glycosidic linkage for substrate hydrolysis, the Odelta2 of Asp241 acts  as the nucleophile to attack the C1 of the D-glucosyl and forms a bond  with C1 to obtain beta-glucosyl-enzyme intermediate, and the  isomaltulose is produced when the O-6 of the hydrolysis product  D-fructose nucleophilically binds to the C1 of the D-glucosyl group of  the intermediate <38>)  "
5.4.99.12," tRNA uridine38-40 = tRNA pseudouridine38-40 (#3# chemical evidence  against a covalent cysteine intermediate in the rearrangement mechanism  of uridine to pseudouridine <15>; #8# structural, computational, and  functional studies provide the basis for a substrate recognition model  for the regional selectivity. By binding to the conserved parts of  tRNAs (elbow and D stem backbone), TruA recognizes multiple tRNAs  independent of sequence variations. Anchored at these two regions, TruA  positions the anticodon stem loop near the active site without  constraining its flexibility, thereby increasing the effective  concentration of each target position, 38, 39, and 40, in the vicinity  of the active site. The thermal motions of the anticodon stem loop  allow the nucleotides at each of the three sites to be dynamically  accessible for modification. TruA utilizes the intrinsic flexibility of  the anticodon stem loop for site promiscuity and also to select against  intrinsically stable tRNAs <10>; #8# the mechanism of pseudouridine  synthase I is deduced from its interaction with 5-fluorouracil-tRNA.  The covalent complex formed between pseudouridine synthase I and  5-fluorouracil-tRNA involves Michael adduct formation between Asp60 of  pseudouridine synthase I and the 6-carbon of 5-fluorouracil39 of tRNA  to form a covalent pseudouridine synthase I-5-fluorouracil-tRNA complex  <9>)  "
5.4.99.13, 2-methylpropanoyl-CoA = butanoyl-CoA (#2# loss of stereocontrol during  the reaction <3>; #7# either a random or ordered sequential mechanism  <4>)  
5.4.99.14," 4-Carboxymethyl-4-methylbut-2-en-1,4-olide =  4-carboxymethyl-3-methylbut-2-en-1,4-olide (#2# mechanism <3>; #1#  isomerization does not involve actual methyl migration, but proceeds  via the 1-methylbislactone <2>)  "
5.4.99.15, 4-[(1->4)-alpha-D-glucosyl]n-1-D-glucose =  1-alpha-D-[(1->4)-alpha-D-glucosyl]n-1-alpha-D-glucopyranoside  
5.4.99.16," maltose = alpha,alpha-trehalose (#3# two-step, double displacement  catalytic mechanism, overview <29>;  #2,21,23,24,25,27,28,30,31,32,33,34,35,36,37,38,39,40# two-step, double  displacement mechanism of the enzyme, overview <35>)  "
5.4.99.17," squalene = hop-22(29)-ene (#8# catalytic mechanism, overview <39>; #12#  catalytic mechanism via Friedel-Crafts alkylation and substrate  specificity, overview <43>; #1,2,4,5,6,7# catalytic mechanism, the  initial reaction catalyzed is the protonation of the terminal double  bond of squalene. The conserved DXDD motif of SHCs is essential for  this protonation reaction, overview <36>; #8# catalytic mechanism, the  initial reaction catalyzed is the protonation of the terminal double  bond of squalene. The conserved DXDD motif of SHCs is essential for  this protonation reaction. In Alicyclobacillus acidocaldarius SHC,  Asp376 of this motif is hydrogen bonded to His451, and an additional  hydrogen bond exists to an ordered water molecule, which connects D376  to the hydroxyl group of the Y495 side chain and thus further enhances  its acidity. The carboxyl groups of Asp374 and Asp377 accommodate the  positive charge of the D376-H451 pair prior to proton transfer. After  proton transfer to the 2,3-double bond of squalene, the D376-H451 pair  loses its charge, leaving the remaining negative charge on the  D374-D377 pair for stabilization of the initial cationic intermediates  (24, 101). Reprotonation of D376 occurs through a water molecule bound  to Y495-OH, which can transfer protons from disordered water in the  solvent-accessible upper cavity of SHC <36>; #1,11# overall mechanism  of the polycyclization reaction of SHCs and structures of squalene  cyclization products, overview <36>) "
5.4.99.17, squalene + H2O = hopan-22-ol  
5.4.99.18," 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole =  5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate (#8# common,  buried carboxylate or CO2 binding site for substrate and product in a  hydrophobic pocket, in which the carboxylate or CO2 interacts with  backbone amides. The carboxylate orients the substrate for proton  transfer from His45 to 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole  to form an enzyme-bound aminoimidazole ribonucleotide and CO2  intermediate. subsequent movement of the aminoimidazole moiety  reorients it for addition of CO2 at C4 to generate  iso-5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate. H5 is now  in a position to remove a C4 proton to produce  5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate <11>; #6# H89 is  not essential and does not function as part of a proton relay system.  For synthesis of  5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate, the carboxylate  moiety is positioned in a small pocket proposed to facilitate  nucleotide decarboxylation. In the reverse direction, enzyme favors  protonation of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate  C4 <10>)  "
5.4.99.19, 16S rRNA uridine516 = 16S rRNA pseudouridine516  
5.4.99.2," (R)-methylmalonyl-CoA = succinyl-CoA (#10,15# mechanism <9,23,26>; #15#  evidence for radical intermediates <24>; #15# intrinsic hydrogen  isotope effect is 51 due to multidimensional tunneling. Corner-cutting  tunneling decreases the distance over which the system tunnels without  a comparable increase in either the effective potential barrier or the  effective mass for tunneling <44>; #15# ONIOM calculations based on  protein structure. Homolytic Co-C5Â’ bond cleavage in the  5Â’-deoxyadenosylcobalamin cofactor is a stepwise process in which  conformational changens in the 5Â’-deoxyadenosine moiety proceed the  actual homolysis step. The movement of the deoxyadenosine moity during  homolysis positions the resulting 5Â’-deoxyadenosyl radical for the  subsequent hydrogen atom transfer from the substrate <42>; #34#  mechanism, overview, a gradual weakening of the electrostatic energy  between the protein and the ribose leads to a progressive increase in  the activation energy barrier for Co-C bond homolysis, key role for the  conserved polar glutamate residue in controlling the initial generation  of radical species <61>)  "
5.4.99.20, 23S rRNA uridine2457 = 23S rRNA pseudouridine2457  
5.4.99.21," 23S rRNA uridine2604 = 23S rRNA pseudouridine2604 (#1# the substrate of  RluF undergoes radical structural rearrangements upon binding. The RluF  target base lies in an RNA stem rather than in a flexible loop and the  substrate conformational change requires disruption of multiple base  pairs. This energetically costly process is driven by interactions of  the RNA with the protein, a mechanism of RluF is proposed <2>)  "
5.4.99.22, 23S rRNA uridine2605 = 23S rRNA pseudouridine2605  
5.4.99.23, 23S rRNA uridine1911/uridine1915/uridine1917 = 23S rRNA  pseudouridine1911/pseudouridine1915/pseudouridine1917  
5.4.99.24, 23S rRNA uridine955/uridine2504/uridine2580 = 23S rRNA  pseudouridine955/pseudouridine2504/pseudouridine2580  
5.4.99.25," tRNA uridine55 = tRNA pseudouridine55 (#8# RluA does not require  thiol(ate) groups to effect catalysis <2>; #4# the mechanism of  uridine55 recognition by Cbf5 and the bacterial TruB are different  <16>; #11# the side chain of the conserved tyrosine in the four  families of pseudouridine synthases (TruA, TruB, RsuA and RluA) plays a  dual role within the active site, maintaining the structural integrity  of the active site through its hydrophobic phenyl ring and acting as a  general base through its OH group for the proton abstraction required  in the last step of pseudouridine synthase-catalyzed formation of  pseudouridine <6>; #8# this enzyme recognizes the preformed  three-dimensional structure of the T loop primarily through shape  complementarity. It accesses its substrate uridyl residue by flipping  out the nucleotide and disrupts the tertiary structure of tRNA <3>;  #8,11# this enzyme undergoes significant conformational changes on  binding to its substrate. These conformational changes include the  ordering of the thumb loop, which binds right into the RNA hairpin  loop, and a 10Â° hinge movement of the C-terminal domain. TruB  recognizes its RNA substrate through a combination of rigid docking and  induced fit, with TruB first rigidly binding to its target and then  maximizing the interaction by induced fit <5>)  "
5.4.99.26, tRNA uridine65 = tRNA pseudouridine65  
5.4.99.27, tRNA uridine13 = tRNA pseudouridine13 (#4# a strictly conserved  glutamate near the active site in TruD is likely to act as a general  base for the proton abstraction at C5 of the uridine base <6>)  
5.4.99.28, tRNA uridine32 = tRNA pseudouridine32 (#1# mechanistic investigations  <2>; #1# RluA does not require thiol(ate) groups to effect catalysis  <1>; #1# RluA recognizes its substrates indirectly by probing RNA loops  for their ability to adopt the reorganized fold <3>)  
5.4.99.29, 23S rRNA uridine746 = 23S rRNA pseudouridine746 (#1# mechanistic  investigations <2>; #1# RluA recognizes its substrates indirectly by  probing RNA loops for their ability to adopt the reorganized fold <3>)  
5.4.99.3, 2-acetolactate = 3-hydroxy-3-methyl-2-oxobutanoate  
5.4.99.30," UDP-beta-L-arabinofuranose = UDP-beta-L-arabinopyranose (#4,6# in  functional UDP-arabinopyranose mutases a specific arginyl residue is  reversibly glycosylated. This arginyl residue together with a DXD motif  is required for catalytic activity <2>; #4,5# the reaction is  reversible and at thermodynamic equilibrium the pyranose form is  favored over the furanose form (90:10) <3>)  "
5.4.99.31," (3S)-2,3-epoxy-2,3-dihydrosqualene = thalianol  "
5.4.99.32," (3S)-2,3-epoxy-2,3-dihydrosqualene =  (17Z)-protosta-17(20),24-dien-3beta-ol  "
5.4.99.33," (3S)-2,3-epoxy-2,3-dihydrosqualene = cucurbitadienol  "
5.4.99.34," (3S)-2,3-epoxy-2,3-dihydrosqualene = germanicol  "
5.4.99.35," (3S)-2,3-epoxy-2,3-dihydrosqualene = taraxerol  "
5.4.99.36," (3S)-2,3-epoxy-2,3-dihydrosqualene = isomultiflorenol  "
5.4.99.37," squalene = dammara-20,24-diene  "
5.4.99.38," (3S)-2,3-epoxy-2,3-dihydrosqualene = camelliol C  "
5.4.99.39," (3S)-2,3-epoxy-2,3-dihydrosqualene = beta-amyrin (#3# no scrambling of  methyl groups is observed during beta-amyrin formation, the isopropyl  group of the lupenyl cation intermediate must be held tightly during  product formation <8>; #1# substrate is used in chair-chair-chair-boat  conformation. Cyclization first generates the tetracyclic dammarenyl  C20 cation with the 17beta-side chain <10>; #14# cyclization pathway of  (3S)-2,3-oxidosqualene to generate beta-amyrin triterpene via bicyclic,  malabaricanyl, dammarenyl, baccharenyl, lupanyl, and oleanyl cation  intermediates, detailed mechanism overview <38>; #14# cyclization  pathway of (3S)-2,3-oxidosqualene to generate beta-amyrin triterpene.  (3S)-2,3-oxidosqualene is folded into a chair-chair-chair-boat-boat  conformation in the enzyme cavity, and the proton released from the  DCTA amino acid motif attacks the epoxide ring, leading to sequential  ring-forming reactions and the construction of 6,6,6,6,6-fused  pentacyclic ring scaffold via several carbocationic intermediates. The  oleanyl cation undergoes rearrangement reactions of 1,2-hydride shifts  and deprotonation of axial-oriented H-12 to yield beta-amyrin <33>;  #39,40# molecular substrate docking and catalytic reaction mechanism  analysis, overview. Residue Y560 is responsible for the high catalytic  efficiency of enzyme GsAS2 compared to GsAS1 <41>; #14# the Phe416  residue is located near the D-ring formation site and works to position  the oxidosqualene substrate correctly within the reaction cavity. On  the other hand, the major catalysis-related function of the Tyr259 and  Trp257 residues is to yield their Pi-electrons to the cationic  intermediate <39>)  "
5.4.99.4," 2-Methyleneglutarate = 2-methylene-3-methylsuccinate (#1# mechanism  <1,3,6>; #1# the steric course of the reaction is such that the acrylyl  residue migrates from the beta-carbon to the alpha-carbon of the  propionate with inversion of configuration at the alpha-carbon <6>; #1#  the enzyme catalyzes the reversible migration of an acryloyl residue  from the alpha-carbon to the beta-carbon of propionate with inversion  of configuration at the alpha-carbon <2>; #1# unimolecular free radical  rearrangement via 3-butenyl and cyclopropylmethyl intermediates is a  reasonable mechanism for the rearrangement step of the enzyme <6>; #1#  mechanism via protein-bound free radicals <8>; #1# rotation of the  exo-methylene group of 2-methyleneglutarate <5>; #1# formation of an  unusual oxygen-sensitive Co(II) species during catalysis <9>)  "
5.4.99.40," (3S)-2,3-epoxy-2,3-dihydrosqualene = alpha-amyrin  "
5.4.99.41," (3S)-2,3-epoxy-2,3-dihydrosqualene = lupeol (#1# the C17 configuration  of the tetracyclic intermediate dammarenyl cation can be deduced from  the angular methyl configuration of the pentacyclic or 6-6-6-6  tetracyclic product <10>; #6# the final proton abstraction takes place  from either of the two gem-dimethyl groups in a 1:1 ratio <6>)  "
5.4.99.42, tRNA uridine31 = tRNA pseudouridine31  
5.4.99.43, 21S rRNA uridine2819 = 21S rRNA pseudouridine2819  
5.4.99.44, mitochondrial tRNA uridine27/28 = mitochondrial tRNA pseudouridine27/28  
5.4.99.45, tRNA uridine38/39 = tRNA pseudouridine38/39  
5.4.99.46," (3S)-2,3-epoxy-2,3-dihydrosqualene = shionone  "
5.4.99.47," (3S)-2,3-epoxy-2,3-dihydrosqualene = parkeol (#6# reaction from  bicyclic C-8 cation (chair-boat form) via protosteryl cation  (chair-boat-chair form) to parkeol, proposed reaction scheme of  cyclization, overview <9>)  "
5.4.99.48," (3S)-2,3-epoxy-2,3-dihydrosqualene = achilleol B  "
5.4.99.49," (3S)-2,3-epoxy-2,3-dihydrosqualene = glutinol  "
5.4.99.5," Chorismate = prephenate (#44# CMs are extremly versatile enzymes and  can be structurally divided into two major groups: the type I or AroH  class, which comprises CMs characterized by a trimericpseudo  alpha/beta-barrel structure, and the type II or AroQ class, which  comprises CMs can also be monofunctional, bifunctional (generally fused  to another shikimate pathway member), exported, and/or allosterically  regulated <73>; #59# the active site is formed within a single chain  without any contribution from the second chain in a dimer <72>; #43#  The active site of the enzyme which is found in a pocket formed by two  different chains is shown. Applying the TPS method of Chandler and  co-workers to study the chorismate to prephenate reaction <76>; #4#  Three active sites are formed in the interstices between three  subunits. Each active site is composed of the residues of two adjacent  subunits. The two Arg hold the chorismate. Crucial distance between  Arg6 and Arg63* controls the conformation of the chorismate. The  residues in the close vicinity to the chorismate substrate are Arg6,  Glu77, Arg89, Tyr 107, Leu114, and Arg115 from one subunit and Phe57*,  Ala59*, Arg63*, Leu72*, and Leu73* from the other subunit. The family  of the chorismate mutase enzymes shares a common E.S active site <69>;  #43# Wild-type-reaction: Arg63, Arg116, Arg7, and Tyr108 required for  the relative orientation of the substrate at the active site, the  structural rearrangement in the Glu78-Arg90-substrate controls the  strength of the hydrogen bonds. The hydrogen bonds connecting the  Glu78-Arg90-substrate cooperatively control the stability of TS  relative to the ES complex and the positive charge on Arg90 polarizes  the substrate in the TS region to gain more electrostatic  stabilization. Method: electron quantum chemical calculations by  fragment molecular orbital (FMO) method. The structural refinement and  reaction path search are performed by the ab initio QM/MM treatment.  Usage of the AMBER standard parameter set (parm.96) for the MM  force-field calculations. Reaction path search: On the basis of the  gas-phase IRC (intrinsic reaction coordinate) profile of chorismate  isomerization, the linear reaction path is calculated first <75>; #16#  via near attack conformation and transition state intermediates,  reaction mechanism, overview <97>; #73# catalytic reaction mechanism,  role of conformational dynamics and entropies in enzyme catalysis,  overview. Large-scale conformational dynamics make important catalytic  contributions to sampling conformational regions in favor of binding  the transition state of substrate <108>; #59# the enzyme catalyzes the  conversion of chorismate to prephenate, which is formally a Claisen  rearrangement that proceeds via an endo-oxabicyclic transition state  with a chair-like geometry <106>)  "
5.4.99.50," (3S)-2,3-epoxy-2,3-dihydrosqualene = friedelin (#2,3,4,5# reaction via  a chair-chair-chair conformation intermediate <2>)  "
5.4.99.51," (3S)-2,3-epoxy-2,3-dihydrosqualene = baccharis oxide  "
5.4.99.52," (3S)-2,3-epoxy-2,3-dihydrosqualene = alpha-seco-amyrin  "
5.4.99.53," (3S)-2,3-epoxy-2,3-dihydrosqualene = marneral  "
5.4.99.54," (3S)-2,3-epoxy-2,3-dihydrosqualene = beta-seco-amyrin  "
5.4.99.55," (3S)-2,3-epoxy-2,3-dihydrosqualene = delta-amyrin  "
5.4.99.56," (3S)-2,3-epoxy-2,3-dihydrosqualene = tirucalla-7,24-dien-3beta-ol  "
5.4.99.57," (3S)-2,3-epoxy-2,3-dihydrosqualene = baruol  "
5.4.99.58, L-lysine = (3R)-3-methyl-D-ornithine  
5.4.99.59, dTDP-alpha-D-fucopyranose = dTDP-alpha-D-fucofuranose  
5.4.99.60, cobalt-precorrin-8 = cobyrinate  
5.4.99.61, Precorrin-8X = hydrogenobyrinate  
5.4.99.62, beta-D-ribopyranose = beta-D-ribofuranose  
5.4.99.63, (2R)-ethylmalonyl-CoA = (2S)-methylsuccinyl-CoA  
5.4.99.64, 2-hydroxy-2-methylpropanoyl-CoA = (S)-3-hydroxybutanoyl-CoA  
5.4.99.65," (3S,22S)-2,3:22,23-diepoxy-2,3,22,23-tetrahydrosqualene =  pre-alpha-onocerin  "
5.4.99.66, pre-alpha-onocerin = alpha-onocerin  
5.4.99.67, 4-amino-4-deoxychorismate = 4-amino-4-deoxyprephenate  
5.4.99.7," (3S)-2,3-epoxy-2,3-dihydrosqualene = lanosterol (#5# mechanism includes  formation of a chair-boat 6-6-5 tricyclic Markovnikov cation and  protosteryl cation <55>; #5# W232 plays a catalytic role influencing  the rearrangement process and determination of deprotonation position  but does not interact in the cyclization process <58>; #2# catalytic  mechanism involving His232 via intermediates parkeol and  protosta-12,24-dien-3-beta-ol, quantum mechanics/molecular mechanics,  overview <80>)  "
5.4.99.8," (3S)-2,3-epoxy-2,3-dihydrosqualene = cycloartenol  "
5.4.99.9," UDP-alpha-D-galactopyranose = UDP-alpha-D-galactofuranose (#14#  catalytic mechanism, overview <43>; #21# mobile loop of enzyme must  move in order for enzyme to bind UDP-galactose substrate <13>;  #1,6,8,10,13# chemical reaction mechanism, overview <42>; #7# reaction  mechanism, overview.  FAD-UDP-alpha-D-galactopyranose/UDP-alpha-D-galactofuranose adduct as  an intermediate in the catalytic cycle, the chemical mechanism for UGM  involves an SN2-type displacement of UDP from  UDP-alpha-D-galactopyranose/UDP-alpha-D-galactofuranose by N5 of FADred  <46>; #18# catalytic reaction mechanism, detailed overview. A covalent  adduct is formed between the substrate and the FADH cofactor,  temporarily breaking the glycosidic bond, followed by an internal  proton transfer between N5FADH and O6FADH. The next step involves  linearization of the sugar and formation of the iminium ion species. In  the next step, the sugar cyclizes into its five-membered ring form.  This step is isotope sensitive and is considered to be the chemical  rate-limiting step of the mechanism. Once the furanose form of the  sugar is reached, another internal proton transfer takes place, and the  glycosidic bond to UDP is formed. Finally, the product of the reaction  exits the active site of the enzyme <54>; #7# detailed reaction  mechanism involving SN2-type steps, overview <56>; #20#  enzyme-substrate binding structure and mechanism <58>; #8# quantum  mechanics-molecular mechanics (QM/MM) molecular dynamics study and  reaction mechanism, characterization of the structures of reactants,  products, intermediate species and transitions states, overview <59>;  #18# reaction mechanism including FAD cofactor, overview. Role of a  covalent flavin N5 intermediate in the isomerization, non-redox  reaction, of UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose  (UDP-Galf) by UDP-galactopyranose mutase (UGM). The flavin is required  to be in the reduced state and functions as a nucleophile. The flavin  must cycle back to the oxidized state for sustained catalysis.  Formation of a N5-iminium ion intermediate, Fformation of N5-adducts in  non-redox reactions involving the flavin in the oxidized or reduced  forms <49>)  "
5.5.1.1," (+)-muconolactone = cis,cis-muconate (#6# a concerted or stepwise  mechanism involving carbonium ion or covalent intermediates are not  likely to be operative for the enzyme-catalyzed syn (cis) elimination  <19>; #15# syn lactonization <14>; #6# Mn2+ and Lys167 provide  electrophilic stabilization of the enol/enolate intermediate that is  formed during the course of the reaction <13>; #6# reaction may proceed  through formation of an intermediate carbanion located alpha to a  carboxyl group, subsequent protonation of this putative carbanion, the  carbanion is generated by attack of the remote carboxylate group on a  double bond <17>; #6# in the reverse reaction the alpha proton of  muconolactone is abstracted by a homolog of Lys166(Lys169) to generate  an enolic intermediate, this intermediate undergoes vinylopous  beta-elimination of the remote carboxylate group to produce  cis,cis-muconate <12>; #1,2# reaction mechanism, DFT QM/MM calculations  and structure-function relationship, overview <38>)  "
5.5.1.10," alpha-pinene oxide = (Z)-2-methyl-5-isopropylhexa-2,5-dienal (#3#  mechanism <1>; #1# pathway <3>)  "
5.5.1.11," 2,4-dichloro-2,5-dihydro-5-oxofuran-2-acetate =  2,4-dichloro-cis,cis-muconate  "
5.5.1.12, geranylgeranyl diphosphate = (+)-copalyl diphosphate  
5.5.1.13," geranylgeranyl diphosphate = ent-copalyl diphosphate (#5# reaction  mechanism <24>; #13,28# the hydrophobicity and size of the side chain  residue at the bifunctional CPS/KS amino acid 710 is responsible for  quenching the ent-kauranyl cation by the addition of a water molecule.  The determination of the final products of CPS/KSs in bryophytes  depends on the sequence and structure of the C-terminal regions of  CPS/KSs. Thus, the type A cyclization reaction of both PpCPS/KS and  JsCPS /KS occurs near the C-terminal region of the polypeptides <23>)  "
5.5.1.14," geranylgeranyl diphosphate = 9alpha-copalyl diphosphate (#2,3# in  contrast to EC 5.5.1.12 and EC 5.5.1.13, this enzyme produces copalyl  diphosphate having the syn conformation <1,2>)  "
5.5.1.15, geranylgeranyl diphosphate = terpentedienyl diphosphate  
5.5.1.16, geranylgeranyl diphosphate = tuberculosinyl diphosphate  
5.5.1.17, (S)-beta-bisabolene = (S)-beta-macrocarpene  
5.5.1.18, carotenoid psi-end group = carotenoid epsilon-end group (#10# acid-base  catalyzed reaction mechanism <5>)  
5.5.1.19, carotenoid psi-end group = carotenoid beta-end group  
5.5.1.2," cis,cis-butadiene-1,2,4-tricarboxylate =  2-carboxy-2,5-dihydro-5-oxofuran-2-acetate (#6,7# lactonization  proceeds by an anti-addition <9>; #16# activation of the carboxylic  nucleophile by a hydrophobic environment is not required for  lactonization <18>)  "
5.5.1.20, prosolanapyrone III = (-)-solanapyrone A  
5.5.1.22, geranyl diphosphate = (-)-bornyl diphosphate  
5.5.1.23, aklaviketone = methyl aklanonate  
5.5.1.24," delta-tocopherol = 2-methyl-6-phytylbenzene-1,4-diol "
5.5.1.24," gamma-tocopherol = 2,3-dimethyl-6-phytylbenzene-1,4-diol "
5.5.1.24," delta-tocotrienol = 6-geranylgeranyl-2-methylbenzene-1,4-diol "
5.5.1.24," gamma-tocotrienol = 6-geranylgeranyl-2,3-dimethylbenzene-1,4-diol  "
5.5.1.25," 3,6-anhydro-L-galactonate = 2-dehydro-3-deoxy-L-galactonate  "
5.5.1.26," nogalaviketone = methyl nogalonate (#1# the mechanism of the  intramolecular aldol condensation catalysed by the enzyme is different  from that of the classical aldolases, which employ covalent Schiff base  formation or a metal ion cofactor. The invariant residue Asp121 acts as  an acid/base catalyst during the reaction. Stabilisation of the  enol(ate) intermediate is mainly achieved by the delocalisation of the  electron pair over the extended p system of the substrate <3>)  "
5.5.1.27," D-galactaro-1,4-lactone = 5-dehydro-4-deoxy-D-glucarate (#1# reaction  mechanism, the reaction product of At Gci from D-galactaro-1,4-lactone  and D-glucaro-1,4-lactone conversion is in both cases the L-threo form  of 3-deoxy-2-keto-hexarate, NMR spectroscopy analysi. The reaction has  to be initiated by proton abstraction from C5 followed by leaving of  the 4-OH group.The leaving group is the hydroxyl that has formed the  lactone ring with the carboxyl group at C1. The proton abstraction  takes place next to the carboxylic acid pointing out from the lactone  rings <1>) "
5.5.1.27," D-glucaro-1,4-lactone = 5-dehydro-4-deoxy-D-glucarate  "
5.5.1.28, geranylgeranyl diphosphate = (-)-kolavenyl diphosphate  
5.5.1.29, geranylgeranyl diphosphate = (+)-kolavenyl diphosphate  
5.5.1.3, Tetrahydroxypteridine = xanthine-8-carboxylate  
5.5.1.30," geranylgeranyl diphosphate = (13E)-labda-7,13-dien-15-yl diphosphate  "
5.5.1.31, 3-geranyl-3-[(Z)-2-isocyanoethenyl]-1H-indole = hapalindole H  
5.5.1.32, 3-geranyl-3-[(Z)-2-isocyanoethenyl]-1H-indole = 12-epi-hapalindole U  
5.5.1.33, 3-geranyl-3-[(Z)-2-isocyanoethenyl]-1H-indole = 12-epi-fischerindole U  
5.5.1.34," (S)-8-oxocitronellyl enol = (+)-cis,trans-nepetalactol  "
5.5.1.35," (S)-8-oxocitronellyl enol = (+)-cis,cis-nepetalactol  "
5.5.1.4," D-glucose 6-phosphate = 1D-myo-inositol 3-phosphate (#8,31# reaction  proceeds with stereospecific loss of the pro-6R and incorporation of  the pro-6S hydrogen into the product. The ring closure thus occurs in a  retention mode at C-6 of the substrate <37>; #33# RNA amounts are  upregulated at least 5fold during salinity stress <1>; #6# reaction  sequence: 1. Oxidation by NAD+ of C-5 of D-glucose 6-phosphate to give  5-oxo-D-glucose 6-phosphate, 2. aldol condensation between C-6 and C-1  of this molecule to give 1L-myo-inosose-2 1-phosphate, 3. reduction by  the NADH first formed to give 1L-myo-inositol 1-phosphate. The NADH and  oxidized intermediates are tightly bound <3>; #6# formation of  5-keto-D-glucose 6-phosphate as an enzyme-bound intermediate in the  conversion of D-glucose 6-phosphate into 1L-myo-inositol 1-phosphate  <5>; #6# pro-S specificity of the first step, the reversible oxidation  of glucose 6-phosphate to 5-ketoglucose 6-phosphate and in the second  oxidation-reduction step, the reduction of myo-inosose-2 1-phosphate to  myo-inositol 1-phosphate <33>; #31# ordered sequential mechanism with  NAD+ adding first <18>; #6# reaction sequence: 1. oxidation by NAD+ of  C-5 of D-glucose 6-phosphate to give 5-oxo-D-glucose 6-phosphate, 2.  aldol condensation between C-6 and C-1 of this molecule to give  1L-myoinosose-2 1-phosphate, 3. reduction by the NADH first formed to  give 1L-myoinositol 1-phosphate. The NADH and oxidized intermediates  are tightly bound <3>; #8,12,31# it is possible that the enzyme has an  aldol step in the enzymatic pathway which is of neither classical  aldolase type <14>; #8# mechanism, the phosphate-bearing carbon-atom in  D-glucose 6-phosphate is the same atom which bears the phosphate in  L-myo-inositol-1-phosphate <2>; #20# no upregulation of transcription  by salinity stress <1>; #5# catalytic reaction mechanism <49>; #7#  catalytic reaction mechanism involving K369, K412, K373, and K489 <42>;  #7,25# catalytic reaction mechanism, induced-fit active site formation  by substrate binding <49>) "
5.5.1.4," D-glucose 6-phosphate = L-myo-inositol 1-phosphate (#58# reaction  mechanism involves 3 reaction steps: 1. oxidation by NAD+, 2.  condensation to a cyclic molecule, 3. reduction by NADH <54>; #44#  reaction mechanism, active site residues are T228, G229, T230, D261,  K274, K278-K373, K306, D332, and K367, mechanism of phosphate and metal  binding in the active site, overview <47>; #44# substrate binding and  metal-dependent reaction mechanism, overview, active site residues are  D225, K274, K278, K306, D332, and K367 <51>)  "
5.5.1.5," 3-carboxy-2,5-dihydro-5-oxofuran-2-acetate = 3-carboxy-cis,cis-muconate  (#2# syn-1,2 addition-elimination reaction <7>)  "
5.5.1.6," A chalcone = a flavanone (#56# rate limiting step is an intramolecular  Michael addition of a 2Â’-oxyanion to the alpha,beta-double bond.  Computational study shows that the active site conformation with larger  catalytic power presents a positively charged lysine resiude much  closer to the substrate than the second active site. Charge is  transferred from the 2Â’-oxyanion to the beta-carbon atom <42>)  "
5.5.1.7," (2R)-2-chloro-2,5-dihydro-5-oxofuran-2-acetate =  3-chloro-cis,cis-muconate (#2# syn cycloisomerization <2>)  "
5.5.1.8," geranyl diphosphate = (+)-bornyl diphosphate (#1,2# mechanism  <2,4,5,6,9>; #1,2# geranyl diphosphate is first stereospecifically  isomerized to linalyl diphosphate which, following rotation about  C-2-B-3 to the cisoid conformer, cyclizes from the anti-endo  configuration. Neryl diphosphate cyclizes either directly or via the  linalyl intermediate without the attendant rotation <9>; #1,2# linalyl  diphosphate is an intermediate <5>; #1,2# solely the diphosphate ester  oxygen of geranyl diphosphate is involved in all the critical bonding  processes in the coupled isomerization-cyclization <5>; #1# both steps  of the coupled isomerization-cyclization sequence are initiated by  ionization of an allylic diphosphate <13>; #1# reaction mechanism,  overview <22>)  "
5.5.1.9," Cycloeucalenol = obtusifoliol (#2# mechanism <2,5>; #2# the enzymatic  reaction can be considered as a biochemical step equivalent to an acid  catalysed cyclopropane ring opening reaction. The production of  obtusifoliol does not involve the passage through a DELTA9(11)  intermediate <2>)  "
5.6.1.1," n ATP + n H2O + a microtubule = n ADP + n phosphate + (n+1) alpha/beta  tubulin heterodimers (#1,3,4,5,6,7,8,10,11,12,16,18,19,20,27# another  member of the AAA-ATPase family, active in splitting microtubules into  tubulin dimers in the centrosome <1,2,3,4,5,6,7,8>; #14# model of  enzyme activity based on defect-containing microtubules <10>; #2#  Dm-Kat60 severs and depolymerizes microtubules from their ends <46>)  "
5.6.1.2," ATP + H2O + a dynein associated with a microtubule at position n = ADP  + phosphate + a dynein associated with a microtubule at position n-1  (toward the minus end) (#15# the active sites for microtubule binding  and ATP hydrolysis communicate via conformational changes transduced  through a ca. 10 nm length antiparallel coilded-coil stalk, which  connects the binding domain to the roughly 300 kDa motor core. A  balancing of opposing conformations in the stalk and microtubule  binding domain (MTBD) enables modest ling-range interactions arising  from ATP-binding in the motor core to induce a reaxation of the MTBD  into the stable low affinity state <93>)  "
5.6.1.3," ATP + H2O + a kinesin associated with a microtubule at position n = ADP  + phosphate a kinesin associated with a microtubule at position n+1  (toward the plus end)  (#2,3,4,5,6,7,8,9,11,14,15,16,17,18,19,20,23,24,25,26,27,28,29#  microtubular motor protein, involved in organelle movement, in mitosis  and meiosis. In contrast to dynein, it moves along microtubules towards  the plus end. Composed of two heavy (a) chains (110kDa) and two more  light (b) chains (65-75 kDa). Also hydrolyzes GTP.  <1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17>; #6# the microtubule-Eg5  complex binds MgATP tightly, followed by rapid ATP hydrolysis with a  subsequent slow step that limits steady-state turnover. Presence of  microtubules accelerates the kinetics of each step in the ATPase  pathway and amplifies the nucleotide-dependent structural transitions  required for force generation. Phosphate product release and Eg5  detachment from the microtubule are coupled with a step occuring at the  slow rate after ATP hydrolysis followed by the second step occuring  more rapidly <30>)  "
5.6.1.4," ATP + H2O + a kinesin associated with a microtubule at position n = ADP  + phosphate + a kinesin associated with a microtubule at position n-1  (toward the minus end) (#1,2,3,5,6,7,8,9,10,12,15,18,20,21,22#  structurally almost identical to EC3.6.4.3 (microtubule-severing  ATPase) but the movement it catalyses is towards the minus end of  microtubules <2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19>; #8#  kinetics, comparison of wild-type enzyme and enzyme with N-terminal  glutathione S-transferase tag, mechanism <25>; #3# mechanism, model of  movement <23>; #13# model for enzymic coupling of depolymerizing  microtubule plus ends to the cell cortex <22>; #8# a molecular  mechanical model for the Kar3/Vik1 heterodimer is described based on  structural, kinetic and motility data revealing a long-range  chemomechanical transmission mechanism that resembles a familiar  fishing tactic. By this this molecular fishing, ATP-binding to Kar3  dissociates catalytically inactive Vik1 off microtubule to facilitate  minus-end sliding of the dimer on the microtubule lattice. When the  dimer binds the frayed ends of the microtubules, the fishing channels  ATP hydrolysis energy into the microtubule depolymerization by a  mechanochemical effect <41>)  "
5.6.1.5," ATP + H2O + polypeptide = ADP + phosphate + unfolded polypeptide  (#2,3,4,5,6,8,9,11,12,14,15,16,17,18,20,21,22,23,24,25,26,27,28,29,30  31,32# belongs to the AAA-type superfamily and, like EC 3.6.4.5,  minus-end-directed kinesin ATPase, is involved in channel gating and  polypeptide unfolding before proteolysis in the proteasome. Six ATPase  subunits are present in the regulatory particle (RP) of 26S proteasome  <1,2,3,4,5,6,7,8,9,10,11,12>)  "
5.6.1.6," ATP + H2O + closed Cl- channel = ADP + phosphate + open Cl- channel  (#11# asymmetric motion of the nucleotide binding domains 1 and 2  during channel gating. Opening of the channel is initiated by ATP at  the nucleotide-binding domain 2 site, whereas separation of the  nucleotide-binding domain dimer at the nucleotide-binding domain 1 site  constitutes the rate-limiting step in channel closing <49>; #2# the  conformation of nucleotide-binding domain 1 changes before that of  nucleotide-binding domain 2 during channel opening. Nucleotide-binding  domain dimerization does not proceed by a symmetric tweezer-like  motion, but instead in an asymmetric fashion led by nucleotide-binding  domain1 <52>; #3# the conformation of nucleotide-binding domain1  changes before that of nucleotide-binding domain 2 during channel  opening. Nucleotide-binding domain dimerization does not proceed by a  symmetric tweezer-like motion, but instead in an asymmetric fashion led  by nucleotide-binding domain1 <52>; #3# ATP binding, conformational  changes, and ATPase and channel activity reaction mechanism, overview  <70>; #3# the structure of the CFTR channel pore is highly asymmetric  with a narrower extracellular entrance and a dilating conformational  change of the extracellular entrance is associated with the channel  transition to a nonhydrolytic, locked-open state <83>; #3# upon channel  opening, the wide cytoplasmic vestibule tightens and the pore-lining  TM12 rotates along its helical axis <81>; #11# regulation of CFTR  activation by R domain phosphorylation followed by ATP binding at the  nucleotide-binding domain-1 site enables the cycling mechanism to  proceed. ATP catalysis at the catalytically active nucleotide?binding  domain-2 is sufficient to drive the gating cycle, CFTR gating mechanism  proceeds in 4 steps, detailed overview. The enzyme being a functional  channel adapts the ATP switch gating mechanism designed for  transporters, ATP Switch model analysis <85>)  "
5.6.1.7," ATP + H2O + a folded polypeptide = ADP + phosphate + an unfolded  polypeptide (#17# negative cooperativity of ATP hydrolysis <1>; #6#  binding and hydrolysis of ATP sets up an alternating cycle in which  each ring of the chaperonin is switched between states with strong and  weak affinity for a non-native protein substrate <7>; #6# enzyme  reaction mechanism and the mechanism by which the C-terminus influences  the activity of GroEL, structure-function relationship, overview <117>;  #6# reaction mechanism of the enzyme complex, the asymmetric and  symmetric GroEL/ES interaction cycles in the presence of substrate  protein, respectively, substrate binding in passive cage model and  active cage model, detailed overview <118>)  "
5.6.1.8," ATP + H2O + myosin bound to actin filament at position n = ADP +  phosphate + myosin bound to actin filament at position n+1 (#11#  terminal phosphate of triphosphate is removed <31>; #7# kinetics <38>;  #11# kinetics and mechanical behaviour <35>; #11# kinetics of  activtation by actin <33>; #23# combined quantum/classical mechanics  study and catalytic mechanism, detailed overview and analysis <67>;  #26# the actin-activated release of inorganic phosphate from the acto  myosin-ADP-phosphate complex is the rate-limiting step in the  steady-state actomyosin ATPase cycle <69>)  "
5.6.1.9, 2 ATP + a reduced flavodoxin + an inactive (R)-2-hydroxyacyl-CoA  dehydratase + 2 H2O = 2 ADP + 2 phosphate + a flavodoxin semiquinone +  an active (R)-2-hydroxyacyl-CoA dehydratase  
5.6.2.1," ATP-independent breakage of single-stranded DNA, followed by passage  and rejoining (#5# mechanism <23>; #5# acts by directing a nucleophilic  attack from the hydroxyl group of an internal Tyr into a phosphodiester  bond in the DNA backbone, resulting in nicking of one strand of the DNA  double helix and formation of a covalent linkage between the  3-phosphate and the Tyr hydroxyl group <22>; #5,8# alters the linking  number in steps of one <23>; #2# enzyme closes its substrate DNA  molecule after the removal of each superhelical turn, dissociation of  the enzyme substrate complex may but does not necessarily occur after  each cycle of the reaction <1>; #65# bcTopo IIIbeta does not act on  partially relaxed DNA. In contrast to ecTopo III Escherichia coli  topoisomerase bcTopo IIIbeta can not further relax this substrate.  bcTopo IIIbeta and ecTopo III exhibit comparable single stranded DNA  binding activities and cleavage site specificities. bcTopo IIIbeta does  not possess decatenation activity. Unlike ecTopo III, bcTopo III beta  is not capable of decatenating replication intermediates <137>; #80#  cleaves single-stranded DNA (ssDNA) via a 5 phosphotyrosine  intermediate <133>; #9# demonstrated that human Topo I specifically  stimulates the origin binding activity of PV E1, apparently through a  protein-protein interaction. Topo I stimulates the origin binding  activity of papillomavirus protein E1. Topo I stimulation of E1 binding  is highly specific, verified by enzyme-linked immunosorbent assays  using a nonorigin DNA fragment, Topo I stimulation of E1 DNA binding  activity is origin specific. E1 does not affect the DNA binding  activity of Topo I. DNA modulates the interaction between E1 and Topo I  (ELISA-based protein interaction assays). Topo I and E2 stimulate the  origin binding of E1 independently(enzyme-linked immunosorbent assay)  <135>; #9# Human topoisomerase I-mediated DNA relaxation reaction  studied following modification of the enzyme at the active site  tyrosine (position 723) <117>; #11# Identification of proteins that  bind nicked DNA intermediates formed in the course of base excision  repair (BER) in cell free extracts of Saccharomyces cerevisiae. Using a  photocrosslinking technique with photoactivable dNTP analogues to trap  proteins that interact with damaged DNA. Top1 has the potential to  interfere with base excision repair in vivo <124>; #32# Vaccinia DNA  topoisomerase (vTopo) catalyzes highly specific nucleophilic  substitution at a single phosphodiester linkage in the pentapyrimidine  recognition sequence 5-(C/T)+5C4+C3+T+2T+1pN-1 using an active-site  tyrosine nucleophile, thereby expelling a 5hydroxyl leaving group of  the DNA. Equilibrium binding and cleavage measurements. Cleavage  reactions and modified substrates for vTopo, kinetic and thermodynamic  parameters for variable length vTopo substrates with guanine base  substitutions and deletions are shown <118>; #8# catalytic mechanism of  DNA cleavage/religation and molecular basis for selectivity of a  cytosine base at the -4 position. E9 acts as a general base in DNA  cleavage, assisted by charge relay through D111 and H365 <219>; #9#  deprotonation of the 5 DNA end might be the limiting step in the  topoisomerase religation mechanism <228>; #8# mechanism of DNA  relaxation for type IA topoisomerases, overview <223>)  "
5.6.2.2," ATP-dependent breakage, passage and rejoining of double-stranded DNA  (#7# processive mode of the reaction can be shifted to a distributive  mode under three different conditions: 1. high ionic strength, above  170 mM, 2. high Mg2+ concentration, above 15 mM, 3. pH-values above 10  in glycine buffer <6>; #3# characterization of interactions between  topoisomerase II and DNA which occurs after DNA strand passage but  before enzyme turnover <34>; #14# model in which the DNA-bound enzyme  acts as an ATP-operated clamp for the capture and transport of a second  DNA segment <54>; #15# enzyme is involved in the chromosome segregation  that occurs at the end of the DNA replication <22>; #7# the catalytic  cycle of topoisomerase II consists of 5 distinct steps: DNA binding,  the pre-strand passage breakage-religation equilibrium, strand passage,  the post-strand passage breakage-religation equilibrium and ATP  hydrolysis/enzyme turnover <23>; #5# mechanistic models of DNA gyrase  <6>; #7# mechanistic studies <5>; #40# active site mapping, catalytic  residue Tyr775 in the gyrase half of the Leishmania enzyme is  responsible for DNA binding, breakage, and rejoining <114>; #12# active  site Y805 <89,107>; #90# catalytic residue is Y815, active site  structure includes residues Q789, D799, A801, S802, R804, and Y805  <105>; #18# relaxation mechanism <116>; #12,14# reaction mechanism,  overview <206>; #3# the DNA substrate undergoes an enzyme-mediated  transition between a closed and open state in the presence of ATP.  Transition has comparable rate constants for both the opening and  closing reaction during steady-state ATP hydrolysis, with an apparent  equilibrium constant near unity. The open and closed states do not  interconvert at a measurable rate <150>; #14# metal-dependent general  acid-base catalysis, quantum mechanical/molecular mechanical  calculations for the topo II religation reaction, substrate-mediated  proton transfer pathway, which involves the 3-OH nucleophile, the  reactive phosphate, water, Arg781, and Tyr782, metal A stabilizes the  transition states, which is consistent with a two-metal mechanism in  topo II, overview <257>)  "
5.6.2.3, Couples ATP hydroysis with the unwinding of duplex DNA at the  replication fork by translocating in the 5'-3' direction. This creates  two antiparallel DNA single strands (ssDNA). The leading ssDNA polymer  is the template for DNA polymerase III holoenzyme which synthesizes a  continuous strand.  
5.6.2.4, Couples ATP hydroysis with the unwinding of duplex DNA by translocating  in the 3'-5' direction.  
5.99.1.1, Benzyl isothiocyanate = benzyl thiocyanate  
5.99.1.4, 2-hydroxy-2H-chromene-2-carboxylate =  (3E)-4-(2-hydroxyphenyl)-2-oxobut-3-enoate  
6.1.1.1," ATP + L-tyrosine + tRNATyr = AMP + diphosphate + L-tyrosyl-tRNATyr  (#4,7# mechanism <44,58>; #7# amino acid residues Y37 and Q195 are  involved in substrate specificity determination <56>; #6# mechanism,  class I enzyme has a class II mode of cognate tRNA recognition <47>;  #13# mechanism, residues Asp78, Tyr169, Gln173, Asp194, and Gln195 are  involved in catalysis <54>; #8# S224 and S226 are involved in the  catalytic mechanism, the sequence 222KKSSS226, termed KMSSS motif,  stabilizes the the transition state for the tyrosine activation  reactionby interacting with the diphosphate moiety of ATP <53>; #3#  S356 and K395 play key roles in tRNA binding, H306, a residue at the  junction of the catalytic and tRNA binding domains, stabilizes the  Tyr-AMP:enzyme complex <48>; #13# the 230KFGKT234 sequence, termed the  KMSKS motif, participates in catalysis of the tyrosine activation  reaction, specifically Lys230, Lys233, and Thr234 stabilize the  transition state by interacting with the diphosphate moiety of the ATP  cofactor <53>; #4,13# the adenine ring is important to the binding of  tyrosinyl adenylate to the enzyme, important water-mediated hydrogen  interactions <45>; #8# functional importance of Ser200 in the catalytic  domain in line with an involvement of A73 rather than N1-N72 in  tyrosine identity, active site structure, role of clusters 1 and 2 in  tRNATyr acceptor arm <70>; #31# reaction via reactive  aminoacyl-adenylate intermediate, anticodon recognition mode and  involved residues Tyr43, Asp177, Tyr170, Gln174 and Gln192, overview,  the lack of cross-reactivity between archaeal/eukaryotic and bacterial  TyrRS-tRNATyr pairs most probably lies in the different sequence of the  last base pair of the acceptor stem, C1-G72 vs G1-C72, of tRNATyr <68>;  #29# molecular dynamics simulations of TyrRS in its free form and  complexed with Tyr, ATP, tyrosyl adenylate and inhibitor respectively  are carried out to investigate the ligand-linked conformational  stability changes associated with its catalytic cycle. Unliganded TyrRS  samples a more relaxed conformational space than substrate-bound TyrRS.  There are three high flexibility regions encompassing residues 114-118,  128-133, and 226-238 respectively. The region which includes the KFGKS  motif shows the highest difference in fluctuations <73>)  "
6.1.1.10," ATP + L-methionine + tRNAMet = AMP + diphosphate + L-methionyl-tRNAMet  (#9# active site structure and reaction mechanism involving Tyr15 and  Thr10, Tyr94 is involved in maintaining the native enzyme conformation  <38>; #12# amino acid residues D138, R139, and F135 are important for  activity <43>; #42# amino acid residues involved in tRNA binding are  K30, N66, S78, and M81 <32>; #10# mechanism, catalytic domain is formed  by amino acid residues A215-K823 <31>; #15# reaction mechanism, Lys261,  Lys295, and Lys301 are located in the catalytic crevice of the enzyme  <45>; #34# substrate binding and mechanism <44>; #8,9# substrate  recognition and structure <30>; #9# substrate recognition, editing,  binding and reaction mechanism <42>; #37# the amino acid acceptor arm  of tRNAMet binds to the plant enzyme <35>; #20# the anticodon sequence  is important for tRNA substrate specificity <39>; #43# two-step  reaction process via anenzyme-L-Met-AMP intermediate <50>; #9# the  aminoacylation reaction is a two-step mechanism: in the first step, the  synthetase recognizes the appropriate amino acid and activates it with  ATP to form the activated intermediate, an aminoacyl-adenylate, aa-AMP,  the second step transfers the aminoacyl moiety onto the 3-hydroxyl of  the CCA end of the tRNA, the methionine-binding pocket is composed of  residues Ala12, Leu13, Tyr15, Trp253, Ala256, Pro257, Tyr260, Ile297,  His301, and Trp305 <57>)  "
6.1.1.11," ATP + L-serine + tRNASer = AMP + diphosphate + L-seryl-tRNASer (#1#  reaction mechanism <47>; #8# catalytic mechanism, specificity of  substrate binding is mediated by the amino acids in motif 2 loop <30>;  #15# subtrate recognition mechanism <28>; #27,28# the tRNA recognition  mechanism of mammalian mitochondrial enzyme differs considerably from  that of its prokaryotic counterpart <33>; #26# the tRNA recognition  mechanism of mammalian mitochondrial enzymediffers considerably from  that of its prokaryotic counterpart <33>; #26# tRNA recoginition  mechanism, dual recognition mode for isoacceptors, the mitochondrial  isozyme specifically recognizes the TPiC loop sequence in each  isoacceptor <34>; #8# tRNA substrate discrimination mechanism <31>)  "
6.1.1.12," ATP + L-aspartate + tRNAAsp = AMP + diphosphate + L-aspartyl-tRNAAsp  (#14# mechanism <42>; #10# active site structure <44>; #9# active site  residues <37>; #10# Asn binding sites K198 and H449, binding mechanism  and free energies <46>; #28# conserved amino acid residues of  functional importance in consensus motifs: Pro227 in motif 1, Arg332  and Glu334 in motif 2, Gly675, Gly679, Asp681, Arg682, and Pro700 in  motif 3 <31>; #28# conserved amino acid residues of functional  importance in consensus motifs: Pro227 in motif 1, Arg332 and Glu334 in  motif 2, Gly675, Gly679, Glu681, Arg682, and Pro700 in motif 3 <31>;  #9,24# determination of structural features for discriminating or  nondiscriminating aminoacylation activity <38>; #9,14# mechanism,  active site structure, substrate binding, simulations of binding and  free energy <41>; #10# mechanism, active site structure, substrate  binding, simulations of binding and free energy, protein-ligand  modeling <41>; #9# pathway for tRNA binding and recognition is proposed  <43>; #10# protein-RNA recognition mechanism, backbone interactions are  an important functional component of the tRNA synthetase interaction  <48>; #14# RNA-binding motif XSKXXLKKXK <47>; #37# active site  structure, AspRS substrate recognition and chiral specificity of  wild-type enzyme and mutant Q199E, substrate binding in regular versus  inverted orientation, overview <58>; #37# active site structure, ligand  and substrate binding, and reaction mechanism <57>)  "
6.1.1.13, ATP + D-alanine + poly(ribitol phosphate) = AMP + diphosphate +  O-D-alanyl-poly(ribitol phosphate)  
6.1.1.14, ATP + glycine + tRNAGly = AMP + diphosphate + glycyl-tRNAGly (#20#  `half-of-the-sites mechanism in aminoacylation <2>)  
6.1.1.15," ATP + L-proline + tRNAPro = AMP + diphosphate + L-prolyl-tRNAPro (#16#  bi uni ping pong mechanism <17>; #16# ATP is the first substrate to  enter into the reaction sequence and prolyl-tRNA is the last product to  dissociate from the enzyme <17>; #22# dual substrate specificity <33>;  #30# enzyme with dual substrate specificity which utilizes L-proline  and L-cysteine as substrates, discriminating mechanism <25>; #15#  induced fit substrate recognition, reaction mechanism, proline binding  site structure <32>; #15# substrate binding mechanism, the two bases  G35 and G36 are sufficient to uniquely identify the cognate tRNAPro  <35>; #15# the C-terminal extremity folds back into the active site  <24>; #16# two-step reaction, Asp350 is involved in the pre-transfer  editing of alanine <22>; #22,30# one tRNA binds per dimeric enzyme,  only 50% of active sites are active <38>; #35# class II synthetases are  limited by a step prior to aminoacyl transfer <43>)  "
6.1.1.16," ATP + L-cysteine + tRNACys = AMP + diphosphate + L-cysteinyl-tRNACys  (#24# substrate binding mechanism, induced fit <20>; #24# the class I  tRNA synthetase CysRS is rate-limited by release of aminoacyl-tRNA,  class I synthetases share two signature motifs, HIGH and KMSKS, and  build their active site by the ubiquitous Rossmann nucleotide-binding  fold, the tight aminoacyl-tRNA product binding by class I enzymes  correlates with the ability of EF-Tu to form a ternary complex with  class I but not class II synthetases, and the further capacity of this  protein to enhance the rate of aminoacylation by class I synthetases  <30>)  "
6.1.1.17," ATP + L-glutamate + tRNAGlu = AMP + diphosphate + L-glutamyl-tRNAGlu  (#13# concerted mechanism <20>; #13# ATP and tRNAGlu bind randomly to  the free enzyme, whereas glutamate binds only to the ternary  enzyme-tRNAGlu-ATP complex. After interconversion of the quarternary  enzyme-substrate complex the end-products dissociate in the order:  diphosphate, AMP, Glu-tRNA <28>; #39# catalytic site structure,  substrate binding and reaction mechanism <45>; #13# the major  recognition element of the tRNAGlu is U at position 34 <47>; #40#  random binding of ATP and L-glutamate to the enzyme-tRNA complex <73>;  #39# the transfer of amino acid to tRNA is accompanied by the  protonation of AMP to H-AMP. Subsequent migration of proton to water  reduces the stability of the complex and loosens the interface both in  the presence and in the absence of AMP. The subsequent undocking of AMP  or tRNA then proceeds along thermodynamically competitive pathways.  Release of the tRNA acceptor stem is further accelerated by the  deprotonation of the alpha-ammonium group on the charging amino acid.  The proposed general base is Glu41 <75>; #46# a two-step reaction , in  the first step, the enzyme condenses the cognate amino acid and ATP,  forming an aminoacyl-adenylate intermediate with a diphosphate as the  leaving group. This reaction is reversible in the absence of the tRNA.  In the absence of tRNAGlu, ATP binding by GluRS is nonproductive  because the alpha-phosphate of ATP and the alpha-carboxyl groups of Glu  are positioned too far apart for a reaction to occur. The presence of  tRNAGlu causes conformational changes surrounding the ATP binding site,  allowing ATP to bind in the productive state, which moves the  alpha-phosphate of the ATP closer to the alpha-carboxyl groups of Glu,  allowing the reaction for the formation of the glutamyl-AMP  intermediate to occur <88>; #41# aminoacylation reaction via a two-step  mechanism involving a very unstable aa-AMP intermediate <91>)  "
6.1.1.18," ATP + L-glutamine + tRNAGln = AMP + diphosphate + L-glutaminyl-tRNAGln  (#5# active site residues are Tyr240 and Phe90 <25>; #15#  aminoacylation reaction mechanism, substrate binding sites, Tyr211 and  a water molecule are responsible for recognition of both hydrogen atoms  of the nitrogen of glutamine sidechain, which is esstial for substrate  recognition <30>; #5# binding of ATP and of tRNAGln induces  conformational changes that change the interaction of the enzyme with  the cognate tRNA, crucial for substrate recognition and selectivity  <29>; #16# structureÂ–function relationship, overview <41>)  "
6.1.1.19," ATP + L-arginine + tRNAArg = AMP + diphosphate + L-arginyl-tRNAArg (#2#  simultaneously with the release of AMP or diphosphate an allosteric  rearrangement occurs. Cooperative binding of AMP and diphosphate  indicates that aminoacylation reaction and backward reaction are  concerted <3>; #2# random ter-ter mechanism, with addition of the three  substrates and release of the products in random order <24>; #12#  mechanism includes the formation of an enzyme-bound aminoacyl-adenylate  as an intermediate in the first step followed by transfer of the amino  acid to tRNA <23>; #5# random addition of substrates with all steps in  rapid equilibrium except for the interconversion of the central  quarternary complexes <22>; #11# rapid equilibrium random ter ter  mechanism <28>)  "
6.1.1.2," ATP + L-tryptophan + tRNATrp = AMP + diphosphate + L-tryptophyl-tRNATrp  (#5# 2-step reaction, tRNATrp substrate recognition, mechanism and  modeling <22>; #30# active site, 2 critical positions for amino acid  discrimination <34>; #40# random, bi-bi kinetic scheme mechanism, KMSKS  motif loop is involved in the catalytic mechanism <30>; #30# wide  opening active site that adopts a compact conformation, modeling of  substrate recognition and binding <29>; #17# a nested, nonlinear model  for the sum of metal-free and metal-catalyzed activities and its use in  determining metal-free enzyme activity jointly with transition-state  metal binding affinity is described, by fitting observed values  obtained from Mg2+-depleted assays with increasing EDTA concentrations  at known Mg2+ concentrations. Trp activation by TrpRS falls  asymptotically to a plateau value 5 orders of magnitude below that  observed for the Mg2+-supplemented enzyme at EDTA concentrations that  reduce the free metal concentration to below 1 pmolar. The fitted  regression model parameters yield a relative rate acceleration of 93000  attributable to the catalytic effect of Mg2+ and an enhanced transition  state binding of Mg2+. Factorial analysis indicates that 80% of the  reduction in free energy of activation effected by TrpRS arises from  protein-ligand interactions <55>; #30# recognition of Trp is by an  induced-fit mechanism involving conformational change of the AIDQ motif  that creates a perfect pocket for the binding and activation of Trp and  causes coupled movements of the N-terminal and C-terminal domains. The  KMSAS loop has an inherent flexibility and binding of ATP stabilizes it  in a closed conformation that secures the position of ATP for  catalysis. Structural data indicate that the catalytic mechanism of the  Trp activation reaction by hTrpRS involves more moderate conformational  changes of the structural elements at the active site compared to  bacterial TrpRS <56>)  "
6.1.1.20," ATP + L-phenylalanine + tRNAPhe = AMP + diphosphate +  L-phenylalanyl-tRNAPhe (#17# reaction mechanism in which ATP and  phenylalanine enter the reaction in an obligatory ordered fashion. A  random mechanism is not completely eliminated <26>; #14# reaction  mechanism <48>; #14# mechanism, the reaction intermediate is bound to  the active site cleft in the catalytic alpha-subunit <61>; #35# Phe391  in motif 2 and Arg472 in motif 3 bind to the adenosine moiety of  tRNAPhe, Arg379 in motif 2 and Arg463 in motif 3 restrain the  conformation with the triphosphate that interacts with the ribosyl  hydroxyl and gamma-phosphate, Asp395 in motif 2 is unique and binds to  phenylalanine to assure proper positioning of the substrate <59>; #14#  substrate binding mechanism, residues S180, Q218, E220, W149, H178,  R204, and Q218 are involved in binding of phenylalanine via hydrogen  bonds <63>; #29# tRNA channeling mechanism <55>; #36# tRNA recognition  and binding mode <50>; #16# tRNAPhe substrate binding mechanism,  base-specific interactions between the 3-end of the tRNA and the  enzymes alpha- and beta-subunit <51>; #39# two-step reaction, the  second reaction step is the ester bond formation between the 2-hydroxyl  group of the 3-terminal adenosine base of the tRNA and the carboxylic  acid function of phenylalanine <62>; #42# residue N217 is essential for  catalysis <79>)  "
6.1.1.21," ATP + L-histidine + tRNAHis = AMP + diphosphate + L-histidyl-tRNAHis  (#8# two molecules of ATP and histidine are bound per molecule of  enzyme <16>; #40,41# 2-step mechanism, elucidation of  structure-activity relationship, the N-terminal catalytic domain  contains the six-stranded antiparallel beta-sheet and the three motifs  characteristics of class II aaRS, a HisRS-specific helical domain  inserted between motifs 2 and 3 that may contact the acceptor stem of  the tRNA, a C-terminal alpha/beta domain may be involved in the  recognition of the anticodon stem and loop of tRNAHis <33>; #8#  interaction mechanism of RNA substrate and enzyme, active site  structure <32>; #38# mechanism, active site structure, ligand induced  structural changes, highly cooperative dynamics <31>; #11# N73 is a  discriminator base involved in histidylation activity, substrate  recognition mechanism <36>; #40# substrate-assisted concerted  mechanism, rate of aminoacyl transfer is independent of the interaction  between the carboxamide group of Q127 and the alpha-carboxylate carbon  <37>; #8# the major groove amine of C73 and the 6-keto oxygen of G-1 of  tRNAHis participate in hydrogen bonding with histidine-tRNA ligase,  while the 5-monophosphate provides necessary electrostatic interactions  with the positive residues of enzyme active site <38>; #4,7,8# relation  between the conservation of active site residues and the molecular  mechanism of aminoacylation reaction, relevant reaction coordinate and  the orientation of the catalytic residue, Arg259, model of active site  with the substrates, Mg2+ ions and water, overview. Calculation of the  transition state structures of the activation step of aminoacylation  reaction using the combined ab-initio/semi-empirical calculation <50>)  "
6.1.1.22," ATP + L-asparagine + tRNAAsn = AMP + diphosphate +  L-asparaginyl-tRNAAsn (#17# mechanism of substrate specificity,  structure of substrate binding sites <11>; #20# substrate binding  structure, active site structure, tRNAAsn and amino acid recognition,  binding of Asn-AMP induces a conformational change in AsnRS <17>)  "
6.1.1.23," ATP + L-aspartate + tRNAAsx = AMP + diphosphate + L-aspartyl-tRNAAsx  (#7# residues H31 and G83 are important determinants for substrate  specificity towards tRNA substrates, molecular modeling <7>; #14#  substrate anticodon, GUC for aspartate and GUU for asparagine,  recognition site structure and mechanism <9>; #7# via reaction  intermediate L-aspartyl adenylate <12>)  "
6.1.1.24, ATP + L-glutamate + tRNAGlx = AMP + diphosphate + glutamyl-tRNAGlx 
6.1.1.24, ATP + L-glutamate + tRNAGlx = AMP + diphosphate + L-glutamyl-tRNAGlx  (#12# active site structure and substrate recognition <11>)  
6.1.1.26, ATP + L-pyrrolysine + tRNAPyl = AMP + diphosphate + L-pyrrolysyl-tRNAPyl  
6.1.1.27, ATP + O-phospho-L-serine + tRNACys = AMP + diphosphate +  O-phospho-L-seryl-tRNACys (#7# anticodon recognition mechanism <1>)  
6.1.1.3," ATP + L-threonine + tRNAThr = AMP + diphosphate + L-threonyl-tRNAThr  (#36# active site structure <28>; #6# functional mechanism and  substrate recognition, editing model, 2 separate active sites for  substrate binding, binding of tRNA is more specific than the binding of  the amino acid <23>; #6# induced fit, Trp434 is involved in  conformational changes during substrate binding <22>; #6# mechanism,  active site structure, and substrate recognition method <24>; #34#  substrate binding and mechanism <26>; #6# the catalytic domain is  located at the C-terminus of the enzyme <27>; #22# determination of  substrate binding sites, catalytic sites, and catalytic mechanism from  structure modeling <35>; #36# reaction mechanism analysis by QM/MM and  MM modeling of full length and truncated enzyme, molecular mechanism  simulation <36>; #9# reaction mechanism and structure-function  relationship, modeling, overview <55>; #36# reaction mechanism and  structure-function relationship, overview. Molecular dynamics  simulation study of the dynamics of the active site organization during  charging step of dimeric ThrRS from Escherichia coli (ecThrRS) bound  with ectRNAThr <62>)  "
6.1.1.4," ATP + L-leucine + tRNALeu = AMP + diphosphate + L-leucyl-tRNALeu (#17#  bi uni uni bi ping-pong mechanism with ordered addition of ATP and  leucine and random release of AMP and leucyl-tRNALeu <16>; #14# each  amino acid is bound through its carboxyl group to the terminal  nucleotide (2- or 3-hydroxyl end) of specific polynucleotide chains  <11>; #22# ATP and tRNA are bound to the enzyme in almost random order,  and diphosphate is dissociated before the rate-limiting step <6>; #14#  A293 is important for the stability of the enzyme conformation and the  editing function and probably is involved in the ATP binding <36>; #36#  active site structure and mechanism, the editing active site binds the  two different substrates using a single amino acid discriminatory  pocket while preserving he same mode of adenine recognition, Asp347 is  involved in the editing process, mechanism of hydrolysis <45>; #14#  Asp345 is involved in the editing process, mechanism of hydrolysis  <45>; #17# Asp419 is involved in the editing process, mechanism of  hydrolysis <45>; #27# recognition of the tRNALeu requires the  discriminator base A73 and the long variable arm of appropriate stem  length, especially the Haloferax volcanii-specific loop sequence  A47CG47D and U47H at the base of the helix <43>; #14# residue E292 is  important for aminoacylation activity <44>)  "
6.1.1.5," ATP + L-isoleucine + tRNAIle = AMP + diphosphate + L-isoleucyl-tRNAIle  (#10# mechanism of aminoacylation in absence of diphosphatase is  ordered ter-ter, in presence of diphosphatase random bi-uni uni-bi  ping-pong <29>; #22# active site structure and mechanism <44>; #23#  editing and substrate recognition and binding mechanism, important  involved residues are Asp238, Thr228, Thr229, and Thr230 <43>; #3#  reaction kinetics and mechanism <37>; #6# substrate recognition  mechanism, Glu551, Thr48, His581 and Lys594are involved <41>; #26#  catalytic and kinetic mechanism analysis, reaction cycle, overview <61>)  "
6.1.1.6," ATP + L-lysine + tRNALys = AMP + diphosphate + L-lysyl-tRNALys (#8,12#  sequential ordered mechanism <8,27>; #6,37# active site structure <40>;  #6# two-step reaction mechanism <32>; #56# active site structure and  substrate binding <33>; #37# bases N73, U35 and U36 play an important  role in tRNA substrate recognition <46>; #54# mechanism of tRNALys and  L-lysine binding <43>; #12# Trp314 is involved in binding of L-lysine,  binding renders the non-polar microenvironment of the residue more  polar <41>; #12# two-step binding mechanism <35>; #45# residue Glu411  plays a key role in the arrangement of diphosphate for the nucleophilic  attack <81>)  "
6.1.1.7," ATP + L-alanine + tRNAAla = AMP + diphosphate + L-alanyl-tRNAAla (#3#  kinetic mechanism, AlaRS belongs to the class II of aminoacyl-tRNA  ligases due to the position of aminoacylation on the 3-terminal tRNA  ribose, and the topology and tRNAbinding orientation of the active-site  protein fold, class II synthetases are rate-limited by a step prior to  aminoacyl transfer, the distinct mechanistic signatures of class I  versus class II tRNA synthetases ensure rapid turnover of  aminoacyl-tRNAs during protein synthesis <29>)  "
6.1.1.9," ATP + L-valine + tRNAVal = AMP + diphosphate + L-valyl-tRNAVal (#2#  Lys593 and Lys554 are in the active site binding valine or threonine,  part of the 554KMSKS558 consensus sequence, mechanism, determination of  diverse amino acid residues of the enzyme molecule involved in  substrate binding, Lys277 plays a crucial role in the fidelity of tRNA  aminoacylation by the enzyme, nucleophilic attack of misacylated tRNA  in the diting site of the enzyme <26>; #1# mechanism and structural  basis of molecular interactions of the enzyme with the C34A35C36  anticodon for tRNAVal recognition by the enzyme <31>; #1# pre- and  post-transfer editing mechanism, mechanism, active site/editing site  <27>; #2# substrate binding mechanism, bases A73 and C75 are involved  in the tRNA substrate recognition and editing reaction <29>; #2#  tRNAVal 3-end, and a purine at position 76, is crucial for substrate  editing mechanism <25>)  "
6.1.2.1," D-alanine + (R)-lactate + ATP = D-alanyl-(R)-lactate + ADP + phosphate  (#7# Arg301 has a dual function in a sequential reaction mechanism,  i.e. substrate orientation in subsite 2 aswell as stabilization of the  transition state, overview <4>)  "
6.1.2.2, carbamoyl phosphate + ATP + H2O = diphosphate + O-carbamoyladenylate +  phosphate 
6.1.2.2, O-carbamoyladenylate + tobramycin = AMP + nebramycin 5' 
6.1.2.2, O-carbamoyladenylate + kanamycin A = AMP + 6''-O-carbamoylkanamycin A 
6.1.2.2, tobramycin + carbamoyl phosphate + ATP + H2O = nebramycin 5' + AMP +  diphosphate + phosphate 
6.1.2.2, kanamycin A + carbamoyl phosphate + ATP + H2O =  6''-O-carbamoylkanamycin A + AMP + diphosphate + phosphate  
6.1.3.1," ATP + a (2R,3S)-2-alkyl-3-hydroxyalkanoate = AMP + diphosphate + a  cis-3-alkyl-4-alkyloxetan-2-one  "
6.2.1.1," ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA (#8# ordered bi  uni uni bi ping-pong mechanism with ordered substrate addition and  release <5>; #33# reaction mechanism involving ([Fe4S4]2+ Nip2+ Nid2+)  cluster <62>; #32# the ACD reaction follows a four-step mechanism  including transient phosphorylation of two active site histidine  residues, structure and reaction mechanism of ACD <66>)  "
6.2.1.10, GTP + a carboxylate + CoA = GDP + phosphate + acyl-CoA  
6.2.1.11, ATP + biotin + CoA = AMP + diphosphate + biotinyl-CoA  
6.2.1.12," ATP + 4-coumarate + CoA = AMP + diphosphate + 4-coumaroyl-CoA (#28# bi  uni uni bi ping pong mechanism, catalytic reaction scheme and kinetics,  overview <71>)  "
6.2.1.13," ATP + acetate + CoA = ADP + phosphate + acetyl-CoA (#3# reaction  mechanism and structural modelling, formation of enzyme-bound acetyl  phosphate and enzyme phosphorylation at His257alpha, overview <15>;  #19# reaction mechanism: the formation of enzyme-bound acetyl phosphate  and enzyme phosphorylation at His-257alpha, respectively, proceeds in  analogy to succinyl-CoA synthetases. In contrast to succinyl-CoA  synthetases, in acetyl-CoA synthetase the phosphoryl group is  transferred from the His-257alpha to ADP via transient phosphorylation  of a second conserved histidine residue in the beta-subunit,  His-71alpha. It is proposed that acetyl-CoA synthetase reaction follows  a four-step mechanism including transient phosphorylation of two active  site histidine residues <15>; #21# the enzyme uses a four-step reaction  mechanism including an additional phosphoryl transfer step, the  important His252, located in the beta subunit, is invovled <22>)  "
6.2.1.14, ATP + 6-carboxyhexanoate + CoA = AMP + diphosphate +  6-carboxyhexanoyl-CoA (#13# strutcure-function analysis <9>)  
6.2.1.15, ATP + arachidonate + CoA = AMP + diphosphate + arachidonoyl-CoA  
6.2.1.16, ATP + acetoacetate + CoA = AMP + diphosphate + acetoacetyl-CoA  
6.2.1.17, ATP + propanoate + CoA = AMP + diphosphate + propanoyl-CoA  
6.2.1.18, ATP + citrate + CoA = ADP + phosphate + (3S)-citryl-CoA  
6.2.1.19, ATP + a long-chain fatty acid + [protein]-L-cysteine = AMP +  diphosphate + a [protein]-S-(long-chain-acyl)-L-cysteine  
6.2.1.2," ATP + a medium-chain fatty acid + CoA = AMP + diphosphate + a  medium-chain acyl-CoA (#8# bi uni uni bi ping-pong mechanism, in which  the order of addition and evolution of substrates and products is ATP,  butyrate, diphosphate, CoA, butyryl-CoA or AMP, and AMP or butyryl-CoA.  Butyryl-CoA and AMP are evolved at random or at the same time <4>)  "
6.2.1.20, ATP + a long-chain fatty acid + an [acyl-carrier protein] = AMP +  diphosphate + a long-chain acyl-[acyl-carrier protein]  
6.2.1.22, ATP + acetate + holo-[citrate (pro-3S)-lyase] = AMP + diphosphate +  acetyl-[citrate (pro-3S)-lyase]  
6.2.1.23," ATP + an alpha,omega-dicarboxylate + CoA = AMP + diphosphate + an  omega-carboxyacyl-CoA  "
6.2.1.24, ATP + phytanate + CoA = AMP + diphosphate + phytanoyl-CoA  
6.2.1.25," ATP + benzoate + CoA = AMP + diphosphate + benzoyl-CoA (#19#  ATP-dependent, two-step mechanism of a benzoate:CoA ligase in the  presence of magnesium, overview. The enzyme follows a mechanism that  involves substrate binding in the thiolation conformation, followed by  substrate rotation to an active orientation upon the transition to the  adenylation conformation <28>)  "
6.2.1.26," ATP + 2-succinylbenzoate + CoA = AMP + diphosphate +  4-(2-carboxyphenyl)-4-oxobutanoyl-CoA (#6# kinetic ordered bi uni uni  bi ping-pong mechanism <10>; #1,2,4# bi uni uni bi ping-pong kinetic  mechanism <12>; #8# the enzyme adopts an ordered bi uni uni bi  ping-pong mechanism, which involves ATP as the first binding substrate  and a large conformational change during the catalysis. In MenE  catalysis, tight gripping interactions of the phosphate-binding loop  (P-loop) with the ATP triphosphate moiety and an open-closed  conformational change to form a compact adenylation active site create  a new binding site for the carboxylate substrate. Analysis of the  adenylation half-reaction in the domain alteration catalytic mechanism  of the adenylateforming enzymes, open-closed conformational change in  ATP configuration of the adenylation active site <13>)  "
6.2.1.27, ATP + 4-hydroxybenzoate + CoA = AMP + diphosphate +  4-hydroxybenzoyl-CoA (#4# pathway <3>)  
6.2.1.28," ATP + (25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-26-oate + CoA = AMP  + diphosphate + (25R)-3alpha,7alpha-dihydroxy-5beta-cholestanoyl-CoA  "
6.2.1.3," ATP + a long-chain fatty acid + CoA = AMP + diphosphate + an acyl-CoA  (#6# mitochondrial long chain fatty acyl-CoA ligase, unlike short chain  ligases and medium chain ligases, does not utilize an adenylate as an  intermediate in the formation of fatty acyl-CoA <34>)  "
6.2.1.30, ATP + phenylacetate + CoA = AMP + diphosphate + phenylacetyl-CoA  
6.2.1.31, ATP + 2-furoate + CoA = AMP + diphosphate + 2-furoyl-CoA  
6.2.1.32," ATP + anthranilate + CoA = AMP + diphosphate + anthraniloyl-CoA (#3#  reaction via anthraniloyl-AMP intermediate. The catalytic cycle of PqsA  consists of two steps: in the first half-reaction of PqsA  (adenylation), anthranilate is activated with ATP/Mg2+ to produce the  intermediate anthraniloyl-AMP with the release of diphosphate. The aryl  moiety is then transferred to the acceptor molecule CoA to form  anthraniloyl-CoA in the second half-reaction (thioester formation). The  two half-reactions are cooperatively catalyzed by a large N-terminal  domain and a smaller C-terminal domain separated by a flexible linker,  the latter undergoes large conformational rearrangements in the course  of the catalytic cycle <6>)  "
6.2.1.33," 4-Chlorobenzoate + CoA + ATP = 4-chlorobenzoyl-CoA + AMP + diphosphate  (#1# two-step reaction consisting of the adenylation of  4-chlorobenzoate with adenosine 5-triphosphate followed by acyl  transfer from 4-chlorobenzoyl adenosine 5-monophosphate diester <1>;  #1# 4-chlorobenzoyl-adenosine 5-phosphate diester is formed by the  first partial reaction <2>; #4# kinetic reaction mechanism, overview  <10>; #4# the enzyme alternates between two conformations during  catalysis of the two half-reactions, structure-function analysis,  domain alternation strategy, overview <9>)  "
6.2.1.34, ferulic acid + CoA + ATP = feruloyl-CoA + products of ATP breakdown  
6.2.1.35, ATP + acetate + an [acyl-carrier protein] = AMP + diphosphate + an  acetyl-[acyl-carrier protein]  
6.2.1.36, 3-hydroxypropanoate + ATP + CoA = 3-hydroxypropanoyl-CoA + AMP +  diphosphate  
6.2.1.37, ATP + 3-hydroxybenzoate + CoA = AMP + diphosphate + 3-hydroxybenzoyl-CoA  
6.2.1.38," [(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetate + ATP + CoA = AMP +  diphosphate + [(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA  "
6.2.1.39, ATP + L-glutamate + BtrI acyl-carrier protein = ADP + phosphate +  L-glutamyl-[BtrI acyl-carrier protein] 
6.2.1.39, ATP + L-glutamate + 4-amino butanoyl-[BtrI acyl-carrier protein] = ADP  + phosphate + 4-(gamma-L-glutamylamino)butanoyl-[BtrI acyl-carrier  protein]  
6.2.1.4, GTP + succinate + CoA = GDP + phosphate + succinyl-CoA (#6# catalytic  mechanism <28>)  
6.2.1.40, ATP + 4-hydroxybutanoate + CoA = AMP + diphosphate +  4-hydroxybutanoyl-CoA  
6.2.1.41," ATP +  3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate  + CoA = AMP + diphosphate +  3-[(3aS,4S,7aS)-7a-methyl-1  5-dioxo-octahydro-1H-inden-4-yl]propanoyl-CoA  "
6.2.1.42, ATP + (25S)-3-oxocholest-4-en-26-oate + CoA = AMP + diphosphate +  (25S)-3-oxocholest-4-en-26-oyl-CoA  
6.2.1.43, ATP + 2-hydroxy-7-methoxy-5-methyl-1-naphthoate + CoA = AMP +  diphosphate + 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA  
6.2.1.44, ATP + 3-(methylsulfanyl)propanoate + CoA = AMP + diphosphate +  3-(methylsulfanyl)propanoyl-CoA  
6.2.1.45," ATP + ubiquitin + [E1 ubiquitin-activating enzyme]-L-cysteine = AMP +  diphosphate + S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine  (#4# ATP-dependant formation of C-S thioester bond between the  C-terminal glycine of ubiquitin and a sulfhydryl side group of a  cysteine residue on the E1 protein <12>; #13# E1 consumes ATP and  converts ubiquitin to a transfer-competent, enzyme-bound thioester. The  reaction begins with ubiquitin-adenylate formation and the release of  diphosohate. The active site cysteine of the E1 then displaces the AMP  leading to a ubiquitin-E1 thioester complex <15>; #2# in the  ATP-dependent activation reaction, ubiquitin is covalently attached to  a cysteine residue of the E1 component through a thiol ester bond <16>;  #10# modeling of a cis-binding mechanism of UFM1 to UBA5, trans-binding  mechanism of UFM1 transfer to the E2, UFC1, and UFM1-UBA5 adenylation  domain interactions, overview. Although the active site Cys in the UBA5  apo structure is located at the N terminus of helix H, this Cys is no  longer part of a helical structure in the complex with UFM1.  Conformational changes in UBA5 are required to bring the active site  Cys into the vicinity of UFM1-AMP mixed anhydride bond, leading to  formation of the thioester bond <35>)  "
6.2.1.46, ATP + L-allo-isoleucine + holo-[CmaA peptidyl-carrier protein] = AMP +  diphosphate + L-allo-isoleucyl-[CmaA peptidyl-carrier protein]  
6.2.1.47, ATP + a medium-chain fatty acid + a holo-[acyl-carrier protein] = AMP +  diphosphate + a medium-chain acyl-[acyl-carrier protein]  
6.2.1.48, ATP + L-carnitine + CoA = AMP + diphosphate + L-carnitinyl-CoA  
6.2.1.49, ATP + a long-chain fatty acid + holo-[mycocerosate synthase] = AMP +  diphosphate + a long-chain acyl-[mycocerosate synthase] 
6.2.1.49, ATP + a long-chain fatty acid = diphosphate + a long-chain  acyl-adenylate ester 
6.2.1.49, a long-chain acyl-adenylate ester + holo-[mycocerosate synthase] = AMP  + a long-chain acyl-[mycocerosate synthase]  
6.2.1.5," ATP + succinate + CoA = ADP + phosphate + succinyl-CoA (#49# reaction  mechanism, Glu435 is a key active site residue, overview. Class I  CoA-transferases first bind the acyl-CoA substrate, forming a  carboxylate product and an enzyme-CoA thioester intermediate, which  accounts for the observed ping-pong kinetics and susceptibility to  borohydride inactivation <46>)  "
6.2.1.50, ATP + 4-hydroxybenzoate + holo-[4-hydroxyphenylalkanoate synthase] =  AMP + diphosphate + 4-hydroxybenzoyl-[4-hydroxyphenylalkanoate synthase] 
6.2.1.50, ATP + 4-hydroxybenzoate = 4-hydroxybenzoyl-adenylate + diphosphate 
6.2.1.50, 4-hydroxybenzoyl-adenylate + holo-[4-hydroxyphenylalkanoate synthase] =  AMP + 4-hydroxybenzoyl-[4-hydroxyphenylalkanoate synthase]  
6.2.1.51, ATP + 17-(4-hydroxyphenyl)heptadecanoate +  holo-[(phenol)carboxyphthiodiolenone synthase] = AMP + diphosphate +  17-(4-hydroxyphenyl)heptadecanoyl-[(phenol)carboxyphthiodiolenone  synthase] 
6.2.1.51, ATP + 19-(4-hydroxyphenyl)nonadecanoate +  holo-[(phenol)carboxyphthiodiolenone synthase] = AMP + diphosphate +  19-(4-hydroxyphenyl)nonadecanoyl-[(phenol)carboxyphthiodiolenone  synthase] 
6.2.1.51, ATP + 17-(4-hydroxyphenyl)heptadecanoate = diphosphate +  17-(4-hydroxyphenyl)heptadecanoyl-adenylate 
6.2.1.51, 17-(4-hydroxyphenyl)heptadecanoyl-adenylate +  holo-[(phenol)carboxyphthiodiolenone synthase] = AMP +  17-(4-hydroxyphenyl)heptadecanoyl-[(phenol)carboxyphthiodiolenone  synthase] 
6.2.1.51, ATP + 19-(4-hydroxyphenyl)nonadecanoate = diphosphate +  19-(4-hydroxyphenyl)nonadecanoyl-adenylate 
6.2.1.51, 19-(4-hydroxyphenyl)nonadecanoyl-adenylate +  holo-[(phenol)carboxyphthiodiolenone synthase] = AMP +  19-(4-hydroxyphenyl)nonadecanoyl-[(phenol)carboxyphthiodiolenone  synthase]  
6.2.1.52, ATP + L-firefly luciferin + CoA = AMP + diphosphate + L-firefly  luciferyl-CoA  
6.2.1.53, ATP + L-proline + holo-[L-prolyl-carrier protein] = AMP + diphosphate +  L-prolyl-[L-prolyl-carrier protein] 
6.2.1.53, ATP + L-proline = diphosphate + (L-prolyl)adenylate 
6.2.1.53, (L-prolyl)adenylate + holo-[L-prolyl-carrier protein] = AMP +  L-prolyl-[L-prolyl-carrier protein]  
6.2.1.54, ATP + D-alanine + holo-[D-alanyl-carrier protein] = AMP + diphosphate +  D-alanyl-[D-alanyl-carrier protein] 
6.2.1.54, (D-alanyl)adenylate + holo-[D-alanyl-carrier protein] = AMP +  D-alanyl-[D-alanyl-carrier protein] 
6.2.1.54, ATP + D-alanine = (D-alanyl)adenylate + diphosphate  
6.2.1.55, ATP + [SAMP]-Gly-Gly + [E1 SAMP-activating enzyme]-L-cysteine =  S-[[SAMP]-Gly-Gly]-[[E1 SAMP-activating enzyme]-L-cysteine] + AMP +  diphosphate (#1# overall reaction <4>) 
6.2.1.55, ATP + [SAMP]-Gly-Gly = diphosphate + [SAMP]-Gly-Gly-AMP (#1# (1a) <4>) 
6.2.1.55, [SAMP]-Gly-Gly-AMP + [E1 SAMP-activating enzyme]-L-cysteine =  S-[[SAMP]-Gly-Gly]-[[E1 SAMP-activating enzyme]-L-cysteine] + AMP (#1#  (1b) <4>)  
6.2.1.56, ATP + 4-hydroxybutanoate + CoA = ADP + phosphate + 4-hydroxybutanoyl-CoA  
6.2.1.57, ATP + stearate + a holo-[(hydroxy)phthioceranic acid synthase] = AMP +  diphosphate + a stearoyl-[(hydroxy)phthioceranic acid synthase] 
6.2.1.57, ATP + stearate = diphosphate + (stearoyl)adenylate 
6.2.1.57, (stearoyl)adenylate + a holo-[(hydroxy)phthioceranic acid synthase] =  AMP + a stearoyl-[(hydroxy)phthioceranic acid synthase] 
6.2.1.57, ATP + palmitate + a holo-[(hydroxy)phthioceranic acid synthase] = AMP +  diphosphate + a palmitoyl-[(hydroxy)phthioceranic acid synthase] 
6.2.1.57, ATP + palmitate = diphosphate + (palmitoyl)adenylate 
6.2.1.57, (palmitoyl)adenylate + a holo-[(hydroxy)phthioceranic acid synthase] =  AMP + a palmitoyl-[(hydroxy)phthioceranic acid synthase]  
6.2.1.58, ATP + isophthalate + CoA = AMP + diphosphate + isophthalyl-CoA  
6.2.1.59, ATP + a long-chain fatty acid + holo-[(phenol)carboxyphthiodiolenone  synthase] = AMP + diphosphate + a long-chain  acyl-[(phenol)carboxyphthiodiolenone synthase] 
6.2.1.59, ATP + a long-chain fatty acid = diphosphate + a long-chain fatty-acyl  adenylate ester 
6.2.1.59, a long-chain fatty-acyl adenylate ester +  holo-[(phenol)carboxyphthiodiolenone synthase] = AMP + a long-chain  acyl-[(phenol)carboxyphthiodiolenone synthase]  
6.2.1.6, ATP + glutarate + CoA = ADP + phosphate + glutaryl-CoA  
6.2.1.60, ATP + a marinolic acid + CoA = AMP + diphosphate + a marinoloyl-CoA 
6.2.1.60, ATP + a pseudomonic acid + CoA = AMP + diphosphate + a pseuodomonoyl-CoA  
6.2.1.61, ATP + salicylate + holo-[non-ribosomal peptide synthase] = AMP +  diphosphate + salicyl-[non-ribosomal peptide synthase] 
6.2.1.61, ATP + salicylate = diphosphate + (salicyl)adenylate 
6.2.1.61, (salicyl)adenylate + holo-[non-ribosomal peptide synthase] = AMP +  salicyl-[non-ribosomal peptide synthase]  
6.2.1.62," ATP + 3,4-dihydroxybenzoate + holo-[aryl-carrier protein] = AMP +  diphosphate + 3,4-dihydroxybenzoyl-[aryl-carrier protein] "
6.2.1.62," ATP + 3,4-dihydroxybenzoate = diphosphate +  (3,4-dihydroxybenzoyl)adenylate "
6.2.1.62," (3,4-dihydroxybenzoyl)adenylate + holo-[aryl-carrier protein] = AMP +  3,4-dihydroxybenzoyl-[aryl-carrier protein]  "
6.2.1.63, ATP + L-arginine + holo-[L-arginyl-carrier protein] = AMP + diphosphate  + L-arginyl-[L-arginyl-carrier protein] 
6.2.1.63, ATP + L-arginine = diphosphate + (L-arginyl)adenylate 
6.2.1.63, (L-arginyl)adenylate + holo-[L-arginyl-carrier protein] = AMP +  L-arginyl-[L-arginyl-carrier protein]  
6.2.1.64, ATP + [NEDD8 protein] + [E1 NEDD8-activating enzyme]-L-cysteine = AMP +  diphosphate + [E1 NEDD8-activating enzyme]-S-[NEDD8  protein]-yl-L-cysteine  
6.2.1.65, ATP + salicylate + CoA = AMP + diphosphate + 2-hydroxybenzoyl-CoA 
6.2.1.65, ATP + salicylate = diphosphate + (2-hydroxybenzoyl)adenylate 
6.2.1.65, (2-hydroxybenzoyl)adenylate + CoA = AMP + 2-hydroxybenzoyl-CoA  
6.2.1.66, ATP + glycine + holo-[glycyl-carrier protein] = AMP + diphosphate +  glycyl-[glycyl-carrier protein] 
6.2.1.66, ATP + glycine = diphosphate + (glycyl)adenylate 
6.2.1.66, (glycyl)adenylate + holo-[glycyl-carrier protein] = AMP +  glycyl-[glycyl-carrier protein]  
6.2.1.67, ATP + L-alanine + holo-[L-alanyl-carrier protein] = AMP + diphosphate +  L-alanyl-[L-alanyl-carrier protein] 
6.2.1.67, ATP + L-alanine = diphosphate + (L-alanyl)adenylate 
6.2.1.67, (L-alanyl)adenylate + holo-[L-alanyl-carrier protein] = AMP +  L-alanyl-[L-alanyl-carrier protein]  
6.2.1.68, ATP + L-glutamate + holo-[L-glutamyl-carrier protein] = AMP +  diphosphate + L-glutamyl-[L-glutamyl-carrier protein] 
6.2.1.68, ATP + L-glutamate = diphosphate + (L-glutamyl)adenylate 
6.2.1.68, (L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein] = AMP +  L-glutamyl-[L-glutamyl-carrier protein]  
6.2.1.69, ATP + L-cysteine + holo-[L-cysteinyl-carrier protein] = AMP +  diphosphate + L-cysteinyl-[L-cysteinyl-carrier protein] 
6.2.1.69, ATP + L-cysteine = diphosphate + (L-cysteinyl)adenylate 
6.2.1.69, (L-cysteinyl)adenylate + holo-[L-cysteinyl-carrier protein] = AMP +  L-cysteinyl-[L-cysteinyl-carrier protein]  
6.2.1.7," ATP + cholate + CoA = AMP + diphosphate + choloyl-CoA (#1# bi uni uni  bi ping-pong mechanism with ATP binding first, random release of the  final products <4>)  "
6.2.1.70, ATP + L-threonine + holo-[L-threonyl-carrier protein] = AMP +  diphosphate + L-threonyl-[L-threonyl-carrier protein] 
6.2.1.70, ATP + L-threonine = diphosphate + (L-threonyl)adenylate 
6.2.1.70, (L-threonyl)adenylate + holo-[L-threonyl-carrier protein] = AMP +  L-threonyl-[L-threonyl-carrier protein]  
6.2.1.71," ATP + 2,3-dihydroxybenzoate + holo-[aryl-carrier protein] = AMP +  diphosphate + 2,3-dihydroxybenzoyl-[aryl-carrier protein] "
6.2.1.71," ATP + 2,3-dihydroxybenzoate = diphosphate +  (2,3-dihydroxybenzoyl)adenylate "
6.2.1.71," (2,3-dihydroxybenzoyl)adenylate + holo-[aryl-carrier protein] = AMP +  2,3-dihydroxybenzoyl-[aryl-carrier protein]  "
6.2.1.72, ATP + L-serine + holo-[L-seryl-carrier protein] = AMP + diphosphate +  L-seryl-[L-seryl-carrier protein] 
6.2.1.72, ATP + L-serine = diphosphate + (L-seryl)adenylate 
6.2.1.72, (L-seryl)adenylate + holo-[L-seryl-carrier protein] = AMP +  L-seryl-[L-seryl-carrier protein]  
6.2.1.73, ATP + L-tryptophan + holo-[L-tryptophyl-carrier protein] = AMP +  diphosphate + L-tryptophyl-[L-tryptophyl-carrier protein] 
6.2.1.73, ATP + tryptophan = diphosphate + (L-tryptophyl)adenylate 
6.2.1.73, (L-tryptophyl)adenylate + holo-[L-tryptophyl-carrier protein] = AMP +  L-tryptophyl-[L-tryptophyl-carrier protein]  
6.2.1.74, ATP + 3-amino-5-hydroxybenzoate + a holo-[acyl-carrier protein] =  3-amino-5-hydroxybenzoyl-[acyl-carrier protein] + AMP + diphosphate  
6.2.1.8, ATP + oxalate + CoA = AMP + diphosphate + oxalyl-CoA  
6.2.1.9, ATP + malate + CoA = ADP + phosphate + malyl-CoA (#2# random site  reaction mechanism <4>)  
6.2.2.1, ATP + sulfide + a [methyl-coenzyme M reductase]-glycine = ADP +  phosphate + a [methyl-coenzyme M reductase]-thioglycine  
6.2.2.2," ATP + a [protein]-(L-amino acyl-L-serine) = ADP + phosphate + a  [protein]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-2-oxazoline "
6.2.2.2, ATP + a [protein]-(L-amino acyl-L-threonine) = ADP + phosphate + a  [protein]-(S  S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline 
6.2.2.2," ATP + a [protein]-(L-amino acyl-L-cysteine) = ADP + phosphate + a  [protein]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline  "
6.2.2.3," ATP + a [protein]-(L-amino acyl-L-cysteine) = ADP + phosphate + a  [protein]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline  "
6.3.1.1, ATP + L-aspartate + NH3 = AMP + diphosphate + L-asparagine  
6.3.1.10," ATP + adenosylcobyric acid + (R)-1-aminopropan-2-yl phosphate = ADP +  phosphate + adenosylcobinamide phosphate (#4# this enzyme forms part of  the anaerobic cobalamin biosynthesis pathway, one of the substrates for  this reaction, (R)-1-aminopropan-2-yl phosphate, is produced by CobD,  EC 4.1.1.81, threonine phosphate decarboxylase <3>) "
6.3.1.10, ATP + adenosylcobyric acid + (R)-1-aminopropan-2-ol = ADP + phosphate +  adenosylcobinamide  
6.3.1.11, ATP + L-glutamate + putrescine = ADP + phosphate +  gamma-L-glutamylputrescine  
6.3.1.12, ATP + D-aspartate +  [beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n =  [beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-6-N-(beta-D-Asp)-L-Lys  D-Ala-D-Ala)]n + ADP + phosphate  
6.3.1.13," 1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol +  L-cysteine + ATP =  1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol  + AMP + diphosphate (#1# Bi Uni Uni Bi Ping Pong reaction mechanism  <3>; #5# the mechanism of MshC has been proposed as bi-uni-uni-bi ping  pong using steady state kinetics and positional isotope exchange  studies. In the first phase of the enzymatic reaction, the nucleophilic  attack of carboxylate of cysteine onto the phosphate of ATP leads to  the formation of the cysteine-adenylate intermediate releasing  inorganic diphosphate. This cysteine-adenylate intermediate is attacked  by the amine of GlcN-Ins to form Cys-GlcN-Ins and in the process  releases AMP, which completes the second phase of the enzymatic  reaction, overview. During this stage, the reacting substrates and  coenzymes are held in place by the amino acid residues W227, H55, T46,  and D251 <11>)  "
6.3.1.14, ATP + diphthine-[translation elongation factor 2] + NH3 = AMP +  diphosphate + diphthamide-[translation elongation factor 2]  
6.3.1.15," ATP + 3-dimethylallyl-4-hydroxybenzoate + 3-amino-4,7-dihydroxycoumarin  = AMP + diphosphate + 8-demethylnovobiocic acid  "
6.3.1.17, ATP + citrate + L-glutamate = ADP + phosphate + beta-citryl-L-glutamate  
6.3.1.18, ATP + L-glutamate + aniline = ADP + phosphate + N5-phenyl-L-glutamine  
6.3.1.19," ATP + [prokaryotic ubiquitin-like protein]-L-glutamate +  [protein]-L-lysine = ADP + phosphate + N6-([prokaryotic ubiquitin-like  protein]-gamma-L-glutamyl)-[protein]-L-lysine (#12# PafA catalyzes a  two-step reaction by forming a gamma-glutamyl phosphate-mixed anhydride  intermediate on the C-terminal glutamate of PupE by hydrolyzing ATP,  followed by attaching it to nucleophilic substrates by catalyzing the  formation of isopeptide bonds between PupE C-terminal glutamate  gamma-carboxylate and the side chain of protein substrate lysine  residues, mechanism of PafA self-pupylation, overview. K320 is the  major target residue for the pupylation of PafA. During the  self-pupylation of PafA, the attachment of the first Pup to PafA is  catalyzed by the other PafA molecule through an intermolecular  reaction, while the formation of the polymeric Pup chain is carried out  in an intramolecular manner through the internal ligase activity of the  already pupylated PafA. Among the three lysine residues, K7, K31 and  K61, in Mycobacterium smegmatis Pup, K7 and K31 are involved in the  formation of the poly-Pup chain in PafA poly-pupylation.  Poly-pupylation of PafA can be reversibly regulated by depupylase Dop  <17>; #2,4,5,6,7,8,9,10,11,12,13,14,15# reaction mechanisms of ligation  to substrates and cleavage from pupylated substrates, overview. Pup  passes a process of disorder-to-order transition <15>)  "
6.3.1.2," ATP + L-glutamate + NH3 = ADP + phosphate + L-glutamine  (#8,19,22,23,24,25,26,27,48,65,70,89,104,127,128,129,130,131,132,133  134,136# reaction mechanism <173>; #87# ordered three-reactant system  with the binding order: NH4+, L-Glu and ATP <33>; #14# reaction  mechanism and transition state analogue, overview <173>; #172# random  catalysis mechanism where the binding order of certain substrates is  kinetically preferred by the enzyme <197>; #134# structure-function  relationship and catalytic mechanism, overview <225>; #136# in the  first step of catalysis, a tightly bound, activated intermediate,  gamma-glutamyl phosphate, is formed when the terminal phosphate of ATP  is transferred to the carboxylate side chain of the substrate  glutamate. In the second step, an enzyme-bound ammonium ion is  deprotonated, forming ammonia that attacks the carbonyl carbon of  gamma-glutamyl phosphate to form a tetrahedral intermediate. The enzyme  subsequently releases free phosphate and glutamine <243>)  "
6.3.1.20, ATP + (R)-lipoate = lipoyl-AMP + diphosphate 
6.3.1.20," ATP + (R)-lipoate + a [lipoyl-carrier protein]-L-lysine = a  [lipoyl-carrier protein]-N6-(lipoyl)lysine + AMP + diphosphate (#14#  LplA structures are determined: LplA/lipoyl-AMP binary complex and  LplA/octyl-5-AMP/apoH-protein ternary complex. These structures  represent a post-lipoate adenylation stage and a pre-lipoate transfer  stage, respectively. Three large scale conformational changes in the  Escherichia coli LplA structure upon completion of the lipoate  adenylation reaction are found, which enable LplA to accommodate  apoprotein for the second reaction <20>) "
6.3.1.20, lipoyl-AMP + a [lipoyl-carrier protein]-L-lysine = a [lipoyl-carrier  protein]-N6-(lipoyl)lysine + AMP  
6.3.1.21," ATP + formate + N1-(5-phospho-beta-D-ribosyl)glycinamide = ADP +  phosphate + N2-formyl-N1-(5-phospho-beta-D-ribosyl)glycinamide (#2#  possible catalytic mechanism for PurT transformylase. In this  mechanism, the breakage of the beta-gamma phosphate bond results in a  shift of the Mg2+-formyl phosphate thereby bringing the carbonyl carbon  of the formyl phosphate near the amine of glycinamide ribonucleotide  (GAR). Asp268 functions to deprotonate the amine of GAR, which then  reacts with the carbonyl group of formyl phosphate to release phosphate  and formyl-GAR <4>)  "
6.3.1.4, ATP + L-aspartate + NH3 = ADP + phosphate + L-asparagine  
6.3.1.5," ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+ (#3# flexible  active site loops of residues 82-7 and 204-225, stabilization of the  loop and active site structure, mechanism <9>; #13# mechanism of  two-step procedure, reaction intermediate <10>; #13# reaction  mechanism, determination of deamido-NAD+-binding site, Asp173 is the  key residue in both deprotonation of the primarily bound ammonium ion,  and stabilization of the tetrahedral transition-state intermediate <15>)  "
6.3.1.6, ATP + L-glutamate + ethylamine = ADP + phosphate + N5-ethyl-L-glutamine  
6.3.1.7, ATP + 4-methylene-L-glutamate + NH3 = AMP + diphosphate +  4-methylene-L-glutamine  
6.3.1.8," glutathione + spermidine + ATP = glutathionylspermidine + ADP +  phosphate (#4# the reaction is catalyzed by trypanothione synthase and  glutathionylspermidine synthase in Crithidia fasciculata <13>; #5# the  reaction is catalyzed by trypanothione synthase, EC 6.3.1.9, and  glutathionylspermidine synthase, EC 6.3.1.8, in Crithidia fasciculata  <13>; #4# the kinetic mechanism obeys a rapid equilibrium random  ter-ter model <16>)  "
6.3.1.9," glutathione + spermidine + ATP = glutathionylspermidine + ADP +  phosphate (#2# ter-reactant mechanism of TryS catalysis, modeling,  overview <19>) "
6.3.1.9," glutathione + glutathionylspermidine + ATP =  N1,N8-bis(glutathionyl)spermidine + ADP + phosphate (#7# the reaction  is catalyzed by trypanothione synthase, which also catalyzes the  reaction of glutathionyspermidine synthase, EC 6.3.1.8, in Crithidia  fasciculata, trypanothione synthase further exhibits amidase and  marginal ATPase activities <9>)  "
6.3.2.1," ATP + (R)-pantoate + beta-alanine = AMP + diphosphate +  (R)-pantothenate (#2# bi uni uni bi ping pong mechanism <4>; #12# the  enzyme catalyzes the ATP-dependent condensation of pantoate with  beta-alanine via a pantoyl adenylate intermediate and follows a bi uni  uni bi ping pong kinetic mechanism. The Mg2+ dependent reaction  involves two sequential steps. Initially binding of ATP with pantoate,  leads to formation of pantoyl adenylate and release of diphosphate.  Second step involves nucleophilic attack by beta-alanine on the active  carbonyl group of pantoyl adenylate and subsequent release of AMP and  pantothenate <39>)  "
6.3.2.10," ATP + UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine +  D-alanyl-D-alanine = ADP + phosphate +  UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D  alanine (#6# ordered kinetic mechanism, E158 and H188 are critical for  enzyme activity <6>)  "
6.3.2.11," ATP + L-histidine + beta-alanine = ADP + phosphate + carnosine (#1#  intermediary formation of enzyme bound beta-Ala <12,14>)  "
6.3.2.12," ATP + 7,8-dihydropteroate + L-glutamate = ADP + phosphate +  7,8-dihydropteroylglutamate  "
6.3.2.13," ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate +  meso-2,6-diaminoheptanedioate = ADP + phosphate +  UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2  6-diaminoheptanedioate (#3# acyl phosphate intermediate <7>; #11# Mur  ligase reaction mechanism, overview <23>)  "
6.3.2.14," 6 ATP + 3 2,3-dihydroxybenzoate + 3 L-serine = enterobactin + 6 AMP + 6  diphosphate (#1# L-Ser-adenylate is an enzyme-bound intermediate <6>;  #3# bi-uni-uni-bi ping-pong kinetic mechanism <9>)  "
6.3.2.16, ATP + D-alanine + alanyl-poly(glycerolphosphate) = ADP + phosphate +  D-alanyl-alanyl-poly(glycerolphosphate)  
6.3.2.17," ATP + tetrahydropteroyl-[gamma-Glu]n + L-glutamate = ADP + phosphate +  tetrahydropteroyl-[gamma-Glu]n+1 (#8# ordered ter-ter mechanism with  MgATP binding first, folate second and Glu last <8>; #16# formation of  a pteroyl-gamma-glutamyl phosphate intermediate <20>; #16# the products  are released in the order: ADP, 5,6,7,8-tetrahydropteroyl-Glu2,  phosphate <21>; #16,17# ordered ter ter mechanism with MgATP binding  first to the enzyme, folate second, and glutamate last <17,19,20,23>;  #16# sequential mechanism <3,21>; #6# processive mechanism, in which  the folate is the first substrate to bind and the folate-Glu product is  the last to be released <76>)  "
6.3.2.18, ATP + L-glutamate + histamine = products of ATP breakdown +  Nalpha-gamma-L-glutamylhistamine  
6.3.2.2," ATP + L-glutamate + L-cysteine = ADP + phosphate +  gamma-L-glutamyl-L-cysteine (#5# partially random mechanism in which  ATP is the obligatory first substrate and both amino acids bind in a  random order to the enzyme*ATP complex. Formation of the  enzyme*substrate quarternary complex is necessary prior to release of  products <19>; #23# bi bi uni uni ping pong mechanism, with  glutamyl-enzyme as intermediate before the addition of cys and the  release of gamma-glutamylcysteine <18>; #5# tri tri sequential  mechanism <18>; #3,43# reaction mechanism <43,44,54>; #4# Cys553 is not  the active site residue <39>; #8# enzyme-bound reaction intermediate is  a gamma-glutamyl-phosphate, active site cysteine, catalytic mechanism  and substrate binding <35>; #54# enzyme-bound reaction intermediate is  a gamma-glutamyl-phosphate, active site cysteine, catalytic mechanism,  active site and substrate binding, Lys38 is an active site residue in  the glutamyl binding site, His150 is essential for activity <35>;  #6,10,53,55# enzyme-bound reaction intermediate is a  gamma-glutamyl-phosphate, active site cysteine, mechanism <35>; #43,48#  no conserved cysteine residue in the active site <35>; #18# rapid  equilibrium random ter-reactant mechanism, substrate binding modeling,  active site model <41>; #18# rapid equilibrium random ter-reactant  mechanism, substrate binding modeling, Cys319 is an active site  cysteine not essential for activity <50>; #18# reaction and kinetic  mechanism, modeling <50>; #18# reaction mechanism via phosphorylated  glutamate intermediate <52>; #4# substrate binding mechanism and  catalytic site structure determination and analysis, Arg127 and  conserved Cys249 are involved <45>; #68# reaction mechanism, overview  <152>)  "
6.3.2.20, ATP + (indol-3-yl)acetate + L-lysine = ADP + phosphate +  N6-[(indol-3-yl)acetyl]-L-lysine  
6.3.2.23, ATP + gamma-L-glutamyl-L-cysteine + beta-alanine = ADP + phosphate +  gamma-L-glutamyl-L-cysteinyl-beta-alanine  
6.3.2.24, ATP + L-tyrosine + L-arginine = AMP + diphosphate + L-tyrosyl-L-arginine  
6.3.2.25," ATP + detyrosinated alpha-tubulin + L-tyrosine = alpha-tubulin + ADP +  phosphate (#6# random sequential mechanism <13>; #13# reaction  mechanism, structure-function analysis, overview <31>)  "
6.3.2.26, 3 ATP + L-2-aminohexanedioate + L-cysteine + L-valine + H2O = 3 AMP + 3  diphosphate + N-[L-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine  
6.3.2.29," ATP + [L-Asp(4-L-Arg)]n + L-Asp = ADP + phosphate +  [L-Asp(4-L-Arg)]n-L-Asp (#8# i.e. the first reaction of cyanophycin  synthesis, the second reaction is catalysed by the enzymes other active  centre <3>; #1,4,6,7,9# i.e. the second reaction of cyanophycin  synthesis catalysed by cyanophycin synthase, the first reaction is  catalysed by the enzymes other active centre <1,2,4,5,6,8>)  "
6.3.2.3," ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate +  glutathione (#4# the catalytic mechanism is proposed to proceed via  phosphorylation of the dipeptide substrate to yield an acyl phosphate  intermediate. This intermediate is subsequently attacked by glycine,  followed by loss of inorganic phosphate, leading to glutathione  formation <35>; #48# determination of reaction and substrate binding  mechanisms, large conformational changes in the catalytic cycle <53>;  #49# mechanism, active site residues are Glu144, Asn146, Lys305, and  Lys364, interaction of these residues with the ligands is essential for  enzyme activity, especially Glu144 seems to be very important for  stabilization of the reaction intermediate, but the active site  residues are not essential for the overall enzyme structure <50>; #34#  residues A534 and A535 are involved in substrate binding and  determination of substrate specificity <41>; #6# substrate binding  kinetics and mechanism, negative cooperativity of gamma-L-Glu-L-Cys  <43>; #47# random ter-reactant reaction mechanism, overview <88>; #31#  the reaction process involves the formation of an acyl phosphate on the  cysteinyl moiety in L-gamma-glutamyl-L-cysteine, followed by the attack  of the glycine and formation of an enzyme-product complex, which  finally dissociates with the release of GSH, ADP and phosphate <89>)  "
6.3.2.30," ATP + [L-Asp(4-L-Arg)]n-L-Asp + L-Arg = ADP + phosphate +  [L-Asp(4-L-Arg)]n+1 (#13# i.e. the first reaction of cyanophycin  synthesis, the second reaction is catalysed by activity EC 6.3.2.29  <4>; #4# i.e. the first reaction of cyanophycin synthesis, the second  reaction is catalysed by activity EC 6.3.2.29, sequence analysis  suggests that cyanophycin synthase has two ATP binding sites  corresponding to two active sites <6>; #12# i.e. the first reaction of  cyanophycin synthesis, the second reaction is catalysed by the activity  EC 6.3.2.29 <2>; #2,8,9,10# i.e. the first reaction of cyanophycin  synthesis, the second reaction is catalysed by the enzymes other active  centre <1,3,5,7,9>)  "
6.3.2.31, GTP + coenzyme F420-0 + L-glutamate = GDP + phosphate + coenzyme F420-1  
6.3.2.32, ATP + coenzyme gamma-F420-2 + L-glutamate = ADP + phosphate + coenzyme  alpha-F420-3  
6.3.2.33," ATP + tetrahydromethanopterin + L-glutamate = ADP + phosphate +  5,6,7,8-tetrahydrosarcinapterin "
6.3.2.33," GTP + tetrahydromethanopterin + L-glutamate = GDP + phosphate +  5,6,7,8-tetrahydrosarcinapterin  "
6.3.2.34, GTP + coenzyme F420-1 + L-glutamate = GDP + phosphate + coenzyme  gamma-F420-2  
6.3.2.35, D-alanine + D-serine + ATP = D-alanyl-D-serine + ADP + phosphate  
6.3.2.36, ATP + (R)-4-phosphopantoate + beta-alanine = AMP + diphosphate +  (R)-4'-phosphopantothenate  
6.3.2.37, ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate + D-lysine =  ADP + phosphate +  UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-Nepsilon-D  lysine  
6.3.2.38, 2 ATP + citrate + N6-acetyl-N6-hydroxy-L-lysine + H2O = 2 ADP + 2  phosphate + N6-acetyl-N2-citryl-N6-hydroxy-L-lysine  
6.3.2.39, ATP + N2-citryl-N6-acetyl-N6-hydroxy-L-lysine +  N6-acetyl-N6-hydroxy-L-lysine = AMP + diphosphate + aerobactin  
6.3.2.4," ATP + 2 D-alanine = ADP + phosphate + D-alanyl-D-alanine (#6# reaction  mechanism via tetrahedral reaction intermediate, overview <57>; #27#  first, the ATP-dependent dimerization reactions catalyzed by DdlA  proceed through the phosphorylation of the D-alanine at the carboxyl  group by the gamma-phosphate of ATP to produce an acylphosphate  intermediate. Then, a tetrahedral intermediate is formed by the  nucleophilic attacking of the amino nitrogen of the second D-alanine on  the acylphosphate intermediate. Finally, a phosphate group is released  from the tetrahedral intermediate to generate the final product of  D-alanyl-D-alanine <64>)  "
6.3.2.40, 2 ATP + S-adenosyl-L-methionine + anthranilate + L-phenylalanine =  cyclopeptine + 2 AMP + 2 diphosphate + S-adenosyl-L-homocysteine  
6.3.2.41, ATP + N-acetyl-L-aspartate + L-glutamate = ADP + phosphate +  N-acetyl-L-aspartyl-L-glutamate  
6.3.2.42, 2 ATP + N-acetyl-L-aspartate + 2 L-glutamate = 2 ADP + 2 phosphate +  N-acetyl-L-aspartyl-L-glutamyl-L-glutamate  
6.3.2.43," ATP + an [amino group carrier protein]-C-terminal-L-glutamate +  L-2-aminoadipate = ADP + phosphate + an [amino group carrier  protein]-C-terminal-N-(1,4-dicarboxybutyl)-L-glutamine (#7#  substrate-recognition mechanism of bifunctional TkLysX/ArgX <5>)  "
6.3.2.44, ATP + (R)-pantoate + beta-alanine = ADP + phosphate + (R)-pantothenate  
6.3.2.45," ATP + UDP-N-acetyl-alpha-D-muramate +  L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate = ADP +  phosphate +  UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2  6-diaminoheptanedioate  "
6.3.2.46," ATP + fumarate + L-2,3-diaminopropanoate = AMP + diphosphate +  N3-fumaroyl-L-2,3-diaminopropanoate  "
6.3.2.47," ATP + 3-({[(2R,3R)-3-carbamoyloxiran-2-yl]carbonyl}amino)-L-alanine +  L-valine = ADP + phosphate +  3-({[(2R,3R)-3-carbamoyloxiran-2-yl]carbonyl}amino)-L-alanyl-L-valine "
6.3.2.47, ATP + 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanine + L-valine =  ADP + phosphate +  3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-valine 
6.3.2.47, ATP + 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanine + L-isoleucine  = ADP + phosphate +  3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-isoleucine 
6.3.2.47, ATP + 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanine + L-leucine =  ADP + phosphate +  3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-leucine  
6.3.2.48," ATP + L-arginine + an L-amino acid = ADP + phosphate + an  L-arginyl-L-amino acid (#1# Xaa is an arbitrary amino acid except Pro  (Arg, Lys, His, Gln, Asn, Glu, Asp, Ala, Ser, Thr, Gly, Val, Leu, Ile,  Met, Cys, Phe, Trp, Tyr) <1>)  "
6.3.2.49, ATP + L-alanine + L-anticapsin = ADP + phosphate + bacilysin  
6.3.2.5," CTP + (R)-4'-phosphopantothenate + L-cysteine = CMP + diphosphate +  N-[(R)-4'-phosphopantothenoyl]-L-cysteine (#4# mechanism <9,12>; #5#  ping pong mechanism <10>; #8# bi uni uni bi ping pong mechanism, with  the nucleotide CTP binding first and CMP released last <16>; #5# bi uni  uni bi ping pong mechanism. 18O from [carboxyl-18O] phosphopantothenate  is incorporated into the AMP or CMP produced during PPCS catalysis,  consistent with the formation of a phosphopantothenoyl cytidylate or  phosphopantothenoyl adenylate intermediate, supporting similar  catalytic mechanisms under both CTP and ATP conditions <17>)  "
6.3.2.50, ATP + L-isoleucine + acetoacetyl-CoA = AMP + diphosphate + tenuazonic  acid + CoA  
6.3.2.51, ATP + (R)-4'-phosphopantothenate + L-cysteine = AMP + diphosphate +  N-[(R)-4'-phosphopantothenoyl]-L-cysteine  
6.3.2.52, ATP + jasmonate + an L-amino acid = AMP + diphosphate + a  jasmonoyl-L-amino acid  
6.3.2.53, ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanine + L-glutamate = ADP +  phosphate + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-L-glutamate  
6.3.2.54," ATP + L-2,3-diaminopropanoate + citrate = AMP + diphosphate +  2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate  "
6.3.2.55, ATP +  2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2  hydroxypropanoate + 2-oxoglutarate = AMP + diphosphate + staphyloferrin  B  
6.3.2.56, ATP +  2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2  hydroxypropanoate + 2-oxoglutarate = AMP + diphosphate + staphyloferrin  B  
6.3.2.57, ATP + N5-[(S)-citryl]-D-ornithine + citrate = AMP + diphosphate +  staphyloferrin A  
6.3.2.58, ATP + D-ornithine + citrate = AMP + diphosphate +  N5-[(S)-citryl]-D-ornithine  
6.3.2.59," ATP + (3R)-3-methyl-D-ornithine + L-lysine = ADP + phosphate +  N6-[(3R)-3-methyl-D-ornithinyl]-L-lysine (#4# reaction mechanism of  isopeptide bond formation starting with phosphorylation of D-Orn by  transfer of a phosphate moiety from activated ATP, structure-function  relationship analysis. The binding of Lys to the enzyme complex is then  followed by an SN2 reaction resulting in L-lysine-Nepsilon-D-ornithine  and inorganic phosphate. PylC harbors two adenine nucleotides bound at  the active site. Whereas one ATP molecule is involved in catalysis, the  second adenine nucleotide functions as a selective anchor for the C-  and N-terminus of the Lys substrate and is responsible for protein  stability <2>)  "
6.3.2.6, ATP + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate +  L-aspartate = ADP + phosphate +  (S)-2-[5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate  
6.3.2.60, ATP + L-glutamate + an [amino-group carrier  protein]-C-terminal-L-glutamate = ADP + phosphate + an [amino-group  carrier protein]-C-terminal-gamma-(L-glutamyl)-L-glutamate (#2#  substrate-recognition mechanism of bifunctional TkLysX/ArgX <1>)  
6.3.2.61, ATP + [tubulin]-L-glutamate + L-glutamate =  [tubulin]-(gamma-L-glutamyl)-L-glutamate + ADP + phosphate (#6# the  enzymatic mechanism of microtubule glutamylation involves two distinct  steps: initiation and elongation <1>) 
6.3.2.61, n ATP + [tubulin]-L-glutamate + n L-glutamate =  [tubulin]-(gamma-(poly-alpha-L-glutamyl)-L-glutamyl)-L-glutamate + n  ADP + n phosphate 
6.3.2.61, ATP + [tubulin]-(gamma-L-glutamyl)-L-glutamate + L-glutamate =  [tubulin]-(alpha-L-glutamyl-gamma-L-glutamyl)-L-glutamate + ADP +  phosphate 
6.3.2.61, ATP + [tubulin]-(alpha-L-glutamyl-gamma-L-glutamyl)-L-glutamate + n  L-glutamate =  [tubulin]-(gamma-(poly-alpha-L-glutamyl)-L-glutamyl)-L-glutamate + n  ADP + n phosphate  
6.3.2.62, n ATP + [beta-tubulin]-L-glutamate + n L-glutamate =  [beta-tubulin]-(gamma-(poly-alpha-L-glutamyl)-L-glutamyl)-L-glutamate +  n ADP + n phosphate 
6.3.2.62, ATP + [beta-tubulin]-L-glutamate + L-glutamate =  [beta-tubulin]-(gamma-L-glutamyl)-L-glutamate + ADP + phosphate 
6.3.2.62, ATP + [beta-tubulin]-(gamma-L-glutamyl)-L-glutamate + L-glutamate =  [beta-tubulin]-(alpha-L-glutamyl-gamma-L-glutamyl)-L-glutamate + ADP +  phosphate 
6.3.2.62, ATP + [beta-tubulin]-(alpha-L-glutamyl-gamma-L-glutamyl)-L-glutamate +  n L-glutamate =  [beta-tubulin]-(gamma-(poly-alpha-L-glutamyl)-L-glutamyl)-L-glutamate +  n ADP + n phosphate  
6.3.2.7, ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate + L-lysine =  ADP + phosphate +  UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-L-lysine  
6.3.2.8," ATP + UDP-N-acetyl-alpha-D-muramate + L-alanine = ADP + phosphate +  UDP-N-acetyl-alpha-D-muramoyl-L-alanine (#4# ligase-catalyzed peptide  formation proceeds through an activated acyl-phosphate linkage during  the reaction process. ATP assists in this process of the peptide bond  formation by donating its gamma-phosphoryl group to activate the  carboxyl group of UDP-N-acetylmuramate <9>; #4# the binding order of  the substrates can be ATP, UDP-N-acetylmuramate, and Ala <17>; #4#  ordered sequential mechanism, with ATP binding first, N-acetylmuramate  second, L-Ala third, and ADP being the last product released <16>; #16#  Mur ligase reaction mechanism, overview <37>)  "
6.3.2.9," ATP + UDP-N-acetyl-alpha-D-muramoyl-L-alanine + D-glutamate = ADP +  phosphate + UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate (#3# a  tetrahedral transition state follows the acyl phosphate in the reaction  pathway <10>; #3# the catalytic mechanism involves a tetrahedral  intermediate <28>; #7# reaction via tetrahedral intermediate. The  enzyme performs binding of the substrates with an ordered kinetic  mechanism in which ligand binding inevitably closes the active site.  Reaction mechanism and structure analysis, overview <40>)  "
6.3.3.1," ATP + 2-(formamido)-N1-(5-phospho-D-ribosyl)acetamidine = ADP +  phosphate + 5-amino-1-(5-phospho-D-ribosyl)imidazole (#1,5# mechanism  <6>; #4# enzyme catalyzes transfer of the oxygen of the formyl group to  phosphate <4>; #4# sequential mechanism in which ATP binds first to the  enzyme and ADP is released last <4>)  "
6.3.3.2," ATP + 5-formyltetrahydrofolate = ADP + phosphate +  5,10-methenyltetrahydrofolate (#4# sequential mechanism <1>; #8# random  sequential mechanism <10>; #7# mechanism involves phosphorylation of  the formyl group at the N5-position, followed by displacement of the  phosphate by the N10 <14>; #12# mechanism is proposed to involve  phosphorylation of the formyl group to create an enol phosphate <2>;  #8# substrate binds to the enzyme by a random mechanism, Cleland-type  mechanism <3>; #13# active site and substrate binding site structure  <22>; #13# active site and substrate binding site structure, binding  and catalytic mechanism <23>; #4# NMR analysis of the catalytic  mechanism <20>)  "
6.3.3.3," ATP + 7,8-diaminononanoate + CO2 = ADP + phosphate + dethiobiotin (#3#  the final intermediate is the phosphoric acid anhydride of the  carbamate <16>; #3# mechanistic model in which binding of Mg2+ and the  triphosphate element of ATP to the enzyme creates the appropriate  geometry for substrate 7,8-diaminononanoate-binding and carbamate  formation <14>; #3# 8-aminocarbamate of (7R,8S)-7,8 diaminononanoate is  an enzyme-bound intermediate <17>; #3# the carbonylation of  7,8-diaminononanoic acid proceeds regiospecifically via the  N7-carbamate <9,11>; #20# enzyme reaction involves three steps:  carbamylation of theN7 position of 7,8-diaminononanoate, formation of a  carbamate-phosphoric anhydride intermediate, and, closure of the ureido  ring to form dethiobiotin and release of the inorganic phosphate <26>)  "
6.3.3.4," ATP + L-N2-(2-carboxyethyl)arginine = AMP + diphosphate +  deoxyamidinoproclavaminate (#1# overview <6>; #1# it has been proposed  that L-N2-(2-carboxyethyl)arginine is first converted into an acyl-AMP  by reaction with ATP and loss of diphosphate, and that the beta-lactam  ring is then formed by the intramolecular attack of the beta-nitrogen  on the activated carboxy group, in a sequential ordered bi-ter kinetic  mechanism <2>)  "
6.3.3.5, O-ureido-D-serine + ATP + H2O = D-cycloserine + CO2 + NH3 + ADP +  phosphate  
6.3.3.6," ATP + (2S,5S)-5-carboxymethylproline = AMP + diphosphate +  (3S,5S)-carbapenam 3-carboxylate  "
6.3.3.7," ATP + Ni-sirohydrochlorin a,c-diamide + 3 reduced electron acceptor +  H2O = ADP + phosphate + 15,173-seco-F430-173-acid + 3 electron acceptor  "
6.3.4.10, ATP + biotin + apo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)]  = AMP + diphosphate + [propionyl-CoA:carbon-dioxide ligase  (ADP-forming)]  
6.3.4.11," ATP + biotin + apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase  (ADP-forming)] = AMP + diphosphate +  [3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)] (#1# the  first reaction step is the reversible formation of biotinyl adenylate,  the biotin residue is transferred to the apoenzyme in a second step <1>)  "
6.3.4.12, ATP + L-glutamate + methylamine = ADP + phosphate +  N5-methyl-L-glutamine  
6.3.4.13," ATP + 5-phospho-D-ribosylamine + glycine = ADP + phosphate +  N1-(5-phospho-D-ribosyl)glycinamide  (#1,2,3,5,6,7,8,9,10,11,13,15,18,20,21,22,24,27,28# mechanism <22>)  "
6.3.4.14," ATP + [biotin carboxyl-carrier protein]-biotin-N6-L-lysine +  hydrogencarbonate- = ADP + phosphate + [biotin carboxyl-carrier  protein]-carboxybiotin-N6-L-lysine (#5# mechanism <29>; #5#  carboxylation proceeds via a carboxyphosphate intermediate <1,4,5>; #5#  MgATP2- and HCO3- add to the enzyme randomly, followed by addition of  biotin. Both HCO3- and MgATP2- add in rapid equilibrium <1>; #5#  reaction mechanism <32>; #5# kinetic mechanism <27>; #5# catalytic  mechanism <33>)  "
6.3.4.15," ATP + biotin + [biotin carboxyl-carrier protein]-L-lysine = AMP +  diphosphate + [biotin carboxyl-carrier protein]-N6-biotinyl-L-lysine  (#15# reaction mechanism involving Lys111, formation of a  biotinyl-5-AMP intermediate, active site structure, ligand binding to  the active site loop, overview <11>; #3# reaction mechanism, the first  step is the reversible formation of a biotinyl-5-AMP intermediate  followed by irreversible transfer of the biotinyl group to the protein  <12>)  "
6.3.4.16," 2 ATP + NH3 + hydrogencarbonate = 2 ADP + phosphate + carbamoyl  phosphate (#15# depending on their physiological role, carbonyl  phosphate synthetases use either glutamine or free ammonia as the  nitrogen donor for carbamoyl phosphate synthesis, all enzymes contain  the structurally equivalent of a triad-type glutamine amidotransferase,  GAT, domain <37>; #4# depending on their physiological role, carbonyl  phosphate synthetases uses either glutamine or free ammonia as the  nitrogen donor for carbamoyl phosphate synthesis, all enzymes contain  the structurell equivalent of a triad-type glutamine amidotransferase,  GAT, domain <37>; #5# depending on their physiological role, carbonyl  phosphate synthetasese uses either glutamine or free ammonia as the  nitrogen donor for carbamoyl phosphate synthesis, all enzymes contain  the structurell equivalent of a triad-type glutamine amidotransferase,  GAT, domain <37>; #15# non-glutamine-utilizing enzymes, lacking the  catalytic cysteine residue, can generate carbamoyl phosphate only in  presence of free ammonia <36>; #10# the enzyme is enzymologically and  structurally a carbamate kinase, stoichiometry <31>; #10# the enzyme  structure is ill-suited for catalysing the characteristic three-step  reaction of carbamoyl-phosphate synthetase and supports the view that  the carbamate kinase-like carbamoyl-phosphate synthetase is in fact a  highly thermostable and very slow carbamate kinase that, in extreme  environment of Pyrococcus furiosus, may have the new function of  making, rather than using, carbamoyl phosphate <30>) "
6.3.4.16, ATP + hydrogencarbonate = ADP + carboxyphosphate 
6.3.4.16, NH3 + carboxyphosphate = carbamate + phosphate 
6.3.4.16, ATP + carbamate = ADP + carbamoyl phosphate  
6.3.4.17, ATP + formate + dihydrofolate = ADP + phosphate + 10-formyldihydrofolate  
6.3.4.18, ATP + 5-amino-1-(5-phospho-D-ribosyl)imidazole + HCO3- = ADP +  phosphate + 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole  
6.3.4.19, [tRNAIle2]-cytidine34 + L-lysine + ATP = [tRNAIle2]-lysidine34 + AMP +  diphosphate + H2O  
6.3.4.2, L-glutamine + H2O = L-glutamate + NH3 
6.3.4.2," ATP + UTP + L-glutamine = ADP + phosphate + CTP + L-glutamate (#6#  mechanism proceeds by formation of a phosphorylated pyrimidinone <22>;  #6# mechanism, the initial chemical step catalyzed by CTP synthetase is  the phosphorylation of UTP by ATP to form an enzyme-bound intermediate  <36>) "
6.3.4.2, ATP + UTP + NH3 = ADP + phosphate + CTP  
6.3.4.20, 7-carboxy-7-carbaguanine + NH3 + ATP = 7-cyano-7-carbaguanine + ADP +  phosphate + H2O  
6.3.4.21," nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O =  beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate (#8#  sequential steady state mechanism <9>; #8# ordered ping pong kinetic  mechanism <6>; #13,18# active site structure <17,18>)  "
6.3.4.22, ATP + agmatine + [tRNAIle2]-cytidine34 + H2O =  [tRNAIle2]-2-agmatinylcytidine34 + AMP + 2 phosphate  
6.3.4.23, ATP + formate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide  = ADP + phosphate +  5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide  
6.3.4.24, ATP + tyramine + L-glutamate = ADP + phosphate + gamma-glutamyltyramine  
6.3.4.25, ATP + dGMP + L-aspartate = ADP + phosphate +  2-amino-2'-deoxy-N6-[(2S)-succino]adenylate  
6.3.4.3," ATP + formate + tetrahydrofolate = ADP + phosphate +  10-formyltetrahydrofolate (#24# substrate binds to the enzyme in a  random fashion, products are not released until all substrates are  bound <5>; #29# stepwise mechanism involving a dissociable  intermediate, consistent only with a sequential mechanism <8>; #10,24#  sequential mechanism, formyl phosphate is an intermediate <25>; #24#  stepwise reaction mechanism, formyl phosphate is a potential  intermediate <10>; #24# direct formylation at the N-10 position,  solvent oxygen is not incorporated into N10-formyltetrahydrofolate  <20>; #7# the enzyme is not trifunctional showing only 10-formyl-THS  synthetase activity, enzyme evolutionary considerations <40>)  "
6.3.4.4," GTP + IMP + L-aspartate = GDP + phosphate + N6-(1,2-dicarboxyethyl)-AMP  (#20# fully random mechanism <18>; #8# sequential rapid equilibrium  fully random mechanism <16>; #17# fully random terter mechanism <4>;  #9# random sequential binding mechanism <3>; #7# phosphate-binding  region of adenylosuccinate synthetase is involved in a conformational  change induced by GTP and IMP binding. GTP and IMP binding depend on  the presence of the other substrate at the active site of the enzyme  <24>; #22# sequential mechanism with a fully random order of substrate  addition <12>; #47# rapid equilibrium random AB steady-state ordered C  kinetic mechanism <75>)  "
6.3.4.5," ATP + L-citrulline + L-aspartate = AMP + diphosphate +  2-(Nomega-L-arginino)succinate (#8# mechanism <2>; #7#  rapid-equilibrium random mechanism <7>; #8# ordered addition of  MgATP2-, citrulline, and aspartate, followed by ordered release of  argininosuccinate, magnesiumdiphosphate and AMP <15>; #8# essential Arg  in the active site participates in the binding of ATP and diphosphate.  The binding of ATP and diphosphate at the same site is mutually  exclusive <17>; #2# catalytic mechanism <31>; #3# detailed catalytic  mechanism <30>; #21# detailed catalytic mechanism, stereochemistry  <32>; #1# it is found that argininosuccinate synthetase is the major  lipid A-interacting protein in liver. Argininosuccinate synthetase also  inhibits the biological activities of natural lipid A and rough-type  lipopolysaccharide and but not smooth-type lipopolysaccharide.  Argininosuccinate synthetase enzyme activity is inhibited by lipid A  and rough-type lipopolysaccharide and smooth-type lipopolysaccharide.  <46>)  "
6.3.4.6," ATP + urea + HCO3- = ADP + phosphate + urea-1-carboxylate (#34# a  biotinyl-protein, the yeast enzyme (but not that from green algae) also  catalyses the reaction of EC 3.5.1.54 allophanate hydrolase, thus  bringing about the hydrolysis of urea to CO2 and NH3, previously also  listed as EC 3.5.1.45 <16>)  "
6.3.4.7, ATP + ribose 5-phosphate + NH3 = ADP + phosphate + 5-phosphoribosylamine  
6.3.4.8, ATP + imidazole-4-acetate + 5-phosphoribosyl diphosphate = ADP +  phosphate + 1-(5-phosphoribosyl)imidazole-4-acetate + diphosphate  
6.3.4.9," ATP + biotin + apo-[methylmalonyl-CoA:pyruvate carboxytransferase] =  AMP + diphosphate + [methylmalonyl-CoA:pyruvate carboxytransferase]  (#1# mechanism, (+)-biotinyl-5-AMP is an intermediate in  holotranscarboxylase synthesis <4>)  "
6.3.5.1, ATP + deamido-NAD+ + L-glutamine + H2O = AMP + diphosphate + NAD+ +  L-glutamate  
6.3.5.10," 4 ATP + adenosylcobyrinic acid a,c-diamide + 4 L-glutamine + 4 H2O = 4  ADP + 4 phosphate + adenosylcobyric acid + 4 L-glutamate (#3# catalytic  mechanism <5>)  "
6.3.5.11," 2 ATP + cobyrinate + 2 L-glutamine + 2 H2O = 2 ADP + 2 phosphate +  cobyrinate a,c-diamide + 2 L-glutamate (#1# catalytic mechanism in  which CbiA catalyzes the amidation of the c-carboxylate, and then the  intermediate is released into solution and binds to the same catalytic  site for the amidation of the a-carboxylate <3>) "
6.3.5.11, ATP + cobyrinate + L-glutamine + H2O = ADP + phosphate + cobyrinate  c-monamide + L-glutamate 
6.3.5.11," ATP + cobyrinate c-monamide + L-glutamine + H2O = ADP + phosphate +  cobyrinate a,c-diamide + L-glutamate  "
6.3.5.12," 2 ATP + Ni-sirohydrochlorin + 2 L-glutamine + 2 H2O = 2 ADP + 2  phosphate + Ni-sirohydrochlorin a,c-diamide + 2 L-glutamate  "
6.3.5.13, L-glutamine + H2O = L-glutamate + NH3 
6.3.5.13," ATP +  beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)  diphospho-ditrans,octacis-undecaprenol + L-glutamine + H2O = ADP +  phosphate +  beta-D-GlcNAc-(1->4)-MurNAc-L-Ala-D-isoglutaminyl-L-Lys-D-Ala-D-Ala  diphospho-ditrans,octacis-undecaprenol + L-glutamate "
6.3.5.13," ATP +  beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)  diphospho-ditrans,octacis-undecaprenol = ADP +  beta-D-GlcNAc-(1->4)-MurNAc-L-Ala-gamma-D-O-P-Glu-L-Lys-D-Ala-D-Ala  diphospho-ditrans,octacis-undecaprenol "
6.3.5.13," beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-O-P-Glu-L-Lys-D-Ala-D  Ala)-diphospho-ditrans,octacis-undecaprenol + NH3 =  beta-D-GlcNAc-(1->4)-MurNAc-L-Ala-D-isoglutaminyl-L-Lys-D-Ala-D-Ala  diphospho-ditrans,octacis-undecaprenol + phosphate  "
6.3.5.2, ATP + XMP + NH3 = AMP + diphosphate + GMP 
6.3.5.2, ATP + XMP + L-glutamine + H2O = AMP + diphosphate + GMP + L-glutamate  (#16# steady-state ordered binding of ATP followed by XMP to the ATPase  domain with glutamine binding in a random manner to the GAT domain  <42>; #16# evidence for ammonia channeling. Ammonia released from  glutamine is not equilibrated with the external medium. Saturating  concentrations of glutamine do not obliterate the incorporation of  external ammonia into GMP. Ammonia in the external medium can access  the thioester intermediate when the ATPPase domain is bound to  substrates <48>) 
6.3.5.2, L-glutamine + H2O = L-glutamate + NH3  
6.3.5.3," ATP + N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide + L-glutamine + H2O  = ADP + phosphate + 2-(formamido)-N1-(5-phospho-D-ribosyl)acetamidine +  L-glutamate (#4# ping-pong mechanism <7,8,9>; #4# Gln binds to the free  enzyme and Glu is released before the addition of ATP. ADP is released,  and phosphoribosyl-formylglycinamide then binds. The liberation of  phosphate is rapid, and 5-phosphoribosylformylglycinamidine is the last  product released <8>; #2# Gln adds first to the enzyme with ATP and  5-phosphoribosylformylglycinamide adding randomly subsequently <6>; #2#  substrates add sequentially to form a quarternary complex. Gln adds  first with ATP and 5-phosphoribosylformylglycinamide adding  subsequently <5>)  "
6.3.5.4," ATP + L-aspartate + L-glutamine + H2O = AMP + diphosphate +  L-asparagine + L-glutamate (#9# mechanism <54>; #11# uni-uni-bi-ter  ping-pong mechanism without abortive complexes. Gln binds first,  followed by Glu release, and Asp and ATP bind in order followed by  ordered release of diphosphate, AMP and Asn. In the presence of 0.5-2.0  mM excess Mg2+ over ATP the binding of substrates after the release of  Glu is in a rapid equilibrium system <4>; #14# NH4+ is bound to the  enzyme followed by MgATP causing Asn release <15>; #9# Arg325 is  involved in stabilization of a pentacovalent intermediate leading to  the formation of beta-aspartyl-AMP <31>; #9# a model for the role of  the catalytic triad in transferring nitrogen from Gln to Asp. An  alternative catalytic mechanism is proposed, which obviates the  participation of a histidine residue in the reaction <29>; #8# hybrid  uni uni bi ter ping pong Theorell-Chance mechanism where the  glutaminase reaction occurs first and Asp binds to the enzyme before  ATP in the sequential segment. Diphosphate is the first product  released in the Theorell-Chance reaction, which is followed by the  ordered release of AMP and Asn <11>; #45,54# reaction mechanism,  structure-function relationship <109>; #65# the enzyme forms a crucial  beta-aspartyl-AMP-Mg2+ intermediate, which then undergoes a  nucleophilic attack of ammonia, forming Asn and releasing AMP and  diphosphate. Ammonia can be free or glutamine-derived <113>)  "
6.3.5.5," 2 ATP + L-glutamine + hydrogencarbonate + H2O = 2 ADP + phosphate +  L-glutamate + carbamoyl phosphate (#8# mechanism <47,60>; #8#  mechanism, formation of enzyme-bound carboxy phosphate <1>; #19#  partially random sequential mechanism in which the ordered addition of  MgATP2- , HCO3-, and Gln is followed by the ordered release of Glu and  phosphate. The formation of carbamate from MgATP2-, HCO3-, and Gln  proceeds via a stepwise, not concerted mechanism, involving at least  one kinetically competent covalent intermediate, such as  carboxyphosphate <4>; #8# mechanism involves at least three steps, the  first of which is an ATP-dependent formation of enzyme-bound activated  carbon dioxide <20>; #8# catalytic mechanism <44>; #8# pathway <50>;  #8# An ordered uni bi mechanism for glutamine hydrolysis that is  consistent with the isotope effects and with the catalytic properties  of the enzyme is proposed <42>; #8# effects of pressure on the partial  reactions, study of the function of monomers of enzyme domains under  conditions of pressure-induced dissociation <56>; #8# four partial  reaction occurs at three active sites connected by a molecular tunnel  of 100 Angstrom, reaction mechanism <41>; #8# in glutamine utilizing  enzymes, the hydrolysis of glutamine to yield ammonia is catalyzed at a  triad-type glutamine amidotransferase domain <63>; #8# pathway,  relationship between mechanism and structure <49>; #8# reaction pathway  of the enzyme small subunit proceeds through the formation of the  glutamyl thioester intermediate <35>; #8# steps of reaction pathway for  glutamine hydrolysis, the Michalis complex, the tetrahedral  intermediate and glutamyl-thioester intermediate models,  stereochemistry of the overall glutaminase reaction <37>; #8# the  chemical mechanism of the bicarbonate-dependent ATPase reaction of  enzyme involves carboxy phosphate, but not CO2, as an reactive  intermediate <46>; #4# the mammalian enzyme is part of  carbamoyl-phosphate synthase-aspartate  carbamoyltransferase-dihydroorotase, CAD, the carbamoyl phosphate  synthesis requires the concerted action of the glutaminase and  carbamoyl-phosphate synthetase domains of CAD <59>; #8# two residues,  Ser948 and Thr1042, appear crucial for allosteric regulation of enzyme  <66>; #8# mechanism for the generation of ammonia within the  L-glutamine amidotransferase domain of CPS, detailed overview <86>; #8#  reaction mechanism, the ammonium is channeled as ammonia through a  channel formed by the small subunit by forming and breaking hydrogen  bonds to Gly292, Ser35, Pro358, Gly293, and Thr37 in a stepwise fashion  as it travels through the hydrophilic passage toward the subunit  interface <83>; #8# reaction mechanism with four separate reactions and  three discrete, reactive, and unstable intermediates involved,  overview. The small subunit contains the active site for the hydrolysis  of glutamine, which is hydrolyzed to glutamate and ammonia via a  thioester intermediate. The ammonia derived from this reaction travels  45 A to the active site for the synthesis of the carboxy phosphate  intermediate, located in the N-terminal half of the large subunit. The  carbamate intermediate, formed by the reaction of ammonia with carboxy  phosphate, is subsequently channeled 45 A to the active site, located  at the C-terminus of the large subunit, for the synthesis of carbamoyl  phosphate, which is phosphorylated by the second molecule of MgATP to  form the ultimate product carbamoyl phosphate. Molecular dynamics  simulations, kinetic and dynamic of the mechanism for ammonia migration  at the atomic level, free-energy profile for the remainder of the  ammonia tunnel within CPS using the umbrella sampling technique,  overview <88>; #45# carbamate, the product of the reaction involving  ATP, bicarbonate, and ammonia, must be delivered from the site of  formation to the site of utilization by traveling nearly 40 A within  the enzyme. The tunnel is composed of three continuous water pockets  and two narrow connecting parts, near residues A23 and G575. The two  narrow parts render two free energy barriers of 6.7 and 8.4 kcal/mol,  respectively. Three water pockets are filled with about 21, 9, and 9  waters, respectively, and the corresponding relative free energies of  carbamate residing in these free energy minima are 5.8, 0, and 1.6  kcal/mol, respectively. The release of phosphate into solution at the  site for the formation of carbamate allows the side chain of R306 to  rotate toward E25, E383, and E604. This rotation is virtually  prohibited by a barrier of at least 23 kcal/mol when phosphate remains  bound. This conformational change not only opens the entrance of the  tunnel but also shields the charge-charge repulsion from the three  glutamate residues when carbamate passes through the tunnel <92>) "
6.3.5.5, L-glutamine + H2O = L-glutamate + NH3 
6.3.5.5, ATP + hydrogencarbonate = ADP + carboxyphosphate 
6.3.5.5, NH3 + carboxyphosphate = carbamate + phosphate 
6.3.5.5, ATP + carbamate = ADP + carbamoyl phosphate  
6.3.5.6, L-glutamine + H2O = L-glutamate + NH3 
6.3.5.6, ATP + L-aspartyl-tRNAAsn + L-glutamine + H2O = ADP + phosphate +  L-asparaginyl-tRNAAsn + L-glutamate 
6.3.5.6, ATP + L-aspartyl-tRNAAsn = ADP + 4-phosphooxy-L-aspartyl-tRNAAsn 
6.3.5.6, 4-phosphooxy-L-aspartyl-tRNAAsn + NH3 = L-asparaginyl-tRNAAsn +  phosphate  
6.3.5.7, L-glutamine + H2O = L-glutamate + NH3 
6.3.5.7, ATP + L-glutamyl-tRNAGln + L-glutamine = ADP + phosphate +  L-glutaminyl-tRNAGln + L-glutamate 
6.3.5.7, ATP + L-glutamyl-tRNAGln = ADP + 5-phosphooxy-L-glutamyl-tRNAGln 
6.3.5.7, 5-phosphooxy-L-glutamyl-tRNAGln + NH3 = L-glutaminyl-tRNAGln + phosphate  
6.3.5.9," 2 ATP + hydrogenobyrinic acid + 2 L-glutamine + 2 H2O = 2 ADP + 2  phosphate + hydrogenobyrinic acid a,c-diamide + 2 L-glutamate  "
6.4.1.1," ATP + pyruvate + HCO3- = ADP + phosphate + oxaloacetate  (#3,12,15,17,41,55# mechanism <54>; #42# mechanism, overview <35>;  #4,7,9,10,12,13,23,24,27,41,49,50,51,52,53# reaction mechanism,  overview <88>; #52# reaction mechanism of ATP cleavage and biotin  carboxylation, overview <90>; #41# catalytic mechanism involves the  decarboxylation of carboxybiotin and removal of a proton from Thr882 by  the resulting biotin enolate with either a concerted or subsequent  transfer of a proton from pyruvate to Thr882. The resulting  enolpyruvate then reacts with CO2 to form oxaloacetate and complete the  reaction <99>)  "
6.4.1.2," ATP + acetyl-CoA + hydrogencarbonate = ADP + phosphate + malonyl-CoA  (#20# non-ordered ter ter mechanism <59>; #10# ordered bi bi uni uni  ping-pong mechanism <19>; #20# ordered mechanism <41>; #2,11,36,65#  catalytic regions analysis <87>; #11# molecular surface of the active  site of the carboxyltransferase domain <99>; #46# substrate  specificity, catalytic mechanism, and structural features <83>; #45#  the enzyme is bifunctional exhibiting both acetyl-CoA carboxylase and  propionyl-CoA carboxylase, EC 6.4.1.3, activities <85>;  #7,8,9,10,11,17,24,35,46,49,66# two-step reaction mechanism,  structure-activity relationship <89>; #9# the enzyme proceeds through a  hybrid (two-site) random Ter Ter mechanism, one that likely involves a  two-step reaction at the biotin carboxylase domain <124>)  "
6.4.1.3, ATP + propanoyl-CoA + HCO3- = ADP + phosphate + (S)-methylmalonyl-CoA  
6.4.1.4," ATP + 3-methylcrotonoyl-CoA + HCO3- = ADP + phosphate +  3-methylglutaconyl-CoA (#9# ATP and HCO3- bind sequentially to the  enzyme. ATP and 3-methylcrotonoyl-CoA bind in ping-pong fashion <15>;  #8# bi bi uni uni ping-pong mechanism, i.e. double-displacement kinetic  mechanism <13>)  "
6.4.1.5, ATP + geranoyl-CoA + HCO3- = ADP + phosphate +  3-(4-methylpent-3-en-1-yl)pent-2-enedioyl-CoA  
6.4.1.6," acetone + CO2 + ATP + 2 H2O = acetoacetate + AMP + 2 phosphate (#2#  biotin-independent, activity is strongly induced by growth on acetone  <1>; #1# activity is induced in suspensions of acetone- and  isopropanol-grown cells <2>)  "
6.4.1.7, ATP + 2-oxoglutarate + HCO3- = ADP + phosphate + oxalosuccinate  
6.4.1.8, 2 ATP + acetophenone + HCO3- + H2O + H+ = 2 ADP + 2 phosphate +  3-oxo-3-phenylpropanoate  
6.4.1.9," ATP + 15,173-seco-F430-173-acid = ADP + phosphate + coenzyme F430  "
6.5.1.1," ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  diphosphate (#7# initial step in DNA ligation is the formation of a  covalent enzyme-adenylate intermediate <32>; #15# uni-uni uni-bi  ping-pong mechanism. The order of substrate addition and product  release is as follows: ATP, diphosphate, nicked DNA, sealed DNA, 5-AMP  <24>; #4# mechanism: 1. formation of a covalent enzyme-adenylate  complex, the ATP is cleaved to AMP and diphosphate with adenylyl  residue linked by a phosphoramidate bond to the epsilon-amino group of  a specific lysine residue at the active site of the protein, 2. the  activated AMP residue of the DNA ligase-adenylate intermediate is  transferred to the 5-phosphate terminus of a single strand break in  double-stranded DNA to generate a covalent DNA-AMP complex with a 5-5  phosphoanhydride bond, 3. in the final step of DNA ligation,  unadenylated DNA ligase is required for the generation of a  phosphodiester bond and catalyzes displacement of the AMP residue  through attack by adjacent 3-hydroxyl group of the adenylylated site  <1,2>) "
6.5.1.1, ATP + [DNA ligase]-L-lysine = [DNA ligase]-N6-(5'-adenylyl)-L-lysine +  diphosphate 
6.5.1.1, [DNA ligase]-N6-(5'-adenylyl)-L-lysine +  5'-phospho-(deoxyribonucleotide)m =  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m + [DNA  ligase]-L-lysine 
6.5.1.1, (deoxyribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m =  (deoxyribonucleotide)n+m + AMP  
6.5.1.2," ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  beta-nicotinamide D-nucleotide (#7# the second step is the transfer of  the AMP moiety from the enzyme to the 5-phosphoryl of the DNA  substrate, recreating a diphosphate linkage and thereby preserving the  high-energy bond. The third step is the nucleophilic attack of the  adjacent 3-hydroxyl group to form a phosphodiester bond and eliminate  AMP <7>; #2,4,5,6,7,9,18,25,26,29,30,32,33,40,69,70# 3 steps of  reaction: 1. adenylation of the ligase in the presence of NAD+, 2.  transferring the adenylate moiety to the 5-phosphate of the nicked DNA  substrate, 3. sealing the nick through the formation of a  phosphodiester bond  <12,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,31>; #7# mechanism,  the initial step is most likely a nucleophilic attack of the  epsilon-amino group of a Lys on the adenylyl phosphorus of NAD+ <1,7>) "
6.5.1.2, [DNA ligase]-N6-(5'-adenylyl)-L-lysine +  5'-phospho-(deoxyribonucleotide)m =  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m + [DNA  ligase]-L-lysine 
6.5.1.2, (deoxyribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m =  (deoxyribonucleotide)n+m + AMP 
6.5.1.2, NAD+ + [DNA ligase]-L-lysine = [DNA ligase]-N6-(5'-adenylyl)-L-lysine +  beta-nicotinamide D-nucleotide  
6.5.1.3, ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  beta-nicotinamide D-nucleotide (#4# mechanism <3>) 
6.5.1.3, ATP + [RNA ligase]-L-lysine = [RNA ligase]-N6-(5'-adenylyl)-L-lysine +  diphosphate 
6.5.1.3, [RNA ligase]-N6-(5'-adenylyl)-L-lysine + 5'-phospho-(ribonucleotide)m =  5'-(5'-diphosphoadenosine)-(ribonucleotide)m + [RNA ligase]-L-lysine 
6.5.1.3, (ribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoadenosine)-(ribonucleotide)m = (ribonucleotide)n+m + AMP  
6.5.1.4," ATP + [RNA]-3'-(3'-phospho-ribonucleoside) = AMP + diphosphate +  [RNA]-3'-(2',3'-cyclophospho)-ribonucleoside (#4# formation of a  covalent cyclase-AMP intermediate <3>; #22# upon binding of Mg2+ to  residue E10, the triphosphate group of the trapped ATP changes its  conformation, with help of ligands R17 and R39. The Nepsilon atom of  H307 attacks the alpha-phosphate group to form a new P-N bond. When a  truncated RNA is bound, its 3-phosphate group may be forced to react  with the phosphate group of AMP, and the activated 3-phosphate group  may be attacked by the 2-hydroxyl group to generate the 2,3-cyclic  phosphodiester <12>) "
6.5.1.4, ATP + [RNA 3'-phosphate cyclase]-L-histidine = [RNA 3'-phosphate  cyclase]-Ntau-(5'-adenylyl)-L-histidine + diphosphate 
6.5.1.4, [RNA 3'-phosphate cyclase]-Ntau-(5'-adenylyl)-L-histidine +  [RNA]-3'-(3'-phospho-ribonucleoside) = [RNA 3'-phosphate  cyclase]-L-histidine +  [RNA]-3'-ribonucleoside-3'-(5'-diphosphoadenosine) 
6.5.1.4," [RNA]-3'-ribonucleoside-3'-(5'-diphosphoadenosine) =  [RNA]-3'-(2',3'-cyclophospho)-ribonucleoside + AMP  "
6.5.1.5," GTP + [RNA]-3'-(3'-phospho-ribonucleoside) = GMP + diphosphate +  [RNA]-3'-(2',3'-cyclophospho)-ribonucleoside "
6.5.1.5, GTP + [RNA 3'-phosphate cyclase]-L-histidine = 5'-guanosyl [RNA  3'-phosphate cyclase]-Ntau-phosphono-L-histidine + diphosphate 
6.5.1.5, 5'-guanosyl [RNA 3'-phosphate cyclase]-Ntau-phosphono-L-histidine +  [RNA]-3'-(3'-phospho-ribonucleoside) = [RNA 3'-phosphate  cyclase]-L-histidine +  [RNA]-3'-ribonucleoside-3'-(5'-diphosphoguanosine) 
6.5.1.5," [RNA]-3'-ribonucleoside-3'-(5'-diphosphoguanosine) =  [RNA]-3'-(2',3'-cyclophospho)-ribonucleoside + GMP  "
6.5.1.6, ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  diphosphate (#1# (1) <1>) 
6.5.1.6, ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  beta-nicotinamide D-nucleotide (#1# (2) <1>) 
6.5.1.6, (deoxyribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m =  (deoxyribonucleotide)n+m + AMP 
6.5.1.6, ATP + [DNA ligase]-L-lysine = 5'-adenosyl [DNA  ligase]-Nepsilon-phosphono-L-lysine + diphosphate 
6.5.1.6, 5'-adenosyl [DNA ligase]-Nepsilon-phosphono-L-lysine +  5'-phospho-(deoxyribonucleotide)m =  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m + [DNA  ligase]-L-lysine 
6.5.1.6, NAD+ + [DNA ligase]-L-lysine = 5'-adenosyl [DNA  ligase]-Nepsilon-phosphono-L-lysine + beta-nicotinamide D-nucleotide  
6.5.1.7, ATP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  diphosphate (#2# (1) <3>) 
6.5.1.7, ADP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + AMP +  phosphate (#2# (2) <3>) 
6.5.1.7, GTP + (deoxyribonucleotide)n-3'-hydroxyl +  5'-phospho-(deoxyribonucleotide)m = (deoxyribonucleotide)n+m + GMP +  diphosphate (#2# (3) <3>) 
6.5.1.7, (deoxyribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m =  (deoxyribonucleotide)n+m + AMP 
6.5.1.7, ATP + [DNA ligase]-L-lysine = 5'-adenosyl [DNA  ligase]-Nepsilon-phosphono-L-lysine + diphosphate 
6.5.1.7, 5'-adenosyl [DNA ligase]-Nepsilon-phosphono-L-lysine +  5'-phospho-(deoxyribonucleotide)m =  5'-(5'-diphosphoadenosine)-(deoxyribonucleotide)m + [DNA  ligase]-L-lysine 
6.5.1.7, ADP + [DNA ligase]-L-lysine = 5'-adenosyl [DNA  ligase]-Nepsilon-phosphono-L-lysine + phosphate 
6.5.1.7, GTP + [DNA ligase]-L-lysine = 5'-guanosyl [DNA  ligase]-Nepsilon-phosphono-L-lysine + diphosphate 
6.5.1.7, 5'-guanosyl [DNA ligase]-Nepsilon-phosphono-L-lysine +  5'-phospho-(deoxyribonucleotide)m =  5'-(5'-diphosphoguanosine)-(deoxyribonucleotide)m + [DNA  ligase]-L-lysine 
6.5.1.7, (deoxyribonucleotide)n-3'-hydroxyl +  5'-(5'-diphosphoguanosine)-(deoxyribonucleotide)m =  (deoxyribonucleotide)n+m + GMP  
6.5.1.8, (ribonucleotide)n-3'-phosphate + 5'-hydroxy-(ribonucleotide)m + GTP =  (ribonucleotide)n+m + GMP + diphosphate 
6.5.1.8, GTP + [RNA ligase]-L-histidine = 5'-guanosyl [RNA  ligase]-Ntau-phosphono-L-histidine + diphosphate 
6.5.1.8, 5'-guanosyl [RNA ligase]-Ntau-phosphono-L-histidine +  (ribonucleotide)n-3'-phosphate =  (ribonucleotide)n-3'-(5'-diphosphoguanosine) + [RNA ligase]-L-histidine 
6.5.1.8, (ribonucleotide)n-3'-(5'-diphosphoguanosine) +  5'-hydroxy-(ribonucleotide)m = (ribonucleotide)n+m + GMP 
6.5.1.8," (ribonucleotide)n-2',3'-cyclophosphate + 5'-hydroxy-(ribonucleotide)m +  GTP + H2O = (ribonucleotide)n+m + GMP + diphosphate "
6.5.1.8," (ribonucleotide)n-2',3'-cyclophosphate + H2O =  (ribonucleotide)n-3'-phosphate "
6.5.1.8, [RNA ligase]-Ntau-(5'-guanosyl-phosphono)-L-histidine +  (ribonucleotide)n-3'-phosphate =  (ribonucleotide)n-3'-(5'-diphosphoguanosine) + [RNA ligase]-L-histidine  
6.5.1.9," ATP + 2,3-diphospho-D-glycerate = ADP + phosphate + cyclic  2,3-bisphosphoglycerate  "
6.6.1.1," ATP + protoporphyrin IX + Mg2+ + H2O = ADP + phosphate +  Mg-protoporphyrin IX + 2 H+ (#2,8,9,14,25# subunits H, I and D from  bchH, bchI and bchD genes combine to form the enzyme complex, the  complex is active only when the three proteins are present  <2,12,15,18,22>; #2,4,6,7,8,9,10,13,23,27# complex three-subunit enzyme  <1,2,3,4,8,10,13,19,21>; #2,3,4,6,7,8,9,10,13,14,26,27# this is the  first committed step of chlorophyll biosynthesis and is a branchpoint  of two major routes in the tetrapyrrole pathway  <1,2,4,5,6,9,11,12,13,14,15,16,19,20,23>; #4# linear reaction for at  least 60 min under standard incubation <1>)  "
6.6.1.2," ATP + hydrogenobyrinic acid a,c-diamide + Co2+ + H2O = ADP + phosphate  + cob(II)yrinic acid a,c-diamide + H+  "
6.7.1.1, ATP + 3-amino-2-hydroxy-4-methoxybenzoate + nitrite = AMP + diphosphate  + cremeomycin + H2O  
7.1.1.1, NADPH + NAD+ + H+[side 1] = NADP+ + NADH + H+[side 2]  
7.1.1.10," 2 reduced ferredoxin [iron-sulfur] cluster + plastoquinone + 6 H+[side  1] = 2 oxidized ferredoxin [iron-sulfur] cluster + plastoquinol + 7  H+[side 2] (#9# proposed models for the electron-transfer mechanism of  NDH, overview. NDH could possess several electron transfer routes,  which would serve to maximize plastoquinone reduction and avoid  deleterious off-target chemistry of the semi-plastoquinone radical <9>)  "
7.1.1.11, 2 reduced ferredoxin [iron-sulfur] cluster + NAD+ + H+ + 2 H+[side 1] =  2 oxidized ferredoxin [iron-sulfur] cluster + NADH + 2 H+[side 2]  
7.1.1.2," NADH + ubiquinone + 6 H+[side 1] = NAD+ + ubiquinol + 7 H+[side 2]  (#17,26# ping-pong mechanism <20,24>; #18# reaction mechanism, overview  <164>; #18# tri-bi enzyme mechanism combined with a simple model of the  conformational changes associated with proton transport, hybrid  ping-pong rapid-equilibrium random bi-bi catalytic mechanism, kinetic  mechanism and general kinetic model for conformational change in a  tri-bi enzyme mechanism, overview <166>)  "
7.1.1.3, 2 ubiquinol + O2 + n H+[side 1] = 2 ubiquinone + 2 H2O + n H+[side 2]  
7.1.1.4, 2 caldariellaquinol + O2 + n H+[side 1] = 2 caldariellaquinone + 2 H2O  + n H+[side 2]  
7.1.1.5, 2 menaquinol + O2 + n H+[side 1] = 2 menaquinone + 2 H2O + n H+[side 2]  
7.1.1.6, plastoquinol + 2 oxidized plastocyanin + 2 H+[side 1] = plastoquinone +  2 reduced plastocyanin + 4 H+[side 2] (#6# mechanism <12>)  
7.1.1.7, 2 quinol + O2[side 2] + 4 H+[side 2] = 2 quinone + 2 H2O[side 2] + 4  H+[side 1] 
7.1.1.7, 2 quinol = 2 quinone + 4 H+[side 1] + 4 e- 
7.1.1.7, O2[side 2] + 4 H+[side 2] + 4 e- = 2 H2O[side 2]  
7.1.1.8," quinol + 2 ferricytochrome c = quinone + 2 ferrocytochrome c + 2  H+[side 2] (#13# 2 reaction mechanism variants, a fully active enzyme  mechanism and a half-of-the sites mechanism of ubiquinol oxidation,  switching between the two variants may regulate the enzyme, Glu272 and  His181 are involved <99>; #13# alternating half-of-sites mechanism of  ubiquinol oxidation <106>; #13# alternating half-of-the-sites mechanism  of ubiquinol oxidation, enzyme links electron transfer from ubiquinol  to cytochrome c by a protonmotive Q cycle mechanism in which ubiquinol  is oxidized at one center in the enzyme, referred to as center P, und  ubiquinone is re-reduced at a second center, referred to as center N  <104>; #13# binding structure and mode of cytochrome c1 within the  enzyme complex and cytochrome c during the catalytic reaction, direct  heme-to-heme electron transfer from the enzyme complex cytochrome c1 to  cytochrome c, half-of-the sites mechanism <100>; #13# reaction and  substrate binding mechanism, overview, conformational changes at the  binding site of inhibitor 5-n-heptyl-6-hydroxy-4,7-dioxobenzothiazole  confirm the proton transfer pathway and reveal plasticity at the active  site <105>; #14# substrate binding mechanism at the Qo site of the  cytochrome bc1 complex <101>; #14# substrate binding site Qo structure,  conformational changes upon inhibitor binding, overview <98>; #18# the  Qo-cycle, overview, reaction mechanism involving cytochrome c, Glu295,  and His161, electron transfer mechanism and formation of the ES complex  involving a binding square, substrate binding mechanism at the Qo site  of the cytochrome bc1 complex <102>; #14# current competing models for  the two-electron oxidation of quinol QH2 at the cytochrome bc1 complex  and related complexes impose distinct requirements for the reaction  intermediate, the initial and rate-limiting step in quinol oxidation,  both in the biological and biomimetic systems, involves electron and  proton transfer, probably via a proton-coupled electron-transfer  mechanism, a neutral semiquinone intermediate is formed in the  biomimetic system, and oxidation of the QH*/QH2 couple for UQH2-0, but  not TMQH2-0, exhibits an unusual and unexpected primary deuterium  kinetic isotope effect on its Arrhenius activation energy, DELTA GTS,  where DELTA GTS for the protiated form is larger than that for the  deuterated form, detailed reaction mechanism, molecular modeling,  electrochemical and computational study, overview <110>; #13# reaction  mechanism, kinetic modeling <113>; #13# reaction mechanism, similar  transition states mediate the Q-cycle and superoxide production by the  cytochrome bc1 complex <115>; #14,18# reaction mechanism of superoxide  generation during ubiquinol oxidation by the cytochrome bc1 complex  <135>; #1,3,13,14,18,21,27# reaction mechanism, structure-function  analysis, overview <132>)  "
7.1.1.9," 4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O (#7,8#  reaction mechanism <5>; #17# proposed mechanism of proton translocation  <136>; #7,8,16,17# mechanism of O2 reduction <3,8,14,16,21>; #7,8#  steady-state kinetics <22>; #17# study of primary intermediates in the  reaction of O2 with the fully reduced enzyme <23>; #7,8# proposal for  complete turnover cycle, i.e. intramolecular electron transfer, O2  reduction and proton pumping <3>; #8# reaction mechanism of cytochrome  c with O2 <63>; #8# schematic diagram of cytochrome c oxidase <8>;  #6,7,8,16,17,20# mechanism of proton pumping <3,5,11,15,21,115>; #17#  proposed electron transfer pathway within the cytochrome c-cytochrome c  oxidase complex <107>; #5# spectra of the A, PM, F and O itnermediate  state of enzyme catalysis by use of a special cuvette to measure  optical changes of millisecond freeze-hyperquench powder samples at  temperatures below -23Â°C. Catalytic cycle of cytochrome c oxidase at  low temperature is similar to that at room temperature <169>) "
7.1.1.9, 4 ferrocytochrome c + O2 + 8 H+[side 1] = 4 ferricytochrome c + 2 H2O +  4 H+[side 2]  
7.1.2.1," ATP + H2O + 4 H+[side 1] = ADP + phosphate + 4 H+[side 2] (#8,20#  mechanism involves a covalent phosphoryl-enzyme intermediate  <10,11,16>; #20# the phosphorylated amino acid being an aspartate <16>;  #20# mechanism and transport function <11>; #32# binding of the  nucleotide to the N-domain is coupled to the movement of a loop beta  structure and to the exposure of the W505 residue located in the loop  <23>)  "
7.1.2.2," ATP + H2O + 4 H+[side 1] = ADP + phosphate + 4 H+[side 2] (#13#  mechanism of proton conduction through F0, and the catalytic mechanism  of F1 <20,21>; #13# X-ray structure is compatible with a catalytic  mechanism in which all three F1-ATPase catalytic sites must fill with  MgATP to initiate steady-state hydrolysis <33>; #14,18# catalytic  mechanism of the enzyme complex <67>; #49# structure-function  relationship from F1 crystal structure in the stable conformational  state, catalytic mechanism, F1 has 2 stable conformational states:  ATP-binding dwell state and catalytic dwell state, betaDP is the  catalytically active form, overview <83>; #88# ATP synthase uses a  unique rotary mechanism to couple ATP synthesis and hydrolysis to  transmembrane proton translocation. As part of the synthesis mechanism,  the torque of the rotor has to be converted into conformational  rearrangements of the catalytic binding sites on the stator to allow  synthesis and release of ATP. The gamma subunit of the rotor plays a  central role in the energy conversion. The N-terminal helix alone is  able to fulfill the function of full-length gamma in ATP synthesis as  long as it connects to the rest of the rotor. This connection can occur  via the epsilon subunit. No direct contact between epsilon and the  gamma ring seems to be required. The epsilon subunit of the rotor  exists in two different conformations during ATP synthesis and ATP  hydrolysis. Reaction mechanism, overview <108>; #13# model of  mechanochemical coupling, overview <105>; #88# reaction mechanism and  structure-fucntion analysis, overview <110>;  #49,50,54,55,85,86,96,97,98,99,100,101,105,106,119,120,121,125,126,127#  reaction mechanism, cytoplasmic pH homeostasis and the problem it  creates for protonmotive force-driven ATP synthesis, adaptive  mechanisms, comparison of alkaliphiles and neutralophiles, detailed  overview <96>; #13# substrate modulation of multi-site activity of F1  is due to the substrate binding to the second catalytic site, bi-site  catalytic mechanism, effects of Mg2+, overview <93>)  "
7.1.3.1, diphosphate + H2O + H+[side 1] = 2 phosphate + H+[side 2]  
7.1.3.2, diphosphate + H2O + Na+[side 1] = 2 phosphate + Na+[side 2]  
7.2.1.1, NADH + H+ + ubiquinone + n Na+[side 1] = NAD+ + ubiquinol + n Na+[side  2]  
7.2.1.2, 2 reduced ferredoxin [iron-sulfur] cluster + NAD+ + H+ + Na+[side 1] =  2 oxidized ferredoxin [iron-sulfur] cluster + NADH + Na+[side 2]  
7.2.1.3," ascorbate[side 1] + Fe(III)[side 2] = monodehydroascorbate[side 1] +  Fe(II)[side 2] (#12,13,14,15,16,17,18# reaction mechanism <19,20>)  "
7.2.2.1, ATP + H2O + n Na+[side 1] = ADP + phosphate + n Na+[side 2]  
7.2.2.10," ATP + H2O + Ca2+[side 1] = ADP + phosphate + Ca2+[side 2] (#10#  mechanism <2>; #24# phosphoenzyme intermediate formation <25>; #4,5,8#  formation of a phosphorylated intermediate <17>; #10# Ca2+ and ATP bind  to the enzyme by a random mechanism, study of relationship between the  various conformations of the enzyme. The calcium binding increases the  spatial separation between the P and N domains. <27>; #2# the enzyme is  a Ca2+-dependent phosphoprotein intermediate <29>; #43# Ca2+ binding  site structure and mechanism <56>; #37# isozyme SPCA2 shows Ca2+- and  Mn2+-dependent phosphoprotein intermediate formation <46>; #4# kinetic  mechanism of isozymes SPCA1 and SPCA2, phosphorylated intermediate,  overview <49>; #10# reaction and kinetic mechanism, phosphorylated  intermediate, detailed overview <37>)  "
7.2.2.11, ATP + H2O + Ni2+-[nickel-binding protein][side 1] = ADP + phosphate +  Ni2+[side 2] + [nickel-binding protein][side 1]  
7.2.2.12," ATP + H2O + Zn2+[side 1] = ADP + phosphate + Zn2+[side 2] (#15# cadmium  and zinc are removed from cells by the CzcCBA efflux pump and by two  soft-metal-transporting P-type ATPases, CadA and ZntA. <11>; #8# HMA2  and HMA4 play essential roles in the homeostasis of Zn. <13>)  "
7.2.2.13," ATP + H2O + Na+[side 1] + K+[side 2] = ADP + phosphate + Na+[side 2] +  K+[side 1] (#2# formation of a phosphorylated intermediate <1>; #4#  reaction sequence and transport mechanism <14>; #12# the enzyme gamma  subunit is located adjacent to the M2-M6-M9 pocket of the alpha subunit  at the transmembrane-extracellular interface. During the E1 to E2  transition, there is no relative change in distance between the alpha  and gamma subunits but there is a relative change in distance between  the beta and gamma subunits <69>)  "
7.2.2.14," ATP + H2O + Mg2+[side 1] = ADP + phosphate + Mg2+[side 2] (#11# a  10-member Arabidopsis gene family, AtMGT for Arabidopsis thaliana  magnesium transport, encodes a Mg2+ transport system, CorA-like  proteins. <21>; #15# Three distinct families of prokaryotic Mg2+  transport proteins have been identified and cloned: MgtE, CorA and  MgtA/B. MgtA/B class of Mg2+ transporter are P-type ATPases. <19>; #15#  Three transporters mediate Mg2+-uptake, the P-type ATPases MgtA and  MgtB, whose expression is transcriptionally induced in low Mg2+ by the  Mg2+-regulated PhoP/PhoQ two-component system, and CorA, whose  transcription is regulated neither by the levels of Mg2+ nor by the  PhoP/PhoQ system. CorA modulates its activity in response to the  presence of PhoP-regulated gene products. <20>; #17# efflux system is  mediated by a ring of conserved aspartic residues at the cytoplasmic  entrance and a carbonyl funnel at the periplasmic side of the pore  <30>; #1,4,8,12,13,18,20,23,24,27,32# Mg2+ transport involves first the  binding of the fully hydrated ion to an extracellular binding loop  connecting the transmembrane domain, passage through the membrane, not  involving electrostatic interactions but two cytsolic domains, one with  extremely high positive charges and the other with negative charge  helping to control the Mg2+ flux in concert with an intracellular Mg2+  bound between the domains of each monomer, transport mechanism,  overview <35>; #24# Mg2+ transport mechanism, structure-function  relationship, overview <38>)  "
7.2.2.15, ATP + H2O + Ag+[side 1] = ADP + phosphate + Ag+[side 2]  
7.2.2.16, ATP + H2O + Fe3+-hydroxamate complex-[hydroxamate-binding protein][side  1] = ADP + phosphate + Fe3+-hydroxamate complex[side 2] +  [hydroxamate-binding protein][side 1] (#2# the FhuC protein contains  two ATP-binding domains <4>; #2# the periplasmic FhuD interacts with a  transmembrane segment and a cytoplasmic loop of the integral FhuB <7>)  
7.2.2.17, ATP + H2O + Fe3+-enterobactin complex-[enterobactin-binding  protein][side 1] = ADP + phosphate + Fe3+-enterobactin complex[side 2]  + [enterobactin-binding protein][side 1]  
7.2.2.18, ATP + H2O + Fe3+-dicitrate-[dicitrate-binding protein][side 1] = ADP +  phosphate + Fe3+-dicitrate[side 2] + [dicitrate-binding protein][side 1]  
7.2.2.19," ATP + H2O + H+[side 1] + K+[side 2] = ADP + phosphate + H+[side 2] +  K+[side 1] (#1,12# mechanistic modeling of the physiological events  linking subcellular processes to largescale patterning involving the  enzyme <60>; #4,5,6,7,11# orientation of the subunits in the membrane  towards cytoplasmic and periplasmic sides and reaction mechanism,  detailed overview <72>)  "
7.2.2.2, ATP + H2O + Cd2+[side 1] = ADP + phosphate + Cd2+[side 2]  
7.2.2.20, ATP + H2O + Zn2+-[zinc-binding protein][side 1] = ADP + phosphate +  Zn2+[side 2] + [zinc-binding protein][side 1]  
7.2.2.21," ATP + H2O + Cd2+[side 1] = ADP + phosphate + Cd2+[side 2] (#9# ATP  forms first a phosphoenzyme which transports the metal across the  membrane <7>; #16# metal binding environment comprises two conserved  Cys residues of the metal binding motif and a Glu in loop 5. function  of the N-terminus in the metal specificity of the enzyme <15>; #9#  reaction cycle involves two Cd2+ ions <14>; #16# Cys14, Cys17 and Glu61  involved in metal binding <15>)  "
7.2.2.22, ATP + H2O + Mn2+[side 1] = ADP + phosphate + Mn2+[side 2]  
7.2.2.3," ATP + H2O + n Na+[side 1] = ADP + phosphate + n Na+[side 2] (#13# CTA3  <22>; #19# efflux in the absence of external Na+ follows first order  kinetics <23>; #32# Ena1 gene plays a fundamental role in the salt  stress response <19>; #1,4,5,14,44# membrane bound ATPase. It splits  the energy-storing adenosine triphosphate, ATP, to yield adenosine  diphosphate, ADP, releasing inorganic phosphate, and moves three sodium  ions out of the cell in exchange for two potassium ions. The protein is  composed of three chains, the larges possessing many hydrophobic  sequences presumed to be transmembranal, the smallest, and the third,  involved in the pumpÂ´s regulation <21>; #33# the enzyme function is  triggered when the cells are suffering K+ starvation <18>)  "
7.2.2.4, ATP + H2O + n Na+[side 1] = ADP + phosphate + n Na+[side 2]  
7.2.2.5, ATP + H2O + Mn2+-[manganese-binding protein][side 1] = ADP + phosphate  + Mn2+[side 2] + [manganese-binding protein][side 1]  
7.2.2.6, ATP + H2O + K+[side 1] = ADP + phosphate + K+[side 2] (#2# catalytic  mechanism <22>)  
7.2.2.7, ATP + H2O + Fe3+-[iron-binding protein][side 1] = ADP + phosphate +  Fe3+[side 2] + [iron-binding protein][side 1]  
7.2.2.8, ATP + H2O + Cu+[side 1] = ADP + phosphate + Cu+[side 2]  
7.2.2.9, ATP + H2O + Cu2+[side 1] = ADP + phosphate + Cu2+[side 2] (#4# the  N-domain can not hydrolyse ATP <23>)  
7.2.4.1," a carboxybiotinyl-[protein] + n Na+[side 1] + H+[side 2] = CO2 + a  biotinyl-[protein] + n Na+[side 2] (#1# residue Asp2O3 in its  dissociated form binds Na+ and promotes its translocation, while the  protonated residue transfers the proton to the acid-labile  carboxybiotin which initiates its decarboxylation. Na+ transport by  oxaloacetate decarboxylation is accompanied by H+ transport in the  opposite direction <3>)  "
7.2.4.2," oxaloacetate = pyruvate + CO2 (#2# not <8>; #2# pyruvate + CO2 =  oxaloacetae <3,13>) "
7.2.4.2, oxaloacetate + 2 Na+[side 1] = pyruvate + CO2 + 2 Na+[side 2]  
7.2.4.3, (S)-methylmalonyl-CoA + Na+[side 1] + H+[side 2] = propanoyl-CoA + CO2  + Na+[side 2]  
7.2.4.4, malonate + H+ + Na+[side 1] = acetate + CO2 + Na+[side 2] (#2# reaction  does not involve intermediate formation of malonyl-CoA but proceeds  directly with free malonate. Catalytic mechanism involves exchange of  the enzyme-bound acetyl residues by malonyl residues and subsequent  decarboxylation releasing CO2 and regenerating the acetyl-enzyme.  Biotin is involved in catalysis <5>; #2# reaction takes place with  retention of configuration <7>)  
7.2.4.5," (2E)-4-carboxybut-2-enoyl-CoA + Na+[side 1] = (2E)-but-2-enoyl-CoA +  CO2 + Na+[side 2] (#6# stereochemistry <6>; #9# mechanism of  carboxy-transfer <11>; #7# energetics <10>; #6# mechanism, interaction  of subunits <9>)  "
7.3.2.1, ATP + H2O + phosphate-[phosphate-binding protein][side 1] = ADP +  phosphate + phosphate[side 2] + [phosphate-binding protein][side 1]  
7.3.2.2, ATP + H2O + phosphonate-[phosphonate-binding protein][side 1] = ADP +  phosphate + phosphonate[side 2] + [phosphonate-binding protein][side 1]  
7.3.2.3, ATP + H2O + sulfate-[sulfate-binding protein][side 1] = ADP + phosphate  + sulfate[side 2] + [sulfate-binding protein][side 1]  
7.3.2.4," ATP + H2O + nitrate-[nitrate-binding protein][side 1] = ADP + phosphate  + nitrate[side 2] + [nitrate-binding protein][side 1] (#13#  phosphorylated His-tagged NrtA1 specifically binds both nitrite and  nitrate with high affinity and appears to be saturated at anion  concentrations higher than 0.04 mM at pH 8.0 and 45Â°C <9>; #18# efflux  transporter coupled to the ATP-dependent H+ pumping activity,  transports intracellular nitrate through the membrane out of the cell  <13>)  "
7.3.2.5, ATP + H2O + molybdate-[molybdate-binding protein][side 1] = ADP +  phosphate + molybdate[side 2] + [molybdate-binding protein][side 1]  
7.3.2.6, ATP + H2O + tungstate-[tungstate-binding protein][side 1] = ADP +  phosphate + tungstate[side 2] + [tungstate-binding protein][side 1]  
7.3.2.7, ATP + H2O + arsenite[side 1] = ADP + phosphate + arsenite[side 2]  
7.4.2.1, ATP + H2O + polar amino acid-[polar amino acid-binding protein][side 1]  = ADP + phosphate + polar amino acid[side 2] + [polar amino  acid-binding protein][side 1]  
7.4.2.10, ATP + H2O + glutathione-[glutathione-binding protein][side 1] = ADP +  phosphate + glutathione[side 2] + [glutathione-binding protein][side 1]  
7.4.2.11, ATP + H2O + L-methionine-[methionine-binding protein][side 1] = ADP +  phosphate + L-methionine[side 2] + [methionine-binding protein][side 1] 
7.4.2.11, ATP + H2O + D-methionine-[methionine-binding protein][side 1] = ADP +  phosphate + D-methionine[side 2] + [methionine-binding protein][side 1]  
7.4.2.12, ATP + H2O + L-cystine-[cystine-binding protein][side 1] = ADP +  phosphate + L-cystine[side 2] + [cystine-binding protein][side 1] 
7.4.2.12, ATP + H2O + D-cystine-[cystine-binding protein][side 1] = ADP +  phosphate + D-cystine[side 2] + [cystine-binding protein][side 1]  
7.4.2.13, ATP + H2O + L-tyrosinyl-[tyrosine-binding protein][side 1] = ADP +  phosphate + L-tyrosine[side 2] + [tyrosine-binding protein][side 1]  
7.4.2.14," ATP + H2O + antigen peptide[side 1] = ADP + phosphate + antigen  peptide[side 2] (#2,3,4# the hydrolysis cycle starts with ATP binding  to monomeric NBDs, followed by dimerization and sequential hydrolysis  of both ATP molecules. After ATP hydrolysis and phosphate release, the  dimer disengages and ADP is replaced by new ATP, reaction mechanism,  detailed overview <1>)  "
7.4.2.2, ATP + H2O + nonpolar amino acid-[nonpolar amino acid-binding  protein][side 1] = ADP + phosphate + nonpolar amino acid[side 2] +  [nonpolar amino acid-binding protein][side 1]  
7.4.2.3," ATP + H2O + mitochondrial-protein[side 1] = ADP + phosphate +  mitochondrial-protein[side 2] (#5# model for efficient translocation  across the mitochondrial inner membrane through regulated interactions  <10>; #12# the mitochondrial Hsp70 chaperone Ssc1 requires the Hsp70  escort protein Hep1, an L-shaped matrix protein with a zinc finger  motif <39>)  "
7.4.2.4," ATP + H2O + chloroplast-protein[side 1] = ADP + phosphate +  chloroplast-protein[side 2] (#3# interaction of transit peptide with  translocation apparatus, identification of a chloroplast-binding  intermediate <12>)  "
7.4.2.5, ATP + H2O + protein[side 1] = ADP + phosphate + protein[side 2]  
7.4.2.6, ATP + H2O + oligopeptide-[oligopeptide-binding protein][side 1] = ADP +  phosphate + oligopeptide[side 2] + [oligopeptide-binding protein][side  1]  
7.4.2.7, ATP + H2O + alpha-factor[side 1] = ADP + phosphate + alpha-factor[side  2]  
7.4.2.8," ATP + H2O + cellular protein[side 1] = ADP + phosphate + cellular  protein[side 2] (#6# analysis of protein-protein interactions of type  III secretion apparatus, direct interactions between chaperone,  effector, and type III component, model of translocation <22>; #1#  isolation of intermediate export complex containing chaperone,  substrate, FliI ATPase and regulator FliH, complex of chaperone and  substrate is required for interaction with ATPase <27>; #1# model of  domain construction and complex of subunits <26>)  "
7.4.2.9, ATP + H2O + a dipeptide-[dipeptide-binding protein][side 1] = ADP +  phosphate + a dipeptide[side 2] + [dipeptide-binding protein][side 1]  
7.5.2.1, ATP + H2O + maltose-[maltose-binding protein][side 1] = ADP + phosphate  + maltose[side 2] + [maltose-binding protein][side 1]  
7.5.2.10, ATP + H2O + D-xylose-[xylose-binding protein][side 1] = ADP + phosphate  + D-xylose[side 2] + [xylose-binding protein][side 1]  
7.5.2.11, ATP + H2O + D-galactose-[galactose-binding protein][side 1] = ADP +  phosphate + D-galactose[side 2] + [galactose-binding protein][side 1]  
7.5.2.12, ATP + H2O + L-arabinose-[arabinose-binding protein][side 1] = ADP +  phosphate + L-arabinose[side 2] + [arabinose-binding protein][side 1]  
7.5.2.13, ATP + H2O + D-xylose-[xylose-binding protein][side 1] = ADP + phosphate  + D-xylose[side 2] + [xylose-binding protein][side 1] (#3# (1) <1>) 
7.5.2.13, ATP + H2O + L-arabinose-[arabinose-binding protein][side 1] = ADP +  phosphate + L-arabinose[side 2] + [arabinose-binding protein][side 1]  (#3# (2) <1>)  
7.5.2.2, ATP + H2O + oligosaccharide-[oligosaccharide-binding protein][side 1] =  ADP + phosphate + oligosaccharide[side 2] + [oligosaccharide-binding  protein][side 1]  
7.5.2.3, ATP + H2O + beta-glucan[side 1] = ADP + phosphate + beta-glucan[side 2]  
7.5.2.4, ATP + H2O + teichoic acid[side 1] = ADP + phosphate + teichoic  acid[side 2]  
7.5.2.5," ATP + H2O + lipopolysaccharide[side 1] = ADP + phosphate +  lipopolysaccharide[side 2] (#3,4,5# LptB2FG tetramer mechanism: 1.  Resting: the LptB nucleotide-binding sites are unoccupied, and the  LptF/G cavity is oriented inwards. 2. Open: ATP binds LptB, inducing  the LptF/G cavity to open away from the IM, and receives the Lipid A  moiety of LPS, which is still embedded in the IM. 3. Close: LptB  hydrolyzes ATP, inducing the LptF/G cavity to close again. LPS is  forced out of the IM into the periplasm <4>)  "
7.5.2.6," ATP + H2O + lipopolysaccharide[side 1] = ADP + phosphate +  lipopolysaccharide[side 2] (#3# spin labeling and electron paramagnetic  resonance spectroscopy are used to systematically explore  rearrangements in MsbA structure during the ATP hydrolysis cycle.  Spin-label accessibility and local dynamics are determined in liposomes  for the nucleotide-free intermediate and the transition state of ATP  hydrolysis. The changes in the electron paramagnetic resonance  parameters between these two intermediates fit a global pattern  consistent with alternating access of the chamber. In the transition  state of ATP hydrolysis, spin labels on the cytoplasmic side report  increase dynamic restrictions and reduce water accessibility, while  those on the extracellular side report increase water penetration <7>) "
7.5.2.6, ATP + H2O + lipid A-core oligosaccharide[side 1] = ADP + phosphate +  lipid A-core oligosaccharide[side 2] (#8# ion coupling is a part of the  mechanism of the homodimeric ABC transporter MsbA <27>)  
7.5.2.7, ATP + H2O + D-ribose-[ribose-binding protein][side 1] = ADP + phosphate  + D-ribose[side 2] + [ribose-binding protein][side 1]  
7.5.2.8, ATP + H2O + D-allose-[allose-binding protein][side 1] = ADP + phosphate  + D-allose[side 2] + [allose-binding protein][side 1]  
7.5.2.9, ATP + H2O + D-galactofuranose-[galactofuranose-binding protein][side 1]  = ADP + phosphate + D-galactofuranose[side 2] +  [galactofuranose-binding protein][side 1]  
7.6.2.1," ATP + H2O + phospholipid [side 1] = ADP + phosphate + phospholipid  [side 2] (#6,35# P-type ATPase <3,11>; #9# The Cdc50p/Lem3p family  comprises a set of subunits specific to phospholipid-translocating  P-type ATPases. Cdc50p physically associates with Drs2p. Cds50p forms a  complex with Drs2p, whereas Lem3p forms a complex with Dnf1p in vivo.  The Cdc50p-Drs2p complex possesses aminophospholipid translocase  activity, which translocates aminophospholipids more efficiently than  phosphatidylcholine. <20>)  "
7.6.2.10, ATP + H2O + sn-glycerol 3-phosphate-[glycerol 3-phosphate-binding  protein][side 1] = ADP + phosphate + sn-glycerol 3-phosphate[side 2] +  [glycerol 3-phosphate-binding protein][side 1]  
7.6.2.11, ATP + H2O + polyamine-[polyamine-binding protein][side 1] = ADP +  phosphate + polyamine[side 2] + [polyamine-binding protein][side 1]  
7.6.2.12, ATP + H2O + capsular polysaccharide-[capsular polysaccharide-binding  protein][side 1] = ADP + phosphate + capsular polysaccharide[side 2] +  [capsular polysaccharide-binding protein][side 1] (#2# mechanism of ATP  hydrolysis and interaction of subunits <10>)  
7.6.2.13," ATP + H2O +  (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-[AI-2-binding  protein][side 1] = ADP + phosphate +  (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran[side 2] +  [AI-2-binding protein][side 1]  "
7.6.2.14, ATP + H2O + aliphatic sulfonate-[sulfonate-binding protein][side 1] =  ADP + phosphate + aliphatic sulfonate[side 2] + [sulfonate-binding  protein][side 1]  
7.6.2.15, ATP + H2O + thiamine-[thiamine-binding protein][side 1] = ADP +  phosphate + thiamine[side 2] + [thiamine-binding protein][side 1]  
7.6.2.16, ATP + H2O + putrescine-[putrescine-binding protein][side 1] = ADP +  phosphate + putrescine[side 2] + [putrescine-binding protein][side 1]  
7.6.2.2," ATP + H2O + xenobiotic[side 1] = ADP + phosphate + xenobiotic[side 2]  (#1,10# mechanism <24,25>; #6# ABC-type, ATP-binding cassette-type,  ATPase, characterized by the presence of two similar ATP-binding  domains, does not undergo phosphorylation during the transport process,  enzymes of Gram-positive bacteria and eukaryotic cells that export a  number of drugs, with unusual specificity, covering various groups of  unrelated substances, while ignoring some that are closely related  structurally, several distinct enzymes may be present in a single  eukaryotic cell, many of them transport glutathione conjugates with  drugs, some also show some flippase, Mg2+-ATPase, EC 3.6.3.1, activity  <27>; #6# positive cooperativity mechanism <26>; #1,10# thermodynamic  data of ATP hydrolysis, mechanism <34>; #10# the high to low affinity  switch in the transport substrate binding site is due to the formation  of the E-S reaction intermediate of the ATPase reaction. The  posthydrolysis E-P state continues to have low affinity for substrate,  suggesting that conformational changes that form the E-S complex are  coupled to the conformational change at the transport substrate site to  do mechanical work. The formation of E-S reaction intermediate during a  single turnover of the catalytic cycle appears to provide the initial  power stroke for movement of drug substrate from inner leaflet to outer  leaflet of lipid bilayer <64>; #10# P-gp mediated-transport mechanism,  overview <80>; #62# the structure of Sav1866 reveals that tight  interaction of the nucleotide-binding domains in the ATP-bound state is  coupled to the outward-facing conformation of the transmembrane  domains. In this conformation, bound substrates may escape into the  outer leaflet of the lipid bilayer or into the aqueous medium  surrounding the cell, depending on their hydrophobicity. Hydrolysis of  ATP is expected to return the transporter to an inward-facing  conformation, again granting access to the binding site from the cell  interior. ABC transporters may thus use an alternating access and  release mechanism first postulated for major facilitator transport  proteins, with the distinction that ATP binding and hydrolysis, rather  than substrate acquisition, may control the conversion of one state  into the other <194>)  "
7.6.2.3, ATP + H2O + glutathione-S-conjugate[side 1] = ADP + phosphate +  glutathione-S-conjugate[side 2]  
7.6.2.4," ATP + H2O + fatty acyl CoA[side 1] = ADP + phosphate + fatty acyl  CoA[side 2] (#4# ALDP exhibits an affinity to both ADP and ATP, ALDRP  exhibits an affinity to ADP but scarcely to ATP <16>)  "
7.6.2.5, ATP + H2O + heme[side 1] = ADP + phosphate + heme[side 2]  
7.6.2.6, ATP + H2O + guanine[side 1] = ADP + phosphate + guanine[side 2]  
7.6.2.7, ATP + H2O + taurine-[taurine-binding protein][side 1] = ADP + phosphate  + taurine[side 2] + [taurine-binding protein][side 1]  
7.6.2.8," ATP + H2O + vitamin B12-[cobalamin-binding protein][side 1] = ADP +  phosphate + vitamin B12[side 2] + [cobalamin-binding protein][side 1]  (#7# the translocation gates of the BtuCDF complex undergo  conformational changes in line with a two-state alternating access  model. Binding of ATP drives the gates to an inward-facing  conformation. Following ATP hydrolysis, the translocation gates restore  to an apo-like conformation. In the presence of ATP, an excess of  vitamin B12 promotes the reopening of the gates toward the periplasm  and the dislodgement of BtuF from the transporter <21>; #10# the  substrate resides in a different place than the BtuF-binding pocket.  Upon binding and hydrolysis of ATP, the complex returns to state III.  The transporter can cycle multiple times between states III and IV  without releasing vitamin B12, resulting in a much higher ATPase rate  than transport rate. This cycling is equivalent to the cycling between  states I and II in the absence of substrate. Occasionally, a vitamin  B12 molecule is released on the cytoplasmic side of the membrane via a  proposed intermediate state. When the binding location becomes vacant,  a new vitamin B12 molecule is bound rapidly. ATPase activity and  transport are uncoupled and ATP hydrolysis is continuously required to  (unproductively) reset the transporter <33>; #10# transport mechanism,  model building showing the substantial conformational changes to  catalyze the translocation of their substrates across biological  membranes, overview. The transport cycle of BtuCD-F can be divided into  a futile cycle in the absence of the substrate-binding protein and a  productive cycle in the presence of vitamin B12-loaded  substrate-binding protein <32>)  "
7.6.2.9," ATP + H2O + quaternary amine-[quaternary amine-binding protein][side 1]  = ADP + phosphate + quaternary amine[side 2] + [quaternary  amine-binding protein][side 1] (#3# a single substrate binding domain  per dimeric translocator complex is sufficient and minimally needed for  transport. Within the complex with two substrate binding domains, the  two domains interact in a cooperative manner and enhance the transport  capacity <11>; #3# busA locus encodes the glycine betaine uptake  system, which expression is reduced by overexpression of busR gene  encoding a DNA binding protein <14>; #1# OpuA is an osmoprotectant  uptake system which imports glycine and betaine. It consists of three  components, the ATPase OpuAA, the integral membrane protein OpuAB and  the extracellular substrate binding domain OpuAC. The ABC transporter  couples ATP hydrolysis with substrate translocation across the membrane  in a vectorial manner <12>; #3# the mechanistica stoichiometry is 2  <13>; #3# the osmotic activation of the transporter is set by the bulk  charge in the lipid headgroup region of the membrane, indicating that  electrostatic interactions between lipids and the transporter are  intrinsic to the osmosensing mechanism <10>)  "
